data_2gva_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gva _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.483 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.326 0.584 . . . . 64.91 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.55 ' HA ' ' CD2' ' B' ' 65' ' ' LEU . 5.5 mt -72.56 78.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.238 -1.023 . . . . 33.8 108.238 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 23.0 mttp -61.85 172.26 1.37 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.715 0.769 . . . . 32.72 111.371 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 5' ' ' GLU . 23.0 t -168.23 168.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.861 -0.792 . . . . 14.46 108.861 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.568 ' N ' ' CG1' ' A' ' 4' ' ' VAL . 23.4 mt-10 -147.04 104.29 3.67 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.679 -0.859 . . . . 22.12 108.679 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -69.36 104.34 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.912 -1.144 . . . . 14.23 107.912 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.653 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.47 171.13 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.083 -1.011 . . . . 25.43 109.665 -179.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.7 Cg_endo -76.32 -24.22 11.0 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.562 2.174 . . . . 13.61 109.899 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -94.21 4.29 54.09 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.553 -0.717 . . . . 15.52 109.258 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.518 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 10.6 mm-40 -117.52 34.1 5.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.27 -0.894 . . . . 17.31 109.372 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -95.4 11.34 33.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 24.78 110.182 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 16.3 mt-30 -138.86 132.76 31.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.007 . . . . 47.9 110.056 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.594 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 11.4 p90 -83.19 -178.36 7.07 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.402 -0.811 . . . . 21.61 109.915 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -130.4 144.67 51.54 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.752 -0.593 . . . . 14.89 109.404 179.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 17.35 109.222 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.498 ' CD2' ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.451 0.643 . . . . 24.0 109.946 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.594 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -106.07 133.27 51.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.399 -0.813 . . . . 23.31 109.342 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.81 151.76 29.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.076 -1.015 . . . . 40.03 109.62 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.527 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -133.62 -166.77 1.83 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.125 -0.984 . . . . 12.39 109.56 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -136.28 169.5 17.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.88 . . . . 17.42 109.934 -179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -158.74 164.68 35.65 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.211 -1.033 . . . . 13.84 108.211 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.656 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.8 m-85 -121.24 109.69 15.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.987 -1.07 . . . . 21.14 110.04 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.555 ' CG2' HG21 ' A' ' 4' ' ' VAL . 29.7 t -95.49 143.08 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 10.66 109.466 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -130.89 -24.56 2.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.146 -0.972 . . . . 25.89 110.76 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -45.96 -16.4 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.972 -1.08 . . . . 24.24 111.384 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.586 ' N ' ' CD2' ' A' ' 37' ' ' LEU . . . -120.19 16.28 10.01 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 108.206 -1.957 . . . . 31.02 108.206 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 36' ' ' ASP . 1.3 p30 -178.02 115.96 0.08 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.706 -0.879 . . . . 43.23 108.828 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 39' ' ' ASN . 1.2 mp0 -36.95 -63.47 0.42 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.66 0.743 . . . . 42.34 109.978 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.8 155.87 68.52 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.449 -0.945 . . . . 3.98 108.449 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.656 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.5 Cg_endo -77.95 141.31 18.86 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.923 1.749 . . . . 17.92 109.936 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 35' ' ' VAL . 29.3 m -113.72 115.33 49.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.316 -0.865 . . . . 20.57 108.957 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 54.6 tp -67.71 107.99 2.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.423 -0.798 . . . . 20.21 109.545 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.502 ' CG1' ' SG ' ' A' ' 33' ' ' CYS . 8.9 p -111.2 163.31 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.476 -0.765 . . . . 10.81 109.324 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 160.84 22.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 36.74 110.232 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.595 HD11 ' CE1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -156.31 119.68 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.798 -0.816 . . . . 19.74 108.798 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.507 ' N ' HD12 ' A' ' 47' ' ' ILE . 1.3 m -60.17 156.03 16.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.984 -1.072 . . . . 22.56 109.757 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -131.95 109.81 10.32 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.977 -0.749 . . . . 20.41 108.977 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.521 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -63.88 145.71 55.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 33.99 109.654 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HG2' ' N ' ' A' ' 52' ' ' GLY . 28.9 tt0 -43.51 -87.67 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.258 -0.901 . . . . 54.92 109.661 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.498 ' N ' ' HG2' ' A' ' 51' ' ' GLU . . . -41.06 -39.07 1.93 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.889 -1.284 . . . . 36.1 109.889 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.533 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -64.11 126.11 89.51 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.095 -1.238 . . . . 54.76 109.34 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.0 Cg_endo -79.62 144.86 17.93 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.401 2.067 . . . . 28.37 110.4 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.479 ' HA ' HD22 ' A' ' 49' ' ' LEU . . . -40.21 146.02 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.396 -0.815 . . . . 17.21 110.169 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.595 ' CE1' HD11 ' A' ' 47' ' ' ILE . 87.4 m-85 -53.82 111.42 0.74 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.297 -0.877 . . . . 17.19 109.222 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.574 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . . . -66.32 -178.85 0.34 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.426 -0.796 . . . . 17.82 109.528 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -78.12 131.79 11.11 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.49 2.127 . . . . 17.28 110.588 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.632 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 153.91 143.01 3.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.15 -1.58 . . . . 17.22 109.15 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 59' ' ' GLY . 3.8 mp -44.77 138.93 3.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.908 -1.348 . . . . 19.57 109.489 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.632 ' CD1' ' O ' ' A' ' 59' ' ' GLY . 17.9 m-85 -119.09 164.18 15.9 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.521 1.153 . . . . 14.61 111.497 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.493 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 48.0 p -145.88 122.76 11.3 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.514 -1.661 . . . . 18.36 106.514 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 1.7 t -60.58 162.67 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 C-N-CA 118.427 -1.309 . . . . 19.13 108.72 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -120.77 130.41 54.01 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.43 -0.794 . . . . 20.65 109.248 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.676 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -73.29 2.81 6.73 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.474 -0.766 . . . . 19.65 109.828 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -19.21 11.71 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.101 -1.444 . . . . 14.72 107.101 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.509 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 1.4 m -96.29 -6.23 38.33 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.134 -0.485 . . . . 11.45 110.391 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.2 m-30 -86.43 161.63 18.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.89 -1.131 . . . . 14.25 110.021 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -144.94 164.78 30.08 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.022 -0.733 . . . . 32.7 109.022 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.445 ' CG1' HG22 ' B' ' 43' ' ' VAL . 1.8 t -120.97 129.1 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 15.63 109.498 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.2 -151.52 22.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.36 -1.496 . . . . 12.7 109.36 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 0.5 OUTLIER 51.93 68.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -1.145 . . . . 26.29 109.211 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 71.07 5.62 5.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.836 . . . . 20.44 109.367 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' HG21 ' B' ' 45' ' ' VAL . . . 86.87 46.52 5.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.523 -1.431 . . . . 13.82 109.523 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.413 ' HB2' ' HE1' ' A' ' 77' ' ' MET . 57.7 m -125.0 116.45 22.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -1.126 . . . . 18.27 109.635 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.6 OUTLIER -59.22 147.15 36.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 12.43 109.129 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 37.8 mtt -160.12 132.32 6.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 35.11 109.725 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.598 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.7 mp -67.16 140.16 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.373 -0.829 . . . . 13.67 109.826 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 8.8 t70 -107.61 -10.27 15.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.324 -0.86 . . . . 24.06 108.962 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.509 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 163.94 67.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.897 -1.52 . . . . 35.04 106.897 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.601 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -31.66 118.73 0.23 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.323 -0.853 . . . . 18.72 112.199 -177.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.508 ' NH1' ' HG3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -91.9 109.87 21.21 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.229 -1.026 . . . . 20.55 108.229 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.8 OUTLIER -75.63 155.19 36.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.205 -0.934 . . . . 14.4 111.382 -178.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 83' ' ' LEU . 35.6 m -159.89 148.95 14.02 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 107.866 -1.161 . . . . 17.65 107.866 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 22.8 Cg_endo -61.5 139.3 81.14 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.99 1.794 . . . . 25.7 110.503 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.489 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -65.66 118.1 9.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -0.921 . . . . 49.29 109.698 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.414 ' C ' ' HD3' ' A' ' 87' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.033 -0.984 . . . . 58.91 109.526 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.482 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.314 0.578 . . . . 64.91 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.554 HG12 ' CB ' ' A' ' 65' ' ' LEU . 5.5 mt -72.97 78.15 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.267 -1.012 . . . . 33.8 108.267 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.602 ' N ' ' CD1' ' B' ' 37' ' ' LEU . 23.0 mttp -61.72 172.22 1.34 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.759 0.79 . . . . 32.72 111.33 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' B' ' 5' ' ' GLU . 23.1 t -168.2 168.44 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.85 -0.796 . . . . 14.46 108.85 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.573 ' N ' ' CG1' ' B' ' 4' ' ' VAL . 23.5 mt-10 -147.15 104.21 3.65 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.726 -0.842 . . . . 22.12 108.726 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.586 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -69.34 104.08 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.962 -1.125 . . . . 14.23 107.962 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.66 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.24 171.11 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.957 . . . . 25.43 109.682 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -76.36 -24.27 10.89 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.474 2.116 . . . . 13.61 109.847 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -94.12 4.1 54.37 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.521 -0.737 . . . . 15.52 109.224 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.508 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 10.5 mm-40 -117.25 33.95 5.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.262 -0.899 . . . . 17.31 109.377 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -95.18 11.3 32.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 24.78 110.209 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.427 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 16.2 mt-30 -138.82 132.88 31.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 47.9 110.088 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.603 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 11.4 p90 -83.26 -178.29 7.03 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.408 -0.807 . . . . 21.61 109.93 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 0.6 OUTLIER -130.48 144.65 51.54 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.738 -0.601 . . . . 14.89 109.426 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.461 0 O-C-N 121.29 -0.882 . . . . 17.35 109.199 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.501 ' CD2' ' CG2' ' B' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.486 0.66 . . . . 24.0 109.919 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.603 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -106.03 133.27 51.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.398 -0.813 . . . . 23.31 109.298 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.79 151.98 29.7 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.037 -1.039 . . . . 40.03 109.573 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.527 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -133.75 -166.78 1.83 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 12.39 109.573 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.0 OUTLIER -136.24 169.57 17.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.234 -0.916 . . . . 17.42 109.949 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -158.87 164.69 35.49 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.177 -1.046 . . . . 13.84 108.177 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.66 ' CD2' ' CD ' ' B' ' 7' ' ' LYS . 22.4 m-85 -121.29 109.75 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 21.14 109.989 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.555 ' CG1' HD12 ' B' ' 37' ' ' LEU . 31.0 t -95.64 143.05 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 10.66 109.446 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' B' ' 36' ' ' ASP . 0.5 OUTLIER -130.9 -24.51 2.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 25.89 110.8 -179.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -46.21 -16.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.002 -1.061 . . . . 24.24 111.38 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.588 ' N ' ' CD2' ' B' ' 37' ' ' LEU . . . -120.15 16.09 10.06 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 108.208 -1.957 . . . . 31.02 108.208 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' B' ' 36' ' ' ASP . 1.3 p30 -177.9 116.03 0.08 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.686 -0.891 . . . . 43.23 108.833 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' B' ' 39' ' ' ASN . 1.1 mp0 -36.91 -63.46 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.679 0.752 . . . . 42.34 110.015 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.88 155.91 69.07 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 108.438 -0.949 . . . . 3.98 108.438 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.654 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.6 Cg_endo -77.93 141.27 18.87 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.939 1.759 . . . . 17.92 109.894 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' B' ' 34' ' ' TYR . 29.3 m -113.78 115.33 49.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.273 -0.892 . . . . 20.57 108.874 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.595 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 54.4 tp -67.59 107.9 2.68 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.397 -0.815 . . . . 20.21 109.603 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.505 ' CG1' ' SG ' ' B' ' 33' ' ' CYS . 8.9 p -111.09 163.27 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.52 -0.737 . . . . 10.81 109.369 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 160.83 21.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 36.74 110.261 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.597 HD11 ' CE1' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -156.2 119.67 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 108.801 -0.814 . . . . 19.74 108.801 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.501 ' CG2' ' CD2' ' B' ' 28' ' ' LEU . 1.3 m -60.23 155.64 17.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.027 . . . . 22.56 109.732 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -131.55 109.85 10.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 20.41 108.982 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -63.83 145.76 55.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 33.99 109.692 -179.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' B' ' 52' ' ' GLY . 28.9 tt0 -43.66 -87.63 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.305 -0.872 . . . . 54.92 109.629 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.493 ' N ' ' HG2' ' B' ' 51' ' ' GLU . . . -41.19 -38.83 1.97 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.852 -1.299 . . . . 36.1 109.852 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.536 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -64.29 126.15 89.8 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.07 -1.253 . . . . 54.76 109.336 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.9 Cg_endo -79.61 144.86 17.94 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.417 2.078 . . . . 28.37 110.421 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.465 ' HA ' HD22 ' B' ' 49' ' ' LEU . . . -40.16 145.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -0.825 . . . . 17.21 110.308 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.597 ' CE1' HD11 ' B' ' 47' ' ' ILE . 87.4 m-85 -53.35 111.73 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 17.19 109.16 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.567 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -67.16 -178.94 0.39 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.389 -0.82 . . . . 17.82 109.594 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.4 Cg_endo -77.71 130.38 10.61 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.458 2.105 . . . . 17.28 110.358 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.635 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 155.94 143.0 3.55 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.205 -1.558 . . . . 17.22 109.205 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 59' ' ' GLY . 3.6 mp -45.43 138.34 4.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.426 . . . . 19.57 109.177 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' B' ' 59' ' ' GLY . 20.0 m-85 -118.43 164.26 15.52 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.49 1.138 . . . . 14.61 111.407 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.499 ' CG2' ' HA ' ' B' ' 86' ' ' ALA . 48.9 p -145.9 122.84 11.34 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 106.386 -1.709 . . . . 18.36 106.386 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.611 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 1.6 t -60.44 163.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 C-N-CA 118.448 -1.301 . . . . 19.13 108.719 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.492 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -121.62 130.3 53.39 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.475 -0.765 . . . . 20.65 109.33 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.64 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.9 OUTLIER -73.13 2.77 6.52 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.492 -0.755 . . . . 19.65 109.889 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.29 -18.97 12.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.126 -1.435 . . . . 14.72 107.126 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 1.4 m -96.35 -6.93 36.51 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 116.132 -0.485 . . . . 11.45 110.416 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.64 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.1 m-30 -85.97 161.25 19.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.851 -1.156 . . . . 14.25 109.958 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -144.57 165.1 28.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.74 . . . . 32.7 109.014 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -121.08 129.2 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 15.63 109.506 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.0 -151.66 22.36 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.333 -1.507 . . . . 12.7 109.333 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.6 OUTLIER 52.0 68.86 0.74 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -1.181 . . . . 26.29 109.228 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.2 OUTLIER 71.22 5.73 5.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 20.44 109.34 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.74 46.56 5.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.558 -1.417 . . . . 13.82 109.558 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.414 ' HB2' ' HE1' ' B' ' 77' ' ' MET . 57.7 m -125.15 116.34 21.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -1.129 . . . . 18.27 109.696 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.534 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.6 OUTLIER -59.05 147.05 36.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 12.43 109.212 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.534 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 37.5 mtt -160.08 132.51 6.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.923 . . . . 35.11 109.643 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.605 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.7 mp -67.37 140.24 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 13.67 109.839 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 8.6 t70 -107.51 -10.27 15.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.367 -0.833 . . . . 24.06 108.966 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.0 OUTLIER 163.89 67.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.923 -1.51 . . . . 35.04 106.923 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.611 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -31.76 118.75 0.24 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.253 -0.885 . . . . 18.72 112.182 -177.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.509 ' NH1' ' HG3' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -91.88 109.94 21.28 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.194 -1.039 . . . . 20.55 108.194 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.582 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -75.65 155.28 35.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.17 -0.956 . . . . 14.4 111.384 -178.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' B' ' 83' ' ' LEU . 35.6 m -159.98 149.21 14.14 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 107.807 -1.183 . . . . 17.65 107.807 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 23.5 Cg_endo -61.76 139.13 78.74 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.024 1.816 . . . . 25.7 110.545 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.499 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -65.49 118.07 8.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 49.29 109.6 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' B' ' 87' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.95 -1.024 . . . . 58.91 109.429 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.528 ' SD ' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.461 0.648 . . . . 64.91 109.493 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.571 ' CG2' HD11 ' B' ' 65' ' ' LEU . 3.9 mt -78.55 77.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.7 -1.222 . . . . 33.8 107.7 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -67.39 167.39 12.68 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.011 0.91 . . . . 32.72 110.848 -178.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.53 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -177.44 160.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.501 -0.926 . . . . 14.46 108.501 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 29.8 mt-10 -134.2 114.65 13.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.67 0.748 . . . . 22.12 109.004 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.583 HD12 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -73.74 99.28 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.788 -1.19 . . . . 14.23 107.788 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.635 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -43.95 169.92 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.335 -0.853 . . . . 25.43 109.925 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 32.5 Cg_endo -74.42 -28.31 10.4 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.469 2.112 . . . . 13.61 110.024 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.96 8.78 41.74 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.826 -0.805 . . . . 15.52 108.826 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.528 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 5.6 mm100 -125.91 22.32 7.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 17.31 109.87 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -95.77 15.23 20.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.105 -0.997 . . . . 24.78 110.162 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 60.7 mt-30 -134.9 141.09 46.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.127 -0.983 . . . . 47.9 109.754 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.625 ' CE1' ' ND2' ' A' ' 29' ' ' ASN . 45.1 p90 -93.96 153.91 17.95 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.3 -0.875 . . . . 21.61 109.32 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 m -113.11 150.45 32.11 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.331 -0.856 . . . . 14.89 108.92 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.487 0 O-C-N 121.289 -0.882 . . . . 17.35 109.541 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.444 HD13 ' HG3' ' A' ' 30' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.435 0.636 . . . . 24.0 110.094 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.625 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 67.4 m-20 -72.21 151.1 43.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.372 -0.83 . . . . 23.31 109.533 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.444 ' HG3' HD13 ' A' ' 28' ' ' LEU . 1.4 mt-10 -134.61 132.64 39.27 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.699 -0.852 . . . . 40.03 108.699 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.523 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -123.41 -174.1 2.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.071 -1.018 . . . . 12.39 110.02 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.7 mp -143.6 152.85 41.9 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.853 -0.795 . . . . 17.42 108.853 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -152.82 -177.67 6.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.974 -1.121 . . . . 13.84 107.974 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.681 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.0 m-85 -129.6 99.62 5.23 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.031 -1.043 . . . . 21.14 109.937 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.5 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 60.6 t -95.24 113.65 30.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.089 -1.007 . . . . 10.66 109.462 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 5.3 t70 -62.46 -28.48 69.85 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.199 -0.938 . . . . 25.89 108.572 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.509 ' CD2' ' HA ' ' B' ' 69' ' ' LYS . 0.7 OUTLIER 46.23 25.26 0.34 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.467 -0.77 . . . . 24.24 109.458 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.07 81.67 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.818 -1.313 . . . . 31.02 109.818 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 64.3 m-20 -86.08 15.21 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -1.209 . . . . 43.23 110.225 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 9.6 mt-10 60.73 11.52 3.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.311 -0.868 . . . . 42.34 110.36 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 71.3 m80 -161.18 152.68 16.01 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.046 -1.094 . . . . 6.37 108.046 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.681 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -75.76 136.59 19.08 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.873 1.715 . . . . 17.92 110.397 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 4.5 m -110.84 118.19 56.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.43 -0.793 . . . . 20.57 109.0 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 45.5 tp -73.22 104.48 4.28 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.351 -0.843 . . . . 20.21 110.255 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.531 HG13 ' CG1' ' B' ' 70' ' ' VAL . 32.6 m -108.46 -177.2 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.527 -0.916 . . . . 10.81 108.527 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.22 154.56 22.23 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.007 -1.077 . . . . 36.74 110.257 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.601 HG13 ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -127.18 170.1 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 109.029 -0.73 . . . . 19.74 109.029 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.523 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 3.6 m -123.01 124.0 42.16 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.356 -0.84 . . . . 22.56 108.808 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.59 ' CB ' ' CB ' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -102.53 163.83 12.0 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.331 -0.856 . . . . 20.41 109.331 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.43 167.68 9.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.897 . . . . 33.99 109.54 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -72.86 87.61 1.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 54.92 109.519 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.34 -25.84 4.48 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.514 -1.434 . . . . 36.1 109.514 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.464 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 2.0 mt-30 -73.7 140.97 78.66 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 54.76 109.433 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.8 Cg_endo -79.5 118.91 3.98 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.577 2.185 . . . . 28.37 110.28 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB3' ' HG3' ' A' ' 31' ' ' GLN . . . -42.52 155.19 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.24 -0.912 . . . . 17.21 110.308 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.618 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 16.3 m-30 -49.86 112.14 0.62 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.531 -0.731 . . . . 17.19 109.377 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.533 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -61.72 176.43 0.44 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.138 -0.976 . . . . 17.82 109.289 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.7 Cg_endo -77.05 119.85 5.2 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.545 2.164 . . . . 17.28 110.221 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.42 177.54 37.86 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.835 -1.306 . . . . 17.22 109.835 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 5.2 mp -71.58 159.48 34.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 19.57 108.469 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.583 ' CE1' HD12 ' A' ' 6' ' ' ILE . 20.5 m-85 -141.8 165.1 28.41 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.849 -1.157 . . . . 14.61 111.784 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.537 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 62.3 p -147.24 119.71 8.47 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.512 -1.662 . . . . 18.36 106.512 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.553 ' CG2' HG23 ' A' ' 2' ' ' ILE . 13.3 t -52.25 169.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 118.548 -1.261 . . . . 19.13 108.493 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.527 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.8 t-80 -131.33 119.64 22.01 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.36 -0.838 . . . . 20.65 108.911 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.605 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -62.35 -12.44 21.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.694 -0.629 . . . . 19.65 109.641 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.2 t -46.98 -20.92 0.17 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.944 -1.097 . . . . 14.72 108.593 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 34.1 m -96.7 -7.93 32.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.496 -0.753 . . . . 11.45 111.035 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.1 m-30 -81.1 161.77 23.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.617 -1.302 . . . . 14.25 109.816 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 5.1 pttm -145.74 174.75 10.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.45 -0.781 . . . . 32.7 109.663 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' B' ' 45' ' ' VAL . 2.5 t -117.19 129.2 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.419 -0.801 . . . . 15.63 109.307 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.14 168.12 35.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.479 -1.448 . . . . 12.7 109.479 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -76.74 0.55 20.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.232 -1.157 . . . . 26.29 109.733 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -26.99 23.16 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.461 -0.774 . . . . 20.44 109.21 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.77 65.31 0.76 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.492 -1.443 . . . . 13.82 109.492 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.14 133.43 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -1.107 . . . . 18.27 109.524 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' O ' ' CG ' ' A' ' 77' ' ' MET . 2.4 tt -73.56 148.66 42.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 12.43 109.519 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 30.3 mtm -155.94 128.97 8.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 35.11 109.558 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.598 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.1 mt -64.72 141.0 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 13.67 109.988 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -108.25 -37.3 6.05 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.637 -1.246 . . . . 24.06 107.637 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.0 tpm_? -168.57 68.06 0.07 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.19 -1.411 . . . . 35.04 107.19 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -31.1 120.23 0.21 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.499 -0.773 . . . . 18.72 111.518 -178.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -90.45 103.25 15.96 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.988 -1.116 . . . . 20.55 107.988 178.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.618 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -75.83 147.33 39.21 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.934 -1.104 . . . . 14.4 111.006 -178.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.466 ' C ' ' CD2' ' A' ' 61' ' ' TYR . 18.1 m -148.22 160.22 37.62 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 107.727 -1.212 . . . . 17.65 107.727 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.7 Cg_endo -62.32 146.63 95.75 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.036 1.824 . . . . 25.7 110.398 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.537 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -79.5 116.6 19.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.152 -0.968 . . . . 49.29 109.696 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.004 -0.998 . . . . 58.91 109.454 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.525 ' SD ' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.502 0.668 . . . . 64.91 109.429 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.568 ' CG2' HD11 ' A' ' 65' ' ' LEU . 4.0 mt -78.29 77.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.719 -1.215 . . . . 33.8 107.719 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.449 ' O ' HG12 ' B' ' 35' ' ' VAL . 0.2 OUTLIER -67.57 167.52 12.81 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.02 0.914 . . . . 32.72 110.869 -178.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.531 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -177.45 160.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.458 -0.942 . . . . 14.46 108.458 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.48 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 29.8 mt-10 -134.52 114.6 13.0 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.924 -0.769 . . . . 22.12 108.924 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.592 HD12 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -73.74 99.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.81 -1.182 . . . . 14.23 107.81 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.64 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.0 169.96 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.34 -0.85 . . . . 25.43 109.898 -178.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.0 Cg_endo -74.39 -28.29 10.47 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.488 2.125 . . . . 13.61 110.088 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.13 9.06 41.03 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.767 -0.827 . . . . 15.52 108.767 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 5.6 mm100 -126.13 22.34 7.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 17.31 109.864 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -95.74 15.14 20.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 24.78 110.151 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.424 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 60.4 mt-30 -134.86 141.1 46.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.038 -1.039 . . . . 47.9 109.736 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.629 ' CE1' ' ND2' ' B' ' 29' ' ' ASN . 45.1 p90 -94.03 153.91 17.92 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.257 -0.902 . . . . 21.61 109.343 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 81.1 m -113.21 150.15 32.73 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.296 -0.877 . . . . 14.89 108.955 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.498 0 O-C-N 121.33 -0.857 . . . . 17.35 109.606 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.443 HD13 ' HG3' ' B' ' 30' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.41 0.624 . . . . 24.0 110.031 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 67.3 m-20 -72.16 151.18 43.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.451 -0.781 . . . . 23.31 109.499 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.443 ' HG3' HD13 ' B' ' 28' ' ' LEU . 1.4 mt-10 -134.63 132.67 39.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 40.03 108.704 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.528 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -123.35 -174.18 2.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.069 -1.019 . . . . 12.39 110.04 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.496 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.8 mp -143.57 152.91 41.99 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.852 -0.795 . . . . 17.42 108.852 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.517 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -152.75 -177.46 6.27 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.925 -1.139 . . . . 13.84 107.925 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.683 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 21.9 m-85 -129.78 99.71 5.23 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.056 -1.027 . . . . 21.14 109.881 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.505 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 62.9 t -95.35 113.74 30.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.171 -0.956 . . . . 10.66 109.435 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 5.3 t70 -62.51 -28.33 69.77 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.189 -0.945 . . . . 25.89 108.527 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.495 ' HB3' ' ND2' ' B' ' 39' ' ' ASN . 0.7 OUTLIER 46.25 25.27 0.34 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.516 -0.74 . . . . 24.24 109.436 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.67 14.01 81.63 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.831 -1.307 . . . . 31.02 109.831 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.495 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 64.2 m-20 -86.0 15.11 5.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -1.211 . . . . 43.23 110.325 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.578 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 9.5 mt-10 60.84 11.42 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.332 -0.855 . . . . 42.34 110.487 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 71.2 m80 -161.15 152.79 16.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.0 -1.111 . . . . 6.38 108.0 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.683 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.4 Cg_endo -75.92 136.71 18.9 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.806 1.671 . . . . 17.92 110.442 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 4.5 m -110.93 118.07 56.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.393 -0.817 . . . . 20.57 109.037 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.615 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 46.0 tp -73.21 104.38 4.24 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.392 -0.818 . . . . 20.21 110.215 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.521 HG13 ' CG1' ' A' ' 70' ' ' VAL . 32.5 m -108.44 -177.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.492 -0.929 . . . . 10.81 108.492 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.09 154.55 22.12 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.949 -1.101 . . . . 36.74 110.316 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.594 HG13 ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -127.21 169.96 17.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.515 -0.74 . . . . 19.74 109.105 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' B' ' 47' ' ' ILE . 3.5 m -122.78 123.99 42.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.328 -0.857 . . . . 22.56 108.838 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.588 ' CB ' ' CB ' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -102.46 163.92 11.96 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.269 -0.894 . . . . 20.41 109.352 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.53 167.83 9.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 33.99 109.513 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -73.0 87.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 54.92 109.435 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.08 -25.96 4.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 36.1 109.568 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 2.1 mt-30 -73.61 140.86 78.88 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.217 -1.167 . . . . 54.76 109.451 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' B' ' 55' ' ' ALA . 36.2 Cg_endo -79.48 118.71 3.95 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.526 2.151 . . . . 28.37 110.322 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.457 ' HB3' ' HG3' ' B' ' 31' ' ' GLN . . . -42.37 155.34 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 17.21 110.291 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 16.5 m-30 -50.09 111.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.449 -0.782 . . . . 17.19 109.416 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.534 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -61.4 176.37 0.42 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 17.82 109.246 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.21 121.04 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.567 2.178 . . . . 17.28 110.41 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.7 177.91 36.91 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.752 -1.339 . . . . 17.22 109.752 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.4 mp -71.36 159.64 34.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -1.13 . . . . 19.57 108.783 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.592 ' CE1' HD12 ' B' ' 6' ' ' ILE . 19.8 m-85 -142.07 165.05 28.5 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.529 1.157 . . . . 14.61 111.77 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.548 ' CG2' ' HA ' ' B' ' 86' ' ' ALA . 60.3 p -147.28 119.82 8.51 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.554 -1.647 . . . . 18.36 106.554 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 13.1 t -52.26 169.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 C-N-CA 118.576 -1.25 . . . . 19.13 108.433 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.534 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.8 t-80 -131.44 119.62 21.87 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.37 -0.831 . . . . 20.65 108.987 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.606 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -62.25 -12.51 20.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.7 -0.625 . . . . 19.65 109.698 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.416 ' C ' ' O ' ' B' ' 65' ' ' LEU . 40.3 t -46.95 -20.48 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.933 -1.104 . . . . 14.72 108.565 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 32.6 m -97.17 -9.0 28.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -0.774 . . . . 11.45 111.032 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.609 ' CE1' HG12 ' B' ' 78' ' ' ILE . 3.0 m-30 -80.22 160.97 25.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.658 -1.276 . . . . 14.25 109.743 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.509 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 4.9 pttm -144.94 175.18 10.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.369 -0.832 . . . . 32.7 109.707 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.531 ' CG1' HG13 ' A' ' 45' ' ' VAL . 2.5 t -117.42 129.2 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.49 -0.756 . . . . 15.63 109.322 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.22 168.36 35.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.564 -1.414 . . . . 12.7 109.564 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.491 ' O ' ' CG ' ' B' ' 72' ' ' GLN . 0.9 OUTLIER -76.93 0.61 20.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.118 -1.225 . . . . 26.29 109.686 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.37 -26.99 23.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.47 -0.769 . . . . 20.44 109.253 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.86 65.43 0.76 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.454 -1.459 . . . . 13.82 109.454 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.3 133.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -1.168 . . . . 18.27 109.53 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' B' ' 77' ' ' MET . 2.5 tt -73.65 148.64 42.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 12.43 109.471 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.429 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 30.3 mtm -155.92 128.88 8.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 35.11 109.505 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.609 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.0 mt -64.79 141.25 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 13.67 110.06 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -108.41 -36.95 6.1 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.581 -1.266 . . . . 24.06 107.581 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.51 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.1 tpm_? -168.91 68.12 0.07 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.184 -1.413 . . . . 35.04 107.184 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.556 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.6 OUTLIER -31.18 120.44 0.22 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.469 -0.787 . . . . 18.72 111.518 -178.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -90.52 103.24 15.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.959 -1.126 . . . . 20.55 107.959 178.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.63 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -75.76 147.21 39.45 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.989 -1.07 . . . . 14.4 110.966 -178.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.469 ' C ' ' CD2' ' B' ' 61' ' ' TYR . 18.1 m -148.13 160.04 38.31 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.651 -1.24 . . . . 17.65 107.651 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.1 Cg_endo -62.17 146.51 95.99 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.974 1.783 . . . . 25.7 110.448 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.548 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -79.46 116.5 19.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.146 -0.971 . . . . 49.29 109.648 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.98 -1.009 . . . . 58.91 109.474 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.505 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.433 -0.58 . . . . 64.91 109.433 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.575 ' CA ' HD21 ' B' ' 65' ' ' LEU . 3.7 mt -72.44 79.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.729 -1.211 . . . . 33.8 107.729 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' C ' HG11 ' A' ' 4' ' ' VAL . 7.2 mttt -69.31 156.38 38.87 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.05 0.929 . . . . 32.72 111.54 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -166.01 168.01 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.18 -1.044 . . . . 14.46 108.18 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.555 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 26.3 mt-10 -143.44 112.63 6.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 22.12 109.541 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.596 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -72.37 102.72 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 C-N-CA 119.003 -1.079 . . . . 14.23 108.107 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 1.3 mmpt? -43.72 162.44 0.19 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.352 -0.842 . . . . 25.43 109.414 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.5 Cg_endo -72.7 -12.71 26.82 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.972 1.781 . . . . 13.61 109.088 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.5 t -99.13 7.15 46.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.234 -1.025 . . . . 15.52 108.234 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 1.5 mm-40 -129.47 41.27 3.48 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.846 -0.798 . . . . 17.31 108.846 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.419 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -101.76 3.65 39.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.122 -0.986 . . . . 24.78 110.291 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -134.84 139.64 45.22 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.129 -0.982 . . . . 47.9 108.607 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.615 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 22.3 p90 -85.62 176.97 7.88 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.035 -1.041 . . . . 21.61 109.298 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -133.98 148.2 51.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.444 -0.785 . . . . 14.89 109.099 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.594 0 O-C-N 121.336 -0.852 . . . . 17.35 109.088 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.495 0.664 . . . . 24.0 110.24 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.615 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -95.17 127.11 40.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.467 -0.77 . . . . 23.31 108.939 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -113.68 160.39 18.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.202 -0.936 . . . . 40.03 109.603 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.557 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -137.5 -169.41 2.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 12.39 109.123 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.553 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.1 mt -133.93 175.87 9.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 17.42 109.544 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.18 161.72 8.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.964 -1.085 . . . . 13.84 108.525 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.627 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 3.1 m-30 -114.34 101.34 9.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.132 -0.98 . . . . 21.14 108.828 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.539 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 13.9 t -107.6 148.21 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.999 -1.063 . . . . 10.66 110.029 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.8 p-10 -113.86 -39.92 3.88 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.408 -0.96 . . . . 25.89 108.408 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.532 ' HA ' ' CD1' ' B' ' 65' ' ' LEU . 0.2 OUTLIER 62.55 -71.01 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.731 -0.84 . . . . 24.24 108.731 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -142.59 28.0 2.2 Favored Glycine 0 C--N 1.296 -1.666 0 N-CA-C 108.238 -1.945 . . . . 31.02 108.238 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -130.89 98.97 4.76 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.593 -0.946 . . . . 43.23 108.722 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' ' 39' ' ' ASN . 3.4 mm-40 -31.36 -37.2 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.284 0.564 . . . . 42.34 111.194 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 39' ' ' ASN . 60.7 m80 -80.67 149.15 67.27 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.87 . . . . 8.33 108.973 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -78.56 149.61 24.11 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.135 1.89 . . . . 17.92 110.466 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.51 HG23 ' CG2' ' B' ' 70' ' ' VAL . 1.8 m -121.52 119.11 58.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.393 -0.923 . . . . 20.57 109.058 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 15.7 tp -72.72 112.25 8.6 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.722 -0.791 . . . . 20.21 109.178 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.594 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 14.3 t -118.44 167.06 12.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.545 -0.722 . . . . 10.81 109.528 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -96.15 139.93 31.6 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.517 -0.873 . . . . 36.74 109.421 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.638 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -121.55 171.63 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.808 . . . . 19.74 109.004 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.489 ' O ' HD21 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -105.56 153.59 21.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.075 -1.016 . . . . 22.56 109.691 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.563 HD13 ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -136.71 105.26 5.79 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.629 -0.878 . . . . 20.41 108.629 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -70.26 143.95 51.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -0.954 . . . . 33.99 109.635 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.17 132.85 39.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 54.92 109.269 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.23 -35.58 4.79 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.452 -1.459 . . . . 36.1 109.452 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 5.1 mt-30 -79.8 138.46 54.01 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.265 -1.138 . . . . 54.76 109.341 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.3 126.13 7.48 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.509 2.139 . . . . 28.37 110.415 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.491 ' HA ' HD22 ' A' ' 49' ' ' LEU . . . -41.35 149.59 0.11 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.353 -0.842 . . . . 17.21 110.295 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.638 ' CE1' HG12 ' A' ' 47' ' ' ILE . 83.1 m-85 -50.94 97.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.476 -0.765 . . . . 17.19 109.026 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.542 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -50.14 176.54 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.176 -0.953 . . . . 17.82 109.407 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.1 Cg_endo -76.68 131.26 12.24 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.418 2.079 . . . . 17.28 110.009 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.67 174.59 27.57 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.777 -1.329 . . . . 17.22 109.777 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.7 143.12 46.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -1.114 . . . . 19.57 108.469 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.6 ' CB ' HG12 ' A' ' 4' ' ' VAL . 22.3 m-85 -127.31 162.89 25.18 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.832 -1.167 . . . . 14.61 111.548 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.521 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 44.8 p -143.04 121.39 12.32 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.534 -1.654 . . . . 18.36 106.534 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 3.3 t -52.54 166.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 C-N-CA 118.873 -1.131 . . . . 19.13 109.012 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -134.84 128.78 33.36 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.561 -0.903 . . . . 20.65 108.561 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.634 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 1.2 pp -73.13 3.15 5.91 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.036 -1.04 . . . . 19.65 110.005 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.7 t -57.04 -19.15 17.17 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.716 -1.216 . . . . 14.72 107.716 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -101.34 -8.01 22.45 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.696 -0.628 . . . . 11.45 110.234 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.634 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 3.4 m-30 -74.66 155.27 37.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.836 -1.165 . . . . 14.25 108.925 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.77 176.53 12.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 32.7 109.678 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -109.45 115.77 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.392 -0.818 . . . . 15.63 109.285 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.06 179.71 10.77 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.508 -1.437 . . . . 12.7 109.508 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.528 ' NE2' ' HA ' ' A' ' 72' ' ' GLN . 9.2 mm-40 -88.46 42.43 1.07 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.222 -1.164 . . . . 26.29 109.298 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.402 ' CG ' ' C ' ' A' ' 72' ' ' GLN . 10.3 m-85 -148.23 34.96 0.81 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.532 -0.73 . . . . 20.44 109.384 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.469 ' O ' HG11 ' B' ' 45' ' ' VAL . . . 48.0 58.78 6.72 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.239 -1.544 . . . . 13.82 109.239 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.407 ' HA ' HG11 ' B' ' 45' ' ' VAL . 4.2 m -156.41 136.16 12.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.335 -1.097 . . . . 18.27 109.919 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -73.06 165.08 25.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.321 -0.862 . . . . 12.43 109.084 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.541 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.1 mtt -166.43 107.86 0.7 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.07 -1.019 . . . . 35.11 110.023 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -42.67 -35.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 13.67 109.588 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER 43.89 55.19 5.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 24.06 109.411 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 67' ' ' SER . 6.5 tmm_? 78.23 80.78 0.07 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.851 -0.796 . . . . 35.04 108.851 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.616 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -55.56 149.03 14.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.768 0.794 . . . . 18.72 111.703 -178.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -99.48 103.46 15.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.094 -1.076 . . . . 20.55 108.094 178.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -75.16 151.57 38.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.185 -0.947 . . . . 14.4 111.568 -178.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 62' ' ' THR . 27.1 m -151.51 155.65 34.37 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.825 -1.176 . . . . 17.65 107.825 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.42 144.23 90.3 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.146 1.898 . . . . 25.7 110.433 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -72.0 139.71 48.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.159 -0.963 . . . . 49.29 109.396 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.009 -0.996 . . . . 58.91 109.551 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.505 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.396 -0.594 . . . . 64.91 109.396 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.57 ' CA ' HD21 ' A' ' 65' ' ' LEU . 3.8 mt -72.7 79.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.664 -1.235 . . . . 33.8 107.664 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.434 ' C ' HG11 ' B' ' 4' ' ' VAL . 7.1 mttt -69.59 156.13 39.41 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.055 0.931 . . . . 32.72 111.549 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.602 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -165.54 168.16 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.229 -1.026 . . . . 14.46 108.229 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.547 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 26.3 mt-10 -143.46 112.55 6.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 22.12 109.556 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.582 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.3 OUTLIER -72.31 102.59 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 118.979 -1.089 . . . . 14.23 108.079 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.526 ' HB3' ' HD2' ' B' ' 8' ' ' PRO . 1.1 mmpt? -43.69 162.57 0.19 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 25.43 109.466 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.4 Cg_endo -72.65 -12.9 27.07 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.007 1.805 . . . . 13.61 109.144 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -98.99 7.15 46.28 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.26 -1.015 . . . . 15.52 108.26 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 1.5 mm-40 -129.53 41.34 3.46 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.416 -0.803 . . . . 17.31 108.885 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.411 ' HB3' ' HD3' ' B' ' 58' ' ' PRO . . . -101.92 3.88 39.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.063 -1.023 . . . . 24.78 110.264 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.43 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 0.9 OUTLIER -134.9 139.49 45.02 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.167 -0.958 . . . . 47.9 108.533 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.609 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 22.1 p90 -85.86 176.7 7.94 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.035 -1.041 . . . . 21.61 109.244 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -133.64 148.67 51.55 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.395 -0.816 . . . . 14.89 109.087 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.604 0 O-C-N 121.37 -0.831 . . . . 17.35 108.997 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.427 0.632 . . . . 24.0 110.231 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.609 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -95.09 127.08 40.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.445 -0.785 . . . . 23.31 108.922 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.6 OUTLIER -113.51 160.68 18.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.175 -0.953 . . . . 40.03 109.581 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.559 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -137.83 -169.63 2.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 12.39 109.02 179.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.555 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.1 mt -133.81 175.85 9.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.923 . . . . 17.42 109.548 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.14 161.69 8.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.955 -1.091 . . . . 13.84 108.497 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.638 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 3.1 m-30 -114.41 101.58 9.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 21.14 108.739 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.551 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 13.5 t -107.73 148.25 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.056 -1.027 . . . . 10.66 110.125 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.8 p-10 -113.95 -40.07 3.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.51 -0.922 . . . . 25.89 108.51 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' B' ' 36' ' ' ASP . 0.2 OUTLIER 62.38 -70.87 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.773 -0.825 . . . . 24.24 108.773 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -142.65 27.73 2.2 Favored Glycine 0 C--N 1.296 -1.669 0 N-CA-C 108.307 -1.917 . . . . 31.02 108.307 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.0 OUTLIER -130.72 99.07 4.82 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.604 -0.939 . . . . 43.23 108.73 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' B' ' 39' ' ' ASN . 3.4 mm-40 -31.55 -37.02 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.3 0.571 . . . . 42.34 111.143 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' B' ' 39' ' ' ASN . 59.8 m80 -80.73 149.18 67.12 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 121.342 -0.849 . . . . 8.33 109.037 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.614 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.4 Cg_endo -78.58 149.48 23.94 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.102 1.868 . . . . 17.92 110.408 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.527 HG23 ' CG2' ' A' ' 70' ' ' VAL . 1.8 m -121.36 119.51 59.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.344 -0.943 . . . . 20.57 109.102 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.638 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 15.3 tp -73.04 111.45 8.16 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.778 -0.769 . . . . 20.21 109.105 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.586 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 12.8 t -117.7 167.16 11.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.633 -0.667 . . . . 10.81 109.449 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.564 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.9 OUTLIER -96.16 140.33 31.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.319 -0.863 . . . . 36.74 109.495 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.64 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -121.96 171.81 10.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.344 -0.847 . . . . 19.74 109.076 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.488 ' O ' HD21 ' B' ' 49' ' ' LEU . 0.3 OUTLIER -105.89 153.15 22.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.051 -1.03 . . . . 22.56 109.77 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -136.36 104.99 5.79 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.684 -0.858 . . . . 20.41 108.684 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -70.01 144.5 52.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 33.99 109.665 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.58 132.88 41.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.893 . . . . 54.92 109.264 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.32 -36.09 4.44 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.398 -1.481 . . . . 36.1 109.398 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.51 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 5.0 mt-30 -79.47 138.34 55.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.27 -1.135 . . . . 54.76 109.34 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.41 126.12 7.39 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.44 2.093 . . . . 28.37 110.372 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.486 ' HA ' HD22 ' B' ' 49' ' ' LEU . . . -41.25 150.58 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.328 -0.857 . . . . 17.21 110.234 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.64 ' CE1' HG12 ' B' ' 47' ' ' ILE . 82.1 m-85 -51.95 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.95 -0.759 . . . . 17.19 108.95 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.529 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -51.53 176.62 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.306 -0.871 . . . . 17.82 109.312 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -76.9 132.12 12.7 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.469 2.113 . . . . 17.28 110.328 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.99 175.15 26.66 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.676 -1.37 . . . . 17.22 109.676 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.43 143.88 46.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -1.138 . . . . 19.57 108.872 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.602 ' CB ' HG12 ' B' ' 4' ' ' VAL . 21.5 m-85 -127.9 163.05 25.3 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.544 1.164 . . . . 14.61 111.556 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.52 ' O ' ' CG2' ' B' ' 84' ' ' VAL . 46.1 p -143.32 121.41 12.14 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.546 -1.65 . . . . 18.36 106.546 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.612 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 3.3 t -52.75 165.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 C-N-CA 118.88 -1.128 . . . . 19.13 109.023 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -134.02 128.55 34.56 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.59 -0.893 . . . . 20.65 108.59 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.641 ' CB ' ' CD2' ' B' ' 68' ' ' PHE . 1.3 pp -72.74 2.95 5.68 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.061 -1.024 . . . . 19.65 110.087 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 28.6 t -56.94 -19.21 16.73 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 107.711 -1.218 . . . . 14.72 107.711 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -101.45 -7.79 22.55 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.723 -0.611 . . . . 11.45 110.166 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.641 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.3 m-30 -74.84 154.97 38.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.889 -1.132 . . . . 14.25 108.833 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.43 176.85 12.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 32.7 109.681 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.594 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -109.8 115.62 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.43 -0.794 . . . . 15.63 109.363 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.91 179.71 10.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.568 -1.413 . . . . 12.7 109.568 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.529 ' NE2' ' HA ' ' B' ' 72' ' ' GLN . 8.8 mm-40 -88.49 42.42 1.07 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.224 -1.162 . . . . 26.29 109.314 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.404 ' CG ' ' C ' ' B' ' 72' ' ' GLN . 9.5 m-85 -148.18 34.79 0.81 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.495 -0.753 . . . . 20.44 109.481 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.436 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 48.34 58.08 7.59 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.292 -1.523 . . . . 13.82 109.292 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.4 m -155.74 136.37 13.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.139 . . . . 18.27 109.963 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.547 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.3 OUTLIER -73.2 164.91 26.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 12.43 109.157 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.1 mtt -166.37 108.12 0.71 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.085 -1.009 . . . . 35.11 110.106 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.7 mt -42.99 -34.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 13.67 109.532 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.7 OUTLIER 43.83 55.27 5.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.832 . . . . 24.06 109.35 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 67' ' ' SER . 6.5 tmm_? 78.23 80.82 0.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.922 -0.77 . . . . 35.04 108.922 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.612 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.0 OUTLIER -55.54 149.11 14.27 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.702 0.763 . . . . 18.72 111.74 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -99.62 103.55 15.26 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.992 -1.114 . . . . 20.55 107.992 178.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -75.22 151.55 38.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.229 -0.92 . . . . 14.4 111.609 -178.224 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' B' ' 62' ' ' THR . 29.9 m -151.55 155.36 34.18 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 107.837 -1.171 . . . . 17.65 107.837 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.22 144.12 91.12 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.237 1.958 . . . . 25.7 110.446 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.497 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -72.0 139.4 48.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 49.29 109.375 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.034 -0.984 . . . . 58.91 109.483 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.4 -0.593 . . . . 64.91 109.4 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.538 ' CG2' HG22 ' A' ' 63' ' ' VAL . 3.0 mt -61.93 83.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.646 -1.242 . . . . 33.8 107.646 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 1' ' ' MET . 14.0 mtpt -75.93 158.05 32.47 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.952 0.882 . . . . 32.72 111.104 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.59 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -164.23 169.05 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.293 -1.002 . . . . 14.46 108.293 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 55.5 mt-10 -144.7 112.6 6.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.94 . . . . 22.12 109.47 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.57 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -72.73 101.98 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.822 -1.177 . . . . 14.23 107.822 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.656 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.69 171.22 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.304 -0.872 . . . . 25.43 109.856 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -74.8 -26.9 10.91 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.36 2.04 . . . . 13.61 109.589 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -88.02 0.08 56.39 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.987 -0.746 . . . . 15.52 108.987 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.8 mm-40 -120.42 33.87 5.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 17.31 109.475 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.95 10.79 38.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 24.78 109.958 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.405 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 15.3 mt-30 -138.93 144.99 39.29 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 47.9 109.96 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.641 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 35.4 p90 -94.3 161.52 14.21 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.323 -0.861 . . . . 21.61 109.195 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -128.92 162.82 26.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.311 -0.868 . . . . 14.89 108.808 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 O-C-N 121.239 -0.913 . . . . 17.35 109.541 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.462 0.649 . . . . 24.0 110.173 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.572 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 90.7 m-20 -64.99 133.55 51.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.387 -0.821 . . . . 23.31 109.745 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.21 142.32 51.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 40.03 109.294 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.568 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -124.14 -179.04 4.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 12.39 109.303 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.5 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.1 mt -127.75 174.33 9.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 17.42 109.579 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -168.45 167.62 11.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.403 -0.962 . . . . 13.84 108.403 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.664 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 18.7 m-85 -120.88 107.38 12.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.138 -0.976 . . . . 21.14 109.545 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 59.2 t -104.02 112.3 37.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.141 -0.974 . . . . 10.66 109.821 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.0 OUTLIER -64.0 -27.34 69.05 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.196 -1.038 . . . . 25.89 108.196 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.532 HD12 ' CA ' ' B' ' 69' ' ' LYS . 0.6 OUTLIER 48.37 30.85 2.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.602 -0.686 . . . . 24.24 109.303 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.61 9.37 78.33 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.457 -1.457 . . . . 31.02 109.457 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 1.9 m-20 -85.43 4.57 34.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -1.149 . . . . 43.23 110.476 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 29.6 mt-10 80.7 -42.61 0.2 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.585 -0.697 . . . . 42.34 110.567 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 47.5 m80 -107.0 155.34 39.38 Favored Pre-proline 0 C--N 1.295 -1.793 0 O-C-N 121.417 -0.802 . . . . 6.33 108.929 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.664 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -77.15 138.12 17.79 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.181 1.92 . . . . 17.92 110.542 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.533 HG22 ' CG1' ' A' ' 45' ' ' VAL . 5.6 m -111.85 117.75 55.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.369 -0.832 . . . . 20.57 108.827 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 67.3 tp -71.56 103.26 2.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.288 -0.882 . . . . 20.21 110.007 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' A' ' 43' ' ' VAL . 3.6 m -106.42 -177.42 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.527 -0.733 . . . . 10.81 109.032 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.26 145.0 40.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.409 -0.917 . . . . 36.74 109.987 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.66 HG12 ' CE1' ' A' ' 56' ' ' TYR . 1.2 tt -135.9 136.47 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.418 -0.801 . . . . 19.74 109.064 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 m -68.67 156.01 39.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 22.56 109.57 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.641 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 2.3 tm? -129.99 114.02 15.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.282 -0.886 . . . . 20.41 109.077 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.509 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -48.85 123.56 7.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.866 . . . . 33.99 110.152 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -47.34 109.27 0.2 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.319 -0.863 . . . . 54.92 109.353 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.78 -29.65 10.55 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.429 -1.468 . . . . 36.1 109.429 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.509 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.7 OUTLIER -65.2 153.68 88.89 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.23 -1.159 . . . . 54.76 109.326 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.8 Cg_endo -77.88 109.95 2.82 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.506 2.138 . . . . 28.37 110.224 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.443 ' CB ' ' HG3' ' A' ' 31' ' ' GLN . . . -38.63 148.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.526 -0.734 . . . . 17.21 110.218 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.66 ' CE1' HG12 ' A' ' 47' ' ' ILE . 83.0 m-85 -46.0 101.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.451 -0.781 . . . . 17.19 109.355 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.428 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -50.63 171.02 0.17 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.907 . . . . 17.82 109.823 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HA ' HG23 ' A' ' 6' ' ' ILE . 35.4 Cg_endo -77.9 114.14 3.57 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.736 2.291 . . . . 17.28 110.117 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.65 -179.82 46.6 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.898 -1.281 . . . . 17.22 109.898 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -75.78 139.76 41.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -1.082 . . . . 19.57 108.114 179.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.59 ' CB ' HG12 ' A' ' 4' ' ' VAL . 18.5 m-85 -126.26 162.15 26.11 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.66 -1.275 . . . . 14.61 111.759 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 52.8 p -142.11 122.25 13.8 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.247 -1.76 . . . . 18.36 106.247 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.552 ' CG1' ' HG ' ' A' ' 81' ' ' LEU . 2.5 t -54.38 162.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 C-N-CA 118.792 -1.163 . . . . 19.13 109.077 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.545 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.5 t-80 -130.46 129.17 42.63 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.246 -1.02 . . . . 20.65 108.246 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.642 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -70.04 1.97 4.06 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.502 -0.749 . . . . 19.65 110.2 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.03 -20.35 9.18 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.448 -1.316 . . . . 14.72 107.448 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -97.58 -8.34 29.21 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.755 -0.591 . . . . 11.45 110.09 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -77.97 154.94 31.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.967 -1.083 . . . . 14.25 109.595 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.54 ' CA ' HD12 ' B' ' 37' ' ' LEU . 0.8 OUTLIER -137.93 175.8 9.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 32.7 109.466 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.529 ' CG1' HG11 ' B' ' 45' ' ' VAL . 10.6 t -122.37 134.4 65.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.43 -0.794 . . . . 15.63 109.475 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.21 -160.24 28.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.382 -1.487 . . . . 12.7 109.382 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 6.2 tp60 61.67 72.73 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -1.177 . . . . 26.29 109.349 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 2.2 m-85 65.51 11.97 7.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 20.44 109.357 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' B' ' 45' ' ' VAL . . . 81.97 48.82 5.6 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.503 -1.439 . . . . 13.82 109.503 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' A' ' 77' ' ' MET . 26.9 t -130.6 125.48 34.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -1.116 . . . . 18.27 109.662 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.5 ' C ' ' CG ' ' A' ' 77' ' ' MET . 3.5 tp -63.96 146.44 54.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 12.43 109.115 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.5 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 3.2 mtm -159.33 144.37 15.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 35.11 109.449 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.624 ' CG1' ' CE1' ' A' ' 68' ' ' PHE . 1.7 mp -65.14 145.48 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 13.67 109.505 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 67' ' ' SER . 4.6 t70 -103.46 -62.28 1.31 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.214 -1.402 . . . . 24.06 107.214 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.524 ' O ' ' C ' ' A' ' 81' ' ' LEU . 5.1 tmm_? -142.28 56.8 1.46 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.292 -1.003 . . . . 35.04 108.292 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.552 ' HG ' ' CG1' ' A' ' 63' ' ' VAL . 6.4 tt 3.43 116.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.524 -1.217 . . . . 18.72 112.849 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.545 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -99.35 96.61 7.84 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.098 -1.075 . . . . 20.55 108.098 178.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.588 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -77.49 150.82 34.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.982 -1.074 . . . . 14.4 111.064 -178.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 62' ' ' THR . 26.4 m -151.15 155.88 34.99 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.106 -1.072 . . . . 17.65 108.106 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.1 Cg_endo -63.86 141.9 80.06 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.053 1.836 . . . . 25.7 110.173 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -70.77 117.79 12.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.206 -0.934 . . . . 49.29 109.602 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.046 -0.978 . . . . 58.91 109.496 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.416 -0.587 . . . . 64.91 109.416 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.545 ' CG2' HG22 ' B' ' 63' ' ' VAL . 3.0 mt -62.0 83.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.644 -1.243 . . . . 33.8 107.644 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' ' 1' ' ' MET . 14.0 mtpt -75.89 158.0 32.58 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.947 0.879 . . . . 32.72 111.104 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.593 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -164.23 168.99 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.296 -1.002 . . . . 14.46 108.296 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.548 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 55.2 mt-10 -144.59 112.62 6.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.19 -0.944 . . . . 22.12 109.448 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.587 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -72.73 101.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.761 -1.2 . . . . 14.23 107.761 179.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.647 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.73 171.23 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.358 -0.839 . . . . 25.43 109.81 -178.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 32.6 Cg_endo -74.92 -26.82 10.72 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.331 2.021 . . . . 13.61 109.532 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -88.03 0.15 56.3 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.0 -0.741 . . . . 15.52 109.0 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.516 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.8 mm-40 -120.42 33.79 5.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 17.31 109.506 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.85 10.77 38.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.136 -0.978 . . . . 24.78 109.937 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -139.01 144.93 39.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.144 -0.973 . . . . 47.9 109.911 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.635 ' CD2' ' CD1' ' B' ' 49' ' ' LEU . 35.4 p90 -94.25 161.46 14.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.376 -0.827 . . . . 21.61 109.178 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 8.7 t -128.78 162.93 26.29 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.242 -0.911 . . . . 14.89 108.792 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.203 -0.935 . . . . 17.35 109.486 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.43 0.633 . . . . 24.0 110.231 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.582 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 90.9 m-20 -64.94 133.6 52.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.8 . . . . 23.31 109.745 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.26 142.32 51.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 40.03 109.259 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.563 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -124.07 -179.16 4.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 12.39 109.378 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.499 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.1 mt -127.63 174.41 9.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.964 . . . . 17.42 109.511 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -168.59 167.57 11.41 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.366 -0.976 . . . . 13.84 108.366 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.667 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 18.9 m-85 -120.83 107.4 12.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.127 -0.983 . . . . 21.14 109.596 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 59.4 t -104.04 112.29 36.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.157 -0.964 . . . . 10.66 109.834 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.0 OUTLIER -63.96 -27.41 69.12 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.155 -1.054 . . . . 25.89 108.155 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.54 HD12 ' CA ' ' A' ' 69' ' ' LYS . 0.6 OUTLIER 48.48 30.74 2.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.637 -0.664 . . . . 24.24 109.278 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.73 9.34 78.79 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.469 -1.453 . . . . 31.02 109.469 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' B' ' 40' ' ' GLU . 1.9 m-20 -85.39 4.5 35.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -1.165 . . . . 43.23 110.504 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' B' ' 39' ' ' ASN . 29.5 mt-10 80.67 -42.62 0.2 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.578 -0.701 . . . . 42.34 110.561 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.501 ' O ' ' HA ' ' B' ' 36' ' ' ASP . 47.5 m80 -106.95 155.34 39.34 Favored Pre-proline 0 C--N 1.294 -1.825 0 O-C-N 121.376 -0.828 . . . . 6.35 108.919 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.667 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.1 Cg_endo -77.2 138.21 17.78 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.12 1.88 . . . . 17.92 110.551 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.54 HG22 ' CG1' ' B' ' 45' ' ' VAL . 5.6 m -111.85 117.7 55.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.338 -0.852 . . . . 20.57 108.784 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.59 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 67.3 tp -71.55 103.19 2.91 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.347 -0.846 . . . . 20.21 110.032 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.54 ' CG1' HG22 ' B' ' 43' ' ' VAL . 3.6 m -106.34 -177.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 109.001 -0.74 . . . . 10.81 109.001 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.27 144.91 40.9 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.408 -0.917 . . . . 36.74 110.006 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.667 HG12 ' CE1' ' B' ' 56' ' ' TYR . 1.2 tt -135.84 136.53 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.454 -0.779 . . . . 19.74 109.068 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 11.0 m -68.67 156.17 38.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -0.984 . . . . 22.56 109.53 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.635 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 2.3 tm? -130.19 113.94 15.08 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.357 -0.839 . . . . 20.41 109.083 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.518 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.3 OUTLIER -48.82 123.6 7.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.873 . . . . 33.99 110.209 -179.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -47.37 109.25 0.2 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.298 -0.876 . . . . 54.92 109.394 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.83 -29.67 10.49 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.431 -1.468 . . . . 36.1 109.431 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.518 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.7 OUTLIER -65.16 153.62 88.92 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.278 -1.131 . . . . 54.76 109.311 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.5 Cg_endo -77.8 109.98 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.52 2.146 . . . . 28.37 110.214 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' B' ' 54' ' ' PRO . . . -38.75 148.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.526 -0.734 . . . . 17.21 110.154 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.667 ' CE1' HG12 ' B' ' 47' ' ' ILE . 83.1 m-85 -46.34 102.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 17.19 109.409 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.433 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -50.82 171.01 0.17 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 17.82 109.737 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.47 ' HA ' HG23 ' B' ' 6' ' ' ILE . 35.6 Cg_endo -78.17 115.31 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.768 2.312 . . . . 17.28 110.397 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.67 -179.27 45.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.747 -1.341 . . . . 17.22 109.747 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -75.44 140.4 42.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -1.102 . . . . 19.57 108.432 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.593 ' CB ' HG12 ' B' ' 4' ' ' VAL . 18.1 m-85 -126.8 162.25 26.3 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.752 -1.218 . . . . 14.61 111.764 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' B' ' 86' ' ' ALA . 52.8 p -142.34 122.26 13.61 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.256 -1.757 . . . . 18.36 106.256 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.545 HG22 ' CG2' ' B' ' 2' ' ' ILE . 2.6 t -54.39 162.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 C-N-CA 118.766 -1.174 . . . . 19.13 109.077 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.552 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.5 t-80 -130.41 129.18 42.72 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.269 -1.012 . . . . 20.65 108.269 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.642 ' CB ' ' CD2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -69.93 1.83 4.09 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.516 -0.74 . . . . 19.65 110.231 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.95 -20.35 8.8 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.419 -1.326 . . . . 14.72 107.419 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.519 ' O ' ' N ' ' B' ' 79' ' ' ASP . 0.5 OUTLIER -97.74 -8.52 28.41 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.74 -0.6 . . . . 11.45 110.062 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.642 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 2.8 m-30 -77.74 154.54 31.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 14.25 109.495 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.532 ' CA ' HD12 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -137.54 176.04 9.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 32.7 109.483 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.531 ' CG1' HG11 ' A' ' 45' ' ' VAL . 10.5 t -122.52 134.37 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 15.63 109.504 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.19 -160.28 28.6 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.356 -1.498 . . . . 12.7 109.356 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 6.3 tp60 61.69 72.79 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -1.164 . . . . 26.29 109.349 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 2.2 m-85 65.43 12.06 7.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 20.44 109.29 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.87 48.88 5.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.495 -1.442 . . . . 13.82 109.495 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' B' ' 77' ' ' MET . 27.1 t -130.59 125.38 33.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 18.27 109.659 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.508 ' C ' ' CG ' ' B' ' 77' ' ' MET . 3.4 tp -63.81 146.46 53.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 12.43 109.131 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.508 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 3.2 mtm -159.43 144.41 15.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.07 -1.019 . . . . 35.11 109.396 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.626 ' CG1' ' CE1' ' B' ' 68' ' ' PHE . 1.7 mp -65.29 145.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 13.67 109.534 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' B' ' 67' ' ' SER . 4.5 t70 -103.59 -62.07 1.34 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.238 -1.393 . . . . 24.06 107.238 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' B' ' 81' ' ' LEU . 5.1 tmm_? -142.51 56.88 1.44 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.286 -1.005 . . . . 35.04 108.286 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.543 ' HG ' ' CG1' ' B' ' 63' ' ' VAL . 6.5 tt 3.4 116.68 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.474 -1.239 . . . . 18.72 112.887 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.4 OUTLIER -99.41 96.51 7.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.109 -1.071 . . . . 20.55 108.109 178.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.584 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -77.35 150.98 35.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.935 -1.103 . . . . 14.4 111.066 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' B' ' 62' ' ' THR . 26.5 m -151.34 155.77 34.68 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.054 -1.091 . . . . 17.65 108.054 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.1 Cg_endo -63.73 141.91 80.94 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.055 1.837 . . . . 25.7 110.195 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.523 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -70.76 117.72 12.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.163 -0.96 . . . . 49.29 109.595 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.046 -0.978 . . . . 58.91 109.476 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.3 -0.629 . . . . 64.91 109.3 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.578 ' CG2' ' CG2' ' A' ' 63' ' ' VAL . 1.7 mt 58.53 78.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.799 -1.186 . . . . 33.8 107.799 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' C ' HG11 ' A' ' 4' ' ' VAL . 6.4 mttt -73.52 157.15 37.29 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.797 0.808 . . . . 32.72 110.672 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.577 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -164.67 159.31 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.022 -0.733 . . . . 14.46 109.022 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 5.1 mt-10 -136.34 113.6 10.68 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 22.12 109.351 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.595 HD12 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -72.36 107.26 3.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.906 -1.146 . . . . 14.23 107.906 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.615 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 4.4 mptt -50.07 172.6 0.11 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.165 -0.959 . . . . 25.43 109.999 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.8 Cg_endo -76.0 -29.23 6.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.557 2.171 . . . . 13.61 109.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 m -92.95 7.01 45.8 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.976 -0.75 . . . . 15.52 108.976 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.1 mm-40 -123.49 29.25 6.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 17.31 109.749 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.22 16.28 17.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 24.78 110.063 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.469 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 18.4 mt-30 -141.84 145.29 34.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.093 -1.004 . . . . 47.9 109.902 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.63 ' CE1' ' ND2' ' A' ' 29' ' ' ASN . 42.2 p90 -96.16 153.37 17.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.363 -0.836 . . . . 21.61 109.458 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.7 p -121.38 168.72 11.36 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.421 -0.8 . . . . 14.89 109.337 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.606 0 O-C-N 121.409 -0.807 . . . . 17.35 109.048 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.445 HD21 ' O ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.443 0.639 . . . . 24.0 110.179 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 64.1 m-20 -53.8 160.8 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 23.31 109.809 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 7.4 mt-10 -150.04 125.45 10.19 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.44 -0.948 . . . . 40.03 108.44 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.531 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -113.6 -179.18 3.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 12.39 110.36 -178.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.451 ' O ' ' OE1' ' A' ' 31' ' ' GLN . 81.2 mt -137.48 147.69 45.48 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.787 -0.819 . . . . 17.42 108.787 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.8 m -151.88 -177.53 6.19 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.802 -1.185 . . . . 13.84 107.802 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.662 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 31.6 m-85 -127.91 112.46 14.72 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.074 -1.016 . . . . 21.14 109.677 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 60.7 t -106.89 109.9 29.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.372 -0.931 . . . . 10.66 109.749 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 38' ' ' GLY . 2.5 p30 -57.75 -39.4 77.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.028 -1.471 . . . . 25.89 107.028 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.537 HD13 ' N ' ' B' ' 69' ' ' LYS . 7.3 tt 62.88 -71.2 0.05 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.831 0.824 . . . . 24.24 109.056 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -178.04 41.53 0.09 OUTLIER Glycine 0 C--N 1.294 -1.791 0 N-CA-C 108.54 -1.824 . . . . 31.02 108.54 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -124.37 23.81 8.17 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.33 -1.1 . . . . 43.23 110.429 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.577 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 14.6 mt-10 50.53 19.28 0.55 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.259 -0.901 . . . . 42.34 110.729 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.577 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 98.6 m-70 -160.08 154.74 20.64 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.278 -1.008 . . . . 7.29 108.278 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.662 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 37.4 Cg_endo -76.36 134.24 15.42 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.921 1.747 . . . . 17.92 110.556 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 3.1 m -108.76 116.69 52.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 119.509 -0.877 . . . . 20.57 108.775 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.569 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 64.6 tp -67.62 101.79 1.07 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.462 -0.895 . . . . 20.21 109.364 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 38.6 t -103.89 166.92 2.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.63 -0.669 . . . . 10.81 109.389 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 24.7 ttmt -98.64 148.78 23.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.185 -0.947 . . . . 36.74 110.198 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.672 HG12 ' CE2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -128.05 163.14 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.395 -0.816 . . . . 19.74 108.971 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 m -111.68 135.49 52.2 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.265 -0.897 . . . . 22.56 109.161 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.615 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -112.14 151.26 29.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 20.41 109.46 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.482 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -87.36 -174.67 4.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 33.99 109.736 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.45 104.47 15.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.352 -0.843 . . . . 54.92 109.575 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.18 -8.29 57.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.589 -1.404 . . . . 36.1 109.589 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.469 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -78.3 143.8 65.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.172 -1.193 . . . . 54.76 109.548 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.0 Cg_endo -79.34 110.87 2.77 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.629 2.22 . . . . 28.37 110.383 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.519 ' CB ' ' HG3' ' A' ' 31' ' ' GLN . . . -42.24 160.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 17.21 110.087 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.672 ' CE2' HG12 ' A' ' 47' ' ' ILE . 11.4 m-30 -54.57 111.05 0.72 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.398 -0.814 . . . . 17.19 109.209 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -60.67 176.22 0.38 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 17.82 109.516 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.47 114.87 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.665 2.244 . . . . 17.28 110.213 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.11 179.73 43.99 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.947 -1.261 . . . . 17.22 109.947 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -75.4 146.29 40.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -1.077 . . . . 19.57 108.256 179.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.595 ' CE1' HD12 ' A' ' 6' ' ' ILE . 23.0 m-85 -132.28 162.92 29.81 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.692 -1.255 . . . . 14.61 111.889 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.508 HG21 ' CB ' ' A' ' 86' ' ' ALA . 59.8 p -145.41 119.71 9.58 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.65 -1.611 . . . . 18.36 106.65 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.589 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 11.2 t -47.53 169.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 C-N-CA 119.086 -1.045 . . . . 19.13 109.266 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.7 t-80 -134.87 122.11 21.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.953 -0.758 . . . . 20.65 108.953 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.607 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -65.92 -9.22 27.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.546 -0.721 . . . . 19.65 109.348 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -53.95 -16.82 2.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.165 -0.959 . . . . 14.72 108.886 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.509 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -104.11 -6.93 20.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 11.45 111.098 -179.306 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.607 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.1 m-30 -74.21 163.25 28.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.704 -1.248 . . . . 14.25 109.663 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.515 ' N ' HD13 ' B' ' 37' ' ' LEU . 25.2 mtmt -149.64 174.02 13.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 32.7 109.31 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' CG1' HG23 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -114.86 109.83 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 15.63 109.065 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.04 -179.45 44.34 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.554 -1.419 . . . . 12.7 109.554 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -88.43 39.21 0.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.254 -1.144 . . . . 26.29 109.524 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -112.23 11.72 20.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.801 . . . . 20.44 109.261 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 46' ' ' LYS . . . 63.69 26.62 70.03 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.341 -1.504 . . . . 13.82 109.341 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -154.17 155.33 35.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -1.133 . . . . 18.27 109.626 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.442 ' CD2' HG22 ' B' ' 2' ' ' ILE . 1.7 tp -67.18 173.55 3.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 12.43 109.536 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.439 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 2.7 mtt -159.39 101.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 35.11 109.607 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.595 ' CG2' ' N ' ' A' ' 81' ' ' LEU . 2.7 mt -41.92 -43.33 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 13.67 109.995 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER 48.69 54.24 10.97 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.341 -0.85 . . . . 24.06 108.991 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 82.01 80.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.023 -0.732 . . . . 35.04 109.023 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.595 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 1.3 pt? -58.81 154.15 15.52 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.46 0.648 . . . . 18.72 110.734 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -104.89 106.11 16.45 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.693 -1.225 . . . . 20.55 107.693 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.613 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -81.51 144.4 31.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.071 -1.018 . . . . 14.4 111.482 -178.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.474 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 35.6 m -144.26 160.58 48.33 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 107.617 -1.253 . . . . 17.65 107.617 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.8 Cg_endo -62.17 147.81 94.35 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.099 1.866 . . . . 25.7 110.658 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.508 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -77.75 124.12 27.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.303 -0.873 . . . . 49.29 109.547 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.03 -0.986 . . . . 58.91 109.502 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.475 ' HG3' ' O ' ' B' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.374 -0.602 . . . . 64.91 109.374 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.574 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 1.7 mt 57.8 77.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.763 -1.199 . . . . 33.8 107.763 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.422 ' C ' HG11 ' B' ' 4' ' ' VAL . 6.4 mttt -73.15 157.35 37.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.791 . . . . 32.72 110.737 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.579 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -164.94 159.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.082 -0.71 . . . . 14.46 109.082 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 5.1 mt-10 -136.24 113.55 10.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.534 -0.729 . . . . 22.12 109.384 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.591 HD12 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -72.26 107.45 3.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.918 -1.142 . . . . 14.23 107.918 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.627 ' HD3' ' CD1' ' B' ' 34' ' ' TYR . 4.4 mptt -50.29 172.66 0.11 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.148 -0.97 . . . . 25.43 109.959 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -75.98 -29.53 6.66 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.618 2.212 . . . . 13.61 109.925 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.5 m -92.65 7.1 44.88 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.031 -0.729 . . . . 15.52 109.031 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.0 mm-40 -123.61 29.25 6.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 17.31 109.685 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.13 16.15 17.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.994 . . . . 24.78 110.057 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.46 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 18.4 mt-30 -141.78 145.22 34.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 47.9 109.954 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.63 ' CE1' ' ND2' ' B' ' 29' ' ' ASN . 42.4 p90 -96.05 153.64 17.67 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.378 -0.826 . . . . 21.61 109.451 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 38.5 p -121.55 168.72 11.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.437 -0.79 . . . . 14.89 109.274 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.614 0 O-C-N 121.447 -0.783 . . . . 17.35 109.101 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.465 HD21 ' O ' ' B' ' 49' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.458 0.647 . . . . 24.0 110.167 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 63.2 m-20 -53.69 160.81 1.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 23.31 109.798 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' B' ' 29' ' ' ASN . 7.6 mt-10 -150.16 125.17 9.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.431 -0.951 . . . . 40.03 108.431 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.533 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -113.4 -179.14 3.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 12.39 110.382 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.453 ' C ' ' SG ' ' B' ' 33' ' ' CYS . 81.2 mt -137.45 147.88 45.67 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.841 -0.8 . . . . 17.42 108.841 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.9 m -152.08 -177.63 6.28 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.769 -1.197 . . . . 13.84 107.769 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.662 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 31.6 m-85 -127.85 112.4 14.68 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.065 -1.022 . . . . 21.14 109.678 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 61.2 t -106.89 110.17 30.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.349 -0.94 . . . . 10.66 109.688 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' B' ' 38' ' ' GLY . 2.4 p30 -57.91 -39.33 77.68 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.997 -1.483 . . . . 25.89 106.997 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 69' ' ' LYS . 7.4 tt 62.87 -70.66 0.06 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.844 0.831 . . . . 24.24 109.046 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -178.47 41.28 0.09 OUTLIER Glycine 0 C--N 1.293 -1.813 0 N-CA-C 108.554 -1.818 . . . . 31.02 108.554 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -124.17 23.72 8.33 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.281 -1.129 . . . . 43.23 110.474 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.57 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 14.1 mt-10 50.82 19.15 0.58 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.247 -0.908 . . . . 42.34 110.703 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 98.6 m-70 -160.06 154.89 20.92 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.274 -1.01 . . . . 7.28 108.274 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.662 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 37.5 Cg_endo -76.51 134.47 15.4 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.88 1.72 . . . . 17.92 110.521 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 3.1 m -109.09 116.59 52.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 119.424 -0.91 . . . . 20.57 108.808 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.574 ' HB2' ' CE2' ' B' ' 34' ' ' TYR . 65.4 tp -67.48 101.83 1.04 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.457 -0.897 . . . . 20.21 109.358 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.547 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 38.0 t -103.92 167.01 2.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.602 -0.686 . . . . 10.81 109.369 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.547 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 24.4 ttmt -98.79 148.23 24.1 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.198 -0.939 . . . . 36.74 110.165 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.663 HG12 ' CE2' ' B' ' 56' ' ' TYR . 0.0 OUTLIER -127.47 163.09 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.383 -0.823 . . . . 19.74 108.95 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 15.3 m -111.6 135.57 52.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.274 -0.891 . . . . 22.56 109.101 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.61 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -112.2 151.42 29.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 20.41 109.373 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.484 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.3 OUTLIER -87.48 -174.69 4.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 33.99 109.751 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.53 104.46 16.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 54.92 109.528 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.19 -8.09 57.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.612 -1.395 . . . . 36.1 109.612 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.466 ' O ' HD13 ' B' ' 49' ' ' LEU . 0.3 OUTLIER -78.63 143.72 63.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 54.76 109.567 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.7 Cg_endo -79.25 111.04 2.82 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.616 2.211 . . . . 28.37 110.432 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.525 ' CB ' ' HG3' ' B' ' 31' ' ' GLN . . . -42.35 160.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 17.21 110.031 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.663 ' CE2' HG12 ' B' ' 47' ' ' ILE . 11.7 m-30 -54.87 110.78 0.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 17.19 109.286 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.518 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -59.96 176.25 0.34 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 17.82 109.494 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 36.0 Cg_endo -78.79 115.83 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.713 2.276 . . . . 17.28 110.439 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.8 -179.79 43.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.833 -1.307 . . . . 17.22 109.833 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.3 OUTLIER -75.37 146.55 40.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -1.103 . . . . 19.57 108.467 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.591 ' CE1' HD12 ' B' ' 6' ' ' ILE . 22.8 m-85 -132.49 162.99 29.81 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.759 -1.213 . . . . 14.61 111.92 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.512 HG21 ' CB ' ' B' ' 86' ' ' ALA . 59.9 p -145.44 119.85 9.65 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.691 -1.596 . . . . 18.36 106.691 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.596 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 11.5 t -47.78 169.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.1 -1.04 . . . . 19.13 109.267 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.7 t-80 -134.77 122.06 21.58 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.943 -0.762 . . . . 20.65 108.943 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.6 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -65.85 -9.28 27.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.444 -0.785 . . . . 19.65 109.254 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 86.4 p -53.85 -16.82 1.97 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.13 -0.981 . . . . 14.72 108.919 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -104.33 -7.09 20.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 11.45 111.13 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.0 m-30 -74.25 162.57 28.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.651 -1.281 . . . . 14.25 109.54 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.537 ' N ' HD13 ' A' ' 37' ' ' LEU . 25.2 mtmt -148.5 173.99 12.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 32.7 109.38 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.478 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -114.6 109.86 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.875 . . . . 15.63 109.029 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.17 -179.45 44.15 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.587 -1.405 . . . . 12.7 109.587 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.443 ' O ' ' NE2' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -88.44 39.23 0.9 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.17 -1.194 . . . . 26.29 109.42 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -112.13 11.64 20.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 20.44 109.251 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 46' ' ' LYS . . . 63.55 27.28 70.68 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.333 -1.507 . . . . 13.82 109.333 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -154.96 155.54 34.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -1.141 . . . . 18.27 109.545 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.532 ' CD2' HG22 ' A' ' 2' ' ' ILE . 1.7 tp -67.34 173.59 3.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 12.43 109.553 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.431 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 2.8 mtt -159.53 101.69 1.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 35.11 109.551 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.595 ' CG2' ' N ' ' B' ' 81' ' ' LEU . 2.7 mt -41.88 -43.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.546 -0.721 . . . . 13.67 110.037 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.4 OUTLIER 48.66 54.32 10.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.307 -0.871 . . . . 24.06 108.985 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.546 ' CB ' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 82.18 80.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.065 -0.717 . . . . 35.04 109.065 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.596 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.3 pt? -58.69 154.03 15.4 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.472 0.653 . . . . 18.72 110.757 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.561 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -104.87 106.18 16.55 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.636 -1.246 . . . . 20.55 107.636 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.612 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -81.5 144.45 31.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.017 -1.052 . . . . 14.4 111.475 -178.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' B' ' 85' ' ' PRO . 35.5 m -144.41 160.47 48.21 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 107.518 -1.289 . . . . 17.65 107.518 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.3 Cg_endo -62.17 148.02 93.98 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.07 1.847 . . . . 25.7 110.657 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.512 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -77.84 124.24 27.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.243 -0.91 . . . . 49.29 109.511 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.026 -0.988 . . . . 58.91 109.527 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.52 ' SD ' ' CG2' ' A' ' 62' ' ' THR . 30.9 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.495 -0.557 . . . . 64.91 109.495 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.529 ' CG2' HG22 ' A' ' 63' ' ' VAL . 2.8 mt -65.23 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.582 -1.266 . . . . 33.8 107.582 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -67.01 155.36 38.85 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.964 0.887 . . . . 32.72 111.461 -177.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -163.37 168.89 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.14 -1.059 . . . . 14.46 108.14 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.0 OUTLIER -146.28 107.54 4.21 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.105 -0.997 . . . . 22.12 109.275 -178.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -66.2 103.92 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.696 -1.224 . . . . 14.23 107.696 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.572 ' HE2' ' CE2' ' A' ' 34' ' ' TYR . 8.2 mmmt -43.61 162.26 0.19 Allowed Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.159 -0.963 . . . . 25.43 109.489 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.42 -11.96 26.93 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.945 1.763 . . . . 13.61 109.155 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.3 t -102.14 7.73 40.9 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.735 -0.839 . . . . 15.52 108.735 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.518 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 9.4 mm-40 -126.71 37.23 4.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.889 . . . . 17.31 109.247 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.64 15.95 23.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.118 -0.989 . . . . 24.78 110.165 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.406 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -136.62 143.73 43.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.116 -0.99 . . . . 47.9 108.81 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.63 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 31.6 p90 -94.0 162.63 13.81 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.121 -0.987 . . . . 21.61 109.116 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -143.71 147.17 33.85 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.256 -0.902 . . . . 14.89 109.407 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 O-C-N 121.348 -0.845 . . . . 17.35 109.078 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 50' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.501 0.667 . . . . 24.0 110.336 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 95.9 m-20 -50.27 115.84 1.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.522 -0.736 . . . . 23.31 109.93 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -115.52 150.23 36.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.944 . . . . 40.03 109.019 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.541 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -125.81 -171.45 2.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.04 -1.037 . . . . 12.39 109.86 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.548 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 30.1 mt -128.12 176.96 7.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.482 -0.761 . . . . 17.42 109.396 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -171.39 158.02 5.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.143 -0.973 . . . . 13.84 108.438 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 2.9 m-30 -113.99 102.64 10.38 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.078 -1.014 . . . . 21.14 108.542 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.542 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 38.5 t -102.41 106.74 20.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.094 -1.004 . . . . 10.66 110.273 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -61.41 -39.01 89.16 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.259 -1.386 . . . . 25.89 107.259 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' B' ' 65' ' ' LEU . 6.9 tt 63.18 -69.36 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.675 0.75 . . . . 24.24 109.381 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -178.49 42.94 0.09 OUTLIER Glycine 0 C--N 1.296 -1.674 0 N-CA-C 108.803 -1.719 . . . . 31.02 108.803 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -124.83 27.66 6.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.284 -1.127 . . . . 43.23 110.205 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.583 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 1.9 mm-40 48.67 21.2 0.39 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.17 -0.957 . . . . 42.34 110.239 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 59.4 m80 -164.57 151.39 9.72 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.196 -1.038 . . . . 6.58 108.196 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.618 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.2 Cg_endo -76.48 144.06 25.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.08 1.853 . . . . 17.92 110.955 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 5.0 m -117.92 118.89 59.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.476 -0.89 . . . . 20.57 109.14 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.643 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 23.5 tp -68.69 110.49 4.31 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.944 -0.702 . . . . 20.21 109.155 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 16.3 t -117.02 167.38 10.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.513 -0.742 . . . . 10.81 109.497 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.567 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -90.74 162.3 14.94 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.659 -0.817 . . . . 36.74 110.216 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.628 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -152.12 161.44 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.759 -0.83 . . . . 19.74 108.759 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.67 151.83 20.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.0 -1.062 . . . . 22.56 109.762 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.63 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 2.7 tm? -134.22 93.62 3.1 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.434 -0.791 . . . . 20.41 108.991 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.526 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.2 p30 -154.59 174.94 14.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.934 -1.104 . . . . 33.99 110.117 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' GLN . 10.4 tt0 73.21 72.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.501 -0.749 . . . . 54.92 109.807 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 51' ' ' GLU . . . 36.45 30.06 0.03 OUTLIER Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.236 -1.146 . . . . 36.1 110.236 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 51' ' ' GLU . 2.4 mt-30 -107.31 131.0 22.04 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.07 -1.253 . . . . 54.76 110.061 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.3 Cg_endo -80.1 142.1 15.13 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.463 2.108 . . . . 28.37 110.004 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.489 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -41.61 141.45 0.77 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 17.21 110.015 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.628 ' CE1' HG12 ' A' ' 47' ' ' ILE . 84.5 m-85 -47.2 98.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 17.19 109.146 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.522 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -49.42 175.36 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 17.82 109.743 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -77.89 118.32 4.42 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.73 2.286 . . . . 17.28 110.369 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.87 171.4 34.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.473 -1.451 . . . . 17.22 109.473 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.2 mp -72.08 147.6 46.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.198 -1.177 . . . . 19.57 108.924 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CB ' HG12 ' A' ' 4' ' ' VAL . 30.7 m-85 -132.04 163.24 28.87 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.579 1.181 . . . . 14.61 111.424 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.52 ' CG2' ' SD ' ' A' ' 1' ' ' MET . 20.6 p -142.17 119.35 11.43 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.616 -1.994 . . . . 18.36 105.616 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.62 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.5 t -52.42 167.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 C-N-CA 118.615 -1.234 . . . . 19.13 109.198 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -129.61 128.75 43.3 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.546 -0.721 . . . . 20.65 109.123 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.676 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -70.88 -0.94 10.23 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.401 -0.812 . . . . 19.65 109.679 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 p -56.6 -19.18 14.77 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.541 -1.281 . . . . 14.72 107.541 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 39.6 m -97.02 -6.97 34.1 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.831 -0.543 . . . . 11.45 110.05 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.3 m-30 -79.7 157.29 27.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 14.25 109.689 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.488 ' HA ' HD12 ' B' ' 37' ' ' LEU . 0.0 OUTLIER -140.15 169.9 16.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.834 . . . . 32.7 109.488 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.575 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 2.2 t -110.08 139.52 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.912 . . . . 15.63 109.425 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.57 -157.55 23.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.341 -1.504 . . . . 12.7 109.341 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 0.0 OUTLIER 63.03 78.34 0.3 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.159 -1.2 . . . . 26.29 109.122 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.5 OUTLIER 69.48 9.39 7.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.433 -0.792 . . . . 20.44 109.472 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.414 ' O ' HG11 ' B' ' 45' ' ' VAL . . . 80.24 46.03 7.79 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.608 -1.397 . . . . 13.82 109.608 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -146.51 140.15 25.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -1.183 . . . . 18.27 109.577 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 77' ' ' MET . 1.4 tp -55.74 156.17 5.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 12.43 109.338 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 15.2 mtt -164.25 130.33 2.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 35.11 109.64 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.598 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.5 mp -63.72 138.49 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 13.67 109.77 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.62 -23.62 12.39 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.379 -0.971 . . . . 24.06 108.379 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 67' ' ' SER . 1.0 OUTLIER 178.44 68.04 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.03 -1.47 . . . . 35.04 107.03 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.62 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -29.05 119.68 0.13 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.274 -0.875 . . . . 18.72 111.685 -177.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -88.6 100.44 13.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 20.55 108.783 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.601 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -69.75 141.06 53.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 14.4 110.638 -179.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 62' ' ' THR . 27.8 m -143.22 153.5 59.83 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.71 -1.219 . . . . 17.65 107.71 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.2 Cg_endo -61.44 141.77 93.23 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.945 1.763 . . . . 25.7 110.317 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.475 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -77.95 117.78 19.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.266 -0.896 . . . . 49.29 109.682 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.993 -1.003 . . . . 58.91 109.455 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.512 ' SD ' ' CG2' ' B' ' 62' ' ' THR . 31.1 ttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.519 -0.548 . . . . 64.91 109.519 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' B' ' 63' ' ' VAL . 2.8 mt -65.28 81.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.572 -1.27 . . . . 33.8 107.572 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -67.2 155.32 39.1 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.981 0.895 . . . . 32.72 111.43 -177.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -163.34 168.92 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.133 -1.062 . . . . 14.46 108.133 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 1.0 OUTLIER -146.3 107.55 4.21 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.104 -0.997 . . . . 22.12 109.258 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.576 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -66.22 104.02 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.718 -1.216 . . . . 14.23 107.718 179.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.576 ' HE2' ' CE2' ' B' ' 34' ' ' TYR . 8.2 mmmt -43.68 162.26 0.19 Allowed Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.147 -0.971 . . . . 25.43 109.479 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.7 Cg_endo -72.38 -12.08 27.1 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.984 1.789 . . . . 13.61 109.115 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 44.6 t -102.03 7.58 41.18 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.753 -0.832 . . . . 15.52 108.753 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.512 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 9.4 mm-40 -126.5 37.32 4.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.288 -0.882 . . . . 17.31 109.254 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.75 15.8 24.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 24.78 110.168 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.39 143.79 44.19 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.074 -1.016 . . . . 47.9 108.82 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.639 ' CD2' ' CD1' ' B' ' 49' ' ' LEU . 31.6 p90 -94.03 162.6 13.82 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.1 -1.0 . . . . 21.61 109.098 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -143.61 147.33 34.2 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.288 -0.883 . . . . 14.89 109.362 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.489 0 O-C-N 121.367 -0.833 . . . . 17.35 109.08 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.514 ' CD2' ' HB3' ' B' ' 50' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.468 0.652 . . . . 24.0 110.312 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.622 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 95.8 m-20 -50.31 115.95 1.67 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 23.31 109.854 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -115.6 150.34 36.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.158 -0.964 . . . . 40.03 108.98 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.555 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -125.92 -171.55 2.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.013 -1.055 . . . . 12.39 109.836 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.543 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 30.0 mt -128.06 176.93 7.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.461 -0.774 . . . . 17.42 109.442 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -171.31 158.09 5.23 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.093 -1.004 . . . . 13.84 108.487 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.636 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 2.9 m-30 -114.06 102.53 10.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.148 -0.97 . . . . 21.14 108.592 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.537 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 38.4 t -102.34 106.67 20.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.147 -1.021 . . . . 10.66 110.309 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.9 OUTLIER -61.17 -39.1 88.86 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.307 -1.368 . . . . 25.89 107.307 178.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.531 ' HG ' ' CD1' ' A' ' 65' ' ' LEU . 6.9 tt 63.33 -69.39 0.07 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.695 0.76 . . . . 24.24 109.313 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -178.52 42.97 0.09 OUTLIER Glycine 0 C--N 1.295 -1.742 0 N-CA-C 108.773 -1.731 . . . . 31.02 108.773 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -124.85 27.65 6.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.246 -1.149 . . . . 43.23 110.234 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.574 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 1.9 mm-40 48.7 21.16 0.39 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.23 -0.919 . . . . 42.34 110.25 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 59.4 m80 -164.57 151.3 9.66 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 108.2 -1.037 . . . . 6.56 108.2 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.622 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.6 Cg_endo -76.33 143.98 25.56 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.137 1.891 . . . . 17.92 111.011 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' B' ' 35' ' ' VAL . 5.0 m -117.87 118.8 59.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.451 -0.9 . . . . 20.57 109.098 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.636 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 23.4 tp -68.67 110.55 4.33 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.898 -0.721 . . . . 20.21 109.218 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.575 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 16.8 t -116.95 167.42 10.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.511 -0.743 . . . . 10.81 109.529 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -90.75 162.24 14.97 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.674 -0.81 . . . . 36.74 110.206 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.633 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -152.06 161.5 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.706 -0.85 . . . . 19.74 108.706 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.71 151.69 20.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.969 -1.082 . . . . 22.56 109.787 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.639 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 2.7 tm? -134.05 93.58 3.12 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.373 -0.829 . . . . 20.41 109.003 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.514 ' HB3' ' CD2' ' B' ' 28' ' ' LEU . 2.2 p30 -154.63 174.74 14.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.956 -1.09 . . . . 33.99 110.152 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' B' ' 53' ' ' GLN . 10.4 tt0 73.25 73.05 0.13 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 54.92 109.814 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' B' ' 51' ' ' GLU . . . 36.37 30.02 0.03 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.273 -1.131 . . . . 36.1 110.273 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' B' ' 51' ' ' GLU . 2.4 mt-30 -107.2 130.84 22.27 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.094 -1.239 . . . . 54.76 110.084 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 36.2 Cg_endo -79.95 141.97 15.33 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.525 2.15 . . . . 28.37 109.986 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.501 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -41.46 141.39 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 17.21 110.031 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.633 ' CE1' HG12 ' B' ' 47' ' ' ILE . 83.5 m-85 -47.03 97.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.327 -0.858 . . . . 17.19 109.11 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -49.15 175.46 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 17.82 109.804 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.1 Cg_endo -77.85 117.59 4.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.651 2.234 . . . . 17.28 110.176 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.35 171.11 35.45 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.542 -1.423 . . . . 17.22 109.542 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.0 mp -72.3 147.14 46.65 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.172 -1.193 . . . . 19.57 108.711 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.598 ' CB ' HG12 ' B' ' 4' ' ' VAL . 30.6 m-85 -131.65 163.11 28.83 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 122.564 1.173 . . . . 14.61 111.446 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.52 ' O ' ' CG2' ' B' ' 84' ' ' VAL . 20.7 p -142.01 119.28 11.47 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 105.627 -1.99 . . . . 18.36 105.627 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.609 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.5 t -52.54 166.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 C-N-CA 118.559 -1.256 . . . . 19.13 109.208 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -129.32 128.66 43.61 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.568 -0.707 . . . . 20.65 109.228 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.662 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -70.69 -1.04 10.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.457 -0.777 . . . . 19.65 109.71 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 p -56.59 -19.23 14.98 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.541 -1.281 . . . . 14.72 107.541 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 38.2 m -96.9 -7.38 33.47 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.853 -0.529 . . . . 11.45 110.131 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.662 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.2 m-30 -79.32 157.06 27.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.065 -1.022 . . . . 14.25 109.642 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.502 ' HA ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.96 169.68 17.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 32.7 109.484 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.549 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 2.2 t -109.88 139.57 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 15.63 109.42 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 75' ' ' SER . . . 136.59 -157.63 23.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.261 -1.536 . . . . 12.7 109.261 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.0 OUTLIER 63.08 78.32 0.3 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.188 -1.183 . . . . 26.29 109.108 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.5 OUTLIER 69.51 9.4 7.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.455 -0.778 . . . . 20.44 109.401 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.445 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 80.26 45.78 7.93 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.639 -1.384 . . . . 13.82 109.639 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.402 ' O ' ' O ' ' B' ' 71' ' ' GLY . 1.5 t -146.24 140.11 26.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -1.163 . . . . 18.27 109.603 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.525 ' O ' ' CG ' ' B' ' 77' ' ' MET . 1.4 tp -55.69 156.23 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 12.43 109.338 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.525 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 15.2 mtt -164.33 130.53 2.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 35.11 109.618 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.5 mp -63.97 138.57 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -0.854 . . . . 13.67 109.841 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.6 -23.76 12.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.334 -0.988 . . . . 24.06 108.334 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.9 OUTLIER 178.55 68.07 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.062 -1.459 . . . . 35.04 107.062 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.609 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.7 OUTLIER -29.15 119.66 0.13 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.297 -0.865 . . . . 18.72 111.659 -177.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -88.52 100.25 12.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.348 -0.845 . . . . 20.55 108.849 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.601 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -69.74 140.93 53.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 14.4 110.626 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' B' ' 62' ' ' THR . 27.3 m -143.08 153.33 60.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 107.756 -1.201 . . . . 17.65 107.756 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.3 Cg_endo -61.23 141.7 94.05 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.911 1.741 . . . . 25.7 110.39 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.483 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -77.89 117.81 19.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.335 -0.853 . . . . 49.29 109.687 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.04 -0.981 . . . . 58.91 109.417 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.506 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.274 0.559 . . . . 64.91 109.496 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.521 ' CD1' ' HB ' ' A' ' 63' ' ' VAL . 3.3 mt 70.12 78.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 107.459 -1.312 . . . . 33.8 107.459 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.512 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -62.01 159.7 13.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.96 0.886 . . . . 32.72 111.666 -177.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.574 ' CG2' ' CG2' ' A' ' 35' ' ' VAL . 82.4 t -160.68 168.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.985 -0.746 . . . . 14.46 108.985 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 30.9 mt-10 -153.29 99.7 2.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 22.12 109.463 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.604 HD12 ' CE1' ' A' ' 61' ' ' TYR . 1.0 OUTLIER -70.32 102.77 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.822 -1.177 . . . . 14.23 107.822 179.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.577 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 3.5 mmpt? -57.64 163.59 3.68 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 25.43 109.308 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.5 -11.94 26.75 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.98 1.787 . . . . 13.61 109.206 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -102.69 13.3 34.78 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.301 -1.0 . . . . 15.52 108.301 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.537 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 5.6 mm-40 -142.86 36.33 1.42 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.452 -0.78 . . . . 17.31 109.41 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -112.78 35.3 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.092 -1.005 . . . . 24.78 110.234 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -140.74 125.19 17.73 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.169 -0.957 . . . . 47.9 109.67 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.632 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 40.4 p90 -89.74 156.66 18.38 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.293 -0.879 . . . . 21.61 109.82 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -131.5 161.85 31.6 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.326 -0.99 . . . . 14.89 108.326 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.628 0 O-C-N 121.093 -1.004 . . . . 17.35 109.095 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.433 ' CD2' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.563 0.697 . . . . 24.0 110.29 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -45.77 133.97 7.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.54 -0.725 . . . . 23.31 110.082 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 35.5 mt-10 -128.53 151.69 49.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.384 -0.822 . . . . 40.03 108.816 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.546 ' OE1' ' CB ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -135.62 -170.43 2.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.978 -1.076 . . . . 12.39 110.294 -179.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 10' ' ' GLN . 11.0 mt -126.65 173.2 9.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.733 -0.84 . . . . 17.42 108.733 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -167.95 160.68 12.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.792 -1.192 . . . . 13.84 108.162 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 3.2 m-85 -107.59 92.17 3.96 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.136 -0.978 . . . . 21.14 109.478 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.574 ' CG2' ' CG2' ' A' ' 4' ' ' VAL . 37.5 t -94.59 121.74 45.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.281 -0.887 . . . . 10.66 110.17 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.487 ' O ' ' HG ' ' A' ' 37' ' ' LEU . 1.9 m-20 -73.35 -36.62 66.17 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.212 -1.033 . . . . 25.89 108.212 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 35' ' ' VAL . 1.0 OUTLIER 39.19 28.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.779 -0.575 . . . . 24.24 110.073 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 67.75 25.98 73.94 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.782 -1.327 . . . . 31.02 109.782 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 36' ' ' ASP . 1.1 t-20 -96.21 15.4 21.06 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.192 -1.181 . . . . 43.23 110.655 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 41' ' ' HIS . 1.7 mt-10 68.5 94.03 0.07 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.023 -1.048 . . . . 42.34 108.601 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 10.6 m80 86.57 167.94 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.646 -0.872 . . . . 6.21 108.646 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 34.0 Cg_endo -77.71 150.26 27.34 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.09 1.86 . . . . 17.92 111.204 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 2.2 m -122.48 120.44 61.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.368 -0.833 . . . . 20.57 109.171 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.637 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 16.6 tp -73.79 109.62 7.44 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.295 -0.878 . . . . 20.21 108.641 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 1.6 p -123.87 160.65 27.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.438 -0.789 . . . . 10.81 109.475 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 4.6 ttmt -77.33 164.56 25.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 36.74 110.438 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.595 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -149.66 172.59 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.906 -0.776 . . . . 19.74 108.906 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 m -108.65 146.87 32.74 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.161 -0.962 . . . . 22.56 109.312 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.632 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -118.01 145.94 44.4 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.237 -0.914 . . . . 20.41 108.61 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.459 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -82.38 140.14 33.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.061 -1.025 . . . . 33.99 109.82 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.28 106.73 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 54.92 109.346 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.95 -12.53 57.6 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.494 . . . . 36.1 109.364 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 50' ' ' ASP . 5.1 mt-30 -81.9 147.22 57.7 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.29 -1.124 . . . . 54.76 109.344 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.8 Cg_endo -78.15 123.23 6.05 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.593 2.195 . . . . 28.37 110.537 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.546 ' CB ' ' OE1' ' A' ' 31' ' ' GLN . . . -37.94 143.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.633 -0.667 . . . . 17.21 110.142 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.606 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 83.9 m-85 -41.49 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.481 -0.762 . . . . 17.19 109.326 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . -43.04 165.41 0.11 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 17.82 109.577 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 35.1 Cg_endo -77.59 105.92 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.57 2.18 . . . . 17.28 110.484 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.54 -174.25 41.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.891 -1.284 . . . . 17.22 109.891 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -76.06 142.42 41.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -1.101 . . . . 19.57 108.396 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.604 ' CE1' HD12 ' A' ' 6' ' ' ILE . 15.9 m-85 -131.74 163.69 27.62 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.767 -1.208 . . . . 14.61 111.68 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.506 ' CG2' ' HG3' ' A' ' 1' ' ' MET . 50.8 p -145.72 120.18 9.68 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.698 -1.593 . . . . 18.36 106.698 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 3.8 t -50.68 171.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 118.708 -1.197 . . . . 19.13 108.885 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.8 t-80 -135.08 125.37 26.3 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.337 -0.852 . . . . 20.65 109.263 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.671 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -70.4 -2.84 14.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.457 -0.777 . . . . 19.65 109.697 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -17.01 14.71 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.023 -1.102 . . . . 14.72 108.023 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -101.73 -9.66 20.65 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.726 -0.609 . . . . 11.45 110.597 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -72.31 164.14 26.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.959 -1.088 . . . . 14.25 109.992 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' A' ' 77' ' ' MET . 2.8 ptmt -146.42 177.04 9.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.947 -0.76 . . . . 32.7 108.947 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.92 158.73 37.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.272 -0.892 . . . . 15.63 109.355 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.96 -140.16 11.61 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.367 -1.493 . . . . 12.7 109.367 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 28.6 tp60 57.23 60.56 2.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.111 -1.229 . . . . 26.29 109.373 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 73.29 2.34 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.494 -0.754 . . . . 20.44 109.469 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' HG21 ' B' ' 45' ' ' VAL . . . 103.9 54.79 0.8 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.962 -1.255 . . . . 13.82 109.962 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.3 t -151.27 147.36 26.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -1.2 . . . . 18.27 109.776 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 77' ' ' MET . 2.6 tp -59.41 165.11 2.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 12.43 109.189 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 12.1 mtp -165.23 104.54 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.972 . . . . 35.11 110.038 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.57 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.4 mt -42.26 -63.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.509 -0.744 . . . . 13.67 109.335 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 38.0 t0 84.9 -45.5 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.387 0.613 . . . . 24.06 110.134 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.573 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.0 tmm_? -171.44 67.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.039 0.923 . . . . 35.04 108.519 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.585 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -38.06 131.19 1.12 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.603 -0.726 . . . . 18.72 111.514 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.526 ' NH1' ' HG2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -96.47 107.0 19.34 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.923 -1.14 . . . . 20.55 107.923 178.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -76.9 146.84 37.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.127 -0.983 . . . . 14.4 111.221 -178.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 62' ' ' THR . 16.3 m -147.63 156.8 45.1 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.93 -1.137 . . . . 17.65 107.93 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.9 Cg_endo -64.01 142.95 83.5 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.163 1.909 . . . . 25.7 110.419 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.428 ' CA ' HG21 ' A' ' 62' ' ' THR . . . -72.23 115.1 11.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 49.29 109.484 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.043 -0.98 . . . . 58.91 109.48 -179.942 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.507 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.43 -0.581 . . . . 64.91 109.43 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.525 ' CD1' ' HB ' ' B' ' 63' ' ' VAL . 3.3 mt 70.26 78.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.475 -1.306 . . . . 33.8 107.475 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 0.0 OUTLIER -61.85 159.56 13.65 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.976 0.893 . . . . 32.72 111.656 -177.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.582 ' CG2' ' CG2' ' B' ' 35' ' ' VAL . 84.3 t -160.52 168.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.964 -0.754 . . . . 14.46 108.964 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 31.0 mt-10 -153.3 99.75 2.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.299 -0.876 . . . . 22.12 109.502 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.59 HD12 ' CE1' ' B' ' 61' ' ' TYR . 1.0 OUTLIER -70.41 102.75 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.756 -1.201 . . . . 14.23 107.756 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.578 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 3.5 mmpt? -57.57 163.44 3.71 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.276 -0.89 . . . . 25.43 109.322 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.6 Cg_endo -72.44 -11.84 26.81 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.931 1.754 . . . . 13.61 109.182 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -102.68 13.21 35.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 15.52 108.33 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.53 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 5.6 mm-40 -142.7 36.22 1.44 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.402 -0.811 . . . . 17.31 109.452 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -112.69 35.4 3.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.986 -1.071 . . . . 24.78 110.274 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -140.8 125.09 17.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.122 -0.986 . . . . 47.9 109.588 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.635 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 40.6 p90 -89.54 157.01 18.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.313 -0.867 . . . . 21.61 109.855 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.2 t -131.89 161.53 32.79 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.327 -0.99 . . . . 14.89 108.327 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.624 0 O-C-N 121.09 -1.006 . . . . 17.35 109.168 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.437 ' CD2' ' O ' ' B' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.563 0.697 . . . . 24.0 110.329 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.602 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -45.73 134.19 7.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.561 -0.712 . . . . 23.31 110.045 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 35.4 mt-10 -128.7 151.76 49.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.322 -0.861 . . . . 40.03 108.783 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.546 ' OE1' ' CB ' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -135.76 -170.55 2.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.948 -1.095 . . . . 12.39 110.223 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.488 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 11.0 mt -126.67 173.2 9.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.692 -0.855 . . . . 17.42 108.692 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -168.0 160.58 12.18 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.782 -1.199 . . . . 13.84 108.136 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.638 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 3.2 m-85 -107.47 92.41 4.06 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.082 -1.011 . . . . 21.14 109.461 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.582 ' CG2' ' CG2' ' B' ' 4' ' ' VAL . 38.5 t -94.81 121.71 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.25 -0.906 . . . . 10.66 110.112 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.488 ' O ' ' HG ' ' B' ' 37' ' ' LEU . 1.9 m-20 -73.35 -36.45 66.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.215 -1.031 . . . . 25.89 108.215 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' B' ' 35' ' ' VAL . 1.0 OUTLIER 39.09 28.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.731 -0.606 . . . . 24.24 109.979 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 67.61 26.22 73.76 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.79 -1.324 . . . . 31.02 109.79 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' B' ' 36' ' ' ASP . 1.1 t-20 -96.45 15.63 20.87 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.228 -1.16 . . . . 43.23 110.568 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' B' ' 41' ' ' HIS . 1.7 mt-10 68.38 93.89 0.07 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.026 -1.046 . . . . 42.34 108.652 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.587 ' CB ' ' O ' ' B' ' 40' ' ' GLU . 10.5 m80 86.66 168.01 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.672 -0.862 . . . . 6.24 108.672 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.614 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 34.1 Cg_endo -77.64 150.43 27.73 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.072 1.848 . . . . 17.92 111.18 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 2.2 m -122.66 120.41 60.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.64 -0.824 . . . . 20.57 109.128 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.638 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 16.7 tp -73.74 109.71 7.46 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.447 -0.901 . . . . 20.21 108.65 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' B' ' 32' ' ' LEU . 1.7 p -123.87 160.71 27.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.382 -0.824 . . . . 10.81 109.466 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.427 ' HD3' ' OE1' ' B' ' 30' ' ' GLU . 4.6 ttmt -77.36 164.65 25.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 36.74 110.434 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.596 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -149.65 172.61 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.448 -0.782 . . . . 19.74 108.9 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.1 m -108.72 146.38 33.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.163 -0.961 . . . . 22.56 109.378 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.635 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -117.5 145.96 43.86 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.201 -0.937 . . . . 20.41 108.615 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.459 ' HB2' ' NE2' ' B' ' 53' ' ' GLN . 0.7 OUTLIER -82.42 140.03 33.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 33.99 109.81 -179.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.18 106.84 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 54.92 109.403 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.88 -12.44 57.69 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.363 -1.495 . . . . 36.1 109.363 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' B' ' 50' ' ' ASP . 5.0 mt-30 -82.09 147.19 56.93 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.364 -1.08 . . . . 54.76 109.359 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.6 Cg_endo -78.08 123.27 6.1 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.646 2.231 . . . . 28.37 110.469 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.546 ' CB ' ' OE1' ' B' ' 31' ' ' GLN . . . -37.88 143.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.528 -0.732 . . . . 17.21 110.19 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.603 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 83.9 m-85 -41.41 97.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.457 -0.777 . . . . 17.19 109.259 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' B' ' 55' ' ' ALA . . . -42.87 165.52 0.1 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 17.82 109.582 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' B' ' 6' ' ' ILE . 35.0 Cg_endo -77.43 104.97 1.97 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.562 2.175 . . . . 17.28 110.122 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.74 -175.03 41.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.946 -1.262 . . . . 17.22 109.946 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.3 OUTLIER -76.31 142.07 41.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.075 -1.083 . . . . 19.57 108.075 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.59 ' CE1' HD12 ' B' ' 6' ' ' ILE . 15.5 m-85 -131.32 163.7 27.27 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.716 -1.24 . . . . 14.61 111.716 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.507 ' CG2' ' HG3' ' B' ' 1' ' ' MET . 50.6 p -145.64 120.09 9.68 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.61 -1.626 . . . . 18.36 106.61 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.587 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 3.8 t -50.64 171.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 118.78 -1.168 . . . . 19.13 108.861 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.518 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.8 t-80 -135.01 125.45 26.59 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.331 -0.856 . . . . 20.65 109.268 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.673 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -70.51 -2.91 15.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.771 . . . . 19.65 109.645 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -17.13 14.53 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.043 -1.095 . . . . 14.72 108.043 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 0.4 OUTLIER -101.63 -10.04 20.4 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.681 -0.637 . . . . 11.45 110.654 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.673 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.8 m-30 -72.05 164.12 26.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.022 -1.049 . . . . 14.25 109.943 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' B' ' 77' ' ' MET . 2.7 ptmt -146.38 177.17 9.23 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.966 -0.753 . . . . 32.7 108.966 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.99 158.72 37.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.266 -0.896 . . . . 15.63 109.348 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' B' ' 75' ' ' SER . . . 127.91 -140.13 11.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.36 -1.496 . . . . 12.7 109.36 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 28.2 tp60 57.19 60.68 2.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.11 -1.23 . . . . 26.29 109.378 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.2 OUTLIER 73.13 2.47 4.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.473 -0.767 . . . . 20.44 109.506 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 46' ' ' LYS . . . 103.78 54.77 0.8 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.975 -1.25 . . . . 13.82 109.975 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.4 ' N ' ' O ' ' B' ' 71' ' ' GLY . 48.1 t -151.34 147.51 27.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 18.27 109.827 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' B' ' 77' ' ' MET . 2.6 tp -59.56 164.9 3.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.291 -0.88 . . . . 12.43 109.175 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 12.5 mtp -165.14 104.37 0.76 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.086 -1.009 . . . . 35.11 110.103 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.585 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.4 mt -42.05 -63.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 13.67 109.425 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 38.0 t0 84.94 -45.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.407 0.622 . . . . 24.06 110.108 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.0 tmm_? -171.51 67.23 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.081 0.943 . . . . 35.04 108.531 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.587 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -38.16 131.13 1.16 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.685 0.755 . . . . 18.72 111.515 -178.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.525 ' NH1' ' HG2' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -96.4 107.1 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.892 -1.151 . . . . 20.55 107.892 178.437 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.603 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -76.98 146.7 37.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 14.4 111.243 -178.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.463 HG21 ' O ' ' B' ' 62' ' ' THR . 16.4 m -147.49 156.64 45.59 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 107.986 -1.116 . . . . 17.65 107.986 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.4 Cg_endo -63.88 142.66 83.13 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.142 1.894 . . . . 25.7 110.515 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.425 ' CA ' HG21 ' B' ' 62' ' ' THR . . . -72.04 115.03 10.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 49.29 109.505 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.038 -0.982 . . . . 58.91 109.499 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.513 ' SD ' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.306 0.574 . . . . 64.91 109.473 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.566 ' CA ' HD21 ' B' ' 65' ' ' LEU . 0.0 OUTLIER -82.65 82.57 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.109 -1.071 . . . . 33.8 108.109 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -68.04 163.59 22.0 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.112 0.958 . . . . 32.72 111.359 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.576 ' CG2' ' N ' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -174.38 167.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.428 -0.953 . . . . 14.46 108.428 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.576 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 31.6 mt-10 -140.39 111.39 7.02 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.899 0.857 . . . . 22.12 109.347 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.603 HG13 ' CE1' ' A' ' 61' ' ' TYR . 6.2 mm -73.86 89.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.279 -1.008 . . . . 14.23 108.279 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.7 mmpm? -41.99 161.89 0.15 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 25.43 109.649 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.9 Cg_endo -72.41 -12.25 27.16 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.037 1.825 . . . . 13.61 109.115 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.0 t -98.17 6.94 46.97 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.675 -0.861 . . . . 15.52 108.675 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.515 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 17.1 mm-40 -128.25 13.36 6.64 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.334 -0.854 . . . . 17.31 109.519 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -88.14 30.3 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 24.78 110.299 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.407 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 18.7 mt-30 -144.55 121.58 11.4 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.161 -0.962 . . . . 47.9 109.678 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.626 ' CD2' ' CB ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.77 -177.39 4.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.448 -0.782 . . . . 21.61 110.429 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 98.1 m -157.05 143.73 18.34 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.433 -0.792 . . . . 14.89 109.044 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.456 ' N ' HG21 ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.573 0 O-C-N 121.351 -0.843 . . . . 17.35 109.574 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.429 HD22 ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.457 0.646 . . . . 24.0 110.301 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.626 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -86.75 104.0 15.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.458 -0.776 . . . . 23.31 109.439 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 22.0 mt-10 -79.97 -176.53 5.53 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.039 -1.038 . . . . 40.03 109.422 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.544 ' CB ' HG23 ' A' ' 47' ' ' ILE . 3.5 mt-30 -168.38 -171.06 1.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 12.39 109.711 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.556 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 2.2 mp -131.39 179.08 6.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 17.42 109.634 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -172.25 159.5 4.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.935 -1.103 . . . . 13.84 109.024 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.619 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 2.8 m-85 -116.02 89.6 3.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 21.14 108.875 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 98.7 t -91.73 115.86 31.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.101 -0.999 . . . . 10.66 110.233 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 73.4 m-20 -60.62 -20.34 60.41 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.178 -1.045 . . . . 25.89 108.178 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 0.9 OUTLIER 40.65 27.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.673 -0.642 . . . . 24.24 109.922 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 61.66 27.46 68.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 120.127 -1.035 . . . . 31.02 110.539 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.592 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 8.8 p30 -106.78 22.68 15.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.677 -1.484 . . . . 43.23 110.417 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.546 ' O ' ' HB3' ' A' ' 41' ' ' HIS . 27.6 mt-10 61.36 50.49 4.7 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.215 -0.928 . . . . 42.34 111.027 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.592 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 2.3 p-80 154.68 149.45 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 108.187 -1.042 . . . . 9.47 108.187 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.611 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.2 Cg_endo -75.88 147.21 30.46 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.947 1.765 . . . . 17.92 110.317 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 14.5 m -121.36 116.68 50.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.242 -0.983 . . . . 20.57 109.069 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.619 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 21.9 tp -68.87 105.68 2.44 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.321 -0.952 . . . . 20.21 108.57 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -121.73 168.64 13.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.57 -0.706 . . . . 10.81 109.165 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' N ' HG11 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -82.63 156.24 23.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 36.74 110.621 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.624 HG12 ' CE2' ' A' ' 56' ' ' TYR . 1.4 tt -143.37 161.72 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.51 -0.922 . . . . 19.74 108.51 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.67 123.88 49.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.925 -1.11 . . . . 22.56 109.423 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 13' ' ' PHE . 1.9 tm? -86.5 125.02 33.45 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.769 -0.826 . . . . 20.41 108.769 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -54.89 139.22 41.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 33.99 109.602 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -55.37 118.93 4.86 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.224 -0.923 . . . . 54.92 109.328 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.39 -23.1 23.62 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.544 -1.422 . . . . 36.1 109.544 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.527 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -67.0 152.14 96.35 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -1.176 . . . . 54.76 109.357 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -79.58 117.05 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.476 2.117 . . . . 28.37 110.085 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -29.71 137.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.221 0.534 . . . . 17.21 111.128 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.624 ' CE2' HG12 ' A' ' 47' ' ' ILE . 99.2 m-85 -41.28 105.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.48 -0.763 . . . . 17.19 109.41 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.402 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -57.98 170.33 0.72 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.069 -1.019 . . . . 17.82 109.277 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 35.2 Cg_endo -77.67 103.24 1.69 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.459 2.106 . . . . 17.28 110.097 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.11 -179.77 44.96 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.921 -1.272 . . . . 17.22 109.921 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -72.69 149.86 43.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.366 -1.079 . . . . 19.57 108.12 179.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.603 ' CE1' HG13 ' A' ' 6' ' ' ILE . 18.0 m-85 -133.92 165.23 25.5 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.692 -1.255 . . . . 14.61 111.724 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 69.8 p -143.96 119.2 10.16 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.949 -1.871 . . . . 18.36 105.949 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.56 HG11 ' CD1' ' A' ' 81' ' ' LEU . 9.8 t -53.84 165.42 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 C-N-CA 118.404 -1.318 . . . . 19.13 108.962 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.529 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -134.15 126.46 30.03 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.47 -0.937 . . . . 20.65 108.47 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.65 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.3 pp -72.88 2.14 7.36 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.144 -0.972 . . . . 19.65 110.246 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.32 -18.96 19.5 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.643 -1.243 . . . . 14.72 107.643 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 1.3 t -100.37 -9.36 22.33 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.72 -0.612 . . . . 11.45 110.302 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 3.9 m-30 -73.48 156.67 37.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.962 -1.086 . . . . 14.25 109.32 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.523 ' N ' HD13 ' B' ' 37' ' ' LEU . 22.3 mtmt -152.89 167.12 30.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 32.7 109.717 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -101.11 123.32 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.513 -0.921 . . . . 15.63 108.513 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 70' ' ' VAL . . . -59.81 -130.7 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.046 -1.222 . . . . 12.7 110.046 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.522 ' C ' ' CG ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -87.2 46.01 1.33 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -1.144 . . . . 26.29 108.869 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.522 ' CG ' ' C ' ' A' ' 72' ' ' GLN . 1.8 m-85 77.06 0.02 3.0 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.993 -0.743 . . . . 20.44 108.993 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.59 -66.48 2.37 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.524 -1.43 . . . . 13.82 109.524 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.431 ' HA ' HG21 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -160.6 170.18 21.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -1.165 . . . . 18.27 109.667 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.9 OUTLIER -66.79 163.6 18.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 12.43 109.433 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.537 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 15.1 mtp -165.6 127.24 1.97 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 35.11 109.401 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.575 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.2 mt -53.93 -41.3 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.306 -0.871 . . . . 13.67 109.946 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 2.1 t0 45.0 54.55 6.83 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.512 -1.292 . . . . 24.06 107.512 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.567 ' CB ' ' O ' ' A' ' 79' ' ' ASP . 0.6 OUTLIER 85.56 116.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.017 -1.475 . . . . 35.04 107.017 -177.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.56 ' CD1' HG11 ' A' ' 63' ' ' VAL . 2.0 pp -94.63 152.02 18.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.332 -0.855 . . . . 18.72 111.274 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -101.52 95.6 6.57 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.905 -1.517 . . . . 20.55 106.905 177.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.624 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 2.0 tp -75.07 150.67 38.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.191 -0.943 . . . . 14.4 111.324 -177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.527 ' C ' ' CD2' ' A' ' 61' ' ' TYR . 24.1 m -147.47 158.96 42.85 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.809 -1.182 . . . . 17.65 107.809 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.3 Cg_endo -63.87 145.88 90.94 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.06 1.84 . . . . 25.7 110.335 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.538 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -80.39 115.37 19.89 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.133 -0.979 . . . . 49.29 109.579 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.2 tptt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.963 -1.018 . . . . 58.91 109.486 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.519 ' SD ' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.461 -0.57 . . . . 64.91 109.461 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.55 ' CA ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -83.26 82.52 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.083 -1.08 . . . . 33.8 108.083 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -67.99 163.59 21.89 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.169 0.985 . . . . 32.72 111.351 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.576 ' CG1' ' CB ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -174.38 167.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.419 -0.956 . . . . 14.46 108.419 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.565 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 31.3 mt-10 -140.27 111.5 7.13 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.866 0.841 . . . . 22.12 109.286 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.6 HG13 ' CE1' ' B' ' 61' ' ' TYR . 6.2 mm -74.04 89.7 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.285 -1.006 . . . . 14.23 108.285 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.587 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.7 mmpm? -41.73 161.81 0.14 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 25.43 109.668 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.7 Cg_endo -72.44 -12.39 27.21 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.957 1.771 . . . . 13.61 109.117 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.5 t -97.94 6.9 47.17 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.655 -0.868 . . . . 15.52 108.655 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.511 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 17.0 mm-40 -128.17 13.14 6.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.316 -0.865 . . . . 17.31 109.609 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -87.92 30.13 0.87 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.973 . . . . 24.78 110.333 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 18.7 mt-30 -144.33 121.71 11.65 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.129 -0.982 . . . . 47.9 109.659 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.626 ' CD2' ' CB ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -77.84 -177.33 4.86 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.456 -0.777 . . . . 21.61 110.42 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 97.7 m -157.14 143.61 18.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.34 -0.85 . . . . 14.89 109.088 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' THR . . . . . 0.466 ' N ' HG21 ' B' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.599 0 O-C-N 121.445 -0.784 . . . . 17.35 109.572 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.432 HD22 ' O ' ' B' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.522 0.677 . . . . 24.0 110.224 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.626 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -86.82 103.79 15.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.426 -0.796 . . . . 23.31 109.465 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 21.7 mt-10 -79.77 -176.65 5.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.043 -1.035 . . . . 40.03 109.524 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.545 ' CB ' HG23 ' B' ' 47' ' ' ILE . 3.5 mt-30 -168.19 -171.12 1.44 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.209 -0.932 . . . . 12.39 109.778 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.56 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 2.2 mp -131.26 179.11 6.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 17.42 109.633 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -172.35 159.43 4.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.925 -1.109 . . . . 13.84 108.946 -179.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.631 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 2.8 m-85 -116.06 89.47 3.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.953 . . . . 21.14 108.911 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.526 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 98.5 t -91.59 116.13 32.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.055 -1.028 . . . . 10.66 110.26 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 73.3 m-20 -60.92 -19.96 61.36 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.213 -1.032 . . . . 25.89 108.213 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.54 ' HB3' ' ND2' ' B' ' 39' ' ' ASN . 0.9 OUTLIER 40.42 27.67 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.644 -0.66 . . . . 24.24 109.867 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 61.58 27.54 68.24 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.552 -1.019 . . . . 31.02 110.552 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.585 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 8.7 p30 -106.83 22.67 15.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.67 -1.488 . . . . 43.23 110.517 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' B' ' 41' ' ' HIS . 27.7 mt-10 61.34 50.58 4.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.172 -0.955 . . . . 42.34 111.026 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 2.3 p-80 154.61 149.35 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.198 -1.038 . . . . 9.49 108.198 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.618 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 34.9 Cg_endo -75.78 147.2 30.81 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.933 1.755 . . . . 17.92 110.33 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 14.5 m -121.36 116.97 51.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 C-N-CA 119.282 -0.967 . . . . 20.57 109.068 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.631 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 22.1 tp -69.25 105.54 2.56 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.333 -0.947 . . . . 20.21 108.568 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.454 HG13 ' SG ' ' B' ' 33' ' ' CYS . 0.5 OUTLIER -121.58 168.57 13.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.63 0 O-C-N 121.589 -0.694 . . . . 10.81 109.161 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.445 ' N ' HG11 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -82.49 156.23 24.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 36.74 110.605 -178.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.624 HG12 ' CE2' ' B' ' 56' ' ' TYR . 1.4 tt -143.42 161.62 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.464 -0.939 . . . . 19.74 108.464 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.59 123.94 49.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.958 -1.089 . . . . 22.56 109.418 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.587 HD13 ' CD2' ' B' ' 13' ' ' PHE . 1.9 tm? -86.56 124.99 33.47 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.3 OUTLIER -54.85 139.27 40.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 33.99 109.666 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -55.4 118.92 4.86 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.232 -0.917 . . . . 54.92 109.31 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.34 -22.94 24.24 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.596 -1.401 . . . . 36.1 109.596 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.529 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 0.6 OUTLIER -67.18 152.18 96.37 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.172 -1.193 . . . . 54.76 109.29 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.506 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -79.55 117.11 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.462 2.108 . . . . 28.37 110.018 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.556 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -29.9 138.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.233 0.54 . . . . 17.21 111.068 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.624 ' CE2' HG12 ' B' ' 47' ' ' ILE . 99.3 m-85 -41.33 105.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 17.19 109.591 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.4 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -57.46 170.32 0.63 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.09 -1.006 . . . . 17.82 109.186 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' B' ' 6' ' ' ILE . 35.3 Cg_endo -78.01 104.2 1.81 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.553 2.169 . . . . 17.28 110.267 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.64 -179.34 46.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.861 -1.295 . . . . 17.22 109.861 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.3 OUTLIER -72.31 150.27 43.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.151 . . . . 19.57 108.449 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.6 ' CE1' HG13 ' B' ' 6' ' ' ILE . 16.4 m-85 -134.34 165.29 25.49 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.775 -1.203 . . . . 14.61 111.75 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.546 ' CG2' ' HA ' ' B' ' 86' ' ' ALA . 67.1 p -144.15 119.23 10.06 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.029 -1.841 . . . . 18.36 106.029 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.562 HG11 ' CD1' ' B' ' 81' ' ' LEU . 9.7 t -53.91 165.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 C-N-CA 118.419 -1.312 . . . . 19.13 109.006 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -134.0 126.44 30.23 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.424 -0.954 . . . . 20.65 108.424 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.65 ' CB ' ' CD2' ' B' ' 68' ' ' PHE . 2.3 pp -72.76 1.9 7.64 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.193 -0.942 . . . . 19.65 110.197 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -19.02 16.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.575 -1.269 . . . . 14.72 107.575 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.518 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 1.3 t -100.5 -9.85 21.67 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.72 -0.613 . . . . 11.45 110.306 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.9 m-30 -72.94 156.46 38.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.979 -1.076 . . . . 14.25 109.206 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.533 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 22.5 mtmt -152.71 166.67 31.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 32.7 109.803 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' B' ' 71' ' ' GLY . 0.5 OUTLIER -100.53 123.14 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.527 -0.916 . . . . 15.63 108.527 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' B' ' 70' ' ' VAL . . . -59.95 -130.71 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.016 -1.233 . . . . 12.7 110.016 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.537 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -87.1 46.25 1.36 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -1.133 . . . . 26.29 108.879 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.537 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 1.8 m-85 76.79 0.05 3.07 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.058 -0.719 . . . . 20.44 109.058 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.64 -66.28 2.45 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.612 -1.395 . . . . 13.82 109.612 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.434 ' HA ' HG21 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -160.7 170.1 21.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -1.186 . . . . 18.27 109.673 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.533 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.9 OUTLIER -66.72 163.45 19.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 12.43 109.462 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 15.2 mtp -165.59 127.42 2.0 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.892 . . . . 35.11 109.381 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.58 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.1 mt -54.22 -41.12 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 13.67 109.921 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 2.1 t0 44.92 54.67 6.66 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.442 -1.318 . . . . 24.06 107.442 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.567 ' CB ' ' O ' ' B' ' 79' ' ' ASP . 0.6 OUTLIER 85.56 116.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.097 -1.445 . . . . 35.04 107.097 -177.324 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.562 ' CD1' HG11 ' B' ' 63' ' ' VAL . 2.0 pp -94.53 152.13 18.79 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 18.72 111.276 -177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -101.7 95.5 6.47 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.93 -1.507 . . . . 20.55 106.93 177.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.622 ' HB3' ' CE1' ' B' ' 56' ' ' TYR . 2.0 tp -75.0 150.57 38.93 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.161 -0.962 . . . . 14.4 111.335 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.536 ' C ' ' CD2' ' B' ' 61' ' ' TYR . 24.1 m -147.47 158.64 43.31 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 107.813 -1.181 . . . . 17.65 107.813 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.0 Cg_endo -63.61 145.94 92.09 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.022 1.815 . . . . 25.7 110.357 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.546 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -80.36 115.54 19.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 49.29 109.564 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 16.2 tptt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.984 -1.008 . . . . 58.91 109.506 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.341 -0.615 . . . . 64.91 109.341 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.589 ' CA ' HD23 ' B' ' 65' ' ' LEU . 0.0 OUTLIER 56.21 88.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.933 -1.104 . . . . 33.8 108.046 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.457 ' CG ' ' HE2' ' A' ' 1' ' ' MET . 0.3 OUTLIER -92.77 167.12 12.08 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.341 -0.849 . . . . 32.72 110.437 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -172.67 165.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.993 -0.743 . . . . 14.46 108.993 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.561 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 34.3 mt-10 -141.74 110.37 6.09 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.908 -0.775 . . . . 22.12 108.908 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.563 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -71.85 100.81 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 119.171 -1.012 . . . . 14.23 108.401 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.579 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 3.0 mmmt -41.49 163.48 0.11 Allowed Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.462 -0.774 . . . . 25.43 109.423 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.68 -13.92 27.16 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.961 1.774 . . . . 13.61 109.224 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -96.58 5.32 51.0 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.716 -0.846 . . . . 15.52 108.716 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 9.1 mm-40 -125.93 34.9 4.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.361 -0.837 . . . . 17.31 109.355 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.95 8.46 42.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 24.78 110.014 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -132.14 144.47 50.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.223 -0.923 . . . . 47.9 109.516 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.635 ' CE1' ' ND2' ' A' ' 29' ' ' ASN . 30.8 p90 -91.68 164.73 13.63 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.259 -0.901 . . . . 21.61 109.407 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -137.7 152.5 49.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.29 -0.881 . . . . 14.89 109.125 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.473 0 O-C-N 121.242 -0.911 . . . . 17.35 109.366 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.326 0.584 . . . . 24.0 110.057 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.635 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 92.8 m-20 -52.92 118.87 4.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.844 . . . . 23.31 109.336 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 5.1 mt-10 -110.98 165.83 11.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 40.03 109.183 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.542 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -144.03 162.98 34.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.051 -1.031 . . . . 12.39 109.861 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.548 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 3.6 mm? -102.64 178.28 4.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.404 -0.81 . . . . 17.42 109.958 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' CD1' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -175.29 159.42 2.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.003 -1.06 . . . . 13.84 108.604 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.633 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 3.1 m-30 -113.96 98.04 6.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.997 . . . . 21.14 108.592 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 14.0 t -107.34 130.23 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 10.66 110.665 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.486 ' O ' HD11 ' A' ' 37' ' ' LEU . 12.5 p-10 -81.01 -30.18 34.99 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.124 -1.065 . . . . 25.89 108.124 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.544 ' CD1' ' ND2' ' A' ' 39' ' ' ASN . 0.4 OUTLIER 31.09 40.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.159 0.504 . . . . 24.24 110.993 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' C ' ' OD1' ' A' ' 39' ' ' ASN . . . 102.07 20.32 12.87 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.811 -1.185 . . . . 31.02 110.597 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.544 ' ND2' ' CD1' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -135.29 103.3 5.46 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.965 -1.315 . . . . 43.23 108.223 178.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -29.54 -38.06 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.356 0.598 . . . . 42.34 111.407 -178.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 39' ' ' ASN . 40.9 m80 -89.03 153.18 49.08 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.312 -0.867 . . . . 7.76 109.177 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 34.8 Cg_endo -76.83 148.38 28.36 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.2 1.933 . . . . 17.92 110.377 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 1.8 m -119.43 119.0 59.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.185 -1.006 . . . . 20.57 109.434 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.633 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 18.5 tp -70.81 109.53 5.05 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.447 -0.946 . . . . 20.21 108.447 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.596 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 2.9 t -121.12 168.96 13.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.635 -0.666 . . . . 10.81 109.725 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -89.53 -175.47 4.71 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.419 -0.801 . . . . 36.74 110.251 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.664 HG12 ' CE2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -168.85 173.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 19.74 109.144 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.4 m -109.18 145.28 36.06 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.3 -0.875 . . . . 22.56 109.148 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.632 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 1.8 tm? -127.76 100.31 5.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.343 -0.848 . . . . 20.41 109.052 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 53' ' ' GLN . 4.0 m-20 -41.4 129.4 3.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.394 -0.816 . . . . 33.99 110.04 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.74 100.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.303 -0.873 . . . . 54.92 109.161 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.37 -37.32 2.79 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.258 -1.537 . . . . 36.1 109.258 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.468 ' O ' HD13 ' A' ' 49' ' ' LEU . 4.3 mt-30 -64.0 151.88 88.71 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.228 -1.16 . . . . 54.76 109.048 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.6 Cg_endo -77.07 117.72 4.52 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.533 2.156 . . . . 28.37 110.439 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.477 ' HB3' ' HG3' ' A' ' 31' ' ' GLN . . . -40.05 148.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.522 -0.736 . . . . 17.21 109.926 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.664 ' CE2' HG12 ' A' ' 47' ' ' ILE . 9.7 m-30 -48.45 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 17.19 109.6 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.48 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -48.65 174.24 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 17.82 109.307 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 36.1 Cg_endo -78.55 125.3 6.81 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.652 2.234 . . . . 17.28 110.368 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.29 -179.24 39.24 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.718 -1.23 . . . . 17.22 110.045 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -73.15 142.6 47.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.369 -1.077 . . . . 19.57 108.577 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.563 ' CZ ' HD11 ' A' ' 6' ' ' ILE . 8.8 m-85 -127.24 163.49 23.78 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.65 -1.281 . . . . 14.61 111.546 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.514 HG21 ' CB ' ' A' ' 86' ' ' ALA . 54.8 p -148.47 117.35 6.72 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.941 -1.503 . . . . 18.36 106.941 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.553 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 15.8 t -47.59 169.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 C-N-CA 119.168 -1.013 . . . . 19.13 109.106 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 7.5 t-80 -133.72 129.72 37.13 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.834 -0.802 . . . . 20.65 108.834 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.575 HD23 ' CA ' ' B' ' 2' ' ' ILE . 0.7 OUTLIER -64.18 -10.52 23.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.511 -0.743 . . . . 19.65 109.89 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' LEU . 1.2 t -45.62 -25.93 0.54 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.589 -0.893 . . . . 14.72 108.589 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 7.2 m -98.19 -12.07 22.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.51 -0.744 . . . . 11.45 110.485 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.633 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.6 m-30 -80.16 153.86 28.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.845 -1.16 . . . . 14.25 109.762 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 68' ' ' PHE . 71.1 mttt -157.37 171.05 21.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.505 -0.747 . . . . 32.7 109.233 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -101.4 100.76 11.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.889 . . . . 15.63 109.124 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.68 -175.98 5.98 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.525 -1.43 . . . . 12.7 109.525 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.72 27.44 1.77 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.143 -1.21 . . . . 26.29 109.314 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 5.0 23.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.434 -0.791 . . . . 20.44 109.627 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.476 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . 67.66 49.47 49.6 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.467 -1.453 . . . . 13.82 109.467 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -170.07 148.88 3.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -1.129 . . . . 18.27 109.707 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.504 ' O ' ' CG ' ' A' ' 77' ' ' MET . 5.1 tt -61.16 159.1 12.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 12.43 109.278 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.504 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.8 mtt -163.79 111.39 1.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.09 -1.006 . . . . 35.11 109.993 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.633 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.5 mt -52.77 145.87 2.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.354 -0.841 . . . . 13.67 109.647 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.577 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -126.06 53.47 1.61 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.804 -1.554 . . . . 24.06 106.804 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.577 ' CB ' ' O ' ' A' ' 79' ' ' ASP . 2.4 tmm_? 89.67 67.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.31 -1.367 . . . . 35.04 107.31 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.553 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -32.78 124.91 0.35 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.373 -0.831 . . . . 18.72 111.678 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.6 103.88 16.52 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.483 -1.303 . . . . 20.55 107.483 178.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.614 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -79.79 145.97 32.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.058 -1.026 . . . . 14.4 111.217 -178.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 62' ' ' THR . 27.2 m -146.53 158.6 46.47 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.96 -1.126 . . . . 17.65 107.96 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.16 141.07 74.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.084 1.856 . . . . 25.7 110.134 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.514 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -69.07 108.3 3.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.139 -0.976 . . . . 49.29 109.482 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.961 -1.018 . . . . 58.91 109.413 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' CG ' ' B' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.335 -0.617 . . . . 64.91 109.335 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.575 ' CA ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER 56.12 88.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.891 -1.131 . . . . 33.8 107.973 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.464 ' CG ' ' HE2' ' B' ' 1' ' ' MET . 0.3 OUTLIER -92.9 167.13 12.04 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.298 -0.876 . . . . 32.72 110.438 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' B' ' 5' ' ' GLU . 0.2 OUTLIER -172.74 165.34 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.692 0.758 . . . . 14.46 108.962 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 34.3 mt-10 -141.67 110.52 6.17 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.882 -0.785 . . . . 22.12 108.882 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.599 HD11 ' CZ ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -71.97 101.06 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 C-N-CA 119.126 -1.03 . . . . 14.23 108.396 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.58 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 3.0 mmmt -41.61 163.61 0.11 Allowed Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.49 -0.756 . . . . 25.43 109.493 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.0 Cg_endo -72.72 -13.95 27.06 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.983 1.789 . . . . 13.61 109.201 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.6 m -96.55 5.19 51.27 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.677 -0.86 . . . . 15.52 108.677 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.535 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 9.1 mm-40 -125.9 34.94 4.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.328 -0.857 . . . . 17.31 109.412 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.92 8.46 42.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 24.78 110.026 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -132.19 144.36 50.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.272 -0.893 . . . . 47.9 109.576 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.637 ' CD2' ' CD1' ' B' ' 49' ' ' LEU . 31.0 p90 -91.6 164.78 13.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.284 -0.885 . . . . 21.61 109.385 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -137.71 152.53 49.34 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.331 -0.856 . . . . 14.89 109.11 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 17.35 109.378 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.379 0.609 . . . . 24.0 110.106 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 92.9 m-20 -52.68 118.91 3.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 23.31 109.348 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 5.1 mt-10 -111.09 165.78 11.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.051 -1.031 . . . . 40.03 109.193 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.547 ' CB ' HG21 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -143.96 162.94 34.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.139 -0.976 . . . . 12.39 109.798 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.554 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 3.6 mm? -102.67 178.07 4.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 17.42 109.91 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -175.08 159.32 2.59 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.92 -1.112 . . . . 13.84 108.619 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.635 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 3.1 m-30 -113.81 97.86 6.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.138 -0.976 . . . . 21.14 108.63 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' B' ' 43' ' ' VAL . 13.9 t -107.24 130.08 59.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.106 -0.996 . . . . 10.66 110.731 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' B' ' 37' ' ' LEU . 12.5 p-10 -80.79 -30.45 35.97 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.128 -1.064 . . . . 25.89 108.128 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.549 ' CD1' ' ND2' ' B' ' 39' ' ' ASN . 0.4 OUTLIER 31.45 40.55 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.171 0.51 . . . . 24.24 110.953 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.448 ' C ' ' OD1' ' B' ' 39' ' ' ASN . . . 101.91 20.61 12.44 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.834 -1.174 . . . . 31.02 110.583 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.549 ' ND2' ' CD1' ' B' ' 37' ' ' LEU . 1.0 OUTLIER -135.43 103.31 5.43 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.016 -1.285 . . . . 43.23 108.211 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -29.57 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.291 0.567 . . . . 42.34 111.384 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' B' ' 39' ' ' ASN . 40.9 m80 -89.14 153.13 48.82 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.375 -0.828 . . . . 7.67 109.183 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.611 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.1 Cg_endo -76.83 148.31 28.3 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.179 1.92 . . . . 17.92 110.38 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' B' ' 35' ' ' VAL . 1.7 m -119.34 119.3 60.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.258 -0.977 . . . . 20.57 109.369 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.635 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 18.6 tp -71.13 109.78 5.4 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.55 -0.907 . . . . 20.21 108.55 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.612 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 3.0 t -121.38 168.84 13.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.613 -0.68 . . . . 10.81 109.776 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.584 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -89.24 -175.4 4.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.493 -0.754 . . . . 36.74 110.314 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.676 HG12 ' CE2' ' B' ' 56' ' ' TYR . 0.0 OUTLIER -168.98 173.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.3 -0.875 . . . . 19.74 109.135 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 24.6 m -109.28 145.22 36.29 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.3 -0.875 . . . . 22.56 109.108 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.637 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 1.8 tm? -127.73 100.35 5.92 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.871 . . . . 20.41 109.059 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.45 ' HB2' ' HB2' ' B' ' 53' ' ' GLN . 3.9 m-20 -41.44 129.42 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 33.99 110.024 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.74 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.293 -0.879 . . . . 54.92 109.152 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.25 -37.15 2.84 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.225 -1.55 . . . . 36.1 109.225 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.46 ' O ' HD13 ' B' ' 49' ' ' LEU . 4.2 mt-30 -64.2 151.91 89.43 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.223 -1.163 . . . . 54.76 109.036 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.9 Cg_endo -77.22 117.63 4.45 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.546 2.164 . . . . 28.37 110.457 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' B' ' 57' ' ' ALA . . . -39.72 148.0 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.523 -0.736 . . . . 17.21 110.09 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.676 ' CE2' HG12 ' B' ' 47' ' ' ILE . 9.5 m-30 -47.99 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.293 -0.88 . . . . 17.19 109.595 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.488 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -47.63 174.19 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 17.82 109.486 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.8 Cg_endo -78.24 124.42 6.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.577 2.185 . . . . 17.28 110.094 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.89 -179.63 40.0 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.536 -1.316 . . . . 17.22 110.148 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.46 HD22 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -73.54 142.25 46.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -1.076 . . . . 19.57 108.33 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.599 ' CZ ' HD11 ' B' ' 6' ' ' ILE . 9.2 m-85 -127.02 163.62 23.33 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.654 -1.279 . . . . 14.61 111.519 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.509 HG21 ' CB ' ' B' ' 86' ' ' ALA . 55.9 p -148.4 117.42 6.77 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.002 -1.481 . . . . 18.36 107.002 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.552 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 16.0 t -47.62 169.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 C-N-CA 119.176 -1.01 . . . . 19.13 109.052 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 7.6 t-80 -133.89 129.91 37.06 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.819 -0.808 . . . . 20.65 108.819 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.589 HD23 ' CA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -64.27 -10.53 24.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.696 . . . . 19.65 109.927 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.435 ' C ' ' O ' ' B' ' 65' ' ' LEU . 1.2 t -45.56 -25.83 0.51 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.56 -0.904 . . . . 14.72 108.56 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 7.1 m -98.28 -12.37 21.64 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.727 . . . . 11.45 110.486 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.628 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.5 m-30 -80.01 153.8 28.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 14.25 109.685 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' B' ' 68' ' ' PHE . 71.1 mttt -157.43 170.73 21.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.541 -0.724 . . . . 32.7 109.199 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.596 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -101.05 100.79 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 15.63 109.034 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.77 -175.91 6.05 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.426 -1.47 . . . . 12.7 109.426 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.61 27.26 1.78 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.202 -1.175 . . . . 26.29 109.358 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.88 5.06 24.12 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.512 -0.742 . . . . 20.44 109.611 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.462 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . 67.36 50.0 47.7 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.41 -1.476 . . . . 13.82 109.41 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' B' ' 74' ' ' GLY . 1.0 OUTLIER -170.37 148.94 3.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -1.135 . . . . 18.27 109.608 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' B' ' 77' ' ' MET . 5.2 tt -61.31 159.29 12.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.927 . . . . 12.43 109.256 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.516 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.8 mtt -163.97 111.36 1.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.079 -1.013 . . . . 35.11 110.026 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.628 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.4 mt -52.77 145.7 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 13.67 109.726 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -125.84 53.52 1.58 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.789 -1.56 . . . . 24.06 106.789 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' B' ' 79' ' ' ASP . 2.4 tmm_? 89.63 67.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.334 -1.358 . . . . 35.04 107.334 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.552 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -32.92 124.93 0.36 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.363 -0.835 . . . . 18.72 111.661 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.54 103.86 16.5 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.451 -1.314 . . . . 20.55 107.451 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.614 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -79.9 145.87 32.45 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.135 -0.978 . . . . 14.4 111.25 -178.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' B' ' 62' ' ' THR . 27.3 m -146.32 158.97 46.67 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 107.967 -1.123 . . . . 17.65 107.967 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -64.42 141.24 73.5 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.049 1.833 . . . . 25.7 110.152 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.509 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -69.17 108.05 3.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.223 -0.923 . . . . 49.29 109.462 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.965 -1.017 . . . . 58.91 109.489 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.519 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.434 -0.58 . . . . 64.91 109.434 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.546 ' HA ' ' CD1' ' B' ' 65' ' ' LEU . 1.6 mt 50.32 78.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.866 -1.161 . . . . 33.8 107.866 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' C ' HG11 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -71.26 155.93 40.13 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.712 0.767 . . . . 32.72 110.57 -178.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.588 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -165.05 165.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.553 0.692 . . . . 14.46 109.262 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.53 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 22.3 mt-10 -138.64 116.89 11.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 22.12 109.258 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.581 HG12 ' CD1' ' A' ' 61' ' ' TYR . 19.4 mm -77.43 97.44 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.259 -0.901 . . . . 14.23 108.743 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.589 ' HD3' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.14 161.15 0.31 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.089 -1.007 . . . . 25.43 110.121 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.93 -29.76 5.06 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.626 2.217 . . . . 13.61 110.214 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.41 -0.85 43.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.492 -0.755 . . . . 15.52 109.131 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.513 ' NE2' ' HA ' ' A' ' 33' ' ' CYS . 9.3 pt20 -129.97 28.88 5.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 17.31 109.644 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -85.03 16.31 3.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 24.78 110.106 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.441 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -138.72 144.33 39.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.082 -1.011 . . . . 47.9 108.828 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.652 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 12.8 p90 -87.01 178.42 6.94 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.168 -0.958 . . . . 21.61 109.743 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 8.7 t -132.22 163.01 29.53 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.58 -0.896 . . . . 14.89 108.58 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.534 0 O-C-N 121.138 -0.977 . . . . 17.35 109.617 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' C ' ' CD1' ' A' ' 28' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.497 0.665 . . . . 24.0 110.292 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.652 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -93.78 131.72 38.87 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.717 -0.845 . . . . 23.31 108.717 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 1.8 mp0 -109.88 159.28 17.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.861 -1.149 . . . . 40.03 109.448 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.537 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -135.68 -165.33 1.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.083 -1.01 . . . . 12.39 110.04 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.559 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -134.64 178.56 6.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.721 . . . . 17.42 109.392 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.513 ' HA ' ' NE2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -172.93 153.74 2.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.955 -1.09 . . . . 13.84 108.893 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 3.1 m-30 -112.06 96.77 6.23 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.506 -0.924 . . . . 21.14 108.506 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 85.7 t -97.12 114.92 35.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.036 -1.04 . . . . 10.66 110.118 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.6 p-10 -59.36 -32.13 69.84 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.301 -1.0 . . . . 25.89 108.301 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.519 ' CD2' ' HA ' ' B' ' 69' ' ' LYS . 0.7 OUTLIER 47.02 28.64 0.92 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.563 -0.711 . . . . 24.24 109.174 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.39 18.14 71.23 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.371 -1.492 . . . . 31.02 109.371 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' OD1' HD21 ' A' ' 37' ' ' LEU . 92.6 m-20 -91.01 26.67 2.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -1.122 . . . . 43.23 110.367 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.527 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 1.7 mm-40 48.35 22.24 0.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.138 -0.976 . . . . 42.34 110.148 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 3.6 m80 -175.88 153.26 1.35 Allowed Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.074 -1.084 . . . . 6.15 108.074 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.625 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.6 Cg_endo -75.73 144.09 27.56 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.923 1.749 . . . . 17.92 110.938 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 14.4 m -119.47 118.37 57.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.735 -0.839 . . . . 20.57 108.735 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.634 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 18.6 tp -68.41 111.79 4.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.781 -0.768 . . . . 20.21 109.339 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 4.0 t -117.2 168.46 8.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.692 -0.63 . . . . 10.81 109.352 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 1.9 mtpt -86.63 174.92 8.57 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.238 -0.914 . . . . 36.74 110.347 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -155.4 165.25 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -0.856 . . . . 19.74 109.028 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.469 ' O ' HD21 ' A' ' 49' ' ' LEU . 30.8 m -110.79 149.54 30.4 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.319 -0.863 . . . . 22.56 108.98 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -133.25 127.96 34.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 20.41 109.341 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.09 148.64 41.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 33.99 109.535 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.62 93.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 54.92 109.544 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.6 -29.39 3.81 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.722 -1.351 . . . . 36.1 109.722 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.9 144.87 85.91 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.177 -1.19 . . . . 54.76 109.597 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -78.2 117.48 4.12 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.696 2.264 . . . . 28.37 110.585 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.477 ' CB ' ' HG3' ' A' ' 31' ' ' GLN . . . -42.78 155.51 0.05 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.249 -0.907 . . . . 17.21 110.196 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.623 ' CE2' ' CB ' ' A' ' 83' ' ' LEU . 15.0 m-30 -49.03 112.53 0.63 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.574 -0.704 . . . . 17.19 109.758 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.533 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -66.13 177.35 0.78 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 17.82 109.313 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -78.21 113.4 3.38 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.586 2.191 . . . . 17.28 110.28 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.06 177.27 43.11 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.912 -1.275 . . . . 17.22 109.912 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 4.9 mp -74.96 152.79 38.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -1.107 . . . . 19.57 108.221 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.588 ' CB ' HG12 ' A' ' 4' ' ' VAL . 17.7 m-85 -140.17 165.18 28.08 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.802 -1.186 . . . . 14.61 111.78 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.519 ' CG2' ' HG3' ' A' ' 1' ' ' MET . 43.8 p -145.64 120.55 9.98 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.356 -1.72 . . . . 18.36 106.356 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 4.7 t -50.38 170.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 C-N-CA 118.739 -1.185 . . . . 19.13 108.791 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.9 t-80 -130.43 122.98 28.77 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.38 -0.825 . . . . 20.65 108.942 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.622 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -66.65 -6.24 14.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.673 -0.642 . . . . 19.65 109.747 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.1 t -54.78 -15.87 2.2 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.058 -1.026 . . . . 14.72 108.565 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 35.1 m -98.79 -5.75 30.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.495 -0.753 . . . . 11.45 110.891 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 2.8 m-30 -81.16 155.7 26.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.763 -1.211 . . . . 14.25 109.988 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.51 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 9.9 mtmt -143.78 171.48 14.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.501 -0.749 . . . . 32.7 109.349 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.464 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.5 OUTLIER -117.77 131.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 15.63 109.603 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.67 175.86 53.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.457 -1.457 . . . . 12.7 109.457 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.2 9.6 12.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.115 -1.226 . . . . 26.29 109.893 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.474 ' O ' ' CG ' ' A' ' 73' ' ' PHE . 30.1 t80 -109.62 9.65 25.07 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.57 -0.707 . . . . 20.44 109.391 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' B' ' 46' ' ' LYS . . . 70.75 71.66 0.99 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.51 -1.436 . . . . 13.82 109.51 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 74' ' ' GLY . 4.5 m -165.86 112.6 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -1.153 . . . . 18.27 109.683 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.518 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -68.51 151.36 46.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 12.43 109.169 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.518 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 7.1 mtp -163.04 139.78 7.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 35.11 109.842 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.617 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.4 mt -67.77 140.78 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 13.67 109.805 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 1.6 t70 -110.1 -19.24 13.12 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.389 -0.967 . . . . 24.06 108.389 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.5 OUTLIER 173.01 68.11 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.878 -1.527 . . . . 35.04 106.878 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.575 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -32.06 119.62 0.27 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.512 -0.767 . . . . 18.72 111.399 -177.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -89.66 110.05 20.97 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.844 -1.169 . . . . 20.55 107.844 178.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.623 ' CB ' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -82.12 143.86 31.17 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.036 -1.04 . . . . 14.4 111.101 -178.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.454 ' C ' ' CD2' ' A' ' 61' ' ' TYR . 4.5 m -143.99 159.56 52.68 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.97 -1.122 . . . . 17.65 107.97 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.6 Cg_endo -63.41 147.58 93.3 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.177 1.918 . . . . 25.7 110.335 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -74.62 118.75 17.93 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.105 -0.997 . . . . 49.29 109.541 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.056 -0.973 . . . . 58.91 109.468 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.519 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.37 -0.604 . . . . 64.91 109.37 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.538 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 1.5 mt 50.33 78.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.806 -1.183 . . . . 33.8 107.806 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.446 ' C ' HG11 ' B' ' 4' ' ' VAL . 0.4 OUTLIER -71.2 156.18 39.86 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.721 0.772 . . . . 32.72 110.553 -178.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.59 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -165.25 165.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.583 0.706 . . . . 14.46 109.283 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.526 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 22.4 mt-10 -138.57 116.92 11.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.497 -0.752 . . . . 22.12 109.333 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.585 HG12 ' CD1' ' B' ' 61' ' ' TYR . 19.7 mm -77.55 97.26 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.265 -0.897 . . . . 14.23 108.754 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.576 ' HD3' ' CG ' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.98 161.17 0.3 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.114 -0.991 . . . . 25.43 110.145 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.02 -29.77 4.93 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.665 2.244 . . . . 13.61 110.169 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.31 -1.05 43.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.436 -0.79 . . . . 15.52 109.058 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.523 ' NE2' ' HA ' ' B' ' 33' ' ' CYS . 9.3 pt20 -129.9 29.0 5.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.861 . . . . 17.31 109.683 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -85.1 16.36 3.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 24.78 110.051 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.447 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -138.67 144.49 39.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.085 -1.009 . . . . 47.9 108.806 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.642 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 12.7 p90 -87.16 178.32 6.92 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.159 -0.963 . . . . 21.61 109.739 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 9.0 t -132.16 163.08 29.31 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.618 -0.882 . . . . 14.89 108.618 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.568 0 O-C-N 121.15 -0.969 . . . . 17.35 109.584 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.505 ' C ' ' CD1' ' B' ' 28' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.522 0.677 . . . . 24.0 110.311 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.642 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -93.65 131.76 38.65 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.677 -0.86 . . . . 23.31 108.677 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 1.8 mp0 -110.02 159.45 17.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.958 -1.089 . . . . 40.03 109.416 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.537 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -135.81 -165.37 1.69 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.118 -0.989 . . . . 12.39 109.988 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.555 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -134.68 178.46 6.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.533 -0.729 . . . . 17.42 109.395 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.523 ' HA ' ' NE2' ' B' ' 10' ' ' GLN . 0.1 OUTLIER -172.83 153.73 2.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.002 -1.061 . . . . 13.84 108.933 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.638 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 3.1 m-30 -112.03 96.68 6.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.462 -0.94 . . . . 21.14 108.462 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.531 ' O ' ' CG2' ' B' ' 43' ' ' VAL . 85.3 t -96.98 115.08 35.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.066 -1.021 . . . . 10.66 110.155 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.6 p-10 -59.58 -31.86 69.84 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.311 -0.996 . . . . 25.89 108.311 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.51 ' CD2' ' HA ' ' A' ' 69' ' ' LYS . 0.7 OUTLIER 46.76 28.61 0.84 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.473 -0.767 . . . . 24.24 109.17 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.54 18.08 71.46 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.33 -1.508 . . . . 31.02 109.33 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.463 ' OD1' HD21 ' B' ' 37' ' ' LEU . 92.7 m-20 -90.88 26.34 2.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.324 -1.103 . . . . 43.23 110.479 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.527 ' O ' ' ND1' ' B' ' 41' ' ' HIS . 1.7 mm-40 48.6 22.02 0.46 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.07 -1.019 . . . . 42.34 110.116 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' B' ' 40' ' ' GLU . 3.6 m80 -175.68 153.18 1.4 Allowed Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 108.085 -1.08 . . . . 6.06 108.085 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.618 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.5 Cg_endo -75.73 144.08 27.55 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.961 1.774 . . . . 17.92 110.884 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' B' ' 35' ' ' VAL . 14.0 m -119.46 118.51 57.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.601 -0.84 . . . . 20.57 108.765 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.638 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 18.9 tp -68.56 111.67 4.88 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.848 -0.741 . . . . 20.21 109.348 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 4.3 t -117.13 168.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.643 -0.661 . . . . 10.81 109.304 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 1.9 mtpt -86.67 174.98 8.51 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.353 -0.842 . . . . 36.74 110.338 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.593 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -155.42 165.24 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.798 . . . . 19.74 109.042 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.469 ' O ' HD21 ' B' ' 49' ' ' LEU . 31.2 m -110.77 149.49 30.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.371 -0.831 . . . . 22.56 108.992 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' B' ' 29' ' ' ASN . 0.3 OUTLIER -133.25 127.83 34.55 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.391 -0.818 . . . . 20.41 109.363 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.94 148.52 42.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 33.99 109.512 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.44 93.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 54.92 109.55 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.32 -29.13 3.92 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.687 -1.365 . . . . 36.1 109.687 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.1 144.91 85.44 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.112 -1.228 . . . . 54.76 109.515 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.4 Cg_endo -78.4 117.32 4.03 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.708 2.272 . . . . 28.37 110.591 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.479 ' CB ' ' HG3' ' B' ' 31' ' ' GLN . . . -42.52 155.7 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.18 -0.95 . . . . 17.21 110.199 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.616 ' CE2' ' CB ' ' B' ' 83' ' ' LEU . 15.2 m-30 -49.34 112.51 0.65 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.485 -0.759 . . . . 17.19 109.876 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -65.85 177.2 0.76 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.322 -0.861 . . . . 17.82 109.258 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 36.0 Cg_endo -78.17 114.51 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.577 2.185 . . . . 17.28 110.444 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.64 177.92 42.36 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.834 -1.306 . . . . 17.22 109.834 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.0 mp -75.11 152.94 38.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -1.097 . . . . 19.57 108.396 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.59 ' CB ' HG12 ' B' ' 4' ' ' VAL . 17.6 m-85 -140.36 165.0 28.6 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.85 -1.156 . . . . 14.61 111.77 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.519 ' CG2' ' HG3' ' B' ' 1' ' ' MET . 43.7 p -145.54 120.35 9.92 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.413 -1.699 . . . . 18.36 106.413 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.563 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 4.8 t -50.14 170.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 C-N-CA 118.836 -1.145 . . . . 19.13 108.769 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.537 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -130.53 123.13 28.91 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.391 -0.818 . . . . 20.65 108.992 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.613 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.61 -6.66 16.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.733 -0.605 . . . . 19.65 109.759 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 28.2 t -54.35 -16.11 2.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.984 -1.073 . . . . 14.72 108.575 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 33.0 m -98.66 -6.27 30.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.485 -0.759 . . . . 11.45 110.917 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.622 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.7 m-30 -80.69 155.47 26.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.751 -1.218 . . . . 14.25 109.844 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.519 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 10.0 mtmt -143.46 171.83 13.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.517 -0.739 . . . . 32.7 109.309 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.509 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -118.04 131.84 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 15.63 109.586 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.83 176.09 53.29 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.46 -1.456 . . . . 12.7 109.46 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.4 9.45 13.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.114 -1.227 . . . . 26.29 109.864 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' B' ' 73' ' ' PHE . 30.1 t80 -109.45 9.65 25.44 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.564 -0.71 . . . . 20.44 109.428 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . 70.76 71.85 0.97 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.506 -1.438 . . . . 13.82 109.506 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' B' ' 74' ' ' GLY . 4.5 m -165.97 112.64 0.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -1.143 . . . . 18.27 109.715 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.517 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.3 OUTLIER -68.58 151.33 46.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 12.43 109.193 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 7.1 mtp -163.1 139.84 7.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 35.11 109.796 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.622 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.4 mt -67.94 140.97 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.349 -0.844 . . . . 13.67 109.895 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 1.6 t70 -110.18 -19.26 13.09 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.376 -0.972 . . . . 24.06 108.376 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.6 OUTLIER 173.08 68.11 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.919 -1.511 . . . . 35.04 106.919 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.563 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -32.02 119.59 0.27 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.521 -0.763 . . . . 18.72 111.447 -177.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -89.66 109.97 20.89 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.91 -1.145 . . . . 20.55 107.91 178.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.616 ' CB ' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -82.1 143.74 31.27 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.042 -1.036 . . . . 14.4 111.095 -178.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.45 ' HB ' ' HD2' ' B' ' 85' ' ' PRO . 4.5 m -143.86 159.66 52.74 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.949 -1.13 . . . . 17.65 107.949 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -63.55 147.84 92.78 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.115 1.877 . . . . 25.7 110.394 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.438 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -74.7 118.68 17.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.13 -0.981 . . . . 49.29 109.627 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.977 -1.011 . . . . 58.91 109.482 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.5 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.531 -0.544 . . . . 64.91 109.531 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.579 ' CG2' HD22 ' B' ' 65' ' ' LEU . 2.8 mt -59.04 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.879 -1.156 . . . . 33.8 107.879 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -63.39 158.65 20.04 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.81 0.814 . . . . 32.72 111.377 -177.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.56 ' HB ' ' CB ' ' A' ' 61' ' ' TYR . 60.6 t -159.99 167.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.579 0.704 . . . . 14.46 109.583 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 22.7 mt-10 -151.7 103.84 2.98 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.946 -0.761 . . . . 22.12 108.946 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.592 HD12 ' CZ ' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -70.67 105.69 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.092 -1.077 . . . . 14.23 108.092 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.655 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.22 173.48 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.419 -0.801 . . . . 25.43 109.988 -178.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.1 Cg_endo -76.26 -22.12 12.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.512 2.142 . . . . 13.61 109.727 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -101.04 8.05 43.12 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.153 -0.684 . . . . 15.52 109.153 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.531 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 17.6 mm-40 -125.25 36.04 4.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.243 -0.911 . . . . 17.31 109.401 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -107.13 16.54 24.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 24.78 110.151 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 4.6 tt0 -137.5 130.23 30.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.099 -1.0 . . . . 47.9 108.705 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.586 ' CD2' ' CB ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.85 -170.69 1.69 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.088 -1.007 . . . . 21.61 110.689 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -143.25 126.98 17.08 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.656 -0.653 . . . . 14.89 109.249 179.066 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.469 0 O-C-N 121.357 -0.84 . . . . 17.35 109.331 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.482 HD23 ' CG2' ' A' ' 48' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.389 0.614 . . . . 24.0 110.145 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.586 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -99.95 117.93 35.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -0.754 . . . . 23.31 109.067 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -86.56 -173.58 4.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.054 -1.029 . . . . 40.03 109.14 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.546 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -173.48 -170.96 0.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 12.39 109.962 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.517 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 4.1 mp -145.52 169.9 17.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.473 -0.767 . . . . 17.42 109.238 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -167.99 166.95 13.01 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.223 -1.028 . . . . 13.84 108.223 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.667 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 31.9 m-85 -118.78 103.19 9.42 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.089 -1.007 . . . . 21.14 109.498 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.534 ' CG2' HG21 ' A' ' 4' ' ' VAL . 54.3 t -85.6 144.87 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.109 -0.994 . . . . 10.66 110.29 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.4 m-20 -128.48 -140.49 0.25 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.715 -0.846 . . . . 25.89 108.715 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.552 ' HG ' ' CD1' ' B' ' 65' ' ' LEU . 0.1 OUTLIER 68.39 -63.13 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.927 -1.108 . . . . 24.24 109.222 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -85.98 16.26 43.55 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.593 -1.803 . . . . 31.02 108.593 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -177.83 111.92 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.468 -1.019 . . . . 43.23 109.083 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' ASN . 1.3 mm-40 -40.78 -66.96 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.476 -0.765 . . . . 42.34 109.763 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -60.06 153.63 54.94 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 108.574 -0.899 . . . . 6.3 108.574 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.667 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.4 Cg_endo -77.34 142.83 21.58 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.146 1.897 . . . . 17.92 110.22 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.501 ' CG2' HG22 ' B' ' 70' ' ' VAL . 27.5 m -113.75 113.83 45.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.32 -0.863 . . . . 20.57 109.302 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.597 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 41.0 tp -69.78 112.09 5.99 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.374 -0.829 . . . . 20.21 110.221 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG11 HG13 ' B' ' 70' ' ' VAL . 4.9 m -112.94 -172.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.9 -0.778 . . . . 10.81 108.9 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -111.93 154.87 24.59 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.467 -0.893 . . . . 36.74 110.329 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.589 HG13 ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -129.15 162.38 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 108.924 -0.769 . . . . 19.74 108.924 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.482 ' CG2' HD23 ' A' ' 28' ' ' LEU . 4.5 m -119.17 73.64 0.95 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.349 -0.844 . . . . 22.56 109.235 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CB ' ' HB2' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -40.62 133.52 1.97 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.759 . . . . 20.41 109.663 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -55.26 -166.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 33.99 109.623 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.22 -83.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 54.92 109.725 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.24 40.85 2.28 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.623 -1.391 . . . . 36.1 109.623 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.93 152.63 46.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.194 -1.18 . . . . 54.76 109.635 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.14 119.25 4.58 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.813 2.342 . . . . 28.37 110.742 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -41.16 146.53 0.18 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.369 -0.832 . . . . 17.21 110.339 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.619 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 14.7 m-30 -52.13 99.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -0.825 . . . . 17.19 109.169 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 56' ' ' TYR . . . -45.61 170.75 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 17.82 109.502 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' A' ' 6' ' ' ILE . 35.2 Cg_endo -77.6 108.32 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.576 2.184 . . . . 17.28 110.143 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.21 -178.12 48.63 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.958 -1.257 . . . . 17.22 109.958 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.4 mp -73.91 149.6 41.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -1.057 . . . . 19.57 108.641 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.592 ' CZ ' HD12 ' A' ' 6' ' ' ILE . 12.1 m-85 -134.98 163.74 29.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.921 -1.112 . . . . 14.61 111.373 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.519 HG21 ' CB ' ' A' ' 86' ' ' ALA . 29.2 p -145.65 119.37 9.2 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.721 -1.585 . . . . 18.36 106.721 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.572 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 18.5 t -47.81 170.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 C-N-CA 119.337 -0.945 . . . . 19.13 109.142 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.2 t-80 -133.82 126.04 29.71 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.823 -0.806 . . . . 20.65 108.823 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.604 ' HG ' ' CD2' ' A' ' 68' ' ' PHE . 4.6 mp -62.67 -8.0 5.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.644 -0.66 . . . . 19.65 110.432 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 65' ' ' LEU . 0.4 OUTLIER -47.29 -24.07 0.68 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.901 -1.124 . . . . 14.72 107.986 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.483 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 3.4 m -98.32 -13.04 20.91 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.68 -0.638 . . . . 11.45 110.673 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.6 m-30 -81.33 156.59 25.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.732 -1.23 . . . . 14.25 110.131 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -155.19 166.76 32.57 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.942 -0.762 . . . . 32.7 108.942 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' CG2' ' B' ' 43' ' ' VAL . 3.0 t -104.05 125.28 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -0.949 . . . . 15.63 109.227 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.6 173.62 55.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.728 -1.349 . . . . 12.7 109.728 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.454 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 1.0 OUTLIER -75.77 -1.14 23.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.206 -1.173 . . . . 26.29 109.83 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.07 -17.0 26.93 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.406 -0.809 . . . . 20.44 109.521 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.13 52.27 2.42 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.624 -1.391 . . . . 13.82 109.624 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.4 m -156.38 115.18 3.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -1.159 . . . . 18.27 109.507 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.475 ' O ' ' CG ' ' A' ' 77' ' ' MET . 7.1 tt -50.44 153.2 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 12.43 109.49 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 25.3 mtt -161.1 123.84 3.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 35.11 109.718 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.642 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.1 mt -61.55 140.64 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.367 -0.833 . . . . 13.67 109.92 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 26.7 t70 -111.35 -16.95 13.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.338 -0.851 . . . . 24.06 108.972 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.483 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 169.09 63.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.577 -1.638 . . . . 35.04 106.577 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.572 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -27.2 119.59 0.09 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.665 -1.152 . . . . 18.72 112.583 -177.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.26 103.33 16.02 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.397 -1.334 . . . . 20.55 107.397 177.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.619 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -77.1 145.39 37.85 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.974 -1.079 . . . . 14.4 111.487 -177.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.48 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 17.8 m -144.75 160.5 47.02 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 107.835 -1.172 . . . . 17.65 107.835 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 84' ' ' VAL . 25.3 Cg_endo -63.93 145.96 90.8 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.065 1.843 . . . . 25.7 110.42 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -81.65 125.37 30.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.1 -1.0 . . . . 49.29 109.477 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.023 -0.989 . . . . 58.91 109.443 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.5 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.456 -0.572 . . . . 64.91 109.456 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.58 ' CG2' HD22 ' A' ' 65' ' ' LEU . 2.8 mt -59.0 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.856 -1.164 . . . . 33.8 107.856 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -63.39 158.66 20.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.803 0.811 . . . . 32.72 111.411 -177.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.56 ' HB ' ' CB ' ' B' ' 61' ' ' TYR . 61.0 t -159.99 167.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.565 0.697 . . . . 14.46 109.617 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 22.6 mt-10 -151.8 104.02 2.98 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.924 -0.769 . . . . 22.12 108.924 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.597 HD12 ' CE1' ' B' ' 61' ' ' TYR . 0.7 OUTLIER -70.82 105.63 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.069 -1.086 . . . . 14.23 108.069 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.664 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.19 173.43 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.43 -0.794 . . . . 25.43 109.974 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.0 Cg_endo -76.18 -22.26 12.98 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.484 2.122 . . . . 13.61 109.777 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -100.97 8.24 43.15 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.575 -0.703 . . . . 15.52 109.136 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 17.5 mm-40 -125.3 35.82 4.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 17.31 109.38 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -106.89 16.3 24.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.112 -0.992 . . . . 24.78 110.12 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.436 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 4.4 tt0 -137.25 130.39 30.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.143 -0.973 . . . . 47.9 108.7 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.596 ' CD2' ' CB ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -77.04 -170.7 1.75 Allowed 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.091 -1.005 . . . . 21.61 110.711 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -143.32 126.74 16.76 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.613 -0.679 . . . . 14.89 109.339 179.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.487 0 O-C-N 121.399 -0.813 . . . . 17.35 109.382 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.485 HD23 ' CG2' ' B' ' 48' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.425 0.631 . . . . 24.0 110.105 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.596 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -100.04 118.0 35.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -0.792 . . . . 23.31 109.02 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -86.61 -173.59 4.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 40.03 109.096 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.541 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -173.5 -171.04 0.65 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.153 -0.967 . . . . 12.39 109.948 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.52 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 4.1 mp -145.41 169.83 17.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.424 -0.798 . . . . 17.42 109.231 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -167.95 166.82 13.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.305 -0.998 . . . . 13.84 108.305 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.678 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 31.6 m-85 -118.7 103.18 9.43 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.091 -1.006 . . . . 21.14 109.478 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' B' ' 4' ' ' VAL . 54.6 t -85.55 144.93 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.077 -1.014 . . . . 10.66 110.228 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.5 m-20 -128.71 -140.57 0.24 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.722 -0.844 . . . . 25.89 108.722 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.559 ' HG ' ' CD1' ' A' ' 65' ' ' LEU . 0.1 OUTLIER 68.48 -63.29 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.941 -1.1 . . . . 24.24 109.263 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -85.89 16.4 42.27 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.58 -1.808 . . . . 31.02 108.58 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' B' ' 40' ' ' GLU . 0.4 OUTLIER -177.96 111.88 0.07 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.545 -0.973 . . . . 43.23 109.066 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 39' ' ' ASN . 1.3 mm-40 -40.71 -67.07 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.514 -0.741 . . . . 42.34 109.777 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -59.94 153.55 54.05 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 108.615 -0.883 . . . . 6.28 108.615 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.678 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.4 Cg_endo -77.35 142.78 21.51 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.121 1.88 . . . . 17.92 110.323 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' B' ' 34' ' ' TYR . 27.4 m -113.7 113.68 44.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.25 -0.906 . . . . 20.57 109.412 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.59 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 40.1 tp -69.65 111.8 5.7 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.407 -0.808 . . . . 20.21 110.161 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.425 HG11 HG13 ' A' ' 70' ' ' VAL . 5.1 m -112.66 -172.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.882 -0.784 . . . . 10.81 108.882 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -111.89 155.08 24.23 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.444 -0.902 . . . . 36.74 110.311 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.601 HG13 ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -129.36 162.31 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.894 -0.78 . . . . 19.74 108.894 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.485 ' CG2' HD23 ' B' ' 28' ' ' LEU . 4.4 m -119.24 73.72 0.95 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.295 -0.878 . . . . 22.56 109.239 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.3 OUTLIER -40.63 133.41 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.521 -0.737 . . . . 20.41 109.671 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.505 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -55.19 -166.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 33.99 109.688 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -83.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 54.92 109.745 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.22 40.62 2.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.64 -1.384 . . . . 36.1 109.64 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.67 152.6 47.18 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.269 -1.136 . . . . 54.76 109.649 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.16 119.22 4.56 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.792 2.328 . . . . 28.37 110.734 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' B' ' 11' ' ' ALA . . . -41.11 146.1 0.19 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.356 -0.84 . . . . 17.21 110.333 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.632 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 14.8 m-30 -51.9 100.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 17.19 109.163 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 56' ' ' TYR . . . -45.9 170.83 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 17.82 109.508 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.467 ' HA ' HG23 ' B' ' 6' ' ' ILE . 35.4 Cg_endo -77.69 108.45 2.56 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.562 2.174 . . . . 17.28 110.186 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.88 -178.33 48.74 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.933 -1.267 . . . . 17.22 109.933 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.4 mp -73.54 150.01 41.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -1.101 . . . . 19.57 108.667 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.597 ' CE1' HD12 ' B' ' 6' ' ' ILE . 12.0 m-85 -135.31 163.8 29.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.926 -1.109 . . . . 14.61 111.349 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.531 HG21 ' CB ' ' B' ' 86' ' ' ALA . 29.4 p -145.73 119.47 9.22 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.67 -1.604 . . . . 18.36 106.67 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.56 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 18.6 t -47.95 170.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 C-N-CA 119.314 -0.954 . . . . 19.13 109.095 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -133.65 126.33 30.6 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.842 -0.799 . . . . 20.65 108.842 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.602 ' HG ' ' CD2' ' B' ' 68' ' ' PHE . 4.5 mp -63.0 -7.92 6.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.64 -0.662 . . . . 19.65 110.465 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' SER . . . . . 0.441 ' C ' ' O ' ' B' ' 65' ' ' LEU . 0.4 OUTLIER -47.17 -24.23 0.66 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.875 -1.141 . . . . 14.72 107.937 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.48 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 3.3 m -98.22 -13.27 20.92 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.774 -0.579 . . . . 11.45 110.753 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.647 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.5 m-30 -81.2 156.37 25.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.761 -1.212 . . . . 14.25 110.011 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' B' ' 77' ' ' MET . 0.0 OUTLIER -154.96 166.93 32.01 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.898 -0.778 . . . . 32.7 108.898 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.501 HG22 ' CG2' ' A' ' 43' ' ' VAL . 3.0 t -104.1 125.35 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 15.63 109.232 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.64 173.68 55.25 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.732 -1.347 . . . . 12.7 109.732 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.446 ' O ' ' CG ' ' B' ' 72' ' ' GLN . 1.0 OUTLIER -75.89 -1.28 24.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.252 -1.146 . . . . 26.29 109.822 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -90.85 -17.35 26.68 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.408 -0.807 . . . . 20.44 109.52 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.54 52.42 2.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.662 -1.375 . . . . 13.82 109.662 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 57.9 m -156.59 115.33 3.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -1.163 . . . . 18.27 109.531 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.459 ' O ' ' CG ' ' B' ' 77' ' ' MET . 7.0 tt -50.53 152.92 1.77 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 12.43 109.447 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.459 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 25.3 mtt -160.94 123.52 3.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 35.11 109.741 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.647 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.0 mt -61.32 140.71 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 13.67 109.924 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 26.6 t70 -111.24 -17.26 13.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.391 -0.818 . . . . 24.06 108.928 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.48 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 169.38 63.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.592 -1.633 . . . . 35.04 106.592 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.56 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.5 OUTLIER -27.2 119.44 0.09 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.711 -1.131 . . . . 18.72 112.576 -177.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.15 103.28 15.97 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.356 -1.349 . . . . 20.55 107.356 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.632 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -77.06 145.22 38.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.905 -1.122 . . . . 14.4 111.515 -177.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.478 ' HB ' ' HD2' ' B' ' 85' ' ' PRO . 17.6 m -144.72 160.44 47.34 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.838 -1.171 . . . . 17.65 107.838 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' B' ' 84' ' ' VAL . 25.5 Cg_endo -63.88 146.01 91.08 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.099 1.866 . . . . 25.7 110.464 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.531 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -81.66 125.33 30.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.987 . . . . 49.29 109.528 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.987 -1.006 . . . . 58.91 109.452 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.474 ' C ' ' CD2' ' B' ' 65' ' ' LEU . 1.7 pmm? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.33 0.586 . . . . 64.91 109.46 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.522 ' N ' HD21 ' B' ' 65' ' ' LEU . 3.0 mt -67.82 80.29 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.113 -1.069 . . . . 33.8 108.113 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.458 ' HB3' ' OD2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -64.35 153.9 37.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.77 0.795 . . . . 32.72 110.906 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.59 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -163.26 165.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.693 -0.854 . . . . 14.46 108.693 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 31.3 mt-10 -141.8 113.03 7.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 22.12 109.381 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -73.96 103.76 2.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 119.014 -1.075 . . . . 14.23 108.231 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.642 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.85 171.4 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.366 -0.834 . . . . 25.43 109.84 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.3 Cg_endo -76.1 -29.28 6.7 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.492 2.128 . . . . 13.61 109.803 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 t -85.12 -0.45 54.57 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.912 -0.774 . . . . 15.52 108.912 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 4.0 mm100 -118.0 35.9 4.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.358 -0.839 . . . . 17.31 109.304 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.06 10.81 40.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 24.78 110.475 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -139.26 131.55 28.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.043 -1.035 . . . . 47.9 108.718 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 26.4 p90 -85.99 177.45 7.58 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.081 -1.012 . . . . 21.61 110.171 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 9.1 t -130.93 162.39 29.8 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.402 -0.962 . . . . 14.89 108.402 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.3 -1.575 0 O-C-N 121.056 -1.028 . . . . 17.35 110.005 -179.561 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 28' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.475 0.655 . . . . 24.0 110.23 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.606 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -101.43 131.35 47.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.811 . . . . 23.31 108.894 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 87.7 mt-10 -113.98 157.98 21.76 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -0.988 . . . . 40.03 109.758 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.565 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -139.78 -167.87 2.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 12.39 109.226 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.3 mp -134.74 176.46 8.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 17.42 109.195 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.48 166.45 8.38 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.063 -1.023 . . . . 13.84 108.58 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.658 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.2 m-85 -120.15 106.11 11.63 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 21.14 109.423 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.531 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 82.2 t -98.89 111.32 28.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.134 -0.979 . . . . 10.66 109.565 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.5 p30 -52.31 -30.2 27.14 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.192 -0.943 . . . . 25.89 108.487 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.525 ' CD2' ' HA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 45.29 36.92 2.47 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.48 -0.762 . . . . 24.24 109.093 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.53 18.92 39.35 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.35 -1.5 . . . . 31.02 109.35 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 90.3 m-20 -92.33 25.86 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -1.113 . . . . 43.23 110.483 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 45.6 mt-10 44.3 25.68 0.13 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.065 -1.022 . . . . 42.34 109.776 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 9.9 m80 -173.03 150.8 2.02 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.952 -1.129 . . . . 3.98 107.952 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.658 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.2 Cg_endo -75.98 136.12 18.11 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.788 1.659 . . . . 17.92 110.622 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 10.3 m -112.16 115.41 49.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.564 -0.902 . . . . 20.57 108.564 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 47.6 tp -66.48 107.48 2.07 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.341 -0.849 . . . . 20.21 109.223 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 3.8 t -112.65 167.58 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.511 -0.743 . . . . 10.81 109.41 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -91.13 163.43 14.28 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.301 -0.874 . . . . 36.74 109.997 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.611 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -151.43 172.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.26 -0.9 . . . . 19.74 109.289 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.09 153.64 24.38 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 22.56 109.255 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.59 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -127.55 101.58 6.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.404 -0.81 . . . . 20.41 109.057 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 2.6 t0 -44.28 144.62 0.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.853 . . . . 33.99 109.999 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -64.24 102.1 0.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 54.92 109.091 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.13 -26.19 6.82 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.02 -1.632 . . . . 36.1 109.02 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.454 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 8.1 mt-30 -76.56 144.24 73.4 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.356 -1.085 . . . . 54.76 109.13 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -78.01 130.16 10.19 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.52 2.147 . . . . 28.37 110.518 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 57' ' ' ALA . . . -39.58 141.72 0.36 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.495 -0.753 . . . . 17.21 110.082 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.611 ' CE1' HG12 ' A' ' 47' ' ' ILE . 87.0 m-85 -43.23 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.407 -0.808 . . . . 17.19 109.027 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . -42.71 166.16 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 17.82 109.699 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.451 ' HA ' HG23 ' A' ' 6' ' ' ILE . 34.3 Cg_endo -77.02 111.91 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.568 2.179 . . . . 17.28 110.062 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.38 -175.73 47.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.804 -1.318 . . . . 17.22 109.804 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 4.7 mp -76.09 147.48 38.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.286 -1.126 . . . . 19.57 108.706 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.59 ' CB ' HG12 ' A' ' 4' ' ' VAL . 20.7 m-85 -137.4 165.13 26.97 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.457 1.122 . . . . 14.61 111.204 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 43.5 p -145.43 120.57 10.13 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.066 -1.827 . . . . 18.36 106.066 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.613 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -53.95 164.97 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 118.392 -1.323 . . . . 19.13 108.877 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.3 t-80 -127.07 129.91 48.91 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.913 -0.773 . . . . 20.65 108.913 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.651 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -71.79 0.56 8.68 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.41 -0.806 . . . . 19.65 109.802 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.36 -21.06 8.49 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.252 -1.388 . . . . 14.72 107.252 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.484 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 24.4 m -95.12 -9.2 34.26 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.855 -0.528 . . . . 11.45 110.058 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.651 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 3.0 m-30 -78.73 156.61 28.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 14.25 109.705 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.517 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 12.2 mttt -146.97 173.89 12.02 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 32.7 109.356 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.592 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -111.58 111.57 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 15.63 109.433 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.22 -177.34 47.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.489 -1.444 . . . . 12.7 109.489 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.93 38.95 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.196 -1.179 . . . . 26.29 109.55 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.12 24.77 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 20.44 109.579 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' HG12 ' B' ' 45' ' ' VAL . . . 50.1 58.75 8.3 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.543 -1.423 . . . . 13.82 109.543 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.25 131.83 1.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -1.114 . . . . 18.27 109.667 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.453 ' O ' ' SD ' ' A' ' 77' ' ' MET . 1.2 tp -69.38 153.74 43.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 12.43 109.108 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 76' ' ' LEU . 4.5 mmt -154.73 121.67 5.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.969 . . . . 35.11 109.557 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.6 mt -57.26 141.96 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 13.67 109.831 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -116.0 -3.32 12.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.422 -0.799 . . . . 24.06 109.034 178.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 156.49 62.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.998 -1.482 . . . . 35.04 106.998 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.613 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -27.75 120.23 0.1 Allowed 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.017 -0.992 . . . . 18.72 112.141 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.494 ' NH1' ' HG3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -91.99 102.15 14.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.67 -0.863 . . . . 20.55 108.67 179.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -70.37 145.26 51.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.279 -0.888 . . . . 14.4 111.281 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 62' ' ' THR . 35.2 m -146.5 151.16 42.65 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.937 -1.134 . . . . 17.65 107.937 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.3 Cg_endo -62.72 145.7 95.03 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.203 1.935 . . . . 25.7 110.464 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.98 115.06 18.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 49.29 109.754 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.019 -0.991 . . . . 58.91 109.431 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.47 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 1.7 pmm? . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.36 0.6 . . . . 64.91 109.516 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.521 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 3.0 mt -67.91 80.13 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.12 -1.067 . . . . 33.8 108.12 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.465 ' HB3' ' OD2' ' B' ' 36' ' ' ASP . 0.0 OUTLIER -64.26 153.87 36.82 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.771 0.796 . . . . 32.72 110.87 -178.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.59 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -163.27 165.05 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.633 -0.877 . . . . 14.46 108.633 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 31.4 mt-10 -141.75 112.87 7.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 22.12 109.478 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.575 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -73.85 103.68 2.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.999 -1.08 . . . . 14.23 108.225 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.635 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.81 171.33 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.402 -0.811 . . . . 25.43 109.852 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -76.1 -29.21 6.76 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.496 2.13 . . . . 13.61 109.856 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.3 t -85.07 -0.59 54.97 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.829 -0.804 . . . . 15.52 108.829 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 4.1 mm100 -118.0 36.03 4.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.419 -0.801 . . . . 17.31 109.292 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.2 10.94 40.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.167 -0.958 . . . . 24.78 110.44 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.454 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 0.5 OUTLIER -139.3 131.61 28.37 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.145 -0.972 . . . . 47.9 108.672 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.605 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 26.3 p90 -86.07 177.53 7.53 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.058 -1.026 . . . . 21.61 110.052 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 9.2 t -130.98 162.38 29.88 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.392 -0.966 . . . . 14.89 108.392 178.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.299 -1.592 0 O-C-N 121.127 -0.983 . . . . 17.35 109.993 -179.613 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.467 0.651 . . . . 24.0 110.253 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.605 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -101.37 131.22 47.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.381 -0.824 . . . . 23.31 108.892 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 87.5 mt-10 -113.89 158.03 21.61 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.109 -0.994 . . . . 40.03 109.826 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.562 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.8 OUTLIER -139.84 -167.96 2.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.216 -0.928 . . . . 12.39 109.223 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.513 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.3 mp -134.68 176.58 8.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 17.42 109.235 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.56 166.51 8.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.09 -1.006 . . . . 13.84 108.543 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.663 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 22.2 m-85 -120.28 106.18 11.65 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.109 -0.994 . . . . 21.14 109.395 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 81.8 t -98.97 111.16 27.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.121 -0.987 . . . . 10.66 109.561 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.5 p30 -52.18 -30.19 25.77 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.205 -0.935 . . . . 25.89 108.495 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.517 ' CD2' ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 45.26 36.93 2.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.473 -0.767 . . . . 24.24 109.065 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.49 19.03 39.49 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.386 -1.486 . . . . 31.02 109.386 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 90.1 m-20 -92.39 25.93 2.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 43.23 110.539 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.575 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 45.3 mt-10 44.29 25.6 0.13 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.053 -1.029 . . . . 42.34 109.84 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 10.0 m80 -172.98 150.78 2.04 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.979 -1.119 . . . . 3.98 107.979 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.1 Cg_endo -76.02 136.1 18.0 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.852 1.702 . . . . 17.92 110.606 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' B' ' 35' ' ' VAL . 10.1 m -112.18 115.45 49.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.613 -0.884 . . . . 20.57 108.613 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.545 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 48.0 tp -66.55 107.49 2.1 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.331 -0.856 . . . . 20.21 109.299 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.592 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 4.0 t -112.65 167.66 5.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.586 -0.697 . . . . 10.81 109.469 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -91.19 163.16 14.36 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.669 -0.812 . . . . 36.74 109.97 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.613 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -151.19 172.86 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.308 -0.87 . . . . 19.74 109.326 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.09 153.53 24.54 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.301 -0.874 . . . . 22.56 109.245 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -127.45 101.66 6.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 20.41 109.061 -179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.454 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 2.6 t0 -44.31 144.61 0.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.341 -0.849 . . . . 33.99 109.97 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -64.21 102.09 0.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 54.92 109.053 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.2 -26.26 6.77 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.059 -1.616 . . . . 36.1 109.059 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.444 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 8.1 mt-30 -76.55 144.47 73.84 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.382 -1.07 . . . . 54.76 109.018 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.15 130.12 10.04 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.544 2.163 . . . . 28.37 110.517 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.484 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -39.62 141.97 0.35 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.49 -0.756 . . . . 17.21 109.99 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.613 ' CE1' HG12 ' B' ' 47' ' ' ILE . 86.4 m-85 -43.61 98.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.833 . . . . 17.19 109.012 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' B' ' 55' ' ' ALA . . . -43.48 166.42 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.839 . . . . 17.82 109.59 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.465 ' HA ' HG23 ' B' ' 6' ' ' ILE . 35.4 Cg_endo -77.54 113.0 3.44 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.625 2.217 . . . . 17.28 110.317 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.56 -175.02 46.83 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.666 -1.374 . . . . 17.22 109.666 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.0 mp -75.99 148.04 38.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -1.111 . . . . 19.57 108.995 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.59 ' CB ' HG12 ' B' ' 4' ' ' VAL . 20.7 m-85 -137.9 165.0 27.59 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.413 1.102 . . . . 14.61 111.254 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' B' ' 84' ' ' VAL . 43.2 p -145.46 120.61 10.13 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.127 -1.805 . . . . 18.36 106.127 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.598 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -54.02 165.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 C-N-CA 118.396 -1.321 . . . . 19.13 108.858 -178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.422 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.3 t-80 -127.01 129.96 49.09 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.97 -0.752 . . . . 20.65 108.97 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.641 ' CB ' ' CD2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -71.87 0.54 8.89 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.377 -0.827 . . . . 19.65 109.735 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -20.94 7.9 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.263 -1.384 . . . . 14.72 107.263 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 23.9 m -95.33 -9.58 32.56 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.899 -0.5 . . . . 11.45 110.058 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.641 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 2.9 m-30 -78.36 156.11 29.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.124 -0.985 . . . . 14.25 109.715 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.525 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 12.2 mttt -146.58 173.37 12.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.805 . . . . 32.7 109.415 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.557 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -111.08 111.63 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 15.63 109.389 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.34 -177.35 48.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.421 -1.472 . . . . 12.7 109.421 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.94 39.0 0.94 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.148 -1.207 . . . . 26.29 109.561 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.08 24.73 4.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 20.44 109.606 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.431 ' C ' HG12 ' A' ' 45' ' ' VAL . . . 50.02 59.14 7.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.519 -1.432 . . . . 13.82 109.519 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.53 131.83 1.84 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.135 . . . . 18.27 109.685 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.448 ' O ' ' SD ' ' B' ' 77' ' ' MET . 1.2 tp -69.41 153.66 43.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.892 . . . . 12.43 109.152 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' B' ' 76' ' ' LEU . 4.5 mmt -154.74 121.77 5.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.097 -1.002 . . . . 35.11 109.573 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.598 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.5 mp -57.4 142.02 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -0.849 . . . . 13.67 109.819 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.7 OUTLIER -115.97 -3.39 12.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.49 -0.756 . . . . 24.06 108.997 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 156.5 63.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.931 -1.507 . . . . 35.04 106.931 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.598 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -27.89 120.33 0.11 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.001 -1.0 . . . . 18.72 112.134 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.485 ' NH1' ' HG3' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -92.04 102.08 14.63 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.675 -0.861 . . . . 20.55 108.675 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.598 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -70.39 145.39 51.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.352 -0.843 . . . . 14.4 111.345 -178.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' B' ' 62' ' ' THR . 35.3 m -146.58 151.03 42.03 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.89 -1.152 . . . . 17.65 107.89 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.9 Cg_endo -62.53 145.71 95.44 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.181 1.92 . . . . 25.7 110.419 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.05 115.07 18.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 49.29 109.76 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.048 -0.977 . . . . 58.91 109.457 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.528 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.3 ttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.534 -0.543 . . . . 64.91 109.534 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.582 ' CG1' ' CD2' ' B' ' 65' ' ' LEU . 2.8 mt -61.52 82.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.962 -1.125 . . . . 33.8 107.962 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 1' ' ' MET . 23.4 mttp -70.33 179.12 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.894 0.854 . . . . 32.72 111.277 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.59 ' CG1' ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 173.56 167.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.902 -0.777 . . . . 14.46 108.902 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.576 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 79.7 mt-10 -141.31 111.17 6.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.545 -0.722 . . . . 22.12 109.259 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.525 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -72.58 105.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.545 -1.28 . . . . 14.23 107.545 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.537 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.7 mmpt? -54.14 160.36 2.43 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.118 -0.989 . . . . 25.43 109.539 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 31.8 Cg_endo -73.79 -9.25 22.31 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.057 1.838 . . . . 13.61 109.19 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.85 7.64 46.16 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.89 -0.782 . . . . 15.52 108.89 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.531 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -142.58 37.41 1.49 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.261 -0.899 . . . . 17.31 109.13 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.58 15.46 6.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 24.78 109.803 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.481 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -143.96 143.63 31.32 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.182 -0.949 . . . . 47.9 108.597 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.598 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 26.0 p90 -85.46 173.31 10.34 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.038 -1.039 . . . . 21.61 109.61 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.9 m -137.6 154.95 49.68 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.471 -0.768 . . . . 14.89 109.0 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.175 -0.953 . . . . 17.35 109.506 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.424 0.63 . . . . 24.0 110.23 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.661 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -46.01 128.45 9.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.427 -0.796 . . . . 23.31 109.546 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -121.13 143.09 49.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.258 -0.901 . . . . 40.03 108.788 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -115.1 -167.29 1.21 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.963 -1.086 . . . . 12.39 110.149 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 21.1 mt -128.44 177.99 6.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.48 -0.762 . . . . 17.42 109.557 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -173.46 150.72 1.85 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.987 -1.07 . . . . 13.84 109.238 -179.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.632 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 2.9 m-85 -109.8 91.32 3.6 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.181 -1.044 . . . . 21.14 108.181 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 97.9 t -92.89 117.58 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.98 . . . . 10.66 110.155 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 27.6 t0 -53.56 -28.49 32.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.415 -0.957 . . . . 25.89 108.415 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' B' ' 69' ' ' LYS . 1.9 tt 43.25 34.47 0.71 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.498 -0.751 . . . . 24.24 109.239 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.35 23.12 52.9 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.457 -1.457 . . . . 31.02 109.457 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.499 ' ND2' HD21 ' A' ' 37' ' ' LEU . 98.6 m-20 -97.33 26.35 4.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -1.155 . . . . 43.23 110.263 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.551 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 42.9 mt-10 49.25 21.62 0.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.134 -0.979 . . . . 42.34 109.949 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 6.0 m80 -174.71 157.11 2.23 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 108.027 -1.101 . . . . 6.32 108.027 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.624 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.8 Cg_endo -75.6 146.14 30.24 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.019 1.813 . . . . 17.92 111.005 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 5.6 m -122.46 118.38 55.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.622 -0.881 . . . . 20.57 108.622 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.632 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 22.4 tp -69.14 109.42 4.04 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.662 -0.815 . . . . 20.21 109.04 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.591 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 3.9 t -117.18 168.89 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.614 -0.678 . . . . 10.81 109.516 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.581 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -88.63 161.93 16.61 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.298 -0.876 . . . . 36.74 110.423 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.589 HG23 ' CD2' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -133.11 164.43 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.485 -0.932 . . . . 19.74 108.485 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -108.76 135.5 49.88 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.193 -0.942 . . . . 22.56 108.565 178.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.593 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -123.88 123.9 41.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 20.41 109.365 -179.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . 1.3 t0 -71.4 142.53 50.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 33.99 109.546 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.29 107.72 0.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 54.92 109.664 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.04 -2.4 44.33 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.859 -1.296 . . . . 36.1 109.859 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.511 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 13.2 mt-30 -89.19 144.5 32.6 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 54.76 109.525 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 55' ' ' ALA . 35.1 Cg_endo -78.38 114.78 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.643 2.229 . . . . 28.37 110.642 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.525 ' CB ' ' HG3' ' A' ' 31' ' ' GLN . . . -43.79 168.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.337 -0.852 . . . . 17.21 110.031 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.589 ' CD2' HG23 ' A' ' 47' ' ' ILE . 31.0 m-85 -66.14 122.85 18.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 17.19 109.657 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.555 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -74.48 179.39 1.31 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.455 -0.778 . . . . 17.82 109.808 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.9 Cg_endo -78.01 115.41 3.77 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.582 2.188 . . . . 17.28 110.436 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 166.85 142.0 3.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.317 -1.513 . . . . 17.22 109.317 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 59' ' ' GLY . 4.0 mp -42.11 144.43 0.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.153 -1.204 . . . . 19.57 109.382 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 59' ' ' GLY . 15.1 m-85 -121.52 166.37 14.28 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.487 1.137 . . . . 14.61 111.253 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.542 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 39.8 p -149.35 120.54 7.79 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.505 -2.035 . . . . 18.36 105.505 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.578 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.9 t -57.89 161.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 C-N-CA 118.107 -1.437 . . . . 19.13 108.934 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 82' ' ' ARG . 5.1 t-80 -116.19 138.41 51.3 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.592 -0.693 . . . . 20.65 109.203 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' A' ' 68' ' ' PHE . 2.1 mt -70.71 -8.44 52.13 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.098 -0.704 . . . . 19.65 109.098 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.93 -24.95 1.16 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.268 -1.012 . . . . 14.72 108.268 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.512 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 3.7 m -93.7 -14.77 25.96 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.825 -0.75 . . . . 11.45 109.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 3.5 m-30 -80.69 147.07 30.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.064 -1.022 . . . . 14.25 109.973 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.528 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 0.1 OUTLIER -146.31 172.87 12.84 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.643 -0.661 . . . . 32.7 109.229 -179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -107.33 109.55 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 15.63 109.171 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.07 -173.08 49.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.582 -1.407 . . . . 12.7 109.582 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.613 ' N ' ' NE2' ' A' ' 72' ' ' GLN . 0.6 OUTLIER -95.87 22.98 6.72 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.261 -1.141 . . . . 26.29 108.948 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 -9.45 26.65 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.283 -0.567 . . . . 20.44 109.704 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.423 ' C ' HG12 ' B' ' 45' ' ' VAL . . . 81.5 40.41 11.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.692 -1.363 . . . . 13.82 109.692 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.492 ' HA ' ' CG1' ' B' ' 45' ' ' VAL . 4.4 m -169.18 138.54 2.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.14 . . . . 18.27 109.564 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.498 ' CD2' ' HB3' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -47.57 160.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 12.43 109.46 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtt -158.64 107.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 35.11 109.708 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.622 HG12 ' CD1' ' A' ' 68' ' ' PHE . 23.4 mt -60.33 138.11 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 13.67 109.815 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 12.1 t70 -103.13 -22.67 13.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.357 -0.84 . . . . 24.06 108.802 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.512 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.5 OUTLIER 171.86 66.74 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.542 -1.281 . . . . 35.04 107.542 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.578 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -21.72 119.01 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.033 -0.985 . . . . 18.72 112.264 -178.248 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -92.68 103.72 16.07 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.601 -0.888 . . . . 20.55 108.601 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -73.78 145.05 45.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.146 -0.971 . . . . 14.4 111.528 -178.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 62' ' ' THR . 2.4 m -149.64 156.25 38.85 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 107.524 -1.287 . . . . 17.65 107.524 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.3 141.13 80.59 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 C-N-CA 121.9 1.733 . . . . 25.7 110.26 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.515 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -70.66 112.13 6.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.191 -0.943 . . . . 49.29 109.5 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.045 -0.978 . . . . 58.91 109.475 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.531 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.3 ttp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.526 -0.546 . . . . 64.91 109.526 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.584 ' CG1' ' CD2' ' A' ' 65' ' ' LEU . 2.8 mt -61.56 82.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.985 -1.117 . . . . 33.8 107.985 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 1' ' ' MET . 23.3 mttp -70.1 179.2 2.43 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.979 0.895 . . . . 32.72 111.284 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.583 ' CG1' ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 173.46 167.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.865 -0.791 . . . . 14.46 108.865 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 79.6 mt-10 -141.36 111.14 6.55 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.62 0.724 . . . . 22.12 109.241 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.513 ' HB ' ' CE1' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -72.55 105.34 2.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.54 -1.281 . . . . 14.23 107.54 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.536 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.7 mmpt? -54.3 160.39 2.54 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.113 -0.992 . . . . 25.43 109.509 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.9 Cg_endo -73.75 -9.25 22.37 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.032 1.821 . . . . 13.61 109.181 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.84 7.51 46.45 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.803 -0.814 . . . . 15.52 108.803 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.532 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 0.0 OUTLIER -142.63 37.6 1.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.206 -0.934 . . . . 17.31 109.093 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.7 15.34 7.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 24.78 109.831 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.478 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -143.91 143.44 31.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.216 -0.927 . . . . 47.9 108.686 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.594 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 26.3 p90 -85.24 173.22 10.55 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.036 -1.04 . . . . 21.61 109.609 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 39.9 m -137.54 155.0 49.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.48 -0.762 . . . . 14.89 108.983 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.461 0 O-C-N 121.186 -0.946 . . . . 17.35 109.59 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.454 0.645 . . . . 24.0 110.234 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.668 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -46.06 128.52 9.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.401 -0.812 . . . . 23.31 109.579 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -121.2 143.11 49.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.894 . . . . 40.03 108.748 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.526 ' HG3' ' CB ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -115.17 -167.24 1.21 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.981 -1.075 . . . . 12.39 110.132 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.556 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 21.0 mt -128.37 177.97 6.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.429 -0.795 . . . . 17.42 109.549 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' B' ' 47' ' ' ILE . 0.8 OUTLIER -173.49 150.65 1.83 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.918 -1.114 . . . . 13.84 109.265 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.64 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 2.9 m-85 -109.77 91.28 3.58 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.18 -1.045 . . . . 21.14 108.18 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.531 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 98.5 t -92.83 117.76 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.961 . . . . 10.66 110.096 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 27.6 t0 -53.71 -28.37 33.58 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.385 -0.968 . . . . 25.89 108.385 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' A' ' 69' ' ' LYS . 1.8 tt 43.11 34.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.572 -0.705 . . . . 24.24 109.256 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.19 23.05 51.81 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.472 -1.451 . . . . 31.02 109.472 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.501 ' ND2' HD21 ' B' ' 37' ' ' LEU . 99.0 m-20 -97.35 26.28 4.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.217 -1.167 . . . . 43.23 110.234 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 43.0 mt-10 49.23 21.74 0.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.13 -0.981 . . . . 42.34 109.976 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 5.9 m80 -174.79 157.13 2.2 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.999 -1.111 . . . . 6.31 107.999 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.618 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.9 Cg_endo -75.59 146.19 30.34 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.97 1.78 . . . . 17.92 110.954 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 5.4 m -122.49 118.36 54.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.633 -0.877 . . . . 20.57 108.633 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.64 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 22.9 tp -69.09 109.57 4.08 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.69 -0.804 . . . . 20.21 109.096 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 3.9 t -117.37 168.86 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.529 -0.732 . . . . 10.81 109.448 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -88.52 161.9 16.72 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.351 -0.843 . . . . 36.74 110.455 -179.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.591 HG23 ' CD2' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -133.08 164.29 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.522 -0.918 . . . . 19.74 108.522 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.502 ' N ' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -108.67 135.47 49.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.242 -0.912 . . . . 22.56 108.576 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.582 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -123.92 123.89 41.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.865 . . . . 20.41 109.362 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.438 ' HA ' HD22 ' B' ' 28' ' ' LEU . 1.3 t0 -71.39 142.35 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 33.99 109.567 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.21 107.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 54.92 109.633 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.08 -2.41 44.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.831 -1.308 . . . . 36.1 109.831 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.515 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 13.2 mt-30 -89.22 144.46 32.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.166 -1.197 . . . . 54.76 109.513 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.37 114.7 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.669 2.246 . . . . 28.37 110.696 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.526 ' CB ' ' HG3' ' B' ' 31' ' ' GLN . . . -43.69 168.67 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 17.21 110.025 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.591 ' CD2' HG23 ' B' ' 47' ' ' ILE . 30.7 m-85 -66.06 122.96 18.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 17.19 109.618 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.547 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -74.53 179.44 1.31 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.443 -0.786 . . . . 17.82 109.844 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.1 Cg_endo -78.0 115.35 3.76 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.619 2.213 . . . . 17.28 110.442 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 166.87 141.95 3.3 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.358 -1.497 . . . . 17.22 109.358 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' B' ' 59' ' ' GLY . 4.0 mp -42.04 144.26 0.47 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -1.162 . . . . 19.57 109.364 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' B' ' 59' ' ' GLY . 15.1 m-85 -121.4 166.24 14.38 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.93 -1.106 . . . . 14.61 111.34 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' B' ' 84' ' ' VAL . 39.2 p -149.31 120.25 7.65 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 105.485 -2.043 . . . . 18.36 105.485 177.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.586 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.8 t -57.44 161.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 C-N-CA 118.143 -1.423 . . . . 19.13 108.936 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' B' ' 82' ' ' ARG . 5.1 t-80 -116.43 138.32 51.46 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.551 -0.718 . . . . 20.65 109.245 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.599 HD22 ' CE2' ' B' ' 68' ' ' PHE . 2.1 mt -70.57 -8.47 51.77 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.065 -0.717 . . . . 19.65 109.065 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.96 -24.84 1.15 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.29 -1.004 . . . . 14.72 108.29 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.513 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 3.8 m -93.78 -14.8 25.82 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.472 -0.767 . . . . 11.45 109.97 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.632 ' CD1' HG12 ' B' ' 78' ' ' ILE . 3.5 m-30 -80.71 146.44 31.06 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.081 -1.012 . . . . 14.25 109.955 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.537 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -145.72 172.62 13.02 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.651 -0.656 . . . . 32.7 109.274 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.591 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -107.2 109.54 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 15.63 109.166 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.95 -172.88 49.12 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.593 -1.403 . . . . 12.7 109.593 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.605 ' N ' ' NE2' ' B' ' 72' ' ' GLN . 0.6 OUTLIER -96.05 22.83 7.06 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.215 -1.168 . . . . 26.29 108.918 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.61 -9.48 26.84 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.757 -0.589 . . . . 20.44 109.69 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.443 ' C ' HG12 ' A' ' 45' ' ' VAL . . . 81.46 41.05 10.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.578 -1.409 . . . . 13.82 109.578 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.512 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 4.3 m -169.79 138.29 1.8 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -1.153 . . . . 18.27 109.688 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.518 ' CD2' ' HB3' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -47.37 160.7 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 12.43 109.462 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtt -158.94 107.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 35.11 109.738 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.632 HG12 ' CD1' ' B' ' 68' ' ' PHE . 23.0 mt -60.26 138.4 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 13.67 109.843 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 12.1 t70 -103.37 -22.81 13.62 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.709 -0.849 . . . . 24.06 108.709 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.513 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.5 OUTLIER 172.09 66.55 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.556 -1.275 . . . . 35.04 107.556 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.586 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.7 OUTLIER -21.5 118.96 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.085 -0.961 . . . . 18.72 112.285 -178.25 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' B' ' 64' ' ' HIS . 0.3 OUTLIER -92.57 103.79 16.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 20.55 108.643 179.363 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -73.85 144.93 45.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.03 -1.044 . . . . 14.4 111.469 -178.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.541 ' C ' ' CD2' ' B' ' 61' ' ' TYR . 2.5 m -149.59 156.14 38.95 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.528 -1.286 . . . . 17.65 107.528 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -63.26 141.08 80.73 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 121.911 1.741 . . . . 25.7 110.211 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.508 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -70.53 112.14 6.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.207 -0.933 . . . . 49.29 109.528 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.015 -0.993 . . . . 58.91 109.5 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.469 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 1.3 ttp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.457 -0.572 . . . . 64.91 109.457 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.541 HG12 ' CB ' ' B' ' 65' ' ' LEU . 6.2 mt -71.29 77.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.213 -1.032 . . . . 33.8 108.213 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' C ' HG11 ' A' ' 4' ' ' VAL . 54.0 mttt -63.53 155.41 29.47 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.937 0.875 . . . . 32.72 111.299 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.596 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -166.84 163.53 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.499 -0.926 . . . . 14.46 108.499 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 64.5 mt-10 -137.12 119.53 15.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.24 -0.913 . . . . 22.12 109.762 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -76.61 101.08 2.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.521 -1.288 . . . . 14.23 107.521 178.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.625 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.9 171.73 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.014 -1.054 . . . . 25.43 109.841 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -75.08 -26.06 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.49 2.126 . . . . 13.61 109.804 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.89 -0.13 56.58 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.906 -0.775 . . . . 15.52 108.906 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.479 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.5 mm-40 -120.59 37.17 4.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.346 -0.846 . . . . 17.31 109.595 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.01 8.45 44.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 24.78 110.236 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -139.71 137.89 35.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.186 -0.946 . . . . 47.9 108.677 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.613 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 30.7 p90 -84.45 173.99 10.43 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.027 -1.046 . . . . 21.61 109.459 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.7 m -142.5 151.67 41.91 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.459 -0.776 . . . . 14.89 109.115 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 O-C-N 121.296 -0.878 . . . . 17.35 109.23 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.359 0.6 . . . . 24.0 110.299 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.592 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -48.65 120.31 3.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 23.31 109.168 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 7.9 mt-10 -109.79 161.3 15.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 40.03 109.334 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.556 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -139.91 -168.92 2.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 12.39 109.647 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.521 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.1 mt -141.44 155.28 45.88 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.684 -0.858 . . . . 17.42 108.684 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.6 m -151.64 -177.25 5.99 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.185 -1.042 . . . . 13.84 108.185 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 16.5 m-85 -131.3 103.81 6.67 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.126 -0.984 . . . . 21.14 109.785 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 3.0 t -109.78 123.27 65.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.145 -0.972 . . . . 10.66 110.069 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -87.66 -36.76 17.25 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.366 -0.976 . . . . 25.89 108.366 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HA ' ' CD1' ' B' ' 65' ' ' LEU . 0.3 OUTLIER 63.79 -71.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.541 -0.911 . . . . 24.24 108.541 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -157.19 29.17 0.52 Allowed Glycine 0 C--N 1.297 -1.633 0 N-CA-C 109.188 -1.565 . . . . 31.02 109.188 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' HIS . 1.7 m-20 -109.51 21.64 16.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -1.178 . . . . 43.23 110.229 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.579 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 3.3 mt-10 42.58 25.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.266 -0.896 . . . . 42.34 110.328 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 98.6 m-70 -160.52 152.79 17.11 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.108 -0.995 . . . . 7.29 108.518 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.692 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -78.35 136.05 13.87 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.903 1.736 . . . . 17.92 110.411 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.539 ' CG1' HG23 ' B' ' 70' ' ' VAL . 2.4 m -112.21 119.34 59.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.351 -0.843 . . . . 20.57 108.744 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.61 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 52.1 tp -75.32 103.51 5.5 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.461 -0.895 . . . . 20.21 110.018 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.6 ' CG1' ' CG1' ' B' ' 70' ' ' VAL . 29.0 m -110.53 178.48 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.643 -0.873 . . . . 10.81 108.643 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.09 127.1 52.95 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.012 -1.075 . . . . 36.74 110.029 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.626 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -108.64 163.17 6.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.884 -0.784 . . . . 19.74 108.884 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.7 m -99.59 158.99 15.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 22.56 109.539 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.613 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -130.37 105.14 7.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.198 -0.939 . . . . 20.41 109.286 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.49 142.29 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 33.99 109.501 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.14 101.58 0.3 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 54.92 109.313 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.62 -20.04 10.3 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.316 -1.514 . . . . 36.1 109.316 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 30.5 mt-30 -78.28 148.53 74.46 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.259 -1.142 . . . . 54.76 109.376 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.99 120.38 5.01 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.665 2.244 . . . . 28.37 110.619 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -38.58 143.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.506 -0.746 . . . . 17.21 110.346 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.626 ' CE1' HG12 ' A' ' 47' ' ' ILE . 86.6 m-85 -44.56 102.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.798 . . . . 17.19 108.844 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.521 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -53.97 176.09 0.13 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 17.82 109.955 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.8 Cg_endo -78.39 111.22 2.99 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.763 2.309 . . . . 17.28 110.27 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 175.25 163.89 28.98 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.905 -1.278 . . . . 17.22 109.905 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.5 OUTLIER -59.84 142.79 52.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.243 -1.151 . . . . 19.57 108.748 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.596 ' CB ' HG12 ' A' ' 4' ' ' VAL . 31.8 m-85 -125.9 161.07 28.3 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.718 -1.238 . . . . 14.61 111.682 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 30.9 p -146.24 121.44 10.17 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.295 -1.743 . . . . 18.36 106.295 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.607 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.9 t -52.47 168.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.806 -1.158 . . . . 19.13 109.381 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.457 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.9 t-80 -133.62 127.14 32.39 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.487 -0.758 . . . . 20.65 109.038 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.664 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -71.11 0.1 8.42 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.292 -0.88 . . . . 19.65 109.997 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.3 p -55.26 -20.55 11.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.401 -1.333 . . . . 14.72 107.401 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 69.6 m -94.18 -27.35 16.24 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.835 -0.54 . . . . 11.45 109.998 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.664 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -60.82 156.27 17.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.1 -1.0 . . . . 14.25 109.127 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HE3' ' OD2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -159.1 172.31 18.35 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.385 -0.822 . . . . 32.7 109.586 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.589 ' CG1' ' CG1' ' B' ' 45' ' ' VAL . 0.1 OUTLIER -97.45 112.19 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 15.63 109.387 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.45 -176.08 48.61 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.547 -1.421 . . . . 12.7 109.547 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.05 33.86 0.87 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -1.162 . . . . 26.29 109.486 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -118.74 15.36 13.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 20.44 109.628 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.06 48.96 70.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.781 -1.328 . . . . 13.82 109.781 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 77' ' ' MET . 0.0 OUTLIER -170.93 138.84 1.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -1.197 . . . . 18.27 109.416 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 77' ' ' MET . 0.2 OUTLIER -45.15 163.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 12.43 109.388 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 76' ' ' LEU . 6.7 mmt -154.22 100.3 2.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 35.11 109.844 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.57 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.5 mt -40.98 -61.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.511 0.672 . . . . 13.67 109.634 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 35.4 t0 81.44 -48.2 0.24 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.476 0.655 . . . . 24.06 109.958 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.0 tpm_? -172.04 66.78 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.107 0.956 . . . . 35.04 108.781 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.607 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -34.84 127.06 0.51 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.499 -0.773 . . . . 18.72 111.597 -179.203 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -94.7 105.38 17.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.167 -1.049 . . . . 20.55 108.167 178.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.617 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -72.83 149.06 43.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 14.4 111.263 -178.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 62' ' ' THR . 34.3 m -150.22 150.68 29.98 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.121 -1.066 . . . . 17.65 108.121 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.2 Cg_endo -61.93 138.35 73.06 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.129 1.886 . . . . 25.7 110.241 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.468 ' CA ' HG22 ' A' ' 62' ' ' THR . . . -66.72 116.61 7.82 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.295 -0.878 . . . . 49.29 109.684 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.001 -1.0 . . . . 58.91 109.41 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.471 ' SD ' ' HB ' ' B' ' 62' ' ' THR . 1.3 ttp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.522 -0.548 . . . . 64.91 109.522 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.542 ' CG1' HD21 ' A' ' 65' ' ' LEU . 6.3 mt -70.6 77.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.16 -1.052 . . . . 33.8 108.16 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.447 ' C ' HG11 ' B' ' 4' ' ' VAL . 53.3 mttt -63.6 155.37 29.85 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.914 0.864 . . . . 32.72 111.308 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.59 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -166.86 163.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.492 -0.929 . . . . 14.46 108.492 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 65.3 mt-10 -137.07 119.6 15.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.344 -0.847 . . . . 22.12 109.798 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.541 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -76.71 101.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.583 -1.265 . . . . 14.23 107.583 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.63 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.88 171.76 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.1 -1.0 . . . . 25.43 109.83 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.6 Cg_endo -75.07 -26.14 11.09 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.539 2.159 . . . . 13.61 109.834 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.86 -0.08 56.5 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.946 -0.761 . . . . 15.52 108.946 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.482 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.5 mm-40 -120.57 37.07 4.38 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 17.31 109.561 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.05 8.71 43.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 24.78 110.204 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.452 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -139.93 137.85 35.12 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.126 -0.984 . . . . 47.9 108.639 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.61 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 30.8 p90 -84.39 174.05 10.41 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 120.984 -1.072 . . . . 21.61 109.504 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -142.53 151.44 41.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.397 -0.814 . . . . 14.89 109.113 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.536 0 O-C-N 121.288 -0.883 . . . . 17.35 109.129 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.349 0.595 . . . . 24.0 110.292 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.587 ' OD1' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -48.69 120.4 3.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.402 -0.811 . . . . 23.31 109.122 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 7.8 mt-10 -109.84 161.39 15.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 40.03 109.283 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.559 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -139.9 -168.85 2.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 12.39 109.67 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.517 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.1 mt -141.55 155.19 45.79 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.717 -0.845 . . . . 17.42 108.717 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.5 m -151.63 -177.21 5.97 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.179 -1.045 . . . . 13.84 108.179 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.69 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 16.3 m-85 -131.35 103.9 6.71 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.103 -0.998 . . . . 21.14 109.692 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' B' ' 43' ' ' VAL . 2.9 t -109.86 123.16 65.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.126 -0.984 . . . . 10.66 110.115 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.1 OUTLIER -87.45 -36.9 17.43 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.336 -0.987 . . . . 25.89 108.336 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.505 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 0.3 OUTLIER 64.13 -71.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.471 -0.937 . . . . 24.24 108.471 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -157.49 29.19 0.5 Allowed Glycine 0 C--N 1.297 -1.61 0 N-CA-C 109.185 -1.566 . . . . 31.02 109.185 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' B' ' 41' ' ' HIS . 1.7 m-20 -109.49 21.53 16.9 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.117 -1.225 . . . . 43.23 110.243 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.585 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 3.2 mt-10 42.78 25.23 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 42.34 110.302 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 98.4 m-70 -160.48 152.85 17.24 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.175 -0.953 . . . . 7.28 108.511 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.69 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 38.3 Cg_endo -78.44 135.9 13.62 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.93 1.753 . . . . 17.92 110.468 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' B' ' 35' ' ' VAL . 2.4 m -111.88 119.34 59.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.62 -0.881 . . . . 20.57 108.62 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.623 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 51.4 tp -75.25 103.43 5.4 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.243 -0.91 . . . . 20.21 110.069 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.589 ' CG1' ' CG1' ' A' ' 70' ' ' VAL . 26.1 m -110.4 178.64 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.738 -0.838 . . . . 10.81 108.738 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.23 127.0 52.91 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.975 -1.09 . . . . 36.74 109.99 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.621 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -108.48 163.3 6.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.889 -0.782 . . . . 19.74 108.889 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 56.5 m -99.71 158.7 15.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.985 -1.072 . . . . 22.56 109.558 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.61 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -130.12 105.25 7.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 20.41 109.3 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.6 142.03 2.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 33.99 109.578 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.9 101.33 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 54.92 109.353 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.92 -19.97 10.06 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.311 -1.516 . . . . 36.1 109.311 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -78.43 148.61 74.09 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.283 -1.128 . . . . 54.76 109.436 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.9 Cg_endo -78.01 120.44 5.02 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.644 2.229 . . . . 28.37 110.587 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.535 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -38.63 143.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 17.21 110.37 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.621 ' CE1' HG12 ' B' ' 47' ' ' ILE . 86.8 m-85 -44.59 102.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 17.19 108.837 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.53 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -53.73 176.06 0.12 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 17.82 109.878 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -78.48 111.34 3.0 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.719 2.279 . . . . 17.28 110.237 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 175.24 164.15 29.39 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.918 -1.273 . . . . 17.22 109.918 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.5 OUTLIER -60.16 142.82 53.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -1.143 . . . . 19.57 108.706 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.59 ' CB ' HG12 ' B' ' 4' ' ' VAL . 31.8 m-85 -125.86 161.13 28.13 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.679 -1.263 . . . . 14.61 111.645 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' B' ' 2' ' ' ILE . 30.8 p -146.28 121.48 10.18 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.325 -1.732 . . . . 18.36 106.325 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.617 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.9 t -52.6 168.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 C-N-CA 118.887 -1.125 . . . . 19.13 109.342 -178.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.461 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -133.61 127.26 32.64 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.508 -0.745 . . . . 20.65 109.058 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.663 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.7 OUTLIER -71.38 0.38 8.33 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.263 -0.898 . . . . 19.65 109.975 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.4 p -55.32 -20.47 11.61 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.294 -1.372 . . . . 14.72 107.294 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 69.8 m -94.35 -27.23 16.2 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.864 -0.522 . . . . 11.45 109.954 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.9 m-30 -60.9 156.13 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.05 -1.031 . . . . 14.25 109.069 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.415 ' HE3' ' OD2' ' B' ' 79' ' ' ASP . 0.0 OUTLIER -159.07 172.45 18.12 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.36 -0.837 . . . . 32.7 109.595 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.6 ' CG1' ' CG1' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -97.62 112.42 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.838 . . . . 15.63 109.392 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.52 -176.1 48.51 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.512 -1.435 . . . . 12.7 109.512 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.0 34.0 0.86 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.196 -1.179 . . . . 26.29 109.496 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -118.91 15.33 13.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 20.44 109.598 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.1 48.84 71.13 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.779 -1.328 . . . . 13.82 109.779 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.459 ' O ' ' HG2' ' B' ' 77' ' ' MET . 0.0 OUTLIER -170.84 138.95 1.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -1.162 . . . . 18.27 109.403 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' B' ' 77' ' ' MET . 0.2 OUTLIER -45.14 163.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 12.43 109.464 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' B' ' 76' ' ' LEU . 6.6 mmt -154.37 100.4 2.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 35.11 109.835 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.589 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.5 mt -41.13 -61.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.514 0.673 . . . . 13.67 109.689 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 35.5 t0 81.41 -48.28 0.24 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.485 0.66 . . . . 24.06 109.961 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.0 tpm_? -171.98 66.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.111 0.958 . . . . 35.04 108.793 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.617 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.0 OUTLIER -34.87 127.22 0.51 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.529 -0.759 . . . . 18.72 111.604 -179.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -94.94 105.1 16.99 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.18 -1.044 . . . . 20.55 108.18 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.611 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -72.52 149.15 44.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 14.4 111.301 -178.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' B' ' 62' ' ' THR . 34.1 m -150.36 150.62 29.52 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.08 -1.081 . . . . 17.65 108.08 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.2 Cg_endo -61.94 138.41 73.39 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.04 1.827 . . . . 25.7 110.295 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.476 ' CA ' HG22 ' B' ' 62' ' ' THR . . . -66.82 116.65 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.319 -0.863 . . . . 49.29 109.635 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.045 -0.978 . . . . 58.91 109.469 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.396 -0.594 . . . . 64.91 109.396 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.548 ' CG1' HD11 ' B' ' 65' ' ' LEU . 1.1 mt 53.02 81.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.689 -1.226 . . . . 33.8 107.689 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.447 ' C ' HG11 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -76.56 157.25 32.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 32.72 110.777 -178.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -164.07 163.38 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.022 -0.733 . . . . 14.46 109.022 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 37.5 mt-10 -138.99 114.14 9.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.486 -0.759 . . . . 22.12 109.039 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.6 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -74.36 102.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 119.201 -1.0 . . . . 14.23 108.528 179.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.642 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.63 170.85 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.299 -0.875 . . . . 25.43 109.478 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.7 Cg_endo -75.92 -21.73 13.92 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.419 2.08 . . . . 13.61 109.61 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.32 5.19 50.3 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.17 -0.678 . . . . 15.52 109.17 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.524 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 19.9 mm-40 -124.15 36.04 4.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 17.31 109.64 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -105.01 15.7 27.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.062 -1.024 . . . . 24.78 110.329 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.408 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 38.9 mt-30 -133.86 135.9 44.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 47.9 109.84 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.624 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 46.9 p90 -92.63 166.66 12.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.189 -0.944 . . . . 21.61 109.492 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -140.5 145.73 37.25 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.308 -0.87 . . . . 14.89 109.124 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 17.35 109.553 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' A' ' 48' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.43 0.634 . . . . 24.0 110.198 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.586 ' CB ' ' CB ' ' A' ' 49' ' ' LEU . 69.5 m-20 -51.08 123.2 8.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.811 . . . . 23.31 109.897 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 35.7 mp0 -98.86 155.16 17.52 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.058 -1.09 . . . . 40.03 108.058 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 1.2 tm0? -146.52 -179.96 7.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.825 -1.172 . . . . 12.39 110.384 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.47 ' HB2' ' OE1' ' A' ' 10' ' ' GLN . 51.0 mt -139.85 145.99 38.77 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.449 -0.782 . . . . 17.42 110.0 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.1 m -152.97 -177.12 6.09 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.148 -1.426 . . . . 13.84 107.148 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.648 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 27.3 m-85 -128.48 113.48 15.56 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.785 -1.197 . . . . 21.14 109.922 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 45.4 t -107.09 115.65 49.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.235 -0.916 . . . . 10.66 110.148 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 39' ' ' ASN . 54.8 m-20 -64.5 -36.55 84.55 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.806 -1.183 . . . . 25.89 107.806 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.558 ' CD2' ' HA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 46.41 48.21 13.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 24.24 109.893 179.303 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.04 -1.21 64.25 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.41 -1.476 . . . . 31.02 109.41 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.2 OUTLIER -105.9 95.73 6.0 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.334 -1.098 . . . . 43.23 108.342 179.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 39' ' ' ASN . 2.5 mp0 -27.33 -41.67 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.437 0.637 . . . . 42.34 111.083 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' ASN . 48.5 m80 -78.16 141.09 61.99 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 108.638 -0.875 . . . . 6.58 108.638 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.648 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -76.23 136.72 18.29 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.898 1.732 . . . . 17.92 110.478 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 2.9 m -107.65 117.65 53.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.614 -0.884 . . . . 20.57 108.614 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 61.7 tp -65.8 97.82 0.36 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.514 -0.874 . . . . 20.21 109.999 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 21.0 t -99.39 168.46 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.813 -0.81 . . . . 10.81 108.813 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.554 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 4.0 ptpp? -117.33 147.7 42.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.928 -1.108 . . . . 36.74 111.565 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.652 ' CG2' ' CE1' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -112.41 178.0 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.563 -0.903 . . . . 19.74 108.563 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.457 HG23 ' HB3' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -126.24 74.93 1.48 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.187 -0.946 . . . . 22.56 109.46 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.624 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -42.78 150.75 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.425 -0.797 . . . . 20.41 109.22 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 26.5 t0 -123.13 148.13 46.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 33.99 109.456 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 48.31 -148.89 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.116 -0.99 . . . . 54.92 109.257 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.12 16.83 56.28 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.647 -1.381 . . . . 36.1 109.647 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -45.72 149.33 1.13 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.178 -1.189 . . . . 54.76 109.469 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.16 113.16 3.35 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.587 2.192 . . . . 28.37 110.002 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 11' ' ' ALA . . . -39.4 153.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.467 -0.771 . . . . 17.21 110.25 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.652 ' CE1' ' CG2' ' A' ' 47' ' ' ILE . 84.5 m-85 -50.58 113.11 0.81 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 17.19 109.351 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.541 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -61.81 177.25 0.38 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 17.82 109.476 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.76 114.43 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.572 2.181 . . . . 17.28 110.398 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.0 179.88 43.98 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 17.22 109.556 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.2 mp -73.96 156.04 38.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -1.121 . . . . 19.57 108.577 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.6 ' CE1' HD11 ' A' ' 6' ' ' ILE . 26.6 m-85 -143.75 163.32 33.64 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.568 1.175 . . . . 14.61 111.577 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.525 ' CG2' ' HG3' ' A' ' 1' ' ' MET . 43.5 p -145.78 123.17 11.65 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.171 -1.789 . . . . 18.36 106.171 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.8 t -54.31 169.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 C-N-CA 118.495 -1.282 . . . . 19.13 108.804 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.513 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -128.11 124.5 37.11 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.861 -0.792 . . . . 20.65 108.861 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.635 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -64.91 -6.79 9.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.849 -0.532 . . . . 19.65 109.923 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.4 p -53.91 -16.19 1.72 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.93 -1.106 . . . . 14.72 108.673 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.475 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 50.1 m -99.52 -4.89 30.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.419 -0.8 . . . . 11.45 111.052 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -81.65 157.78 24.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.7 -1.25 . . . . 14.25 109.832 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.543 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 5.3 pttt -142.98 171.74 13.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.401 -0.812 . . . . 32.7 109.624 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.467 HG22 HG23 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -125.83 112.68 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 15.63 109.046 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.479 ' C ' ' NE2' ' A' ' 72' ' ' GLN . . . -71.95 -173.64 20.09 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.568 -1.413 . . . . 12.7 109.568 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.48 ' N ' ' NE2' ' A' ' 72' ' ' GLN . 0.8 OUTLIER -89.4 34.53 0.81 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.209 -1.171 . . . . 26.29 109.508 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -133.87 24.7 3.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.405 -0.81 . . . . 20.44 109.441 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' B' ' 46' ' ' LYS . . . 51.49 56.58 14.74 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 13.82 109.635 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.7 m -148.64 105.27 3.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -1.211 . . . . 18.27 109.752 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.496 ' CD1' HG22 ' B' ' 2' ' ' ILE . 5.0 tt -70.23 146.56 50.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 12.43 109.277 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.486 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 4.2 mtm -157.34 144.53 18.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 35.11 109.583 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.606 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.3 mp -69.73 141.76 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 13.67 109.615 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -107.5 -37.2 6.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.809 -1.182 . . . . 24.06 107.809 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -167.94 67.53 0.08 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.404 -1.332 . . . . 35.04 107.404 178.664 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.601 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -27.41 118.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.416 -0.811 . . . . 18.72 111.632 -178.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 20.0 tpt180 -92.09 104.58 16.95 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.066 -1.087 . . . . 20.55 108.066 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.578 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -72.64 150.7 42.78 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.052 0.929 . . . . 14.4 111.591 -178.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 62' ' ' THR . 34.7 m -152.07 154.36 32.42 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.741 -1.207 . . . . 17.65 107.741 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.4 Cg_endo -62.93 145.93 94.66 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.211 1.941 . . . . 25.7 110.749 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.24 121.85 22.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.238 -0.913 . . . . 49.29 109.525 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 tptt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.977 -1.011 . . . . 58.91 109.454 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.403 -0.591 . . . . 64.91 109.403 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.549 ' CG1' HD11 ' A' ' 65' ' ' LEU . 1.2 mt 52.83 81.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.662 -1.236 . . . . 33.8 107.662 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.444 ' C ' HG11 ' B' ' 4' ' ' VAL . 0.0 OUTLIER -76.32 157.2 32.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 32.72 110.839 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.567 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -164.06 163.46 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.014 -0.735 . . . . 14.46 109.014 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 37.6 mt-10 -139.1 114.06 9.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 22.12 109.019 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -74.3 102.17 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 119.183 -1.007 . . . . 14.23 108.46 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.627 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.73 171.03 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.307 -0.871 . . . . 25.43 109.507 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.6 Cg_endo -75.86 -21.93 13.84 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.346 2.031 . . . . 13.61 109.678 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.18 5.33 50.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.615 -0.678 . . . . 15.52 109.222 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.511 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 19.7 mm-40 -124.23 35.97 4.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 17.31 109.637 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -104.96 15.63 27.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -0.942 . . . . 24.78 110.339 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.416 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 38.9 mt-30 -133.78 135.92 44.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.0 . . . . 47.9 109.916 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.62 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 47.0 p90 -92.62 166.68 12.37 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.168 -0.958 . . . . 21.61 109.519 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 25.0 m -140.54 145.73 37.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 14.89 109.046 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 17.35 109.528 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.454 ' HB3' HG23 ' B' ' 48' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.395 0.616 . . . . 24.0 110.134 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.589 ' CB ' ' CB ' ' B' ' 49' ' ' LEU . 69.6 m-20 -51.14 123.13 8.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.462 -0.774 . . . . 23.31 109.947 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 35.6 mp0 -98.76 155.11 17.51 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.082 -1.081 . . . . 40.03 108.082 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' B' ' 10' ' ' GLN . 1.2 tm0? -146.53 -179.88 7.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.783 -1.198 . . . . 12.39 110.318 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.459 ' HB2' ' OE1' ' B' ' 10' ' ' GLN . 50.9 mt -139.98 145.92 38.45 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.442 -0.786 . . . . 17.42 110.019 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.561 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.1 m -152.88 -176.98 5.99 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.069 -1.456 . . . . 13.84 107.069 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.642 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 27.3 m-85 -128.61 113.41 15.39 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.867 -1.146 . . . . 21.14 109.914 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 45.5 t -107.09 115.83 49.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.293 -0.879 . . . . 10.66 110.126 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' B' ' 39' ' ' ASN . 55.0 m-20 -64.6 -36.48 84.37 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.806 -1.183 . . . . 25.89 107.806 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.543 ' CD2' ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 46.34 48.37 13.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.556 -0.715 . . . . 24.24 109.876 179.333 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.65 -0.72 64.25 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.389 -1.485 . . . . 31.02 109.389 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' B' ' 36' ' ' ASP . 0.2 OUTLIER -106.14 95.93 6.12 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.378 -1.072 . . . . 43.23 108.278 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' B' ' 39' ' ' ASN . 2.4 mp0 -27.55 -41.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.452 0.644 . . . . 42.34 111.126 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' B' ' 39' ' ' ASN . 48.5 m80 -78.19 141.2 62.01 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.659 -0.867 . . . . 6.56 108.659 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.642 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.6 Cg_endo -76.3 136.7 18.13 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.909 1.739 . . . . 17.92 110.51 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 2.9 m -107.6 117.55 53.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.645 -0.872 . . . . 20.57 108.645 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.57 HD11 ' CE2' ' B' ' 34' ' ' TYR . 61.6 tp -65.75 97.79 0.35 Allowed 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.486 -0.885 . . . . 20.21 110.017 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 21.2 t -99.4 168.34 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.866 -0.79 . . . . 10.81 108.866 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.544 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 4.0 ptpp? -117.13 147.8 42.11 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.94 -1.104 . . . . 36.74 111.59 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.649 ' CG2' ' CE1' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -112.58 177.98 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.564 -0.902 . . . . 19.74 108.564 179.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.454 HG23 ' HB3' ' B' ' 28' ' ' LEU . 0.1 OUTLIER -126.16 74.97 1.48 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.118 -0.989 . . . . 22.56 109.519 179.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.62 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -42.85 150.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.428 -0.795 . . . . 20.41 109.129 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' B' ' 53' ' ' GLN . 26.6 t0 -123.13 148.21 45.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.101 -1.0 . . . . 33.99 109.446 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 48.18 -148.8 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 54.92 109.276 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.14 16.78 56.43 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.582 -1.407 . . . . 36.1 109.582 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -45.64 149.26 1.11 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.198 -1.178 . . . . 54.76 109.523 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.06 113.19 3.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.614 2.209 . . . . 28.37 109.938 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' B' ' 11' ' ' ALA . . . -39.4 153.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.483 -0.761 . . . . 17.21 110.22 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.649 ' CE1' ' CG2' ' B' ' 47' ' ' ILE . 84.8 m-85 -50.45 113.0 0.78 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.4 -0.813 . . . . 17.19 109.238 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -61.86 177.33 0.38 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 17.82 109.483 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.8 Cg_endo -77.6 113.77 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.532 2.155 . . . . 17.28 110.215 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.33 179.33 44.87 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.724 -1.35 . . . . 17.22 109.724 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.0 mp -74.06 155.87 38.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -1.173 . . . . 19.57 108.315 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.599 ' CE1' HD11 ' B' ' 6' ' ' ILE . 26.5 m-85 -143.56 163.26 33.67 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.551 1.167 . . . . 14.61 111.564 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.525 ' CG2' ' HG3' ' B' ' 1' ' ' MET . 43.3 p -145.67 122.99 11.6 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.283 -1.747 . . . . 18.36 106.283 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.588 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.8 t -54.28 168.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 C-N-CA 118.497 -1.281 . . . . 19.13 108.828 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -128.05 124.49 37.22 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.418 -0.801 . . . . 20.65 108.907 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.626 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -64.78 -6.9 9.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.82 -0.55 . . . . 19.65 109.903 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 13.6 p -53.86 -16.14 1.65 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.005 -1.06 . . . . 14.72 108.616 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.476 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 50.4 m -99.67 -5.32 29.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.475 -0.765 . . . . 11.45 111.002 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.626 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.8 m-30 -81.26 157.08 25.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.647 -1.283 . . . . 14.25 109.779 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.558 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 5.3 pttt -142.28 171.64 13.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.832 . . . . 32.7 109.66 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.469 HG21 HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -125.65 112.66 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.346 -0.846 . . . . 15.63 109.092 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.472 ' C ' ' NE2' ' B' ' 72' ' ' GLN . . . -72.02 -173.64 20.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.586 -1.406 . . . . 12.7 109.586 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.482 ' N ' ' NE2' ' B' ' 72' ' ' GLN . 0.8 OUTLIER -89.3 34.5 0.8 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.214 -1.168 . . . . 26.29 109.503 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.94 24.81 3.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -0.797 . . . . 20.44 109.439 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . 51.32 56.9 12.92 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.604 -1.399 . . . . 13.82 109.604 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -149.03 105.38 3.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -1.196 . . . . 18.27 109.709 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' A' ' 2' ' ' ILE . 5.1 tt -70.48 146.65 50.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.865 . . . . 12.43 109.257 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.506 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 4.1 mtm -157.42 144.72 18.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -0.954 . . . . 35.11 109.515 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.607 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.3 mp -70.06 142.12 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 13.67 109.571 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -107.69 -37.07 6.25 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.766 -1.198 . . . . 24.06 107.766 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.476 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER -168.09 67.6 0.08 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.424 -1.324 . . . . 35.04 107.424 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.588 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.6 OUTLIER -27.47 118.52 0.09 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.356 -0.838 . . . . 18.72 111.574 -178.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 20.0 tpt180 -91.99 104.85 17.21 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.056 -1.091 . . . . 20.55 108.056 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.582 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -72.88 150.64 42.45 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.013 0.911 . . . . 14.4 111.538 -178.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' B' ' 62' ' ' THR . 34.7 m -151.99 154.42 32.62 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 107.75 -1.204 . . . . 17.65 107.75 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.1 Cg_endo -62.89 145.93 94.73 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.176 1.917 . . . . 25.7 110.774 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.27 121.85 22.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.242 -0.911 . . . . 49.29 109.535 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 tptt . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.017 -0.992 . . . . 58.91 109.45 -179.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.53 ' CG ' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.532 -0.544 . . . . 64.91 109.532 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' A' ' 63' ' ' VAL . 3.3 mt -62.17 81.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.044 -1.095 . . . . 33.8 108.044 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 10.8 mttt -54.98 157.52 3.21 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.857 0.836 . . . . 32.72 111.508 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.556 ' HB ' ' CB ' ' A' ' 61' ' ' TYR . 80.8 t -161.14 166.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.719 0.771 . . . . 14.46 109.774 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 34.1 mt-10 -152.14 105.63 3.08 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.63 -0.878 . . . . 22.12 108.63 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.587 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -73.77 104.35 2.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 119.038 -1.065 . . . . 14.23 108.172 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.607 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.75 171.87 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 25.43 109.974 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.5 Cg_endo -75.83 -24.88 11.14 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.468 2.112 . . . . 13.61 110.211 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.0 t -93.02 0.77 57.44 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.437 -0.789 . . . . 15.52 108.887 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.518 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.6 mm-40 -116.51 43.2 2.26 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.342 -0.849 . . . . 17.31 108.932 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -108.39 10.02 27.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 24.78 110.304 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 1.4 tt0 -136.81 134.34 36.89 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.109 -0.994 . . . . 47.9 108.952 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.608 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 30.2 p90 -87.49 175.48 7.93 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.046 -1.033 . . . . 21.61 109.756 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.416 HG21 ' N ' ' A' ' 15' ' ' THR . 57.6 m -137.57 151.95 48.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.874 -0.787 . . . . 14.89 108.874 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.416 ' N ' HG21 ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.531 0 O-C-N 121.229 -0.919 . . . . 17.35 109.439 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.518 HD21 ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.462 0.649 . . . . 24.0 109.985 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.605 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -98.82 122.58 42.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 23.31 108.996 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.459 ' OE1' ' HD3' ' A' ' 46' ' ' LYS . 4.8 mt-10 -108.94 156.96 19.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.244 -0.91 . . . . 40.03 109.887 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.539 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -141.26 -172.85 3.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 12.39 109.419 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.486 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 4.7 mp -133.99 159.16 41.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 17.42 109.48 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' SG ' ' CD1' ' A' ' 6' ' ' ILE . 13.4 m -155.46 177.17 11.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.095 -1.003 . . . . 13.84 108.324 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.681 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 35.3 m-85 -126.65 110.98 13.77 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.093 -1.005 . . . . 21.14 108.935 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.535 ' CG2' HG21 ' A' ' 4' ' ' VAL . 50.9 t -89.59 151.66 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.016 -1.053 . . . . 10.66 110.378 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.2 m-20 -129.01 -145.49 0.3 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.713 -0.617 . . . . 25.89 109.348 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.534 ' HG ' ' CD2' ' B' ' 65' ' ' LEU . 0.3 OUTLIER 67.6 -65.33 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 24.24 109.094 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -83.39 6.13 74.07 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 109.028 -1.629 . . . . 31.02 109.028 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' A' ' 38' ' ' GLY . 4.4 m-80 -162.41 109.07 1.27 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.431 -1.041 . . . . 43.23 109.006 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' ASN . 26.0 mt-10 -39.22 -61.22 0.8 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.617 0.722 . . . . 42.34 109.632 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 22.8 m80 -71.47 164.55 56.73 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 108.174 -1.047 . . . . 9.47 108.174 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.681 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.7 Cg_endo -78.27 140.52 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.868 1.712 . . . . 17.92 110.6 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.529 ' CG2' HG23 ' B' ' 70' ' ' VAL . 33.0 m -111.94 113.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.375 -0.828 . . . . 20.57 109.17 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.614 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 32.4 tp -67.35 110.66 3.65 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.906 . . . . 20.21 109.505 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.581 ' CG2' ' N ' ' B' ' 75' ' ' SER . 9.9 p -122.4 153.35 26.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.492 -0.755 . . . . 10.81 109.175 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 2.6 tttt -73.3 148.48 43.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 36.74 110.055 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.604 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.8 OUTLIER -139.92 123.02 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.724 -0.843 . . . . 19.74 108.724 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.518 ' CG2' HD21 ' A' ' 28' ' ' LEU . 1.3 m -63.31 156.69 24.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.08 -1.013 . . . . 22.56 110.05 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.608 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -122.33 117.14 25.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.805 . . . . 20.41 108.902 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.531 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -47.13 140.25 5.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 33.99 109.812 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.85 109.49 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 54.92 109.478 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.97 -16.72 59.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.6 -1.4 . . . . 36.1 109.6 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.531 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -73.69 150.57 88.78 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.285 -1.127 . . . . 54.76 109.522 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.33 122.87 5.8 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.665 2.243 . . . . 28.37 110.184 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.52 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -40.1 147.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.396 -0.815 . . . . 17.21 110.483 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 89.1 m-85 -47.96 116.22 1.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.483 -0.761 . . . . 17.19 109.026 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.534 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -66.63 176.77 0.97 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 17.82 109.62 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -78.4 105.6 2.0 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.686 2.257 . . . . 17.28 110.261 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.49 176.69 48.16 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.99 -1.244 . . . . 17.22 109.99 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -73.5 143.59 46.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -1.111 . . . . 19.57 108.426 179.293 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.587 ' CE1' HD11 ' A' ' 6' ' ' ILE . 33.3 m-85 -130.29 162.73 28.33 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.773 -1.204 . . . . 14.61 111.25 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.53 ' HB ' ' CG ' ' A' ' 1' ' ' MET . 33.4 p -142.9 119.78 11.27 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.896 -1.89 . . . . 18.36 105.896 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.7 t -53.05 166.94 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 C-N-CA 118.59 -1.244 . . . . 19.13 109.467 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -129.36 130.46 46.08 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.545 -0.722 . . . . 20.65 109.134 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.644 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -72.58 1.58 7.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.43 -0.794 . . . . 19.65 110.116 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -55.42 -19.25 8.69 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.496 -1.298 . . . . 14.72 107.496 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 7.1 m -99.07 -3.93 33.56 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.932 -0.48 . . . . 11.45 110.33 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.644 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.4 m-30 -85.41 157.47 20.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.863 -1.148 . . . . 14.25 110.215 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.458 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.5 ptpt -154.41 174.33 15.01 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.023 -0.732 . . . . 32.7 109.023 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' B' ' 43' ' ' VAL . 1.0 OUTLIER -114.58 111.76 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 15.63 109.556 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.34 -170.25 46.59 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.315 -1.514 . . . . 12.7 109.315 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -90.5 20.79 4.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.154 -1.204 . . . . 26.29 109.481 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.82 -12.74 35.44 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.501 -0.75 . . . . 20.44 109.237 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' B' ' 46' ' ' LYS . . . 85.01 35.05 13.12 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.509 -1.436 . . . . 13.82 109.509 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.547 ' N ' ' CG2' ' B' ' 45' ' ' VAL . 22.8 p -164.33 150.82 11.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -1.199 . . . . 18.27 109.647 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 69' ' ' LYS . 16.3 tp -63.69 156.74 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.853 . . . . 12.43 109.126 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 32.0 mtt -154.95 113.43 3.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.092 -1.005 . . . . 35.11 109.749 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.601 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.9 mt -55.67 139.91 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.314 -0.866 . . . . 13.67 109.472 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -106.19 -27.39 11.09 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.443 -0.947 . . . . 24.06 108.443 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 67' ' ' SER . 5.7 tpm_? 179.74 67.75 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.992 -1.485 . . . . 35.04 106.992 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.568 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -29.39 118.09 0.13 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.387 -0.824 . . . . 18.72 111.913 -177.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -92.09 108.14 19.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.716 -1.216 . . . . 20.55 107.716 178.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.61 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 12.7 tp -80.25 150.42 30.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.229 -0.919 . . . . 14.4 111.093 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.531 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 25.0 m -147.44 152.47 42.23 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 108.039 -1.097 . . . . 17.65 108.039 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -62.37 141.58 87.72 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.103 1.868 . . . . 25.7 110.662 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -73.59 116.44 14.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.437 -0.789 . . . . 49.29 109.625 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.007 -0.996 . . . . 58.91 109.482 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.528 ' CG ' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.518 -0.549 . . . . 64.91 109.518 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.537 ' CG2' HG22 ' B' ' 63' ' ' VAL . 3.2 mt -62.19 81.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.993 -1.114 . . . . 33.8 107.993 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 10.8 mttt -54.83 157.37 3.16 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.877 0.846 . . . . 32.72 111.487 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.562 ' HB ' ' CB ' ' B' ' 61' ' ' TYR . 83.1 t -161.09 166.03 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.751 0.786 . . . . 14.46 109.739 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 34.4 mt-10 -151.97 105.69 3.12 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.629 -0.878 . . . . 22.12 108.629 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.589 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.3 OUTLIER -73.77 104.55 2.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.01 -1.076 . . . . 14.23 108.178 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.612 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.83 171.9 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.442 -0.786 . . . . 25.43 109.99 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.5 Cg_endo -75.8 -25.04 11.05 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.487 2.125 . . . . 13.61 110.238 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t -92.8 0.65 57.45 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 108.938 -0.764 . . . . 15.52 108.938 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.6 mm-40 -116.43 43.25 2.24 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.345 -0.847 . . . . 17.31 108.928 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -108.4 10.09 27.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.91 . . . . 24.78 110.312 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 1.4 tt0 -136.86 134.22 36.65 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.114 -0.991 . . . . 47.9 108.943 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.609 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 30.2 p90 -87.44 175.47 7.95 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.028 -1.045 . . . . 21.61 109.74 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.411 HG21 ' N ' ' B' ' 15' ' ' THR . 59.3 m -137.48 152.04 49.11 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.845 -0.798 . . . . 14.89 108.845 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' THR . . . . . 0.411 ' N ' HG21 ' B' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.494 0 O-C-N 121.256 -0.903 . . . . 17.35 109.401 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' B' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.478 0.656 . . . . 24.0 109.969 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.601 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -98.75 122.53 42.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.479 -0.763 . . . . 23.31 109.035 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 4.9 mt-10 -109.0 156.79 19.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.189 -0.944 . . . . 40.03 109.911 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.542 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -141.13 -172.83 3.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 12.39 109.423 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 4.7 mp -133.99 159.13 41.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.154 -0.966 . . . . 17.42 109.412 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.514 ' SG ' ' CD1' ' B' ' 6' ' ' ILE . 13.1 m -155.41 177.21 11.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.309 -0.997 . . . . 13.84 108.309 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.679 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 34.6 m-85 -126.72 111.04 13.8 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.157 -0.964 . . . . 21.14 108.92 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' B' ' 4' ' ' VAL . 50.9 t -89.69 151.65 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.012 -1.055 . . . . 10.66 110.397 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.1 m-20 -128.92 -145.6 0.3 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.307 -0.627 . . . . 25.89 109.307 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.534 ' HG ' ' CD2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER 67.65 -65.4 0.24 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.134 -0.979 . . . . 24.24 109.057 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -83.27 6.11 73.73 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.041 -1.623 . . . . 31.02 109.041 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' B' ' 38' ' ' GLY . 4.5 m-80 -162.39 109.02 1.27 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.438 -1.036 . . . . 43.23 108.986 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' B' ' 39' ' ' ASN . 26.1 mt-10 -39.08 -61.39 0.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.701 0.762 . . . . 42.34 109.573 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.459 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 22.6 m80 -71.24 164.57 56.04 Favored Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 108.256 -1.016 . . . . 9.49 108.256 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.679 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.6 Cg_endo -78.32 140.7 17.57 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.855 1.703 . . . . 17.92 110.507 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.522 ' CG2' HG23 ' A' ' 70' ' ' VAL . 32.9 m -112.13 113.33 43.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.394 -0.816 . . . . 20.57 109.197 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.626 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 32.3 tp -67.46 110.72 3.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.313 -0.867 . . . . 20.21 109.616 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 75' ' ' SER . 9.9 p -122.28 153.81 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.494 -0.754 . . . . 10.81 109.108 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 2.6 tttt -73.73 148.55 42.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 36.74 110.027 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.593 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -139.75 123.04 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.739 -0.837 . . . . 19.74 108.739 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.519 ' CG2' HD21 ' B' ' 28' ' ' LEU . 1.3 m -63.39 156.66 25.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.015 -1.053 . . . . 22.56 109.982 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.609 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -122.26 116.98 25.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.422 -0.799 . . . . 20.41 108.94 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -47.0 140.33 4.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 33.99 109.832 -179.486 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.92 109.45 0.83 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 54.92 109.478 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.99 -16.75 59.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.581 -1.408 . . . . 36.1 109.581 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.538 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.8 OUTLIER -73.7 150.47 88.71 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -1.148 . . . . 54.76 109.568 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.7 Cg_endo -78.22 122.82 5.84 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.656 2.237 . . . . 28.37 110.225 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.524 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -40.11 147.15 0.1 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 17.21 110.404 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 88.9 m-85 -48.13 115.59 1.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.462 -0.773 . . . . 17.19 109.171 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.526 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -65.64 176.88 0.79 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 17.82 109.583 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 36.1 Cg_endo -78.68 106.72 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.741 2.294 . . . . 17.28 110.424 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.82 176.9 48.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.876 -1.29 . . . . 17.22 109.876 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.3 OUTLIER -73.37 144.14 46.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.385 -1.068 . . . . 19.57 108.632 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.589 ' CE1' HD11 ' B' ' 6' ' ' ILE . 33.7 m-85 -130.78 162.82 28.68 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.756 -1.215 . . . . 14.61 111.375 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.528 ' HB ' ' CG ' ' B' ' 1' ' ' MET . 33.2 p -143.09 119.68 11.07 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 105.975 -1.861 . . . . 18.36 105.975 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.577 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.7 t -53.12 166.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 118.575 -1.25 . . . . 19.13 109.438 -177.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -129.2 130.32 46.17 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.552 -0.718 . . . . 20.65 109.196 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.636 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -72.47 1.69 7.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.421 -0.799 . . . . 19.65 110.092 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -55.49 -19.24 9.02 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.45 -1.315 . . . . 14.72 107.45 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 7.0 m -99.08 -3.98 33.42 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.902 -0.499 . . . . 11.45 110.351 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.3 m-30 -85.35 157.62 20.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.913 -1.117 . . . . 14.25 110.182 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.46 ' O ' HD13 ' B' ' 76' ' ' LEU . 1.5 ptpt -154.57 174.17 15.32 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.991 -0.744 . . . . 32.7 108.991 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.529 HG23 ' CG2' ' A' ' 43' ' ' VAL . 1.0 OUTLIER -114.44 111.77 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 15.63 109.55 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.2 -170.24 46.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.332 -1.507 . . . . 12.7 109.332 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.65 21.17 4.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.138 -1.213 . . . . 26.29 109.458 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.16 -12.82 34.31 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.448 -0.782 . . . . 20.44 109.253 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.449 ' C ' ' CG2' ' A' ' 45' ' ' VAL . . . 85.15 34.72 13.82 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.546 -1.422 . . . . 13.82 109.546 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.581 ' N ' ' CG2' ' A' ' 45' ' ' VAL . 21.9 p -163.93 150.87 11.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -1.183 . . . . 18.27 109.683 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 2' ' ' ILE . 16.3 tp -63.72 157.0 25.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 12.43 109.09 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 31.9 mtt -155.15 113.5 3.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.013 . . . . 35.11 109.679 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.9 mt -55.74 139.95 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 13.67 109.476 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -106.19 -27.3 11.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.417 -0.957 . . . . 24.06 108.417 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' B' ' 67' ' ' SER . 5.8 tpm_? 179.65 67.78 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.956 -1.498 . . . . 35.04 106.956 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.577 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -29.34 118.13 0.13 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.349 -0.841 . . . . 18.72 111.85 -177.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -92.2 108.07 19.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.709 -1.219 . . . . 20.55 107.709 178.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.598 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 12.6 tp -80.13 150.26 30.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.184 -0.947 . . . . 14.4 111.07 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.548 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 25.0 m -147.32 152.58 42.9 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.111 -1.07 . . . . 17.65 108.111 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.3 Cg_endo -62.32 141.72 88.51 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.166 1.91 . . . . 25.7 110.666 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' B' ' 60' ' ' LEU . . . -73.69 116.54 14.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 49.29 109.497 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.959 -1.02 . . . . 58.91 109.425 179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.523 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.308 0.575 . . . . 64.91 109.484 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.516 ' N ' HD21 ' B' ' 65' ' ' LEU . 2.7 mt 69.3 72.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.975 -1.12 . . . . 33.8 107.975 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.49 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 18.8 mttt -54.1 158.74 2.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.017 0.913 . . . . 32.72 111.461 -178.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.579 ' HB ' ' CB ' ' A' ' 61' ' ' TYR . 66.4 t -160.46 168.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.93 -0.766 . . . . 14.46 108.93 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.508 ' N ' HG13 ' A' ' 4' ' ' VAL . 43.1 mt-10 -154.6 103.26 2.45 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.79 0.805 . . . . 22.12 108.843 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.578 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -69.34 108.43 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.893 -1.151 . . . . 14.23 107.893 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.654 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.11 172.79 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.203 -0.936 . . . . 25.43 109.406 -179.042 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.5 Cg_endo -76.23 -21.6 13.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.475 2.117 . . . . 13.61 110.128 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.42 4.15 46.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.529 -0.732 . . . . 15.52 109.443 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.525 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 24.0 mm-40 -114.84 38.71 3.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 17.31 109.288 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.13 52.24 0.72 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.877 . . . . 24.78 109.738 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 5.0 pt20 -176.63 135.63 0.24 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.364 -0.835 . . . . 47.9 108.896 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.614 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 37.7 p90 -95.61 172.67 7.91 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.721 -1.237 . . . . 21.61 109.874 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 8.0 t -137.03 162.03 34.43 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.497 -0.927 . . . . 14.89 108.497 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.623 0 O-C-N 121.178 -0.951 . . . . 17.35 109.271 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.524 ' C ' ' CD1' ' A' ' 28' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.523 0.678 . . . . 24.0 110.903 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.611 ' CB ' ' CD1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -72.47 127.67 33.26 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.931 -0.766 . . . . 23.31 108.931 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.6 mt-10 -118.11 165.51 13.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.018 -1.051 . . . . 40.03 109.281 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.581 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -146.37 179.99 7.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.106 -0.996 . . . . 12.39 109.671 -179.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.491 ' O ' ' OE1' ' A' ' 31' ' ' GLN . 39.3 mt -123.92 154.04 40.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 17.42 109.316 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 11.1 m -154.06 172.98 16.65 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.611 -1.255 . . . . 13.84 107.611 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.684 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 29.2 m-85 -121.45 99.03 6.24 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.951 -1.093 . . . . 21.14 109.45 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.549 ' CG2' ' CG2' ' A' ' 4' ' ' VAL . 61.7 t -93.73 126.16 46.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.041 -1.037 . . . . 10.66 110.602 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' GLY . 25.3 t0 -101.19 44.66 1.0 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.591 -1.263 . . . . 25.89 107.591 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -35.77 -29.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.223 0.535 . . . . 24.24 110.197 -178.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 160.84 52.3 0.02 OUTLIER Glycine 0 N--CA 1.479 1.535 0 N-CA-C 109.438 -1.465 . . . . 31.02 109.438 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' ND2' HD12 ' A' ' 37' ' ' LEU . 37.3 m-20 -126.83 17.98 7.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.07 -1.253 . . . . 43.23 110.035 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.591 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 2.6 mm-40 56.56 14.64 1.77 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.326 -0.859 . . . . 42.34 110.252 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 77.5 m-70 -162.53 161.72 19.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.326 -0.99 . . . . 6.32 108.326 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.684 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.0 Cg_endo -78.06 136.57 14.78 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.892 1.728 . . . . 17.92 110.021 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 3.6 m -111.34 115.24 49.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.249 -0.907 . . . . 20.57 109.453 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 18.9 tp -71.76 88.73 1.01 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.182 -0.949 . . . . 20.21 109.482 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' B' ' 75' ' ' SER . 6.1 p -103.21 152.88 5.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.632 -0.877 . . . . 10.81 108.632 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 3.7 mtpt -72.08 167.03 21.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 36.74 110.493 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.608 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -146.47 177.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.567 -0.901 . . . . 19.74 108.567 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.461 HG22 HD12 ' A' ' 28' ' ' LEU . 97.8 m -117.6 151.29 37.47 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.186 -0.946 . . . . 22.56 109.464 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -124.74 149.19 47.56 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.291 -1.003 . . . . 20.41 108.291 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -106.18 143.5 34.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.078 -1.014 . . . . 33.99 110.202 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.21 127.04 14.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 54.92 109.477 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.7 -28.67 7.47 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.652 -1.379 . . . . 36.1 109.652 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.97 137.35 72.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.198 -1.178 . . . . 54.76 109.564 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.5 Cg_endo -78.58 124.2 6.26 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.413 2.075 . . . . 28.37 109.959 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' A' ' 12' ' ' GLN . . . -40.24 147.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.4 -0.812 . . . . 17.21 110.0 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 84.9 m-85 -45.9 105.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 17.19 109.137 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.508 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -58.1 174.79 0.32 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 17.82 109.628 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.78 114.15 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.605 2.203 . . . . 17.28 110.149 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.25 179.76 46.0 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.474 -1.45 . . . . 17.22 109.474 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.6 mp -75.4 146.31 40.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -1.217 . . . . 19.57 108.111 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.579 ' CB ' ' HB ' ' A' ' 4' ' ' VAL . 20.4 m-85 -133.07 167.43 20.32 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.866 -1.146 . . . . 14.61 111.591 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.523 ' CG2' ' HG3' ' A' ' 1' ' ' MET . 44.8 p -150.59 119.5 6.65 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.336 -1.727 . . . . 18.36 106.336 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.595 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -52.01 164.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.374 -1.33 . . . . 19.13 108.568 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -123.47 123.89 41.65 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.397 -0.814 . . . . 20.65 109.003 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.651 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -67.94 -4.02 11.73 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.834 -0.542 . . . . 19.65 110.209 -179.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.3 t -55.98 -15.86 4.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.076 -1.015 . . . . 14.72 108.449 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 80' ' ' ARG . 16.6 m -95.76 -7.0 38.39 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.525 -0.734 . . . . 11.45 110.633 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.651 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -83.15 159.64 22.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.818 -1.176 . . . . 14.25 109.674 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' CG ' ' O ' ' A' ' 68' ' ' PHE . 10.3 mtmt -157.82 172.14 19.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.49 -0.756 . . . . 32.7 109.253 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.78 98.29 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 15.63 109.008 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.8 -149.92 4.11 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.825 -1.31 . . . . 12.7 109.825 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.3 21.04 17.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.27 -1.135 . . . . 26.29 109.685 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.09 -11.98 42.46 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.05 -0.722 . . . . 20.44 109.05 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 84.69 24.23 46.9 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.495 -1.442 . . . . 13.82 109.495 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.456 ' HA ' HG23 ' B' ' 45' ' ' VAL . 4.7 p -161.03 152.25 18.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -1.179 . . . . 18.27 109.633 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.442 ' C ' ' CD2' ' A' ' 76' ' ' LEU . 4.7 tt -62.95 149.23 45.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.319 -0.863 . . . . 12.43 109.381 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.3 mtt -150.55 133.98 16.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 35.11 109.412 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.616 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.2 mt -66.29 139.24 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.877 . . . . 13.67 109.721 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 8.3 t70 -106.64 -19.58 13.62 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.507 -0.923 . . . . 24.06 108.507 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.491 ' NH1' ' HG2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER 172.71 68.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.198 -1.408 . . . . 35.04 107.198 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.595 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -31.63 116.88 0.19 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.693 0.758 . . . . 18.72 111.179 -178.14 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.01 104.97 17.49 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.463 -0.94 . . . . 20.55 108.463 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.615 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -73.38 144.82 46.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 14.4 111.024 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 62' ' ' THR . 27.6 m -146.72 156.61 48.32 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.956 -1.128 . . . . 17.65 107.956 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.0 Cg_endo -63.03 144.97 93.89 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.134 1.889 . . . . 25.7 110.334 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' O ' ' CB ' ' A' ' 87' ' ' LYS . . . -73.11 115.73 12.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.135 -0.978 . . . . 49.29 109.705 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.02 -0.99 . . . . 58.91 109.531 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.53 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.399 -0.593 . . . . 64.91 109.399 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.522 ' N ' HD21 ' A' ' 65' ' ' LEU . 2.7 mt 68.6 72.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.874 -1.158 . . . . 33.8 107.874 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.494 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 18.9 mttt -54.4 158.62 2.32 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.009 0.909 . . . . 32.72 111.412 -178.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.57 ' HB ' ' CB ' ' B' ' 61' ' ' TYR . 68.2 t -160.25 168.0 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.994 -0.743 . . . . 14.46 108.994 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 42.3 mt-10 -154.02 103.09 2.54 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.418 -0.801 . . . . 22.12 108.975 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.578 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -69.18 108.53 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.934 -1.135 . . . . 14.23 107.934 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.661 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.25 172.5 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 25.43 109.36 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 35.1 Cg_endo -76.16 -21.39 13.81 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.488 2.125 . . . . 13.61 110.122 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.63 4.15 45.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.475 -0.765 . . . . 15.52 109.442 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.529 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 24.1 mm-40 -114.69 38.36 3.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.93 . . . . 17.31 109.187 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.14 53.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 24.78 109.709 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.524 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 4.8 pt20 -177.24 135.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.376 -0.828 . . . . 47.9 108.884 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.624 ' CD1' ' CB ' ' B' ' 29' ' ' ASN . 37.9 p90 -95.77 172.75 7.84 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.753 -1.217 . . . . 21.61 109.891 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 8.3 t -137.28 161.91 34.94 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.488 -0.93 . . . . 14.89 108.488 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.615 0 O-C-N 121.17 -0.956 . . . . 17.35 109.438 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.519 ' C ' ' CD1' ' B' ' 28' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.577 0.703 . . . . 24.0 110.846 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.624 ' CB ' ' CD1' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -72.38 127.47 32.67 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.894 -0.78 . . . . 23.31 108.894 179.03 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 6.5 mt-10 -118.06 165.24 13.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.012 -1.055 . . . . 40.03 109.322 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.578 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.9 OUTLIER -146.03 -179.9 7.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.137 -0.977 . . . . 12.39 109.765 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.479 ' O ' ' OE1' ' B' ' 31' ' ' GLN . 40.3 mt -124.2 153.71 41.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 17.42 109.309 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 10.3 m -153.73 172.98 16.44 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.716 -1.216 . . . . 13.84 107.716 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.687 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 29.3 m-85 -121.39 98.91 6.19 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.895 -1.128 . . . . 21.14 109.461 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.563 ' CG2' ' CG2' ' B' ' 4' ' ' VAL . 61.7 t -93.6 126.17 46.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.03 -1.044 . . . . 10.66 110.573 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' B' ' 38' ' ' GLY . 26.1 t0 -101.11 44.37 1.02 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.579 -1.267 . . . . 25.89 107.579 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.526 ' N ' HD13 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -35.65 -30.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.1 0.476 . . . . 24.24 110.185 -178.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 161.05 51.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 109.415 -1.474 . . . . 31.02 109.415 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.451 ' ND2' HD12 ' B' ' 37' ' ' LEU . 37.7 m-20 -126.54 18.28 7.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.167 -1.196 . . . . 43.23 110.092 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.59 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 2.6 mm-40 56.36 14.58 1.65 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.237 -0.914 . . . . 42.34 110.302 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 77.4 m-70 -162.41 161.6 20.14 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.344 -0.984 . . . . 6.31 108.344 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.687 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.8 Cg_endo -78.02 136.55 14.83 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.877 1.718 . . . . 17.92 109.998 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 3.6 m -111.39 115.42 49.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.242 -0.911 . . . . 20.57 109.339 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.604 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 19.0 tp -71.99 88.8 1.08 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.219 -0.926 . . . . 20.21 109.503 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 75' ' ' SER . 6.3 p -103.0 153.38 5.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.648 -0.871 . . . . 10.81 108.648 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 3.8 mtpt -72.32 167.44 20.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 36.74 110.428 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.593 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -146.94 177.12 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.628 -0.878 . . . . 19.74 108.628 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.481 HG21 ' N ' ' B' ' 49' ' ' LEU . 98.5 m -117.39 151.28 37.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.123 -0.986 . . . . 22.56 109.468 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.619 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -124.88 148.86 48.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.226 -1.028 . . . . 20.41 108.226 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -105.95 143.61 33.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 33.99 110.076 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.22 126.84 13.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.771 . . . . 54.92 109.528 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.81 -28.49 7.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.712 -1.355 . . . . 36.1 109.712 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.08 137.45 72.53 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.277 -1.131 . . . . 54.76 109.483 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.57 124.14 6.24 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.394 2.063 . . . . 28.37 109.96 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' B' ' 12' ' ' GLN . . . -40.29 147.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 17.21 109.913 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.616 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 84.1 m-85 -46.2 105.85 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 17.19 109.252 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.496 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -57.85 174.65 0.31 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 17.82 109.59 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -77.99 115.18 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.624 2.216 . . . . 17.28 110.43 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.49 -179.46 44.87 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.31 -1.516 . . . . 17.22 109.31 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 4.0 mp -75.29 146.86 40.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.134 -1.216 . . . . 19.57 108.457 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.578 ' CE1' HD11 ' B' ' 6' ' ' ILE . 19.9 m-85 -133.54 167.69 20.01 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.498 1.142 . . . . 14.61 111.452 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.53 ' CG2' ' HG3' ' B' ' 1' ' ' MET . 45.8 p -150.87 119.45 6.49 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.296 -1.742 . . . . 18.36 106.296 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.592 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -52.0 163.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.404 -1.318 . . . . 19.13 108.597 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.514 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -123.16 124.35 42.86 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.406 -0.809 . . . . 20.65 109.022 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.653 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -68.24 -3.95 12.47 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.879 -0.513 . . . . 19.65 110.169 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 10.4 t -55.93 -16.08 4.27 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.132 -0.98 . . . . 14.72 108.376 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' B' ' 80' ' ' ARG . 16.6 m -95.66 -6.7 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.609 -0.682 . . . . 11.45 110.707 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.653 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.9 m-30 -83.33 159.78 21.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.852 -1.155 . . . . 14.25 109.657 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.461 ' CG ' ' O ' ' B' ' 68' ' ' PHE . 10.3 mtmt -158.09 171.29 20.5 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.475 -0.766 . . . . 32.7 109.269 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.99 98.59 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 15.63 108.959 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.44 -150.47 4.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.707 -1.357 . . . . 12.7 109.707 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.78 21.64 16.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.238 -1.154 . . . . 26.29 109.859 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.66 -11.82 41.38 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.02 -0.733 . . . . 20.44 109.02 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 84.44 24.99 44.82 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.532 -1.427 . . . . 13.82 109.532 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.453 ' HA ' HG23 ' A' ' 45' ' ' VAL . 4.7 p -161.68 152.18 17.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -1.17 . . . . 18.27 109.639 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.438 ' C ' ' CD2' ' B' ' 76' ' ' LEU . 4.6 tt -63.14 149.24 45.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 12.43 109.412 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 14.4 mtt -150.44 133.69 16.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 35.11 109.502 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.619 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.2 mt -66.18 138.86 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 13.67 109.686 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 8.2 t70 -106.23 -19.87 13.57 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.558 -0.905 . . . . 24.06 108.558 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.505 ' NH1' ' HG2' ' B' ' 80' ' ' ARG . 0.0 OUTLIER 173.0 68.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.208 -1.404 . . . . 35.04 107.208 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.592 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -32.03 117.04 0.21 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.672 0.748 . . . . 18.72 111.214 -178.117 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.15 105.0 17.51 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.473 -0.936 . . . . 20.55 108.473 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.616 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -73.34 145.05 46.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 14.4 110.96 -178.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' B' ' 62' ' ' THR . 28.0 m -147.04 156.41 47.11 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 107.938 -1.134 . . . . 17.65 107.938 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.8 Cg_endo -62.87 144.77 94.02 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.185 1.923 . . . . 25.7 110.338 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' B' ' 62' ' ' THR . . . -72.93 115.91 12.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.194 -0.941 . . . . 49.29 109.681 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' B' ' 86' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.973 -1.013 . . . . 58.91 109.528 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.53 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.545 -0.539 . . . . 64.91 109.545 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.536 ' CD1' ' HB ' ' A' ' 63' ' ' VAL . 1.8 mt -58.42 85.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.887 -1.153 . . . . 33.8 107.887 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 20.7 mttt -63.61 157.97 22.49 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.815 0.817 . . . . 32.72 111.595 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 61' ' ' TYR . 58.8 t -160.01 167.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-O 121.609 0.719 . . . . 14.46 109.691 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 77.3 mt-10 -154.95 107.14 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.705 -0.85 . . . . 22.12 108.705 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.595 HD12 ' CE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -74.54 107.96 5.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 118.991 -1.083 . . . . 14.23 108.3 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.675 ' CD ' ' CD1' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.44 171.85 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.449 -0.782 . . . . 25.43 110.011 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.3 Cg_endo -76.7 -25.61 9.12 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.59 2.193 . . . . 13.61 109.753 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.73 8.39 44.39 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.921 -0.77 . . . . 15.52 108.921 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.528 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 10.2 mm-40 -121.38 32.83 5.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.277 -0.889 . . . . 17.31 109.474 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.91 11.47 37.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.141 -0.974 . . . . 24.78 110.324 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -138.77 138.01 37.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.032 -1.042 . . . . 47.9 110.104 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.613 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 11.6 p90 -88.37 173.29 8.82 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.397 -0.814 . . . . 21.61 109.769 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 10.0 t -130.91 163.97 26.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.535 -0.913 . . . . 14.89 108.535 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.591 0 O-C-N 121.147 -0.97 . . . . 17.35 109.575 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.937 0.875 . . . . 24.0 110.877 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.613 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -105.49 128.64 53.67 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.57 -0.9 . . . . 23.31 108.57 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -111.38 151.14 28.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.988 -1.07 . . . . 40.03 109.972 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.541 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -133.71 175.86 9.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.895 . . . . 12.39 109.523 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.456 ' C ' ' SG ' ' A' ' 33' ' ' CYS . 3.5 mp -127.31 155.52 43.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 17.42 109.131 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 1.9 m -153.73 -176.81 6.0 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.316 -0.994 . . . . 13.84 108.316 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.675 ' CD1' ' CD ' ' A' ' 7' ' ' LYS . 35.2 m-85 -130.75 102.92 6.3 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.117 -0.989 . . . . 21.14 109.561 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.533 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 78.7 t -90.8 125.94 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.07 -1.019 . . . . 10.66 110.324 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 39' ' ' ASN . 3.7 m-20 -68.51 -41.93 79.3 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.589 -0.893 . . . . 25.89 108.589 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.527 HD12 ' CA ' ' B' ' 69' ' ' LYS . 0.6 OUTLIER 47.51 48.24 16.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.798 . . . . 24.24 109.77 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.06 4.94 51.3 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.321 -1.511 . . . . 31.02 109.321 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.5 OUTLIER -104.58 95.76 6.13 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.356 -1.085 . . . . 43.23 108.47 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 39' ' ' ASN . 9.3 mt-10 -30.6 -37.31 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.41 0.624 . . . . 42.34 110.81 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -85.24 146.37 44.89 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 108.644 -0.873 . . . . 6.32 108.644 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.672 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.9 Cg_endo -76.37 137.11 18.42 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.967 1.778 . . . . 17.92 110.599 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 5.8 m -108.68 113.93 45.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.366 -0.833 . . . . 20.57 109.162 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.581 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 28.0 tp -65.63 110.28 2.7 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.368 -0.832 . . . . 20.21 109.386 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.6 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 6.6 t -115.52 165.46 10.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.518 -0.739 . . . . 10.81 109.351 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.555 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 9.8 mtpt -96.42 125.44 40.91 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.488 -0.885 . . . . 36.74 109.457 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.637 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.8 OUTLIER -117.4 136.26 55.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.31 -0.869 . . . . 19.74 109.332 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.482 ' OG1' ' CZ ' ' A' ' 80' ' ' ARG . 12.5 m -68.05 163.7 21.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.113 -0.992 . . . . 22.56 109.303 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.603 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 1.1 tm? -151.89 93.42 1.84 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.807 -0.812 . . . . 20.41 108.807 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.28 -158.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 33.99 109.823 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 48.94 -154.18 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 54.92 109.159 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.471 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . -79.61 -2.44 88.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.445 -1.462 . . . . 36.1 109.445 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -73.41 114.28 30.17 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.286 -1.126 . . . . 54.76 110.118 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 52' ' ' GLY . 36.4 Cg_endo -80.3 153.44 21.27 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.5 2.133 . . . . 28.37 110.243 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . . . -39.74 128.25 2.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.288 -0.882 . . . . 17.21 110.296 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.637 ' CE1' HG12 ' A' ' 47' ' ' ILE . 86.7 m-85 -47.5 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.783 . . . . 17.19 109.009 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.531 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -48.76 175.61 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 17.82 109.589 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.5 Cg_endo -77.05 128.31 9.82 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.637 2.225 . . . . 17.28 110.192 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.06 176.73 32.46 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.614 -1.394 . . . . 17.22 109.614 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.8 mp -74.21 146.49 43.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -1.162 . . . . 19.57 108.362 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.595 ' CE1' HD12 ' A' ' 6' ' ' ILE . 20.2 m-85 -131.79 163.66 27.72 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.902 -1.124 . . . . 14.61 111.274 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 24.1 p -146.38 120.77 9.64 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.414 -1.698 . . . . 18.36 106.414 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 6.2 t -49.19 168.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 C-N-CA 118.837 -1.145 . . . . 19.13 108.776 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.7 t-80 -135.37 124.53 24.46 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.393 -0.817 . . . . 20.65 109.11 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.683 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -68.63 -5.3 19.28 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.285 -0.885 . . . . 19.65 109.572 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.5 t -55.94 -18.28 8.72 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.367 -0.975 . . . . 14.72 108.367 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -101.48 -5.53 25.12 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.525 -0.735 . . . . 11.45 110.187 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.683 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -75.36 157.9 33.57 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.919 -1.113 . . . . 14.25 108.938 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.524 ' CA ' HD12 ' B' ' 37' ' ' LEU . 20.5 mttt -146.63 164.44 32.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 32.7 109.797 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -111.57 112.18 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 15.63 109.156 179.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.5 -176.93 43.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.457 -1.457 . . . . 12.7 109.457 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.528 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -90.57 22.54 3.42 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.158 -1.201 . . . . 26.29 109.367 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.25 -16.37 31.39 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.425 -0.797 . . . . 20.44 109.318 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 90.14 28.02 19.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.651 -1.38 . . . . 13.82 109.651 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' LEU . 58.0 m -161.0 124.54 3.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -1.182 . . . . 18.27 109.485 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 77' ' ' MET . 1.1 tp -46.94 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 12.43 109.333 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -162.5 113.57 1.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -0.923 . . . . 35.11 109.526 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 81' ' ' LEU . 3.4 mt -43.14 -40.01 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.511 -0.743 . . . . 13.67 110.178 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.511 ' O ' ' HB3' ' A' ' 80' ' ' ARG . 1.6 t70 45.77 55.16 7.12 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.407 -0.96 . . . . 24.06 108.407 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 80.22 88.52 0.05 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.674 -0.861 . . . . 35.04 108.674 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.596 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 0.8 OUTLIER -65.46 157.87 28.32 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.752 0.787 . . . . 18.72 111.268 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 5.7 ttt180 -106.93 102.1 11.48 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.128 -1.064 . . . . 20.55 108.128 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.597 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -75.06 147.29 40.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.003 -1.061 . . . . 14.4 111.205 -178.375 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 62' ' ' THR . 33.9 m -147.85 155.56 44.4 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.094 -1.076 . . . . 17.65 108.094 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.55 144.02 83.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.091 1.861 . . . . 25.7 110.277 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 87' ' ' LYS . . . -72.83 128.11 34.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 49.29 109.521 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 86' ' ' ALA . 29.7 mmtm . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.062 -0.97 . . . . 58.91 109.487 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.513 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.435 -0.58 . . . . 64.91 109.435 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.534 ' CD1' ' HB ' ' B' ' 63' ' ' VAL . 1.9 mt -58.64 85.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.842 -1.17 . . . . 33.8 107.842 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 20.7 mttt -63.63 157.99 22.48 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.804 0.812 . . . . 32.72 111.6 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.569 ' HB ' ' CB ' ' B' ' 61' ' ' TYR . 58.6 t -159.94 167.38 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.592 0.71 . . . . 14.46 109.68 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 77.6 mt-10 -154.83 107.18 2.74 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.761 -0.829 . . . . 22.12 108.761 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.586 HD12 ' CE1' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -74.52 107.82 5.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 118.983 -1.087 . . . . 14.23 108.322 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.672 ' CD ' ' CD1' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.4 171.85 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.438 -0.789 . . . . 25.43 109.967 -179.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 34.5 Cg_endo -76.69 -25.68 9.06 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.598 2.199 . . . . 13.61 109.718 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.65 8.24 44.68 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.94 -0.763 . . . . 15.52 108.94 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 10.0 mm-40 -121.21 32.84 5.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.262 -0.898 . . . . 17.31 109.547 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.96 11.48 37.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.97 . . . . 24.78 110.338 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -138.78 138.14 37.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -0.993 . . . . 47.9 110.055 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.617 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 11.5 p90 -88.5 173.21 8.81 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.426 -0.796 . . . . 21.61 109.74 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 10.0 t -130.85 164.1 25.97 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.512 -0.921 . . . . 14.89 108.512 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.562 0 O-C-N 121.103 -0.998 . . . . 17.35 109.611 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' B' ' 28' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.888 0.852 . . . . 24.0 110.896 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.617 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -105.52 128.7 53.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.603 -0.888 . . . . 23.31 108.603 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.9 OUTLIER -111.51 151.03 29.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.992 -1.068 . . . . 40.03 109.971 -179.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.539 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.7 OUTLIER -133.64 175.89 9.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 12.39 109.486 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.451 ' C ' ' SG ' ' B' ' 33' ' ' CYS . 3.6 mp -127.27 155.59 43.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 17.42 109.164 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 1.9 m -153.78 -176.75 5.98 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.296 -1.001 . . . . 13.84 108.296 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' CD ' ' B' ' 7' ' ' LYS . 35.4 m-85 -130.86 102.9 6.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.164 -0.96 . . . . 21.14 109.544 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' B' ' 4' ' ' VAL . 78.5 t -90.78 125.96 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.004 -1.06 . . . . 10.66 110.307 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' B' ' 39' ' ' ASN . 3.8 m-20 -68.46 -41.95 79.47 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.601 -0.889 . . . . 25.89 108.601 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.524 HD12 ' CA ' ' A' ' 69' ' ' LYS . 0.6 OUTLIER 47.49 48.2 16.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.421 -0.799 . . . . 24.24 109.749 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.16 4.78 51.23 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.348 -1.501 . . . . 31.02 109.348 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.5 OUTLIER -104.44 95.72 6.12 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.33 -1.1 . . . . 43.23 108.507 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' B' ' 39' ' ' ASN . 9.3 mt-10 -30.52 -37.35 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.471 0.653 . . . . 42.34 110.858 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -85.2 146.4 45.06 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.64 -0.874 . . . . 6.3 108.64 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.66 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.9 Cg_endo -76.37 137.09 18.4 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.958 1.772 . . . . 17.92 110.551 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 5.9 m -108.7 114.0 45.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.362 -0.836 . . . . 20.57 109.076 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.584 ' HB2' ' CE2' ' B' ' 34' ' ' TYR . 28.8 tp -65.66 110.1 2.64 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.407 -0.808 . . . . 20.21 109.372 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.587 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 6.5 t -115.36 165.4 10.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.493 -0.755 . . . . 10.81 109.306 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.554 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 9.8 mtpt -96.31 125.52 40.87 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.538 -0.865 . . . . 36.74 109.492 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.632 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -117.43 136.38 54.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.331 -0.856 . . . . 19.74 109.368 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.483 ' OG1' ' CZ ' ' B' ' 80' ' ' ARG . 12.6 m -68.18 163.67 22.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 22.56 109.285 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.602 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 1.1 tm? -151.9 93.41 1.84 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.35 -158.0 0.85 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 33.99 109.836 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 49.02 -154.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 54.92 109.162 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.459 ' O ' ' HD3' ' B' ' 54' ' ' PRO . . . -79.62 -2.2 87.72 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.512 -1.435 . . . . 36.1 109.512 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -73.59 114.37 31.41 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.251 -1.147 . . . . 54.76 110.008 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' B' ' 52' ' ' GLY . 36.3 Cg_endo -80.29 153.33 21.27 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.512 2.141 . . . . 28.37 110.244 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.521 ' HA ' ' HG ' ' B' ' 49' ' ' LEU . . . -39.84 128.43 2.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.358 -0.839 . . . . 17.21 110.26 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.632 ' CE1' HG12 ' B' ' 47' ' ' ILE . 85.2 m-85 -47.79 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.871 -0.788 . . . . 17.19 108.871 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.522 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -50.5 175.72 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.86 . . . . 17.82 109.394 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.6 Cg_endo -77.34 129.5 10.35 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.611 2.207 . . . . 17.28 110.503 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.89 177.15 30.73 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.424 -1.47 . . . . 17.22 109.424 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 4.1 mp -73.73 146.99 43.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.222 -1.163 . . . . 19.57 108.794 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.586 ' CE1' HD12 ' B' ' 6' ' ' ILE . 19.6 m-85 -132.24 163.78 27.84 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.957 -1.089 . . . . 14.61 111.319 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' B' ' 2' ' ' ILE . 24.3 p -146.54 120.86 9.59 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.424 -1.695 . . . . 18.36 106.424 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.584 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 6.1 t -49.37 168.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 C-N-CA 118.82 -1.152 . . . . 19.13 108.826 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.543 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.7 t-80 -135.21 124.5 24.64 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.393 -0.817 . . . . 20.65 109.089 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.682 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -68.61 -5.4 19.75 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.244 -0.91 . . . . 19.65 109.533 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 33.4 t -55.79 -18.44 8.48 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.306 -0.998 . . . . 14.72 108.306 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -101.31 -5.92 24.8 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.544 -0.722 . . . . 11.45 110.185 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.682 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.9 m-30 -75.02 157.72 34.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.91 -1.119 . . . . 14.25 108.893 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.527 ' CA ' HD12 ' A' ' 37' ' ' LEU . 20.6 mttt -146.36 164.78 31.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -0.979 . . . . 32.7 109.815 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.6 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -111.83 112.12 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.415 -0.803 . . . . 15.63 109.158 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.51 -177.0 43.03 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.481 -1.448 . . . . 12.7 109.481 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.54 22.57 3.39 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.146 -1.208 . . . . 26.29 109.348 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.29 -16.36 31.31 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.46 -0.775 . . . . 20.44 109.363 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 90.39 27.62 19.73 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.665 -1.374 . . . . 13.82 109.665 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 76' ' ' LEU . 58.0 m -160.76 124.53 3.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -1.223 . . . . 18.27 109.569 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 35' ' ' VAL . 1.1 tp -46.93 170.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 12.43 109.357 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' B' ' 76' ' ' LEU . 0.8 OUTLIER -162.48 113.58 1.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 35.11 109.553 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.599 ' CG2' ' N ' ' B' ' 81' ' ' LEU . 3.4 mt -43.11 -40.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.48 -0.763 . . . . 13.67 110.212 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' B' ' 80' ' ' ARG . 1.6 t70 45.85 55.17 7.2 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.354 -0.98 . . . . 24.06 108.354 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 80.21 88.57 0.05 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.69 -0.856 . . . . 35.04 108.69 -178.81 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.599 ' N ' ' CG2' ' B' ' 78' ' ' ILE . 0.8 OUTLIER -65.4 157.89 28.11 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.779 0.799 . . . . 18.72 111.267 -178.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 5.7 ttt180 -107.06 102.09 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.065 -1.087 . . . . 20.55 108.065 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -75.04 147.45 40.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.047 -1.033 . . . . 14.4 111.162 -178.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.463 HG21 ' O ' ' B' ' 62' ' ' THR . 33.8 m -148.02 155.31 43.83 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 108.11 -1.07 . . . . 17.65 108.11 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.1 Cg_endo -64.33 143.95 84.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.153 1.902 . . . . 25.7 110.257 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' B' ' 87' ' ' LYS . . . -72.79 128.08 34.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 49.29 109.586 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' B' ' 86' ' ' ALA . 29.7 mmtm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.047 -0.978 . . . . 58.91 109.519 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.48 ' O ' ' CB ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.33 -0.618 . . . . 64.91 109.33 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.539 HG12 ' CB ' ' B' ' 65' ' ' LEU . 4.8 mt 73.74 75.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.162 -1.051 . . . . 33.8 108.162 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -68.99 155.35 40.49 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.756 0.788 . . . . 32.72 110.841 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.591 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -160.35 167.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.534 -0.913 . . . . 14.46 108.534 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.542 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 60.3 mt-10 -143.52 109.67 5.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 22.12 109.534 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.598 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -72.29 101.04 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.899 -1.149 . . . . 14.23 107.899 179.218 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.642 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.42 169.84 0.07 OUTLIER Pre-proline 0 N--CA 1.486 1.361 0 O-C-N 121.306 -0.871 . . . . 25.43 109.611 -179.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -75.3 -24.09 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.444 2.096 . . . . 13.61 109.812 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -93.31 1.39 56.99 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.094 -0.706 . . . . 15.52 109.094 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.487 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 29.3 mm-40 -120.08 39.7 3.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 17.31 109.165 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.65 22.44 15.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.119 -0.988 . . . . 24.78 110.22 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.454 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -142.72 132.71 24.33 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.054 -1.029 . . . . 47.9 108.786 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.632 ' CD1' ' CB ' ' A' ' 29' ' ' ASN . 33.3 p90 -88.56 176.88 6.95 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.013 -1.054 . . . . 21.61 109.774 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 16.1 m -130.7 153.75 48.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.674 -0.862 . . . . 14.89 108.674 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.551 0 O-C-N 121.211 -0.931 . . . . 17.35 109.439 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.435 0.636 . . . . 24.0 109.96 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.632 ' CB ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -99.05 129.92 45.35 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.451 -0.944 . . . . 23.31 108.451 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.07 152.55 33.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.998 -1.064 . . . . 40.03 109.612 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.547 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -135.24 171.54 14.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 12.39 109.897 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.524 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 3.3 mm? -105.89 179.13 4.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 17.42 110.252 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -173.51 158.16 3.37 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.85 -1.167 . . . . 13.84 107.85 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.649 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 20.1 m-85 -111.98 106.33 14.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.964 -1.085 . . . . 21.14 109.36 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.538 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 25.7 t -107.4 117.59 53.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 10.66 110.627 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -95.3 41.29 1.1 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.543 -1.281 . . . . 25.89 107.543 178.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.55 ' O ' ' CD1' ' B' ' 65' ' ' LEU . 1.7 pp -35.19 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.377 0.608 . . . . 24.24 110.319 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 165.55 50.81 0.02 OUTLIER Glycine 0 C--N 1.298 -1.576 0 C-N-CA 119.333 -1.413 . . . . 31.02 109.696 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 61.9 m-20 -126.13 18.26 7.74 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.223 -1.163 . . . . 43.23 110.101 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 51.3 mt-10 58.96 27.8 16.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 42.34 109.949 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 3.3 p-80 176.42 162.62 0.47 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.531 -0.914 . . . . 6.37 108.531 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.649 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.7 Cg_endo -76.5 135.74 16.71 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.774 1.65 . . . . 17.92 110.231 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 2.9 m -111.1 117.31 54.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.648 -0.821 . . . . 20.57 108.994 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.562 HD11 ' CE2' ' A' ' 34' ' ' TYR . 41.1 tp -70.75 95.94 1.18 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.292 -0.88 . . . . 20.21 109.167 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.461 ' O ' HD11 ' A' ' 32' ' ' LEU . 4.4 p -105.65 161.28 5.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.6 -0.687 . . . . 10.81 109.35 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -177.75 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 36.74 110.634 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.612 HG22 ' CD1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -167.66 149.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.115 -1.069 . . . . 19.74 108.115 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.424 ' N ' HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -91.58 152.97 20.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.864 -1.148 . . . . 22.56 109.476 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.589 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -131.93 102.82 6.0 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.471 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 29.4 t70 -44.87 142.45 1.78 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 33.99 109.739 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.25 103.31 0.37 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.825 . . . . 54.92 109.322 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.1 -25.14 7.98 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.367 -1.493 . . . . 36.1 109.367 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.469 ' O ' HD13 ' A' ' 49' ' ' LEU . 31.3 mt-30 -76.48 147.76 79.26 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.323 -1.104 . . . . 54.76 109.229 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.6 Cg_endo -78.12 126.13 7.62 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.662 2.241 . . . . 28.37 110.39 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.506 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -40.03 156.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.419 -0.801 . . . . 17.21 110.02 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.612 ' CD1' HG22 ' A' ' 47' ' ' ILE . 74.3 m-85 -58.27 111.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 17.19 109.153 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.406 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -56.58 170.05 0.55 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 17.82 109.782 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.483 ' HA ' HG23 ' A' ' 6' ' ' ILE . 35.5 Cg_endo -78.17 106.07 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.678 2.252 . . . . 17.28 110.392 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.11 -176.12 43.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.585 -1.406 . . . . 17.22 109.585 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -76.28 138.84 40.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -1.142 . . . . 19.57 108.613 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CE1' HD11 ' A' ' 6' ' ' ILE . 25.5 m-85 -128.63 164.65 22.42 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.776 -1.203 . . . . 14.61 111.699 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.527 HG21 ' CB ' ' A' ' 86' ' ' ALA . 47.6 p -145.46 121.89 10.99 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.268 -1.753 . . . . 18.36 106.268 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.609 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -54.41 167.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 118.632 -1.227 . . . . 19.13 108.624 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.508 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -130.12 126.57 37.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.249 -0.907 . . . . 20.65 109.501 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.675 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -73.06 1.53 8.82 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.425 -0.797 . . . . 19.65 110.034 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 t -57.29 -19.05 19.61 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.383 -1.34 . . . . 14.72 107.383 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 69.8 m -95.12 -25.02 16.6 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.127 0.489 . . . . 11.45 110.179 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.675 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.2 m-30 -61.92 158.95 15.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.98 . . . . 14.25 109.486 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.449 ' HA ' HD23 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -153.73 176.24 12.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 32.7 109.404 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' CG2' HG23 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -113.44 123.37 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 15.63 109.387 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.75 -162.06 28.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.378 -1.489 . . . . 12.7 109.378 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.451 ' HB2' ' SD ' ' A' ' 77' ' ' MET . 0.3 OUTLIER 59.27 72.22 0.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -1.188 . . . . 26.29 109.311 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.3 OUTLIER 70.41 6.66 5.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 20.44 109.381 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.03 45.21 5.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.492 -1.443 . . . . 13.82 109.492 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -129.13 140.46 51.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 18.27 109.522 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.2 OUTLIER -43.69 158.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 12.43 109.355 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.52 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -165.54 104.73 0.72 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 35.11 110.112 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.58 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.1 mt -41.12 -64.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.613 0.721 . . . . 13.67 109.738 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 15.6 t70 84.86 -46.69 0.08 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.481 0.657 . . . . 24.06 110.003 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.581 ' O ' ' CB ' ' A' ' 67' ' ' SER . 1.9 tpm_? -171.25 66.56 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.491 -0.929 . . . . 35.04 108.491 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.609 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.3 pt? -39.58 125.7 1.79 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.659 0.742 . . . . 18.72 111.71 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -92.51 106.67 18.62 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.434 -0.95 . . . . 20.55 108.434 178.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.593 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -72.66 151.89 42.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.294 -0.879 . . . . 14.4 111.056 -178.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 62' ' ' THR . 33.1 m -154.08 156.4 31.9 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.011 -1.107 . . . . 17.65 108.011 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.2 Cg_endo -62.64 144.16 93.7 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.184 1.923 . . . . 25.7 110.201 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.527 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -75.91 117.04 17.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.14 -0.975 . . . . 49.29 109.557 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.99 -1.005 . . . . 58.91 109.416 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.478 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.336 -0.616 . . . . 64.91 109.336 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 65' ' ' LEU . 4.8 mt 73.72 75.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.064 -1.087 . . . . 33.8 108.064 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -69.16 155.49 40.3 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.778 0.799 . . . . 32.72 110.788 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.586 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -160.45 168.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.548 -0.908 . . . . 14.46 108.548 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.536 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 60.1 mt-10 -143.79 109.75 5.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.33 -0.856 . . . . 22.12 109.536 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.589 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -72.35 100.98 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.942 -1.133 . . . . 14.23 107.942 179.254 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.644 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.37 169.78 0.07 OUTLIER Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 25.43 109.602 -179.244 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.0 Cg_endo -75.23 -24.06 12.83 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.419 2.079 . . . . 13.61 109.777 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -93.28 1.4 57.02 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.526 -0.734 . . . . 15.52 109.1 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.493 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 29.1 mm-40 -120.06 39.51 3.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.262 -0.899 . . . . 17.31 109.171 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.49 22.45 15.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 24.78 110.3 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -142.7 132.8 24.49 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.997 -1.064 . . . . 47.9 108.843 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.632 ' CD1' ' CB ' ' B' ' 29' ' ' ASN . 33.4 p90 -88.63 176.8 6.96 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.007 -1.058 . . . . 21.61 109.746 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.3 m -130.68 153.68 48.72 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.737 -0.838 . . . . 14.89 108.737 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.609 0 O-C-N 121.251 -0.906 . . . . 17.35 109.501 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.345 0.593 . . . . 24.0 110.011 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.632 ' CB ' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -99.07 129.92 45.37 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.478 -0.934 . . . . 23.31 108.478 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.03 152.58 33.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.037 -1.04 . . . . 40.03 109.572 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.557 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -135.21 171.53 14.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.153 -0.967 . . . . 12.39 109.94 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.531 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 3.3 mm? -105.79 179.28 4.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 17.42 110.219 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -173.69 158.27 3.29 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.797 -1.186 . . . . 13.84 107.797 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.657 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 20.2 m-85 -112.13 106.4 15.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.988 -1.07 . . . . 21.14 109.309 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 25.4 t -107.57 117.46 53.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 10.66 110.633 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.2 OUTLIER -95.21 41.34 1.1 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.433 -1.321 . . . . 25.89 107.433 178.289 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.547 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 1.6 pp -35.29 -31.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.397 0.618 . . . . 24.24 110.284 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 165.83 50.98 0.02 OUTLIER Glycine 0 C--N 1.298 -1.559 0 C-N-CA 119.286 -1.435 . . . . 31.02 109.653 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.581 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 62.1 m-20 -126.19 18.37 7.7 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.164 -1.198 . . . . 43.23 110.116 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' B' ' 39' ' ' ASN . 51.2 mt-10 58.79 27.87 16.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.139 -0.976 . . . . 42.34 109.956 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 3.3 p-80 176.38 162.35 0.46 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 6.38 108.594 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.657 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.7 Cg_endo -76.39 135.68 16.87 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.77 1.646 . . . . 17.92 110.24 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 2.9 m -111.01 117.4 54.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.358 -0.839 . . . . 20.57 108.997 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.544 HD11 ' CE2' ' B' ' 34' ' ' TYR . 41.8 tp -70.86 95.82 1.2 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.643 -0.823 . . . . 20.21 109.215 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.469 ' O ' HD11 ' B' ' 32' ' ' LEU . 4.4 p -105.46 161.37 5.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.612 -0.68 . . . . 10.81 109.448 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -177.84 1.89 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 36.74 110.552 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.611 HG22 ' CD1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -167.61 149.63 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.069 -1.085 . . . . 19.74 108.069 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.433 ' N ' HD11 ' B' ' 47' ' ' ILE . 0.2 OUTLIER -91.82 153.15 19.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.839 -1.163 . . . . 22.56 109.429 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.589 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -132.21 102.96 5.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.741 -0.837 . . . . 20.41 108.741 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.441 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 29.4 t70 -45.12 142.45 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 33.99 109.898 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.1 103.41 0.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 54.92 109.319 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.93 -25.16 8.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.37 -1.492 . . . . 36.1 109.37 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.471 ' O ' HD13 ' B' ' 49' ' ' LEU . 31.5 mt-30 -76.39 147.72 79.48 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.265 -1.138 . . . . 54.76 109.301 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.7 Cg_endo -78.05 126.31 7.78 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.591 2.194 . . . . 28.37 110.391 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.519 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -40.11 156.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.396 -0.815 . . . . 17.21 110.024 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.611 ' CD1' HG22 ' B' ' 47' ' ' ILE . 73.3 m-85 -58.11 111.01 1.05 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.4 -0.813 . . . . 17.19 109.077 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.418 ' O ' HG23 ' B' ' 6' ' ' ILE . . . -56.76 170.04 0.57 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 17.82 109.799 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' B' ' 6' ' ' ILE . 35.4 Cg_endo -77.76 104.99 1.95 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.71 2.273 . . . . 17.28 110.118 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.3 -176.6 41.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.708 -1.357 . . . . 17.22 109.708 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -76.53 138.34 40.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -1.146 . . . . 19.57 108.366 179.143 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.589 ' CE1' HD11 ' B' ' 6' ' ' ILE . 25.5 m-85 -128.08 164.46 22.37 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.729 -1.232 . . . . 14.61 111.607 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.516 HG21 ' CB ' ' B' ' 86' ' ' ALA . 46.9 p -145.13 122.04 11.31 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.175 -1.787 . . . . 18.36 106.175 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.608 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -54.73 167.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 118.562 -1.255 . . . . 19.13 108.594 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -130.4 126.68 37.66 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.271 -0.893 . . . . 20.65 109.49 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.667 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.8 OUTLIER -73.18 1.17 9.78 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.434 -0.791 . . . . 19.65 110.014 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -56.86 -19.38 17.2 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.323 -1.362 . . . . 14.72 107.323 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 70.9 m -94.77 -25.06 16.82 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.146 0.498 . . . . 11.45 110.201 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.667 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.2 m-30 -61.93 158.59 15.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 14.25 109.466 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.438 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -153.4 176.29 12.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 32.7 109.407 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.49 ' CG2' HG23 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -113.45 123.57 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 15.63 109.34 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.53 -162.2 29.29 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.426 -1.47 . . . . 12.7 109.426 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.3 OUTLIER 59.43 72.13 0.54 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -1.189 . . . . 26.29 109.328 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.3 OUTLIER 70.45 6.81 5.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 20.44 109.322 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.84 45.25 5.2 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.438 -1.465 . . . . 13.82 109.438 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.423 ' O ' ' C ' ' B' ' 76' ' ' LEU . 0.3 OUTLIER -129.16 140.34 51.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -1.167 . . . . 18.27 109.48 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.2 OUTLIER -43.58 158.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -0.895 . . . . 12.43 109.376 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 0.6 OUTLIER -165.49 104.93 0.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.962 . . . . 35.11 110.083 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.58 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.0 OUTLIER -41.37 -64.4 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.556 0.694 . . . . 13.67 109.682 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 15.4 t70 84.74 -46.52 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.422 0.63 . . . . 24.06 110.007 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' B' ' 67' ' ' SER . 1.9 tpm_? -171.42 66.41 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.036 0.922 . . . . 35.04 108.517 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.608 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.2 pt? -39.41 125.65 1.71 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.653 0.739 . . . . 18.72 111.721 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.7 OUTLIER -92.48 106.59 18.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.517 -0.919 . . . . 20.55 108.517 178.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.597 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -72.64 151.72 42.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.183 -0.948 . . . . 14.4 111.072 -178.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' B' ' 62' ' ' THR . 33.4 m -153.86 156.53 32.16 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 107.959 -1.126 . . . . 17.65 107.959 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.3 Cg_endo -62.83 144.32 93.33 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.117 1.878 . . . . 25.7 110.151 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.516 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -75.96 117.03 17.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.242 -0.911 . . . . 49.29 109.617 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.009 -0.996 . . . . 58.91 109.458 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.489 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.416 -0.587 . . . . 64.91 109.416 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.527 ' CG2' HG22 ' A' ' 63' ' ' VAL . 2.7 mt -66.89 79.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.598 -1.26 . . . . 33.8 107.598 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -74.33 159.96 31.7 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.907 0.861 . . . . 32.72 110.595 -178.186 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.574 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -162.43 167.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.437 -0.949 . . . . 14.46 108.437 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.534 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 33.2 mt-10 -142.3 112.54 7.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 22.12 109.693 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -75.25 99.52 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.815 -1.18 . . . . 14.23 107.815 179.071 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.647 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.1 mttm -53.88 165.8 0.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.357 -0.84 . . . . 25.43 109.762 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 29.8 Cg_endo -70.89 -15.61 32.85 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.922 1.748 . . . . 13.61 108.796 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.14 -2.65 49.46 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.905 -0.776 . . . . 15.52 108.905 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 1.5 mm100 -129.49 43.66 3.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.205 -0.935 . . . . 17.31 109.581 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.83 20.03 16.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.05 -1.031 . . . . 24.78 110.068 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -135.73 140.63 44.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.121 -0.987 . . . . 47.9 109.689 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.611 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 41.3 p90 -94.78 164.01 13.12 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.201 -0.937 . . . . 21.61 109.469 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.1 m -135.07 147.26 49.54 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.341 -0.85 . . . . 14.89 109.181 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.479 0 O-C-N 121.273 -0.892 . . . . 17.35 109.364 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.414 HD22 ' O ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.381 0.61 . . . . 24.0 110.313 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.519 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 86.0 m-20 -68.59 109.99 4.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.364 -0.835 . . . . 23.31 109.041 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 18.6 mt-10 -87.01 -173.33 4.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.219 -0.925 . . . . 40.03 109.899 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.53 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 1.7 tm0? -176.33 -177.84 0.9 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.852 . . . . 12.39 109.47 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.518 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 13.3 mt -140.98 168.93 18.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 17.42 109.366 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -164.91 161.87 20.37 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.055 -1.091 . . . . 13.84 108.055 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 49.6 m-85 -111.44 111.72 22.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.994 -1.066 . . . . 21.14 109.716 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.463 ' HA ' ' HB ' ' A' ' 4' ' ' VAL . 4.6 t -106.87 140.39 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 10.66 110.871 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -111.72 39.34 2.39 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.556 -1.276 . . . . 25.89 107.556 178.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.533 HD21 ' CD1' ' B' ' 76' ' ' LEU . 1.1 pp -63.5 58.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.976 -0.452 . . . . 24.24 110.468 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 107.33 1.87 35.47 Favored Glycine 0 N--CA 1.482 1.76 0 C-N-CA 119.609 -1.282 . . . . 31.02 109.902 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 40' ' ' GLU . 1.2 m-20 -124.87 98.78 5.85 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.23 -1.159 . . . . 43.23 108.528 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -32.61 -56.85 0.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.55 0.691 . . . . 42.34 110.579 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 39' ' ' ASN . 7.2 m-70 -66.25 152.16 94.65 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 108.638 -0.875 . . . . 6.8 108.638 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.672 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.8 Cg_endo -77.34 139.75 18.87 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.982 1.788 . . . . 17.92 110.041 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.53 HG22 ' CG1' ' A' ' 45' ' ' VAL . 3.4 m -112.91 115.4 49.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.317 -0.865 . . . . 20.57 109.569 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 59.9 tp -72.51 101.62 3.02 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.875 . . . . 20.21 109.867 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.53 ' CG1' HG22 ' A' ' 43' ' ' VAL . 2.6 m -99.82 -168.94 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.977 -0.749 . . . . 10.81 108.977 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' B' ' 73' ' ' PHE . 1.3 mtpp -106.57 178.61 4.51 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.507 -0.877 . . . . 36.74 110.809 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -157.64 156.47 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.242 -1.021 . . . . 19.74 108.242 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -111.46 68.57 0.67 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.12 -0.988 . . . . 22.56 109.479 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.611 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 2.2 tm? -42.12 114.8 0.59 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.492 -0.755 . . . . 20.41 109.306 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.425 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -57.32 151.81 15.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 33.99 109.89 -179.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -63.53 117.5 6.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 54.92 109.223 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.62 -27.35 19.2 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.301 -1.52 . . . . 36.1 109.301 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.47 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.16 146.27 96.83 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.281 -1.129 . . . . 54.76 109.286 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.5 Cg_endo -77.52 119.76 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.577 2.184 . . . . 28.37 110.642 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.506 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -41.41 144.3 0.36 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -0.826 . . . . 17.21 110.035 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.62 ' CE2' ' CB ' ' A' ' 83' ' ' LEU . 15.4 m-30 -45.3 108.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 17.19 109.135 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.478 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -59.04 173.87 0.43 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.056 -1.028 . . . . 17.82 109.055 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.9 Cg_endo -77.52 110.41 2.96 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.42 2.08 . . . . 17.28 110.024 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.53 -178.99 48.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.867 -1.293 . . . . 17.22 109.867 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -77.54 140.59 39.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -1.085 . . . . 19.57 108.511 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.591 ' HB3' ' CD2' ' A' ' 83' ' ' LEU . 17.9 m-85 -130.0 163.96 25.34 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.771 -1.205 . . . . 14.61 111.81 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.506 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 48.9 p -145.69 121.61 10.65 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.442 -1.688 . . . . 18.36 106.442 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.584 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -51.27 167.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.792 -1.163 . . . . 19.13 109.2 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -128.25 127.47 42.88 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.833 -0.803 . . . . 20.65 108.833 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.653 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -71.39 0.66 7.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.477 -0.764 . . . . 19.65 110.014 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 t -57.12 -17.69 11.8 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.787 -1.19 . . . . 14.72 107.787 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 80' ' ' ARG . 16.5 m -97.81 -5.45 34.77 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.782 -0.574 . . . . 11.45 110.372 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.653 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.3 m-30 -83.6 159.77 21.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.936 -1.102 . . . . 14.25 109.771 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.499 ' HA ' ' CD1' ' B' ' 37' ' ' LEU . 53.7 mttm -149.11 173.25 13.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.773 . . . . 32.7 109.302 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.528 HG12 ' CG1' ' B' ' 45' ' ' VAL . 0.9 OUTLIER -107.28 116.12 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 15.63 108.932 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 175.93 4.86 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.779 -1.328 . . . . 12.7 109.779 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.06 12.7 8.98 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.214 -1.168 . . . . 26.29 109.763 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' O ' ' HG3' ' B' ' 46' ' ' LYS . 0.1 OUTLIER -123.25 19.37 9.84 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.532 -0.73 . . . . 20.44 109.201 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.53 57.27 9.31 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.794 -1.322 . . . . 13.82 109.794 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.0 t -146.65 134.77 21.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.171 -1.193 . . . . 18.27 109.871 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.525 ' CD1' HD21 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -76.98 145.17 38.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 12.43 109.071 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.497 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 11.0 mtm -157.09 120.33 4.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.037 . . . . 35.11 109.926 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.617 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.3 mt -62.34 136.88 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 13.67 109.374 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.34 -30.41 11.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.166 -1.05 . . . . 24.06 108.166 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.488 ' O ' ' OG ' ' A' ' 67' ' ' SER . 2.6 tpm_? -176.42 71.06 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.049 -1.463 . . . . 35.04 107.049 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.584 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -30.89 118.29 0.18 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.731 0.776 . . . . 18.72 111.579 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 6.1 mtp180 -89.35 110.94 21.68 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.015 -1.106 . . . . 20.55 108.015 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.62 ' CB ' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -81.93 144.38 30.99 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.141 -0.975 . . . . 14.4 111.164 -178.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.46 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 11.9 m -145.98 158.91 47.96 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.705 -1.22 . . . . 17.65 107.705 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.1 Cg_endo -61.79 145.77 97.02 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.02 1.813 . . . . 25.7 110.145 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.506 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -73.18 119.8 17.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.156 -0.965 . . . . 49.29 109.732 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.985 -1.007 . . . . 58.91 109.411 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.482 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.432 -0.581 . . . . 64.91 109.432 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.538 ' CG2' HG22 ' B' ' 63' ' ' VAL . 2.7 mt -66.89 78.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.586 -1.265 . . . . 33.8 107.586 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -74.2 159.84 31.98 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.934 0.873 . . . . 32.72 110.595 -178.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.572 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -162.41 167.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.442 -0.947 . . . . 14.46 108.442 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.535 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 33.7 mt-10 -142.32 112.7 7.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 22.12 109.659 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.572 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.7 OUTLIER -75.41 99.7 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.759 -1.201 . . . . 14.23 107.759 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.656 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.2 mttm -54.02 165.83 0.73 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.821 . . . . 25.43 109.785 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 29.9 Cg_endo -70.84 -15.63 33.03 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.89 1.727 . . . . 13.61 108.814 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.13 -2.66 49.47 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.858 -0.793 . . . . 15.52 108.858 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.531 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 1.5 mm100 -129.5 43.74 3.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 17.31 109.649 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.84 19.52 16.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.074 -1.017 . . . . 24.78 110.087 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -135.32 140.7 45.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.119 -0.988 . . . . 47.9 109.679 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.61 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 41.0 p90 -94.85 164.08 13.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 21.61 109.487 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 87.9 m -135.14 147.21 49.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.303 -0.873 . . . . 14.89 109.134 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.28 -0.887 . . . . 17.35 109.368 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.416 HD22 ' O ' ' B' ' 49' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.403 0.621 . . . . 24.0 110.302 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.516 ' CG ' ' CD1' ' B' ' 13' ' ' PHE . 85.2 m-20 -68.75 109.73 3.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.827 . . . . 23.31 109.082 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 18.2 mt-10 -86.69 -173.5 4.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.141 -0.974 . . . . 40.03 109.909 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.541 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 1.7 tm0? -176.12 -177.82 0.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.353 -0.842 . . . . 12.39 109.489 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.522 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 13.2 mt -141.1 168.73 19.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 17.42 109.33 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -164.61 162.02 21.31 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.041 -1.096 . . . . 13.84 108.041 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.667 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 49.6 m-85 -111.52 111.52 22.59 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.01 . . . . 21.14 109.698 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.458 ' HA ' ' HB ' ' B' ' 4' ' ' VAL . 4.6 t -106.68 140.26 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 10.66 110.92 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.9 OUTLIER -111.64 39.25 2.39 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.571 -1.27 . . . . 25.89 107.571 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 76' ' ' LEU . 1.1 pp -63.46 58.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.973 -0.454 . . . . 24.24 110.493 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 107.14 2.21 35.95 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.868 -1.293 . . . . 31.02 109.868 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' B' ' 41' ' ' HIS . 1.2 m-20 -125.16 98.61 5.73 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.284 -1.127 . . . . 43.23 108.527 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.6 OUTLIER -32.49 -56.53 0.34 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.553 0.692 . . . . 42.34 110.678 -179.242 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' B' ' 39' ' ' ASN . 7.3 m-70 -66.53 152.21 95.21 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 108.68 -0.859 . . . . 6.77 108.68 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.667 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.8 Cg_endo -77.34 139.56 18.71 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.038 1.825 . . . . 17.92 110.031 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 3.4 m -112.8 115.36 49.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.289 -0.882 . . . . 20.57 109.61 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.584 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 59.3 tp -72.43 101.8 3.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.284 -0.885 . . . . 20.21 109.827 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' B' ' 43' ' ' VAL . 2.6 m -100.09 -169.07 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.987 -0.746 . . . . 10.81 108.987 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 73' ' ' PHE . 1.3 mtpp -106.52 178.4 4.57 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.429 -0.908 . . . . 36.74 110.765 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.583 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -157.34 156.64 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.318 -0.993 . . . . 19.74 108.318 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.421 ' O ' ' C ' ' B' ' 49' ' ' LEU . 0.3 OUTLIER -111.54 68.63 0.67 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.129 -0.982 . . . . 22.56 109.463 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.61 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 2.2 tm? -42.24 114.54 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.586 -0.696 . . . . 20.41 109.314 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.42 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.8 OUTLIER -57.05 151.77 14.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.864 . . . . 33.99 109.909 -179.435 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -63.53 117.77 7.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.378 -0.827 . . . . 54.92 109.202 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.36 -27.35 18.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.301 -1.52 . . . . 36.1 109.301 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 0.3 OUTLIER -69.18 146.19 96.73 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.315 -1.109 . . . . 54.76 109.346 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.8 Cg_endo -77.4 119.63 4.99 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.614 2.209 . . . . 28.37 110.714 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.509 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -41.28 144.33 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.415 -0.803 . . . . 17.21 110.004 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.613 ' CE2' ' CB ' ' B' ' 83' ' ' LEU . 15.5 m-30 -45.51 108.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 17.19 109.166 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.469 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -58.83 173.76 0.42 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.012 -1.055 . . . . 17.82 109.008 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.59 110.73 3.01 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.444 2.096 . . . . 17.28 110.236 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.76 -178.57 48.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.817 -1.313 . . . . 17.22 109.817 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -77.42 140.96 39.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.351 -1.088 . . . . 19.57 108.601 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.582 ' HB3' ' CD2' ' B' ' 83' ' ' LEU . 17.9 m-85 -130.39 164.02 25.61 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.812 -1.18 . . . . 14.61 111.698 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.491 ' CG2' ' HA ' ' B' ' 86' ' ' ALA . 51.0 p -145.73 121.83 10.78 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.473 -1.677 . . . . 18.36 106.473 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.592 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -51.63 166.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 C-N-CA 118.751 -1.179 . . . . 19.13 109.197 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -127.53 127.24 43.62 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.919 -0.771 . . . . 20.65 108.919 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.656 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -70.99 0.45 7.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.442 -0.786 . . . . 19.65 110.053 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 3.8 t -57.09 -17.36 10.16 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.821 -1.178 . . . . 14.72 107.821 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 16.2 m -98.19 -5.64 32.98 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.767 -0.583 . . . . 11.45 110.358 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.656 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.3 m-30 -83.27 159.28 21.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.895 -1.128 . . . . 14.25 109.691 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.526 ' HA ' ' CD1' ' A' ' 37' ' ' LEU . 53.0 mttm -148.84 173.3 13.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 32.7 109.21 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.524 HG12 ' CG1' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -107.32 116.01 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 15.63 108.998 179.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 175.87 4.88 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.809 -1.316 . . . . 12.7 109.809 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.95 12.79 8.61 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.209 -1.171 . . . . 26.29 109.748 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.468 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -123.41 19.29 9.71 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.565 -0.71 . . . . 20.44 109.234 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.66 57.26 9.2 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.667 -1.373 . . . . 13.82 109.667 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.4 t -146.65 134.55 21.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -1.152 . . . . 18.27 109.86 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.533 ' CD1' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -76.84 145.11 38.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 12.43 109.062 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.491 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 11.2 mtm -157.05 120.4 4.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 35.11 109.847 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.616 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.2 mt -62.38 137.11 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 13.67 109.382 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -100.52 -30.3 11.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.164 -1.05 . . . . 24.06 108.164 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.491 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.6 tpm_? -176.5 71.18 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.045 -1.465 . . . . 35.04 107.045 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.592 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -30.99 118.32 0.18 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.723 0.773 . . . . 18.72 111.604 -177.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 6.1 mtp180 -89.36 110.79 21.55 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.074 -1.084 . . . . 20.55 108.074 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.613 ' CB ' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -81.78 144.37 31.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.172 -0.955 . . . . 14.4 111.217 -178.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.457 ' HB ' ' HD2' ' B' ' 85' ' ' PRO . 12.3 m -146.04 158.92 47.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 107.718 -1.215 . . . . 17.65 107.718 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.9 Cg_endo -61.77 145.74 97.06 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.015 1.81 . . . . 25.7 110.171 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.491 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -73.19 119.82 17.96 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.102 -0.999 . . . . 49.29 109.7 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 58.91 109.389 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.459 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 1.2 pmm? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.321 0.582 . . . . 64.91 109.477 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.563 HG21 ' CD1' ' B' ' 65' ' ' LEU . 2.3 mt -74.33 66.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.102 -1.073 . . . . 33.8 108.102 178.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.515 ' N ' HD12 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -56.84 178.58 0.06 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.839 0.828 . . . . 32.72 111.097 -178.486 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER 174.3 166.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.605 -0.887 . . . . 14.46 108.605 -179.872 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.567 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 25.3 mt-10 -137.6 113.79 10.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.822 -0.807 . . . . 22.12 108.822 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -72.53 103.81 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.472 -1.307 . . . . 14.23 107.472 179.449 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.638 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.64 171.46 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.978 -1.076 . . . . 25.43 109.638 -178.846 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.2 Cg_endo -75.05 -28.18 9.3 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.437 2.091 . . . . 13.61 110.041 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -88.03 -0.26 56.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.468 -0.77 . . . . 15.52 109.029 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.9 mm-40 -116.21 36.91 3.87 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.395 -0.816 . . . . 17.31 109.218 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.62 10.79 40.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 24.78 110.062 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 13.4 mt-30 -137.74 136.16 37.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.227 -0.921 . . . . 47.9 109.745 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.6 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 31.0 p90 -86.21 165.98 16.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.2 -0.938 . . . . 21.61 109.556 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -133.45 149.75 51.77 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.383 -0.823 . . . . 14.89 109.27 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.297 -0.877 . . . . 17.35 109.218 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.578 0.704 . . . . 24.0 110.18 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.596 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -88.09 129.45 35.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.563 -0.711 . . . . 23.31 109.77 -179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 14.7 mt-10 -115.09 162.38 17.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.302 -0.874 . . . . 40.03 109.34 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.553 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -148.92 -173.53 4.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.108 -0.995 . . . . 12.39 109.876 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.512 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 25.1 mt -133.71 159.35 40.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 17.42 109.221 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.5 m -154.23 168.44 26.54 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.937 -1.135 . . . . 13.84 107.937 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.68 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 29.4 m-85 -120.53 105.92 11.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.951 -1.093 . . . . 21.14 109.589 -179.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.473 ' O ' HG21 ' A' ' 43' ' ' VAL . 39.9 t -97.8 139.69 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.002 -1.061 . . . . 10.66 111.095 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.4 m-20 -115.22 -140.49 0.38 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.318 -0.993 . . . . 25.89 108.318 178.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.536 HD21 ' CD2' ' B' ' 65' ' ' LEU . 0.2 OUTLIER 67.44 -68.41 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.924 -1.11 . . . . 24.24 108.47 179.467 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -78.66 -1.47 83.27 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 107.913 -2.075 . . . . 31.02 107.913 178.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -160.12 110.26 1.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.513 -0.992 . . . . 43.23 108.95 179.748 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 39' ' ' ASN . 2.0 mm-40 -37.68 -63.29 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.642 0.734 . . . . 42.34 109.81 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 37.3 m80 -69.0 163.95 52.08 Favored Pre-proline 0 C--N 1.293 -1.882 0 N-CA-C 108.076 -1.083 . . . . 8.11 108.076 179.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.68 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -76.53 141.48 22.43 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 121.699 1.599 . . . . 17.92 109.748 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' TYR . 25.7 m -113.72 115.89 51.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.315 -0.866 . . . . 20.57 109.46 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.628 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 52.0 tp -74.23 103.39 4.63 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.366 -0.833 . . . . 20.21 109.749 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.447 HG13 HG13 ' B' ' 70' ' ' VAL . 1.3 m -107.43 176.15 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.509 -0.744 . . . . 10.81 109.172 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' HA ' HD21 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -100.28 139.85 35.37 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.314 -0.955 . . . . 36.74 109.527 179.66 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.61 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -124.02 170.59 14.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.42 -0.8 . . . . 19.74 109.261 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.77 142.53 44.0 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.175 -0.953 . . . . 22.56 109.497 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.6 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -110.41 147.48 33.93 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 20.41 108.721 179.711 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 1.0 OUTLIER -85.26 145.24 27.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 33.99 109.831 -179.332 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.19 119.82 5.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.36 -0.838 . . . . 54.92 109.614 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.79 -15.55 46.73 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.681 -1.368 . . . . 36.1 109.681 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.519 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -74.99 145.19 80.67 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.202 -1.176 . . . . 54.76 109.343 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.84 121.9 5.64 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.596 2.197 . . . . 28.37 110.74 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.456 ' HB3' ' HG3' ' A' ' 31' ' ' GLN . . . -38.92 149.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.501 -0.749 . . . . 17.21 110.388 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.619 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 89.6 m-85 -46.49 105.36 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.758 -0.83 . . . . 17.19 108.758 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -58.88 176.73 0.27 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.382 -0.824 . . . . 17.82 110.023 -179.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.8 Cg_endo -77.69 110.26 2.91 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.737 2.291 . . . . 17.28 110.338 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 173.65 151.94 8.54 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.563 -1.415 . . . . 17.22 109.563 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 5.1 mp -49.27 150.22 1.83 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.321 . . . . 19.57 108.779 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.615 ' CD1' ' O ' ' A' ' 59' ' ' GLY . 19.1 m-85 -128.57 163.89 24.02 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.768 -1.207 . . . . 14.61 111.564 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.459 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 55.8 p -147.69 118.73 7.69 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.411 -1.7 . . . . 18.36 106.411 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.563 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 8.6 t -53.33 169.86 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 C-N-CA 118.809 -1.157 . . . . 19.13 108.917 -178.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.9 t-80 -128.08 120.14 26.8 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.426 -0.796 . . . . 20.65 109.066 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.61 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -65.08 -8.28 15.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.727 -0.608 . . . . 19.65 109.914 -179.176 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.3 p -52.28 -17.95 1.36 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.02 -1.05 . . . . 14.72 108.402 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 2.3 m -95.94 -6.06 39.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.566 -0.709 . . . . 11.45 110.79 -179.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.61 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -86.61 164.64 16.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.741 -1.224 . . . . 14.25 110.174 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 1.4 mtpp -159.33 178.78 9.59 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.876 -0.787 . . . . 32.7 108.876 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.464 HG13 HG13 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -118.6 114.82 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 15.63 109.38 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.472 ' C ' ' NE2' ' A' ' 72' ' ' GLN . . . -74.46 -167.88 18.67 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.461 -1.456 . . . . 12.7 109.461 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.543 ' N ' ' NE2' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -88.35 39.97 0.93 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -1.168 . . . . 26.29 109.48 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 28.3 m-85 -134.21 27.8 3.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.35 -0.844 . . . . 20.44 109.261 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 73' ' ' PHE . . . 44.7 49.01 8.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.583 -1.407 . . . . 13.82 109.583 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -149.51 145.67 26.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -1.181 . . . . 18.27 109.66 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.8 OUTLIER -88.41 149.49 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 12.43 109.119 179.72 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 54.6 mtm -157.4 137.84 12.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -0.984 . . . . 35.11 109.637 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.0 mt -69.98 139.59 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 13.67 110.105 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.1 -25.48 11.55 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.221 -1.029 . . . . 24.06 108.221 178.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -179.92 68.01 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.125 -1.435 . . . . 35.04 107.125 179.144 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.563 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -33.23 120.48 0.37 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.281 -0.872 . . . . 18.72 111.644 -178.247 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -91.45 113.21 25.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.922 -1.14 . . . . 20.55 107.922 178.786 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.619 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -82.55 148.85 27.82 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.028 -1.045 . . . . 14.4 110.959 -178.553 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 62' ' ' THR . 32.6 m -150.65 150.13 27.62 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 107.96 -1.126 . . . . 17.65 107.96 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.1 Cg_endo -61.37 140.89 90.46 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.164 1.91 . . . . 25.7 110.581 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.11 117.15 8.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 49.29 109.651 -178.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.005 -0.998 . . . . 58.91 109.49 179.991 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.469 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 1.2 pmm? . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.471 -0.566 . . . . 64.91 109.471 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.563 HG21 ' CD1' ' A' ' 65' ' ' LEU . 2.3 mt -74.25 66.57 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.043 -1.095 . . . . 33.8 108.043 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.517 ' N ' HD12 ' B' ' 37' ' ' LEU . 0.5 OUTLIER -56.93 178.76 0.05 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.88 0.848 . . . . 32.72 110.992 -178.455 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.558 ' CG2' ' N ' ' B' ' 5' ' ' GLU . 0.2 OUTLIER 174.19 166.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.625 -0.879 . . . . 14.46 108.625 -179.84 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 25.2 mt-10 -137.34 113.99 10.36 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.826 -0.805 . . . . 22.12 108.826 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.55 ' O ' ' CG2' ' B' ' 6' ' ' ILE . 0.1 OUTLIER -72.74 103.75 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 107.529 -1.286 . . . . 14.23 107.529 179.48 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.637 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.63 171.27 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.995 -1.065 . . . . 25.43 109.564 -178.791 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.3 Cg_endo -74.96 -28.3 9.35 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.445 2.096 . . . . 13.61 110.088 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -87.6 -0.73 57.27 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.02 -0.733 . . . . 15.52 109.02 179.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.6 mm-40 -115.9 37.08 3.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.342 -0.849 . . . . 17.31 109.301 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.71 10.77 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 24.78 110.004 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.427 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 13.7 mt-30 -137.62 136.14 37.23 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 47.9 109.785 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.602 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 30.8 p90 -86.15 165.97 16.14 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.248 -0.908 . . . . 21.61 109.573 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 89.7 m -133.42 149.84 51.79 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.385 -0.822 . . . . 14.89 109.234 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.479 0 O-C-N 121.251 -0.905 . . . . 17.35 109.224 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.577 0.704 . . . . 24.0 110.089 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.602 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -88.47 129.25 35.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.601 -0.687 . . . . 23.31 109.802 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 14.7 mt-10 -114.89 162.27 17.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 40.03 109.387 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.543 ' CB ' HG21 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -148.76 -173.48 4.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.994 . . . . 12.39 109.892 -179.814 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.517 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 25.3 mt -133.85 159.41 40.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 17.42 109.264 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.5 m -154.27 168.24 27.24 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.963 -1.125 . . . . 13.84 107.963 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 29.7 m-85 -120.38 105.93 11.36 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.957 -1.089 . . . . 21.14 109.652 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.481 ' O ' HG21 ' B' ' 43' ' ' VAL . 40.0 t -97.93 139.65 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.087 -1.008 . . . . 10.66 110.995 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' B' ' 38' ' ' GLY . 4.4 m-20 -115.27 -140.46 0.38 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.292 -1.003 . . . . 25.89 108.292 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.523 HD21 ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 67.33 -68.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.925 -1.109 . . . . 24.24 108.405 179.479 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -78.6 -1.54 83.08 Favored Glycine 0 C--N 1.297 -1.587 0 N-CA-C 107.873 -2.091 . . . . 31.02 107.873 178.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.451 ' O ' ' C ' ' B' ' 40' ' ' GLU . 0.1 OUTLIER -160.37 110.12 1.77 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.512 -0.993 . . . . 43.23 108.869 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' B' ' 39' ' ' ASN . 2.0 mm-40 -37.37 -63.53 0.44 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.633 0.73 . . . . 42.34 109.827 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.477 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 37.9 m80 -68.89 164.1 49.99 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 108.03 -1.1 . . . . 8.13 108.03 179.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.672 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.3 Cg_endo -76.51 141.53 22.54 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.722 1.615 . . . . 17.92 109.836 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' B' ' 34' ' ' TYR . 25.5 m -113.73 115.77 50.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.255 -0.903 . . . . 20.57 109.495 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 52.1 tp -74.26 103.15 4.56 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.417 -0.802 . . . . 20.21 109.741 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 70' ' ' VAL . 1.3 m -107.07 176.19 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.505 -0.747 . . . . 10.81 109.147 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.443 ' HA ' HD21 ' B' ' 32' ' ' LEU . 0.3 OUTLIER -100.17 139.87 35.23 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.393 -0.923 . . . . 36.74 109.526 179.627 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.606 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -124.12 170.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.383 -0.823 . . . . 19.74 109.254 -179.748 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.7 142.27 44.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.206 -0.934 . . . . 22.56 109.575 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -110.21 147.54 33.58 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.285 -0.884 . . . . 20.41 108.763 179.676 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.518 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 1.0 OUTLIER -85.37 145.11 27.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.128 -0.983 . . . . 33.99 109.854 -179.355 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.85 119.84 5.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 54.92 109.595 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.74 -15.56 46.44 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.707 -1.357 . . . . 36.1 109.707 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.518 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -75.0 145.12 80.56 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 54.76 109.311 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.8 Cg_endo -77.78 121.75 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.616 2.211 . . . . 28.37 110.731 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.458 ' HB3' ' HG3' ' B' ' 31' ' ' GLN . . . -38.68 150.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.548 -0.72 . . . . 17.21 110.415 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 89.4 m-85 -46.79 105.4 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.324 -0.86 . . . . 17.19 108.724 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.544 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -58.83 176.89 0.26 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 17.82 110.121 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.78 110.26 2.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.673 2.249 . . . . 17.28 110.278 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 173.68 151.96 8.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.579 -1.408 . . . . 17.22 109.579 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.1 mp -49.25 150.1 1.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.985 -1.303 . . . . 19.57 108.724 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.615 ' CD1' ' O ' ' B' ' 59' ' ' GLY . 18.7 m-85 -128.55 163.86 24.08 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.833 -1.167 . . . . 14.61 111.589 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.47 ' N ' ' O ' ' B' ' 84' ' ' VAL . 53.8 p -147.6 118.71 7.73 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.481 -1.674 . . . . 18.36 106.481 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.562 ' CG2' HG23 ' B' ' 2' ' ' ILE . 9.2 t -53.3 169.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.811 -1.156 . . . . 19.13 108.878 -178.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -128.2 120.1 26.57 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.499 -0.751 . . . . 20.65 109.05 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.613 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -64.9 -8.43 15.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.709 -0.619 . . . . 19.65 109.923 -179.151 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 96.0 p -52.05 -17.98 1.25 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.952 -1.092 . . . . 14.72 108.377 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 2.4 m -95.96 -6.59 38.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.502 -0.749 . . . . 11.45 110.776 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.626 ' N ' ' CD1' ' B' ' 68' ' ' PHE . 1.8 m-30 -86.15 164.4 17.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.73 -1.231 . . . . 14.25 110.046 -179.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' B' ' 68' ' ' PHE . 1.4 mtpp -159.09 179.06 9.38 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.82 -0.808 . . . . 32.7 108.82 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.465 HG23 HG23 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -118.73 115.13 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 15.63 109.427 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.483 ' C ' ' NE2' ' B' ' 72' ' ' GLN . . . -74.58 -168.09 19.66 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.495 -1.442 . . . . 12.7 109.495 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.55 ' N ' ' NE2' ' B' ' 72' ' ' GLN . 0.6 OUTLIER -88.13 39.71 0.91 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.167 -1.196 . . . . 26.29 109.475 179.937 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.449 ' O ' ' OG ' ' B' ' 75' ' ' SER . 28.6 m-85 -133.99 28.09 3.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 20.44 109.38 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.39 49.1 8.46 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.627 -1.389 . . . . 13.82 109.627 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -149.67 145.69 26.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -1.145 . . . . 18.27 109.684 -179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.8 OUTLIER -88.58 149.62 23.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 12.43 109.072 179.734 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.492 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 54.4 mtm -157.52 138.18 13.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.123 -0.986 . . . . 35.11 109.52 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.606 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.9 mp -70.4 139.52 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.856 . . . . 13.67 110.134 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.84 -25.53 11.65 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.138 -1.06 . . . . 24.06 108.138 178.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.0 OUTLIER -179.77 68.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.186 -1.413 . . . . 35.04 107.186 179.17 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.551 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -33.21 120.28 0.36 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.311 -0.859 . . . . 18.72 111.607 -178.187 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -91.32 113.09 25.26 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.979 -1.119 . . . . 20.55 107.979 178.723 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.625 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -82.42 148.93 27.92 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.037 -1.039 . . . . 14.4 110.986 -178.603 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' B' ' 62' ' ' THR . 32.5 m -150.63 150.04 27.45 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.994 -1.113 . . . . 17.65 107.994 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.0 Cg_endo -61.41 140.44 87.83 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.188 1.925 . . . . 25.7 110.6 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.51 117.47 8.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 49.29 109.62 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.027 -0.987 . . . . 58.91 109.484 -179.98 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.358 -0.608 . . . . 64.91 109.358 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.52 ' CD1' ' HB ' ' A' ' 63' ' ' VAL . 2.2 mt -60.4 84.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.897 -1.149 . . . . 33.8 107.897 179.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 1' ' ' MET . 17.4 mttt -57.85 157.14 7.92 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.847 0.832 . . . . 32.72 111.569 -177.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 61' ' ' TYR . 59.8 t -160.52 167.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.585 0.707 . . . . 14.46 109.724 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 38.9 mt-10 -154.09 101.44 2.41 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.771 0.796 . . . . 22.12 108.931 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.592 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -71.38 101.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.986 -1.116 . . . . 14.23 107.986 179.642 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.557 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 15.6 mmmt -50.52 163.3 0.47 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.414 -0.803 . . . . 25.43 109.252 -179.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.5 Cg_endo -71.98 -10.1 25.62 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.818 1.679 . . . . 13.61 109.247 179.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.82 12.21 31.07 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.533 -0.914 . . . . 15.52 108.533 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.529 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 7.6 mm-40 -137.08 38.45 2.54 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.31 -0.869 . . . . 17.31 109.211 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -111.96 31.48 6.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.96 . . . . 24.78 110.19 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 12.0 mt-30 -140.3 132.36 27.9 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.261 -0.9 . . . . 47.9 109.501 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.604 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 33.6 p90 -89.52 155.81 19.05 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.213 -0.93 . . . . 21.61 109.671 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.1 m -134.6 150.16 50.67 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.885 -0.783 . . . . 14.89 108.885 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.572 0 O-C-N 121.164 -0.96 . . . . 17.35 109.236 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.459 HD22 ' O ' ' A' ' 49' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.447 0.642 . . . . 24.0 110.418 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.653 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -47.61 117.75 1.95 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.433 -0.792 . . . . 23.31 109.569 179.607 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -112.87 147.68 36.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.255 -0.903 . . . . 40.03 109.593 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.549 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -131.22 -169.71 2.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.121 -0.987 . . . . 12.39 109.341 179.843 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.549 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -128.56 177.53 6.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 17.42 109.32 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -172.43 162.69 5.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.053 -1.029 . . . . 13.84 108.467 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.655 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 4.1 m-30 -114.58 95.25 5.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.154 -0.966 . . . . 21.14 109.187 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.538 ' CG2' HG21 ' A' ' 4' ' ' VAL . 92.2 t -84.87 115.45 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 10.66 110.234 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 t0 -66.1 -22.67 66.41 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.381 -0.824 . . . . 25.89 108.805 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.53 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 0.8 OUTLIER 43.23 26.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.771 . . . . 24.24 109.567 179.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 58.6 22.3 52.23 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.891 -1.284 . . . . 31.02 109.891 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 19.2 p30 -100.64 27.8 5.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.983 -1.304 . . . . 43.23 110.079 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.628 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 12.2 mt-10 47.72 71.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 42.34 109.871 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.628 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER 142.92 144.46 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.287 0 N-CA-C 108.572 -0.899 . . . . 6.58 108.572 179.451 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.655 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -79.57 142.96 16.64 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.206 1.938 . . . . 17.92 110.841 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.533 HG22 ' CG1' ' B' ' 70' ' ' VAL . 6.9 m -120.52 119.3 59.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.441 -0.948 . . . . 20.57 108.441 178.469 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.651 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 17.7 tp -66.88 112.72 4.44 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.428 -0.795 . . . . 20.21 109.241 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 3.6 t -119.47 168.4 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.576 -0.702 . . . . 10.81 109.572 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -90.57 149.89 21.96 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.431 -0.793 . . . . 36.74 109.954 -179.776 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.587 HG12 ' CE1' ' A' ' 56' ' ' TYR . 1.6 tt -130.21 176.86 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.802 -0.814 . . . . 19.74 108.802 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.412 HG23 ' CZ ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -125.4 135.24 52.18 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.184 -0.948 . . . . 22.56 109.094 179.453 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.604 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -104.67 99.99 9.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.209 -0.932 . . . . 20.41 109.003 179.981 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.69 156.44 36.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 33.99 109.606 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.27 136.81 57.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.221 -0.924 . . . . 54.92 109.228 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.86 -35.05 3.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.321 -1.512 . . . . 36.1 109.321 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 4.3 mt-30 -77.32 124.04 86.98 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.243 -1.151 . . . . 54.76 109.245 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.1 Cg_endo -78.63 138.28 15.11 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.279 1.986 . . . . 28.37 110.406 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.545 ' CB ' ' OE1' ' A' ' 31' ' ' GLN . . . -35.84 138.16 0.19 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.637 -0.664 . . . . 17.21 110.424 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 83.7 m-85 -51.75 109.99 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 17.19 109.511 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.495 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -59.72 174.33 0.45 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.263 -0.898 . . . . 17.82 109.252 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.7 Cg_endo -77.48 110.32 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.632 2.221 . . . . 17.28 110.406 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.37 179.85 48.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.743 -1.343 . . . . 17.22 109.743 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -74.83 143.99 43.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -1.114 . . . . 19.57 108.76 179.483 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.592 ' CE1' HD11 ' A' ' 6' ' ' ILE . 27.0 m-85 -132.42 164.58 26.21 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.873 -1.142 . . . . 14.61 111.206 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.484 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 31.1 p -144.11 118.96 9.9 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.925 -1.88 . . . . 18.36 105.925 178.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.59 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.6 t -52.36 166.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 C-N-CA 118.434 -1.307 . . . . 19.13 108.999 -178.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -129.13 128.81 44.22 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.417 -0.802 . . . . 20.65 109.3 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.676 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -71.3 0.19 8.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.691 -0.631 . . . . 19.65 110.051 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -57.25 -17.66 12.7 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.645 -1.243 . . . . 14.72 107.645 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 80' ' ' ARG . 50.4 m -96.41 -8.38 32.52 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.782 -0.574 . . . . 11.45 110.193 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.8 m-30 -77.69 155.04 31.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.052 . . . . 14.25 109.585 -178.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.529 ' CA ' HD12 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -134.71 172.9 12.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.406 -0.809 . . . . 32.7 109.731 -179.651 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.532 HG12 ' CG2' ' B' ' 45' ' ' VAL . 8.7 t -124.41 133.34 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.492 -0.755 . . . . 15.63 109.376 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.26 -157.56 27.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.435 -1.466 . . . . 12.7 109.435 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.499 ' NE2' ' HA ' ' A' ' 72' ' ' GLN . 6.5 tp-100 55.88 72.42 0.49 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -1.181 . . . . 26.29 109.098 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER 73.32 5.95 5.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.779 . . . . 20.44 109.402 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.462 ' O ' HG12 ' B' ' 45' ' ' VAL . . . 78.29 45.07 10.34 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.474 -1.451 . . . . 13.82 109.474 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.3 OUTLIER -127.07 119.66 27.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.144 . . . . 18.27 109.713 -179.913 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.536 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.8 OUTLIER -54.95 144.68 22.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 12.43 109.106 179.801 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 30.9 mtp -160.28 140.8 11.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 35.11 109.783 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.617 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.3 mp -68.56 141.66 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.816 . . . . 13.67 109.73 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 39.5 t0 -108.61 -21.26 12.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.689 -0.856 . . . . 24.06 108.689 178.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.48 ' O ' ' OG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER 174.22 66.76 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.1 -1.444 . . . . 35.04 107.1 179.497 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.59 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -28.3 119.7 0.11 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.257 -0.883 . . . . 18.72 111.961 -178.07 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 5.3 ttp180 -93.14 102.87 15.18 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.841 -1.17 . . . . 20.55 107.841 178.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.604 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 7.0 tp -74.13 149.75 40.85 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.158 -0.964 . . . . 14.4 111.184 -178.211 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.511 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 17.8 m -146.33 152.98 47.63 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.214 -1.032 . . . . 17.65 108.214 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 26.0 Cg_endo -64.51 142.97 80.37 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.2 1.933 . . . . 25.7 110.402 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -76.94 123.67 26.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 49.29 109.692 -178.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.003 -0.999 . . . . 58.91 109.432 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.516 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.387 -0.597 . . . . 64.91 109.387 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.521 ' CD1' ' HB ' ' B' ' 63' ' ' VAL . 2.2 mt -60.23 84.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.881 -1.155 . . . . 33.8 107.881 179.065 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.533 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 17.5 mttt -57.75 157.25 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.815 0.817 . . . . 32.72 111.543 -177.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' B' ' 61' ' ' TYR . 58.6 t -160.63 167.16 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.551 0.691 . . . . 14.46 109.726 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 38.5 mt-10 -154.08 101.29 2.4 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.715 0.769 . . . . 22.12 108.963 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.593 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -71.28 101.77 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.994 -1.113 . . . . 14.23 107.994 179.664 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.54 ' HB3' ' HD2' ' B' ' 8' ' ' PRO . 15.7 mmmt -50.58 163.59 0.46 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.454 -0.779 . . . . 25.43 109.216 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.5 Cg_endo -72.23 -10.16 25.38 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.835 1.69 . . . . 13.61 109.205 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.62 12.06 31.6 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.485 -0.932 . . . . 15.52 108.485 178.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.541 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 7.7 mm-40 -136.91 38.19 2.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.869 . . . . 17.31 109.33 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -111.73 31.43 6.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.098 -1.001 . . . . 24.78 110.288 -179.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' B' ' 31' ' ' GLN . 11.9 mt-30 -140.26 132.26 27.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 47.9 109.504 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.608 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 33.0 p90 -89.33 155.75 19.15 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.249 -0.907 . . . . 21.61 109.662 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -134.63 150.27 50.65 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.83 -0.804 . . . . 14.89 108.83 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 17.35 109.209 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.462 HD22 ' O ' ' B' ' 49' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.426 0.631 . . . . 24.0 110.408 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.664 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -47.56 117.81 1.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.434 -0.791 . . . . 23.31 109.627 179.668 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -112.77 148.02 35.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.218 -0.926 . . . . 40.03 109.584 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.542 ' CB ' HG21 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -131.6 -169.81 2.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.219 -0.926 . . . . 12.39 109.236 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.548 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -128.53 177.63 6.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.289 -0.882 . . . . 17.42 109.276 179.889 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.477 ' SG ' ' HB ' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -172.51 162.56 5.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.992 -1.067 . . . . 13.84 108.4 -179.653 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.646 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 4.1 m-30 -114.51 95.36 5.22 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.125 -0.984 . . . . 21.14 109.203 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.545 ' CG2' HG21 ' B' ' 4' ' ' VAL . 92.6 t -84.92 115.41 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.028 -1.045 . . . . 10.66 110.27 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' B' ' 39' ' ' ASN . 1.1 t0 -66.0 -22.71 66.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.389 -0.819 . . . . 25.89 108.862 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.529 HD12 ' CA ' ' A' ' 69' ' ' LYS . 0.8 OUTLIER 43.23 26.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 24.24 109.55 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 58.64 22.56 53.18 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.862 -1.295 . . . . 31.02 109.862 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 19.1 p30 -100.89 27.66 5.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.016 -1.285 . . . . 43.23 110.034 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.631 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 12.2 mt-10 47.88 71.87 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 42.34 109.817 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.631 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 0.2 OUTLIER 142.89 144.44 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.196 0 N-CA-C 108.591 -0.892 . . . . 6.56 108.591 179.48 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.646 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.7 Cg_endo -79.56 143.14 16.79 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.235 1.957 . . . . 17.92 110.762 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.53 HG22 ' CG1' ' A' ' 70' ' ' VAL . 7.1 m -120.73 119.12 58.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.446 -0.946 . . . . 20.57 108.446 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.641 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 17.0 tp -66.71 112.96 4.48 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.413 -0.804 . . . . 20.21 109.294 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.575 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 3.7 t -119.71 168.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.552 -0.718 . . . . 10.81 109.553 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.575 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.5 OUTLIER -90.64 149.84 21.93 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.443 -0.786 . . . . 36.74 110.007 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.596 HG12 ' CE1' ' B' ' 56' ' ' TYR . 1.6 tt -130.11 176.95 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.836 -0.801 . . . . 19.74 108.836 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.57 134.94 51.78 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.228 -0.92 . . . . 22.56 109.149 179.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.608 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -104.48 100.07 9.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.169 -0.957 . . . . 20.41 109.05 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.8 156.44 37.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 33.99 109.642 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.25 136.77 57.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.867 . . . . 54.92 109.245 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.76 -34.56 4.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.388 -1.485 . . . . 36.1 109.388 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.482 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 4.3 mt-30 -77.71 123.99 86.49 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.234 -1.157 . . . . 54.76 109.202 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.476 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.8 Cg_endo -78.54 138.06 15.1 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.343 2.029 . . . . 28.37 110.478 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.541 ' CB ' ' OE1' ' B' ' 31' ' ' GLN . . . -35.62 137.78 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.384 0.612 . . . . 17.21 110.478 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 84.6 m-85 -51.28 109.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 17.19 109.558 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.48 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -59.72 174.25 0.46 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 17.82 109.27 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.26 109.53 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.541 2.161 . . . . 17.28 110.193 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.08 179.52 48.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.83 -1.308 . . . . 17.22 109.83 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -75.2 143.73 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -1.14 . . . . 19.57 108.474 179.263 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.593 ' CE1' HD11 ' B' ' 6' ' ' ILE . 27.0 m-85 -132.04 164.57 25.92 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.835 -1.165 . . . . 14.61 111.173 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' B' ' 1' ' ' MET . 31.9 p -143.99 119.0 10.0 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 105.907 -1.886 . . . . 18.36 105.907 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.593 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.5 t -52.52 166.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 C-N-CA 118.42 -1.312 . . . . 19.13 108.941 -178.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.512 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -129.26 128.73 43.84 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.413 -0.804 . . . . 20.65 109.287 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.678 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -71.23 0.17 8.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.621 -0.674 . . . . 19.65 110.11 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -57.2 -17.7 12.52 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.67 -1.233 . . . . 14.72 107.67 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' B' ' 80' ' ' ARG . 51.1 m -96.23 -8.78 32.03 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.773 -0.58 . . . . 11.45 110.255 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.678 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.8 m-30 -77.3 155.01 32.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.023 -1.048 . . . . 14.25 109.542 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.525 ' CA ' HD12 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -134.83 172.58 12.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.424 -0.797 . . . . 32.7 109.703 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' A' ' 43' ' ' VAL . 9.5 t -124.14 133.31 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.462 -0.774 . . . . 15.63 109.387 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.37 -157.3 27.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.506 -1.438 . . . . 12.7 109.506 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' B' ' 72' ' ' GLN . 6.5 tp-100 55.68 72.27 0.5 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -1.164 . . . . 26.29 109.131 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.1 OUTLIER 73.44 5.94 5.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 20.44 109.467 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 45' ' ' VAL . . . 78.32 45.1 10.26 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.547 -1.421 . . . . 13.82 109.547 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' B' ' 77' ' ' MET . 0.3 OUTLIER -127.13 119.57 26.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -1.1 . . . . 18.27 109.755 -179.916 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.53 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.8 OUTLIER -54.94 144.54 22.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 12.43 109.152 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 31.1 mtp -160.14 141.1 12.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 35.11 109.749 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.613 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.3 mp -68.87 141.83 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 13.67 109.775 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.468 ' HB2' ' HG2' ' B' ' 69' ' ' LYS . 39.1 t0 -108.66 -21.23 12.79 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.685 -0.857 . . . . 24.06 108.685 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.474 ' O ' ' OG ' ' B' ' 67' ' ' SER . 0.0 OUTLIER 174.08 66.58 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.075 -1.454 . . . . 35.04 107.075 179.541 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.593 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -28.01 119.98 0.11 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.27 -0.877 . . . . 18.72 111.893 -178.097 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 5.4 ttp180 -93.38 103.09 15.34 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.814 -1.18 . . . . 20.55 107.814 178.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.604 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 7.0 tp -74.35 149.59 40.5 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.113 -0.992 . . . . 14.4 111.148 -178.237 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.491 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 17.6 m -146.19 153.14 48.4 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.224 -1.028 . . . . 17.65 108.224 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 26.5 Cg_endo -64.6 143.34 81.0 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.155 1.903 . . . . 25.7 110.397 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' B' ' 60' ' ' LEU . . . -77.38 123.82 27.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.87 . . . . 49.29 109.643 -178.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.04 -0.981 . . . . 58.91 109.433 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 tpp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.489 -0.559 . . . . 64.91 109.489 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.512 ' N ' HD23 ' B' ' 65' ' ' LEU . 2.1 mt -59.46 84.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.962 -1.125 . . . . 33.8 107.962 179.297 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 1' ' ' MET . 15.3 mtpp -67.1 152.5 45.65 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.827 0.823 . . . . 32.72 111.306 -178.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.585 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -164.15 167.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 108.381 -0.97 . . . . 14.46 108.381 179.593 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.572 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 24.3 mt-10 -141.08 118.0 11.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.336 -0.853 . . . . 22.12 109.361 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.596 HG13 ' CE1' ' A' ' 61' ' ' TYR . 10.4 mm -75.71 92.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.919 -1.141 . . . . 14.23 107.919 179.163 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.641 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -44.89 171.66 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 25.43 110.19 -178.677 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -74.73 -29.28 8.89 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.481 2.121 . . . . 13.61 109.728 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -6.74 58.17 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.762 -0.829 . . . . 15.52 108.762 178.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 1.3 mm100 -118.35 40.56 3.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.417 -0.802 . . . . 17.31 109.342 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -103.69 7.96 37.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.092 -1.005 . . . . 24.78 109.646 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 37.5 mt-30 -138.05 138.89 39.24 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.323 -0.861 . . . . 47.9 109.624 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.64 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 36.1 p90 -92.13 161.32 14.79 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.15 -0.969 . . . . 21.61 108.76 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.1 m -130.02 152.54 49.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.103 -0.998 . . . . 14.89 109.687 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.457 0 O-C-N 121.333 -0.854 . . . . 17.35 109.314 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.411 0.624 . . . . 24.0 110.451 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.626 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 98.0 m-20 -78.33 129.59 35.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.496 -0.752 . . . . 23.31 109.277 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -123.28 149.06 45.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 40.03 109.17 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -136.33 -170.17 2.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 12.39 109.65 -179.985 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.543 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 5.9 mp -132.03 174.49 10.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.327 -0.858 . . . . 17.42 109.526 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -162.69 159.37 24.29 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.258 -1.015 . . . . 13.84 108.258 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 15.0 m-85 -114.77 96.64 5.83 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.152 -0.968 . . . . 21.14 109.384 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.514 ' CG1' ' HG ' ' A' ' 37' ' ' LEU . 3.0 t -105.18 127.5 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 10.66 110.461 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 16.8 p-10 -86.48 -27.54 24.01 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.496 -0.927 . . . . 25.89 108.496 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.514 ' HG ' ' CG1' ' A' ' 35' ' ' VAL . 0.4 OUTLIER 47.4 23.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 24.24 109.625 179.775 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.27 8.03 69.05 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.976 -1.25 . . . . 31.02 109.976 179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' CG ' ' O ' ' A' ' 36' ' ' ASP . 1.7 m-20 -87.07 19.21 3.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.094 -1.239 . . . . 43.23 110.008 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.61 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 5.1 mt-10 45.98 72.03 0.25 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 42.34 109.862 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.61 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER 143.64 147.65 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.207 0 N-CA-C 108.6 -0.889 . . . . 7.76 108.6 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.692 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -79.5 137.5 13.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.068 1.845 . . . . 17.92 110.542 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 2.8 m -114.53 118.7 59.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.35 -0.844 . . . . 20.57 108.827 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 56.7 tp -76.48 106.65 8.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.435 -0.791 . . . . 20.21 110.661 -178.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.558 ' CG1' ' CG1' ' B' ' 70' ' ' VAL . 21.2 m -115.24 -169.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.816 -0.809 . . . . 10.81 108.816 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -108.48 152.01 25.29 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.333 -0.947 . . . . 36.74 110.395 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.63 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -141.41 126.15 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.57 -0.706 . . . . 19.74 109.141 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -64.36 147.12 53.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.062 . . . . 22.56 109.357 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.64 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 2.9 tm? -124.31 73.09 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 20.41 109.235 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 2.0 t70 -134.96 -175.48 3.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.916 -1.115 . . . . 33.99 109.72 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 53' ' ' GLN . 16.0 tt0 69.82 67.66 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.414 -0.804 . . . . 54.92 109.558 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 51' ' ' GLU . . . 38.17 27.85 0.04 OUTLIER Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.522 -1.031 . . . . 36.1 110.522 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 51' ' ' GLU . 3.5 mt-30 -105.96 125.58 32.8 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 120.897 -1.355 . . . . 54.76 109.913 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.8 Cg_endo -78.73 146.35 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.313 2.008 . . . . 28.37 109.677 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -37.93 143.27 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.439 -0.788 . . . . 17.21 110.496 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE1' HG12 ' A' ' 47' ' ' ILE . 79.5 m-85 -58.54 107.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.498 -0.751 . . . . 17.19 109.273 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -57.58 173.33 0.36 Allowed Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.107 -0.996 . . . . 17.82 108.983 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.8 Cg_endo -78.28 107.89 2.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.486 2.124 . . . . 17.28 110.09 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.23 179.32 47.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.963 -1.255 . . . . 17.22 109.963 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -77.12 137.74 39.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.385 -1.068 . . . . 19.57 108.642 179.203 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.596 ' CE1' HG13 ' A' ' 6' ' ' ILE . 26.9 m-85 -128.55 163.21 25.48 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.751 -1.218 . . . . 14.61 111.569 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 43.5 p -141.74 117.58 10.47 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.163 -1.791 . . . . 18.36 106.163 177.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.61 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -50.14 164.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 118.77 -1.172 . . . . 19.13 108.936 -178.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.3 t-80 -128.39 129.13 45.74 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.504 -0.747 . . . . 20.65 109.113 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.635 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -72.59 2.19 6.88 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.519 -0.738 . . . . 19.65 109.985 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -18.91 30.66 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.002 -1.481 . . . . 14.72 107.002 178.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.478 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 14.7 m -96.19 -9.64 30.05 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.9 -0.5 . . . . 11.45 109.907 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 3.4 m-30 -78.05 154.37 31.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.112 -0.992 . . . . 14.25 109.951 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 3.8 mtmt -157.6 -178.38 7.29 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.528 -0.733 . . . . 32.7 109.182 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.565 ' CG1' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -109.96 105.82 19.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.434 -0.791 . . . . 15.63 109.132 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.22 -155.0 12.15 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.994 -1.243 . . . . 12.7 109.994 -179.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.478 ' NE2' ' HA ' ' A' ' 72' ' ' GLN . 12.6 tp60 -98.55 42.47 1.09 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.321 -1.105 . . . . 26.29 109.68 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 74' ' ' GLY . 2.8 m-85 -129.22 22.14 5.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 20.44 109.625 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 73' ' ' PHE . . . 44.79 52.56 7.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.627 -1.389 . . . . 13.82 109.627 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 76' ' ' LEU . 16.8 t -176.66 130.18 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -1.116 . . . . 18.27 109.448 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.508 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.1 OUTLIER -44.1 160.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.907 . . . . 12.43 109.159 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.4 mtt -163.7 118.67 1.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 35.11 109.585 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.608 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.3 mp -54.07 138.14 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 13.67 109.324 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -105.77 -34.8 7.56 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.011 -1.107 . . . . 24.06 108.011 178.516 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.478 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.2 OUTLIER -170.12 67.07 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.169 -1.419 . . . . 35.04 107.169 178.804 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.61 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -27.99 120.05 0.11 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.21 -0.905 . . . . 18.72 111.859 -178.177 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -91.61 102.06 14.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 20.55 108.545 179.063 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -70.21 140.86 52.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.369 -0.832 . . . . 14.4 110.807 -178.818 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 62' ' ' THR . 33.5 m -140.61 148.8 54.67 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.774 -1.195 . . . . 17.65 107.774 178.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.8 Cg_endo -63.08 141.12 82.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.05 1.834 . . . . 25.7 110.265 179.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -71.83 108.44 5.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.309 -0.869 . . . . 49.29 109.461 -178.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.008 -0.996 . . . . 58.91 109.438 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.3 tpp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.474 -0.565 . . . . 64.91 109.474 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.516 ' N ' HD23 ' A' ' 65' ' ' LEU . 2.1 mt -59.41 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.033 -1.099 . . . . 33.8 108.033 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' ' 1' ' ' MET . 15.2 mtpp -67.02 152.18 46.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.841 0.829 . . . . 32.72 111.265 -178.039 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.594 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -163.8 168.18 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.462 -0.94 . . . . 14.46 108.462 179.481 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.568 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 25.2 mt-10 -141.17 118.0 11.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.337 -0.852 . . . . 22.12 109.363 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.585 HG13 ' CE1' ' B' ' 61' ' ' TYR . 10.4 mm -75.85 92.53 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.869 -1.16 . . . . 14.23 107.869 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.643 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.79 171.39 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.916 . . . . 25.43 110.189 -178.735 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.5 Cg_endo -74.65 -28.83 9.5 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.462 2.108 . . . . 13.61 109.85 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.51 -6.73 58.62 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.741 -0.837 . . . . 15.52 108.741 178.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 1.2 mm100 -118.28 40.26 3.23 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.418 -0.801 . . . . 17.31 109.306 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -103.62 8.98 37.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 24.78 109.711 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.437 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 37.2 mt-30 -138.99 138.68 37.47 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.286 -0.884 . . . . 47.9 109.638 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.638 ' CD2' ' CD1' ' B' ' 49' ' ' LEU . 36.1 p90 -91.92 161.32 14.87 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.176 -0.952 . . . . 21.61 108.815 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 96.7 m -130.28 152.05 50.12 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.103 -0.998 . . . . 14.89 109.667 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.463 0 O-C-N 121.395 -0.816 . . . . 17.35 109.354 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.522 0.677 . . . . 24.0 110.475 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.617 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 97.9 m-20 -77.95 130.01 36.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 23.31 109.141 179.559 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -123.58 148.95 45.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 40.03 109.047 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -136.24 -170.14 2.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.111 -0.993 . . . . 12.39 109.648 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.532 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 5.9 mp -132.19 174.35 10.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.38 -0.825 . . . . 17.42 109.455 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -162.53 159.58 24.99 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.273 -1.01 . . . . 13.84 108.273 -179.547 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.691 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 14.9 m-85 -115.06 96.52 5.73 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.204 -0.935 . . . . 21.14 109.358 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.508 ' O ' ' CG2' ' B' ' 43' ' ' VAL . 3.1 t -105.09 127.62 59.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.163 -0.961 . . . . 10.66 110.491 -179.495 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 16.7 p-10 -86.52 -27.43 24.01 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.512 -0.922 . . . . 25.89 108.512 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.508 ' HG ' ' CG1' ' B' ' 35' ' ' VAL . 0.4 OUTLIER 47.3 23.93 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 24.24 109.486 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.83 8.47 69.6 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.961 -1.256 . . . . 31.02 109.961 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.447 ' CG ' ' O ' ' B' ' 36' ' ' ASP . 2.1 m-20 -87.23 18.62 3.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -1.219 . . . . 43.23 109.942 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.6 ' O ' ' CB ' ' B' ' 41' ' ' HIS . 5.3 mt-10 46.76 71.37 0.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.89 . . . . 42.34 109.822 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.6 ' CB ' ' O ' ' B' ' 40' ' ' GLU . 0.2 OUTLIER 144.09 147.77 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.251 0 N-CA-C 108.57 -0.9 . . . . 7.67 108.57 179.383 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.691 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 38.4 Cg_endo -79.38 137.37 13.18 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.148 1.899 . . . . 17.92 110.52 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 2.8 m -114.53 118.54 58.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.331 -0.856 . . . . 20.57 108.871 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 56.8 tp -76.45 106.98 8.4 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.361 -0.837 . . . . 20.21 110.638 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.565 ' CG1' ' CG1' ' A' ' 70' ' ' VAL . 22.0 m -115.65 -169.55 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.862 -0.792 . . . . 10.81 108.862 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -108.22 151.8 25.44 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.334 -0.947 . . . . 36.74 110.44 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.643 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -141.23 126.14 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.503 -0.748 . . . . 19.74 109.056 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -64.49 146.88 53.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.002 -1.061 . . . . 22.56 109.322 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.638 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 2.9 tm? -123.95 73.1 1.19 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 20.41 109.281 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' B' ' 53' ' ' GLN . 1.9 t70 -134.86 -175.46 3.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.941 -1.099 . . . . 33.99 109.8 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' B' ' 53' ' ' GLN . 16.5 tt0 69.84 67.73 0.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.348 -0.845 . . . . 54.92 109.588 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' B' ' 51' ' ' GLU . . . 38.07 28.04 0.04 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.537 -1.025 . . . . 36.1 110.537 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' B' ' 51' ' ' GLU . 3.3 mt-30 -106.13 125.71 32.38 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.888 -1.36 . . . . 54.76 109.894 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.454 ' C ' HD22 ' B' ' 49' ' ' LEU . 35.4 Cg_endo -78.8 146.62 21.03 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.408 2.072 . . . . 28.37 109.68 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.504 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -38.24 143.37 0.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.45 -0.781 . . . . 17.21 110.479 -179.291 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.643 ' CE1' HG12 ' B' ' 47' ' ' ILE . 79.9 m-85 -58.49 106.99 0.44 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.458 -0.776 . . . . 17.19 109.201 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.451 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -57.58 173.29 0.37 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.105 -0.997 . . . . 17.82 109.076 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' B' ' 6' ' ' ILE . 35.5 Cg_endo -78.05 107.12 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.491 2.127 . . . . 17.28 110.031 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.15 179.26 46.52 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.576 -1.297 . . . . 17.22 110.106 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -77.42 137.4 38.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.405 -1.056 . . . . 19.57 108.445 179.121 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.594 ' CB ' HG12 ' B' ' 4' ' ' VAL . 26.9 m-85 -128.38 163.09 25.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.691 -1.255 . . . . 14.61 111.492 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' B' ' 2' ' ' ILE . 43.8 p -141.57 118.01 10.86 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.145 -1.798 . . . . 18.36 106.145 177.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -50.64 165.16 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 118.74 -1.184 . . . . 19.13 108.947 -178.171 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -128.51 129.15 45.64 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.5 -0.75 . . . . 20.65 109.142 -179.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.647 ' CB ' ' CD2' ' B' ' 68' ' ' PHE . 0.8 OUTLIER -72.57 2.24 6.77 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.54 -0.725 . . . . 19.65 109.964 179.777 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.21 -19.51 34.16 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.843 -1.539 . . . . 14.72 106.843 178.386 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.483 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 14.4 m -95.68 -9.49 31.84 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.931 -0.481 . . . . 11.45 110.027 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.647 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.4 m-30 -78.06 154.18 31.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.037 . . . . 14.25 109.897 -178.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -157.53 -178.93 7.7 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.538 -0.726 . . . . 32.7 109.159 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.558 ' CG1' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -109.44 105.98 19.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.456 -0.778 . . . . 15.63 109.09 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.26 -154.37 11.43 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.981 -1.248 . . . . 12.7 109.981 -179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.491 ' NE2' ' HA ' ' B' ' 72' ' ' GLN . 12.5 tp60 -99.08 42.22 1.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -1.09 . . . . 26.29 109.661 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -128.91 21.95 5.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.895 . . . . 20.44 109.613 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.98 52.74 7.81 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.563 -1.415 . . . . 13.82 109.563 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.422 ' O ' ' C ' ' B' ' 76' ' ' LEU . 17.0 t -176.99 129.93 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 18.27 109.435 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.508 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.1 OUTLIER -43.79 159.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.877 . . . . 12.43 109.138 179.976 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.5 mtt -163.38 118.99 1.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 35.11 109.54 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.616 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.2 mp -54.38 138.5 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.193 -0.942 . . . . 13.67 109.354 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' B' ' 67' ' ' SER . 0.2 OUTLIER -106.13 -34.73 7.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.111 -1.07 . . . . 24.06 108.111 178.515 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.483 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.2 OUTLIER -170.21 66.56 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.275 -1.38 . . . . 35.04 107.275 178.816 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.616 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.7 OUTLIER -27.62 120.04 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.113 -0.949 . . . . 18.72 111.731 -178.161 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -91.78 101.95 14.55 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 20.55 108.53 179.097 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.602 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -70.27 140.67 52.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 14.4 110.84 -178.727 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' B' ' 62' ' ' THR . 33.6 m -140.41 148.79 55.16 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.843 -1.169 . . . . 17.65 107.843 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.0 Cg_endo -63.06 141.11 82.22 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.995 1.797 . . . . 25.7 110.326 179.338 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' B' ' 60' ' ' LEU . . . -71.53 108.27 4.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 49.29 109.466 -178.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.035 -0.983 . . . . 58.91 109.489 179.999 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.1 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.579 -0.526 . . . . 64.91 109.579 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.524 ' CG2' HG22 ' A' ' 63' ' ' VAL . 3.3 mt -64.16 78.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.592 -1.262 . . . . 33.8 107.592 178.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -71.0 177.23 3.82 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.104 0.954 . . . . 32.72 111.549 -177.771 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.588 ' CG1' ' CB ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER 176.35 163.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.739 -0.837 . . . . 14.46 108.739 179.753 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.524 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 26.1 mt-10 -137.96 108.36 6.51 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.63 0.728 . . . . 22.12 109.093 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.596 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -71.94 100.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 C-N-CA 118.906 -1.118 . . . . 14.23 108.07 179.615 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.581 ' HE2' ' CE2' ' A' ' 34' ' ' TYR . 6.7 mptt -44.67 170.17 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.343 -0.848 . . . . 25.43 109.902 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 32.1 Cg_endo -73.67 -27.48 12.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.275 1.984 . . . . 13.61 109.78 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 p -86.35 -2.92 58.84 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.613 -0.884 . . . . 15.52 108.613 178.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.7 mm-40 -118.75 41.29 3.05 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.429 -0.794 . . . . 17.31 109.119 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.426 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -104.88 14.72 29.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.076 -1.015 . . . . 24.78 109.999 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 29.6 mt-30 -142.24 146.59 35.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.165 -0.959 . . . . 47.9 109.68 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.598 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 34.9 p90 -93.84 159.42 15.2 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.296 -0.878 . . . . 21.61 109.537 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 t -134.76 162.67 31.7 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.449 -0.945 . . . . 14.89 108.449 178.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.608 0 O-C-N 121.217 -0.927 . . . . 17.35 109.162 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.368 0.604 . . . . 24.0 110.1 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.589 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 99.1 m-20 -59.16 130.53 47.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.821 . . . . 23.31 109.48 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -121.27 152.49 38.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.944 . . . . 40.03 108.949 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.539 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -133.13 -170.93 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 12.39 109.789 -179.634 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 2.1 mp -130.49 174.83 9.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 17.42 108.872 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -171.85 162.88 6.22 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 13.84 108.699 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.652 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 3.0 m-30 -114.87 90.22 3.29 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.226 -0.921 . . . . 21.14 108.817 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.532 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 94.0 t -89.94 119.77 37.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.197 -0.939 . . . . 10.66 110.32 -179.234 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 48.7 m-20 -68.48 -30.96 69.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.509 -0.923 . . . . 25.89 108.509 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.461 HD21 ' OD1' ' A' ' 39' ' ' ASN . 1.0 OUTLIER 48.17 30.98 2.35 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.503 -0.748 . . . . 24.24 109.318 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.31 9.69 64.66 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.391 -1.484 . . . . 31.02 109.391 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' OD1' HD21 ' A' ' 37' ' ' LEU . 1.4 m-20 -81.95 14.01 3.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -1.168 . . . . 43.23 110.659 -179.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.58 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 10.0 mt-10 57.23 15.61 2.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.131 -0.981 . . . . 42.34 110.093 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 63.3 m80 -164.74 149.4 8.17 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.683 -1.228 . . . . 6.32 107.683 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.643 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.1 Cg_endo -74.81 146.19 33.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.653 1.569 . . . . 17.92 110.631 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 12.5 m -123.5 116.2 47.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 119.531 -0.868 . . . . 20.57 108.78 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.652 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 21.9 tp -68.92 104.98 2.22 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.296 -0.962 . . . . 20.21 108.678 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 74' ' ' GLY . 9.1 p -120.0 163.09 17.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.587 -0.695 . . . . 10.81 109.275 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' B' ' 74' ' ' GLY . 0.0 OUTLIER -82.47 157.64 23.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 36.74 110.28 -179.055 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.623 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -138.7 176.38 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.282 -1.007 . . . . 19.74 108.282 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.92 144.23 42.84 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.042 -1.036 . . . . 22.56 109.38 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 2.9 tm? -128.57 122.61 31.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.29 -0.881 . . . . 20.41 109.037 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -53.51 159.44 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 33.99 109.999 -179.279 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -70.05 108.96 4.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.403 -0.81 . . . . 54.92 109.497 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.79 -13.5 67.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.561 -1.416 . . . . 36.1 109.561 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -67.07 157.03 86.3 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.227 -1.161 . . . . 54.76 109.536 179.98 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -78.35 106.69 2.18 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.564 2.176 . . . . 28.37 110.254 179.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.495 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -41.95 160.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.386 -0.821 . . . . 17.21 110.028 -179.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.623 ' CE1' HG12 ' A' ' 47' ' ' ILE . 75.5 m-85 -58.4 104.98 0.25 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.406 -0.809 . . . . 17.19 108.838 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.521 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -57.44 176.14 0.24 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 17.82 109.418 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.0 Cg_endo -77.79 120.06 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.532 2.154 . . . . 17.28 110.166 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.66 177.42 39.06 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.779 -1.328 . . . . 17.22 109.779 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -72.04 149.37 44.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -1.187 . . . . 19.57 108.269 179.139 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 6' ' ' ILE . 22.2 m-85 -133.34 163.36 29.51 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.77 -1.206 . . . . 14.61 111.705 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 34.2 p -147.93 120.08 8.31 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.456 -1.683 . . . . 18.36 106.456 178.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.609 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 5.7 t -51.82 170.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 C-N-CA 118.672 -1.211 . . . . 19.13 108.955 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.477 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.9 t-80 -134.67 125.93 28.08 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.421 -0.799 . . . . 20.65 109.187 -179.237 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.661 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -72.27 1.08 8.31 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.27 -0.894 . . . . 19.65 109.802 179.724 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.3 p -57.64 -19.17 24.55 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.521 -1.289 . . . . 14.72 107.521 178.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 9.7 m -96.76 -18.57 19.53 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.772 -0.58 . . . . 11.45 110.128 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.661 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.6 m-30 -66.29 158.48 28.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 14.25 109.346 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 0.0 OUTLIER -140.46 178.89 7.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 32.7 109.769 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.463 HG22 HG23 ' B' ' 43' ' ' VAL . 1.7 t -126.12 129.77 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.509 -0.744 . . . . 15.63 109.495 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.21 -170.67 25.33 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.677 -1.369 . . . . 12.7 109.677 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' CB ' ' A' ' 73' ' ' PHE . 25.9 tp60 69.5 80.76 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -1.148 . . . . 26.29 109.358 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.504 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 3.0 m-85 75.34 12.03 3.32 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.424 -0.798 . . . . 20.44 109.462 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' B' ' 46' ' ' LYS . . . 70.77 47.77 38.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.558 -1.417 . . . . 13.82 109.558 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -144.03 144.48 31.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -1.168 . . . . 18.27 109.639 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 77' ' ' MET . 1.0 OUTLIER -50.73 169.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 12.43 109.187 179.776 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 2.3 mtp -165.52 106.01 0.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 35.11 110.25 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.573 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -42.43 -63.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.513 -0.742 . . . . 13.67 109.403 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 9.5 t70 83.34 -45.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.392 0.615 . . . . 24.06 110.039 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.7 tpm_? -174.24 66.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.113 0.958 . . . . 35.04 108.632 179.646 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.609 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.5 pt? -36.07 128.81 0.7 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.668 0.747 . . . . 18.72 111.527 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -94.52 104.67 16.62 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.248 -1.019 . . . . 20.55 108.248 178.721 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.617 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -74.23 147.26 42.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 14.4 110.898 -178.761 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 62' ' ' THR . 32.5 m -148.37 155.85 42.59 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.09 -1.078 . . . . 17.65 108.09 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.8 Cg_endo -63.08 143.6 90.85 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.105 1.87 . . . . 25.7 110.322 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.457 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -69.81 125.43 26.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.228 -0.92 . . . . 49.29 109.702 -178.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.2 tptp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.004 -0.998 . . . . 58.91 109.512 -179.965 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.532 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.564 -0.532 . . . . 64.91 109.564 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' B' ' 63' ' ' VAL . 3.3 mt -64.2 78.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 33.8 107.657 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.9 OUTLIER -70.82 177.3 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.07 0.938 . . . . 32.72 111.542 -177.754 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.592 ' CG1' ' CB ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER 176.29 163.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.714 -0.847 . . . . 14.46 108.714 179.743 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 26.0 mt-10 -137.82 108.38 6.57 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.605 0.716 . . . . 22.12 109.103 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.58 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -71.94 100.18 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.95 -1.1 . . . . 14.23 108.075 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.58 ' HD3' ' CG ' ' B' ' 34' ' ' TYR . 6.7 mptt -44.75 170.05 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.33 -0.856 . . . . 25.43 109.898 -179.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.9 Cg_endo -73.59 -27.5 12.83 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.365 2.043 . . . . 13.61 109.722 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.2 p -86.39 -2.74 58.69 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.664 -0.865 . . . . 15.52 108.664 178.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.7 mm-40 -118.9 41.26 3.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.399 -0.813 . . . . 17.31 109.095 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.439 ' HB3' ' HD3' ' B' ' 58' ' ' PRO . . . -104.9 14.84 28.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.123 -0.986 . . . . 24.78 109.986 -179.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' B' ' 31' ' ' GLN . 29.7 mt-30 -142.35 146.48 35.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 47.9 109.742 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.594 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 34.5 p90 -93.79 159.32 15.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.338 -0.851 . . . . 21.61 109.615 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.3 t -134.78 162.49 32.21 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.496 -0.928 . . . . 14.89 108.496 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.298 -1.633 0 O-C-N 121.166 -0.958 . . . . 17.35 109.18 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.384 0.612 . . . . 24.0 110.146 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.588 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 99.1 m-20 -59.06 130.58 47.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 23.31 109.439 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -121.34 152.41 39.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.948 . . . . 40.03 109.002 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.548 ' CB ' HG21 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -133.08 -170.8 2.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.09 -1.006 . . . . 12.39 109.84 -179.612 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 2.1 mp -130.61 174.76 9.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.834 -0.802 . . . . 17.42 108.834 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -171.91 162.67 6.09 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.877 -1.14 . . . . 13.84 108.725 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.646 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 3.0 m-30 -114.66 90.33 3.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.212 -0.93 . . . . 21.14 108.824 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 96.0 t -90.06 119.73 37.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.181 -0.949 . . . . 10.66 110.238 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 48.7 m-20 -68.36 -31.01 70.1 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.51 -0.922 . . . . 25.89 108.51 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.469 HD21 ' OD1' ' B' ' 39' ' ' ASN . 1.0 OUTLIER 48.27 31.03 2.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.548 -0.72 . . . . 24.24 109.252 179.804 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.28 9.52 64.28 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.438 -1.465 . . . . 31.02 109.438 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.469 ' OD1' HD21 ' B' ' 37' ' ' LEU . 1.4 m-20 -81.77 13.87 2.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -1.162 . . . . 43.23 110.726 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.574 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 10.0 mt-10 57.32 15.62 2.7 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.124 -0.985 . . . . 42.34 110.115 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 63.5 m80 -164.73 149.41 8.19 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 107.745 -1.206 . . . . 6.31 107.745 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.646 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.3 Cg_endo -74.83 146.15 33.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.648 1.565 . . . . 17.92 110.628 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' B' ' 35' ' ' VAL . 12.6 m -123.47 116.25 47.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 C-N-CA 119.495 -0.882 . . . . 20.57 108.816 179.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.635 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 21.8 tp -68.87 105.1 2.24 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.341 -0.943 . . . . 20.21 108.655 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 74' ' ' GLY . 9.1 p -120.15 163.08 18.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.534 -0.729 . . . . 10.81 109.228 -179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -82.55 157.59 23.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.394 -0.816 . . . . 36.74 110.328 -179.114 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.617 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -138.59 176.35 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.227 -1.027 . . . . 19.74 108.227 179.447 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 144.42 42.46 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.006 -1.059 . . . . 22.56 109.405 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 2.9 tm? -128.68 122.4 30.68 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.317 -0.865 . . . . 20.41 109.067 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 0.1 OUTLIER -53.38 159.34 1.43 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 33.99 110.033 -179.324 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -69.95 108.95 4.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.481 -0.762 . . . . 54.92 109.487 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.81 -13.57 67.16 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.563 -1.415 . . . . 36.1 109.563 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.492 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -67.03 157.18 85.71 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.218 -1.166 . . . . 54.76 109.487 179.962 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.0 Cg_endo -78.39 106.67 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.624 2.216 . . . . 28.37 110.257 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -42.0 160.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 17.21 109.976 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.617 ' CE1' HG12 ' B' ' 47' ' ' ILE . 75.2 m-85 -58.92 105.56 0.33 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.347 -0.846 . . . . 17.19 108.805 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.523 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -57.65 176.09 0.25 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.309 -0.869 . . . . 17.82 109.275 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.3 Cg_endo -78.03 121.12 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.637 2.225 . . . . 17.28 110.445 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.94 177.88 38.41 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.657 -1.377 . . . . 17.22 109.657 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.3 OUTLIER -71.73 150.0 44.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -1.182 . . . . 19.57 108.555 179.387 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.592 ' CB ' ' CG1' ' B' ' 4' ' ' VAL . 21.1 m-85 -134.02 163.31 29.85 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 120.763 -1.211 . . . . 14.61 111.702 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' B' ' 2' ' ' ILE . 33.9 p -147.98 120.25 8.38 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.445 -1.687 . . . . 18.36 106.445 178.402 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 5.9 t -52.04 169.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 118.631 -1.228 . . . . 19.13 108.965 -178.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.477 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -134.43 125.86 28.34 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.453 -0.779 . . . . 20.65 109.224 -179.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.648 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.7 OUTLIER -72.16 0.8 8.77 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.272 -0.893 . . . . 19.65 109.755 179.791 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 94.8 p -57.34 -19.24 21.39 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 107.53 -1.285 . . . . 14.72 107.53 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 10.3 m -96.69 -18.64 19.54 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.843 -0.536 . . . . 11.45 110.143 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.648 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.6 m-30 -66.26 157.89 30.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.004 . . . . 14.25 109.331 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.442 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.94 178.91 6.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 32.7 109.837 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.462 HG22 HG23 ' A' ' 43' ' ' VAL . 1.7 t -126.06 129.78 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.759 . . . . 15.63 109.535 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' B' ' 72' ' ' GLN . . . 143.19 -170.69 25.31 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.69 -1.364 . . . . 12.7 109.69 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.5 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 25.9 tp60 69.47 80.83 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -1.159 . . . . 26.29 109.341 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.5 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 3.0 m-85 75.33 11.9 3.35 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.443 -0.785 . . . . 20.44 109.49 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 45' ' ' VAL . . . 70.91 47.7 37.58 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.502 -1.439 . . . . 13.82 109.502 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -144.06 144.41 31.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -1.146 . . . . 18.27 109.635 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' B' ' 77' ' ' MET . 1.0 OUTLIER -50.66 169.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 12.43 109.151 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 2.3 mtp -165.58 105.95 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 35.11 110.303 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.8 mt -42.35 -64.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.568 -0.708 . . . . 13.67 109.416 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 9.4 t70 83.51 -45.16 0.11 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.4 0.619 . . . . 24.06 110.073 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.7 tpm_? -174.32 66.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.505 -0.924 . . . . 35.04 108.505 179.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.616 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.5 pt? -36.17 128.81 0.72 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.703 0.763 . . . . 18.72 111.545 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -94.5 104.44 16.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.29 -1.004 . . . . 20.55 108.29 178.791 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.611 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -73.98 147.39 43.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.189 -0.944 . . . . 14.4 110.842 -178.753 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.437 ' C ' ' CD2' ' B' ' 61' ' ' TYR . 32.6 m -148.66 155.64 41.58 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.046 -1.094 . . . . 17.65 108.046 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.9 Cg_endo -62.89 143.8 92.16 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.076 1.851 . . . . 25.7 110.328 179.074 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.462 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -69.96 125.63 27.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -0.907 . . . . 49.29 109.724 -178.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 7.2 tptp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.978 -1.01 . . . . 58.91 109.571 179.979 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.435 ' C ' HG13 ' A' ' 2' ' ' ILE . 2.8 ttm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.444 -0.576 . . . . 64.91 109.444 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.542 ' CG2' HG22 ' A' ' 63' ' ' VAL . 3.2 mt 69.66 64.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.705 -1.22 . . . . 33.8 107.705 -178.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 26.6 mttt -54.93 162.11 1.39 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.777 0.799 . . . . 32.72 111.28 -178.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.593 ' HB ' ' CB ' ' A' ' 61' ' ' TYR . 58.6 t -160.2 167.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.534 0.683 . . . . 14.46 109.53 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.509 ' N ' HG13 ' A' ' 4' ' ' VAL . 46.8 mt-10 -152.34 106.07 3.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.544 -0.722 . . . . 22.12 109.201 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.572 HD12 ' CE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -74.64 101.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.104 -1.073 . . . . 14.23 108.104 179.505 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.615 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.78 171.22 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.403 -0.81 . . . . 25.43 109.831 -179.324 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.4 Cg_endo -74.95 -28.45 9.26 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.463 2.109 . . . . 13.61 110.131 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.7 m -92.96 4.11 54.55 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.478 -0.764 . . . . 15.52 109.127 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.535 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 18.4 mm-40 -121.03 34.1 5.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 17.31 109.352 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -106.89 18.55 21.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 24.78 110.284 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.408 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 19.2 mt-30 -137.57 129.39 28.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.067 -1.02 . . . . 47.9 109.864 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.555 ' CD2' ' CB ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.54 -174.32 3.32 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.425 -0.797 . . . . 21.61 110.578 -179.541 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.407 HG21 ' N ' ' A' ' 15' ' ' THR . 56.2 m -158.68 145.41 17.31 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.777 -0.823 . . . . 14.89 108.777 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.407 ' N ' HG21 ' A' ' 14' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.534 0 O-C-N 121.244 -0.91 . . . . 17.35 109.625 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.501 0.667 . . . . 24.0 110.096 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.555 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -74.5 111.19 9.44 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.725 -0.843 . . . . 23.31 108.725 179.602 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 14.9 mm-40 -82.63 -172.77 4.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.035 -1.04 . . . . 40.03 109.015 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -171.18 179.92 2.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.073 -1.017 . . . . 12.39 110.249 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.465 ' O ' ' OE1' ' A' ' 31' ' ' GLN . 1.4 mt -140.5 148.56 41.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.579 -0.701 . . . . 17.42 109.174 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.4 m -152.04 -178.55 6.83 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.918 -1.141 . . . . 13.84 107.918 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.659 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 38.0 m-85 -128.01 106.21 8.93 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.053 -1.03 . . . . 21.14 109.395 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.536 ' CG2' HG21 ' A' ' 4' ' ' VAL . 73.8 t -98.1 141.3 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.072 -1.017 . . . . 10.66 111.168 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' N ' HG11 ' A' ' 35' ' ' VAL . 4.1 m-20 -111.15 35.72 3.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.008 -1.108 . . . . 25.89 108.008 178.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.568 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.0 pt? -40.94 -25.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.658 -0.651 . . . . 24.24 110.266 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 39' ' ' ASN . . . 176.8 47.33 0.06 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 108.983 -1.647 . . . . 31.02 108.983 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' O ' ' C ' ' A' ' 40' ' ' GLU . 74.3 m-20 -149.55 109.66 4.13 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.481 -1.011 . . . . 43.23 108.751 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 39' ' ' ASN . 26.0 mt-10 -34.24 -56.84 0.5 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.64 0.733 . . . . 42.34 110.128 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' ASN . 50.9 m-70 -73.41 160.37 82.59 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 108.662 -0.866 . . . . 6.58 108.662 179.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.659 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.3 Cg_endo -77.43 140.47 19.28 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.054 1.836 . . . . 17.92 109.87 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 3.2 m -108.58 114.27 46.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.198 -0.939 . . . . 20.57 109.532 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.603 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 54.8 tp -68.01 106.94 2.51 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.388 -0.82 . . . . 20.21 109.623 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 2.1 t -110.44 169.28 3.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.48 -0.762 . . . . 10.81 109.03 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.576 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -92.93 162.89 13.89 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.33 -0.857 . . . . 36.74 110.394 -179.264 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.567 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -138.42 165.11 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.634 -0.876 . . . . 19.74 108.634 179.698 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 48' ' ' THR . 9.0 m -124.7 71.59 1.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 22.56 109.278 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -40.4 137.04 1.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.508 -0.745 . . . . 20.41 109.674 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -78.02 165.4 24.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 33.99 109.367 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.41 114.8 10.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 54.92 109.495 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.77 -6.32 64.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.685 -1.366 . . . . 36.1 109.685 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.43 ' O ' HD13 ' A' ' 49' ' ' LEU . 1.1 mt-30 -89.06 144.45 32.7 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.128 -1.219 . . . . 54.76 109.522 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.5 Cg_endo -78.54 123.95 6.17 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.642 2.228 . . . . 28.37 110.332 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.516 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -40.41 142.74 0.38 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 17.21 110.54 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 12.0 m-30 -45.98 104.39 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 17.19 109.153 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.35 168.64 0.36 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.992 -1.067 . . . . 17.82 109.185 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HA ' HG23 ' A' ' 6' ' ' ILE . 34.4 Cg_endo -76.98 113.39 3.62 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.52 2.147 . . . . 17.28 110.193 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.19 -176.56 48.08 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.923 -1.271 . . . . 17.22 109.923 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -75.81 139.25 41.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -1.09 . . . . 19.57 108.406 179.121 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.593 ' CB ' ' HB ' ' A' ' 4' ' ' VAL . 19.0 m-85 -127.83 166.11 18.86 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.725 -1.234 . . . . 14.61 111.456 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.427 HG21 ' C ' ' A' ' 61' ' ' TYR . 44.5 p -149.94 120.28 7.35 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.46 -1.681 . . . . 18.36 106.46 179.008 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -50.45 166.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 118.738 -1.185 . . . . 19.13 108.886 -178.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -125.23 123.98 40.72 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.865 -0.791 . . . . 20.65 108.865 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.621 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -69.47 -3.28 13.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.636 -0.665 . . . . 19.65 110.113 -179.187 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 t -58.83 -13.89 7.41 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.068 -1.02 . . . . 14.72 108.409 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 19.6 m -95.61 -7.72 36.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.755 . . . . 11.45 110.709 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 2.1 m-30 -81.25 159.16 24.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.899 -1.125 . . . . 14.25 109.882 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' N ' HD13 ' B' ' 37' ' ' LEU . 12.0 mtmt -153.03 173.84 14.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.485 -0.76 . . . . 32.7 108.997 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.559 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.6 OUTLIER -110.68 118.08 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 15.63 109.53 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.19 -176.15 48.94 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.294 -1.523 . . . . 12.7 109.294 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.0 19.86 3.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.09 -1.241 . . . . 26.29 109.77 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 -11.39 23.5 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.511 -0.743 . . . . 20.44 109.561 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' ' OG ' ' A' ' 75' ' ' SER . . . 84.48 50.27 4.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.712 -1.355 . . . . 13.82 109.712 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -170.69 153.88 4.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -1.161 . . . . 18.27 109.553 179.933 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.481 ' C ' ' CG ' ' A' ' 77' ' ' MET . 10.6 tt -81.16 150.52 28.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 12.43 109.476 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.481 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 2.2 mtt -155.78 129.19 8.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 35.11 109.355 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.632 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.1 mt -63.18 139.44 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 13.67 109.841 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 6.9 t0 -104.4 -18.48 14.4 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.257 -1.016 . . . . 24.06 108.257 178.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.4 tmm_? 172.23 71.69 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.863 -1.532 . . . . 35.04 106.863 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.585 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -34.0 119.21 0.39 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.607 0.718 . . . . 18.72 111.199 -178.05 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 64' ' ' HIS . 5.9 mtt180 -88.75 110.07 20.69 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.466 -0.939 . . . . 20.55 108.466 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.59 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -81.13 141.63 34.06 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.187 -0.946 . . . . 14.4 110.49 -179.112 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 25.9 m -145.28 159.08 50.09 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.193 -1.04 . . . . 17.65 108.193 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.08 141.61 77.34 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.124 1.882 . . . . 25.7 110.206 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.407 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -67.68 122.44 18.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.096 -1.003 . . . . 49.29 109.521 -178.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.961 -1.019 . . . . 58.91 109.469 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.426 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 2.8 ttm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.446 -0.576 . . . . 64.91 109.446 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.538 ' CG2' HG22 ' B' ' 63' ' ' VAL . 3.2 mt 69.54 64.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.759 -1.2 . . . . 33.8 107.759 -178.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.534 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 26.7 mttt -54.87 162.16 1.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.823 0.821 . . . . 32.72 111.269 -178.148 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.589 ' HB ' ' CB ' ' B' ' 61' ' ' TYR . 58.9 t -160.19 167.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.5 0.667 . . . . 14.46 109.601 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.519 ' N ' HG13 ' B' ' 4' ' ' VAL . 46.4 mt-10 -152.26 106.2 3.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.613 0.721 . . . . 22.12 109.088 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.569 HD12 ' CE1' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -74.69 101.06 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.141 -1.059 . . . . 14.23 108.141 179.43 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.609 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.73 171.16 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.445 -0.785 . . . . 25.43 109.827 -179.323 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.4 Cg_endo -75.03 -28.28 9.25 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.407 2.071 . . . . 13.61 110.179 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 12.8 m -93.03 4.21 54.4 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.508 -0.745 . . . . 15.52 109.122 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 18.4 mm-40 -121.15 34.0 5.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.258 -0.901 . . . . 17.31 109.36 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -106.85 18.68 21.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 24.78 110.282 -179.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.412 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 19.1 mt-30 -137.56 129.51 28.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.057 -1.027 . . . . 47.9 109.825 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -77.62 -174.45 3.42 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.395 -0.815 . . . . 21.61 110.529 -179.563 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.411 HG21 ' N ' ' B' ' 15' ' ' THR . 55.9 m -158.6 145.44 17.43 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.764 -0.828 . . . . 14.89 108.764 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 15' ' ' THR . . . . . 0.411 ' N ' HG21 ' B' ' 14' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.503 0 O-C-N 121.262 -0.899 . . . . 17.35 109.561 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.456 HD21 ' O ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.493 0.663 . . . . 24.0 110.114 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.538 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -74.52 111.14 9.41 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.736 -0.838 . . . . 23.31 108.736 179.548 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 14.8 mm-40 -82.66 -172.74 4.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.035 -1.04 . . . . 40.03 108.97 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.532 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -171.21 179.96 2.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.081 -1.012 . . . . 12.39 110.3 179.848 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.478 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.4 mt -140.58 148.56 41.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.538 -0.726 . . . . 17.42 109.176 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.4 m -151.96 -178.35 6.7 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.868 -1.16 . . . . 13.84 107.868 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.655 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 37.5 m-85 -128.22 106.28 8.93 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.09 -1.006 . . . . 21.14 109.3 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' B' ' 4' ' ' VAL . 73.8 t -98.14 141.27 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.127 -0.983 . . . . 10.66 111.168 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.499 ' N ' HG11 ' B' ' 35' ' ' VAL . 4.1 m-20 -111.11 35.69 3.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.031 -1.1 . . . . 25.89 108.031 178.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' B' ' 37' ' ' LEU . 2.0 pt? -40.99 -25.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.647 -0.658 . . . . 24.24 110.271 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 176.71 47.47 0.06 OUTLIER Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.002 -1.639 . . . . 31.02 109.002 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.489 ' O ' ' C ' ' B' ' 40' ' ' GLU . 74.5 m-20 -149.64 109.67 4.12 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.502 -0.999 . . . . 43.23 108.757 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' B' ' 39' ' ' ASN . 26.1 mt-10 -34.21 -56.86 0.5 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.692 0.758 . . . . 42.34 110.159 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.468 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 51.0 m-70 -73.41 160.48 82.35 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 108.693 -0.855 . . . . 6.56 108.693 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.655 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.5 Cg_endo -77.46 140.34 19.11 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.098 1.865 . . . . 17.92 109.837 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 3.2 m -108.48 114.32 46.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.168 -0.957 . . . . 20.57 109.572 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.597 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 54.8 tp -68.07 106.99 2.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.428 -0.795 . . . . 20.21 109.534 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 2.1 t -110.46 169.25 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 10.81 109.038 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.574 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -92.85 162.98 13.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.314 -0.866 . . . . 36.74 110.378 -179.291 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.563 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -138.49 165.1 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.579 -0.897 . . . . 19.74 108.579 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' B' ' 48' ' ' THR . 9.5 m -124.73 71.6 1.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.223 -0.923 . . . . 22.56 109.366 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -40.36 136.97 1.15 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.559 -0.713 . . . . 20.41 109.709 179.93 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.45 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.4 OUTLIER -77.98 165.49 24.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 33.99 109.324 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.47 114.85 11.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 54.92 109.528 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.75 -6.45 64.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.665 -1.374 . . . . 36.1 109.665 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.428 ' O ' HD13 ' B' ' 49' ' ' LEU . 1.1 mt-30 -88.99 144.46 32.82 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.148 -1.207 . . . . 54.76 109.53 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.6 Cg_endo -78.54 123.87 6.14 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.62 2.213 . . . . 28.37 110.343 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.526 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -40.46 142.76 0.38 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.361 -0.837 . . . . 17.21 110.467 -179.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 12.2 m-30 -46.16 104.51 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 17.19 109.246 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.22 168.6 0.35 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.99 -1.069 . . . . 17.82 109.084 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.486 ' HA ' HG23 ' B' ' 6' ' ' ILE . 34.8 Cg_endo -77.19 114.55 3.8 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.603 2.202 . . . . 17.28 110.458 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.12 47.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.8 -1.32 . . . . 17.22 109.8 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -75.45 139.59 42.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -1.079 . . . . 19.57 108.692 179.45 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.589 ' CB ' ' HB ' ' B' ' 4' ' ' VAL . 18.1 m-85 -128.25 166.04 19.34 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.765 -1.21 . . . . 14.61 111.437 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.444 ' N ' ' O ' ' B' ' 84' ' ' VAL . 44.4 p -150.0 120.46 7.41 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.432 -1.692 . . . . 18.36 106.432 179.007 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.588 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -50.61 166.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 C-N-CA 118.741 -1.183 . . . . 19.13 108.908 -178.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -125.19 124.12 41.06 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.411 -0.806 . . . . 20.65 108.863 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.624 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -69.61 -3.2 13.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.676 -0.64 . . . . 19.65 110.084 -179.166 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.7 t -58.91 -13.86 7.51 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.069 -1.019 . . . . 14.72 108.329 179.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 19.7 m -95.62 -7.86 36.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.756 . . . . 11.45 110.724 -179.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' B' ' 68' ' ' PHE . 2.1 m-30 -81.15 159.2 24.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.859 -1.151 . . . . 14.25 109.795 -179.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.468 ' CA ' HD13 ' A' ' 37' ' ' LEU . 12.0 mtmt -153.04 173.91 14.85 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.977 -0.749 . . . . 32.7 108.977 179.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.566 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -110.66 118.2 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 15.63 109.51 179.935 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.32 -176.22 48.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.337 -1.505 . . . . 12.7 109.337 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.93 19.87 3.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.109 -1.23 . . . . 26.29 109.793 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -11.23 23.54 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.529 -0.732 . . . . 20.44 109.573 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.414 ' C ' ' OG ' ' B' ' 75' ' ' SER . . . 84.32 50.46 4.28 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.73 -1.348 . . . . 13.82 109.73 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' B' ' 74' ' ' GLY . 0.9 OUTLIER -170.88 153.91 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -1.178 . . . . 18.27 109.614 179.889 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.484 ' C ' ' CG ' ' B' ' 77' ' ' MET . 10.6 tt -81.23 150.58 28.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 12.43 109.469 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.484 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 2.2 mtt -155.88 129.14 8.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 35.11 109.402 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.624 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.1 mt -63.11 139.51 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 13.67 109.827 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 6.9 t0 -104.5 -18.45 14.36 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.233 -1.025 . . . . 24.06 108.233 178.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.4 tmm_? 172.25 71.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.893 -1.521 . . . . 35.04 106.893 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.588 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -33.98 119.11 0.39 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.643 0.735 . . . . 18.72 111.136 -178.005 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' B' ' 64' ' ' HIS . 5.9 mtt180 -88.67 110.03 20.62 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.498 -0.927 . . . . 20.55 108.498 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.597 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -81.02 141.83 33.99 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.116 -0.99 . . . . 14.4 110.415 -179.069 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' B' ' 62' ' ' THR . 25.4 m -145.59 158.86 49.46 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.185 -1.043 . . . . 17.65 108.185 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -63.93 141.57 78.16 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.078 1.852 . . . . 25.7 110.27 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.401 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -67.63 122.52 18.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.123 -0.986 . . . . 49.29 109.541 -178.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.972 -1.013 . . . . 58.91 109.498 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.358 0.599 . . . . 64.91 109.393 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 63' ' ' VAL . 4.3 mt 75.24 83.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.662 -1.236 . . . . 33.8 107.662 -179.086 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -80.55 173.16 12.88 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.133 0.968 . . . . 32.72 111.927 -177.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER 179.77 168.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.775 -0.824 . . . . 14.46 108.775 -179.778 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 35.9 mt-10 -141.71 112.67 7.34 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.426 -0.796 . . . . 22.12 109.442 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.586 HD11 ' CD1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -71.52 104.8 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.483 -1.303 . . . . 14.23 107.483 179.017 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.637 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -51.32 162.0 0.71 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.88 . . . . 25.43 110.123 -178.909 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.68 -18.6 15.13 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.505 2.136 . . . . 13.61 109.116 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -92.12 8.38 38.18 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.682 -0.859 . . . . 15.52 108.682 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.531 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -147.74 38.97 0.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.362 -0.836 . . . . 17.31 109.246 179.326 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.11 6.9 44.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 24.78 109.756 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 29.3 mt-30 -127.29 155.64 43.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 47.9 109.282 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.639 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 37.1 p90 -96.45 160.49 14.38 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.165 -0.959 . . . . 21.61 109.406 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -127.2 160.79 30.2 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.315 -0.866 . . . . 14.89 108.8 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.299 -1.613 0 O-C-N 121.274 -0.892 . . . . 17.35 108.963 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.341 0.591 . . . . 24.0 109.637 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.577 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 85.7 m-20 -43.72 134.73 4.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 23.31 109.638 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -125.99 161.77 26.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.884 . . . . 40.03 109.163 179.942 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.538 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -140.39 -172.36 3.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 12.39 109.602 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.513 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 2.7 mp -130.75 171.42 13.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 17.42 109.361 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -162.21 154.32 19.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.104 -0.997 . . . . 13.84 108.711 -179.613 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.679 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 27.1 m-85 -115.32 104.31 11.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 21.14 109.604 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 36' ' ' ASP . 64.1 t -80.23 165.33 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.807 -1.183 . . . . 10.66 109.536 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 39' ' ' ASN . 6.2 m-20 -137.21 -52.87 0.68 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.299 -0.876 . . . . 25.89 109.676 -179.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -42.09 -44.65 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.66 0.743 . . . . 24.24 109.11 179.919 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 39' ' ' ASN . . . -88.57 32.21 4.58 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.613 -1.395 . . . . 31.02 109.613 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 2.5 p30 161.16 117.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.384 -1.068 . . . . 43.23 109.594 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -42.5 -64.79 0.55 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 42.34 109.509 179.941 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 5.5 m-70 -68.68 163.4 55.11 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 107.96 -1.126 . . . . 4.1 107.96 179.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.679 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.9 Cg_endo -78.1 140.48 17.88 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.541 1.494 . . . . 17.92 109.692 -179.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' TYR . 6.0 m -116.32 114.32 45.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.313 -0.867 . . . . 20.57 109.003 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 43.8 tp -69.75 107.73 3.61 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.347 -0.846 . . . . 20.21 109.835 -179.437 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.568 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 0.8 OUTLIER -109.13 164.19 5.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.56 -0.904 . . . . 10.81 108.56 179.635 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' N ' HG11 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -86.96 170.0 11.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.159 -0.963 . . . . 36.74 109.803 -179.67 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.606 HG12 ' CZ ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -156.6 171.65 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.347 -0.846 . . . . 19.74 109.315 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -107.82 147.8 30.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.201 -0.937 . . . . 22.56 109.45 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.639 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 1.8 tm? -129.39 112.15 13.54 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.219 -0.926 . . . . 20.41 108.778 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 53' ' ' GLN . 2.7 t70 -61.75 138.18 58.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -0.816 . . . . 33.99 110.223 -178.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.28 124.38 16.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.346 -0.847 . . . . 54.92 108.834 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.47 -31.15 8.39 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.979 -1.648 . . . . 36.1 108.979 -179.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.469 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -73.77 146.51 85.63 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.375 -1.074 . . . . 54.76 109.155 179.648 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.44 118.2 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.426 2.084 . . . . 28.37 109.997 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.467 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -41.58 154.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 17.21 109.711 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CB ' ' A' ' 83' ' ' LEU . 6.8 m-30 -45.07 105.57 0.06 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.239 -0.913 . . . . 17.19 108.892 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.519 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -61.97 176.15 0.48 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 17.82 109.347 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.0 Cg_endo -77.61 129.97 10.43 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.602 2.202 . . . . 17.28 110.523 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.598 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 153.03 148.25 4.83 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.767 -1.333 . . . . 17.22 109.767 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.495 HD21 ' N ' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -46.78 146.23 1.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.137 -1.213 . . . . 19.57 108.838 179.481 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 59' ' ' GLY . 16.3 m-85 -125.77 161.85 26.41 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.667 -1.271 . . . . 14.61 111.7 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.516 ' N ' ' O ' ' A' ' 84' ' ' VAL . 43.2 p -144.86 121.6 11.2 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.459 -1.682 . . . . 18.36 106.459 178.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.571 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -59.98 163.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 118.529 -1.268 . . . . 19.13 108.922 -178.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.473 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.2 t-80 -127.27 128.19 45.59 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.037 -0.727 . . . . 20.65 109.037 -179.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.664 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -71.52 0.98 7.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.471 -0.768 . . . . 19.65 110.159 -179.833 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -20.78 6.58 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.283 -1.377 . . . . 14.72 107.283 178.647 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 5.8 m -95.11 -8.31 36.87 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.903 -0.498 . . . . 11.45 110.218 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.664 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.6 m-30 -84.73 156.87 21.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.953 -1.092 . . . . 14.25 109.336 -179.167 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.03 174.69 7.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.397 -0.814 . . . . 32.7 109.435 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.1 OUTLIER -103.13 109.82 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.821 . . . . 15.63 109.254 -179.965 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 72' ' ' GLN . . . -77.31 50.83 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.104 -1.199 . . . . 12.7 110.104 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER 40.05 49.39 2.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -1.094 . . . . 26.29 110.102 179.62 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 74' ' ' GLY . 1.7 m-85 -143.35 31.26 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 20.44 109.334 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.473 ' HA3' ' HG2' ' B' ' 46' ' ' LYS . . . 44.61 44.96 8.55 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.624 -1.39 . . . . 13.82 109.624 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 74' ' ' GLY . 46.6 m -166.57 114.27 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -1.209 . . . . 18.27 109.832 -179.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.543 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -68.04 155.36 39.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 12.43 109.037 179.678 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.543 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 8.1 mtp -162.54 157.06 21.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 35.11 109.754 -179.743 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.603 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.3 mt -80.65 135.06 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 13.67 109.899 179.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 79' ' ' ASP . 46.9 t0 -103.18 -20.55 14.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.376 -0.972 . . . . 24.06 108.376 178.327 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 67' ' ' SER . 5.1 tmm_? 175.79 69.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.93 -1.507 . . . . 35.04 106.93 179.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.571 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -32.23 120.21 0.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.458 -0.792 . . . . 18.72 111.635 -177.711 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -92.12 99.44 12.24 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.322 -0.992 . . . . 20.55 108.322 178.996 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.63 ' CB ' ' CE2' ' A' ' 56' ' ' TYR . 1.5 tp -67.43 157.54 33.91 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.019 0.914 . . . . 14.4 111.159 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 62' ' ' THR . 21.3 m -156.55 147.98 16.9 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.818 -1.178 . . . . 17.65 107.818 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -63.12 135.24 49.87 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 121.815 1.677 . . . . 25.7 109.872 179.352 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.511 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -61.85 118.8 7.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.942 . . . . 49.29 109.792 -178.521 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.01 -0.995 . . . . 58.91 109.454 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.487 ' O ' ' CB ' ' B' ' 2' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.339 0.59 . . . . 64.91 109.425 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' B' ' 63' ' ' VAL . 4.2 mt 75.25 83.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.632 -1.247 . . . . 33.8 107.632 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -80.74 173.07 12.97 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.136 0.97 . . . . 32.72 111.957 -177.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.582 ' CG2' ' N ' ' B' ' 5' ' ' GLU . 0.2 OUTLIER 179.83 168.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.781 -0.822 . . . . 14.46 108.781 -179.773 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.582 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 36.5 mt-10 -141.54 112.65 7.39 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.401 -0.812 . . . . 22.12 109.522 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -71.5 104.72 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.475 -1.306 . . . . 14.23 107.475 179.05 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.654 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -51.32 162.05 0.7 Allowed Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.881 . . . . 25.43 110.154 -178.874 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -76.54 -18.8 15.27 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.472 2.114 . . . . 13.61 109.15 178.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -92.03 8.6 36.92 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.719 -0.845 . . . . 15.52 108.719 178.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.536 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 0.0 OUTLIER -147.92 38.92 0.92 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.35 -0.844 . . . . 17.31 109.229 179.353 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.18 7.05 44.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 24.78 109.721 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' B' ' 31' ' ' GLN . 29.0 mt-30 -127.52 155.59 43.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 47.9 109.203 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.64 ' CD2' ' CD1' ' B' ' 49' ' ' LEU . 37.4 p90 -96.37 160.53 14.37 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.089 -1.007 . . . . 21.61 109.363 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -127.2 160.84 30.04 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.838 -0.801 . . . . 14.89 108.838 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.649 0 O-C-N 121.318 -0.864 . . . . 17.35 109.002 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.317 0.579 . . . . 24.0 109.681 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.586 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 85.8 m-20 -43.59 134.38 4.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 23.31 109.735 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 1.0 OUTLIER -125.65 161.74 26.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.362 -0.836 . . . . 40.03 109.192 179.889 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.545 ' CB ' HG21 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -140.32 -172.33 3.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.166 -0.959 . . . . 12.39 109.605 179.954 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.504 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 2.7 mp -130.76 171.63 12.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 17.42 109.372 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -162.45 154.28 18.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.06 -1.025 . . . . 13.84 108.776 -179.688 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.682 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 27.4 m-85 -115.23 104.36 11.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 21.14 109.645 -179.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.518 HG13 ' N ' ' B' ' 36' ' ' ASP . 63.2 t -80.32 165.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.849 -1.157 . . . . 10.66 109.509 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' B' ' 39' ' ' ASN . 6.2 m-20 -137.24 -52.76 0.67 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.304 -0.873 . . . . 25.89 109.683 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.525 ' O ' ' CD1' ' B' ' 37' ' ' LEU . 0.1 OUTLIER -42.09 -44.67 3.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 24.24 109.088 179.921 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 39' ' ' ASN . . . -88.52 32.06 4.63 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.651 -1.38 . . . . 31.02 109.651 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' ASP . 2.5 p30 161.23 117.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.397 -1.06 . . . . 43.23 109.577 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.0 OUTLIER -42.45 -64.67 0.57 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.355 -0.841 . . . . 42.34 109.508 179.942 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.486 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 5.6 m-70 -68.95 163.41 56.68 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 107.97 -1.122 . . . . 4.06 107.97 179.078 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.682 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.9 Cg_endo -77.98 140.67 18.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.507 1.471 . . . . 17.92 109.702 -179.736 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' B' ' 34' ' ' TYR . 5.9 m -116.49 114.29 45.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.339 -0.851 . . . . 20.57 108.981 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.604 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 43.6 tp -69.77 107.48 3.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.379 -0.826 . . . . 20.21 109.946 -179.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.586 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -108.88 164.12 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.627 -0.879 . . . . 10.81 108.627 179.592 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.49 ' N ' HG11 ' B' ' 45' ' ' VAL . 1.0 OUTLIER -86.85 170.11 11.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.948 . . . . 36.74 109.741 -179.645 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.61 HG12 ' CZ ' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -156.72 171.46 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.283 -0.886 . . . . 19.74 109.379 179.861 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 18.3 m -107.5 147.71 30.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 22.56 109.442 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.64 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 1.7 tm? -129.24 112.22 13.68 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.198 -0.939 . . . . 20.41 108.781 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' B' ' 53' ' ' GLN . 2.7 t70 -61.69 138.3 58.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.827 . . . . 33.99 110.202 -179.014 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.41 124.39 17.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 54.92 108.771 179.379 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.52 -31.25 8.3 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.987 -1.645 . . . . 36.1 108.987 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 0.4 OUTLIER -73.61 146.45 85.94 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.35 -1.088 . . . . 54.76 109.153 179.694 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.4 Cg_endo -78.35 118.03 4.2 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.453 2.102 . . . . 28.37 109.998 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.458 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -41.49 154.81 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.454 -0.779 . . . . 17.21 109.764 -179.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.631 ' CE2' ' CB ' ' B' ' 83' ' ' LEU . 6.7 m-30 -44.96 105.82 0.06 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 17.19 108.769 179.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -62.48 176.19 0.52 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 17.82 109.439 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.7 Cg_endo -77.46 128.53 9.63 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.547 2.165 . . . . 17.28 110.152 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.61 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 155.4 147.97 4.88 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.889 -1.284 . . . . 17.22 109.889 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.486 HD21 ' N ' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -47.43 145.69 2.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.055 -1.262 . . . . 19.57 108.527 179.209 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.61 ' CD1' ' O ' ' B' ' 59' ' ' GLY . 17.0 m-85 -125.25 161.87 25.95 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.624 -1.297 . . . . 14.61 111.663 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.516 ' O ' ' CG2' ' B' ' 84' ' ' VAL . 43.5 p -144.87 121.73 11.27 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.445 -1.687 . . . . 18.36 106.445 178.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -60.15 163.22 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 C-N-CA 118.517 -1.273 . . . . 19.13 108.974 -178.519 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.47 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -127.41 128.28 45.55 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.527 -0.733 . . . . 20.65 109.036 -179.287 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.654 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -71.48 0.88 7.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.476 -0.765 . . . . 19.65 110.093 -179.828 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -20.89 6.15 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.268 -1.382 . . . . 14.72 107.268 178.721 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 5.6 m -95.14 -8.98 34.86 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.897 -0.502 . . . . 11.45 110.245 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.654 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.6 m-30 -84.07 156.57 22.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.945 -1.097 . . . . 14.25 109.206 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -167.8 174.43 7.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.431 -0.793 . . . . 32.7 109.435 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.568 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -102.76 109.91 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 15.63 109.273 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' B' ' 72' ' ' GLN . . . -77.44 50.58 3.2 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.143 -1.183 . . . . 12.7 110.143 -179.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 71' ' ' GLY . 0.0 OUTLIER 40.28 49.62 2.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.331 -1.099 . . . . 26.29 110.041 179.653 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -143.65 31.35 1.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 20.44 109.323 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.479 ' HA2' HG21 ' A' ' 45' ' ' VAL . . . 44.56 44.73 8.37 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.621 -1.392 . . . . 13.82 109.621 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 74' ' ' GLY . 46.6 m -166.41 114.53 0.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -1.205 . . . . 18.27 109.824 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.54 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.3 OUTLIER -68.13 155.36 39.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 12.43 109.019 179.634 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 8.1 mtp -162.68 157.13 21.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 35.11 109.682 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.612 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.3 mt -80.78 135.36 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.442 -0.787 . . . . 13.67 109.91 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 47.2 t0 -103.19 -20.74 14.03 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.358 -0.979 . . . . 24.06 108.358 178.287 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' B' ' 67' ' ' SER . 5.1 tmm_? 175.96 69.7 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.982 -1.488 . . . . 35.04 106.982 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.579 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -32.45 120.2 0.31 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.464 -0.789 . . . . 18.72 111.684 -177.725 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -92.15 99.32 12.14 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.23 -1.026 . . . . 20.55 108.23 179.064 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.631 ' CB ' ' CE2' ' B' ' 56' ' ' TYR . 1.5 tp -67.4 157.62 33.68 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.034 0.921 . . . . 14.4 111.127 -178.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' B' ' 62' ' ' THR . 21.2 m -156.6 148.13 16.99 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.841 -1.17 . . . . 17.65 107.841 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.5 Cg_endo -63.31 135.17 48.84 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.774 1.649 . . . . 25.7 109.88 179.383 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.493 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -61.83 118.43 7.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.318 -0.864 . . . . 49.29 109.761 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' B' ' 86' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.975 -1.012 . . . . 58.91 109.475 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.468 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.302 0.572 . . . . 64.91 109.53 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 63' ' ' VAL . 5.3 mt -69.67 82.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.909 -1.145 . . . . 33.8 107.909 179.178 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.488 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 mttt -59.19 156.21 12.72 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.894 0.854 . . . . 32.72 111.531 -177.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 61' ' ' TYR . 49.0 t -159.57 167.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 109.19 -0.67 . . . . 14.46 109.19 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 30.2 mt-10 -152.63 100.93 2.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.741 0.782 . . . . 22.12 109.185 -179.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.578 HD12 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -66.96 103.56 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.852 -1.166 . . . . 14.23 107.852 179.493 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 2.2 mmpt? -50.18 159.23 0.84 Allowed Pre-proline 0 N--CA 1.485 1.291 0 O-C-N 121.302 -0.874 . . . . 25.43 109.66 -179.115 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.2 Cg_endo -76.16 -3.31 13.67 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.28 1.987 . . . . 13.61 109.37 179.374 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.15 -10.45 33.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.483 -0.76 . . . . 15.52 109.408 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 12' ' ' GLN . 25.7 mm-40 -97.54 -76.34 0.52 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.293 -0.879 . . . . 17.31 108.863 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 10' ' ' GLN . . . 23.64 45.54 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.205 0.526 . . . . 24.78 111.195 179.295 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.2 pt20 -179.04 132.42 0.12 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 47.9 109.557 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 31.9 p90 -97.45 156.27 16.55 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.953 -1.092 . . . . 21.61 109.486 179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 t -124.92 164.08 20.86 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.651 -0.87 . . . . 14.89 108.651 178.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.523 0 O-C-N 121.116 -0.99 . . . . 17.35 109.53 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 29' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.521 0.677 . . . . 24.0 110.657 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.604 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -42.2 159.3 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 23.31 109.942 179.686 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -156.71 137.22 13.09 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.753 -0.832 . . . . 40.03 108.753 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.531 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -120.89 -166.34 1.33 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.947 -1.095 . . . . 12.39 110.334 -179.231 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.525 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 4.4 mp -127.37 175.25 8.35 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.933 -0.766 . . . . 17.42 108.933 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.79 160.14 6.74 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.796 -1.19 . . . . 13.84 108.663 -179.545 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.655 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 2.9 m-30 -112.54 86.37 2.35 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.259 -0.9 . . . . 21.14 109.199 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' A' ' 4' ' ' VAL . 59.2 t -83.11 110.37 18.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.156 -0.965 . . . . 10.66 110.227 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' LEU . 36.8 t0 -53.58 -34.79 59.61 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.779 -1.193 . . . . 25.89 107.779 178.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.533 ' CD2' ' HA ' ' B' ' 69' ' ' LYS . 1.0 OUTLIER 41.27 34.36 0.32 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.303 0.573 . . . . 24.24 109.73 179.317 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.25 23.75 34.44 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.301 -1.52 . . . . 31.02 109.301 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.596 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 43.3 m-20 -88.26 26.53 1.39 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.304 -1.116 . . . . 43.23 110.01 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.77 14.18 3.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.046 -1.034 . . . . 42.34 109.876 179.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER 175.61 167.1 0.39 Allowed Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.437 -0.949 . . . . 6.32 108.437 179.883 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 33.8 Cg_endo -75.81 145.16 28.46 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.722 1.614 . . . . 17.92 110.421 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 6.6 m -119.9 119.77 61.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.482 -0.887 . . . . 20.57 109.171 179.356 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.655 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 14.7 tp -72.47 112.85 8.89 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.886 -0.725 . . . . 20.21 109.276 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.436 HG21 ' C ' ' B' ' 74' ' ' GLY . 1.7 p -130.78 161.51 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.386 -0.822 . . . . 10.81 109.127 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 0.6 OUTLIER -80.75 160.34 24.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.038 -1.039 . . . . 36.74 110.407 -179.094 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.622 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -140.64 161.91 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.46 -0.941 . . . . 19.74 108.46 179.353 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 143.0 28.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.97 -1.081 . . . . 22.56 109.683 -179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -114.0 146.58 39.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.366 -0.834 . . . . 20.41 108.858 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.492 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -81.33 142.88 32.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 33.99 109.538 -179.583 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.12 116.89 3.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 54.92 109.477 -179.905 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.11 -6.55 83.37 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.652 -1.379 . . . . 36.1 109.652 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -83.89 148.78 54.96 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 54.76 109.451 179.999 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.5 Cg_endo -77.01 119.47 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.617 2.211 . . . . 28.37 110.776 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.531 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -42.01 147.85 0.21 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 17.21 110.267 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.622 ' CE1' HG12 ' A' ' 47' ' ' ILE . 86.8 m-85 -44.07 112.09 0.36 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 17.19 109.131 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -63.92 176.58 0.63 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 17.82 109.779 -179.58 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -77.8 113.54 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.756 2.304 . . . . 17.28 110.433 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.8 172.84 38.83 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.389 -1.484 . . . . 17.22 109.389 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.3 mp -70.41 146.63 50.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 19.57 108.811 179.494 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.578 ' CE1' HD12 ' A' ' 6' ' ' ILE . 26.6 m-85 -131.24 163.59 27.45 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.945 -1.097 . . . . 14.61 110.921 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.522 HG21 ' CB ' ' A' ' 86' ' ' ALA . 44.1 p -144.4 117.17 8.72 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.066 -1.827 . . . . 18.36 106.066 178.623 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.628 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -49.81 163.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 C-N-CA 118.681 -1.208 . . . . 19.13 108.71 -178.143 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -128.3 126.62 41.16 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.409 -0.807 . . . . 20.65 109.381 -178.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.661 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -74.05 2.51 8.65 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.533 -0.729 . . . . 19.65 110.054 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.9 p -58.88 -18.02 29.22 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.546 -1.279 . . . . 14.72 107.546 178.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 23.8 m -97.83 -16.4 19.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.842 -0.536 . . . . 11.45 110.151 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.661 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.0 m-30 -68.14 157.3 35.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.125 -0.984 . . . . 14.25 109.441 -178.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.521 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 0.1 OUTLIER -150.48 -179.76 7.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.385 -0.822 . . . . 32.7 109.613 -179.995 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.404 HG23 ' CG2' ' B' ' 43' ' ' VAL . 0.1 OUTLIER -120.82 110.88 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 15.63 109.121 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' N ' ' SD ' ' A' ' 77' ' ' MET . . . -81.7 -175.07 50.03 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.658 -1.377 . . . . 12.7 109.658 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -89.55 20.17 4.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.152 -1.205 . . . . 26.29 109.574 -179.974 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -93.73 -2.64 53.5 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.394 -0.816 . . . . 20.44 109.348 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 81.16 26.89 51.3 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.68 -1.368 . . . . 13.82 109.68 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.6 153.7 32.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.082 -1.246 . . . . 18.27 109.82 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.24 176.81 0.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.348 -0.845 . . . . 12.43 109.664 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 2.1 ptm -167.68 100.12 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 35.11 109.691 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.583 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.9 mt -36.86 -64.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.478 0.656 . . . . 13.67 110.301 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 9.0 t0 84.53 -45.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.484 0.659 . . . . 24.06 110.014 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.8 tpm_? -173.84 67.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.147 0.975 . . . . 35.04 108.526 179.424 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.628 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.2 pt? -40.96 126.8 2.59 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.483 -0.781 . . . . 18.72 111.931 -178.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 1.4 ttt180 -94.11 110.4 22.11 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.693 -1.225 . . . . 20.55 107.693 178.239 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.61 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 11.8 tp -80.2 150.42 30.12 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.056 -1.027 . . . . 14.4 111.112 -178.148 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.543 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 21.2 m -147.08 157.57 46.06 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 108.161 -1.051 . . . . 17.65 108.161 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.6 Cg_endo -62.56 142.0 88.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.058 1.838 . . . . 25.7 110.321 179.11 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.522 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -76.38 116.47 17.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.229 -0.919 . . . . 49.29 109.739 -178.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.012 -0.995 . . . . 58.91 109.425 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.464 ' SD ' ' HB ' ' B' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.308 0.575 . . . . 64.91 109.556 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' B' ' 63' ' ' VAL . 5.2 mt -69.48 82.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.91 -1.144 . . . . 33.8 107.91 179.114 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.494 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 2.3 mttt -59.12 156.4 12.12 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.915 0.864 . . . . 32.72 111.543 -178.0 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 61' ' ' TYR . 49.2 t -159.7 167.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 109.2 -0.667 . . . . 14.46 109.2 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 30.0 mt-10 -152.45 100.94 2.62 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.808 0.813 . . . . 22.12 109.296 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.582 HD12 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -66.92 103.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.838 -1.171 . . . . 14.23 107.838 179.454 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.572 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 2.2 mmpt? -50.08 159.39 0.8 Allowed Pre-proline 0 N--CA 1.486 1.328 0 O-C-N 121.294 -0.879 . . . . 25.43 109.69 -179.156 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.7 Cg_endo -76.26 -3.26 13.61 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.353 2.035 . . . . 13.61 109.37 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.28 -10.48 32.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.461 -0.775 . . . . 15.52 109.394 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.529 ' O ' ' C ' ' B' ' 11' ' ' ALA . 25.6 mm-40 -97.48 -76.45 0.52 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.282 -0.886 . . . . 17.31 108.865 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' B' ' 10' ' ' GLN . . . 23.77 45.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.164 0.507 . . . . 24.78 111.175 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' B' ' 10' ' ' GLN . 1.2 pt20 -178.94 132.28 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 47.9 109.616 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.598 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 32.5 p90 -97.21 156.35 16.45 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.954 -1.091 . . . . 21.61 109.551 179.7 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.4 t -124.97 163.94 21.21 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.656 -0.868 . . . . 14.89 108.656 178.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.133 -0.979 . . . . 17.35 109.538 -179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' B' ' 29' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.482 0.658 . . . . 24.0 110.612 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.598 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -42.3 159.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.471 -0.768 . . . . 23.31 109.942 179.717 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -156.77 136.99 12.82 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.764 -0.828 . . . . 40.03 108.764 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.532 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -120.77 -166.41 1.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.992 -1.068 . . . . 12.39 110.342 -179.277 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.525 ' CD1' ' OE1' ' B' ' 10' ' ' GLN . 4.4 mp -127.16 175.43 8.14 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.871 -0.788 . . . . 17.42 108.871 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.99 160.1 6.38 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.834 -1.166 . . . . 13.84 108.59 -179.549 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.644 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 2.9 m-30 -112.52 86.41 2.35 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 21.14 109.201 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.527 ' CG2' HG21 ' B' ' 4' ' ' VAL . 59.5 t -83.22 110.57 18.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.189 -0.944 . . . . 10.66 110.236 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' B' ' 37' ' ' LEU . 36.8 t0 -53.7 -34.74 59.78 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.79 -1.189 . . . . 25.89 107.79 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.521 ' CD2' ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER 41.26 34.38 0.32 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.79 -0.568 . . . . 24.24 109.717 179.345 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.23 23.58 33.71 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.3 -1.52 . . . . 31.02 109.3 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.59 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 45.1 m-20 -88.09 26.46 1.38 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.285 -1.126 . . . . 43.23 110.022 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.8 14.22 4.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.082 -1.011 . . . . 42.34 109.893 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 0.6 OUTLIER 175.61 167.01 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.454 -0.943 . . . . 6.3 108.454 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.618 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 33.8 Cg_endo -75.62 145.31 29.25 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.711 1.608 . . . . 17.92 110.49 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 6.6 m -120.03 119.94 61.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 C-N-CA 119.378 -0.929 . . . . 20.57 109.16 179.312 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.644 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 14.8 tp -72.76 112.92 9.24 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.93 -0.708 . . . . 20.21 109.172 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.418 HG21 ' C ' ' A' ' 74' ' ' GLY . 1.7 p -130.82 161.52 40.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.421 -0.799 . . . . 10.81 109.077 -179.758 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -80.74 160.31 24.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.985 . . . . 36.74 110.399 -179.093 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.621 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -140.57 161.88 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.378 -0.971 . . . . 19.74 108.378 179.41 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.07 142.98 28.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.952 -1.092 . . . . 22.56 109.744 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.591 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -113.85 146.82 39.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 20.41 108.888 179.873 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.496 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -81.63 142.78 32.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 33.99 109.536 -179.572 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.05 117.14 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 54.92 109.417 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.12 -6.81 83.04 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.599 -1.4 . . . . 36.1 109.599 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.496 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -83.79 148.89 55.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.188 -1.183 . . . . 54.76 109.508 -179.958 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.5 Cg_endo -77.03 119.39 5.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.715 2.277 . . . . 28.37 110.761 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.534 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -42.0 147.69 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 17.21 110.35 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.621 ' CE1' HG12 ' B' ' 47' ' ' ILE . 86.9 m-85 -43.76 112.54 0.4 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.543 -0.723 . . . . 17.19 109.07 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.538 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -64.54 176.38 0.74 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 17.82 109.879 -179.348 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.3 112.47 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.606 2.204 . . . . 17.28 110.112 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.56 172.31 39.54 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.54 -1.424 . . . . 17.22 109.54 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 3.0 mp -70.67 146.01 50.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -1.165 . . . . 19.57 108.438 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.582 ' CE1' HD12 ' B' ' 6' ' ' ILE . 27.5 m-85 -130.69 163.51 27.08 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.909 -1.119 . . . . 14.61 110.908 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.527 HG21 ' CB ' ' B' ' 86' ' ' ALA . 44.5 p -144.26 117.2 8.82 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.049 -1.834 . . . . 18.36 106.049 178.562 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.629 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -49.86 163.64 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 C-N-CA 118.644 -1.222 . . . . 19.13 108.734 -178.134 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -128.07 126.79 41.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.338 -0.851 . . . . 20.65 109.356 -178.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.663 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.8 OUTLIER -74.22 2.48 9.02 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.533 -0.73 . . . . 19.65 110.008 -179.996 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 84.1 p -58.85 -18.03 29.04 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.512 -1.292 . . . . 14.72 107.512 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 23.7 m -97.89 -16.39 19.77 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.85 -0.531 . . . . 11.45 110.172 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.0 m-30 -68.21 156.98 36.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 14.25 109.454 -178.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.533 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -149.89 -179.85 7.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 32.7 109.715 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.44 HG23 ' CG2' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -120.75 110.87 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 15.63 109.061 179.788 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.457 ' N ' ' SD ' ' B' ' 77' ' ' MET . . . -81.85 -174.68 49.75 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.619 -1.392 . . . . 12.7 109.619 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.01 20.27 4.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.168 -1.195 . . . . 26.29 109.54 -179.932 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -93.75 -2.7 53.37 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.477 -0.764 . . . . 20.44 109.349 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 80.96 27.79 48.54 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.533 -1.427 . . . . 13.82 109.533 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.34 153.52 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -1.211 . . . . 18.27 109.788 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.12 176.83 0.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 12.43 109.584 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' B' ' 69' ' ' LYS . 2.1 ptm -167.71 99.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 35.11 109.685 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.565 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.9 mt -36.67 -64.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.511 0.672 . . . . 13.67 110.329 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 9.1 t0 84.44 -45.38 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.435 0.636 . . . . 24.06 110.061 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.9 tpm_? -173.96 67.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.155 0.978 . . . . 35.04 108.488 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.629 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.2 pt? -40.83 126.78 2.52 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.503 -0.771 . . . . 18.72 111.984 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 1.4 ttt180 -94.11 110.48 22.19 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.677 -1.231 . . . . 20.55 107.677 178.221 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.608 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 11.7 tp -80.28 150.39 30.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.091 -1.006 . . . . 14.4 111.166 -178.188 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.556 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 21.2 m -146.98 157.89 45.91 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 108.214 -1.032 . . . . 17.65 108.214 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.0 Cg_endo -62.77 142.1 87.7 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.015 1.81 . . . . 25.7 110.334 179.134 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.527 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -76.57 116.44 17.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.21 -0.931 . . . . 49.29 109.743 -178.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.994 -1.003 . . . . 58.91 109.44 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.375 0.607 . . . . 64.91 109.418 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 62' ' ' THR . 0.9 OUTLIER -68.62 73.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.664 -1.236 . . . . 33.8 107.664 178.987 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 1' ' ' MET . 1.6 mttt -62.61 157.0 21.75 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.178 0.989 . . . . 32.72 112.372 -177.669 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 61' ' ' TYR . 60.0 t -159.44 169.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.562 -0.903 . . . . 14.46 108.562 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 34' ' ' TYR . 68.0 mt-10 -152.25 103.02 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.132 -0.98 . . . . 22.12 109.634 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.595 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -75.36 105.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.853 -1.166 . . . . 14.23 107.853 179.116 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.641 ' HG3' ' CD1' ' A' ' 34' ' ' TYR . 4.9 mttm -55.57 166.13 1.05 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.8 . . . . 25.43 109.704 -179.27 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.7 Cg_endo -72.19 -17.91 27.43 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.925 1.75 . . . . 13.61 108.955 179.303 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -90.78 -6.46 54.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.984 -0.747 . . . . 15.52 108.984 178.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 2.4 mm100 -120.53 40.62 3.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 17.31 109.505 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -104.13 14.12 31.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.125 -0.985 . . . . 24.78 110.017 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.444 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 24.3 mt-30 -137.83 137.36 38.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 47.9 109.911 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.596 ' CD2' HD13 ' A' ' 49' ' ' LEU . 37.2 p90 -92.53 170.52 9.68 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.363 -0.836 . . . . 21.61 109.577 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -141.94 162.88 34.38 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.637 -0.875 . . . . 14.89 108.637 179.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.298 -1.632 0 O-C-N 121.194 -0.941 . . . . 17.35 109.187 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.455 0.645 . . . . 24.0 109.984 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.591 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 95.0 m-20 -74.51 119.59 18.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.446 -0.784 . . . . 23.31 109.318 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -108.53 143.96 36.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.083 -1.011 . . . . 40.03 109.242 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.552 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -130.18 -179.9 5.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 12.39 109.548 -179.857 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.529 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.2 mp -133.78 159.15 41.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 17.42 109.795 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.7 m -152.09 177.54 10.39 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.992 -1.114 . . . . 13.84 107.992 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.666 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 51.4 m-85 -126.88 122.65 35.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.895 -1.128 . . . . 21.14 110.095 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.585 ' CG1' ' HG ' ' A' ' 37' ' ' LEU . 96.7 t -109.35 129.24 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.215 -0.928 . . . . 10.66 109.964 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -121.64 -14.68 8.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.405 -0.81 . . . . 25.89 109.81 -179.593 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.606 ' CD1' ' N ' ' A' ' 38' ' ' GLY . 2.6 pp -36.61 -29.74 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.653 -0.654 . . . . 24.24 110.551 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.606 ' N ' ' CD1' ' A' ' 37' ' ' LEU . . . -124.59 19.7 7.02 Favored Glycine 0 N--CA 1.482 1.734 0 N-CA-C 109.565 -1.414 . . . . 31.02 109.565 -179.012 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -165.43 114.49 1.03 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.322 -1.105 . . . . 43.23 109.14 179.84 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 39' ' ' ASN . 39.8 mt-10 -39.08 -66.59 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.663 . . . . 42.34 109.946 -179.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.432 ' N ' ' ND1' ' A' ' 41' ' ' HIS . 2.1 m-70 -63.5 153.36 83.09 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 108.224 -1.028 . . . . 6.37 108.224 179.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.666 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -78.38 138.39 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.889 1.726 . . . . 17.92 110.277 -179.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 5.0 m -109.44 116.93 53.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.419 -0.801 . . . . 20.57 109.131 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.609 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 57.2 tp -71.86 108.13 4.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.276 -0.89 . . . . 20.21 109.937 -179.428 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.515 HG13 ' CG1' ' B' ' 70' ' ' VAL . 1.1 m -103.44 175.67 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.002 -0.74 . . . . 10.81 109.002 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -105.48 125.6 51.17 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.302 -0.959 . . . . 36.74 109.338 179.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.63 HG12 ' CE1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -120.9 132.33 70.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.277 -0.89 . . . . 19.74 109.602 -179.689 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.1 m -66.63 156.71 34.41 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.246 -0.908 . . . . 22.56 109.299 179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.596 HD13 ' CD2' ' A' ' 13' ' ' PHE . 2.8 tm? -130.09 111.27 12.31 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.321 -0.862 . . . . 20.41 108.744 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.503 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -42.4 122.53 2.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 33.99 109.945 -179.2 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -51.02 101.67 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.353 -0.842 . . . . 54.92 109.277 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.44 -24.08 10.0 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.263 -1.535 . . . . 36.1 109.263 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.503 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -73.61 157.97 86.94 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.293 -1.122 . . . . 54.76 109.351 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -78.79 114.34 3.42 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.529 2.153 . . . . 28.37 110.142 179.546 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . -38.81 142.01 0.24 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.477 -0.764 . . . . 17.21 109.888 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE1' HG12 ' A' ' 47' ' ' ILE . 88.5 m-85 -41.9 101.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.393 -0.817 . . . . 17.19 109.408 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 6' ' ' ILE . . . -50.72 169.36 0.21 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.16 -0.963 . . . . 17.82 109.207 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HA ' HG23 ' A' ' 6' ' ' ILE . 35.2 Cg_endo -77.25 122.11 6.0 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.62 2.213 . . . . 17.28 110.457 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.97 179.89 40.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.526 -1.43 . . . . 17.22 109.526 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -72.96 138.51 46.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -1.175 . . . . 19.57 108.448 179.294 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.595 ' CE1' HD11 ' A' ' 6' ' ' ILE . 20.2 m-85 -125.11 162.11 25.32 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.611 -1.306 . . . . 14.61 111.738 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 58.8 p -144.74 120.62 10.62 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.505 -1.665 . . . . 18.36 106.505 179.06 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.607 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -54.6 165.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 C-N-CA 118.581 -1.248 . . . . 19.13 109.136 -178.472 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -127.55 127.07 43.3 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.523 -0.736 . . . . 20.65 109.031 -179.227 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.667 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -69.31 -2.89 11.92 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.569 -0.707 . . . . 19.65 109.797 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 t -54.37 -19.67 5.96 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 107.775 -1.194 . . . . 14.72 107.775 179.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 82' ' ' ARG . 3.8 m -94.7 -8.84 36.59 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.756 -0.59 . . . . 11.45 110.188 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.667 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.3 m-30 -85.34 156.76 20.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.882 -1.136 . . . . 14.25 109.462 -179.272 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.434 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -148.52 176.54 10.23 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.054 -0.721 . . . . 32.7 109.054 179.545 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.516 ' CG1' HG13 ' B' ' 45' ' ' VAL . 1.7 t -127.23 118.43 49.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.302 -0.874 . . . . 15.63 109.474 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 72' ' ' GLN . . . -82.5 -99.46 0.48 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.326 -1.509 . . . . 12.7 109.326 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.589 ' O ' ' CG ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER 170.33 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -1.129 . . . . 26.29 109.565 179.754 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER 151.72 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.784 -0.821 . . . . 20.44 108.784 179.923 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -114.5 -88.06 1.56 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.442 -1.463 . . . . 13.82 109.442 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER 177.93 174.73 0.53 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -1.145 . . . . 18.27 109.678 -179.989 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' A' ' 77' ' ' MET . 6.3 tp -43.51 146.61 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 12.43 109.659 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.526 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 5.1 mtt -151.85 151.22 31.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 35.11 109.272 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.604 HG12 ' CE1' ' A' ' 68' ' ' PHE . 6.5 mt -76.96 137.26 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 13.67 110.308 -179.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -104.89 -26.73 12.09 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.931 -1.137 . . . . 24.06 107.931 178.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER 179.02 69.95 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.021 -1.474 . . . . 35.04 107.021 179.014 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.607 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -30.19 121.43 0.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.342 -0.845 . . . . 18.72 111.71 -178.038 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.51 ' N ' ' OG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -91.85 101.27 13.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 20.55 108.808 179.398 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.61 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -70.08 145.85 51.35 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.946 0.879 . . . . 14.4 110.883 -179.02 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.486 ' C ' ' CD2' ' A' ' 61' ' ' TYR . 25.6 m -148.73 156.75 41.43 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 107.793 -1.188 . . . . 17.65 107.793 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.0 Cg_endo -63.79 140.02 71.73 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.979 1.786 . . . . 25.7 110.15 179.023 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -71.44 118.31 14.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.939 . . . . 49.29 109.64 -178.703 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.012 -0.994 . . . . 58.91 109.435 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.478 ' O ' ' N ' ' B' ' 3' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.371 0.605 . . . . 64.91 109.408 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' B' ' 62' ' ' THR . 0.9 OUTLIER -68.73 73.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.699 -1.223 . . . . 33.8 107.699 179.028 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.491 ' O ' HG21 ' B' ' 4' ' ' VAL . 1.5 mttt -62.63 156.82 22.29 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.157 0.979 . . . . 32.72 112.352 -177.623 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' B' ' 61' ' ' TYR . 60.4 t -159.42 168.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.552 -0.906 . . . . 14.46 108.552 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 68.6 mt-10 -152.22 103.02 2.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 22.12 109.648 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.587 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -75.4 106.06 4.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.79 -1.189 . . . . 14.23 107.79 179.18 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.632 ' HG3' ' CD1' ' B' ' 34' ' ' TYR . 4.9 mttm -55.75 166.23 1.08 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.492 -0.755 . . . . 25.43 109.709 -179.241 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.9 Cg_endo -72.05 -18.01 27.82 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.987 1.791 . . . . 13.61 109.003 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -90.77 -6.4 54.41 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.988 -0.745 . . . . 15.52 108.988 178.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 2.5 mm100 -120.68 40.73 3.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.895 . . . . 17.31 109.413 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.431 ' HB3' ' HD3' ' B' ' 58' ' ' PRO . . . -104.28 14.17 30.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 24.78 109.976 -179.346 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.444 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 24.7 mt-30 -137.86 137.34 38.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.148 -0.97 . . . . 47.9 109.854 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.597 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 37.2 p90 -92.47 170.59 9.64 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.398 -0.814 . . . . 21.61 109.568 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -141.91 163.02 34.03 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.57 -0.9 . . . . 14.89 108.57 179.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.606 0 O-C-N 121.217 -0.927 . . . . 17.35 109.18 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.435 0.636 . . . . 24.0 109.998 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.597 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 95.4 m-20 -74.71 119.44 18.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.439 -0.788 . . . . 23.31 109.33 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -108.37 144.08 36.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.069 -1.019 . . . . 40.03 109.2 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.557 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -130.27 -179.9 5.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -0.994 . . . . 12.39 109.51 -179.902 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.528 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.3 mp -133.76 159.16 41.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 17.42 109.722 -179.782 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.8 m -152.07 177.76 10.16 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.008 -1.108 . . . . 13.84 108.008 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.67 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 50.7 m-85 -127.19 122.58 34.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.881 -1.137 . . . . 21.14 110.091 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' B' ' 37' ' ' LEU . 96.6 t -109.27 129.16 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.234 -0.916 . . . . 10.66 109.937 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' B' ' 36' ' ' ASP . 0.4 OUTLIER -121.48 -14.68 8.19 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.432 -0.793 . . . . 25.89 109.788 -179.654 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.599 ' CD1' ' N ' ' B' ' 38' ' ' GLY . 2.6 pp -36.6 -29.7 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.654 -0.654 . . . . 24.24 110.58 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.599 ' N ' ' CD1' ' B' ' 37' ' ' LEU . . . -124.65 19.58 7.02 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 109.591 -1.404 . . . . 31.02 109.591 -178.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' B' ' 39' ' ' ASN . 0.1 OUTLIER -165.43 114.68 1.03 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.38 -1.07 . . . . 43.23 109.056 179.832 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' B' ' 39' ' ' ASN . 39.9 mt-10 -39.12 -66.48 0.28 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.536 0.684 . . . . 42.34 110.057 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.436 ' ND1' ' N ' ' B' ' 41' ' ' HIS . 2.1 m-70 -63.56 153.39 83.21 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.223 -1.029 . . . . 6.38 108.223 179.28 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 38.2 Cg_endo -78.42 138.29 15.51 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.85 1.7 . . . . 17.92 110.241 -179.357 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 4.8 m -109.37 116.99 53.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.423 -0.798 . . . . 20.57 109.191 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.613 ' HB2' ' CE2' ' B' ' 34' ' ' TYR . 57.0 tp -71.69 108.11 4.86 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.86 . . . . 20.21 109.982 -179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.516 HG13 ' CG1' ' A' ' 70' ' ' VAL . 1.1 m -103.48 175.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.466 -0.771 . . . . 10.81 109.055 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -105.44 125.37 50.91 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.385 -0.926 . . . . 36.74 109.431 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.622 HG12 ' CE1' ' B' ' 56' ' ' TYR . 1.0 OUTLIER -120.72 132.39 70.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.334 -0.854 . . . . 19.74 109.608 -179.638 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 59.8 m -66.72 156.81 34.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 22.56 109.238 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.596 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 2.8 tm? -130.17 111.28 12.28 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.288 -0.883 . . . . 20.41 108.746 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.509 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -42.43 122.62 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 33.99 109.944 -179.124 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -51.06 101.64 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.356 -0.84 . . . . 54.92 109.322 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.47 -24.0 10.03 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.297 -1.521 . . . . 36.1 109.297 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.509 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.8 OUTLIER -73.79 157.85 86.83 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.295 -1.12 . . . . 54.76 109.362 179.883 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.7 114.47 3.46 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.518 2.145 . . . . 28.37 110.098 179.582 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' B' ' 54' ' ' PRO . . . -38.82 141.76 0.26 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.465 -0.772 . . . . 17.21 109.949 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.622 ' CE1' HG12 ' B' ' 47' ' ' ILE . 88.7 m-85 -41.5 100.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.439 -0.788 . . . . 17.19 109.317 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.432 ' O ' HG23 ' B' ' 6' ' ' ILE . . . -50.01 169.5 0.19 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.987 . . . . 17.82 109.287 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.454 ' HA ' HG23 ' B' ' 6' ' ' ILE . 34.6 Cg_endo -77.06 120.84 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.48 2.12 . . . . 17.28 110.188 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.35 179.07 41.59 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.69 -1.364 . . . . 17.22 109.69 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -73.18 137.98 45.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -1.153 . . . . 19.57 107.969 178.884 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.587 ' CE1' HD11 ' B' ' 6' ' ' ILE . 21.2 m-85 -124.55 162.35 24.23 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.502 -1.374 . . . . 14.61 111.703 -179.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' B' ' 2' ' ' ILE . 58.1 p -144.86 120.46 10.43 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.492 -1.67 . . . . 18.36 106.492 179.08 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.62 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -54.4 166.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 C-N-CA 118.578 -1.249 . . . . 19.13 109.056 -178.451 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -128.27 127.2 42.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.033 -0.728 . . . . 20.65 109.033 -179.275 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.654 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -69.36 -2.75 11.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.514 -0.741 . . . . 19.65 109.771 -179.964 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 9.2 t -54.54 -19.52 6.04 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 107.729 -1.211 . . . . 14.72 107.729 179.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' B' ' 82' ' ' ARG . 3.8 m -95.1 -9.26 34.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.829 -0.544 . . . . 11.45 110.147 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.654 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.3 m-30 -84.93 155.89 21.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.878 -1.139 . . . . 14.25 109.269 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.427 ' O ' HD13 ' B' ' 76' ' ' LEU . 0.2 OUTLIER -147.77 176.56 10.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.497 -0.752 . . . . 32.7 109.016 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.515 ' CG1' HG13 ' A' ' 45' ' ' VAL . 1.7 t -127.13 118.63 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.867 . . . . 15.63 109.476 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' B' ' 72' ' ' GLN . . . -82.69 -99.2 0.5 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.4 -1.48 . . . . 12.7 109.4 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.579 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER 170.1 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.191 -1.181 . . . . 26.29 109.569 179.769 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.579 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 0.7 OUTLIER 151.61 -33.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.768 -0.827 . . . . 20.44 108.768 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -114.68 -87.76 1.51 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.487 -1.445 . . . . 13.82 109.487 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 177.58 174.69 0.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -1.154 . . . . 18.27 109.606 179.931 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' B' ' 77' ' ' MET . 6.3 tp -43.6 146.49 0.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 12.43 109.633 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.507 ' N ' ' HG ' ' B' ' 76' ' ' LEU . 5.0 mtt -151.74 151.34 31.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.383 -0.823 . . . . 35.11 109.13 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.613 HG12 ' CE1' ' B' ' 68' ' ' PHE . 6.5 mt -77.16 137.47 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 13.67 110.351 -179.571 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -104.84 -26.71 12.12 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.91 -1.144 . . . . 24.06 107.91 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.0 OUTLIER 178.99 70.03 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.006 -1.479 . . . . 35.04 107.006 179.054 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.62 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -30.19 121.5 0.18 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.3 -0.864 . . . . 18.72 111.697 -178.055 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.513 ' N ' ' OG ' ' B' ' 67' ' ' SER . 0.0 OUTLIER -91.84 101.45 14.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.832 -0.803 . . . . 20.55 108.832 179.37 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.603 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -70.2 145.54 51.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 14.4 110.9 -179.073 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.469 ' C ' ' CD2' ' B' ' 61' ' ' TYR . 25.8 m -148.49 156.95 42.24 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 107.714 -1.217 . . . . 17.65 107.714 179.369 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.4 Cg_endo -64.01 140.21 71.31 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.936 1.757 . . . . 25.7 110.034 179.1 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.483 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -71.55 118.29 14.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 49.29 109.693 -178.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.979 -1.01 . . . . 58.91 109.428 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.492 ' CG ' ' HB ' ' A' ' 62' ' ' THR . 1.5 ttp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.307 0.575 . . . . 64.91 109.565 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.542 ' N ' HD21 ' B' ' 65' ' ' LEU . 5.2 mt -71.32 75.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.134 -1.062 . . . . 33.8 108.134 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' C ' HG11 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -63.02 156.38 24.87 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.907 0.86 . . . . 32.72 111.155 -178.283 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.57 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -163.85 167.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.464 -0.939 . . . . 14.46 108.464 179.983 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.533 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 34.3 mt-10 -141.01 113.55 8.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 22.12 109.59 -179.66 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -72.83 103.28 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.106 -1.072 . . . . 14.23 108.106 179.346 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.601 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 24.2 mmmt -51.49 163.41 0.59 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 25.43 109.369 -179.471 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.9 Cg_endo -73.04 -12.61 25.97 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.059 1.839 . . . . 13.61 109.383 179.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.6 3.72 54.75 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.615 -0.883 . . . . 15.52 108.615 178.491 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.484 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.8 mm-40 -127.38 41.32 3.54 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.374 -0.829 . . . . 17.31 108.86 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.23 11.76 36.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 24.78 110.258 -179.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.411 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 32.4 mt-30 -136.42 134.43 37.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.123 -0.985 . . . . 47.9 110.121 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.614 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 20.4 p90 -84.72 164.83 18.32 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.318 -0.863 . . . . 21.61 109.436 179.735 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -130.89 140.31 50.19 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.349 -0.844 . . . . 14.89 109.256 179.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.534 0 O-C-N 121.413 -0.805 . . . . 17.35 109.225 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.516 ' O ' ' CG2' ' A' ' 15' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.524 0.678 . . . . 24.0 109.997 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.607 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -103.04 131.57 49.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.461 -0.774 . . . . 23.31 109.206 -179.863 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -117.19 148.58 41.48 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.064 -1.022 . . . . 40.03 109.76 -179.762 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.576 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -126.9 -163.91 1.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.172 -0.955 . . . . 12.39 109.496 179.729 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.564 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -136.35 177.98 7.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 17.42 109.609 -179.794 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.479 ' HB2' HG23 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -171.74 162.52 6.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 13.84 108.709 -179.768 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 3.5 m-30 -115.5 111.43 20.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.249 -0.907 . . . . 21.14 108.761 -179.848 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.504 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 99.2 t -100.81 144.74 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.896 -1.127 . . . . 10.66 110.51 -179.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -125.54 -137.8 0.27 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.517 -0.92 . . . . 25.89 108.517 179.455 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.561 ' HB3' ' CD1' ' B' ' 65' ' ' LEU . 0.2 OUTLIER 68.48 -62.68 0.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.825 -1.172 . . . . 24.24 108.818 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -88.53 24.29 12.72 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.647 -1.781 . . . . 31.02 108.647 179.21 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.488 ' ND2' HG13 ' A' ' 43' ' ' VAL . 0.3 OUTLIER 176.39 114.41 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.548 -0.972 . . . . 43.23 108.655 -179.731 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 39' ' ' ASN . 4.3 mt-10 -38.91 -64.07 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.618 0.723 . . . . 42.34 109.995 -179.336 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.5 m80 -68.6 162.74 60.37 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 108.745 -0.835 . . . . 8.11 108.745 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.628 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.5 Cg_endo -78.12 148.83 24.83 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.126 1.884 . . . . 17.92 110.307 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.488 HG13 ' ND2' ' A' ' 39' ' ' ASN . 18.5 m -119.74 119.53 60.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.294 -0.879 . . . . 20.57 109.262 179.363 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.634 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 20.6 tp -71.65 114.12 9.39 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.426 0.632 . . . . 20.21 109.557 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.478 HG21 ' N ' ' B' ' 75' ' ' SER . 3.3 p -122.09 163.05 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.455 -0.778 . . . . 10.81 109.316 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.67 173.05 12.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.919 . . . . 36.74 110.369 -179.167 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.577 HD11 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -163.96 131.4 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.484 -0.932 . . . . 19.74 108.484 179.97 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.421 ' CG2' HD23 ' A' ' 28' ' ' LEU . 3.8 m -74.82 154.45 38.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.894 -1.129 . . . . 22.56 109.464 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -123.35 119.98 31.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -0.866 . . . . 20.41 109.037 -179.839 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.504 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -53.95 137.41 39.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 33.99 109.875 -179.455 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -57.36 118.21 4.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 54.92 109.244 179.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.74 -12.23 69.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.341 -1.504 . . . . 36.1 109.341 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.504 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -79.84 148.74 69.34 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.26 -1.141 . . . . 54.76 109.37 179.871 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.3 Cg_endo -77.08 121.08 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.589 2.193 . . . . 28.37 110.319 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -37.82 145.69 0.07 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.578 -0.702 . . . . 17.21 110.607 -179.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 75.2 m-85 -43.74 105.36 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.41 -0.806 . . . . 17.19 109.226 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.519 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -57.37 176.03 0.24 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 17.82 109.67 -179.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.54 115.16 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.645 2.23 . . . . 17.28 110.353 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.23 176.33 41.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.667 -1.373 . . . . 17.22 109.667 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.0 mp -73.33 145.34 46.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 19.57 108.842 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.579 ' CE1' HD11 ' A' ' 6' ' ' ILE . 38.8 m-85 -132.56 162.8 30.34 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.43 1.11 . . . . 14.61 111.103 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.492 ' HB ' ' CG ' ' A' ' 1' ' ' MET . 38.7 p -142.32 121.83 13.27 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.945 -1.872 . . . . 18.36 105.945 178.16 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.596 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.0 t -55.26 163.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 C-N-CA 118.372 -1.331 . . . . 19.13 109.017 -177.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -123.05 130.99 53.5 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.49 -0.756 . . . . 20.65 109.383 -178.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.663 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -73.87 2.85 7.61 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.475 -0.766 . . . . 19.65 109.853 179.827 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -56.2 -19.49 13.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 107.176 -1.416 . . . . 14.72 107.176 178.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.487 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 4.1 m -96.47 -7.01 35.9 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 116.057 -0.52 . . . . 11.45 110.212 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.1 m-30 -83.95 161.95 20.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.985 -1.072 . . . . 14.25 109.848 -178.856 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.76 170.13 22.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.453 -0.78 . . . . 32.7 109.326 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.497 HG23 ' CG2' ' B' ' 43' ' ' VAL . 0.5 OUTLIER -121.36 116.74 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 15.63 109.156 179.733 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.71 -170.82 17.73 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.763 -1.335 . . . . 12.7 109.763 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.537 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -89.67 20.9 3.75 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.248 -1.148 . . . . 26.29 109.468 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 5.7 t80 -112.47 10.25 19.69 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.315 -0.866 . . . . 20.44 109.573 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.424 ' C ' HG21 ' B' ' 45' ' ' VAL . . . 63.02 56.25 21.82 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.597 -1.401 . . . . 13.82 109.597 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.531 ' N ' HG21 ' B' ' 45' ' ' VAL . 1.4 m -157.27 120.06 3.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -1.146 . . . . 18.27 109.585 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.533 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -70.46 155.38 40.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 12.43 109.312 179.817 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 45.8 mtm -163.64 130.81 3.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 35.11 109.736 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.608 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.5 mp -64.64 142.0 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 13.67 109.805 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -105.59 -36.14 7.2 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.131 -1.063 . . . . 24.06 108.131 178.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.487 ' C ' ' HB3' ' A' ' 67' ' ' SER . 2.1 ttp180 -170.34 68.07 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 106.851 -1.537 . . . . 35.04 106.851 178.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.596 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -29.46 117.12 0.12 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.243 -0.889 . . . . 18.72 112.063 -177.674 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -92.21 113.0 25.15 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.004 -1.11 . . . . 20.55 108.004 178.825 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.608 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 15.3 tp -81.91 153.39 26.34 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.078 0.942 . . . . 14.4 111.023 -178.499 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.57 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 33.0 m -152.23 152.14 28.86 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.831 -1.174 . . . . 17.65 107.831 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.4 Cg_endo -60.99 141.54 94.77 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.019 1.812 . . . . 25.7 110.537 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.81 122.57 22.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 49.29 109.702 -178.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.979 -1.01 . . . . 58.91 109.446 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.496 ' CG ' ' HB ' ' B' ' 62' ' ' THR . 1.5 ttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.525 -0.546 . . . . 64.91 109.525 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.539 ' N ' HD21 ' A' ' 65' ' ' LEU . 5.3 mt -71.68 75.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.119 -1.067 . . . . 33.8 108.119 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.435 ' C ' HG11 ' B' ' 4' ' ' VAL . 0.5 OUTLIER -63.01 156.19 25.39 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.917 0.865 . . . . 32.72 111.179 -178.277 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.564 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -163.67 167.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.468 -0.938 . . . . 14.46 108.468 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.544 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 34.5 mt-10 -141.04 113.63 8.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.958 . . . . 22.12 109.566 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.563 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.3 OUTLIER -72.92 103.23 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.164 -1.05 . . . . 14.23 108.164 179.317 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.592 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 24.1 mmmt -51.44 163.34 0.59 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.322 -0.861 . . . . 25.43 109.338 -179.45 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.3 Cg_endo -73.05 -12.54 25.9 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.05 1.833 . . . . 13.61 109.437 179.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.63 3.63 54.84 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.584 -0.895 . . . . 15.52 108.584 178.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.48 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.7 mm-40 -127.18 41.12 3.58 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.385 -0.822 . . . . 17.31 108.898 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.08 11.92 36.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 24.78 110.294 -179.121 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.413 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 32.7 mt-30 -136.46 134.35 37.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.997 . . . . 47.9 110.158 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.623 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 20.6 p90 -84.7 164.8 18.36 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.355 -0.841 . . . . 21.61 109.465 179.701 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -130.86 140.34 50.22 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.39 -0.819 . . . . 14.89 109.29 179.047 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 15' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' B' ' 28' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.527 0 O-C-N 121.333 -0.854 . . . . 17.35 109.269 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.502 ' O ' ' CG2' ' B' ' 15' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.469 0.652 . . . . 24.0 110.018 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.623 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -103.01 131.58 49.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.715 . . . . 23.31 109.155 -179.928 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.5 OUTLIER -117.13 148.53 41.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 40.03 109.708 -179.74 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.581 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -126.78 -163.84 1.28 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.173 -0.955 . . . . 12.39 109.503 179.704 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.559 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 0.5 OUTLIER -136.46 177.92 7.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 17.42 109.573 -179.785 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.484 ' HB2' HG23 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -171.69 162.56 6.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.018 -1.051 . . . . 13.84 108.718 -179.679 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.64 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 3.5 m-30 -115.6 111.4 20.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 21.14 108.763 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.502 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 99.4 t -100.87 144.65 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.896 -1.128 . . . . 10.66 110.521 -179.541 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.7 OUTLIER -125.46 -137.87 0.27 Allowed 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.519 -0.919 . . . . 25.89 108.519 179.462 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.555 ' HB3' ' CD1' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 68.5 -62.71 0.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.877 -1.139 . . . . 24.24 108.754 -179.974 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -88.41 24.12 13.1 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 108.589 -1.804 . . . . 31.02 108.589 179.291 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.491 ' ND2' ' CG1' ' B' ' 43' ' ' VAL . 0.3 OUTLIER 176.48 114.39 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.588 -0.948 . . . . 43.23 108.644 -179.722 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' B' ' 39' ' ' ASN . 4.4 mt-10 -38.77 -64.21 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.511 -0.743 . . . . 42.34 109.985 -179.306 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . 0.409 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 1.5 m80 -68.51 162.92 58.47 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 108.722 -0.844 . . . . 8.13 108.722 179.578 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.622 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.0 Cg_endo -78.19 148.8 24.58 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.159 1.906 . . . . 17.92 110.314 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.497 ' CG2' HG23 ' A' ' 70' ' ' VAL . 18.5 m -119.71 119.66 61.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 119.575 -0.85 . . . . 20.57 109.222 179.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.64 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 20.4 tp -71.75 114.28 9.67 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.464 0.649 . . . . 20.21 109.52 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.531 HG21 ' N ' ' A' ' 75' ' ' SER . 3.1 p -122.18 162.78 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.478 -0.763 . . . . 10.81 109.327 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 172.95 12.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.908 . . . . 36.74 110.374 -179.163 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.586 HD11 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -163.89 131.37 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.513 -0.921 . . . . 19.74 108.513 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.433 ' CG2' HD23 ' B' ' 28' ' ' LEU . 3.8 m -74.84 154.17 38.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.918 -1.114 . . . . 22.56 109.461 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.622 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -123.09 120.1 32.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.361 -0.837 . . . . 20.41 109.059 -179.845 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.51 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -54.02 137.37 39.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 33.99 109.845 -179.391 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.28 118.36 5.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -0.865 . . . . 54.92 109.22 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 -12.21 69.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.342 -1.503 . . . . 36.1 109.342 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.51 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -79.85 148.73 69.28 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.261 -1.141 . . . . 54.76 109.361 179.92 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.4 Cg_endo -77.15 120.95 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.579 2.186 . . . . 28.37 110.367 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.546 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -37.6 145.46 0.06 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.611 -0.681 . . . . 17.21 110.68 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.603 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 75.5 m-85 -43.57 105.13 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.49 -0.756 . . . . 17.19 109.155 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.522 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -57.26 176.04 0.24 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 17.82 109.75 -179.546 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -78.38 114.48 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.678 2.252 . . . . 17.28 110.182 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.38 176.12 42.5 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.687 -1.365 . . . . 17.22 109.687 -179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 2.8 mp -73.56 145.13 45.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -1.161 . . . . 19.57 108.664 179.33 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.571 ' CD2' HD22 ' B' ' 83' ' ' LEU . 38.3 m-85 -132.27 162.66 30.43 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 122.461 1.124 . . . . 14.61 111.155 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.496 ' HB ' ' CG ' ' B' ' 1' ' ' MET . 38.5 p -142.22 121.69 13.24 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.976 -1.861 . . . . 18.36 105.976 178.185 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.599 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 1.9 t -55.24 163.14 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 C-N-CA 118.37 -1.332 . . . . 19.13 109.07 -178.017 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -122.95 131.1 53.57 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.49 -0.757 . . . . 20.65 109.374 -178.716 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.65 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.7 OUTLIER -73.87 2.73 7.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.561 -0.712 . . . . 19.65 109.894 179.769 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -56.13 -19.52 13.7 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.105 -1.443 . . . . 14.72 107.105 178.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.48 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 4.1 m -96.5 -7.35 34.92 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.896 -0.503 . . . . 11.45 110.149 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.2 m-30 -83.69 161.71 20.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.912 -1.117 . . . . 14.25 109.776 -178.848 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.62 170.15 22.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 32.7 109.28 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.479 HG23 ' CG2' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -121.27 116.87 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 15.63 109.253 179.748 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.99 -170.88 19.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.73 -1.348 . . . . 12.7 109.73 -179.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -89.63 20.99 3.67 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.251 -1.147 . . . . 26.29 109.478 -179.882 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' B' ' 73' ' ' PHE . 5.7 t80 -112.51 10.36 19.63 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.392 -0.817 . . . . 20.44 109.558 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.91 56.43 20.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.657 -1.377 . . . . 13.82 109.657 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.478 ' N ' HG21 ' A' ' 45' ' ' VAL . 1.4 m -157.52 120.01 3.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -1.174 . . . . 18.27 109.616 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.538 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.3 OUTLIER -70.5 155.35 40.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 12.43 109.324 179.891 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 45.7 mtm -163.56 130.91 3.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 35.11 109.679 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.607 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.5 mp -64.78 142.25 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 13.67 109.783 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -105.73 -36.19 7.13 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.091 -1.078 . . . . 24.06 108.091 178.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.48 ' C ' ' HB3' ' B' ' 67' ' ' SER . 2.1 ttp180 -170.31 68.23 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.886 -1.524 . . . . 35.04 106.886 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.599 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -29.57 117.1 0.13 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.212 -0.904 . . . . 18.72 112.104 -177.683 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.3 OUTLIER -92.18 112.94 25.07 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.051 -1.092 . . . . 20.55 108.051 178.825 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.603 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 15.3 tp -81.93 153.34 26.34 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.082 0.944 . . . . 14.4 111.008 -178.472 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.557 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 33.0 m -152.15 152.04 28.83 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.803 -1.184 . . . . 17.65 107.803 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.2 Cg_endo -60.94 141.58 94.97 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.951 1.767 . . . . 25.7 110.523 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.75 122.54 22.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 49.29 109.751 -178.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.975 -1.012 . . . . 58.91 109.442 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' C ' ' A' ' 2' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.475 -0.565 . . . . 64.91 109.475 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.581 ' N ' ' CD2' ' B' ' 65' ' ' LEU . 0.0 OUTLIER -43.15 131.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.614 -0.884 . . . . 33.8 108.614 179.396 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 1.3 mttp -102.82 153.78 19.84 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.117 -0.99 . . . . 32.72 110.394 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.585 ' HB ' ' CB ' ' A' ' 61' ' ' TYR . 32.7 t -159.78 166.13 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.684 0.754 . . . . 14.46 109.777 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 32.7 mt-10 -153.05 103.06 2.7 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.684 -0.858 . . . . 22.12 108.684 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.587 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -71.84 103.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.032 -1.099 . . . . 14.23 108.032 179.837 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.647 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.63 171.19 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.446 -0.784 . . . . 25.43 109.643 -179.258 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -75.05 -22.66 14.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.334 2.023 . . . . 13.61 109.718 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.54 2.18 54.19 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.975 -0.75 . . . . 15.52 108.975 178.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.512 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 8.7 mm-40 -121.49 40.99 3.46 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.263 -0.898 . . . . 17.31 109.205 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -109.37 12.34 24.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.16 -0.963 . . . . 24.78 109.796 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -131.7 141.63 49.61 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.509 -0.922 . . . . 47.9 108.509 179.846 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 37.1 p90 -93.68 167.65 11.52 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.019 -1.051 . . . . 21.61 109.73 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.453 HG21 ' N ' ' A' ' 15' ' ' THR . 99.7 m -135.1 149.96 50.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.79 -0.819 . . . . 14.89 108.79 179.159 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.453 ' N ' HG21 ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.512 0 O-C-N 121.212 -0.93 . . . . 17.35 109.413 -179.763 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.406 0.622 . . . . 24.0 109.979 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.595 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 97.3 m-20 -69.39 129.91 41.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 23.31 109.378 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 33.9 mt-10 -112.06 163.62 14.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.148 -0.97 . . . . 40.03 109.16 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.543 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -150.7 -176.83 5.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.071 . . . . 12.39 110.038 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.525 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 27.9 mt -133.31 158.61 42.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.464 -0.772 . . . . 17.42 109.076 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 12.4 m -155.51 172.92 17.45 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.161 -1.052 . . . . 13.84 108.161 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.671 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 32.6 m-85 -121.9 104.48 9.58 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.092 -1.005 . . . . 21.14 109.176 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.52 ' HA ' HG21 ' A' ' 4' ' ' VAL . 42.4 t -79.8 159.55 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.096 -1.002 . . . . 10.66 110.655 -179.294 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 38' ' ' GLY . 31.6 m-20 -140.84 -147.96 0.23 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.714 -0.847 . . . . 25.89 108.714 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.532 ' HG ' ' CD1' ' B' ' 65' ' ' LEU . 0.2 OUTLIER 67.71 -61.89 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 24.24 109.188 -179.983 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -87.15 21.18 21.86 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.059 -1.616 . . . . 31.02 109.059 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 36' ' ' ASP . 1.5 p30 176.19 112.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -1.063 . . . . 43.23 109.324 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' ASN . 3.1 mt-10 -41.7 -63.13 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 42.34 109.955 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -65.0 154.55 86.28 Favored Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.512 -0.742 . . . . 9.47 109.001 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.671 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.8 Cg_endo -78.26 143.92 20.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.233 1.955 . . . . 17.92 110.248 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' B' ' 70' ' ' VAL . 19.3 m -116.15 116.11 51.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.236 -0.915 . . . . 20.57 109.194 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 55.2 tp -73.14 102.35 3.56 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.29 -0.882 . . . . 20.21 109.683 -179.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' B' ' 70' ' ' VAL . 1.2 m -107.14 -178.41 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.568 -0.708 . . . . 10.81 109.164 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 1.1 mtpt -101.07 154.3 18.83 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.569 -0.852 . . . . 36.74 109.748 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.61 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -140.55 173.45 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.336 -0.852 . . . . 19.74 109.364 -179.879 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.16 145.89 37.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.277 -0.889 . . . . 22.56 109.263 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.587 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 3.0 tm? -127.34 126.97 43.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.315 -0.865 . . . . 20.41 109.041 -179.669 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 3.2 m-20 -63.39 142.38 58.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 33.99 109.821 -179.417 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.66 123.63 17.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 54.92 109.295 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.23 -16.08 50.32 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.391 -1.484 . . . . 36.1 109.391 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -75.18 153.72 86.33 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.309 -1.113 . . . . 54.76 109.381 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.57 110.03 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.621 2.214 . . . . 28.37 110.334 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -41.69 151.34 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -0.829 . . . . 17.21 109.849 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 89.8 m-85 -46.03 101.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.871 . . . . 17.19 109.072 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -53.07 173.6 0.17 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.907 . . . . 17.82 109.492 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.7 Cg_endo -78.13 114.62 3.61 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.682 2.255 . . . . 17.28 110.34 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.47 -178.91 45.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.695 -1.362 . . . . 17.22 109.695 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.4 mp -74.16 147.2 42.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -1.134 . . . . 19.57 108.717 179.45 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.587 ' CE1' HD11 ' A' ' 6' ' ' ILE . 25.7 m-85 -136.28 166.32 23.71 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 120.962 -1.086 . . . . 14.61 111.059 -179.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 33.4 p -149.51 123.27 9.26 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.902 -1.888 . . . . 18.36 105.902 178.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.587 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 1.7 t -54.17 162.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 118.338 -1.345 . . . . 19.13 108.693 -178.268 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -124.83 128.14 48.24 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.393 -0.817 . . . . 20.65 109.066 -179.116 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.652 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -72.43 2.82 5.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.463 -0.773 . . . . 19.65 110.141 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 t -56.09 -20.09 15.84 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.114 -1.439 . . . . 14.72 107.114 178.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 80' ' ' ARG . 26.4 m -96.43 -8.44 32.28 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 116.126 -0.488 . . . . 11.45 110.154 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.652 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 2.2 m-30 -79.88 161.56 25.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.951 -1.093 . . . . 14.25 109.872 -178.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.51 ' NZ ' ' HB2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -165.68 174.35 9.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.795 . . . . 32.7 109.151 179.673 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.538 HG12 ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -100.06 104.46 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 15.63 109.466 -179.893 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.51 -168.01 37.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.595 -1.402 . . . . 12.7 109.595 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 23.32 2.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.129 -1.218 . . . . 26.29 109.888 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.527 ' CD2' ' HE2' ' A' ' 77' ' ' MET . 59.2 t80 -93.86 -13.2 27.49 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.51 -0.744 . . . . 20.44 109.51 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 87.07 49.89 3.86 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.613 -1.395 . . . . 13.82 109.613 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 171.2 172.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -1.197 . . . . 18.27 109.645 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.472 ' C ' ' CG ' ' A' ' 77' ' ' MET . 14.7 tp -77.15 149.94 35.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 12.43 109.622 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.527 ' HE2' ' CD2' ' A' ' 73' ' ' PHE . 8.6 mtp -155.57 135.51 12.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 35.11 109.401 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.2 mp -67.15 142.09 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 13.67 110.028 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.454 ' OD1' ' HD3' ' A' ' 69' ' ' LYS . 1.5 t70 -107.66 -41.18 5.09 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.572 -1.269 . . . . 24.06 107.572 178.014 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.477 ' O ' ' OG ' ' A' ' 67' ' ' SER . 0.3 OUTLIER -163.43 66.73 0.18 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.167 -1.42 . . . . 35.04 107.167 178.457 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.587 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -28.41 119.61 0.12 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.218 -0.901 . . . . 18.72 112.095 -177.99 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -92.98 101.14 13.48 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.296 -1.002 . . . . 20.55 108.296 178.896 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.621 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -70.72 146.51 49.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.085 -1.01 . . . . 14.4 110.943 -178.625 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 62' ' ' THR . 16.8 m -145.9 152.02 46.97 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.283 -1.006 . . . . 17.65 108.283 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 26.6 Cg_endo -64.76 144.34 83.37 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.306 2.004 . . . . 25.7 110.496 179.248 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.99 120.48 21.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.268 -0.895 . . . . 49.29 109.535 -179.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.981 -1.009 . . . . 58.91 109.463 179.979 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.458 ' O ' ' C ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.454 -0.573 . . . . 64.91 109.454 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 2' ' ' ILE . . . . . 0.579 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -42.87 131.68 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.701 -0.851 . . . . 33.8 108.701 179.318 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 1.4 mttp -102.84 153.73 19.9 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.122 -0.986 . . . . 32.72 110.37 -178.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' B' ' 61' ' ' TYR . 33.4 t -159.79 166.19 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.68 0.752 . . . . 14.46 109.75 -179.393 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 32.5 mt-10 -153.21 102.96 2.66 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.67 -0.863 . . . . 22.12 108.67 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.584 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -71.77 103.89 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.047 -1.094 . . . . 14.23 108.047 179.769 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.645 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.68 171.23 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.366 -0.834 . . . . 25.43 109.619 -179.28 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.1 Cg_endo -74.97 -22.78 14.52 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.433 2.089 . . . . 13.61 109.759 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.6 2.32 54.12 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.977 -0.749 . . . . 15.52 108.977 179.074 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.524 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 8.8 mm-40 -121.67 41.06 3.46 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.289 -0.882 . . . . 17.31 109.136 179.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -109.41 12.31 24.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.958 . . . . 24.78 109.785 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.422 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -131.52 141.8 49.81 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.198 -0.939 . . . . 47.9 108.577 179.825 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . 0.586 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 37.2 p90 -93.96 167.45 11.6 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.011 -1.056 . . . . 21.61 109.713 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.454 HG21 ' N ' ' B' ' 15' ' ' THR . 100.0 m -134.82 150.22 50.47 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.795 -0.817 . . . . 14.89 108.795 179.156 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 15' ' ' THR . . . . . 0.454 ' N ' HG21 ' B' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.468 0 O-C-N 121.204 -0.935 . . . . 17.35 109.415 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.383 0.611 . . . . 24.0 110.024 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.583 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 97.0 m-20 -69.3 129.99 41.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 23.31 109.368 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 34.1 mt-10 -112.16 163.61 14.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.058 -1.026 . . . . 40.03 109.157 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.549 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -150.77 -176.91 5.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 12.39 110.021 -179.902 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 32' ' ' LEU . . . . . 0.525 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 27.9 mt -133.19 158.71 42.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.468 -0.77 . . . . 17.42 109.101 179.6 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 12.2 m -155.66 172.91 17.51 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.146 -1.057 . . . . 13.84 108.146 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.666 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 32.4 m-85 -122.01 104.57 9.61 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.051 -1.031 . . . . 21.14 109.109 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . 0.525 ' HA ' HG21 ' B' ' 4' ' ' VAL . 42.4 t -79.85 159.67 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.073 -1.017 . . . . 10.66 110.686 -179.311 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.498 ' N ' ' CG1' ' B' ' 35' ' ' VAL . 31.7 m-20 -140.89 -147.9 0.23 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.728 -0.841 . . . . 25.89 108.728 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 37' ' ' LEU . . . . . 0.517 ' HB3' ' CD1' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 67.78 -61.96 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 24.24 109.183 179.966 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -87.13 21.14 22.01 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.074 -1.61 . . . . 31.02 109.074 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 39' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' B' ' 36' ' ' ASP . 1.5 p30 176.23 112.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -1.076 . . . . 43.23 109.361 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' B' ' 39' ' ' ASN . 3.2 mt-10 -41.65 -63.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.372 -0.83 . . . . 42.34 109.898 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -65.0 154.43 86.57 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 109.002 -0.74 . . . . 9.49 109.002 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.666 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.9 Cg_endo -78.19 143.74 20.29 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.245 1.963 . . . . 17.92 110.241 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 43' ' ' VAL . . . . . 0.497 ' CG2' HG23 ' A' ' 70' ' ' VAL . 19.2 m -115.97 116.22 51.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.318 -0.863 . . . . 20.57 109.15 179.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.604 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 54.9 tp -73.3 102.59 3.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.271 -0.893 . . . . 20.21 109.68 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.538 ' CG1' HG12 ' A' ' 70' ' ' VAL . 1.2 m -107.27 -178.38 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.552 -0.718 . . . . 10.81 109.23 179.797 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 1.1 mtpt -101.08 154.42 18.74 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.469 -0.892 . . . . 36.74 109.718 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 47' ' ' ILE . . . . . 0.618 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -140.72 173.38 9.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.325 -0.86 . . . . 19.74 109.317 -179.894 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.14 145.85 37.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 22.56 109.274 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.586 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 2.9 tm? -127.3 126.9 43.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.311 -0.868 . . . . 20.41 109.061 -179.678 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.472 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 3.1 m-20 -63.34 142.27 58.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.968 . . . . 33.99 109.868 -179.441 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.42 123.78 17.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 54.92 109.395 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.0 -15.97 50.23 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.437 -1.465 . . . . 36.1 109.437 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 53' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -75.25 153.85 86.2 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.29 -1.123 . . . . 54.76 109.469 179.943 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.2 Cg_endo -77.67 109.79 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.628 2.218 . . . . 28.37 110.383 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.537 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -41.39 150.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -0.82 . . . . 17.21 110.041 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.618 ' CE1' HG12 ' B' ' 47' ' ' ILE . 90.2 m-85 -45.53 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.375 -0.828 . . . . 17.19 109.003 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 57' ' ' ALA . . . . . 0.468 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -53.02 173.56 0.17 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 17.82 109.654 -179.602 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.79 113.44 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.617 2.211 . . . . 17.28 110.077 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.4 -179.43 46.63 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.776 -1.33 . . . . 17.22 109.776 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 3.1 mp -74.47 146.8 42.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -1.167 . . . . 19.57 108.414 179.14 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.584 ' CE1' HD11 ' B' ' 6' ' ' ILE . 27.1 m-85 -135.9 166.1 24.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.956 -1.09 . . . . 14.61 110.978 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 62' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 2' ' ' ILE . 33.0 p -149.14 123.24 9.47 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 105.943 -1.873 . . . . 18.36 105.943 178.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.581 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 1.7 t -54.12 162.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 118.276 -1.37 . . . . 19.13 108.721 -178.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 64' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -124.89 128.23 48.33 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.422 -0.799 . . . . 20.65 109.06 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . 0.662 ' CB ' ' CD2' ' B' ' 68' ' ' PHE . 0.7 OUTLIER -72.67 2.84 5.79 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.46 -0.775 . . . . 19.65 110.132 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.1 t -56.01 -20.08 15.2 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.099 -1.445 . . . . 14.72 107.099 178.284 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' B' ' 80' ' ' ARG . 25.8 m -96.41 -8.45 32.33 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 116.096 -0.502 . . . . 11.45 110.239 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.662 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 2.3 m-30 -79.86 161.46 25.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.004 -1.06 . . . . 14.25 109.756 -178.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.517 ' NZ ' ' HB2' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -165.56 174.41 9.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.455 -0.778 . . . . 32.7 109.132 179.679 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.525 HG12 ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -100.1 104.48 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 15.63 109.393 -179.93 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.45 -167.87 37.32 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.613 -1.395 . . . . 12.7 109.613 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 23.02 2.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.113 -1.228 . . . . 26.29 109.863 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.537 ' CD2' ' HE2' ' B' ' 77' ' ' MET . 59.0 t80 -93.6 -13.35 27.78 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.493 -0.755 . . . . 20.44 109.481 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 74' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 87.26 49.9 3.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.547 -1.421 . . . . 13.82 109.547 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' B' ' 74' ' ' GLY . 0.3 OUTLIER 171.28 172.91 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -1.16 . . . . 18.27 109.588 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.473 ' C ' ' CG ' ' B' ' 77' ' ' MET . 14.7 tp -77.23 150.02 35.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.295 -0.878 . . . . 12.43 109.659 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.537 ' HE2' ' CD2' ' B' ' 73' ' ' PHE . 8.5 mtp -155.71 135.15 12.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 35.11 109.493 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.609 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.2 mp -66.81 142.1 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 13.67 110.116 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.452 ' OD1' ' HD3' ' B' ' 69' ' ' LYS . 1.5 t70 -107.8 -40.98 5.12 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.606 -1.257 . . . . 24.06 107.606 177.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 80' ' ' ARG . . . . . 0.477 ' O ' ' OG ' ' B' ' 67' ' ' SER . 0.3 OUTLIER -163.56 66.79 0.18 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.12 -1.437 . . . . 35.04 107.12 178.422 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.581 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -28.47 119.58 0.12 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.215 -0.902 . . . . 18.72 112.036 -178.046 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 82' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -92.94 101.12 13.46 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.268 -1.012 . . . . 20.55 108.268 178.861 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.618 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -70.7 146.47 49.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.977 . . . . 14.4 110.91 -178.67 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 62' ' ' THR . 16.8 m -145.82 152.34 48.06 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.296 -1.001 . . . . 17.65 108.296 179.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 26.7 Cg_endo -65.05 144.45 82.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.254 1.969 . . . . 25.7 110.56 179.274 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.97 120.38 21.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 49.29 109.605 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.001 -0.999 . . . . 58.91 109.471 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.483 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.326 0.584 . . . . 64.91 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.55 ' HA ' ' CD2' ' B' ' 65' ' ' LEU . 5.5 mt -72.56 78.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.238 -1.023 . . . . 33.8 108.238 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 37' ' ' LEU . 23.0 mttp -61.85 172.26 1.37 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.715 0.769 . . . . 32.72 111.371 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 5' ' ' GLU . 23.0 t -168.23 168.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.861 -0.792 . . . . 14.46 108.861 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.568 ' N ' ' CG1' ' A' ' 4' ' ' VAL . 23.4 mt-10 -147.04 104.29 3.67 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.679 -0.859 . . . . 22.12 108.679 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -69.36 104.34 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.912 -1.144 . . . . 14.23 107.912 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.653 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.47 171.13 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.083 -1.011 . . . . 25.43 109.665 -179.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.7 Cg_endo -76.32 -24.22 11.0 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.562 2.174 . . . . 13.61 109.899 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -94.21 4.29 54.09 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.553 -0.717 . . . . 15.52 109.258 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.518 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 10.6 mm-40 -117.52 34.1 5.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.27 -0.894 . . . . 17.31 109.372 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -95.4 11.34 33.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 24.78 110.182 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 16.3 mt-30 -138.86 132.76 31.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.007 . . . . 47.9 110.056 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.594 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 11.4 p90 -83.19 -178.36 7.07 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.402 -0.811 . . . . 21.61 109.915 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -130.4 144.67 51.54 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.752 -0.593 . . . . 14.89 109.404 179.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.2 118.91 30.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 17.35 109.222 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -129.51 138.02 51.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 34.38 109.603 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -44.7 150.38 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 38.77 109.108 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 26' ' ' TYR . . . -162.12 158.93 31.01 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.745 -1.342 . . . . 34.58 109.745 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.634 ' N ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -144.32 112.55 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.155 . . . . 41.87 108.868 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -45.78 -91.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.442 -0.786 . . . . 47.21 109.719 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 58.45 1.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 71.56 109.67 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 58.49 18.38 5.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.926 . . . . 66.6 109.418 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 24' ' ' LYS . . . -99.48 -54.07 1.1 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.484 -1.446 . . . . 55.49 109.484 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' CD ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -143.87 153.02 56.95 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.278 -1.131 . . . . 44.99 109.297 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.83 132.84 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.663 2.242 . . . . 44.1 110.412 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.634 ' CE1' ' N ' ' A' ' 19' ' ' VAL . 14.7 p90 -135.64 108.5 7.57 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.204 -0.935 . . . . 32.09 109.754 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -84.92 63.32 8.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 29.25 108.893 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.579 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -55.86 165.97 0.82 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.545 -0.722 . . . . 24.0 109.946 -179.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.594 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -106.07 133.27 51.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.399 -0.813 . . . . 23.31 109.342 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.81 151.76 29.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.076 -1.015 . . . . 40.03 109.62 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.527 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -133.62 -166.77 1.83 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.125 -0.984 . . . . 12.39 109.56 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -136.28 169.5 17.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.88 . . . . 17.42 109.934 -179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -158.74 164.68 35.65 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.211 -1.033 . . . . 13.84 108.211 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.656 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.8 m-85 -121.24 109.69 15.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.987 -1.07 . . . . 21.14 110.04 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.555 ' CG2' HG21 ' A' ' 4' ' ' VAL . 29.7 t -95.49 143.08 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 10.66 109.466 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -130.89 -24.56 2.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.146 -0.972 . . . . 25.89 110.76 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -45.96 -16.4 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.972 -1.08 . . . . 24.24 111.384 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.586 ' N ' ' CD2' ' A' ' 37' ' ' LEU . . . -120.19 16.28 10.01 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 108.206 -1.957 . . . . 31.02 108.206 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 36' ' ' ASP . 1.3 p30 -178.02 115.96 0.08 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.706 -0.879 . . . . 43.23 108.828 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 39' ' ' ASN . 1.2 mp0 -36.95 -63.47 0.42 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.66 0.743 . . . . 42.34 109.978 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.8 155.87 68.52 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.449 -0.945 . . . . 3.98 108.449 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.656 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.5 Cg_endo -77.95 141.31 18.86 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.923 1.749 . . . . 17.92 109.936 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 35' ' ' VAL . 29.3 m -113.72 115.33 49.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.316 -0.865 . . . . 20.57 108.957 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 54.6 tp -67.71 107.99 2.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.423 -0.798 . . . . 20.21 109.545 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.502 ' CG1' ' SG ' ' A' ' 33' ' ' CYS . 8.9 p -111.2 163.31 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.476 -0.765 . . . . 10.81 109.324 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 160.84 22.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 36.74 110.232 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.595 HD11 ' CE1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -156.31 119.68 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.798 -0.816 . . . . 19.74 108.798 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.507 ' N ' HD12 ' A' ' 47' ' ' ILE . 1.3 m -60.17 156.03 16.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.984 -1.072 . . . . 22.56 109.757 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -131.95 109.81 10.32 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.977 -0.749 . . . . 20.41 108.977 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.521 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -63.88 145.71 55.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 33.99 109.654 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HG2' ' N ' ' A' ' 52' ' ' GLY . 28.9 tt0 -43.51 -87.67 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.258 -0.901 . . . . 54.92 109.661 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' N ' ' HG2' ' A' ' 51' ' ' GLU . . . -41.06 -39.07 1.93 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.889 -1.284 . . . . 36.1 109.889 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.533 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -64.11 126.11 89.51 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.095 -1.238 . . . . 54.76 109.34 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.0 Cg_endo -79.62 144.86 17.93 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.401 2.067 . . . . 28.37 110.4 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.479 ' HA ' HD22 ' A' ' 49' ' ' LEU . . . -40.21 146.02 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.396 -0.815 . . . . 17.21 110.169 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.595 ' CE1' HD11 ' A' ' 47' ' ' ILE . 87.4 m-85 -53.82 111.42 0.74 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.297 -0.877 . . . . 17.19 109.222 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.574 ' CB ' ' CD ' ' A' ' 58' ' ' PRO . . . -66.32 -178.85 0.34 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.426 -0.796 . . . . 17.82 109.528 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -78.12 131.79 11.11 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.49 2.127 . . . . 17.28 110.588 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.632 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 153.91 143.01 3.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.15 -1.58 . . . . 17.22 109.15 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 59' ' ' GLY . 3.8 mp -44.77 138.93 3.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.908 -1.348 . . . . 19.57 109.489 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.632 ' CD1' ' O ' ' A' ' 59' ' ' GLY . 17.9 m-85 -119.09 164.18 15.9 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.521 1.153 . . . . 14.61 111.497 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.493 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 48.0 p -145.88 122.76 11.3 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.514 -1.661 . . . . 18.36 106.514 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 1.7 t -60.58 162.67 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 C-N-CA 118.427 -1.309 . . . . 19.13 108.72 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -120.77 130.41 54.01 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.43 -0.794 . . . . 20.65 109.248 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.676 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -73.29 2.81 6.73 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.474 -0.766 . . . . 19.65 109.828 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -19.21 11.71 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.101 -1.444 . . . . 14.72 107.101 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.509 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 1.4 m -96.29 -6.23 38.33 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.134 -0.485 . . . . 11.45 110.391 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.2 m-30 -86.43 161.63 18.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.89 -1.131 . . . . 14.25 110.021 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -144.94 164.78 30.08 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.022 -0.733 . . . . 32.7 109.022 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.445 ' CG1' HG22 ' B' ' 43' ' ' VAL . 1.8 t -120.97 129.1 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 15.63 109.498 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.2 -151.52 22.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.36 -1.496 . . . . 12.7 109.36 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 0.5 OUTLIER 51.93 68.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -1.145 . . . . 26.29 109.211 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 71.07 5.62 5.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.836 . . . . 20.44 109.367 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' HG21 ' B' ' 45' ' ' VAL . . . 86.87 46.52 5.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.523 -1.431 . . . . 13.82 109.523 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.413 ' HB2' ' HE1' ' A' ' 77' ' ' MET . 57.7 m -125.0 116.45 22.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -1.126 . . . . 18.27 109.635 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.6 OUTLIER -59.22 147.15 36.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 12.43 109.129 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 37.8 mtt -160.12 132.32 6.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 35.11 109.725 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.598 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.7 mp -67.16 140.16 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.373 -0.829 . . . . 13.67 109.826 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 8.8 t70 -107.61 -10.27 15.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.324 -0.86 . . . . 24.06 108.962 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.509 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 163.94 67.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.897 -1.52 . . . . 35.04 106.897 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.601 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -31.66 118.73 0.23 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.323 -0.853 . . . . 18.72 112.199 -177.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.508 ' NH1' ' HG3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -91.9 109.87 21.21 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.229 -1.026 . . . . 20.55 108.229 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.8 OUTLIER -75.63 155.19 36.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.205 -0.934 . . . . 14.4 111.382 -178.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 83' ' ' LEU . 35.6 m -159.89 148.95 14.02 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 107.866 -1.161 . . . . 17.65 107.866 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 22.8 Cg_endo -61.5 139.3 81.14 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.99 1.794 . . . . 25.7 110.503 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.489 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -65.66 118.1 9.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -0.921 . . . . 49.29 109.698 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.414 ' C ' ' HD3' ' A' ' 87' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.033 -0.984 . . . . 58.91 109.526 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.482 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.314 0.578 . . . . 64.91 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.554 HG12 ' CB ' ' A' ' 65' ' ' LEU . 5.5 mt -72.97 78.15 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.267 -1.012 . . . . 33.8 108.267 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.602 ' N ' ' CD1' ' B' ' 37' ' ' LEU . 23.0 mttp -61.72 172.22 1.34 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.759 0.79 . . . . 32.72 111.33 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' B' ' 5' ' ' GLU . 23.1 t -168.2 168.44 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.85 -0.796 . . . . 14.46 108.85 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.573 ' N ' ' CG1' ' B' ' 4' ' ' VAL . 23.5 mt-10 -147.15 104.21 3.65 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.726 -0.842 . . . . 22.12 108.726 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.586 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -69.34 104.08 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.962 -1.125 . . . . 14.23 107.962 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.66 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.24 171.11 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.957 . . . . 25.43 109.682 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -76.36 -24.27 10.89 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.474 2.116 . . . . 13.61 109.847 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -94.12 4.1 54.37 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.521 -0.737 . . . . 15.52 109.224 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.508 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 10.5 mm-40 -117.25 33.95 5.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.262 -0.899 . . . . 17.31 109.377 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -95.18 11.3 32.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 24.78 110.209 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.427 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 16.2 mt-30 -138.82 132.88 31.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 47.9 110.088 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.603 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 11.4 p90 -83.26 -178.29 7.03 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.408 -0.807 . . . . 21.61 109.93 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 0.6 OUTLIER -130.48 144.65 51.54 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.738 -0.601 . . . . 14.89 109.426 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.18 118.99 30.91 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.29 -0.882 . . . . 17.35 109.199 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' B' ' 17' ' ' SER . 5.1 tpp180 -129.59 138.05 51.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 34.38 109.579 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.2 OUTLIER -44.74 150.44 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 38.77 109.082 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' B' ' 26' ' ' TYR . . . -162.22 159.0 31.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.34 . . . . 34.58 109.751 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.628 ' N ' ' CE1' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -144.48 112.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.28 -1.129 . . . . 41.87 108.952 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -45.67 -91.32 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.405 -0.81 . . . . 47.21 109.752 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.32 58.53 1.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 71.56 109.613 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 58.37 18.37 5.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 66.6 109.438 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.414 ' C ' ' HG3' ' B' ' 24' ' ' LYS . . . -99.52 -53.82 1.11 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.441 -1.464 . . . . 55.49 109.441 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.471 ' CD ' ' N ' ' B' ' 24' ' ' LYS . 0.0 OUTLIER -144.08 152.93 55.99 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.302 -1.116 . . . . 44.99 109.334 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.75 132.92 12.31 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.647 2.231 . . . . 44.1 110.434 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' B' ' 19' ' ' VAL . 14.7 p90 -135.72 108.55 7.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.181 -0.949 . . . . 32.09 109.794 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -85.06 63.43 8.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.142 -0.974 . . . . 29.25 108.884 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.586 ' HB2' ' CE2' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -55.95 165.97 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.484 -0.76 . . . . 24.0 109.919 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.603 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -106.03 133.27 51.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.398 -0.813 . . . . 23.31 109.298 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.79 151.98 29.7 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.037 -1.039 . . . . 40.03 109.573 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.527 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -133.75 -166.78 1.83 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 12.39 109.573 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.0 OUTLIER -136.24 169.57 17.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.234 -0.916 . . . . 17.42 109.949 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -158.87 164.69 35.49 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.177 -1.046 . . . . 13.84 108.177 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.66 ' CD2' ' CD ' ' B' ' 7' ' ' LYS . 22.4 m-85 -121.29 109.75 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 21.14 109.989 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.555 ' CG1' HD12 ' B' ' 37' ' ' LEU . 31.0 t -95.64 143.05 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 10.66 109.446 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' B' ' 36' ' ' ASP . 0.5 OUTLIER -130.9 -24.51 2.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 25.89 110.8 -179.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -46.21 -16.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.002 -1.061 . . . . 24.24 111.38 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.588 ' N ' ' CD2' ' B' ' 37' ' ' LEU . . . -120.15 16.09 10.06 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 108.208 -1.957 . . . . 31.02 108.208 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' B' ' 36' ' ' ASP . 1.3 p30 -177.9 116.03 0.08 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.686 -0.891 . . . . 43.23 108.833 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' B' ' 39' ' ' ASN . 1.1 mp0 -36.91 -63.46 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.679 0.752 . . . . 42.34 110.015 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.88 155.91 69.07 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 108.438 -0.949 . . . . 3.98 108.438 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.654 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.6 Cg_endo -77.93 141.27 18.87 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.939 1.759 . . . . 17.92 109.894 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' B' ' 34' ' ' TYR . 29.3 m -113.78 115.33 49.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.273 -0.892 . . . . 20.57 108.874 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.595 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 54.4 tp -67.59 107.9 2.68 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.397 -0.815 . . . . 20.21 109.603 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.505 ' CG1' ' SG ' ' B' ' 33' ' ' CYS . 8.9 p -111.09 163.27 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.52 -0.737 . . . . 10.81 109.369 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 160.83 21.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 36.74 110.261 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.597 HD11 ' CE1' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -156.2 119.67 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 108.801 -0.814 . . . . 19.74 108.801 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.501 ' CG2' ' CD2' ' B' ' 28' ' ' LEU . 1.3 m -60.23 155.64 17.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.027 . . . . 22.56 109.732 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -131.55 109.85 10.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 20.41 108.982 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -63.83 145.76 55.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 33.99 109.692 -179.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' B' ' 52' ' ' GLY . 28.9 tt0 -43.66 -87.63 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.305 -0.872 . . . . 54.92 109.629 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.493 ' N ' ' HG2' ' B' ' 51' ' ' GLU . . . -41.19 -38.83 1.97 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.852 -1.299 . . . . 36.1 109.852 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.536 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -64.29 126.15 89.8 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.07 -1.253 . . . . 54.76 109.336 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.9 Cg_endo -79.61 144.86 17.94 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.417 2.078 . . . . 28.37 110.421 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.465 ' HA ' HD22 ' B' ' 49' ' ' LEU . . . -40.16 145.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -0.825 . . . . 17.21 110.308 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.597 ' CE1' HD11 ' B' ' 47' ' ' ILE . 87.4 m-85 -53.35 111.73 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 17.19 109.16 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.567 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -67.16 -178.94 0.39 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.389 -0.82 . . . . 17.82 109.594 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.4 Cg_endo -77.71 130.38 10.61 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.458 2.105 . . . . 17.28 110.358 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.635 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 155.94 143.0 3.55 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.205 -1.558 . . . . 17.22 109.205 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 59' ' ' GLY . 3.6 mp -45.43 138.34 4.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.426 . . . . 19.57 109.177 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' B' ' 59' ' ' GLY . 20.0 m-85 -118.43 164.26 15.52 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.49 1.138 . . . . 14.61 111.407 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.499 ' CG2' ' HA ' ' B' ' 86' ' ' ALA . 48.9 p -145.9 122.84 11.34 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 106.386 -1.709 . . . . 18.36 106.386 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.611 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 1.6 t -60.44 163.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 C-N-CA 118.448 -1.301 . . . . 19.13 108.719 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.492 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -121.62 130.3 53.39 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.475 -0.765 . . . . 20.65 109.33 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.64 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.9 OUTLIER -73.13 2.77 6.52 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.492 -0.755 . . . . 19.65 109.889 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.29 -18.97 12.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.126 -1.435 . . . . 14.72 107.126 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 1.4 m -96.35 -6.93 36.51 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 116.132 -0.485 . . . . 11.45 110.416 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.64 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.1 m-30 -85.97 161.25 19.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.851 -1.156 . . . . 14.25 109.958 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -144.57 165.1 28.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.74 . . . . 32.7 109.014 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -121.08 129.2 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 15.63 109.506 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.0 -151.66 22.36 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.333 -1.507 . . . . 12.7 109.333 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.6 OUTLIER 52.0 68.86 0.74 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -1.181 . . . . 26.29 109.228 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.2 OUTLIER 71.22 5.73 5.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 20.44 109.34 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.74 46.56 5.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.558 -1.417 . . . . 13.82 109.558 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.414 ' HB2' ' HE1' ' B' ' 77' ' ' MET . 57.7 m -125.15 116.34 21.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -1.129 . . . . 18.27 109.696 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.534 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.6 OUTLIER -59.05 147.05 36.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 12.43 109.212 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.534 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 37.5 mtt -160.08 132.51 6.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.923 . . . . 35.11 109.643 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.605 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.7 mp -67.37 140.24 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 13.67 109.839 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 8.6 t70 -107.51 -10.27 15.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.367 -0.833 . . . . 24.06 108.966 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.0 OUTLIER 163.89 67.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.923 -1.51 . . . . 35.04 106.923 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.611 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -31.76 118.75 0.24 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.253 -0.885 . . . . 18.72 112.182 -177.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.509 ' NH1' ' HG3' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -91.88 109.94 21.28 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.194 -1.039 . . . . 20.55 108.194 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.582 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -75.65 155.28 35.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.17 -0.956 . . . . 14.4 111.384 -178.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' B' ' 83' ' ' LEU . 35.6 m -159.98 149.21 14.14 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 107.807 -1.183 . . . . 17.65 107.807 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 23.5 Cg_endo -61.76 139.13 78.74 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.024 1.816 . . . . 25.7 110.545 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.499 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -65.49 118.07 8.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 49.29 109.6 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' B' ' 87' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.95 -1.024 . . . . 58.91 109.429 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.528 ' SD ' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.461 0.648 . . . . 64.91 109.493 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.571 ' CG2' HD11 ' B' ' 65' ' ' LEU . 3.9 mt -78.55 77.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.7 -1.222 . . . . 33.8 107.7 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.448 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -67.39 167.39 12.68 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.011 0.91 . . . . 32.72 110.848 -178.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.53 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -177.44 160.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.501 -0.926 . . . . 14.46 108.501 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 29.8 mt-10 -134.2 114.65 13.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.67 0.748 . . . . 22.12 109.004 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.583 HD12 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -73.74 99.28 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.788 -1.19 . . . . 14.23 107.788 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.635 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -43.95 169.92 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.335 -0.853 . . . . 25.43 109.925 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 32.5 Cg_endo -74.42 -28.31 10.4 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.469 2.112 . . . . 13.61 110.024 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.96 8.78 41.74 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.826 -0.805 . . . . 15.52 108.826 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.528 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 5.6 mm100 -125.91 22.32 7.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 17.31 109.87 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -95.77 15.23 20.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.105 -0.997 . . . . 24.78 110.162 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 60.7 mt-30 -134.9 141.09 46.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.127 -0.983 . . . . 47.9 109.754 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.625 ' CE1' ' ND2' ' A' ' 29' ' ' ASN . 45.1 p90 -93.96 153.91 17.95 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.3 -0.875 . . . . 21.61 109.32 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 m -113.11 150.45 32.11 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.331 -0.856 . . . . 14.89 108.92 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.86 121.91 44.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.289 -0.882 . . . . 17.35 109.541 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 27' ' ' SER . 0.6 OUTLIER -136.59 156.05 49.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 34.38 109.355 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 16' ' ' ARG . 94.6 p -42.43 155.25 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.428 -0.795 . . . . 38.77 109.475 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.583 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -157.42 165.72 33.49 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.199 -1.16 . . . . 34.58 110.199 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.547 ' N ' ' CE1' ' A' ' 26' ' ' TYR . 1.4 t -155.59 126.53 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.366 -1.079 . . . . 41.87 109.029 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 3.4 m -64.29 -17.27 63.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 47.21 109.716 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.429 ' O ' ' HB3' ' A' ' 22' ' ' GLN . 0.0 OUTLIER 175.86 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.956 . . . . 71.56 109.712 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.429 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 0.5 OUTLIER 174.97 43.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.125 -0.984 . . . . 66.6 109.797 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' C ' ' HG3' ' A' ' 24' ' ' LYS . . . -133.3 -55.28 0.08 OUTLIER Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.022 -1.631 . . . . 55.49 109.022 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.403 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -138.18 152.14 71.11 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.478 -1.013 . . . . 44.99 108.881 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.9 Cg_endo -77.26 161.76 31.8 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.559 2.172 . . . . 44.1 110.523 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.66 ' O ' ' N ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -157.41 50.94 0.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 32.09 110.143 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 26' ' ' TYR . 13.5 m -30.56 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.267 0.556 . . . . 29.25 110.679 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -82.8 150.18 26.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.376 -0.828 . . . . 24.0 110.094 -179.055 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.625 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 67.4 m-20 -72.21 151.1 43.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.372 -0.83 . . . . 23.31 109.533 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.444 ' HG3' HD13 ' A' ' 28' ' ' LEU . 1.4 mt-10 -134.61 132.64 39.27 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.699 -0.852 . . . . 40.03 108.699 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.523 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -123.41 -174.1 2.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.071 -1.018 . . . . 12.39 110.02 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.7 mp -143.6 152.85 41.9 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.853 -0.795 . . . . 17.42 108.853 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -152.82 -177.67 6.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.974 -1.121 . . . . 13.84 107.974 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.681 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.0 m-85 -129.6 99.62 5.23 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.031 -1.043 . . . . 21.14 109.937 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.5 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 60.6 t -95.24 113.65 30.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.089 -1.007 . . . . 10.66 109.462 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 5.3 t70 -62.46 -28.48 69.85 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.199 -0.938 . . . . 25.89 108.572 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.509 ' CD2' ' HA ' ' B' ' 69' ' ' LYS . 0.7 OUTLIER 46.23 25.26 0.34 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.467 -0.77 . . . . 24.24 109.458 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.07 81.67 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.818 -1.313 . . . . 31.02 109.818 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 64.3 m-20 -86.08 15.21 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -1.209 . . . . 43.23 110.225 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 9.6 mt-10 60.73 11.52 3.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.311 -0.868 . . . . 42.34 110.36 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 71.3 m80 -161.18 152.68 16.01 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.046 -1.094 . . . . 6.37 108.046 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.681 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -75.76 136.59 19.08 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.873 1.715 . . . . 17.92 110.397 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 4.5 m -110.84 118.19 56.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.43 -0.793 . . . . 20.57 109.0 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 45.5 tp -73.22 104.48 4.28 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.351 -0.843 . . . . 20.21 110.255 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.531 HG13 ' CG1' ' B' ' 70' ' ' VAL . 32.6 m -108.46 -177.2 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.527 -0.916 . . . . 10.81 108.527 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.22 154.56 22.23 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.007 -1.077 . . . . 36.74 110.257 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.601 HG13 ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -127.18 170.1 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 109.029 -0.73 . . . . 19.74 109.029 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.523 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 3.6 m -123.01 124.0 42.16 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.356 -0.84 . . . . 22.56 108.808 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.59 ' CB ' ' CB ' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -102.53 163.83 12.0 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.331 -0.856 . . . . 20.41 109.331 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.43 167.68 9.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.897 . . . . 33.99 109.54 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -72.86 87.61 1.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 54.92 109.519 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.34 -25.84 4.48 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.514 -1.434 . . . . 36.1 109.514 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.464 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 2.0 mt-30 -73.7 140.97 78.66 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 54.76 109.433 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.8 Cg_endo -79.5 118.91 3.98 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.577 2.185 . . . . 28.37 110.28 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB3' ' HG3' ' A' ' 31' ' ' GLN . . . -42.52 155.19 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.24 -0.912 . . . . 17.21 110.308 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.618 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 16.3 m-30 -49.86 112.14 0.62 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.531 -0.731 . . . . 17.19 109.377 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.533 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -61.72 176.43 0.44 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.138 -0.976 . . . . 17.82 109.289 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.7 Cg_endo -77.05 119.85 5.2 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.545 2.164 . . . . 17.28 110.221 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.42 177.54 37.86 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.835 -1.306 . . . . 17.22 109.835 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 5.2 mp -71.58 159.48 34.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 19.57 108.469 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.583 ' CE1' HD12 ' A' ' 6' ' ' ILE . 20.5 m-85 -141.8 165.1 28.41 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.849 -1.157 . . . . 14.61 111.784 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.537 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 62.3 p -147.24 119.71 8.47 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.512 -1.662 . . . . 18.36 106.512 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.553 ' CG2' HG23 ' A' ' 2' ' ' ILE . 13.3 t -52.25 169.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 118.548 -1.261 . . . . 19.13 108.493 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.527 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.8 t-80 -131.33 119.64 22.01 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.36 -0.838 . . . . 20.65 108.911 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.605 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -62.35 -12.44 21.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.694 -0.629 . . . . 19.65 109.641 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.2 t -46.98 -20.92 0.17 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.944 -1.097 . . . . 14.72 108.593 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 34.1 m -96.7 -7.93 32.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.496 -0.753 . . . . 11.45 111.035 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.1 m-30 -81.1 161.77 23.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.617 -1.302 . . . . 14.25 109.816 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.493 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 5.1 pttm -145.74 174.75 10.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.45 -0.781 . . . . 32.7 109.663 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' B' ' 45' ' ' VAL . 2.5 t -117.19 129.2 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.419 -0.801 . . . . 15.63 109.307 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.14 168.12 35.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.479 -1.448 . . . . 12.7 109.479 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -76.74 0.55 20.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.232 -1.157 . . . . 26.29 109.733 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -26.99 23.16 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.461 -0.774 . . . . 20.44 109.21 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.77 65.31 0.76 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.492 -1.443 . . . . 13.82 109.492 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.14 133.43 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -1.107 . . . . 18.27 109.524 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' O ' ' CG ' ' A' ' 77' ' ' MET . 2.4 tt -73.56 148.66 42.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 12.43 109.519 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 30.3 mtm -155.94 128.97 8.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 35.11 109.558 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.598 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.1 mt -64.72 141.0 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 13.67 109.988 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -108.25 -37.3 6.05 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.637 -1.246 . . . . 24.06 107.637 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.0 tpm_? -168.57 68.06 0.07 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.19 -1.411 . . . . 35.04 107.19 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -31.1 120.23 0.21 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.499 -0.773 . . . . 18.72 111.518 -178.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -90.45 103.25 15.96 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.988 -1.116 . . . . 20.55 107.988 178.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.618 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -75.83 147.33 39.21 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.934 -1.104 . . . . 14.4 111.006 -178.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.466 ' C ' ' CD2' ' A' ' 61' ' ' TYR . 18.1 m -148.22 160.22 37.62 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 107.727 -1.212 . . . . 17.65 107.727 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.7 Cg_endo -62.32 146.63 95.75 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.036 1.824 . . . . 25.7 110.398 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.537 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -79.5 116.6 19.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.152 -0.968 . . . . 49.29 109.696 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.004 -0.998 . . . . 58.91 109.454 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.525 ' SD ' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.502 0.668 . . . . 64.91 109.429 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.568 ' CG2' HD11 ' A' ' 65' ' ' LEU . 4.0 mt -78.29 77.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.719 -1.215 . . . . 33.8 107.719 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.449 ' O ' HG12 ' B' ' 35' ' ' VAL . 0.2 OUTLIER -67.57 167.52 12.81 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.02 0.914 . . . . 32.72 110.869 -178.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.531 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -177.45 160.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.458 -0.942 . . . . 14.46 108.458 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.48 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 29.8 mt-10 -134.52 114.6 13.0 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.924 -0.769 . . . . 22.12 108.924 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.592 HD12 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -73.74 99.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.81 -1.182 . . . . 14.23 107.81 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.64 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.0 169.96 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.34 -0.85 . . . . 25.43 109.898 -178.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.0 Cg_endo -74.39 -28.29 10.47 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.488 2.125 . . . . 13.61 110.088 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.13 9.06 41.03 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.767 -0.827 . . . . 15.52 108.767 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 5.6 mm100 -126.13 22.34 7.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 17.31 109.864 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -95.74 15.14 20.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 24.78 110.151 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.424 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 60.4 mt-30 -134.86 141.1 46.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.038 -1.039 . . . . 47.9 109.736 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.629 ' CE1' ' ND2' ' B' ' 29' ' ' ASN . 45.1 p90 -94.03 153.91 17.92 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.257 -0.902 . . . . 21.61 109.343 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 81.1 m -113.21 150.15 32.73 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.296 -0.877 . . . . 14.89 108.955 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.61 121.86 44.42 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.33 -0.857 . . . . 17.35 109.606 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' B' ' 27' ' ' SER . 0.6 OUTLIER -136.46 156.11 49.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 34.38 109.336 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 16' ' ' ARG . 94.6 p -42.45 155.29 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.375 -0.828 . . . . 38.77 109.495 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -157.41 165.71 33.48 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.782 -1.199 . . . . 34.58 110.164 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.54 ' N ' ' CE1' ' B' ' 26' ' ' TYR . 1.4 t -155.58 126.46 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.355 -1.085 . . . . 41.87 109.09 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.41 ' O ' ' CG ' ' B' ' 21' ' ' ARG . 3.4 m -64.23 -17.22 63.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 47.21 109.709 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' B' ' 22' ' ' GLN . 0.0 OUTLIER 175.75 -58.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.112 -0.992 . . . . 71.56 109.698 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.423 ' HB3' ' O ' ' B' ' 21' ' ' ARG . 0.5 OUTLIER 175.26 43.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.96 . . . . 66.6 109.749 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.22 -55.39 0.08 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.043 -1.623 . . . . 55.49 109.043 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.08 152.17 71.36 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.395 -1.062 . . . . 44.99 108.847 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.9 Cg_endo -77.18 161.98 31.86 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.497 2.131 . . . . 44.1 110.562 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.66 ' O ' ' N ' ' B' ' 28' ' ' LEU . 0.0 OUTLIER -157.61 50.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.137 -0.977 . . . . 32.09 110.066 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.485 ' C ' ' O ' ' B' ' 26' ' ' TYR . 13.4 m -30.62 83.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.346 0.593 . . . . 29.25 110.694 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' B' ' 26' ' ' TYR . 0.8 OUTLIER -82.81 150.26 26.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.333 -0.854 . . . . 24.0 110.031 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 67.3 m-20 -72.16 151.18 43.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.451 -0.781 . . . . 23.31 109.499 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.443 ' HG3' HD13 ' B' ' 28' ' ' LEU . 1.4 mt-10 -134.63 132.67 39.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 40.03 108.704 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.528 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -123.35 -174.18 2.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.069 -1.019 . . . . 12.39 110.04 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.496 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.8 mp -143.57 152.91 41.99 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.852 -0.795 . . . . 17.42 108.852 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.517 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -152.75 -177.46 6.27 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.925 -1.139 . . . . 13.84 107.925 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.683 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 21.9 m-85 -129.78 99.71 5.23 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.056 -1.027 . . . . 21.14 109.881 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.505 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 62.9 t -95.35 113.74 30.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.171 -0.956 . . . . 10.66 109.435 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 5.3 t70 -62.51 -28.33 69.77 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.189 -0.945 . . . . 25.89 108.527 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.495 ' HB3' ' ND2' ' B' ' 39' ' ' ASN . 0.7 OUTLIER 46.25 25.27 0.34 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.516 -0.74 . . . . 24.24 109.436 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.67 14.01 81.63 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.831 -1.307 . . . . 31.02 109.831 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.495 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 64.2 m-20 -86.0 15.11 5.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -1.211 . . . . 43.23 110.325 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.578 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 9.5 mt-10 60.84 11.42 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.332 -0.855 . . . . 42.34 110.487 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 71.2 m80 -161.15 152.79 16.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.0 -1.111 . . . . 6.38 108.0 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.683 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.4 Cg_endo -75.92 136.71 18.9 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.806 1.671 . . . . 17.92 110.442 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 4.5 m -110.93 118.07 56.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.393 -0.817 . . . . 20.57 109.037 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.615 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 46.0 tp -73.21 104.38 4.24 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.392 -0.818 . . . . 20.21 110.215 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.521 HG13 ' CG1' ' A' ' 70' ' ' VAL . 32.5 m -108.44 -177.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.492 -0.929 . . . . 10.81 108.492 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.09 154.55 22.12 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.949 -1.101 . . . . 36.74 110.316 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.594 HG13 ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -127.21 169.96 17.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.515 -0.74 . . . . 19.74 109.105 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' B' ' 47' ' ' ILE . 3.5 m -122.78 123.99 42.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.328 -0.857 . . . . 22.56 108.838 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.588 ' CB ' ' CB ' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -102.46 163.92 11.96 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.269 -0.894 . . . . 20.41 109.352 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.53 167.83 9.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 33.99 109.513 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -73.0 87.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 54.92 109.435 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.08 -25.96 4.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 36.1 109.568 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 2.1 mt-30 -73.61 140.86 78.88 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.217 -1.167 . . . . 54.76 109.451 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' B' ' 55' ' ' ALA . 36.2 Cg_endo -79.48 118.71 3.95 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.526 2.151 . . . . 28.37 110.322 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.457 ' HB3' ' HG3' ' B' ' 31' ' ' GLN . . . -42.37 155.34 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 17.21 110.291 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 16.5 m-30 -50.09 111.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.449 -0.782 . . . . 17.19 109.416 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.534 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -61.4 176.37 0.42 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 17.82 109.246 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.21 121.04 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.567 2.178 . . . . 17.28 110.41 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.7 177.91 36.91 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.752 -1.339 . . . . 17.22 109.752 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.4 mp -71.36 159.64 34.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -1.13 . . . . 19.57 108.783 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.592 ' CE1' HD12 ' B' ' 6' ' ' ILE . 19.8 m-85 -142.07 165.05 28.5 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.529 1.157 . . . . 14.61 111.77 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.548 ' CG2' ' HA ' ' B' ' 86' ' ' ALA . 60.3 p -147.28 119.82 8.51 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.554 -1.647 . . . . 18.36 106.554 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 13.1 t -52.26 169.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 C-N-CA 118.576 -1.25 . . . . 19.13 108.433 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.534 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.8 t-80 -131.44 119.62 21.87 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.37 -0.831 . . . . 20.65 108.987 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.606 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -62.25 -12.51 20.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.7 -0.625 . . . . 19.65 109.698 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.416 ' C ' ' O ' ' B' ' 65' ' ' LEU . 40.3 t -46.95 -20.48 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.933 -1.104 . . . . 14.72 108.565 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 32.6 m -97.17 -9.0 28.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -0.774 . . . . 11.45 111.032 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.609 ' CE1' HG12 ' B' ' 78' ' ' ILE . 3.0 m-30 -80.22 160.97 25.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.658 -1.276 . . . . 14.25 109.743 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.509 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 4.9 pttm -144.94 175.18 10.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.369 -0.832 . . . . 32.7 109.707 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.531 ' CG1' HG13 ' A' ' 45' ' ' VAL . 2.5 t -117.42 129.2 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.49 -0.756 . . . . 15.63 109.322 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.22 168.36 35.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.564 -1.414 . . . . 12.7 109.564 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.491 ' O ' ' CG ' ' B' ' 72' ' ' GLN . 0.9 OUTLIER -76.93 0.61 20.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.118 -1.225 . . . . 26.29 109.686 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.37 -26.99 23.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.47 -0.769 . . . . 20.44 109.253 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.86 65.43 0.76 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.454 -1.459 . . . . 13.82 109.454 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.3 133.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -1.168 . . . . 18.27 109.53 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.429 ' O ' ' CG ' ' B' ' 77' ' ' MET . 2.5 tt -73.65 148.64 42.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 12.43 109.471 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.429 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 30.3 mtm -155.92 128.88 8.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 35.11 109.505 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.609 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.0 mt -64.79 141.25 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 13.67 110.06 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -108.41 -36.95 6.1 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.581 -1.266 . . . . 24.06 107.581 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.51 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.1 tpm_? -168.91 68.12 0.07 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.184 -1.413 . . . . 35.04 107.184 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.556 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.6 OUTLIER -31.18 120.44 0.22 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.469 -0.787 . . . . 18.72 111.518 -178.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -90.52 103.24 15.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.959 -1.126 . . . . 20.55 107.959 178.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.63 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -75.76 147.21 39.45 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.989 -1.07 . . . . 14.4 110.966 -178.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.469 ' C ' ' CD2' ' B' ' 61' ' ' TYR . 18.1 m -148.13 160.04 38.31 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.651 -1.24 . . . . 17.65 107.651 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.1 Cg_endo -62.17 146.51 95.99 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.974 1.783 . . . . 25.7 110.448 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.548 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -79.46 116.5 19.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.146 -0.971 . . . . 49.29 109.648 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.98 -1.009 . . . . 58.91 109.474 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.433 -0.58 . . . . 64.91 109.433 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.575 ' CA ' HD21 ' B' ' 65' ' ' LEU . 3.7 mt -72.44 79.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.729 -1.211 . . . . 33.8 107.729 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' C ' HG11 ' A' ' 4' ' ' VAL . 7.2 mttt -69.31 156.38 38.87 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.05 0.929 . . . . 32.72 111.54 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.6 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -166.01 168.01 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.18 -1.044 . . . . 14.46 108.18 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.555 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 26.3 mt-10 -143.44 112.63 6.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 22.12 109.541 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.596 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -72.37 102.72 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 C-N-CA 119.003 -1.079 . . . . 14.23 108.107 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 1.3 mmpt? -43.72 162.44 0.19 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.352 -0.842 . . . . 25.43 109.414 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.5 Cg_endo -72.7 -12.71 26.82 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.972 1.781 . . . . 13.61 109.088 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.5 t -99.13 7.15 46.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.234 -1.025 . . . . 15.52 108.234 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 1.5 mm-40 -129.47 41.27 3.48 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.846 -0.798 . . . . 17.31 108.846 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.419 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -101.76 3.65 39.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.122 -0.986 . . . . 24.78 110.291 -179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -134.84 139.64 45.22 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.129 -0.982 . . . . 47.9 108.607 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.615 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 22.3 p90 -85.62 176.97 7.88 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.035 -1.041 . . . . 21.61 109.298 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -133.98 148.2 51.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.444 -0.785 . . . . 14.89 109.099 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.32 110.78 22.08 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.336 -0.852 . . . . 17.35 109.088 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.448 ' NH1' ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -136.8 152.37 50.22 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.358 -0.839 . . . . 34.38 109.593 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 p -45.64 146.33 1.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.824 . . . . 38.77 109.378 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -145.85 166.82 27.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.17 -1.572 . . . . 34.58 109.17 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -141.3 117.14 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.069 -1.253 . . . . 41.87 109.415 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 96.6 p -55.4 90.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.348 -0.845 . . . . 47.21 109.652 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER 48.07 41.9 16.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.306 -0.871 . . . . 71.56 109.694 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 65.77 19.41 11.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 66.6 109.715 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 20' ' ' SER . . . -96.22 -55.48 1.27 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.175 -1.57 . . . . 55.49 109.175 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -140.76 151.33 62.73 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.429 -1.042 . . . . 44.99 108.894 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.76 124.25 7.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.458 2.105 . . . . 44.1 110.696 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.8 p90 -135.45 144.23 46.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.332 -0.855 . . . . 32.09 109.789 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.32 80.64 1.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 29.25 108.679 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.553 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -94.58 168.3 10.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 24.0 110.24 -179.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.615 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -95.17 127.11 40.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.467 -0.77 . . . . 23.31 108.939 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -113.68 160.39 18.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.202 -0.936 . . . . 40.03 109.603 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.557 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -137.5 -169.41 2.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 12.39 109.123 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.553 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.1 mt -133.93 175.87 9.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 17.42 109.544 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.18 161.72 8.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.964 -1.085 . . . . 13.84 108.525 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.627 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 3.1 m-30 -114.34 101.34 9.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.132 -0.98 . . . . 21.14 108.828 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.539 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 13.9 t -107.6 148.21 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.999 -1.063 . . . . 10.66 110.029 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.566 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.8 p-10 -113.86 -39.92 3.88 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.408 -0.96 . . . . 25.89 108.408 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.532 ' HA ' ' CD1' ' B' ' 65' ' ' LEU . 0.2 OUTLIER 62.55 -71.01 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.731 -0.84 . . . . 24.24 108.731 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -142.59 28.0 2.2 Favored Glycine 0 C--N 1.296 -1.666 0 N-CA-C 108.238 -1.945 . . . . 31.02 108.238 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -130.89 98.97 4.76 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.593 -0.946 . . . . 43.23 108.722 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' ' 39' ' ' ASN . 3.4 mm-40 -31.36 -37.2 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.284 0.564 . . . . 42.34 111.194 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 39' ' ' ASN . 60.7 m80 -80.67 149.15 67.27 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.87 . . . . 8.33 108.973 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -78.56 149.61 24.11 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.135 1.89 . . . . 17.92 110.466 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.51 HG23 ' CG2' ' B' ' 70' ' ' VAL . 1.8 m -121.52 119.11 58.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.393 -0.923 . . . . 20.57 109.058 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 15.7 tp -72.72 112.25 8.6 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.722 -0.791 . . . . 20.21 109.178 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.594 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 14.3 t -118.44 167.06 12.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.545 -0.722 . . . . 10.81 109.528 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -96.15 139.93 31.6 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.517 -0.873 . . . . 36.74 109.421 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.638 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -121.55 171.63 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.808 . . . . 19.74 109.004 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.489 ' O ' HD21 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -105.56 153.59 21.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.075 -1.016 . . . . 22.56 109.691 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.563 HD13 ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -136.71 105.26 5.79 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.629 -0.878 . . . . 20.41 108.629 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -70.26 143.95 51.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -0.954 . . . . 33.99 109.635 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.17 132.85 39.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 54.92 109.269 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.23 -35.58 4.79 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.452 -1.459 . . . . 36.1 109.452 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 5.1 mt-30 -79.8 138.46 54.01 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.265 -1.138 . . . . 54.76 109.341 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.3 126.13 7.48 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.509 2.139 . . . . 28.37 110.415 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.491 ' HA ' HD22 ' A' ' 49' ' ' LEU . . . -41.35 149.59 0.11 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.353 -0.842 . . . . 17.21 110.295 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.638 ' CE1' HG12 ' A' ' 47' ' ' ILE . 83.1 m-85 -50.94 97.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.476 -0.765 . . . . 17.19 109.026 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.542 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -50.14 176.54 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.176 -0.953 . . . . 17.82 109.407 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.1 Cg_endo -76.68 131.26 12.24 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.418 2.079 . . . . 17.28 110.009 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.67 174.59 27.57 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.777 -1.329 . . . . 17.22 109.777 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.7 143.12 46.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -1.114 . . . . 19.57 108.469 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.6 ' CB ' HG12 ' A' ' 4' ' ' VAL . 22.3 m-85 -127.31 162.89 25.18 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.832 -1.167 . . . . 14.61 111.548 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.521 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 44.8 p -143.04 121.39 12.32 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.534 -1.654 . . . . 18.36 106.534 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 3.3 t -52.54 166.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 C-N-CA 118.873 -1.131 . . . . 19.13 109.012 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -134.84 128.78 33.36 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.561 -0.903 . . . . 20.65 108.561 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.634 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 1.2 pp -73.13 3.15 5.91 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.036 -1.04 . . . . 19.65 110.005 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.7 t -57.04 -19.15 17.17 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.716 -1.216 . . . . 14.72 107.716 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -101.34 -8.01 22.45 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.696 -0.628 . . . . 11.45 110.234 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.634 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 3.4 m-30 -74.66 155.27 37.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.836 -1.165 . . . . 14.25 108.925 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.77 176.53 12.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 32.7 109.678 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -109.45 115.77 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.392 -0.818 . . . . 15.63 109.285 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.06 179.71 10.77 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.508 -1.437 . . . . 12.7 109.508 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.528 ' NE2' ' HA ' ' A' ' 72' ' ' GLN . 9.2 mm-40 -88.46 42.43 1.07 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.222 -1.164 . . . . 26.29 109.298 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.402 ' CG ' ' C ' ' A' ' 72' ' ' GLN . 10.3 m-85 -148.23 34.96 0.81 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.532 -0.73 . . . . 20.44 109.384 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.469 ' O ' HG11 ' B' ' 45' ' ' VAL . . . 48.0 58.78 6.72 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.239 -1.544 . . . . 13.82 109.239 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.407 ' HA ' HG11 ' B' ' 45' ' ' VAL . 4.2 m -156.41 136.16 12.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.335 -1.097 . . . . 18.27 109.919 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -73.06 165.08 25.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.321 -0.862 . . . . 12.43 109.084 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.541 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.1 mtt -166.43 107.86 0.7 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.07 -1.019 . . . . 35.11 110.023 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -42.67 -35.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 13.67 109.588 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER 43.89 55.19 5.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 24.06 109.411 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 67' ' ' SER . 6.5 tmm_? 78.23 80.78 0.07 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.851 -0.796 . . . . 35.04 108.851 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.616 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -55.56 149.03 14.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.768 0.794 . . . . 18.72 111.703 -178.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -99.48 103.46 15.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.094 -1.076 . . . . 20.55 108.094 178.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -75.16 151.57 38.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.185 -0.947 . . . . 14.4 111.568 -178.278 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 62' ' ' THR . 27.1 m -151.51 155.65 34.37 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.825 -1.176 . . . . 17.65 107.825 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.42 144.23 90.3 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.146 1.898 . . . . 25.7 110.433 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -72.0 139.71 48.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.159 -0.963 . . . . 49.29 109.396 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.009 -0.996 . . . . 58.91 109.551 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.505 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.396 -0.594 . . . . 64.91 109.396 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.57 ' CA ' HD21 ' A' ' 65' ' ' LEU . 3.8 mt -72.7 79.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.664 -1.235 . . . . 33.8 107.664 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.434 ' C ' HG11 ' B' ' 4' ' ' VAL . 7.1 mttt -69.59 156.13 39.41 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.055 0.931 . . . . 32.72 111.549 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.602 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -165.54 168.16 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.229 -1.026 . . . . 14.46 108.229 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.547 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 26.3 mt-10 -143.46 112.55 6.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 22.12 109.556 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.582 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.3 OUTLIER -72.31 102.59 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 118.979 -1.089 . . . . 14.23 108.079 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.526 ' HB3' ' HD2' ' B' ' 8' ' ' PRO . 1.1 mmpt? -43.69 162.57 0.19 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 25.43 109.466 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.4 Cg_endo -72.65 -12.9 27.07 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.007 1.805 . . . . 13.61 109.144 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -98.99 7.15 46.28 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.26 -1.015 . . . . 15.52 108.26 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 1.5 mm-40 -129.53 41.34 3.46 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.416 -0.803 . . . . 17.31 108.885 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.411 ' HB3' ' HD3' ' B' ' 58' ' ' PRO . . . -101.92 3.88 39.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.063 -1.023 . . . . 24.78 110.264 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.43 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 0.9 OUTLIER -134.9 139.49 45.02 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.167 -0.958 . . . . 47.9 108.533 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.609 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 22.1 p90 -85.86 176.7 7.94 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.035 -1.041 . . . . 21.61 109.244 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -133.64 148.67 51.55 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.395 -0.816 . . . . 14.89 109.087 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.82 110.71 22.07 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.37 -0.831 . . . . 17.35 108.997 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.448 ' CG ' ' NH1' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -136.53 152.67 50.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.247 -0.908 . . . . 34.38 109.582 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.403 ' C ' ' O ' ' B' ' 16' ' ' ARG . 18.6 p -45.75 146.69 1.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 38.77 109.384 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -146.34 166.72 28.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.219 -1.552 . . . . 34.58 109.219 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' B' ' 24' ' ' LYS . 0.8 OUTLIER -141.15 117.36 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.015 -1.286 . . . . 41.87 109.409 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 98.2 p -55.67 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.377 -0.827 . . . . 47.21 109.677 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER 48.43 41.94 17.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.291 -0.881 . . . . 71.56 109.719 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 65.64 19.28 11.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -0.945 . . . . 66.6 109.77 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.19 -55.42 1.28 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.154 -1.578 . . . . 55.49 109.154 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' B' ' 19' ' ' VAL . 1.0 OUTLIER -140.77 151.21 62.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.377 -1.072 . . . . 44.99 108.902 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.67 124.62 7.67 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.499 2.133 . . . . 44.1 110.619 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 6.7 p90 -136.0 144.17 45.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 32.09 109.774 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.49 80.9 1.86 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.875 . . . . 29.25 108.666 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.555 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -94.7 168.28 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 24.0 110.231 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.609 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -95.09 127.08 40.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.445 -0.785 . . . . 23.31 108.922 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.6 OUTLIER -113.51 160.68 18.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.175 -0.953 . . . . 40.03 109.581 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.559 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -137.83 -169.63 2.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 12.39 109.02 179.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.555 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.1 mt -133.81 175.85 9.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.923 . . . . 17.42 109.548 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.14 161.69 8.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.955 -1.091 . . . . 13.84 108.497 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.638 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 3.1 m-30 -114.41 101.58 9.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 21.14 108.739 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.551 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 13.5 t -107.73 148.25 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.056 -1.027 . . . . 10.66 110.125 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.8 p-10 -113.95 -40.07 3.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.51 -0.922 . . . . 25.89 108.51 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' B' ' 36' ' ' ASP . 0.2 OUTLIER 62.38 -70.87 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.773 -0.825 . . . . 24.24 108.773 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -142.65 27.73 2.2 Favored Glycine 0 C--N 1.296 -1.669 0 N-CA-C 108.307 -1.917 . . . . 31.02 108.307 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.0 OUTLIER -130.72 99.07 4.82 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.604 -0.939 . . . . 43.23 108.73 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' B' ' 39' ' ' ASN . 3.4 mm-40 -31.55 -37.02 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.3 0.571 . . . . 42.34 111.143 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' B' ' 39' ' ' ASN . 59.8 m80 -80.73 149.18 67.12 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 121.342 -0.849 . . . . 8.33 109.037 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.614 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.4 Cg_endo -78.58 149.48 23.94 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.102 1.868 . . . . 17.92 110.408 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.527 HG23 ' CG2' ' A' ' 70' ' ' VAL . 1.8 m -121.36 119.51 59.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.344 -0.943 . . . . 20.57 109.102 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.638 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 15.3 tp -73.04 111.45 8.16 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.778 -0.769 . . . . 20.21 109.105 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.586 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 12.8 t -117.7 167.16 11.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.633 -0.667 . . . . 10.81 109.449 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.564 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.9 OUTLIER -96.16 140.33 31.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.319 -0.863 . . . . 36.74 109.495 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.64 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -121.96 171.81 10.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.344 -0.847 . . . . 19.74 109.076 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.488 ' O ' HD21 ' B' ' 49' ' ' LEU . 0.3 OUTLIER -105.89 153.15 22.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.051 -1.03 . . . . 22.56 109.77 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -136.36 104.99 5.79 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.684 -0.858 . . . . 20.41 108.684 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -70.01 144.5 52.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 33.99 109.665 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.58 132.88 41.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.893 . . . . 54.92 109.264 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.32 -36.09 4.44 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.398 -1.481 . . . . 36.1 109.398 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.51 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 5.0 mt-30 -79.47 138.34 55.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.27 -1.135 . . . . 54.76 109.34 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.41 126.12 7.39 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.44 2.093 . . . . 28.37 110.372 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.486 ' HA ' HD22 ' B' ' 49' ' ' LEU . . . -41.25 150.58 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.328 -0.857 . . . . 17.21 110.234 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.64 ' CE1' HG12 ' B' ' 47' ' ' ILE . 82.1 m-85 -51.95 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.95 -0.759 . . . . 17.19 108.95 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.529 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -51.53 176.62 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.306 -0.871 . . . . 17.82 109.312 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -76.9 132.12 12.7 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.469 2.113 . . . . 17.28 110.328 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.99 175.15 26.66 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.676 -1.37 . . . . 17.22 109.676 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.43 143.88 46.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -1.138 . . . . 19.57 108.872 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.602 ' CB ' HG12 ' B' ' 4' ' ' VAL . 21.5 m-85 -127.9 163.05 25.3 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.544 1.164 . . . . 14.61 111.556 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.52 ' O ' ' CG2' ' B' ' 84' ' ' VAL . 46.1 p -143.32 121.41 12.14 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.546 -1.65 . . . . 18.36 106.546 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.612 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 3.3 t -52.75 165.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 C-N-CA 118.88 -1.128 . . . . 19.13 109.023 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -134.02 128.55 34.56 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.59 -0.893 . . . . 20.65 108.59 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.641 ' CB ' ' CD2' ' B' ' 68' ' ' PHE . 1.3 pp -72.74 2.95 5.68 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.061 -1.024 . . . . 19.65 110.087 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 28.6 t -56.94 -19.21 16.73 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 107.711 -1.218 . . . . 14.72 107.711 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -101.45 -7.79 22.55 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.723 -0.611 . . . . 11.45 110.166 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.641 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.3 m-30 -74.84 154.97 38.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.889 -1.132 . . . . 14.25 108.833 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.43 176.85 12.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 32.7 109.681 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.594 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -109.8 115.62 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.43 -0.794 . . . . 15.63 109.363 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.91 179.71 10.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.568 -1.413 . . . . 12.7 109.568 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.529 ' NE2' ' HA ' ' B' ' 72' ' ' GLN . 8.8 mm-40 -88.49 42.42 1.07 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.224 -1.162 . . . . 26.29 109.314 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.404 ' CG ' ' C ' ' B' ' 72' ' ' GLN . 9.5 m-85 -148.18 34.79 0.81 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.495 -0.753 . . . . 20.44 109.481 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.436 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 48.34 58.08 7.59 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.292 -1.523 . . . . 13.82 109.292 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.4 m -155.74 136.37 13.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.139 . . . . 18.27 109.963 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.547 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.3 OUTLIER -73.2 164.91 26.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 12.43 109.157 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.1 mtt -166.37 108.12 0.71 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.085 -1.009 . . . . 35.11 110.106 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.7 mt -42.99 -34.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 13.67 109.532 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.7 OUTLIER 43.83 55.27 5.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.832 . . . . 24.06 109.35 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 67' ' ' SER . 6.5 tmm_? 78.23 80.82 0.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.922 -0.77 . . . . 35.04 108.922 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.612 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.0 OUTLIER -55.54 149.11 14.27 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.702 0.763 . . . . 18.72 111.74 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -99.62 103.55 15.26 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.992 -1.114 . . . . 20.55 107.992 178.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -75.22 151.55 38.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.229 -0.92 . . . . 14.4 111.609 -178.224 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' B' ' 62' ' ' THR . 29.9 m -151.55 155.36 34.18 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 107.837 -1.171 . . . . 17.65 107.837 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.22 144.12 91.12 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.237 1.958 . . . . 25.7 110.446 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.497 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -72.0 139.4 48.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 49.29 109.375 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.034 -0.984 . . . . 58.91 109.483 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.4 -0.593 . . . . 64.91 109.4 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.538 ' CG2' HG22 ' A' ' 63' ' ' VAL . 3.0 mt -61.93 83.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.646 -1.242 . . . . 33.8 107.646 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 1' ' ' MET . 14.0 mtpt -75.93 158.05 32.47 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.952 0.882 . . . . 32.72 111.104 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.59 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -164.23 169.05 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.293 -1.002 . . . . 14.46 108.293 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 55.5 mt-10 -144.7 112.6 6.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.94 . . . . 22.12 109.47 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.57 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -72.73 101.98 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.822 -1.177 . . . . 14.23 107.822 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.656 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.69 171.22 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.304 -0.872 . . . . 25.43 109.856 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -74.8 -26.9 10.91 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.36 2.04 . . . . 13.61 109.589 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -88.02 0.08 56.39 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.987 -0.746 . . . . 15.52 108.987 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.8 mm-40 -120.42 33.87 5.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 17.31 109.475 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.95 10.79 38.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 24.78 109.958 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.405 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 15.3 mt-30 -138.93 144.99 39.29 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 47.9 109.96 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.641 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 35.4 p90 -94.3 161.52 14.21 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.323 -0.861 . . . . 21.61 109.195 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -128.92 162.82 26.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.311 -0.868 . . . . 14.89 108.808 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.28 111.03 23.45 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.239 -0.913 . . . . 17.35 109.541 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -117.08 137.56 52.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -0.863 . . . . 34.38 109.087 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.4 t -50.54 90.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 38.77 109.813 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -85.44 161.76 35.77 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.304 -1.518 . . . . 34.58 109.304 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.477 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 2.1 t -132.94 123.93 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.187 -1.184 . . . . 41.87 109.386 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -64.54 89.37 0.07 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.279 -0.888 . . . . 47.21 109.632 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 20' ' ' SER . 1.2 mpt_? 43.56 53.68 5.71 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.261 -0.899 . . . . 71.56 109.749 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.72 20.77 0.79 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 66.6 109.722 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' SER . . . -99.73 -39.67 3.33 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.309 -1.516 . . . . 55.49 109.309 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 20' ' ' SER . 14.5 mttm -156.52 148.81 17.68 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.354 -1.086 . . . . 44.99 109.151 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.42 131.13 11.38 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.535 2.157 . . . . 44.1 110.5 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.604 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 5.5 p90 -144.71 139.5 27.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.182 -0.949 . . . . 32.09 109.603 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 p -102.01 80.43 2.0 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 29.25 108.868 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -91.33 143.35 26.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 24.0 110.173 -179.168 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.572 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 90.7 m-20 -64.99 133.55 51.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.387 -0.821 . . . . 23.31 109.745 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.21 142.32 51.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 40.03 109.294 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.568 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -124.14 -179.04 4.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 12.39 109.303 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.5 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.1 mt -127.75 174.33 9.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 17.42 109.579 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -168.45 167.62 11.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.403 -0.962 . . . . 13.84 108.403 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.664 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 18.7 m-85 -120.88 107.38 12.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.138 -0.976 . . . . 21.14 109.545 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 59.2 t -104.02 112.3 37.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.141 -0.974 . . . . 10.66 109.821 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.0 OUTLIER -64.0 -27.34 69.05 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.196 -1.038 . . . . 25.89 108.196 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.532 HD12 ' CA ' ' B' ' 69' ' ' LYS . 0.6 OUTLIER 48.37 30.85 2.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.602 -0.686 . . . . 24.24 109.303 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.61 9.37 78.33 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.457 -1.457 . . . . 31.02 109.457 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 1.9 m-20 -85.43 4.57 34.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -1.149 . . . . 43.23 110.476 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 29.6 mt-10 80.7 -42.61 0.2 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.585 -0.697 . . . . 42.34 110.567 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 47.5 m80 -107.0 155.34 39.38 Favored Pre-proline 0 C--N 1.295 -1.793 0 O-C-N 121.417 -0.802 . . . . 6.33 108.929 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.664 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -77.15 138.12 17.79 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.181 1.92 . . . . 17.92 110.542 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.533 HG22 ' CG1' ' A' ' 45' ' ' VAL . 5.6 m -111.85 117.75 55.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.369 -0.832 . . . . 20.57 108.827 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 67.3 tp -71.56 103.26 2.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.288 -0.882 . . . . 20.21 110.007 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' A' ' 43' ' ' VAL . 3.6 m -106.42 -177.42 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.527 -0.733 . . . . 10.81 109.032 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.26 145.0 40.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.409 -0.917 . . . . 36.74 109.987 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.66 HG12 ' CE1' ' A' ' 56' ' ' TYR . 1.2 tt -135.9 136.47 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.418 -0.801 . . . . 19.74 109.064 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.1 m -68.67 156.01 39.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 22.56 109.57 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.641 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 2.3 tm? -129.99 114.02 15.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.282 -0.886 . . . . 20.41 109.077 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.509 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -48.85 123.56 7.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.866 . . . . 33.99 110.152 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -47.34 109.27 0.2 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.319 -0.863 . . . . 54.92 109.353 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.78 -29.65 10.55 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.429 -1.468 . . . . 36.1 109.429 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.509 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.7 OUTLIER -65.2 153.68 88.89 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.23 -1.159 . . . . 54.76 109.326 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.8 Cg_endo -77.88 109.95 2.82 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.506 2.138 . . . . 28.37 110.224 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.443 ' CB ' ' HG3' ' A' ' 31' ' ' GLN . . . -38.63 148.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.526 -0.734 . . . . 17.21 110.218 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.66 ' CE1' HG12 ' A' ' 47' ' ' ILE . 83.0 m-85 -46.0 101.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.451 -0.781 . . . . 17.19 109.355 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.428 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -50.63 171.02 0.17 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.907 . . . . 17.82 109.823 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HA ' HG23 ' A' ' 6' ' ' ILE . 35.4 Cg_endo -77.9 114.14 3.57 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.736 2.291 . . . . 17.28 110.117 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.65 -179.82 46.6 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.898 -1.281 . . . . 17.22 109.898 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -75.78 139.76 41.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -1.082 . . . . 19.57 108.114 179.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.59 ' CB ' HG12 ' A' ' 4' ' ' VAL . 18.5 m-85 -126.26 162.15 26.11 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.66 -1.275 . . . . 14.61 111.759 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 52.8 p -142.11 122.25 13.8 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.247 -1.76 . . . . 18.36 106.247 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.552 ' CG1' ' HG ' ' A' ' 81' ' ' LEU . 2.5 t -54.38 162.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 C-N-CA 118.792 -1.163 . . . . 19.13 109.077 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.545 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.5 t-80 -130.46 129.17 42.63 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.246 -1.02 . . . . 20.65 108.246 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.642 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -70.04 1.97 4.06 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.502 -0.749 . . . . 19.65 110.2 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.03 -20.35 9.18 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.448 -1.316 . . . . 14.72 107.448 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -97.58 -8.34 29.21 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.755 -0.591 . . . . 11.45 110.09 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -77.97 154.94 31.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.967 -1.083 . . . . 14.25 109.595 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.54 ' CA ' HD12 ' B' ' 37' ' ' LEU . 0.8 OUTLIER -137.93 175.8 9.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 32.7 109.466 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.529 ' CG1' HG11 ' B' ' 45' ' ' VAL . 10.6 t -122.37 134.4 65.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.43 -0.794 . . . . 15.63 109.475 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.21 -160.24 28.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.382 -1.487 . . . . 12.7 109.382 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 6.2 tp60 61.67 72.73 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -1.177 . . . . 26.29 109.349 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 2.2 m-85 65.51 11.97 7.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 20.44 109.357 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' B' ' 45' ' ' VAL . . . 81.97 48.82 5.6 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.503 -1.439 . . . . 13.82 109.503 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' A' ' 77' ' ' MET . 26.9 t -130.6 125.48 34.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -1.116 . . . . 18.27 109.662 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.5 ' C ' ' CG ' ' A' ' 77' ' ' MET . 3.5 tp -63.96 146.44 54.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 12.43 109.115 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.5 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 3.2 mtm -159.33 144.37 15.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 35.11 109.449 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.624 ' CG1' ' CE1' ' A' ' 68' ' ' PHE . 1.7 mp -65.14 145.48 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 13.67 109.505 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 67' ' ' SER . 4.6 t70 -103.46 -62.28 1.31 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.214 -1.402 . . . . 24.06 107.214 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.524 ' O ' ' C ' ' A' ' 81' ' ' LEU . 5.1 tmm_? -142.28 56.8 1.46 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.292 -1.003 . . . . 35.04 108.292 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.552 ' HG ' ' CG1' ' A' ' 63' ' ' VAL . 6.4 tt 3.43 116.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.524 -1.217 . . . . 18.72 112.849 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.545 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -99.35 96.61 7.84 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.098 -1.075 . . . . 20.55 108.098 178.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.588 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -77.49 150.82 34.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.982 -1.074 . . . . 14.4 111.064 -178.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 62' ' ' THR . 26.4 m -151.15 155.88 34.99 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.106 -1.072 . . . . 17.65 108.106 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.1 Cg_endo -63.86 141.9 80.06 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.053 1.836 . . . . 25.7 110.173 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -70.77 117.79 12.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.206 -0.934 . . . . 49.29 109.602 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.046 -0.978 . . . . 58.91 109.496 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.416 -0.587 . . . . 64.91 109.416 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.545 ' CG2' HG22 ' B' ' 63' ' ' VAL . 3.0 mt -62.0 83.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.644 -1.243 . . . . 33.8 107.644 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' ' 1' ' ' MET . 14.0 mtpt -75.89 158.0 32.58 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.947 0.879 . . . . 32.72 111.104 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.593 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -164.23 168.99 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.296 -1.002 . . . . 14.46 108.296 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.548 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 55.2 mt-10 -144.59 112.62 6.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.19 -0.944 . . . . 22.12 109.448 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.587 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -72.73 101.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.761 -1.2 . . . . 14.23 107.761 179.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.647 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.73 171.23 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.358 -0.839 . . . . 25.43 109.81 -178.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 32.6 Cg_endo -74.92 -26.82 10.72 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.331 2.021 . . . . 13.61 109.532 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -88.03 0.15 56.3 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.0 -0.741 . . . . 15.52 109.0 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.516 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.8 mm-40 -120.42 33.79 5.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 17.31 109.506 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.85 10.77 38.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.136 -0.978 . . . . 24.78 109.937 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -139.01 144.93 39.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.144 -0.973 . . . . 47.9 109.911 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.635 ' CD2' ' CD1' ' B' ' 49' ' ' LEU . 35.4 p90 -94.25 161.46 14.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.376 -0.827 . . . . 21.61 109.178 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 8.7 t -128.78 162.93 26.29 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.242 -0.911 . . . . 14.89 108.792 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.43 111.07 23.48 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.203 -0.935 . . . . 17.35 109.486 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' B' ' 18' ' ' GLY . 0.0 OUTLIER -117.12 137.66 52.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 34.38 109.093 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 28.5 t -50.6 90.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 38.77 109.835 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -85.53 161.88 35.74 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.361 -1.496 . . . . 34.58 109.361 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.474 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 2.1 t -133.07 123.84 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -1.206 . . . . 41.87 109.369 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.48 ' O ' ' N ' ' B' ' 23' ' ' GLY . 0.4 OUTLIER -64.49 89.38 0.06 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.314 -0.866 . . . . 47.21 109.681 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' B' ' 20' ' ' SER . 1.2 mpt_? 43.54 53.67 5.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.236 -0.915 . . . . 71.56 109.692 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.83 20.7 0.81 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 66.6 109.722 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' B' ' 20' ' ' SER . . . -99.63 -39.9 3.3 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.242 -1.543 . . . . 55.49 109.242 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 mttm -156.27 148.94 17.99 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.329 -1.101 . . . . 44.99 109.16 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.46 131.19 11.39 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.512 2.141 . . . . 44.1 110.532 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.6 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 5.4 p90 -144.76 139.5 27.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 32.09 109.614 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -102.05 80.41 1.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 29.25 108.848 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.54 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -91.31 143.31 26.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 24.0 110.231 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.582 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 90.9 m-20 -64.94 133.6 52.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.8 . . . . 23.31 109.745 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.26 142.32 51.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 40.03 109.259 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.563 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -124.07 -179.16 4.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 12.39 109.378 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.499 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.1 mt -127.63 174.41 9.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.964 . . . . 17.42 109.511 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -168.59 167.57 11.41 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.366 -0.976 . . . . 13.84 108.366 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.667 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 18.9 m-85 -120.83 107.4 12.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.127 -0.983 . . . . 21.14 109.596 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 59.4 t -104.04 112.29 36.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.157 -0.964 . . . . 10.66 109.834 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.0 OUTLIER -63.96 -27.41 69.12 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.155 -1.054 . . . . 25.89 108.155 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.54 HD12 ' CA ' ' A' ' 69' ' ' LYS . 0.6 OUTLIER 48.48 30.74 2.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.637 -0.664 . . . . 24.24 109.278 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.73 9.34 78.79 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.469 -1.453 . . . . 31.02 109.469 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' B' ' 40' ' ' GLU . 1.9 m-20 -85.39 4.5 35.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -1.165 . . . . 43.23 110.504 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' B' ' 39' ' ' ASN . 29.5 mt-10 80.67 -42.62 0.2 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.578 -0.701 . . . . 42.34 110.561 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.501 ' O ' ' HA ' ' B' ' 36' ' ' ASP . 47.5 m80 -106.95 155.34 39.34 Favored Pre-proline 0 C--N 1.294 -1.825 0 O-C-N 121.376 -0.828 . . . . 6.35 108.919 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.667 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.1 Cg_endo -77.2 138.21 17.78 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.12 1.88 . . . . 17.92 110.551 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.54 HG22 ' CG1' ' B' ' 45' ' ' VAL . 5.6 m -111.85 117.7 55.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.338 -0.852 . . . . 20.57 108.784 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.59 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 67.3 tp -71.55 103.19 2.91 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.347 -0.846 . . . . 20.21 110.032 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.54 ' CG1' HG22 ' B' ' 43' ' ' VAL . 3.6 m -106.34 -177.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 109.001 -0.74 . . . . 10.81 109.001 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.27 144.91 40.9 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.408 -0.917 . . . . 36.74 110.006 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.667 HG12 ' CE1' ' B' ' 56' ' ' TYR . 1.2 tt -135.84 136.53 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.454 -0.779 . . . . 19.74 109.068 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 11.0 m -68.67 156.17 38.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -0.984 . . . . 22.56 109.53 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.635 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 2.3 tm? -130.19 113.94 15.08 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.357 -0.839 . . . . 20.41 109.083 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.518 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.3 OUTLIER -48.82 123.6 7.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.873 . . . . 33.99 110.209 -179.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -47.37 109.25 0.2 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.298 -0.876 . . . . 54.92 109.394 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.83 -29.67 10.49 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.431 -1.468 . . . . 36.1 109.431 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.518 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.7 OUTLIER -65.16 153.62 88.92 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.278 -1.131 . . . . 54.76 109.311 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.5 Cg_endo -77.8 109.98 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.52 2.146 . . . . 28.37 110.214 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' B' ' 54' ' ' PRO . . . -38.75 148.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.526 -0.734 . . . . 17.21 110.154 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.667 ' CE1' HG12 ' B' ' 47' ' ' ILE . 83.1 m-85 -46.34 102.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 17.19 109.409 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.433 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -50.82 171.01 0.17 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 17.82 109.737 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.47 ' HA ' HG23 ' B' ' 6' ' ' ILE . 35.6 Cg_endo -78.17 115.31 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.768 2.312 . . . . 17.28 110.397 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.67 -179.27 45.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.747 -1.341 . . . . 17.22 109.747 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -75.44 140.4 42.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -1.102 . . . . 19.57 108.432 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.593 ' CB ' HG12 ' B' ' 4' ' ' VAL . 18.1 m-85 -126.8 162.25 26.3 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.752 -1.218 . . . . 14.61 111.764 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' B' ' 86' ' ' ALA . 52.8 p -142.34 122.26 13.61 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.256 -1.757 . . . . 18.36 106.256 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.545 HG22 ' CG2' ' B' ' 2' ' ' ILE . 2.6 t -54.39 162.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 C-N-CA 118.766 -1.174 . . . . 19.13 109.077 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.552 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.5 t-80 -130.41 129.18 42.72 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.269 -1.012 . . . . 20.65 108.269 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.642 ' CB ' ' CD2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -69.93 1.83 4.09 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.516 -0.74 . . . . 19.65 110.231 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.95 -20.35 8.8 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.419 -1.326 . . . . 14.72 107.419 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.519 ' O ' ' N ' ' B' ' 79' ' ' ASP . 0.5 OUTLIER -97.74 -8.52 28.41 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.74 -0.6 . . . . 11.45 110.062 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.642 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 2.8 m-30 -77.74 154.54 31.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 14.25 109.495 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.532 ' CA ' HD12 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -137.54 176.04 9.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 32.7 109.483 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.531 ' CG1' HG11 ' A' ' 45' ' ' VAL . 10.5 t -122.52 134.37 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 15.63 109.504 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.19 -160.28 28.6 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.356 -1.498 . . . . 12.7 109.356 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 6.3 tp60 61.69 72.79 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -1.164 . . . . 26.29 109.349 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 2.2 m-85 65.43 12.06 7.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 20.44 109.29 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.87 48.88 5.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.495 -1.442 . . . . 13.82 109.495 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' B' ' 77' ' ' MET . 27.1 t -130.59 125.38 33.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 18.27 109.659 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.508 ' C ' ' CG ' ' B' ' 77' ' ' MET . 3.4 tp -63.81 146.46 53.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 12.43 109.131 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.508 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 3.2 mtm -159.43 144.41 15.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.07 -1.019 . . . . 35.11 109.396 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.626 ' CG1' ' CE1' ' B' ' 68' ' ' PHE . 1.7 mp -65.29 145.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 13.67 109.534 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' B' ' 67' ' ' SER . 4.5 t70 -103.59 -62.07 1.34 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.238 -1.393 . . . . 24.06 107.238 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' B' ' 81' ' ' LEU . 5.1 tmm_? -142.51 56.88 1.44 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.286 -1.005 . . . . 35.04 108.286 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.543 ' HG ' ' CG1' ' B' ' 63' ' ' VAL . 6.5 tt 3.4 116.68 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.474 -1.239 . . . . 18.72 112.887 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.4 OUTLIER -99.41 96.51 7.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.109 -1.071 . . . . 20.55 108.109 178.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.584 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -77.35 150.98 35.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.935 -1.103 . . . . 14.4 111.066 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' B' ' 62' ' ' THR . 26.5 m -151.34 155.77 34.68 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.054 -1.091 . . . . 17.65 108.054 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.1 Cg_endo -63.73 141.91 80.94 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.055 1.837 . . . . 25.7 110.195 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.523 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -70.76 117.72 12.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.163 -0.96 . . . . 49.29 109.595 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.046 -0.978 . . . . 58.91 109.476 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.3 -0.629 . . . . 64.91 109.3 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.578 ' CG2' ' CG2' ' A' ' 63' ' ' VAL . 1.7 mt 58.53 78.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.799 -1.186 . . . . 33.8 107.799 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' C ' HG11 ' A' ' 4' ' ' VAL . 6.4 mttt -73.52 157.15 37.29 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.797 0.808 . . . . 32.72 110.672 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.577 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -164.67 159.31 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.022 -0.733 . . . . 14.46 109.022 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 5.1 mt-10 -136.34 113.6 10.68 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 22.12 109.351 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.595 HD12 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -72.36 107.26 3.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.906 -1.146 . . . . 14.23 107.906 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.615 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 4.4 mptt -50.07 172.6 0.11 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.165 -0.959 . . . . 25.43 109.999 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.8 Cg_endo -76.0 -29.23 6.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.557 2.171 . . . . 13.61 109.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 m -92.95 7.01 45.8 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.976 -0.75 . . . . 15.52 108.976 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.1 mm-40 -123.49 29.25 6.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 17.31 109.749 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.22 16.28 17.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 24.78 110.063 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.469 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 18.4 mt-30 -141.84 145.29 34.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.093 -1.004 . . . . 47.9 109.902 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.63 ' CE1' ' ND2' ' A' ' 29' ' ' ASN . 42.2 p90 -96.16 153.37 17.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.363 -0.836 . . . . 21.61 109.458 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.7 p -121.38 168.72 11.36 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.421 -0.8 . . . . 14.89 109.337 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.53 113.72 27.31 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.409 -0.807 . . . . 17.35 109.048 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.456 ' HB2' ' OE1' ' A' ' 30' ' ' GLU . 25.2 mtt180 -141.62 155.11 45.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -0.883 . . . . 34.38 109.501 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' ARG . 26.6 p -42.71 133.57 3.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.39 -0.819 . . . . 38.77 109.714 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 26' ' ' TYR . . . -131.94 157.97 22.66 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.36 -1.496 . . . . 34.58 109.36 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -135.44 117.9 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.11 -1.229 . . . . 41.87 109.475 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.457 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 7.5 p -64.0 -146.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.331 -0.855 . . . . 47.21 109.183 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 22' ' ' GLN . 6.3 mtp180 -53.16 -46.64 68.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.114 -0.991 . . . . 71.56 109.155 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.481 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 2.8 pt20 164.69 46.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.429 -0.795 . . . . 66.6 109.471 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.13 -60.36 0.42 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.483 -1.447 . . . . 55.49 109.483 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.55 160.74 49.98 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.296 -1.12 . . . . 44.99 109.281 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.7 Cg_endo -77.33 80.33 2.93 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.695 2.264 . . . . 44.1 110.906 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 4.7 p90 -68.68 139.0 55.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.254 -0.904 . . . . 32.09 109.671 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.74 80.74 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 29.25 108.664 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.574 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -104.81 164.07 12.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 24.0 110.179 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 64.1 m-20 -53.8 160.8 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 23.31 109.809 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.456 ' OE1' ' HB2' ' A' ' 16' ' ' ARG . 7.4 mt-10 -150.04 125.45 10.19 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.44 -0.948 . . . . 40.03 108.44 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.531 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -113.6 -179.18 3.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 12.39 110.36 -178.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.451 ' O ' ' OE1' ' A' ' 31' ' ' GLN . 81.2 mt -137.48 147.69 45.48 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.787 -0.819 . . . . 17.42 108.787 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.8 m -151.88 -177.53 6.19 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.802 -1.185 . . . . 13.84 107.802 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.662 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 31.6 m-85 -127.91 112.46 14.72 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.074 -1.016 . . . . 21.14 109.677 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 60.7 t -106.89 109.9 29.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.372 -0.931 . . . . 10.66 109.749 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 38' ' ' GLY . 2.5 p30 -57.75 -39.4 77.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.028 -1.471 . . . . 25.89 107.028 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.537 HD13 ' N ' ' B' ' 69' ' ' LYS . 7.3 tt 62.88 -71.2 0.05 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.831 0.824 . . . . 24.24 109.056 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -178.04 41.53 0.09 OUTLIER Glycine 0 C--N 1.294 -1.791 0 N-CA-C 108.54 -1.824 . . . . 31.02 108.54 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -124.37 23.81 8.17 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.33 -1.1 . . . . 43.23 110.429 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.577 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 14.6 mt-10 50.53 19.28 0.55 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.259 -0.901 . . . . 42.34 110.729 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.577 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 98.6 m-70 -160.08 154.74 20.64 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.278 -1.008 . . . . 7.29 108.278 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.662 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 37.4 Cg_endo -76.36 134.24 15.42 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.921 1.747 . . . . 17.92 110.556 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 3.1 m -108.76 116.69 52.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 119.509 -0.877 . . . . 20.57 108.775 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.569 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 64.6 tp -67.62 101.79 1.07 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.462 -0.895 . . . . 20.21 109.364 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 38.6 t -103.89 166.92 2.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.63 -0.669 . . . . 10.81 109.389 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 24.7 ttmt -98.64 148.78 23.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.185 -0.947 . . . . 36.74 110.198 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.672 HG12 ' CE2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -128.05 163.14 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.395 -0.816 . . . . 19.74 108.971 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.9 m -111.68 135.49 52.2 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.265 -0.897 . . . . 22.56 109.161 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.615 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -112.14 151.26 29.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 20.41 109.46 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.482 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -87.36 -174.67 4.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 33.99 109.736 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.45 104.47 15.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.352 -0.843 . . . . 54.92 109.575 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.18 -8.29 57.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.589 -1.404 . . . . 36.1 109.589 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.469 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -78.3 143.8 65.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.172 -1.193 . . . . 54.76 109.548 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.0 Cg_endo -79.34 110.87 2.77 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.629 2.22 . . . . 28.37 110.383 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.519 ' CB ' ' HG3' ' A' ' 31' ' ' GLN . . . -42.24 160.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 17.21 110.087 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.672 ' CE2' HG12 ' A' ' 47' ' ' ILE . 11.4 m-30 -54.57 111.05 0.72 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.398 -0.814 . . . . 17.19 109.209 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -60.67 176.22 0.38 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 17.82 109.516 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.47 114.87 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.665 2.244 . . . . 17.28 110.213 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.11 179.73 43.99 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.947 -1.261 . . . . 17.22 109.947 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -75.4 146.29 40.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -1.077 . . . . 19.57 108.256 179.132 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.595 ' CE1' HD12 ' A' ' 6' ' ' ILE . 23.0 m-85 -132.28 162.92 29.81 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.692 -1.255 . . . . 14.61 111.889 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.508 HG21 ' CB ' ' A' ' 86' ' ' ALA . 59.8 p -145.41 119.71 9.58 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.65 -1.611 . . . . 18.36 106.65 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.589 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 11.2 t -47.53 169.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 C-N-CA 119.086 -1.045 . . . . 19.13 109.266 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.557 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.7 t-80 -134.87 122.11 21.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.953 -0.758 . . . . 20.65 108.953 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.607 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -65.92 -9.22 27.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.546 -0.721 . . . . 19.65 109.348 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -53.95 -16.82 2.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.165 -0.959 . . . . 14.72 108.886 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.509 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -104.11 -6.93 20.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 11.45 111.098 -179.306 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.607 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.1 m-30 -74.21 163.25 28.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.704 -1.248 . . . . 14.25 109.663 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.515 ' N ' HD13 ' B' ' 37' ' ' LEU . 25.2 mtmt -149.64 174.02 13.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 32.7 109.31 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' CG1' HG23 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -114.86 109.83 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 15.63 109.065 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.04 -179.45 44.34 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.554 -1.419 . . . . 12.7 109.554 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -88.43 39.21 0.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.254 -1.144 . . . . 26.29 109.524 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -112.23 11.72 20.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.801 . . . . 20.44 109.261 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 46' ' ' LYS . . . 63.69 26.62 70.03 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.341 -1.504 . . . . 13.82 109.341 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -154.17 155.33 35.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -1.133 . . . . 18.27 109.626 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.442 ' CD2' HG22 ' B' ' 2' ' ' ILE . 1.7 tp -67.18 173.55 3.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 12.43 109.536 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.439 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 2.7 mtt -159.39 101.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 35.11 109.607 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.595 ' CG2' ' N ' ' A' ' 81' ' ' LEU . 2.7 mt -41.92 -43.33 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 13.67 109.995 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER 48.69 54.24 10.97 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.341 -0.85 . . . . 24.06 108.991 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 82.01 80.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.023 -0.732 . . . . 35.04 109.023 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.595 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 1.3 pt? -58.81 154.15 15.52 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.46 0.648 . . . . 18.72 110.734 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -104.89 106.11 16.45 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.693 -1.225 . . . . 20.55 107.693 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.613 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -81.51 144.4 31.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.071 -1.018 . . . . 14.4 111.482 -178.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.474 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 35.6 m -144.26 160.58 48.33 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 107.617 -1.253 . . . . 17.65 107.617 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.8 Cg_endo -62.17 147.81 94.35 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.099 1.866 . . . . 25.7 110.658 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.508 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -77.75 124.12 27.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.303 -0.873 . . . . 49.29 109.547 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.03 -0.986 . . . . 58.91 109.502 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.475 ' HG3' ' O ' ' B' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.374 -0.602 . . . . 64.91 109.374 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.574 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 1.7 mt 57.8 77.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.763 -1.199 . . . . 33.8 107.763 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.422 ' C ' HG11 ' B' ' 4' ' ' VAL . 6.4 mttt -73.15 157.35 37.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.791 . . . . 32.72 110.737 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.579 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -164.94 159.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.082 -0.71 . . . . 14.46 109.082 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 5.1 mt-10 -136.24 113.55 10.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.534 -0.729 . . . . 22.12 109.384 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.591 HD12 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -72.26 107.45 3.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.918 -1.142 . . . . 14.23 107.918 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.627 ' HD3' ' CD1' ' B' ' 34' ' ' TYR . 4.4 mptt -50.29 172.66 0.11 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.148 -0.97 . . . . 25.43 109.959 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -75.98 -29.53 6.66 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.618 2.212 . . . . 13.61 109.925 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.5 m -92.65 7.1 44.88 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.031 -0.729 . . . . 15.52 109.031 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.0 mm-40 -123.61 29.25 6.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 17.31 109.685 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.13 16.15 17.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.994 . . . . 24.78 110.057 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.46 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 18.4 mt-30 -141.78 145.22 34.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 47.9 109.954 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.63 ' CE1' ' ND2' ' B' ' 29' ' ' ASN . 42.4 p90 -96.05 153.64 17.67 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.378 -0.826 . . . . 21.61 109.451 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 38.5 p -121.55 168.72 11.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.437 -0.79 . . . . 14.89 109.274 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.54 113.47 26.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.447 -0.783 . . . . 17.35 109.101 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.461 ' HB2' ' OE1' ' B' ' 30' ' ' GLU . 24.7 mtt180 -141.44 154.94 45.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.256 -0.903 . . . . 34.38 109.539 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.423 ' C ' ' O ' ' B' ' 16' ' ' ARG . 27.0 p -42.6 133.54 3.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.46 -0.775 . . . . 38.77 109.735 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -131.88 157.9 22.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.32 -1.512 . . . . 34.58 109.32 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.459 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -135.34 117.89 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.111 -1.229 . . . . 41.87 109.43 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 7.4 p -63.99 -146.31 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.316 -0.865 . . . . 47.21 109.16 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.481 ' O ' ' CB ' ' B' ' 22' ' ' GLN . 6.5 mtp180 -53.28 -46.73 69.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.119 -0.988 . . . . 71.56 109.199 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' B' ' 21' ' ' ARG . 2.8 pt20 164.82 46.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.442 -0.786 . . . . 66.6 109.478 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.11 -60.38 0.42 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.464 -1.454 . . . . 55.49 109.464 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.48 160.58 50.76 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.222 -1.164 . . . . 44.99 109.323 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.25 80.53 2.87 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.707 2.271 . . . . 44.1 110.864 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 4.9 p90 -68.74 138.93 55.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.232 -0.918 . . . . 32.09 109.689 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.61 80.68 1.82 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.968 . . . . 29.25 108.656 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.582 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -104.75 164.06 12.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.237 -0.915 . . . . 24.0 110.167 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 63.2 m-20 -53.69 160.81 1.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 23.31 109.798 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.461 ' OE1' ' HB2' ' B' ' 16' ' ' ARG . 7.6 mt-10 -150.16 125.17 9.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.431 -0.951 . . . . 40.03 108.431 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.533 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -113.4 -179.14 3.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 12.39 110.382 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.453 ' C ' ' SG ' ' B' ' 33' ' ' CYS . 81.2 mt -137.45 147.88 45.67 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.841 -0.8 . . . . 17.42 108.841 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.9 m -152.08 -177.63 6.28 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.769 -1.197 . . . . 13.84 107.769 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.662 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 31.6 m-85 -127.85 112.4 14.68 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.065 -1.022 . . . . 21.14 109.678 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 61.2 t -106.89 110.17 30.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.349 -0.94 . . . . 10.66 109.688 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' B' ' 38' ' ' GLY . 2.4 p30 -57.91 -39.33 77.68 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.997 -1.483 . . . . 25.89 106.997 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 69' ' ' LYS . 7.4 tt 62.87 -70.66 0.06 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.844 0.831 . . . . 24.24 109.046 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -178.47 41.28 0.09 OUTLIER Glycine 0 C--N 1.293 -1.813 0 N-CA-C 108.554 -1.818 . . . . 31.02 108.554 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -124.17 23.72 8.33 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.281 -1.129 . . . . 43.23 110.474 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.57 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 14.1 mt-10 50.82 19.15 0.58 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.247 -0.908 . . . . 42.34 110.703 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 98.6 m-70 -160.06 154.89 20.92 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.274 -1.01 . . . . 7.28 108.274 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.662 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 37.5 Cg_endo -76.51 134.47 15.4 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.88 1.72 . . . . 17.92 110.521 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 3.1 m -109.09 116.59 52.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 119.424 -0.91 . . . . 20.57 108.808 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.574 ' HB2' ' CE2' ' B' ' 34' ' ' TYR . 65.4 tp -67.48 101.83 1.04 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.457 -0.897 . . . . 20.21 109.358 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.547 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 38.0 t -103.92 167.01 2.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.602 -0.686 . . . . 10.81 109.369 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.547 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 24.4 ttmt -98.79 148.23 24.1 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.198 -0.939 . . . . 36.74 110.165 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.663 HG12 ' CE2' ' B' ' 56' ' ' TYR . 0.0 OUTLIER -127.47 163.09 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.383 -0.823 . . . . 19.74 108.95 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 15.3 m -111.6 135.57 52.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.274 -0.891 . . . . 22.56 109.101 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.61 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -112.2 151.42 29.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 20.41 109.373 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.484 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.3 OUTLIER -87.48 -174.69 4.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 33.99 109.751 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.53 104.46 16.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 54.92 109.528 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.19 -8.09 57.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.612 -1.395 . . . . 36.1 109.612 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.466 ' O ' HD13 ' B' ' 49' ' ' LEU . 0.3 OUTLIER -78.63 143.72 63.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 54.76 109.567 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.7 Cg_endo -79.25 111.04 2.82 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.616 2.211 . . . . 28.37 110.432 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.525 ' CB ' ' HG3' ' B' ' 31' ' ' GLN . . . -42.35 160.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 17.21 110.031 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.663 ' CE2' HG12 ' B' ' 47' ' ' ILE . 11.7 m-30 -54.87 110.78 0.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 17.19 109.286 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.518 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -59.96 176.25 0.34 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 17.82 109.494 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 36.0 Cg_endo -78.79 115.83 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.713 2.276 . . . . 17.28 110.439 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.8 -179.79 43.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.833 -1.307 . . . . 17.22 109.833 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.3 OUTLIER -75.37 146.55 40.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -1.103 . . . . 19.57 108.467 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.591 ' CE1' HD12 ' B' ' 6' ' ' ILE . 22.8 m-85 -132.49 162.99 29.81 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.759 -1.213 . . . . 14.61 111.92 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.512 HG21 ' CB ' ' B' ' 86' ' ' ALA . 59.9 p -145.44 119.85 9.65 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.691 -1.596 . . . . 18.36 106.691 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.596 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 11.5 t -47.78 169.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.1 -1.04 . . . . 19.13 109.267 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.561 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.7 t-80 -134.77 122.06 21.58 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.943 -0.762 . . . . 20.65 108.943 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.6 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -65.85 -9.28 27.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.444 -0.785 . . . . 19.65 109.254 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 86.4 p -53.85 -16.82 1.97 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.13 -0.981 . . . . 14.72 108.919 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.517 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -104.33 -7.09 20.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 11.45 111.13 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.0 m-30 -74.25 162.57 28.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.651 -1.281 . . . . 14.25 109.54 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.537 ' N ' HD13 ' A' ' 37' ' ' LEU . 25.2 mtmt -148.5 173.99 12.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 32.7 109.38 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.478 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -114.6 109.86 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.875 . . . . 15.63 109.029 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.17 -179.45 44.15 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.587 -1.405 . . . . 12.7 109.587 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.443 ' O ' ' NE2' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -88.44 39.23 0.9 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.17 -1.194 . . . . 26.29 109.42 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -112.13 11.64 20.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 20.44 109.251 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 46' ' ' LYS . . . 63.55 27.28 70.68 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.333 -1.507 . . . . 13.82 109.333 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -154.96 155.54 34.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -1.141 . . . . 18.27 109.545 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.532 ' CD2' HG22 ' A' ' 2' ' ' ILE . 1.7 tp -67.34 173.59 3.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 12.43 109.553 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.431 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 2.8 mtt -159.53 101.69 1.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 35.11 109.551 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.595 ' CG2' ' N ' ' B' ' 81' ' ' LEU . 2.7 mt -41.88 -43.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.546 -0.721 . . . . 13.67 110.037 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.4 OUTLIER 48.66 54.32 10.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.307 -0.871 . . . . 24.06 108.985 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.546 ' CB ' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 82.18 80.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.065 -0.717 . . . . 35.04 109.065 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.596 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.3 pt? -58.69 154.03 15.4 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.472 0.653 . . . . 18.72 110.757 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.561 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -104.87 106.18 16.55 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.636 -1.246 . . . . 20.55 107.636 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.612 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -81.5 144.45 31.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.017 -1.052 . . . . 14.4 111.475 -178.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.467 ' HB ' ' HD2' ' B' ' 85' ' ' PRO . 35.5 m -144.41 160.47 48.21 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 107.518 -1.289 . . . . 17.65 107.518 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.3 Cg_endo -62.17 148.02 93.98 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.07 1.847 . . . . 25.7 110.657 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.512 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -77.84 124.24 27.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.243 -0.91 . . . . 49.29 109.511 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.026 -0.988 . . . . 58.91 109.527 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.52 ' SD ' ' CG2' ' A' ' 62' ' ' THR . 30.9 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.495 -0.557 . . . . 64.91 109.495 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.529 ' CG2' HG22 ' A' ' 63' ' ' VAL . 2.8 mt -65.23 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.582 -1.266 . . . . 33.8 107.582 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -67.01 155.36 38.85 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.964 0.887 . . . . 32.72 111.461 -177.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -163.37 168.89 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.14 -1.059 . . . . 14.46 108.14 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.0 OUTLIER -146.28 107.54 4.21 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.105 -0.997 . . . . 22.12 109.275 -178.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -66.2 103.92 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.696 -1.224 . . . . 14.23 107.696 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.572 ' HE2' ' CE2' ' A' ' 34' ' ' TYR . 8.2 mmmt -43.61 162.26 0.19 Allowed Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.159 -0.963 . . . . 25.43 109.489 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.42 -11.96 26.93 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.945 1.763 . . . . 13.61 109.155 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.3 t -102.14 7.73 40.9 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.735 -0.839 . . . . 15.52 108.735 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.518 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 9.4 mm-40 -126.71 37.23 4.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.889 . . . . 17.31 109.247 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.64 15.95 23.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.118 -0.989 . . . . 24.78 110.165 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.406 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -136.62 143.73 43.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.116 -0.99 . . . . 47.9 108.81 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.63 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 31.6 p90 -94.0 162.63 13.81 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.121 -0.987 . . . . 21.61 109.116 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -143.71 147.17 33.85 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.256 -0.902 . . . . 14.89 109.407 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.26 110.82 22.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.348 -0.845 . . . . 17.35 109.078 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.8 90.85 0.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.194 -0.941 . . . . 34.38 109.715 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.07 161.85 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 38.77 109.861 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 26' ' ' TYR . . . 170.01 148.9 6.09 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.855 -1.698 . . . . 34.58 108.855 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.454 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -133.53 126.32 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.031 -1.276 . . . . 41.87 109.214 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 4.2 p -68.03 -32.1 72.23 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.204 -0.935 . . . . 47.21 108.759 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' O ' ' CG ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER 170.89 -60.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.051 -0.722 . . . . 71.56 109.051 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.542 ' CG ' ' O ' ' A' ' 21' ' ' ARG . 39.6 mt-30 -162.27 31.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.545 -0.722 . . . . 66.6 109.733 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -110.68 -57.11 0.5 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.548 -1.421 . . . . 55.49 109.548 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 23' ' ' GLY . 24.2 mttt -159.26 156.68 26.34 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.352 -1.087 . . . . 44.99 109.168 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' GLY . 34.0 Cg_endo -76.83 73.87 5.15 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.559 2.173 . . . . 44.1 110.494 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.584 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 2.5 p90 -62.36 137.21 58.22 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.43 -0.793 . . . . 32.09 109.844 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.5 80.71 1.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 29.25 108.813 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.561 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -110.53 161.97 15.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 24.0 110.336 -179.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 95.9 m-20 -50.27 115.84 1.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.522 -0.736 . . . . 23.31 109.93 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -115.52 150.23 36.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.944 . . . . 40.03 109.019 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.541 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -125.81 -171.45 2.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.04 -1.037 . . . . 12.39 109.86 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.548 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 30.1 mt -128.12 176.96 7.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.482 -0.761 . . . . 17.42 109.396 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -171.39 158.02 5.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.143 -0.973 . . . . 13.84 108.438 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.643 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 2.9 m-30 -113.99 102.64 10.38 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.078 -1.014 . . . . 21.14 108.542 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.542 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 38.5 t -102.41 106.74 20.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.094 -1.004 . . . . 10.66 110.273 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -61.41 -39.01 89.16 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.259 -1.386 . . . . 25.89 107.259 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' B' ' 65' ' ' LEU . 6.9 tt 63.18 -69.36 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.675 0.75 . . . . 24.24 109.381 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -178.49 42.94 0.09 OUTLIER Glycine 0 C--N 1.296 -1.674 0 N-CA-C 108.803 -1.719 . . . . 31.02 108.803 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -124.83 27.66 6.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.284 -1.127 . . . . 43.23 110.205 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.583 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 1.9 mm-40 48.67 21.2 0.39 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.17 -0.957 . . . . 42.34 110.239 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 59.4 m80 -164.57 151.39 9.72 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.196 -1.038 . . . . 6.58 108.196 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.618 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.2 Cg_endo -76.48 144.06 25.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.08 1.853 . . . . 17.92 110.955 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 5.0 m -117.92 118.89 59.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.476 -0.89 . . . . 20.57 109.14 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.643 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 23.5 tp -68.69 110.49 4.31 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.944 -0.702 . . . . 20.21 109.155 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 16.3 t -117.02 167.38 10.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.513 -0.742 . . . . 10.81 109.497 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.567 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -90.74 162.3 14.94 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.659 -0.817 . . . . 36.74 110.216 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.628 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -152.12 161.44 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.759 -0.83 . . . . 19.74 108.759 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.67 151.83 20.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.0 -1.062 . . . . 22.56 109.762 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.63 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 2.7 tm? -134.22 93.62 3.1 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.434 -0.791 . . . . 20.41 108.991 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.526 ' HB3' ' CD2' ' A' ' 28' ' ' LEU . 2.2 p30 -154.59 174.94 14.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.934 -1.104 . . . . 33.99 110.117 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' GLN . 10.4 tt0 73.21 72.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.501 -0.749 . . . . 54.92 109.807 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 51' ' ' GLU . . . 36.45 30.06 0.03 OUTLIER Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.236 -1.146 . . . . 36.1 110.236 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 51' ' ' GLU . 2.4 mt-30 -107.31 131.0 22.04 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.07 -1.253 . . . . 54.76 110.061 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.3 Cg_endo -80.1 142.1 15.13 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.463 2.108 . . . . 28.37 110.004 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.489 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -41.61 141.45 0.77 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 17.21 110.015 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.628 ' CE1' HG12 ' A' ' 47' ' ' ILE . 84.5 m-85 -47.2 98.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 17.19 109.146 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.522 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -49.42 175.36 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 17.82 109.743 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -77.89 118.32 4.42 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.73 2.286 . . . . 17.28 110.369 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.87 171.4 34.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.473 -1.451 . . . . 17.22 109.473 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.2 mp -72.08 147.6 46.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.198 -1.177 . . . . 19.57 108.924 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CB ' HG12 ' A' ' 4' ' ' VAL . 30.7 m-85 -132.04 163.24 28.87 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.579 1.181 . . . . 14.61 111.424 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.52 ' CG2' ' SD ' ' A' ' 1' ' ' MET . 20.6 p -142.17 119.35 11.43 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.616 -1.994 . . . . 18.36 105.616 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.62 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.5 t -52.42 167.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 C-N-CA 118.615 -1.234 . . . . 19.13 109.198 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -129.61 128.75 43.3 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.546 -0.721 . . . . 20.65 109.123 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.676 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -70.88 -0.94 10.23 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.401 -0.812 . . . . 19.65 109.679 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 p -56.6 -19.18 14.77 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.541 -1.281 . . . . 14.72 107.541 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 39.6 m -97.02 -6.97 34.1 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.831 -0.543 . . . . 11.45 110.05 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.3 m-30 -79.7 157.29 27.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 14.25 109.689 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.488 ' HA ' HD12 ' B' ' 37' ' ' LEU . 0.0 OUTLIER -140.15 169.9 16.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.834 . . . . 32.7 109.488 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.575 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 2.2 t -110.08 139.52 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.912 . . . . 15.63 109.425 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.57 -157.55 23.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.341 -1.504 . . . . 12.7 109.341 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 0.0 OUTLIER 63.03 78.34 0.3 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.159 -1.2 . . . . 26.29 109.122 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.5 OUTLIER 69.48 9.39 7.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.433 -0.792 . . . . 20.44 109.472 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.414 ' O ' HG11 ' B' ' 45' ' ' VAL . . . 80.24 46.03 7.79 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.608 -1.397 . . . . 13.82 109.608 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.5 t -146.51 140.15 25.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -1.183 . . . . 18.27 109.577 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 77' ' ' MET . 1.4 tp -55.74 156.17 5.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 12.43 109.338 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 15.2 mtt -164.25 130.33 2.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 35.11 109.64 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.598 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.5 mp -63.72 138.49 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 13.67 109.77 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.62 -23.62 12.39 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.379 -0.971 . . . . 24.06 108.379 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 67' ' ' SER . 1.0 OUTLIER 178.44 68.04 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.03 -1.47 . . . . 35.04 107.03 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.62 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -29.05 119.68 0.13 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.274 -0.875 . . . . 18.72 111.685 -177.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -88.6 100.44 13.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 20.55 108.783 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.601 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -69.75 141.06 53.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 14.4 110.638 -179.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 62' ' ' THR . 27.8 m -143.22 153.5 59.83 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.71 -1.219 . . . . 17.65 107.71 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.2 Cg_endo -61.44 141.77 93.23 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.945 1.763 . . . . 25.7 110.317 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.475 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -77.95 117.78 19.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.266 -0.896 . . . . 49.29 109.682 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.993 -1.003 . . . . 58.91 109.455 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.512 ' SD ' ' CG2' ' B' ' 62' ' ' THR . 31.1 ttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.519 -0.548 . . . . 64.91 109.519 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' B' ' 63' ' ' VAL . 2.8 mt -65.28 81.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.572 -1.27 . . . . 33.8 107.572 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -67.2 155.32 39.1 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.981 0.895 . . . . 32.72 111.43 -177.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.598 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -163.34 168.92 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.133 -1.062 . . . . 14.46 108.133 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 1.0 OUTLIER -146.3 107.55 4.21 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.104 -0.997 . . . . 22.12 109.258 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.576 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -66.22 104.02 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.718 -1.216 . . . . 14.23 107.718 179.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.576 ' HE2' ' CE2' ' B' ' 34' ' ' TYR . 8.2 mmmt -43.68 162.26 0.19 Allowed Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.147 -0.971 . . . . 25.43 109.479 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.7 Cg_endo -72.38 -12.08 27.1 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.984 1.789 . . . . 13.61 109.115 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 44.6 t -102.03 7.58 41.18 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.753 -0.832 . . . . 15.52 108.753 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.512 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 9.4 mm-40 -126.5 37.32 4.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.288 -0.882 . . . . 17.31 109.254 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.75 15.8 24.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 24.78 110.168 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.39 143.79 44.19 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.074 -1.016 . . . . 47.9 108.82 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.639 ' CD2' ' CD1' ' B' ' 49' ' ' LEU . 31.6 p90 -94.03 162.6 13.82 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.1 -1.0 . . . . 21.61 109.098 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -143.61 147.33 34.2 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.288 -0.883 . . . . 14.89 109.362 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.48 110.82 22.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.367 -0.833 . . . . 17.35 109.08 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.78 90.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 34.38 109.679 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.0 161.8 0.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.843 . . . . 38.77 109.851 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.549 ' CA ' ' O ' ' B' ' 26' ' ' TYR . . . 170.04 148.82 6.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.765 -1.734 . . . . 34.58 108.765 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.447 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.0 OUTLIER -133.43 126.39 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.048 -1.266 . . . . 41.87 109.181 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' B' ' 21' ' ' ARG . 4.2 p -68.15 -31.87 71.74 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.189 -0.944 . . . . 47.21 108.819 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER 170.79 -60.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.064 -0.717 . . . . 71.56 109.064 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.554 ' CG ' ' O ' ' B' ' 21' ' ' ARG . 39.7 mt-30 -162.35 31.39 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 66.6 109.763 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' B' ' 24' ' ' LYS . . . -110.63 -57.17 0.5 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.567 -1.413 . . . . 55.49 109.567 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' B' ' 23' ' ' GLY . 24.5 mttt -159.25 156.68 26.37 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.292 -1.123 . . . . 44.99 109.146 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.44 ' C ' ' O ' ' B' ' 18' ' ' GLY . 34.1 Cg_endo -76.8 73.84 5.15 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.535 2.157 . . . . 44.1 110.51 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 2.5 p90 -62.36 137.2 58.21 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.452 -0.78 . . . . 32.09 109.838 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.53 80.84 1.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.107 -0.996 . . . . 29.25 108.778 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.565 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -110.61 161.98 15.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 24.0 110.312 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.622 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 95.8 m-20 -50.31 115.95 1.67 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 23.31 109.854 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -115.6 150.34 36.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.158 -0.964 . . . . 40.03 108.98 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.555 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -125.92 -171.55 2.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.013 -1.055 . . . . 12.39 109.836 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.543 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 30.0 mt -128.06 176.93 7.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.461 -0.774 . . . . 17.42 109.442 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -171.31 158.09 5.23 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.093 -1.004 . . . . 13.84 108.487 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.636 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 2.9 m-30 -114.06 102.53 10.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.148 -0.97 . . . . 21.14 108.592 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.537 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 38.4 t -102.34 106.67 20.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.147 -1.021 . . . . 10.66 110.309 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.9 OUTLIER -61.17 -39.1 88.86 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.307 -1.368 . . . . 25.89 107.307 178.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.531 ' HG ' ' CD1' ' A' ' 65' ' ' LEU . 6.9 tt 63.33 -69.39 0.07 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.695 0.76 . . . . 24.24 109.313 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -178.52 42.97 0.09 OUTLIER Glycine 0 C--N 1.295 -1.742 0 N-CA-C 108.773 -1.731 . . . . 31.02 108.773 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -124.85 27.65 6.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.246 -1.149 . . . . 43.23 110.234 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.574 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 1.9 mm-40 48.7 21.16 0.39 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.23 -0.919 . . . . 42.34 110.25 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 59.4 m80 -164.57 151.3 9.66 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 108.2 -1.037 . . . . 6.56 108.2 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.622 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.6 Cg_endo -76.33 143.98 25.56 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.137 1.891 . . . . 17.92 111.011 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' B' ' 35' ' ' VAL . 5.0 m -117.87 118.8 59.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.451 -0.9 . . . . 20.57 109.098 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.636 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 23.4 tp -68.67 110.55 4.33 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.898 -0.721 . . . . 20.21 109.218 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.575 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 16.8 t -116.95 167.42 10.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.511 -0.743 . . . . 10.81 109.529 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -90.75 162.24 14.97 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.674 -0.81 . . . . 36.74 110.206 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.633 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -152.06 161.5 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.706 -0.85 . . . . 19.74 108.706 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.71 151.69 20.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.969 -1.082 . . . . 22.56 109.787 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.639 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 2.7 tm? -134.05 93.58 3.12 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.373 -0.829 . . . . 20.41 109.003 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.514 ' HB3' ' CD2' ' B' ' 28' ' ' LEU . 2.2 p30 -154.63 174.74 14.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.956 -1.09 . . . . 33.99 110.152 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' B' ' 53' ' ' GLN . 10.4 tt0 73.25 73.05 0.13 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 54.92 109.814 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' B' ' 51' ' ' GLU . . . 36.37 30.02 0.03 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.273 -1.131 . . . . 36.1 110.273 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' B' ' 51' ' ' GLU . 2.4 mt-30 -107.2 130.84 22.27 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.094 -1.239 . . . . 54.76 110.084 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 36.2 Cg_endo -79.95 141.97 15.33 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.525 2.15 . . . . 28.37 109.986 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.501 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -41.46 141.39 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 17.21 110.031 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.633 ' CE1' HG12 ' B' ' 47' ' ' ILE . 83.5 m-85 -47.03 97.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.327 -0.858 . . . . 17.19 109.11 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -49.15 175.46 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 17.82 109.804 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.1 Cg_endo -77.85 117.59 4.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.651 2.234 . . . . 17.28 110.176 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.35 171.11 35.45 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.542 -1.423 . . . . 17.22 109.542 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.0 mp -72.3 147.14 46.65 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.172 -1.193 . . . . 19.57 108.711 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.598 ' CB ' HG12 ' B' ' 4' ' ' VAL . 30.6 m-85 -131.65 163.11 28.83 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 122.564 1.173 . . . . 14.61 111.446 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.52 ' O ' ' CG2' ' B' ' 84' ' ' VAL . 20.7 p -142.01 119.28 11.47 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 105.627 -1.99 . . . . 18.36 105.627 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.609 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.5 t -52.54 166.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 C-N-CA 118.559 -1.256 . . . . 19.13 109.208 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -129.32 128.66 43.61 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.568 -0.707 . . . . 20.65 109.228 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.662 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -70.69 -1.04 10.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.457 -0.777 . . . . 19.65 109.71 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 p -56.59 -19.23 14.98 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.541 -1.281 . . . . 14.72 107.541 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 38.2 m -96.9 -7.38 33.47 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.853 -0.529 . . . . 11.45 110.131 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.662 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.2 m-30 -79.32 157.06 27.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.065 -1.022 . . . . 14.25 109.642 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.502 ' HA ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.96 169.68 17.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 32.7 109.484 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.549 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 2.2 t -109.88 139.57 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 15.63 109.42 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 75' ' ' SER . . . 136.59 -157.63 23.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.261 -1.536 . . . . 12.7 109.261 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.0 OUTLIER 63.08 78.32 0.3 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.188 -1.183 . . . . 26.29 109.108 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.5 OUTLIER 69.51 9.4 7.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.455 -0.778 . . . . 20.44 109.401 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.445 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 80.26 45.78 7.93 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.639 -1.384 . . . . 13.82 109.639 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.402 ' O ' ' O ' ' B' ' 71' ' ' GLY . 1.5 t -146.24 140.11 26.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -1.163 . . . . 18.27 109.603 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.525 ' O ' ' CG ' ' B' ' 77' ' ' MET . 1.4 tp -55.69 156.23 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 12.43 109.338 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.525 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 15.2 mtt -164.33 130.53 2.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 35.11 109.618 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.5 mp -63.97 138.57 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -0.854 . . . . 13.67 109.841 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.6 -23.76 12.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.334 -0.988 . . . . 24.06 108.334 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.9 OUTLIER 178.55 68.07 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.062 -1.459 . . . . 35.04 107.062 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.609 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.7 OUTLIER -29.15 119.66 0.13 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.297 -0.865 . . . . 18.72 111.659 -177.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -88.52 100.25 12.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.348 -0.845 . . . . 20.55 108.849 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.601 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -69.74 140.93 53.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 14.4 110.626 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' B' ' 62' ' ' THR . 27.3 m -143.08 153.33 60.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 107.756 -1.201 . . . . 17.65 107.756 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.3 Cg_endo -61.23 141.7 94.05 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.911 1.741 . . . . 25.7 110.39 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.483 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -77.89 117.81 19.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.335 -0.853 . . . . 49.29 109.687 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.04 -0.981 . . . . 58.91 109.417 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.506 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.274 0.559 . . . . 64.91 109.496 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.521 ' CD1' ' HB ' ' A' ' 63' ' ' VAL . 3.3 mt 70.12 78.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 107.459 -1.312 . . . . 33.8 107.459 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.512 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -62.01 159.7 13.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.96 0.886 . . . . 32.72 111.666 -177.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.574 ' CG2' ' CG2' ' A' ' 35' ' ' VAL . 82.4 t -160.68 168.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.985 -0.746 . . . . 14.46 108.985 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 30.9 mt-10 -153.29 99.7 2.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 22.12 109.463 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.604 HD12 ' CE1' ' A' ' 61' ' ' TYR . 1.0 OUTLIER -70.32 102.77 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.822 -1.177 . . . . 14.23 107.822 179.206 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.577 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 3.5 mmpt? -57.64 163.59 3.68 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 25.43 109.308 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.5 -11.94 26.75 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.98 1.787 . . . . 13.61 109.206 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -102.69 13.3 34.78 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.301 -1.0 . . . . 15.52 108.301 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.537 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 5.6 mm-40 -142.86 36.33 1.42 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.452 -0.78 . . . . 17.31 109.41 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -112.78 35.3 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.092 -1.005 . . . . 24.78 110.234 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -140.74 125.19 17.73 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.169 -0.957 . . . . 47.9 109.67 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.632 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 40.4 p90 -89.74 156.66 18.38 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.293 -0.879 . . . . 21.61 109.82 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -131.5 161.85 31.6 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.326 -0.99 . . . . 14.89 108.326 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.451 HG21 ' HB3' ' A' ' 27' ' ' SER . 0.2 OUTLIER -78.61 109.38 12.76 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.093 -1.004 . . . . 17.35 109.095 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -120.09 148.3 43.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.277 -0.89 . . . . 34.38 109.455 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 t -51.65 153.05 2.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -0.861 . . . . 38.77 109.505 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -155.45 -179.9 30.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.271 -1.531 . . . . 34.58 109.271 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -153.67 117.77 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -1.229 . . . . 41.87 109.2 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 22' ' ' GLN . 54.3 p -57.17 83.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.344 -0.847 . . . . 47.21 109.812 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER 67.79 -59.82 0.41 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.163 -0.96 . . . . 71.56 109.728 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 20' ' ' SER . 11.9 pt20 170.97 47.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 66.6 109.604 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.32 -55.59 0.1 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.408 -1.477 . . . . 55.49 109.408 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -135.78 150.72 72.54 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.368 -1.078 . . . . 44.99 109.259 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.9 131.48 11.14 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.615 2.21 . . . . 44.1 110.638 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 5.5 p90 -133.09 143.28 49.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.2 -0.938 . . . . 32.09 109.749 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.451 ' HB3' HG21 ' A' ' 15' ' ' THR . 0.2 OUTLIER -102.93 81.09 1.95 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -0.888 . . . . 29.25 108.846 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.542 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -93.1 134.66 35.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.858 . . . . 24.0 110.29 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -45.77 133.97 7.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.54 -0.725 . . . . 23.31 110.082 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 35.5 mt-10 -128.53 151.69 49.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.384 -0.822 . . . . 40.03 108.816 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.546 ' OE1' ' CB ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -135.62 -170.43 2.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.978 -1.076 . . . . 12.39 110.294 -179.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 10' ' ' GLN . 11.0 mt -126.65 173.2 9.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.733 -0.84 . . . . 17.42 108.733 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -167.95 160.68 12.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.792 -1.192 . . . . 13.84 108.162 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.637 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 3.2 m-85 -107.59 92.17 3.96 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.136 -0.978 . . . . 21.14 109.478 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.574 ' CG2' ' CG2' ' A' ' 4' ' ' VAL . 37.5 t -94.59 121.74 45.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.281 -0.887 . . . . 10.66 110.17 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.487 ' O ' ' HG ' ' A' ' 37' ' ' LEU . 1.9 m-20 -73.35 -36.62 66.17 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.212 -1.033 . . . . 25.89 108.212 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 35' ' ' VAL . 1.0 OUTLIER 39.19 28.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.779 -0.575 . . . . 24.24 110.073 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 67.75 25.98 73.94 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.782 -1.327 . . . . 31.02 109.782 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 36' ' ' ASP . 1.1 t-20 -96.21 15.4 21.06 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.192 -1.181 . . . . 43.23 110.655 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 41' ' ' HIS . 1.7 mt-10 68.5 94.03 0.07 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.023 -1.048 . . . . 42.34 108.601 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.583 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 10.6 m80 86.57 167.94 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.646 -0.872 . . . . 6.21 108.646 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 34.0 Cg_endo -77.71 150.26 27.34 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.09 1.86 . . . . 17.92 111.204 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 2.2 m -122.48 120.44 61.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.368 -0.833 . . . . 20.57 109.171 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.637 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 16.6 tp -73.79 109.62 7.44 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.295 -0.878 . . . . 20.21 108.641 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 1.6 p -123.87 160.65 27.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.438 -0.789 . . . . 10.81 109.475 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 4.6 ttmt -77.33 164.56 25.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 36.74 110.438 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.595 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -149.66 172.59 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.906 -0.776 . . . . 19.74 108.906 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 m -108.65 146.87 32.74 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.161 -0.962 . . . . 22.56 109.312 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.632 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -118.01 145.94 44.4 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.237 -0.914 . . . . 20.41 108.61 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.459 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -82.38 140.14 33.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.061 -1.025 . . . . 33.99 109.82 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.28 106.73 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 54.92 109.346 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.95 -12.53 57.6 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.494 . . . . 36.1 109.364 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 50' ' ' ASP . 5.1 mt-30 -81.9 147.22 57.7 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.29 -1.124 . . . . 54.76 109.344 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.8 Cg_endo -78.15 123.23 6.05 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.593 2.195 . . . . 28.37 110.537 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.546 ' CB ' ' OE1' ' A' ' 31' ' ' GLN . . . -37.94 143.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.633 -0.667 . . . . 17.21 110.142 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.606 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 83.9 m-85 -41.49 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.481 -0.762 . . . . 17.19 109.326 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . -43.04 165.41 0.11 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 17.82 109.577 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 35.1 Cg_endo -77.59 105.92 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.57 2.18 . . . . 17.28 110.484 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.54 -174.25 41.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.891 -1.284 . . . . 17.22 109.891 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -76.06 142.42 41.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -1.101 . . . . 19.57 108.396 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.604 ' CE1' HD12 ' A' ' 6' ' ' ILE . 15.9 m-85 -131.74 163.69 27.62 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.767 -1.208 . . . . 14.61 111.68 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.506 ' CG2' ' HG3' ' A' ' 1' ' ' MET . 50.8 p -145.72 120.18 9.68 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.698 -1.593 . . . . 18.36 106.698 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 3.8 t -50.68 171.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 118.708 -1.197 . . . . 19.13 108.885 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.8 t-80 -135.08 125.37 26.3 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.337 -0.852 . . . . 20.65 109.263 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.671 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -70.4 -2.84 14.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.457 -0.777 . . . . 19.65 109.697 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -17.01 14.71 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.023 -1.102 . . . . 14.72 108.023 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -101.73 -9.66 20.65 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.726 -0.609 . . . . 11.45 110.597 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -72.31 164.14 26.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.959 -1.088 . . . . 14.25 109.992 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' A' ' 77' ' ' MET . 2.8 ptmt -146.42 177.04 9.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.947 -0.76 . . . . 32.7 108.947 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.92 158.73 37.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.272 -0.892 . . . . 15.63 109.355 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.96 -140.16 11.61 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.367 -1.493 . . . . 12.7 109.367 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 28.6 tp60 57.23 60.56 2.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.111 -1.229 . . . . 26.29 109.373 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 73.29 2.34 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.494 -0.754 . . . . 20.44 109.469 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' HG21 ' B' ' 45' ' ' VAL . . . 103.9 54.79 0.8 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.962 -1.255 . . . . 13.82 109.962 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.3 t -151.27 147.36 26.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -1.2 . . . . 18.27 109.776 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 77' ' ' MET . 2.6 tp -59.41 165.11 2.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 12.43 109.189 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 12.1 mtp -165.23 104.54 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.972 . . . . 35.11 110.038 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.57 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.4 mt -42.26 -63.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.509 -0.744 . . . . 13.67 109.335 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 38.0 t0 84.9 -45.5 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.387 0.613 . . . . 24.06 110.134 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.573 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.0 tmm_? -171.44 67.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.039 0.923 . . . . 35.04 108.519 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.585 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -38.06 131.19 1.12 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.603 -0.726 . . . . 18.72 111.514 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.526 ' NH1' ' HG2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -96.47 107.0 19.34 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.923 -1.14 . . . . 20.55 107.923 178.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -76.9 146.84 37.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.127 -0.983 . . . . 14.4 111.221 -178.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 62' ' ' THR . 16.3 m -147.63 156.8 45.1 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.93 -1.137 . . . . 17.65 107.93 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.9 Cg_endo -64.01 142.95 83.5 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.163 1.909 . . . . 25.7 110.419 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.428 ' CA ' HG21 ' A' ' 62' ' ' THR . . . -72.23 115.1 11.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 49.29 109.484 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.043 -0.98 . . . . 58.91 109.48 -179.942 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.507 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.43 -0.581 . . . . 64.91 109.43 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.525 ' CD1' ' HB ' ' B' ' 63' ' ' VAL . 3.3 mt 70.26 78.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.475 -1.306 . . . . 33.8 107.475 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 0.0 OUTLIER -61.85 159.56 13.65 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.976 0.893 . . . . 32.72 111.656 -177.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.582 ' CG2' ' CG2' ' B' ' 35' ' ' VAL . 84.3 t -160.52 168.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.964 -0.754 . . . . 14.46 108.964 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 31.0 mt-10 -153.3 99.75 2.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.299 -0.876 . . . . 22.12 109.502 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.59 HD12 ' CE1' ' B' ' 61' ' ' TYR . 1.0 OUTLIER -70.41 102.75 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.756 -1.201 . . . . 14.23 107.756 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.578 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 3.5 mmpt? -57.57 163.44 3.71 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.276 -0.89 . . . . 25.43 109.322 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.6 Cg_endo -72.44 -11.84 26.81 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.931 1.754 . . . . 13.61 109.182 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -102.68 13.21 35.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 15.52 108.33 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.53 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 5.6 mm-40 -142.7 36.22 1.44 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.402 -0.811 . . . . 17.31 109.452 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -112.69 35.4 3.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.986 -1.071 . . . . 24.78 110.274 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -140.8 125.09 17.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.122 -0.986 . . . . 47.9 109.588 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.635 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 40.6 p90 -89.54 157.01 18.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.313 -0.867 . . . . 21.61 109.855 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.2 t -131.89 161.53 32.79 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.327 -0.99 . . . . 14.89 108.327 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.467 HG21 ' HB3' ' B' ' 27' ' ' SER . 0.2 OUTLIER -78.32 109.46 12.48 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.09 -1.006 . . . . 17.35 109.168 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -120.29 148.24 43.97 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.31 -0.868 . . . . 34.38 109.531 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.0 t -51.56 153.12 2.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 38.77 109.466 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -155.54 -179.82 30.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.164 -1.574 . . . . 34.58 109.164 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' B' ' 21' ' ' ARG . 0.7 OUTLIER -153.77 117.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.254 . . . . 41.87 109.201 179.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.492 ' O ' ' N ' ' B' ' 22' ' ' GLN . 53.8 p -57.3 83.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.849 . . . . 47.21 109.832 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER 67.69 -59.78 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.216 -0.927 . . . . 71.56 109.773 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' B' ' 20' ' ' SER . 11.9 pt20 170.9 48.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 66.6 109.615 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.44 -55.55 0.1 OUTLIER Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.4 -1.48 . . . . 55.49 109.4 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -135.84 150.7 72.38 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.281 -1.129 . . . . 44.99 109.223 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.0 131.54 11.08 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.532 2.154 . . . . 44.1 110.602 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.56 ' CD1' ' C ' ' B' ' 26' ' ' TYR . 5.4 p90 -133.01 143.36 49.37 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.926 . . . . 32.09 109.807 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.467 ' HB3' HG21 ' B' ' 15' ' ' THR . 0.2 OUTLIER -103.04 81.1 1.93 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 29.25 108.809 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.555 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -93.11 134.68 35.02 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.31 -0.869 . . . . 24.0 110.329 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.602 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -45.73 134.19 7.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.561 -0.712 . . . . 23.31 110.045 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 35.4 mt-10 -128.7 151.76 49.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.322 -0.861 . . . . 40.03 108.783 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.546 ' OE1' ' CB ' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -135.76 -170.55 2.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.948 -1.095 . . . . 12.39 110.223 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.488 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 11.0 mt -126.67 173.2 9.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.692 -0.855 . . . . 17.42 108.692 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -168.0 160.58 12.18 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.782 -1.199 . . . . 13.84 108.136 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.638 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 3.2 m-85 -107.47 92.41 4.06 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.082 -1.011 . . . . 21.14 109.461 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.582 ' CG2' ' CG2' ' B' ' 4' ' ' VAL . 38.5 t -94.81 121.71 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.25 -0.906 . . . . 10.66 110.112 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.488 ' O ' ' HG ' ' B' ' 37' ' ' LEU . 1.9 m-20 -73.35 -36.45 66.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.215 -1.031 . . . . 25.89 108.215 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' B' ' 35' ' ' VAL . 1.0 OUTLIER 39.09 28.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.731 -0.606 . . . . 24.24 109.979 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 67.61 26.22 73.76 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.79 -1.324 . . . . 31.02 109.79 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' B' ' 36' ' ' ASP . 1.1 t-20 -96.45 15.63 20.87 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.228 -1.16 . . . . 43.23 110.568 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' B' ' 41' ' ' HIS . 1.7 mt-10 68.38 93.89 0.07 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.026 -1.046 . . . . 42.34 108.652 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.587 ' CB ' ' O ' ' B' ' 40' ' ' GLU . 10.5 m80 86.66 168.01 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.672 -0.862 . . . . 6.24 108.672 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.614 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 34.1 Cg_endo -77.64 150.43 27.73 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.072 1.848 . . . . 17.92 111.18 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 2.2 m -122.66 120.41 60.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.64 -0.824 . . . . 20.57 109.128 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.638 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 16.7 tp -73.74 109.71 7.46 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.447 -0.901 . . . . 20.21 108.65 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' B' ' 32' ' ' LEU . 1.7 p -123.87 160.71 27.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.382 -0.824 . . . . 10.81 109.466 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.427 ' HD3' ' OE1' ' B' ' 30' ' ' GLU . 4.6 ttmt -77.36 164.65 25.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 36.74 110.434 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.596 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -149.65 172.61 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.448 -0.782 . . . . 19.74 108.9 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.1 m -108.72 146.38 33.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.163 -0.961 . . . . 22.56 109.378 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.635 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -117.5 145.96 43.86 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.201 -0.937 . . . . 20.41 108.615 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.459 ' HB2' ' NE2' ' B' ' 53' ' ' GLN . 0.7 OUTLIER -82.42 140.03 33.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 33.99 109.81 -179.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.18 106.84 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 54.92 109.403 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.88 -12.44 57.69 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.363 -1.495 . . . . 36.1 109.363 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' B' ' 50' ' ' ASP . 5.0 mt-30 -82.09 147.19 56.93 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.364 -1.08 . . . . 54.76 109.359 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.6 Cg_endo -78.08 123.27 6.1 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.646 2.231 . . . . 28.37 110.469 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.546 ' CB ' ' OE1' ' B' ' 31' ' ' GLN . . . -37.88 143.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.528 -0.732 . . . . 17.21 110.19 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.603 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 83.9 m-85 -41.41 97.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.457 -0.777 . . . . 17.19 109.259 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' B' ' 55' ' ' ALA . . . -42.87 165.52 0.1 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 17.82 109.582 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' B' ' 6' ' ' ILE . 35.0 Cg_endo -77.43 104.97 1.97 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.562 2.175 . . . . 17.28 110.122 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.74 -175.03 41.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.946 -1.262 . . . . 17.22 109.946 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.3 OUTLIER -76.31 142.07 41.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.075 -1.083 . . . . 19.57 108.075 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.59 ' CE1' HD12 ' B' ' 6' ' ' ILE . 15.5 m-85 -131.32 163.7 27.27 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.716 -1.24 . . . . 14.61 111.716 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.507 ' CG2' ' HG3' ' B' ' 1' ' ' MET . 50.6 p -145.64 120.09 9.68 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.61 -1.626 . . . . 18.36 106.61 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.587 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 3.8 t -50.64 171.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 118.78 -1.168 . . . . 19.13 108.861 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.518 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.8 t-80 -135.01 125.45 26.59 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.331 -0.856 . . . . 20.65 109.268 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.673 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -70.51 -2.91 15.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.771 . . . . 19.65 109.645 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -17.13 14.53 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.043 -1.095 . . . . 14.72 108.043 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 0.4 OUTLIER -101.63 -10.04 20.4 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.681 -0.637 . . . . 11.45 110.654 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.673 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.8 m-30 -72.05 164.12 26.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.022 -1.049 . . . . 14.25 109.943 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' B' ' 77' ' ' MET . 2.7 ptmt -146.38 177.17 9.23 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.966 -0.753 . . . . 32.7 108.966 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.99 158.72 37.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.266 -0.896 . . . . 15.63 109.348 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' B' ' 75' ' ' SER . . . 127.91 -140.13 11.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.36 -1.496 . . . . 12.7 109.36 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 28.2 tp60 57.19 60.68 2.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.11 -1.23 . . . . 26.29 109.378 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.2 OUTLIER 73.13 2.47 4.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.473 -0.767 . . . . 20.44 109.506 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 46' ' ' LYS . . . 103.78 54.77 0.8 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.975 -1.25 . . . . 13.82 109.975 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.4 ' N ' ' O ' ' B' ' 71' ' ' GLY . 48.1 t -151.34 147.51 27.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 18.27 109.827 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' B' ' 77' ' ' MET . 2.6 tp -59.56 164.9 3.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.291 -0.88 . . . . 12.43 109.175 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 12.5 mtp -165.14 104.37 0.76 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.086 -1.009 . . . . 35.11 110.103 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.585 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.4 mt -42.05 -63.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 13.67 109.425 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 38.0 t0 84.94 -45.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.407 0.622 . . . . 24.06 110.108 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.0 tmm_? -171.51 67.23 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.081 0.943 . . . . 35.04 108.531 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.587 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -38.16 131.13 1.16 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.685 0.755 . . . . 18.72 111.515 -178.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.525 ' NH1' ' HG2' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -96.4 107.1 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.892 -1.151 . . . . 20.55 107.892 178.437 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.603 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -76.98 146.7 37.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 14.4 111.243 -178.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.463 HG21 ' O ' ' B' ' 62' ' ' THR . 16.4 m -147.49 156.64 45.59 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 107.986 -1.116 . . . . 17.65 107.986 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.4 Cg_endo -63.88 142.66 83.13 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.142 1.894 . . . . 25.7 110.515 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.425 ' CA ' HG21 ' B' ' 62' ' ' THR . . . -72.04 115.03 10.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 49.29 109.505 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.038 -0.982 . . . . 58.91 109.499 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' SD ' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.306 0.574 . . . . 64.91 109.473 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.566 ' CA ' HD21 ' B' ' 65' ' ' LEU . 0.0 OUTLIER -82.65 82.57 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.109 -1.071 . . . . 33.8 108.109 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -68.04 163.59 22.0 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.112 0.958 . . . . 32.72 111.359 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.576 ' CG2' ' N ' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -174.38 167.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.428 -0.953 . . . . 14.46 108.428 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.576 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 31.6 mt-10 -140.39 111.39 7.02 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.899 0.857 . . . . 22.12 109.347 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.603 HG13 ' CE1' ' A' ' 61' ' ' TYR . 6.2 mm -73.86 89.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.279 -1.008 . . . . 14.23 108.279 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.7 mmpm? -41.99 161.89 0.15 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 25.43 109.649 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.9 Cg_endo -72.41 -12.25 27.16 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.037 1.825 . . . . 13.61 109.115 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.0 t -98.17 6.94 46.97 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.675 -0.861 . . . . 15.52 108.675 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.515 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 17.1 mm-40 -128.25 13.36 6.64 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.334 -0.854 . . . . 17.31 109.519 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -88.14 30.3 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 24.78 110.299 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.407 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 18.7 mt-30 -144.55 121.58 11.4 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.161 -0.962 . . . . 47.9 109.678 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.626 ' CD2' ' CB ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.77 -177.39 4.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.448 -0.782 . . . . 21.61 110.429 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 98.1 m -157.05 143.73 18.34 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.433 -0.792 . . . . 14.89 109.044 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.459 HG23 ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -78.89 122.72 26.46 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.351 -0.843 . . . . 17.35 109.574 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 18' ' ' GLY . 6.3 mtt180 -132.95 133.89 43.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 34.38 109.35 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.71 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 38.77 109.369 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -101.67 167.63 18.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.577 -1.409 . . . . 34.58 109.577 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.5 t -141.33 119.18 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -1.157 . . . . 41.87 108.962 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 24' ' ' LYS . 6.3 m -57.45 87.75 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.305 -0.872 . . . . 47.21 109.687 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.2 mtp180 46.44 51.85 11.34 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.252 -0.905 . . . . 71.56 109.729 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 56.48 16.23 2.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 66.6 109.842 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 20' ' ' SER . . . -93.52 -53.85 1.77 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.142 -1.583 . . . . 55.49 109.142 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 20' ' ' SER . 4.4 mmtt -142.68 150.41 53.81 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.348 -1.09 . . . . 44.99 109.072 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.91 129.74 10.89 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.445 2.097 . . . . 44.1 110.483 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.615 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 8.2 p90 -144.31 135.06 24.97 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.186 -0.946 . . . . 32.09 109.561 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.459 ' HB2' HG23 ' A' ' 15' ' ' THR . 0.1 OUTLIER -98.32 78.51 2.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 29.25 108.611 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -83.75 161.94 20.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 24.0 110.301 -178.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.626 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -86.75 104.0 15.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.458 -0.776 . . . . 23.31 109.439 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 22.0 mt-10 -79.97 -176.53 5.53 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.039 -1.038 . . . . 40.03 109.422 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.544 ' CB ' HG23 ' A' ' 47' ' ' ILE . 3.5 mt-30 -168.38 -171.06 1.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 12.39 109.711 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.556 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 2.2 mp -131.39 179.08 6.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 17.42 109.634 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -172.25 159.5 4.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.935 -1.103 . . . . 13.84 109.024 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.619 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 2.8 m-85 -116.02 89.6 3.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 21.14 108.875 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 98.7 t -91.73 115.86 31.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.101 -0.999 . . . . 10.66 110.233 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 73.4 m-20 -60.62 -20.34 60.41 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.178 -1.045 . . . . 25.89 108.178 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 0.9 OUTLIER 40.65 27.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.673 -0.642 . . . . 24.24 109.922 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 61.66 27.46 68.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 120.127 -1.035 . . . . 31.02 110.539 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.592 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 8.8 p30 -106.78 22.68 15.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.677 -1.484 . . . . 43.23 110.417 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.546 ' O ' ' HB3' ' A' ' 41' ' ' HIS . 27.6 mt-10 61.36 50.49 4.7 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.215 -0.928 . . . . 42.34 111.027 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.592 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 2.3 p-80 154.68 149.45 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 108.187 -1.042 . . . . 9.47 108.187 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.611 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.2 Cg_endo -75.88 147.21 30.46 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.947 1.765 . . . . 17.92 110.317 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 14.5 m -121.36 116.68 50.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.242 -0.983 . . . . 20.57 109.069 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.619 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 21.9 tp -68.87 105.68 2.44 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.321 -0.952 . . . . 20.21 108.57 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.461 HG11 ' N ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -121.73 168.64 13.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.57 -0.706 . . . . 10.81 109.165 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' N ' HG11 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -82.63 156.24 23.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 36.74 110.621 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.624 HG12 ' CE2' ' A' ' 56' ' ' TYR . 1.4 tt -143.37 161.72 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.51 -0.922 . . . . 19.74 108.51 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.67 123.88 49.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.925 -1.11 . . . . 22.56 109.423 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 13' ' ' PHE . 1.9 tm? -86.5 125.02 33.45 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.769 -0.826 . . . . 20.41 108.769 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -54.89 139.22 41.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 33.99 109.602 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -55.37 118.93 4.86 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.224 -0.923 . . . . 54.92 109.328 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.39 -23.1 23.62 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.544 -1.422 . . . . 36.1 109.544 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.527 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -67.0 152.14 96.35 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -1.176 . . . . 54.76 109.357 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -79.58 117.05 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.476 2.117 . . . . 28.37 110.085 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -29.71 137.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.221 0.534 . . . . 17.21 111.128 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.624 ' CE2' HG12 ' A' ' 47' ' ' ILE . 99.2 m-85 -41.28 105.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.48 -0.763 . . . . 17.19 109.41 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.402 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -57.98 170.33 0.72 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.069 -1.019 . . . . 17.82 109.277 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 35.2 Cg_endo -77.67 103.24 1.69 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.459 2.106 . . . . 17.28 110.097 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.11 -179.77 44.96 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.921 -1.272 . . . . 17.22 109.921 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -72.69 149.86 43.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.366 -1.079 . . . . 19.57 108.12 179.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.603 ' CE1' HG13 ' A' ' 6' ' ' ILE . 18.0 m-85 -133.92 165.23 25.5 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.692 -1.255 . . . . 14.61 111.724 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.538 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 69.8 p -143.96 119.2 10.16 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.949 -1.871 . . . . 18.36 105.949 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.56 HG11 ' CD1' ' A' ' 81' ' ' LEU . 9.8 t -53.84 165.42 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 C-N-CA 118.404 -1.318 . . . . 19.13 108.962 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.529 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -134.15 126.46 30.03 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.47 -0.937 . . . . 20.65 108.47 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.65 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 2.3 pp -72.88 2.14 7.36 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.144 -0.972 . . . . 19.65 110.246 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.32 -18.96 19.5 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.643 -1.243 . . . . 14.72 107.643 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 1.3 t -100.37 -9.36 22.33 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.72 -0.612 . . . . 11.45 110.302 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 3.9 m-30 -73.48 156.67 37.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.962 -1.086 . . . . 14.25 109.32 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.523 ' N ' HD13 ' B' ' 37' ' ' LEU . 22.3 mtmt -152.89 167.12 30.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 32.7 109.717 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -101.11 123.32 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.513 -0.921 . . . . 15.63 108.513 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 70' ' ' VAL . . . -59.81 -130.7 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.046 -1.222 . . . . 12.7 110.046 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.522 ' C ' ' CG ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -87.2 46.01 1.33 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -1.144 . . . . 26.29 108.869 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.522 ' CG ' ' C ' ' A' ' 72' ' ' GLN . 1.8 m-85 77.06 0.02 3.0 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.993 -0.743 . . . . 20.44 108.993 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.59 -66.48 2.37 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.524 -1.43 . . . . 13.82 109.524 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.431 ' HA ' HG21 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -160.6 170.18 21.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -1.165 . . . . 18.27 109.667 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.9 OUTLIER -66.79 163.6 18.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 12.43 109.433 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.537 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 15.1 mtp -165.6 127.24 1.97 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 35.11 109.401 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.575 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.2 mt -53.93 -41.3 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.306 -0.871 . . . . 13.67 109.946 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 2.1 t0 45.0 54.55 6.83 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.512 -1.292 . . . . 24.06 107.512 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.567 ' CB ' ' O ' ' A' ' 79' ' ' ASP . 0.6 OUTLIER 85.56 116.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.017 -1.475 . . . . 35.04 107.017 -177.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' CD1' HG11 ' A' ' 63' ' ' VAL . 2.0 pp -94.63 152.02 18.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.332 -0.855 . . . . 18.72 111.274 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -101.52 95.6 6.57 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.905 -1.517 . . . . 20.55 106.905 177.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.624 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 2.0 tp -75.07 150.67 38.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.191 -0.943 . . . . 14.4 111.324 -177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.527 ' C ' ' CD2' ' A' ' 61' ' ' TYR . 24.1 m -147.47 158.96 42.85 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.809 -1.182 . . . . 17.65 107.809 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.3 Cg_endo -63.87 145.88 90.94 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.06 1.84 . . . . 25.7 110.335 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.538 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -80.39 115.37 19.89 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.133 -0.979 . . . . 49.29 109.579 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.2 tptt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.963 -1.018 . . . . 58.91 109.486 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.519 ' SD ' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.461 -0.57 . . . . 64.91 109.461 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.55 ' CA ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -83.26 82.52 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.083 -1.08 . . . . 33.8 108.083 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -67.99 163.59 21.89 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.169 0.985 . . . . 32.72 111.351 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.576 ' CG1' ' CB ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -174.38 167.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.419 -0.956 . . . . 14.46 108.419 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.565 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 31.3 mt-10 -140.27 111.5 7.13 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.866 0.841 . . . . 22.12 109.286 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.6 HG13 ' CE1' ' B' ' 61' ' ' TYR . 6.2 mm -74.04 89.7 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.285 -1.006 . . . . 14.23 108.285 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.587 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.7 mmpm? -41.73 161.81 0.14 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 25.43 109.668 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.7 Cg_endo -72.44 -12.39 27.21 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.957 1.771 . . . . 13.61 109.117 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.5 t -97.94 6.9 47.17 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.655 -0.868 . . . . 15.52 108.655 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.511 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 17.0 mm-40 -128.17 13.14 6.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.316 -0.865 . . . . 17.31 109.609 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -87.92 30.13 0.87 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.973 . . . . 24.78 110.333 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 18.7 mt-30 -144.33 121.71 11.65 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.129 -0.982 . . . . 47.9 109.659 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.626 ' CD2' ' CB ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -77.84 -177.33 4.86 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.456 -0.777 . . . . 21.61 110.42 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 97.7 m -157.14 143.61 18.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.34 -0.85 . . . . 14.89 109.088 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.466 ' N ' HG21 ' B' ' 14' ' ' THR . 0.2 OUTLIER -78.8 122.86 26.58 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.445 -0.784 . . . . 17.35 109.572 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' B' ' 18' ' ' GLY . 6.3 mtt180 -133.12 133.97 43.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 34.38 109.296 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.401 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.9 OUTLIER -45.83 98.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 38.77 109.362 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -101.59 167.72 19.06 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.624 -1.39 . . . . 34.58 109.624 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' B' ' 21' ' ' ARG . 1.4 t -141.46 119.21 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -1.128 . . . . 41.87 108.955 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.515 ' N ' ' O ' ' B' ' 24' ' ' LYS . 6.4 m -57.5 87.59 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.424 -0.797 . . . . 47.21 109.732 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' B' ' 19' ' ' VAL . 4.2 mtp180 46.64 51.78 11.79 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.262 -0.898 . . . . 71.56 109.7 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 56.49 16.39 2.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 66.6 109.792 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 20' ' ' SER . . . -93.61 -53.87 1.76 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.171 -1.572 . . . . 55.49 109.171 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' B' ' 20' ' ' SER . 4.4 mmtt -142.69 150.56 54.32 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.324 -1.103 . . . . 44.99 109.039 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.03 129.76 10.79 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.464 2.109 . . . . 44.1 110.505 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.625 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 8.0 p90 -144.27 135.07 25.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.201 -0.937 . . . . 32.09 109.604 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.466 ' HB2' HG23 ' B' ' 15' ' ' THR . 0.1 OUTLIER -98.28 78.52 2.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 29.25 108.609 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.587 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -83.73 162.01 20.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 24.0 110.224 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.626 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -86.82 103.79 15.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.426 -0.796 . . . . 23.31 109.465 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 21.7 mt-10 -79.77 -176.65 5.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.043 -1.035 . . . . 40.03 109.524 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.545 ' CB ' HG23 ' B' ' 47' ' ' ILE . 3.5 mt-30 -168.19 -171.12 1.44 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.209 -0.932 . . . . 12.39 109.778 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.56 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 2.2 mp -131.26 179.11 6.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 17.42 109.633 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.524 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -172.35 159.43 4.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.925 -1.109 . . . . 13.84 108.946 -179.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.631 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 2.8 m-85 -116.06 89.47 3.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.953 . . . . 21.14 108.911 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.526 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 98.5 t -91.59 116.13 32.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.055 -1.028 . . . . 10.66 110.26 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 73.3 m-20 -60.92 -19.96 61.36 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.213 -1.032 . . . . 25.89 108.213 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.54 ' HB3' ' ND2' ' B' ' 39' ' ' ASN . 0.9 OUTLIER 40.42 27.67 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.644 -0.66 . . . . 24.24 109.867 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 61.58 27.54 68.24 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.552 -1.019 . . . . 31.02 110.552 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.585 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 8.7 p30 -106.83 22.67 15.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.67 -1.488 . . . . 43.23 110.517 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' B' ' 41' ' ' HIS . 27.7 mt-10 61.34 50.58 4.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.172 -0.955 . . . . 42.34 111.026 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 2.3 p-80 154.61 149.35 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.198 -1.038 . . . . 9.49 108.198 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.618 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 34.9 Cg_endo -75.78 147.2 30.81 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.933 1.755 . . . . 17.92 110.33 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 14.5 m -121.36 116.97 51.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 C-N-CA 119.282 -0.967 . . . . 20.57 109.068 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.631 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 22.1 tp -69.25 105.54 2.56 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.333 -0.947 . . . . 20.21 108.568 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.454 HG13 ' SG ' ' B' ' 33' ' ' CYS . 0.5 OUTLIER -121.58 168.57 13.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.63 0 O-C-N 121.589 -0.694 . . . . 10.81 109.161 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.445 ' N ' HG11 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -82.49 156.23 24.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 36.74 110.605 -178.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.624 HG12 ' CE2' ' B' ' 56' ' ' TYR . 1.4 tt -143.42 161.62 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.464 -0.939 . . . . 19.74 108.464 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.59 123.94 49.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.958 -1.089 . . . . 22.56 109.418 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.587 HD13 ' CD2' ' B' ' 13' ' ' PHE . 1.9 tm? -86.56 124.99 33.47 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.525 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.3 OUTLIER -54.85 139.27 40.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 33.99 109.666 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -55.4 118.92 4.86 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.232 -0.917 . . . . 54.92 109.31 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.34 -22.94 24.24 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.596 -1.401 . . . . 36.1 109.596 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.529 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 0.6 OUTLIER -67.18 152.18 96.37 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.172 -1.193 . . . . 54.76 109.29 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.506 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -79.55 117.11 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.462 2.108 . . . . 28.37 110.018 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.556 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -29.9 138.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.233 0.54 . . . . 17.21 111.068 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.624 ' CE2' HG12 ' B' ' 47' ' ' ILE . 99.3 m-85 -41.33 105.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 17.19 109.591 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.4 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -57.46 170.32 0.63 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.09 -1.006 . . . . 17.82 109.186 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' B' ' 6' ' ' ILE . 35.3 Cg_endo -78.01 104.2 1.81 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.553 2.169 . . . . 17.28 110.267 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.64 -179.34 46.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.861 -1.295 . . . . 17.22 109.861 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.3 OUTLIER -72.31 150.27 43.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.151 . . . . 19.57 108.449 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.6 ' CE1' HG13 ' B' ' 6' ' ' ILE . 16.4 m-85 -134.34 165.29 25.49 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.775 -1.203 . . . . 14.61 111.75 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.546 ' CG2' ' HA ' ' B' ' 86' ' ' ALA . 67.1 p -144.15 119.23 10.06 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.029 -1.841 . . . . 18.36 106.029 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.562 HG11 ' CD1' ' B' ' 81' ' ' LEU . 9.7 t -53.91 165.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 C-N-CA 118.419 -1.312 . . . . 19.13 109.006 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -134.0 126.44 30.23 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.424 -0.954 . . . . 20.65 108.424 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.65 ' CB ' ' CD2' ' B' ' 68' ' ' PHE . 2.3 pp -72.76 1.9 7.64 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.193 -0.942 . . . . 19.65 110.197 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -19.02 16.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.575 -1.269 . . . . 14.72 107.575 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.518 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 1.3 t -100.5 -9.85 21.67 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.72 -0.613 . . . . 11.45 110.306 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.9 m-30 -72.94 156.46 38.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.979 -1.076 . . . . 14.25 109.206 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.533 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 22.5 mtmt -152.71 166.67 31.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 32.7 109.803 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' B' ' 71' ' ' GLY . 0.5 OUTLIER -100.53 123.14 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.527 -0.916 . . . . 15.63 108.527 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' B' ' 70' ' ' VAL . . . -59.95 -130.71 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.016 -1.233 . . . . 12.7 110.016 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.537 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -87.1 46.25 1.36 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -1.133 . . . . 26.29 108.879 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.537 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 1.8 m-85 76.79 0.05 3.07 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.058 -0.719 . . . . 20.44 109.058 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.64 -66.28 2.45 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.612 -1.395 . . . . 13.82 109.612 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.434 ' HA ' HG21 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -160.7 170.1 21.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -1.186 . . . . 18.27 109.673 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.533 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.9 OUTLIER -66.72 163.45 19.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 12.43 109.462 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 15.2 mtp -165.59 127.42 2.0 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.892 . . . . 35.11 109.381 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.58 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.1 mt -54.22 -41.12 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 13.67 109.921 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 2.1 t0 44.92 54.67 6.66 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.442 -1.318 . . . . 24.06 107.442 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.567 ' CB ' ' O ' ' B' ' 79' ' ' ASP . 0.6 OUTLIER 85.56 116.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.097 -1.445 . . . . 35.04 107.097 -177.324 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.562 ' CD1' HG11 ' B' ' 63' ' ' VAL . 2.0 pp -94.53 152.13 18.79 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 18.72 111.276 -177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -101.7 95.5 6.47 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.93 -1.507 . . . . 20.55 106.93 177.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.622 ' HB3' ' CE1' ' B' ' 56' ' ' TYR . 2.0 tp -75.0 150.57 38.93 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.161 -0.962 . . . . 14.4 111.335 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.536 ' C ' ' CD2' ' B' ' 61' ' ' TYR . 24.1 m -147.47 158.64 43.31 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 107.813 -1.181 . . . . 17.65 107.813 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.0 Cg_endo -63.61 145.94 92.09 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.022 1.815 . . . . 25.7 110.357 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.546 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -80.36 115.54 19.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 49.29 109.564 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 16.2 tptt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.984 -1.008 . . . . 58.91 109.506 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.341 -0.615 . . . . 64.91 109.341 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.589 ' CA ' HD23 ' B' ' 65' ' ' LEU . 0.0 OUTLIER 56.21 88.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.933 -1.104 . . . . 33.8 108.046 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.457 ' CG ' ' HE2' ' A' ' 1' ' ' MET . 0.3 OUTLIER -92.77 167.12 12.08 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.341 -0.849 . . . . 32.72 110.437 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.561 ' CG2' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -172.67 165.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.993 -0.743 . . . . 14.46 108.993 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.561 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 34.3 mt-10 -141.74 110.37 6.09 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.908 -0.775 . . . . 22.12 108.908 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.563 HD11 ' CZ ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -71.85 100.81 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 119.171 -1.012 . . . . 14.23 108.401 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.579 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 3.0 mmmt -41.49 163.48 0.11 Allowed Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.462 -0.774 . . . . 25.43 109.423 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.68 -13.92 27.16 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.961 1.774 . . . . 13.61 109.224 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -96.58 5.32 51.0 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.716 -0.846 . . . . 15.52 108.716 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 9.1 mm-40 -125.93 34.9 4.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.361 -0.837 . . . . 17.31 109.355 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.95 8.46 42.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 24.78 110.014 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -132.14 144.47 50.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.223 -0.923 . . . . 47.9 109.516 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.635 ' CE1' ' ND2' ' A' ' 29' ' ' ASN . 30.8 p90 -91.68 164.73 13.63 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.259 -0.901 . . . . 21.61 109.407 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -137.7 152.5 49.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.29 -0.881 . . . . 14.89 109.125 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.99 117.16 28.58 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.242 -0.911 . . . . 17.35 109.366 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -130.35 134.68 47.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.925 . . . . 34.38 109.516 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 16' ' ' ARG . 6.3 t -44.89 113.55 0.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 38.77 109.349 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 26' ' ' TYR . . . -116.45 177.5 16.9 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.716 -1.354 . . . . 34.58 109.716 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.642 ' N ' ' CE2' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -144.81 114.7 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -1.14 . . . . 41.87 108.632 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.3 p -49.32 -91.23 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.196 -0.94 . . . . 47.21 109.685 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 18.5 ttt180 -113.71 54.47 0.74 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 71.56 109.548 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 54.63 21.4 3.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 66.6 109.531 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.85 -45.91 1.24 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.535 -1.426 . . . . 55.49 109.535 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -142.17 154.74 64.86 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.362 -1.081 . . . . 44.99 109.42 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.25 152.73 31.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.654 2.236 . . . . 44.1 110.713 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.642 ' CE2' ' N ' ' A' ' 19' ' ' VAL . 5.4 p90 -159.83 119.47 2.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 32.09 109.732 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.03 80.58 3.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 29.25 109.288 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.562 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -92.93 142.19 27.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 24.0 110.057 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.635 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 92.8 m-20 -52.92 118.87 4.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.844 . . . . 23.31 109.336 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 5.1 mt-10 -110.98 165.83 11.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 40.03 109.183 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.542 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -144.03 162.98 34.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.051 -1.031 . . . . 12.39 109.861 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.548 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 3.6 mm? -102.64 178.28 4.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.404 -0.81 . . . . 17.42 109.958 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' CD1' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -175.29 159.42 2.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.003 -1.06 . . . . 13.84 108.604 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.633 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 3.1 m-30 -113.96 98.04 6.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.997 . . . . 21.14 108.592 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 14.0 t -107.34 130.23 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 10.66 110.665 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.486 ' O ' HD11 ' A' ' 37' ' ' LEU . 12.5 p-10 -81.01 -30.18 34.99 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.124 -1.065 . . . . 25.89 108.124 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.544 ' CD1' ' ND2' ' A' ' 39' ' ' ASN . 0.4 OUTLIER 31.09 40.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.159 0.504 . . . . 24.24 110.993 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' C ' ' OD1' ' A' ' 39' ' ' ASN . . . 102.07 20.32 12.87 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.811 -1.185 . . . . 31.02 110.597 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.544 ' ND2' ' CD1' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -135.29 103.3 5.46 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.965 -1.315 . . . . 43.23 108.223 178.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -29.54 -38.06 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.356 0.598 . . . . 42.34 111.407 -178.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 39' ' ' ASN . 40.9 m80 -89.03 153.18 49.08 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.312 -0.867 . . . . 7.76 109.177 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 34.8 Cg_endo -76.83 148.38 28.36 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.2 1.933 . . . . 17.92 110.377 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 1.8 m -119.43 119.0 59.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.185 -1.006 . . . . 20.57 109.434 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.633 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 18.5 tp -70.81 109.53 5.05 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.447 -0.946 . . . . 20.21 108.447 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.596 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 2.9 t -121.12 168.96 13.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.635 -0.666 . . . . 10.81 109.725 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -89.53 -175.47 4.71 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.419 -0.801 . . . . 36.74 110.251 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.664 HG12 ' CE2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -168.85 173.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 19.74 109.144 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.4 m -109.18 145.28 36.06 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.3 -0.875 . . . . 22.56 109.148 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.632 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 1.8 tm? -127.76 100.31 5.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.343 -0.848 . . . . 20.41 109.052 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 53' ' ' GLN . 4.0 m-20 -41.4 129.4 3.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.394 -0.816 . . . . 33.99 110.04 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.74 100.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.303 -0.873 . . . . 54.92 109.161 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.37 -37.32 2.79 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.258 -1.537 . . . . 36.1 109.258 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.468 ' O ' HD13 ' A' ' 49' ' ' LEU . 4.3 mt-30 -64.0 151.88 88.71 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.228 -1.16 . . . . 54.76 109.048 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.6 Cg_endo -77.07 117.72 4.52 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.533 2.156 . . . . 28.37 110.439 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.477 ' HB3' ' HG3' ' A' ' 31' ' ' GLN . . . -40.05 148.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.522 -0.736 . . . . 17.21 109.926 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.664 ' CE2' HG12 ' A' ' 47' ' ' ILE . 9.7 m-30 -48.45 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 17.19 109.6 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.48 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -48.65 174.24 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 17.82 109.307 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 36.1 Cg_endo -78.55 125.3 6.81 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.652 2.234 . . . . 17.28 110.368 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.29 -179.24 39.24 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.718 -1.23 . . . . 17.22 110.045 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -73.15 142.6 47.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.369 -1.077 . . . . 19.57 108.577 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.563 ' CZ ' HD11 ' A' ' 6' ' ' ILE . 8.8 m-85 -127.24 163.49 23.78 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.65 -1.281 . . . . 14.61 111.546 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.514 HG21 ' CB ' ' A' ' 86' ' ' ALA . 54.8 p -148.47 117.35 6.72 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.941 -1.503 . . . . 18.36 106.941 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.553 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 15.8 t -47.59 169.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 C-N-CA 119.168 -1.013 . . . . 19.13 109.106 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 7.5 t-80 -133.72 129.72 37.13 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.834 -0.802 . . . . 20.65 108.834 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.575 HD23 ' CA ' ' B' ' 2' ' ' ILE . 0.7 OUTLIER -64.18 -10.52 23.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.511 -0.743 . . . . 19.65 109.89 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' LEU . 1.2 t -45.62 -25.93 0.54 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.589 -0.893 . . . . 14.72 108.589 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 7.2 m -98.19 -12.07 22.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.51 -0.744 . . . . 11.45 110.485 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.633 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.6 m-30 -80.16 153.86 28.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.845 -1.16 . . . . 14.25 109.762 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 68' ' ' PHE . 71.1 mttt -157.37 171.05 21.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.505 -0.747 . . . . 32.7 109.233 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -101.4 100.76 11.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.889 . . . . 15.63 109.124 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.68 -175.98 5.98 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.525 -1.43 . . . . 12.7 109.525 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.72 27.44 1.77 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.143 -1.21 . . . . 26.29 109.314 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 5.0 23.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.434 -0.791 . . . . 20.44 109.627 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.476 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . 67.66 49.47 49.6 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.467 -1.453 . . . . 13.82 109.467 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -170.07 148.88 3.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -1.129 . . . . 18.27 109.707 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.504 ' O ' ' CG ' ' A' ' 77' ' ' MET . 5.1 tt -61.16 159.1 12.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 12.43 109.278 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.504 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.8 mtt -163.79 111.39 1.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.09 -1.006 . . . . 35.11 109.993 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.633 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.5 mt -52.77 145.87 2.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.354 -0.841 . . . . 13.67 109.647 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.577 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -126.06 53.47 1.61 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.804 -1.554 . . . . 24.06 106.804 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.577 ' CB ' ' O ' ' A' ' 79' ' ' ASP . 2.4 tmm_? 89.67 67.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.31 -1.367 . . . . 35.04 107.31 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.553 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -32.78 124.91 0.35 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.373 -0.831 . . . . 18.72 111.678 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.6 103.88 16.52 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.483 -1.303 . . . . 20.55 107.483 178.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.614 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -79.79 145.97 32.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.058 -1.026 . . . . 14.4 111.217 -178.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 62' ' ' THR . 27.2 m -146.53 158.6 46.47 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.96 -1.126 . . . . 17.65 107.96 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.16 141.07 74.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.084 1.856 . . . . 25.7 110.134 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -69.07 108.3 3.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.139 -0.976 . . . . 49.29 109.482 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.961 -1.018 . . . . 58.91 109.413 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' CG ' ' B' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.335 -0.617 . . . . 64.91 109.335 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.575 ' CA ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER 56.12 88.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.891 -1.131 . . . . 33.8 107.973 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.464 ' CG ' ' HE2' ' B' ' 1' ' ' MET . 0.3 OUTLIER -92.9 167.13 12.04 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.298 -0.876 . . . . 32.72 110.438 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' B' ' 5' ' ' GLU . 0.2 OUTLIER -172.74 165.34 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.692 0.758 . . . . 14.46 108.962 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 34.3 mt-10 -141.67 110.52 6.17 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.882 -0.785 . . . . 22.12 108.882 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.599 HD11 ' CZ ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -71.97 101.06 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 C-N-CA 119.126 -1.03 . . . . 14.23 108.396 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.58 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 3.0 mmmt -41.61 163.61 0.11 Allowed Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.49 -0.756 . . . . 25.43 109.493 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.0 Cg_endo -72.72 -13.95 27.06 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.983 1.789 . . . . 13.61 109.201 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.6 m -96.55 5.19 51.27 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.677 -0.86 . . . . 15.52 108.677 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.535 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 9.1 mm-40 -125.9 34.94 4.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.328 -0.857 . . . . 17.31 109.412 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.92 8.46 42.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 24.78 110.026 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -132.19 144.36 50.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.272 -0.893 . . . . 47.9 109.576 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.637 ' CD2' ' CD1' ' B' ' 49' ' ' LEU . 31.0 p90 -91.6 164.78 13.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.284 -0.885 . . . . 21.61 109.385 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -137.71 152.53 49.34 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.331 -0.856 . . . . 14.89 109.11 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.01 117.21 28.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 17.35 109.378 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.2 OUTLIER -130.39 134.62 47.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 34.38 109.621 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.411 ' C ' ' O ' ' B' ' 16' ' ' ARG . 6.3 t -44.8 113.63 0.59 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.912 . . . . 38.77 109.297 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' B' ' 26' ' ' TYR . . . -116.59 177.44 16.82 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.645 -1.382 . . . . 34.58 109.645 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.63 ' N ' ' CE2' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -144.8 114.76 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -1.17 . . . . 41.87 108.611 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 31.2 p -49.38 -91.18 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.227 -0.921 . . . . 47.21 109.659 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.514 ' O ' ' CG ' ' B' ' 21' ' ' ARG . 18.4 ttt180 -113.71 54.31 0.75 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 71.56 109.577 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 54.79 21.4 3.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 66.6 109.477 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.83 -46.0 1.24 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.539 -1.424 . . . . 55.49 109.539 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -142.12 154.88 65.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.244 -1.151 . . . . 44.99 109.395 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.33 152.64 30.68 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.686 2.257 . . . . 44.1 110.711 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.63 ' CE2' ' N ' ' B' ' 19' ' ' VAL . 5.4 p90 -159.78 119.48 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 32.09 109.775 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.07 80.54 3.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 29.25 109.33 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.57 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.3 OUTLIER -92.88 142.0 27.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 24.0 110.106 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 92.9 m-20 -52.68 118.91 3.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 23.31 109.348 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 5.1 mt-10 -111.09 165.78 11.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.051 -1.031 . . . . 40.03 109.193 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.547 ' CB ' HG21 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -143.96 162.94 34.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.139 -0.976 . . . . 12.39 109.798 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.554 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 3.6 mm? -102.67 178.07 4.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 17.42 109.91 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -175.08 159.32 2.59 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.92 -1.112 . . . . 13.84 108.619 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.635 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 3.1 m-30 -113.81 97.86 6.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.138 -0.976 . . . . 21.14 108.63 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' B' ' 43' ' ' VAL . 13.9 t -107.24 130.08 59.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.106 -0.996 . . . . 10.66 110.731 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' B' ' 37' ' ' LEU . 12.5 p-10 -80.79 -30.45 35.97 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.128 -1.064 . . . . 25.89 108.128 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.549 ' CD1' ' ND2' ' B' ' 39' ' ' ASN . 0.4 OUTLIER 31.45 40.55 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.171 0.51 . . . . 24.24 110.953 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.448 ' C ' ' OD1' ' B' ' 39' ' ' ASN . . . 101.91 20.61 12.44 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.834 -1.174 . . . . 31.02 110.583 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.549 ' ND2' ' CD1' ' B' ' 37' ' ' LEU . 1.0 OUTLIER -135.43 103.31 5.43 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.016 -1.285 . . . . 43.23 108.211 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -29.57 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.291 0.567 . . . . 42.34 111.384 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' B' ' 39' ' ' ASN . 40.9 m80 -89.14 153.13 48.82 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.375 -0.828 . . . . 7.67 109.183 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.611 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.1 Cg_endo -76.83 148.31 28.3 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.179 1.92 . . . . 17.92 110.38 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' B' ' 35' ' ' VAL . 1.7 m -119.34 119.3 60.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.258 -0.977 . . . . 20.57 109.369 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.635 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 18.6 tp -71.13 109.78 5.4 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.55 -0.907 . . . . 20.21 108.55 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.612 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 3.0 t -121.38 168.84 13.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.613 -0.68 . . . . 10.81 109.776 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.584 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -89.24 -175.4 4.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.493 -0.754 . . . . 36.74 110.314 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.676 HG12 ' CE2' ' B' ' 56' ' ' TYR . 0.0 OUTLIER -168.98 173.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.3 -0.875 . . . . 19.74 109.135 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 24.6 m -109.28 145.22 36.29 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.3 -0.875 . . . . 22.56 109.108 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.637 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 1.8 tm? -127.73 100.35 5.92 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.871 . . . . 20.41 109.059 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.45 ' HB2' ' HB2' ' B' ' 53' ' ' GLN . 3.9 m-20 -41.44 129.42 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 33.99 110.024 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.74 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.293 -0.879 . . . . 54.92 109.152 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.25 -37.15 2.84 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.225 -1.55 . . . . 36.1 109.225 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.46 ' O ' HD13 ' B' ' 49' ' ' LEU . 4.2 mt-30 -64.2 151.91 89.43 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.223 -1.163 . . . . 54.76 109.036 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.9 Cg_endo -77.22 117.63 4.45 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.546 2.164 . . . . 28.37 110.457 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' B' ' 57' ' ' ALA . . . -39.72 148.0 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.523 -0.736 . . . . 17.21 110.09 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.676 ' CE2' HG12 ' B' ' 47' ' ' ILE . 9.5 m-30 -47.99 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.293 -0.88 . . . . 17.19 109.595 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.488 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -47.63 174.19 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 17.82 109.486 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.8 Cg_endo -78.24 124.42 6.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.577 2.185 . . . . 17.28 110.094 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.89 -179.63 40.0 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.536 -1.316 . . . . 17.22 110.148 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.46 HD22 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -73.54 142.25 46.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -1.076 . . . . 19.57 108.33 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.599 ' CZ ' HD11 ' B' ' 6' ' ' ILE . 9.2 m-85 -127.02 163.62 23.33 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.654 -1.279 . . . . 14.61 111.519 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.509 HG21 ' CB ' ' B' ' 86' ' ' ALA . 55.9 p -148.4 117.42 6.77 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.002 -1.481 . . . . 18.36 107.002 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.552 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 16.0 t -47.62 169.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 C-N-CA 119.176 -1.01 . . . . 19.13 109.052 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 7.6 t-80 -133.89 129.91 37.06 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.819 -0.808 . . . . 20.65 108.819 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.589 HD23 ' CA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -64.27 -10.53 24.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.696 . . . . 19.65 109.927 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.435 ' C ' ' O ' ' B' ' 65' ' ' LEU . 1.2 t -45.56 -25.83 0.51 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.56 -0.904 . . . . 14.72 108.56 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 7.1 m -98.28 -12.37 21.64 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.727 . . . . 11.45 110.486 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.628 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.5 m-30 -80.01 153.8 28.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 14.25 109.685 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' B' ' 68' ' ' PHE . 71.1 mttt -157.43 170.73 21.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.541 -0.724 . . . . 32.7 109.199 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.596 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -101.05 100.79 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 15.63 109.034 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.77 -175.91 6.05 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.426 -1.47 . . . . 12.7 109.426 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.61 27.26 1.78 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.202 -1.175 . . . . 26.29 109.358 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.88 5.06 24.12 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.512 -0.742 . . . . 20.44 109.611 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.462 ' O ' ' OG ' ' B' ' 75' ' ' SER . . . 67.36 50.0 47.7 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.41 -1.476 . . . . 13.82 109.41 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' B' ' 74' ' ' GLY . 1.0 OUTLIER -170.37 148.94 3.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -1.135 . . . . 18.27 109.608 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.516 ' O ' ' CG ' ' B' ' 77' ' ' MET . 5.2 tt -61.31 159.29 12.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.927 . . . . 12.43 109.256 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.516 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.8 mtt -163.97 111.36 1.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.079 -1.013 . . . . 35.11 110.026 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.628 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.4 mt -52.77 145.7 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 13.67 109.726 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -125.84 53.52 1.58 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.789 -1.56 . . . . 24.06 106.789 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.559 ' CB ' ' O ' ' B' ' 79' ' ' ASP . 2.4 tmm_? 89.63 67.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.334 -1.358 . . . . 35.04 107.334 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.552 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -32.92 124.93 0.36 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.363 -0.835 . . . . 18.72 111.661 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.54 103.86 16.5 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.451 -1.314 . . . . 20.55 107.451 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.614 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -79.9 145.87 32.45 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.135 -0.978 . . . . 14.4 111.25 -178.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' B' ' 62' ' ' THR . 27.3 m -146.32 158.97 46.67 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 107.967 -1.123 . . . . 17.65 107.967 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -64.42 141.24 73.5 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.049 1.833 . . . . 25.7 110.152 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.509 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -69.17 108.05 3.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.223 -0.923 . . . . 49.29 109.462 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.965 -1.017 . . . . 58.91 109.489 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.434 -0.58 . . . . 64.91 109.434 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.546 ' HA ' ' CD1' ' B' ' 65' ' ' LEU . 1.6 mt 50.32 78.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.866 -1.161 . . . . 33.8 107.866 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' C ' HG11 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -71.26 155.93 40.13 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.712 0.767 . . . . 32.72 110.57 -178.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.588 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -165.05 165.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.553 0.692 . . . . 14.46 109.262 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.53 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 22.3 mt-10 -138.64 116.89 11.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 22.12 109.258 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.581 HG12 ' CD1' ' A' ' 61' ' ' TYR . 19.4 mm -77.43 97.44 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.259 -0.901 . . . . 14.23 108.743 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.589 ' HD3' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.14 161.15 0.31 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.089 -1.007 . . . . 25.43 110.121 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.93 -29.76 5.06 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.626 2.217 . . . . 13.61 110.214 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.41 -0.85 43.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.492 -0.755 . . . . 15.52 109.131 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' NE2' ' HA ' ' A' ' 33' ' ' CYS . 9.3 pt20 -129.97 28.88 5.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 17.31 109.644 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -85.03 16.31 3.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 24.78 110.106 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.441 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -138.72 144.33 39.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.082 -1.011 . . . . 47.9 108.828 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.652 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 12.8 p90 -87.01 178.42 6.94 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.168 -0.958 . . . . 21.61 109.743 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 8.7 t -132.22 163.01 29.53 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.58 -0.896 . . . . 14.89 108.58 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -97.0 156.08 16.5 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.138 -0.977 . . . . 17.35 109.617 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.8 OUTLIER -178.23 132.81 0.14 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 34.38 109.469 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 16' ' ' ARG . 1.2 t -43.81 152.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 38.77 109.427 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 26' ' ' TYR . . . -164.52 132.11 2.61 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.671 -1.371 . . . . 34.58 109.671 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.27 125.5 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.153 -1.204 . . . . 41.87 108.808 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.517 ' CB ' ' HE2' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -64.88 -163.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.375 -0.828 . . . . 47.21 109.785 -179.053 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.05 17.07 20.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 71.56 109.361 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -114.69 2.39 14.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.286 -0.884 . . . . 66.6 109.556 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.52 8.55 67.83 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.62 -1.392 . . . . 55.49 109.62 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.517 ' HE2' ' CB ' ' A' ' 20' ' ' SER . 24.0 pttt -101.96 144.68 29.07 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.181 -1.188 . . . . 44.99 109.313 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.5 151.25 25.53 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.545 2.163 . . . . 44.1 110.584 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.607 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 2.4 p90 -158.35 154.98 27.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 32.09 109.997 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 m -117.25 84.01 2.08 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.824 -1.176 . . . . 29.25 107.824 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -88.43 157.17 18.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.248 -0.908 . . . . 24.0 110.292 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.652 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -93.78 131.72 38.87 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.717 -0.845 . . . . 23.31 108.717 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 1.8 mp0 -109.88 159.28 17.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.861 -1.149 . . . . 40.03 109.448 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.537 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -135.68 -165.33 1.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.083 -1.01 . . . . 12.39 110.04 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.559 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -134.64 178.56 6.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.721 . . . . 17.42 109.392 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.513 ' HA ' ' NE2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -172.93 153.74 2.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.955 -1.09 . . . . 13.84 108.893 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 3.1 m-30 -112.06 96.77 6.23 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.506 -0.924 . . . . 21.14 108.506 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 85.7 t -97.12 114.92 35.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.036 -1.04 . . . . 10.66 110.118 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.6 p-10 -59.36 -32.13 69.84 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.301 -1.0 . . . . 25.89 108.301 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.519 ' CD2' ' HA ' ' B' ' 69' ' ' LYS . 0.7 OUTLIER 47.02 28.64 0.92 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.563 -0.711 . . . . 24.24 109.174 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.39 18.14 71.23 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.371 -1.492 . . . . 31.02 109.371 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' OD1' HD21 ' A' ' 37' ' ' LEU . 92.6 m-20 -91.01 26.67 2.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -1.122 . . . . 43.23 110.367 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.527 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 1.7 mm-40 48.35 22.24 0.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.138 -0.976 . . . . 42.34 110.148 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 3.6 m80 -175.88 153.26 1.35 Allowed Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.074 -1.084 . . . . 6.15 108.074 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.625 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.6 Cg_endo -75.73 144.09 27.56 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.923 1.749 . . . . 17.92 110.938 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 14.4 m -119.47 118.37 57.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.735 -0.839 . . . . 20.57 108.735 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.634 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 18.6 tp -68.41 111.79 4.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.781 -0.768 . . . . 20.21 109.339 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 4.0 t -117.2 168.46 8.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.692 -0.63 . . . . 10.81 109.352 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 1.9 mtpt -86.63 174.92 8.57 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.238 -0.914 . . . . 36.74 110.347 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -155.4 165.25 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -0.856 . . . . 19.74 109.028 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.469 ' O ' HD21 ' A' ' 49' ' ' LEU . 30.8 m -110.79 149.54 30.4 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.319 -0.863 . . . . 22.56 108.98 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -133.25 127.96 34.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 20.41 109.341 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.09 148.64 41.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 33.99 109.535 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.62 93.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 54.92 109.544 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.6 -29.39 3.81 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.722 -1.351 . . . . 36.1 109.722 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.9 144.87 85.91 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.177 -1.19 . . . . 54.76 109.597 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -78.2 117.48 4.12 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.696 2.264 . . . . 28.37 110.585 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.477 ' CB ' ' HG3' ' A' ' 31' ' ' GLN . . . -42.78 155.51 0.05 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.249 -0.907 . . . . 17.21 110.196 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.623 ' CE2' ' CB ' ' A' ' 83' ' ' LEU . 15.0 m-30 -49.03 112.53 0.63 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.574 -0.704 . . . . 17.19 109.758 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.533 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -66.13 177.35 0.78 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 17.82 109.313 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -78.21 113.4 3.38 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.586 2.191 . . . . 17.28 110.28 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.06 177.27 43.11 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.912 -1.275 . . . . 17.22 109.912 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 4.9 mp -74.96 152.79 38.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -1.107 . . . . 19.57 108.221 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.588 ' CB ' HG12 ' A' ' 4' ' ' VAL . 17.7 m-85 -140.17 165.18 28.08 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.802 -1.186 . . . . 14.61 111.78 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.519 ' CG2' ' HG3' ' A' ' 1' ' ' MET . 43.8 p -145.64 120.55 9.98 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.356 -1.72 . . . . 18.36 106.356 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 4.7 t -50.38 170.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 C-N-CA 118.739 -1.185 . . . . 19.13 108.791 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.9 t-80 -130.43 122.98 28.77 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.38 -0.825 . . . . 20.65 108.942 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.622 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -66.65 -6.24 14.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.673 -0.642 . . . . 19.65 109.747 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.1 t -54.78 -15.87 2.2 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.058 -1.026 . . . . 14.72 108.565 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 35.1 m -98.79 -5.75 30.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.495 -0.753 . . . . 11.45 110.891 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 2.8 m-30 -81.16 155.7 26.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.763 -1.211 . . . . 14.25 109.988 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.51 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 9.9 mtmt -143.78 171.48 14.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.501 -0.749 . . . . 32.7 109.349 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.464 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.5 OUTLIER -117.77 131.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 15.63 109.603 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.67 175.86 53.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.457 -1.457 . . . . 12.7 109.457 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.2 9.6 12.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.115 -1.226 . . . . 26.29 109.893 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.474 ' O ' ' CG ' ' A' ' 73' ' ' PHE . 30.1 t80 -109.62 9.65 25.07 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.57 -0.707 . . . . 20.44 109.391 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' B' ' 46' ' ' LYS . . . 70.75 71.66 0.99 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.51 -1.436 . . . . 13.82 109.51 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 74' ' ' GLY . 4.5 m -165.86 112.6 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -1.153 . . . . 18.27 109.683 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.518 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -68.51 151.36 46.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 12.43 109.169 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.518 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 7.1 mtp -163.04 139.78 7.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 35.11 109.842 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.617 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.4 mt -67.77 140.78 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 13.67 109.805 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 1.6 t70 -110.1 -19.24 13.12 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.389 -0.967 . . . . 24.06 108.389 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.5 OUTLIER 173.01 68.11 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.878 -1.527 . . . . 35.04 106.878 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.575 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -32.06 119.62 0.27 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.512 -0.767 . . . . 18.72 111.399 -177.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -89.66 110.05 20.97 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.844 -1.169 . . . . 20.55 107.844 178.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.623 ' CB ' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -82.12 143.86 31.17 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.036 -1.04 . . . . 14.4 111.101 -178.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.454 ' C ' ' CD2' ' A' ' 61' ' ' TYR . 4.5 m -143.99 159.56 52.68 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.97 -1.122 . . . . 17.65 107.97 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.6 Cg_endo -63.41 147.58 93.3 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.177 1.918 . . . . 25.7 110.335 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -74.62 118.75 17.93 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.105 -0.997 . . . . 49.29 109.541 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.056 -0.973 . . . . 58.91 109.468 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.519 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.37 -0.604 . . . . 64.91 109.37 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.538 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 1.5 mt 50.33 78.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.806 -1.183 . . . . 33.8 107.806 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.446 ' C ' HG11 ' B' ' 4' ' ' VAL . 0.4 OUTLIER -71.2 156.18 39.86 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.721 0.772 . . . . 32.72 110.553 -178.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.59 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -165.25 165.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.583 0.706 . . . . 14.46 109.283 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.526 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 22.4 mt-10 -138.57 116.92 11.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.497 -0.752 . . . . 22.12 109.333 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.585 HG12 ' CD1' ' B' ' 61' ' ' TYR . 19.7 mm -77.55 97.26 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.265 -0.897 . . . . 14.23 108.754 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.576 ' HD3' ' CG ' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.98 161.17 0.3 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.114 -0.991 . . . . 25.43 110.145 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.02 -29.77 4.93 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.665 2.244 . . . . 13.61 110.169 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.31 -1.05 43.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.436 -0.79 . . . . 15.52 109.058 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.523 ' NE2' ' HA ' ' B' ' 33' ' ' CYS . 9.3 pt20 -129.9 29.0 5.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.861 . . . . 17.31 109.683 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -85.1 16.36 3.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 24.78 110.051 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.447 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -138.67 144.49 39.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.085 -1.009 . . . . 47.9 108.806 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.642 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 12.7 p90 -87.16 178.32 6.92 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.159 -0.963 . . . . 21.61 109.739 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 9.0 t -132.16 163.08 29.31 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.618 -0.882 . . . . 14.89 108.618 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' B' ' 16' ' ' ARG . 0.2 OUTLIER -97.13 155.92 16.61 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.15 -0.969 . . . . 17.35 109.584 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.7 OUTLIER -178.13 132.64 0.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 34.38 109.429 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.429 ' C ' ' O ' ' B' ' 16' ' ' ARG . 1.2 t -43.53 152.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 38.77 109.477 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.579 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -164.59 132.1 2.6 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.699 -1.36 . . . . 34.58 109.699 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.33 125.47 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.15 -1.206 . . . . 41.87 108.733 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.509 ' CB ' ' HE2' ' B' ' 24' ' ' LYS . 0.3 OUTLIER -64.9 -163.08 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.374 -0.829 . . . . 47.21 109.695 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.28 17.32 20.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 71.56 109.332 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -114.91 2.57 14.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.316 -0.865 . . . . 66.6 109.521 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.34 68.4 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.648 -1.381 . . . . 55.49 109.648 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.509 ' HE2' ' CB ' ' B' ' 20' ' ' SER . 24.1 pttt -101.77 144.64 28.98 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 44.99 109.368 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.45 151.27 25.71 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.555 2.17 . . . . 44.1 110.588 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.597 ' CD1' ' C ' ' B' ' 26' ' ' TYR . 2.4 p90 -158.25 155.25 28.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.2 -0.937 . . . . 32.09 109.92 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 42.9 m -117.44 83.93 2.07 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.817 -1.179 . . . . 29.25 107.817 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.583 ' HB3' ' CE1' ' B' ' 26' ' ' TYR . 0.7 OUTLIER -88.45 157.09 18.77 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 24.0 110.311 -178.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.642 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -93.65 131.76 38.65 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.677 -0.86 . . . . 23.31 108.677 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 1.8 mp0 -110.02 159.45 17.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.958 -1.089 . . . . 40.03 109.416 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.537 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -135.81 -165.37 1.69 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.118 -0.989 . . . . 12.39 109.988 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.555 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 0.4 OUTLIER -134.68 178.46 6.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.533 -0.729 . . . . 17.42 109.395 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.523 ' HA ' ' NE2' ' B' ' 10' ' ' GLN . 0.1 OUTLIER -172.83 153.73 2.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.002 -1.061 . . . . 13.84 108.933 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.638 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 3.1 m-30 -112.03 96.68 6.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.462 -0.94 . . . . 21.14 108.462 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.531 ' O ' ' CG2' ' B' ' 43' ' ' VAL . 85.3 t -96.98 115.08 35.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.066 -1.021 . . . . 10.66 110.155 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.6 p-10 -59.58 -31.86 69.84 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.311 -0.996 . . . . 25.89 108.311 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.51 ' CD2' ' HA ' ' A' ' 69' ' ' LYS . 0.7 OUTLIER 46.76 28.61 0.84 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.473 -0.767 . . . . 24.24 109.17 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.54 18.08 71.46 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.33 -1.508 . . . . 31.02 109.33 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.463 ' OD1' HD21 ' B' ' 37' ' ' LEU . 92.7 m-20 -90.88 26.34 2.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.324 -1.103 . . . . 43.23 110.479 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.527 ' O ' ' ND1' ' B' ' 41' ' ' HIS . 1.7 mm-40 48.6 22.02 0.46 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.07 -1.019 . . . . 42.34 110.116 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' B' ' 40' ' ' GLU . 3.6 m80 -175.68 153.18 1.4 Allowed Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 108.085 -1.08 . . . . 6.06 108.085 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.618 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.5 Cg_endo -75.73 144.08 27.55 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.961 1.774 . . . . 17.92 110.884 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' B' ' 35' ' ' VAL . 14.0 m -119.46 118.51 57.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.601 -0.84 . . . . 20.57 108.765 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.638 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 18.9 tp -68.56 111.67 4.88 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.848 -0.741 . . . . 20.21 109.348 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 4.3 t -117.13 168.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.643 -0.661 . . . . 10.81 109.304 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 1.9 mtpt -86.67 174.98 8.51 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.353 -0.842 . . . . 36.74 110.338 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.593 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -155.42 165.24 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.798 . . . . 19.74 109.042 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.469 ' O ' HD21 ' B' ' 49' ' ' LEU . 31.2 m -110.77 149.49 30.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.371 -0.831 . . . . 22.56 108.992 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' B' ' 29' ' ' ASN . 0.3 OUTLIER -133.25 127.83 34.55 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.391 -0.818 . . . . 20.41 109.363 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.94 148.52 42.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 33.99 109.512 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.44 93.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 54.92 109.55 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.32 -29.13 3.92 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.687 -1.365 . . . . 36.1 109.687 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.1 144.91 85.44 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.112 -1.228 . . . . 54.76 109.515 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.4 Cg_endo -78.4 117.32 4.03 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.708 2.272 . . . . 28.37 110.591 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.479 ' CB ' ' HG3' ' B' ' 31' ' ' GLN . . . -42.52 155.7 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.18 -0.95 . . . . 17.21 110.199 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.616 ' CE2' ' CB ' ' B' ' 83' ' ' LEU . 15.2 m-30 -49.34 112.51 0.65 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.485 -0.759 . . . . 17.19 109.876 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -65.85 177.2 0.76 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.322 -0.861 . . . . 17.82 109.258 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 36.0 Cg_endo -78.17 114.51 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.577 2.185 . . . . 17.28 110.444 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.64 177.92 42.36 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.834 -1.306 . . . . 17.22 109.834 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.0 mp -75.11 152.94 38.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -1.097 . . . . 19.57 108.396 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.59 ' CB ' HG12 ' B' ' 4' ' ' VAL . 17.6 m-85 -140.36 165.0 28.6 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.85 -1.156 . . . . 14.61 111.77 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.519 ' CG2' ' HG3' ' B' ' 1' ' ' MET . 43.7 p -145.54 120.35 9.92 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.413 -1.699 . . . . 18.36 106.413 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.563 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 4.8 t -50.14 170.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 C-N-CA 118.836 -1.145 . . . . 19.13 108.769 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.537 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -130.53 123.13 28.91 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.391 -0.818 . . . . 20.65 108.992 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.613 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.61 -6.66 16.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.733 -0.605 . . . . 19.65 109.759 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 28.2 t -54.35 -16.11 2.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.984 -1.073 . . . . 14.72 108.575 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 33.0 m -98.66 -6.27 30.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.485 -0.759 . . . . 11.45 110.917 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.622 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.7 m-30 -80.69 155.47 26.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.751 -1.218 . . . . 14.25 109.844 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.519 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 10.0 mtmt -143.46 171.83 13.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.517 -0.739 . . . . 32.7 109.309 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.509 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -118.04 131.84 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 15.63 109.586 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.83 176.09 53.29 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.46 -1.456 . . . . 12.7 109.46 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.4 9.45 13.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.114 -1.227 . . . . 26.29 109.864 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' B' ' 73' ' ' PHE . 30.1 t80 -109.45 9.65 25.44 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.564 -0.71 . . . . 20.44 109.428 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . 70.76 71.85 0.97 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.506 -1.438 . . . . 13.82 109.506 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' B' ' 74' ' ' GLY . 4.5 m -165.97 112.64 0.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -1.143 . . . . 18.27 109.715 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.517 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.3 OUTLIER -68.58 151.33 46.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 12.43 109.193 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 7.1 mtp -163.1 139.84 7.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 35.11 109.796 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.622 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.4 mt -67.94 140.97 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.349 -0.844 . . . . 13.67 109.895 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 1.6 t70 -110.18 -19.26 13.09 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.376 -0.972 . . . . 24.06 108.376 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.6 OUTLIER 173.08 68.11 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.919 -1.511 . . . . 35.04 106.919 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.563 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -32.02 119.59 0.27 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.521 -0.763 . . . . 18.72 111.447 -177.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -89.66 109.97 20.89 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.91 -1.145 . . . . 20.55 107.91 178.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.616 ' CB ' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -82.1 143.74 31.27 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.042 -1.036 . . . . 14.4 111.095 -178.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.45 ' HB ' ' HD2' ' B' ' 85' ' ' PRO . 4.5 m -143.86 159.66 52.74 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.949 -1.13 . . . . 17.65 107.949 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -63.55 147.84 92.78 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.115 1.877 . . . . 25.7 110.394 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.438 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -74.7 118.68 17.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.13 -0.981 . . . . 49.29 109.627 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.977 -1.011 . . . . 58.91 109.482 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.5 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.531 -0.544 . . . . 64.91 109.531 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.579 ' CG2' HD22 ' B' ' 65' ' ' LEU . 2.8 mt -59.04 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.879 -1.156 . . . . 33.8 107.879 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -63.39 158.65 20.04 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.81 0.814 . . . . 32.72 111.377 -177.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.56 ' HB ' ' CB ' ' A' ' 61' ' ' TYR . 60.6 t -159.99 167.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.579 0.704 . . . . 14.46 109.583 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 22.7 mt-10 -151.7 103.84 2.98 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.946 -0.761 . . . . 22.12 108.946 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.592 HD12 ' CZ ' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -70.67 105.69 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.092 -1.077 . . . . 14.23 108.092 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.655 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.22 173.48 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.419 -0.801 . . . . 25.43 109.988 -178.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.1 Cg_endo -76.26 -22.12 12.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.512 2.142 . . . . 13.61 109.727 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -101.04 8.05 43.12 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.153 -0.684 . . . . 15.52 109.153 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.531 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 17.6 mm-40 -125.25 36.04 4.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.243 -0.911 . . . . 17.31 109.401 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -107.13 16.54 24.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 24.78 110.151 -179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 4.6 tt0 -137.5 130.23 30.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.099 -1.0 . . . . 47.9 108.705 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.586 ' CD2' ' CB ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.85 -170.69 1.69 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.088 -1.007 . . . . 21.61 110.689 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -143.25 126.98 17.08 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.656 -0.653 . . . . 14.89 109.249 179.066 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.2 112.21 21.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.357 -0.84 . . . . 17.35 109.331 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 18' ' ' GLY . 6.6 tpm_? -131.82 142.32 49.69 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.295 -0.878 . . . . 34.38 109.518 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.83 87.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 38.77 109.348 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -81.91 172.2 52.86 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.653 -1.379 . . . . 34.58 109.653 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.457 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -139.16 116.96 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.301 -1.117 . . . . 41.87 108.946 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 24' ' ' LYS . 3.3 m -58.18 108.68 0.63 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.294 -0.879 . . . . 47.21 109.64 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 44.79 38.2 2.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.269 -0.895 . . . . 71.56 109.569 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 58.53 18.43 5.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 66.6 109.574 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.7 -55.94 1.05 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.457 -1.457 . . . . 55.49 109.457 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' SER . 7.5 mttt -126.93 147.99 63.67 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.301 -1.117 . . . . 44.99 109.332 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.11 129.96 9.98 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.578 2.185 . . . . 44.1 110.54 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 8.3 p90 -137.17 139.37 41.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.109 -0.995 . . . . 32.09 109.69 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.05 77.58 2.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 29.25 108.833 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -93.08 158.95 15.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 24.0 110.145 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.586 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -99.95 117.93 35.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -0.754 . . . . 23.31 109.067 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -86.56 -173.58 4.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.054 -1.029 . . . . 40.03 109.14 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.546 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -173.48 -170.96 0.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 12.39 109.962 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.517 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 4.1 mp -145.52 169.9 17.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.473 -0.767 . . . . 17.42 109.238 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -167.99 166.95 13.01 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.223 -1.028 . . . . 13.84 108.223 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.667 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 31.9 m-85 -118.78 103.19 9.42 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.089 -1.007 . . . . 21.14 109.498 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.534 ' CG2' HG21 ' A' ' 4' ' ' VAL . 54.3 t -85.6 144.87 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.109 -0.994 . . . . 10.66 110.29 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.4 m-20 -128.48 -140.49 0.25 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.715 -0.846 . . . . 25.89 108.715 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.552 ' HG ' ' CD1' ' B' ' 65' ' ' LEU . 0.1 OUTLIER 68.39 -63.13 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.927 -1.108 . . . . 24.24 109.222 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -85.98 16.26 43.55 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.593 -1.803 . . . . 31.02 108.593 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -177.83 111.92 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.468 -1.019 . . . . 43.23 109.083 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' ASN . 1.3 mm-40 -40.78 -66.96 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.476 -0.765 . . . . 42.34 109.763 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -60.06 153.63 54.94 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 108.574 -0.899 . . . . 6.3 108.574 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.667 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.4 Cg_endo -77.34 142.83 21.58 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.146 1.897 . . . . 17.92 110.22 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.501 ' CG2' HG22 ' B' ' 70' ' ' VAL . 27.5 m -113.75 113.83 45.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.32 -0.863 . . . . 20.57 109.302 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.597 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 41.0 tp -69.78 112.09 5.99 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.374 -0.829 . . . . 20.21 110.221 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG11 HG13 ' B' ' 70' ' ' VAL . 4.9 m -112.94 -172.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.9 -0.778 . . . . 10.81 108.9 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -111.93 154.87 24.59 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.467 -0.893 . . . . 36.74 110.329 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.589 HG13 ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -129.15 162.38 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 108.924 -0.769 . . . . 19.74 108.924 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.482 ' CG2' HD23 ' A' ' 28' ' ' LEU . 4.5 m -119.17 73.64 0.95 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.349 -0.844 . . . . 22.56 109.235 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CB ' ' HB2' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -40.62 133.52 1.97 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.759 . . . . 20.41 109.663 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -55.26 -166.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 33.99 109.623 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.22 -83.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 54.92 109.725 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.24 40.85 2.28 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.623 -1.391 . . . . 36.1 109.623 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.93 152.63 46.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.194 -1.18 . . . . 54.76 109.635 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.14 119.25 4.58 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.813 2.342 . . . . 28.37 110.742 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -41.16 146.53 0.18 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.369 -0.832 . . . . 17.21 110.339 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.619 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 14.7 m-30 -52.13 99.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -0.825 . . . . 17.19 109.169 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 56' ' ' TYR . . . -45.61 170.75 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 17.82 109.502 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' A' ' 6' ' ' ILE . 35.2 Cg_endo -77.6 108.32 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.576 2.184 . . . . 17.28 110.143 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.21 -178.12 48.63 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.958 -1.257 . . . . 17.22 109.958 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.4 mp -73.91 149.6 41.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -1.057 . . . . 19.57 108.641 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.592 ' CZ ' HD12 ' A' ' 6' ' ' ILE . 12.1 m-85 -134.98 163.74 29.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.921 -1.112 . . . . 14.61 111.373 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.519 HG21 ' CB ' ' A' ' 86' ' ' ALA . 29.2 p -145.65 119.37 9.2 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.721 -1.585 . . . . 18.36 106.721 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 18.5 t -47.81 170.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 C-N-CA 119.337 -0.945 . . . . 19.13 109.142 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.2 t-80 -133.82 126.04 29.71 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.823 -0.806 . . . . 20.65 108.823 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.604 ' HG ' ' CD2' ' A' ' 68' ' ' PHE . 4.6 mp -62.67 -8.0 5.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.644 -0.66 . . . . 19.65 110.432 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 65' ' ' LEU . 0.4 OUTLIER -47.29 -24.07 0.68 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.901 -1.124 . . . . 14.72 107.986 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.483 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 3.4 m -98.32 -13.04 20.91 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.68 -0.638 . . . . 11.45 110.673 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.6 m-30 -81.33 156.59 25.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.732 -1.23 . . . . 14.25 110.131 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -155.19 166.76 32.57 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.942 -0.762 . . . . 32.7 108.942 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 ' CG2' ' B' ' 43' ' ' VAL . 3.0 t -104.05 125.28 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -0.949 . . . . 15.63 109.227 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.6 173.62 55.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.728 -1.349 . . . . 12.7 109.728 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.454 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 1.0 OUTLIER -75.77 -1.14 23.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.206 -1.173 . . . . 26.29 109.83 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.07 -17.0 26.93 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.406 -0.809 . . . . 20.44 109.521 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.13 52.27 2.42 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.624 -1.391 . . . . 13.82 109.624 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.4 m -156.38 115.18 3.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -1.159 . . . . 18.27 109.507 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.475 ' O ' ' CG ' ' A' ' 77' ' ' MET . 7.1 tt -50.44 153.2 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 12.43 109.49 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 25.3 mtt -161.1 123.84 3.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 35.11 109.718 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.642 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.1 mt -61.55 140.64 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.367 -0.833 . . . . 13.67 109.92 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 26.7 t70 -111.35 -16.95 13.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.338 -0.851 . . . . 24.06 108.972 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.483 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 169.09 63.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.577 -1.638 . . . . 35.04 106.577 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.572 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -27.2 119.59 0.09 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.665 -1.152 . . . . 18.72 112.583 -177.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.26 103.33 16.02 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.397 -1.334 . . . . 20.55 107.397 177.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.619 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -77.1 145.39 37.85 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.974 -1.079 . . . . 14.4 111.487 -177.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.48 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 17.8 m -144.75 160.5 47.02 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 107.835 -1.172 . . . . 17.65 107.835 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 84' ' ' VAL . 25.3 Cg_endo -63.93 145.96 90.8 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.065 1.843 . . . . 25.7 110.42 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -81.65 125.37 30.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.1 -1.0 . . . . 49.29 109.477 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.023 -0.989 . . . . 58.91 109.443 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.5 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.456 -0.572 . . . . 64.91 109.456 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.58 ' CG2' HD22 ' A' ' 65' ' ' LEU . 2.8 mt -59.0 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.856 -1.164 . . . . 33.8 107.856 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -63.39 158.66 20.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.803 0.811 . . . . 32.72 111.411 -177.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.56 ' HB ' ' CB ' ' B' ' 61' ' ' TYR . 61.0 t -159.99 167.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.565 0.697 . . . . 14.46 109.617 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 22.6 mt-10 -151.8 104.02 2.98 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.924 -0.769 . . . . 22.12 108.924 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.597 HD12 ' CE1' ' B' ' 61' ' ' TYR . 0.7 OUTLIER -70.82 105.63 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.069 -1.086 . . . . 14.23 108.069 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.664 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.19 173.43 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.43 -0.794 . . . . 25.43 109.974 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.0 Cg_endo -76.18 -22.26 12.98 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.484 2.122 . . . . 13.61 109.777 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -100.97 8.24 43.15 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.575 -0.703 . . . . 15.52 109.136 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 17.5 mm-40 -125.3 35.82 4.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 17.31 109.38 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -106.89 16.3 24.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.112 -0.992 . . . . 24.78 110.12 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.436 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 4.4 tt0 -137.25 130.39 30.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.143 -0.973 . . . . 47.9 108.7 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.596 ' CD2' ' CB ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -77.04 -170.7 1.75 Allowed 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.091 -1.005 . . . . 21.61 110.711 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -143.32 126.74 16.76 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.613 -0.679 . . . . 14.89 109.339 179.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.06 112.28 21.73 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.399 -0.813 . . . . 17.35 109.382 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' B' ' 18' ' ' GLY . 6.6 tpm_? -131.89 142.13 49.58 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.295 -0.878 . . . . 34.38 109.534 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.54 87.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.905 . . . . 38.77 109.35 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.588 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -82.13 172.29 52.62 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.613 -1.395 . . . . 34.58 109.613 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.456 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.6 OUTLIER -139.31 116.88 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -1.151 . . . . 41.87 108.97 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.515 ' N ' ' O ' ' B' ' 24' ' ' LYS . 3.3 m -58.05 108.74 0.63 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.307 -0.871 . . . . 47.21 109.643 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' B' ' 20' ' ' SER . 5.4 mmm180 44.75 38.18 2.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.296 -0.878 . . . . 71.56 109.575 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 58.57 18.4 5.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 66.6 109.615 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.59 -56.15 1.05 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.479 -1.449 . . . . 55.49 109.479 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' B' ' 20' ' ' SER . 7.5 mttt -126.67 147.85 62.42 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.232 -1.158 . . . . 44.99 109.299 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.03 129.76 9.93 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.564 2.176 . . . . 44.1 110.615 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.605 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 8.3 p90 -136.87 139.36 41.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 32.09 109.743 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.95 77.86 2.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.158 -0.964 . . . . 29.25 108.827 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.598 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -93.34 158.98 15.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 24.0 110.105 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.596 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -100.04 118.0 35.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -0.792 . . . . 23.31 109.02 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -86.61 -173.59 4.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 40.03 109.096 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.541 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -173.5 -171.04 0.65 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.153 -0.967 . . . . 12.39 109.948 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.52 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 4.1 mp -145.41 169.83 17.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.424 -0.798 . . . . 17.42 109.231 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -167.95 166.82 13.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.305 -0.998 . . . . 13.84 108.305 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.678 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 31.6 m-85 -118.7 103.18 9.43 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.091 -1.006 . . . . 21.14 109.478 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' B' ' 4' ' ' VAL . 54.6 t -85.55 144.93 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.077 -1.014 . . . . 10.66 110.228 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.5 m-20 -128.71 -140.57 0.24 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.722 -0.844 . . . . 25.89 108.722 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.559 ' HG ' ' CD1' ' A' ' 65' ' ' LEU . 0.1 OUTLIER 68.48 -63.29 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.941 -1.1 . . . . 24.24 109.263 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -85.89 16.4 42.27 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.58 -1.808 . . . . 31.02 108.58 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' B' ' 40' ' ' GLU . 0.4 OUTLIER -177.96 111.88 0.07 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.545 -0.973 . . . . 43.23 109.066 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 39' ' ' ASN . 1.3 mm-40 -40.71 -67.07 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.514 -0.741 . . . . 42.34 109.777 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -59.94 153.55 54.05 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 108.615 -0.883 . . . . 6.28 108.615 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.678 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.4 Cg_endo -77.35 142.78 21.51 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.121 1.88 . . . . 17.92 110.323 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' B' ' 34' ' ' TYR . 27.4 m -113.7 113.68 44.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.25 -0.906 . . . . 20.57 109.412 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.59 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 40.1 tp -69.65 111.8 5.7 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.407 -0.808 . . . . 20.21 110.161 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.425 HG11 HG13 ' A' ' 70' ' ' VAL . 5.1 m -112.66 -172.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.882 -0.784 . . . . 10.81 108.882 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -111.89 155.08 24.23 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.444 -0.902 . . . . 36.74 110.311 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.601 HG13 ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -129.36 162.31 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.894 -0.78 . . . . 19.74 108.894 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.485 ' CG2' HD23 ' B' ' 28' ' ' LEU . 4.4 m -119.24 73.72 0.95 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.295 -0.878 . . . . 22.56 109.239 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.3 OUTLIER -40.63 133.41 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.521 -0.737 . . . . 20.41 109.671 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.505 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -55.19 -166.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 33.99 109.688 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -83.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 54.92 109.745 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.22 40.62 2.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.64 -1.384 . . . . 36.1 109.64 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.67 152.6 47.18 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.269 -1.136 . . . . 54.76 109.649 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.16 119.22 4.56 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.792 2.328 . . . . 28.37 110.734 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' B' ' 11' ' ' ALA . . . -41.11 146.1 0.19 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.356 -0.84 . . . . 17.21 110.333 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.632 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 14.8 m-30 -51.9 100.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 17.19 109.163 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' B' ' 56' ' ' TYR . . . -45.9 170.83 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 17.82 109.508 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.467 ' HA ' HG23 ' B' ' 6' ' ' ILE . 35.4 Cg_endo -77.69 108.45 2.56 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.562 2.174 . . . . 17.28 110.186 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.88 -178.33 48.74 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.933 -1.267 . . . . 17.22 109.933 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.4 mp -73.54 150.01 41.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -1.101 . . . . 19.57 108.667 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.597 ' CE1' HD12 ' B' ' 6' ' ' ILE . 12.0 m-85 -135.31 163.8 29.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.926 -1.109 . . . . 14.61 111.349 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.531 HG21 ' CB ' ' B' ' 86' ' ' ALA . 29.4 p -145.73 119.47 9.22 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.67 -1.604 . . . . 18.36 106.67 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.56 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 18.6 t -47.95 170.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 C-N-CA 119.314 -0.954 . . . . 19.13 109.095 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.553 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -133.65 126.33 30.6 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.842 -0.799 . . . . 20.65 108.842 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.602 ' HG ' ' CD2' ' B' ' 68' ' ' PHE . 4.5 mp -63.0 -7.92 6.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.64 -0.662 . . . . 19.65 110.465 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' SER . . . . . 0.441 ' C ' ' O ' ' B' ' 65' ' ' LEU . 0.4 OUTLIER -47.17 -24.23 0.66 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.875 -1.141 . . . . 14.72 107.937 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.48 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 3.3 m -98.22 -13.27 20.92 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.774 -0.579 . . . . 11.45 110.753 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.647 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.5 m-30 -81.2 156.37 25.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.761 -1.212 . . . . 14.25 110.011 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' B' ' 77' ' ' MET . 0.0 OUTLIER -154.96 166.93 32.01 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.898 -0.778 . . . . 32.7 108.898 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.501 HG22 ' CG2' ' A' ' 43' ' ' VAL . 3.0 t -104.1 125.35 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 15.63 109.232 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.64 173.68 55.25 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.732 -1.347 . . . . 12.7 109.732 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.446 ' O ' ' CG ' ' B' ' 72' ' ' GLN . 1.0 OUTLIER -75.89 -1.28 24.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.252 -1.146 . . . . 26.29 109.822 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -90.85 -17.35 26.68 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.408 -0.807 . . . . 20.44 109.52 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.54 52.42 2.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.662 -1.375 . . . . 13.82 109.662 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 57.9 m -156.59 115.33 3.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -1.163 . . . . 18.27 109.531 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.459 ' O ' ' CG ' ' B' ' 77' ' ' MET . 7.0 tt -50.53 152.92 1.77 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 12.43 109.447 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.459 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 25.3 mtt -160.94 123.52 3.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 35.11 109.741 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.647 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.0 mt -61.32 140.71 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 13.67 109.924 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 26.6 t70 -111.24 -17.26 13.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.391 -0.818 . . . . 24.06 108.928 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.48 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 169.38 63.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.592 -1.633 . . . . 35.04 106.592 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.56 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.5 OUTLIER -27.2 119.44 0.09 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.711 -1.131 . . . . 18.72 112.576 -177.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.15 103.28 15.97 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.356 -1.349 . . . . 20.55 107.356 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.632 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -77.06 145.22 38.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.905 -1.122 . . . . 14.4 111.515 -177.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.478 ' HB ' ' HD2' ' B' ' 85' ' ' PRO . 17.6 m -144.72 160.44 47.34 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.838 -1.171 . . . . 17.65 107.838 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' B' ' 84' ' ' VAL . 25.5 Cg_endo -63.88 146.01 91.08 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.099 1.866 . . . . 25.7 110.464 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.531 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -81.66 125.33 30.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.987 . . . . 49.29 109.528 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.987 -1.006 . . . . 58.91 109.452 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.474 ' C ' ' CD2' ' B' ' 65' ' ' LEU . 1.7 pmm? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.33 0.586 . . . . 64.91 109.46 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.522 ' N ' HD21 ' B' ' 65' ' ' LEU . 3.0 mt -67.82 80.29 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.113 -1.069 . . . . 33.8 108.113 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.458 ' HB3' ' OD2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -64.35 153.9 37.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.77 0.795 . . . . 32.72 110.906 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.59 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -163.26 165.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.693 -0.854 . . . . 14.46 108.693 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 31.3 mt-10 -141.8 113.03 7.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 22.12 109.381 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -73.96 103.76 2.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 119.014 -1.075 . . . . 14.23 108.231 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.642 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.85 171.4 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.366 -0.834 . . . . 25.43 109.84 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.3 Cg_endo -76.1 -29.28 6.7 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.492 2.128 . . . . 13.61 109.803 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 t -85.12 -0.45 54.57 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.912 -0.774 . . . . 15.52 108.912 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 4.0 mm100 -118.0 35.9 4.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.358 -0.839 . . . . 17.31 109.304 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.06 10.81 40.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 24.78 110.475 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.463 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -139.26 131.55 28.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.043 -1.035 . . . . 47.9 108.718 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.606 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 26.4 p90 -85.99 177.45 7.58 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.081 -1.012 . . . . 21.61 110.171 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 9.1 t -130.93 162.39 29.8 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.402 -0.962 . . . . 14.89 108.402 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 15.0 t -110.38 161.92 15.17 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.056 -1.028 . . . . 17.35 110.005 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -177.33 145.86 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.997 -0.742 . . . . 34.38 108.997 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.01 87.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 38.77 109.751 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -78.45 -174.81 44.49 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.11 -1.596 . . . . 34.58 109.11 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.484 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 1.3 t -149.58 117.79 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.26 . . . . 41.87 109.173 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.72 -95.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.386 -0.822 . . . . 47.21 109.805 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.519 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 7.9 ttp180 -119.74 51.95 1.14 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 71.56 109.606 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 21' ' ' ARG . 5.5 mt-30 67.67 13.88 9.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 66.6 109.629 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.53 -52.57 1.54 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.285 -1.526 . . . . 55.49 109.285 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -148.74 148.25 27.22 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.351 -1.088 . . . . 44.99 109.028 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 35.0 Cg_endo -77.55 138.09 16.99 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.501 2.134 . . . . 44.1 110.755 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.8 p90 -124.96 141.27 52.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.207 -0.933 . . . . 32.09 109.926 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.8 75.92 4.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.265 -1.013 . . . . 29.25 108.265 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.584 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 2.0 mm? -91.98 159.51 15.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.34 -0.85 . . . . 24.0 110.23 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.606 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -101.43 131.35 47.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.811 . . . . 23.31 108.894 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 87.7 mt-10 -113.98 157.98 21.76 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -0.988 . . . . 40.03 109.758 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.565 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -139.78 -167.87 2.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 12.39 109.226 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.3 mp -134.74 176.46 8.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 17.42 109.195 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.48 166.45 8.38 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.063 -1.023 . . . . 13.84 108.58 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.658 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.2 m-85 -120.15 106.11 11.63 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 21.14 109.423 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.531 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 82.2 t -98.89 111.32 28.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.134 -0.979 . . . . 10.66 109.565 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.5 p30 -52.31 -30.2 27.14 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.192 -0.943 . . . . 25.89 108.487 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.525 ' CD2' ' HA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 45.29 36.92 2.47 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.48 -0.762 . . . . 24.24 109.093 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.53 18.92 39.35 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.35 -1.5 . . . . 31.02 109.35 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 90.3 m-20 -92.33 25.86 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -1.113 . . . . 43.23 110.483 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 45.6 mt-10 44.3 25.68 0.13 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.065 -1.022 . . . . 42.34 109.776 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 9.9 m80 -173.03 150.8 2.02 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.952 -1.129 . . . . 3.98 107.952 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.658 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.2 Cg_endo -75.98 136.12 18.11 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.788 1.659 . . . . 17.92 110.622 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 10.3 m -112.16 115.41 49.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.564 -0.902 . . . . 20.57 108.564 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 47.6 tp -66.48 107.48 2.07 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.341 -0.849 . . . . 20.21 109.223 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 3.8 t -112.65 167.58 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.511 -0.743 . . . . 10.81 109.41 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -91.13 163.43 14.28 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.301 -0.874 . . . . 36.74 109.997 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.611 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -151.43 172.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.26 -0.9 . . . . 19.74 109.289 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.09 153.64 24.38 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 22.56 109.255 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.59 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -127.55 101.58 6.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.404 -0.81 . . . . 20.41 109.057 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 2.6 t0 -44.28 144.62 0.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.853 . . . . 33.99 109.999 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -64.24 102.1 0.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 54.92 109.091 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.13 -26.19 6.82 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.02 -1.632 . . . . 36.1 109.02 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.454 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 8.1 mt-30 -76.56 144.24 73.4 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.356 -1.085 . . . . 54.76 109.13 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -78.01 130.16 10.19 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.52 2.147 . . . . 28.37 110.518 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 57' ' ' ALA . . . -39.58 141.72 0.36 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.495 -0.753 . . . . 17.21 110.082 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.611 ' CE1' HG12 ' A' ' 47' ' ' ILE . 87.0 m-85 -43.23 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.407 -0.808 . . . . 17.19 109.027 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.495 ' N ' ' O ' ' A' ' 55' ' ' ALA . . . -42.71 166.16 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 17.82 109.699 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.451 ' HA ' HG23 ' A' ' 6' ' ' ILE . 34.3 Cg_endo -77.02 111.91 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.568 2.179 . . . . 17.28 110.062 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.38 -175.73 47.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.804 -1.318 . . . . 17.22 109.804 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 4.7 mp -76.09 147.48 38.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.286 -1.126 . . . . 19.57 108.706 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.59 ' CB ' HG12 ' A' ' 4' ' ' VAL . 20.7 m-85 -137.4 165.13 26.97 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.457 1.122 . . . . 14.61 111.204 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 43.5 p -145.43 120.57 10.13 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.066 -1.827 . . . . 18.36 106.066 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.613 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -53.95 164.97 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 118.392 -1.323 . . . . 19.13 108.877 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.421 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.3 t-80 -127.07 129.91 48.91 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.913 -0.773 . . . . 20.65 108.913 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.651 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -71.79 0.56 8.68 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.41 -0.806 . . . . 19.65 109.802 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.36 -21.06 8.49 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.252 -1.388 . . . . 14.72 107.252 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.484 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 24.4 m -95.12 -9.2 34.26 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.855 -0.528 . . . . 11.45 110.058 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.651 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 3.0 m-30 -78.73 156.61 28.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 14.25 109.705 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.517 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 12.2 mttt -146.97 173.89 12.02 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 32.7 109.356 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.592 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -111.58 111.57 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 15.63 109.433 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.22 -177.34 47.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.489 -1.444 . . . . 12.7 109.489 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.93 38.95 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.196 -1.179 . . . . 26.29 109.55 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.12 24.77 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 20.44 109.579 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' HG12 ' B' ' 45' ' ' VAL . . . 50.1 58.75 8.3 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.543 -1.423 . . . . 13.82 109.543 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.25 131.83 1.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -1.114 . . . . 18.27 109.667 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.453 ' O ' ' SD ' ' A' ' 77' ' ' MET . 1.2 tp -69.38 153.74 43.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 12.43 109.108 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 76' ' ' LEU . 4.5 mmt -154.73 121.67 5.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.969 . . . . 35.11 109.557 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.6 mt -57.26 141.96 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 13.67 109.831 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -116.0 -3.32 12.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.422 -0.799 . . . . 24.06 109.034 178.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 156.49 62.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.998 -1.482 . . . . 35.04 106.998 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.613 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -27.75 120.23 0.1 Allowed 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.017 -0.992 . . . . 18.72 112.141 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.494 ' NH1' ' HG3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -91.99 102.15 14.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.67 -0.863 . . . . 20.55 108.67 179.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -70.37 145.26 51.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.279 -0.888 . . . . 14.4 111.281 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 62' ' ' THR . 35.2 m -146.5 151.16 42.65 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.937 -1.134 . . . . 17.65 107.937 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.3 Cg_endo -62.72 145.7 95.03 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.203 1.935 . . . . 25.7 110.464 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -78.98 115.06 18.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 49.29 109.754 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.019 -0.991 . . . . 58.91 109.431 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.47 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 1.7 pmm? . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.36 0.6 . . . . 64.91 109.516 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.521 ' HA ' ' CD2' ' A' ' 65' ' ' LEU . 3.0 mt -67.91 80.13 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.12 -1.067 . . . . 33.8 108.12 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.465 ' HB3' ' OD2' ' B' ' 36' ' ' ASP . 0.0 OUTLIER -64.26 153.87 36.82 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.771 0.796 . . . . 32.72 110.87 -178.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.59 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -163.27 165.05 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.633 -0.877 . . . . 14.46 108.633 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 31.4 mt-10 -141.75 112.87 7.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 22.12 109.478 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.575 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -73.85 103.68 2.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.999 -1.08 . . . . 14.23 108.225 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.635 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.81 171.33 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.402 -0.811 . . . . 25.43 109.852 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -76.1 -29.21 6.76 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.496 2.13 . . . . 13.61 109.856 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.3 t -85.07 -0.59 54.97 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.829 -0.804 . . . . 15.52 108.829 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 4.1 mm100 -118.0 36.03 4.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.419 -0.801 . . . . 17.31 109.292 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.2 10.94 40.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.167 -0.958 . . . . 24.78 110.44 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.454 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 0.5 OUTLIER -139.3 131.61 28.37 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.145 -0.972 . . . . 47.9 108.672 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.605 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 26.3 p90 -86.07 177.53 7.53 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.058 -1.026 . . . . 21.61 110.052 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 9.2 t -130.98 162.38 29.88 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.392 -0.966 . . . . 14.89 108.392 178.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' B' ' 16' ' ' ARG . 15.0 t -110.4 161.96 15.14 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.127 -0.983 . . . . 17.35 109.993 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' B' ' 15' ' ' THR . 0.3 OUTLIER -177.31 145.85 0.46 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.961 -0.755 . . . . 34.38 108.961 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.99 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 38.77 109.763 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.574 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -78.49 -174.85 44.65 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.118 -1.593 . . . . 34.58 109.118 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.481 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.3 t -149.5 117.86 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -1.222 . . . . 41.87 109.139 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.83 -95.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.361 -0.837 . . . . 47.21 109.815 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.523 ' O ' ' CG ' ' B' ' 21' ' ' ARG . 8.0 ttp180 -119.79 51.9 1.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 71.56 109.636 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' B' ' 21' ' ' ARG . 5.5 mt-30 67.63 13.94 9.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 66.6 109.627 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.55 -52.66 1.53 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.257 -1.537 . . . . 55.49 109.257 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -148.64 148.34 27.79 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.345 -1.091 . . . . 44.99 109.03 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.9 Cg_endo -77.65 138.17 16.87 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.479 2.12 . . . . 44.1 110.683 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.593 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 6.9 p90 -125.12 141.23 52.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 32.09 109.875 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.81 75.91 4.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.25 -1.018 . . . . 29.25 108.25 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.591 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 2.0 mm? -91.96 159.41 15.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.373 -0.83 . . . . 24.0 110.253 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.605 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -101.37 131.22 47.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.381 -0.824 . . . . 23.31 108.892 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 87.5 mt-10 -113.89 158.03 21.61 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.109 -0.994 . . . . 40.03 109.826 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.562 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.8 OUTLIER -139.84 -167.96 2.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.216 -0.928 . . . . 12.39 109.223 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.513 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.3 mp -134.68 176.58 8.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 17.42 109.235 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.481 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.56 166.51 8.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.09 -1.006 . . . . 13.84 108.543 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.663 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 22.2 m-85 -120.28 106.18 11.65 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.109 -0.994 . . . . 21.14 109.395 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 81.8 t -98.97 111.16 27.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.121 -0.987 . . . . 10.66 109.561 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.5 p30 -52.18 -30.19 25.77 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.205 -0.935 . . . . 25.89 108.495 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.517 ' CD2' ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 45.26 36.93 2.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.473 -0.767 . . . . 24.24 109.065 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.49 19.03 39.49 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.386 -1.486 . . . . 31.02 109.386 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 90.1 m-20 -92.39 25.93 2.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 43.23 110.539 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.575 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 45.3 mt-10 44.29 25.6 0.13 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.053 -1.029 . . . . 42.34 109.84 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 10.0 m80 -172.98 150.78 2.04 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.979 -1.119 . . . . 3.98 107.979 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.1 Cg_endo -76.02 136.1 18.0 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.852 1.702 . . . . 17.92 110.606 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' B' ' 35' ' ' VAL . 10.1 m -112.18 115.45 49.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.613 -0.884 . . . . 20.57 108.613 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.545 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 48.0 tp -66.55 107.49 2.1 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.331 -0.856 . . . . 20.21 109.299 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.592 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 4.0 t -112.65 167.66 5.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.586 -0.697 . . . . 10.81 109.469 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -91.19 163.16 14.36 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.669 -0.812 . . . . 36.74 109.97 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.613 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -151.19 172.86 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.308 -0.87 . . . . 19.74 109.326 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.09 153.53 24.54 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.301 -0.874 . . . . 22.56 109.245 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.58 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -127.45 101.66 6.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 20.41 109.061 -179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.454 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 2.6 t0 -44.31 144.61 0.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.341 -0.849 . . . . 33.99 109.97 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -64.21 102.09 0.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 54.92 109.053 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.2 -26.26 6.77 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.059 -1.616 . . . . 36.1 109.059 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.444 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 8.1 mt-30 -76.55 144.47 73.84 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.382 -1.07 . . . . 54.76 109.018 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.15 130.12 10.04 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.544 2.163 . . . . 28.37 110.517 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.484 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -39.62 141.97 0.35 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.49 -0.756 . . . . 17.21 109.99 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.613 ' CE1' HG12 ' B' ' 47' ' ' ILE . 86.4 m-85 -43.61 98.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.833 . . . . 17.19 109.012 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' B' ' 55' ' ' ALA . . . -43.48 166.42 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.839 . . . . 17.82 109.59 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.465 ' HA ' HG23 ' B' ' 6' ' ' ILE . 35.4 Cg_endo -77.54 113.0 3.44 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.625 2.217 . . . . 17.28 110.317 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.56 -175.02 46.83 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.666 -1.374 . . . . 17.22 109.666 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.0 mp -75.99 148.04 38.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -1.111 . . . . 19.57 108.995 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.59 ' CB ' HG12 ' B' ' 4' ' ' VAL . 20.7 m-85 -137.9 165.0 27.59 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.413 1.102 . . . . 14.61 111.254 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' B' ' 84' ' ' VAL . 43.2 p -145.46 120.61 10.13 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.127 -1.805 . . . . 18.36 106.127 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.598 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -54.02 165.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 C-N-CA 118.396 -1.321 . . . . 19.13 108.858 -178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.422 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.3 t-80 -127.01 129.96 49.09 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.97 -0.752 . . . . 20.65 108.97 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.641 ' CB ' ' CD2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -71.87 0.54 8.89 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.377 -0.827 . . . . 19.65 109.735 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -20.94 7.9 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.263 -1.384 . . . . 14.72 107.263 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 23.9 m -95.33 -9.58 32.56 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.899 -0.5 . . . . 11.45 110.058 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.641 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 2.9 m-30 -78.36 156.11 29.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.124 -0.985 . . . . 14.25 109.715 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.525 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 12.2 mttt -146.58 173.37 12.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.805 . . . . 32.7 109.415 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.557 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -111.08 111.63 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 15.63 109.389 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.34 -177.35 48.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.421 -1.472 . . . . 12.7 109.421 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.94 39.0 0.94 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.148 -1.207 . . . . 26.29 109.561 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.08 24.73 4.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 20.44 109.606 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.431 ' C ' HG12 ' A' ' 45' ' ' VAL . . . 50.02 59.14 7.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.519 -1.432 . . . . 13.82 109.519 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.53 131.83 1.84 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.135 . . . . 18.27 109.685 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.448 ' O ' ' SD ' ' B' ' 77' ' ' MET . 1.2 tp -69.41 153.66 43.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.892 . . . . 12.43 109.152 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' B' ' 76' ' ' LEU . 4.5 mmt -154.74 121.77 5.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.097 -1.002 . . . . 35.11 109.573 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.598 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.5 mp -57.4 142.02 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -0.849 . . . . 13.67 109.819 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.7 OUTLIER -115.97 -3.39 12.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.49 -0.756 . . . . 24.06 108.997 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 156.5 63.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.931 -1.507 . . . . 35.04 106.931 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.598 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -27.89 120.33 0.11 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.001 -1.0 . . . . 18.72 112.134 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.485 ' NH1' ' HG3' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -92.04 102.08 14.63 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.675 -0.861 . . . . 20.55 108.675 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.598 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -70.39 145.39 51.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.352 -0.843 . . . . 14.4 111.345 -178.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' B' ' 62' ' ' THR . 35.3 m -146.58 151.03 42.03 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.89 -1.152 . . . . 17.65 107.89 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.9 Cg_endo -62.53 145.71 95.44 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.181 1.92 . . . . 25.7 110.419 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.05 115.07 18.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 49.29 109.76 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.048 -0.977 . . . . 58.91 109.457 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.528 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.3 ttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.534 -0.543 . . . . 64.91 109.534 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.582 ' CG1' ' CD2' ' B' ' 65' ' ' LEU . 2.8 mt -61.52 82.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.962 -1.125 . . . . 33.8 107.962 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 1' ' ' MET . 23.4 mttp -70.33 179.12 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.894 0.854 . . . . 32.72 111.277 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.59 ' CG1' ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 173.56 167.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.902 -0.777 . . . . 14.46 108.902 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.576 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 79.7 mt-10 -141.31 111.17 6.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.545 -0.722 . . . . 22.12 109.259 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.525 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -72.58 105.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.545 -1.28 . . . . 14.23 107.545 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.7 mmpt? -54.14 160.36 2.43 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.118 -0.989 . . . . 25.43 109.539 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 31.8 Cg_endo -73.79 -9.25 22.31 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.057 1.838 . . . . 13.61 109.19 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.85 7.64 46.16 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.89 -0.782 . . . . 15.52 108.89 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.531 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -142.58 37.41 1.49 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.261 -0.899 . . . . 17.31 109.13 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.58 15.46 6.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 24.78 109.803 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.481 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -143.96 143.63 31.32 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.182 -0.949 . . . . 47.9 108.597 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.598 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 26.0 p90 -85.46 173.31 10.34 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.038 -1.039 . . . . 21.61 109.61 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.9 m -137.6 154.95 49.68 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.471 -0.768 . . . . 14.89 109.0 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.46 111.03 22.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.175 -0.953 . . . . 17.35 109.506 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 17' ' ' SER . 5.7 ttt180 -136.59 149.05 47.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 34.38 109.09 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 16' ' ' ARG . 5.4 p -43.91 148.48 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 38.77 109.321 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -144.04 179.67 21.2 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.581 -1.407 . . . . 34.58 109.581 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -155.58 117.18 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -1.127 . . . . 41.87 108.795 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.461 ' O ' ' N ' ' A' ' 22' ' ' GLN . 0.1 OUTLIER -60.33 79.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.323 -0.861 . . . . 47.21 109.632 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER 68.25 -60.18 0.42 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.166 -0.959 . . . . 71.56 109.372 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.7 pt20 175.86 43.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 66.6 109.513 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.99 -51.16 0.41 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.491 -1.444 . . . . 55.49 109.491 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.422 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 18.6 pttm -153.32 159.77 31.76 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.301 -1.117 . . . . 44.99 109.329 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.7 Cg_endo -77.26 120.94 5.5 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.596 2.197 . . . . 44.1 110.675 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.588 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 4.0 p90 -126.34 139.02 53.62 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.268 -0.895 . . . . 32.09 109.627 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -103.29 80.52 1.84 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 29.25 108.846 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.587 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -102.58 134.33 46.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 24.0 110.23 -179.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.661 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -46.01 128.45 9.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.427 -0.796 . . . . 23.31 109.546 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -121.13 143.09 49.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.258 -0.901 . . . . 40.03 108.788 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -115.1 -167.29 1.21 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.963 -1.086 . . . . 12.39 110.149 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.554 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 21.1 mt -128.44 177.99 6.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.48 -0.762 . . . . 17.42 109.557 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -173.46 150.72 1.85 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.987 -1.07 . . . . 13.84 109.238 -179.461 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.632 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 2.9 m-85 -109.8 91.32 3.6 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.181 -1.044 . . . . 21.14 108.181 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 97.9 t -92.89 117.58 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.98 . . . . 10.66 110.155 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 27.6 t0 -53.56 -28.49 32.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.415 -0.957 . . . . 25.89 108.415 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' B' ' 69' ' ' LYS . 1.9 tt 43.25 34.47 0.71 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.498 -0.751 . . . . 24.24 109.239 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.35 23.12 52.9 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.457 -1.457 . . . . 31.02 109.457 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.499 ' ND2' HD21 ' A' ' 37' ' ' LEU . 98.6 m-20 -97.33 26.35 4.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -1.155 . . . . 43.23 110.263 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.551 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 42.9 mt-10 49.25 21.62 0.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.134 -0.979 . . . . 42.34 109.949 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 6.0 m80 -174.71 157.11 2.23 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 108.027 -1.101 . . . . 6.32 108.027 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.624 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.8 Cg_endo -75.6 146.14 30.24 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.019 1.813 . . . . 17.92 111.005 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 5.6 m -122.46 118.38 55.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.622 -0.881 . . . . 20.57 108.622 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.632 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 22.4 tp -69.14 109.42 4.04 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.662 -0.815 . . . . 20.21 109.04 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.591 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 3.9 t -117.18 168.89 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.614 -0.678 . . . . 10.81 109.516 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.581 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -88.63 161.93 16.61 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.298 -0.876 . . . . 36.74 110.423 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.589 HG23 ' CD2' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -133.11 164.43 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.485 -0.932 . . . . 19.74 108.485 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -108.76 135.5 49.88 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.193 -0.942 . . . . 22.56 108.565 178.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.593 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -123.88 123.9 41.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 20.41 109.365 -179.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . 1.3 t0 -71.4 142.53 50.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 33.99 109.546 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.29 107.72 0.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 54.92 109.664 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.04 -2.4 44.33 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.859 -1.296 . . . . 36.1 109.859 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.511 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 13.2 mt-30 -89.19 144.5 32.6 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 54.76 109.525 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 55' ' ' ALA . 35.1 Cg_endo -78.38 114.78 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.643 2.229 . . . . 28.37 110.642 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.525 ' CB ' ' HG3' ' A' ' 31' ' ' GLN . . . -43.79 168.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.337 -0.852 . . . . 17.21 110.031 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.589 ' CD2' HG23 ' A' ' 47' ' ' ILE . 31.0 m-85 -66.14 122.85 18.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 17.19 109.657 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.555 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -74.48 179.39 1.31 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.455 -0.778 . . . . 17.82 109.808 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.9 Cg_endo -78.01 115.41 3.77 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.582 2.188 . . . . 17.28 110.436 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 166.85 142.0 3.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.317 -1.513 . . . . 17.22 109.317 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 59' ' ' GLY . 4.0 mp -42.11 144.43 0.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.153 -1.204 . . . . 19.57 109.382 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 59' ' ' GLY . 15.1 m-85 -121.52 166.37 14.28 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.487 1.137 . . . . 14.61 111.253 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.542 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 39.8 p -149.35 120.54 7.79 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.505 -2.035 . . . . 18.36 105.505 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.578 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.9 t -57.89 161.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 C-N-CA 118.107 -1.437 . . . . 19.13 108.934 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 82' ' ' ARG . 5.1 t-80 -116.19 138.41 51.3 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.592 -0.693 . . . . 20.65 109.203 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' A' ' 68' ' ' PHE . 2.1 mt -70.71 -8.44 52.13 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.098 -0.704 . . . . 19.65 109.098 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.93 -24.95 1.16 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.268 -1.012 . . . . 14.72 108.268 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.512 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 3.7 m -93.7 -14.77 25.96 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.825 -0.75 . . . . 11.45 109.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 3.5 m-30 -80.69 147.07 30.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.064 -1.022 . . . . 14.25 109.973 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.528 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 0.1 OUTLIER -146.31 172.87 12.84 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.643 -0.661 . . . . 32.7 109.229 -179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -107.33 109.55 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 15.63 109.171 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.07 -173.08 49.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.582 -1.407 . . . . 12.7 109.582 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.613 ' N ' ' NE2' ' A' ' 72' ' ' GLN . 0.6 OUTLIER -95.87 22.98 6.72 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.261 -1.141 . . . . 26.29 108.948 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 -9.45 26.65 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.283 -0.567 . . . . 20.44 109.704 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.423 ' C ' HG12 ' B' ' 45' ' ' VAL . . . 81.5 40.41 11.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.692 -1.363 . . . . 13.82 109.692 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.492 ' HA ' ' CG1' ' B' ' 45' ' ' VAL . 4.4 m -169.18 138.54 2.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.14 . . . . 18.27 109.564 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.498 ' CD2' ' HB3' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -47.57 160.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 12.43 109.46 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtt -158.64 107.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 35.11 109.708 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.622 HG12 ' CD1' ' A' ' 68' ' ' PHE . 23.4 mt -60.33 138.11 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 13.67 109.815 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 12.1 t70 -103.13 -22.67 13.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.357 -0.84 . . . . 24.06 108.802 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.512 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.5 OUTLIER 171.86 66.74 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.542 -1.281 . . . . 35.04 107.542 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.578 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -21.72 119.01 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.033 -0.985 . . . . 18.72 112.264 -178.248 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -92.68 103.72 16.07 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.601 -0.888 . . . . 20.55 108.601 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -73.78 145.05 45.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.146 -0.971 . . . . 14.4 111.528 -178.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 62' ' ' THR . 2.4 m -149.64 156.25 38.85 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 107.524 -1.287 . . . . 17.65 107.524 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.3 141.13 80.59 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 C-N-CA 121.9 1.733 . . . . 25.7 110.26 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.515 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -70.66 112.13 6.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.191 -0.943 . . . . 49.29 109.5 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.045 -0.978 . . . . 58.91 109.475 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.531 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.3 ttp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.526 -0.546 . . . . 64.91 109.526 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.584 ' CG1' ' CD2' ' A' ' 65' ' ' LEU . 2.8 mt -61.56 82.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.985 -1.117 . . . . 33.8 107.985 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 1' ' ' MET . 23.3 mttp -70.1 179.2 2.43 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.979 0.895 . . . . 32.72 111.284 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.583 ' CG1' ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 173.46 167.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.865 -0.791 . . . . 14.46 108.865 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 79.6 mt-10 -141.36 111.14 6.55 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.62 0.724 . . . . 22.12 109.241 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.513 ' HB ' ' CE1' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -72.55 105.34 2.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.54 -1.281 . . . . 14.23 107.54 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.536 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.7 mmpt? -54.3 160.39 2.54 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.113 -0.992 . . . . 25.43 109.509 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.9 Cg_endo -73.75 -9.25 22.37 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.032 1.821 . . . . 13.61 109.181 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.84 7.51 46.45 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.803 -0.814 . . . . 15.52 108.803 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.532 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 0.0 OUTLIER -142.63 37.6 1.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.206 -0.934 . . . . 17.31 109.093 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.7 15.34 7.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 24.78 109.831 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.478 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -143.91 143.44 31.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.216 -0.927 . . . . 47.9 108.686 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.594 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 26.3 p90 -85.24 173.22 10.55 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.036 -1.04 . . . . 21.61 109.609 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 39.9 m -137.54 155.0 49.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.48 -0.762 . . . . 14.89 108.983 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.43 110.75 22.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.186 -0.946 . . . . 17.35 109.59 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 17' ' ' SER . 5.6 ttt180 -136.34 149.1 48.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.319 -0.863 . . . . 34.38 109.082 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.427 ' C ' ' O ' ' B' ' 16' ' ' ARG . 5.5 p -43.86 148.44 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 38.77 109.284 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -144.01 179.62 21.22 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.567 -1.413 . . . . 34.58 109.567 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' B' ' 21' ' ' ARG . 0.2 OUTLIER -155.5 117.16 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -1.138 . . . . 41.87 108.803 179.579 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.468 ' O ' ' N ' ' B' ' 22' ' ' GLN . 0.1 OUTLIER -60.28 79.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.317 -0.864 . . . . 47.21 109.562 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER 68.26 -60.22 0.42 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.164 -0.96 . . . . 71.56 109.389 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.7 pt20 175.87 43.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 66.6 109.553 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.85 -51.29 0.41 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.507 -1.437 . . . . 55.49 109.507 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.424 ' HB2' ' HD2' ' B' ' 25' ' ' PRO . 18.8 pttm -153.17 159.7 31.86 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.322 -1.105 . . . . 44.99 109.361 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.9 Cg_endo -77.26 120.74 5.43 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.667 2.245 . . . . 44.1 110.657 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.587 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 4.0 p90 -126.15 139.06 53.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.248 -0.907 . . . . 32.09 109.575 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -103.24 80.51 1.84 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 29.25 108.847 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.582 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -102.64 134.38 46.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 24.0 110.234 -179.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.668 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -46.06 128.52 9.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.401 -0.812 . . . . 23.31 109.579 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -121.2 143.11 49.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.894 . . . . 40.03 108.748 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.526 ' HG3' ' CB ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -115.17 -167.24 1.21 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.981 -1.075 . . . . 12.39 110.132 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.556 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 21.0 mt -128.37 177.97 6.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.429 -0.795 . . . . 17.42 109.549 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.499 ' SG ' HG12 ' B' ' 47' ' ' ILE . 0.8 OUTLIER -173.49 150.65 1.83 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.918 -1.114 . . . . 13.84 109.265 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.64 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 2.9 m-85 -109.77 91.28 3.58 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.18 -1.045 . . . . 21.14 108.18 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.531 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 98.5 t -92.83 117.76 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.961 . . . . 10.66 110.096 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 27.6 t0 -53.71 -28.37 33.58 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.385 -0.968 . . . . 25.89 108.385 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' A' ' 69' ' ' LYS . 1.8 tt 43.11 34.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.572 -0.705 . . . . 24.24 109.256 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.19 23.05 51.81 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.472 -1.451 . . . . 31.02 109.472 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.501 ' ND2' HD21 ' B' ' 37' ' ' LEU . 99.0 m-20 -97.35 26.28 4.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.217 -1.167 . . . . 43.23 110.234 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 43.0 mt-10 49.23 21.74 0.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.13 -0.981 . . . . 42.34 109.976 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 5.9 m80 -174.79 157.13 2.2 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.999 -1.111 . . . . 6.31 107.999 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.618 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.9 Cg_endo -75.59 146.19 30.34 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.97 1.78 . . . . 17.92 110.954 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 5.4 m -122.49 118.36 54.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.633 -0.877 . . . . 20.57 108.633 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.64 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 22.9 tp -69.09 109.57 4.08 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.69 -0.804 . . . . 20.21 109.096 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 3.9 t -117.37 168.86 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.529 -0.732 . . . . 10.81 109.448 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -88.52 161.9 16.72 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.351 -0.843 . . . . 36.74 110.455 -179.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.591 HG23 ' CD2' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -133.08 164.29 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.522 -0.918 . . . . 19.74 108.522 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.502 ' N ' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -108.67 135.47 49.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.242 -0.912 . . . . 22.56 108.576 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.582 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -123.92 123.89 41.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.865 . . . . 20.41 109.362 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.438 ' HA ' HD22 ' B' ' 28' ' ' LEU . 1.3 t0 -71.39 142.35 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 33.99 109.567 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.21 107.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 54.92 109.633 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.08 -2.41 44.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.831 -1.308 . . . . 36.1 109.831 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.515 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 13.2 mt-30 -89.22 144.46 32.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.166 -1.197 . . . . 54.76 109.513 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.37 114.7 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.669 2.246 . . . . 28.37 110.696 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.526 ' CB ' ' HG3' ' B' ' 31' ' ' GLN . . . -43.69 168.67 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 17.21 110.025 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.591 ' CD2' HG23 ' B' ' 47' ' ' ILE . 30.7 m-85 -66.06 122.96 18.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 17.19 109.618 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.547 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -74.53 179.44 1.31 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.443 -0.786 . . . . 17.82 109.844 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.1 Cg_endo -78.0 115.35 3.76 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.619 2.213 . . . . 17.28 110.442 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 166.87 141.95 3.3 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.358 -1.497 . . . . 17.22 109.358 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' B' ' 59' ' ' GLY . 4.0 mp -42.04 144.26 0.47 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -1.162 . . . . 19.57 109.364 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' B' ' 59' ' ' GLY . 15.1 m-85 -121.4 166.24 14.38 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.93 -1.106 . . . . 14.61 111.34 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' B' ' 84' ' ' VAL . 39.2 p -149.31 120.25 7.65 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 105.485 -2.043 . . . . 18.36 105.485 177.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.586 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.8 t -57.44 161.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 C-N-CA 118.143 -1.423 . . . . 19.13 108.936 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' B' ' 82' ' ' ARG . 5.1 t-80 -116.43 138.32 51.46 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.551 -0.718 . . . . 20.65 109.245 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.599 HD22 ' CE2' ' B' ' 68' ' ' PHE . 2.1 mt -70.57 -8.47 51.77 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.065 -0.717 . . . . 19.65 109.065 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.96 -24.84 1.15 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.29 -1.004 . . . . 14.72 108.29 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.513 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 3.8 m -93.78 -14.8 25.82 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.472 -0.767 . . . . 11.45 109.97 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.632 ' CD1' HG12 ' B' ' 78' ' ' ILE . 3.5 m-30 -80.71 146.44 31.06 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.081 -1.012 . . . . 14.25 109.955 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.537 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -145.72 172.62 13.02 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.651 -0.656 . . . . 32.7 109.274 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.591 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -107.2 109.54 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 15.63 109.166 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.95 -172.88 49.12 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.593 -1.403 . . . . 12.7 109.593 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.605 ' N ' ' NE2' ' B' ' 72' ' ' GLN . 0.6 OUTLIER -96.05 22.83 7.06 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.215 -1.168 . . . . 26.29 108.918 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.61 -9.48 26.84 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.757 -0.589 . . . . 20.44 109.69 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.443 ' C ' HG12 ' A' ' 45' ' ' VAL . . . 81.46 41.05 10.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.578 -1.409 . . . . 13.82 109.578 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.512 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 4.3 m -169.79 138.29 1.8 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -1.153 . . . . 18.27 109.688 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.518 ' CD2' ' HB3' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -47.37 160.7 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 12.43 109.462 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtt -158.94 107.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 35.11 109.738 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.632 HG12 ' CD1' ' B' ' 68' ' ' PHE . 23.0 mt -60.26 138.4 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 13.67 109.843 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 12.1 t70 -103.37 -22.81 13.62 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.709 -0.849 . . . . 24.06 108.709 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.513 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.5 OUTLIER 172.09 66.55 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.556 -1.275 . . . . 35.04 107.556 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.586 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.7 OUTLIER -21.5 118.96 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.085 -0.961 . . . . 18.72 112.285 -178.25 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' B' ' 64' ' ' HIS . 0.3 OUTLIER -92.57 103.79 16.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 20.55 108.643 179.363 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.575 ' HB3' ' CZ ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -73.85 144.93 45.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.03 -1.044 . . . . 14.4 111.469 -178.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.541 ' C ' ' CD2' ' B' ' 61' ' ' TYR . 2.5 m -149.59 156.14 38.95 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.528 -1.286 . . . . 17.65 107.528 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -63.26 141.08 80.73 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 121.911 1.741 . . . . 25.7 110.211 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.508 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -70.53 112.14 6.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.207 -0.933 . . . . 49.29 109.528 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.015 -0.993 . . . . 58.91 109.5 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.469 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 1.3 ttp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.457 -0.572 . . . . 64.91 109.457 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.541 HG12 ' CB ' ' B' ' 65' ' ' LEU . 6.2 mt -71.29 77.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.213 -1.032 . . . . 33.8 108.213 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' C ' HG11 ' A' ' 4' ' ' VAL . 54.0 mttt -63.53 155.41 29.47 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.937 0.875 . . . . 32.72 111.299 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.596 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -166.84 163.53 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.499 -0.926 . . . . 14.46 108.499 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 64.5 mt-10 -137.12 119.53 15.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.24 -0.913 . . . . 22.12 109.762 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -76.61 101.08 2.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.521 -1.288 . . . . 14.23 107.521 178.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.625 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.9 171.73 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.014 -1.054 . . . . 25.43 109.841 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -75.08 -26.06 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.49 2.126 . . . . 13.61 109.804 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.89 -0.13 56.58 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.906 -0.775 . . . . 15.52 108.906 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.479 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.5 mm-40 -120.59 37.17 4.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.346 -0.846 . . . . 17.31 109.595 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.01 8.45 44.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 24.78 110.236 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -139.71 137.89 35.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.186 -0.946 . . . . 47.9 108.677 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.613 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 30.7 p90 -84.45 173.99 10.43 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.027 -1.046 . . . . 21.61 109.459 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.7 m -142.5 151.67 41.91 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.459 -0.776 . . . . 14.89 109.115 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.03 109.87 16.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.296 -0.878 . . . . 17.35 109.23 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.61 151.76 50.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 34.38 109.33 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.68 134.9 57.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.875 . . . . 38.77 109.35 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -130.51 -170.74 12.77 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.422 -1.471 . . . . 34.58 109.422 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.52 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -155.81 121.81 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.132 . . . . 41.87 108.572 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -72.42 54.65 0.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.122 -0.986 . . . . 47.21 109.859 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.482 ' C ' ' CG ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER 67.3 -60.47 0.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.171 -0.956 . . . . 71.56 109.24 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.482 ' CG ' ' C ' ' A' ' 21' ' ' ARG . 17.9 mt-30 -156.67 29.92 0.32 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 66.6 109.153 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 24' ' ' LYS . . . -117.31 39.7 2.57 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.587 -1.405 . . . . 55.49 109.587 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 13.9 mttt 78.64 163.78 0.13 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.406 -1.055 . . . . 44.99 109.05 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 33.3 Cg_endo -75.96 135.89 17.89 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.464 2.109 . . . . 44.1 110.717 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.596 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.7 p90 -124.74 144.34 50.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.447 -0.783 . . . . 32.09 109.604 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.88 79.5 2.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 29.25 108.778 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.532 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -99.29 134.13 42.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 24.0 110.299 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.592 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -48.65 120.31 3.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 23.31 109.168 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 7.9 mt-10 -109.79 161.3 15.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 40.03 109.334 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.556 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -139.91 -168.92 2.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 12.39 109.647 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.521 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.1 mt -141.44 155.28 45.88 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.684 -0.858 . . . . 17.42 108.684 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.6 m -151.64 -177.25 5.99 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.185 -1.042 . . . . 13.84 108.185 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 16.5 m-85 -131.3 103.81 6.67 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.126 -0.984 . . . . 21.14 109.785 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 3.0 t -109.78 123.27 65.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.145 -0.972 . . . . 10.66 110.069 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -87.66 -36.76 17.25 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.366 -0.976 . . . . 25.89 108.366 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.496 ' HA ' ' CD1' ' B' ' 65' ' ' LEU . 0.3 OUTLIER 63.79 -71.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.541 -0.911 . . . . 24.24 108.541 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -157.19 29.17 0.52 Allowed Glycine 0 C--N 1.297 -1.633 0 N-CA-C 109.188 -1.565 . . . . 31.02 109.188 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' HIS . 1.7 m-20 -109.51 21.64 16.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -1.178 . . . . 43.23 110.229 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.579 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 3.3 mt-10 42.58 25.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.266 -0.896 . . . . 42.34 110.328 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 98.6 m-70 -160.52 152.79 17.11 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.108 -0.995 . . . . 7.29 108.518 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.692 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -78.35 136.05 13.87 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.903 1.736 . . . . 17.92 110.411 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.539 ' CG1' HG23 ' B' ' 70' ' ' VAL . 2.4 m -112.21 119.34 59.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.351 -0.843 . . . . 20.57 108.744 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.61 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 52.1 tp -75.32 103.51 5.5 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.461 -0.895 . . . . 20.21 110.018 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.6 ' CG1' ' CG1' ' B' ' 70' ' ' VAL . 29.0 m -110.53 178.48 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.643 -0.873 . . . . 10.81 108.643 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.09 127.1 52.95 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.012 -1.075 . . . . 36.74 110.029 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.626 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -108.64 163.17 6.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.884 -0.784 . . . . 19.74 108.884 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.7 m -99.59 158.99 15.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 22.56 109.539 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.613 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -130.37 105.14 7.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.198 -0.939 . . . . 20.41 109.286 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.49 142.29 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 33.99 109.501 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.14 101.58 0.3 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 54.92 109.313 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.62 -20.04 10.3 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.316 -1.514 . . . . 36.1 109.316 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 30.5 mt-30 -78.28 148.53 74.46 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.259 -1.142 . . . . 54.76 109.376 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.99 120.38 5.01 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.665 2.244 . . . . 28.37 110.619 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -38.58 143.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.506 -0.746 . . . . 17.21 110.346 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.626 ' CE1' HG12 ' A' ' 47' ' ' ILE . 86.6 m-85 -44.56 102.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.798 . . . . 17.19 108.844 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.521 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -53.97 176.09 0.13 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 17.82 109.955 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.8 Cg_endo -78.39 111.22 2.99 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.763 2.309 . . . . 17.28 110.27 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 175.25 163.89 28.98 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.905 -1.278 . . . . 17.22 109.905 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.5 OUTLIER -59.84 142.79 52.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.243 -1.151 . . . . 19.57 108.748 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.596 ' CB ' HG12 ' A' ' 4' ' ' VAL . 31.8 m-85 -125.9 161.07 28.3 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.718 -1.238 . . . . 14.61 111.682 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 30.9 p -146.24 121.44 10.17 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.295 -1.743 . . . . 18.36 106.295 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.607 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.9 t -52.47 168.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.806 -1.158 . . . . 19.13 109.381 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.457 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.9 t-80 -133.62 127.14 32.39 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.487 -0.758 . . . . 20.65 109.038 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.664 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -71.11 0.1 8.42 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.292 -0.88 . . . . 19.65 109.997 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.3 p -55.26 -20.55 11.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.401 -1.333 . . . . 14.72 107.401 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 69.6 m -94.18 -27.35 16.24 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.835 -0.54 . . . . 11.45 109.998 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.664 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -60.82 156.27 17.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.1 -1.0 . . . . 14.25 109.127 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HE3' ' OD2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -159.1 172.31 18.35 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.385 -0.822 . . . . 32.7 109.586 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.589 ' CG1' ' CG1' ' B' ' 45' ' ' VAL . 0.1 OUTLIER -97.45 112.19 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 15.63 109.387 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.45 -176.08 48.61 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.547 -1.421 . . . . 12.7 109.547 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.05 33.86 0.87 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -1.162 . . . . 26.29 109.486 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -118.74 15.36 13.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 20.44 109.628 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.06 48.96 70.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.781 -1.328 . . . . 13.82 109.781 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.453 ' O ' ' HG2' ' A' ' 77' ' ' MET . 0.0 OUTLIER -170.93 138.84 1.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -1.197 . . . . 18.27 109.416 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 77' ' ' MET . 0.2 OUTLIER -45.15 163.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 12.43 109.388 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 76' ' ' LEU . 6.7 mmt -154.22 100.3 2.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 35.11 109.844 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.57 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.5 mt -40.98 -61.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.511 0.672 . . . . 13.67 109.634 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 35.4 t0 81.44 -48.2 0.24 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.476 0.655 . . . . 24.06 109.958 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.0 tpm_? -172.04 66.78 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.107 0.956 . . . . 35.04 108.781 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.607 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -34.84 127.06 0.51 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.499 -0.773 . . . . 18.72 111.597 -179.203 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -94.7 105.38 17.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.167 -1.049 . . . . 20.55 108.167 178.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.617 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -72.83 149.06 43.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 14.4 111.263 -178.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 62' ' ' THR . 34.3 m -150.22 150.68 29.98 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.121 -1.066 . . . . 17.65 108.121 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.2 Cg_endo -61.93 138.35 73.06 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.129 1.886 . . . . 25.7 110.241 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.468 ' CA ' HG22 ' A' ' 62' ' ' THR . . . -66.72 116.61 7.82 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.295 -0.878 . . . . 49.29 109.684 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.001 -1.0 . . . . 58.91 109.41 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.471 ' SD ' ' HB ' ' B' ' 62' ' ' THR . 1.3 ttp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.522 -0.548 . . . . 64.91 109.522 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.542 ' CG1' HD21 ' A' ' 65' ' ' LEU . 6.3 mt -70.6 77.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.16 -1.052 . . . . 33.8 108.16 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.447 ' C ' HG11 ' B' ' 4' ' ' VAL . 53.3 mttt -63.6 155.37 29.85 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.914 0.864 . . . . 32.72 111.308 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.59 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -166.86 163.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.492 -0.929 . . . . 14.46 108.492 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 65.3 mt-10 -137.07 119.6 15.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.344 -0.847 . . . . 22.12 109.798 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.541 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -76.71 101.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.583 -1.265 . . . . 14.23 107.583 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.63 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.88 171.76 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.1 -1.0 . . . . 25.43 109.83 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.6 Cg_endo -75.07 -26.14 11.09 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.539 2.159 . . . . 13.61 109.834 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.86 -0.08 56.5 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.946 -0.761 . . . . 15.52 108.946 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.482 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.5 mm-40 -120.57 37.07 4.38 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 17.31 109.561 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.05 8.71 43.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 24.78 110.204 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.452 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -139.93 137.85 35.12 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.126 -0.984 . . . . 47.9 108.639 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.61 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 30.8 p90 -84.39 174.05 10.41 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 120.984 -1.072 . . . . 21.61 109.504 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -142.53 151.44 41.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.397 -0.814 . . . . 14.89 109.113 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.73 110.38 17.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.288 -0.883 . . . . 17.35 109.129 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.13 151.59 51.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.337 -0.852 . . . . 34.38 109.346 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.57 134.81 57.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 38.77 109.383 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -130.52 -170.63 12.74 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.398 -1.481 . . . . 34.58 109.398 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.518 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.3 OUTLIER -155.86 121.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -1.129 . . . . 41.87 108.568 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.503 ' O ' ' N ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -72.48 54.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.129 -0.982 . . . . 47.21 109.876 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.493 ' C ' ' CG ' ' B' ' 22' ' ' GLN . 0.3 OUTLIER 67.22 -60.45 0.37 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.211 -0.93 . . . . 71.56 109.24 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' B' ' 20' ' ' SER . 17.6 mt-30 -156.63 29.98 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 66.6 109.201 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' B' ' 24' ' ' LYS . . . -117.42 39.69 2.57 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.61 -1.396 . . . . 55.49 109.61 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.508 ' CB ' ' O ' ' B' ' 23' ' ' GLY . 14.0 mttt 78.57 163.73 0.13 Allowed Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.404 -1.056 . . . . 44.99 109.038 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' B' ' 24' ' ' LYS . 33.2 Cg_endo -75.92 136.05 18.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.454 2.103 . . . . 44.1 110.701 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 6.7 p90 -124.88 144.31 50.39 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.388 -0.82 . . . . 32.09 109.596 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.79 79.49 2.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 29.25 108.735 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.54 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -99.28 134.03 42.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 24.0 110.292 -179.107 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.587 ' OD1' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -48.69 120.4 3.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.402 -0.811 . . . . 23.31 109.122 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 7.8 mt-10 -109.84 161.39 15.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 40.03 109.283 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.559 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -139.9 -168.85 2.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 12.39 109.67 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.517 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.1 mt -141.55 155.19 45.79 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.717 -0.845 . . . . 17.42 108.717 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.5 m -151.63 -177.21 5.97 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.179 -1.045 . . . . 13.84 108.179 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.69 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 16.3 m-85 -131.35 103.9 6.71 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.103 -0.998 . . . . 21.14 109.692 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' B' ' 43' ' ' VAL . 2.9 t -109.86 123.16 65.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.126 -0.984 . . . . 10.66 110.115 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.1 OUTLIER -87.45 -36.9 17.43 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.336 -0.987 . . . . 25.89 108.336 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.505 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 0.3 OUTLIER 64.13 -71.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.471 -0.937 . . . . 24.24 108.471 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -157.49 29.19 0.5 Allowed Glycine 0 C--N 1.297 -1.61 0 N-CA-C 109.185 -1.566 . . . . 31.02 109.185 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' B' ' 41' ' ' HIS . 1.7 m-20 -109.49 21.53 16.9 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.117 -1.225 . . . . 43.23 110.243 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.585 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 3.2 mt-10 42.78 25.23 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 42.34 110.302 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 98.4 m-70 -160.48 152.85 17.24 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.175 -0.953 . . . . 7.28 108.511 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.69 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 38.3 Cg_endo -78.44 135.9 13.62 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.93 1.753 . . . . 17.92 110.468 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' B' ' 35' ' ' VAL . 2.4 m -111.88 119.34 59.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.62 -0.881 . . . . 20.57 108.62 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.623 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 51.4 tp -75.25 103.43 5.4 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.243 -0.91 . . . . 20.21 110.069 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.589 ' CG1' ' CG1' ' A' ' 70' ' ' VAL . 26.1 m -110.4 178.64 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.738 -0.838 . . . . 10.81 108.738 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.23 127.0 52.91 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.975 -1.09 . . . . 36.74 109.99 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.621 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -108.48 163.3 6.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.889 -0.782 . . . . 19.74 108.889 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 56.5 m -99.71 158.7 15.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.985 -1.072 . . . . 22.56 109.558 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.61 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -130.12 105.25 7.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 20.41 109.3 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.6 142.03 2.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 33.99 109.578 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.9 101.33 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 54.92 109.353 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.92 -19.97 10.06 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.311 -1.516 . . . . 36.1 109.311 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -78.43 148.61 74.09 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.283 -1.128 . . . . 54.76 109.436 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.9 Cg_endo -78.01 120.44 5.02 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.644 2.229 . . . . 28.37 110.587 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.535 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -38.63 143.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 17.21 110.37 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.621 ' CE1' HG12 ' B' ' 47' ' ' ILE . 86.8 m-85 -44.59 102.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 17.19 108.837 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.53 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -53.73 176.06 0.12 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 17.82 109.878 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -78.48 111.34 3.0 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.719 2.279 . . . . 17.28 110.237 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 175.24 164.15 29.39 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.918 -1.273 . . . . 17.22 109.918 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.5 OUTLIER -60.16 142.82 53.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -1.143 . . . . 19.57 108.706 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.59 ' CB ' HG12 ' B' ' 4' ' ' VAL . 31.8 m-85 -125.86 161.13 28.13 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.679 -1.263 . . . . 14.61 111.645 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' B' ' 2' ' ' ILE . 30.8 p -146.28 121.48 10.18 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.325 -1.732 . . . . 18.36 106.325 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.617 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.9 t -52.6 168.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 C-N-CA 118.887 -1.125 . . . . 19.13 109.342 -178.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.461 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -133.61 127.26 32.64 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.508 -0.745 . . . . 20.65 109.058 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.663 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.7 OUTLIER -71.38 0.38 8.33 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.263 -0.898 . . . . 19.65 109.975 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.4 p -55.32 -20.47 11.61 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.294 -1.372 . . . . 14.72 107.294 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 69.8 m -94.35 -27.23 16.2 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.864 -0.522 . . . . 11.45 109.954 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.9 m-30 -60.9 156.13 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.05 -1.031 . . . . 14.25 109.069 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.415 ' HE3' ' OD2' ' B' ' 79' ' ' ASP . 0.0 OUTLIER -159.07 172.45 18.12 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.36 -0.837 . . . . 32.7 109.595 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.6 ' CG1' ' CG1' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -97.62 112.42 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.838 . . . . 15.63 109.392 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.52 -176.1 48.51 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.512 -1.435 . . . . 12.7 109.512 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.0 34.0 0.86 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.196 -1.179 . . . . 26.29 109.496 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -118.91 15.33 13.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 20.44 109.598 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.1 48.84 71.13 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.779 -1.328 . . . . 13.82 109.779 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.459 ' O ' ' HG2' ' B' ' 77' ' ' MET . 0.0 OUTLIER -170.84 138.95 1.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -1.162 . . . . 18.27 109.403 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' B' ' 77' ' ' MET . 0.2 OUTLIER -45.14 163.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 12.43 109.464 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' B' ' 76' ' ' LEU . 6.6 mmt -154.37 100.4 2.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 35.11 109.835 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.589 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.5 mt -41.13 -61.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.514 0.673 . . . . 13.67 109.689 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 35.5 t0 81.41 -48.28 0.24 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.485 0.66 . . . . 24.06 109.961 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.0 tpm_? -171.98 66.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.111 0.958 . . . . 35.04 108.793 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.617 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.0 OUTLIER -34.87 127.22 0.51 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.529 -0.759 . . . . 18.72 111.604 -179.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -94.94 105.1 16.99 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.18 -1.044 . . . . 20.55 108.18 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.611 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -72.52 149.15 44.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 14.4 111.301 -178.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' B' ' 62' ' ' THR . 34.1 m -150.36 150.62 29.52 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.08 -1.081 . . . . 17.65 108.08 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.2 Cg_endo -61.94 138.41 73.39 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.04 1.827 . . . . 25.7 110.295 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.476 ' CA ' HG22 ' B' ' 62' ' ' THR . . . -66.82 116.65 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.319 -0.863 . . . . 49.29 109.635 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.045 -0.978 . . . . 58.91 109.469 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.396 -0.594 . . . . 64.91 109.396 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.548 ' CG1' HD11 ' B' ' 65' ' ' LEU . 1.1 mt 53.02 81.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.689 -1.226 . . . . 33.8 107.689 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.447 ' C ' HG11 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -76.56 157.25 32.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 32.72 110.777 -178.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -164.07 163.38 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.022 -0.733 . . . . 14.46 109.022 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 37.5 mt-10 -138.99 114.14 9.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.486 -0.759 . . . . 22.12 109.039 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.6 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -74.36 102.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 119.201 -1.0 . . . . 14.23 108.528 179.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.642 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.63 170.85 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.299 -0.875 . . . . 25.43 109.478 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.7 Cg_endo -75.92 -21.73 13.92 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.419 2.08 . . . . 13.61 109.61 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.32 5.19 50.3 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.17 -0.678 . . . . 15.52 109.17 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.524 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 19.9 mm-40 -124.15 36.04 4.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 17.31 109.64 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -105.01 15.7 27.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.062 -1.024 . . . . 24.78 110.329 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.408 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 38.9 mt-30 -133.86 135.9 44.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 47.9 109.84 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.624 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 46.9 p90 -92.63 166.66 12.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.189 -0.944 . . . . 21.61 109.492 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -140.5 145.73 37.25 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.308 -0.87 . . . . 14.89 109.124 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.24 118.02 20.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 17.35 109.553 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -130.42 145.64 51.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 34.38 109.344 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.48 117.81 3.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 38.77 109.405 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 26' ' ' TYR . . . -119.36 162.73 13.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.474 -1.45 . . . . 34.58 109.474 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.619 ' N ' ' CE1' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -143.98 113.37 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.246 . . . . 41.87 109.281 179.179 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 m -47.1 -85.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.789 . . . . 47.21 109.663 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.77 58.37 1.64 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 71.56 109.417 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 58.79 16.28 4.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.926 . . . . 66.6 109.328 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.38 -55.45 1.26 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.318 -1.513 . . . . 55.49 109.318 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -145.27 151.94 49.19 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.345 -1.091 . . . . 44.99 109.192 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.44 131.1 11.34 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.622 2.215 . . . . 44.1 110.809 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.642 ' CE2' ' HB2' ' A' ' 28' ' ' LEU . 13.9 p90 -131.44 100.08 5.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.331 -0.855 . . . . 32.09 109.736 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 m -71.5 76.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 29.25 109.136 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.642 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -87.77 142.88 27.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 24.0 110.198 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.586 ' CB ' ' CB ' ' A' ' 49' ' ' LEU . 69.5 m-20 -51.08 123.2 8.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.811 . . . . 23.31 109.897 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 35.7 mp0 -98.86 155.16 17.52 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.058 -1.09 . . . . 40.03 108.058 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 1.2 tm0? -146.52 -179.96 7.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.825 -1.172 . . . . 12.39 110.384 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.47 ' HB2' ' OE1' ' A' ' 10' ' ' GLN . 51.0 mt -139.85 145.99 38.77 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.449 -0.782 . . . . 17.42 110.0 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 4.1 m -152.97 -177.12 6.09 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.148 -1.426 . . . . 13.84 107.148 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.648 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 27.3 m-85 -128.48 113.48 15.56 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.785 -1.197 . . . . 21.14 109.922 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 45.4 t -107.09 115.65 49.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.235 -0.916 . . . . 10.66 110.148 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 39' ' ' ASN . 54.8 m-20 -64.5 -36.55 84.55 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.806 -1.183 . . . . 25.89 107.806 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.558 ' CD2' ' HA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 46.41 48.21 13.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 24.24 109.893 179.303 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.04 -1.21 64.25 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.41 -1.476 . . . . 31.02 109.41 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.2 OUTLIER -105.9 95.73 6.0 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.334 -1.098 . . . . 43.23 108.342 179.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 39' ' ' ASN . 2.5 mp0 -27.33 -41.67 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.437 0.637 . . . . 42.34 111.083 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' ASN . 48.5 m80 -78.16 141.09 61.99 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 108.638 -0.875 . . . . 6.58 108.638 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.648 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -76.23 136.72 18.29 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.898 1.732 . . . . 17.92 110.478 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 2.9 m -107.65 117.65 53.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.614 -0.884 . . . . 20.57 108.614 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 61.7 tp -65.8 97.82 0.36 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.514 -0.874 . . . . 20.21 109.999 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 21.0 t -99.39 168.46 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.813 -0.81 . . . . 10.81 108.813 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.554 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 4.0 ptpp? -117.33 147.7 42.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.928 -1.108 . . . . 36.74 111.565 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.652 ' CG2' ' CE1' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -112.41 178.0 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.563 -0.903 . . . . 19.74 108.563 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.457 HG23 ' HB3' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -126.24 74.93 1.48 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.187 -0.946 . . . . 22.56 109.46 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.624 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -42.78 150.75 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.425 -0.797 . . . . 20.41 109.22 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 26.5 t0 -123.13 148.13 46.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 33.99 109.456 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 48.31 -148.89 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.116 -0.99 . . . . 54.92 109.257 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.12 16.83 56.28 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.647 -1.381 . . . . 36.1 109.647 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -45.72 149.33 1.13 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.178 -1.189 . . . . 54.76 109.469 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.16 113.16 3.35 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.587 2.192 . . . . 28.37 110.002 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 11' ' ' ALA . . . -39.4 153.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.467 -0.771 . . . . 17.21 110.25 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.652 ' CE1' ' CG2' ' A' ' 47' ' ' ILE . 84.5 m-85 -50.58 113.11 0.81 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 17.19 109.351 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.541 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -61.81 177.25 0.38 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 17.82 109.476 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.76 114.43 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.572 2.181 . . . . 17.28 110.398 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.0 179.88 43.98 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 17.22 109.556 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.5 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.2 mp -73.96 156.04 38.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -1.121 . . . . 19.57 108.577 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.6 ' CE1' HD11 ' A' ' 6' ' ' ILE . 26.6 m-85 -143.75 163.32 33.64 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.568 1.175 . . . . 14.61 111.577 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.525 ' CG2' ' HG3' ' A' ' 1' ' ' MET . 43.5 p -145.78 123.17 11.65 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.171 -1.789 . . . . 18.36 106.171 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.8 t -54.31 169.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 C-N-CA 118.495 -1.282 . . . . 19.13 108.804 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.513 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -128.11 124.5 37.11 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.861 -0.792 . . . . 20.65 108.861 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.635 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -64.91 -6.79 9.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.849 -0.532 . . . . 19.65 109.923 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.4 p -53.91 -16.19 1.72 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.93 -1.106 . . . . 14.72 108.673 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.475 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 50.1 m -99.52 -4.89 30.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.419 -0.8 . . . . 11.45 111.052 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -81.65 157.78 24.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.7 -1.25 . . . . 14.25 109.832 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.543 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 5.3 pttt -142.98 171.74 13.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.401 -0.812 . . . . 32.7 109.624 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.467 HG22 HG23 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -125.83 112.68 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 15.63 109.046 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.479 ' C ' ' NE2' ' A' ' 72' ' ' GLN . . . -71.95 -173.64 20.09 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.568 -1.413 . . . . 12.7 109.568 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.48 ' N ' ' NE2' ' A' ' 72' ' ' GLN . 0.8 OUTLIER -89.4 34.53 0.81 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.209 -1.171 . . . . 26.29 109.508 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -133.87 24.7 3.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.405 -0.81 . . . . 20.44 109.441 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' B' ' 46' ' ' LYS . . . 51.49 56.58 14.74 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 13.82 109.635 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.7 m -148.64 105.27 3.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -1.211 . . . . 18.27 109.752 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.496 ' CD1' HG22 ' B' ' 2' ' ' ILE . 5.0 tt -70.23 146.56 50.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 12.43 109.277 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.486 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 4.2 mtm -157.34 144.53 18.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 35.11 109.583 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.606 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.3 mp -69.73 141.76 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 13.67 109.615 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -107.5 -37.2 6.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.809 -1.182 . . . . 24.06 107.809 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -167.94 67.53 0.08 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.404 -1.332 . . . . 35.04 107.404 178.664 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.601 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.6 OUTLIER -27.41 118.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.416 -0.811 . . . . 18.72 111.632 -178.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 20.0 tpt180 -92.09 104.58 16.95 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.066 -1.087 . . . . 20.55 108.066 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.578 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -72.64 150.7 42.78 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.052 0.929 . . . . 14.4 111.591 -178.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 62' ' ' THR . 34.7 m -152.07 154.36 32.42 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.741 -1.207 . . . . 17.65 107.741 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.4 Cg_endo -62.93 145.93 94.66 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.211 1.941 . . . . 25.7 110.749 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.24 121.85 22.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.238 -0.913 . . . . 49.29 109.525 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 tptt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.977 -1.011 . . . . 58.91 109.454 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.403 -0.591 . . . . 64.91 109.403 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.549 ' CG1' HD11 ' A' ' 65' ' ' LEU . 1.2 mt 52.83 81.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.662 -1.236 . . . . 33.8 107.662 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.444 ' C ' HG11 ' B' ' 4' ' ' VAL . 0.0 OUTLIER -76.32 157.2 32.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 32.72 110.839 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.567 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -164.06 163.46 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.014 -0.735 . . . . 14.46 109.014 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 37.6 mt-10 -139.1 114.06 9.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 22.12 109.019 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -74.3 102.17 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 119.183 -1.007 . . . . 14.23 108.46 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.627 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.73 171.03 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.307 -0.871 . . . . 25.43 109.507 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.6 Cg_endo -75.86 -21.93 13.84 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.346 2.031 . . . . 13.61 109.678 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.18 5.33 50.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.615 -0.678 . . . . 15.52 109.222 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.511 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 19.7 mm-40 -124.23 35.97 4.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 17.31 109.637 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -104.96 15.63 27.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -0.942 . . . . 24.78 110.339 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.416 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 38.9 mt-30 -133.78 135.92 44.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.0 . . . . 47.9 109.916 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.62 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 47.0 p90 -92.62 166.68 12.37 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.168 -0.958 . . . . 21.61 109.519 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 25.0 m -140.54 145.73 37.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 14.89 109.046 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.29 118.0 20.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 17.35 109.528 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -130.3 145.68 51.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 34.38 109.404 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.54 117.82 3.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 38.77 109.378 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' B' ' 26' ' ' TYR . . . -119.45 162.75 13.67 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.42 -1.472 . . . . 34.58 109.42 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.623 ' N ' ' CE1' ' B' ' 26' ' ' TYR . 1.0 OUTLIER -144.02 113.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.115 -1.226 . . . . 41.87 109.288 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.7 m -47.17 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.743 . . . . 47.21 109.64 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.88 58.62 1.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 71.56 109.345 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 58.67 16.13 4.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.226 -0.922 . . . . 66.6 109.329 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.27 -55.31 1.28 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.325 -1.51 . . . . 55.49 109.325 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -145.35 151.94 48.87 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.251 -1.147 . . . . 44.99 109.184 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.47 131.1 11.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.607 2.205 . . . . 44.1 110.807 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.629 ' CE2' ' HB2' ' B' ' 28' ' ' LEU . 13.9 p90 -131.45 100.08 5.04 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.322 -0.861 . . . . 32.09 109.701 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.2 m -71.55 76.33 0.8 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 29.25 109.204 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.629 ' HB2' ' CE2' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -87.79 142.91 27.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.224 -0.923 . . . . 24.0 110.134 -179.346 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.589 ' CB ' ' CB ' ' B' ' 49' ' ' LEU . 69.6 m-20 -51.14 123.13 8.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.462 -0.774 . . . . 23.31 109.947 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 35.6 mp0 -98.76 155.11 17.51 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.082 -1.081 . . . . 40.03 108.082 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' B' ' 10' ' ' GLN . 1.2 tm0? -146.53 -179.88 7.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.783 -1.198 . . . . 12.39 110.318 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.459 ' HB2' ' OE1' ' B' ' 10' ' ' GLN . 50.9 mt -139.98 145.92 38.45 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.442 -0.786 . . . . 17.42 110.019 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.561 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 4.1 m -152.88 -176.98 5.99 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.069 -1.456 . . . . 13.84 107.069 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.642 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 27.3 m-85 -128.61 113.41 15.39 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.867 -1.146 . . . . 21.14 109.914 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 45.5 t -107.09 115.83 49.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.293 -0.879 . . . . 10.66 110.126 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' B' ' 39' ' ' ASN . 55.0 m-20 -64.6 -36.48 84.37 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.806 -1.183 . . . . 25.89 107.806 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.543 ' CD2' ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 46.34 48.37 13.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.556 -0.715 . . . . 24.24 109.876 179.333 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.65 -0.72 64.25 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.389 -1.485 . . . . 31.02 109.389 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' B' ' 36' ' ' ASP . 0.2 OUTLIER -106.14 95.93 6.12 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.378 -1.072 . . . . 43.23 108.278 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' B' ' 39' ' ' ASN . 2.4 mp0 -27.55 -41.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.452 0.644 . . . . 42.34 111.126 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' B' ' 39' ' ' ASN . 48.5 m80 -78.19 141.2 62.01 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.659 -0.867 . . . . 6.56 108.659 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.642 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.6 Cg_endo -76.3 136.7 18.13 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.909 1.739 . . . . 17.92 110.51 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 2.9 m -107.6 117.55 53.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.645 -0.872 . . . . 20.57 108.645 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.57 HD11 ' CE2' ' B' ' 34' ' ' TYR . 61.6 tp -65.75 97.79 0.35 Allowed 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.486 -0.885 . . . . 20.21 110.017 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.544 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 21.2 t -99.4 168.34 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.866 -0.79 . . . . 10.81 108.866 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.544 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 4.0 ptpp? -117.13 147.8 42.11 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.94 -1.104 . . . . 36.74 111.59 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.649 ' CG2' ' CE1' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -112.58 177.98 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.564 -0.902 . . . . 19.74 108.564 179.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.454 HG23 ' HB3' ' B' ' 28' ' ' LEU . 0.1 OUTLIER -126.16 74.97 1.48 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.118 -0.989 . . . . 22.56 109.519 179.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.62 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -42.85 150.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.428 -0.795 . . . . 20.41 109.129 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' B' ' 53' ' ' GLN . 26.6 t0 -123.13 148.21 45.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.101 -1.0 . . . . 33.99 109.446 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 48.18 -148.8 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 54.92 109.276 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.14 16.78 56.43 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.582 -1.407 . . . . 36.1 109.582 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -45.64 149.26 1.11 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.198 -1.178 . . . . 54.76 109.523 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.06 113.19 3.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.614 2.209 . . . . 28.37 109.938 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' B' ' 11' ' ' ALA . . . -39.4 153.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.483 -0.761 . . . . 17.21 110.22 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.649 ' CE1' ' CG2' ' B' ' 47' ' ' ILE . 84.8 m-85 -50.45 113.0 0.78 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.4 -0.813 . . . . 17.19 109.238 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -61.86 177.33 0.38 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 17.82 109.483 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.8 Cg_endo -77.6 113.77 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.532 2.155 . . . . 17.28 110.215 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.33 179.33 44.87 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.724 -1.35 . . . . 17.22 109.724 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.0 mp -74.06 155.87 38.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -1.173 . . . . 19.57 108.315 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.599 ' CE1' HD11 ' B' ' 6' ' ' ILE . 26.5 m-85 -143.56 163.26 33.67 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.551 1.167 . . . . 14.61 111.564 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.525 ' CG2' ' HG3' ' B' ' 1' ' ' MET . 43.3 p -145.67 122.99 11.6 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.283 -1.747 . . . . 18.36 106.283 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.588 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.8 t -54.28 168.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 C-N-CA 118.497 -1.281 . . . . 19.13 108.828 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -128.05 124.49 37.22 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.418 -0.801 . . . . 20.65 108.907 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.626 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -64.78 -6.9 9.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.82 -0.55 . . . . 19.65 109.903 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 13.6 p -53.86 -16.14 1.65 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.005 -1.06 . . . . 14.72 108.616 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.476 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 50.4 m -99.67 -5.32 29.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.475 -0.765 . . . . 11.45 111.002 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.626 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.8 m-30 -81.26 157.08 25.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.647 -1.283 . . . . 14.25 109.779 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.558 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 5.3 pttt -142.28 171.64 13.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.832 . . . . 32.7 109.66 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.469 HG21 HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -125.65 112.66 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.346 -0.846 . . . . 15.63 109.092 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.472 ' C ' ' NE2' ' B' ' 72' ' ' GLN . . . -72.02 -173.64 20.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.586 -1.406 . . . . 12.7 109.586 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.482 ' N ' ' NE2' ' B' ' 72' ' ' GLN . 0.8 OUTLIER -89.3 34.5 0.8 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.214 -1.168 . . . . 26.29 109.503 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.94 24.81 3.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -0.797 . . . . 20.44 109.439 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . 51.32 56.9 12.92 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.604 -1.399 . . . . 13.82 109.604 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -149.03 105.38 3.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -1.196 . . . . 18.27 109.709 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' A' ' 2' ' ' ILE . 5.1 tt -70.48 146.65 50.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.865 . . . . 12.43 109.257 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.506 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 4.1 mtm -157.42 144.72 18.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -0.954 . . . . 35.11 109.515 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.607 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.3 mp -70.06 142.12 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 13.67 109.571 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -107.69 -37.07 6.25 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.766 -1.198 . . . . 24.06 107.766 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.476 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER -168.09 67.6 0.08 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.424 -1.324 . . . . 35.04 107.424 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.588 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.6 OUTLIER -27.47 118.52 0.09 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.356 -0.838 . . . . 18.72 111.574 -178.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 20.0 tpt180 -91.99 104.85 17.21 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.056 -1.091 . . . . 20.55 108.056 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.582 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -72.88 150.64 42.45 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.013 0.911 . . . . 14.4 111.538 -178.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' B' ' 62' ' ' THR . 34.7 m -151.99 154.42 32.62 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 107.75 -1.204 . . . . 17.65 107.75 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.1 Cg_endo -62.89 145.93 94.73 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.176 1.917 . . . . 25.7 110.774 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.27 121.85 22.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.242 -0.911 . . . . 49.29 109.535 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 tptt . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.017 -0.992 . . . . 58.91 109.45 -179.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.53 ' CG ' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.532 -0.544 . . . . 64.91 109.532 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' A' ' 63' ' ' VAL . 3.3 mt -62.17 81.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.044 -1.095 . . . . 33.8 108.044 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 10.8 mttt -54.98 157.52 3.21 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.857 0.836 . . . . 32.72 111.508 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.556 ' HB ' ' CB ' ' A' ' 61' ' ' TYR . 80.8 t -161.14 166.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.719 0.771 . . . . 14.46 109.774 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 34.1 mt-10 -152.14 105.63 3.08 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.63 -0.878 . . . . 22.12 108.63 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.587 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -73.77 104.35 2.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 119.038 -1.065 . . . . 14.23 108.172 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.607 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.75 171.87 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 25.43 109.974 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.5 Cg_endo -75.83 -24.88 11.14 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.468 2.112 . . . . 13.61 110.211 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.0 t -93.02 0.77 57.44 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.437 -0.789 . . . . 15.52 108.887 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.518 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.6 mm-40 -116.51 43.2 2.26 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.342 -0.849 . . . . 17.31 108.932 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -108.39 10.02 27.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 24.78 110.304 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 1.4 tt0 -136.81 134.34 36.89 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.109 -0.994 . . . . 47.9 108.952 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.608 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 30.2 p90 -87.49 175.48 7.93 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.046 -1.033 . . . . 21.61 109.756 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.416 HG21 ' N ' ' A' ' 15' ' ' THR . 57.6 m -137.57 151.95 48.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.874 -0.787 . . . . 14.89 108.874 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.416 ' N ' HG21 ' A' ' 14' ' ' THR . 0.2 OUTLIER -87.15 117.19 25.72 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.229 -0.919 . . . . 17.35 109.439 -179.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 17' ' ' SER . 9.0 tpt180 -125.8 146.28 49.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 34.38 109.37 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.433 ' N ' ' HG3' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -62.27 95.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 38.77 109.503 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.568 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -91.02 175.71 40.11 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.498 -1.441 . . . . 34.58 109.498 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 20' ' ' SER . 1.5 t -144.73 121.96 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -1.158 . . . . 41.87 108.988 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 19' ' ' VAL . 3.4 p -51.37 -174.87 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.375 -0.828 . . . . 47.21 109.699 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' GLN . 0.2 OUTLIER -43.4 -33.58 1.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.93 . . . . 71.56 109.684 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.8 OUTLIER 163.39 46.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 66.6 109.581 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 24' ' ' LYS . . . -120.93 -59.12 0.23 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.454 -1.458 . . . . 55.49 109.454 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 22.5 mttp -149.94 163.39 24.81 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.297 -1.119 . . . . 44.99 109.475 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.6 Cg_endo -78.13 132.38 11.49 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.617 2.211 . . . . 44.1 110.083 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 10.4 p90 -122.84 138.95 54.5 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.119 -0.988 . . . . 32.09 109.622 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.45 74.71 5.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 29.25 108.972 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.573 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -85.05 169.03 14.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 24.0 109.985 -179.498 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.605 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -98.82 122.58 42.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 23.31 108.996 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' OE1' ' HD3' ' A' ' 46' ' ' LYS . 4.8 mt-10 -108.94 156.96 19.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.244 -0.91 . . . . 40.03 109.887 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.539 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -141.26 -172.85 3.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 12.39 109.419 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.486 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 4.7 mp -133.99 159.16 41.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 17.42 109.48 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' SG ' ' CD1' ' A' ' 6' ' ' ILE . 13.4 m -155.46 177.17 11.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.095 -1.003 . . . . 13.84 108.324 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.681 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 35.3 m-85 -126.65 110.98 13.77 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.093 -1.005 . . . . 21.14 108.935 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.535 ' CG2' HG21 ' A' ' 4' ' ' VAL . 50.9 t -89.59 151.66 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.016 -1.053 . . . . 10.66 110.378 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.2 m-20 -129.01 -145.49 0.3 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.713 -0.617 . . . . 25.89 109.348 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' HG ' ' CD2' ' B' ' 65' ' ' LEU . 0.3 OUTLIER 67.6 -65.33 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 24.24 109.094 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -83.39 6.13 74.07 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 109.028 -1.629 . . . . 31.02 109.028 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' A' ' 38' ' ' GLY . 4.4 m-80 -162.41 109.07 1.27 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.431 -1.041 . . . . 43.23 109.006 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' ASN . 26.0 mt-10 -39.22 -61.22 0.8 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.617 0.722 . . . . 42.34 109.632 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 22.8 m80 -71.47 164.55 56.73 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 108.174 -1.047 . . . . 9.47 108.174 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.681 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.7 Cg_endo -78.27 140.52 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.868 1.712 . . . . 17.92 110.6 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.529 ' CG2' HG23 ' B' ' 70' ' ' VAL . 33.0 m -111.94 113.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.375 -0.828 . . . . 20.57 109.17 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.614 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 32.4 tp -67.35 110.66 3.65 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.906 . . . . 20.21 109.505 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.581 ' CG2' ' N ' ' B' ' 75' ' ' SER . 9.9 p -122.4 153.35 26.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.492 -0.755 . . . . 10.81 109.175 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 2.6 tttt -73.3 148.48 43.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 36.74 110.055 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.604 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.8 OUTLIER -139.92 123.02 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.724 -0.843 . . . . 19.74 108.724 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.518 ' CG2' HD21 ' A' ' 28' ' ' LEU . 1.3 m -63.31 156.69 24.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.08 -1.013 . . . . 22.56 110.05 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.608 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -122.33 117.14 25.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.805 . . . . 20.41 108.902 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.531 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -47.13 140.25 5.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 33.99 109.812 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.85 109.49 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 54.92 109.478 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.97 -16.72 59.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.6 -1.4 . . . . 36.1 109.6 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.531 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -73.69 150.57 88.78 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.285 -1.127 . . . . 54.76 109.522 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.33 122.87 5.8 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.665 2.243 . . . . 28.37 110.184 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.52 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -40.1 147.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.396 -0.815 . . . . 17.21 110.483 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 89.1 m-85 -47.96 116.22 1.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.483 -0.761 . . . . 17.19 109.026 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.534 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -66.63 176.77 0.97 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 17.82 109.62 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -78.4 105.6 2.0 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.686 2.257 . . . . 17.28 110.261 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.49 176.69 48.16 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.99 -1.244 . . . . 17.22 109.99 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -73.5 143.59 46.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -1.111 . . . . 19.57 108.426 179.293 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.587 ' CE1' HD11 ' A' ' 6' ' ' ILE . 33.3 m-85 -130.29 162.73 28.33 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.773 -1.204 . . . . 14.61 111.25 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.53 ' HB ' ' CG ' ' A' ' 1' ' ' MET . 33.4 p -142.9 119.78 11.27 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.896 -1.89 . . . . 18.36 105.896 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.7 t -53.05 166.94 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 C-N-CA 118.59 -1.244 . . . . 19.13 109.467 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -129.36 130.46 46.08 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.545 -0.722 . . . . 20.65 109.134 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.644 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -72.58 1.58 7.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.43 -0.794 . . . . 19.65 110.116 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -55.42 -19.25 8.69 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.496 -1.298 . . . . 14.72 107.496 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 7.1 m -99.07 -3.93 33.56 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.932 -0.48 . . . . 11.45 110.33 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.644 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.4 m-30 -85.41 157.47 20.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.863 -1.148 . . . . 14.25 110.215 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.458 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.5 ptpt -154.41 174.33 15.01 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.023 -0.732 . . . . 32.7 109.023 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' B' ' 43' ' ' VAL . 1.0 OUTLIER -114.58 111.76 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 15.63 109.556 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.34 -170.25 46.59 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.315 -1.514 . . . . 12.7 109.315 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -90.5 20.79 4.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.154 -1.204 . . . . 26.29 109.481 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.82 -12.74 35.44 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.501 -0.75 . . . . 20.44 109.237 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' B' ' 46' ' ' LYS . . . 85.01 35.05 13.12 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.509 -1.436 . . . . 13.82 109.509 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.547 ' N ' ' CG2' ' B' ' 45' ' ' VAL . 22.8 p -164.33 150.82 11.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -1.199 . . . . 18.27 109.647 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 69' ' ' LYS . 16.3 tp -63.69 156.74 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.853 . . . . 12.43 109.126 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 32.0 mtt -154.95 113.43 3.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.092 -1.005 . . . . 35.11 109.749 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.601 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.9 mt -55.67 139.91 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.314 -0.866 . . . . 13.67 109.472 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -106.19 -27.39 11.09 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.443 -0.947 . . . . 24.06 108.443 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 67' ' ' SER . 5.7 tpm_? 179.74 67.75 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.992 -1.485 . . . . 35.04 106.992 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.568 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -29.39 118.09 0.13 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.387 -0.824 . . . . 18.72 111.913 -177.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -92.09 108.14 19.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.716 -1.216 . . . . 20.55 107.716 178.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.61 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 12.7 tp -80.25 150.42 30.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.229 -0.919 . . . . 14.4 111.093 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.531 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 25.0 m -147.44 152.47 42.23 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 108.039 -1.097 . . . . 17.65 108.039 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -62.37 141.58 87.72 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.103 1.868 . . . . 25.7 110.662 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -73.59 116.44 14.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.437 -0.789 . . . . 49.29 109.625 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.007 -0.996 . . . . 58.91 109.482 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.528 ' CG ' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.518 -0.549 . . . . 64.91 109.518 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.537 ' CG2' HG22 ' B' ' 63' ' ' VAL . 3.2 mt -62.19 81.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.993 -1.114 . . . . 33.8 107.993 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 10.8 mttt -54.83 157.37 3.16 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.877 0.846 . . . . 32.72 111.487 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.562 ' HB ' ' CB ' ' B' ' 61' ' ' TYR . 83.1 t -161.09 166.03 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.751 0.786 . . . . 14.46 109.739 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 34.4 mt-10 -151.97 105.69 3.12 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.629 -0.878 . . . . 22.12 108.629 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.589 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.3 OUTLIER -73.77 104.55 2.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.01 -1.076 . . . . 14.23 108.178 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.612 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.83 171.9 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.442 -0.786 . . . . 25.43 109.99 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.5 Cg_endo -75.8 -25.04 11.05 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.487 2.125 . . . . 13.61 110.238 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t -92.8 0.65 57.45 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 108.938 -0.764 . . . . 15.52 108.938 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.6 mm-40 -116.43 43.25 2.24 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.345 -0.847 . . . . 17.31 108.928 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -108.4 10.09 27.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.91 . . . . 24.78 110.312 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.451 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 1.4 tt0 -136.86 134.22 36.65 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.114 -0.991 . . . . 47.9 108.943 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.609 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 30.2 p90 -87.44 175.47 7.95 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.028 -1.045 . . . . 21.61 109.74 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.411 HG21 ' N ' ' B' ' 15' ' ' THR . 59.3 m -137.48 152.04 49.11 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.845 -0.798 . . . . 14.89 108.845 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.411 ' N ' HG21 ' B' ' 14' ' ' THR . 0.2 OUTLIER -87.29 117.17 25.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.256 -0.903 . . . . 17.35 109.401 -179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' B' ' 17' ' ' SER . 9.0 tpt180 -125.77 146.36 49.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 34.38 109.366 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.431 ' N ' ' HG3' ' B' ' 16' ' ' ARG . 0.5 OUTLIER -62.38 95.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 38.77 109.447 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.58 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -90.98 175.77 40.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.473 -1.451 . . . . 34.58 109.473 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.465 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.5 t -144.79 121.99 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.196 . . . . 41.87 109.024 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.461 ' O ' ' O ' ' B' ' 19' ' ' VAL . 3.5 p -51.41 -174.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.315 -0.866 . . . . 47.21 109.674 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 22' ' ' GLN . 0.2 OUTLIER -43.37 -33.62 1.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 71.56 109.642 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' B' ' 21' ' ' ARG . 0.8 OUTLIER 163.31 46.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 66.6 109.589 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' B' ' 24' ' ' LYS . . . -120.97 -59.05 0.23 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.514 -1.434 . . . . 55.49 109.514 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.453 ' HB3' ' HD2' ' B' ' 25' ' ' PRO . 22.4 mttp -149.97 163.36 24.91 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.296 -1.12 . . . . 44.99 109.441 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' B' ' 24' ' ' LYS . 35.0 Cg_endo -78.1 132.26 11.44 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.65 2.233 . . . . 44.1 110.039 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.6 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 10.6 p90 -122.74 139.06 54.39 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.137 -0.977 . . . . 32.09 109.662 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.57 74.93 5.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 29.25 108.954 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.576 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -85.2 168.94 14.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 24.0 109.969 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.601 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -98.75 122.53 42.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.479 -0.763 . . . . 23.31 109.035 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 4.9 mt-10 -109.0 156.79 19.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.189 -0.944 . . . . 40.03 109.911 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.542 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -141.13 -172.83 3.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 12.39 109.423 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 4.7 mp -133.99 159.13 41.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.154 -0.966 . . . . 17.42 109.412 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.514 ' SG ' ' CD1' ' B' ' 6' ' ' ILE . 13.1 m -155.41 177.21 11.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.309 -0.997 . . . . 13.84 108.309 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.679 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 34.6 m-85 -126.72 111.04 13.8 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.157 -0.964 . . . . 21.14 108.92 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' B' ' 4' ' ' VAL . 50.9 t -89.69 151.65 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.012 -1.055 . . . . 10.66 110.397 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.1 m-20 -128.92 -145.6 0.3 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.307 -0.627 . . . . 25.89 109.307 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.534 ' HG ' ' CD2' ' A' ' 65' ' ' LEU . 0.3 OUTLIER 67.65 -65.4 0.24 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.134 -0.979 . . . . 24.24 109.057 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -83.27 6.11 73.73 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.041 -1.623 . . . . 31.02 109.041 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' B' ' 38' ' ' GLY . 4.5 m-80 -162.39 109.02 1.27 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.438 -1.036 . . . . 43.23 108.986 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' B' ' 39' ' ' ASN . 26.1 mt-10 -39.08 -61.39 0.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.701 0.762 . . . . 42.34 109.573 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.459 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 22.6 m80 -71.24 164.57 56.04 Favored Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 108.256 -1.016 . . . . 9.49 108.256 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.679 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.6 Cg_endo -78.32 140.7 17.57 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.855 1.703 . . . . 17.92 110.507 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.522 ' CG2' HG23 ' A' ' 70' ' ' VAL . 32.9 m -112.13 113.33 43.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.394 -0.816 . . . . 20.57 109.197 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.626 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 32.3 tp -67.46 110.72 3.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.313 -0.867 . . . . 20.21 109.616 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 75' ' ' SER . 9.9 p -122.28 153.81 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.494 -0.754 . . . . 10.81 109.108 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 2.6 tttt -73.73 148.55 42.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 36.74 110.027 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.593 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -139.75 123.04 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.739 -0.837 . . . . 19.74 108.739 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.519 ' CG2' HD21 ' B' ' 28' ' ' LEU . 1.3 m -63.39 156.66 25.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.015 -1.053 . . . . 22.56 109.982 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.609 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -122.26 116.98 25.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.422 -0.799 . . . . 20.41 108.94 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -47.0 140.33 4.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 33.99 109.832 -179.486 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.92 109.45 0.83 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 54.92 109.478 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.99 -16.75 59.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.581 -1.408 . . . . 36.1 109.581 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.538 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.8 OUTLIER -73.7 150.47 88.71 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -1.148 . . . . 54.76 109.568 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.7 Cg_endo -78.22 122.82 5.84 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.656 2.237 . . . . 28.37 110.225 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.524 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -40.11 147.15 0.1 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 17.21 110.404 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.598 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 88.9 m-85 -48.13 115.59 1.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.462 -0.773 . . . . 17.19 109.171 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.526 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -65.64 176.88 0.79 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 17.82 109.583 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 36.1 Cg_endo -78.68 106.72 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.741 2.294 . . . . 17.28 110.424 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.82 176.9 48.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.876 -1.29 . . . . 17.22 109.876 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.3 OUTLIER -73.37 144.14 46.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.385 -1.068 . . . . 19.57 108.632 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.589 ' CE1' HD11 ' B' ' 6' ' ' ILE . 33.7 m-85 -130.78 162.82 28.68 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.756 -1.215 . . . . 14.61 111.375 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.528 ' HB ' ' CG ' ' B' ' 1' ' ' MET . 33.2 p -143.09 119.68 11.07 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 105.975 -1.861 . . . . 18.36 105.975 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.577 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.7 t -53.12 166.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 118.575 -1.25 . . . . 19.13 109.438 -177.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -129.2 130.32 46.17 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.552 -0.718 . . . . 20.65 109.196 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.636 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -72.47 1.69 7.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.421 -0.799 . . . . 19.65 110.092 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -55.49 -19.24 9.02 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.45 -1.315 . . . . 14.72 107.45 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 7.0 m -99.08 -3.98 33.42 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.902 -0.499 . . . . 11.45 110.351 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.3 m-30 -85.35 157.62 20.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.913 -1.117 . . . . 14.25 110.182 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.46 ' O ' HD13 ' B' ' 76' ' ' LEU . 1.5 ptpt -154.57 174.17 15.32 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.991 -0.744 . . . . 32.7 108.991 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.529 HG23 ' CG2' ' A' ' 43' ' ' VAL . 1.0 OUTLIER -114.44 111.77 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 15.63 109.55 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.2 -170.24 46.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.332 -1.507 . . . . 12.7 109.332 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.65 21.17 4.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.138 -1.213 . . . . 26.29 109.458 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.16 -12.82 34.31 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.448 -0.782 . . . . 20.44 109.253 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.449 ' C ' ' CG2' ' A' ' 45' ' ' VAL . . . 85.15 34.72 13.82 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.546 -1.422 . . . . 13.82 109.546 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.581 ' N ' ' CG2' ' A' ' 45' ' ' VAL . 21.9 p -163.93 150.87 11.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -1.183 . . . . 18.27 109.683 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 2' ' ' ILE . 16.3 tp -63.72 157.0 25.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 12.43 109.09 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 31.9 mtt -155.15 113.5 3.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.013 . . . . 35.11 109.679 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.9 mt -55.74 139.95 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 13.67 109.476 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -106.19 -27.3 11.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.417 -0.957 . . . . 24.06 108.417 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.505 ' O ' ' CB ' ' B' ' 67' ' ' SER . 5.8 tpm_? 179.65 67.78 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.956 -1.498 . . . . 35.04 106.956 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.577 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -29.34 118.13 0.13 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.349 -0.841 . . . . 18.72 111.85 -177.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -92.2 108.07 19.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.709 -1.219 . . . . 20.55 107.709 178.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.598 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 12.6 tp -80.13 150.26 30.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.184 -0.947 . . . . 14.4 111.07 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.548 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 25.0 m -147.32 152.58 42.9 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.111 -1.07 . . . . 17.65 108.111 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.3 Cg_endo -62.32 141.72 88.51 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.166 1.91 . . . . 25.7 110.666 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' B' ' 60' ' ' LEU . . . -73.69 116.54 14.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 49.29 109.497 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.959 -1.02 . . . . 58.91 109.425 179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.523 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.308 0.575 . . . . 64.91 109.484 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.516 ' N ' HD21 ' B' ' 65' ' ' LEU . 2.7 mt 69.3 72.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.975 -1.12 . . . . 33.8 107.975 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.49 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 18.8 mttt -54.1 158.74 2.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.017 0.913 . . . . 32.72 111.461 -178.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.579 ' HB ' ' CB ' ' A' ' 61' ' ' TYR . 66.4 t -160.46 168.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.93 -0.766 . . . . 14.46 108.93 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.508 ' N ' HG13 ' A' ' 4' ' ' VAL . 43.1 mt-10 -154.6 103.26 2.45 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.79 0.805 . . . . 22.12 108.843 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.578 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -69.34 108.43 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.893 -1.151 . . . . 14.23 107.893 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.654 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.11 172.79 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.203 -0.936 . . . . 25.43 109.406 -179.042 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.5 Cg_endo -76.23 -21.6 13.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.475 2.117 . . . . 13.61 110.128 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.42 4.15 46.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.529 -0.732 . . . . 15.52 109.443 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.525 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 24.0 mm-40 -114.84 38.71 3.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 17.31 109.288 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.13 52.24 0.72 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.877 . . . . 24.78 109.738 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 5.0 pt20 -176.63 135.63 0.24 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.364 -0.835 . . . . 47.9 108.896 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.614 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 37.7 p90 -95.61 172.67 7.91 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.721 -1.237 . . . . 21.61 109.874 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 8.0 t -137.03 162.03 34.43 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.497 -0.927 . . . . 14.89 108.497 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 112.75 24.78 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.178 -0.951 . . . . 17.35 109.271 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.449 ' NH1' ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -126.15 139.39 53.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.346 -0.846 . . . . 34.38 109.424 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -44.68 152.57 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 38.77 109.456 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.59 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -158.91 167.26 34.75 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.411 -1.476 . . . . 34.58 109.411 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 1.8 t -135.55 118.81 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.204 -1.174 . . . . 41.87 109.152 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 21' ' ' ARG . 2.9 p -55.49 94.09 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.459 -0.776 . . . . 47.21 109.808 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 20' ' ' SER . 29.0 mtm180 41.95 50.19 4.16 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -0.817 . . . . 71.56 109.842 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 56.98 70.02 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 66.6 109.757 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -151.79 -57.87 0.01 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.016 -1.634 . . . . 55.49 109.016 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 5.5 mmtt -138.58 148.66 59.71 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.474 -1.015 . . . . 44.99 108.626 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.66 113.42 3.65 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.35 2.034 . . . . 44.1 110.368 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.59 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 4.6 p90 -119.89 168.83 10.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.282 -0.886 . . . . 32.09 110.007 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.01 83.65 2.17 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.85 -1.167 . . . . 29.25 107.85 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.553 ' CD2' ' CE1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -92.28 143.55 26.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 24.0 110.903 -178.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.611 ' CB ' ' CD1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -72.47 127.67 33.26 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.931 -0.766 . . . . 23.31 108.931 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 6.6 mt-10 -118.11 165.51 13.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.018 -1.051 . . . . 40.03 109.281 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.581 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -146.37 179.99 7.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.106 -0.996 . . . . 12.39 109.671 -179.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.491 ' O ' ' OE1' ' A' ' 31' ' ' GLN . 39.3 mt -123.92 154.04 40.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 17.42 109.316 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 11.1 m -154.06 172.98 16.65 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.611 -1.255 . . . . 13.84 107.611 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.684 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 29.2 m-85 -121.45 99.03 6.24 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.951 -1.093 . . . . 21.14 109.45 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.549 ' CG2' ' CG2' ' A' ' 4' ' ' VAL . 61.7 t -93.73 126.16 46.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.041 -1.037 . . . . 10.66 110.602 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' GLY . 25.3 t0 -101.19 44.66 1.0 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.591 -1.263 . . . . 25.89 107.591 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -35.77 -29.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.223 0.535 . . . . 24.24 110.197 -178.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 160.84 52.3 0.02 OUTLIER Glycine 0 N--CA 1.479 1.535 0 N-CA-C 109.438 -1.465 . . . . 31.02 109.438 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' ND2' HD12 ' A' ' 37' ' ' LEU . 37.3 m-20 -126.83 17.98 7.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.07 -1.253 . . . . 43.23 110.035 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.591 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 2.6 mm-40 56.56 14.64 1.77 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.326 -0.859 . . . . 42.34 110.252 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 77.5 m-70 -162.53 161.72 19.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.326 -0.99 . . . . 6.32 108.326 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.684 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.0 Cg_endo -78.06 136.57 14.78 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.892 1.728 . . . . 17.92 110.021 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 3.6 m -111.34 115.24 49.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.249 -0.907 . . . . 20.57 109.453 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 18.9 tp -71.76 88.73 1.01 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.182 -0.949 . . . . 20.21 109.482 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' B' ' 75' ' ' SER . 6.1 p -103.21 152.88 5.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.632 -0.877 . . . . 10.81 108.632 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 3.7 mtpt -72.08 167.03 21.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 36.74 110.493 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.608 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.2 OUTLIER -146.47 177.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.567 -0.901 . . . . 19.74 108.567 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.461 HG22 HD12 ' A' ' 28' ' ' LEU . 97.8 m -117.6 151.29 37.47 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.186 -0.946 . . . . 22.56 109.464 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -124.74 149.19 47.56 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.291 -1.003 . . . . 20.41 108.291 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -106.18 143.5 34.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.078 -1.014 . . . . 33.99 110.202 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.21 127.04 14.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 54.92 109.477 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.7 -28.67 7.47 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.652 -1.379 . . . . 36.1 109.652 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.97 137.35 72.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.198 -1.178 . . . . 54.76 109.564 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.5 Cg_endo -78.58 124.2 6.26 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.413 2.075 . . . . 28.37 109.959 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' A' ' 12' ' ' GLN . . . -40.24 147.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.4 -0.812 . . . . 17.21 110.0 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 84.9 m-85 -45.9 105.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 17.19 109.137 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.508 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -58.1 174.79 0.32 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 17.82 109.628 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.78 114.15 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.605 2.203 . . . . 17.28 110.149 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.25 179.76 46.0 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.474 -1.45 . . . . 17.22 109.474 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.6 mp -75.4 146.31 40.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -1.217 . . . . 19.57 108.111 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.579 ' CB ' ' HB ' ' A' ' 4' ' ' VAL . 20.4 m-85 -133.07 167.43 20.32 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.866 -1.146 . . . . 14.61 111.591 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.523 ' CG2' ' HG3' ' A' ' 1' ' ' MET . 44.8 p -150.59 119.5 6.65 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.336 -1.727 . . . . 18.36 106.336 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.595 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -52.01 164.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.374 -1.33 . . . . 19.13 108.568 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -123.47 123.89 41.65 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.397 -0.814 . . . . 20.65 109.003 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.651 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -67.94 -4.02 11.73 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.834 -0.542 . . . . 19.65 110.209 -179.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.3 t -55.98 -15.86 4.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.076 -1.015 . . . . 14.72 108.449 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 80' ' ' ARG . 16.6 m -95.76 -7.0 38.39 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.525 -0.734 . . . . 11.45 110.633 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.651 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -83.15 159.64 22.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.818 -1.176 . . . . 14.25 109.674 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' CG ' ' O ' ' A' ' 68' ' ' PHE . 10.3 mtmt -157.82 172.14 19.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.49 -0.756 . . . . 32.7 109.253 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.78 98.29 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 15.63 109.008 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.8 -149.92 4.11 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.825 -1.31 . . . . 12.7 109.825 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.3 21.04 17.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.27 -1.135 . . . . 26.29 109.685 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.09 -11.98 42.46 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.05 -0.722 . . . . 20.44 109.05 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 84.69 24.23 46.9 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.495 -1.442 . . . . 13.82 109.495 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.456 ' HA ' HG23 ' B' ' 45' ' ' VAL . 4.7 p -161.03 152.25 18.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -1.179 . . . . 18.27 109.633 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.442 ' C ' ' CD2' ' A' ' 76' ' ' LEU . 4.7 tt -62.95 149.23 45.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.319 -0.863 . . . . 12.43 109.381 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.3 mtt -150.55 133.98 16.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 35.11 109.412 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.616 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.2 mt -66.29 139.24 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.877 . . . . 13.67 109.721 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 8.3 t70 -106.64 -19.58 13.62 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.507 -0.923 . . . . 24.06 108.507 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.491 ' NH1' ' HG2' ' A' ' 80' ' ' ARG . 0.0 OUTLIER 172.71 68.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.198 -1.408 . . . . 35.04 107.198 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.595 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -31.63 116.88 0.19 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.693 0.758 . . . . 18.72 111.179 -178.14 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.01 104.97 17.49 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.463 -0.94 . . . . 20.55 108.463 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.615 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -73.38 144.82 46.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 14.4 111.024 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 62' ' ' THR . 27.6 m -146.72 156.61 48.32 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.956 -1.128 . . . . 17.65 107.956 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.0 Cg_endo -63.03 144.97 93.89 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.134 1.889 . . . . 25.7 110.334 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' O ' ' CB ' ' A' ' 87' ' ' LYS . . . -73.11 115.73 12.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.135 -0.978 . . . . 49.29 109.705 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.02 -0.99 . . . . 58.91 109.531 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.53 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.399 -0.593 . . . . 64.91 109.399 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.522 ' N ' HD21 ' A' ' 65' ' ' LEU . 2.7 mt 68.6 72.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.874 -1.158 . . . . 33.8 107.874 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.494 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 18.9 mttt -54.4 158.62 2.32 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.009 0.909 . . . . 32.72 111.412 -178.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.57 ' HB ' ' CB ' ' B' ' 61' ' ' TYR . 68.2 t -160.25 168.0 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.994 -0.743 . . . . 14.46 108.994 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 42.3 mt-10 -154.02 103.09 2.54 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.418 -0.801 . . . . 22.12 108.975 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.578 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -69.18 108.53 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.934 -1.135 . . . . 14.23 107.934 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.661 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.25 172.5 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 25.43 109.36 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 35.1 Cg_endo -76.16 -21.39 13.81 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.488 2.125 . . . . 13.61 110.122 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.63 4.15 45.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.475 -0.765 . . . . 15.52 109.442 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.529 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 24.1 mm-40 -114.69 38.36 3.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.93 . . . . 17.31 109.187 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.14 53.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 24.78 109.709 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.524 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 4.8 pt20 -177.24 135.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.376 -0.828 . . . . 47.9 108.884 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.624 ' CD1' ' CB ' ' B' ' 29' ' ' ASN . 37.9 p90 -95.77 172.75 7.84 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.753 -1.217 . . . . 21.61 109.891 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 8.3 t -137.28 161.91 34.94 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.488 -0.93 . . . . 14.89 108.488 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.93 112.78 24.85 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.17 -0.956 . . . . 17.35 109.438 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.438 ' CG ' ' NH1' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -126.21 139.27 53.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.299 -0.876 . . . . 34.38 109.378 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.6 OUTLIER -44.52 152.74 0.19 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.911 . . . . 38.77 109.403 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -159.2 167.22 34.91 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.424 -1.471 . . . . 34.58 109.424 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' B' ' 24' ' ' LYS . 1.8 t -135.47 119.06 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.116 -1.226 . . . . 41.87 109.149 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.43 ' O ' ' C ' ' B' ' 21' ' ' ARG . 3.0 p -55.69 94.22 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.341 -0.85 . . . . 47.21 109.768 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' B' ' 20' ' ' SER . 28.4 mtm180 41.65 50.54 3.87 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.425 -0.797 . . . . 71.56 109.832 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 56.73 70.18 0.67 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 66.6 109.81 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.1 -57.72 0.01 OUTLIER Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.048 -1.621 . . . . 55.49 109.048 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' B' ' 19' ' ' VAL . 5.5 mmtt -138.56 148.38 58.64 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.388 -1.066 . . . . 44.99 108.714 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.45 113.47 3.68 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.371 2.047 . . . . 44.1 110.403 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.578 ' CE1' ' HA3' ' B' ' 18' ' ' GLY . 4.3 p90 -120.16 168.49 11.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.23 -0.919 . . . . 32.09 110.081 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.68 83.82 2.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.938 -1.134 . . . . 29.25 107.938 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.558 ' CD2' ' CE1' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -92.4 143.42 26.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 24.0 110.846 -178.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.624 ' CB ' ' CD1' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -72.38 127.47 32.67 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.894 -0.78 . . . . 23.31 108.894 179.03 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 6.5 mt-10 -118.06 165.24 13.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.012 -1.055 . . . . 40.03 109.322 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.578 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.9 OUTLIER -146.03 -179.9 7.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.137 -0.977 . . . . 12.39 109.765 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.479 ' O ' ' OE1' ' B' ' 31' ' ' GLN . 40.3 mt -124.2 153.71 41.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 17.42 109.309 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 10.3 m -153.73 172.98 16.44 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.716 -1.216 . . . . 13.84 107.716 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.687 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 29.3 m-85 -121.39 98.91 6.19 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.895 -1.128 . . . . 21.14 109.461 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.563 ' CG2' ' CG2' ' B' ' 4' ' ' VAL . 61.7 t -93.6 126.17 46.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.03 -1.044 . . . . 10.66 110.573 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' B' ' 38' ' ' GLY . 26.1 t0 -101.11 44.37 1.02 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.579 -1.267 . . . . 25.89 107.579 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.526 ' N ' HD13 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -35.65 -30.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.1 0.476 . . . . 24.24 110.185 -178.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 161.05 51.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 109.415 -1.474 . . . . 31.02 109.415 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.451 ' ND2' HD12 ' B' ' 37' ' ' LEU . 37.7 m-20 -126.54 18.28 7.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.167 -1.196 . . . . 43.23 110.092 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.59 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 2.6 mm-40 56.36 14.58 1.65 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.237 -0.914 . . . . 42.34 110.302 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 77.4 m-70 -162.41 161.6 20.14 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.344 -0.984 . . . . 6.31 108.344 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.687 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.8 Cg_endo -78.02 136.55 14.83 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.877 1.718 . . . . 17.92 109.998 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 3.6 m -111.39 115.42 49.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.242 -0.911 . . . . 20.57 109.339 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.604 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 19.0 tp -71.99 88.8 1.08 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.219 -0.926 . . . . 20.21 109.503 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 75' ' ' SER . 6.3 p -103.0 153.38 5.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.648 -0.871 . . . . 10.81 108.648 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 3.8 mtpt -72.32 167.44 20.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 36.74 110.428 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.593 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -146.94 177.12 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.628 -0.878 . . . . 19.74 108.628 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.481 HG21 ' N ' ' B' ' 49' ' ' LEU . 98.5 m -117.39 151.28 37.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.123 -0.986 . . . . 22.56 109.468 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.619 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -124.88 148.86 48.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.226 -1.028 . . . . 20.41 108.226 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -105.95 143.61 33.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 33.99 110.076 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.22 126.84 13.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.771 . . . . 54.92 109.528 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.81 -28.49 7.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.712 -1.355 . . . . 36.1 109.712 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.08 137.45 72.53 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.277 -1.131 . . . . 54.76 109.483 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.57 124.14 6.24 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.394 2.063 . . . . 28.37 109.96 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' B' ' 12' ' ' GLN . . . -40.29 147.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 17.21 109.913 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.616 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 84.1 m-85 -46.2 105.85 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 17.19 109.252 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.496 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -57.85 174.65 0.31 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 17.82 109.59 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -77.99 115.18 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.624 2.216 . . . . 17.28 110.43 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.49 -179.46 44.87 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.31 -1.516 . . . . 17.22 109.31 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 4.0 mp -75.29 146.86 40.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.134 -1.216 . . . . 19.57 108.457 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.578 ' CE1' HD11 ' B' ' 6' ' ' ILE . 19.9 m-85 -133.54 167.69 20.01 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.498 1.142 . . . . 14.61 111.452 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.53 ' CG2' ' HG3' ' B' ' 1' ' ' MET . 45.8 p -150.87 119.45 6.49 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.296 -1.742 . . . . 18.36 106.296 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.592 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -52.0 163.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.404 -1.318 . . . . 19.13 108.597 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.514 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -123.16 124.35 42.86 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.406 -0.809 . . . . 20.65 109.022 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.653 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -68.24 -3.95 12.47 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.879 -0.513 . . . . 19.65 110.169 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 10.4 t -55.93 -16.08 4.27 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.132 -0.98 . . . . 14.72 108.376 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' B' ' 80' ' ' ARG . 16.6 m -95.66 -6.7 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.609 -0.682 . . . . 11.45 110.707 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.653 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.9 m-30 -83.33 159.78 21.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.852 -1.155 . . . . 14.25 109.657 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.461 ' CG ' ' O ' ' B' ' 68' ' ' PHE . 10.3 mtmt -158.09 171.29 20.5 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.475 -0.766 . . . . 32.7 109.269 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -106.99 98.59 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 15.63 108.959 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.44 -150.47 4.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.707 -1.357 . . . . 12.7 109.707 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.78 21.64 16.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.238 -1.154 . . . . 26.29 109.859 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.66 -11.82 41.38 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.02 -0.733 . . . . 20.44 109.02 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 84.44 24.99 44.82 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.532 -1.427 . . . . 13.82 109.532 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.453 ' HA ' HG23 ' A' ' 45' ' ' VAL . 4.7 p -161.68 152.18 17.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -1.17 . . . . 18.27 109.639 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.438 ' C ' ' CD2' ' B' ' 76' ' ' LEU . 4.6 tt -63.14 149.24 45.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 12.43 109.412 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 14.4 mtt -150.44 133.69 16.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 35.11 109.502 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.619 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.2 mt -66.18 138.86 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 13.67 109.686 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 8.2 t70 -106.23 -19.87 13.57 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.558 -0.905 . . . . 24.06 108.558 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.505 ' NH1' ' HG2' ' B' ' 80' ' ' ARG . 0.0 OUTLIER 173.0 68.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.208 -1.404 . . . . 35.04 107.208 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.592 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -32.03 117.04 0.21 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.672 0.748 . . . . 18.72 111.214 -178.117 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.15 105.0 17.51 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.473 -0.936 . . . . 20.55 108.473 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.616 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -73.34 145.05 46.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 14.4 110.96 -178.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' B' ' 62' ' ' THR . 28.0 m -147.04 156.41 47.11 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 107.938 -1.134 . . . . 17.65 107.938 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.8 Cg_endo -62.87 144.77 94.02 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.185 1.923 . . . . 25.7 110.338 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' B' ' 62' ' ' THR . . . -72.93 115.91 12.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.194 -0.941 . . . . 49.29 109.681 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' B' ' 86' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.973 -1.013 . . . . 58.91 109.528 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.53 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.545 -0.539 . . . . 64.91 109.545 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.536 ' CD1' ' HB ' ' A' ' 63' ' ' VAL . 1.8 mt -58.42 85.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.887 -1.153 . . . . 33.8 107.887 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 20.7 mttt -63.61 157.97 22.49 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.815 0.817 . . . . 32.72 111.595 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 61' ' ' TYR . 58.8 t -160.01 167.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-O 121.609 0.719 . . . . 14.46 109.691 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 77.3 mt-10 -154.95 107.14 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.705 -0.85 . . . . 22.12 108.705 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.595 HD12 ' CE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -74.54 107.96 5.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 118.991 -1.083 . . . . 14.23 108.3 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.675 ' CD ' ' CD1' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.44 171.85 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.449 -0.782 . . . . 25.43 110.011 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.3 Cg_endo -76.7 -25.61 9.12 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.59 2.193 . . . . 13.61 109.753 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.73 8.39 44.39 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.921 -0.77 . . . . 15.52 108.921 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.528 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 10.2 mm-40 -121.38 32.83 5.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.277 -0.889 . . . . 17.31 109.474 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.91 11.47 37.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.141 -0.974 . . . . 24.78 110.324 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -138.77 138.01 37.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.032 -1.042 . . . . 47.9 110.104 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.613 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 11.6 p90 -88.37 173.29 8.82 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.397 -0.814 . . . . 21.61 109.769 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 10.0 t -130.91 163.97 26.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.535 -0.913 . . . . 14.89 108.535 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 112.7 24.16 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.147 -0.97 . . . . 17.35 109.575 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -114.93 137.66 51.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 34.38 109.182 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 16' ' ' ARG . 3.4 m -43.98 123.73 3.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 38.77 109.411 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.565 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -133.57 144.27 16.17 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.458 -1.457 . . . . 34.58 109.458 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.541 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 1.6 t -138.88 121.73 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -1.162 . . . . 41.87 109.219 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.469 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -66.69 165.31 15.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 47.21 109.693 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -16.2 8.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 71.56 109.75 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -82.62 8.23 12.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -0.98 . . . . 66.6 109.709 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.4 3.14 85.73 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.035 -1.226 . . . . 55.49 110.035 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -89.59 140.87 28.27 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.068 -1.254 . . . . 44.99 109.252 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 36.4 Cg_endo -78.26 131.92 11.05 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.54 2.16 . . . . 44.1 110.232 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.588 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 4.9 p90 -128.02 20.97 6.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.76 -1.213 . . . . 32.09 110.92 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.572 ' C ' ' O ' ' A' ' 26' ' ' TYR . 3.4 m 12.6 61.76 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.53 0.681 . . . . 29.25 110.879 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.588 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -62.18 168.6 3.26 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.937 0.875 . . . . 24.0 110.877 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.613 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -105.49 128.64 53.67 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.57 -0.9 . . . . 23.31 108.57 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -111.38 151.14 28.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.988 -1.07 . . . . 40.03 109.972 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.541 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -133.71 175.86 9.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.895 . . . . 12.39 109.523 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.456 ' C ' ' SG ' ' A' ' 33' ' ' CYS . 3.5 mp -127.31 155.52 43.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 17.42 109.131 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 1.9 m -153.73 -176.81 6.0 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.316 -0.994 . . . . 13.84 108.316 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.675 ' CD1' ' CD ' ' A' ' 7' ' ' LYS . 35.2 m-85 -130.75 102.92 6.3 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.117 -0.989 . . . . 21.14 109.561 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.533 ' O ' ' CG2' ' A' ' 43' ' ' VAL . 78.7 t -90.8 125.94 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.07 -1.019 . . . . 10.66 110.324 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 39' ' ' ASN . 3.7 m-20 -68.51 -41.93 79.3 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.589 -0.893 . . . . 25.89 108.589 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.527 HD12 ' CA ' ' B' ' 69' ' ' LYS . 0.6 OUTLIER 47.51 48.24 16.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.798 . . . . 24.24 109.77 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.06 4.94 51.3 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.321 -1.511 . . . . 31.02 109.321 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.5 OUTLIER -104.58 95.76 6.13 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.356 -1.085 . . . . 43.23 108.47 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 39' ' ' ASN . 9.3 mt-10 -30.6 -37.31 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.41 0.624 . . . . 42.34 110.81 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -85.24 146.37 44.89 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 108.644 -0.873 . . . . 6.32 108.644 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.672 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.9 Cg_endo -76.37 137.11 18.42 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.967 1.778 . . . . 17.92 110.599 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 5.8 m -108.68 113.93 45.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.366 -0.833 . . . . 20.57 109.162 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.581 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 28.0 tp -65.63 110.28 2.7 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.368 -0.832 . . . . 20.21 109.386 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.6 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 6.6 t -115.52 165.46 10.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.518 -0.739 . . . . 10.81 109.351 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.555 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 9.8 mtpt -96.42 125.44 40.91 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.488 -0.885 . . . . 36.74 109.457 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.637 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.8 OUTLIER -117.4 136.26 55.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.31 -0.869 . . . . 19.74 109.332 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.482 ' OG1' ' CZ ' ' A' ' 80' ' ' ARG . 12.5 m -68.05 163.7 21.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.113 -0.992 . . . . 22.56 109.303 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.603 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 1.1 tm? -151.89 93.42 1.84 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.807 -0.812 . . . . 20.41 108.807 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.28 -158.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 33.99 109.823 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 48.94 -154.18 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 54.92 109.159 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . -79.61 -2.44 88.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.445 -1.462 . . . . 36.1 109.445 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -73.41 114.28 30.17 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.286 -1.126 . . . . 54.76 110.118 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 52' ' ' GLY . 36.4 Cg_endo -80.3 153.44 21.27 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.5 2.133 . . . . 28.37 110.243 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . . . -39.74 128.25 2.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.288 -0.882 . . . . 17.21 110.296 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.637 ' CE1' HG12 ' A' ' 47' ' ' ILE . 86.7 m-85 -47.5 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.783 . . . . 17.19 109.009 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.531 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -48.76 175.61 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 17.82 109.589 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.5 Cg_endo -77.05 128.31 9.82 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.637 2.225 . . . . 17.28 110.192 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.06 176.73 32.46 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.614 -1.394 . . . . 17.22 109.614 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.8 mp -74.21 146.49 43.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -1.162 . . . . 19.57 108.362 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.595 ' CE1' HD12 ' A' ' 6' ' ' ILE . 20.2 m-85 -131.79 163.66 27.72 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.902 -1.124 . . . . 14.61 111.274 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 24.1 p -146.38 120.77 9.64 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.414 -1.698 . . . . 18.36 106.414 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 6.2 t -49.19 168.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 C-N-CA 118.837 -1.145 . . . . 19.13 108.776 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.7 t-80 -135.37 124.53 24.46 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.393 -0.817 . . . . 20.65 109.11 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.683 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -68.63 -5.3 19.28 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.285 -0.885 . . . . 19.65 109.572 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.5 t -55.94 -18.28 8.72 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.367 -0.975 . . . . 14.72 108.367 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -101.48 -5.53 25.12 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.525 -0.735 . . . . 11.45 110.187 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.683 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -75.36 157.9 33.57 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.919 -1.113 . . . . 14.25 108.938 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.524 ' CA ' HD12 ' B' ' 37' ' ' LEU . 20.5 mttt -146.63 164.44 32.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 32.7 109.797 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -111.57 112.18 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 15.63 109.156 179.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.5 -176.93 43.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.457 -1.457 . . . . 12.7 109.457 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.528 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -90.57 22.54 3.42 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.158 -1.201 . . . . 26.29 109.367 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.25 -16.37 31.39 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.425 -0.797 . . . . 20.44 109.318 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 90.14 28.02 19.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.651 -1.38 . . . . 13.82 109.651 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' LEU . 58.0 m -161.0 124.54 3.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -1.182 . . . . 18.27 109.485 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.467 ' O ' ' HG2' ' A' ' 77' ' ' MET . 1.1 tp -46.94 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 12.43 109.333 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -162.5 113.57 1.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -0.923 . . . . 35.11 109.526 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 81' ' ' LEU . 3.4 mt -43.14 -40.01 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.511 -0.743 . . . . 13.67 110.178 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.511 ' O ' ' HB3' ' A' ' 80' ' ' ARG . 1.6 t70 45.77 55.16 7.12 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.407 -0.96 . . . . 24.06 108.407 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 80.22 88.52 0.05 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.674 -0.861 . . . . 35.04 108.674 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.596 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 0.8 OUTLIER -65.46 157.87 28.32 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.752 0.787 . . . . 18.72 111.268 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 5.7 ttt180 -106.93 102.1 11.48 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.128 -1.064 . . . . 20.55 108.128 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.597 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -75.06 147.29 40.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.003 -1.061 . . . . 14.4 111.205 -178.375 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 62' ' ' THR . 33.9 m -147.85 155.56 44.4 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.094 -1.076 . . . . 17.65 108.094 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.55 144.02 83.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.091 1.861 . . . . 25.7 110.277 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 87' ' ' LYS . . . -72.83 128.11 34.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 49.29 109.521 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 86' ' ' ALA . 29.7 mmtm . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.062 -0.97 . . . . 58.91 109.487 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.513 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.435 -0.58 . . . . 64.91 109.435 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.534 ' CD1' ' HB ' ' B' ' 63' ' ' VAL . 1.9 mt -58.64 85.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.842 -1.17 . . . . 33.8 107.842 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 20.7 mttt -63.63 157.99 22.48 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.804 0.812 . . . . 32.72 111.6 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.569 ' HB ' ' CB ' ' B' ' 61' ' ' TYR . 58.6 t -159.94 167.38 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.592 0.71 . . . . 14.46 109.68 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 77.6 mt-10 -154.83 107.18 2.74 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.761 -0.829 . . . . 22.12 108.761 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.586 HD12 ' CE1' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -74.52 107.82 5.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 118.983 -1.087 . . . . 14.23 108.322 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.672 ' CD ' ' CD1' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.4 171.85 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.438 -0.789 . . . . 25.43 109.967 -179.064 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 34.5 Cg_endo -76.69 -25.68 9.06 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.598 2.199 . . . . 13.61 109.718 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.65 8.24 44.68 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.94 -0.763 . . . . 15.52 108.94 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 10.0 mm-40 -121.21 32.84 5.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.262 -0.898 . . . . 17.31 109.547 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.96 11.48 37.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.97 . . . . 24.78 110.338 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -138.78 138.14 37.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -0.993 . . . . 47.9 110.055 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.617 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 11.5 p90 -88.5 173.21 8.81 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.426 -0.796 . . . . 21.61 109.74 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 10.0 t -130.85 164.1 25.97 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.512 -0.921 . . . . 14.89 108.512 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.02 112.75 24.28 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.103 -0.998 . . . . 17.35 109.611 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.0 OUTLIER -114.93 137.73 51.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 34.38 109.163 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.433 ' C ' ' O ' ' B' ' 16' ' ' ARG . 3.4 m -43.98 123.75 3.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 38.77 109.431 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.569 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -133.61 144.18 16.06 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.45 -1.46 . . . . 34.58 109.45 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.54 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.6 t -138.86 121.68 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -1.16 . . . . 41.87 109.23 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.466 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 0.8 OUTLIER -66.51 165.4 14.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.274 -0.891 . . . . 47.21 109.73 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -16.03 9.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.819 . . . . 71.56 109.784 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -82.75 8.27 12.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 66.6 109.702 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.36 3.18 85.62 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.997 -1.241 . . . . 55.49 109.997 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -89.62 140.93 28.22 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.235 . . . . 44.99 109.293 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 36.4 Cg_endo -78.34 131.87 10.93 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.567 2.178 . . . . 44.1 110.218 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' B' ' 28' ' ' LEU . 4.8 p90 -127.99 20.96 6.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.766 -1.209 . . . . 32.09 110.935 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.59 ' C ' ' O ' ' B' ' 26' ' ' TYR . 3.4 m 12.6 61.8 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 121.551 0.691 . . . . 29.25 110.867 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.596 ' HB3' ' CD1' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -62.22 168.67 3.24 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.888 0.852 . . . . 24.0 110.896 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.617 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -105.52 128.7 53.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.603 -0.888 . . . . 23.31 108.603 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.9 OUTLIER -111.51 151.03 29.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.992 -1.068 . . . . 40.03 109.971 -179.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.539 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.7 OUTLIER -133.64 175.89 9.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 12.39 109.486 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.451 ' C ' ' SG ' ' B' ' 33' ' ' CYS . 3.6 mp -127.27 155.59 43.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 17.42 109.164 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 1.9 m -153.78 -176.75 5.98 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.296 -1.001 . . . . 13.84 108.296 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' CD ' ' B' ' 7' ' ' LYS . 35.4 m-85 -130.86 102.9 6.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.164 -0.96 . . . . 21.14 109.544 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' B' ' 4' ' ' VAL . 78.5 t -90.78 125.96 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.004 -1.06 . . . . 10.66 110.307 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' B' ' 39' ' ' ASN . 3.8 m-20 -68.46 -41.95 79.47 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.601 -0.889 . . . . 25.89 108.601 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.524 HD12 ' CA ' ' A' ' 69' ' ' LYS . 0.6 OUTLIER 47.49 48.2 16.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.421 -0.799 . . . . 24.24 109.749 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.16 4.78 51.23 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.348 -1.501 . . . . 31.02 109.348 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.5 OUTLIER -104.44 95.72 6.12 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.33 -1.1 . . . . 43.23 108.507 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' B' ' 39' ' ' ASN . 9.3 mt-10 -30.52 -37.35 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.471 0.653 . . . . 42.34 110.858 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -85.2 146.4 45.06 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.64 -0.874 . . . . 6.3 108.64 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.66 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.9 Cg_endo -76.37 137.09 18.4 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.958 1.772 . . . . 17.92 110.551 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 5.9 m -108.7 114.0 45.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.362 -0.836 . . . . 20.57 109.076 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.584 ' HB2' ' CE2' ' B' ' 34' ' ' TYR . 28.8 tp -65.66 110.1 2.64 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.407 -0.808 . . . . 20.21 109.372 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.587 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 6.5 t -115.36 165.4 10.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.493 -0.755 . . . . 10.81 109.306 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.554 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 9.8 mtpt -96.31 125.52 40.87 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.538 -0.865 . . . . 36.74 109.492 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.632 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -117.43 136.38 54.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.331 -0.856 . . . . 19.74 109.368 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.483 ' OG1' ' CZ ' ' B' ' 80' ' ' ARG . 12.6 m -68.18 163.67 22.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 22.56 109.285 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.602 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 1.1 tm? -151.9 93.41 1.84 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.35 -158.0 0.85 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 33.99 109.836 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 49.02 -154.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 54.92 109.162 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.459 ' O ' ' HD3' ' B' ' 54' ' ' PRO . . . -79.62 -2.2 87.72 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.512 -1.435 . . . . 36.1 109.512 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -73.59 114.37 31.41 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.251 -1.147 . . . . 54.76 110.008 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' B' ' 52' ' ' GLY . 36.3 Cg_endo -80.29 153.33 21.27 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.512 2.141 . . . . 28.37 110.244 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.521 ' HA ' ' HG ' ' B' ' 49' ' ' LEU . . . -39.84 128.43 2.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.358 -0.839 . . . . 17.21 110.26 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.632 ' CE1' HG12 ' B' ' 47' ' ' ILE . 85.2 m-85 -47.79 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.871 -0.788 . . . . 17.19 108.871 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.522 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -50.5 175.72 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.86 . . . . 17.82 109.394 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.6 Cg_endo -77.34 129.5 10.35 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.611 2.207 . . . . 17.28 110.503 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.89 177.15 30.73 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.424 -1.47 . . . . 17.22 109.424 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 4.1 mp -73.73 146.99 43.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.222 -1.163 . . . . 19.57 108.794 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.586 ' CE1' HD12 ' B' ' 6' ' ' ILE . 19.6 m-85 -132.24 163.78 27.84 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.957 -1.089 . . . . 14.61 111.319 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' B' ' 2' ' ' ILE . 24.3 p -146.54 120.86 9.59 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.424 -1.695 . . . . 18.36 106.424 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.584 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 6.1 t -49.37 168.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 C-N-CA 118.82 -1.152 . . . . 19.13 108.826 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.543 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.7 t-80 -135.21 124.5 24.64 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.393 -0.817 . . . . 20.65 109.089 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.682 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -68.61 -5.4 19.75 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.244 -0.91 . . . . 19.65 109.533 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 33.4 t -55.79 -18.44 8.48 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.306 -0.998 . . . . 14.72 108.306 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -101.31 -5.92 24.8 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.544 -0.722 . . . . 11.45 110.185 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.682 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.9 m-30 -75.02 157.72 34.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.91 -1.119 . . . . 14.25 108.893 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.527 ' CA ' HD12 ' A' ' 37' ' ' LEU . 20.6 mttt -146.36 164.78 31.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -0.979 . . . . 32.7 109.815 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.6 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -111.83 112.12 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.415 -0.803 . . . . 15.63 109.158 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.51 -177.0 43.03 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.481 -1.448 . . . . 12.7 109.481 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.531 ' O ' ' CG ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.54 22.57 3.39 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.146 -1.208 . . . . 26.29 109.348 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.29 -16.36 31.31 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.46 -0.775 . . . . 20.44 109.363 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 90.39 27.62 19.73 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.665 -1.374 . . . . 13.82 109.665 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 76' ' ' LEU . 58.0 m -160.76 124.53 3.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -1.223 . . . . 18.27 109.569 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.464 HD23 HG12 ' A' ' 35' ' ' VAL . 1.1 tp -46.93 170.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 12.43 109.357 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' B' ' 76' ' ' LEU . 0.8 OUTLIER -162.48 113.58 1.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 35.11 109.553 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.599 ' CG2' ' N ' ' B' ' 81' ' ' LEU . 3.4 mt -43.11 -40.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.48 -0.763 . . . . 13.67 110.212 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' B' ' 80' ' ' ARG . 1.6 t70 45.85 55.17 7.2 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.354 -0.98 . . . . 24.06 108.354 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 80.21 88.57 0.05 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.69 -0.856 . . . . 35.04 108.69 -178.81 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.599 ' N ' ' CG2' ' B' ' 78' ' ' ILE . 0.8 OUTLIER -65.4 157.89 28.11 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.779 0.799 . . . . 18.72 111.267 -178.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 5.7 ttt180 -107.06 102.09 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.065 -1.087 . . . . 20.55 108.065 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -75.04 147.45 40.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.047 -1.033 . . . . 14.4 111.162 -178.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.463 HG21 ' O ' ' B' ' 62' ' ' THR . 33.8 m -148.02 155.31 43.83 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 108.11 -1.07 . . . . 17.65 108.11 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.1 Cg_endo -64.33 143.95 84.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.153 1.902 . . . . 25.7 110.257 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' B' ' 87' ' ' LYS . . . -72.79 128.08 34.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 49.29 109.586 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' B' ' 86' ' ' ALA . 29.7 mmtm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.047 -0.978 . . . . 58.91 109.519 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.48 ' O ' ' CB ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.33 -0.618 . . . . 64.91 109.33 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.539 HG12 ' CB ' ' B' ' 65' ' ' LEU . 4.8 mt 73.74 75.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.162 -1.051 . . . . 33.8 108.162 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -68.99 155.35 40.49 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.756 0.788 . . . . 32.72 110.841 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.591 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -160.35 167.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.534 -0.913 . . . . 14.46 108.534 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.542 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 60.3 mt-10 -143.52 109.67 5.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 22.12 109.534 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.598 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -72.29 101.04 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.899 -1.149 . . . . 14.23 107.899 179.218 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.642 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.42 169.84 0.07 OUTLIER Pre-proline 0 N--CA 1.486 1.361 0 O-C-N 121.306 -0.871 . . . . 25.43 109.611 -179.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -75.3 -24.09 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.444 2.096 . . . . 13.61 109.812 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -93.31 1.39 56.99 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.094 -0.706 . . . . 15.52 109.094 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.487 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 29.3 mm-40 -120.08 39.7 3.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 17.31 109.165 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.65 22.44 15.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.119 -0.988 . . . . 24.78 110.22 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.454 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -142.72 132.71 24.33 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.054 -1.029 . . . . 47.9 108.786 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.632 ' CD1' ' CB ' ' A' ' 29' ' ' ASN . 33.3 p90 -88.56 176.88 6.95 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.013 -1.054 . . . . 21.61 109.774 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 16.1 m -130.7 153.75 48.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.674 -0.862 . . . . 14.89 108.674 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.53 114.62 28.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.211 -0.931 . . . . 17.35 109.439 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' GLY . 15.1 mmt180 -134.8 143.81 47.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 34.38 109.077 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 t -51.9 89.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 38.77 109.297 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -84.54 140.82 19.23 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.692 -1.363 . . . . 34.58 109.692 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.39 123.51 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.246 -1.15 . . . . 41.87 108.837 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -55.49 -90.28 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.332 -0.855 . . . . 47.21 109.576 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -136.15 62.11 1.63 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 71.56 109.449 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 57.7 17.65 4.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 66.6 109.338 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.6 -48.26 1.31 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.541 -1.424 . . . . 55.49 109.541 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.08 150.72 21.56 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.266 -1.137 . . . . 44.99 109.37 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.28 136.13 14.06 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.598 2.199 . . . . 44.1 110.56 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.584 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 4.0 p90 -136.48 136.81 39.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 32.09 109.589 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 m -102.36 79.59 1.86 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 29.25 109.26 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -96.51 161.96 13.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 24.0 109.96 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.632 ' CB ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -99.05 129.92 45.35 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.451 -0.944 . . . . 23.31 108.451 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.07 152.55 33.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.998 -1.064 . . . . 40.03 109.612 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.547 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -135.24 171.54 14.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 12.39 109.897 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.524 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 3.3 mm? -105.89 179.13 4.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 17.42 110.252 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -173.51 158.16 3.37 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.85 -1.167 . . . . 13.84 107.85 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.649 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 20.1 m-85 -111.98 106.33 14.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.964 -1.085 . . . . 21.14 109.36 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.538 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 25.7 t -107.4 117.59 53.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 10.66 110.627 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -95.3 41.29 1.1 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.543 -1.281 . . . . 25.89 107.543 178.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.55 ' O ' ' CD1' ' B' ' 65' ' ' LEU . 1.7 pp -35.19 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.377 0.608 . . . . 24.24 110.319 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 165.55 50.81 0.02 OUTLIER Glycine 0 C--N 1.298 -1.576 0 C-N-CA 119.333 -1.413 . . . . 31.02 109.696 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 61.9 m-20 -126.13 18.26 7.74 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.223 -1.163 . . . . 43.23 110.101 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 51.3 mt-10 58.96 27.8 16.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 42.34 109.949 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 3.3 p-80 176.42 162.62 0.47 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.531 -0.914 . . . . 6.37 108.531 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.649 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.7 Cg_endo -76.5 135.74 16.71 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.774 1.65 . . . . 17.92 110.231 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 2.9 m -111.1 117.31 54.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.648 -0.821 . . . . 20.57 108.994 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.562 HD11 ' CE2' ' A' ' 34' ' ' TYR . 41.1 tp -70.75 95.94 1.18 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.292 -0.88 . . . . 20.21 109.167 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.461 ' O ' HD11 ' A' ' 32' ' ' LEU . 4.4 p -105.65 161.28 5.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.6 -0.687 . . . . 10.81 109.35 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -177.75 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 36.74 110.634 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.612 HG22 ' CD1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -167.66 149.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.115 -1.069 . . . . 19.74 108.115 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.424 ' N ' HD11 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -91.58 152.97 20.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.864 -1.148 . . . . 22.56 109.476 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.589 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -131.93 102.82 6.0 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.471 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 29.4 t70 -44.87 142.45 1.78 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 33.99 109.739 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.25 103.31 0.37 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.825 . . . . 54.92 109.322 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.1 -25.14 7.98 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.367 -1.493 . . . . 36.1 109.367 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.469 ' O ' HD13 ' A' ' 49' ' ' LEU . 31.3 mt-30 -76.48 147.76 79.26 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.323 -1.104 . . . . 54.76 109.229 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.6 Cg_endo -78.12 126.13 7.62 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.662 2.241 . . . . 28.37 110.39 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.506 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -40.03 156.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.419 -0.801 . . . . 17.21 110.02 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.612 ' CD1' HG22 ' A' ' 47' ' ' ILE . 74.3 m-85 -58.27 111.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 17.19 109.153 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.406 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -56.58 170.05 0.55 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 17.82 109.782 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.483 ' HA ' HG23 ' A' ' 6' ' ' ILE . 35.5 Cg_endo -78.17 106.07 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.678 2.252 . . . . 17.28 110.392 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.11 -176.12 43.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.585 -1.406 . . . . 17.22 109.585 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -76.28 138.84 40.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -1.142 . . . . 19.57 108.613 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CE1' HD11 ' A' ' 6' ' ' ILE . 25.5 m-85 -128.63 164.65 22.42 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.776 -1.203 . . . . 14.61 111.699 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.527 HG21 ' CB ' ' A' ' 86' ' ' ALA . 47.6 p -145.46 121.89 10.99 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.268 -1.753 . . . . 18.36 106.268 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.609 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -54.41 167.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 118.632 -1.227 . . . . 19.13 108.624 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.508 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -130.12 126.57 37.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.249 -0.907 . . . . 20.65 109.501 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.675 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -73.06 1.53 8.82 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.425 -0.797 . . . . 19.65 110.034 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 t -57.29 -19.05 19.61 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.383 -1.34 . . . . 14.72 107.383 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 69.8 m -95.12 -25.02 16.6 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.127 0.489 . . . . 11.45 110.179 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.675 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.2 m-30 -61.92 158.95 15.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.98 . . . . 14.25 109.486 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.449 ' HA ' HD23 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -153.73 176.24 12.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 32.7 109.404 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' CG2' HG23 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -113.44 123.37 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 15.63 109.387 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.75 -162.06 28.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.378 -1.489 . . . . 12.7 109.378 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.451 ' HB2' ' SD ' ' A' ' 77' ' ' MET . 0.3 OUTLIER 59.27 72.22 0.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -1.188 . . . . 26.29 109.311 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.3 OUTLIER 70.41 6.66 5.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 20.44 109.381 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.03 45.21 5.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.492 -1.443 . . . . 13.82 109.492 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -129.13 140.46 51.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 18.27 109.522 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.2 OUTLIER -43.69 158.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 12.43 109.355 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.52 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -165.54 104.73 0.72 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 35.11 110.112 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.58 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.1 mt -41.12 -64.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.613 0.721 . . . . 13.67 109.738 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 15.6 t70 84.86 -46.69 0.08 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.481 0.657 . . . . 24.06 110.003 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.581 ' O ' ' CB ' ' A' ' 67' ' ' SER . 1.9 tpm_? -171.25 66.56 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.491 -0.929 . . . . 35.04 108.491 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.609 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.3 pt? -39.58 125.7 1.79 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.659 0.742 . . . . 18.72 111.71 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -92.51 106.67 18.62 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.434 -0.95 . . . . 20.55 108.434 178.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.593 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -72.66 151.89 42.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.294 -0.879 . . . . 14.4 111.056 -178.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 62' ' ' THR . 33.1 m -154.08 156.4 31.9 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.011 -1.107 . . . . 17.65 108.011 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.2 Cg_endo -62.64 144.16 93.7 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.184 1.923 . . . . 25.7 110.201 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.527 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -75.91 117.04 17.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.14 -0.975 . . . . 49.29 109.557 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.99 -1.005 . . . . 58.91 109.416 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.478 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.336 -0.616 . . . . 64.91 109.336 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 65' ' ' LEU . 4.8 mt 73.72 75.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.064 -1.087 . . . . 33.8 108.064 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -69.16 155.49 40.3 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.778 0.799 . . . . 32.72 110.788 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.586 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.1 OUTLIER -160.45 168.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.548 -0.908 . . . . 14.46 108.548 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.536 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 60.1 mt-10 -143.79 109.75 5.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.33 -0.856 . . . . 22.12 109.536 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.589 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -72.35 100.98 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.942 -1.133 . . . . 14.23 107.942 179.254 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.644 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.37 169.78 0.07 OUTLIER Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 25.43 109.602 -179.244 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.0 Cg_endo -75.23 -24.06 12.83 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.419 2.079 . . . . 13.61 109.777 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -93.28 1.4 57.02 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.526 -0.734 . . . . 15.52 109.1 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.493 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 29.1 mm-40 -120.06 39.51 3.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.262 -0.899 . . . . 17.31 109.171 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.49 22.45 15.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 24.78 110.3 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -142.7 132.8 24.49 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.997 -1.064 . . . . 47.9 108.843 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.632 ' CD1' ' CB ' ' B' ' 29' ' ' ASN . 33.4 p90 -88.63 176.8 6.96 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.007 -1.058 . . . . 21.61 109.746 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.3 m -130.68 153.68 48.72 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.737 -0.838 . . . . 14.89 108.737 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.53 114.39 28.59 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.251 -0.906 . . . . 17.35 109.501 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' B' ' 18' ' ' GLY . 15.0 mmt180 -134.5 143.92 47.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.329 -0.857 . . . . 34.38 109.105 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.1 t -51.92 90.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 38.77 109.243 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -84.85 140.57 18.78 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.718 -1.353 . . . . 34.58 109.718 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.18 123.39 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.171 -1.194 . . . . 41.87 108.89 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -55.39 -90.15 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.37 -0.831 . . . . 47.21 109.552 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -136.3 61.96 1.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 71.56 109.495 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 57.76 17.76 4.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 66.6 109.271 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.69 -48.57 1.26 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.434 -1.467 . . . . 55.49 109.434 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.82 150.73 21.93 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.243 -1.151 . . . . 44.99 109.414 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.16 135.97 14.13 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.662 2.241 . . . . 44.1 110.658 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 4.0 p90 -136.38 136.91 40.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.228 -0.92 . . . . 32.09 109.643 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 2.6 m -102.49 79.69 1.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 29.25 109.202 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.571 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -96.55 161.96 13.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 24.0 110.011 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.632 ' CB ' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -99.07 129.92 45.37 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.478 -0.934 . . . . 23.31 108.478 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.03 152.58 33.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.037 -1.04 . . . . 40.03 109.572 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.557 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -135.21 171.53 14.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.153 -0.967 . . . . 12.39 109.94 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.531 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 3.3 mm? -105.79 179.28 4.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 17.42 110.219 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -173.69 158.27 3.29 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.797 -1.186 . . . . 13.84 107.797 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.657 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 20.2 m-85 -112.13 106.4 15.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.988 -1.07 . . . . 21.14 109.309 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.54 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 25.4 t -107.57 117.46 53.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 10.66 110.633 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.2 OUTLIER -95.21 41.34 1.1 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.433 -1.321 . . . . 25.89 107.433 178.289 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.547 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 1.6 pp -35.29 -31.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.397 0.618 . . . . 24.24 110.284 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 165.83 50.98 0.02 OUTLIER Glycine 0 C--N 1.298 -1.559 0 C-N-CA 119.286 -1.435 . . . . 31.02 109.653 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.581 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 62.1 m-20 -126.19 18.37 7.7 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.164 -1.198 . . . . 43.23 110.116 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' B' ' 39' ' ' ASN . 51.2 mt-10 58.79 27.87 16.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.139 -0.976 . . . . 42.34 109.956 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 3.3 p-80 176.38 162.35 0.46 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 6.38 108.594 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.657 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.7 Cg_endo -76.39 135.68 16.87 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.77 1.646 . . . . 17.92 110.24 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 2.9 m -111.01 117.4 54.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.358 -0.839 . . . . 20.57 108.997 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.544 HD11 ' CE2' ' B' ' 34' ' ' TYR . 41.8 tp -70.86 95.82 1.2 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.643 -0.823 . . . . 20.21 109.215 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.469 ' O ' HD11 ' B' ' 32' ' ' LEU . 4.4 p -105.46 161.37 5.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.612 -0.68 . . . . 10.81 109.448 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -177.84 1.89 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 36.74 110.552 -179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.611 HG22 ' CD1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -167.61 149.63 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.069 -1.085 . . . . 19.74 108.069 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.433 ' N ' HD11 ' B' ' 47' ' ' ILE . 0.2 OUTLIER -91.82 153.15 19.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.839 -1.163 . . . . 22.56 109.429 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.589 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -132.21 102.96 5.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.741 -0.837 . . . . 20.41 108.741 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.441 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 29.4 t70 -45.12 142.45 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 33.99 109.898 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.1 103.41 0.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 54.92 109.319 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.93 -25.16 8.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.37 -1.492 . . . . 36.1 109.37 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.471 ' O ' HD13 ' B' ' 49' ' ' LEU . 31.5 mt-30 -76.39 147.72 79.48 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.265 -1.138 . . . . 54.76 109.301 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.7 Cg_endo -78.05 126.31 7.78 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.591 2.194 . . . . 28.37 110.391 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.519 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -40.11 156.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.396 -0.815 . . . . 17.21 110.024 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.611 ' CD1' HG22 ' B' ' 47' ' ' ILE . 73.3 m-85 -58.11 111.01 1.05 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.4 -0.813 . . . . 17.19 109.077 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.418 ' O ' HG23 ' B' ' 6' ' ' ILE . . . -56.76 170.04 0.57 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 17.82 109.799 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.469 ' HA ' HG23 ' B' ' 6' ' ' ILE . 35.4 Cg_endo -77.76 104.99 1.95 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.71 2.273 . . . . 17.28 110.118 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.3 -176.6 41.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.708 -1.357 . . . . 17.22 109.708 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -76.53 138.34 40.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -1.146 . . . . 19.57 108.366 179.143 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.589 ' CE1' HD11 ' B' ' 6' ' ' ILE . 25.5 m-85 -128.08 164.46 22.37 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.729 -1.232 . . . . 14.61 111.607 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.516 HG21 ' CB ' ' B' ' 86' ' ' ALA . 46.9 p -145.13 122.04 11.31 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.175 -1.787 . . . . 18.36 106.175 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.608 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -54.73 167.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 118.562 -1.255 . . . . 19.13 108.594 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -130.4 126.68 37.66 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.271 -0.893 . . . . 20.65 109.49 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.667 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.8 OUTLIER -73.18 1.17 9.78 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.434 -0.791 . . . . 19.65 110.014 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -56.86 -19.38 17.2 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.323 -1.362 . . . . 14.72 107.323 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 70.9 m -94.77 -25.06 16.82 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.146 0.498 . . . . 11.45 110.201 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.667 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.2 m-30 -61.93 158.59 15.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 14.25 109.466 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.438 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -153.4 176.29 12.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 32.7 109.407 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.49 ' CG2' HG23 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -113.45 123.57 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 15.63 109.34 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.53 -162.2 29.29 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.426 -1.47 . . . . 12.7 109.426 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.3 OUTLIER 59.43 72.13 0.54 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -1.189 . . . . 26.29 109.328 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.3 OUTLIER 70.45 6.81 5.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 20.44 109.322 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.84 45.25 5.2 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.438 -1.465 . . . . 13.82 109.438 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.423 ' O ' ' C ' ' B' ' 76' ' ' LEU . 0.3 OUTLIER -129.16 140.34 51.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -1.167 . . . . 18.27 109.48 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.2 OUTLIER -43.58 158.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -0.895 . . . . 12.43 109.376 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 0.6 OUTLIER -165.49 104.93 0.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.962 . . . . 35.11 110.083 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.58 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.0 OUTLIER -41.37 -64.4 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.556 0.694 . . . . 13.67 109.682 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 15.4 t70 84.74 -46.52 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.422 0.63 . . . . 24.06 110.007 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' B' ' 67' ' ' SER . 1.9 tpm_? -171.42 66.41 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.036 0.922 . . . . 35.04 108.517 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.608 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.2 pt? -39.41 125.65 1.71 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.653 0.739 . . . . 18.72 111.721 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.7 OUTLIER -92.48 106.59 18.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.517 -0.919 . . . . 20.55 108.517 178.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.597 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -72.64 151.72 42.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.183 -0.948 . . . . 14.4 111.072 -178.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' B' ' 62' ' ' THR . 33.4 m -153.86 156.53 32.16 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 107.959 -1.126 . . . . 17.65 107.959 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.3 Cg_endo -62.83 144.32 93.33 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.117 1.878 . . . . 25.7 110.151 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.516 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -75.96 117.03 17.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.242 -0.911 . . . . 49.29 109.617 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.009 -0.996 . . . . 58.91 109.458 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.416 -0.587 . . . . 64.91 109.416 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.527 ' CG2' HG22 ' A' ' 63' ' ' VAL . 2.7 mt -66.89 79.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.598 -1.26 . . . . 33.8 107.598 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -74.33 159.96 31.7 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.907 0.861 . . . . 32.72 110.595 -178.186 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.574 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -162.43 167.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.437 -0.949 . . . . 14.46 108.437 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.534 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 33.2 mt-10 -142.3 112.54 7.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 22.12 109.693 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -75.25 99.52 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.815 -1.18 . . . . 14.23 107.815 179.071 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.647 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.1 mttm -53.88 165.8 0.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.357 -0.84 . . . . 25.43 109.762 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 29.8 Cg_endo -70.89 -15.61 32.85 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.922 1.748 . . . . 13.61 108.796 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.14 -2.65 49.46 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.905 -0.776 . . . . 15.52 108.905 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 1.5 mm100 -129.49 43.66 3.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.205 -0.935 . . . . 17.31 109.581 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.83 20.03 16.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.05 -1.031 . . . . 24.78 110.068 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -135.73 140.63 44.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.121 -0.987 . . . . 47.9 109.689 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.611 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 41.3 p90 -94.78 164.01 13.12 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.201 -0.937 . . . . 21.61 109.469 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.1 m -135.07 147.26 49.54 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.341 -0.85 . . . . 14.89 109.181 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 113.94 25.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.273 -0.892 . . . . 17.35 109.364 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 17' ' ' SER . 50.6 ttt180 -145.23 158.3 43.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 34.38 109.341 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -42.74 147.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.491 -0.756 . . . . 38.77 109.399 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -151.66 173.16 31.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.37 -1.492 . . . . 34.58 109.37 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.403 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -147.78 120.53 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.116 -1.226 . . . . 41.87 109.002 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 m -59.19 -88.71 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.338 -0.851 . . . . 47.21 109.626 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.32 63.69 1.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 71.56 109.566 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 54.46 19.27 2.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 66.6 109.498 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.06 -47.23 1.61 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.575 -1.41 . . . . 55.49 109.575 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -156.29 153.03 24.37 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.223 -1.163 . . . . 44.99 109.363 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.53 143.16 24.12 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.562 2.175 . . . . 44.1 110.701 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.591 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 2.7 p90 -146.29 136.27 23.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 32.09 109.752 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 m -105.42 80.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 29.25 108.902 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.507 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -97.18 158.48 15.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.86 . . . . 24.0 110.313 -179.071 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.519 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 86.0 m-20 -68.59 109.99 4.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.364 -0.835 . . . . 23.31 109.041 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 18.6 mt-10 -87.01 -173.33 4.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.219 -0.925 . . . . 40.03 109.899 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.53 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 1.7 tm0? -176.33 -177.84 0.9 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.852 . . . . 12.39 109.47 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.518 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 13.3 mt -140.98 168.93 18.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 17.42 109.366 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -164.91 161.87 20.37 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.055 -1.091 . . . . 13.84 108.055 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 49.6 m-85 -111.44 111.72 22.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.994 -1.066 . . . . 21.14 109.716 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.463 ' HA ' ' HB ' ' A' ' 4' ' ' VAL . 4.6 t -106.87 140.39 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 10.66 110.871 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -111.72 39.34 2.39 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.556 -1.276 . . . . 25.89 107.556 178.526 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.533 HD21 ' CD1' ' B' ' 76' ' ' LEU . 1.1 pp -63.5 58.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.976 -0.452 . . . . 24.24 110.468 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 107.33 1.87 35.47 Favored Glycine 0 N--CA 1.482 1.76 0 C-N-CA 119.609 -1.282 . . . . 31.02 109.902 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 40' ' ' GLU . 1.2 m-20 -124.87 98.78 5.85 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.23 -1.159 . . . . 43.23 108.528 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -32.61 -56.85 0.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.55 0.691 . . . . 42.34 110.579 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 39' ' ' ASN . 7.2 m-70 -66.25 152.16 94.65 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 108.638 -0.875 . . . . 6.8 108.638 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.672 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.8 Cg_endo -77.34 139.75 18.87 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.982 1.788 . . . . 17.92 110.041 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.53 HG22 ' CG1' ' A' ' 45' ' ' VAL . 3.4 m -112.91 115.4 49.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.317 -0.865 . . . . 20.57 109.569 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 59.9 tp -72.51 101.62 3.02 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.875 . . . . 20.21 109.867 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.53 ' CG1' HG22 ' A' ' 43' ' ' VAL . 2.6 m -99.82 -168.94 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.977 -0.749 . . . . 10.81 108.977 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' B' ' 73' ' ' PHE . 1.3 mtpp -106.57 178.61 4.51 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.507 -0.877 . . . . 36.74 110.809 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -157.64 156.47 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.242 -1.021 . . . . 19.74 108.242 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -111.46 68.57 0.67 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.12 -0.988 . . . . 22.56 109.479 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.611 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 2.2 tm? -42.12 114.8 0.59 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.492 -0.755 . . . . 20.41 109.306 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.425 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -57.32 151.81 15.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 33.99 109.89 -179.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -63.53 117.5 6.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 54.92 109.223 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.62 -27.35 19.2 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.301 -1.52 . . . . 36.1 109.301 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.47 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.16 146.27 96.83 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.281 -1.129 . . . . 54.76 109.286 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.5 Cg_endo -77.52 119.76 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.577 2.184 . . . . 28.37 110.642 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.506 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -41.41 144.3 0.36 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -0.826 . . . . 17.21 110.035 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.62 ' CE2' ' CB ' ' A' ' 83' ' ' LEU . 15.4 m-30 -45.3 108.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 17.19 109.135 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.478 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -59.04 173.87 0.43 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.056 -1.028 . . . . 17.82 109.055 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.9 Cg_endo -77.52 110.41 2.96 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.42 2.08 . . . . 17.28 110.024 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.53 -178.99 48.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.867 -1.293 . . . . 17.22 109.867 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -77.54 140.59 39.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -1.085 . . . . 19.57 108.511 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.591 ' HB3' ' CD2' ' A' ' 83' ' ' LEU . 17.9 m-85 -130.0 163.96 25.34 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.771 -1.205 . . . . 14.61 111.81 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.506 ' CG2' ' HA ' ' A' ' 86' ' ' ALA . 48.9 p -145.69 121.61 10.65 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.442 -1.688 . . . . 18.36 106.442 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.584 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -51.27 167.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.792 -1.163 . . . . 19.13 109.2 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -128.25 127.47 42.88 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.833 -0.803 . . . . 20.65 108.833 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.653 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -71.39 0.66 7.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.477 -0.764 . . . . 19.65 110.014 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 t -57.12 -17.69 11.8 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.787 -1.19 . . . . 14.72 107.787 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 80' ' ' ARG . 16.5 m -97.81 -5.45 34.77 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.782 -0.574 . . . . 11.45 110.372 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.653 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.3 m-30 -83.6 159.77 21.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.936 -1.102 . . . . 14.25 109.771 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.499 ' HA ' ' CD1' ' B' ' 37' ' ' LEU . 53.7 mttm -149.11 173.25 13.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.773 . . . . 32.7 109.302 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.528 HG12 ' CG1' ' B' ' 45' ' ' VAL . 0.9 OUTLIER -107.28 116.12 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 15.63 108.932 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 175.93 4.86 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.779 -1.328 . . . . 12.7 109.779 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.06 12.7 8.98 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.214 -1.168 . . . . 26.29 109.763 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' O ' ' HG3' ' B' ' 46' ' ' LYS . 0.1 OUTLIER -123.25 19.37 9.84 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.532 -0.73 . . . . 20.44 109.201 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.53 57.27 9.31 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.794 -1.322 . . . . 13.82 109.794 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.0 t -146.65 134.77 21.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.171 -1.193 . . . . 18.27 109.871 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.525 ' CD1' HD21 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -76.98 145.17 38.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 12.43 109.071 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.497 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 11.0 mtm -157.09 120.33 4.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.037 . . . . 35.11 109.926 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.617 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.3 mt -62.34 136.88 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 13.67 109.374 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.34 -30.41 11.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.166 -1.05 . . . . 24.06 108.166 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.488 ' O ' ' OG ' ' A' ' 67' ' ' SER . 2.6 tpm_? -176.42 71.06 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.049 -1.463 . . . . 35.04 107.049 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.584 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -30.89 118.29 0.18 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.731 0.776 . . . . 18.72 111.579 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 6.1 mtp180 -89.35 110.94 21.68 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.015 -1.106 . . . . 20.55 108.015 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.62 ' CB ' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -81.93 144.38 30.99 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.141 -0.975 . . . . 14.4 111.164 -178.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.46 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 11.9 m -145.98 158.91 47.96 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.705 -1.22 . . . . 17.65 107.705 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.1 Cg_endo -61.79 145.77 97.02 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.02 1.813 . . . . 25.7 110.145 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.506 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -73.18 119.8 17.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.156 -0.965 . . . . 49.29 109.732 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.985 -1.007 . . . . 58.91 109.411 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.482 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.432 -0.581 . . . . 64.91 109.432 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.538 ' CG2' HG22 ' B' ' 63' ' ' VAL . 2.7 mt -66.89 78.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.586 -1.265 . . . . 33.8 107.586 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -74.2 159.84 31.98 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.934 0.873 . . . . 32.72 110.595 -178.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.572 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -162.41 167.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.442 -0.947 . . . . 14.46 108.442 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.535 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 33.7 mt-10 -142.32 112.7 7.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 22.12 109.659 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.572 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.7 OUTLIER -75.41 99.7 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.759 -1.201 . . . . 14.23 107.759 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.656 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.2 mttm -54.02 165.83 0.73 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.821 . . . . 25.43 109.785 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 29.9 Cg_endo -70.84 -15.63 33.03 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.89 1.727 . . . . 13.61 108.814 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.13 -2.66 49.47 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.858 -0.793 . . . . 15.52 108.858 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.531 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 1.5 mm100 -129.5 43.74 3.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 17.31 109.649 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.84 19.52 16.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.074 -1.017 . . . . 24.78 110.087 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -135.32 140.7 45.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.119 -0.988 . . . . 47.9 109.679 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.61 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 41.0 p90 -94.85 164.08 13.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 21.61 109.487 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 87.9 m -135.14 147.21 49.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.303 -0.873 . . . . 14.89 109.134 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.37 113.92 25.64 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.28 -0.887 . . . . 17.35 109.368 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' B' ' 17' ' ' SER . 50.7 ttt180 -145.26 158.37 43.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 34.38 109.346 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.1 OUTLIER -42.62 147.97 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.432 -0.792 . . . . 38.77 109.391 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -152.02 173.18 31.27 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.414 -1.474 . . . . 34.58 109.414 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.403 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.8 OUTLIER -147.99 120.47 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.07 -1.253 . . . . 41.87 109.035 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -59.16 -88.6 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.298 -0.877 . . . . 47.21 109.652 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.45 63.54 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 71.56 109.621 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 54.54 19.52 2.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 66.6 109.392 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.18 -47.46 1.57 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.568 -1.413 . . . . 55.49 109.568 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -156.14 153.18 24.94 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.294 -1.121 . . . . 44.99 109.365 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.61 143.22 23.94 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.56 2.173 . . . . 44.1 110.745 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 2.7 p90 -146.26 136.27 23.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 32.09 109.692 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.5 m -105.34 80.91 1.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.87 . . . . 29.25 108.815 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.51 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.3 OUTLIER -97.18 158.58 15.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.915 . . . . 24.0 110.302 -179.139 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.516 ' CG ' ' CD1' ' B' ' 13' ' ' PHE . 85.2 m-20 -68.75 109.73 3.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.827 . . . . 23.31 109.082 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 18.2 mt-10 -86.69 -173.5 4.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.141 -0.974 . . . . 40.03 109.909 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.541 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 1.7 tm0? -176.12 -177.82 0.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.353 -0.842 . . . . 12.39 109.489 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.522 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 13.2 mt -141.1 168.73 19.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 17.42 109.33 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -164.61 162.02 21.31 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.041 -1.096 . . . . 13.84 108.041 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.667 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 49.6 m-85 -111.52 111.52 22.59 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.01 . . . . 21.14 109.698 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.458 ' HA ' ' HB ' ' B' ' 4' ' ' VAL . 4.6 t -106.68 140.26 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 10.66 110.92 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.9 OUTLIER -111.64 39.25 2.39 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.571 -1.27 . . . . 25.89 107.571 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 76' ' ' LEU . 1.1 pp -63.46 58.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.973 -0.454 . . . . 24.24 110.493 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 107.14 2.21 35.95 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.868 -1.293 . . . . 31.02 109.868 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' B' ' 41' ' ' HIS . 1.2 m-20 -125.16 98.61 5.73 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.284 -1.127 . . . . 43.23 108.527 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.6 OUTLIER -32.49 -56.53 0.34 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.553 0.692 . . . . 42.34 110.678 -179.242 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' B' ' 39' ' ' ASN . 7.3 m-70 -66.53 152.21 95.21 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 108.68 -0.859 . . . . 6.77 108.68 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.667 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.8 Cg_endo -77.34 139.56 18.71 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.038 1.825 . . . . 17.92 110.031 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 3.4 m -112.8 115.36 49.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.289 -0.882 . . . . 20.57 109.61 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.584 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 59.3 tp -72.43 101.8 3.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.284 -0.885 . . . . 20.21 109.827 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' B' ' 43' ' ' VAL . 2.6 m -100.09 -169.07 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.987 -0.746 . . . . 10.81 108.987 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 73' ' ' PHE . 1.3 mtpp -106.52 178.4 4.57 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.429 -0.908 . . . . 36.74 110.765 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.583 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -157.34 156.64 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.318 -0.993 . . . . 19.74 108.318 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.421 ' O ' ' C ' ' B' ' 49' ' ' LEU . 0.3 OUTLIER -111.54 68.63 0.67 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.129 -0.982 . . . . 22.56 109.463 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.61 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 2.2 tm? -42.24 114.54 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.586 -0.696 . . . . 20.41 109.314 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.42 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.8 OUTLIER -57.05 151.77 14.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.864 . . . . 33.99 109.909 -179.435 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -63.53 117.77 7.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.378 -0.827 . . . . 54.92 109.202 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.36 -27.35 18.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.301 -1.52 . . . . 36.1 109.301 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.48 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 0.3 OUTLIER -69.18 146.19 96.73 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.315 -1.109 . . . . 54.76 109.346 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.8 Cg_endo -77.4 119.63 4.99 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.614 2.209 . . . . 28.37 110.714 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.509 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -41.28 144.33 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.415 -0.803 . . . . 17.21 110.004 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.613 ' CE2' ' CB ' ' B' ' 83' ' ' LEU . 15.5 m-30 -45.51 108.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 17.19 109.166 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.469 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -58.83 173.76 0.42 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.012 -1.055 . . . . 17.82 109.008 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.59 110.73 3.01 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.444 2.096 . . . . 17.28 110.236 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.76 -178.57 48.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.817 -1.313 . . . . 17.22 109.817 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -77.42 140.96 39.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.351 -1.088 . . . . 19.57 108.601 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.582 ' HB3' ' CD2' ' B' ' 83' ' ' LEU . 17.9 m-85 -130.39 164.02 25.61 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.812 -1.18 . . . . 14.61 111.698 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.491 ' CG2' ' HA ' ' B' ' 86' ' ' ALA . 51.0 p -145.73 121.83 10.78 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.473 -1.677 . . . . 18.36 106.473 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.592 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -51.63 166.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 C-N-CA 118.751 -1.179 . . . . 19.13 109.197 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -127.53 127.24 43.62 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.919 -0.771 . . . . 20.65 108.919 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.656 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -70.99 0.45 7.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.442 -0.786 . . . . 19.65 110.053 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 3.8 t -57.09 -17.36 10.16 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.821 -1.178 . . . . 14.72 107.821 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 16.2 m -98.19 -5.64 32.98 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.767 -0.583 . . . . 11.45 110.358 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.656 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.3 m-30 -83.27 159.28 21.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.895 -1.128 . . . . 14.25 109.691 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.526 ' HA ' ' CD1' ' A' ' 37' ' ' LEU . 53.0 mttm -148.84 173.3 13.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 32.7 109.21 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.524 HG12 ' CG1' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -107.32 116.01 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 15.63 108.998 179.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 175.87 4.88 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.809 -1.316 . . . . 12.7 109.809 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.95 12.79 8.61 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.209 -1.171 . . . . 26.29 109.748 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.468 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -123.41 19.29 9.71 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.565 -0.71 . . . . 20.44 109.234 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.66 57.26 9.2 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.667 -1.373 . . . . 13.82 109.667 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.4 t -146.65 134.55 21.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -1.152 . . . . 18.27 109.86 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.533 ' CD1' HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -76.84 145.11 38.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 12.43 109.062 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.491 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 11.2 mtm -157.05 120.4 4.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 35.11 109.847 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.616 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.2 mt -62.38 137.11 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 13.67 109.382 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -100.52 -30.3 11.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.164 -1.05 . . . . 24.06 108.164 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.491 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.6 tpm_? -176.5 71.18 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.045 -1.465 . . . . 35.04 107.045 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.592 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -30.99 118.32 0.18 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.723 0.773 . . . . 18.72 111.604 -177.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 6.1 mtp180 -89.36 110.79 21.55 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.074 -1.084 . . . . 20.55 108.074 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.613 ' CB ' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -81.78 144.37 31.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.172 -0.955 . . . . 14.4 111.217 -178.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.457 ' HB ' ' HD2' ' B' ' 85' ' ' PRO . 12.3 m -146.04 158.92 47.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 107.718 -1.215 . . . . 17.65 107.718 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.9 Cg_endo -61.77 145.74 97.06 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.015 1.81 . . . . 25.7 110.171 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.491 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -73.19 119.82 17.96 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.102 -0.999 . . . . 49.29 109.7 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 58.91 109.389 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 1.2 pmm? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.321 0.582 . . . . 64.91 109.477 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.563 HG21 ' CD1' ' B' ' 65' ' ' LEU . 2.3 mt -74.33 66.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.102 -1.073 . . . . 33.8 108.102 178.747 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.515 ' N ' HD12 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -56.84 178.58 0.06 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.839 0.828 . . . . 32.72 111.097 -178.486 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.567 ' CG2' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER 174.3 166.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.605 -0.887 . . . . 14.46 108.605 -179.872 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.567 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 25.3 mt-10 -137.6 113.79 10.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.822 -0.807 . . . . 22.12 108.822 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -72.53 103.81 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.472 -1.307 . . . . 14.23 107.472 179.449 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.638 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.64 171.46 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.978 -1.076 . . . . 25.43 109.638 -178.846 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.2 Cg_endo -75.05 -28.18 9.3 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.437 2.091 . . . . 13.61 110.041 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -88.03 -0.26 56.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.468 -0.77 . . . . 15.52 109.029 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.9 mm-40 -116.21 36.91 3.87 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.395 -0.816 . . . . 17.31 109.218 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.62 10.79 40.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 24.78 110.062 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.428 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 13.4 mt-30 -137.74 136.16 37.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.227 -0.921 . . . . 47.9 109.745 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.6 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 31.0 p90 -86.21 165.98 16.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.2 -0.938 . . . . 21.61 109.556 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -133.45 149.75 51.77 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.383 -0.823 . . . . 14.89 109.27 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.519 ' CG2' ' OG ' ' A' ' 27' ' ' SER . 0.2 OUTLIER -74.38 113.67 11.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.297 -0.877 . . . . 17.35 109.218 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.446 ' CG ' ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -124.3 127.18 47.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 34.38 109.627 -179.675 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 t -48.25 106.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 38.77 109.277 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.618 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -114.88 137.46 14.0 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.757 -1.337 . . . . 34.58 109.757 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.95 122.41 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.196 -1.179 . . . . 41.87 109.15 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -69.76 90.18 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.456 -0.777 . . . . 47.21 109.47 -179.45 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 22' ' ' GLN . 0.6 OUTLIER 70.81 -66.89 0.27 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.216 -0.928 . . . . 71.56 109.323 -179.9 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 5.7 pt20 174.78 48.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 66.6 109.498 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HG2' ' A' ' 24' ' ' LYS . . . -119.99 -60.61 0.25 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.749 -1.34 . . . . 55.49 109.749 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 23' ' ' GLY . 10.9 mttt -144.21 158.44 54.94 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.306 -1.114 . . . . 44.99 109.543 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.47 82.09 2.48 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.657 2.238 . . . . 44.1 110.616 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.618 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 6.8 p90 -72.02 142.55 49.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 32.09 109.946 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.519 ' OG ' ' CG2' ' A' ' 15' ' ' THR . 0.3 OUTLIER -101.58 80.53 2.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.352 -0.842 . . . . 29.25 108.865 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -94.46 171.27 8.91 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.348 -0.845 . . . . 24.0 110.18 -179.321 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.596 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -88.09 129.45 35.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.563 -0.711 . . . . 23.31 109.77 -179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 14.7 mt-10 -115.09 162.38 17.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.302 -0.874 . . . . 40.03 109.34 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.553 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -148.92 -173.53 4.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.108 -0.995 . . . . 12.39 109.876 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.512 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 25.1 mt -133.71 159.35 40.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 17.42 109.221 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.5 m -154.23 168.44 26.54 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.937 -1.135 . . . . 13.84 107.937 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.68 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 29.4 m-85 -120.53 105.92 11.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.951 -1.093 . . . . 21.14 109.589 -179.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.473 ' O ' HG21 ' A' ' 43' ' ' VAL . 39.9 t -97.8 139.69 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.002 -1.061 . . . . 10.66 111.095 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.4 m-20 -115.22 -140.49 0.38 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.318 -0.993 . . . . 25.89 108.318 178.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.536 HD21 ' CD2' ' B' ' 65' ' ' LEU . 0.2 OUTLIER 67.44 -68.41 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.924 -1.11 . . . . 24.24 108.47 179.467 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -78.66 -1.47 83.27 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 107.913 -2.075 . . . . 31.02 107.913 178.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -160.12 110.26 1.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.513 -0.992 . . . . 43.23 108.95 179.748 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 39' ' ' ASN . 2.0 mm-40 -37.68 -63.29 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.642 0.734 . . . . 42.34 109.81 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 37.3 m80 -69.0 163.95 52.08 Favored Pre-proline 0 C--N 1.293 -1.882 0 N-CA-C 108.076 -1.083 . . . . 8.11 108.076 179.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.68 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -76.53 141.48 22.43 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 121.699 1.599 . . . . 17.92 109.748 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' TYR . 25.7 m -113.72 115.89 51.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.315 -0.866 . . . . 20.57 109.46 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.628 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 52.0 tp -74.23 103.39 4.63 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.366 -0.833 . . . . 20.21 109.749 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.447 HG13 HG13 ' B' ' 70' ' ' VAL . 1.3 m -107.43 176.15 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.509 -0.744 . . . . 10.81 109.172 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' HA ' HD21 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -100.28 139.85 35.37 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.314 -0.955 . . . . 36.74 109.527 179.66 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.61 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -124.02 170.59 14.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.42 -0.8 . . . . 19.74 109.261 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.77 142.53 44.0 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.175 -0.953 . . . . 22.56 109.497 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.6 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -110.41 147.48 33.93 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 20.41 108.721 179.711 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 1.0 OUTLIER -85.26 145.24 27.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 33.99 109.831 -179.332 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.19 119.82 5.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.36 -0.838 . . . . 54.92 109.614 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.79 -15.55 46.73 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.681 -1.368 . . . . 36.1 109.681 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.519 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -74.99 145.19 80.67 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.202 -1.176 . . . . 54.76 109.343 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.84 121.9 5.64 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.596 2.197 . . . . 28.37 110.74 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.456 ' HB3' ' HG3' ' A' ' 31' ' ' GLN . . . -38.92 149.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.501 -0.749 . . . . 17.21 110.388 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.619 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 89.6 m-85 -46.49 105.36 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.758 -0.83 . . . . 17.19 108.758 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -58.88 176.73 0.27 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.382 -0.824 . . . . 17.82 110.023 -179.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.8 Cg_endo -77.69 110.26 2.91 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.737 2.291 . . . . 17.28 110.338 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 173.65 151.94 8.54 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.563 -1.415 . . . . 17.22 109.563 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 5.1 mp -49.27 150.22 1.83 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.321 . . . . 19.57 108.779 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.615 ' CD1' ' O ' ' A' ' 59' ' ' GLY . 19.1 m-85 -128.57 163.89 24.02 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.768 -1.207 . . . . 14.61 111.564 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.459 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 55.8 p -147.69 118.73 7.69 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.411 -1.7 . . . . 18.36 106.411 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.563 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 8.6 t -53.33 169.86 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 C-N-CA 118.809 -1.157 . . . . 19.13 108.917 -178.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.9 t-80 -128.08 120.14 26.8 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.426 -0.796 . . . . 20.65 109.066 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.61 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -65.08 -8.28 15.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.727 -0.608 . . . . 19.65 109.914 -179.176 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.3 p -52.28 -17.95 1.36 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.02 -1.05 . . . . 14.72 108.402 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 2.3 m -95.94 -6.06 39.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.566 -0.709 . . . . 11.45 110.79 -179.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.61 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -86.61 164.64 16.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.741 -1.224 . . . . 14.25 110.174 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 1.4 mtpp -159.33 178.78 9.59 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.876 -0.787 . . . . 32.7 108.876 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.464 HG13 HG13 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -118.6 114.82 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 15.63 109.38 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.472 ' C ' ' NE2' ' A' ' 72' ' ' GLN . . . -74.46 -167.88 18.67 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.461 -1.456 . . . . 12.7 109.461 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.543 ' N ' ' NE2' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -88.35 39.97 0.93 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -1.168 . . . . 26.29 109.48 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 28.3 m-85 -134.21 27.8 3.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.35 -0.844 . . . . 20.44 109.261 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 73' ' ' PHE . . . 44.7 49.01 8.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.583 -1.407 . . . . 13.82 109.583 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -149.51 145.67 26.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -1.181 . . . . 18.27 109.66 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.8 OUTLIER -88.41 149.49 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 12.43 109.119 179.72 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 54.6 mtm -157.4 137.84 12.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -0.984 . . . . 35.11 109.637 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.0 mt -69.98 139.59 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 13.67 110.105 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.1 -25.48 11.55 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.221 -1.029 . . . . 24.06 108.221 178.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -179.92 68.01 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.125 -1.435 . . . . 35.04 107.125 179.144 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.563 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -33.23 120.48 0.37 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.281 -0.872 . . . . 18.72 111.644 -178.247 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -91.45 113.21 25.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.922 -1.14 . . . . 20.55 107.922 178.786 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.619 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -82.55 148.85 27.82 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.028 -1.045 . . . . 14.4 110.959 -178.553 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 62' ' ' THR . 32.6 m -150.65 150.13 27.62 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 107.96 -1.126 . . . . 17.65 107.96 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.1 Cg_endo -61.37 140.89 90.46 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.164 1.91 . . . . 25.7 110.581 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.11 117.15 8.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 49.29 109.651 -178.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.005 -0.998 . . . . 58.91 109.49 179.991 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.469 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 1.2 pmm? . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.471 -0.566 . . . . 64.91 109.471 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.563 HG21 ' CD1' ' A' ' 65' ' ' LEU . 2.3 mt -74.25 66.57 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.043 -1.095 . . . . 33.8 108.043 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.517 ' N ' HD12 ' B' ' 37' ' ' LEU . 0.5 OUTLIER -56.93 178.76 0.05 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.88 0.848 . . . . 32.72 110.992 -178.455 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.558 ' CG2' ' N ' ' B' ' 5' ' ' GLU . 0.2 OUTLIER 174.19 166.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.625 -0.879 . . . . 14.46 108.625 -179.84 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 25.2 mt-10 -137.34 113.99 10.36 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.826 -0.805 . . . . 22.12 108.826 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.55 ' O ' ' CG2' ' B' ' 6' ' ' ILE . 0.1 OUTLIER -72.74 103.75 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 107.529 -1.286 . . . . 14.23 107.529 179.48 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.637 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.63 171.27 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.995 -1.065 . . . . 25.43 109.564 -178.791 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.3 Cg_endo -74.96 -28.3 9.35 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.445 2.096 . . . . 13.61 110.088 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -87.6 -0.73 57.27 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.02 -0.733 . . . . 15.52 109.02 179.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.6 mm-40 -115.9 37.08 3.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.342 -0.849 . . . . 17.31 109.301 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.71 10.77 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 24.78 110.004 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.427 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 13.7 mt-30 -137.62 136.14 37.23 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 47.9 109.785 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.602 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 30.8 p90 -86.15 165.97 16.14 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.248 -0.908 . . . . 21.61 109.573 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 89.7 m -133.42 149.84 51.79 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.385 -0.822 . . . . 14.89 109.234 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.534 ' CG2' ' OG ' ' B' ' 27' ' ' SER . 0.2 OUTLIER -74.45 113.76 12.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.251 -0.905 . . . . 17.35 109.224 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -124.28 127.27 47.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 34.38 109.606 -179.71 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.4 t -48.29 106.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.941 . . . . 38.77 109.244 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.608 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -115.14 137.39 13.89 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.751 -1.34 . . . . 34.58 109.751 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.02 122.37 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.232 -1.158 . . . . 41.87 109.127 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' B' ' 21' ' ' ARG . 0.2 OUTLIER -69.79 89.9 0.58 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.51 -0.744 . . . . 47.21 109.525 -179.419 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' B' ' 22' ' ' GLN . 0.6 OUTLIER 70.97 -67.09 0.27 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.206 -0.934 . . . . 71.56 109.318 -179.817 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.464 ' HB3' ' O ' ' B' ' 21' ' ' ARG . 5.6 pt20 175.05 48.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 66.6 109.431 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' B' ' 24' ' ' LYS . . . -120.12 -60.77 0.25 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.749 -1.34 . . . . 55.49 109.749 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' B' ' 23' ' ' GLY . 10.9 mttt -144.21 158.26 55.3 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.239 -1.154 . . . . 44.99 109.594 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' B' ' 24' ' ' LYS . 34.2 Cg_endo -77.2 81.92 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.742 2.295 . . . . 44.1 110.628 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.608 ' CE1' ' HA3' ' B' ' 18' ' ' GLY . 6.8 p90 -72.07 142.6 49.24 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.323 -0.86 . . . . 32.09 109.899 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.534 ' OG ' ' CG2' ' B' ' 15' ' ' THR . 0.3 OUTLIER -101.79 80.43 2.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.372 -0.83 . . . . 29.25 108.863 179.643 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.588 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -94.3 171.54 8.76 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.383 -0.823 . . . . 24.0 110.089 -179.369 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.602 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -88.47 129.25 35.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.601 -0.687 . . . . 23.31 109.802 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 14.7 mt-10 -114.89 162.27 17.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 40.03 109.387 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.543 ' CB ' HG21 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -148.76 -173.48 4.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.994 . . . . 12.39 109.892 -179.814 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.517 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 25.3 mt -133.85 159.41 40.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 17.42 109.264 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.5 m -154.27 168.24 27.24 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.963 -1.125 . . . . 13.84 107.963 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 29.7 m-85 -120.38 105.93 11.36 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.957 -1.089 . . . . 21.14 109.652 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.481 ' O ' HG21 ' B' ' 43' ' ' VAL . 40.0 t -97.93 139.65 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.087 -1.008 . . . . 10.66 110.995 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' B' ' 38' ' ' GLY . 4.4 m-20 -115.27 -140.46 0.38 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.292 -1.003 . . . . 25.89 108.292 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.523 HD21 ' CD2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 67.33 -68.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.925 -1.109 . . . . 24.24 108.405 179.479 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -78.6 -1.54 83.08 Favored Glycine 0 C--N 1.297 -1.587 0 N-CA-C 107.873 -2.091 . . . . 31.02 107.873 178.209 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.451 ' O ' ' C ' ' B' ' 40' ' ' GLU . 0.1 OUTLIER -160.37 110.12 1.77 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.512 -0.993 . . . . 43.23 108.869 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' B' ' 39' ' ' ASN . 2.0 mm-40 -37.37 -63.53 0.44 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.633 0.73 . . . . 42.34 109.827 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.477 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 37.9 m80 -68.89 164.1 49.99 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 108.03 -1.1 . . . . 8.13 108.03 179.061 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.672 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.3 Cg_endo -76.51 141.53 22.54 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.722 1.615 . . . . 17.92 109.836 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' B' ' 34' ' ' TYR . 25.5 m -113.73 115.77 50.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.255 -0.903 . . . . 20.57 109.495 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 52.1 tp -74.26 103.15 4.56 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.417 -0.802 . . . . 20.21 109.741 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 70' ' ' VAL . 1.3 m -107.07 176.19 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.505 -0.747 . . . . 10.81 109.147 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.443 ' HA ' HD21 ' B' ' 32' ' ' LEU . 0.3 OUTLIER -100.17 139.87 35.23 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.393 -0.923 . . . . 36.74 109.526 179.627 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.606 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -124.12 170.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.383 -0.823 . . . . 19.74 109.254 -179.748 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.7 142.27 44.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.206 -0.934 . . . . 22.56 109.575 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -110.21 147.54 33.58 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.285 -0.884 . . . . 20.41 108.763 179.676 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.518 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 1.0 OUTLIER -85.37 145.11 27.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.128 -0.983 . . . . 33.99 109.854 -179.355 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.85 119.84 5.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 54.92 109.595 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.74 -15.56 46.44 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.707 -1.357 . . . . 36.1 109.707 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.518 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -75.0 145.12 80.56 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 54.76 109.311 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.8 Cg_endo -77.78 121.75 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.616 2.211 . . . . 28.37 110.731 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.458 ' HB3' ' HG3' ' B' ' 31' ' ' GLN . . . -38.68 150.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.548 -0.72 . . . . 17.21 110.415 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 89.4 m-85 -46.79 105.4 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.324 -0.86 . . . . 17.19 108.724 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.544 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -58.83 176.89 0.26 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 17.82 110.121 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.78 110.26 2.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.673 2.249 . . . . 17.28 110.278 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 173.68 151.96 8.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.579 -1.408 . . . . 17.22 109.579 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.1 mp -49.25 150.1 1.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.985 -1.303 . . . . 19.57 108.724 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.615 ' CD1' ' O ' ' B' ' 59' ' ' GLY . 18.7 m-85 -128.55 163.86 24.08 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.833 -1.167 . . . . 14.61 111.589 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.47 ' N ' ' O ' ' B' ' 84' ' ' VAL . 53.8 p -147.6 118.71 7.73 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.481 -1.674 . . . . 18.36 106.481 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.562 ' CG2' HG23 ' B' ' 2' ' ' ILE . 9.2 t -53.3 169.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.811 -1.156 . . . . 19.13 108.878 -178.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -128.2 120.1 26.57 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.499 -0.751 . . . . 20.65 109.05 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.613 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -64.9 -8.43 15.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.709 -0.619 . . . . 19.65 109.923 -179.151 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 96.0 p -52.05 -17.98 1.25 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.952 -1.092 . . . . 14.72 108.377 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 2.4 m -95.96 -6.59 38.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.502 -0.749 . . . . 11.45 110.776 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.626 ' N ' ' CD1' ' B' ' 68' ' ' PHE . 1.8 m-30 -86.15 164.4 17.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.73 -1.231 . . . . 14.25 110.046 -179.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' B' ' 68' ' ' PHE . 1.4 mtpp -159.09 179.06 9.38 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.82 -0.808 . . . . 32.7 108.82 179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.465 HG23 HG23 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -118.73 115.13 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 15.63 109.427 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.483 ' C ' ' NE2' ' B' ' 72' ' ' GLN . . . -74.58 -168.09 19.66 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.495 -1.442 . . . . 12.7 109.495 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.55 ' N ' ' NE2' ' B' ' 72' ' ' GLN . 0.6 OUTLIER -88.13 39.71 0.91 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.167 -1.196 . . . . 26.29 109.475 179.937 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.449 ' O ' ' OG ' ' B' ' 75' ' ' SER . 28.6 m-85 -133.99 28.09 3.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 20.44 109.38 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.39 49.1 8.46 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.627 -1.389 . . . . 13.82 109.627 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -149.67 145.69 26.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -1.145 . . . . 18.27 109.684 -179.971 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.8 OUTLIER -88.58 149.62 23.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 12.43 109.072 179.734 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.492 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 54.4 mtm -157.52 138.18 13.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.123 -0.986 . . . . 35.11 109.52 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.606 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.9 mp -70.4 139.52 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.856 . . . . 13.67 110.134 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.84 -25.53 11.65 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.138 -1.06 . . . . 24.06 108.138 178.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.0 OUTLIER -179.77 68.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.186 -1.413 . . . . 35.04 107.186 179.17 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.551 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -33.21 120.28 0.36 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.311 -0.859 . . . . 18.72 111.607 -178.187 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -91.32 113.09 25.26 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.979 -1.119 . . . . 20.55 107.979 178.723 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.625 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -82.42 148.93 27.92 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.037 -1.039 . . . . 14.4 110.986 -178.603 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' B' ' 62' ' ' THR . 32.5 m -150.63 150.04 27.45 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.994 -1.113 . . . . 17.65 107.994 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.0 Cg_endo -61.41 140.44 87.83 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.188 1.925 . . . . 25.7 110.6 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.51 117.47 8.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 49.29 109.62 -178.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.027 -0.987 . . . . 58.91 109.484 -179.98 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.358 -0.608 . . . . 64.91 109.358 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.52 ' CD1' ' HB ' ' A' ' 63' ' ' VAL . 2.2 mt -60.4 84.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.897 -1.149 . . . . 33.8 107.897 179.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 1' ' ' MET . 17.4 mttt -57.85 157.14 7.92 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.847 0.832 . . . . 32.72 111.569 -177.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 61' ' ' TYR . 59.8 t -160.52 167.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.585 0.707 . . . . 14.46 109.724 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 38.9 mt-10 -154.09 101.44 2.41 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.771 0.796 . . . . 22.12 108.931 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.592 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -71.38 101.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.986 -1.116 . . . . 14.23 107.986 179.642 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.557 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 15.6 mmmt -50.52 163.3 0.47 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.414 -0.803 . . . . 25.43 109.252 -179.393 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.557 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.5 Cg_endo -71.98 -10.1 25.62 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.818 1.679 . . . . 13.61 109.247 179.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.82 12.21 31.07 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.533 -0.914 . . . . 15.52 108.533 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.529 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 7.6 mm-40 -137.08 38.45 2.54 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.31 -0.869 . . . . 17.31 109.211 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -111.96 31.48 6.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.96 . . . . 24.78 110.19 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 12.0 mt-30 -140.3 132.36 27.9 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.261 -0.9 . . . . 47.9 109.501 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.604 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 33.6 p90 -89.52 155.81 19.05 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.213 -0.93 . . . . 21.61 109.671 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.1 m -134.6 150.16 50.67 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.885 -0.783 . . . . 14.89 108.885 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.46 ' CG2' ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -82.15 108.82 15.91 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.164 -0.96 . . . . 17.35 109.236 179.93 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.475 ' NH1' ' HG3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -124.77 146.58 49.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.362 -0.836 . . . . 34.38 109.352 -179.828 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 16' ' ' ARG . 1.5 m -44.05 143.72 1.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 38.77 109.458 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -147.72 175.52 27.02 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.172 -1.571 . . . . 34.58 109.172 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -150.09 118.53 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.066 -1.255 . . . . 41.87 108.999 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 1.3 m -61.8 83.61 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.387 -0.82 . . . . 47.21 109.561 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 20' ' ' SER . 19.5 mtt180 68.37 -61.68 0.39 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.301 -0.874 . . . . 71.56 109.475 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 15.8 pt20 174.06 45.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 66.6 109.542 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.72 -56.98 0.25 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.619 -1.392 . . . . 55.49 109.619 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.437 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 5.9 pttt -143.11 158.87 57.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.303 -1.116 . . . . 44.99 109.38 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 24' ' ' LYS . 34.7 Cg_endo -77.56 124.17 6.85 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.695 2.263 . . . . 44.1 110.784 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.597 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 3.8 p90 -130.14 136.35 49.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.314 -0.866 . . . . 32.09 109.601 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.46 ' HB2' ' CG2' ' A' ' 15' ' ' THR . 0.0 OUTLIER -104.01 80.2 1.71 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 29.25 108.684 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.53 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.4 OUTLIER -89.23 138.78 31.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 24.0 110.418 -179.008 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.653 ' N ' ' OD1' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -47.61 117.75 1.95 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.433 -0.792 . . . . 23.31 109.569 179.607 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -112.87 147.68 36.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.255 -0.903 . . . . 40.03 109.593 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.549 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -131.22 -169.71 2.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.121 -0.987 . . . . 12.39 109.341 179.843 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.549 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -128.56 177.53 6.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 17.42 109.32 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -172.43 162.69 5.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.053 -1.029 . . . . 13.84 108.467 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.655 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 4.1 m-30 -114.58 95.25 5.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.154 -0.966 . . . . 21.14 109.187 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.538 ' CG2' HG21 ' A' ' 4' ' ' VAL . 92.2 t -84.87 115.45 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 10.66 110.234 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 t0 -66.1 -22.67 66.41 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.381 -0.824 . . . . 25.89 108.805 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.53 ' HB3' ' ND2' ' A' ' 39' ' ' ASN . 0.8 OUTLIER 43.23 26.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.771 . . . . 24.24 109.567 179.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 58.6 22.3 52.23 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.891 -1.284 . . . . 31.02 109.891 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.53 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 19.2 p30 -100.64 27.8 5.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.983 -1.304 . . . . 43.23 110.079 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.628 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 12.2 mt-10 47.72 71.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 42.34 109.871 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.628 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER 142.92 144.46 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.287 0 N-CA-C 108.572 -0.899 . . . . 6.58 108.572 179.451 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.655 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -79.57 142.96 16.64 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.206 1.938 . . . . 17.92 110.841 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.533 HG22 ' CG1' ' B' ' 70' ' ' VAL . 6.9 m -120.52 119.3 59.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.441 -0.948 . . . . 20.57 108.441 178.469 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.651 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 17.7 tp -66.88 112.72 4.44 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.428 -0.795 . . . . 20.21 109.241 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 3.6 t -119.47 168.4 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.576 -0.702 . . . . 10.81 109.572 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -90.57 149.89 21.96 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.431 -0.793 . . . . 36.74 109.954 -179.776 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.587 HG12 ' CE1' ' A' ' 56' ' ' TYR . 1.6 tt -130.21 176.86 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.802 -0.814 . . . . 19.74 108.802 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.412 HG23 ' CZ ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -125.4 135.24 52.18 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.184 -0.948 . . . . 22.56 109.094 179.453 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.604 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -104.67 99.99 9.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.209 -0.932 . . . . 20.41 109.003 179.981 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.69 156.44 36.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 33.99 109.606 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.27 136.81 57.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.221 -0.924 . . . . 54.92 109.228 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.86 -35.05 3.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.321 -1.512 . . . . 36.1 109.321 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.477 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 4.3 mt-30 -77.32 124.04 86.98 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.243 -1.151 . . . . 54.76 109.245 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.1 Cg_endo -78.63 138.28 15.11 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.279 1.986 . . . . 28.37 110.406 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.545 ' CB ' ' OE1' ' A' ' 31' ' ' GLN . . . -35.84 138.16 0.19 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.637 -0.664 . . . . 17.21 110.424 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 83.7 m-85 -51.75 109.99 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 17.19 109.511 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.495 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -59.72 174.33 0.45 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.263 -0.898 . . . . 17.82 109.252 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 34.7 Cg_endo -77.48 110.32 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.632 2.221 . . . . 17.28 110.406 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.37 179.85 48.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.743 -1.343 . . . . 17.22 109.743 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -74.83 143.99 43.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -1.114 . . . . 19.57 108.76 179.483 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.592 ' CE1' HD11 ' A' ' 6' ' ' ILE . 27.0 m-85 -132.42 164.58 26.21 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.873 -1.142 . . . . 14.61 111.206 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.484 ' HB ' ' HG3' ' A' ' 1' ' ' MET . 31.1 p -144.11 118.96 9.9 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.925 -1.88 . . . . 18.36 105.925 178.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.59 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.6 t -52.36 166.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 C-N-CA 118.434 -1.307 . . . . 19.13 108.999 -178.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -129.13 128.81 44.22 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.417 -0.802 . . . . 20.65 109.3 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.676 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -71.3 0.19 8.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.691 -0.631 . . . . 19.65 110.051 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -57.25 -17.66 12.7 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.645 -1.243 . . . . 14.72 107.645 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 80' ' ' ARG . 50.4 m -96.41 -8.38 32.52 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.782 -0.574 . . . . 11.45 110.193 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.676 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.8 m-30 -77.69 155.04 31.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.052 . . . . 14.25 109.585 -178.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.529 ' CA ' HD12 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -134.71 172.9 12.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.406 -0.809 . . . . 32.7 109.731 -179.651 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.532 HG12 ' CG2' ' B' ' 45' ' ' VAL . 8.7 t -124.41 133.34 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.492 -0.755 . . . . 15.63 109.376 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.26 -157.56 27.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.435 -1.466 . . . . 12.7 109.435 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.499 ' NE2' ' HA ' ' A' ' 72' ' ' GLN . 6.5 tp-100 55.88 72.42 0.49 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -1.181 . . . . 26.29 109.098 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER 73.32 5.95 5.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.779 . . . . 20.44 109.402 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.462 ' O ' HG12 ' B' ' 45' ' ' VAL . . . 78.29 45.07 10.34 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.474 -1.451 . . . . 13.82 109.474 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.3 OUTLIER -127.07 119.66 27.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.144 . . . . 18.27 109.713 -179.913 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.536 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.8 OUTLIER -54.95 144.68 22.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 12.43 109.106 179.801 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 30.9 mtp -160.28 140.8 11.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 35.11 109.783 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.617 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.3 mp -68.56 141.66 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.816 . . . . 13.67 109.73 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 39.5 t0 -108.61 -21.26 12.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.689 -0.856 . . . . 24.06 108.689 178.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.48 ' O ' ' OG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER 174.22 66.76 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.1 -1.444 . . . . 35.04 107.1 179.497 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.59 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -28.3 119.7 0.11 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.257 -0.883 . . . . 18.72 111.961 -178.07 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 5.3 ttp180 -93.14 102.87 15.18 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.841 -1.17 . . . . 20.55 107.841 178.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.604 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 7.0 tp -74.13 149.75 40.85 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.158 -0.964 . . . . 14.4 111.184 -178.211 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.511 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 17.8 m -146.33 152.98 47.63 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.214 -1.032 . . . . 17.65 108.214 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 26.0 Cg_endo -64.51 142.97 80.37 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.2 1.933 . . . . 25.7 110.402 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 60' ' ' LEU . . . -76.94 123.67 26.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 49.29 109.692 -178.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.003 -0.999 . . . . 58.91 109.432 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.516 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.387 -0.597 . . . . 64.91 109.387 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.521 ' CD1' ' HB ' ' B' ' 63' ' ' VAL . 2.2 mt -60.23 84.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.881 -1.155 . . . . 33.8 107.881 179.065 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.533 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 17.5 mttt -57.75 157.25 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.815 0.817 . . . . 32.72 111.543 -177.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' B' ' 61' ' ' TYR . 58.6 t -160.63 167.16 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.551 0.691 . . . . 14.46 109.726 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 38.5 mt-10 -154.08 101.29 2.4 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.715 0.769 . . . . 22.12 108.963 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.593 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -71.28 101.77 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.994 -1.113 . . . . 14.23 107.994 179.664 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.54 ' HB3' ' HD2' ' B' ' 8' ' ' PRO . 15.7 mmmt -50.58 163.59 0.46 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.454 -0.779 . . . . 25.43 109.216 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.5 Cg_endo -72.23 -10.16 25.38 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.835 1.69 . . . . 13.61 109.205 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.62 12.06 31.6 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.485 -0.932 . . . . 15.52 108.485 178.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.541 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 7.7 mm-40 -136.91 38.19 2.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.869 . . . . 17.31 109.33 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -111.73 31.43 6.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.098 -1.001 . . . . 24.78 110.288 -179.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' B' ' 31' ' ' GLN . 11.9 mt-30 -140.26 132.26 27.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 47.9 109.504 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.608 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 33.0 p90 -89.33 155.75 19.15 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.249 -0.907 . . . . 21.61 109.662 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -134.63 150.27 50.65 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.83 -0.804 . . . . 14.89 108.83 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.458 ' CG2' ' HB2' ' B' ' 27' ' ' SER . 0.2 OUTLIER -82.17 108.7 15.83 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 17.35 109.209 179.989 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.47 ' NH1' ' HG3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -124.56 146.62 48.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 34.38 109.417 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 16' ' ' ARG . 1.5 m -44.09 143.73 1.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 38.77 109.405 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -147.74 175.56 27.01 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.154 -1.578 . . . . 34.58 109.154 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' B' ' 21' ' ' ARG . 0.5 OUTLIER -149.96 118.64 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.13 -1.217 . . . . 41.87 109.087 179.421 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' B' ' 21' ' ' ARG . 1.3 m -61.87 83.51 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.363 -0.836 . . . . 47.21 109.535 -179.213 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' B' ' 20' ' ' SER . 19.6 mtt180 68.45 -61.93 0.39 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.315 -0.865 . . . . 71.56 109.466 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' B' ' 20' ' ' SER . 15.8 pt20 174.27 45.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 66.6 109.585 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.71 -57.04 0.25 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.581 -1.408 . . . . 55.49 109.581 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.439 ' HB2' ' HD2' ' B' ' 25' ' ' PRO . 5.9 pttt -143.0 158.89 58.06 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 44.99 109.419 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' B' ' 24' ' ' LYS . 34.7 Cg_endo -77.58 124.1 6.81 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.639 2.226 . . . . 44.1 110.808 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.583 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 3.8 p90 -130.0 136.35 49.32 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.262 -0.899 . . . . 32.09 109.67 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.458 ' HB2' ' CG2' ' B' ' 15' ' ' THR . 0.0 OUTLIER -103.99 80.26 1.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.9 . . . . 29.25 108.623 179.651 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.543 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.4 OUTLIER -89.33 138.64 31.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 24.0 110.408 -178.995 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.664 ' N ' ' OD1' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -47.56 117.81 1.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.434 -0.791 . . . . 23.31 109.627 179.668 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -112.77 148.02 35.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.218 -0.926 . . . . 40.03 109.584 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.542 ' CB ' HG21 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -131.6 -169.81 2.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.219 -0.926 . . . . 12.39 109.236 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.548 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -128.53 177.63 6.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.289 -0.882 . . . . 17.42 109.276 179.889 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.477 ' SG ' ' HB ' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -172.51 162.56 5.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.992 -1.067 . . . . 13.84 108.4 -179.653 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.646 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 4.1 m-30 -114.51 95.36 5.22 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.125 -0.984 . . . . 21.14 109.203 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.545 ' CG2' HG21 ' B' ' 4' ' ' VAL . 92.6 t -84.92 115.41 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.028 -1.045 . . . . 10.66 110.27 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' B' ' 39' ' ' ASN . 1.1 t0 -66.0 -22.71 66.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.389 -0.819 . . . . 25.89 108.862 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.529 HD12 ' CA ' ' A' ' 69' ' ' LYS . 0.8 OUTLIER 43.23 26.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 24.24 109.55 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 58.64 22.56 53.18 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.862 -1.295 . . . . 31.02 109.862 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 19.1 p30 -100.89 27.66 5.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.016 -1.285 . . . . 43.23 110.034 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.631 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 12.2 mt-10 47.88 71.87 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 42.34 109.817 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.631 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 0.2 OUTLIER 142.89 144.44 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.196 0 N-CA-C 108.591 -0.892 . . . . 6.56 108.591 179.48 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.646 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.7 Cg_endo -79.56 143.14 16.79 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.235 1.957 . . . . 17.92 110.762 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.53 HG22 ' CG1' ' A' ' 70' ' ' VAL . 7.1 m -120.73 119.12 58.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.446 -0.946 . . . . 20.57 108.446 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.641 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 17.0 tp -66.71 112.96 4.48 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.413 -0.804 . . . . 20.21 109.294 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.575 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 3.7 t -119.71 168.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.552 -0.718 . . . . 10.81 109.553 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.575 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.5 OUTLIER -90.64 149.84 21.93 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.443 -0.786 . . . . 36.74 110.007 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.596 HG12 ' CE1' ' B' ' 56' ' ' TYR . 1.6 tt -130.11 176.95 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.836 -0.801 . . . . 19.74 108.836 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.57 134.94 51.78 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.228 -0.92 . . . . 22.56 109.149 179.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.608 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -104.48 100.07 9.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.169 -0.957 . . . . 20.41 109.05 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.8 156.44 37.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 33.99 109.642 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.25 136.77 57.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.867 . . . . 54.92 109.245 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.76 -34.56 4.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.388 -1.485 . . . . 36.1 109.388 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.482 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 4.3 mt-30 -77.71 123.99 86.49 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.234 -1.157 . . . . 54.76 109.202 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.476 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.8 Cg_endo -78.54 138.06 15.1 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.343 2.029 . . . . 28.37 110.478 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.541 ' CB ' ' OE1' ' B' ' 31' ' ' GLN . . . -35.62 137.78 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.384 0.612 . . . . 17.21 110.478 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 84.6 m-85 -51.28 109.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 17.19 109.558 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.48 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -59.72 174.25 0.46 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 17.82 109.27 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.26 109.53 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.541 2.161 . . . . 17.28 110.193 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.08 179.52 48.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.83 -1.308 . . . . 17.22 109.83 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -75.2 143.73 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -1.14 . . . . 19.57 108.474 179.263 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.593 ' CE1' HD11 ' B' ' 6' ' ' ILE . 27.0 m-85 -132.04 164.57 25.92 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.835 -1.165 . . . . 14.61 111.173 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' B' ' 1' ' ' MET . 31.9 p -143.99 119.0 10.0 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 105.907 -1.886 . . . . 18.36 105.907 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.593 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.5 t -52.52 166.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 C-N-CA 118.42 -1.312 . . . . 19.13 108.941 -178.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.512 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -129.26 128.73 43.84 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.413 -0.804 . . . . 20.65 109.287 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.678 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -71.23 0.17 8.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.621 -0.674 . . . . 19.65 110.11 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -57.2 -17.7 12.52 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.67 -1.233 . . . . 14.72 107.67 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' B' ' 80' ' ' ARG . 51.1 m -96.23 -8.78 32.03 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.773 -0.58 . . . . 11.45 110.255 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.678 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.8 m-30 -77.3 155.01 32.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.023 -1.048 . . . . 14.25 109.542 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.525 ' CA ' HD12 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -134.83 172.58 12.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.424 -0.797 . . . . 32.7 109.703 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' A' ' 43' ' ' VAL . 9.5 t -124.14 133.31 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.462 -0.774 . . . . 15.63 109.387 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.37 -157.3 27.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.506 -1.438 . . . . 12.7 109.506 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' B' ' 72' ' ' GLN . 6.5 tp-100 55.68 72.27 0.5 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -1.164 . . . . 26.29 109.131 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.1 OUTLIER 73.44 5.94 5.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 20.44 109.467 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 45' ' ' VAL . . . 78.32 45.1 10.26 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.547 -1.421 . . . . 13.82 109.547 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' B' ' 77' ' ' MET . 0.3 OUTLIER -127.13 119.57 26.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -1.1 . . . . 18.27 109.755 -179.916 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.53 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.8 OUTLIER -54.94 144.54 22.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 12.43 109.152 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 31.1 mtp -160.14 141.1 12.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 35.11 109.749 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.613 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.3 mp -68.87 141.83 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 13.67 109.775 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.468 ' HB2' ' HG2' ' B' ' 69' ' ' LYS . 39.1 t0 -108.66 -21.23 12.79 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.685 -0.857 . . . . 24.06 108.685 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.474 ' O ' ' OG ' ' B' ' 67' ' ' SER . 0.0 OUTLIER 174.08 66.58 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.075 -1.454 . . . . 35.04 107.075 179.541 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.593 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -28.01 119.98 0.11 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.27 -0.877 . . . . 18.72 111.893 -178.097 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 5.4 ttp180 -93.38 103.09 15.34 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.814 -1.18 . . . . 20.55 107.814 178.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.604 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 7.0 tp -74.35 149.59 40.5 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.113 -0.992 . . . . 14.4 111.148 -178.237 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.491 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 17.6 m -146.19 153.14 48.4 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.224 -1.028 . . . . 17.65 108.224 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 26.5 Cg_endo -64.6 143.34 81.0 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.155 1.903 . . . . 25.7 110.397 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' B' ' 60' ' ' LEU . . . -77.38 123.82 27.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.87 . . . . 49.29 109.643 -178.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.04 -0.981 . . . . 58.91 109.433 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 tpp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.489 -0.559 . . . . 64.91 109.489 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.512 ' N ' HD23 ' B' ' 65' ' ' LEU . 2.1 mt -59.46 84.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.962 -1.125 . . . . 33.8 107.962 179.297 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 1' ' ' MET . 15.3 mtpp -67.1 152.5 45.65 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.827 0.823 . . . . 32.72 111.306 -178.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.585 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -164.15 167.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 108.381 -0.97 . . . . 14.46 108.381 179.593 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.572 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 24.3 mt-10 -141.08 118.0 11.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.336 -0.853 . . . . 22.12 109.361 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.596 HG13 ' CE1' ' A' ' 61' ' ' TYR . 10.4 mm -75.71 92.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.919 -1.141 . . . . 14.23 107.919 179.163 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.641 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -44.89 171.66 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 25.43 110.19 -178.677 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -74.73 -29.28 8.89 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.481 2.121 . . . . 13.61 109.728 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -6.74 58.17 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.762 -0.829 . . . . 15.52 108.762 178.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 1.3 mm100 -118.35 40.56 3.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.417 -0.802 . . . . 17.31 109.342 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -103.69 7.96 37.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.092 -1.005 . . . . 24.78 109.646 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 37.5 mt-30 -138.05 138.89 39.24 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.323 -0.861 . . . . 47.9 109.624 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.64 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 36.1 p90 -92.13 161.32 14.79 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.15 -0.969 . . . . 21.61 108.76 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.1 m -130.02 152.54 49.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.103 -0.998 . . . . 14.89 109.687 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.87 109.69 22.35 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.333 -0.854 . . . . 17.35 109.314 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 18' ' ' GLY . 5.0 mtp180 -123.64 152.35 42.07 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.319 -0.863 . . . . 34.38 109.06 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -57.77 84.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 38.77 109.366 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.549 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -77.68 160.43 48.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.314 -1.515 . . . . 34.58 109.314 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 1.6 t -128.76 124.1 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.116 -1.226 . . . . 41.87 108.964 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -92.14 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.23 -0.919 . . . . 47.21 109.63 -179.134 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.513 ' HG2' ' NH1' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -90.14 -54.97 3.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.307 -0.87 . . . . 71.56 109.475 179.939 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.79 38.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 66.6 109.792 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -168.31 36.39 0.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.373 -1.491 . . . . 55.49 109.373 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.539 ' CG ' ' O ' ' A' ' 23' ' ' GLY . 2.8 mttp -170.36 102.15 0.43 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.495 -1.003 . . . . 44.99 108.745 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 33.5 Cg_endo -75.71 68.46 6.31 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.161 1.907 . . . . 44.1 110.805 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.2 p90 -63.05 137.67 58.33 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.349 -0.844 . . . . 32.09 109.436 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 m -99.86 78.8 2.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.124 -0.985 . . . . 29.25 108.866 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.576 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -100.4 160.75 14.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 24.0 110.451 -179.009 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.626 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 98.0 m-20 -78.33 129.59 35.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.496 -0.752 . . . . 23.31 109.277 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -123.28 149.06 45.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 40.03 109.17 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -136.33 -170.17 2.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 12.39 109.65 -179.985 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.543 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 5.9 mp -132.03 174.49 10.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.327 -0.858 . . . . 17.42 109.526 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -162.69 159.37 24.29 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.258 -1.015 . . . . 13.84 108.258 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 15.0 m-85 -114.77 96.64 5.83 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.152 -0.968 . . . . 21.14 109.384 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.514 ' CG1' ' HG ' ' A' ' 37' ' ' LEU . 3.0 t -105.18 127.5 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 10.66 110.461 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 16.8 p-10 -86.48 -27.54 24.01 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.496 -0.927 . . . . 25.89 108.496 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.514 ' HG ' ' CG1' ' A' ' 35' ' ' VAL . 0.4 OUTLIER 47.4 23.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 24.24 109.625 179.775 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.27 8.03 69.05 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.976 -1.25 . . . . 31.02 109.976 179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' CG ' ' O ' ' A' ' 36' ' ' ASP . 1.7 m-20 -87.07 19.21 3.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.094 -1.239 . . . . 43.23 110.008 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 5.1 mt-10 45.98 72.03 0.25 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 42.34 109.862 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.61 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER 143.64 147.65 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.207 0 N-CA-C 108.6 -0.889 . . . . 7.76 108.6 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.692 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -79.5 137.5 13.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.068 1.845 . . . . 17.92 110.542 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 2.8 m -114.53 118.7 59.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.35 -0.844 . . . . 20.57 108.827 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 56.7 tp -76.48 106.65 8.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.435 -0.791 . . . . 20.21 110.661 -178.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.558 ' CG1' ' CG1' ' B' ' 70' ' ' VAL . 21.2 m -115.24 -169.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.816 -0.809 . . . . 10.81 108.816 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -108.48 152.01 25.29 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.333 -0.947 . . . . 36.74 110.395 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.63 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -141.41 126.15 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.57 -0.706 . . . . 19.74 109.141 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -64.36 147.12 53.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.062 . . . . 22.56 109.357 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.64 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 2.9 tm? -124.31 73.09 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 20.41 109.235 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 2.0 t70 -134.96 -175.48 3.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.916 -1.115 . . . . 33.99 109.72 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 53' ' ' GLN . 16.0 tt0 69.82 67.66 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.414 -0.804 . . . . 54.92 109.558 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 51' ' ' GLU . . . 38.17 27.85 0.04 OUTLIER Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.522 -1.031 . . . . 36.1 110.522 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 51' ' ' GLU . 3.5 mt-30 -105.96 125.58 32.8 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 120.897 -1.355 . . . . 54.76 109.913 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.8 Cg_endo -78.73 146.35 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.313 2.008 . . . . 28.37 109.677 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -37.93 143.27 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.439 -0.788 . . . . 17.21 110.496 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE1' HG12 ' A' ' 47' ' ' ILE . 79.5 m-85 -58.54 107.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.498 -0.751 . . . . 17.19 109.273 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -57.58 173.33 0.36 Allowed Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.107 -0.996 . . . . 17.82 108.983 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.8 Cg_endo -78.28 107.89 2.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.486 2.124 . . . . 17.28 110.09 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.23 179.32 47.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.963 -1.255 . . . . 17.22 109.963 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -77.12 137.74 39.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.385 -1.068 . . . . 19.57 108.642 179.203 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.596 ' CE1' HG13 ' A' ' 6' ' ' ILE . 26.9 m-85 -128.55 163.21 25.48 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.751 -1.218 . . . . 14.61 111.569 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 43.5 p -141.74 117.58 10.47 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.163 -1.791 . . . . 18.36 106.163 177.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.61 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -50.14 164.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 118.77 -1.172 . . . . 19.13 108.936 -178.185 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.3 t-80 -128.39 129.13 45.74 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.504 -0.747 . . . . 20.65 109.113 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.635 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -72.59 2.19 6.88 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.519 -0.738 . . . . 19.65 109.985 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -18.91 30.66 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.002 -1.481 . . . . 14.72 107.002 178.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.478 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 14.7 m -96.19 -9.64 30.05 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.9 -0.5 . . . . 11.45 109.907 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.635 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 3.4 m-30 -78.05 154.37 31.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.112 -0.992 . . . . 14.25 109.951 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 3.8 mtmt -157.6 -178.38 7.29 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.528 -0.733 . . . . 32.7 109.182 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.565 ' CG1' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -109.96 105.82 19.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.434 -0.791 . . . . 15.63 109.132 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.22 -155.0 12.15 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.994 -1.243 . . . . 12.7 109.994 -179.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.478 ' NE2' ' HA ' ' A' ' 72' ' ' GLN . 12.6 tp60 -98.55 42.47 1.09 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.321 -1.105 . . . . 26.29 109.68 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 74' ' ' GLY . 2.8 m-85 -129.22 22.14 5.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 20.44 109.625 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 73' ' ' PHE . . . 44.79 52.56 7.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.627 -1.389 . . . . 13.82 109.627 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 76' ' ' LEU . 16.8 t -176.66 130.18 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -1.116 . . . . 18.27 109.448 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.508 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.1 OUTLIER -44.1 160.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.907 . . . . 12.43 109.159 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.4 mtt -163.7 118.67 1.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 35.11 109.585 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.608 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.3 mp -54.07 138.14 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 13.67 109.324 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -105.77 -34.8 7.56 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.011 -1.107 . . . . 24.06 108.011 178.516 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.478 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.2 OUTLIER -170.12 67.07 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.169 -1.419 . . . . 35.04 107.169 178.804 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.61 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.7 OUTLIER -27.99 120.05 0.11 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.21 -0.905 . . . . 18.72 111.859 -178.177 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -91.61 102.06 14.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 20.55 108.545 179.063 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -70.21 140.86 52.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.369 -0.832 . . . . 14.4 110.807 -178.818 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 62' ' ' THR . 33.5 m -140.61 148.8 54.67 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.774 -1.195 . . . . 17.65 107.774 178.688 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.8 Cg_endo -63.08 141.12 82.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.05 1.834 . . . . 25.7 110.265 179.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 60' ' ' LEU . . . -71.83 108.44 5.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.309 -0.869 . . . . 49.29 109.461 -178.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.008 -0.996 . . . . 58.91 109.438 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.3 tpp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.474 -0.565 . . . . 64.91 109.474 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.516 ' N ' HD23 ' A' ' 65' ' ' LEU . 2.1 mt -59.41 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.033 -1.099 . . . . 33.8 108.033 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' ' 1' ' ' MET . 15.2 mtpp -67.02 152.18 46.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.841 0.829 . . . . 32.72 111.265 -178.039 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.594 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -163.8 168.18 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.462 -0.94 . . . . 14.46 108.462 179.481 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.568 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 25.2 mt-10 -141.17 118.0 11.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.337 -0.852 . . . . 22.12 109.363 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.585 HG13 ' CE1' ' B' ' 61' ' ' TYR . 10.4 mm -75.85 92.53 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.869 -1.16 . . . . 14.23 107.869 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.643 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.79 171.39 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.916 . . . . 25.43 110.189 -178.735 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.5 Cg_endo -74.65 -28.83 9.5 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.462 2.108 . . . . 13.61 109.85 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.51 -6.73 58.62 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.741 -0.837 . . . . 15.52 108.741 178.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 1.2 mm100 -118.28 40.26 3.23 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.418 -0.801 . . . . 17.31 109.306 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -103.62 8.98 37.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 24.78 109.711 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.437 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 37.2 mt-30 -138.99 138.68 37.47 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.286 -0.884 . . . . 47.9 109.638 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.638 ' CD2' ' CD1' ' B' ' 49' ' ' LEU . 36.1 p90 -91.92 161.32 14.87 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.176 -0.952 . . . . 21.61 108.815 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 96.7 m -130.28 152.05 50.12 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.103 -0.998 . . . . 14.89 109.667 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.36 110.14 22.54 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.395 -0.816 . . . . 17.35 109.354 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' B' ' 18' ' ' GLY . 4.8 mtp180 -124.26 151.91 43.63 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.298 -0.876 . . . . 34.38 109.012 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 17.8 t -57.32 84.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 38.77 109.406 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.552 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -77.81 160.46 48.7 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.316 -1.514 . . . . 34.58 109.316 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' B' ' 24' ' ' LYS . 1.5 t -128.77 124.03 60.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.129 -1.218 . . . . 41.87 108.955 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -92.27 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.235 -0.916 . . . . 47.21 109.656 -179.103 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.528 ' NH1' ' HG2' ' B' ' 21' ' ' ARG . 0.0 OUTLIER -90.02 -55.02 3.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 71.56 109.403 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.98 38.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.192 -0.942 . . . . 66.6 109.812 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.547 ' O ' ' CG ' ' B' ' 24' ' ' LYS . . . -168.24 36.14 0.21 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.416 -1.474 . . . . 55.49 109.416 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' B' ' 23' ' ' GLY . 2.8 mttp -170.12 102.21 0.44 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.506 -0.996 . . . . 44.99 108.761 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 33.7 Cg_endo -75.58 68.08 6.28 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.172 1.915 . . . . 44.1 110.816 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.612 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 6.1 p90 -62.72 137.59 58.3 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.348 -0.845 . . . . 32.09 109.396 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -100.12 78.67 2.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 29.25 108.917 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.58 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -100.21 160.55 14.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 24.0 110.475 -179.005 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.617 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 97.9 m-20 -77.95 130.01 36.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 23.31 109.141 179.559 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -123.58 148.95 45.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 40.03 109.047 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.522 ' NE2' ' O ' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -136.24 -170.14 2.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.111 -0.993 . . . . 12.39 109.648 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.532 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 5.9 mp -132.19 174.35 10.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.38 -0.825 . . . . 17.42 109.455 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -162.53 159.58 24.99 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.273 -1.01 . . . . 13.84 108.273 -179.547 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.691 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 14.9 m-85 -115.06 96.52 5.73 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.204 -0.935 . . . . 21.14 109.358 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.508 ' O ' ' CG2' ' B' ' 43' ' ' VAL . 3.1 t -105.09 127.62 59.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.163 -0.961 . . . . 10.66 110.491 -179.495 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 16.7 p-10 -86.52 -27.43 24.01 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.512 -0.922 . . . . 25.89 108.512 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.508 ' HG ' ' CG1' ' B' ' 35' ' ' VAL . 0.4 OUTLIER 47.3 23.93 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 24.24 109.486 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.83 8.47 69.6 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.961 -1.256 . . . . 31.02 109.961 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.447 ' CG ' ' O ' ' B' ' 36' ' ' ASP . 2.1 m-20 -87.23 18.62 3.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -1.219 . . . . 43.23 109.942 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.6 ' O ' ' CB ' ' B' ' 41' ' ' HIS . 5.3 mt-10 46.76 71.37 0.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.89 . . . . 42.34 109.822 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.6 ' CB ' ' O ' ' B' ' 40' ' ' GLU . 0.2 OUTLIER 144.09 147.77 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.251 0 N-CA-C 108.57 -0.9 . . . . 7.67 108.57 179.383 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.691 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 38.4 Cg_endo -79.38 137.37 13.18 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.148 1.899 . . . . 17.92 110.52 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 2.8 m -114.53 118.54 58.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.331 -0.856 . . . . 20.57 108.871 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 56.8 tp -76.45 106.98 8.4 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.361 -0.837 . . . . 20.21 110.638 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.565 ' CG1' ' CG1' ' A' ' 70' ' ' VAL . 22.0 m -115.65 -169.55 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.862 -0.792 . . . . 10.81 108.862 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -108.22 151.8 25.44 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.334 -0.947 . . . . 36.74 110.44 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.643 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -141.23 126.14 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.503 -0.748 . . . . 19.74 109.056 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -64.49 146.88 53.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.002 -1.061 . . . . 22.56 109.322 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.638 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 2.9 tm? -123.95 73.1 1.19 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 20.41 109.281 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' B' ' 53' ' ' GLN . 1.9 t70 -134.86 -175.46 3.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.941 -1.099 . . . . 33.99 109.8 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' B' ' 53' ' ' GLN . 16.5 tt0 69.84 67.73 0.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.348 -0.845 . . . . 54.92 109.588 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' B' ' 51' ' ' GLU . . . 38.07 28.04 0.04 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.537 -1.025 . . . . 36.1 110.537 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' B' ' 51' ' ' GLU . 3.3 mt-30 -106.13 125.71 32.38 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.888 -1.36 . . . . 54.76 109.894 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.454 ' C ' HD22 ' B' ' 49' ' ' LEU . 35.4 Cg_endo -78.8 146.62 21.03 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.408 2.072 . . . . 28.37 109.68 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.504 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -38.24 143.37 0.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.45 -0.781 . . . . 17.21 110.479 -179.291 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.643 ' CE1' HG12 ' B' ' 47' ' ' ILE . 79.9 m-85 -58.49 106.99 0.44 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.458 -0.776 . . . . 17.19 109.201 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.451 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -57.58 173.29 0.37 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.105 -0.997 . . . . 17.82 109.076 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' B' ' 6' ' ' ILE . 35.5 Cg_endo -78.05 107.12 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.491 2.127 . . . . 17.28 110.031 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.15 179.26 46.52 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.576 -1.297 . . . . 17.22 110.106 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -77.42 137.4 38.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.405 -1.056 . . . . 19.57 108.445 179.121 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.594 ' CB ' HG12 ' B' ' 4' ' ' VAL . 26.9 m-85 -128.38 163.09 25.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.691 -1.255 . . . . 14.61 111.492 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' B' ' 2' ' ' ILE . 43.8 p -141.57 118.01 10.86 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.145 -1.798 . . . . 18.36 106.145 177.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -50.64 165.16 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 118.74 -1.184 . . . . 19.13 108.947 -178.171 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -128.51 129.15 45.64 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.5 -0.75 . . . . 20.65 109.142 -179.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.647 ' CB ' ' CD2' ' B' ' 68' ' ' PHE . 0.8 OUTLIER -72.57 2.24 6.77 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.54 -0.725 . . . . 19.65 109.964 179.777 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.21 -19.51 34.16 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.843 -1.539 . . . . 14.72 106.843 178.386 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.483 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 14.4 m -95.68 -9.49 31.84 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.931 -0.481 . . . . 11.45 110.027 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.647 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.4 m-30 -78.06 154.18 31.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.037 . . . . 14.25 109.897 -178.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -157.53 -178.93 7.7 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.538 -0.726 . . . . 32.7 109.159 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.558 ' CG1' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -109.44 105.98 19.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.456 -0.778 . . . . 15.63 109.09 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.26 -154.37 11.43 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.981 -1.248 . . . . 12.7 109.981 -179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.491 ' NE2' ' HA ' ' B' ' 72' ' ' GLN . 12.5 tp60 -99.08 42.22 1.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -1.09 . . . . 26.29 109.661 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -128.91 21.95 5.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.895 . . . . 20.44 109.613 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.98 52.74 7.81 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.563 -1.415 . . . . 13.82 109.563 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.422 ' O ' ' C ' ' B' ' 76' ' ' LEU . 17.0 t -176.99 129.93 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 18.27 109.435 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.508 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.1 OUTLIER -43.79 159.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.877 . . . . 12.43 109.138 179.976 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.5 mtt -163.38 118.99 1.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 35.11 109.54 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.616 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.2 mp -54.38 138.5 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.193 -0.942 . . . . 13.67 109.354 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' B' ' 67' ' ' SER . 0.2 OUTLIER -106.13 -34.73 7.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.111 -1.07 . . . . 24.06 108.111 178.515 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.483 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.2 OUTLIER -170.21 66.56 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.275 -1.38 . . . . 35.04 107.275 178.816 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.616 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.7 OUTLIER -27.62 120.04 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.113 -0.949 . . . . 18.72 111.731 -178.161 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -91.78 101.95 14.55 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 20.55 108.53 179.097 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.602 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -70.27 140.67 52.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 14.4 110.84 -178.727 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' B' ' 62' ' ' THR . 33.6 m -140.41 148.79 55.16 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.843 -1.169 . . . . 17.65 107.843 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.0 Cg_endo -63.06 141.11 82.22 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.995 1.797 . . . . 25.7 110.326 179.338 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' B' ' 60' ' ' LEU . . . -71.53 108.27 4.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 49.29 109.466 -178.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.035 -0.983 . . . . 58.91 109.489 179.999 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.1 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.579 -0.526 . . . . 64.91 109.579 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.524 ' CG2' HG22 ' A' ' 63' ' ' VAL . 3.3 mt -64.16 78.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.592 -1.262 . . . . 33.8 107.592 178.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -71.0 177.23 3.82 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.104 0.954 . . . . 32.72 111.549 -177.771 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.588 ' CG1' ' CB ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER 176.35 163.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.739 -0.837 . . . . 14.46 108.739 179.753 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.524 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 26.1 mt-10 -137.96 108.36 6.51 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.63 0.728 . . . . 22.12 109.093 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.596 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -71.94 100.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 C-N-CA 118.906 -1.118 . . . . 14.23 108.07 179.615 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.581 ' HE2' ' CE2' ' A' ' 34' ' ' TYR . 6.7 mptt -44.67 170.17 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.343 -0.848 . . . . 25.43 109.902 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 32.1 Cg_endo -73.67 -27.48 12.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.275 1.984 . . . . 13.61 109.78 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 p -86.35 -2.92 58.84 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.613 -0.884 . . . . 15.52 108.613 178.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.7 mm-40 -118.75 41.29 3.05 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.429 -0.794 . . . . 17.31 109.119 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.426 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -104.88 14.72 29.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.076 -1.015 . . . . 24.78 109.999 -179.38 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.464 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 29.6 mt-30 -142.24 146.59 35.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.165 -0.959 . . . . 47.9 109.68 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.598 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 34.9 p90 -93.84 159.42 15.2 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.296 -0.878 . . . . 21.61 109.537 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 t -134.76 162.67 31.7 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.449 -0.945 . . . . 14.89 108.449 178.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.8 119.17 31.87 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.217 -0.927 . . . . 17.35 109.162 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 17' ' ' SER . 0.4 OUTLIER -145.89 84.14 1.65 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.113 -0.992 . . . . 34.38 110.024 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 16' ' ' ARG . 42.0 m 55.81 161.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 38.77 110.178 179.337 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 26' ' ' TYR . . . -179.15 160.29 25.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.303 -1.519 . . . . 34.58 109.303 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.539 ' N ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -158.34 118.93 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -1.168 . . . . 41.87 109.408 179.178 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.7 m -58.54 -77.49 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.849 . . . . 47.21 109.584 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.16 60.94 1.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 71.56 109.499 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.53 23.35 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.938 . . . . 66.6 109.544 -179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.8 -43.34 1.82 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.161 -1.576 . . . . 55.49 109.161 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.426 ' O ' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -155.45 158.52 31.92 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.34 -1.094 . . . . 44.99 109.01 179.757 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.1 Cg_endo -76.8 157.77 35.2 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.549 2.166 . . . . 44.1 110.765 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -161.37 45.27 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -0.996 . . . . 32.09 110.189 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.573 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -7.18 73.8 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 121.23 0.538 . . . . 29.25 111.717 -179.78 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.595 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -78.21 144.6 36.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.262 -0.899 . . . . 24.0 110.1 -179.391 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.589 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 99.1 m-20 -59.16 130.53 47.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.821 . . . . 23.31 109.48 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -121.27 152.49 38.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.944 . . . . 40.03 108.949 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.539 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -133.13 -170.93 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 12.39 109.789 -179.634 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 2.1 mp -130.49 174.83 9.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 17.42 108.872 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -171.85 162.88 6.22 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 13.84 108.699 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.652 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 3.0 m-30 -114.87 90.22 3.29 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.226 -0.921 . . . . 21.14 108.817 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.532 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 94.0 t -89.94 119.77 37.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.197 -0.939 . . . . 10.66 110.32 -179.234 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.539 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 48.7 m-20 -68.48 -30.96 69.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.509 -0.923 . . . . 25.89 108.509 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.461 HD21 ' OD1' ' A' ' 39' ' ' ASN . 1.0 OUTLIER 48.17 30.98 2.35 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.503 -0.748 . . . . 24.24 109.318 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.31 9.69 64.66 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.391 -1.484 . . . . 31.02 109.391 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' OD1' HD21 ' A' ' 37' ' ' LEU . 1.4 m-20 -81.95 14.01 3.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -1.168 . . . . 43.23 110.659 -179.437 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.58 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 10.0 mt-10 57.23 15.61 2.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.131 -0.981 . . . . 42.34 110.093 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 63.3 m80 -164.74 149.4 8.17 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.683 -1.228 . . . . 6.32 107.683 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.643 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.1 Cg_endo -74.81 146.19 33.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.653 1.569 . . . . 17.92 110.631 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 12.5 m -123.5 116.2 47.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 119.531 -0.868 . . . . 20.57 108.78 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.652 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 21.9 tp -68.92 104.98 2.22 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.296 -0.962 . . . . 20.21 108.678 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.435 HG23 ' O ' ' B' ' 74' ' ' GLY . 9.1 p -120.0 163.09 17.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.587 -0.695 . . . . 10.81 109.275 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' B' ' 74' ' ' GLY . 0.0 OUTLIER -82.47 157.64 23.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 36.74 110.28 -179.055 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.623 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -138.7 176.38 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.282 -1.007 . . . . 19.74 108.282 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.92 144.23 42.84 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.042 -1.036 . . . . 22.56 109.38 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.598 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 2.9 tm? -128.57 122.61 31.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.29 -0.881 . . . . 20.41 109.037 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -53.51 159.44 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 33.99 109.999 -179.279 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -70.05 108.96 4.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.403 -0.81 . . . . 54.92 109.497 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.79 -13.5 67.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.561 -1.416 . . . . 36.1 109.561 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -67.07 157.03 86.3 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.227 -1.161 . . . . 54.76 109.536 179.98 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -78.35 106.69 2.18 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.564 2.176 . . . . 28.37 110.254 179.677 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.495 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -41.95 160.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.386 -0.821 . . . . 17.21 110.028 -179.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.623 ' CE1' HG12 ' A' ' 47' ' ' ILE . 75.5 m-85 -58.4 104.98 0.25 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.406 -0.809 . . . . 17.19 108.838 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.521 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -57.44 176.14 0.24 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 17.82 109.418 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.0 Cg_endo -77.79 120.06 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.532 2.154 . . . . 17.28 110.166 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.66 177.42 39.06 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.779 -1.328 . . . . 17.22 109.779 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -72.04 149.37 44.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -1.187 . . . . 19.57 108.269 179.139 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 6' ' ' ILE . 22.2 m-85 -133.34 163.36 29.51 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.77 -1.206 . . . . 14.61 111.705 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 34.2 p -147.93 120.08 8.31 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.456 -1.683 . . . . 18.36 106.456 178.385 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.609 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 5.7 t -51.82 170.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 C-N-CA 118.672 -1.211 . . . . 19.13 108.955 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.477 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.9 t-80 -134.67 125.93 28.08 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.421 -0.799 . . . . 20.65 109.187 -179.237 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.661 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -72.27 1.08 8.31 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.27 -0.894 . . . . 19.65 109.802 179.724 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.3 p -57.64 -19.17 24.55 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.521 -1.289 . . . . 14.72 107.521 178.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 9.7 m -96.76 -18.57 19.53 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.772 -0.58 . . . . 11.45 110.128 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.661 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.6 m-30 -66.29 158.48 28.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 14.25 109.346 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 0.0 OUTLIER -140.46 178.89 7.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 32.7 109.769 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.463 HG22 HG23 ' B' ' 43' ' ' VAL . 1.7 t -126.12 129.77 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.509 -0.744 . . . . 15.63 109.495 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.21 -170.67 25.33 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.677 -1.369 . . . . 12.7 109.677 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' CB ' ' A' ' 73' ' ' PHE . 25.9 tp60 69.5 80.76 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -1.148 . . . . 26.29 109.358 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.504 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 3.0 m-85 75.34 12.03 3.32 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.424 -0.798 . . . . 20.44 109.462 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' B' ' 46' ' ' LYS . . . 70.77 47.77 38.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.558 -1.417 . . . . 13.82 109.558 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -144.03 144.48 31.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -1.168 . . . . 18.27 109.639 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 77' ' ' MET . 1.0 OUTLIER -50.73 169.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 12.43 109.187 179.776 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 2.3 mtp -165.52 106.01 0.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 35.11 110.25 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.573 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -42.43 -63.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.513 -0.742 . . . . 13.67 109.403 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 9.5 t70 83.34 -45.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.392 0.615 . . . . 24.06 110.039 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.7 tpm_? -174.24 66.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.113 0.958 . . . . 35.04 108.632 179.646 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.609 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.5 pt? -36.07 128.81 0.7 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.668 0.747 . . . . 18.72 111.527 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -94.52 104.67 16.62 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.248 -1.019 . . . . 20.55 108.248 178.721 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.617 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -74.23 147.26 42.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 14.4 110.898 -178.761 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 62' ' ' THR . 32.5 m -148.37 155.85 42.59 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.09 -1.078 . . . . 17.65 108.09 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.8 Cg_endo -63.08 143.6 90.85 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.105 1.87 . . . . 25.7 110.322 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.457 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -69.81 125.43 26.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.228 -0.92 . . . . 49.29 109.702 -178.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.2 tptp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.004 -0.998 . . . . 58.91 109.512 -179.965 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.532 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.564 -0.532 . . . . 64.91 109.564 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' B' ' 63' ' ' VAL . 3.3 mt -64.2 78.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 33.8 107.657 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.9 OUTLIER -70.82 177.3 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.07 0.938 . . . . 32.72 111.542 -177.754 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.592 ' CG1' ' CB ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER 176.29 163.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.714 -0.847 . . . . 14.46 108.714 179.743 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 26.0 mt-10 -137.82 108.38 6.57 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.605 0.716 . . . . 22.12 109.103 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.58 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -71.94 100.18 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.95 -1.1 . . . . 14.23 108.075 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.58 ' HD3' ' CG ' ' B' ' 34' ' ' TYR . 6.7 mptt -44.75 170.05 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.33 -0.856 . . . . 25.43 109.898 -179.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.9 Cg_endo -73.59 -27.5 12.83 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.365 2.043 . . . . 13.61 109.722 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.2 p -86.39 -2.74 58.69 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.664 -0.865 . . . . 15.52 108.664 178.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.7 mm-40 -118.9 41.26 3.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.399 -0.813 . . . . 17.31 109.095 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.439 ' HB3' ' HD3' ' B' ' 58' ' ' PRO . . . -104.9 14.84 28.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.123 -0.986 . . . . 24.78 109.986 -179.374 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' B' ' 31' ' ' GLN . 29.7 mt-30 -142.35 146.48 35.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 47.9 109.742 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.594 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 34.5 p90 -93.79 159.32 15.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.338 -0.851 . . . . 21.61 109.615 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.3 t -134.78 162.49 32.21 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.496 -0.928 . . . . 14.89 108.496 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.68 119.12 31.77 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.166 -0.958 . . . . 17.35 109.18 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' B' ' 17' ' ' SER . 0.4 OUTLIER -145.88 84.22 1.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.125 -0.984 . . . . 34.38 109.953 -179.822 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.453 ' O ' ' O ' ' B' ' 16' ' ' ARG . 40.8 m 55.74 161.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 38.77 110.223 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.536 ' HA3' ' CD1' ' B' ' 26' ' ' TYR . . . -178.95 160.24 25.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.373 -1.491 . . . . 34.58 109.373 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.544 ' N ' ' CE1' ' B' ' 26' ' ' TYR . 0.6 OUTLIER -158.29 118.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -1.173 . . . . 41.87 109.464 179.13 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 74.6 m -58.56 -77.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.24 -0.913 . . . . 47.21 109.617 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.23 60.83 1.47 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 71.56 109.461 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.64 23.44 0.42 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 66.6 109.54 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.92 -43.24 1.82 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.175 -1.57 . . . . 55.49 109.175 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.43 ' O ' HG11 ' B' ' 19' ' ' VAL . 0.0 OUTLIER -155.54 158.55 31.89 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.388 -1.066 . . . . 44.99 108.978 179.703 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.5 Cg_endo -76.77 157.83 35.32 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.555 2.17 . . . . 44.1 110.724 -179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.6 ' CD1' ' C ' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -161.44 45.24 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.146 -0.971 . . . . 32.09 110.203 179.893 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.572 ' C ' ' O ' ' B' ' 26' ' ' TYR . 0.7 OUTLIER -7.13 73.8 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-O 121.256 0.55 . . . . 29.25 111.712 -179.783 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.596 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -78.21 144.5 36.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 24.0 110.146 -179.382 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.588 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 99.1 m-20 -59.06 130.58 47.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 23.31 109.439 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -121.34 152.41 39.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.948 . . . . 40.03 109.002 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.548 ' CB ' HG21 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -133.08 -170.8 2.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.09 -1.006 . . . . 12.39 109.84 -179.612 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.533 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 2.1 mp -130.61 174.76 9.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.834 -0.802 . . . . 17.42 108.834 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -171.91 162.67 6.09 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.877 -1.14 . . . . 13.84 108.725 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.646 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 3.0 m-30 -114.66 90.33 3.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.212 -0.93 . . . . 21.14 108.824 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 96.0 t -90.06 119.73 37.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.181 -0.949 . . . . 10.66 110.238 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.537 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 48.7 m-20 -68.36 -31.01 70.1 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.51 -0.922 . . . . 25.89 108.51 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.469 HD21 ' OD1' ' B' ' 39' ' ' ASN . 1.0 OUTLIER 48.27 31.03 2.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.548 -0.72 . . . . 24.24 109.252 179.804 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.28 9.52 64.28 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.438 -1.465 . . . . 31.02 109.438 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.469 ' OD1' HD21 ' B' ' 37' ' ' LEU . 1.4 m-20 -81.77 13.87 2.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -1.162 . . . . 43.23 110.726 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.574 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 10.0 mt-10 57.32 15.62 2.7 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.124 -0.985 . . . . 42.34 110.115 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 63.5 m80 -164.73 149.41 8.19 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 107.745 -1.206 . . . . 6.31 107.745 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.646 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.3 Cg_endo -74.83 146.15 33.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.648 1.565 . . . . 17.92 110.628 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' B' ' 35' ' ' VAL . 12.6 m -123.47 116.25 47.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 C-N-CA 119.495 -0.882 . . . . 20.57 108.816 179.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.635 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 21.8 tp -68.87 105.1 2.24 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.341 -0.943 . . . . 20.21 108.655 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 74' ' ' GLY . 9.1 p -120.15 163.08 18.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.534 -0.729 . . . . 10.81 109.228 -179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -82.55 157.59 23.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.394 -0.816 . . . . 36.74 110.328 -179.114 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.617 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -138.59 176.35 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.227 -1.027 . . . . 19.74 108.227 179.447 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 144.42 42.46 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.006 -1.059 . . . . 22.56 109.405 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 2.9 tm? -128.68 122.4 30.68 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.317 -0.865 . . . . 20.41 109.067 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 0.1 OUTLIER -53.38 159.34 1.43 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 33.99 110.033 -179.324 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -69.95 108.95 4.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.481 -0.762 . . . . 54.92 109.487 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.81 -13.57 67.16 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.563 -1.415 . . . . 36.1 109.563 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.492 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -67.03 157.18 85.71 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.218 -1.166 . . . . 54.76 109.487 179.962 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.0 Cg_endo -78.39 106.67 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.624 2.216 . . . . 28.37 110.257 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -42.0 160.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 17.21 109.976 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.617 ' CE1' HG12 ' B' ' 47' ' ' ILE . 75.2 m-85 -58.92 105.56 0.33 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.347 -0.846 . . . . 17.19 108.805 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.523 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -57.65 176.09 0.25 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.309 -0.869 . . . . 17.82 109.275 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.3 Cg_endo -78.03 121.12 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.637 2.225 . . . . 17.28 110.445 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.94 177.88 38.41 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.657 -1.377 . . . . 17.22 109.657 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.3 OUTLIER -71.73 150.0 44.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -1.182 . . . . 19.57 108.555 179.387 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.592 ' CB ' ' CG1' ' B' ' 4' ' ' VAL . 21.1 m-85 -134.02 163.31 29.85 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 120.763 -1.211 . . . . 14.61 111.702 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' B' ' 2' ' ' ILE . 33.9 p -147.98 120.25 8.38 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.445 -1.687 . . . . 18.36 106.445 178.402 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 5.9 t -52.04 169.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 118.631 -1.228 . . . . 19.13 108.965 -178.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.477 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -134.43 125.86 28.34 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.453 -0.779 . . . . 20.65 109.224 -179.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.648 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.7 OUTLIER -72.16 0.8 8.77 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.272 -0.893 . . . . 19.65 109.755 179.791 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 94.8 p -57.34 -19.24 21.39 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 107.53 -1.285 . . . . 14.72 107.53 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 10.3 m -96.69 -18.64 19.54 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.843 -0.536 . . . . 11.45 110.143 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.648 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.6 m-30 -66.26 157.89 30.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.004 . . . . 14.25 109.331 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.442 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.94 178.91 6.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 32.7 109.837 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.462 HG22 HG23 ' A' ' 43' ' ' VAL . 1.7 t -126.06 129.78 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.759 . . . . 15.63 109.535 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' B' ' 72' ' ' GLN . . . 143.19 -170.69 25.31 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.69 -1.364 . . . . 12.7 109.69 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.5 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 25.9 tp60 69.47 80.83 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -1.159 . . . . 26.29 109.341 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.5 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 3.0 m-85 75.33 11.9 3.35 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.443 -0.785 . . . . 20.44 109.49 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 45' ' ' VAL . . . 70.91 47.7 37.58 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.502 -1.439 . . . . 13.82 109.502 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -144.06 144.41 31.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -1.146 . . . . 18.27 109.635 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' B' ' 77' ' ' MET . 1.0 OUTLIER -50.66 169.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 12.43 109.151 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 2.3 mtp -165.58 105.95 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 35.11 110.303 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.8 mt -42.35 -64.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.568 -0.708 . . . . 13.67 109.416 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 9.4 t70 83.51 -45.16 0.11 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.4 0.619 . . . . 24.06 110.073 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.7 tpm_? -174.32 66.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.505 -0.924 . . . . 35.04 108.505 179.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.616 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.5 pt? -36.17 128.81 0.72 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.703 0.763 . . . . 18.72 111.545 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -94.5 104.44 16.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.29 -1.004 . . . . 20.55 108.29 178.791 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.611 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -73.98 147.39 43.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.189 -0.944 . . . . 14.4 110.842 -178.753 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.437 ' C ' ' CD2' ' B' ' 61' ' ' TYR . 32.6 m -148.66 155.64 41.58 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.046 -1.094 . . . . 17.65 108.046 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.9 Cg_endo -62.89 143.8 92.16 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.076 1.851 . . . . 25.7 110.328 179.074 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.462 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -69.96 125.63 27.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -0.907 . . . . 49.29 109.724 -178.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 7.2 tptp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.978 -1.01 . . . . 58.91 109.571 179.979 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' C ' HG13 ' A' ' 2' ' ' ILE . 2.8 ttm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.444 -0.576 . . . . 64.91 109.444 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.542 ' CG2' HG22 ' A' ' 63' ' ' VAL . 3.2 mt 69.66 64.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.705 -1.22 . . . . 33.8 107.705 -178.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 26.6 mttt -54.93 162.11 1.39 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.777 0.799 . . . . 32.72 111.28 -178.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.593 ' HB ' ' CB ' ' A' ' 61' ' ' TYR . 58.6 t -160.2 167.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.534 0.683 . . . . 14.46 109.53 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' N ' HG13 ' A' ' 4' ' ' VAL . 46.8 mt-10 -152.34 106.07 3.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.544 -0.722 . . . . 22.12 109.201 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.572 HD12 ' CE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -74.64 101.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.104 -1.073 . . . . 14.23 108.104 179.505 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.615 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.78 171.22 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.403 -0.81 . . . . 25.43 109.831 -179.324 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.4 Cg_endo -74.95 -28.45 9.26 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.463 2.109 . . . . 13.61 110.131 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.7 m -92.96 4.11 54.55 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.478 -0.764 . . . . 15.52 109.127 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.535 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 18.4 mm-40 -121.03 34.1 5.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 17.31 109.352 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 55' ' ' ALA . . . -106.89 18.55 21.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 24.78 110.284 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.408 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 19.2 mt-30 -137.57 129.39 28.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.067 -1.02 . . . . 47.9 109.864 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.555 ' CD2' ' CB ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.54 -174.32 3.32 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.425 -0.797 . . . . 21.61 110.578 -179.541 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.407 HG21 ' N ' ' A' ' 15' ' ' THR . 56.2 m -158.68 145.41 17.31 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.777 -0.823 . . . . 14.89 108.777 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.407 ' N ' HG21 ' A' ' 14' ' ' THR . 0.3 OUTLIER -83.2 116.82 22.55 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.244 -0.91 . . . . 17.35 109.625 -179.493 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -154.8 158.26 39.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 34.38 109.28 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 16' ' ' ARG . 4.7 t -42.23 145.25 0.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.481 -0.762 . . . . 38.77 109.516 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -147.9 168.77 28.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.398 -1.481 . . . . 34.58 109.398 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.465 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 2.0 t -147.04 122.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -1.206 . . . . 41.87 109.175 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 22' ' ' GLN . 0.1 OUTLIER -57.79 -156.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.878 . . . . 47.21 109.603 -179.543 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.515 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -67.58 58.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.166 -0.959 . . . . 71.56 109.782 -179.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.9 mt-30 62.86 20.84 12.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 66.6 109.584 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -98.11 -47.7 2.01 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.608 -1.397 . . . . 55.49 109.608 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 23' ' ' GLY . 19.3 mttt -158.99 159.82 29.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.269 -1.136 . . . . 44.99 109.429 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.7 Cg_endo -77.44 150.67 28.61 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.53 2.153 . . . . 44.1 110.372 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.588 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 5.1 p90 -155.39 140.54 17.48 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.199 -0.938 . . . . 32.09 109.9 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 m -102.3 79.97 1.91 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 29.25 108.677 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.584 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -105.63 173.41 6.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 24.0 110.096 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.555 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -74.5 111.19 9.44 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.725 -0.843 . . . . 23.31 108.725 179.602 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 14.9 mm-40 -82.63 -172.77 4.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.035 -1.04 . . . . 40.03 109.015 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 0.5 OUTLIER -171.18 179.92 2.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.073 -1.017 . . . . 12.39 110.249 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.465 ' O ' ' OE1' ' A' ' 31' ' ' GLN . 1.4 mt -140.5 148.56 41.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.579 -0.701 . . . . 17.42 109.174 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.4 m -152.04 -178.55 6.83 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.918 -1.141 . . . . 13.84 107.918 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.659 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 38.0 m-85 -128.01 106.21 8.93 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.053 -1.03 . . . . 21.14 109.395 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.536 ' CG2' HG21 ' A' ' 4' ' ' VAL . 73.8 t -98.1 141.3 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.072 -1.017 . . . . 10.66 111.168 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' N ' HG11 ' A' ' 35' ' ' VAL . 4.1 m-20 -111.15 35.72 3.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.008 -1.108 . . . . 25.89 108.008 178.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.568 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 2.0 pt? -40.94 -25.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.658 -0.651 . . . . 24.24 110.266 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 39' ' ' ASN . . . 176.8 47.33 0.06 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 108.983 -1.647 . . . . 31.02 108.983 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' O ' ' C ' ' A' ' 40' ' ' GLU . 74.3 m-20 -149.55 109.66 4.13 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.481 -1.011 . . . . 43.23 108.751 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 39' ' ' ASN . 26.0 mt-10 -34.24 -56.84 0.5 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.64 0.733 . . . . 42.34 110.128 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.467 ' O ' ' O ' ' A' ' 39' ' ' ASN . 50.9 m-70 -73.41 160.37 82.59 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 108.662 -0.866 . . . . 6.58 108.662 179.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.659 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.3 Cg_endo -77.43 140.47 19.28 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.054 1.836 . . . . 17.92 109.87 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 3.2 m -108.58 114.27 46.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.198 -0.939 . . . . 20.57 109.532 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.603 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 54.8 tp -68.01 106.94 2.51 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.388 -0.82 . . . . 20.21 109.623 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 2.1 t -110.44 169.28 3.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.48 -0.762 . . . . 10.81 109.03 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.576 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -92.93 162.89 13.89 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.33 -0.857 . . . . 36.74 110.394 -179.264 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.567 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -138.42 165.11 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.634 -0.876 . . . . 19.74 108.634 179.698 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 48' ' ' THR . 9.0 m -124.7 71.59 1.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 22.56 109.278 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -40.4 137.04 1.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.508 -0.745 . . . . 20.41 109.674 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -78.02 165.4 24.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 33.99 109.367 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.41 114.8 10.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 54.92 109.495 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.77 -6.32 64.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.685 -1.366 . . . . 36.1 109.685 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.43 ' O ' HD13 ' A' ' 49' ' ' LEU . 1.1 mt-30 -89.06 144.45 32.7 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.128 -1.219 . . . . 54.76 109.522 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.5 Cg_endo -78.54 123.95 6.17 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.642 2.228 . . . . 28.37 110.332 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.516 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -40.41 142.74 0.38 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 17.21 110.54 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.59 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 12.0 m-30 -45.98 104.39 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 17.19 109.153 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.35 168.64 0.36 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.992 -1.067 . . . . 17.82 109.185 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HA ' HG23 ' A' ' 6' ' ' ILE . 34.4 Cg_endo -76.98 113.39 3.62 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.52 2.147 . . . . 17.28 110.193 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.19 -176.56 48.08 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.923 -1.271 . . . . 17.22 109.923 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -75.81 139.25 41.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -1.09 . . . . 19.57 108.406 179.121 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.593 ' CB ' ' HB ' ' A' ' 4' ' ' VAL . 19.0 m-85 -127.83 166.11 18.86 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.725 -1.234 . . . . 14.61 111.456 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.427 HG21 ' C ' ' A' ' 61' ' ' TYR . 44.5 p -149.94 120.28 7.35 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.46 -1.681 . . . . 18.36 106.46 179.008 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -50.45 166.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 118.738 -1.185 . . . . 19.13 108.886 -178.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -125.23 123.98 40.72 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.865 -0.791 . . . . 20.65 108.865 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.621 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -69.47 -3.28 13.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.636 -0.665 . . . . 19.65 110.113 -179.187 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 t -58.83 -13.89 7.41 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.068 -1.02 . . . . 14.72 108.409 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 19.6 m -95.61 -7.72 36.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.755 . . . . 11.45 110.709 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 2.1 m-30 -81.25 159.16 24.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.899 -1.125 . . . . 14.25 109.882 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' N ' HD13 ' B' ' 37' ' ' LEU . 12.0 mtmt -153.03 173.84 14.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.485 -0.76 . . . . 32.7 108.997 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.559 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.6 OUTLIER -110.68 118.08 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 15.63 109.53 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.19 -176.15 48.94 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.294 -1.523 . . . . 12.7 109.294 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.0 19.86 3.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.09 -1.241 . . . . 26.29 109.77 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 -11.39 23.5 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.511 -0.743 . . . . 20.44 109.561 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' ' OG ' ' A' ' 75' ' ' SER . . . 84.48 50.27 4.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.712 -1.355 . . . . 13.82 109.712 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -170.69 153.88 4.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -1.161 . . . . 18.27 109.553 179.933 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.481 ' C ' ' CG ' ' A' ' 77' ' ' MET . 10.6 tt -81.16 150.52 28.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 12.43 109.476 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.481 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 2.2 mtt -155.78 129.19 8.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 35.11 109.355 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.632 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.1 mt -63.18 139.44 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 13.67 109.841 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 6.9 t0 -104.4 -18.48 14.4 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.257 -1.016 . . . . 24.06 108.257 178.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.4 tmm_? 172.23 71.69 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.863 -1.532 . . . . 35.04 106.863 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.585 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -34.0 119.21 0.39 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.607 0.718 . . . . 18.72 111.199 -178.05 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 64' ' ' HIS . 5.9 mtt180 -88.75 110.07 20.69 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.466 -0.939 . . . . 20.55 108.466 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.59 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -81.13 141.63 34.06 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.187 -0.946 . . . . 14.4 110.49 -179.112 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 25.9 m -145.28 159.08 50.09 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.193 -1.04 . . . . 17.65 108.193 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.08 141.61 77.34 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.124 1.882 . . . . 25.7 110.206 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.407 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -67.68 122.44 18.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.096 -1.003 . . . . 49.29 109.521 -178.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.961 -1.019 . . . . 58.91 109.469 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.426 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 2.8 ttm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.446 -0.576 . . . . 64.91 109.446 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.538 ' CG2' HG22 ' B' ' 63' ' ' VAL . 3.2 mt 69.54 64.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.759 -1.2 . . . . 33.8 107.759 -178.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.534 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 26.7 mttt -54.87 162.16 1.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.823 0.821 . . . . 32.72 111.269 -178.148 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.589 ' HB ' ' CB ' ' B' ' 61' ' ' TYR . 58.9 t -160.19 167.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.5 0.667 . . . . 14.46 109.601 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.519 ' N ' HG13 ' B' ' 4' ' ' VAL . 46.4 mt-10 -152.26 106.2 3.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.613 0.721 . . . . 22.12 109.088 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.569 HD12 ' CE1' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -74.69 101.06 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.141 -1.059 . . . . 14.23 108.141 179.43 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.609 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.73 171.16 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.445 -0.785 . . . . 25.43 109.827 -179.323 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.4 Cg_endo -75.03 -28.28 9.25 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.407 2.071 . . . . 13.61 110.179 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 12.8 m -93.03 4.21 54.4 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.508 -0.745 . . . . 15.52 109.122 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 18.4 mm-40 -121.15 34.0 5.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.258 -0.901 . . . . 17.31 109.36 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' B' ' 55' ' ' ALA . . . -106.85 18.68 21.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 24.78 110.282 -179.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.412 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 19.1 mt-30 -137.56 129.51 28.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.057 -1.027 . . . . 47.9 109.825 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -77.62 -174.45 3.42 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.395 -0.815 . . . . 21.61 110.529 -179.563 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.411 HG21 ' N ' ' B' ' 15' ' ' THR . 55.9 m -158.6 145.44 17.43 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.764 -0.828 . . . . 14.89 108.764 179.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.411 ' N ' HG21 ' B' ' 14' ' ' THR . 0.3 OUTLIER -83.33 116.87 22.64 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.262 -0.899 . . . . 17.35 109.561 -179.468 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.7 OUTLIER -154.81 158.34 39.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.301 -0.875 . . . . 34.38 109.315 179.857 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.442 ' C ' ' O ' ' B' ' 16' ' ' ARG . 4.8 t -42.25 145.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -0.787 . . . . 38.77 109.533 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -147.78 168.73 28.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.365 -1.494 . . . . 34.58 109.365 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.464 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 2.0 t -147.05 122.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.122 -1.223 . . . . 41.87 109.159 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.49 ' O ' ' N ' ' B' ' 22' ' ' GLN . 0.1 OUTLIER -57.78 -156.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 47.21 109.6 -179.546 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.528 ' O ' ' CG ' ' B' ' 21' ' ' ARG . 0.0 OUTLIER -67.58 58.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 71.56 109.737 -179.901 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' B' ' 20' ' ' SER . 2.9 mt-30 62.85 20.82 12.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 66.6 109.579 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' B' ' 24' ' ' LYS . . . -98.22 -47.66 2.0 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.586 -1.406 . . . . 55.49 109.586 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' B' ' 23' ' ' GLY . 19.4 mttt -159.0 159.84 29.24 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.3 -1.118 . . . . 44.99 109.345 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' B' ' 24' ' ' LYS . 34.5 Cg_endo -77.49 150.71 28.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.548 2.165 . . . . 44.1 110.35 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 5.1 p90 -155.43 140.55 17.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.155 -0.966 . . . . 32.09 109.842 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.4 m -102.3 79.95 1.9 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.885 . . . . 29.25 108.68 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -105.61 173.45 6.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.9 . . . . 24.0 110.114 -179.187 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.538 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -74.52 111.14 9.41 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.736 -0.838 . . . . 23.31 108.736 179.548 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 14.8 mm-40 -82.66 -172.74 4.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.035 -1.04 . . . . 40.03 108.97 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.532 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -171.21 179.96 2.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.081 -1.012 . . . . 12.39 110.3 179.848 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.478 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.4 mt -140.58 148.56 41.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.538 -0.726 . . . . 17.42 109.176 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.4 m -151.96 -178.35 6.7 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.868 -1.16 . . . . 13.84 107.868 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.655 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 37.5 m-85 -128.22 106.28 8.93 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.09 -1.006 . . . . 21.14 109.3 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' B' ' 4' ' ' VAL . 73.8 t -98.14 141.27 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.127 -0.983 . . . . 10.66 111.168 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.499 ' N ' HG11 ' B' ' 35' ' ' VAL . 4.1 m-20 -111.11 35.69 3.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.031 -1.1 . . . . 25.89 108.031 178.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' B' ' 37' ' ' LEU . 2.0 pt? -40.99 -25.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.647 -0.658 . . . . 24.24 110.271 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 176.71 47.47 0.06 OUTLIER Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.002 -1.639 . . . . 31.02 109.002 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.489 ' O ' ' C ' ' B' ' 40' ' ' GLU . 74.5 m-20 -149.64 109.67 4.12 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.502 -0.999 . . . . 43.23 108.757 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' B' ' 39' ' ' ASN . 26.1 mt-10 -34.21 -56.86 0.5 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.692 0.758 . . . . 42.34 110.159 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.468 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 51.0 m-70 -73.41 160.48 82.35 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 108.693 -0.855 . . . . 6.56 108.693 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.655 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.5 Cg_endo -77.46 140.34 19.11 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.098 1.865 . . . . 17.92 109.837 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.547 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 3.2 m -108.48 114.32 46.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.168 -0.957 . . . . 20.57 109.572 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.597 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 54.8 tp -68.07 106.99 2.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.428 -0.795 . . . . 20.21 109.534 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 2.1 t -110.46 169.25 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 10.81 109.038 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.574 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -92.85 162.98 13.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.314 -0.866 . . . . 36.74 110.378 -179.291 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.563 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -138.49 165.1 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.579 -0.897 . . . . 19.74 108.579 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' B' ' 48' ' ' THR . 9.5 m -124.73 71.6 1.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.223 -0.923 . . . . 22.56 109.366 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -40.36 136.97 1.15 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.559 -0.713 . . . . 20.41 109.709 179.93 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.45 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.4 OUTLIER -77.98 165.49 24.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 33.99 109.324 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.47 114.85 11.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 54.92 109.528 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.75 -6.45 64.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.665 -1.374 . . . . 36.1 109.665 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.428 ' O ' HD13 ' B' ' 49' ' ' LEU . 1.1 mt-30 -88.99 144.46 32.82 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.148 -1.207 . . . . 54.76 109.53 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.6 Cg_endo -78.54 123.87 6.14 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.62 2.213 . . . . 28.37 110.343 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.526 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -40.46 142.76 0.38 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.361 -0.837 . . . . 17.21 110.467 -179.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 12.2 m-30 -46.16 104.51 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 17.19 109.246 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.22 168.6 0.35 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.99 -1.069 . . . . 17.82 109.084 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.486 ' HA ' HG23 ' B' ' 6' ' ' ILE . 34.8 Cg_endo -77.19 114.55 3.8 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.603 2.202 . . . . 17.28 110.458 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.12 47.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.8 -1.32 . . . . 17.22 109.8 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -75.45 139.59 42.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -1.079 . . . . 19.57 108.692 179.45 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.589 ' CB ' ' HB ' ' B' ' 4' ' ' VAL . 18.1 m-85 -128.25 166.04 19.34 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.765 -1.21 . . . . 14.61 111.437 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.444 ' N ' ' O ' ' B' ' 84' ' ' VAL . 44.4 p -150.0 120.46 7.41 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.432 -1.692 . . . . 18.36 106.432 179.007 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.588 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -50.61 166.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 C-N-CA 118.741 -1.183 . . . . 19.13 108.908 -178.379 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.508 ' N ' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -125.19 124.12 41.06 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.411 -0.806 . . . . 20.65 108.863 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.624 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -69.61 -3.2 13.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.676 -0.64 . . . . 19.65 110.084 -179.166 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.7 t -58.91 -13.86 7.51 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.069 -1.019 . . . . 14.72 108.329 179.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 19.7 m -95.62 -7.86 36.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.756 . . . . 11.45 110.724 -179.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.631 ' N ' ' CD1' ' B' ' 68' ' ' PHE . 2.1 m-30 -81.15 159.2 24.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.859 -1.151 . . . . 14.25 109.795 -179.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.468 ' CA ' HD13 ' A' ' 37' ' ' LEU . 12.0 mtmt -153.04 173.91 14.85 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.977 -0.749 . . . . 32.7 108.977 179.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.566 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -110.66 118.2 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 15.63 109.51 179.935 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.32 -176.22 48.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.337 -1.505 . . . . 12.7 109.337 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.93 19.87 3.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.109 -1.23 . . . . 26.29 109.793 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -11.23 23.54 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.529 -0.732 . . . . 20.44 109.573 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.414 ' C ' ' OG ' ' B' ' 75' ' ' SER . . . 84.32 50.46 4.28 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.73 -1.348 . . . . 13.82 109.73 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' B' ' 74' ' ' GLY . 0.9 OUTLIER -170.88 153.91 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -1.178 . . . . 18.27 109.614 179.889 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.484 ' C ' ' CG ' ' B' ' 77' ' ' MET . 10.6 tt -81.23 150.58 28.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 12.43 109.469 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.484 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 2.2 mtt -155.88 129.14 8.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 35.11 109.402 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.624 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.1 mt -63.11 139.51 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 13.67 109.827 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 6.9 t0 -104.5 -18.45 14.36 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.233 -1.025 . . . . 24.06 108.233 178.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.4 tmm_? 172.25 71.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.893 -1.521 . . . . 35.04 106.893 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.588 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -33.98 119.11 0.39 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.643 0.735 . . . . 18.72 111.136 -178.005 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' B' ' 64' ' ' HIS . 5.9 mtt180 -88.67 110.03 20.62 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.498 -0.927 . . . . 20.55 108.498 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.597 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -81.02 141.83 33.99 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.116 -0.99 . . . . 14.4 110.415 -179.069 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' B' ' 62' ' ' THR . 25.4 m -145.59 158.86 49.46 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.185 -1.043 . . . . 17.65 108.185 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -63.93 141.57 78.16 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.078 1.852 . . . . 25.7 110.27 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.401 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -67.63 122.52 18.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.123 -0.986 . . . . 49.29 109.541 -178.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.972 -1.013 . . . . 58.91 109.498 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.358 0.599 . . . . 64.91 109.393 . . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 63' ' ' VAL . 4.3 mt 75.24 83.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.662 -1.236 . . . . 33.8 107.662 -179.086 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -80.55 173.16 12.88 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.133 0.968 . . . . 32.72 111.927 -177.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER 179.77 168.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.775 -0.824 . . . . 14.46 108.775 -179.778 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 35.9 mt-10 -141.71 112.67 7.34 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.426 -0.796 . . . . 22.12 109.442 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.586 HD11 ' CD1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -71.52 104.8 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.483 -1.303 . . . . 14.23 107.483 179.017 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.637 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -51.32 162.0 0.71 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.88 . . . . 25.43 110.123 -178.909 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.68 -18.6 15.13 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.505 2.136 . . . . 13.61 109.116 179.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -92.12 8.38 38.18 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.682 -0.859 . . . . 15.52 108.682 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.531 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -147.74 38.97 0.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.362 -0.836 . . . . 17.31 109.246 179.326 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.11 6.9 44.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 24.78 109.756 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 29.3 mt-30 -127.29 155.64 43.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 47.9 109.282 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.639 ' CD2' ' CD1' ' A' ' 49' ' ' LEU . 37.1 p90 -96.45 160.49 14.38 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.165 -0.959 . . . . 21.61 109.406 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -127.2 160.79 30.2 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.315 -0.866 . . . . 14.89 108.8 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.6 107.83 20.04 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.274 -0.892 . . . . 17.35 108.963 179.849 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 18' ' ' GLY . 7.3 mmt180 -136.93 154.24 50.51 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.372 -0.83 . . . . 34.38 109.504 -179.678 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.1 m -59.81 83.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 38.77 109.468 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.597 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -76.17 132.55 12.89 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.397 -1.481 . . . . 34.58 109.397 179.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.401 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -101.49 124.68 55.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.267 -1.137 . . . . 41.87 108.835 179.773 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.443 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 3.9 m -69.22 -93.16 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.474 -0.766 . . . . 47.21 109.659 -179.112 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.479 ' O ' ' HB3' ' A' ' 22' ' ' GLN . 0.1 OUTLIER -91.72 -56.14 3.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 71.56 109.444 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER 166.8 45.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 66.6 109.456 179.851 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -126.08 -56.98 0.15 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.545 -1.422 . . . . 55.49 109.545 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.26 150.11 74.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.258 -1.142 . . . . 44.99 109.384 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.32 79.79 3.2 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.552 2.168 . . . . 44.1 110.607 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.597 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 4.4 p90 -56.78 139.07 52.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.227 -0.92 . . . . 32.09 109.581 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.94 79.75 1.93 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 29.25 109.407 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.543 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -117.44 136.0 53.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 24.0 109.637 -179.848 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.577 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 85.7 m-20 -43.72 134.73 4.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 23.31 109.638 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.483 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -125.99 161.77 26.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.884 . . . . 40.03 109.163 179.942 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.538 ' CB ' HG21 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -140.39 -172.36 3.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 12.39 109.602 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.513 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 2.7 mp -130.75 171.42 13.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 17.42 109.361 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -162.21 154.32 19.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.104 -0.997 . . . . 13.84 108.711 -179.613 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.679 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 27.1 m-85 -115.32 104.31 11.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 21.14 109.604 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 36' ' ' ASP . 64.1 t -80.23 165.33 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.807 -1.183 . . . . 10.66 109.536 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 39' ' ' ASN . 6.2 m-20 -137.21 -52.87 0.68 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.299 -0.876 . . . . 25.89 109.676 -179.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' O ' ' CD1' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -42.09 -44.65 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.66 0.743 . . . . 24.24 109.11 179.919 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 39' ' ' ASN . . . -88.57 32.21 4.58 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.613 -1.395 . . . . 31.02 109.613 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 2.5 p30 161.16 117.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.384 -1.068 . . . . 43.23 109.594 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -42.5 -64.79 0.55 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 42.34 109.509 179.941 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 5.5 m-70 -68.68 163.4 55.11 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 107.96 -1.126 . . . . 4.1 107.96 179.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.679 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.9 Cg_endo -78.1 140.48 17.88 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.541 1.494 . . . . 17.92 109.692 -179.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' TYR . 6.0 m -116.32 114.32 45.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.313 -0.867 . . . . 20.57 109.003 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 43.8 tp -69.75 107.73 3.61 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.347 -0.846 . . . . 20.21 109.835 -179.437 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.568 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 0.8 OUTLIER -109.13 164.19 5.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.56 -0.904 . . . . 10.81 108.56 179.635 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' N ' HG11 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -86.96 170.0 11.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.159 -0.963 . . . . 36.74 109.803 -179.67 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.606 HG12 ' CZ ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -156.6 171.65 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.347 -0.846 . . . . 19.74 109.315 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -107.82 147.8 30.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.201 -0.937 . . . . 22.56 109.45 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.639 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 1.8 tm? -129.39 112.15 13.54 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.219 -0.926 . . . . 20.41 108.778 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 53' ' ' GLN . 2.7 t70 -61.75 138.18 58.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -0.816 . . . . 33.99 110.223 -178.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.28 124.38 16.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.346 -0.847 . . . . 54.92 108.834 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.47 -31.15 8.39 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.979 -1.648 . . . . 36.1 108.979 -179.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.469 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -73.77 146.51 85.63 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.375 -1.074 . . . . 54.76 109.155 179.648 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.44 118.2 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.426 2.084 . . . . 28.37 109.997 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.467 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -41.58 154.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 17.21 109.711 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE2' ' CB ' ' A' ' 83' ' ' LEU . 6.8 m-30 -45.07 105.57 0.06 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.239 -0.913 . . . . 17.19 108.892 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.519 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -61.97 176.15 0.48 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 17.82 109.347 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.0 Cg_endo -77.61 129.97 10.43 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.602 2.202 . . . . 17.28 110.523 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.598 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 153.03 148.25 4.83 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.767 -1.333 . . . . 17.22 109.767 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.495 HD21 ' N ' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -46.78 146.23 1.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.137 -1.213 . . . . 19.57 108.838 179.481 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 59' ' ' GLY . 16.3 m-85 -125.77 161.85 26.41 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.667 -1.271 . . . . 14.61 111.7 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.516 ' N ' ' O ' ' A' ' 84' ' ' VAL . 43.2 p -144.86 121.6 11.2 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.459 -1.682 . . . . 18.36 106.459 178.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.571 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -59.98 163.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 118.529 -1.268 . . . . 19.13 108.922 -178.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.473 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.2 t-80 -127.27 128.19 45.59 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.037 -0.727 . . . . 20.65 109.037 -179.313 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.664 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -71.52 0.98 7.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.471 -0.768 . . . . 19.65 110.159 -179.833 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -20.78 6.58 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.283 -1.377 . . . . 14.72 107.283 178.647 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 5.8 m -95.11 -8.31 36.87 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.903 -0.498 . . . . 11.45 110.218 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.664 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.6 m-30 -84.73 156.87 21.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.953 -1.092 . . . . 14.25 109.336 -179.167 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -168.03 174.69 7.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.397 -0.814 . . . . 32.7 109.435 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.1 OUTLIER -103.13 109.82 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.821 . . . . 15.63 109.254 -179.965 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 72' ' ' GLN . . . -77.31 50.83 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.104 -1.199 . . . . 12.7 110.104 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER 40.05 49.39 2.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -1.094 . . . . 26.29 110.102 179.62 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 74' ' ' GLY . 1.7 m-85 -143.35 31.26 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 20.44 109.334 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.473 ' HA3' ' HG2' ' B' ' 46' ' ' LYS . . . 44.61 44.96 8.55 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.624 -1.39 . . . . 13.82 109.624 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 74' ' ' GLY . 46.6 m -166.57 114.27 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -1.209 . . . . 18.27 109.832 -179.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.543 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -68.04 155.36 39.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 12.43 109.037 179.678 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.543 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 8.1 mtp -162.54 157.06 21.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 35.11 109.754 -179.743 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.603 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.3 mt -80.65 135.06 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 13.67 109.899 179.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 79' ' ' ASP . 46.9 t0 -103.18 -20.55 14.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.376 -0.972 . . . . 24.06 108.376 178.327 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 67' ' ' SER . 5.1 tmm_? 175.79 69.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.93 -1.507 . . . . 35.04 106.93 179.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.571 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -32.23 120.21 0.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.458 -0.792 . . . . 18.72 111.635 -177.711 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -92.12 99.44 12.24 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.322 -0.992 . . . . 20.55 108.322 178.996 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.63 ' CB ' ' CE2' ' A' ' 56' ' ' TYR . 1.5 tp -67.43 157.54 33.91 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.019 0.914 . . . . 14.4 111.159 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 62' ' ' THR . 21.3 m -156.55 147.98 16.9 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.818 -1.178 . . . . 17.65 107.818 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -63.12 135.24 49.87 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 121.815 1.677 . . . . 25.7 109.872 179.352 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.511 ' HA ' ' CG2' ' A' ' 62' ' ' THR . . . -61.85 118.8 7.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.942 . . . . 49.29 109.792 -178.521 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.01 -0.995 . . . . 58.91 109.454 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.487 ' O ' ' CB ' ' B' ' 2' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.339 0.59 . . . . 64.91 109.425 . . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' B' ' 63' ' ' VAL . 4.2 mt 75.25 83.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.632 -1.247 . . . . 33.8 107.632 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -80.74 173.07 12.97 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.136 0.97 . . . . 32.72 111.957 -177.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.582 ' CG2' ' N ' ' B' ' 5' ' ' GLU . 0.2 OUTLIER 179.83 168.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.781 -0.822 . . . . 14.46 108.781 -179.773 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.582 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 36.5 mt-10 -141.54 112.65 7.39 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.401 -0.812 . . . . 22.12 109.522 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -71.5 104.72 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.475 -1.306 . . . . 14.23 107.475 179.05 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.654 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -51.32 162.05 0.7 Allowed Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.881 . . . . 25.43 110.154 -178.874 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -76.54 -18.8 15.27 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.472 2.114 . . . . 13.61 109.15 178.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -92.03 8.6 36.92 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.719 -0.845 . . . . 15.52 108.719 178.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.536 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 0.0 OUTLIER -147.92 38.92 0.92 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.35 -0.844 . . . . 17.31 109.229 179.353 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.18 7.05 44.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 24.78 109.721 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' B' ' 31' ' ' GLN . 29.0 mt-30 -127.52 155.59 43.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 47.9 109.203 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.64 ' CD2' ' CD1' ' B' ' 49' ' ' LEU . 37.4 p90 -96.37 160.53 14.37 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.089 -1.007 . . . . 21.61 109.363 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -127.2 160.84 30.04 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.838 -0.801 . . . . 14.89 108.838 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.63 107.77 20.0 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.318 -0.864 . . . . 17.35 109.002 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' B' ' 18' ' ' GLY . 7.2 mmt180 -136.95 154.04 50.55 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.373 -0.829 . . . . 34.38 109.512 -179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.1 m -59.49 83.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.372 -0.83 . . . . 38.77 109.427 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.59 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -76.35 132.5 12.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.393 -1.483 . . . . 34.58 109.393 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.403 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -101.42 124.83 55.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.169 -1.195 . . . . 41.87 108.758 179.837 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.442 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 4.0 m -69.31 -93.32 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.786 . . . . 47.21 109.544 -179.101 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' B' ' 22' ' ' GLN . 0.1 OUTLIER -91.61 -56.42 3.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.905 . . . . 71.56 109.438 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.481 ' HB3' ' O ' ' B' ' 21' ' ' ARG . 0.0 OUTLIER 167.18 45.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 66.6 109.518 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.94 -57.2 0.15 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.588 -1.405 . . . . 55.49 109.588 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 150.08 74.68 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.249 -1.147 . . . . 44.99 109.389 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.3 79.88 3.17 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.603 2.202 . . . . 44.1 110.631 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.59 ' CE1' ' HA3' ' B' ' 18' ' ' GLY . 4.4 p90 -56.9 139.12 52.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 32.09 109.535 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.98 79.62 1.91 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 29.25 109.36 -179.864 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.54 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -117.36 135.92 53.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 24.0 109.681 -179.94 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.586 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 85.8 m-20 -43.59 134.38 4.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 23.31 109.735 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 1.0 OUTLIER -125.65 161.74 26.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.362 -0.836 . . . . 40.03 109.192 179.889 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.545 ' CB ' HG21 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -140.32 -172.33 3.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.166 -0.959 . . . . 12.39 109.605 179.954 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.504 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 2.7 mp -130.76 171.63 12.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 17.42 109.372 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -162.45 154.28 18.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.06 -1.025 . . . . 13.84 108.776 -179.688 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.682 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 27.4 m-85 -115.23 104.36 11.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 21.14 109.645 -179.653 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.518 HG13 ' N ' ' B' ' 36' ' ' ASP . 63.2 t -80.32 165.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.849 -1.157 . . . . 10.66 109.509 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' B' ' 39' ' ' ASN . 6.2 m-20 -137.24 -52.76 0.67 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.304 -0.873 . . . . 25.89 109.683 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.525 ' O ' ' CD1' ' B' ' 37' ' ' LEU . 0.1 OUTLIER -42.09 -44.67 3.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 24.24 109.088 179.921 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 39' ' ' ASN . . . -88.52 32.06 4.63 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.651 -1.38 . . . . 31.02 109.651 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' ASP . 2.5 p30 161.23 117.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.397 -1.06 . . . . 43.23 109.577 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.0 OUTLIER -42.45 -64.67 0.57 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.355 -0.841 . . . . 42.34 109.508 179.942 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.486 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 5.6 m-70 -68.95 163.41 56.68 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 107.97 -1.122 . . . . 4.06 107.97 179.078 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.682 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.9 Cg_endo -77.98 140.67 18.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.507 1.471 . . . . 17.92 109.702 -179.736 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' B' ' 34' ' ' TYR . 5.9 m -116.49 114.29 45.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.339 -0.851 . . . . 20.57 108.981 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.604 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 43.6 tp -69.77 107.48 3.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.379 -0.826 . . . . 20.21 109.946 -179.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.586 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -108.88 164.12 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.627 -0.879 . . . . 10.81 108.627 179.592 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.49 ' N ' HG11 ' B' ' 45' ' ' VAL . 1.0 OUTLIER -86.85 170.11 11.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.948 . . . . 36.74 109.741 -179.645 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.61 HG12 ' CZ ' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -156.72 171.46 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.283 -0.886 . . . . 19.74 109.379 179.861 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 18.3 m -107.5 147.71 30.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 22.56 109.442 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.64 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 1.7 tm? -129.24 112.22 13.68 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.198 -0.939 . . . . 20.41 108.781 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' B' ' 53' ' ' GLN . 2.7 t70 -61.69 138.3 58.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.827 . . . . 33.99 110.202 -179.014 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.41 124.39 17.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 54.92 108.771 179.379 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.52 -31.25 8.3 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.987 -1.645 . . . . 36.1 108.987 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' B' ' 50' ' ' ASP . 0.4 OUTLIER -73.61 146.45 85.94 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.35 -1.088 . . . . 54.76 109.153 179.694 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.4 Cg_endo -78.35 118.03 4.2 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.453 2.102 . . . . 28.37 109.998 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.458 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -41.49 154.81 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.454 -0.779 . . . . 17.21 109.764 -179.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.631 ' CE2' ' CB ' ' B' ' 83' ' ' LEU . 6.7 m-30 -44.96 105.82 0.06 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 17.19 108.769 179.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -62.48 176.19 0.52 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 17.82 109.439 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.7 Cg_endo -77.46 128.53 9.63 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.547 2.165 . . . . 17.28 110.152 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.61 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 155.4 147.97 4.88 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.889 -1.284 . . . . 17.22 109.889 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.486 HD21 ' N ' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -47.43 145.69 2.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.055 -1.262 . . . . 19.57 108.527 179.209 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.61 ' CD1' ' O ' ' B' ' 59' ' ' GLY . 17.0 m-85 -125.25 161.87 25.95 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.624 -1.297 . . . . 14.61 111.663 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.516 ' O ' ' CG2' ' B' ' 84' ' ' VAL . 43.5 p -144.87 121.73 11.27 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.445 -1.687 . . . . 18.36 106.445 178.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -60.15 163.22 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 C-N-CA 118.517 -1.273 . . . . 19.13 108.974 -178.519 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.47 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -127.41 128.28 45.55 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.527 -0.733 . . . . 20.65 109.036 -179.287 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.654 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -71.48 0.88 7.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.476 -0.765 . . . . 19.65 110.093 -179.828 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -20.89 6.15 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.268 -1.382 . . . . 14.72 107.268 178.721 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 5.6 m -95.14 -8.98 34.86 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.897 -0.502 . . . . 11.45 110.245 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.654 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.6 m-30 -84.07 156.57 22.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.945 -1.097 . . . . 14.25 109.206 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -167.8 174.43 7.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.431 -0.793 . . . . 32.7 109.435 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.568 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.1 OUTLIER -102.76 109.91 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 15.63 109.273 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' B' ' 72' ' ' GLN . . . -77.44 50.58 3.2 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.143 -1.183 . . . . 12.7 110.143 -179.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 71' ' ' GLY . 0.0 OUTLIER 40.28 49.62 2.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.331 -1.099 . . . . 26.29 110.041 179.653 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -143.65 31.35 1.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 20.44 109.323 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.479 ' HA2' HG21 ' A' ' 45' ' ' VAL . . . 44.56 44.73 8.37 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.621 -1.392 . . . . 13.82 109.621 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 74' ' ' GLY . 46.6 m -166.41 114.53 0.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -1.205 . . . . 18.27 109.824 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.54 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.3 OUTLIER -68.13 155.36 39.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 12.43 109.019 179.634 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 8.1 mtp -162.68 157.13 21.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 35.11 109.682 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.612 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.3 mt -80.78 135.36 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.442 -0.787 . . . . 13.67 109.91 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 47.2 t0 -103.19 -20.74 14.03 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.358 -0.979 . . . . 24.06 108.358 178.287 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' B' ' 67' ' ' SER . 5.1 tmm_? 175.96 69.7 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.982 -1.488 . . . . 35.04 106.982 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.579 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -32.45 120.2 0.31 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.464 -0.789 . . . . 18.72 111.684 -177.725 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -92.15 99.32 12.14 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.23 -1.026 . . . . 20.55 108.23 179.064 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.631 ' CB ' ' CE2' ' B' ' 56' ' ' TYR . 1.5 tp -67.4 157.62 33.68 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.034 0.921 . . . . 14.4 111.127 -178.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' B' ' 62' ' ' THR . 21.2 m -156.6 148.13 16.99 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.841 -1.17 . . . . 17.65 107.841 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.5 Cg_endo -63.31 135.17 48.84 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.774 1.649 . . . . 25.7 109.88 179.383 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.493 ' HA ' ' CG2' ' B' ' 62' ' ' THR . . . -61.83 118.43 7.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.318 -0.864 . . . . 49.29 109.761 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' B' ' 86' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.975 -1.012 . . . . 58.91 109.475 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.468 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.302 0.572 . . . . 64.91 109.53 . . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.534 ' CG2' HG22 ' A' ' 63' ' ' VAL . 5.3 mt -69.67 82.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.909 -1.145 . . . . 33.8 107.909 179.178 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.488 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 mttt -59.19 156.21 12.72 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.894 0.854 . . . . 32.72 111.531 -177.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' A' ' 61' ' ' TYR . 49.0 t -159.57 167.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 109.19 -0.67 . . . . 14.46 109.19 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 30.2 mt-10 -152.63 100.93 2.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.741 0.782 . . . . 22.12 109.185 -179.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.578 HD12 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -66.96 103.56 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.852 -1.166 . . . . 14.23 107.852 179.493 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 2.2 mmpt? -50.18 159.23 0.84 Allowed Pre-proline 0 N--CA 1.485 1.291 0 O-C-N 121.302 -0.874 . . . . 25.43 109.66 -179.115 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.2 Cg_endo -76.16 -3.31 13.67 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.28 1.987 . . . . 13.61 109.37 179.374 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.15 -10.45 33.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.483 -0.76 . . . . 15.52 109.408 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 12' ' ' GLN . 25.7 mm-40 -97.54 -76.34 0.52 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.293 -0.879 . . . . 17.31 108.863 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 10' ' ' GLN . . . 23.64 45.54 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.205 0.526 . . . . 24.78 111.195 179.295 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.2 pt20 -179.04 132.42 0.12 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 47.9 109.557 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 31.9 p90 -97.45 156.27 16.55 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.953 -1.092 . . . . 21.61 109.486 179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 t -124.92 164.08 20.86 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.651 -0.87 . . . . 14.89 108.651 178.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.41 HG21 ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -85.81 112.13 20.82 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.116 -0.99 . . . . 17.35 109.53 -179.773 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.02 153.57 39.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 34.38 109.385 179.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -52.27 144.32 12.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 38.77 109.368 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.579 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -155.45 119.48 0.93 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.26 -1.536 . . . . 34.58 109.26 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 22' ' ' GLN . 1.4 t -101.71 123.68 55.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -1.22 . . . . 41.87 109.217 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.94 -15.08 18.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 47.21 109.493 -179.517 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HG2' ' HG2' ' A' ' 22' ' ' GLN . 2.2 ttt180 -177.6 -59.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.351 -0.843 . . . . 71.56 109.283 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER 174.93 57.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 66.6 109.471 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.78 -50.71 0.04 OUTLIER Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.582 -1.407 . . . . 55.49 109.582 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.39 108.66 59.85 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.287 -1.125 . . . . 44.99 109.377 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.79 72.07 5.26 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.173 1.915 . . . . 44.1 110.18 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 5.2 p90 -69.27 140.22 54.43 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.533 -0.729 . . . . 32.09 110.403 -179.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.41 ' HB2' HG21 ' A' ' 15' ' ' THR . 0.0 OUTLIER -105.54 81.46 1.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.097 -1.075 . . . . 29.25 108.097 178.922 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -90.71 138.48 31.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 24.0 110.657 -178.55 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.604 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -42.2 159.3 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 23.31 109.942 179.686 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -156.71 137.22 13.09 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.753 -0.832 . . . . 40.03 108.753 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.531 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -120.89 -166.34 1.33 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.947 -1.095 . . . . 12.39 110.334 -179.231 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.525 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 4.4 mp -127.37 175.25 8.35 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.933 -0.766 . . . . 17.42 108.933 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.79 160.14 6.74 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.796 -1.19 . . . . 13.84 108.663 -179.545 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.655 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 2.9 m-30 -112.54 86.37 2.35 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.259 -0.9 . . . . 21.14 109.199 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.537 ' CG2' HG21 ' A' ' 4' ' ' VAL . 59.2 t -83.11 110.37 18.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.156 -0.965 . . . . 10.66 110.227 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' LEU . 36.8 t0 -53.58 -34.79 59.61 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.779 -1.193 . . . . 25.89 107.779 178.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' CD2' ' HA ' ' B' ' 69' ' ' LYS . 1.0 OUTLIER 41.27 34.36 0.32 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.303 0.573 . . . . 24.24 109.73 179.317 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.25 23.75 34.44 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.301 -1.52 . . . . 31.02 109.301 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.596 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 43.3 m-20 -88.26 26.53 1.39 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.304 -1.116 . . . . 43.23 110.01 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.77 14.18 3.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.046 -1.034 . . . . 42.34 109.876 179.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER 175.61 167.1 0.39 Allowed Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.437 -0.949 . . . . 6.32 108.437 179.883 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 33.8 Cg_endo -75.81 145.16 28.46 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.722 1.614 . . . . 17.92 110.421 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 6.6 m -119.9 119.77 61.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.482 -0.887 . . . . 20.57 109.171 179.356 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.655 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 14.7 tp -72.47 112.85 8.89 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.886 -0.725 . . . . 20.21 109.276 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.436 HG21 ' C ' ' B' ' 74' ' ' GLY . 1.7 p -130.78 161.51 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.386 -0.822 . . . . 10.81 109.127 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 0.6 OUTLIER -80.75 160.34 24.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.038 -1.039 . . . . 36.74 110.407 -179.094 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.622 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -140.64 161.91 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.46 -0.941 . . . . 19.74 108.46 179.353 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 143.0 28.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.97 -1.081 . . . . 22.56 109.683 -179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -114.0 146.58 39.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.366 -0.834 . . . . 20.41 108.858 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.492 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -81.33 142.88 32.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 33.99 109.538 -179.583 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.12 116.89 3.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 54.92 109.477 -179.905 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.11 -6.55 83.37 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.652 -1.379 . . . . 36.1 109.652 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -83.89 148.78 54.96 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 54.76 109.451 179.999 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.5 Cg_endo -77.01 119.47 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.617 2.211 . . . . 28.37 110.776 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.531 ' HB3' ' N ' ' A' ' 13' ' ' PHE . . . -42.01 147.85 0.21 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 17.21 110.267 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.622 ' CE1' HG12 ' A' ' 47' ' ' ILE . 86.8 m-85 -44.07 112.09 0.36 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 17.19 109.131 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -63.92 176.58 0.63 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 17.82 109.779 -179.58 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -77.8 113.54 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.756 2.304 . . . . 17.28 110.433 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.8 172.84 38.83 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.389 -1.484 . . . . 17.22 109.389 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.3 mp -70.41 146.63 50.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 19.57 108.811 179.494 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.578 ' CE1' HD12 ' A' ' 6' ' ' ILE . 26.6 m-85 -131.24 163.59 27.45 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.945 -1.097 . . . . 14.61 110.921 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.522 HG21 ' CB ' ' A' ' 86' ' ' ALA . 44.1 p -144.4 117.17 8.72 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.066 -1.827 . . . . 18.36 106.066 178.623 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.628 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -49.81 163.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 C-N-CA 118.681 -1.208 . . . . 19.13 108.71 -178.143 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -128.3 126.62 41.16 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.409 -0.807 . . . . 20.65 109.381 -178.901 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.661 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -74.05 2.51 8.65 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.533 -0.729 . . . . 19.65 110.054 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.9 p -58.88 -18.02 29.22 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.546 -1.279 . . . . 14.72 107.546 178.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 23.8 m -97.83 -16.4 19.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.842 -0.536 . . . . 11.45 110.151 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.661 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.0 m-30 -68.14 157.3 35.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.125 -0.984 . . . . 14.25 109.441 -178.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.521 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 0.1 OUTLIER -150.48 -179.76 7.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.385 -0.822 . . . . 32.7 109.613 -179.995 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.404 HG23 ' CG2' ' B' ' 43' ' ' VAL . 0.1 OUTLIER -120.82 110.88 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 15.63 109.121 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' N ' ' SD ' ' A' ' 77' ' ' MET . . . -81.7 -175.07 50.03 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.658 -1.377 . . . . 12.7 109.658 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.524 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -89.55 20.17 4.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.152 -1.205 . . . . 26.29 109.574 -179.974 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -93.73 -2.64 53.5 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.394 -0.816 . . . . 20.44 109.348 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 81.16 26.89 51.3 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.68 -1.368 . . . . 13.82 109.68 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.6 153.7 32.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.082 -1.246 . . . . 18.27 109.82 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.24 176.81 0.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.348 -0.845 . . . . 12.43 109.664 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 2.1 ptm -167.68 100.12 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 35.11 109.691 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.583 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.9 mt -36.86 -64.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.478 0.656 . . . . 13.67 110.301 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 9.0 t0 84.53 -45.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.484 0.659 . . . . 24.06 110.014 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.8 tpm_? -173.84 67.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.147 0.975 . . . . 35.04 108.526 179.424 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.628 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.2 pt? -40.96 126.8 2.59 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.483 -0.781 . . . . 18.72 111.931 -178.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 1.4 ttt180 -94.11 110.4 22.11 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.693 -1.225 . . . . 20.55 107.693 178.239 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.61 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 11.8 tp -80.2 150.42 30.12 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.056 -1.027 . . . . 14.4 111.112 -178.148 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.543 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 21.2 m -147.08 157.57 46.06 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 108.161 -1.051 . . . . 17.65 108.161 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.6 Cg_endo -62.56 142.0 88.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.058 1.838 . . . . 25.7 110.321 179.11 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -76.38 116.47 17.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.229 -0.919 . . . . 49.29 109.739 -178.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.012 -0.995 . . . . 58.91 109.425 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.464 ' SD ' ' HB ' ' B' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.308 0.575 . . . . 64.91 109.556 . . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.539 ' CG2' HG22 ' B' ' 63' ' ' VAL . 5.2 mt -69.48 82.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.91 -1.144 . . . . 33.8 107.91 179.114 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.494 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 2.3 mttt -59.12 156.4 12.12 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.915 0.864 . . . . 32.72 111.543 -178.0 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' B' ' 61' ' ' TYR . 49.2 t -159.7 167.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 109.2 -0.667 . . . . 14.46 109.2 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 30.0 mt-10 -152.45 100.94 2.62 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.808 0.813 . . . . 22.12 109.296 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.582 HD12 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -66.92 103.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.838 -1.171 . . . . 14.23 107.838 179.454 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.572 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 2.2 mmpt? -50.08 159.39 0.8 Allowed Pre-proline 0 N--CA 1.486 1.328 0 O-C-N 121.294 -0.879 . . . . 25.43 109.69 -179.156 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.7 Cg_endo -76.26 -3.26 13.61 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.353 2.035 . . . . 13.61 109.37 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.28 -10.48 32.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.461 -0.775 . . . . 15.52 109.394 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.529 ' O ' ' C ' ' B' ' 11' ' ' ALA . 25.6 mm-40 -97.48 -76.45 0.52 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.282 -0.886 . . . . 17.31 108.865 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' B' ' 10' ' ' GLN . . . 23.77 45.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.164 0.507 . . . . 24.78 111.175 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' B' ' 10' ' ' GLN . 1.2 pt20 -178.94 132.28 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 47.9 109.616 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.598 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 32.5 p90 -97.21 156.35 16.45 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.954 -1.091 . . . . 21.61 109.551 179.7 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.4 t -124.97 163.94 21.21 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.656 -0.868 . . . . 14.89 108.656 178.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.4 HG21 ' HB2' ' B' ' 27' ' ' SER . 0.2 OUTLIER -85.82 112.26 20.95 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.133 -0.979 . . . . 17.35 109.538 -179.798 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.09 153.42 39.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 34.38 109.437 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -52.11 144.24 12.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 38.77 109.424 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -155.3 119.6 0.94 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.197 -1.561 . . . . 34.58 109.197 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.4 HG13 ' HA ' ' B' ' 22' ' ' GLN . 1.4 t -101.86 123.66 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.107 -1.231 . . . . 41.87 109.148 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -15.2 19.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 47.21 109.488 -179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.464 ' HG2' ' CG ' ' B' ' 22' ' ' GLN . 2.1 ttt180 -177.49 -59.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.363 -0.836 . . . . 71.56 109.268 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.464 ' CG ' ' HG2' ' B' ' 21' ' ' ARG . 0.0 OUTLIER 175.08 57.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 66.6 109.435 179.768 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.8 -50.7 0.04 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.485 -1.446 . . . . 55.49 109.485 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.34 108.64 59.74 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.294 -1.121 . . . . 44.99 109.412 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.76 72.17 5.2 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.224 1.949 . . . . 44.1 110.234 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.586 ' CE1' ' HA3' ' B' ' 18' ' ' GLY . 5.4 p90 -69.34 140.44 54.31 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.565 -0.709 . . . . 32.09 110.342 -179.58 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.4 ' HB2' HG21 ' B' ' 15' ' ' THR . 0.0 OUTLIER -105.79 81.44 1.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.061 -1.088 . . . . 29.25 108.061 178.899 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.571 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -90.67 138.59 31.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 24.0 110.612 -178.504 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.598 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -42.3 159.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.471 -0.768 . . . . 23.31 109.942 179.717 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -156.77 136.99 12.82 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.764 -0.828 . . . . 40.03 108.764 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.532 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -120.77 -166.41 1.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.992 -1.068 . . . . 12.39 110.342 -179.277 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.525 ' CD1' ' OE1' ' B' ' 10' ' ' GLN . 4.4 mp -127.16 175.43 8.14 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.871 -0.788 . . . . 17.42 108.871 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.99 160.1 6.38 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.834 -1.166 . . . . 13.84 108.59 -179.549 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.644 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 2.9 m-30 -112.52 86.41 2.35 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 21.14 109.201 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.527 ' CG2' HG21 ' B' ' 4' ' ' VAL . 59.5 t -83.22 110.57 18.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.189 -0.944 . . . . 10.66 110.236 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' B' ' 37' ' ' LEU . 36.8 t0 -53.7 -34.74 59.78 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.79 -1.189 . . . . 25.89 107.79 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.521 ' CD2' ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER 41.26 34.38 0.32 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.79 -0.568 . . . . 24.24 109.717 179.345 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.23 23.58 33.71 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.3 -1.52 . . . . 31.02 109.3 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.59 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 45.1 m-20 -88.09 26.46 1.38 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.285 -1.126 . . . . 43.23 110.022 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.8 14.22 4.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.082 -1.011 . . . . 42.34 109.893 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 0.6 OUTLIER 175.61 167.01 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.454 -0.943 . . . . 6.3 108.454 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.618 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 33.8 Cg_endo -75.62 145.31 29.25 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.711 1.608 . . . . 17.92 110.49 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 6.6 m -120.03 119.94 61.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 C-N-CA 119.378 -0.929 . . . . 20.57 109.16 179.312 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.644 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 14.8 tp -72.76 112.92 9.24 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.93 -0.708 . . . . 20.21 109.172 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.418 HG21 ' C ' ' A' ' 74' ' ' GLY . 1.7 p -130.82 161.52 40.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.421 -0.799 . . . . 10.81 109.077 -179.758 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -80.74 160.31 24.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.985 . . . . 36.74 110.399 -179.093 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.621 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -140.57 161.88 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.378 -0.971 . . . . 19.74 108.378 179.41 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.07 142.98 28.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.952 -1.092 . . . . 22.56 109.744 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.591 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -113.85 146.82 39.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 20.41 108.888 179.873 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.496 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -81.63 142.78 32.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 33.99 109.536 -179.572 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.05 117.14 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 54.92 109.417 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.12 -6.81 83.04 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.599 -1.4 . . . . 36.1 109.599 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.496 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -83.79 148.89 55.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.188 -1.183 . . . . 54.76 109.508 -179.958 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.5 Cg_endo -77.03 119.39 5.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.715 2.277 . . . . 28.37 110.761 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.534 ' HB3' ' N ' ' B' ' 13' ' ' PHE . . . -42.0 147.69 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 17.21 110.35 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.621 ' CE1' HG12 ' B' ' 47' ' ' ILE . 86.9 m-85 -43.76 112.54 0.4 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.543 -0.723 . . . . 17.19 109.07 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.538 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -64.54 176.38 0.74 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 17.82 109.879 -179.348 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.3 112.47 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.606 2.204 . . . . 17.28 110.112 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.56 172.31 39.54 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.54 -1.424 . . . . 17.22 109.54 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 3.0 mp -70.67 146.01 50.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -1.165 . . . . 19.57 108.438 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.582 ' CE1' HD12 ' B' ' 6' ' ' ILE . 27.5 m-85 -130.69 163.51 27.08 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.909 -1.119 . . . . 14.61 110.908 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.527 HG21 ' CB ' ' B' ' 86' ' ' ALA . 44.5 p -144.26 117.2 8.82 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.049 -1.834 . . . . 18.36 106.049 178.562 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.629 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -49.86 163.64 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 C-N-CA 118.644 -1.222 . . . . 19.13 108.734 -178.134 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -128.07 126.79 41.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.338 -0.851 . . . . 20.65 109.356 -178.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.663 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.8 OUTLIER -74.22 2.48 9.02 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.533 -0.73 . . . . 19.65 110.008 -179.996 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 84.1 p -58.85 -18.03 29.04 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.512 -1.292 . . . . 14.72 107.512 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 23.7 m -97.89 -16.39 19.77 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.85 -0.531 . . . . 11.45 110.172 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.0 m-30 -68.21 156.98 36.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 14.25 109.454 -178.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.533 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -149.89 -179.85 7.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 32.7 109.715 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.44 HG23 ' CG2' ' A' ' 43' ' ' VAL . 0.1 OUTLIER -120.75 110.87 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 15.63 109.061 179.788 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.457 ' N ' ' SD ' ' B' ' 77' ' ' MET . . . -81.85 -174.68 49.75 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.619 -1.392 . . . . 12.7 109.619 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.01 20.27 4.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.168 -1.195 . . . . 26.29 109.54 -179.932 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -93.75 -2.7 53.37 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.477 -0.764 . . . . 20.44 109.349 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 80.96 27.79 48.54 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.533 -1.427 . . . . 13.82 109.533 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.34 153.52 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -1.211 . . . . 18.27 109.788 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.12 176.83 0.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 12.43 109.584 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' B' ' 69' ' ' LYS . 2.1 ptm -167.71 99.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 35.11 109.685 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.565 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.9 mt -36.67 -64.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.511 0.672 . . . . 13.67 110.329 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 9.1 t0 84.44 -45.38 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.435 0.636 . . . . 24.06 110.061 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.9 tpm_? -173.96 67.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.155 0.978 . . . . 35.04 108.488 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.629 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.2 pt? -40.83 126.78 2.52 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.503 -0.771 . . . . 18.72 111.984 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 1.4 ttt180 -94.11 110.48 22.19 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.677 -1.231 . . . . 20.55 107.677 178.221 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.608 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 11.7 tp -80.28 150.39 30.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.091 -1.006 . . . . 14.4 111.166 -178.188 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.556 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 21.2 m -146.98 157.89 45.91 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 108.214 -1.032 . . . . 17.65 108.214 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.0 Cg_endo -62.77 142.1 87.7 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.015 1.81 . . . . 25.7 110.334 179.134 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.527 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -76.57 116.44 17.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.21 -0.931 . . . . 49.29 109.743 -178.786 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.994 -1.003 . . . . 58.91 109.44 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.375 0.607 . . . . 64.91 109.418 . . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 62' ' ' THR . 0.9 OUTLIER -68.62 73.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.664 -1.236 . . . . 33.8 107.664 178.987 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 1' ' ' MET . 1.6 mttt -62.61 157.0 21.75 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.178 0.989 . . . . 32.72 112.372 -177.669 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 61' ' ' TYR . 60.0 t -159.44 169.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.562 -0.903 . . . . 14.46 108.562 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 34' ' ' TYR . 68.0 mt-10 -152.25 103.02 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.132 -0.98 . . . . 22.12 109.634 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.595 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -75.36 105.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.853 -1.166 . . . . 14.23 107.853 179.116 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.641 ' HG3' ' CD1' ' A' ' 34' ' ' TYR . 4.9 mttm -55.57 166.13 1.05 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.8 . . . . 25.43 109.704 -179.27 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.7 Cg_endo -72.19 -17.91 27.43 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.925 1.75 . . . . 13.61 108.955 179.303 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -90.78 -6.46 54.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.984 -0.747 . . . . 15.52 108.984 178.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 2.4 mm100 -120.53 40.62 3.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 17.31 109.505 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB3' ' HD3' ' A' ' 58' ' ' PRO . . . -104.13 14.12 31.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.125 -0.985 . . . . 24.78 110.017 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.444 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 24.3 mt-30 -137.83 137.36 38.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 47.9 109.911 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.596 ' CD2' HD13 ' A' ' 49' ' ' LEU . 37.2 p90 -92.53 170.52 9.68 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.363 -0.836 . . . . 21.61 109.577 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -141.94 162.88 34.38 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.637 -0.875 . . . . 14.89 108.637 179.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.58 111.13 22.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.194 -0.941 . . . . 17.35 109.187 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -131.46 146.7 52.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.318 -0.864 . . . . 34.38 109.368 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.01 93.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 38.77 109.403 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -87.86 -178.87 47.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.402 -1.479 . . . . 34.58 109.402 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.529 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 2.0 t -138.46 125.11 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 41.87 108.37 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -73.43 54.24 0.43 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.032 -1.043 . . . . 47.21 109.638 -179.286 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.452 ' C ' ' CG ' ' A' ' 22' ' ' GLN . 0.8 OUTLIER 66.82 -59.76 0.36 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.3 -0.875 . . . . 71.56 109.267 -179.736 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 20' ' ' SER . 10.5 mt-30 -153.49 26.82 0.51 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 66.6 109.445 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 24' ' ' LYS . . . -112.29 37.85 3.5 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.275 -1.53 . . . . 55.49 109.275 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.525 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 73.54 174.92 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.546 -0.973 . . . . 44.99 109.213 -179.741 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.525 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 34.6 Cg_endo -77.29 132.83 12.79 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.592 2.195 . . . . 44.1 110.714 -179.605 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 4.9 p90 -119.6 144.2 47.24 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.167 -0.958 . . . . 32.09 109.721 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -96.08 78.02 3.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.189 -0.945 . . . . 29.25 108.788 179.521 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.585 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 4.0 mm? -110.66 164.5 12.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.857 . . . . 24.0 109.984 -179.178 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.591 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 95.0 m-20 -74.51 119.59 18.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.446 -0.784 . . . . 23.31 109.318 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -108.53 143.96 36.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.083 -1.011 . . . . 40.03 109.242 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.552 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -130.18 -179.9 5.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 12.39 109.548 -179.857 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.529 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 1.2 mp -133.78 159.15 41.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 17.42 109.795 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 2.7 m -152.09 177.54 10.39 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.992 -1.114 . . . . 13.84 107.992 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.666 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 51.4 m-85 -126.88 122.65 35.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.895 -1.128 . . . . 21.14 110.095 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.585 ' CG1' ' HG ' ' A' ' 37' ' ' LEU . 96.7 t -109.35 129.24 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.215 -0.928 . . . . 10.66 109.964 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -121.64 -14.68 8.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.405 -0.81 . . . . 25.89 109.81 -179.593 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.606 ' CD1' ' N ' ' A' ' 38' ' ' GLY . 2.6 pp -36.61 -29.74 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.653 -0.654 . . . . 24.24 110.551 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.606 ' N ' ' CD1' ' A' ' 37' ' ' LEU . . . -124.59 19.7 7.02 Favored Glycine 0 N--CA 1.482 1.734 0 N-CA-C 109.565 -1.414 . . . . 31.02 109.565 -179.012 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -165.43 114.49 1.03 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.322 -1.105 . . . . 43.23 109.14 179.84 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 39' ' ' ASN . 39.8 mt-10 -39.08 -66.59 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.663 . . . . 42.34 109.946 -179.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.432 ' N ' ' ND1' ' A' ' 41' ' ' HIS . 2.1 m-70 -63.5 153.36 83.09 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 108.224 -1.028 . . . . 6.37 108.224 179.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.666 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -78.38 138.39 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.889 1.726 . . . . 17.92 110.277 -179.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 43' ' ' VAL . 5.0 m -109.44 116.93 53.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.419 -0.801 . . . . 20.57 109.131 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.609 ' HB2' ' CE2' ' A' ' 34' ' ' TYR . 57.2 tp -71.86 108.13 4.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.276 -0.89 . . . . 20.21 109.937 -179.428 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.515 HG13 ' CG1' ' B' ' 70' ' ' VAL . 1.1 m -103.44 175.67 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.002 -0.74 . . . . 10.81 109.002 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -105.48 125.6 51.17 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.302 -0.959 . . . . 36.74 109.338 179.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.63 HG12 ' CE1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -120.9 132.33 70.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.277 -0.89 . . . . 19.74 109.602 -179.689 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 60.1 m -66.63 156.71 34.41 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.246 -0.908 . . . . 22.56 109.299 179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.596 HD13 ' CD2' ' A' ' 13' ' ' PHE . 2.8 tm? -130.09 111.27 12.31 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.321 -0.862 . . . . 20.41 108.744 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.503 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -42.4 122.53 2.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 33.99 109.945 -179.2 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -51.02 101.67 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.353 -0.842 . . . . 54.92 109.277 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.44 -24.08 10.0 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.263 -1.535 . . . . 36.1 109.263 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.503 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -73.61 157.97 86.94 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.293 -1.122 . . . . 54.76 109.351 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -78.79 114.34 3.42 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.529 2.153 . . . . 28.37 110.142 179.546 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.459 ' C ' ' O ' ' A' ' 54' ' ' PRO . . . -38.81 142.01 0.24 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.477 -0.764 . . . . 17.21 109.888 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.63 ' CE1' HG12 ' A' ' 47' ' ' ILE . 88.5 m-85 -41.9 101.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.393 -0.817 . . . . 17.19 109.408 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 6' ' ' ILE . . . -50.72 169.36 0.21 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.16 -0.963 . . . . 17.82 109.207 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HA ' HG23 ' A' ' 6' ' ' ILE . 35.2 Cg_endo -77.25 122.11 6.0 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.62 2.213 . . . . 17.28 110.457 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.97 179.89 40.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.526 -1.43 . . . . 17.22 109.526 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -72.96 138.51 46.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -1.175 . . . . 19.57 108.448 179.294 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.595 ' CE1' HD11 ' A' ' 6' ' ' ILE . 20.2 m-85 -125.11 162.11 25.32 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.611 -1.306 . . . . 14.61 111.738 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 58.8 p -144.74 120.62 10.62 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.505 -1.665 . . . . 18.36 106.505 179.06 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.607 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -54.6 165.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 C-N-CA 118.581 -1.248 . . . . 19.13 109.136 -178.472 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -127.55 127.07 43.3 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.523 -0.736 . . . . 20.65 109.031 -179.227 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.667 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -69.31 -2.89 11.92 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.569 -0.707 . . . . 19.65 109.797 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 t -54.37 -19.67 5.96 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 107.775 -1.194 . . . . 14.72 107.775 179.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 82' ' ' ARG . 3.8 m -94.7 -8.84 36.59 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.756 -0.59 . . . . 11.45 110.188 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.667 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.3 m-30 -85.34 156.76 20.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.882 -1.136 . . . . 14.25 109.462 -179.272 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -148.52 176.54 10.23 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.054 -0.721 . . . . 32.7 109.054 179.545 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.516 ' CG1' HG13 ' B' ' 45' ' ' VAL . 1.7 t -127.23 118.43 49.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.302 -0.874 . . . . 15.63 109.474 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 72' ' ' GLN . . . -82.5 -99.46 0.48 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.326 -1.509 . . . . 12.7 109.326 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.589 ' O ' ' CG ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER 170.33 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -1.129 . . . . 26.29 109.565 179.754 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER 151.72 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.784 -0.821 . . . . 20.44 108.784 179.923 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -114.5 -88.06 1.56 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.442 -1.463 . . . . 13.82 109.442 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER 177.93 174.73 0.53 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -1.145 . . . . 18.27 109.678 -179.989 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' A' ' 77' ' ' MET . 6.3 tp -43.51 146.61 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 12.43 109.659 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.526 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 5.1 mtt -151.85 151.22 31.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 35.11 109.272 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.604 HG12 ' CE1' ' A' ' 68' ' ' PHE . 6.5 mt -76.96 137.26 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 13.67 110.308 -179.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -104.89 -26.73 12.09 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.931 -1.137 . . . . 24.06 107.931 178.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER 179.02 69.95 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.021 -1.474 . . . . 35.04 107.021 179.014 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.607 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -30.19 121.43 0.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.342 -0.845 . . . . 18.72 111.71 -178.038 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.51 ' N ' ' OG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -91.85 101.27 13.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 20.55 108.808 179.398 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.61 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -70.08 145.85 51.35 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.946 0.879 . . . . 14.4 110.883 -179.02 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.486 ' C ' ' CD2' ' A' ' 61' ' ' TYR . 25.6 m -148.73 156.75 41.43 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 107.793 -1.188 . . . . 17.65 107.793 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.0 Cg_endo -63.79 140.02 71.73 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.979 1.786 . . . . 25.7 110.15 179.023 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 62' ' ' THR . . . -71.44 118.31 14.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.939 . . . . 49.29 109.64 -178.703 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.012 -0.994 . . . . 58.91 109.435 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.478 ' O ' ' N ' ' B' ' 3' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.371 0.605 . . . . 64.91 109.408 . . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' B' ' 62' ' ' THR . 0.9 OUTLIER -68.73 73.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.699 -1.223 . . . . 33.8 107.699 179.028 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.491 ' O ' HG21 ' B' ' 4' ' ' VAL . 1.5 mttt -62.63 156.82 22.29 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.157 0.979 . . . . 32.72 112.352 -177.623 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' B' ' 61' ' ' TYR . 60.4 t -159.42 168.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.552 -0.906 . . . . 14.46 108.552 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 68.6 mt-10 -152.22 103.02 2.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 22.12 109.648 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.587 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -75.4 106.06 4.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.79 -1.189 . . . . 14.23 107.79 179.18 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.632 ' HG3' ' CD1' ' B' ' 34' ' ' TYR . 4.9 mttm -55.75 166.23 1.08 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.492 -0.755 . . . . 25.43 109.709 -179.241 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.9 Cg_endo -72.05 -18.01 27.82 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.987 1.791 . . . . 13.61 109.003 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -90.77 -6.4 54.41 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.988 -0.745 . . . . 15.52 108.988 178.64 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 2.5 mm100 -120.68 40.73 3.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.895 . . . . 17.31 109.413 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.431 ' HB3' ' HD3' ' B' ' 58' ' ' PRO . . . -104.28 14.17 30.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 24.78 109.976 -179.346 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.444 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 24.7 mt-30 -137.86 137.34 38.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.148 -0.97 . . . . 47.9 109.854 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.597 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 37.2 p90 -92.47 170.59 9.64 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.398 -0.814 . . . . 21.61 109.568 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -141.91 163.02 34.03 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.57 -0.9 . . . . 14.89 108.57 179.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.64 111.15 22.54 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.217 -0.927 . . . . 17.35 109.18 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -131.49 146.77 52.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.32 -0.863 . . . . 34.38 109.359 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.98 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 38.77 109.435 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.572 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -87.92 -178.96 47.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.447 -1.461 . . . . 34.58 109.447 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.526 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.9 t -138.32 125.09 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -1.155 . . . . 41.87 108.43 179.31 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.523 ' O ' ' N ' ' B' ' 22' ' ' GLN . 0.3 OUTLIER -73.5 54.35 0.45 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.066 -1.021 . . . . 47.21 109.599 -179.256 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.463 ' C ' ' CG ' ' B' ' 22' ' ' GLN . 0.7 OUTLIER 66.76 -59.86 0.36 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.266 -0.896 . . . . 71.56 109.288 -179.73 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' B' ' 20' ' ' SER . 10.4 mt-30 -153.44 26.95 0.51 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 66.6 109.472 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' B' ' 24' ' ' LYS . . . -112.43 37.94 3.45 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.219 -1.553 . . . . 55.49 109.219 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.514 ' CG ' ' HD2' ' B' ' 25' ' ' PRO . 0.0 OUTLIER 73.35 175.03 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.391 -1.064 . . . . 44.99 109.266 -179.738 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.514 ' HD2' ' CG ' ' B' ' 24' ' ' LYS . 34.2 Cg_endo -77.39 132.84 12.69 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.559 2.173 . . . . 44.1 110.737 -179.599 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.587 ' CE1' ' HB2' ' B' ' 28' ' ' LEU . 4.9 p90 -119.55 144.14 47.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.938 . . . . 32.09 109.75 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -96.06 78.15 3.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 29.25 108.686 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.587 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 4.1 mm? -110.71 164.64 12.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 24.0 109.998 -179.27 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.597 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 95.4 m-20 -74.71 119.44 18.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.439 -0.788 . . . . 23.31 109.33 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -108.37 144.08 36.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.069 -1.019 . . . . 40.03 109.2 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.557 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -130.27 -179.9 5.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -0.994 . . . . 12.39 109.51 -179.902 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.528 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 1.3 mp -133.76 159.16 41.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 17.42 109.722 -179.782 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 2.8 m -152.07 177.76 10.16 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.008 -1.108 . . . . 13.84 108.008 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.67 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 50.7 m-85 -127.19 122.58 34.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.881 -1.137 . . . . 21.14 110.091 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' B' ' 37' ' ' LEU . 96.6 t -109.27 129.16 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.234 -0.916 . . . . 10.66 109.937 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' B' ' 36' ' ' ASP . 0.4 OUTLIER -121.48 -14.68 8.19 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.432 -0.793 . . . . 25.89 109.788 -179.654 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.599 ' CD1' ' N ' ' B' ' 38' ' ' GLY . 2.6 pp -36.6 -29.7 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.654 -0.654 . . . . 24.24 110.58 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.599 ' N ' ' CD1' ' B' ' 37' ' ' LEU . . . -124.65 19.58 7.02 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 109.591 -1.404 . . . . 31.02 109.591 -178.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' B' ' 39' ' ' ASN . 0.1 OUTLIER -165.43 114.68 1.03 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.38 -1.07 . . . . 43.23 109.056 179.832 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' B' ' 39' ' ' ASN . 39.9 mt-10 -39.12 -66.48 0.28 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.536 0.684 . . . . 42.34 110.057 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.436 ' ND1' ' N ' ' B' ' 41' ' ' HIS . 2.1 m-70 -63.56 153.39 83.21 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.223 -1.029 . . . . 6.38 108.223 179.28 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 38.2 Cg_endo -78.42 138.29 15.51 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.85 1.7 . . . . 17.92 110.241 -179.357 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' B' ' 43' ' ' VAL . 4.8 m -109.37 116.99 53.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.423 -0.798 . . . . 20.57 109.191 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.613 ' HB2' ' CE2' ' B' ' 34' ' ' TYR . 57.0 tp -71.69 108.11 4.86 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.86 . . . . 20.21 109.982 -179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.516 HG13 ' CG1' ' A' ' 70' ' ' VAL . 1.1 m -103.48 175.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.466 -0.771 . . . . 10.81 109.055 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -105.44 125.37 50.91 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.385 -0.926 . . . . 36.74 109.431 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.622 HG12 ' CE1' ' B' ' 56' ' ' TYR . 1.0 OUTLIER -120.72 132.39 70.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.334 -0.854 . . . . 19.74 109.608 -179.638 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 59.8 m -66.72 156.81 34.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 22.56 109.238 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.596 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 2.8 tm? -130.17 111.28 12.28 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.288 -0.883 . . . . 20.41 108.746 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.509 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -42.43 122.62 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 33.99 109.944 -179.124 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -51.06 101.64 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.356 -0.84 . . . . 54.92 109.322 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.47 -24.0 10.03 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.297 -1.521 . . . . 36.1 109.297 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.509 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.8 OUTLIER -73.79 157.85 86.83 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.295 -1.12 . . . . 54.76 109.362 179.883 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.7 114.47 3.46 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.518 2.145 . . . . 28.37 110.098 179.582 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' B' ' 54' ' ' PRO . . . -38.82 141.76 0.26 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.465 -0.772 . . . . 17.21 109.949 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.622 ' CE1' HG12 ' B' ' 47' ' ' ILE . 88.7 m-85 -41.5 100.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.439 -0.788 . . . . 17.19 109.317 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.432 ' O ' HG23 ' B' ' 6' ' ' ILE . . . -50.01 169.5 0.19 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.987 . . . . 17.82 109.287 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.454 ' HA ' HG23 ' B' ' 6' ' ' ILE . 34.6 Cg_endo -77.06 120.84 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.48 2.12 . . . . 17.28 110.188 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.35 179.07 41.59 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.69 -1.364 . . . . 17.22 109.69 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 0.4 OUTLIER -73.18 137.98 45.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -1.153 . . . . 19.57 107.969 178.884 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.587 ' CE1' HD11 ' B' ' 6' ' ' ILE . 21.2 m-85 -124.55 162.35 24.23 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.502 -1.374 . . . . 14.61 111.703 -179.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' B' ' 2' ' ' ILE . 58.1 p -144.86 120.46 10.43 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.492 -1.67 . . . . 18.36 106.492 179.08 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.62 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -54.4 166.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 C-N-CA 118.578 -1.249 . . . . 19.13 109.056 -178.451 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -128.27 127.2 42.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.033 -0.728 . . . . 20.65 109.033 -179.275 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.654 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -69.36 -2.75 11.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.514 -0.741 . . . . 19.65 109.771 -179.964 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 9.2 t -54.54 -19.52 6.04 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 107.729 -1.211 . . . . 14.72 107.729 179.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' B' ' 82' ' ' ARG . 3.8 m -95.1 -9.26 34.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.829 -0.544 . . . . 11.45 110.147 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.654 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.3 m-30 -84.93 155.89 21.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.878 -1.139 . . . . 14.25 109.269 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.427 ' O ' HD13 ' B' ' 76' ' ' LEU . 0.2 OUTLIER -147.77 176.56 10.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.497 -0.752 . . . . 32.7 109.016 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.515 ' CG1' HG13 ' A' ' 45' ' ' VAL . 1.7 t -127.13 118.63 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.867 . . . . 15.63 109.476 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' B' ' 72' ' ' GLN . . . -82.69 -99.2 0.5 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.4 -1.48 . . . . 12.7 109.4 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.579 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER 170.1 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.191 -1.181 . . . . 26.29 109.569 179.769 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.579 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 0.7 OUTLIER 151.61 -33.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.768 -0.827 . . . . 20.44 108.768 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -114.68 -87.76 1.51 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.487 -1.445 . . . . 13.82 109.487 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 177.58 174.69 0.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -1.154 . . . . 18.27 109.606 179.931 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' B' ' 77' ' ' MET . 6.3 tp -43.6 146.49 0.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 12.43 109.633 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.507 ' N ' ' HG ' ' B' ' 76' ' ' LEU . 5.0 mtt -151.74 151.34 31.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.383 -0.823 . . . . 35.11 109.13 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.613 HG12 ' CE1' ' B' ' 68' ' ' PHE . 6.5 mt -77.16 137.47 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 13.67 110.351 -179.571 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -104.84 -26.71 12.12 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.91 -1.144 . . . . 24.06 107.91 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.0 OUTLIER 178.99 70.03 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.006 -1.479 . . . . 35.04 107.006 179.054 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.62 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -30.19 121.5 0.18 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.3 -0.864 . . . . 18.72 111.697 -178.055 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.513 ' N ' ' OG ' ' B' ' 67' ' ' SER . 0.0 OUTLIER -91.84 101.45 14.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.832 -0.803 . . . . 20.55 108.832 179.37 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.603 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -70.2 145.54 51.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 14.4 110.9 -179.073 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.469 ' C ' ' CD2' ' B' ' 61' ' ' TYR . 25.8 m -148.49 156.95 42.24 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 107.714 -1.217 . . . . 17.65 107.714 179.369 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.4 Cg_endo -64.01 140.21 71.31 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.936 1.757 . . . . 25.7 110.034 179.1 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.483 ' CB ' HG21 ' B' ' 62' ' ' THR . . . -71.55 118.29 14.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 49.29 109.693 -178.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.979 -1.01 . . . . 58.91 109.428 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.492 ' CG ' ' HB ' ' A' ' 62' ' ' THR . 1.5 ttp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.307 0.575 . . . . 64.91 109.565 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.542 ' N ' HD21 ' B' ' 65' ' ' LEU . 5.2 mt -71.32 75.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.134 -1.062 . . . . 33.8 108.134 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' C ' HG11 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -63.02 156.38 24.87 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.907 0.86 . . . . 32.72 111.155 -178.283 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.57 HG12 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -163.85 167.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.464 -0.939 . . . . 14.46 108.464 179.983 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.533 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 34.3 mt-10 -141.01 113.55 8.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 22.12 109.59 -179.66 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -72.83 103.28 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.106 -1.072 . . . . 14.23 108.106 179.346 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.601 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 24.2 mmmt -51.49 163.41 0.59 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 25.43 109.369 -179.471 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.9 Cg_endo -73.04 -12.61 25.97 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.059 1.839 . . . . 13.61 109.383 179.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.6 3.72 54.75 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.615 -0.883 . . . . 15.52 108.615 178.491 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.484 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.8 mm-40 -127.38 41.32 3.54 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.374 -0.829 . . . . 17.31 108.86 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.23 11.76 36.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 24.78 110.258 -179.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.411 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 32.4 mt-30 -136.42 134.43 37.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.123 -0.985 . . . . 47.9 110.121 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.614 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 20.4 p90 -84.72 164.83 18.32 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.318 -0.863 . . . . 21.61 109.436 179.735 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -130.89 140.31 50.19 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.349 -0.844 . . . . 14.89 109.256 179.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -107.35 115.39 30.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.413 -0.805 . . . . 17.35 109.225 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.461 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -129.14 72.78 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.062 -1.024 . . . . 34.38 109.663 -179.819 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER 38.65 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.331 0.586 . . . . 38.77 109.906 179.681 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -89.42 154.04 23.87 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.643 -1.383 . . . . 34.58 109.643 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.482 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 2.4 t -128.88 123.79 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -1.171 . . . . 41.87 109.012 179.595 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.409 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 3.4 m -56.47 -93.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 47.21 109.732 -179.295 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.466 ' NH1' ' HG3' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -127.82 58.91 1.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.169 -0.957 . . . . 71.56 109.482 -179.873 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 56.4 18.72 3.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 66.6 109.308 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.34 -52.49 0.63 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.418 -1.473 . . . . 55.49 109.418 179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -138.48 143.04 36.78 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.344 -1.092 . . . . 44.99 109.167 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.9 145.08 19.56 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.533 2.156 . . . . 44.1 110.923 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.6 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 4.5 p90 -145.73 136.83 24.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.285 -0.884 . . . . 32.09 109.235 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 m -100.85 79.41 2.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 29.25 109.154 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.588 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -92.54 169.36 10.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 24.0 109.997 -179.484 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.607 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -103.04 131.57 49.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.461 -0.774 . . . . 23.31 109.206 -179.863 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -117.19 148.58 41.48 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.064 -1.022 . . . . 40.03 109.76 -179.762 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.576 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -126.9 -163.91 1.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.172 -0.955 . . . . 12.39 109.496 179.729 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.564 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -136.35 177.98 7.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 17.42 109.609 -179.794 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.479 ' HB2' HG23 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -171.74 162.52 6.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 13.84 108.709 -179.768 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.634 ' CE1' ' HB2' ' A' ' 44' ' ' LEU . 3.5 m-30 -115.5 111.43 20.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.249 -0.907 . . . . 21.14 108.761 -179.848 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.504 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 99.2 t -100.81 144.74 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.896 -1.127 . . . . 10.66 110.51 -179.602 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -125.54 -137.8 0.27 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.517 -0.92 . . . . 25.89 108.517 179.455 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.561 ' HB3' ' CD1' ' B' ' 65' ' ' LEU . 0.2 OUTLIER 68.48 -62.68 0.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.825 -1.172 . . . . 24.24 108.818 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -88.53 24.29 12.72 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.647 -1.781 . . . . 31.02 108.647 179.21 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.488 ' ND2' HG13 ' A' ' 43' ' ' VAL . 0.3 OUTLIER 176.39 114.41 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.548 -0.972 . . . . 43.23 108.655 -179.731 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 39' ' ' ASN . 4.3 mt-10 -38.91 -64.07 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.618 0.723 . . . . 42.34 109.995 -179.336 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.5 m80 -68.6 162.74 60.37 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 108.745 -0.835 . . . . 8.11 108.745 179.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.628 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.5 Cg_endo -78.12 148.83 24.83 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.126 1.884 . . . . 17.92 110.307 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.488 HG13 ' ND2' ' A' ' 39' ' ' ASN . 18.5 m -119.74 119.53 60.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.294 -0.879 . . . . 20.57 109.262 179.363 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.634 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 20.6 tp -71.65 114.12 9.39 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.426 0.632 . . . . 20.21 109.557 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.478 HG21 ' N ' ' B' ' 75' ' ' SER . 3.3 p -122.09 163.05 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.455 -0.778 . . . . 10.81 109.316 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.67 173.05 12.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.919 . . . . 36.74 110.369 -179.167 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.577 HD11 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -163.96 131.4 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.484 -0.932 . . . . 19.74 108.484 179.97 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.421 ' CG2' HD23 ' A' ' 28' ' ' LEU . 3.8 m -74.82 154.45 38.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.894 -1.129 . . . . 22.56 109.464 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.614 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -123.35 119.98 31.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -0.866 . . . . 20.41 109.037 -179.839 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.504 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -53.95 137.41 39.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 33.99 109.875 -179.455 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -57.36 118.21 4.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 54.92 109.244 179.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.74 -12.23 69.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.341 -1.504 . . . . 36.1 109.341 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.504 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -79.84 148.74 69.34 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.26 -1.141 . . . . 54.76 109.37 179.871 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.3 Cg_endo -77.08 121.08 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.589 2.193 . . . . 28.37 110.319 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -37.82 145.69 0.07 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.578 -0.702 . . . . 17.21 110.607 -179.597 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 75.2 m-85 -43.74 105.36 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.41 -0.806 . . . . 17.19 109.226 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.519 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -57.37 176.03 0.24 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 17.82 109.67 -179.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.54 115.16 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.645 2.23 . . . . 17.28 110.353 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.23 176.33 41.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.667 -1.373 . . . . 17.22 109.667 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.0 mp -73.33 145.34 46.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 19.57 108.842 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.579 ' CE1' HD11 ' A' ' 6' ' ' ILE . 38.8 m-85 -132.56 162.8 30.34 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.43 1.11 . . . . 14.61 111.103 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.492 ' HB ' ' CG ' ' A' ' 1' ' ' MET . 38.7 p -142.32 121.83 13.27 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.945 -1.872 . . . . 18.36 105.945 178.16 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.596 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.0 t -55.26 163.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 C-N-CA 118.372 -1.331 . . . . 19.13 109.017 -177.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -123.05 130.99 53.5 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.49 -0.756 . . . . 20.65 109.383 -178.739 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.663 ' HB2' ' CD2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -73.87 2.85 7.61 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.475 -0.766 . . . . 19.65 109.853 179.827 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -56.2 -19.49 13.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 107.176 -1.416 . . . . 14.72 107.176 178.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.487 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 4.1 m -96.47 -7.01 35.9 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 116.057 -0.52 . . . . 11.45 110.212 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.1 m-30 -83.95 161.95 20.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.985 -1.072 . . . . 14.25 109.848 -178.856 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.76 170.13 22.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.453 -0.78 . . . . 32.7 109.326 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.497 HG23 ' CG2' ' B' ' 43' ' ' VAL . 0.5 OUTLIER -121.36 116.74 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 15.63 109.156 179.733 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.71 -170.82 17.73 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.763 -1.335 . . . . 12.7 109.763 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.537 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -89.67 20.9 3.75 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.248 -1.148 . . . . 26.29 109.468 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 5.7 t80 -112.47 10.25 19.69 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.315 -0.866 . . . . 20.44 109.573 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.424 ' C ' HG21 ' B' ' 45' ' ' VAL . . . 63.02 56.25 21.82 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.597 -1.401 . . . . 13.82 109.597 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.531 ' N ' HG21 ' B' ' 45' ' ' VAL . 1.4 m -157.27 120.06 3.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -1.146 . . . . 18.27 109.585 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.533 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.3 OUTLIER -70.46 155.38 40.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 12.43 109.312 179.817 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 45.8 mtm -163.64 130.81 3.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 35.11 109.736 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.608 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.5 mp -64.64 142.0 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 13.67 109.805 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -105.59 -36.14 7.2 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.131 -1.063 . . . . 24.06 108.131 178.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.487 ' C ' ' HB3' ' A' ' 67' ' ' SER . 2.1 ttp180 -170.34 68.07 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 106.851 -1.537 . . . . 35.04 106.851 178.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.596 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -29.46 117.12 0.12 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.243 -0.889 . . . . 18.72 112.063 -177.674 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -92.21 113.0 25.15 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.004 -1.11 . . . . 20.55 108.004 178.825 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.608 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 15.3 tp -81.91 153.39 26.34 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.078 0.942 . . . . 14.4 111.023 -178.499 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.57 ' N ' ' HG ' ' A' ' 83' ' ' LEU . 33.0 m -152.23 152.14 28.86 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.831 -1.174 . . . . 17.65 107.831 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.4 Cg_endo -60.99 141.54 94.77 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.019 1.812 . . . . 25.7 110.537 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.81 122.57 22.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 49.29 109.702 -178.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.979 -1.01 . . . . 58.91 109.446 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.496 ' CG ' ' HB ' ' B' ' 62' ' ' THR . 1.5 ttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.525 -0.546 . . . . 64.91 109.525 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.539 ' N ' HD21 ' A' ' 65' ' ' LEU . 5.3 mt -71.68 75.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.119 -1.067 . . . . 33.8 108.119 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.435 ' C ' HG11 ' B' ' 4' ' ' VAL . 0.5 OUTLIER -63.01 156.19 25.39 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.917 0.865 . . . . 32.72 111.179 -178.277 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.564 HG12 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -163.67 167.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.468 -0.938 . . . . 14.46 108.468 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.544 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 34.5 mt-10 -141.04 113.63 8.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.958 . . . . 22.12 109.566 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.563 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.3 OUTLIER -72.92 103.23 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.164 -1.05 . . . . 14.23 108.164 179.317 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.592 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 24.1 mmmt -51.44 163.34 0.59 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.322 -0.861 . . . . 25.43 109.338 -179.45 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.3 Cg_endo -73.05 -12.54 25.9 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.05 1.833 . . . . 13.61 109.437 179.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.63 3.63 54.84 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.584 -0.895 . . . . 15.52 108.584 178.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.48 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.7 mm-40 -127.18 41.12 3.58 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.385 -0.822 . . . . 17.31 108.898 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.08 11.92 36.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 24.78 110.294 -179.121 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.413 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 32.7 mt-30 -136.46 134.35 37.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.997 . . . . 47.9 110.158 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.623 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 20.6 p90 -84.7 164.8 18.36 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.355 -0.841 . . . . 21.61 109.465 179.701 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -130.86 140.34 50.22 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.39 -0.819 . . . . 14.89 109.29 179.047 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' B' ' 28' ' ' LEU . 0.4 OUTLIER -107.3 115.26 29.86 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.333 -0.854 . . . . 17.35 109.269 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . 0.459 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.7 OUTLIER -129.02 72.78 1.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.004 . . . . 34.38 109.711 -179.898 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.459 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.6 OUTLIER 38.62 90.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.396 0.617 . . . . 38.77 109.905 179.73 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.589 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -89.59 154.01 23.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.677 -1.369 . . . . 34.58 109.677 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.483 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 2.4 t -128.82 123.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -1.143 . . . . 41.87 109.003 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.408 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 3.4 m -56.48 -93.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.356 -0.84 . . . . 47.21 109.78 -179.386 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.458 ' NH1' ' HG3' ' B' ' 21' ' ' ARG . 0.8 OUTLIER -127.8 58.96 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.146 -0.971 . . . . 71.56 109.479 -179.87 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 56.32 18.66 3.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 66.6 109.337 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.3 -52.54 0.63 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.379 -1.489 . . . . 55.49 109.379 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -138.45 143.16 37.34 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.256 -1.144 . . . . 44.99 109.164 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.94 145.01 19.4 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.512 2.141 . . . . 44.1 110.915 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.601 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 4.4 p90 -145.66 136.81 24.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -0.872 . . . . 32.09 109.173 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.8 m -100.75 79.52 2.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.96 . . . . 29.25 109.137 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.594 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -92.59 169.28 10.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.942 . . . . 24.0 110.018 -179.557 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.623 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -103.01 131.58 49.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.715 . . . . 23.31 109.155 -179.928 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.5 OUTLIER -117.13 148.53 41.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 40.03 109.708 -179.74 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.581 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -126.78 -163.84 1.28 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.173 -0.955 . . . . 12.39 109.503 179.704 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.559 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 0.5 OUTLIER -136.46 177.92 7.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 17.42 109.573 -179.785 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.484 ' HB2' HG23 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -171.69 162.56 6.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.018 -1.051 . . . . 13.84 108.718 -179.679 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.64 ' CE1' ' HB2' ' B' ' 44' ' ' LEU . 3.5 m-30 -115.6 111.4 20.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 21.14 108.763 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.502 ' CG2' ' HB ' ' B' ' 4' ' ' VAL . 99.4 t -100.87 144.65 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.896 -1.128 . . . . 10.66 110.521 -179.541 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.7 OUTLIER -125.46 -137.87 0.27 Allowed 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.519 -0.919 . . . . 25.89 108.519 179.462 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.555 ' HB3' ' CD1' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 68.5 -62.71 0.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.877 -1.139 . . . . 24.24 108.754 -179.974 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -88.41 24.12 13.1 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 108.589 -1.804 . . . . 31.02 108.589 179.291 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.491 ' ND2' ' CG1' ' B' ' 43' ' ' VAL . 0.3 OUTLIER 176.48 114.39 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.588 -0.948 . . . . 43.23 108.644 -179.722 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' B' ' 39' ' ' ASN . 4.4 mt-10 -38.77 -64.21 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.511 -0.743 . . . . 42.34 109.985 -179.306 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . 0.409 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 1.5 m80 -68.51 162.92 58.47 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 108.722 -0.844 . . . . 8.13 108.722 179.578 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.622 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.0 Cg_endo -78.19 148.8 24.58 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.159 1.906 . . . . 17.92 110.314 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.497 ' CG2' HG23 ' A' ' 70' ' ' VAL . 18.5 m -119.71 119.66 61.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 119.575 -0.85 . . . . 20.57 109.222 179.297 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.64 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 20.4 tp -71.75 114.28 9.67 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.464 0.649 . . . . 20.21 109.52 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.531 HG21 ' N ' ' A' ' 75' ' ' SER . 3.1 p -122.18 162.78 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.478 -0.763 . . . . 10.81 109.327 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 172.95 12.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.908 . . . . 36.74 110.374 -179.163 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.586 HD11 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -163.89 131.37 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.513 -0.921 . . . . 19.74 108.513 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.433 ' CG2' HD23 ' B' ' 28' ' ' LEU . 3.8 m -74.84 154.17 38.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.918 -1.114 . . . . 22.56 109.461 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.622 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -123.09 120.1 32.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.361 -0.837 . . . . 20.41 109.059 -179.845 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.51 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -54.02 137.37 39.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 33.99 109.845 -179.391 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.28 118.36 5.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -0.865 . . . . 54.92 109.22 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 -12.21 69.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.342 -1.503 . . . . 36.1 109.342 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.51 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -79.85 148.73 69.28 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.261 -1.141 . . . . 54.76 109.361 179.92 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.4 Cg_endo -77.15 120.95 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.579 2.186 . . . . 28.37 110.367 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.546 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -37.6 145.46 0.06 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.611 -0.681 . . . . 17.21 110.68 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.603 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 75.5 m-85 -43.57 105.13 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.49 -0.756 . . . . 17.19 109.155 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.522 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -57.26 176.04 0.24 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 17.82 109.75 -179.546 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -78.38 114.48 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.678 2.252 . . . . 17.28 110.182 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.38 176.12 42.5 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.687 -1.365 . . . . 17.22 109.687 -179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 2.8 mp -73.56 145.13 45.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -1.161 . . . . 19.57 108.664 179.33 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.571 ' CD2' HD22 ' B' ' 83' ' ' LEU . 38.3 m-85 -132.27 162.66 30.43 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 122.461 1.124 . . . . 14.61 111.155 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.496 ' HB ' ' CG ' ' B' ' 1' ' ' MET . 38.5 p -142.22 121.69 13.24 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.976 -1.861 . . . . 18.36 105.976 178.185 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.599 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 1.9 t -55.24 163.14 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 C-N-CA 118.37 -1.332 . . . . 19.13 109.07 -178.017 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -122.95 131.1 53.57 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.49 -0.757 . . . . 20.65 109.374 -178.716 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.65 ' HB2' ' CD2' ' B' ' 68' ' ' PHE . 0.7 OUTLIER -73.87 2.73 7.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.561 -0.712 . . . . 19.65 109.894 179.769 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -56.13 -19.52 13.7 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.105 -1.443 . . . . 14.72 107.105 178.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.48 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 4.1 m -96.5 -7.35 34.92 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.896 -0.503 . . . . 11.45 110.149 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.2 m-30 -83.69 161.71 20.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.912 -1.117 . . . . 14.25 109.776 -178.848 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.62 170.15 22.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 32.7 109.28 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.479 HG23 ' CG2' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -121.27 116.87 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 15.63 109.253 179.748 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.99 -170.88 19.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.73 -1.348 . . . . 12.7 109.73 -179.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . 0.534 ' O ' ' CG ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -89.63 20.99 3.67 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.251 -1.147 . . . . 26.29 109.478 -179.882 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' B' ' 73' ' ' PHE . 5.7 t80 -112.51 10.36 19.63 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.392 -0.817 . . . . 20.44 109.558 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.91 56.43 20.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.657 -1.377 . . . . 13.82 109.657 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.478 ' N ' HG21 ' A' ' 45' ' ' VAL . 1.4 m -157.52 120.01 3.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -1.174 . . . . 18.27 109.616 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.538 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.3 OUTLIER -70.5 155.35 40.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 12.43 109.324 179.891 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 45.7 mtm -163.56 130.91 3.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 35.11 109.679 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.607 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.5 mp -64.78 142.25 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 13.67 109.783 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -105.73 -36.19 7.13 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.091 -1.078 . . . . 24.06 108.091 178.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.48 ' C ' ' HB3' ' B' ' 67' ' ' SER . 2.1 ttp180 -170.31 68.23 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.886 -1.524 . . . . 35.04 106.886 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.599 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.9 OUTLIER -29.57 117.1 0.13 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.212 -0.904 . . . . 18.72 112.104 -177.683 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.3 OUTLIER -92.18 112.94 25.07 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.051 -1.092 . . . . 20.55 108.051 178.825 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.603 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 15.3 tp -81.93 153.34 26.34 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.082 0.944 . . . . 14.4 111.008 -178.472 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.557 ' N ' ' HG ' ' B' ' 83' ' ' LEU . 33.0 m -152.15 152.04 28.83 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.803 -1.184 . . . . 17.65 107.803 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.2 Cg_endo -60.94 141.58 94.97 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.951 1.767 . . . . 25.7 110.523 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.75 122.54 22.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 49.29 109.751 -178.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.975 -1.012 . . . . 58.91 109.442 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' C ' ' A' ' 2' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.475 -0.565 . . . . 64.91 109.475 . . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.581 ' N ' ' CD2' ' B' ' 65' ' ' LEU . 0.0 OUTLIER -43.15 131.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.614 -0.884 . . . . 33.8 108.614 179.396 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 1.3 mttp -102.82 153.78 19.84 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.117 -0.99 . . . . 32.72 110.394 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.585 ' HB ' ' CB ' ' A' ' 61' ' ' TYR . 32.7 t -159.78 166.13 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.684 0.754 . . . . 14.46 109.777 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 32.7 mt-10 -153.05 103.06 2.7 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.684 -0.858 . . . . 22.12 108.684 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.587 HD11 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -71.84 103.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.032 -1.099 . . . . 14.23 108.032 179.837 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.647 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.63 171.19 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.446 -0.784 . . . . 25.43 109.643 -179.258 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -75.05 -22.66 14.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.334 2.023 . . . . 13.61 109.718 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.54 2.18 54.19 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.975 -0.75 . . . . 15.52 108.975 178.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.512 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 8.7 mm-40 -121.49 40.99 3.46 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.263 -0.898 . . . . 17.31 109.205 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -109.37 12.34 24.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.16 -0.963 . . . . 24.78 109.796 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.446 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -131.7 141.63 49.61 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.509 -0.922 . . . . 47.9 108.509 179.846 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 37.1 p90 -93.68 167.65 11.52 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.019 -1.051 . . . . 21.61 109.73 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.453 HG21 ' N ' ' A' ' 15' ' ' THR . 99.7 m -135.1 149.96 50.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.79 -0.819 . . . . 14.89 108.79 179.159 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.453 ' N ' HG21 ' A' ' 14' ' ' THR . 0.2 OUTLIER -84.22 111.89 19.78 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.212 -0.93 . . . . 17.35 109.413 -179.763 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.87 139.15 46.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 34.38 109.408 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.63 125.32 8.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 38.77 109.332 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -121.0 175.62 16.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.385 -1.486 . . . . 34.58 109.385 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.431 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -144.66 116.47 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.164 -1.197 . . . . 41.87 109.021 179.499 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -44.28 -86.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 47.21 109.398 -179.371 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.519 ' N ' ' OG ' ' A' ' 20' ' ' SER . 6.0 ttp180 -136.97 56.25 1.8 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 71.56 109.423 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.6 OUTLIER 69.78 16.06 7.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 66.6 109.448 -179.95 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.39 -54.87 0.93 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.505 -1.438 . . . . 55.49 109.505 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.57 149.93 29.74 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.281 -1.129 . . . . 44.99 109.393 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 35.2 Cg_endo -78.13 133.56 12.32 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.689 2.259 . . . . 44.1 110.769 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.588 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.9 p90 -126.7 144.31 50.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.312 -0.868 . . . . 32.09 109.441 179.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 m -98.98 79.41 2.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.042 . . . . 29.25 109.234 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.582 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -102.57 155.02 18.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 24.0 109.979 -179.624 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.595 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 97.3 m-20 -69.39 129.91 41.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 23.31 109.378 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 33.9 mt-10 -112.06 163.62 14.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.148 -0.97 . . . . 40.03 109.16 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.543 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -150.7 -176.83 5.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.071 . . . . 12.39 110.038 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.525 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . 27.9 mt -133.31 158.61 42.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.464 -0.772 . . . . 17.42 109.076 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 12.4 m -155.51 172.92 17.45 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.161 -1.052 . . . . 13.84 108.161 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.671 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 32.6 m-85 -121.9 104.48 9.58 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.092 -1.005 . . . . 21.14 109.176 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.52 ' HA ' HG21 ' A' ' 4' ' ' VAL . 42.4 t -79.8 159.55 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.096 -1.002 . . . . 10.66 110.655 -179.294 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 38' ' ' GLY . 31.6 m-20 -140.84 -147.96 0.23 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.714 -0.847 . . . . 25.89 108.714 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.532 ' HG ' ' CD1' ' B' ' 65' ' ' LEU . 0.2 OUTLIER 67.71 -61.89 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 24.24 109.188 -179.983 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -87.15 21.18 21.86 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.059 -1.616 . . . . 31.02 109.059 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 36' ' ' ASP . 1.5 p30 176.19 112.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -1.063 . . . . 43.23 109.324 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' ASN . 3.1 mt-10 -41.7 -63.13 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 42.34 109.955 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -65.0 154.55 86.28 Favored Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.512 -0.742 . . . . 9.47 109.001 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.671 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.8 Cg_endo -78.26 143.92 20.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.233 1.955 . . . . 17.92 110.248 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.523 ' CG2' HG23 ' B' ' 70' ' ' VAL . 19.3 m -116.15 116.11 51.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.236 -0.915 . . . . 20.57 109.194 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 55.2 tp -73.14 102.35 3.56 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.29 -0.882 . . . . 20.21 109.683 -179.754 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' B' ' 70' ' ' VAL . 1.2 m -107.14 -178.41 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.568 -0.708 . . . . 10.81 109.164 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 1.1 mtpt -101.07 154.3 18.83 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.569 -0.852 . . . . 36.74 109.748 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.61 HG12 ' CE1' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -140.55 173.45 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.336 -0.852 . . . . 19.74 109.364 -179.879 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.16 145.89 37.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.277 -0.889 . . . . 22.56 109.263 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.587 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 3.0 tm? -127.34 126.97 43.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.315 -0.865 . . . . 20.41 109.041 -179.669 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.478 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 3.2 m-20 -63.39 142.38 58.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 33.99 109.821 -179.417 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.66 123.63 17.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 54.92 109.295 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.23 -16.08 50.32 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.391 -1.484 . . . . 36.1 109.391 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -75.18 153.72 86.33 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.309 -1.113 . . . . 54.76 109.381 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.57 110.03 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.621 2.214 . . . . 28.37 110.334 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -41.69 151.34 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -0.829 . . . . 17.21 109.849 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 89.8 m-85 -46.03 101.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.871 . . . . 17.19 109.072 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' CB ' ' HD2' ' A' ' 58' ' ' PRO . . . -53.07 173.6 0.17 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.907 . . . . 17.82 109.492 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 57' ' ' ALA . 35.7 Cg_endo -78.13 114.62 3.61 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.682 2.255 . . . . 17.28 110.34 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.47 -178.91 45.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.695 -1.362 . . . . 17.22 109.695 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.4 mp -74.16 147.2 42.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -1.134 . . . . 19.57 108.717 179.45 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.587 ' CE1' HD11 ' A' ' 6' ' ' ILE . 25.7 m-85 -136.28 166.32 23.71 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 120.962 -1.086 . . . . 14.61 111.059 -179.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 33.4 p -149.51 123.27 9.26 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.902 -1.888 . . . . 18.36 105.902 178.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.587 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 1.7 t -54.17 162.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 118.338 -1.345 . . . . 19.13 108.693 -178.268 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -124.83 128.14 48.24 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.393 -0.817 . . . . 20.65 109.066 -179.116 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.652 ' CB ' ' CD2' ' A' ' 68' ' ' PHE . 0.7 OUTLIER -72.43 2.82 5.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.463 -0.773 . . . . 19.65 110.141 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 t -56.09 -20.09 15.84 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.114 -1.439 . . . . 14.72 107.114 178.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 80' ' ' ARG . 26.4 m -96.43 -8.44 32.28 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 116.126 -0.488 . . . . 11.45 110.154 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.652 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 2.2 m-30 -79.88 161.56 25.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.951 -1.093 . . . . 14.25 109.872 -178.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.51 ' NZ ' ' HB2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -165.68 174.35 9.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.795 . . . . 32.7 109.151 179.673 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.538 HG12 ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -100.06 104.46 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 15.63 109.466 -179.893 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.51 -168.01 37.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.595 -1.402 . . . . 12.7 109.595 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 23.32 2.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.129 -1.218 . . . . 26.29 109.888 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.527 ' CD2' ' HE2' ' A' ' 77' ' ' MET . 59.2 t80 -93.86 -13.2 27.49 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.51 -0.744 . . . . 20.44 109.51 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 87.07 49.89 3.86 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.613 -1.395 . . . . 13.82 109.613 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 171.2 172.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -1.197 . . . . 18.27 109.645 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.472 ' C ' ' CG ' ' A' ' 77' ' ' MET . 14.7 tp -77.15 149.94 35.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 12.43 109.622 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.527 ' HE2' ' CD2' ' A' ' 73' ' ' PHE . 8.6 mtp -155.57 135.51 12.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 35.11 109.401 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.2 mp -67.15 142.09 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 13.67 110.028 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.454 ' OD1' ' HD3' ' A' ' 69' ' ' LYS . 1.5 t70 -107.66 -41.18 5.09 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.572 -1.269 . . . . 24.06 107.572 178.014 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.477 ' O ' ' OG ' ' A' ' 67' ' ' SER . 0.3 OUTLIER -163.43 66.73 0.18 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.167 -1.42 . . . . 35.04 107.167 178.457 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.587 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -28.41 119.61 0.12 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.218 -0.901 . . . . 18.72 112.095 -177.99 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -92.98 101.14 13.48 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.296 -1.002 . . . . 20.55 108.296 178.896 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.621 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -70.72 146.51 49.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.085 -1.01 . . . . 14.4 110.943 -178.625 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 62' ' ' THR . 16.8 m -145.9 152.02 46.97 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.283 -1.006 . . . . 17.65 108.283 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 26.6 Cg_endo -64.76 144.34 83.37 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.306 2.004 . . . . 25.7 110.496 179.248 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.99 120.48 21.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.268 -0.895 . . . . 49.29 109.535 -179.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.981 -1.009 . . . . 58.91 109.463 179.979 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.458 ' O ' ' C ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.454 -0.573 . . . . 64.91 109.454 . . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.579 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -42.87 131.68 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.701 -0.851 . . . . 33.8 108.701 179.318 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 1.4 mttp -102.84 153.73 19.9 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.122 -0.986 . . . . 32.72 110.37 -178.878 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' B' ' 61' ' ' TYR . 33.4 t -159.79 166.19 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.68 0.752 . . . . 14.46 109.75 -179.393 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 32.5 mt-10 -153.21 102.96 2.66 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.67 -0.863 . . . . 22.12 108.67 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.584 HD11 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -71.77 103.89 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.047 -1.094 . . . . 14.23 108.047 179.769 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.645 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.68 171.23 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.366 -0.834 . . . . 25.43 109.619 -179.28 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.1 Cg_endo -74.97 -22.78 14.52 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.433 2.089 . . . . 13.61 109.759 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.6 2.32 54.12 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.977 -0.749 . . . . 15.52 108.977 179.074 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.524 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 8.8 mm-40 -121.67 41.06 3.46 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.289 -0.882 . . . . 17.31 109.136 179.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -109.41 12.31 24.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.958 . . . . 24.78 109.785 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.422 ' HA ' ' HB1' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -131.52 141.8 49.81 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.198 -0.939 . . . . 47.9 108.577 179.825 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . 0.586 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 37.2 p90 -93.96 167.45 11.6 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.011 -1.056 . . . . 21.61 109.713 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.454 HG21 ' N ' ' B' ' 15' ' ' THR . 100.0 m -134.82 150.22 50.47 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.795 -0.817 . . . . 14.89 108.795 179.156 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 15' ' ' THR . . . . . 0.454 ' N ' HG21 ' B' ' 14' ' ' THR . 0.2 OUTLIER -84.53 111.91 19.93 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.204 -0.935 . . . . 17.35 109.415 -179.807 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.9 139.12 45.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.299 -0.876 . . . . 34.38 109.38 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.63 125.38 8.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 38.77 109.324 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -121.0 175.75 16.13 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.396 -1.482 . . . . 34.58 109.396 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.433 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -144.75 116.47 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.118 -1.224 . . . . 41.87 108.985 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' B' ' 21' ' ' ARG . 0.3 OUTLIER -44.31 -86.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.88 . . . . 47.21 109.494 -179.404 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . 0.492 ' N ' ' OG ' ' B' ' 20' ' ' SER . 5.9 ttp180 -137.1 56.28 1.79 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.205 -0.934 . . . . 71.56 109.447 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 22' ' ' GLN . . . . . 0.43 ' CB ' ' O ' ' B' ' 21' ' ' ARG . 0.7 OUTLIER 69.86 15.87 7.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 66.6 109.451 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.21 -55.06 0.93 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.48 -1.448 . . . . 55.49 109.48 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 149.92 30.04 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.269 -1.136 . . . . 44.99 109.351 179.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 35.3 Cg_endo -78.1 133.79 12.54 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.608 2.205 . . . . 44.1 110.754 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' B' ' 26' ' ' TYR . 6.9 p90 -126.92 144.13 51.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 32.09 109.493 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -98.82 79.3 2.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.012 . . . . 29.25 109.297 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.579 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -102.46 155.04 18.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 24.0 110.024 -179.65 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.583 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 97.0 m-20 -69.3 129.99 41.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 23.31 109.368 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 34.1 mt-10 -112.16 163.61 14.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.058 -1.026 . . . . 40.03 109.157 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.549 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -150.77 -176.91 5.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 12.39 110.021 -179.902 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 32' ' ' LEU . . . . . 0.525 ' HB3' ' CD1' ' B' ' 44' ' ' LEU . 27.9 mt -133.19 158.71 42.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.468 -0.77 . . . . 17.42 109.101 179.6 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 12.2 m -155.66 172.91 17.51 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.146 -1.057 . . . . 13.84 108.146 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.666 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 32.4 m-85 -122.01 104.57 9.61 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.051 -1.031 . . . . 21.14 109.109 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . 0.525 ' HA ' HG21 ' B' ' 4' ' ' VAL . 42.4 t -79.85 159.67 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.073 -1.017 . . . . 10.66 110.686 -179.311 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.498 ' N ' ' CG1' ' B' ' 35' ' ' VAL . 31.7 m-20 -140.89 -147.9 0.23 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.728 -0.841 . . . . 25.89 108.728 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 37' ' ' LEU . . . . . 0.517 ' HB3' ' CD1' ' A' ' 65' ' ' LEU . 0.2 OUTLIER 67.78 -61.96 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 24.24 109.183 179.966 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -87.13 21.14 22.01 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.074 -1.61 . . . . 31.02 109.074 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' B' ' 36' ' ' ASP . 1.5 p30 176.23 112.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -1.076 . . . . 43.23 109.361 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' B' ' 39' ' ' ASN . 3.2 mt-10 -41.65 -63.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.372 -0.83 . . . . 42.34 109.898 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -65.0 154.43 86.57 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 109.002 -0.74 . . . . 9.49 109.002 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.666 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.9 Cg_endo -78.19 143.74 20.29 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.245 1.963 . . . . 17.92 110.241 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 43' ' ' VAL . . . . . 0.497 ' CG2' HG23 ' A' ' 70' ' ' VAL . 19.2 m -115.97 116.22 51.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.318 -0.863 . . . . 20.57 109.15 179.673 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.604 ' HB2' ' CE1' ' B' ' 34' ' ' TYR . 54.9 tp -73.3 102.59 3.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.271 -0.893 . . . . 20.21 109.68 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.538 ' CG1' HG12 ' A' ' 70' ' ' VAL . 1.2 m -107.27 -178.38 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.552 -0.718 . . . . 10.81 109.23 179.797 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 1.1 mtpt -101.08 154.42 18.74 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.469 -0.892 . . . . 36.74 109.718 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 47' ' ' ILE . . . . . 0.618 HG12 ' CE1' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -140.72 173.38 9.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.325 -0.86 . . . . 19.74 109.317 -179.894 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.14 145.85 37.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 22.56 109.274 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.586 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 2.9 tm? -127.3 126.9 43.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.311 -0.868 . . . . 20.41 109.061 -179.678 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.472 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 3.1 m-20 -63.34 142.27 58.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.968 . . . . 33.99 109.868 -179.441 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.42 123.78 17.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 54.92 109.395 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.0 -15.97 50.23 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.437 -1.465 . . . . 36.1 109.437 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 53' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -75.25 153.85 86.2 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.29 -1.123 . . . . 54.76 109.469 179.943 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.2 Cg_endo -77.67 109.79 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.628 2.218 . . . . 28.37 110.383 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.537 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -41.39 150.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -0.82 . . . . 17.21 110.041 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.618 ' CE1' HG12 ' B' ' 47' ' ' ILE . 90.2 m-85 -45.53 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.375 -0.828 . . . . 17.19 109.003 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 57' ' ' ALA . . . . . 0.468 ' CB ' ' HD2' ' B' ' 58' ' ' PRO . . . -53.02 173.56 0.17 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 17.82 109.654 -179.602 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.79 113.44 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.617 2.211 . . . . 17.28 110.077 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.4 -179.43 46.63 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.776 -1.33 . . . . 17.22 109.776 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 3.1 mp -74.47 146.8 42.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -1.167 . . . . 19.57 108.414 179.14 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.584 ' CE1' HD11 ' B' ' 6' ' ' ILE . 27.1 m-85 -135.9 166.1 24.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.956 -1.09 . . . . 14.61 110.978 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 62' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' B' ' 2' ' ' ILE . 33.0 p -149.14 123.24 9.47 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 105.943 -1.873 . . . . 18.36 105.943 178.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.581 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 1.7 t -54.12 162.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 118.276 -1.37 . . . . 19.13 108.721 -178.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 64' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -124.89 128.23 48.33 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.422 -0.799 . . . . 20.65 109.06 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . 0.662 ' CB ' ' CD2' ' B' ' 68' ' ' PHE . 0.7 OUTLIER -72.67 2.84 5.79 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.46 -0.775 . . . . 19.65 110.132 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.1 t -56.01 -20.08 15.2 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.099 -1.445 . . . . 14.72 107.099 178.284 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' B' ' 80' ' ' ARG . 25.8 m -96.41 -8.45 32.33 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 116.096 -0.502 . . . . 11.45 110.239 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.662 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 2.3 m-30 -79.86 161.46 25.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.004 -1.06 . . . . 14.25 109.756 -178.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.517 ' NZ ' ' HB2' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -165.56 174.41 9.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.455 -0.778 . . . . 32.7 109.132 179.679 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.525 HG12 ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -100.1 104.48 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 15.63 109.393 -179.93 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.45 -167.87 37.32 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.613 -1.395 . . . . 12.7 109.613 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 23.02 2.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.113 -1.228 . . . . 26.29 109.863 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.537 ' CD2' ' HE2' ' B' ' 77' ' ' MET . 59.0 t80 -93.6 -13.35 27.78 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.493 -0.755 . . . . 20.44 109.481 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 87.26 49.9 3.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.547 -1.421 . . . . 13.82 109.547 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' B' ' 74' ' ' GLY . 0.3 OUTLIER 171.28 172.91 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -1.16 . . . . 18.27 109.588 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.473 ' C ' ' CG ' ' B' ' 77' ' ' MET . 14.7 tp -77.23 150.02 35.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.295 -0.878 . . . . 12.43 109.659 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.537 ' HE2' ' CD2' ' B' ' 73' ' ' PHE . 8.5 mtp -155.71 135.15 12.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 35.11 109.493 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.609 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.2 mp -66.81 142.1 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 13.67 110.116 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.452 ' OD1' ' HD3' ' B' ' 69' ' ' LYS . 1.5 t70 -107.8 -40.98 5.12 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.606 -1.257 . . . . 24.06 107.606 177.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 80' ' ' ARG . . . . . 0.477 ' O ' ' OG ' ' B' ' 67' ' ' SER . 0.3 OUTLIER -163.56 66.79 0.18 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.12 -1.437 . . . . 35.04 107.12 178.422 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.581 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -28.47 119.58 0.12 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.215 -0.902 . . . . 18.72 112.036 -178.046 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 82' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -92.94 101.12 13.46 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.268 -1.012 . . . . 20.55 108.268 178.861 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.618 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -70.7 146.47 49.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.977 . . . . 14.4 110.91 -178.67 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 62' ' ' THR . 16.8 m -145.82 152.34 48.06 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.296 -1.001 . . . . 17.65 108.296 179.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 26.7 Cg_endo -65.05 144.45 82.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.254 1.969 . . . . 25.7 110.56 179.274 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.97 120.38 21.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 49.29 109.605 -179.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.001 -0.999 . . . . 58.91 109.471 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.634 ' SD ' HG21 ' A' ' 62' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.326 0.584 . . . . 64.909999999999997 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.964 ' HA ' HD22 ' B' ' 65' ' ' LEU . 5.5 mt -72.56 78.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.238 -1.023 . . . . 33.799999999999997 108.238 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 1.021 ' N ' HD12 ' A' ' 37' ' ' LEU . 23.0 mttp -61.85 172.26 1.37 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.715 0.769 . . . . 32.719999999999999 111.371 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.007 HG22 HG22 ' A' ' 35' ' ' VAL . 23.0 t -168.23 168.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.861 -0.792 . . . . 14.460000000000001 108.861 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.591 ' N ' HG12 ' A' ' 4' ' ' VAL . 23.4 mt-10 -147.04 104.29 3.67 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.679 -0.859 . . . . 22.120000000000001 108.679 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.626 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -69.36 104.34 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.912 -1.144 . . . . 14.23 107.912 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.653 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.47 171.13 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.083 -1.011 . . . . 25.43 109.665 -179.152 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.7 Cg_endo -76.32 -24.22 11.0 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.562 2.174 . . . . 13.609999999999999 109.899 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -94.21 4.29 54.09 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.553 -0.717 . . . . 15.52 109.258 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.832 ' OE1' HD13 ' A' ' 32' ' ' LEU . 10.6 mm-40 -117.52 34.1 5.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.27 -0.894 . . . . 17.309999999999999 109.372 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.4 11.34 33.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 24.780000000000001 110.182 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 45.2 mt-30 -138.86 132.76 31.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.007 . . . . 47.899999999999999 110.056 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.624 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 11.4 p90 -83.19 -178.36 7.07 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.402 -0.811 . . . . 21.609999999999999 109.915 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -130.4 144.67 51.54 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.752 -0.593 . . . . 14.890000000000001 109.404 179.342 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 17.350000000000001 109.222 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.719 ' CD2' HG22 ' A' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.451 0.643 . . . . 24.0 109.946 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.657 ' ND2' ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -106.07 133.27 51.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.399 -0.813 . . . . 23.309999999999999 109.342 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.81 151.76 29.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.076 -1.015 . . . . 40.030000000000001 109.62 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.675 HE21 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -133.62 -166.77 1.83 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.125 -0.984 . . . . 12.390000000000001 109.56 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.887 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -136.28 169.5 17.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.88 . . . . 17.420000000000002 109.934 -179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -158.74 164.68 35.65 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.211 -1.033 . . . . 13.84 108.211 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.665 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.8 m-85 -121.24 109.69 15.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.987 -1.07 . . . . 21.140000000000001 110.04 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.007 HG22 HG22 ' A' ' 4' ' ' VAL . 29.7 t -95.49 143.08 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 10.66 109.466 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.643 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -130.89 -24.56 2.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.146 -0.972 . . . . 25.890000000000001 110.76 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.021 HD12 ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -45.96 -16.4 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.972 -1.08 . . . . 24.239999999999998 111.384 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.596 ' H ' HD22 ' A' ' 37' ' ' LEU . . . -120.19 16.28 10.01 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 108.206 -1.957 . . . . 31.02 108.206 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.643 ' ND2' ' HA ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -178.02 115.96 0.08 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.706 -0.879 . . . . 43.229999999999997 108.828 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 39' ' ' ASN . 1.2 mp0 -36.95 -63.47 0.42 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.66 0.743 . . . . 42.340000000000003 109.978 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.8 155.87 68.52 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.449 -0.945 . . . . 2.8599999999999999 108.449 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.665 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.5 Cg_endo -77.95 141.31 18.86 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.923 1.749 . . . . 17.920000000000002 109.936 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.916 HG22 ' O ' ' A' ' 35' ' ' VAL . 29.3 m -113.72 115.33 49.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.316 -0.865 . . . . 20.57 108.957 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' A' ' 32' ' ' LEU . 54.6 tp -67.71 107.99 2.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.423 -0.798 . . . . 20.210000000000001 109.545 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.502 ' CG1' ' SG ' ' A' ' 33' ' ' CYS . 8.9 p -111.2 163.31 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.476 -0.765 . . . . 10.81 109.324 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 160.84 22.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 36.740000000000002 110.232 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.62 HD12 ' CE1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -156.31 119.68 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.798 -0.816 . . . . 19.739999999999998 108.798 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.719 HG22 ' CD2' ' A' ' 28' ' ' LEU . 1.3 m -60.17 156.03 16.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.984 -1.072 . . . . 22.559999999999999 109.757 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.579 ' HG ' ' HB3' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -131.95 109.81 10.32 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.977 -0.749 . . . . 20.41 108.977 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.541 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -63.88 145.71 55.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 33.990000000000002 109.654 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' A' ' 52' ' ' GLY . 28.9 tt0 -43.51 -87.67 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.258 -0.901 . . . . 54.920000000000002 109.661 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' N ' ' HG2' ' A' ' 51' ' ' GLU . . . -41.06 -39.07 1.93 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.889 -1.284 . . . . 36.100000000000001 109.889 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.541 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -64.11 126.11 89.51 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.095 -1.238 . . . . 54.759999999999998 109.34 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.545 ' C ' HD11 ' A' ' 49' ' ' LEU . 36.0 Cg_endo -79.62 144.86 17.93 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.401 2.067 . . . . 28.370000000000001 110.4 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.675 ' HB1' HE21 ' A' ' 31' ' ' GLN . . . -40.21 146.02 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.396 -0.815 . . . . 17.210000000000001 110.169 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.62 ' CE1' HD12 ' A' ' 47' ' ' ILE . 87.4 m-85 -53.82 111.42 0.74 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.297 -0.877 . . . . 17.190000000000001 109.222 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.027 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -66.32 -178.85 0.34 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.426 -0.796 . . . . 17.82 109.528 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 1.027 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -78.12 131.79 11.11 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.49 2.127 . . . . 17.280000000000001 110.588 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.632 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 153.91 143.01 3.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.15 -1.58 . . . . 17.219999999999999 109.15 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.438 HD23 ' CE ' ' A' ' 3' ' ' LYS . 3.8 mp -44.77 138.93 3.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.908 -1.348 . . . . 19.57 109.489 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.632 ' CD1' ' O ' ' A' ' 59' ' ' GLY . 17.9 m-85 -119.09 164.18 15.9 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.521 1.153 . . . . 14.609999999999999 111.497 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 84' ' ' VAL . 48.0 p -145.88 122.76 11.3 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.514 -1.661 . . . . 18.359999999999999 106.514 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.683 HG11 ' HB2' ' A' ' 81' ' ' LEU . 1.7 t -60.58 162.67 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 C-N-CA 118.427 -1.309 . . . . 19.129999999999999 108.72 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -120.77 130.41 54.01 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.43 -0.794 . . . . 20.649999999999999 109.248 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.97 HD22 ' HA ' ' B' ' 2' ' ' ILE . 0.9 OUTLIER -73.29 2.81 6.73 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.474 -0.766 . . . . 19.649999999999999 109.828 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -19.21 11.71 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.101 -1.444 . . . . 14.720000000000001 107.101 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.533 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 1.4 m -96.29 -6.23 38.33 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.134 -0.485 . . . . 11.449999999999999 110.391 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.699 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.2 m-30 -86.43 161.63 18.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.89 -1.131 . . . . 14.25 110.021 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -144.94 164.78 30.08 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.022 -0.733 . . . . 32.700000000000003 109.022 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.848 HG21 HG21 ' B' ' 43' ' ' VAL . 1.8 t -120.97 129.1 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 15.630000000000001 109.498 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.2 -151.52 22.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.36 -1.496 . . . . 12.699999999999999 109.36 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 0.5 OUTLIER 51.93 68.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -1.145 . . . . 26.289999999999999 109.211 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 71.07 5.62 5.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.836 . . . . 20.440000000000001 109.367 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.87 46.52 5.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.523 -1.431 . . . . 13.82 109.523 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.41 ' HB2' ' HE3' ' A' ' 77' ' ' MET . 57.7 m -125.0 116.45 22.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -1.126 . . . . 18.27 109.635 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.6 OUTLIER -59.22 147.15 36.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 12.43 109.129 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 37.8 mtt -160.12 132.32 6.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 35.109999999999999 109.725 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.86 HD12 HD12 ' B' ' 78' ' ' ILE . 2.7 mp -67.16 140.16 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.373 -0.829 . . . . 13.67 109.826 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 8.8 t70 -107.61 -10.27 15.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.324 -0.86 . . . . 24.059999999999999 108.962 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 163.94 67.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.897 -1.52 . . . . 35.039999999999999 106.897 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.683 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -31.66 118.73 0.23 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.323 -0.853 . . . . 18.719999999999999 112.199 -177.518 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.517 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -91.9 109.87 21.21 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.229 -1.026 . . . . 20.550000000000001 108.229 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.8 OUTLIER -75.63 155.19 36.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.205 -0.934 . . . . 14.4 111.382 -178.435 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 62' ' ' THR . 35.6 m -159.89 148.95 14.02 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 107.866 -1.161 . . . . 17.649999999999999 107.866 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 22.8 Cg_endo -61.5 139.3 81.14 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.99 1.794 . . . . 25.699999999999999 110.503 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.521 ' CA ' HG23 ' A' ' 62' ' ' THR . . . -65.66 118.1 9.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -0.921 . . . . 49.289999999999999 109.698 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.033 -0.984 . . . . 58.909999999999997 109.526 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.637 ' SD ' HG21 ' B' ' 62' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.314 0.578 . . . . 64.909999999999997 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.97 ' HA ' HD22 ' A' ' 65' ' ' LEU . 5.5 mt -72.97 78.15 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.267 -1.012 . . . . 33.799999999999997 108.267 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 1.006 ' N ' HD12 ' B' ' 37' ' ' LEU . 23.0 mttp -61.72 172.22 1.34 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.759 0.79 . . . . 32.719999999999999 111.33 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.983 HG22 HG22 ' B' ' 35' ' ' VAL . 23.1 t -168.2 168.44 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.85 -0.796 . . . . 14.460000000000001 108.85 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.601 ' N ' HG12 ' B' ' 4' ' ' VAL . 23.5 mt-10 -147.15 104.21 3.65 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.726 -0.842 . . . . 22.120000000000001 108.726 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.63 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -69.34 104.08 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.962 -1.125 . . . . 14.23 107.962 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.66 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.24 171.11 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.957 . . . . 25.43 109.682 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -76.36 -24.27 10.89 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.474 2.116 . . . . 13.609999999999999 109.847 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -94.12 4.1 54.37 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.521 -0.737 . . . . 15.52 109.224 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.818 ' OE1' HD13 ' B' ' 32' ' ' LEU . 10.5 mm-40 -117.25 33.95 5.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.262 -0.899 . . . . 17.309999999999999 109.377 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.18 11.3 32.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 24.780000000000001 110.209 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.443 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 45.1 mt-30 -138.82 132.88 31.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 47.899999999999999 110.088 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.63 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 11.4 p90 -83.26 -178.29 7.03 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.408 -0.807 . . . . 21.609999999999999 109.93 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 0.6 OUTLIER -130.48 144.65 51.54 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.738 -0.601 . . . . 14.890000000000001 109.426 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.461 0 O-C-N 121.29 -0.882 . . . . 17.350000000000001 109.199 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.728 ' CD2' HG22 ' B' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.486 0.66 . . . . 24.0 109.919 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.654 ' ND2' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -106.03 133.27 51.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.398 -0.813 . . . . 23.309999999999999 109.298 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.79 151.98 29.7 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.037 -1.039 . . . . 40.030000000000001 109.573 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.685 HE21 ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -133.75 -166.78 1.83 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 12.390000000000001 109.573 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.888 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.0 OUTLIER -136.24 169.57 17.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.234 -0.916 . . . . 17.420000000000002 109.949 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -158.87 164.69 35.49 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.177 -1.046 . . . . 13.84 108.177 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.66 ' CD2' ' CD ' ' B' ' 7' ' ' LYS . 22.4 m-85 -121.29 109.75 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 21.140000000000001 109.989 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.983 HG22 HG22 ' B' ' 4' ' ' VAL . 31.0 t -95.64 143.05 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 10.66 109.446 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.635 ' HA ' ' ND2' ' B' ' 39' ' ' ASN . 0.5 OUTLIER -130.9 -24.51 2.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 25.890000000000001 110.8 -179.206 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 1.006 HD12 ' N ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -46.21 -16.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.002 -1.061 . . . . 24.239999999999998 111.38 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.59 ' H ' HD22 ' B' ' 37' ' ' LEU . . . -120.15 16.09 10.06 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 108.208 -1.957 . . . . 31.02 108.208 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.635 ' ND2' ' HA ' ' B' ' 36' ' ' ASP . 0.4 OUTLIER -177.9 116.03 0.08 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.686 -0.891 . . . . 43.229999999999997 108.833 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' B' ' 39' ' ' ASN . 1.1 mp0 -36.91 -63.46 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.679 0.752 . . . . 42.340000000000003 110.015 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.88 155.91 69.07 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 108.438 -0.949 . . . . 2.8599999999999999 108.438 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.658 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.6 Cg_endo -77.93 141.27 18.87 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.939 1.759 . . . . 17.920000000000002 109.894 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.927 HG22 ' O ' ' B' ' 35' ' ' VAL . 29.3 m -113.78 115.33 49.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.273 -0.892 . . . . 20.57 108.874 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.888 HD11 ' HB3' ' B' ' 32' ' ' LEU . 54.4 tp -67.59 107.9 2.68 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.397 -0.815 . . . . 20.210000000000001 109.603 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.505 ' CG1' ' SG ' ' B' ' 33' ' ' CYS . 8.9 p -111.09 163.27 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.52 -0.737 . . . . 10.81 109.369 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 160.83 21.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 36.740000000000002 110.261 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.621 HD12 ' CE1' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -156.2 119.67 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 108.801 -0.814 . . . . 19.739999999999998 108.801 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.728 HG22 ' CD2' ' B' ' 28' ' ' LEU . 1.3 m -60.23 155.64 17.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.027 . . . . 22.559999999999999 109.732 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.568 ' HG ' ' HB3' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -131.55 109.85 10.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 20.41 108.982 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.545 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -63.83 145.76 55.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 33.990000000000002 109.692 -179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' B' ' 52' ' ' GLY . 28.9 tt0 -43.66 -87.63 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.305 -0.872 . . . . 54.920000000000002 109.629 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.48 ' N ' ' HG2' ' B' ' 51' ' ' GLU . . . -41.19 -38.83 1.97 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.852 -1.299 . . . . 36.100000000000001 109.852 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.545 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -64.29 126.15 89.8 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.07 -1.253 . . . . 54.759999999999998 109.336 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.553 ' C ' HD11 ' B' ' 49' ' ' LEU . 35.9 Cg_endo -79.61 144.86 17.94 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.417 2.078 . . . . 28.370000000000001 110.421 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.685 ' HB1' HE21 ' B' ' 31' ' ' GLN . . . -40.16 145.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -0.825 . . . . 17.210000000000001 110.308 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.621 ' CE1' HD12 ' B' ' 47' ' ' ILE . 87.4 m-85 -53.35 111.73 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 17.190000000000001 109.16 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 1.004 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -67.16 -178.94 0.39 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.389 -0.82 . . . . 17.82 109.594 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 1.004 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.4 Cg_endo -77.71 130.38 10.61 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.458 2.105 . . . . 17.280000000000001 110.358 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.635 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 155.94 143.0 3.55 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.205 -1.558 . . . . 17.219999999999999 109.205 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.439 HD23 ' CE ' ' B' ' 3' ' ' LYS . 3.6 mp -45.43 138.34 4.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.426 . . . . 19.57 109.177 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' B' ' 59' ' ' GLY . 20.0 m-85 -118.43 164.26 15.52 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.49 1.138 . . . . 14.609999999999999 111.407 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.744 ' O ' HG22 ' B' ' 84' ' ' VAL . 48.9 p -145.9 122.84 11.34 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 106.386 -1.709 . . . . 18.359999999999999 106.386 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.682 HG11 ' HB2' ' B' ' 81' ' ' LEU . 1.6 t -60.44 163.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 C-N-CA 118.448 -1.301 . . . . 19.129999999999999 108.719 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.492 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -121.62 130.3 53.39 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.475 -0.765 . . . . 20.649999999999999 109.33 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 2' ' ' ILE . 0.9 OUTLIER -73.13 2.77 6.52 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.492 -0.755 . . . . 19.649999999999999 109.889 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.29 -18.97 12.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.126 -1.435 . . . . 14.720000000000001 107.126 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.537 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 1.4 m -96.35 -6.93 36.51 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 116.132 -0.485 . . . . 11.449999999999999 110.416 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.664 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.1 m-30 -85.97 161.25 19.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.851 -1.156 . . . . 14.25 109.958 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -144.57 165.1 28.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.74 . . . . 32.700000000000003 109.014 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.84 HG21 HG21 ' A' ' 43' ' ' VAL . 1.8 t -121.08 129.2 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 15.630000000000001 109.506 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.0 -151.66 22.36 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.333 -1.507 . . . . 12.699999999999999 109.333 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.6 OUTLIER 52.0 68.86 0.74 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -1.181 . . . . 26.289999999999999 109.228 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.2 OUTLIER 71.22 5.73 5.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 20.440000000000001 109.34 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.74 46.56 5.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.558 -1.417 . . . . 13.82 109.558 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 57.7 m -125.15 116.34 21.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -1.129 . . . . 18.27 109.696 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.534 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.6 OUTLIER -59.05 147.05 36.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 12.43 109.212 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.534 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 37.5 mtt -160.08 132.51 6.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.923 . . . . 35.109999999999999 109.643 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.86 HD12 HD12 ' A' ' 78' ' ' ILE . 2.7 mp -67.37 140.24 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 13.67 109.839 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 8.6 t70 -107.51 -10.27 15.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.367 -0.833 . . . . 24.059999999999999 108.966 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.537 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 163.89 67.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.923 -1.51 . . . . 35.039999999999999 106.923 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.682 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.9 OUTLIER -31.76 118.75 0.24 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.253 -0.885 . . . . 18.719999999999999 112.182 -177.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.517 ' HG3' ' NH1' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -91.88 109.94 21.28 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.194 -1.039 . . . . 20.550000000000001 108.194 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -75.65 155.28 35.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.17 -0.956 . . . . 14.4 111.384 -178.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.744 HG22 ' O ' ' B' ' 62' ' ' THR . 35.6 m -159.98 149.21 14.14 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 107.807 -1.183 . . . . 17.649999999999999 107.807 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 23.5 Cg_endo -61.76 139.13 78.74 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.024 1.816 . . . . 25.699999999999999 110.545 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.527 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -65.49 118.07 8.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 49.289999999999999 109.6 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.422 ' HD3' ' C ' ' B' ' 87' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.95 -1.024 . . . . 58.909999999999997 109.429 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.594 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.461 0.648 . . . . 64.909999999999997 109.493 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.914 HG23 ' CD1' ' B' ' 65' ' ' LEU . 3.9 mt -78.55 77.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.7 -1.222 . . . . 33.799999999999997 107.7 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.49 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -67.39 167.39 12.68 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.011 0.91 . . . . 32.719999999999999 110.848 -178.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.941 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -177.44 160.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.501 -0.926 . . . . 14.460000000000001 108.501 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 29.8 mt-10 -134.2 114.65 13.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.67 0.748 . . . . 22.120000000000001 109.004 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.716 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -73.74 99.28 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.788 -1.19 . . . . 14.23 107.788 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.669 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -43.95 169.92 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.335 -0.853 . . . . 25.43 109.925 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 32.5 Cg_endo -74.42 -28.31 10.4 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.469 2.112 . . . . 13.609999999999999 110.024 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.96 8.78 41.74 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.826 -0.805 . . . . 15.52 108.826 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.552 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 5.6 mm100 -125.91 22.32 7.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 17.309999999999999 109.87 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -95.77 15.23 20.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.105 -0.997 . . . . 24.780000000000001 110.162 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 60.7 mt-30 -134.9 141.09 46.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.127 -0.983 . . . . 47.899999999999999 109.754 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.744 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 45.1 p90 -93.96 153.91 17.95 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.3 -0.875 . . . . 21.609999999999999 109.32 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 m -113.11 150.45 32.11 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.331 -0.856 . . . . 14.890000000000001 108.92 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.551 HG23 ' OD1' ' A' ' 29' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.487 0 O-C-N 121.289 -0.882 . . . . 17.350000000000001 109.541 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.435 0.636 . . . . 24.0 110.094 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.775 ' O ' HD12 ' A' ' 28' ' ' LEU . 67.4 m-20 -72.21 151.1 43.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.372 -0.83 . . . . 23.309999999999999 109.533 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.61 132.64 39.27 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.699 -0.852 . . . . 40.030000000000001 108.699 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.748 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -123.41 -174.1 2.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.071 -1.018 . . . . 12.390000000000001 110.02 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.951 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.7 mp -143.6 152.85 41.9 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.853 -0.795 . . . . 17.420000000000002 108.853 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -152.82 -177.67 6.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.974 -1.121 . . . . 13.84 107.974 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.69 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.0 m-85 -129.6 99.62 5.23 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.031 -1.043 . . . . 21.140000000000001 109.937 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.877 HG22 ' HB ' ' A' ' 4' ' ' VAL . 60.6 t -95.24 113.65 30.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.089 -1.007 . . . . 10.66 109.462 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 5.3 t70 -62.46 -28.48 69.85 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.199 -0.938 . . . . 25.890000000000001 108.572 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.684 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.7 OUTLIER 46.23 25.26 0.34 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.467 -0.77 . . . . 24.239999999999998 109.458 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.07 81.67 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.818 -1.313 . . . . 31.02 109.818 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 64.3 m-20 -86.08 15.21 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -1.209 . . . . 43.229999999999997 110.225 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 9.6 mt-10 60.73 11.52 3.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.311 -0.868 . . . . 42.340000000000003 110.36 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 71.3 m80 -161.18 152.68 16.01 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.046 -1.094 . . . . 6.3700000000000001 108.046 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.69 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -75.76 136.59 19.08 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.873 1.715 . . . . 17.920000000000002 110.397 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 35' ' ' VAL . 4.5 m -110.84 118.19 56.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.43 -0.793 . . . . 20.57 109.0 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.951 HD11 ' HB3' ' A' ' 32' ' ' LEU . 45.5 tp -73.22 104.48 4.28 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.351 -0.843 . . . . 20.210000000000001 110.255 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.618 HG13 HG23 ' A' ' 43' ' ' VAL . 32.6 m -108.46 -177.2 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.527 -0.916 . . . . 10.81 108.527 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HD2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.22 154.56 22.23 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.007 -1.077 . . . . 36.740000000000002 110.257 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.593 HG13 ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -127.18 170.1 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 109.029 -0.73 . . . . 19.739999999999998 109.029 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.523 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 3.6 m -123.01 124.0 42.16 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.356 -0.84 . . . . 22.559999999999999 108.808 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -102.53 163.83 12.0 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.331 -0.856 . . . . 20.41 109.331 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.43 167.68 9.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.897 . . . . 33.990000000000002 109.54 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -72.86 87.61 1.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 54.920000000000002 109.519 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.34 -25.84 4.48 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.514 -1.434 . . . . 36.100000000000001 109.514 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.636 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.0 mt-30 -73.7 140.97 78.66 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 54.759999999999998 109.433 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 53' ' ' GLN . 35.8 Cg_endo -79.5 118.91 3.98 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.577 2.185 . . . . 28.370000000000001 110.28 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.748 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.52 155.19 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.24 -0.912 . . . . 17.210000000000001 110.308 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.655 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 16.3 m-30 -49.86 112.14 0.62 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.531 -0.731 . . . . 17.190000000000001 109.377 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.002 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -61.72 176.43 0.44 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.138 -0.976 . . . . 17.82 109.289 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 1.002 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.7 Cg_endo -77.05 119.85 5.2 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.545 2.164 . . . . 17.280000000000001 110.221 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.42 177.54 37.86 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.835 -1.306 . . . . 17.219999999999999 109.835 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 5.2 mp -71.58 159.48 34.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 19.57 108.469 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.941 ' CB ' HG13 ' A' ' 4' ' ' VAL . 20.5 m-85 -141.8 165.1 28.41 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.849 -1.157 . . . . 14.609999999999999 111.784 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 84' ' ' VAL . 62.3 p -147.24 119.71 8.47 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.512 -1.662 . . . . 18.359999999999999 106.512 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.826 ' HB ' HD12 ' A' ' 2' ' ' ILE . 13.3 t -52.25 169.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 118.548 -1.261 . . . . 19.129999999999999 108.493 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.561 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.8 t-80 -131.33 119.64 22.01 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.36 -0.838 . . . . 20.649999999999999 108.911 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.936 HD13 HG23 ' B' ' 2' ' ' ILE . 0.0 OUTLIER -62.35 -12.44 21.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.694 -0.629 . . . . 19.649999999999999 109.641 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.2 t -46.98 -20.92 0.17 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.944 -1.097 . . . . 14.720000000000001 108.593 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 34.1 m -96.7 -7.93 32.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.496 -0.753 . . . . 11.449999999999999 111.035 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.659 ' C ' HD11 ' B' ' 37' ' ' LEU . 3.1 m-30 -81.1 161.77 23.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.617 -1.302 . . . . 14.25 109.816 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 5.1 pttm -145.74 174.75 10.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.45 -0.781 . . . . 32.700000000000003 109.663 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.816 HG21 HG21 ' B' ' 43' ' ' VAL . 2.5 t -117.19 129.2 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.419 -0.801 . . . . 15.630000000000001 109.307 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.14 168.12 35.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.479 -1.448 . . . . 12.699999999999999 109.479 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -76.74 0.55 20.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.232 -1.157 . . . . 26.289999999999999 109.733 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -26.99 23.16 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.461 -0.774 . . . . 20.440000000000001 109.21 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.77 65.31 0.76 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.492 -1.443 . . . . 13.82 109.492 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.14 133.43 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -1.107 . . . . 18.27 109.524 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 68' ' ' PHE . 2.4 tt -73.56 148.66 42.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 12.43 109.519 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 30.3 mtm -155.94 128.97 8.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 35.109999999999999 109.558 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' B' ' 78' ' ' ILE . 3.1 mt -64.72 141.0 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 13.67 109.988 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -108.25 -37.3 6.05 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.637 -1.246 . . . . 24.059999999999999 107.637 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.0 tpm_? -168.57 68.06 0.07 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.19 -1.411 . . . . 35.039999999999999 107.19 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -31.1 120.23 0.21 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.499 -0.773 . . . . 18.719999999999999 111.518 -178.276 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.539 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -90.45 103.25 15.96 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.988 -1.116 . . . . 20.550000000000001 107.988 178.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -75.83 147.33 39.21 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.934 -1.104 . . . . 14.4 111.006 -178.49 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 62' ' ' THR . 18.1 m -148.22 160.22 37.62 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 107.727 -1.212 . . . . 17.649999999999999 107.727 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.7 Cg_endo -62.32 146.63 95.75 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.036 1.824 . . . . 25.699999999999999 110.398 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -79.5 116.6 19.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.152 -0.968 . . . . 49.289999999999999 109.696 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.004 -0.998 . . . . 58.909999999999997 109.454 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.502 0.668 . . . . 64.909999999999997 109.429 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.936 HG23 HD13 ' A' ' 65' ' ' LEU . 4.0 mt -78.29 77.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.719 -1.215 . . . . 33.799999999999997 107.719 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.48 ' O ' HG13 ' B' ' 35' ' ' VAL . 0.2 OUTLIER -67.57 167.52 12.81 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.02 0.914 . . . . 32.719999999999999 110.869 -178.215 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.933 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -177.45 160.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.458 -0.942 . . . . 14.460000000000001 108.458 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.48 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 29.8 mt-10 -134.52 114.6 13.0 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.924 -0.769 . . . . 22.120000000000001 108.924 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.724 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -73.74 99.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.81 -1.182 . . . . 14.23 107.81 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.671 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.0 169.96 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.34 -0.85 . . . . 25.43 109.898 -178.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.0 Cg_endo -74.39 -28.29 10.47 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.488 2.125 . . . . 13.609999999999999 110.088 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.13 9.06 41.03 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.767 -0.827 . . . . 15.52 108.767 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.549 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 5.6 mm100 -126.13 22.34 7.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 17.309999999999999 109.864 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -95.74 15.14 20.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 24.780000000000001 110.151 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.547 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 60.4 mt-30 -134.86 141.1 46.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.038 -1.039 . . . . 47.899999999999999 109.736 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.737 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 45.1 p90 -94.03 153.91 17.92 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.257 -0.902 . . . . 21.609999999999999 109.343 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 81.1 m -113.21 150.15 32.73 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.296 -0.877 . . . . 14.890000000000001 108.955 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' THR . . . . . 0.551 HG23 ' OD1' ' B' ' 29' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.498 0 O-C-N 121.33 -0.857 . . . . 17.350000000000001 109.606 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.771 HD12 ' O ' ' B' ' 29' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.41 0.624 . . . . 24.0 110.031 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.771 ' O ' HD12 ' B' ' 28' ' ' LEU . 67.3 m-20 -72.16 151.18 43.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.451 -0.781 . . . . 23.309999999999999 109.499 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.63 132.67 39.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 40.030000000000001 108.704 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.756 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -123.35 -174.18 2.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.069 -1.019 . . . . 12.390000000000001 110.04 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.926 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.8 mp -143.57 152.91 41.99 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.852 -0.795 . . . . 17.420000000000002 108.852 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -152.75 -177.46 6.27 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.925 -1.139 . . . . 13.84 107.925 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.693 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 21.9 m-85 -129.78 99.71 5.23 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.056 -1.027 . . . . 21.140000000000001 109.881 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.873 HG22 ' HB ' ' B' ' 4' ' ' VAL . 62.9 t -95.35 113.74 30.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.171 -0.956 . . . . 10.66 109.435 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 5.3 t70 -62.51 -28.33 69.77 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.189 -0.945 . . . . 25.890000000000001 108.527 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.659 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER 46.25 25.27 0.34 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.516 -0.74 . . . . 24.239999999999998 109.436 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.67 14.01 81.63 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.831 -1.307 . . . . 31.02 109.831 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 64.2 m-20 -86.0 15.11 5.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -1.211 . . . . 43.229999999999997 110.325 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.578 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 9.5 mt-10 60.84 11.42 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.332 -0.855 . . . . 42.340000000000003 110.487 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 71.2 m80 -161.15 152.79 16.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.0 -1.111 . . . . 6.3799999999999999 108.0 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.693 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.4 Cg_endo -75.92 136.71 18.9 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.806 1.671 . . . . 17.920000000000002 110.442 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.857 HG22 ' O ' ' B' ' 35' ' ' VAL . 4.5 m -110.93 118.07 56.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.393 -0.817 . . . . 20.57 109.037 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.926 HD11 ' HB3' ' B' ' 32' ' ' LEU . 46.0 tp -73.21 104.38 4.24 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.392 -0.818 . . . . 20.210000000000001 110.215 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.626 HG13 HG23 ' B' ' 43' ' ' VAL . 32.5 m -108.44 -177.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.492 -0.929 . . . . 10.81 108.492 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.419 ' HD2' HD21 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -109.09 154.55 22.12 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.949 -1.101 . . . . 36.740000000000002 110.316 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.591 HG13 ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -127.21 169.96 17.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.515 -0.74 . . . . 19.739999999999998 109.105 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' B' ' 47' ' ' ILE . 3.5 m -122.78 123.99 42.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.328 -0.857 . . . . 22.559999999999999 108.838 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.643 HD12 ' O ' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -102.46 163.92 11.96 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.269 -0.894 . . . . 20.41 109.352 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.53 167.83 9.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 33.990000000000002 109.513 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -73.0 87.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 54.920000000000002 109.435 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.08 -25.96 4.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 36.100000000000001 109.568 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.643 ' O ' HD12 ' B' ' 49' ' ' LEU . 2.1 mt-30 -73.61 140.86 78.88 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.217 -1.167 . . . . 54.759999999999998 109.451 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' B' ' 55' ' ' ALA . 36.2 Cg_endo -79.48 118.71 3.95 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.526 2.151 . . . . 28.370000000000001 110.322 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.756 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.37 155.34 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 17.210000000000001 110.291 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.665 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 16.5 m-30 -50.09 111.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.449 -0.782 . . . . 17.190000000000001 109.416 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -61.4 176.37 0.42 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 17.82 109.246 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.21 121.04 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.567 2.178 . . . . 17.280000000000001 110.41 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.7 177.91 36.91 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.752 -1.339 . . . . 17.219999999999999 109.752 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.4 mp -71.36 159.64 34.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -1.13 . . . . 19.57 108.783 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.933 ' CB ' HG13 ' B' ' 4' ' ' VAL . 19.8 m-85 -142.07 165.05 28.5 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.529 1.157 . . . . 14.609999999999999 111.77 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.747 ' O ' HG22 ' B' ' 84' ' ' VAL . 60.3 p -147.28 119.82 8.51 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.554 -1.647 . . . . 18.359999999999999 106.554 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.845 ' HB ' HD12 ' B' ' 2' ' ' ILE . 13.1 t -52.26 169.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 C-N-CA 118.576 -1.25 . . . . 19.129999999999999 108.433 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.557 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.8 t-80 -131.44 119.62 21.87 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.37 -0.831 . . . . 20.649999999999999 108.987 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.914 ' CD1' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -62.25 -12.51 20.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.7 -0.625 . . . . 19.649999999999999 109.698 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.416 ' C ' ' O ' ' B' ' 65' ' ' LEU . 40.3 t -46.95 -20.48 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.933 -1.104 . . . . 14.720000000000001 108.565 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.511 ' HB2' ' HA ' ' B' ' 81' ' ' LEU . 32.6 m -97.17 -9.0 28.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -0.774 . . . . 11.449999999999999 111.032 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.684 ' C ' HD11 ' A' ' 37' ' ' LEU . 3.0 m-30 -80.22 160.97 25.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.658 -1.276 . . . . 14.25 109.743 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.52 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 4.9 pttm -144.94 175.18 10.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.369 -0.832 . . . . 32.700000000000003 109.707 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 43' ' ' VAL . 2.5 t -117.42 129.2 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.49 -0.756 . . . . 15.630000000000001 109.322 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.22 168.36 35.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.564 -1.414 . . . . 12.699999999999999 109.564 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.491 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 0.9 OUTLIER -76.93 0.61 20.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.118 -1.225 . . . . 26.289999999999999 109.686 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.37 -26.99 23.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.47 -0.769 . . . . 20.440000000000001 109.253 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.86 65.43 0.76 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.454 -1.459 . . . . 13.82 109.454 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.3 133.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -1.168 . . . . 18.27 109.53 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' B' ' 68' ' ' PHE . 2.5 tt -73.65 148.64 42.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 12.43 109.471 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.432 ' HG3' ' C ' ' B' ' 76' ' ' LEU . 30.3 mtm -155.92 128.88 8.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 35.109999999999999 109.505 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' A' ' 78' ' ' ILE . 3.0 mt -64.79 141.25 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 13.67 110.06 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -108.41 -36.95 6.1 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.581 -1.266 . . . . 24.059999999999999 107.581 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.51 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.1 tpm_? -168.91 68.12 0.07 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.184 -1.413 . . . . 35.039999999999999 107.184 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.671 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.6 OUTLIER -31.18 120.44 0.22 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.469 -0.787 . . . . 18.719999999999999 111.518 -178.218 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -90.52 103.24 15.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.959 -1.126 . . . . 20.550000000000001 107.959 178.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.665 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -75.76 147.21 39.45 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.989 -1.07 . . . . 14.4 110.966 -178.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.747 HG22 ' O ' ' B' ' 62' ' ' THR . 18.1 m -148.13 160.04 38.31 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.651 -1.24 . . . . 17.649999999999999 107.651 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.1 Cg_endo -62.17 146.51 95.99 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.974 1.783 . . . . 25.699999999999999 110.448 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.609 ' HA ' HG23 ' B' ' 62' ' ' THR . . . -79.46 116.5 19.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.146 -0.971 . . . . 49.289999999999999 109.648 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.98 -1.009 . . . . 58.909999999999997 109.474 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.524 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.433 -0.58 . . . . 64.909999999999997 109.433 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.608 HG21 HG21 ' A' ' 63' ' ' VAL . 3.7 mt -72.44 79.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.729 -1.211 . . . . 33.799999999999997 107.729 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -69.31 156.38 38.87 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.05 0.929 . . . . 32.719999999999999 111.54 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.878 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -166.01 168.01 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.18 -1.044 . . . . 14.460000000000001 108.18 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.555 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 26.3 mt-10 -143.44 112.63 6.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 22.120000000000001 109.541 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.71 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -72.37 102.72 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 C-N-CA 119.003 -1.079 . . . . 14.23 108.107 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 1.3 mmpt? -43.72 162.44 0.19 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.352 -0.842 . . . . 25.43 109.414 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.5 Cg_endo -72.7 -12.71 26.82 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.972 1.781 . . . . 13.609999999999999 109.088 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.5 t -99.13 7.15 46.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.234 -1.025 . . . . 15.52 108.234 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 1.5 mm-40 -129.47 41.27 3.48 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.846 -0.798 . . . . 17.309999999999999 108.846 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.76 3.65 39.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.122 -0.986 . . . . 24.780000000000001 110.291 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.485 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -134.84 139.64 45.22 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.129 -0.982 . . . . 47.899999999999999 108.607 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.706 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 22.3 p90 -85.62 176.97 7.88 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.035 -1.041 . . . . 21.609999999999999 109.298 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -133.98 148.2 51.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.444 -0.785 . . . . 14.890000000000001 109.099 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.594 0 O-C-N 121.336 -0.852 . . . . 17.350000000000001 109.088 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.495 0.664 . . . . 24.0 110.24 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.684 ' ND2' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -95.17 127.11 40.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.467 -0.77 . . . . 23.309999999999999 108.939 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -113.68 160.39 18.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.202 -0.936 . . . . 40.030000000000001 109.603 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.792 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -137.5 -169.41 2.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 12.390000000000001 109.123 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.973 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.1 mt -133.93 175.87 9.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 17.420000000000002 109.544 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.18 161.72 8.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.964 -1.085 . . . . 13.84 108.525 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.744 ' CE1' HD13 ' A' ' 44' ' ' LEU . 3.1 m-30 -114.34 101.34 9.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.132 -0.98 . . . . 21.140000000000001 108.828 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.878 HG22 ' HB ' ' A' ' 4' ' ' VAL . 13.9 t -107.6 148.21 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.999 -1.063 . . . . 10.66 110.029 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.942 ' O ' HD12 ' A' ' 37' ' ' LEU . 1.8 p-10 -113.86 -39.92 3.88 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.408 -0.96 . . . . 25.890000000000001 108.408 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.942 HD12 ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER 62.55 -71.01 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.731 -0.84 . . . . 24.239999999999998 108.731 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -142.59 28.0 2.2 Favored Glycine 0 C--N 1.296 -1.666 0 N-CA-C 108.238 -1.945 . . . . 31.02 108.238 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -130.89 98.97 4.76 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.593 -0.946 . . . . 43.229999999999997 108.722 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' ' 39' ' ' ASN . 3.4 mm-40 -31.36 -37.2 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.284 0.564 . . . . 42.340000000000003 111.194 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 39' ' ' ASN . 60.7 m80 -80.67 149.15 67.27 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.87 . . . . 7.0 108.973 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.633 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -78.56 149.61 24.11 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.135 1.89 . . . . 17.920000000000002 110.466 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 35' ' ' VAL . 1.8 m -121.52 119.11 58.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.393 -0.923 . . . . 20.57 109.058 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.973 HD11 ' HB3' ' A' ' 32' ' ' LEU . 15.7 tp -72.72 112.25 8.6 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.722 -0.791 . . . . 20.210000000000001 109.178 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.606 HG23 HG23 ' A' ' 43' ' ' VAL . 14.3 t -118.44 167.06 12.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.545 -0.722 . . . . 10.81 109.528 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -96.15 139.93 31.6 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.517 -0.873 . . . . 36.740000000000002 109.421 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.956 HD13 HD12 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -121.55 171.63 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.808 . . . . 19.739999999999998 109.004 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.426 ' OG1' ' HD3' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -105.56 153.59 21.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.075 -1.016 . . . . 22.559999999999999 109.691 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -136.71 105.26 5.79 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.629 -0.878 . . . . 20.41 108.629 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -70.26 143.95 51.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -0.954 . . . . 33.990000000000002 109.635 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.17 132.85 39.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 54.920000000000002 109.269 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.23 -35.58 4.79 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.452 -1.459 . . . . 36.100000000000001 109.452 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 5.1 mt-30 -79.8 138.46 54.01 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.265 -1.138 . . . . 54.759999999999998 109.341 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.3 126.13 7.48 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.509 2.139 . . . . 28.370000000000001 110.415 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.792 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -41.35 149.59 0.11 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.353 -0.842 . . . . 17.210000000000001 110.295 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.71 ' O ' HG21 ' A' ' 6' ' ' ILE . 83.1 m-85 -50.94 97.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.476 -0.765 . . . . 17.190000000000001 109.026 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.995 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.14 176.54 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.176 -0.953 . . . . 17.82 109.407 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.995 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.1 Cg_endo -76.68 131.26 12.24 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.418 2.079 . . . . 17.280000000000001 110.009 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.67 174.59 27.57 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.777 -1.329 . . . . 17.219999999999999 109.777 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.7 OUTLIER -73.7 143.12 46.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -1.114 . . . . 19.57 108.469 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.725 ' HB3' HD22 ' A' ' 83' ' ' LEU . 22.3 m-85 -127.31 162.89 25.18 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.832 -1.167 . . . . 14.609999999999999 111.548 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.8 p -143.04 121.39 12.32 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.534 -1.654 . . . . 18.359999999999999 106.534 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.834 ' CG1' HD12 ' A' ' 81' ' ' LEU . 3.3 t -52.54 166.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 C-N-CA 118.873 -1.131 . . . . 19.129999999999999 109.012 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -134.84 128.78 33.36 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.561 -0.903 . . . . 20.649999999999999 108.561 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.723 HD11 ' O ' ' B' ' 37' ' ' LEU . 1.2 pp -73.13 3.15 5.91 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.036 -1.04 . . . . 19.649999999999999 110.005 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.7 t -57.04 -19.15 17.17 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.716 -1.216 . . . . 14.720000000000001 107.716 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -101.34 -8.01 22.45 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.696 -0.628 . . . . 11.449999999999999 110.234 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.4 m-30 -74.66 155.27 37.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.836 -1.165 . . . . 14.25 108.925 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.77 176.53 12.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 32.700000000000003 109.678 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.757 HG21 HG21 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -109.45 115.77 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.392 -0.818 . . . . 15.630000000000001 109.285 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.06 179.71 10.77 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.508 -1.437 . . . . 12.699999999999999 109.508 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.402 ' C ' ' CG ' ' A' ' 73' ' ' PHE . 9.2 mm100 -88.46 42.43 1.07 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.222 -1.164 . . . . 26.289999999999999 109.298 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.402 ' CG ' ' C ' ' A' ' 72' ' ' GLN . 10.3 m-85 -148.23 34.96 0.81 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.532 -0.73 . . . . 20.440000000000001 109.384 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' HG13 ' B' ' 45' ' ' VAL . . . 48.0 58.78 6.72 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.239 -1.544 . . . . 13.82 109.239 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.435 ' HA ' HG13 ' B' ' 45' ' ' VAL . 4.2 m -156.41 136.16 12.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.335 -1.097 . . . . 18.27 109.919 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.958 HD11 HD21 ' B' ' 37' ' ' LEU . 0.3 OUTLIER -73.06 165.08 25.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.321 -0.862 . . . . 12.43 109.084 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.541 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.1 mtt -166.43 107.86 0.7 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.07 -1.019 . . . . 35.109999999999999 110.023 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.61 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -42.67 -35.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 13.67 109.588 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER 43.89 55.19 5.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 24.059999999999999 109.411 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 67' ' ' SER . 6.5 tmm_? 78.23 80.78 0.07 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.851 -0.796 . . . . 35.039999999999999 108.851 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.834 HD12 ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -55.56 149.03 14.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.768 0.794 . . . . 18.719999999999999 111.703 -178.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -99.48 103.46 15.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.094 -1.076 . . . . 20.550000000000001 108.094 178.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.956 HD12 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -75.16 151.57 38.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.185 -0.947 . . . . 14.4 111.568 -178.278 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 62' ' ' THR . 27.1 m -151.51 155.65 34.37 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.825 -1.176 . . . . 17.649999999999999 107.825 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 24.7 Cg_endo -63.42 144.23 90.3 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.146 1.898 . . . . 25.699999999999999 110.433 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.544 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -72.0 139.71 48.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.159 -0.963 . . . . 49.289999999999999 109.396 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.009 -0.996 . . . . 58.909999999999997 109.551 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.521 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.396 -0.594 . . . . 64.909999999999997 109.396 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.601 ' CA ' HD22 ' A' ' 65' ' ' LEU . 3.8 mt -72.7 79.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.664 -1.235 . . . . 33.799999999999997 107.664 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -69.59 156.13 39.41 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.055 0.931 . . . . 32.719999999999999 111.549 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.899 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -165.54 168.16 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.229 -1.026 . . . . 14.460000000000001 108.229 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.547 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 26.3 mt-10 -143.46 112.55 6.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 22.120000000000001 109.556 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.704 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -72.31 102.59 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 118.979 -1.089 . . . . 14.23 108.079 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.551 ' HB3' ' HD2' ' B' ' 8' ' ' PRO . 1.1 mmpt? -43.69 162.57 0.19 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 25.43 109.466 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.4 Cg_endo -72.65 -12.9 27.07 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.007 1.805 . . . . 13.609999999999999 109.144 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -98.99 7.15 46.28 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.26 -1.015 . . . . 15.52 108.26 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 1.5 mm-40 -129.53 41.34 3.46 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.416 -0.803 . . . . 17.309999999999999 108.885 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.92 3.88 39.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.063 -1.023 . . . . 24.780000000000001 110.264 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.464 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.9 OUTLIER -134.9 139.49 45.02 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.167 -0.958 . . . . 47.899999999999999 108.533 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.704 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 22.1 p90 -85.86 176.7 7.94 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.035 -1.041 . . . . 21.609999999999999 109.244 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -133.64 148.67 51.55 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.395 -0.816 . . . . 14.890000000000001 109.087 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.604 0 O-C-N 121.37 -0.831 . . . . 17.350000000000001 108.997 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.427 0.632 . . . . 24.0 110.231 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.687 ' ND2' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -95.09 127.08 40.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.445 -0.785 . . . . 23.309999999999999 108.922 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.6 OUTLIER -113.51 160.68 18.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.175 -0.953 . . . . 40.030000000000001 109.581 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.817 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -137.83 -169.63 2.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 12.390000000000001 109.02 179.48 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.949 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.1 mt -133.81 175.85 9.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.923 . . . . 17.420000000000002 109.548 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.14 161.69 8.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.955 -1.091 . . . . 13.84 108.497 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.742 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.1 m-30 -114.41 101.58 9.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 21.140000000000001 108.739 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.899 HG22 ' HB ' ' B' ' 4' ' ' VAL . 13.5 t -107.73 148.25 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.056 -1.027 . . . . 10.66 110.125 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.94 ' O ' HD12 ' B' ' 37' ' ' LEU . 1.8 p-10 -113.95 -40.07 3.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.51 -0.922 . . . . 25.890000000000001 108.51 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.958 HD21 HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER 62.38 -70.87 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.773 -0.825 . . . . 24.239999999999998 108.773 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -142.65 27.73 2.2 Favored Glycine 0 C--N 1.296 -1.669 0 N-CA-C 108.307 -1.917 . . . . 31.02 108.307 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.0 OUTLIER -130.72 99.07 4.82 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.604 -0.939 . . . . 43.229999999999997 108.73 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' B' ' 39' ' ' ASN . 3.4 mm-40 -31.55 -37.02 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.3 0.571 . . . . 42.340000000000003 111.143 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' B' ' 39' ' ' ASN . 59.8 m80 -80.73 149.18 67.12 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 121.342 -0.849 . . . . 6.9800000000000004 109.037 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.634 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.4 Cg_endo -78.58 149.48 23.94 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.102 1.868 . . . . 17.920000000000002 110.408 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.84 HG22 ' O ' ' B' ' 35' ' ' VAL . 1.8 m -121.36 119.51 59.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.344 -0.943 . . . . 20.57 109.102 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.949 HD11 ' HB3' ' B' ' 32' ' ' LEU . 15.3 tp -73.04 111.45 8.16 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.778 -0.769 . . . . 20.210000000000001 109.105 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.608 HG23 HG23 ' B' ' 43' ' ' VAL . 12.8 t -117.7 167.16 11.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.633 -0.667 . . . . 10.81 109.449 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.564 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.9 OUTLIER -96.16 140.33 31.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.319 -0.863 . . . . 36.740000000000002 109.495 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.943 HD13 HD12 ' B' ' 83' ' ' LEU . 0.3 OUTLIER -121.96 171.81 10.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.344 -0.847 . . . . 19.739999999999998 109.076 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.423 ' OG1' ' HD3' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -105.89 153.15 22.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.051 -1.03 . . . . 22.559999999999999 109.77 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -136.36 104.99 5.79 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.684 -0.858 . . . . 20.41 108.684 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -70.01 144.5 52.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 33.990000000000002 109.665 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.58 132.88 41.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.893 . . . . 54.920000000000002 109.264 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.32 -36.09 4.44 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.398 -1.481 . . . . 36.100000000000001 109.398 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.51 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 5.0 mt-30 -79.47 138.34 55.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.27 -1.135 . . . . 54.759999999999998 109.34 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.41 126.12 7.39 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.44 2.093 . . . . 28.370000000000001 110.372 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.817 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -41.25 150.58 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.328 -0.857 . . . . 17.210000000000001 110.234 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.704 ' O ' HG21 ' B' ' 6' ' ' ILE . 82.1 m-85 -51.95 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.95 -0.759 . . . . 17.190000000000001 108.95 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.978 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -51.53 176.62 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.306 -0.871 . . . . 17.82 109.312 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.978 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -76.9 132.12 12.7 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.469 2.113 . . . . 17.280000000000001 110.328 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.99 175.15 26.66 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.676 -1.37 . . . . 17.219999999999999 109.676 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.524 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.7 OUTLIER -73.43 143.88 46.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -1.138 . . . . 19.57 108.872 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.701 ' HB3' HD22 ' B' ' 83' ' ' LEU . 21.5 m-85 -127.9 163.05 25.3 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.544 1.164 . . . . 14.609999999999999 111.556 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.69 ' O ' HG22 ' B' ' 84' ' ' VAL . 46.1 p -143.32 121.41 12.14 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.546 -1.65 . . . . 18.359999999999999 106.546 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.834 ' CG1' HD12 ' B' ' 81' ' ' LEU . 3.3 t -52.75 165.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 C-N-CA 118.88 -1.128 . . . . 19.129999999999999 109.023 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -134.02 128.55 34.56 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.59 -0.893 . . . . 20.649999999999999 108.59 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.729 HD11 ' O ' ' A' ' 37' ' ' LEU . 1.3 pp -72.74 2.95 5.68 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.061 -1.024 . . . . 19.649999999999999 110.087 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 28.6 t -56.94 -19.21 16.73 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 107.711 -1.218 . . . . 14.720000000000001 107.711 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -101.45 -7.79 22.55 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.723 -0.611 . . . . 11.449999999999999 110.166 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.641 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.3 m-30 -74.84 154.97 38.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.889 -1.132 . . . . 14.25 108.833 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.43 176.85 12.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 32.700000000000003 109.681 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -109.8 115.62 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.43 -0.794 . . . . 15.630000000000001 109.363 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.91 179.71 10.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.568 -1.413 . . . . 12.699999999999999 109.568 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.404 ' C ' ' CG ' ' B' ' 73' ' ' PHE . 9.2 mm100 -88.49 42.42 1.07 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.224 -1.162 . . . . 26.289999999999999 109.314 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.404 ' CG ' ' C ' ' B' ' 72' ' ' GLN . 9.5 m-85 -148.18 34.79 0.81 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.495 -0.753 . . . . 20.440000000000001 109.481 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.435 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 48.34 58.08 7.59 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.292 -1.523 . . . . 13.82 109.292 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.4 m -155.74 136.37 13.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.139 . . . . 18.27 109.963 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.904 HD11 HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -73.2 164.91 26.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 12.43 109.157 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.1 mtt -166.37 108.12 0.71 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.085 -1.009 . . . . 35.109999999999999 110.106 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.615 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.7 mt -42.99 -34.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 13.67 109.532 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.7 OUTLIER 43.83 55.27 5.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.832 . . . . 24.059999999999999 109.35 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 67' ' ' SER . 6.5 tmm_? 78.23 80.82 0.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.922 -0.77 . . . . 35.039999999999999 108.922 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.834 HD12 ' CG1' ' B' ' 63' ' ' VAL . 1.0 OUTLIER -55.54 149.11 14.27 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.702 0.763 . . . . 18.719999999999999 111.74 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -99.62 103.55 15.26 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.992 -1.114 . . . . 20.550000000000001 107.992 178.311 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.943 HD12 HD13 ' B' ' 47' ' ' ILE . 0.6 OUTLIER -75.22 151.55 38.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.229 -0.92 . . . . 14.4 111.609 -178.224 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.69 HG22 ' O ' ' B' ' 62' ' ' THR . 29.9 m -151.55 155.36 34.18 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 107.837 -1.171 . . . . 17.649999999999999 107.837 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 24.7 Cg_endo -63.22 144.12 91.12 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.237 1.958 . . . . 25.699999999999999 110.446 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.525 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -72.0 139.4 48.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 49.289999999999999 109.375 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.034 -0.984 . . . . 58.909999999999997 109.483 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.4 -0.593 . . . . 64.909999999999997 109.4 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.707 ' N ' HD22 ' B' ' 65' ' ' LEU . 3.0 mt -61.93 83.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.646 -1.242 . . . . 33.799999999999997 107.646 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 1' ' ' MET . 14.0 mtpt -75.93 158.05 32.47 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.952 0.882 . . . . 32.719999999999999 111.104 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.893 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -164.23 169.05 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.293 -1.002 . . . . 14.460000000000001 108.293 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 55.5 mt-10 -144.7 112.6 6.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.94 . . . . 22.120000000000001 109.47 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.746 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -72.73 101.98 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.822 -1.177 . . . . 14.23 107.822 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.656 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.69 171.22 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.304 -0.872 . . . . 25.43 109.856 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -74.8 -26.9 10.91 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.36 2.04 . . . . 13.609999999999999 109.589 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -88.02 0.08 56.39 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.987 -0.746 . . . . 15.52 108.987 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.8 mm-40 -120.42 33.87 5.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 17.309999999999999 109.475 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.95 10.79 38.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 24.780000000000001 109.958 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 15.3 mt-30 -138.93 144.99 39.29 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 47.899999999999999 109.96 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.737 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 35.4 p90 -94.3 161.52 14.21 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.323 -0.861 . . . . 21.609999999999999 109.195 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -128.92 162.82 26.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.311 -0.868 . . . . 14.890000000000001 108.808 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 O-C-N 121.239 -0.913 . . . . 17.350000000000001 109.541 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.605 HD22 ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.462 0.649 . . . . 24.0 110.173 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.569 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 90.7 m-20 -64.99 133.55 51.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.387 -0.821 . . . . 23.309999999999999 109.745 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.21 142.32 51.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 40.030000000000001 109.294 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.91 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -124.14 -179.04 4.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 12.390000000000001 109.303 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.9 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.1 mt -127.75 174.33 9.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 17.420000000000002 109.579 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -168.45 167.62 11.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.403 -0.962 . . . . 13.84 108.403 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.668 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 18.7 m-85 -120.88 107.38 12.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.138 -0.976 . . . . 21.140000000000001 109.545 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.927 ' O ' HG22 ' A' ' 43' ' ' VAL . 59.2 t -104.02 112.3 37.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.141 -0.974 . . . . 10.66 109.821 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.0 OUTLIER -64.0 -27.34 69.05 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.196 -1.038 . . . . 25.890000000000001 108.196 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.666 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.6 OUTLIER 48.37 30.85 2.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.602 -0.686 . . . . 24.239999999999998 109.303 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.61 9.37 78.33 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.457 -1.457 . . . . 31.02 109.457 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.615 ' OD1' HD23 ' A' ' 37' ' ' LEU . 1.9 m-20 -85.43 4.57 34.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -1.149 . . . . 43.229999999999997 110.476 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 29.6 mt-10 80.7 -42.61 0.2 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.585 -0.697 . . . . 42.340000000000003 110.567 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.521 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 47.5 m80 -107.0 155.34 39.38 Favored Pre-proline 0 C--N 1.295 -1.793 0 O-C-N 121.417 -0.802 . . . . 5.75 108.929 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.668 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -77.15 138.12 17.79 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.181 1.92 . . . . 17.920000000000002 110.542 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.927 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.6 m -111.85 117.75 55.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.369 -0.832 . . . . 20.57 108.827 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.9 HD11 ' HB3' ' A' ' 32' ' ' LEU . 67.3 tp -71.56 103.26 2.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.288 -0.882 . . . . 20.210000000000001 110.007 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 43' ' ' VAL . 3.6 m -106.42 -177.42 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.527 -0.733 . . . . 10.81 109.032 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.26 145.0 40.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.409 -0.917 . . . . 36.740000000000002 109.987 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.856 HD13 HD12 ' A' ' 83' ' ' LEU . 1.2 tt -135.9 136.47 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.418 -0.801 . . . . 19.739999999999998 109.064 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.605 ' CG2' HD22 ' A' ' 28' ' ' LEU . 11.1 m -68.67 156.01 39.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 22.559999999999999 109.57 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.641 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 2.3 tm? -129.99 114.02 15.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.282 -0.886 . . . . 20.41 109.077 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -48.85 123.56 7.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.866 . . . . 33.990000000000002 110.152 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -47.34 109.27 0.2 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.319 -0.863 . . . . 54.920000000000002 109.353 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.78 -29.65 10.55 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.429 -1.468 . . . . 36.100000000000001 109.429 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.604 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -65.2 153.68 88.89 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.23 -1.159 . . . . 54.759999999999998 109.326 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.8 Cg_endo -77.88 109.95 2.82 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.506 2.138 . . . . 28.370000000000001 110.224 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.91 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -38.63 148.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.526 -0.734 . . . . 17.210000000000001 110.218 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.746 ' O ' HG21 ' A' ' 6' ' ' ILE . 83.0 m-85 -46.0 101.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.451 -0.781 . . . . 17.190000000000001 109.355 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.845 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.63 171.02 0.17 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.907 . . . . 17.82 109.823 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.845 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -77.9 114.14 3.57 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.736 2.291 . . . . 17.280000000000001 110.117 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.65 -179.82 46.6 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.898 -1.281 . . . . 17.219999999999999 109.898 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -75.78 139.76 41.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -1.082 . . . . 19.57 108.114 179.009 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.766 ' HB3' HD22 ' A' ' 83' ' ' LEU . 18.5 m-85 -126.26 162.15 26.11 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.66 -1.275 . . . . 14.609999999999999 111.759 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.772 ' O ' HG22 ' A' ' 84' ' ' VAL . 52.8 p -142.11 122.25 13.8 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.247 -1.76 . . . . 18.359999999999999 106.247 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.598 HG21 HG21 ' A' ' 2' ' ' ILE . 2.5 t -54.38 162.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 C-N-CA 118.792 -1.163 . . . . 19.129999999999999 109.077 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.545 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.5 t-80 -130.46 129.17 42.63 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.246 -1.02 . . . . 20.649999999999999 108.246 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.711 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.5 OUTLIER -70.04 1.97 4.06 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.502 -0.749 . . . . 19.649999999999999 110.2 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.03 -20.35 9.18 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.448 -1.316 . . . . 14.720000000000001 107.448 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -97.58 -8.34 29.21 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.755 -0.591 . . . . 11.449999999999999 110.09 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -77.97 154.94 31.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.967 -1.083 . . . . 14.25 109.595 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.93 175.8 9.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 32.700000000000003 109.466 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.912 HG11 ' CG2' ' B' ' 43' ' ' VAL . 10.6 t -122.37 134.4 65.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.43 -0.794 . . . . 15.630000000000001 109.475 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.21 -160.24 28.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.382 -1.487 . . . . 12.699999999999999 109.382 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 6.2 tp60 61.67 72.73 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -1.177 . . . . 26.289999999999999 109.349 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 2.2 m-85 65.51 11.97 7.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 20.440000000000001 109.357 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' B' ' 45' ' ' VAL . . . 81.97 48.82 5.6 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.503 -1.439 . . . . 13.82 109.503 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 77' ' ' MET . 26.9 t -130.6 125.48 34.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -1.116 . . . . 18.27 109.662 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.689 ' CD1' HG22 ' A' ' 70' ' ' VAL . 3.5 tp -63.96 146.44 54.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 12.43 109.115 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.5 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 3.2 mtm -159.33 144.37 15.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 35.109999999999999 109.449 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.624 ' CG1' ' CE1' ' A' ' 68' ' ' PHE . 1.7 mp -65.14 145.48 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 13.67 109.505 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 67' ' ' SER . 4.6 t70 -103.46 -62.28 1.31 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.214 -1.402 . . . . 24.059999999999999 107.214 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.524 ' O ' ' C ' ' A' ' 81' ' ' LEU . 5.1 tmm_? -142.28 56.8 1.46 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.292 -1.003 . . . . 35.039999999999999 108.292 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.632 HD21 ' HG ' ' A' ' 83' ' ' LEU . 6.4 tt 3.43 116.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.524 -1.217 . . . . 18.719999999999999 112.849 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.545 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -99.35 96.61 7.84 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.098 -1.075 . . . . 20.550000000000001 108.098 178.299 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.856 HD12 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -77.49 150.82 34.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.982 -1.074 . . . . 14.4 111.064 -178.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 62' ' ' THR . 26.4 m -151.15 155.88 34.99 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.106 -1.072 . . . . 17.649999999999999 108.106 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.1 Cg_endo -63.86 141.9 80.06 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.053 1.836 . . . . 25.699999999999999 110.173 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.707 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -70.77 117.79 12.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.206 -0.934 . . . . 49.289999999999999 109.602 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.046 -0.978 . . . . 58.909999999999997 109.496 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.416 -0.587 . . . . 64.909999999999997 109.416 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.711 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.0 mt -62.0 83.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.644 -1.243 . . . . 33.799999999999997 107.644 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' ' 1' ' ' MET . 14.0 mtpt -75.89 158.0 32.58 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.947 0.879 . . . . 32.719999999999999 111.104 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.863 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -164.23 168.99 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.296 -1.002 . . . . 14.460000000000001 108.296 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.548 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 55.2 mt-10 -144.59 112.62 6.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.19 -0.944 . . . . 22.120000000000001 109.448 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.743 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -72.73 101.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.761 -1.2 . . . . 14.23 107.761 179.255 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.656 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.73 171.23 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.358 -0.839 . . . . 25.43 109.81 -178.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 32.6 Cg_endo -74.92 -26.82 10.72 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.331 2.021 . . . . 13.609999999999999 109.532 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -88.03 0.15 56.3 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.0 -0.741 . . . . 15.52 109.0 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.516 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.8 mm-40 -120.42 33.79 5.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 17.309999999999999 109.506 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.85 10.77 38.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.136 -0.978 . . . . 24.780000000000001 109.937 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.483 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 15.3 mt-30 -139.01 144.93 39.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.144 -0.973 . . . . 47.899999999999999 109.911 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.726 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 35.4 p90 -94.25 161.46 14.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.376 -0.827 . . . . 21.609999999999999 109.178 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 8.7 t -128.78 162.93 26.29 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.242 -0.911 . . . . 14.890000000000001 108.792 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.203 -0.935 . . . . 17.350000000000001 109.486 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.603 HD22 ' CG2' ' B' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.43 0.633 . . . . 24.0 110.231 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.574 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 90.9 m-20 -64.94 133.6 52.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.8 . . . . 23.309999999999999 109.745 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.26 142.32 51.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 40.030000000000001 109.259 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.892 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -124.07 -179.16 4.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 12.390000000000001 109.378 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.877 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.1 mt -127.63 174.41 9.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.964 . . . . 17.420000000000002 109.511 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -168.59 167.57 11.41 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.366 -0.976 . . . . 13.84 108.366 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 18.9 m-85 -120.83 107.4 12.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.127 -0.983 . . . . 21.140000000000001 109.596 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.908 ' O ' HG22 ' B' ' 43' ' ' VAL . 59.4 t -104.04 112.29 36.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.157 -0.964 . . . . 10.66 109.834 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.0 OUTLIER -63.96 -27.41 69.12 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.155 -1.054 . . . . 25.890000000000001 108.155 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.655 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER 48.48 30.74 2.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.637 -0.664 . . . . 24.239999999999998 109.278 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.73 9.34 78.79 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.469 -1.453 . . . . 31.02 109.469 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.609 ' OD1' HD23 ' B' ' 37' ' ' LEU . 1.9 m-20 -85.39 4.5 35.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -1.165 . . . . 43.229999999999997 110.504 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' B' ' 39' ' ' ASN . 29.5 mt-10 80.67 -42.62 0.2 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.578 -0.701 . . . . 42.340000000000003 110.561 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' B' ' 36' ' ' ASP . 47.5 m80 -106.95 155.34 39.34 Favored Pre-proline 0 C--N 1.294 -1.825 0 O-C-N 121.376 -0.828 . . . . 5.7800000000000002 108.919 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.672 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.1 Cg_endo -77.2 138.21 17.78 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.12 1.88 . . . . 17.920000000000002 110.551 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.912 ' CG2' HG11 ' A' ' 70' ' ' VAL . 5.6 m -111.85 117.7 55.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.338 -0.852 . . . . 20.57 108.784 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.877 HD11 ' HB3' ' B' ' 32' ' ' LEU . 67.3 tp -71.55 103.19 2.91 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.347 -0.846 . . . . 20.210000000000001 110.032 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.565 HG13 HG23 ' B' ' 43' ' ' VAL . 3.6 m -106.34 -177.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 109.001 -0.74 . . . . 10.81 109.001 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.27 144.91 40.9 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.408 -0.917 . . . . 36.740000000000002 110.006 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.833 HD13 HD12 ' B' ' 83' ' ' LEU . 1.2 tt -135.84 136.53 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.454 -0.779 . . . . 19.739999999999998 109.068 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.603 ' CG2' HD22 ' B' ' 28' ' ' LEU . 11.0 m -68.67 156.17 38.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -0.984 . . . . 22.559999999999999 109.53 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.635 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 2.3 tm? -130.19 113.94 15.08 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.357 -0.839 . . . . 20.41 109.083 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.3 OUTLIER -48.82 123.6 7.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.873 . . . . 33.990000000000002 110.209 -179.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -47.37 109.25 0.2 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.298 -0.876 . . . . 54.920000000000002 109.394 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.83 -29.67 10.49 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.431 -1.468 . . . . 36.100000000000001 109.431 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.618 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.7 OUTLIER -65.16 153.62 88.92 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.278 -1.131 . . . . 54.759999999999998 109.311 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.5 Cg_endo -77.8 109.98 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.52 2.146 . . . . 28.370000000000001 110.214 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.892 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -38.75 148.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.526 -0.734 . . . . 17.210000000000001 110.154 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.743 ' O ' HG21 ' B' ' 6' ' ' ILE . 83.1 m-85 -46.34 102.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 17.190000000000001 109.409 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.864 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -50.82 171.01 0.17 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 17.82 109.737 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.864 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -78.17 115.31 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.768 2.312 . . . . 17.280000000000001 110.397 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.67 -179.27 45.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.747 -1.341 . . . . 17.219999999999999 109.747 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.732 HD23 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -75.44 140.4 42.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -1.102 . . . . 19.57 108.432 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.768 ' HB3' HD22 ' B' ' 83' ' ' LEU . 18.1 m-85 -126.8 162.25 26.3 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.752 -1.218 . . . . 14.609999999999999 111.764 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.767 ' O ' HG22 ' B' ' 84' ' ' VAL . 52.8 p -142.34 122.26 13.61 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.256 -1.757 . . . . 18.359999999999999 106.256 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.6 HG21 HG21 ' B' ' 2' ' ' ILE . 2.6 t -54.39 162.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 C-N-CA 118.766 -1.174 . . . . 19.129999999999999 109.077 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.552 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.5 t-80 -130.41 129.18 42.72 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.269 -1.012 . . . . 20.649999999999999 108.269 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.707 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -69.93 1.83 4.09 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.516 -0.74 . . . . 19.649999999999999 110.231 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.95 -20.35 8.8 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.419 -1.326 . . . . 14.720000000000001 107.419 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.519 ' O ' ' N ' ' B' ' 79' ' ' ASP . 0.5 OUTLIER -97.74 -8.52 28.41 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.74 -0.6 . . . . 11.449999999999999 110.062 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.666 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.8 m-30 -77.74 154.54 31.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 14.25 109.495 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.54 176.04 9.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 32.700000000000003 109.483 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.91 HG11 ' CG2' ' A' ' 43' ' ' VAL . 10.5 t -122.52 134.37 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 15.630000000000001 109.504 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.19 -160.28 28.6 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.356 -1.498 . . . . 12.699999999999999 109.356 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 6.3 tp60 61.69 72.79 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -1.164 . . . . 26.289999999999999 109.349 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 2.2 m-85 65.43 12.06 7.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 20.440000000000001 109.29 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 45' ' ' VAL . . . 81.87 48.88 5.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.495 -1.442 . . . . 13.82 109.495 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 77' ' ' MET . 27.1 t -130.59 125.38 33.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 18.27 109.659 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.692 ' CD1' HG22 ' B' ' 70' ' ' VAL . 3.4 tp -63.81 146.46 53.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 12.43 109.131 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.508 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 3.2 mtm -159.43 144.41 15.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.07 -1.019 . . . . 35.109999999999999 109.396 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.626 ' CG1' ' CE1' ' B' ' 68' ' ' PHE . 1.7 mp -65.29 145.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 13.67 109.534 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' B' ' 67' ' ' SER . 4.5 t70 -103.59 -62.07 1.34 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.238 -1.393 . . . . 24.059999999999999 107.238 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' B' ' 81' ' ' LEU . 5.1 tmm_? -142.51 56.88 1.44 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.286 -1.005 . . . . 35.039999999999999 108.286 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.641 HD21 ' HG ' ' B' ' 83' ' ' LEU . 6.5 tt 3.4 116.68 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.474 -1.239 . . . . 18.719999999999999 112.887 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.4 OUTLIER -99.41 96.51 7.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.109 -1.071 . . . . 20.550000000000001 108.109 178.292 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.833 HD12 HD13 ' B' ' 47' ' ' ILE . 0.9 OUTLIER -77.35 150.98 35.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.935 -1.103 . . . . 14.4 111.066 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.767 HG22 ' O ' ' B' ' 62' ' ' THR . 26.5 m -151.34 155.77 34.68 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.054 -1.091 . . . . 17.649999999999999 108.054 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.1 Cg_endo -63.73 141.91 80.94 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.055 1.837 . . . . 25.699999999999999 110.195 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.726 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -70.76 117.72 12.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.163 -0.96 . . . . 49.289999999999999 109.595 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.046 -0.978 . . . . 58.909999999999997 109.476 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.517 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.3 -0.629 . . . . 64.909999999999997 109.3 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.955 ' H ' HD22 ' B' ' 65' ' ' LEU . 1.7 mt 58.53 78.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.799 -1.186 . . . . 33.799999999999997 107.799 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -73.52 157.15 37.29 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.797 0.808 . . . . 32.719999999999999 110.672 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.876 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -164.67 159.31 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.022 -0.733 . . . . 14.460000000000001 109.022 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 5.1 mt-10 -136.34 113.6 10.68 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 22.120000000000001 109.351 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.697 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -72.36 107.26 3.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.906 -1.146 . . . . 14.23 107.906 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.603 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 4.4 mptt -50.07 172.6 0.11 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.165 -0.959 . . . . 25.43 109.999 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.8 Cg_endo -76.0 -29.23 6.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.557 2.171 . . . . 13.609999999999999 109.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 m -92.95 7.01 45.8 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.976 -0.75 . . . . 15.52 108.976 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.1 mm-40 -123.49 29.25 6.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 17.309999999999999 109.749 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.22 16.28 17.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 24.780000000000001 110.063 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 54.8 mt-30 -141.84 145.29 34.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.093 -1.004 . . . . 47.899999999999999 109.902 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.753 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 42.2 p90 -96.16 153.37 17.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.363 -0.836 . . . . 21.609999999999999 109.458 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.7 p -121.38 168.72 11.36 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.421 -0.8 . . . . 14.890000000000001 109.337 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.606 0 O-C-N 121.409 -0.807 . . . . 17.350000000000001 109.048 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.443 0.639 . . . . 24.0 110.179 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.591 ' CB ' ' HB3' ' A' ' 49' ' ' LEU . 4.7 m120 -53.8 160.8 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 23.309999999999999 109.809 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 7.4 mt-10 -150.04 125.45 10.19 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.44 -0.948 . . . . 40.030000000000001 108.44 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.998 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -113.6 -179.18 3.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 12.390000000000001 110.36 -178.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.922 ' HB3' HD11 ' A' ' 44' ' ' LEU . 81.2 mt -137.48 147.69 45.48 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.787 -0.819 . . . . 17.420000000000002 108.787 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.96 ' SG ' HD13 ' A' ' 47' ' ' ILE . 2.8 m -151.88 -177.53 6.19 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.802 -1.185 . . . . 13.84 107.802 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.667 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 31.6 m-85 -127.91 112.46 14.72 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.074 -1.016 . . . . 21.140000000000001 109.677 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.876 HG22 ' HB ' ' A' ' 4' ' ' VAL . 60.7 t -106.89 109.9 29.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.372 -0.931 . . . . 10.66 109.749 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 2.5 p30 -57.75 -39.4 77.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.028 -1.471 . . . . 25.890000000000001 107.028 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.754 HD11 ' CA ' ' B' ' 69' ' ' LYS . 7.3 tt 62.88 -71.2 0.05 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.831 0.824 . . . . 24.239999999999998 109.056 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.705 ' N ' HD23 ' A' ' 37' ' ' LEU . . . -178.04 41.53 0.09 OUTLIER Glycine 0 C--N 1.294 -1.791 0 N-CA-C 108.54 -1.824 . . . . 31.02 108.54 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -124.37 23.81 8.17 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.33 -1.1 . . . . 43.229999999999997 110.429 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.577 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 14.6 mt-10 50.53 19.28 0.55 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.259 -0.901 . . . . 42.340000000000003 110.729 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.577 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 98.6 m-70 -160.08 154.74 20.64 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.278 -1.008 . . . . 6.9900000000000002 108.278 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.667 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 37.4 Cg_endo -76.36 134.24 15.42 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.921 1.747 . . . . 17.920000000000002 110.556 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.817 HG23 HG23 ' A' ' 45' ' ' VAL . 3.1 m -108.76 116.69 52.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 119.509 -0.877 . . . . 20.57 108.775 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.922 HD11 ' HB3' ' A' ' 32' ' ' LEU . 64.6 tp -67.62 101.79 1.07 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.462 -0.895 . . . . 20.210000000000001 109.364 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.817 HG23 HG23 ' A' ' 43' ' ' VAL . 38.6 t -103.89 166.92 2.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.63 -0.669 . . . . 10.81 109.389 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.766 ' HA ' HD23 ' A' ' 32' ' ' LEU . 24.7 ttmt -98.64 148.78 23.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.185 -0.947 . . . . 36.740000000000002 110.198 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.96 HD13 ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -128.05 163.14 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.395 -0.816 . . . . 19.739999999999998 108.971 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.401 ' N ' HG23 ' A' ' 47' ' ' ILE . 14.9 m -111.68 135.49 52.2 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.265 -0.897 . . . . 22.559999999999999 109.161 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.62 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -112.14 151.26 29.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 20.41 109.46 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.36 -174.67 4.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 33.990000000000002 109.736 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.45 104.47 15.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.352 -0.843 . . . . 54.920000000000002 109.575 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.18 -8.29 57.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.589 -1.404 . . . . 36.100000000000001 109.589 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.42 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -78.3 143.8 65.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.172 -1.193 . . . . 54.759999999999998 109.548 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.0 Cg_endo -79.34 110.87 2.77 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.629 2.22 . . . . 28.370000000000001 110.383 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.998 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.24 160.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 17.210000000000001 110.087 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.673 ' CE2' HG12 ' A' ' 47' ' ' ILE . 11.4 m-30 -54.57 111.05 0.72 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.398 -0.814 . . . . 17.190000000000001 109.209 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.984 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -60.67 176.22 0.38 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 17.82 109.516 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.984 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.47 114.87 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.665 2.244 . . . . 17.280000000000001 110.213 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.11 179.73 43.99 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.947 -1.261 . . . . 17.219999999999999 109.947 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.718 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -75.4 146.29 40.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -1.077 . . . . 19.57 108.256 179.132 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.697 ' CE1' HD13 ' A' ' 6' ' ' ILE . 23.0 m-85 -132.28 162.92 29.81 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.692 -1.255 . . . . 14.609999999999999 111.889 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.563 ' O ' HG22 ' A' ' 84' ' ' VAL . 59.8 p -145.41 119.71 9.58 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.65 -1.611 . . . . 18.359999999999999 106.65 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.913 ' CG1' HD12 ' A' ' 81' ' ' LEU . 11.2 t -47.53 169.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 C-N-CA 119.086 -1.045 . . . . 19.129999999999999 109.266 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.577 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.7 t-80 -134.87 122.11 21.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.953 -0.758 . . . . 20.649999999999999 108.953 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.908 HD22 ' H ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -65.92 -9.22 27.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.546 -0.721 . . . . 19.649999999999999 109.348 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -53.95 -16.82 2.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.165 -0.959 . . . . 14.720000000000001 108.886 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -104.11 -6.93 20.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 11.449999999999999 111.098 -179.306 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.1 m-30 -74.21 163.25 28.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.704 -1.248 . . . . 14.25 109.663 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.674 ' CA ' HD11 ' B' ' 37' ' ' LEU . 25.2 mtmt -149.64 174.02 13.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 32.700000000000003 109.31 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 HD13 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -114.86 109.83 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 15.630000000000001 109.065 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.04 -179.45 44.34 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.554 -1.419 . . . . 12.699999999999999 109.554 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -88.43 39.21 0.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.254 -1.144 . . . . 26.289999999999999 109.524 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -112.23 11.72 20.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.801 . . . . 20.440000000000001 109.261 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 46' ' ' LYS . . . 63.69 26.62 70.03 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.341 -1.504 . . . . 13.82 109.341 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -154.17 155.33 35.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -1.133 . . . . 18.27 109.626 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 76' ' ' LEU . 1.7 tp -67.18 173.55 3.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 12.43 109.536 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.439 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 2.7 mtt -159.39 101.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 35.109999999999999 109.607 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.595 ' CG2' ' N ' ' A' ' 81' ' ' LEU . 2.7 mt -41.92 -43.33 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 13.67 109.995 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER 48.69 54.24 10.97 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.341 -0.85 . . . . 24.059999999999999 108.991 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 82.01 80.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.023 -0.732 . . . . 35.039999999999999 109.023 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.913 HD12 ' CG1' ' A' ' 63' ' ' VAL . 1.3 pt? -58.81 154.15 15.52 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.46 0.648 . . . . 18.719999999999999 110.734 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -104.89 106.11 16.45 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.693 -1.225 . . . . 20.550000000000001 107.693 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.674 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -81.51 144.4 31.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.071 -1.018 . . . . 14.4 111.482 -178.021 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 62' ' ' THR . 35.6 m -144.26 160.58 48.33 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 107.617 -1.253 . . . . 17.649999999999999 107.617 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.8 Cg_endo -62.17 147.81 94.35 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.099 1.866 . . . . 25.699999999999999 110.658 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -77.75 124.12 27.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.303 -0.873 . . . . 49.289999999999999 109.547 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.03 -0.986 . . . . 58.909999999999997 109.502 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.518 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.374 -0.602 . . . . 64.909999999999997 109.374 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.908 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.7 mt 57.8 77.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.763 -1.199 . . . . 33.799999999999997 107.763 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -73.15 157.35 37.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.791 . . . . 32.719999999999999 110.737 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.869 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -164.94 159.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.082 -0.71 . . . . 14.460000000000001 109.082 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 5.1 mt-10 -136.24 113.55 10.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.534 -0.729 . . . . 22.120000000000001 109.384 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.696 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -72.26 107.45 3.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.918 -1.142 . . . . 14.23 107.918 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.617 ' HD3' ' CD1' ' B' ' 34' ' ' TYR . 4.4 mptt -50.29 172.66 0.11 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.148 -0.97 . . . . 25.43 109.959 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -75.98 -29.53 6.66 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.618 2.212 . . . . 13.609999999999999 109.925 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.5 m -92.65 7.1 44.88 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.031 -0.729 . . . . 15.52 109.031 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.0 mm-40 -123.61 29.25 6.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 17.309999999999999 109.685 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.13 16.15 17.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.994 . . . . 24.780000000000001 110.057 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.573 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 54.6 mt-30 -141.78 145.22 34.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 47.899999999999999 109.954 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.761 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 42.4 p90 -96.05 153.64 17.67 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.378 -0.826 . . . . 21.609999999999999 109.451 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 38.5 p -121.55 168.72 11.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.437 -0.79 . . . . 14.890000000000001 109.274 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.614 0 O-C-N 121.447 -0.783 . . . . 17.350000000000001 109.101 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.458 0.647 . . . . 24.0 110.167 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.585 ' CB ' ' HB3' ' B' ' 49' ' ' LEU . 4.7 m120 -53.69 160.81 1.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 23.309999999999999 109.798 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' B' ' 29' ' ' ASN . 7.6 mt-10 -150.16 125.17 9.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.431 -0.951 . . . . 40.030000000000001 108.431 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.955 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -113.4 -179.14 3.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 12.390000000000001 110.382 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.93 ' HB3' HD11 ' B' ' 44' ' ' LEU . 81.2 mt -137.45 147.88 45.67 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.841 -0.8 . . . . 17.420000000000002 108.841 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.946 ' SG ' HD13 ' B' ' 47' ' ' ILE . 2.9 m -152.08 -177.63 6.28 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.769 -1.197 . . . . 13.84 107.769 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.668 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 31.6 m-85 -127.85 112.4 14.68 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.065 -1.022 . . . . 21.140000000000001 109.678 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.869 HG22 ' HB ' ' B' ' 4' ' ' VAL . 61.2 t -106.89 110.17 30.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.349 -0.94 . . . . 10.66 109.688 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' B' ' 38' ' ' GLY . 2.4 p30 -57.91 -39.33 77.68 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.997 -1.483 . . . . 25.890000000000001 106.997 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.721 HD23 ' N ' ' B' ' 38' ' ' GLY . 7.4 tt 62.87 -70.66 0.06 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.844 0.831 . . . . 24.239999999999998 109.046 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.721 ' N ' HD23 ' B' ' 37' ' ' LEU . . . -178.47 41.28 0.09 OUTLIER Glycine 0 C--N 1.293 -1.813 0 N-CA-C 108.554 -1.818 . . . . 31.02 108.554 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -124.17 23.72 8.33 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.281 -1.129 . . . . 43.229999999999997 110.474 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.57 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 14.1 mt-10 50.82 19.15 0.58 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.247 -0.908 . . . . 42.340000000000003 110.703 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 98.6 m-70 -160.06 154.89 20.92 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.274 -1.01 . . . . 6.9900000000000002 108.274 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.668 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 37.5 Cg_endo -76.51 134.47 15.4 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.88 1.72 . . . . 17.920000000000002 110.521 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.804 HG23 HG23 ' B' ' 45' ' ' VAL . 3.1 m -109.09 116.59 52.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 119.424 -0.91 . . . . 20.57 108.808 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.93 HD11 ' HB3' ' B' ' 32' ' ' LEU . 65.4 tp -67.48 101.83 1.04 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.457 -0.897 . . . . 20.210000000000001 109.358 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.804 HG23 HG23 ' B' ' 43' ' ' VAL . 38.0 t -103.92 167.01 2.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.602 -0.686 . . . . 10.81 109.369 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.756 ' HA ' HD23 ' B' ' 32' ' ' LEU . 24.4 ttmt -98.79 148.23 24.1 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.198 -0.939 . . . . 36.740000000000002 110.165 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.946 HD13 ' SG ' ' B' ' 33' ' ' CYS . 0.0 OUTLIER -127.47 163.09 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.383 -0.823 . . . . 19.739999999999998 108.95 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.4 ' N ' HG23 ' B' ' 47' ' ' ILE . 15.3 m -111.6 135.57 52.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.274 -0.891 . . . . 22.559999999999999 109.101 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.617 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -112.2 151.42 29.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 20.41 109.373 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.48 -174.69 4.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 33.990000000000002 109.751 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.53 104.46 16.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 54.920000000000002 109.528 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.19 -8.09 57.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.612 -1.395 . . . . 36.100000000000001 109.612 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.434 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.3 OUTLIER -78.63 143.72 63.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 54.759999999999998 109.567 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.7 Cg_endo -79.25 111.04 2.82 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.616 2.211 . . . . 28.370000000000001 110.432 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.955 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.35 160.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 17.210000000000001 110.031 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.66 ' CE2' HG12 ' B' ' 47' ' ' ILE . 11.7 m-30 -54.87 110.78 0.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 17.190000000000001 109.286 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.932 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -59.96 176.25 0.34 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 17.82 109.494 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.932 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 36.0 Cg_endo -78.79 115.83 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.713 2.276 . . . . 17.280000000000001 110.439 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.8 -179.79 43.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.833 -1.307 . . . . 17.219999999999999 109.833 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.718 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -75.37 146.55 40.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -1.103 . . . . 19.57 108.467 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.696 ' CE1' HD13 ' B' ' 6' ' ' ILE . 22.8 m-85 -132.49 162.99 29.81 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.759 -1.213 . . . . 14.609999999999999 111.92 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.566 ' O ' HG22 ' B' ' 84' ' ' VAL . 59.9 p -145.44 119.85 9.65 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.691 -1.596 . . . . 18.359999999999999 106.691 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.926 ' CG1' HD12 ' B' ' 81' ' ' LEU . 11.5 t -47.78 169.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.1 -1.04 . . . . 19.129999999999999 109.267 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.58 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.7 t-80 -134.77 122.06 21.58 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.943 -0.762 . . . . 20.649999999999999 108.943 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.955 HD22 ' H ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -65.85 -9.28 27.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.444 -0.785 . . . . 19.649999999999999 109.254 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 86.4 p -53.85 -16.82 1.97 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.13 -0.981 . . . . 14.720000000000001 108.919 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -104.33 -7.09 20.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 11.449999999999999 111.13 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.0 m-30 -74.25 162.57 28.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.651 -1.281 . . . . 14.25 109.54 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.754 ' CA ' HD11 ' A' ' 37' ' ' LEU . 25.2 mtmt -148.5 173.99 12.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 32.700000000000003 109.38 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.536 HG22 HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -114.6 109.86 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.875 . . . . 15.630000000000001 109.029 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.17 -179.45 44.15 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.587 -1.405 . . . . 12.699999999999999 109.587 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.443 ' O ' ' NE2' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -88.44 39.23 0.9 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.17 -1.194 . . . . 26.289999999999999 109.42 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -112.13 11.64 20.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 20.440000000000001 109.251 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 46' ' ' LYS . . . 63.55 27.28 70.68 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.333 -1.507 . . . . 13.82 109.333 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -154.96 155.54 34.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -1.141 . . . . 18.27 109.545 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.515 ' CD2' HG21 ' A' ' 2' ' ' ILE . 1.7 tp -67.34 173.59 3.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 12.43 109.553 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.431 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 2.8 mtt -159.53 101.69 1.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 35.109999999999999 109.551 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.595 ' CG2' ' N ' ' B' ' 81' ' ' LEU . 2.7 mt -41.88 -43.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.546 -0.721 . . . . 13.67 110.037 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.4 OUTLIER 48.66 54.32 10.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.307 -0.871 . . . . 24.059999999999999 108.985 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.546 ' CB ' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 82.18 80.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.065 -0.717 . . . . 35.039999999999999 109.065 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.926 HD12 ' CG1' ' B' ' 63' ' ' VAL . 1.3 pt? -58.69 154.03 15.4 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.472 0.653 . . . . 18.719999999999999 110.757 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.561 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -104.87 106.18 16.55 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.636 -1.246 . . . . 20.550000000000001 107.636 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.3 OUTLIER -81.5 144.45 31.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.017 -1.052 . . . . 14.4 111.475 -178.062 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.566 HG22 ' O ' ' B' ' 62' ' ' THR . 35.5 m -144.41 160.47 48.21 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 107.518 -1.289 . . . . 17.649999999999999 107.518 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.3 Cg_endo -62.17 148.02 93.98 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.07 1.847 . . . . 25.699999999999999 110.657 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -77.84 124.24 27.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.243 -0.91 . . . . 49.289999999999999 109.511 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.026 -0.988 . . . . 58.909999999999997 109.527 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.784 ' SD ' HG21 ' A' ' 62' ' ' THR . 30.9 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.495 -0.557 . . . . 64.909999999999997 109.495 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.842 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.8 mt -65.23 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.582 -1.266 . . . . 33.799999999999997 107.582 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -67.01 155.36 38.85 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.964 0.887 . . . . 32.719999999999999 111.461 -177.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.986 HG11 HD21 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -163.37 168.89 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.14 -1.059 . . . . 14.460000000000001 108.14 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.0 OUTLIER -146.28 107.54 4.21 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.105 -0.997 . . . . 22.120000000000001 109.275 -178.846 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.612 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -66.2 103.92 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.696 -1.224 . . . . 14.23 107.696 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.582 ' HE2' ' CE2' ' A' ' 34' ' ' TYR . 8.2 mmmt -43.61 162.26 0.19 Allowed Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.159 -0.963 . . . . 25.43 109.489 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.42 -11.96 26.93 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.945 1.763 . . . . 13.609999999999999 109.155 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.3 t -102.14 7.73 40.9 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.735 -0.839 . . . . 15.52 108.735 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.524 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 9.4 mm-40 -126.71 37.23 4.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.889 . . . . 17.309999999999999 109.247 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.64 15.95 23.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.118 -0.989 . . . . 24.780000000000001 110.165 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -136.62 143.73 43.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.116 -0.99 . . . . 47.899999999999999 108.81 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 31.6 p90 -94.0 162.63 13.81 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.121 -0.987 . . . . 21.609999999999999 109.116 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -143.71 147.17 33.85 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.256 -0.902 . . . . 14.890000000000001 109.407 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 O-C-N 121.348 -0.845 . . . . 17.350000000000001 109.078 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' A' ' 50' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.501 0.667 . . . . 24.0 110.336 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 95.9 m-20 -50.27 115.84 1.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.522 -0.736 . . . . 23.309999999999999 109.93 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -115.52 150.23 36.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.944 . . . . 40.030000000000001 109.019 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.568 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -125.81 -171.45 2.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.04 -1.037 . . . . 12.390000000000001 109.86 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.925 ' HB3' HD11 ' A' ' 44' ' ' LEU . 30.1 mt -128.12 176.96 7.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.482 -0.761 . . . . 17.420000000000002 109.396 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -171.39 158.02 5.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.143 -0.973 . . . . 13.84 108.438 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.745 ' HE1' HD13 ' A' ' 44' ' ' LEU . 2.9 m-30 -113.99 102.64 10.38 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.078 -1.014 . . . . 21.140000000000001 108.542 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.976 ' O ' HG22 ' A' ' 43' ' ' VAL . 38.5 t -102.41 106.74 20.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.094 -1.004 . . . . 10.66 110.273 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -61.41 -39.01 89.16 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.259 -1.386 . . . . 25.890000000000001 107.259 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.861 HD23 ' N ' ' A' ' 38' ' ' GLY . 6.9 tt 63.18 -69.36 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.675 0.75 . . . . 24.239999999999998 109.381 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.861 ' N ' HD23 ' A' ' 37' ' ' LEU . . . -178.49 42.94 0.09 OUTLIER Glycine 0 C--N 1.296 -1.674 0 N-CA-C 108.803 -1.719 . . . . 31.02 108.803 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -124.83 27.66 6.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.284 -1.127 . . . . 43.229999999999997 110.205 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.583 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 1.9 mm-40 48.67 21.2 0.39 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.17 -0.957 . . . . 42.340000000000003 110.239 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 59.4 m80 -164.57 151.39 9.72 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.196 -1.038 . . . . 6.5700000000000003 108.196 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.2 Cg_endo -76.48 144.06 25.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.08 1.853 . . . . 17.920000000000002 110.955 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.976 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.0 m -117.92 118.89 59.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.476 -0.89 . . . . 20.57 109.14 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.925 HD11 ' HB3' ' A' ' 32' ' ' LEU . 23.5 tp -68.69 110.49 4.31 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.944 -0.702 . . . . 20.210000000000001 109.155 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 16.3 t -117.02 167.38 10.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.513 -0.742 . . . . 10.81 109.497 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.567 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -90.74 162.3 14.94 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.659 -0.817 . . . . 36.740000000000002 110.216 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.054 HD13 HD12 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -152.12 161.44 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.759 -0.83 . . . . 19.739999999999998 108.759 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.67 151.83 20.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.0 -1.062 . . . . 22.559999999999999 109.762 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.716 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.7 tm? -134.22 93.62 3.1 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.434 -0.791 . . . . 20.41 108.991 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.721 ' HB3' HD22 ' A' ' 28' ' ' LEU . 2.2 p30 -154.59 174.94 14.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.934 -1.104 . . . . 33.990000000000002 110.117 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' GLN . 10.4 tt0 73.21 72.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.501 -0.749 . . . . 54.920000000000002 109.807 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 51' ' ' GLU . . . 36.45 30.06 0.03 OUTLIER Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.236 -1.146 . . . . 36.100000000000001 110.236 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.645 ' O ' HD21 ' A' ' 49' ' ' LEU . 2.4 mt-30 -107.31 131.0 22.04 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.07 -1.253 . . . . 54.759999999999998 110.061 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.3 Cg_endo -80.1 142.1 15.13 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.463 2.108 . . . . 28.370000000000001 110.004 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.701 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -41.61 141.45 0.77 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 17.210000000000001 110.015 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 84.5 m-85 -47.2 98.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 17.190000000000001 109.146 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -49.42 175.36 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 17.82 109.743 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -77.89 118.32 4.42 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.73 2.286 . . . . 17.280000000000001 110.369 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.87 171.4 34.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.473 -1.451 . . . . 17.219999999999999 109.473 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.2 mp -72.08 147.6 46.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.198 -1.177 . . . . 19.57 108.924 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.912 ' HB3' HD22 ' A' ' 83' ' ' LEU . 30.7 m-85 -132.04 163.24 28.87 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.579 1.181 . . . . 14.609999999999999 111.424 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.867 ' O ' HG22 ' A' ' 84' ' ' VAL . 20.6 p -142.17 119.35 11.43 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.616 -1.994 . . . . 18.359999999999999 105.616 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.5 t -52.42 167.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 C-N-CA 118.615 -1.234 . . . . 19.129999999999999 109.198 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.498 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.1 t-80 -129.61 128.75 43.3 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.546 -0.721 . . . . 20.649999999999999 109.123 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.855 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -70.88 -0.94 10.23 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.401 -0.812 . . . . 19.649999999999999 109.679 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 p -56.6 -19.18 14.77 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.541 -1.281 . . . . 14.720000000000001 107.541 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 39.6 m -97.02 -6.97 34.1 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.831 -0.543 . . . . 11.449999999999999 110.05 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.817 ' C ' HD11 ' B' ' 37' ' ' LEU . 3.3 m-30 -79.7 157.29 27.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 14.25 109.689 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -140.15 169.9 16.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.834 . . . . 32.700000000000003 109.488 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.778 HG21 HG21 ' B' ' 43' ' ' VAL . 2.2 t -110.08 139.52 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.912 . . . . 15.630000000000001 109.425 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.57 -157.55 23.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.341 -1.504 . . . . 12.699999999999999 109.341 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 0.0 OUTLIER 63.03 78.34 0.3 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.159 -1.2 . . . . 26.289999999999999 109.122 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.5 OUTLIER 69.48 9.39 7.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.433 -0.792 . . . . 20.440000000000001 109.472 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' O ' HG13 ' B' ' 45' ' ' VAL . . . 80.24 46.03 7.79 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.608 -1.397 . . . . 13.82 109.608 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.412 ' HA ' HG13 ' B' ' 45' ' ' VAL . 1.5 t -146.51 140.15 25.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -1.183 . . . . 18.27 109.577 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 77' ' ' MET . 1.4 tp -55.74 156.17 5.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 12.43 109.338 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 15.2 mtt -164.25 130.33 2.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 35.109999999999999 109.64 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.908 HD12 HD12 ' B' ' 78' ' ' ILE . 2.5 mp -63.72 138.49 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 13.67 109.77 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.62 -23.62 12.39 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.379 -0.971 . . . . 24.059999999999999 108.379 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 67' ' ' SER . 1.0 OUTLIER 178.44 68.04 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.03 -1.47 . . . . 35.039999999999999 107.03 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -29.05 119.68 0.13 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.274 -0.875 . . . . 18.719999999999999 111.685 -177.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -88.6 100.44 13.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 20.550000000000001 108.783 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.054 HD12 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -69.75 141.06 53.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 14.4 110.638 -179.153 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 62' ' ' THR . 27.8 m -143.22 153.5 59.83 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.71 -1.219 . . . . 17.649999999999999 107.71 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.2 Cg_endo -61.44 141.77 93.23 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.945 1.763 . . . . 25.699999999999999 110.317 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.596 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -77.95 117.78 19.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.266 -0.896 . . . . 49.289999999999999 109.682 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.993 -1.003 . . . . 58.909999999999997 109.455 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.788 ' SD ' HG21 ' B' ' 62' ' ' THR . 31.1 ttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.519 -0.548 . . . . 64.909999999999997 109.519 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.855 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.8 mt -65.28 81.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.572 -1.27 . . . . 33.799999999999997 107.572 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -67.2 155.32 39.1 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.981 0.895 . . . . 32.719999999999999 111.43 -177.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.978 HG11 HD21 ' B' ' 83' ' ' LEU . 0.1 OUTLIER -163.34 168.92 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.133 -1.062 . . . . 14.460000000000001 108.133 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 1.0 OUTLIER -146.3 107.55 4.21 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.104 -0.997 . . . . 22.120000000000001 109.258 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.606 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -66.22 104.02 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.718 -1.216 . . . . 14.23 107.718 179.024 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.586 ' HE2' ' CE2' ' B' ' 34' ' ' TYR . 8.2 mmmt -43.68 162.26 0.19 Allowed Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.147 -0.971 . . . . 25.43 109.479 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.7 Cg_endo -72.38 -12.08 27.1 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.984 1.789 . . . . 13.609999999999999 109.115 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 44.6 t -102.03 7.58 41.18 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.753 -0.832 . . . . 15.52 108.753 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.515 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 9.4 mm-40 -126.5 37.32 4.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.288 -0.882 . . . . 17.309999999999999 109.254 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.75 15.8 24.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 24.780000000000001 110.168 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.39 143.79 44.19 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.074 -1.016 . . . . 47.899999999999999 108.82 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.702 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 31.6 p90 -94.03 162.6 13.82 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.1 -1.0 . . . . 21.609999999999999 109.098 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -143.61 147.33 34.2 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.288 -0.883 . . . . 14.890000000000001 109.362 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.489 0 O-C-N 121.367 -0.833 . . . . 17.350000000000001 109.08 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.714 HD22 ' HB3' ' B' ' 50' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.468 0.652 . . . . 24.0 110.312 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.622 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 95.8 m-20 -50.31 115.95 1.67 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 23.309999999999999 109.854 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -115.6 150.34 36.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.158 -0.964 . . . . 40.030000000000001 108.98 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.578 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -125.92 -171.55 2.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.013 -1.055 . . . . 12.390000000000001 109.836 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.893 ' HB3' HD11 ' B' ' 44' ' ' LEU . 30.0 mt -128.06 176.93 7.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.461 -0.774 . . . . 17.420000000000002 109.442 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -171.31 158.09 5.23 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.093 -1.004 . . . . 13.84 108.487 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.761 ' HE1' HD13 ' B' ' 44' ' ' LEU . 2.9 m-30 -114.06 102.53 10.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.148 -0.97 . . . . 21.140000000000001 108.592 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.962 ' O ' HG22 ' B' ' 43' ' ' VAL . 38.4 t -102.34 106.67 20.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.147 -1.021 . . . . 10.66 110.309 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 0.9 OUTLIER -61.17 -39.1 88.86 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.307 -1.368 . . . . 25.890000000000001 107.307 178.544 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.853 HD23 ' N ' ' B' ' 38' ' ' GLY . 6.9 tt 63.33 -69.39 0.07 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.695 0.76 . . . . 24.239999999999998 109.313 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.853 ' N ' HD23 ' B' ' 37' ' ' LEU . . . -178.52 42.97 0.09 OUTLIER Glycine 0 C--N 1.295 -1.742 0 N-CA-C 108.773 -1.731 . . . . 31.02 108.773 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -124.85 27.65 6.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.246 -1.149 . . . . 43.229999999999997 110.234 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.574 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 1.9 mm-40 48.7 21.16 0.39 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.23 -0.919 . . . . 42.340000000000003 110.25 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 59.4 m80 -164.57 151.3 9.66 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 108.2 -1.037 . . . . 6.5599999999999996 108.2 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.638 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.6 Cg_endo -76.33 143.98 25.56 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.137 1.891 . . . . 17.920000000000002 111.011 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.962 HG22 ' O ' ' B' ' 35' ' ' VAL . 5.0 m -117.87 118.8 59.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.451 -0.9 . . . . 20.57 109.098 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.893 HD11 ' HB3' ' B' ' 32' ' ' LEU . 23.4 tp -68.67 110.55 4.33 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.898 -0.721 . . . . 20.210000000000001 109.218 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.575 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 16.8 t -116.95 167.42 10.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.511 -0.743 . . . . 10.81 109.529 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -90.75 162.24 14.97 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.674 -0.81 . . . . 36.740000000000002 110.206 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 1.037 HD13 HD12 ' B' ' 83' ' ' LEU . 0.5 OUTLIER -152.06 161.5 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.706 -0.85 . . . . 19.739999999999998 108.706 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.71 151.69 20.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.969 -1.082 . . . . 22.559999999999999 109.787 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.717 HD13 ' O ' ' B' ' 49' ' ' LEU . 2.7 tm? -134.05 93.58 3.12 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.373 -0.829 . . . . 20.41 109.003 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.714 ' HB3' HD22 ' B' ' 28' ' ' LEU . 2.2 p30 -154.63 174.74 14.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.956 -1.09 . . . . 33.990000000000002 110.152 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' B' ' 53' ' ' GLN . 10.4 tt0 73.25 73.05 0.13 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 54.920000000000002 109.814 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' B' ' 51' ' ' GLU . . . 36.37 30.02 0.03 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.273 -1.131 . . . . 36.100000000000001 110.273 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.651 ' O ' HD21 ' B' ' 49' ' ' LEU . 2.4 mt-30 -107.2 130.84 22.27 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.094 -1.239 . . . . 54.759999999999998 110.084 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 36.2 Cg_endo -79.95 141.97 15.33 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.525 2.15 . . . . 28.370000000000001 109.986 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.702 ' HB2' ' CD2' ' B' ' 13' ' ' PHE . . . -41.46 141.39 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 17.210000000000001 110.031 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 83.5 m-85 -47.03 97.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.327 -0.858 . . . . 17.190000000000001 109.11 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.948 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -49.15 175.46 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 17.82 109.804 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.948 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.1 Cg_endo -77.85 117.59 4.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.651 2.234 . . . . 17.280000000000001 110.176 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.35 171.11 35.45 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.542 -1.423 . . . . 17.219999999999999 109.542 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.0 mp -72.3 147.14 46.65 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.172 -1.193 . . . . 19.57 108.711 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.93 ' HB3' HD22 ' B' ' 83' ' ' LEU . 30.6 m-85 -131.65 163.11 28.83 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 122.564 1.173 . . . . 14.609999999999999 111.446 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.85 ' O ' HG22 ' B' ' 84' ' ' VAL . 20.7 p -142.01 119.28 11.47 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 105.627 -1.99 . . . . 18.359999999999999 105.627 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.5 t -52.54 166.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 C-N-CA 118.559 -1.256 . . . . 19.129999999999999 109.208 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.488 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.1 t-80 -129.32 128.66 43.61 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.568 -0.707 . . . . 20.649999999999999 109.228 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.842 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -70.69 -1.04 10.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.457 -0.777 . . . . 19.649999999999999 109.71 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 p -56.59 -19.23 14.98 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.541 -1.281 . . . . 14.720000000000001 107.541 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 38.2 m -96.9 -7.38 33.47 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.853 -0.529 . . . . 11.449999999999999 110.131 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.822 ' C ' HD11 ' A' ' 37' ' ' LEU . 3.2 m-30 -79.32 157.06 27.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.065 -1.022 . . . . 14.25 109.642 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' B' ' 77' ' ' MET . 0.0 OUTLIER -139.96 169.68 17.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 32.700000000000003 109.484 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.751 HG21 HG21 ' A' ' 43' ' ' VAL . 2.2 t -109.88 139.57 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 15.630000000000001 109.42 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 75' ' ' SER . . . 136.59 -157.63 23.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.261 -1.536 . . . . 12.699999999999999 109.261 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.0 OUTLIER 63.08 78.32 0.3 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.188 -1.183 . . . . 26.289999999999999 109.108 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.5 OUTLIER 69.51 9.4 7.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.455 -0.778 . . . . 20.440000000000001 109.401 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 80.26 45.78 7.93 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.639 -1.384 . . . . 13.82 109.639 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.414 ' HA ' HG13 ' A' ' 45' ' ' VAL . 1.5 t -146.24 140.11 26.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -1.163 . . . . 18.27 109.603 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.525 ' O ' ' CG ' ' B' ' 77' ' ' MET . 1.4 tp -55.69 156.23 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 12.43 109.338 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.525 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 15.2 mtt -164.33 130.53 2.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 35.109999999999999 109.618 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.908 HD12 HD12 ' A' ' 78' ' ' ILE . 2.5 mp -63.97 138.57 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -0.854 . . . . 13.67 109.841 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.6 -23.76 12.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.334 -0.988 . . . . 24.059999999999999 108.334 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.9 OUTLIER 178.55 68.07 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.062 -1.459 . . . . 35.039999999999999 107.062 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.659 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.7 OUTLIER -29.15 119.66 0.13 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.297 -0.865 . . . . 18.719999999999999 111.659 -177.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -88.52 100.25 12.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.348 -0.845 . . . . 20.550000000000001 108.849 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.037 HD12 HD13 ' B' ' 47' ' ' ILE . 0.9 OUTLIER -69.74 140.93 53.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 14.4 110.626 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.85 HG22 ' O ' ' B' ' 62' ' ' THR . 27.3 m -143.08 153.33 60.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 107.756 -1.201 . . . . 17.649999999999999 107.756 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.3 Cg_endo -61.23 141.7 94.05 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.911 1.741 . . . . 25.699999999999999 110.39 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.584 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -77.89 117.81 19.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.335 -0.853 . . . . 49.289999999999999 109.687 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.04 -0.981 . . . . 58.909999999999997 109.417 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.513 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.274 0.559 . . . . 64.909999999999997 109.496 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.757 ' CA ' HD22 ' B' ' 65' ' ' LEU . 3.3 mt 70.12 78.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 107.459 -1.312 . . . . 33.799999999999997 107.459 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.521 ' C ' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -62.01 159.7 13.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.96 0.886 . . . . 32.719999999999999 111.666 -177.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.084 ' CG2' HG22 ' A' ' 35' ' ' VAL . 82.4 t -160.68 168.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.985 -0.746 . . . . 14.460000000000001 108.985 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.597 ' N ' HG12 ' A' ' 4' ' ' VAL . 30.9 mt-10 -153.29 99.7 2.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 22.120000000000001 109.463 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.995 HG21 ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -70.32 102.77 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.822 -1.177 . . . . 14.23 107.822 179.206 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 3.5 mmpt? -57.64 163.59 3.68 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 25.43 109.308 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.5 -11.94 26.75 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.98 1.787 . . . . 13.609999999999999 109.206 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -102.69 13.3 34.78 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.301 -1.0 . . . . 15.52 108.301 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.537 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 5.6 mm-40 -142.86 36.33 1.42 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.452 -0.78 . . . . 17.309999999999999 109.41 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -112.78 35.3 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.092 -1.005 . . . . 24.780000000000001 110.234 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -140.74 125.19 17.73 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.169 -0.957 . . . . 47.899999999999999 109.67 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.643 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 40.4 p90 -89.74 156.66 18.38 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.293 -0.879 . . . . 21.609999999999999 109.82 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -131.5 161.85 31.6 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.326 -0.99 . . . . 14.890000000000001 108.326 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.628 0 O-C-N 121.093 -1.004 . . . . 17.350000000000001 109.095 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.563 0.697 . . . . 24.0 110.29 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -45.77 133.97 7.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.54 -0.725 . . . . 23.309999999999999 110.082 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 35.5 mt-10 -128.53 151.69 49.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.384 -0.822 . . . . 40.030000000000001 108.816 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.927 ' OE1' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -135.62 -170.43 2.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.978 -1.076 . . . . 12.390000000000001 110.294 -179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.836 ' HB3' HD11 ' A' ' 44' ' ' LEU . 11.0 mt -126.65 173.2 9.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.733 -0.84 . . . . 17.420000000000002 108.733 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.546 ' SG ' HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -167.95 160.68 12.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.792 -1.192 . . . . 13.84 108.162 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.69 ' CE1' HD13 ' A' ' 44' ' ' LEU . 3.2 m-85 -107.59 92.17 3.96 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.136 -0.978 . . . . 21.140000000000001 109.478 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.084 HG22 ' CG2' ' A' ' 4' ' ' VAL . 37.5 t -94.59 121.74 45.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.281 -0.887 . . . . 10.66 110.17 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.746 ' C ' HD23 ' A' ' 37' ' ' LEU . 1.9 m-20 -73.35 -36.62 66.17 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.212 -1.033 . . . . 25.890000000000001 108.212 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.746 HD23 ' C ' ' A' ' 36' ' ' ASP . 1.0 OUTLIER 39.19 28.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.779 -0.575 . . . . 24.239999999999998 110.073 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 67.75 25.98 73.94 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.782 -1.327 . . . . 31.02 109.782 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 36' ' ' ASP . 1.1 t-20 -96.21 15.4 21.06 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.192 -1.181 . . . . 43.229999999999997 110.655 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 41' ' ' HIS . 1.7 mt-10 68.5 94.03 0.07 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.023 -1.048 . . . . 42.340000000000003 108.601 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.626 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 10.6 m80 86.57 167.94 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.646 -0.872 . . . . 5.0999999999999996 108.646 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 41' ' ' HIS . 34.0 Cg_endo -77.71 150.26 27.34 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.09 1.86 . . . . 17.920000000000002 111.204 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.863 HG22 ' O ' ' A' ' 35' ' ' VAL . 2.2 m -122.48 120.44 61.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.368 -0.833 . . . . 20.57 109.171 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' A' ' 32' ' ' LEU . 16.6 tp -73.79 109.62 7.44 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.295 -0.878 . . . . 20.210000000000001 108.641 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 1.6 p -123.87 160.65 27.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.438 -0.789 . . . . 10.81 109.475 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HA ' HD23 ' A' ' 32' ' ' LEU . 4.6 ttmt -77.33 164.56 25.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 36.740000000000002 110.438 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.977 HD13 HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -149.66 172.59 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.906 -0.776 . . . . 19.739999999999998 108.906 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 m -108.65 146.87 32.74 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.161 -0.962 . . . . 22.559999999999999 109.312 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.643 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -118.01 145.94 44.4 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.237 -0.914 . . . . 20.41 108.61 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.454 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -82.38 140.14 33.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.061 -1.025 . . . . 33.990000000000002 109.82 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.28 106.73 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 54.920000000000002 109.346 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.95 -12.53 57.6 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.494 . . . . 36.100000000000001 109.364 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.454 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 2.4 mt-30 -81.9 147.22 57.7 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.29 -1.124 . . . . 54.759999999999998 109.344 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.8 Cg_endo -78.15 123.23 6.05 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.593 2.195 . . . . 28.370000000000001 110.537 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.927 ' HB1' ' OE1' ' A' ' 31' ' ' GLN . . . -37.94 143.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.633 -0.667 . . . . 17.210000000000001 110.142 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.995 ' O ' HG21 ' A' ' 6' ' ' ILE . 83.9 m-85 -41.49 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.481 -0.762 . . . . 17.190000000000001 109.326 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.695 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -43.04 165.41 0.11 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 17.82 109.577 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.695 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.1 Cg_endo -77.59 105.92 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.57 2.18 . . . . 17.280000000000001 110.484 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.54 -174.25 41.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.891 -1.284 . . . . 17.219999999999999 109.891 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -76.06 142.42 41.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -1.101 . . . . 19.57 108.396 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.71 ' HB3' HD22 ' A' ' 83' ' ' LEU . 15.9 m-85 -131.74 163.69 27.62 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.767 -1.208 . . . . 14.609999999999999 111.68 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 84' ' ' VAL . 50.8 p -145.72 120.18 9.68 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.698 -1.593 . . . . 18.359999999999999 106.698 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.615 ' CG1' HD12 ' A' ' 81' ' ' LEU . 3.8 t -50.68 171.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 118.708 -1.197 . . . . 19.129999999999999 108.885 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.603 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.8 t-80 -135.08 125.37 26.3 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.337 -0.852 . . . . 20.649999999999999 109.263 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.764 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -70.4 -2.84 14.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.457 -0.777 . . . . 19.649999999999999 109.697 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -17.01 14.71 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.023 -1.102 . . . . 14.720000000000001 108.023 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -101.73 -9.66 20.65 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.726 -0.609 . . . . 11.449999999999999 110.597 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -72.31 164.14 26.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.959 -1.088 . . . . 14.25 109.992 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' A' ' 77' ' ' MET . 2.8 ptmt -146.42 177.04 9.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.947 -0.76 . . . . 32.700000000000003 108.947 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.435 HG23 HG21 ' B' ' 45' ' ' VAL . 6.2 p -126.92 158.73 37.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.272 -0.892 . . . . 15.630000000000001 109.355 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.96 -140.16 11.61 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.367 -1.493 . . . . 12.699999999999999 109.367 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 28.6 tp60 57.23 60.56 2.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.111 -1.229 . . . . 26.289999999999999 109.373 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 73.29 2.34 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.494 -0.754 . . . . 20.440000000000001 109.469 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' B' ' 46' ' ' LYS . . . 103.9 54.79 0.8 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.962 -1.255 . . . . 13.82 109.962 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.3 t -151.27 147.36 26.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -1.2 . . . . 18.27 109.776 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.638 ' HB2' HD13 ' B' ' 81' ' ' LEU . 2.6 tp -59.41 165.11 2.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 12.43 109.189 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 12.1 mtp -165.23 104.54 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.972 . . . . 35.109999999999999 110.038 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.4 mt -42.26 -63.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.509 -0.744 . . . . 13.67 109.335 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 38.0 t0 84.9 -45.5 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.387 0.613 . . . . 24.059999999999999 110.134 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.573 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.0 tmm_? -171.44 67.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.039 0.923 . . . . 35.039999999999999 108.519 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -38.06 131.19 1.12 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.603 -0.726 . . . . 18.719999999999999 111.514 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -96.47 107.0 19.34 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.923 -1.14 . . . . 20.550000000000001 107.923 178.391 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.977 HD12 HD13 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -76.9 146.84 37.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.127 -0.983 . . . . 14.4 111.221 -178.264 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 62' ' ' THR . 16.3 m -147.63 156.8 45.1 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.93 -1.137 . . . . 17.649999999999999 107.93 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.9 Cg_endo -64.01 142.95 83.5 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.163 1.909 . . . . 25.699999999999999 110.419 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.705 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -72.23 115.1 11.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 49.289999999999999 109.484 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.043 -0.98 . . . . 58.909999999999997 109.48 -179.942 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.43 -0.581 . . . . 64.909999999999997 109.43 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.764 ' CA ' HD22 ' A' ' 65' ' ' LEU . 3.3 mt 70.26 78.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.475 -1.306 . . . . 33.799999999999997 107.475 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 0.0 OUTLIER -61.85 159.56 13.65 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.976 0.893 . . . . 32.719999999999999 111.656 -177.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.081 ' CG2' HG22 ' B' ' 35' ' ' VAL . 84.3 t -160.52 168.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.964 -0.754 . . . . 14.460000000000001 108.964 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.618 ' N ' HG12 ' B' ' 4' ' ' VAL . 31.0 mt-10 -153.3 99.75 2.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.299 -0.876 . . . . 22.120000000000001 109.502 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.99 HG21 ' O ' ' B' ' 56' ' ' TYR . 1.0 OUTLIER -70.41 102.75 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.756 -1.201 . . . . 14.23 107.756 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.587 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 3.5 mmpt? -57.57 163.44 3.71 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.276 -0.89 . . . . 25.43 109.322 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.6 Cg_endo -72.44 -11.84 26.81 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.931 1.754 . . . . 13.609999999999999 109.182 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -102.68 13.21 35.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 15.52 108.33 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.53 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 5.6 mm-40 -142.7 36.22 1.44 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.402 -0.811 . . . . 17.309999999999999 109.452 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -112.69 35.4 3.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.986 -1.071 . . . . 24.780000000000001 110.274 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -140.8 125.09 17.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.122 -0.986 . . . . 47.899999999999999 109.588 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.644 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 40.6 p90 -89.54 157.01 18.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.313 -0.867 . . . . 21.609999999999999 109.855 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.2 t -131.89 161.53 32.79 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.327 -0.99 . . . . 14.890000000000001 108.327 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.624 0 O-C-N 121.09 -1.006 . . . . 17.350000000000001 109.168 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.592 HD23 ' O ' ' B' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.563 0.697 . . . . 24.0 110.329 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.627 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -45.73 134.19 7.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.561 -0.712 . . . . 23.309999999999999 110.045 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 35.4 mt-10 -128.7 151.76 49.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.322 -0.861 . . . . 40.030000000000001 108.783 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.924 ' OE1' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -135.76 -170.55 2.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.948 -1.095 . . . . 12.390000000000001 110.223 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.845 ' HB3' HD11 ' B' ' 44' ' ' LEU . 11.0 mt -126.67 173.2 9.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.692 -0.855 . . . . 17.420000000000002 108.692 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.536 ' SG ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -168.0 160.58 12.18 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.782 -1.199 . . . . 13.84 108.136 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.688 ' CE1' HD13 ' B' ' 44' ' ' LEU . 3.2 m-85 -107.47 92.41 4.06 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.082 -1.011 . . . . 21.140000000000001 109.461 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 1.081 HG22 ' CG2' ' B' ' 4' ' ' VAL . 38.5 t -94.81 121.71 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.25 -0.906 . . . . 10.66 110.112 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.742 ' C ' HD23 ' B' ' 37' ' ' LEU . 1.9 m-20 -73.35 -36.45 66.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.215 -1.031 . . . . 25.890000000000001 108.215 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.742 HD23 ' C ' ' B' ' 36' ' ' ASP . 1.0 OUTLIER 39.09 28.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.731 -0.606 . . . . 24.239999999999998 109.979 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 67.61 26.22 73.76 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.79 -1.324 . . . . 31.02 109.79 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' B' ' 36' ' ' ASP . 1.1 t-20 -96.45 15.63 20.87 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.228 -1.16 . . . . 43.229999999999997 110.568 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' B' ' 41' ' ' HIS . 1.7 mt-10 68.38 93.89 0.07 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.026 -1.046 . . . . 42.340000000000003 108.652 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.629 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 10.5 m80 86.66 168.01 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.672 -0.862 . . . . 5.1100000000000003 108.672 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.632 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 34.1 Cg_endo -77.64 150.43 27.73 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.072 1.848 . . . . 17.920000000000002 111.18 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.891 HG22 ' O ' ' B' ' 35' ' ' VAL . 2.2 m -122.66 120.41 60.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.64 -0.824 . . . . 20.57 109.128 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.845 HD11 ' HB3' ' B' ' 32' ' ' LEU . 16.7 tp -73.74 109.71 7.46 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.447 -0.901 . . . . 20.210000000000001 108.65 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' B' ' 32' ' ' LEU . 1.7 p -123.87 160.71 27.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.382 -0.824 . . . . 10.81 109.466 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.485 ' HA ' HD23 ' B' ' 32' ' ' LEU . 4.6 ttmt -77.36 164.65 25.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 36.740000000000002 110.434 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.961 HD13 HD12 ' B' ' 83' ' ' LEU . 0.4 OUTLIER -149.65 172.61 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.448 -0.782 . . . . 19.739999999999998 108.9 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.1 m -108.72 146.38 33.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.163 -0.961 . . . . 22.559999999999999 109.378 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.644 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -117.5 145.96 43.86 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.201 -0.937 . . . . 20.41 108.615 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.476 ' HB2' ' NE2' ' B' ' 53' ' ' GLN . 0.7 OUTLIER -82.42 140.03 33.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 33.990000000000002 109.81 -179.221 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.18 106.84 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 54.920000000000002 109.403 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.88 -12.44 57.69 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.363 -1.495 . . . . 36.100000000000001 109.363 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.476 ' NE2' ' HB2' ' B' ' 50' ' ' ASP . 5.0 mt-30 -82.09 147.19 56.93 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.364 -1.08 . . . . 54.759999999999998 109.359 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.6 Cg_endo -78.08 123.27 6.1 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.646 2.231 . . . . 28.370000000000001 110.469 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.924 ' HB1' ' OE1' ' B' ' 31' ' ' GLN . . . -37.88 143.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.528 -0.732 . . . . 17.210000000000001 110.19 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.99 ' O ' HG21 ' B' ' 6' ' ' ILE . 83.9 m-85 -41.41 97.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.457 -0.777 . . . . 17.190000000000001 109.259 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -42.87 165.52 0.1 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 17.82 109.582 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.67 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.43 104.97 1.97 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.562 2.175 . . . . 17.280000000000001 110.122 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.74 -175.03 41.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.946 -1.262 . . . . 17.219999999999999 109.946 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.707 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -76.31 142.07 41.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.075 -1.083 . . . . 19.57 108.075 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.693 ' HB3' HD22 ' B' ' 83' ' ' LEU . 15.5 m-85 -131.32 163.7 27.27 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.716 -1.24 . . . . 14.609999999999999 111.716 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.746 ' O ' HG22 ' B' ' 84' ' ' VAL . 50.6 p -145.64 120.09 9.68 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.61 -1.626 . . . . 18.359999999999999 106.61 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.628 ' CG1' HD12 ' B' ' 81' ' ' LEU . 3.8 t -50.64 171.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 118.78 -1.168 . . . . 19.129999999999999 108.861 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.583 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.8 t-80 -135.01 125.45 26.59 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.331 -0.856 . . . . 20.649999999999999 109.268 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.757 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -70.51 -2.91 15.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.771 . . . . 19.649999999999999 109.645 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -17.13 14.53 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.043 -1.095 . . . . 14.720000000000001 108.043 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 0.4 OUTLIER -101.63 -10.04 20.4 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.681 -0.637 . . . . 11.449999999999999 110.654 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.691 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.8 m-30 -72.05 164.12 26.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.022 -1.049 . . . . 14.25 109.943 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' B' ' 77' ' ' MET . 2.7 ptmt -146.38 177.17 9.23 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.966 -0.753 . . . . 32.700000000000003 108.966 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.459 HG23 HG21 ' A' ' 45' ' ' VAL . 6.2 p -126.99 158.72 37.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.266 -0.896 . . . . 15.630000000000001 109.348 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' B' ' 75' ' ' SER . . . 127.91 -140.13 11.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.36 -1.496 . . . . 12.699999999999999 109.36 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 28.2 tp60 57.19 60.68 2.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.11 -1.23 . . . . 26.289999999999999 109.378 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.2 OUTLIER 73.13 2.47 4.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.473 -0.767 . . . . 20.440000000000001 109.506 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 46' ' ' LYS . . . 103.78 54.77 0.8 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.975 -1.25 . . . . 13.82 109.975 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.4 ' N ' ' O ' ' B' ' 71' ' ' GLY . 48.1 t -151.34 147.51 27.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 18.27 109.827 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.633 ' HB2' HD13 ' A' ' 81' ' ' LEU . 2.6 tp -59.56 164.9 3.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.291 -0.88 . . . . 12.43 109.175 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 12.5 mtp -165.14 104.37 0.76 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.086 -1.009 . . . . 35.109999999999999 110.103 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.607 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.4 mt -42.05 -63.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 13.67 109.425 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 38.0 t0 84.94 -45.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.407 0.622 . . . . 24.059999999999999 110.108 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.0 tmm_? -171.51 67.23 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.081 0.943 . . . . 35.039999999999999 108.531 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.743 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -38.16 131.13 1.16 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.685 0.755 . . . . 18.719999999999999 111.515 -178.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -96.4 107.1 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.892 -1.151 . . . . 20.550000000000001 107.892 178.437 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.961 HD12 HD13 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -76.98 146.7 37.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 14.4 111.243 -178.317 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.746 HG22 ' O ' ' B' ' 62' ' ' THR . 16.4 m -147.49 156.64 45.59 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 107.986 -1.116 . . . . 17.649999999999999 107.986 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.4 Cg_endo -63.88 142.66 83.13 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.142 1.894 . . . . 25.699999999999999 110.515 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.707 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -72.04 115.03 10.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 49.289999999999999 109.505 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.038 -0.982 . . . . 58.909999999999997 109.499 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.57 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.306 0.574 . . . . 64.909999999999997 109.473 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.893 HD12 ' HB ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -82.65 82.57 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.109 -1.071 . . . . 33.799999999999997 108.109 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -68.04 163.59 22.0 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.112 0.958 . . . . 32.719999999999999 111.359 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.987 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -174.38 167.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.428 -0.953 . . . . 14.460000000000001 108.428 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.576 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 31.6 mt-10 -140.39 111.39 7.02 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.899 0.857 . . . . 22.120000000000001 109.347 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.844 HG21 ' O ' ' A' ' 56' ' ' TYR . 6.2 mm -73.86 89.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.279 -1.008 . . . . 14.23 108.279 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.594 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.7 mmpm? -41.99 161.89 0.15 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 25.43 109.649 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.9 Cg_endo -72.41 -12.25 27.16 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.037 1.825 . . . . 13.609999999999999 109.115 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.0 t -98.17 6.94 46.97 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.675 -0.861 . . . . 15.52 108.675 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.531 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 17.1 mm-40 -128.25 13.36 6.64 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.334 -0.854 . . . . 17.309999999999999 109.519 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -88.14 30.3 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 24.780000000000001 110.299 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.413 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 18.7 mt-30 -144.55 121.58 11.4 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.161 -0.962 . . . . 47.899999999999999 109.678 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.626 ' CD2' ' CB ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.77 -177.39 4.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.448 -0.782 . . . . 21.609999999999999 110.429 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 98.1 m -157.05 143.73 18.34 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.433 -0.792 . . . . 14.890000000000001 109.044 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.573 0 O-C-N 121.351 -0.843 . . . . 17.350000000000001 109.574 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.485 HD22 HG22 ' A' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.457 0.646 . . . . 24.0 110.301 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.626 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -86.75 104.0 15.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.458 -0.776 . . . . 23.309999999999999 109.439 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 22.0 mt-10 -79.97 -176.53 5.53 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.039 -1.038 . . . . 40.030000000000001 109.422 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.57 ' CB ' HG22 ' A' ' 47' ' ' ILE . 3.5 mt-30 -168.38 -171.06 1.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 12.390000000000001 109.711 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.909 ' HB3' HD11 ' A' ' 44' ' ' LEU . 2.2 mp -131.39 179.08 6.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 17.420000000000002 109.634 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -172.25 159.5 4.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.935 -1.103 . . . . 13.84 109.024 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.776 ' HE1' HD13 ' A' ' 44' ' ' LEU . 2.8 m-85 -116.02 89.6 3.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 21.140000000000001 108.875 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.94 ' O ' HG22 ' A' ' 43' ' ' VAL . 98.7 t -91.73 115.86 31.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.101 -0.999 . . . . 10.66 110.233 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 73.4 m-20 -60.62 -20.34 60.41 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.178 -1.045 . . . . 25.890000000000001 108.178 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.798 HD11 ' CA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 40.65 27.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.673 -0.642 . . . . 24.239999999999998 109.922 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 61.66 27.46 68.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 120.127 -1.035 . . . . 31.02 110.539 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.56 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 8.8 p30 -106.78 22.68 15.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.677 -1.484 . . . . 43.229999999999997 110.417 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' A' ' 41' ' ' HIS . 27.6 mt-10 61.36 50.49 4.7 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.215 -0.928 . . . . 42.340000000000003 111.027 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.552 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 6.1 p80 154.68 149.45 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 108.187 -1.042 . . . . 8.3100000000000005 108.187 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.629 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.2 Cg_endo -75.88 147.21 30.46 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.947 1.765 . . . . 17.920000000000002 110.317 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 35' ' ' VAL . 14.5 m -121.36 116.68 50.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.242 -0.983 . . . . 20.57 109.069 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.909 HD11 ' HB3' ' A' ' 32' ' ' LEU . 21.9 tp -68.87 105.68 2.44 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.321 -0.952 . . . . 20.210000000000001 108.57 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' B' ' 75' ' ' SER . 0.5 OUTLIER -121.73 168.64 13.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.57 -0.706 . . . . 10.81 109.165 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -82.63 156.24 23.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 36.740000000000002 110.621 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.115 HD11 ' HB2' ' A' ' 83' ' ' LEU . 1.4 tt -143.37 161.72 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.51 -0.922 . . . . 19.739999999999998 108.51 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.573 HG21 ' CZ ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -108.67 123.88 49.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.925 -1.11 . . . . 22.559999999999999 109.423 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.912 HD11 ' O ' ' A' ' 53' ' ' GLN . 1.9 tm? -86.5 125.02 33.45 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.769 -0.826 . . . . 20.41 108.769 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -54.89 139.22 41.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 33.990000000000002 109.602 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -55.37 118.93 4.86 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.224 -0.923 . . . . 54.920000000000002 109.328 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.39 -23.1 23.62 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.544 -1.422 . . . . 36.100000000000001 109.544 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.912 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -67.0 152.14 96.35 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -1.176 . . . . 54.759999999999998 109.357 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -79.58 117.05 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.476 2.117 . . . . 28.370000000000001 110.085 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -29.71 137.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.221 0.534 . . . . 17.210000000000001 111.128 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.844 ' O ' HG21 ' A' ' 6' ' ' ILE . 99.2 m-85 -41.28 105.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.48 -0.763 . . . . 17.190000000000001 109.41 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.815 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.98 170.33 0.72 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.069 -1.019 . . . . 17.82 109.277 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.815 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.67 103.24 1.69 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.459 2.106 . . . . 17.280000000000001 110.097 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.11 -179.77 44.96 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.921 -1.272 . . . . 17.219999999999999 109.921 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.784 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -72.69 149.86 43.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.366 -1.079 . . . . 19.57 108.12 179.075 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.987 ' CB ' HG13 ' A' ' 4' ' ' VAL . 18.0 m-85 -133.92 165.23 25.5 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.692 -1.255 . . . . 14.609999999999999 111.724 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 84' ' ' VAL . 69.8 p -143.96 119.2 10.16 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.949 -1.871 . . . . 18.359999999999999 105.949 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 81' ' ' LEU . 9.8 t -53.84 165.42 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 C-N-CA 118.404 -1.318 . . . . 19.129999999999999 108.962 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.529 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -134.15 126.46 30.03 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.47 -0.937 . . . . 20.649999999999999 108.47 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' B' ' 2' ' ' ILE . 2.3 pp -72.88 2.14 7.36 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.144 -0.972 . . . . 19.649999999999999 110.246 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.32 -18.96 19.5 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.643 -1.243 . . . . 14.720000000000001 107.643 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 1.3 t -100.37 -9.36 22.33 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.72 -0.612 . . . . 11.449999999999999 110.302 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 3.9 m-30 -73.48 156.67 37.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.962 -1.086 . . . . 14.25 109.32 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.763 ' CA ' HD11 ' B' ' 37' ' ' LEU . 22.3 mtmt -152.89 167.12 30.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 32.700000000000003 109.717 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.525 HG21 HG21 ' B' ' 43' ' ' VAL . 0.5 OUTLIER -101.11 123.32 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.513 -0.921 . . . . 15.630000000000001 108.513 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 70' ' ' VAL . . . -59.81 -130.7 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.046 -1.222 . . . . 12.699999999999999 110.046 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.522 ' C ' ' CG ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -87.2 46.01 1.33 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -1.144 . . . . 26.289999999999999 108.869 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.522 ' CG ' ' C ' ' A' ' 72' ' ' GLN . 1.8 m-85 77.06 0.02 3.0 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.993 -0.743 . . . . 20.440000000000001 108.993 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.59 -66.48 2.37 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.524 -1.43 . . . . 13.82 109.524 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.476 ' HA ' HG22 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -160.6 170.18 21.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -1.165 . . . . 18.27 109.667 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.9 OUTLIER -66.79 163.6 18.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 12.43 109.433 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.537 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 15.1 mtp -165.6 127.24 1.97 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 35.109999999999999 109.401 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.2 mt -53.93 -41.3 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.306 -0.871 . . . . 13.67 109.946 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 2.1 t0 45.0 54.55 6.83 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.512 -1.292 . . . . 24.059999999999999 107.512 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.573 ' CZ ' HG21 ' A' ' 48' ' ' THR . 0.6 OUTLIER 85.56 116.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.017 -1.475 . . . . 35.039999999999999 107.017 -177.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.062 HD13 HG13 ' A' ' 63' ' ' VAL . 2.0 pp -94.63 152.02 18.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.332 -0.855 . . . . 18.719999999999999 111.274 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -101.52 95.6 6.57 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.905 -1.517 . . . . 20.550000000000001 106.905 177.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.115 ' HB2' HD11 ' A' ' 47' ' ' ILE . 2.0 tp -75.07 150.67 38.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.191 -0.943 . . . . 14.4 111.324 -177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 62' ' ' THR . 24.1 m -147.47 158.96 42.85 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.809 -1.182 . . . . 17.649999999999999 107.809 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.3 Cg_endo -63.87 145.88 90.94 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.06 1.84 . . . . 25.699999999999999 110.335 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.784 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -80.39 115.37 19.89 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.133 -0.979 . . . . 49.289999999999999 109.579 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.2 tptt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.963 -1.018 . . . . 58.909999999999997 109.486 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.567 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.461 -0.57 . . . . 64.909999999999997 109.461 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.904 HD12 ' HB ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -83.26 82.52 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.083 -1.08 . . . . 33.799999999999997 108.083 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -67.99 163.59 21.89 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.169 0.985 . . . . 32.719999999999999 111.351 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.004 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -174.38 167.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.419 -0.956 . . . . 14.460000000000001 108.419 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.565 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 31.3 mt-10 -140.27 111.5 7.13 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.866 0.841 . . . . 22.120000000000001 109.286 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.828 HG21 ' O ' ' B' ' 56' ' ' TYR . 6.2 mm -74.04 89.7 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.285 -1.006 . . . . 14.23 108.285 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.598 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.7 mmpm? -41.73 161.81 0.14 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 25.43 109.668 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.7 Cg_endo -72.44 -12.39 27.21 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.957 1.771 . . . . 13.609999999999999 109.117 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.5 t -97.94 6.9 47.17 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.655 -0.868 . . . . 15.52 108.655 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.524 ' HB3' ' HB2' ' B' ' 32' ' ' LEU . 17.0 mm-40 -128.17 13.14 6.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.316 -0.865 . . . . 17.309999999999999 109.609 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -87.92 30.13 0.87 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.973 . . . . 24.780000000000001 110.333 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 18.7 mt-30 -144.33 121.71 11.65 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.129 -0.982 . . . . 47.899999999999999 109.659 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.626 ' CD2' ' CB ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -77.84 -177.33 4.86 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.456 -0.777 . . . . 21.609999999999999 110.42 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 97.7 m -157.14 143.61 18.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.34 -0.85 . . . . 14.890000000000001 109.088 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.599 0 O-C-N 121.445 -0.784 . . . . 17.350000000000001 109.572 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.473 HD22 HG22 ' B' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.522 0.677 . . . . 24.0 110.224 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.626 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -86.82 103.79 15.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.426 -0.796 . . . . 23.309999999999999 109.465 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 21.7 mt-10 -79.77 -176.65 5.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.043 -1.035 . . . . 40.030000000000001 109.524 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.582 ' CB ' HG22 ' B' ' 47' ' ' ILE . 3.5 mt-30 -168.19 -171.12 1.44 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.209 -0.932 . . . . 12.390000000000001 109.778 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.934 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.2 mp -131.26 179.11 6.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 17.420000000000002 109.633 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.534 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -172.35 159.43 4.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.925 -1.109 . . . . 13.84 108.946 -179.435 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.758 ' HE1' HD13 ' B' ' 44' ' ' LEU . 2.8 m-85 -116.06 89.47 3.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.953 . . . . 21.140000000000001 108.911 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.946 ' O ' HG22 ' B' ' 43' ' ' VAL . 98.5 t -91.59 116.13 32.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.055 -1.028 . . . . 10.66 110.26 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 73.3 m-20 -60.92 -19.96 61.36 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.213 -1.032 . . . . 25.890000000000001 108.213 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.763 HD11 ' CA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 40.42 27.67 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.644 -0.66 . . . . 24.239999999999998 109.867 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 61.58 27.54 68.24 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.552 -1.019 . . . . 31.02 110.552 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.552 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 8.7 p30 -106.83 22.67 15.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.67 -1.488 . . . . 43.229999999999997 110.517 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.545 ' O ' ' HB3' ' B' ' 41' ' ' HIS . 27.7 mt-10 61.34 50.58 4.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.172 -0.955 . . . . 42.340000000000003 111.026 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.547 ' O ' ' HA ' ' B' ' 36' ' ' ASP . 6.1 p80 154.61 149.35 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.198 -1.038 . . . . 8.3399999999999999 108.198 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.636 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 34.9 Cg_endo -75.78 147.2 30.81 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.933 1.755 . . . . 17.920000000000002 110.33 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.946 HG22 ' O ' ' B' ' 35' ' ' VAL . 14.5 m -121.36 116.97 51.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 C-N-CA 119.282 -0.967 . . . . 20.57 109.068 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.934 HD11 ' HB3' ' B' ' 32' ' ' LEU . 22.1 tp -69.25 105.54 2.56 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.333 -0.947 . . . . 20.210000000000001 108.568 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -121.58 168.57 13.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.63 0 O-C-N 121.589 -0.694 . . . . 10.81 109.161 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.437 ' N ' HG13 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -82.49 156.23 24.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 36.740000000000002 110.605 -178.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 1.077 HD11 ' HB2' ' B' ' 83' ' ' LEU . 1.4 tt -143.42 161.62 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.464 -0.939 . . . . 19.739999999999998 108.464 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.583 HG21 ' CZ ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -108.59 123.94 49.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.958 -1.089 . . . . 22.559999999999999 109.418 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.922 HD11 ' O ' ' B' ' 53' ' ' GLN . 1.9 tm? -86.56 124.99 33.47 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.535 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.3 OUTLIER -54.85 139.27 40.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 33.990000000000002 109.666 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -55.4 118.92 4.86 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.232 -0.917 . . . . 54.920000000000002 109.31 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.34 -22.94 24.24 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.596 -1.401 . . . . 36.100000000000001 109.596 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.922 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.6 OUTLIER -67.18 152.18 96.37 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.172 -1.193 . . . . 54.759999999999998 109.29 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.506 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -79.55 117.11 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.462 2.108 . . . . 28.370000000000001 110.018 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.588 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -29.9 138.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.233 0.54 . . . . 17.210000000000001 111.068 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.828 ' O ' HG21 ' B' ' 6' ' ' ILE . 99.3 m-85 -41.33 105.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 17.190000000000001 109.591 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.792 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.46 170.32 0.63 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.09 -1.006 . . . . 17.82 109.186 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.792 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.3 Cg_endo -78.01 104.2 1.81 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.553 2.169 . . . . 17.280000000000001 110.267 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.64 -179.34 46.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.861 -1.295 . . . . 17.219999999999999 109.861 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.777 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -72.31 150.27 43.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.151 . . . . 19.57 108.449 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 1.004 ' CB ' HG13 ' B' ' 4' ' ' VAL . 16.4 m-85 -134.34 165.29 25.49 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.775 -1.203 . . . . 14.609999999999999 111.75 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.822 ' O ' HG22 ' B' ' 84' ' ' VAL . 67.1 p -144.15 119.23 10.06 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.029 -1.841 . . . . 18.359999999999999 106.029 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 1.069 HG13 HD13 ' B' ' 81' ' ' LEU . 9.7 t -53.91 165.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 C-N-CA 118.419 -1.312 . . . . 19.129999999999999 109.006 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -134.0 126.44 30.23 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.424 -0.954 . . . . 20.649999999999999 108.424 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.763 HD22 ' HA ' ' A' ' 2' ' ' ILE . 2.3 pp -72.76 1.9 7.64 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.193 -0.942 . . . . 19.649999999999999 110.197 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -19.02 16.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.575 -1.269 . . . . 14.720000000000001 107.575 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.521 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 1.3 t -100.5 -9.85 21.67 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.72 -0.613 . . . . 11.449999999999999 110.306 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.9 m-30 -72.94 156.46 38.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.979 -1.076 . . . . 14.25 109.206 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.798 ' CA ' HD11 ' A' ' 37' ' ' LEU . 22.5 mtmt -152.71 166.67 31.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 32.700000000000003 109.803 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -100.53 123.14 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.527 -0.916 . . . . 15.630000000000001 108.527 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' B' ' 70' ' ' VAL . . . -59.95 -130.71 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.016 -1.233 . . . . 12.699999999999999 110.016 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.537 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -87.1 46.25 1.36 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -1.133 . . . . 26.289999999999999 108.879 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.537 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 1.8 m-85 76.79 0.05 3.07 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.058 -0.719 . . . . 20.440000000000001 109.058 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.64 -66.28 2.45 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.612 -1.395 . . . . 13.82 109.612 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.482 ' HA ' HG22 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -160.7 170.1 21.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -1.186 . . . . 18.27 109.673 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.533 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.9 OUTLIER -66.72 163.45 19.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 12.43 109.462 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 15.2 mtp -165.59 127.42 2.0 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.892 . . . . 35.109999999999999 109.381 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.601 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.1 mt -54.22 -41.12 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 13.67 109.921 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 2.1 t0 44.92 54.67 6.66 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.442 -1.318 . . . . 24.059999999999999 107.442 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.583 ' CZ ' HG21 ' B' ' 48' ' ' THR . 0.6 OUTLIER 85.56 116.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.097 -1.445 . . . . 35.039999999999999 107.097 -177.324 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 1.069 HD13 HG13 ' B' ' 63' ' ' VAL . 2.0 pp -94.53 152.13 18.79 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 18.719999999999999 111.276 -177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.533 ' N ' HD12 ' B' ' 81' ' ' LEU . 0.0 OUTLIER -101.7 95.5 6.47 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.93 -1.507 . . . . 20.550000000000001 106.93 177.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.077 ' HB2' HD11 ' B' ' 47' ' ' ILE . 2.0 tp -75.0 150.57 38.93 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.161 -0.962 . . . . 14.4 111.335 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.822 HG22 ' O ' ' B' ' 62' ' ' THR . 24.1 m -147.47 158.64 43.31 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 107.813 -1.181 . . . . 17.649999999999999 107.813 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.0 Cg_endo -63.61 145.94 92.09 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.022 1.815 . . . . 25.699999999999999 110.357 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.777 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -80.36 115.54 19.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 49.289999999999999 109.564 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 16.2 tptt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.984 -1.008 . . . . 58.909999999999997 109.506 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.341 -0.615 . . . . 64.909999999999997 109.341 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.988 HG23 ' CD2' ' B' ' 65' ' ' LEU . 0.0 OUTLIER 56.21 88.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.933 -1.104 . . . . 33.799999999999997 108.046 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -92.77 167.12 12.08 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.341 -0.849 . . . . 32.719999999999999 110.437 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.912 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -172.67 165.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.993 -0.743 . . . . 14.460000000000001 108.993 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.561 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 34.3 mt-10 -141.74 110.37 6.09 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.908 -0.775 . . . . 22.120000000000001 108.908 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.825 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -71.85 100.81 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 119.171 -1.012 . . . . 14.23 108.401 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 3.0 mmmt -41.49 163.48 0.11 Allowed Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.462 -0.774 . . . . 25.43 109.423 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.68 -13.92 27.16 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.961 1.774 . . . . 13.609999999999999 109.224 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -96.58 5.32 51.0 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.716 -0.846 . . . . 15.52 108.716 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 9.1 mm-40 -125.93 34.9 4.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.361 -0.837 . . . . 17.309999999999999 109.355 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.95 8.46 42.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 24.780000000000001 110.014 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 41.6 mt-30 -132.14 144.47 50.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.223 -0.923 . . . . 47.899999999999999 109.516 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.72 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 30.8 p90 -91.68 164.73 13.63 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.259 -0.901 . . . . 21.609999999999999 109.407 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -137.7 152.5 49.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.29 -0.881 . . . . 14.890000000000001 109.125 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.473 0 O-C-N 121.242 -0.911 . . . . 17.350000000000001 109.366 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.44 HD22 HG23 ' A' ' 48' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.326 0.584 . . . . 24.0 110.057 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.635 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 92.8 m-20 -52.92 118.87 4.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.844 . . . . 23.309999999999999 109.336 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 5.1 mt-10 -110.98 165.83 11.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 40.030000000000001 109.183 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.685 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -144.03 162.98 34.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.051 -1.031 . . . . 12.390000000000001 109.861 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' HD11 ' A' ' 44' ' ' LEU . 3.6 mm? -102.64 178.28 4.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.404 -0.81 . . . . 17.420000000000002 109.958 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.527 ' SG ' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -175.29 159.42 2.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.003 -1.06 . . . . 13.84 108.604 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.767 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.1 m-30 -113.96 98.04 6.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.997 . . . . 21.140000000000001 108.592 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.898 HG22 ' HB ' ' A' ' 4' ' ' VAL . 14.0 t -107.34 130.23 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 10.66 110.665 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.909 ' O ' HD12 ' A' ' 37' ' ' LEU . 12.5 p-10 -81.01 -30.18 34.99 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.124 -1.065 . . . . 25.890000000000001 108.124 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.909 HD12 ' O ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER 31.09 40.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.159 0.504 . . . . 24.239999999999998 110.993 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.722 ' C ' HD21 ' A' ' 39' ' ' ASN . . . 102.07 20.32 12.87 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.811 -1.185 . . . . 31.02 110.597 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.722 HD21 ' C ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER -135.29 103.3 5.46 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.965 -1.315 . . . . 43.229999999999997 108.223 178.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -29.54 -38.06 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.356 0.598 . . . . 42.340000000000003 111.407 -178.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 39' ' ' ASN . 40.9 m80 -89.03 153.18 49.08 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.312 -0.867 . . . . 6.5899999999999999 109.177 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 34.8 Cg_endo -76.83 148.38 28.36 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.2 1.933 . . . . 17.920000000000002 110.377 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 35' ' ' VAL . 1.8 m -119.43 119.0 59.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.185 -1.006 . . . . 20.57 109.434 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.905 HD11 ' HB3' ' A' ' 32' ' ' LEU . 18.5 tp -70.81 109.53 5.05 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.447 -0.946 . . . . 20.210000000000001 108.447 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.596 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 2.9 t -121.12 168.96 13.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.635 -0.666 . . . . 10.81 109.725 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -89.53 -175.47 4.71 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.419 -0.801 . . . . 36.740000000000002 110.251 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.687 ' CD1' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -168.85 173.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 19.739999999999998 109.144 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.47 ' N ' HG23 ' A' ' 47' ' ' ILE . 24.4 m -109.18 145.28 36.06 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.3 -0.875 . . . . 22.559999999999999 109.148 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 53' ' ' GLN . 1.8 tm? -127.76 100.31 5.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.343 -0.848 . . . . 20.41 109.052 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 53' ' ' GLN . 4.0 m-20 -41.4 129.4 3.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.394 -0.816 . . . . 33.990000000000002 110.04 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.74 100.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.303 -0.873 . . . . 54.920000000000002 109.161 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.37 -37.32 2.79 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.258 -1.537 . . . . 36.100000000000001 109.258 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.651 ' O ' HD11 ' A' ' 49' ' ' LEU . 4.3 mt-30 -64.0 151.88 88.71 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.228 -1.16 . . . . 54.759999999999998 109.048 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.6 Cg_endo -77.07 117.72 4.52 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.533 2.156 . . . . 28.370000000000001 110.439 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.72 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -40.05 148.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.522 -0.736 . . . . 17.210000000000001 109.926 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.825 ' O ' HG21 ' A' ' 6' ' ' ILE . 9.7 m-30 -48.45 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 17.190000000000001 109.6 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.942 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -48.65 174.24 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 17.82 109.307 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.942 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 36.1 Cg_endo -78.55 125.3 6.81 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.652 2.234 . . . . 17.280000000000001 110.368 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.29 -179.24 39.24 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.718 -1.23 . . . . 17.219999999999999 110.045 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -73.15 142.6 47.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.369 -1.077 . . . . 19.57 108.577 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.912 ' CB ' HG13 ' A' ' 4' ' ' VAL . 8.8 m-85 -127.24 163.49 23.78 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.65 -1.281 . . . . 14.609999999999999 111.546 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.662 ' O ' HG22 ' A' ' 84' ' ' VAL . 54.8 p -148.47 117.35 6.72 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.941 -1.503 . . . . 18.359999999999999 106.941 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.817 ' HB ' HD12 ' A' ' 2' ' ' ILE . 15.8 t -47.59 169.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 C-N-CA 119.168 -1.013 . . . . 19.129999999999999 109.106 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.55 ' N ' HG12 ' A' ' 63' ' ' VAL . 7.5 t-80 -133.72 129.72 37.13 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.834 -0.802 . . . . 20.649999999999999 108.834 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.007 ' CD2' HG23 ' B' ' 2' ' ' ILE . 0.7 OUTLIER -64.18 -10.52 23.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.511 -0.743 . . . . 19.649999999999999 109.89 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' LEU . 1.2 t -45.62 -25.93 0.54 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.589 -0.893 . . . . 14.720000000000001 108.589 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 7.2 m -98.19 -12.07 22.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.51 -0.744 . . . . 11.449999999999999 110.485 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 1.005 ' CD2' HD23 ' A' ' 65' ' ' LEU . 2.6 m-30 -80.16 153.86 28.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.845 -1.16 . . . . 14.25 109.762 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 68' ' ' PHE . 71.1 mttt -157.37 171.05 21.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.505 -0.747 . . . . 32.700000000000003 109.233 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -101.4 100.76 11.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.889 . . . . 15.630000000000001 109.124 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.68 -175.98 5.98 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.525 -1.43 . . . . 12.699999999999999 109.525 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.72 27.44 1.77 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.143 -1.21 . . . . 26.289999999999999 109.314 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 5.0 23.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.434 -0.791 . . . . 20.440000000000001 109.627 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.475 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . 67.66 49.47 49.6 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.467 -1.453 . . . . 13.82 109.467 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -170.07 148.88 3.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -1.129 . . . . 18.27 109.707 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.943 HD23 ' N ' ' A' ' 77' ' ' MET . 5.1 tt -61.16 159.1 12.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 12.43 109.278 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.943 ' N ' HD23 ' A' ' 76' ' ' LEU . 1.8 mtt -163.79 111.39 1.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.09 -1.006 . . . . 35.109999999999999 109.993 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.97 HD12 HD12 ' B' ' 78' ' ' ILE . 3.5 mt -52.77 145.87 2.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.354 -0.841 . . . . 13.67 109.647 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.577 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -126.06 53.47 1.61 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.804 -1.554 . . . . 24.059999999999999 106.804 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.58 ' H ' HG22 ' A' ' 78' ' ' ILE . 2.4 tmm_? 89.67 67.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.31 -1.367 . . . . 35.039999999999999 107.31 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -32.78 124.91 0.35 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.373 -0.831 . . . . 18.719999999999999 111.678 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.6 103.88 16.52 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.483 -1.303 . . . . 20.550000000000001 107.483 178.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.687 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -79.79 145.97 32.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.058 -1.026 . . . . 14.4 111.217 -178.021 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 62' ' ' THR . 27.2 m -146.53 158.6 46.47 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.96 -1.126 . . . . 17.649999999999999 107.96 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.16 141.07 74.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.084 1.856 . . . . 25.699999999999999 110.134 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.732 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -69.07 108.3 3.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.139 -0.976 . . . . 49.289999999999999 109.482 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.961 -1.018 . . . . 58.909999999999997 109.413 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' CG ' ' B' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.335 -0.617 . . . . 64.909999999999997 109.335 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 1.007 HG23 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 56.12 88.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.891 -1.131 . . . . 33.799999999999997 107.973 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.535 ' O ' HG13 ' B' ' 35' ' ' VAL . 0.3 OUTLIER -92.9 167.13 12.04 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.298 -0.876 . . . . 32.719999999999999 110.438 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.911 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -172.74 165.34 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.692 0.758 . . . . 14.460000000000001 108.962 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 34.3 mt-10 -141.67 110.52 6.17 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.882 -0.785 . . . . 22.120000000000001 108.882 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.827 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -71.97 101.06 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 C-N-CA 119.126 -1.03 . . . . 14.23 108.396 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.582 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 3.0 mmmt -41.61 163.61 0.11 Allowed Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.49 -0.756 . . . . 25.43 109.493 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.0 Cg_endo -72.72 -13.95 27.06 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.983 1.789 . . . . 13.609999999999999 109.201 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.6 m -96.55 5.19 51.27 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.677 -0.86 . . . . 15.52 108.677 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.535 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 9.1 mm-40 -125.9 34.94 4.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.328 -0.857 . . . . 17.309999999999999 109.412 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.92 8.46 42.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 24.780000000000001 110.026 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -132.19 144.36 50.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.272 -0.893 . . . . 47.899999999999999 109.576 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.702 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 31.0 p90 -91.6 164.78 13.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.284 -0.885 . . . . 21.609999999999999 109.385 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -137.71 152.53 49.34 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.331 -0.856 . . . . 14.890000000000001 109.11 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 17.350000000000001 109.378 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.437 HD22 HG23 ' B' ' 48' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.379 0.609 . . . . 24.0 110.106 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 92.9 m-20 -52.68 118.91 3.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 23.309999999999999 109.348 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 5.1 mt-10 -111.09 165.78 11.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.051 -1.031 . . . . 40.030000000000001 109.193 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.696 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -143.96 162.94 34.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.139 -0.976 . . . . 12.390000000000001 109.798 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.935 ' HB3' HD11 ' B' ' 44' ' ' LEU . 3.6 mm? -102.67 178.07 4.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 17.420000000000002 109.91 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -175.08 159.32 2.59 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.92 -1.112 . . . . 13.84 108.619 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.769 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.1 m-30 -113.81 97.86 6.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.138 -0.976 . . . . 21.140000000000001 108.63 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.878 ' O ' HG22 ' B' ' 43' ' ' VAL . 13.9 t -107.24 130.08 59.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.106 -0.996 . . . . 10.66 110.731 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.929 ' O ' HD12 ' B' ' 37' ' ' LEU . 12.5 p-10 -80.79 -30.45 35.97 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.128 -1.064 . . . . 25.890000000000001 108.128 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.929 HD12 ' O ' ' B' ' 36' ' ' ASP . 0.4 OUTLIER 31.45 40.55 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.171 0.51 . . . . 24.239999999999998 110.953 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.704 ' C ' HD21 ' B' ' 39' ' ' ASN . . . 101.91 20.61 12.44 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.834 -1.174 . . . . 31.02 110.583 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.704 HD21 ' C ' ' B' ' 38' ' ' GLY . 0.6 OUTLIER -135.43 103.31 5.43 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.016 -1.285 . . . . 43.229999999999997 108.211 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -29.57 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.291 0.567 . . . . 42.340000000000003 111.384 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' B' ' 39' ' ' ASN . 40.9 m80 -89.14 153.13 48.82 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.375 -0.828 . . . . 6.5 109.183 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.1 Cg_endo -76.83 148.31 28.3 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.179 1.92 . . . . 17.920000000000002 110.38 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.878 HG22 ' O ' ' B' ' 35' ' ' VAL . 1.7 m -119.34 119.3 60.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.258 -0.977 . . . . 20.57 109.369 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.935 HD11 ' HB3' ' B' ' 32' ' ' LEU . 18.6 tp -71.13 109.78 5.4 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.55 -0.907 . . . . 20.210000000000001 108.55 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.612 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 3.0 t -121.38 168.84 13.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.613 -0.68 . . . . 10.81 109.776 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.584 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -89.24 -175.4 4.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.493 -0.754 . . . . 36.740000000000002 110.314 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.677 ' CD1' HD12 ' B' ' 83' ' ' LEU . 0.0 OUTLIER -168.98 173.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.3 -0.875 . . . . 19.739999999999998 109.135 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.477 ' N ' HG23 ' B' ' 47' ' ' ILE . 24.6 m -109.28 145.22 36.29 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.3 -0.875 . . . . 22.559999999999999 109.108 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.67 HD11 ' O ' ' B' ' 53' ' ' GLN . 1.8 tm? -127.73 100.35 5.92 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.871 . . . . 20.41 109.059 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' B' ' 53' ' ' GLN . 3.9 m-20 -41.44 129.42 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 33.990000000000002 110.024 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.74 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.293 -0.879 . . . . 54.920000000000002 109.152 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.25 -37.15 2.84 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.225 -1.55 . . . . 36.100000000000001 109.225 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.67 ' O ' HD11 ' B' ' 49' ' ' LEU . 4.2 mt-30 -64.2 151.91 89.43 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.223 -1.163 . . . . 54.759999999999998 109.036 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.9 Cg_endo -77.22 117.63 4.45 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.546 2.164 . . . . 28.370000000000001 110.457 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.702 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -39.72 148.0 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.523 -0.736 . . . . 17.210000000000001 110.09 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.827 ' O ' HG21 ' B' ' 6' ' ' ILE . 9.5 m-30 -47.99 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.293 -0.88 . . . . 17.190000000000001 109.595 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.919 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -47.63 174.19 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 17.82 109.486 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.919 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.8 Cg_endo -78.24 124.42 6.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.577 2.185 . . . . 17.280000000000001 110.094 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.89 -179.63 40.0 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.536 -1.316 . . . . 17.219999999999999 110.148 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -73.54 142.25 46.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -1.076 . . . . 19.57 108.33 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.911 ' CB ' HG13 ' B' ' 4' ' ' VAL . 9.2 m-85 -127.02 163.62 23.33 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.654 -1.279 . . . . 14.609999999999999 111.519 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.661 ' O ' HG22 ' B' ' 84' ' ' VAL . 55.9 p -148.4 117.42 6.77 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.002 -1.481 . . . . 18.359999999999999 107.002 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.803 ' HB ' HD12 ' B' ' 2' ' ' ILE . 16.0 t -47.62 169.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 C-N-CA 119.176 -1.01 . . . . 19.129999999999999 109.052 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.55 ' N ' HG12 ' B' ' 63' ' ' VAL . 7.6 t-80 -133.89 129.91 37.06 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.819 -0.808 . . . . 20.649999999999999 108.819 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.997 HD23 ' CD2' ' B' ' 68' ' ' PHE . 0.7 OUTLIER -64.27 -10.53 24.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.696 . . . . 19.649999999999999 109.927 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.435 ' C ' ' O ' ' B' ' 65' ' ' LEU . 1.2 t -45.56 -25.83 0.51 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.56 -0.904 . . . . 14.720000000000001 108.56 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 7.1 m -98.28 -12.37 21.64 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.727 . . . . 11.449999999999999 110.486 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.997 ' CD2' HD23 ' B' ' 65' ' ' LEU . 2.5 m-30 -80.01 153.8 28.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 14.25 109.685 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' B' ' 68' ' ' PHE . 71.1 mttt -157.43 170.73 21.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.541 -0.724 . . . . 32.700000000000003 109.199 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.596 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -101.05 100.79 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 15.630000000000001 109.034 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.77 -175.91 6.05 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.426 -1.47 . . . . 12.699999999999999 109.426 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.61 27.26 1.78 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.202 -1.175 . . . . 26.289999999999999 109.358 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.88 5.06 24.12 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.512 -0.742 . . . . 20.440000000000001 109.611 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.466 ' C ' HG13 ' A' ' 45' ' ' VAL . . . 67.36 50.0 47.7 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.41 -1.476 . . . . 13.82 109.41 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.463 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -170.37 148.94 3.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -1.135 . . . . 18.27 109.608 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.942 HD23 ' N ' ' B' ' 77' ' ' MET . 5.2 tt -61.31 159.29 12.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.927 . . . . 12.43 109.256 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.942 ' N ' HD23 ' B' ' 76' ' ' LEU . 1.8 mtt -163.97 111.36 1.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.079 -1.013 . . . . 35.109999999999999 110.026 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.97 HD12 HD12 ' A' ' 78' ' ' ILE . 3.4 mt -52.77 145.7 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 13.67 109.726 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -125.84 53.52 1.58 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.789 -1.56 . . . . 24.059999999999999 106.789 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.582 ' H ' HG22 ' B' ' 78' ' ' ILE . 2.4 tmm_? 89.63 67.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.334 -1.358 . . . . 35.039999999999999 107.334 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.668 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -32.92 124.93 0.36 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.363 -0.835 . . . . 18.719999999999999 111.661 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.54 103.86 16.5 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.451 -1.314 . . . . 20.550000000000001 107.451 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.677 HD12 ' CD1' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -79.9 145.87 32.45 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.135 -0.978 . . . . 14.4 111.25 -178.048 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.661 HG22 ' O ' ' B' ' 62' ' ' THR . 27.3 m -146.32 158.97 46.67 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 107.967 -1.123 . . . . 17.649999999999999 107.967 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -64.42 141.24 73.5 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.049 1.833 . . . . 25.699999999999999 110.152 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -69.17 108.05 3.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.223 -0.923 . . . . 49.289999999999999 109.462 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.965 -1.017 . . . . 58.909999999999997 109.489 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.434 -0.58 . . . . 64.909999999999997 109.434 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.851 ' H ' HD22 ' B' ' 65' ' ' LEU . 1.6 mt 50.32 78.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.866 -1.161 . . . . 33.799999999999997 107.866 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.26 155.93 40.13 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.712 0.767 . . . . 32.719999999999999 110.57 -178.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.814 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -165.05 165.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.553 0.692 . . . . 14.460000000000001 109.262 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.53 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 22.3 mt-10 -138.64 116.89 11.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 22.120000000000001 109.258 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.747 HG21 ' O ' ' A' ' 56' ' ' TYR . 19.4 mm -77.43 97.44 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.259 -0.901 . . . . 14.23 108.743 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.596 ' HD3' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.14 161.15 0.31 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.089 -1.007 . . . . 25.43 110.121 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.93 -29.76 5.06 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.626 2.217 . . . . 13.609999999999999 110.214 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.41 -0.85 43.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.492 -0.755 . . . . 15.52 109.131 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 9.3 pt20 -129.97 28.88 5.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 17.309999999999999 109.644 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -85.03 16.31 3.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 24.780000000000001 110.106 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -138.72 144.33 39.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.082 -1.011 . . . . 47.899999999999999 108.828 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.741 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 12.8 p90 -87.01 178.42 6.94 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.168 -0.958 . . . . 21.609999999999999 109.743 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 8.7 t -132.22 163.01 29.53 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.58 -0.896 . . . . 14.890000000000001 108.58 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.534 0 O-C-N 121.138 -0.977 . . . . 17.350000000000001 109.617 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.893 HD11 ' HG3' ' A' ' 30' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.497 0.665 . . . . 24.0 110.292 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.786 ' N ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -93.78 131.72 38.87 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.717 -0.845 . . . . 23.309999999999999 108.717 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.893 ' HG3' HD11 ' A' ' 28' ' ' LEU . 1.8 mp0 -109.88 159.28 17.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.861 -1.149 . . . . 40.030000000000001 109.448 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.905 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -135.68 -165.33 1.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.083 -1.01 . . . . 12.390000000000001 110.04 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.896 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -134.64 178.56 6.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.721 . . . . 17.420000000000002 109.392 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' NE2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -172.93 153.74 2.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.955 -1.09 . . . . 13.84 108.893 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.753 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.1 m-30 -112.06 96.77 6.23 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.506 -0.924 . . . . 21.140000000000001 108.506 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.994 ' O ' HG22 ' A' ' 43' ' ' VAL . 85.7 t -97.12 114.92 35.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.036 -1.04 . . . . 10.66 110.118 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.6 p-10 -59.36 -32.13 69.84 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.301 -1.0 . . . . 25.890000000000001 108.301 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.7 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.7 OUTLIER 47.02 28.64 0.92 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.563 -0.711 . . . . 24.239999999999998 109.174 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.39 18.14 71.23 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.371 -1.492 . . . . 31.02 109.371 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.554 ' ND2' HD23 ' A' ' 37' ' ' LEU . 11.4 m120 -91.01 26.67 2.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -1.122 . . . . 43.229999999999997 110.367 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.527 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 1.7 mm-40 48.35 22.24 0.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.138 -0.976 . . . . 42.340000000000003 110.148 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.549 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 3.6 m80 -175.88 153.26 1.35 Allowed Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.074 -1.084 . . . . 5.3799999999999999 108.074 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.645 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.6 Cg_endo -75.73 144.09 27.56 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.923 1.749 . . . . 17.920000000000002 110.938 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.994 HG22 ' O ' ' A' ' 35' ' ' VAL . 14.4 m -119.47 118.37 57.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.735 -0.839 . . . . 20.57 108.735 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.896 HD11 ' HB3' ' A' ' 32' ' ' LEU . 18.6 tp -68.41 111.79 4.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.781 -0.768 . . . . 20.210000000000001 109.339 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 4.0 t -117.2 168.46 8.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.692 -0.63 . . . . 10.81 109.352 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 1.9 mtpt -86.63 174.92 8.57 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.238 -0.914 . . . . 36.740000000000002 110.347 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -155.4 165.25 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -0.856 . . . . 19.739999999999998 109.028 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.475 HG23 HD13 ' A' ' 28' ' ' LEU . 30.8 m -110.79 149.54 30.4 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.319 -0.863 . . . . 22.559999999999999 108.98 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -133.25 127.96 34.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 20.41 109.341 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.09 148.64 41.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 33.990000000000002 109.535 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.62 93.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 54.920000000000002 109.544 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.6 -29.39 3.81 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.722 -1.351 . . . . 36.100000000000001 109.722 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.456 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -72.9 144.87 85.91 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.177 -1.19 . . . . 54.759999999999998 109.597 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -78.2 117.48 4.12 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.696 2.264 . . . . 28.370000000000001 110.585 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.905 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.78 155.51 0.05 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.249 -0.907 . . . . 17.210000000000001 110.196 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.747 ' O ' HG21 ' A' ' 6' ' ' ILE . 15.0 m-30 -49.03 112.53 0.63 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.574 -0.704 . . . . 17.190000000000001 109.758 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.005 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -66.13 177.35 0.78 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 17.82 109.313 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 1.005 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -78.21 113.4 3.38 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.586 2.191 . . . . 17.280000000000001 110.28 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.06 177.27 43.11 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.912 -1.275 . . . . 17.219999999999999 109.912 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 4.9 mp -74.96 152.79 38.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -1.107 . . . . 19.57 108.221 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.724 ' HB3' HD22 ' A' ' 83' ' ' LEU . 17.7 m-85 -140.17 165.18 28.08 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.802 -1.186 . . . . 14.609999999999999 111.78 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.734 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.8 p -145.64 120.55 9.98 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.356 -1.72 . . . . 18.359999999999999 106.356 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.712 ' HB ' HD13 ' A' ' 2' ' ' ILE . 4.7 t -50.38 170.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 C-N-CA 118.739 -1.185 . . . . 19.129999999999999 108.791 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.589 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -130.43 122.98 28.77 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.38 -0.825 . . . . 20.649999999999999 108.942 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.852 HD22 ' H ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -66.65 -6.24 14.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.673 -0.642 . . . . 19.649999999999999 109.747 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.1 t -54.78 -15.87 2.2 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.058 -1.026 . . . . 14.720000000000001 108.565 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 35.1 m -98.79 -5.75 30.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.495 -0.753 . . . . 11.449999999999999 110.891 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.67 ' C ' HD11 ' B' ' 37' ' ' LEU . 2.8 m-30 -81.16 155.7 26.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.763 -1.211 . . . . 14.25 109.988 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.666 ' HA ' HD21 ' B' ' 37' ' ' LEU . 9.9 mtmt -143.78 171.48 14.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.501 -0.749 . . . . 32.700000000000003 109.349 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.708 HG21 HG21 ' B' ' 43' ' ' VAL . 0.5 OUTLIER -117.77 131.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 15.630000000000001 109.603 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.67 175.86 53.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.457 -1.457 . . . . 12.699999999999999 109.457 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.2 9.6 12.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.115 -1.226 . . . . 26.289999999999999 109.893 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 73' ' ' PHE . 30.1 t80 -109.62 9.65 25.07 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.57 -0.707 . . . . 20.440000000000001 109.391 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' B' ' 46' ' ' LYS . . . 70.75 71.66 0.99 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.51 -1.436 . . . . 13.82 109.51 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -165.86 112.6 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -1.153 . . . . 18.27 109.683 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.813 ' CD1' HG11 ' B' ' 35' ' ' VAL . 0.3 OUTLIER -68.51 151.36 46.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 12.43 109.169 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.518 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 7.1 mtp -163.04 139.78 7.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 35.109999999999999 109.842 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.884 HD12 HD12 ' B' ' 78' ' ' ILE . 3.4 mt -67.77 140.78 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 13.67 109.805 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.472 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 1.6 t70 -110.1 -19.24 13.12 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.389 -0.967 . . . . 24.059999999999999 108.389 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.5 OUTLIER 173.01 68.11 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.878 -1.527 . . . . 35.039999999999999 106.878 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -32.06 119.62 0.27 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.512 -0.767 . . . . 18.719999999999999 111.399 -177.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -89.66 110.05 20.97 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.844 -1.169 . . . . 20.550000000000001 107.844 178.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.724 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -82.12 143.86 31.17 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.036 -1.04 . . . . 14.4 111.101 -178.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 62' ' ' THR . 4.5 m -143.99 159.56 52.68 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.97 -1.122 . . . . 17.649999999999999 107.97 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.6 Cg_endo -63.41 147.58 93.3 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.177 1.918 . . . . 25.699999999999999 110.335 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.573 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -74.62 118.75 17.93 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.105 -0.997 . . . . 49.289999999999999 109.541 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.056 -0.973 . . . . 58.909999999999997 109.468 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.528 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.37 -0.604 . . . . 64.909999999999997 109.37 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.852 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.5 mt 50.33 78.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.806 -1.183 . . . . 33.799999999999997 107.806 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.2 156.18 39.86 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.721 0.772 . . . . 32.719999999999999 110.553 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.825 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -165.25 165.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.583 0.706 . . . . 14.460000000000001 109.283 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.526 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 22.4 mt-10 -138.57 116.92 11.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.497 -0.752 . . . . 22.120000000000001 109.333 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.754 HG21 ' O ' ' B' ' 56' ' ' TYR . 19.7 mm -77.55 97.26 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.265 -0.897 . . . . 14.23 108.754 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.585 ' HE2' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.98 161.17 0.3 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.114 -0.991 . . . . 25.43 110.145 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.02 -29.77 4.93 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.665 2.244 . . . . 13.609999999999999 110.169 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.31 -1.05 43.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.436 -0.79 . . . . 15.52 109.058 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.522 ' NE2' ' HA ' ' B' ' 33' ' ' CYS . 9.3 pt20 -129.9 29.0 5.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.861 . . . . 17.309999999999999 109.683 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -85.1 16.36 3.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 24.780000000000001 110.051 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.589 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -138.67 144.49 39.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.085 -1.009 . . . . 47.899999999999999 108.806 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.724 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 12.7 p90 -87.16 178.32 6.92 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.159 -0.963 . . . . 21.609999999999999 109.739 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 9.0 t -132.16 163.08 29.31 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.618 -0.882 . . . . 14.890000000000001 108.618 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.568 0 O-C-N 121.15 -0.969 . . . . 17.350000000000001 109.584 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.864 HD11 ' HG3' ' B' ' 30' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.522 0.677 . . . . 24.0 110.311 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.781 ' N ' HD12 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -93.65 131.76 38.65 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.677 -0.86 . . . . 23.309999999999999 108.677 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.864 ' HG3' HD11 ' B' ' 28' ' ' LEU . 1.8 mp0 -110.02 159.45 17.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.958 -1.089 . . . . 40.030000000000001 109.416 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.925 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -135.81 -165.37 1.69 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.118 -0.989 . . . . 12.390000000000001 109.988 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -134.68 178.46 6.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.533 -0.729 . . . . 17.420000000000002 109.395 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.522 ' HA ' ' NE2' ' B' ' 10' ' ' GLN . 0.1 OUTLIER -172.83 153.73 2.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.002 -1.061 . . . . 13.84 108.933 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.763 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.1 m-30 -112.03 96.68 6.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.462 -0.94 . . . . 21.140000000000001 108.462 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 1.01 ' O ' HG22 ' B' ' 43' ' ' VAL . 85.3 t -96.98 115.08 35.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.066 -1.021 . . . . 10.66 110.155 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.6 p-10 -59.58 -31.86 69.84 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.311 -0.996 . . . . 25.890000000000001 108.311 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.67 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER 46.76 28.61 0.84 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.473 -0.767 . . . . 24.239999999999998 109.17 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.54 18.08 71.46 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.33 -1.508 . . . . 31.02 109.33 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.564 ' ND2' HD23 ' B' ' 37' ' ' LEU . 11.4 m120 -90.88 26.34 2.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.324 -1.103 . . . . 43.229999999999997 110.479 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.527 ' O ' ' ND1' ' B' ' 41' ' ' HIS . 1.7 mm-40 48.6 22.02 0.46 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.07 -1.019 . . . . 42.340000000000003 110.116 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.532 ' O ' ' HA ' ' B' ' 36' ' ' ASP . 3.6 m80 -175.68 153.18 1.4 Allowed Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 108.085 -1.08 . . . . 5.2999999999999998 108.085 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.643 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.5 Cg_endo -75.73 144.08 27.55 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.961 1.774 . . . . 17.920000000000002 110.884 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 1.01 HG22 ' O ' ' B' ' 35' ' ' VAL . 14.0 m -119.46 118.51 57.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.601 -0.84 . . . . 20.57 108.765 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' B' ' 32' ' ' LEU . 18.9 tp -68.56 111.67 4.88 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.848 -0.741 . . . . 20.210000000000001 109.348 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 4.3 t -117.13 168.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.643 -0.661 . . . . 10.81 109.304 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 1.9 mtpt -86.67 174.98 8.51 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.353 -0.842 . . . . 36.740000000000002 110.338 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.593 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -155.42 165.24 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.798 . . . . 19.739999999999998 109.042 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.479 HG23 HD13 ' B' ' 28' ' ' LEU . 31.2 m -110.77 149.49 30.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.371 -0.831 . . . . 22.559999999999999 108.992 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' B' ' 29' ' ' ASN . 0.3 OUTLIER -133.25 127.83 34.55 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.391 -0.818 . . . . 20.41 109.363 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.94 148.52 42.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 33.990000000000002 109.512 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.44 93.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 54.920000000000002 109.55 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.32 -29.13 3.92 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.687 -1.365 . . . . 36.100000000000001 109.687 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.454 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -73.1 144.91 85.44 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.112 -1.228 . . . . 54.759999999999998 109.515 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.4 Cg_endo -78.4 117.32 4.03 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.708 2.272 . . . . 28.370000000000001 110.591 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.925 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.52 155.7 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.18 -0.95 . . . . 17.210000000000001 110.199 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.754 ' O ' HG21 ' B' ' 6' ' ' ILE . 15.2 m-30 -49.34 112.51 0.65 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.485 -0.759 . . . . 17.190000000000001 109.876 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -65.85 177.2 0.76 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.322 -0.861 . . . . 17.82 109.258 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 36.0 Cg_endo -78.17 114.51 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.577 2.185 . . . . 17.280000000000001 110.444 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.64 177.92 42.36 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.834 -1.306 . . . . 17.219999999999999 109.834 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.0 mp -75.11 152.94 38.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -1.097 . . . . 19.57 108.396 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.726 ' HB3' HD22 ' B' ' 83' ' ' LEU . 17.6 m-85 -140.36 165.0 28.6 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.85 -1.156 . . . . 14.609999999999999 111.77 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.736 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.7 p -145.54 120.35 9.92 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.413 -1.699 . . . . 18.359999999999999 106.413 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.728 ' HB ' HD13 ' B' ' 2' ' ' ILE . 4.8 t -50.14 170.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 C-N-CA 118.836 -1.145 . . . . 19.129999999999999 108.769 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.586 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -130.53 123.13 28.91 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.391 -0.818 . . . . 20.649999999999999 108.992 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.851 HD22 ' H ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -66.61 -6.66 16.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.733 -0.605 . . . . 19.649999999999999 109.759 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 28.2 t -54.35 -16.11 2.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.984 -1.073 . . . . 14.720000000000001 108.575 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 33.0 m -98.66 -6.27 30.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.485 -0.759 . . . . 11.449999999999999 110.917 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.7 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.7 m-30 -80.69 155.47 26.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.751 -1.218 . . . . 14.25 109.844 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.656 ' HA ' HD21 ' A' ' 37' ' ' LEU . 10.0 mtmt -143.46 171.83 13.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.517 -0.739 . . . . 32.700000000000003 109.309 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.753 HG21 HG21 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -118.04 131.84 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 15.630000000000001 109.586 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.83 176.09 53.29 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.46 -1.456 . . . . 12.699999999999999 109.46 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.4 9.45 13.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.114 -1.227 . . . . 26.289999999999999 109.864 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' B' ' 73' ' ' PHE . 30.1 t80 -109.45 9.65 25.44 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.564 -0.71 . . . . 20.440000000000001 109.428 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . 70.76 71.85 0.97 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.506 -1.438 . . . . 13.82 109.506 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -165.97 112.64 0.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -1.143 . . . . 18.27 109.715 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.822 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -68.58 151.33 46.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 12.43 109.193 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 7.1 mtp -163.1 139.84 7.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 35.109999999999999 109.796 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.884 HD12 HD12 ' A' ' 78' ' ' ILE . 3.4 mt -67.94 140.97 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.349 -0.844 . . . . 13.67 109.895 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.468 ' HB2' ' HG3' ' B' ' 69' ' ' LYS . 1.6 t70 -110.18 -19.26 13.09 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.376 -0.972 . . . . 24.059999999999999 108.376 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.6 OUTLIER 173.08 68.11 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.919 -1.511 . . . . 35.039999999999999 106.919 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.659 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -32.02 119.59 0.27 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.521 -0.763 . . . . 18.719999999999999 111.447 -177.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -89.66 109.97 20.89 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.91 -1.145 . . . . 20.550000000000001 107.91 178.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.726 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -82.1 143.74 31.27 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.042 -1.036 . . . . 14.4 111.095 -178.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.736 HG22 ' O ' ' B' ' 62' ' ' THR . 4.5 m -143.86 159.66 52.74 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.949 -1.13 . . . . 17.649999999999999 107.949 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -63.55 147.84 92.78 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.115 1.877 . . . . 25.699999999999999 110.394 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.576 ' HA ' HG23 ' B' ' 62' ' ' THR . . . -74.7 118.68 17.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.13 -0.981 . . . . 49.289999999999999 109.627 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.977 -1.011 . . . . 58.909999999999997 109.482 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.5 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.531 -0.544 . . . . 64.909999999999997 109.531 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.831 ' HA ' HD21 ' B' ' 65' ' ' LEU . 2.8 mt -59.04 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.879 -1.156 . . . . 33.799999999999997 107.879 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -63.39 158.65 20.04 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.81 0.814 . . . . 32.719999999999999 111.377 -177.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.055 HG22 HG22 ' A' ' 35' ' ' VAL . 60.6 t -159.99 167.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.579 0.704 . . . . 14.460000000000001 109.583 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.607 ' N ' HG12 ' A' ' 4' ' ' VAL . 22.7 mt-10 -151.7 103.84 2.98 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.946 -0.761 . . . . 22.120000000000001 108.946 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.744 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -70.67 105.69 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.092 -1.077 . . . . 14.23 108.092 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.655 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.22 173.48 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.419 -0.801 . . . . 25.43 109.988 -178.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.1 Cg_endo -76.26 -22.12 12.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.512 2.142 . . . . 13.609999999999999 109.727 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -101.04 8.05 43.12 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.153 -0.684 . . . . 15.52 109.153 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.531 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 17.6 mm-40 -125.25 36.04 4.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.243 -0.911 . . . . 17.309999999999999 109.401 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.13 16.54 24.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 24.780000000000001 110.151 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 4.6 tt0 -137.5 130.23 30.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.099 -1.0 . . . . 47.899999999999999 108.705 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.597 ' H ' ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -76.85 -170.69 1.69 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.088 -1.007 . . . . 21.609999999999999 110.689 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -143.25 126.98 17.08 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.656 -0.653 . . . . 14.890000000000001 109.249 179.066 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.469 0 O-C-N 121.357 -0.84 . . . . 17.350000000000001 109.331 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.706 HD22 HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.389 0.614 . . . . 24.0 110.145 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.586 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -99.95 117.93 35.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -0.754 . . . . 23.309999999999999 109.067 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -86.56 -173.58 4.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.054 -1.029 . . . . 40.030000000000001 109.14 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.579 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -173.48 -170.96 0.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 12.390000000000001 109.962 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' A' ' 44' ' ' LEU . 4.1 mp -145.52 169.9 17.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.473 -0.767 . . . . 17.420000000000002 109.238 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -167.99 166.95 13.01 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.223 -1.028 . . . . 13.84 108.223 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.678 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 31.9 m-85 -118.78 103.19 9.42 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.089 -1.007 . . . . 21.140000000000001 109.498 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.055 HG22 HG22 ' A' ' 4' ' ' VAL . 54.3 t -85.6 144.87 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.109 -0.994 . . . . 10.66 110.29 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.4 m-20 -128.48 -140.49 0.25 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.715 -0.846 . . . . 25.890000000000001 108.715 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.959 ' HG ' HD13 ' B' ' 65' ' ' LEU . 0.1 OUTLIER 68.39 -63.13 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.927 -1.108 . . . . 24.239999999999998 109.222 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -85.98 16.26 43.55 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.593 -1.803 . . . . 31.02 108.593 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -177.83 111.92 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.468 -1.019 . . . . 43.229999999999997 109.083 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' ASN . 1.3 mm-40 -40.78 -66.96 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.476 -0.765 . . . . 42.340000000000003 109.763 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -60.06 153.63 54.94 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 108.574 -0.899 . . . . 5.5800000000000001 108.574 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.678 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.4 Cg_endo -77.34 142.83 21.58 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.146 1.897 . . . . 17.920000000000002 110.22 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.878 HG21 HG21 ' B' ' 70' ' ' VAL . 27.5 m -113.75 113.83 45.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.32 -0.863 . . . . 20.57 109.302 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' A' ' 32' ' ' LEU . 41.0 tp -69.78 112.09 5.99 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.374 -0.829 . . . . 20.210000000000001 110.221 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.603 HG12 ' CG1' ' B' ' 70' ' ' VAL . 4.9 m -112.94 -172.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.9 -0.778 . . . . 10.81 108.9 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -111.93 154.87 24.59 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.467 -0.893 . . . . 36.740000000000002 110.329 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.583 HG13 ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -129.15 162.38 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 108.924 -0.769 . . . . 19.739999999999998 108.924 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.706 HG22 HD22 ' A' ' 28' ' ' LEU . 4.5 m -119.17 73.64 0.95 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.349 -0.844 . . . . 22.559999999999999 109.235 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -40.62 133.52 1.97 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.759 . . . . 20.41 109.663 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -55.26 -166.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 33.990000000000002 109.623 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.22 -83.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 54.920000000000002 109.725 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.24 40.85 2.28 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.623 -1.391 . . . . 36.100000000000001 109.623 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.536 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -89.93 152.63 46.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.194 -1.18 . . . . 54.759999999999998 109.635 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.14 119.25 4.58 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.813 2.342 . . . . 28.370000000000001 110.742 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.61 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -41.16 146.53 0.18 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.369 -0.832 . . . . 17.210000000000001 110.339 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.744 ' O ' HG21 ' A' ' 6' ' ' ILE . 14.7 m-30 -52.13 99.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -0.825 . . . . 17.190000000000001 109.169 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.818 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -45.61 170.75 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 17.82 109.502 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.818 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.6 108.32 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.576 2.184 . . . . 17.280000000000001 110.143 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.21 -178.12 48.63 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.958 -1.257 . . . . 17.219999999999999 109.958 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 6.4 mp -73.91 149.6 41.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -1.057 . . . . 19.57 108.641 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.745 ' HB3' HD22 ' A' ' 83' ' ' LEU . 12.1 m-85 -134.98 163.74 29.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.921 -1.112 . . . . 14.609999999999999 111.373 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.771 ' O ' HG22 ' A' ' 84' ' ' VAL . 29.2 p -145.65 119.37 9.2 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.721 -1.585 . . . . 18.359999999999999 106.721 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.578 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 18.5 t -47.81 170.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 C-N-CA 119.337 -0.945 . . . . 19.129999999999999 109.142 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.2 t-80 -133.82 126.04 29.71 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.823 -0.806 . . . . 20.649999999999999 108.823 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.939 HD13 ' HG ' ' B' ' 37' ' ' LEU . 4.6 mp -62.67 -8.0 5.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.644 -0.66 . . . . 19.649999999999999 110.432 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.407 ' OG ' ' HD3' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -47.29 -24.07 0.68 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.901 -1.124 . . . . 14.720000000000001 107.986 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 3.4 m -98.32 -13.04 20.91 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.68 -0.638 . . . . 11.449999999999999 110.673 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.673 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.6 m-30 -81.33 156.59 25.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.732 -1.23 . . . . 14.25 110.131 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -155.19 166.76 32.57 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.942 -0.762 . . . . 32.700000000000003 108.942 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.899 HG21 HG21 ' B' ' 43' ' ' VAL . 3.0 t -104.05 125.28 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -0.949 . . . . 15.630000000000001 109.227 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.6 173.62 55.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.728 -1.349 . . . . 12.699999999999999 109.728 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.0 OUTLIER -75.77 -1.14 23.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.206 -1.173 . . . . 26.289999999999999 109.83 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.07 -17.0 26.93 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.406 -0.809 . . . . 20.440000000000001 109.521 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.13 52.27 2.42 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.624 -1.391 . . . . 13.82 109.624 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.4 m -156.38 115.18 3.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -1.159 . . . . 18.27 109.507 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.754 HD12 HG11 ' B' ' 35' ' ' VAL . 7.1 tt -50.44 153.2 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 12.43 109.49 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.495 ' N ' HD23 ' A' ' 76' ' ' LEU . 25.3 mtt -161.1 123.84 3.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 35.109999999999999 109.718 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.934 HD12 HD12 ' B' ' 78' ' ' ILE . 3.1 mt -61.55 140.64 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.367 -0.833 . . . . 13.67 109.92 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 26.7 t70 -111.35 -16.95 13.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.338 -0.851 . . . . 24.059999999999999 108.972 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.505 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 169.09 63.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.577 -1.638 . . . . 35.039999999999999 106.577 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -27.2 119.59 0.09 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.665 -1.152 . . . . 18.719999999999999 112.583 -177.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.26 103.33 16.02 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.397 -1.334 . . . . 20.550000000000001 107.397 177.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.887 HD11 HG11 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -77.1 145.39 37.85 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.974 -1.079 . . . . 14.4 111.487 -177.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 62' ' ' THR . 17.8 m -144.75 160.5 47.02 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 107.835 -1.172 . . . . 17.649999999999999 107.835 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.3 Cg_endo -63.93 145.96 90.8 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.065 1.843 . . . . 25.699999999999999 110.42 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.581 ' CA ' HG23 ' A' ' 62' ' ' THR . . . -81.65 125.37 30.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.1 -1.0 . . . . 49.289999999999999 109.477 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.023 -0.989 . . . . 58.909999999999997 109.443 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.5 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.456 -0.572 . . . . 64.909999999999997 109.456 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.831 ' HA ' HD21 ' A' ' 65' ' ' LEU . 2.8 mt -59.0 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.856 -1.164 . . . . 33.799999999999997 107.856 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -63.39 158.66 20.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.803 0.811 . . . . 32.719999999999999 111.411 -177.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.12 HG22 HG22 ' B' ' 35' ' ' VAL . 61.0 t -159.99 167.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.565 0.697 . . . . 14.460000000000001 109.617 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.6 ' N ' HG12 ' B' ' 4' ' ' VAL . 22.6 mt-10 -151.8 104.02 2.98 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.924 -0.769 . . . . 22.120000000000001 108.924 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.738 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -70.82 105.63 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.069 -1.086 . . . . 14.23 108.069 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.664 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.19 173.43 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.43 -0.794 . . . . 25.43 109.974 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.0 Cg_endo -76.18 -22.26 12.98 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.484 2.122 . . . . 13.609999999999999 109.777 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -100.97 8.24 43.15 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.575 -0.703 . . . . 15.52 109.136 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 17.5 mm-40 -125.3 35.82 4.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 17.309999999999999 109.38 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.89 16.3 24.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.112 -0.992 . . . . 24.780000000000001 110.12 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 4.4 tt0 -137.25 130.39 30.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.143 -0.973 . . . . 47.899999999999999 108.7 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.599 ' H ' ' HB2' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -77.04 -170.7 1.75 Allowed 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.091 -1.005 . . . . 21.609999999999999 110.711 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -143.32 126.74 16.76 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.613 -0.679 . . . . 14.890000000000001 109.339 179.083 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.487 0 O-C-N 121.399 -0.813 . . . . 17.350000000000001 109.382 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.712 HD22 HG22 ' B' ' 48' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.425 0.631 . . . . 24.0 110.105 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.596 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -100.04 118.0 35.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -0.792 . . . . 23.309999999999999 109.02 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -86.61 -173.59 4.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 40.030000000000001 109.096 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.573 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -173.5 -171.04 0.65 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.153 -0.967 . . . . 12.390000000000001 109.948 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.922 ' HB3' HD11 ' B' ' 44' ' ' LEU . 4.1 mp -145.41 169.83 17.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.424 -0.798 . . . . 17.420000000000002 109.231 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -167.95 166.82 13.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.305 -0.998 . . . . 13.84 108.305 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.686 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 31.6 m-85 -118.7 103.18 9.43 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.091 -1.006 . . . . 21.140000000000001 109.478 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 1.12 HG22 HG22 ' B' ' 4' ' ' VAL . 54.6 t -85.55 144.93 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.077 -1.014 . . . . 10.66 110.228 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.5 m-20 -128.71 -140.57 0.24 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.722 -0.844 . . . . 25.890000000000001 108.722 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.939 ' HG ' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER 68.48 -63.29 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.941 -1.1 . . . . 24.239999999999998 109.263 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -85.89 16.4 42.27 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.58 -1.808 . . . . 31.02 108.58 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' B' ' 40' ' ' GLU . 0.4 OUTLIER -177.96 111.88 0.07 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.545 -0.973 . . . . 43.229999999999997 109.066 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 39' ' ' ASN . 1.3 mm-40 -40.71 -67.07 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.514 -0.741 . . . . 42.340000000000003 109.777 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -59.94 153.55 54.05 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 108.615 -0.883 . . . . 5.5599999999999996 108.615 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.686 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.4 Cg_endo -77.35 142.78 21.51 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.121 1.88 . . . . 17.920000000000002 110.323 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.899 HG21 HG21 ' A' ' 70' ' ' VAL . 27.4 m -113.7 113.68 44.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.25 -0.906 . . . . 20.57 109.412 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.922 HD11 ' HB3' ' B' ' 32' ' ' LEU . 40.1 tp -69.65 111.8 5.7 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.407 -0.808 . . . . 20.210000000000001 110.161 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.588 HG12 ' CG1' ' A' ' 70' ' ' VAL . 5.1 m -112.66 -172.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.882 -0.784 . . . . 10.81 108.882 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -111.89 155.08 24.23 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.444 -0.902 . . . . 36.740000000000002 110.311 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.591 HG13 ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -129.36 162.31 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.894 -0.78 . . . . 19.739999999999998 108.894 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.712 HG22 HD22 ' B' ' 28' ' ' LEU . 4.4 m -119.24 73.72 0.95 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.295 -0.878 . . . . 22.559999999999999 109.239 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -40.63 133.41 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.521 -0.737 . . . . 20.41 109.671 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.505 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -55.19 -166.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 33.990000000000002 109.688 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -83.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 54.920000000000002 109.745 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.22 40.62 2.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.64 -1.384 . . . . 36.100000000000001 109.64 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.539 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.1 OUTLIER -89.67 152.6 47.18 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.269 -1.136 . . . . 54.759999999999998 109.649 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.16 119.22 4.56 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.792 2.328 . . . . 28.370000000000001 110.734 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -41.11 146.1 0.19 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.356 -0.84 . . . . 17.210000000000001 110.333 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.738 ' O ' HG21 ' B' ' 6' ' ' ILE . 14.8 m-30 -51.9 100.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 17.190000000000001 109.163 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.834 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -45.9 170.83 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 17.82 109.508 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.834 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -77.69 108.45 2.56 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.562 2.174 . . . . 17.280000000000001 110.186 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.88 -178.33 48.74 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.933 -1.267 . . . . 17.219999999999999 109.933 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 6.4 mp -73.54 150.01 41.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -1.101 . . . . 19.57 108.667 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.743 ' HB3' HD22 ' B' ' 83' ' ' LEU . 12.0 m-85 -135.31 163.8 29.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.926 -1.109 . . . . 14.609999999999999 111.349 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.784 ' O ' HG22 ' B' ' 84' ' ' VAL . 29.4 p -145.73 119.47 9.22 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.67 -1.604 . . . . 18.359999999999999 106.67 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.569 HG21 HG21 ' B' ' 2' ' ' ILE . 18.6 t -47.95 170.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 C-N-CA 119.314 -0.954 . . . . 19.129999999999999 109.095 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.562 ' N ' HG12 ' B' ' 63' ' ' VAL . 2.2 t-80 -133.65 126.33 30.6 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.842 -0.799 . . . . 20.649999999999999 108.842 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.959 HD13 ' HG ' ' A' ' 37' ' ' LEU . 4.5 mp -63.0 -7.92 6.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.64 -0.662 . . . . 19.649999999999999 110.465 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.441 ' C ' ' O ' ' B' ' 65' ' ' LEU . 0.4 OUTLIER -47.17 -24.23 0.66 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.875 -1.141 . . . . 14.720000000000001 107.937 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.502 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 3.3 m -98.22 -13.27 20.92 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.774 -0.579 . . . . 11.449999999999999 110.753 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.68 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.5 m-30 -81.2 156.37 25.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.761 -1.212 . . . . 14.25 110.011 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' B' ' 77' ' ' MET . 0.0 OUTLIER -154.96 166.93 32.01 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.898 -0.778 . . . . 32.700000000000003 108.898 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.878 HG21 HG21 ' A' ' 43' ' ' VAL . 3.0 t -104.1 125.35 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 15.630000000000001 109.232 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.64 173.68 55.25 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.732 -1.347 . . . . 12.699999999999999 109.732 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.446 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 1.0 OUTLIER -75.89 -1.28 24.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.252 -1.146 . . . . 26.289999999999999 109.822 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -90.85 -17.35 26.68 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.408 -0.807 . . . . 20.440000000000001 109.52 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.54 52.42 2.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.662 -1.375 . . . . 13.82 109.662 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 57.9 m -156.59 115.33 3.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -1.163 . . . . 18.27 109.531 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.771 HD12 HG11 ' A' ' 35' ' ' VAL . 7.0 tt -50.53 152.92 1.77 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 12.43 109.447 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.489 ' N ' HD23 ' B' ' 76' ' ' LEU . 25.3 mtt -160.94 123.52 3.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 35.109999999999999 109.741 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.934 HD12 HD12 ' A' ' 78' ' ' ILE . 3.0 mt -61.32 140.71 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 13.67 109.924 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 26.6 t70 -111.24 -17.26 13.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.391 -0.818 . . . . 24.059999999999999 108.928 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.502 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 169.38 63.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.592 -1.633 . . . . 35.039999999999999 106.592 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.636 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.5 OUTLIER -27.2 119.44 0.09 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.711 -1.131 . . . . 18.719999999999999 112.576 -177.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.15 103.28 15.97 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.356 -1.349 . . . . 20.550000000000001 107.356 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.892 HD11 HG11 ' B' ' 4' ' ' VAL . 0.4 OUTLIER -77.06 145.22 38.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.905 -1.122 . . . . 14.4 111.515 -177.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.784 HG22 ' O ' ' B' ' 62' ' ' THR . 17.6 m -144.72 160.44 47.34 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.838 -1.171 . . . . 17.649999999999999 107.838 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.5 Cg_endo -63.88 146.01 91.08 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.099 1.866 . . . . 25.699999999999999 110.464 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -81.66 125.33 30.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.987 . . . . 49.289999999999999 109.528 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.987 -1.006 . . . . 58.909999999999997 109.452 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.483 ' C ' HD22 ' B' ' 65' ' ' LEU . 1.7 pmm? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.33 0.586 . . . . 64.909999999999997 109.46 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.848 ' CA ' HD22 ' B' ' 65' ' ' LEU . 3.0 mt -67.82 80.29 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.113 -1.069 . . . . 33.799999999999997 108.113 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.485 ' HB3' ' OD2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -64.35 153.9 37.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.77 0.795 . . . . 32.719999999999999 110.906 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.886 HG11 HD21 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -163.26 165.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.693 -0.854 . . . . 14.460000000000001 108.693 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 31.3 mt-10 -141.8 113.03 7.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 22.120000000000001 109.381 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.857 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -73.96 103.76 2.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 119.014 -1.075 . . . . 14.23 108.231 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.652 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.85 171.4 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.366 -0.834 . . . . 25.43 109.84 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.3 Cg_endo -76.1 -29.28 6.7 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.492 2.128 . . . . 13.609999999999999 109.803 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 t -85.12 -0.45 54.57 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.912 -0.774 . . . . 15.52 108.912 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 31.3 mm-40 -118.0 35.9 4.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.358 -0.839 . . . . 17.309999999999999 109.304 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -101.06 10.81 40.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 24.780000000000001 110.475 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.434 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -139.26 131.55 28.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.043 -1.035 . . . . 47.899999999999999 108.718 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.634 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 26.4 p90 -85.99 177.45 7.58 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.081 -1.012 . . . . 21.609999999999999 110.171 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 9.1 t -130.93 162.39 29.8 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.402 -0.962 . . . . 14.890000000000001 108.402 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.3 -1.575 0 O-C-N 121.056 -1.028 . . . . 17.350000000000001 110.005 -179.561 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.475 0.655 . . . . 24.0 110.23 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.634 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -101.43 131.35 47.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.811 . . . . 23.309999999999999 108.894 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 87.7 mt-10 -113.98 157.98 21.76 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -0.988 . . . . 40.030000000000001 109.758 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.616 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -139.78 -167.87 2.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 12.390000000000001 109.226 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.915 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.3 mp -134.74 176.46 8.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 17.420000000000002 109.195 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.48 166.45 8.38 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.063 -1.023 . . . . 13.84 108.58 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.663 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.2 m-85 -120.15 106.11 11.63 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 21.140000000000001 109.423 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.979 ' O ' HG22 ' A' ' 43' ' ' VAL . 82.2 t -98.89 111.32 28.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.134 -0.979 . . . . 10.66 109.565 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.5 p30 -52.31 -30.2 27.14 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.192 -0.943 . . . . 25.890000000000001 108.487 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.679 HD21 ' HA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 45.29 36.92 2.47 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.48 -0.762 . . . . 24.239999999999998 109.093 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.53 18.92 39.35 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.35 -1.5 . . . . 31.02 109.35 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.493 HD22 HD23 ' A' ' 37' ' ' LEU . 11.8 m120 -92.33 25.86 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -1.113 . . . . 43.229999999999997 110.483 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 45.6 mt-10 44.3 25.68 0.13 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.065 -1.022 . . . . 42.340000000000003 109.776 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 9.9 m80 -173.03 150.8 2.02 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.952 -1.129 . . . . 2.8599999999999999 107.952 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.2 Cg_endo -75.98 136.12 18.11 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.788 1.659 . . . . 17.920000000000002 110.622 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 35' ' ' VAL . 10.3 m -112.16 115.41 49.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.564 -0.902 . . . . 20.57 108.564 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.915 HD11 ' HB3' ' A' ' 32' ' ' LEU . 47.6 tp -66.48 107.48 2.07 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.341 -0.849 . . . . 20.210000000000001 109.223 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 3.8 t -112.65 167.58 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.511 -0.743 . . . . 10.81 109.41 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -91.13 163.43 14.28 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.301 -0.874 . . . . 36.740000000000002 109.997 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.94 HD13 HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -151.43 172.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.26 -0.9 . . . . 19.739999999999998 109.289 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.842 HG21 ' NH1' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -110.09 153.64 24.38 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 22.559999999999999 109.255 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.6 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -127.55 101.58 6.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.404 -0.81 . . . . 20.41 109.057 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 2.6 t0 -44.28 144.62 0.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.853 . . . . 33.990000000000002 109.999 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -64.24 102.1 0.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 54.920000000000002 109.091 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.13 -26.19 6.82 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.02 -1.632 . . . . 36.100000000000001 109.02 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.497 ' O ' HD12 ' A' ' 49' ' ' LEU . 8.1 mt-30 -76.56 144.24 73.4 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.356 -1.085 . . . . 54.759999999999998 109.13 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -78.01 130.16 10.19 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.52 2.147 . . . . 28.370000000000001 110.518 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.616 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -39.58 141.72 0.36 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.495 -0.753 . . . . 17.210000000000001 110.082 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.857 ' O ' HG21 ' A' ' 6' ' ' ILE . 87.0 m-85 -43.23 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.407 -0.808 . . . . 17.190000000000001 109.027 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.733 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -42.71 166.16 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 17.82 109.699 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.733 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.3 Cg_endo -77.02 111.91 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.568 2.179 . . . . 17.280000000000001 110.062 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.38 -175.73 47.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.804 -1.318 . . . . 17.219999999999999 109.804 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 4.7 mp -76.09 147.48 38.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.286 -1.126 . . . . 19.57 108.706 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.768 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.7 m-85 -137.4 165.13 26.97 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.457 1.122 . . . . 14.609999999999999 111.204 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.796 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.5 p -145.43 120.57 10.13 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.066 -1.827 . . . . 18.359999999999999 106.066 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -53.95 164.97 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 118.392 -1.323 . . . . 19.129999999999999 108.877 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.433 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.3 t-80 -127.07 129.91 48.91 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.913 -0.773 . . . . 20.649999999999999 108.913 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.861 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -71.79 0.56 8.68 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.41 -0.806 . . . . 19.649999999999999 109.802 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.36 -21.06 8.49 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.252 -1.388 . . . . 14.720000000000001 107.252 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.507 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 24.4 m -95.12 -9.2 34.26 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.855 -0.528 . . . . 11.449999999999999 110.058 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.672 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.0 m-30 -78.73 156.61 28.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 14.25 109.705 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.672 ' HA ' HD21 ' B' ' 37' ' ' LEU . 12.2 mttt -146.97 173.89 12.02 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 32.700000000000003 109.356 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.614 HG22 HD13 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -111.58 111.57 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 15.630000000000001 109.433 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.22 -177.34 47.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.489 -1.444 . . . . 12.699999999999999 109.489 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.93 38.95 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.196 -1.179 . . . . 26.289999999999999 109.55 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.12 24.77 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 20.440000000000001 109.579 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.442 ' C ' HG13 ' B' ' 45' ' ' VAL . . . 50.1 58.75 8.3 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.543 -1.423 . . . . 13.82 109.543 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.25 131.83 1.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -1.114 . . . . 18.27 109.667 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.513 HD11 HD12 ' B' ' 37' ' ' LEU . 1.2 tp -69.38 153.74 43.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 12.43 109.108 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 76' ' ' LEU . 4.5 mmt -154.73 121.67 5.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.969 . . . . 35.109999999999999 109.557 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.943 HD12 HD12 ' B' ' 78' ' ' ILE . 2.6 mt -57.26 141.96 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 13.67 109.831 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -116.0 -3.32 12.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.422 -0.799 . . . . 24.059999999999999 109.034 178.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.842 ' NH1' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER 156.49 62.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.998 -1.482 . . . . 35.039999999999999 106.998 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -27.75 120.23 0.1 Allowed 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.017 -0.992 . . . . 18.719999999999999 112.141 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -91.99 102.15 14.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.67 -0.863 . . . . 20.550000000000001 108.67 179.05 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.94 HD12 HD13 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -70.37 145.26 51.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.279 -0.888 . . . . 14.4 111.281 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 62' ' ' THR . 35.2 m -146.5 151.16 42.65 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.937 -1.134 . . . . 17.649999999999999 107.937 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.3 Cg_endo -62.72 145.7 95.03 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.203 1.935 . . . . 25.699999999999999 110.464 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -78.98 115.06 18.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 49.289999999999999 109.754 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.019 -0.991 . . . . 58.909999999999997 109.431 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.478 ' C ' HD22 ' A' ' 65' ' ' LEU . 1.7 pmm? . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.36 0.6 . . . . 64.909999999999997 109.516 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.861 ' CA ' HD22 ' A' ' 65' ' ' LEU . 3.0 mt -67.91 80.13 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.12 -1.067 . . . . 33.799999999999997 108.12 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.49 ' HB3' ' OD2' ' B' ' 36' ' ' ASP . 0.0 OUTLIER -64.26 153.87 36.82 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.771 0.796 . . . . 32.719999999999999 110.87 -178.458 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.886 HG11 HD21 ' B' ' 83' ' ' LEU . 0.1 OUTLIER -163.27 165.05 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.633 -0.877 . . . . 14.460000000000001 108.633 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 31.4 mt-10 -141.75 112.87 7.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 22.120000000000001 109.478 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.844 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -73.85 103.68 2.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.999 -1.08 . . . . 14.23 108.225 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.655 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.81 171.33 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.402 -0.811 . . . . 25.43 109.852 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -76.1 -29.21 6.76 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.496 2.13 . . . . 13.609999999999999 109.856 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.3 t -85.07 -0.59 54.97 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.829 -0.804 . . . . 15.52 108.829 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 31.4 mm-40 -118.0 36.03 4.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.419 -0.801 . . . . 17.309999999999999 109.292 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -101.2 10.94 40.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.167 -0.958 . . . . 24.780000000000001 110.44 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.442 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.5 OUTLIER -139.3 131.61 28.37 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.145 -0.972 . . . . 47.899999999999999 108.672 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.634 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 26.3 p90 -86.07 177.53 7.53 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.058 -1.026 . . . . 21.609999999999999 110.052 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 9.2 t -130.98 162.38 29.88 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.392 -0.966 . . . . 14.890000000000001 108.392 178.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.299 -1.592 0 O-C-N 121.127 -0.983 . . . . 17.350000000000001 109.993 -179.613 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.45 ' HA ' HD13 ' B' ' 28' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.467 0.651 . . . . 24.0 110.253 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.634 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -101.37 131.22 47.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.381 -0.824 . . . . 23.309999999999999 108.892 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 87.5 mt-10 -113.89 158.03 21.61 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.109 -0.994 . . . . 40.030000000000001 109.826 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.598 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -139.84 -167.96 2.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.216 -0.928 . . . . 12.390000000000001 109.223 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.897 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.3 mp -134.68 176.58 8.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 17.420000000000002 109.235 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.56 166.51 8.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.09 -1.006 . . . . 13.84 108.543 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.67 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 22.2 m-85 -120.28 106.18 11.65 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.109 -0.994 . . . . 21.140000000000001 109.395 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.96 ' O ' HG22 ' B' ' 43' ' ' VAL . 81.8 t -98.97 111.16 27.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.121 -0.987 . . . . 10.66 109.561 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.5 p30 -52.18 -30.19 25.77 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.205 -0.935 . . . . 25.890000000000001 108.495 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.672 HD21 ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 45.26 36.93 2.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.473 -0.767 . . . . 24.239999999999998 109.065 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.49 19.03 39.49 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.386 -1.486 . . . . 31.02 109.386 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.484 HD22 HD23 ' B' ' 37' ' ' LEU . 11.7 m120 -92.39 25.93 2.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 43.229999999999997 110.539 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.575 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 45.3 mt-10 44.29 25.6 0.13 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.053 -1.029 . . . . 42.340000000000003 109.84 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 10.0 m80 -172.98 150.78 2.04 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.979 -1.119 . . . . 2.8599999999999999 107.979 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.1 Cg_endo -76.02 136.1 18.0 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.852 1.702 . . . . 17.920000000000002 110.606 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.96 HG22 ' O ' ' B' ' 35' ' ' VAL . 10.1 m -112.18 115.45 49.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.613 -0.884 . . . . 20.57 108.613 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.897 HD11 ' HB3' ' B' ' 32' ' ' LEU . 48.0 tp -66.55 107.49 2.1 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.331 -0.856 . . . . 20.210000000000001 109.299 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.592 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 4.0 t -112.65 167.66 5.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.586 -0.697 . . . . 10.81 109.469 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -91.19 163.16 14.36 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.669 -0.812 . . . . 36.740000000000002 109.97 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.975 HD13 HD12 ' B' ' 83' ' ' LEU . 0.4 OUTLIER -151.19 172.86 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.308 -0.87 . . . . 19.739999999999998 109.326 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.834 HG21 ' NH1' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -110.09 153.53 24.54 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.301 -0.874 . . . . 22.559999999999999 109.245 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.59 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -127.45 101.66 6.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 20.41 109.061 -179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.454 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 2.6 t0 -44.31 144.61 0.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.341 -0.849 . . . . 33.990000000000002 109.97 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -64.21 102.09 0.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 54.920000000000002 109.053 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.2 -26.26 6.77 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.059 -1.616 . . . . 36.100000000000001 109.059 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.498 ' O ' HD12 ' B' ' 49' ' ' LEU . 8.1 mt-30 -76.55 144.47 73.84 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.382 -1.07 . . . . 54.759999999999998 109.018 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.15 130.12 10.04 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.544 2.163 . . . . 28.370000000000001 110.517 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.598 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -39.62 141.97 0.35 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.49 -0.756 . . . . 17.210000000000001 109.99 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.844 ' O ' HG21 ' B' ' 6' ' ' ILE . 86.4 m-85 -43.61 98.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.833 . . . . 17.190000000000001 109.012 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.721 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -43.48 166.42 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.839 . . . . 17.82 109.59 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.721 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -77.54 113.0 3.44 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.625 2.217 . . . . 17.280000000000001 110.317 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.56 -175.02 46.83 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.666 -1.374 . . . . 17.219999999999999 109.666 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.0 mp -75.99 148.04 38.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -1.111 . . . . 19.57 108.995 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.781 ' HB3' HD22 ' B' ' 83' ' ' LEU . 20.7 m-85 -137.9 165.0 27.59 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.413 1.102 . . . . 14.609999999999999 111.254 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.789 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.2 p -145.46 120.61 10.13 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.127 -1.805 . . . . 18.359999999999999 106.127 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.662 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -54.02 165.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 C-N-CA 118.396 -1.321 . . . . 19.129999999999999 108.858 -178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.433 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.3 t-80 -127.01 129.96 49.09 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.97 -0.752 . . . . 20.649999999999999 108.97 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.848 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -71.87 0.54 8.89 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.377 -0.827 . . . . 19.649999999999999 109.735 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -20.94 7.9 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.263 -1.384 . . . . 14.720000000000001 107.263 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.495 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 23.9 m -95.33 -9.58 32.56 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.899 -0.5 . . . . 11.449999999999999 110.058 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.661 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.9 m-30 -78.36 156.11 29.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.124 -0.985 . . . . 14.25 109.715 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.679 ' HA ' HD21 ' A' ' 37' ' ' LEU . 12.2 mttt -146.58 173.37 12.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.805 . . . . 32.700000000000003 109.415 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.659 HG22 HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -111.08 111.63 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 15.630000000000001 109.389 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.34 -177.35 48.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.421 -1.472 . . . . 12.699999999999999 109.421 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.94 39.0 0.94 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.148 -1.207 . . . . 26.289999999999999 109.561 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.08 24.73 4.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 20.440000000000001 109.606 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.451 ' C ' HG13 ' A' ' 45' ' ' VAL . . . 50.02 59.14 7.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.519 -1.432 . . . . 13.82 109.519 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.53 131.83 1.84 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.135 . . . . 18.27 109.685 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 37' ' ' LEU . 1.2 tp -69.41 153.66 43.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.892 . . . . 12.43 109.152 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' B' ' 76' ' ' LEU . 4.5 mmt -154.74 121.77 5.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.097 -1.002 . . . . 35.109999999999999 109.573 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.943 HD12 HD12 ' A' ' 78' ' ' ILE . 2.5 mp -57.4 142.02 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -0.849 . . . . 13.67 109.819 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.7 OUTLIER -115.97 -3.39 12.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.49 -0.756 . . . . 24.059999999999999 108.997 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.834 ' NH1' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER 156.5 63.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.931 -1.507 . . . . 35.039999999999999 106.931 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.662 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.8 OUTLIER -27.89 120.33 0.11 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.001 -1.0 . . . . 18.719999999999999 112.134 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.496 ' HG3' ' NH1' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -92.04 102.08 14.63 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.675 -0.861 . . . . 20.550000000000001 108.675 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.975 HD12 HD13 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -70.39 145.39 51.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.352 -0.843 . . . . 14.4 111.345 -178.714 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.789 HG22 ' O ' ' B' ' 62' ' ' THR . 35.3 m -146.58 151.03 42.03 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.89 -1.152 . . . . 17.649999999999999 107.89 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.9 Cg_endo -62.53 145.71 95.44 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.181 1.92 . . . . 25.699999999999999 110.419 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -79.05 115.07 18.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 49.289999999999999 109.76 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.048 -0.977 . . . . 58.909999999999997 109.457 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.528 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.3 ttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.534 -0.543 . . . . 64.909999999999997 109.534 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.664 HG21 HG21 ' A' ' 63' ' ' VAL . 2.8 mt -61.52 82.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.962 -1.125 . . . . 33.799999999999997 107.962 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.62 ' C ' HG12 ' A' ' 4' ' ' VAL . 23.4 mttp -70.33 179.12 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.894 0.854 . . . . 32.719999999999999 111.277 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.043 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 173.56 167.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.902 -0.777 . . . . 14.460000000000001 108.902 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.576 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 79.7 mt-10 -141.31 111.17 6.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.545 -0.722 . . . . 22.120000000000001 109.259 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.834 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -72.58 105.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.545 -1.28 . . . . 14.23 107.545 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.538 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.7 mmpt? -54.14 160.36 2.43 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.118 -0.989 . . . . 25.43 109.539 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 31.8 Cg_endo -73.79 -9.25 22.31 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.057 1.838 . . . . 13.609999999999999 109.19 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.85 7.64 46.16 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.89 -0.782 . . . . 15.52 108.89 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.804 ' NE2' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -142.58 37.41 1.49 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.261 -0.899 . . . . 17.309999999999999 109.13 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.58 15.46 6.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 24.780000000000001 109.803 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.476 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -143.96 143.63 31.32 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.182 -0.949 . . . . 47.899999999999999 108.597 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.67 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 26.0 p90 -85.46 173.31 10.34 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.038 -1.039 . . . . 21.609999999999999 109.61 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 15' ' ' THR . 39.9 m -137.6 154.95 49.68 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.471 -0.768 . . . . 14.890000000000001 109.0 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.175 -0.953 . . . . 17.350000000000001 109.506 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.667 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.424 0.63 . . . . 24.0 110.23 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.661 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -46.01 128.45 9.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.427 -0.796 . . . . 23.309999999999999 109.546 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -121.13 143.09 49.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.258 -0.901 . . . . 40.030000000000001 108.788 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.938 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -115.1 -167.29 1.21 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.963 -1.086 . . . . 12.390000000000001 110.149 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.886 ' HB3' HD11 ' A' ' 44' ' ' LEU . 21.1 mt -128.44 177.99 6.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.48 -0.762 . . . . 17.420000000000002 109.557 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.566 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -173.46 150.72 1.85 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.987 -1.07 . . . . 13.84 109.238 -179.461 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.762 ' HE1' HD13 ' A' ' 44' ' ' LEU . 2.9 m-85 -109.8 91.32 3.6 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.181 -1.044 . . . . 21.140000000000001 108.181 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.866 HG22 ' HB ' ' A' ' 4' ' ' VAL . 97.9 t -92.89 117.58 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.98 . . . . 10.66 110.155 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 27.6 t0 -53.56 -28.49 32.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.415 -0.957 . . . . 25.890000000000001 108.415 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.83 HD21 ' HA ' ' B' ' 69' ' ' LYS . 1.9 tt 43.25 34.47 0.71 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.498 -0.751 . . . . 24.239999999999998 109.239 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.35 23.12 52.9 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.457 -1.457 . . . . 31.02 109.457 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -97.33 26.35 4.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -1.155 . . . . 43.229999999999997 110.263 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.551 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 42.9 mt-10 49.25 21.62 0.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.134 -0.979 . . . . 42.340000000000003 109.949 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 6.0 m80 -174.71 157.11 2.23 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 108.027 -1.101 . . . . 6.1600000000000001 108.027 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.641 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.8 Cg_endo -75.6 146.14 30.24 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.019 1.813 . . . . 17.920000000000002 111.005 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.6 m -122.46 118.38 55.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.622 -0.881 . . . . 20.57 108.622 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 32' ' ' LEU . 22.4 tp -69.14 109.42 4.04 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.662 -0.815 . . . . 20.210000000000001 109.04 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.591 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 3.9 t -117.18 168.89 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.614 -0.678 . . . . 10.81 109.516 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.581 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -88.63 161.93 16.61 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.298 -0.876 . . . . 36.740000000000002 110.423 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.693 HD12 ' HE2' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -133.11 164.43 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.485 -0.932 . . . . 19.739999999999998 108.485 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -108.76 135.5 49.88 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.193 -0.942 . . . . 22.559999999999999 108.565 178.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.667 ' O ' HD23 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -123.88 123.9 41.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 20.41 109.365 -179.22 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . 1.3 t0 -71.4 142.53 50.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 33.990000000000002 109.546 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.29 107.72 0.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 54.920000000000002 109.664 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.04 -2.4 44.33 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.859 -1.296 . . . . 36.100000000000001 109.859 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.625 ' O ' HD12 ' A' ' 49' ' ' LEU . 13.2 mt-30 -89.19 144.5 32.6 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 54.759999999999998 109.525 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 55' ' ' ALA . 35.1 Cg_endo -78.38 114.78 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.643 2.229 . . . . 28.370000000000001 110.642 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.938 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -43.79 168.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.337 -0.852 . . . . 17.210000000000001 110.031 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.834 ' HB3' HD13 ' A' ' 6' ' ' ILE . 31.0 m-85 -66.14 122.85 18.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 17.190000000000001 109.657 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.997 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -74.48 179.39 1.31 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.455 -0.778 . . . . 17.82 109.808 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.997 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.9 Cg_endo -78.01 115.41 3.77 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.582 2.188 . . . . 17.280000000000001 110.436 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 166.85 142.0 3.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.317 -1.513 . . . . 17.219999999999999 109.317 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 59' ' ' GLY . 4.0 mp -42.11 144.43 0.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.153 -1.204 . . . . 19.57 109.382 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 1.043 ' CB ' HG13 ' A' ' 4' ' ' VAL . 15.1 m-85 -121.52 166.37 14.28 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.487 1.137 . . . . 14.609999999999999 111.253 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.572 HG23 ' CA ' ' A' ' 86' ' ' ALA . 39.8 p -149.35 120.54 7.79 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.505 -2.035 . . . . 18.359999999999999 105.505 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.9 t -57.89 161.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 C-N-CA 118.107 -1.437 . . . . 19.129999999999999 108.934 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 82' ' ' ARG . 5.1 t-80 -116.19 138.41 51.3 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.592 -0.693 . . . . 20.649999999999999 109.203 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.751 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.1 mt -70.71 -8.44 52.13 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.098 -0.704 . . . . 19.649999999999999 109.098 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.418 ' OG ' ' HD3' ' A' ' 82' ' ' ARG . 0.5 OUTLIER -47.93 -24.95 1.16 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.268 -1.012 . . . . 14.720000000000001 108.268 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.54 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 3.7 m -93.7 -14.77 25.96 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.825 -0.75 . . . . 11.449999999999999 109.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.756 ' HB3' HD21 ' A' ' 76' ' ' LEU . 3.5 m-30 -80.69 147.07 30.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.064 -1.022 . . . . 14.25 109.973 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.8 ' HA ' HD21 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -146.31 172.87 12.84 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.643 -0.661 . . . . 32.700000000000003 109.229 -179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.67 HG22 HD13 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -107.33 109.55 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 15.630000000000001 109.171 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.07 -173.08 49.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.582 -1.407 . . . . 12.699999999999999 109.582 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.463 ' OE1' ' N ' ' A' ' 72' ' ' GLN . 5.0 mp0 -95.87 22.98 6.72 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.261 -1.141 . . . . 26.289999999999999 108.948 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 -9.45 26.65 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.283 -0.567 . . . . 20.440000000000001 109.704 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.436 ' C ' HG13 ' B' ' 45' ' ' VAL . . . 81.5 40.41 11.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.692 -1.363 . . . . 13.82 109.692 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.499 ' HA ' ' CG1' ' B' ' 45' ' ' VAL . 4.4 m -169.18 138.54 2.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.14 . . . . 18.27 109.564 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.756 HD21 ' HB3' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -47.57 160.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 12.43 109.46 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtt -158.64 107.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 35.109999999999999 109.708 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.626 HG12 ' CD1' ' A' ' 68' ' ' PHE . 23.4 mt -60.33 138.11 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 13.67 109.815 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 12.1 t70 -103.13 -22.67 13.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.357 -0.84 . . . . 24.059999999999999 108.802 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.54 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.5 OUTLIER 171.86 66.74 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.542 -1.281 . . . . 35.039999999999999 107.542 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.892 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -21.72 119.01 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.033 -0.985 . . . . 18.719999999999999 112.264 -178.248 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -92.68 103.72 16.07 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.601 -0.888 . . . . 20.550000000000001 108.601 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.974 HD11 HG11 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -73.78 145.05 45.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.146 -0.971 . . . . 14.4 111.528 -178.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 62' ' ' THR . 2.4 m -149.64 156.25 38.85 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 107.524 -1.287 . . . . 17.649999999999999 107.524 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 24.7 Cg_endo -63.3 141.13 80.59 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 C-N-CA 121.9 1.733 . . . . 25.699999999999999 110.26 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.572 ' CA ' HG23 ' A' ' 62' ' ' THR . . . -70.66 112.13 6.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.191 -0.943 . . . . 49.289999999999999 109.5 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.045 -0.978 . . . . 58.909999999999997 109.475 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.531 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.3 ttp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.526 -0.546 . . . . 64.909999999999997 109.526 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.666 HG21 HG21 ' B' ' 63' ' ' VAL . 2.8 mt -61.56 82.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.985 -1.117 . . . . 33.799999999999997 107.985 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.635 ' C ' HG12 ' B' ' 4' ' ' VAL . 23.3 mttp -70.1 179.2 2.43 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.979 0.895 . . . . 32.719999999999999 111.284 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.046 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 173.46 167.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.865 -0.791 . . . . 14.460000000000001 108.865 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 79.6 mt-10 -141.36 111.14 6.55 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.62 0.724 . . . . 22.120000000000001 109.241 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.829 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -72.55 105.34 2.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.54 -1.281 . . . . 14.23 107.54 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.541 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.7 mmpt? -54.3 160.39 2.54 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.113 -0.992 . . . . 25.43 109.509 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.9 Cg_endo -73.75 -9.25 22.37 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.032 1.821 . . . . 13.609999999999999 109.181 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.84 7.51 46.45 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.803 -0.814 . . . . 15.52 108.803 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.795 ' NE2' HD13 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -142.63 37.6 1.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.206 -0.934 . . . . 17.309999999999999 109.093 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.7 15.34 7.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 24.780000000000001 109.831 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.467 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -143.91 143.44 31.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.216 -0.927 . . . . 47.899999999999999 108.686 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.666 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 26.3 p90 -85.24 173.22 10.55 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.036 -1.04 . . . . 21.609999999999999 109.609 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.42 HG22 ' N ' ' B' ' 15' ' ' THR . 39.9 m -137.54 155.0 49.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.48 -0.762 . . . . 14.890000000000001 108.983 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' THR . . . . . 0.42 ' N ' HG22 ' B' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.461 0 O-C-N 121.186 -0.946 . . . . 17.350000000000001 109.59 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.656 HD23 ' O ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.454 0.645 . . . . 24.0 110.234 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.668 ' OD1' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -46.06 128.52 9.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.401 -0.812 . . . . 23.309999999999999 109.579 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -121.2 143.11 49.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.894 . . . . 40.030000000000001 108.748 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.958 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -115.17 -167.24 1.21 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.981 -1.075 . . . . 12.390000000000001 110.132 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.908 ' HB3' HD11 ' B' ' 44' ' ' LEU . 21.0 mt -128.37 177.97 6.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.429 -0.795 . . . . 17.420000000000002 109.549 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.571 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.8 OUTLIER -173.49 150.65 1.83 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.918 -1.114 . . . . 13.84 109.265 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.772 ' HE1' HD13 ' B' ' 44' ' ' LEU . 2.9 m-85 -109.77 91.28 3.58 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.18 -1.045 . . . . 21.140000000000001 108.18 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.898 HG22 ' HB ' ' B' ' 4' ' ' VAL . 98.5 t -92.83 117.76 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.961 . . . . 10.66 110.096 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 27.6 t0 -53.71 -28.37 33.58 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.385 -0.968 . . . . 25.890000000000001 108.385 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.8 HD21 ' HA ' ' A' ' 69' ' ' LYS . 1.8 tt 43.11 34.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.572 -0.705 . . . . 24.239999999999998 109.256 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.19 23.05 51.81 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.472 -1.451 . . . . 31.02 109.472 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -97.35 26.28 4.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.217 -1.167 . . . . 43.229999999999997 110.234 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 43.0 mt-10 49.23 21.74 0.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.13 -0.981 . . . . 42.340000000000003 109.976 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 5.9 m80 -174.79 157.13 2.2 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.999 -1.111 . . . . 6.1500000000000004 107.999 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.635 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.9 Cg_endo -75.59 146.19 30.34 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.97 1.78 . . . . 17.920000000000002 110.954 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.859 HG22 ' O ' ' B' ' 35' ' ' VAL . 5.4 m -122.49 118.36 54.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.633 -0.877 . . . . 20.57 108.633 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.908 HD11 ' HB3' ' B' ' 32' ' ' LEU . 22.9 tp -69.09 109.57 4.08 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.69 -0.804 . . . . 20.210000000000001 109.096 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 3.9 t -117.37 168.86 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.529 -0.732 . . . . 10.81 109.448 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -88.52 161.9 16.72 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.351 -0.843 . . . . 36.740000000000002 110.455 -179.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.687 HD12 ' HE2' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -133.08 164.29 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.522 -0.918 . . . . 19.739999999999998 108.522 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.502 ' N ' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -108.67 135.47 49.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.242 -0.912 . . . . 22.559999999999999 108.576 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.656 ' O ' HD23 ' B' ' 28' ' ' LEU . 0.3 OUTLIER -123.92 123.89 41.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.865 . . . . 20.41 109.362 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.433 ' HB3' ' HG3' ' B' ' 53' ' ' GLN . 1.3 t0 -71.39 142.35 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 33.990000000000002 109.567 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.21 107.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 54.920000000000002 109.633 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.08 -2.41 44.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.831 -1.308 . . . . 36.100000000000001 109.831 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.628 ' O ' HD12 ' B' ' 49' ' ' LEU . 13.2 mt-30 -89.22 144.46 32.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.166 -1.197 . . . . 54.759999999999998 109.513 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.37 114.7 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.669 2.246 . . . . 28.370000000000001 110.696 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.958 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -43.69 168.67 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 17.210000000000001 110.025 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.829 ' HB3' HD13 ' B' ' 6' ' ' ILE . 30.7 m-85 -66.06 122.96 18.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 17.190000000000001 109.618 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.995 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -74.53 179.44 1.31 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.443 -0.786 . . . . 17.82 109.844 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.995 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.1 Cg_endo -78.0 115.35 3.76 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.619 2.213 . . . . 17.280000000000001 110.442 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 166.87 141.95 3.3 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.358 -1.497 . . . . 17.219999999999999 109.358 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' B' ' 59' ' ' GLY . 4.0 mp -42.04 144.26 0.47 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -1.162 . . . . 19.57 109.364 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 1.046 ' CB ' HG13 ' B' ' 4' ' ' VAL . 15.1 m-85 -121.4 166.24 14.38 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.93 -1.106 . . . . 14.609999999999999 111.34 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.571 HG23 ' CA ' ' B' ' 86' ' ' ALA . 39.2 p -149.31 120.25 7.65 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 105.485 -2.043 . . . . 18.359999999999999 105.485 177.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.925 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.8 t -57.44 161.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 C-N-CA 118.143 -1.423 . . . . 19.129999999999999 108.936 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' B' ' 82' ' ' ARG . 5.1 t-80 -116.43 138.32 51.46 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.551 -0.718 . . . . 20.649999999999999 109.245 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.754 HD23 ' CD2' ' B' ' 68' ' ' PHE . 2.1 mt -70.57 -8.47 51.77 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.065 -0.717 . . . . 19.649999999999999 109.065 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' SER . . . . . 0.42 ' OG ' ' HD3' ' B' ' 82' ' ' ARG . 0.5 OUTLIER -47.96 -24.84 1.15 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.29 -1.004 . . . . 14.720000000000001 108.29 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.538 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 3.8 m -93.78 -14.8 25.82 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.472 -0.767 . . . . 11.449999999999999 109.97 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.766 ' HB3' HD21 ' B' ' 76' ' ' LEU . 3.5 m-30 -80.71 146.44 31.06 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.081 -1.012 . . . . 14.25 109.955 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.83 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -145.72 172.62 13.02 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.651 -0.656 . . . . 32.700000000000003 109.274 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.709 HG22 HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -107.2 109.54 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 15.630000000000001 109.166 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.95 -172.88 49.12 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.593 -1.403 . . . . 12.699999999999999 109.593 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.459 ' OE1' ' N ' ' B' ' 72' ' ' GLN . 5.0 mp0 -96.05 22.83 7.06 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.215 -1.168 . . . . 26.289999999999999 108.918 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.61 -9.48 26.84 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.757 -0.589 . . . . 20.440000000000001 109.69 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.464 ' C ' HG13 ' A' ' 45' ' ' VAL . . . 81.46 41.05 10.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.578 -1.409 . . . . 13.82 109.578 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.521 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 4.3 m -169.79 138.29 1.8 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -1.153 . . . . 18.27 109.688 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.774 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -47.37 160.7 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 12.43 109.462 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtt -158.94 107.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 35.109999999999999 109.738 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.636 HG12 ' CD1' ' B' ' 68' ' ' PHE . 23.0 mt -60.26 138.4 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 13.67 109.843 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 12.1 t70 -103.37 -22.81 13.62 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.709 -0.849 . . . . 24.059999999999999 108.709 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.538 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.5 OUTLIER 172.09 66.55 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.556 -1.275 . . . . 35.039999999999999 107.556 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.925 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.7 OUTLIER -21.5 118.96 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.085 -0.961 . . . . 18.719999999999999 112.285 -178.25 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' B' ' 64' ' ' HIS . 0.3 OUTLIER -92.57 103.79 16.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 20.550000000000001 108.643 179.363 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.957 HD11 HG11 ' B' ' 4' ' ' VAL . 0.7 OUTLIER -73.85 144.93 45.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.03 -1.044 . . . . 14.4 111.469 -178.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 62' ' ' THR . 2.5 m -149.59 156.14 38.95 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.528 -1.286 . . . . 17.649999999999999 107.528 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 24.6 Cg_endo -63.26 141.08 80.73 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 121.911 1.741 . . . . 25.699999999999999 110.211 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.571 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -70.53 112.14 6.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.207 -0.933 . . . . 49.289999999999999 109.528 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.015 -0.993 . . . . 58.909999999999997 109.5 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.485 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 1.3 ttp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.457 -0.572 . . . . 64.909999999999997 109.457 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.873 ' HA ' HD22 ' B' ' 65' ' ' LEU . 6.2 mt -71.29 77.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.213 -1.032 . . . . 33.799999999999997 108.213 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 35' ' ' VAL . 54.0 mttt -63.53 155.41 29.47 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.937 0.875 . . . . 32.719999999999999 111.299 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.81 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -166.84 163.53 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.499 -0.926 . . . . 14.460000000000001 108.499 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 64.5 mt-10 -137.12 119.53 15.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.24 -0.913 . . . . 22.120000000000001 109.762 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -76.61 101.08 2.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.521 -1.288 . . . . 14.23 107.521 178.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.652 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.9 171.73 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.014 -1.054 . . . . 25.43 109.841 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -75.08 -26.06 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.49 2.126 . . . . 13.609999999999999 109.804 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.89 -0.13 56.58 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.906 -0.775 . . . . 15.52 108.906 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.479 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.5 mm-40 -120.59 37.17 4.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.346 -0.846 . . . . 17.309999999999999 109.595 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.01 8.45 44.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 24.780000000000001 110.236 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -139.71 137.89 35.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.186 -0.946 . . . . 47.899999999999999 108.677 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.667 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 30.7 p90 -84.45 173.99 10.43 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.027 -1.046 . . . . 21.609999999999999 109.459 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.7 m -142.5 151.67 41.91 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.459 -0.776 . . . . 14.890000000000001 109.115 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 O-C-N 121.296 -0.878 . . . . 17.350000000000001 109.23 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.359 0.6 . . . . 24.0 110.299 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -48.65 120.31 3.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 23.309999999999999 109.168 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 7.9 mt-10 -109.79 161.3 15.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 40.030000000000001 109.334 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.76 HE21 ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -139.91 -168.92 2.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 12.390000000000001 109.647 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.944 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.1 mt -141.44 155.28 45.88 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.684 -0.858 . . . . 17.420000000000002 108.684 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.613 ' SG ' HD11 ' A' ' 6' ' ' ILE . 2.6 m -151.64 -177.25 5.99 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.185 -1.042 . . . . 13.84 108.185 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.701 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 16.5 m-85 -131.3 103.81 6.67 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.126 -0.984 . . . . 21.140000000000001 109.785 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 43' ' ' VAL . 3.0 t -109.78 123.27 65.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.145 -0.972 . . . . 10.66 110.069 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -87.66 -36.76 17.25 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.366 -0.976 . . . . 25.890000000000001 108.366 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.791 HD21 HD11 ' B' ' 76' ' ' LEU . 0.3 OUTLIER 63.79 -71.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.541 -0.911 . . . . 24.239999999999998 108.541 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -157.19 29.17 0.52 Allowed Glycine 0 C--N 1.297 -1.633 0 N-CA-C 109.188 -1.565 . . . . 31.02 109.188 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' HIS . 1.7 m-20 -109.51 21.64 16.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -1.178 . . . . 43.229999999999997 110.229 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.579 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 3.3 mt-10 42.58 25.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.266 -0.896 . . . . 42.340000000000003 110.328 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 98.6 m-70 -160.52 152.79 17.11 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.108 -0.995 . . . . 6.9900000000000002 108.518 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.701 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -78.35 136.05 13.87 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.903 1.736 . . . . 17.920000000000002 110.411 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 35' ' ' VAL . 2.4 m -112.21 119.34 59.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.351 -0.843 . . . . 20.57 108.744 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.944 HD11 ' HB3' ' A' ' 32' ' ' LEU . 52.1 tp -75.32 103.51 5.5 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.461 -0.895 . . . . 20.210000000000001 110.018 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.737 HG13 HG23 ' A' ' 43' ' ' VAL . 29.0 m -110.53 178.48 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.643 -0.873 . . . . 10.81 108.643 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HD3' HD21 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -106.09 127.1 52.95 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.012 -1.075 . . . . 36.740000000000002 110.029 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.996 HD13 HD12 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -108.64 163.17 6.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.884 -0.784 . . . . 19.739999999999998 108.884 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 49' ' ' LEU . 56.7 m -99.59 158.99 15.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 22.559999999999999 109.539 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.799 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -130.37 105.14 7.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.198 -0.939 . . . . 20.41 109.286 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.49 142.29 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 33.990000000000002 109.501 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.14 101.58 0.3 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 54.920000000000002 109.313 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.62 -20.04 10.3 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.316 -1.514 . . . . 36.100000000000001 109.316 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 30.5 mt-30 -78.28 148.53 74.46 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.259 -1.142 . . . . 54.759999999999998 109.376 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.99 120.38 5.01 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.665 2.244 . . . . 28.370000000000001 110.619 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.799 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -38.58 143.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.506 -0.746 . . . . 17.210000000000001 110.346 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.767 ' HB3' HD13 ' A' ' 6' ' ' ILE . 86.6 m-85 -44.56 102.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.798 . . . . 17.190000000000001 108.844 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.97 176.09 0.13 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 17.82 109.955 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.8 Cg_endo -78.39 111.22 2.99 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.763 2.309 . . . . 17.280000000000001 110.27 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 175.25 163.89 28.98 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.905 -1.278 . . . . 17.219999999999999 109.905 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.751 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.5 OUTLIER -59.84 142.79 52.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.243 -1.151 . . . . 19.57 108.748 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.716 ' HB3' HD22 ' A' ' 83' ' ' LEU . 31.8 m-85 -125.9 161.07 28.3 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.718 -1.238 . . . . 14.609999999999999 111.682 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.726 ' O ' HG22 ' A' ' 84' ' ' VAL . 30.9 p -146.24 121.44 10.17 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.295 -1.743 . . . . 18.359999999999999 106.295 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.614 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.9 t -52.47 168.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.806 -1.158 . . . . 19.129999999999999 109.381 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.548 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -133.62 127.14 32.39 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.487 -0.758 . . . . 20.649999999999999 109.038 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.885 HD22 ' HA ' ' B' ' 2' ' ' ILE . 0.7 OUTLIER -71.11 0.1 8.42 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.292 -0.88 . . . . 19.649999999999999 109.997 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.3 p -55.26 -20.55 11.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.401 -1.333 . . . . 14.720000000000001 107.401 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 69.6 m -94.18 -27.35 16.24 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.835 -0.54 . . . . 11.449999999999999 109.998 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.684 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -60.82 156.27 17.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.1 -1.0 . . . . 14.25 109.127 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HE3' ' OD2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -159.1 172.31 18.35 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.385 -0.822 . . . . 32.700000000000003 109.586 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.637 HG21 HG11 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -97.45 112.19 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 15.630000000000001 109.387 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.45 -176.08 48.61 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.547 -1.421 . . . . 12.699999999999999 109.547 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -90.05 33.86 0.87 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -1.162 . . . . 26.289999999999999 109.486 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -118.74 15.36 13.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 20.440000000000001 109.628 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.06 48.96 70.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.781 -1.328 . . . . 13.82 109.781 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 77' ' ' MET . 0.0 OUTLIER -170.93 138.84 1.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -1.197 . . . . 18.27 109.416 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.8 HD11 HD21 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -45.15 163.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 12.43 109.388 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 75' ' ' SER . 6.7 mmt -154.22 100.3 2.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 35.109999999999999 109.844 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.5 mt -40.98 -61.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.511 0.672 . . . . 13.67 109.634 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 35.4 t0 81.44 -48.2 0.24 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.476 0.655 . . . . 24.059999999999999 109.958 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.0 tpm_? -172.04 66.78 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.107 0.956 . . . . 35.039999999999999 108.781 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' B' ' 76' ' ' LEU . 1.0 OUTLIER -34.84 127.06 0.51 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.499 -0.773 . . . . 18.719999999999999 111.597 -179.203 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -94.7 105.38 17.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.167 -1.049 . . . . 20.550000000000001 108.167 178.632 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.996 HD12 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -72.83 149.06 43.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 14.4 111.263 -178.425 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 62' ' ' THR . 34.3 m -150.22 150.68 29.98 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.121 -1.066 . . . . 17.649999999999999 108.121 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.2 Cg_endo -61.93 138.35 73.06 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.129 1.886 . . . . 25.699999999999999 110.241 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -66.72 116.61 7.82 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.295 -0.878 . . . . 49.289999999999999 109.684 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.001 -1.0 . . . . 58.909999999999997 109.41 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.488 ' SD ' ' HB ' ' B' ' 62' ' ' THR . 1.3 ttp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.522 -0.548 . . . . 64.909999999999997 109.522 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.885 ' HA ' HD22 ' A' ' 65' ' ' LEU . 6.3 mt -70.6 77.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.16 -1.052 . . . . 33.799999999999997 108.16 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.466 ' O ' HG13 ' B' ' 35' ' ' VAL . 53.3 mttt -63.6 155.37 29.85 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.914 0.864 . . . . 32.719999999999999 111.308 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.826 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -166.86 163.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.492 -0.929 . . . . 14.460000000000001 108.492 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 65.3 mt-10 -137.07 119.6 15.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.344 -0.847 . . . . 22.120000000000001 109.798 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.755 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -76.71 101.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.583 -1.265 . . . . 14.23 107.583 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.66 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.88 171.76 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.1 -1.0 . . . . 25.43 109.83 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.6 Cg_endo -75.07 -26.14 11.09 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.539 2.159 . . . . 13.609999999999999 109.834 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.86 -0.08 56.5 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.946 -0.761 . . . . 15.52 108.946 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.482 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.5 mm-40 -120.57 37.07 4.38 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 17.309999999999999 109.561 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.05 8.71 43.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 24.780000000000001 110.204 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.454 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -139.93 137.85 35.12 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.126 -0.984 . . . . 47.899999999999999 108.639 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 30.8 p90 -84.39 174.05 10.41 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 120.984 -1.072 . . . . 21.609999999999999 109.504 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -142.53 151.44 41.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.397 -0.814 . . . . 14.890000000000001 109.113 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.536 0 O-C-N 121.288 -0.883 . . . . 17.350000000000001 109.129 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.349 0.595 . . . . 24.0 110.292 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.593 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -48.69 120.4 3.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.402 -0.811 . . . . 23.309999999999999 109.122 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 7.8 mt-10 -109.84 161.39 15.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 40.030000000000001 109.283 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.767 HE21 ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -139.9 -168.85 2.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 12.390000000000001 109.67 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.913 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.1 mt -141.55 155.19 45.79 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.717 -0.845 . . . . 17.420000000000002 108.717 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.625 ' SG ' HD11 ' B' ' 6' ' ' ILE . 2.5 m -151.63 -177.21 5.97 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.179 -1.045 . . . . 13.84 108.179 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.699 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 16.3 m-85 -131.35 103.9 6.71 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.103 -0.998 . . . . 21.140000000000001 109.692 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.854 ' O ' HG22 ' B' ' 43' ' ' VAL . 2.9 t -109.86 123.16 65.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.126 -0.984 . . . . 10.66 110.115 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.768 ' O ' HD12 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -87.45 -36.9 17.43 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.336 -0.987 . . . . 25.890000000000001 108.336 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 76' ' ' LEU . 0.3 OUTLIER 64.13 -71.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.471 -0.937 . . . . 24.239999999999998 108.471 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -157.49 29.19 0.5 Allowed Glycine 0 C--N 1.297 -1.61 0 N-CA-C 109.185 -1.566 . . . . 31.02 109.185 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' B' ' 41' ' ' HIS . 1.7 m-20 -109.49 21.53 16.9 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.117 -1.225 . . . . 43.229999999999997 110.243 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.585 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 3.2 mt-10 42.78 25.23 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 42.340000000000003 110.302 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 98.4 m-70 -160.48 152.85 17.24 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.175 -0.953 . . . . 6.9900000000000002 108.511 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.699 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 38.3 Cg_endo -78.44 135.9 13.62 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.93 1.753 . . . . 17.920000000000002 110.468 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.854 HG22 ' O ' ' B' ' 35' ' ' VAL . 2.4 m -111.88 119.34 59.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.62 -0.881 . . . . 20.57 108.62 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.913 HD11 ' HB3' ' B' ' 32' ' ' LEU . 51.4 tp -75.25 103.43 5.4 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.243 -0.91 . . . . 20.210000000000001 110.069 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.744 HG13 HG23 ' B' ' 43' ' ' VAL . 26.1 m -110.4 178.64 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.738 -0.838 . . . . 10.81 108.738 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.466 ' HD3' HD21 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -106.23 127.0 52.91 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.975 -1.09 . . . . 36.740000000000002 109.99 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 1.01 HD13 HD12 ' B' ' 83' ' ' LEU . 0.5 OUTLIER -108.48 163.3 6.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.889 -0.782 . . . . 19.739999999999998 108.889 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.431 HG22 ' N ' ' B' ' 49' ' ' LEU . 56.5 m -99.71 158.7 15.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.985 -1.072 . . . . 22.559999999999999 109.558 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -130.12 105.25 7.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 20.41 109.3 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.6 142.03 2.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 33.990000000000002 109.578 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.9 101.33 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 54.920000000000002 109.353 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.92 -19.97 10.06 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.311 -1.516 . . . . 36.100000000000001 109.311 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -78.43 148.61 74.09 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.283 -1.128 . . . . 54.759999999999998 109.436 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.9 Cg_endo -78.01 120.44 5.02 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.644 2.229 . . . . 28.370000000000001 110.587 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.768 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -38.63 143.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 17.210000000000001 110.37 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.755 ' HB3' HD13 ' B' ' 6' ' ' ILE . 86.8 m-85 -44.59 102.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 17.190000000000001 108.837 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.978 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -53.73 176.06 0.12 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 17.82 109.878 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.978 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -78.48 111.34 3.0 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.719 2.279 . . . . 17.280000000000001 110.237 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 175.24 164.15 29.39 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.918 -1.273 . . . . 17.219999999999999 109.918 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.716 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.5 OUTLIER -60.16 142.82 53.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -1.143 . . . . 19.57 108.706 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.698 ' HB3' HD22 ' B' ' 83' ' ' LEU . 31.8 m-85 -125.86 161.13 28.13 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.679 -1.263 . . . . 14.609999999999999 111.645 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.728 ' O ' HG22 ' B' ' 84' ' ' VAL . 30.8 p -146.28 121.48 10.18 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.325 -1.732 . . . . 18.359999999999999 106.325 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.9 t -52.6 168.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 C-N-CA 118.887 -1.125 . . . . 19.129999999999999 109.342 -178.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.534 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -133.61 127.26 32.64 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.508 -0.745 . . . . 20.649999999999999 109.058 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.873 HD22 ' HA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -71.38 0.38 8.33 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.263 -0.898 . . . . 19.649999999999999 109.975 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.4 p -55.32 -20.47 11.61 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.294 -1.372 . . . . 14.720000000000001 107.294 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 69.8 m -94.35 -27.23 16.2 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.864 -0.522 . . . . 11.449999999999999 109.954 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.69 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.9 m-30 -60.9 156.13 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.05 -1.031 . . . . 14.25 109.069 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.418 ' HE3' ' OD2' ' B' ' 79' ' ' ASP . 0.0 OUTLIER -159.07 172.45 18.12 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.36 -0.837 . . . . 32.700000000000003 109.595 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.78 HG21 HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -97.62 112.42 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.838 . . . . 15.630000000000001 109.392 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.52 -176.1 48.51 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.512 -1.435 . . . . 12.699999999999999 109.512 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -90.0 34.0 0.86 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.196 -1.179 . . . . 26.289999999999999 109.496 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -118.91 15.33 13.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 20.440000000000001 109.598 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.1 48.84 71.13 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.779 -1.328 . . . . 13.82 109.779 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' B' ' 77' ' ' MET . 0.0 OUTLIER -170.84 138.95 1.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -1.162 . . . . 18.27 109.403 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.791 HD11 HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -45.14 163.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 12.43 109.464 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 75' ' ' SER . 6.6 mmt -154.37 100.4 2.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 35.109999999999999 109.835 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.609 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.5 mt -41.13 -61.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.514 0.673 . . . . 13.67 109.689 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 35.5 t0 81.41 -48.28 0.24 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.485 0.66 . . . . 24.059999999999999 109.961 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.0 tpm_? -171.98 66.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.111 0.958 . . . . 35.039999999999999 108.793 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.723 HD13 ' HB2' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -34.87 127.22 0.51 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.529 -0.759 . . . . 18.719999999999999 111.604 -179.252 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -94.94 105.1 16.99 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.18 -1.044 . . . . 20.550000000000001 108.18 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.01 HD12 HD13 ' B' ' 47' ' ' ILE . 0.6 OUTLIER -72.52 149.15 44.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 14.4 111.301 -178.454 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.728 HG22 ' O ' ' B' ' 62' ' ' THR . 34.1 m -150.36 150.62 29.52 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.08 -1.081 . . . . 17.649999999999999 108.08 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.2 Cg_endo -61.94 138.41 73.39 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.04 1.827 . . . . 25.699999999999999 110.295 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.716 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -66.82 116.65 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.319 -0.863 . . . . 49.289999999999999 109.635 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.045 -0.978 . . . . 58.909999999999997 109.469 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.533 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.396 -0.594 . . . . 64.909999999999997 109.396 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.927 ' H ' HD22 ' B' ' 65' ' ' LEU . 1.1 mt 53.02 81.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.689 -1.226 . . . . 33.799999999999997 107.689 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -76.56 157.25 32.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 32.719999999999999 110.777 -178.162 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.864 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -164.07 163.38 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.022 -0.733 . . . . 14.460000000000001 109.022 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 37.5 mt-10 -138.99 114.14 9.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.486 -0.759 . . . . 22.120000000000001 109.039 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -74.36 102.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 119.201 -1.0 . . . . 14.23 108.528 179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.674 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.63 170.85 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.299 -0.875 . . . . 25.43 109.478 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.7 Cg_endo -75.92 -21.73 13.92 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.419 2.08 . . . . 13.609999999999999 109.61 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.32 5.19 50.3 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.17 -0.678 . . . . 15.52 109.17 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.524 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 19.9 mm-40 -124.15 36.04 4.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 17.309999999999999 109.64 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.57 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -105.01 15.7 27.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.062 -1.024 . . . . 24.780000000000001 110.329 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.42 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 38.9 mt-30 -133.86 135.9 44.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 47.899999999999999 109.84 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.708 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 46.9 p90 -92.63 166.66 12.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.189 -0.944 . . . . 21.609999999999999 109.492 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -140.5 145.73 37.25 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.308 -0.87 . . . . 14.890000000000001 109.124 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 17.350000000000001 109.553 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.43 0.634 . . . . 24.0 110.198 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.586 ' CB ' ' CB ' ' A' ' 49' ' ' LEU . 4.3 m120 -51.08 123.2 8.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.811 . . . . 23.309999999999999 109.897 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 35.7 mp0 -98.86 155.16 17.52 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.058 -1.09 . . . . 40.030000000000001 108.058 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 1.2 tm0? -146.52 -179.96 7.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.825 -1.172 . . . . 12.390000000000001 110.384 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.89 ' HB3' HD11 ' A' ' 44' ' ' LEU . 51.0 mt -139.85 145.99 38.77 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.449 -0.782 . . . . 17.420000000000002 110.0 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.764 ' SG ' HD11 ' A' ' 47' ' ' ILE . 4.1 m -152.97 -177.12 6.09 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.148 -1.426 . . . . 13.84 107.148 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.674 ' CD2' ' HD3' ' A' ' 7' ' ' LYS . 27.3 m-85 -128.48 113.48 15.56 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.785 -1.197 . . . . 21.140000000000001 109.922 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.864 HG22 ' HB ' ' A' ' 4' ' ' VAL . 45.4 t -107.09 115.65 49.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.235 -0.916 . . . . 10.66 110.148 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 39' ' ' ASN . 54.8 m-20 -64.5 -36.55 84.55 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.806 -1.183 . . . . 25.890000000000001 107.806 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 46.41 48.21 13.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 24.239999999999998 109.893 179.303 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.04 -1.21 64.25 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.41 -1.476 . . . . 31.02 109.41 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.2 OUTLIER -105.9 95.73 6.0 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.334 -1.098 . . . . 43.229999999999997 108.342 179.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 39' ' ' ASN . 2.5 mp0 -27.33 -41.67 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.437 0.637 . . . . 42.340000000000003 111.083 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' ASN . 48.5 m80 -78.16 141.09 61.99 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 108.638 -0.875 . . . . 6.5700000000000003 108.638 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.65 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -76.23 136.72 18.29 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.898 1.732 . . . . 17.920000000000002 110.478 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.829 HG23 HG23 ' A' ' 45' ' ' VAL . 2.9 m -107.65 117.65 53.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.614 -0.884 . . . . 20.57 108.614 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.89 HD11 ' HB3' ' A' ' 32' ' ' LEU . 61.7 tp -65.8 97.82 0.36 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.514 -0.874 . . . . 20.210000000000001 109.999 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.829 HG23 HG23 ' A' ' 43' ' ' VAL . 21.0 t -99.39 168.46 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.813 -0.81 . . . . 10.81 108.813 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.576 ' N ' HG12 ' A' ' 45' ' ' VAL . 4.0 ptpp? -117.33 147.7 42.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.928 -1.108 . . . . 36.740000000000002 111.565 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.004 HG21 ' CE1' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -112.41 178.0 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.563 -0.903 . . . . 19.739999999999998 108.563 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.431 ' H ' HG22 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -126.24 74.93 1.48 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.187 -0.946 . . . . 22.559999999999999 109.46 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.627 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -42.78 150.75 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.425 -0.797 . . . . 20.41 109.22 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 26.5 t0 -123.13 148.13 46.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 33.990000000000002 109.456 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 48.31 -148.89 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.116 -0.99 . . . . 54.920000000000002 109.257 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.12 16.83 56.28 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.647 -1.381 . . . . 36.100000000000001 109.647 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -45.72 149.33 1.13 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.178 -1.189 . . . . 54.759999999999998 109.469 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.16 113.16 3.35 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.587 2.192 . . . . 28.370000000000001 110.002 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.708 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -39.4 153.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.467 -0.771 . . . . 17.210000000000001 110.25 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 1.004 ' CE1' HG21 ' A' ' 47' ' ' ILE . 84.5 m-85 -50.58 113.11 0.81 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 17.190000000000001 109.351 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.013 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -61.81 177.25 0.38 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 17.82 109.476 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 1.013 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.76 114.43 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.572 2.181 . . . . 17.280000000000001 110.398 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.0 179.88 43.98 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 17.219999999999999 109.556 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.2 mp -73.96 156.04 38.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -1.121 . . . . 19.57 108.577 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.723 ' HB3' HD22 ' A' ' 83' ' ' LEU . 26.6 m-85 -143.75 163.32 33.64 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.568 1.175 . . . . 14.609999999999999 111.577 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.773 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.5 p -145.78 123.17 11.65 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.171 -1.789 . . . . 18.359999999999999 106.171 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.8 t -54.31 169.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 C-N-CA 118.495 -1.282 . . . . 19.129999999999999 108.804 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.547 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.1 t-80 -128.11 124.5 37.11 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.861 -0.792 . . . . 20.649999999999999 108.861 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.969 HD22 ' H ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -64.91 -6.79 9.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.849 -0.532 . . . . 19.649999999999999 109.923 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.4 p -53.91 -16.19 1.72 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.93 -1.106 . . . . 14.720000000000001 108.673 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.495 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 50.1 m -99.52 -4.89 30.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.419 -0.8 . . . . 11.449999999999999 111.052 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -81.65 157.78 24.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.7 -1.25 . . . . 14.25 109.832 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.658 ' HA ' HD21 ' B' ' 37' ' ' LEU . 5.3 pttt -142.98 171.74 13.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.401 -0.812 . . . . 32.700000000000003 109.624 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.61 HG11 HG21 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -125.83 112.68 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 15.630000000000001 109.046 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.95 -173.64 20.09 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.568 -1.413 . . . . 12.699999999999999 109.568 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 72' ' ' GLN . 2.2 mp0 -89.4 34.53 0.81 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.209 -1.171 . . . . 26.289999999999999 109.508 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -133.87 24.7 3.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.405 -0.81 . . . . 20.440000000000001 109.441 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' B' ' 46' ' ' LYS . . . 51.49 56.58 14.74 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 13.82 109.635 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.7 m -148.64 105.27 3.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -1.211 . . . . 18.27 109.752 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 76' ' ' LEU . 5.0 tt -70.23 146.56 50.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 12.43 109.277 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.486 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 4.2 mtm -157.34 144.53 18.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 35.109999999999999 109.583 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.983 HD12 HD12 ' B' ' 78' ' ' ILE . 2.3 mp -69.73 141.76 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 13.67 109.615 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -107.5 -37.2 6.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.809 -1.182 . . . . 24.059999999999999 107.809 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.495 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -167.94 67.53 0.08 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.404 -1.332 . . . . 35.039999999999999 107.404 178.664 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.692 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -27.41 118.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.416 -0.811 . . . . 18.719999999999999 111.632 -178.426 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 20.0 tpt180 -92.09 104.58 16.95 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.066 -1.087 . . . . 20.550000000000001 108.066 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.732 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -72.64 150.7 42.78 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.052 0.929 . . . . 14.4 111.591 -178.159 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 62' ' ' THR . 34.7 m -152.07 154.36 32.42 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.741 -1.207 . . . . 17.649999999999999 107.741 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.4 Cg_endo -62.93 145.93 94.66 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.211 1.941 . . . . 25.699999999999999 110.749 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -75.24 121.85 22.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.238 -0.913 . . . . 49.289999999999999 109.525 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 tptt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.977 -1.011 . . . . 58.909999999999997 109.454 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.535 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.403 -0.591 . . . . 64.909999999999997 109.403 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.969 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.2 mt 52.83 81.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.662 -1.236 . . . . 33.799999999999997 107.662 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.417 ' O ' HG13 ' B' ' 35' ' ' VAL . 0.0 OUTLIER -76.32 157.2 32.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 32.719999999999999 110.839 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.879 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.2 OUTLIER -164.06 163.46 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.014 -0.735 . . . . 14.460000000000001 109.014 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 37.6 mt-10 -139.1 114.06 9.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 22.120000000000001 109.019 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.589 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -74.3 102.17 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 119.183 -1.007 . . . . 14.23 108.46 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.656 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.73 171.03 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.307 -0.871 . . . . 25.43 109.507 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.6 Cg_endo -75.86 -21.93 13.84 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.346 2.031 . . . . 13.609999999999999 109.678 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.18 5.33 50.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.615 -0.678 . . . . 15.52 109.222 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.511 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 19.7 mm-40 -124.23 35.97 4.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 17.309999999999999 109.637 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -104.96 15.63 27.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -0.942 . . . . 24.780000000000001 110.339 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.434 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 38.9 mt-30 -133.78 135.92 44.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.0 . . . . 47.899999999999999 109.916 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 47.0 p90 -92.62 166.68 12.37 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.168 -0.958 . . . . 21.609999999999999 109.519 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 25.0 m -140.54 145.73 37.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 14.890000000000001 109.046 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 17.350000000000001 109.528 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.406 ' HB3' HG22 ' B' ' 48' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.395 0.616 . . . . 24.0 110.134 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.589 ' CB ' ' CB ' ' B' ' 49' ' ' LEU . 4.3 m120 -51.14 123.13 8.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.462 -0.774 . . . . 23.309999999999999 109.947 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 35.6 mp0 -98.76 155.11 17.51 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.082 -1.081 . . . . 40.030000000000001 108.082 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' B' ' 10' ' ' GLN . 1.2 tm0? -146.53 -179.88 7.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.783 -1.198 . . . . 12.390000000000001 110.318 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.891 ' HB3' HD11 ' B' ' 44' ' ' LEU . 50.9 mt -139.98 145.92 38.45 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.442 -0.786 . . . . 17.420000000000002 110.019 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.763 ' SG ' HD11 ' B' ' 47' ' ' ILE . 4.1 m -152.88 -176.98 5.99 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.069 -1.456 . . . . 13.84 107.069 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.656 ' CD2' ' HD3' ' B' ' 7' ' ' LYS . 27.3 m-85 -128.61 113.41 15.39 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.867 -1.146 . . . . 21.140000000000001 109.914 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.879 HG22 ' HB ' ' B' ' 4' ' ' VAL . 45.5 t -107.09 115.83 49.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.293 -0.879 . . . . 10.66 110.126 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' B' ' 39' ' ' ASN . 55.0 m-20 -64.6 -36.48 84.37 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.806 -1.183 . . . . 25.890000000000001 107.806 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.658 HD21 ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 46.34 48.37 13.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.556 -0.715 . . . . 24.239999999999998 109.876 179.333 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.65 -0.72 64.25 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.389 -1.485 . . . . 31.02 109.389 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.2 OUTLIER -106.14 95.93 6.12 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.378 -1.072 . . . . 43.229999999999997 108.278 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' B' ' 39' ' ' ASN . 2.4 mp0 -27.55 -41.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.452 0.644 . . . . 42.340000000000003 111.126 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' B' ' 39' ' ' ASN . 48.5 m80 -78.19 141.2 62.01 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.659 -0.867 . . . . 6.5599999999999996 108.659 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.646 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.6 Cg_endo -76.3 136.7 18.13 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.909 1.739 . . . . 17.920000000000002 110.51 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.839 HG23 HG23 ' B' ' 45' ' ' VAL . 2.9 m -107.6 117.55 53.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.645 -0.872 . . . . 20.57 108.645 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.891 HD11 ' HB3' ' B' ' 32' ' ' LEU . 61.6 tp -65.75 97.79 0.35 Allowed 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.486 -0.885 . . . . 20.210000000000001 110.017 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.839 HG23 HG23 ' B' ' 43' ' ' VAL . 21.2 t -99.4 168.34 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.866 -0.79 . . . . 10.81 108.866 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.559 ' N ' HG12 ' B' ' 45' ' ' VAL . 4.0 ptpp? -117.13 147.8 42.11 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.94 -1.104 . . . . 36.740000000000002 111.59 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 1.019 HG21 ' CZ ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -112.58 177.98 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.564 -0.902 . . . . 19.739999999999998 108.564 179.191 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.435 ' H ' HG22 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -126.16 74.97 1.48 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.118 -0.989 . . . . 22.559999999999999 109.519 179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.624 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -42.85 150.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.428 -0.795 . . . . 20.41 109.129 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 53' ' ' GLN . 26.6 t0 -123.13 148.21 45.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.101 -1.0 . . . . 33.990000000000002 109.446 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 48.18 -148.8 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 54.920000000000002 109.276 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.14 16.78 56.43 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.582 -1.407 . . . . 36.100000000000001 109.582 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -45.64 149.26 1.11 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.198 -1.178 . . . . 54.759999999999998 109.523 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.06 113.19 3.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.614 2.209 . . . . 28.370000000000001 109.938 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.701 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -39.4 153.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.483 -0.761 . . . . 17.210000000000001 110.22 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 1.019 ' CZ ' HG21 ' B' ' 47' ' ' ILE . 84.8 m-85 -50.45 113.0 0.78 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.4 -0.813 . . . . 17.190000000000001 109.238 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -61.86 177.33 0.38 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 17.82 109.483 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.8 Cg_endo -77.6 113.77 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.532 2.155 . . . . 17.280000000000001 110.215 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.33 179.33 44.87 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.724 -1.35 . . . . 17.219999999999999 109.724 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.0 mp -74.06 155.87 38.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -1.173 . . . . 19.57 108.315 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.731 ' HB3' HD22 ' B' ' 83' ' ' LEU . 26.5 m-85 -143.56 163.26 33.67 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.551 1.167 . . . . 14.609999999999999 111.564 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.767 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.3 p -145.67 122.99 11.6 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.283 -1.747 . . . . 18.359999999999999 106.283 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.685 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.8 t -54.28 168.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 C-N-CA 118.497 -1.281 . . . . 19.129999999999999 108.828 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.538 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.1 t-80 -128.05 124.49 37.22 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.418 -0.801 . . . . 20.649999999999999 108.907 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.927 HD22 ' H ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -64.78 -6.9 9.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.82 -0.55 . . . . 19.649999999999999 109.903 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 13.6 p -53.86 -16.14 1.65 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.005 -1.06 . . . . 14.720000000000001 108.616 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.498 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 50.4 m -99.67 -5.32 29.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.475 -0.765 . . . . 11.449999999999999 111.002 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.637 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.8 m-30 -81.26 157.08 25.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.647 -1.283 . . . . 14.25 109.779 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.702 ' HA ' HD21 ' A' ' 37' ' ' LEU . 5.3 pttt -142.28 171.64 13.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.832 . . . . 32.700000000000003 109.66 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -125.65 112.66 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.346 -0.846 . . . . 15.630000000000001 109.092 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.02 -173.64 20.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.586 -1.406 . . . . 12.699999999999999 109.586 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' B' ' 72' ' ' GLN . 2.2 mp0 -89.3 34.5 0.8 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.214 -1.168 . . . . 26.289999999999999 109.503 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.94 24.81 3.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -0.797 . . . . 20.440000000000001 109.439 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . 51.32 56.9 12.92 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.604 -1.399 . . . . 13.82 109.604 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -149.03 105.38 3.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -1.196 . . . . 18.27 109.709 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.689 ' C ' HD23 ' B' ' 76' ' ' LEU . 5.1 tt -70.48 146.65 50.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.865 . . . . 12.43 109.257 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.506 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 4.1 mtm -157.42 144.72 18.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -0.954 . . . . 35.109999999999999 109.515 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.983 HD12 HD12 ' A' ' 78' ' ' ILE . 2.3 mp -70.06 142.12 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 13.67 109.571 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -107.69 -37.07 6.25 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.766 -1.198 . . . . 24.059999999999999 107.766 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.498 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER -168.09 67.6 0.08 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.424 -1.324 . . . . 35.039999999999999 107.424 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.685 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.6 OUTLIER -27.47 118.52 0.09 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.356 -0.838 . . . . 18.719999999999999 111.574 -178.4 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 20.0 tpt180 -91.99 104.85 17.21 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.056 -1.091 . . . . 20.550000000000001 108.056 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.731 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -72.88 150.64 42.45 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.013 0.911 . . . . 14.4 111.538 -178.15 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.767 HG22 ' O ' ' B' ' 62' ' ' THR . 34.7 m -151.99 154.42 32.62 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 107.75 -1.204 . . . . 17.649999999999999 107.75 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.1 Cg_endo -62.89 145.93 94.73 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.176 1.917 . . . . 25.699999999999999 110.774 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -75.27 121.85 22.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.242 -0.911 . . . . 49.289999999999999 109.535 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 tptt . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.017 -0.992 . . . . 58.909999999999997 109.45 -179.942 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.538 ' CG ' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.532 -0.544 . . . . 64.909999999999997 109.532 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.819 ' N ' HD22 ' B' ' 65' ' ' LEU . 3.3 mt -62.17 81.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.044 -1.095 . . . . 33.799999999999997 108.044 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.536 ' HD3' HD21 ' A' ' 60' ' ' LEU . 10.8 mttt -54.98 157.52 3.21 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.857 0.836 . . . . 32.719999999999999 111.508 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.111 HG22 HG22 ' A' ' 35' ' ' VAL . 80.8 t -161.14 166.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.719 0.771 . . . . 14.460000000000001 109.774 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.615 ' N ' HG12 ' A' ' 4' ' ' VAL . 34.1 mt-10 -152.14 105.63 3.08 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.63 -0.878 . . . . 22.120000000000001 108.63 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.766 HD11 ' SG ' ' A' ' 33' ' ' CYS . 0.3 OUTLIER -73.77 104.35 2.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 119.038 -1.065 . . . . 14.23 108.172 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.635 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.75 171.87 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 25.43 109.974 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.5 Cg_endo -75.83 -24.88 11.14 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.468 2.112 . . . . 13.609999999999999 110.211 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.0 t -93.02 0.77 57.44 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.437 -0.789 . . . . 15.52 108.887 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.518 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.6 mm-40 -116.51 43.2 2.26 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.342 -0.849 . . . . 17.309999999999999 108.932 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -108.39 10.02 27.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 24.780000000000001 110.304 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.455 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 1.4 tt0 -136.81 134.34 36.89 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.109 -0.994 . . . . 47.899999999999999 108.952 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 30.2 p90 -87.49 175.48 7.93 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.046 -1.033 . . . . 21.609999999999999 109.756 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -137.57 151.95 48.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.874 -0.787 . . . . 14.890000000000001 108.874 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.531 0 O-C-N 121.229 -0.919 . . . . 17.350000000000001 109.439 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.532 HD22 ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.462 0.649 . . . . 24.0 109.985 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.633 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -98.82 122.58 42.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 23.309999999999999 108.996 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.46 ' OE1' ' HD3' ' A' ' 46' ' ' LYS . 4.8 mt-10 -108.94 156.96 19.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.244 -0.91 . . . . 40.030000000000001 109.887 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.622 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -141.26 -172.85 3.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 12.390000000000001 109.419 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.929 ' HB3' HD11 ' A' ' 44' ' ' LEU . 4.7 mp -133.99 159.16 41.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 17.420000000000002 109.48 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.766 ' SG ' HD11 ' A' ' 6' ' ' ILE . 13.4 m -155.46 177.17 11.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.095 -1.003 . . . . 13.84 108.324 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.689 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 35.3 m-85 -126.65 110.98 13.77 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.093 -1.005 . . . . 21.140000000000001 108.935 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.111 HG22 HG22 ' A' ' 4' ' ' VAL . 50.9 t -89.59 151.66 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.016 -1.053 . . . . 10.66 110.378 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.2 m-20 -129.01 -145.49 0.3 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.713 -0.617 . . . . 25.890000000000001 109.348 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.861 ' HG ' HD21 ' B' ' 65' ' ' LEU . 0.3 OUTLIER 67.6 -65.33 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 24.239999999999998 109.094 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -83.39 6.13 74.07 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 109.028 -1.629 . . . . 31.02 109.028 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' A' ' 38' ' ' GLY . 4.4 m-80 -162.41 109.07 1.27 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.431 -1.041 . . . . 43.229999999999997 109.006 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' ASN . 26.0 mt-10 -39.22 -61.22 0.8 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.617 0.722 . . . . 42.340000000000003 109.632 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 22.8 m80 -71.47 164.55 56.73 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 108.174 -1.047 . . . . 8.3100000000000005 108.174 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.689 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.7 Cg_endo -78.27 140.52 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.868 1.712 . . . . 17.920000000000002 110.6 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.045 HG21 HG21 ' B' ' 70' ' ' VAL . 33.0 m -111.94 113.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.375 -0.828 . . . . 20.57 109.17 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.929 HD11 ' HB3' ' A' ' 32' ' ' LEU . 32.4 tp -67.35 110.66 3.65 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.906 . . . . 20.210000000000001 109.505 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.581 ' CG2' ' N ' ' B' ' 75' ' ' SER . 9.9 p -122.4 153.35 26.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.492 -0.755 . . . . 10.81 109.175 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 2.6 tttt -73.3 148.48 43.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 36.740000000000002 110.055 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.032 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -139.92 123.02 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.724 -0.843 . . . . 19.739999999999998 108.724 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.532 ' CG2' HD22 ' A' ' 28' ' ' LEU . 1.3 m -63.31 156.69 24.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.08 -1.013 . . . . 22.559999999999999 110.05 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.759 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -122.33 117.14 25.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.805 . . . . 20.41 108.902 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -47.13 140.25 5.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 33.990000000000002 109.812 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.85 109.49 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 54.920000000000002 109.478 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.97 -16.72 59.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.6 -1.4 . . . . 36.100000000000001 109.6 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -73.69 150.57 88.78 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.285 -1.127 . . . . 54.759999999999998 109.522 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.33 122.87 5.8 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.665 2.243 . . . . 28.370000000000001 110.184 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.759 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -40.1 147.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.396 -0.815 . . . . 17.210000000000001 110.483 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.621 ' HB3' HD13 ' A' ' 6' ' ' ILE . 89.1 m-85 -47.96 116.22 1.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.483 -0.761 . . . . 17.190000000000001 109.026 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.004 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -66.63 176.77 0.97 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 17.82 109.62 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 1.004 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -78.4 105.6 2.0 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.686 2.257 . . . . 17.280000000000001 110.261 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.49 176.69 48.16 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.99 -1.244 . . . . 17.219999999999999 109.99 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.779 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -73.5 143.59 46.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -1.111 . . . . 19.57 108.426 179.293 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.565 ' CB ' ' HB ' ' A' ' 4' ' ' VAL . 33.3 m-85 -130.29 162.73 28.33 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.773 -1.204 . . . . 14.609999999999999 111.25 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.709 ' O ' HG22 ' A' ' 84' ' ' VAL . 33.4 p -142.9 119.78 11.27 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.896 -1.89 . . . . 18.359999999999999 105.896 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.634 ' HB ' HD13 ' A' ' 2' ' ' ILE . 2.7 t -53.05 166.94 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 C-N-CA 118.59 -1.244 . . . . 19.129999999999999 109.467 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -129.36 130.46 46.08 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.545 -0.722 . . . . 20.649999999999999 109.134 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.879 HD21 ' HG ' ' B' ' 37' ' ' LEU . 0.5 OUTLIER -72.58 1.58 7.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.43 -0.794 . . . . 19.649999999999999 110.116 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -55.42 -19.25 8.69 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.496 -1.298 . . . . 14.720000000000001 107.496 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.516 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 7.1 m -99.07 -3.93 33.56 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.932 -0.48 . . . . 11.449999999999999 110.33 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.4 m-30 -85.41 157.47 20.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.863 -1.148 . . . . 14.25 110.215 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.425 ' HG2' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ptpt -154.41 174.33 15.01 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.023 -0.732 . . . . 32.700000000000003 109.023 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.05 HG21 HG21 ' B' ' 43' ' ' VAL . 1.0 OUTLIER -114.58 111.76 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 15.630000000000001 109.556 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.34 -170.25 46.59 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.315 -1.514 . . . . 12.699999999999999 109.315 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.1 tm0? -90.5 20.79 4.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.154 -1.204 . . . . 26.289999999999999 109.481 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.82 -12.74 35.44 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.501 -0.75 . . . . 20.440000000000001 109.237 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' B' ' 46' ' ' LYS . . . 85.01 35.05 13.12 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.509 -1.436 . . . . 13.82 109.509 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.547 ' N ' ' CG2' ' B' ' 45' ' ' VAL . 22.8 p -164.33 150.82 11.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -1.199 . . . . 18.27 109.647 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.688 HD22 HG21 ' B' ' 2' ' ' ILE . 16.3 tp -63.69 156.74 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.853 . . . . 12.43 109.126 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 32.0 mtt -154.95 113.43 3.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.092 -1.005 . . . . 35.109999999999999 109.749 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.96 HD12 HD12 ' B' ' 78' ' ' ILE . 2.9 mt -55.67 139.91 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.314 -0.866 . . . . 13.67 109.472 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.425 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 10.9 t70 -106.19 -27.39 11.09 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.443 -0.947 . . . . 24.059999999999999 108.443 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.516 ' C ' ' HB3' ' A' ' 67' ' ' SER . 5.7 tpm_? 179.74 67.75 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.992 -1.485 . . . . 35.039999999999999 106.992 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -29.39 118.09 0.13 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.387 -0.824 . . . . 18.719999999999999 111.913 -177.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -92.09 108.14 19.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.716 -1.216 . . . . 20.550000000000001 107.716 178.729 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.032 ' HB2' HD11 ' A' ' 47' ' ' ILE . 12.7 tp -80.25 150.42 30.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.229 -0.919 . . . . 14.4 111.093 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 62' ' ' THR . 25.0 m -147.44 152.47 42.23 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 108.039 -1.097 . . . . 17.649999999999999 108.039 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -62.37 141.58 87.72 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.103 1.868 . . . . 25.699999999999999 110.662 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.779 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.59 116.44 14.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.437 -0.789 . . . . 49.289999999999999 109.625 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.007 -0.996 . . . . 58.909999999999997 109.482 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.535 ' CG ' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.518 -0.549 . . . . 64.909999999999997 109.518 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.832 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.2 mt -62.19 81.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.993 -1.114 . . . . 33.799999999999997 107.993 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 10.8 mttt -54.83 157.37 3.16 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.877 0.846 . . . . 32.719999999999999 111.487 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.031 HG22 HG22 ' B' ' 35' ' ' VAL . 83.1 t -161.09 166.03 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.751 0.786 . . . . 14.460000000000001 109.739 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.619 ' N ' HG12 ' B' ' 4' ' ' VAL . 34.4 mt-10 -151.97 105.69 3.12 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.629 -0.878 . . . . 22.120000000000001 108.629 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.758 HD11 ' SG ' ' B' ' 33' ' ' CYS . 0.3 OUTLIER -73.77 104.55 2.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.01 -1.076 . . . . 14.23 108.178 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.641 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.83 171.9 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.442 -0.786 . . . . 25.43 109.99 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.5 Cg_endo -75.8 -25.04 11.05 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.487 2.125 . . . . 13.609999999999999 110.238 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t -92.8 0.65 57.45 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 108.938 -0.764 . . . . 15.52 108.938 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.6 mm-40 -116.43 43.25 2.24 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.345 -0.847 . . . . 17.309999999999999 108.928 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -108.4 10.09 27.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.91 . . . . 24.780000000000001 110.312 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.454 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 1.4 tt0 -136.86 134.22 36.65 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.114 -0.991 . . . . 47.899999999999999 108.943 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.629 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 30.2 p90 -87.44 175.47 7.95 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.028 -1.045 . . . . 21.609999999999999 109.74 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 59.3 m -137.48 152.04 49.11 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.845 -0.798 . . . . 14.890000000000001 108.845 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.494 0 O-C-N 121.256 -0.903 . . . . 17.350000000000001 109.401 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.519 HD22 ' CG2' ' B' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.478 0.656 . . . . 24.0 109.969 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.628 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -98.75 122.53 42.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.479 -0.763 . . . . 23.309999999999999 109.035 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 4.9 mt-10 -109.0 156.79 19.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.189 -0.944 . . . . 40.030000000000001 109.911 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.623 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -141.13 -172.83 3.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 12.390000000000001 109.423 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.943 ' HB3' HD11 ' B' ' 44' ' ' LEU . 4.7 mp -133.99 159.13 41.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.154 -0.966 . . . . 17.420000000000002 109.412 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.758 ' SG ' HD11 ' B' ' 6' ' ' ILE . 13.1 m -155.41 177.21 11.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.309 -0.997 . . . . 13.84 108.309 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.684 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 34.6 m-85 -126.72 111.04 13.8 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.157 -0.964 . . . . 21.140000000000001 108.92 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 1.031 HG22 HG22 ' B' ' 4' ' ' VAL . 50.9 t -89.69 151.65 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.012 -1.055 . . . . 10.66 110.397 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.1 m-20 -128.92 -145.6 0.3 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.307 -0.627 . . . . 25.890000000000001 109.307 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.879 ' HG ' HD21 ' A' ' 65' ' ' LEU . 0.3 OUTLIER 67.65 -65.4 0.24 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.134 -0.979 . . . . 24.239999999999998 109.057 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -83.27 6.11 73.73 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.041 -1.623 . . . . 31.02 109.041 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' B' ' 38' ' ' GLY . 4.5 m-80 -162.39 109.02 1.27 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.438 -1.036 . . . . 43.229999999999997 108.986 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' B' ' 39' ' ' ASN . 26.1 mt-10 -39.08 -61.39 0.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.701 0.762 . . . . 42.340000000000003 109.573 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.461 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 22.6 m80 -71.24 164.57 56.04 Favored Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 108.256 -1.016 . . . . 8.3399999999999999 108.256 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.684 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.6 Cg_endo -78.32 140.7 17.57 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.855 1.703 . . . . 17.920000000000002 110.507 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 1.05 HG21 HG21 ' A' ' 70' ' ' VAL . 32.9 m -112.13 113.33 43.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.394 -0.816 . . . . 20.57 109.197 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.943 HD11 ' HB3' ' B' ' 32' ' ' LEU . 32.3 tp -67.46 110.72 3.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.313 -0.867 . . . . 20.210000000000001 109.616 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 75' ' ' SER . 9.9 p -122.28 153.81 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.494 -0.754 . . . . 10.81 109.108 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 2.6 tttt -73.73 148.55 42.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 36.740000000000002 110.027 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.999 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.8 OUTLIER -139.75 123.04 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.739 -0.837 . . . . 19.739999999999998 108.739 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.519 ' CG2' HD22 ' B' ' 28' ' ' LEU . 1.3 m -63.39 156.66 25.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.015 -1.053 . . . . 22.559999999999999 109.982 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.764 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -122.26 116.98 25.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.422 -0.799 . . . . 20.41 108.94 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.545 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -47.0 140.33 4.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 33.990000000000002 109.832 -179.486 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.92 109.45 0.83 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 54.920000000000002 109.478 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.99 -16.75 59.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.581 -1.408 . . . . 36.100000000000001 109.581 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.545 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.8 OUTLIER -73.7 150.47 88.71 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -1.148 . . . . 54.759999999999998 109.568 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.7 Cg_endo -78.22 122.82 5.84 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.656 2.237 . . . . 28.370000000000001 110.225 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.764 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -40.11 147.15 0.1 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 17.210000000000001 110.404 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.619 ' HB3' HD13 ' B' ' 6' ' ' ILE . 88.9 m-85 -48.13 115.59 1.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.462 -0.773 . . . . 17.190000000000001 109.171 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -65.64 176.88 0.79 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 17.82 109.583 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 36.1 Cg_endo -78.68 106.72 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.741 2.294 . . . . 17.280000000000001 110.424 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.82 176.9 48.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.876 -1.29 . . . . 17.219999999999999 109.876 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.808 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -73.37 144.14 46.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.385 -1.068 . . . . 19.57 108.632 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.571 ' CB ' ' HB ' ' B' ' 4' ' ' VAL . 33.7 m-85 -130.78 162.82 28.68 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.756 -1.215 . . . . 14.609999999999999 111.375 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.718 ' O ' HG22 ' B' ' 84' ' ' VAL . 33.2 p -143.09 119.68 11.07 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 105.975 -1.861 . . . . 18.359999999999999 105.975 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.639 ' HB ' HD13 ' B' ' 2' ' ' ILE . 2.7 t -53.12 166.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 118.575 -1.25 . . . . 19.129999999999999 109.438 -177.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -129.2 130.32 46.17 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.552 -0.718 . . . . 20.649999999999999 109.196 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.861 HD21 ' HG ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -72.47 1.69 7.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.421 -0.799 . . . . 19.649999999999999 110.092 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -55.49 -19.24 9.02 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.45 -1.315 . . . . 14.720000000000001 107.45 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.509 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 7.0 m -99.08 -3.98 33.42 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.902 -0.499 . . . . 11.449999999999999 110.351 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.659 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.3 m-30 -85.35 157.62 20.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.913 -1.117 . . . . 14.25 110.182 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.422 ' HG2' ' HB2' ' B' ' 79' ' ' ASP . 1.5 ptpt -154.57 174.17 15.32 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.991 -0.744 . . . . 32.700000000000003 108.991 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 1.045 HG21 HG21 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -114.44 111.77 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 15.630000000000001 109.55 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.2 -170.24 46.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.332 -1.507 . . . . 12.699999999999999 109.332 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 1.1 tm0? -90.65 21.17 4.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.138 -1.213 . . . . 26.289999999999999 109.458 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.16 -12.82 34.31 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.448 -0.782 . . . . 20.440000000000001 109.253 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.48 ' C ' HG22 ' A' ' 45' ' ' VAL . . . 85.15 34.72 13.82 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.546 -1.422 . . . . 13.82 109.546 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.581 ' N ' ' CG2' ' A' ' 45' ' ' VAL . 21.9 p -163.93 150.87 11.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -1.183 . . . . 18.27 109.683 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.715 HD22 HG21 ' A' ' 2' ' ' ILE . 16.3 tp -63.72 157.0 25.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 12.43 109.09 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' B' ' 76' ' ' LEU . 31.9 mtt -155.15 113.5 3.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.013 . . . . 35.109999999999999 109.679 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.96 HD12 HD12 ' A' ' 78' ' ' ILE . 2.9 mt -55.74 139.95 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 13.67 109.476 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.422 ' HB2' ' HG2' ' B' ' 69' ' ' LYS . 10.7 t70 -106.19 -27.3 11.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.417 -0.957 . . . . 24.059999999999999 108.417 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.509 ' C ' ' HB3' ' B' ' 67' ' ' SER . 5.8 tpm_? 179.65 67.78 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.956 -1.498 . . . . 35.039999999999999 106.956 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.639 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -29.34 118.13 0.13 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.349 -0.841 . . . . 18.719999999999999 111.85 -177.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -92.2 108.07 19.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.709 -1.219 . . . . 20.550000000000001 107.709 178.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.999 ' HB2' HD11 ' B' ' 47' ' ' ILE . 12.6 tp -80.13 150.26 30.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.184 -0.947 . . . . 14.4 111.07 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.718 HG22 ' O ' ' B' ' 62' ' ' THR . 25.0 m -147.32 152.58 42.9 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.111 -1.07 . . . . 17.649999999999999 108.111 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.3 Cg_endo -62.32 141.72 88.51 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.166 1.91 . . . . 25.699999999999999 110.666 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -73.69 116.54 14.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 49.289999999999999 109.497 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.959 -1.02 . . . . 58.909999999999997 109.425 179.999 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.308 0.575 . . . . 64.909999999999997 109.484 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.696 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.7 mt 69.3 72.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.975 -1.12 . . . . 33.799999999999997 107.975 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.497 ' C ' HG23 ' A' ' 4' ' ' VAL . 18.8 mttt -54.1 158.74 2.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.017 0.913 . . . . 32.719999999999999 111.461 -178.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.05 ' CG2' HG22 ' A' ' 35' ' ' VAL . 66.4 t -160.46 168.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.93 -0.766 . . . . 14.460000000000001 108.93 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.589 ' N ' HG12 ' A' ' 4' ' ' VAL . 43.1 mt-10 -154.6 103.26 2.45 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.79 0.805 . . . . 22.120000000000001 108.843 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.561 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -69.34 108.43 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.893 -1.151 . . . . 14.23 107.893 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.654 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.11 172.79 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.203 -0.936 . . . . 25.43 109.406 -179.042 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.5 Cg_endo -76.23 -21.6 13.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.475 2.117 . . . . 13.609999999999999 110.128 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.42 4.15 46.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.529 -0.732 . . . . 15.52 109.443 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.699 ' OE1' HD12 ' A' ' 32' ' ' LEU . 24.0 mm-40 -114.84 38.71 3.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 17.309999999999999 109.288 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.13 52.24 0.72 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.877 . . . . 24.780000000000001 109.738 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.63 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 5.0 pt20 -176.63 135.63 0.24 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.364 -0.835 . . . . 47.899999999999999 108.896 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.634 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 37.7 p90 -95.61 172.67 7.91 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.721 -1.237 . . . . 21.609999999999999 109.874 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 8.0 t -137.03 162.03 34.43 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.497 -0.927 . . . . 14.890000000000001 108.497 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.623 0 O-C-N 121.178 -0.951 . . . . 17.350000000000001 109.271 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.772 ' C ' HD12 ' A' ' 28' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.523 0.678 . . . . 24.0 110.903 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.611 ' CB ' ' CD1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -72.47 127.67 33.26 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.931 -0.766 . . . . 23.309999999999999 108.931 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.7 ' CG ' HD11 ' A' ' 28' ' ' LEU . 6.6 mt-10 -118.11 165.51 13.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.018 -1.051 . . . . 40.030000000000001 109.281 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.652 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -146.37 179.99 7.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.106 -0.996 . . . . 12.390000000000001 109.671 -179.604 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.699 HD12 ' OE1' ' A' ' 10' ' ' GLN . 39.3 mt -123.92 154.04 40.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 17.420000000000002 109.316 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 11.1 m -154.06 172.98 16.65 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.611 -1.255 . . . . 13.84 107.611 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.847 ' CE2' HD13 ' A' ' 44' ' ' LEU . 29.2 m-85 -121.45 99.03 6.24 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.951 -1.093 . . . . 21.140000000000001 109.45 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.05 HG22 ' CG2' ' A' ' 4' ' ' VAL . 61.7 t -93.73 126.16 46.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.041 -1.037 . . . . 10.66 110.602 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' GLY . 25.3 t0 -101.19 44.66 1.0 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.591 -1.263 . . . . 25.890000000000001 107.591 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.83 HD21 HG22 ' B' ' 70' ' ' VAL . 0.1 OUTLIER -35.77 -29.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.223 0.535 . . . . 24.239999999999998 110.197 -178.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.628 ' H ' HD12 ' A' ' 37' ' ' LEU . . . 160.84 52.3 0.02 OUTLIER Glycine 0 N--CA 1.479 1.535 0 N-CA-C 109.438 -1.465 . . . . 31.02 109.438 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.508 HD21 ' C ' ' A' ' 38' ' ' GLY . 5.8 m120 -126.83 17.98 7.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.07 -1.253 . . . . 43.229999999999997 110.035 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.591 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 2.6 mm-40 56.56 14.64 1.77 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.326 -0.859 . . . . 42.340000000000003 110.252 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 77.5 m-70 -162.53 161.72 19.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.326 -0.99 . . . . 6.1600000000000001 108.326 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.691 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.0 Cg_endo -78.06 136.57 14.78 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.892 1.728 . . . . 17.920000000000002 110.021 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.916 HG22 ' O ' ' A' ' 35' ' ' VAL . 3.6 m -111.34 115.24 49.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.249 -0.907 . . . . 20.57 109.453 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.847 HD13 ' CE2' ' A' ' 34' ' ' TYR . 18.9 tp -71.76 88.73 1.01 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.182 -0.949 . . . . 20.210000000000001 109.482 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.478 HG22 ' C ' ' B' ' 74' ' ' GLY . 6.1 p -103.21 152.88 5.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.632 -0.877 . . . . 10.81 108.632 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 3.7 mtpt -72.08 167.03 21.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 36.740000000000002 110.493 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.983 ' CD1' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -146.47 177.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.567 -0.901 . . . . 19.739999999999998 108.567 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.769 HG23 HD13 ' A' ' 28' ' ' LEU . 97.8 m -117.6 151.29 37.47 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.186 -0.946 . . . . 22.559999999999999 109.464 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.651 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -124.74 149.19 47.56 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.291 -1.003 . . . . 20.41 108.291 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' H ' HD13 ' A' ' 49' ' ' LEU . 23.4 t0 -106.18 143.5 34.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.078 -1.014 . . . . 33.990000000000002 110.202 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.21 127.04 14.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 54.920000000000002 109.477 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.7 -28.67 7.47 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.652 -1.379 . . . . 36.100000000000001 109.652 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.97 137.35 72.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.198 -1.178 . . . . 54.759999999999998 109.564 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.5 Cg_endo -78.58 124.2 6.26 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.413 2.075 . . . . 28.370000000000001 109.959 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.652 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -40.24 147.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.4 -0.812 . . . . 17.210000000000001 110.0 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 84.9 m-85 -45.9 105.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 17.190000000000001 109.137 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -58.1 174.79 0.32 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 17.82 109.628 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.78 114.15 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.605 2.203 . . . . 17.280000000000001 110.149 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.25 179.76 46.0 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.474 -1.45 . . . . 17.219999999999999 109.474 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.6 mp -75.4 146.31 40.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -1.217 . . . . 19.57 108.111 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.682 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.4 m-85 -133.07 167.43 20.32 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.866 -1.146 . . . . 14.609999999999999 111.591 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.642 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.8 p -150.59 119.5 6.65 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.336 -1.727 . . . . 18.359999999999999 106.336 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.602 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -52.01 164.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.374 -1.33 . . . . 19.129999999999999 108.568 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.533 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -123.47 123.89 41.65 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.397 -0.814 . . . . 20.649999999999999 109.003 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.717 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.2 OUTLIER -67.94 -4.02 11.73 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.834 -0.542 . . . . 19.649999999999999 110.209 -179.307 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.3 t -55.98 -15.86 4.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.076 -1.015 . . . . 14.720000000000001 108.449 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.49 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 16.6 m -95.76 -7.0 38.39 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.525 -0.734 . . . . 11.449999999999999 110.633 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.664 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -83.15 159.64 22.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.818 -1.176 . . . . 14.25 109.674 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.766 ' HA ' HD22 ' B' ' 37' ' ' LEU . 10.3 mtmt -157.82 172.14 19.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.49 -0.756 . . . . 32.700000000000003 109.253 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.794 HG22 HD21 ' B' ' 37' ' ' LEU . 0.0 OUTLIER -107.78 98.29 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 15.630000000000001 109.008 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.8 -149.92 4.11 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.825 -1.31 . . . . 12.699999999999999 109.825 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.3 21.04 17.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.27 -1.135 . . . . 26.289999999999999 109.685 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.09 -11.98 42.46 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.05 -0.722 . . . . 20.440000000000001 109.05 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 84.69 24.23 46.9 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.495 -1.442 . . . . 13.82 109.495 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.7 p -161.03 152.25 18.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -1.179 . . . . 18.27 109.633 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 76' ' ' LEU . 4.7 tt -62.95 149.23 45.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.319 -0.863 . . . . 12.43 109.381 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.51 ' N ' HD23 ' A' ' 76' ' ' LEU . 14.3 mtt -150.55 133.98 16.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 35.109999999999999 109.412 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' B' ' 78' ' ' ILE . 3.2 mt -66.29 139.24 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.877 . . . . 13.67 109.721 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 8.3 t70 -106.64 -19.58 13.62 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.507 -0.923 . . . . 24.059999999999999 108.507 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.49 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 172.71 68.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.198 -1.408 . . . . 35.039999999999999 107.198 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -31.63 116.88 0.19 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.693 0.758 . . . . 18.719999999999999 111.179 -178.14 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.01 104.97 17.49 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.463 -0.94 . . . . 20.550000000000001 108.463 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.983 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -73.38 144.82 46.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 14.4 111.024 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 62' ' ' THR . 27.6 m -146.72 156.61 48.32 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.956 -1.128 . . . . 17.649999999999999 107.956 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.0 Cg_endo -63.03 144.97 93.89 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.134 1.889 . . . . 25.699999999999999 110.334 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.11 115.73 12.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.135 -0.978 . . . . 49.289999999999999 109.705 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.02 -0.99 . . . . 58.909999999999997 109.531 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.534 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.399 -0.593 . . . . 64.909999999999997 109.399 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.717 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.7 mt 68.6 72.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.874 -1.158 . . . . 33.799999999999997 107.874 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.494 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 18.9 mttt -54.4 158.62 2.32 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.009 0.909 . . . . 32.719999999999999 111.412 -178.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.072 ' CG2' HG22 ' B' ' 35' ' ' VAL . 68.2 t -160.25 168.0 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.994 -0.743 . . . . 14.460000000000001 108.994 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.612 ' N ' HG12 ' B' ' 4' ' ' VAL . 42.3 mt-10 -154.02 103.09 2.54 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.418 -0.801 . . . . 22.120000000000001 108.975 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.559 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -69.18 108.53 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.934 -1.135 . . . . 14.23 107.934 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.661 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.25 172.5 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 25.43 109.36 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 35.1 Cg_endo -76.16 -21.39 13.81 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.488 2.125 . . . . 13.609999999999999 110.122 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.63 4.15 45.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.475 -0.765 . . . . 15.52 109.442 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.696 ' OE1' HD12 ' B' ' 32' ' ' LEU . 24.1 mm-40 -114.69 38.36 3.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.93 . . . . 17.309999999999999 109.187 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.14 53.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 24.780000000000001 109.709 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.614 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 4.8 pt20 -177.24 135.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.376 -0.828 . . . . 47.899999999999999 108.884 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.628 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 37.9 p90 -95.77 172.75 7.84 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.753 -1.217 . . . . 21.609999999999999 109.891 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 8.3 t -137.28 161.91 34.94 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.488 -0.93 . . . . 14.890000000000001 108.488 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.615 0 O-C-N 121.17 -0.956 . . . . 17.350000000000001 109.438 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.774 ' C ' HD12 ' B' ' 28' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.577 0.703 . . . . 24.0 110.846 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.624 ' CB ' ' CD1' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -72.38 127.47 32.67 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.894 -0.78 . . . . 23.309999999999999 108.894 179.03 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.712 ' CG ' HD11 ' B' ' 28' ' ' LEU . 6.5 mt-10 -118.06 165.24 13.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.012 -1.055 . . . . 40.030000000000001 109.322 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.63 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.9 OUTLIER -146.03 -179.9 7.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.137 -0.977 . . . . 12.390000000000001 109.765 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.696 HD12 ' OE1' ' B' ' 10' ' ' GLN . 40.3 mt -124.2 153.71 41.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 17.420000000000002 109.309 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 10.3 m -153.73 172.98 16.44 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.716 -1.216 . . . . 13.84 107.716 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.829 ' CE2' HD13 ' B' ' 44' ' ' LEU . 29.3 m-85 -121.39 98.91 6.19 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.895 -1.128 . . . . 21.140000000000001 109.461 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 1.072 HG22 ' CG2' ' B' ' 4' ' ' VAL . 61.7 t -93.6 126.17 46.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.03 -1.044 . . . . 10.66 110.573 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' B' ' 38' ' ' GLY . 26.1 t0 -101.11 44.37 1.02 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.579 -1.267 . . . . 25.890000000000001 107.579 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.794 HD21 HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -35.65 -30.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.1 0.476 . . . . 24.239999999999998 110.185 -178.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.626 ' H ' HD12 ' B' ' 37' ' ' LEU . . . 161.05 51.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 109.415 -1.474 . . . . 31.02 109.415 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.501 HD21 ' C ' ' B' ' 38' ' ' GLY . 5.8 m120 -126.54 18.28 7.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.167 -1.196 . . . . 43.229999999999997 110.092 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.59 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 2.6 mm-40 56.36 14.58 1.65 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.237 -0.914 . . . . 42.340000000000003 110.302 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 77.4 m-70 -162.41 161.6 20.14 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.344 -0.984 . . . . 6.1500000000000004 108.344 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.694 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.8 Cg_endo -78.02 136.55 14.83 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.877 1.718 . . . . 17.920000000000002 109.998 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.911 HG22 ' O ' ' B' ' 35' ' ' VAL . 3.6 m -111.39 115.42 49.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.242 -0.911 . . . . 20.57 109.339 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.829 HD13 ' CE2' ' B' ' 34' ' ' TYR . 19.0 tp -71.99 88.8 1.08 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.219 -0.926 . . . . 20.210000000000001 109.503 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.42 HG22 ' C ' ' A' ' 74' ' ' GLY . 6.3 p -103.0 153.38 5.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.648 -0.871 . . . . 10.81 108.648 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 3.8 mtpt -72.32 167.44 20.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 36.740000000000002 110.428 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.975 ' CD1' HD12 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -146.94 177.12 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.628 -0.878 . . . . 19.739999999999998 108.628 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.771 HG23 HD13 ' B' ' 28' ' ' LEU . 98.5 m -117.39 151.28 37.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.123 -0.986 . . . . 22.559999999999999 109.468 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -124.88 148.86 48.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.226 -1.028 . . . . 20.41 108.226 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.465 ' H ' HD13 ' B' ' 49' ' ' LEU . 23.2 t0 -105.95 143.61 33.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 33.990000000000002 110.076 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.22 126.84 13.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.771 . . . . 54.920000000000002 109.528 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.81 -28.49 7.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.712 -1.355 . . . . 36.100000000000001 109.712 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.08 137.45 72.53 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.277 -1.131 . . . . 54.759999999999998 109.483 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.57 124.14 6.24 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.394 2.063 . . . . 28.370000000000001 109.96 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.666 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -40.29 147.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 17.210000000000001 109.913 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 84.1 m-85 -46.2 105.85 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 17.190000000000001 109.252 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.918 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.85 174.65 0.31 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 17.82 109.59 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.918 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -77.99 115.18 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.624 2.216 . . . . 17.280000000000001 110.43 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.49 -179.46 44.87 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.31 -1.516 . . . . 17.219999999999999 109.31 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 4.0 mp -75.29 146.86 40.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.134 -1.216 . . . . 19.57 108.457 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.672 ' HB3' HD22 ' B' ' 83' ' ' LEU . 19.9 m-85 -133.54 167.69 20.01 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.498 1.142 . . . . 14.609999999999999 111.452 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.646 ' O ' HG22 ' B' ' 84' ' ' VAL . 45.8 p -150.87 119.45 6.49 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.296 -1.742 . . . . 18.359999999999999 106.296 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.598 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -52.0 163.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.404 -1.318 . . . . 19.129999999999999 108.597 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -123.16 124.35 42.86 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.406 -0.809 . . . . 20.649999999999999 109.022 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.706 HD11 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -68.24 -3.95 12.47 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.879 -0.513 . . . . 19.649999999999999 110.169 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 10.4 t -55.93 -16.08 4.27 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.132 -0.98 . . . . 14.720000000000001 108.376 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.497 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 16.6 m -95.66 -6.7 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.609 -0.682 . . . . 11.449999999999999 110.707 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.665 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.9 m-30 -83.33 159.78 21.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.852 -1.155 . . . . 14.25 109.657 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.794 ' HA ' HD22 ' A' ' 37' ' ' LEU . 10.3 mtmt -158.09 171.29 20.5 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.475 -0.766 . . . . 32.700000000000003 109.269 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.83 HG22 HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -106.99 98.59 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 15.630000000000001 108.959 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.44 -150.47 4.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.707 -1.357 . . . . 12.699999999999999 109.707 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.78 21.64 16.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.238 -1.154 . . . . 26.289999999999999 109.859 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.66 -11.82 41.38 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.02 -0.733 . . . . 20.440000000000001 109.02 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.478 ' C ' HG22 ' A' ' 45' ' ' VAL . . . 84.44 24.99 44.82 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.532 -1.427 . . . . 13.82 109.532 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.7 p -161.68 152.18 17.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -1.17 . . . . 18.27 109.639 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.685 ' C ' HD23 ' B' ' 76' ' ' LEU . 4.6 tt -63.14 149.24 45.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 12.43 109.412 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.507 ' N ' HD23 ' B' ' 76' ' ' LEU . 14.4 mtt -150.44 133.69 16.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 35.109999999999999 109.502 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' A' ' 78' ' ' ILE . 3.2 mt -66.18 138.86 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 13.67 109.686 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 8.2 t70 -106.23 -19.87 13.57 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.558 -0.905 . . . . 24.059999999999999 108.558 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.497 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 173.0 68.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.208 -1.404 . . . . 35.039999999999999 107.208 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.636 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -32.03 117.04 0.21 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.672 0.748 . . . . 18.719999999999999 111.214 -178.117 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.523 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.15 105.0 17.51 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.473 -0.936 . . . . 20.550000000000001 108.473 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.975 HD12 ' CD1' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -73.34 145.05 46.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 14.4 110.96 -178.775 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.646 HG22 ' O ' ' B' ' 62' ' ' THR . 28.0 m -147.04 156.41 47.11 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 107.938 -1.134 . . . . 17.649999999999999 107.938 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.8 Cg_endo -62.87 144.77 94.02 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.185 1.923 . . . . 25.699999999999999 110.338 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -72.93 115.91 12.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.194 -0.941 . . . . 49.289999999999999 109.681 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' B' ' 86' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.973 -1.013 . . . . 58.909999999999997 109.528 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.598 ' C ' HD22 ' B' ' 65' ' ' LEU . 1.4 pmm? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.545 -0.539 . . . . 64.909999999999997 109.545 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.992 ' N ' HD22 ' B' ' 65' ' ' LEU . 1.8 mt -58.42 85.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.887 -1.153 . . . . 33.799999999999997 107.887 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 20.7 mttt -63.61 157.97 22.49 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.815 0.817 . . . . 32.719999999999999 111.595 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.061 HG22 HG22 ' A' ' 35' ' ' VAL . 58.8 t -160.01 167.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-O 121.609 0.719 . . . . 14.460000000000001 109.691 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.584 ' N ' HG12 ' A' ' 4' ' ' VAL . 77.3 mt-10 -154.95 107.14 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.705 -0.85 . . . . 22.120000000000001 108.705 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.744 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -74.54 107.96 5.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 118.991 -1.083 . . . . 14.23 108.3 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.675 ' CD ' ' CD1' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.44 171.85 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.449 -0.782 . . . . 25.43 110.011 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.3 Cg_endo -76.7 -25.61 9.12 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.59 2.193 . . . . 13.609999999999999 109.753 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.73 8.39 44.39 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.921 -0.77 . . . . 15.52 108.921 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.528 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 10.2 mm-40 -121.38 32.83 5.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.277 -0.889 . . . . 17.309999999999999 109.474 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.424 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -97.91 11.47 37.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.141 -0.974 . . . . 24.780000000000001 110.324 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -138.77 138.01 37.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.032 -1.042 . . . . 47.899999999999999 110.104 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.646 ' CD2' HD12 ' A' ' 49' ' ' LEU . 11.6 p90 -88.37 173.29 8.82 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.397 -0.814 . . . . 21.609999999999999 109.769 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 10.0 t -130.91 163.97 26.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.535 -0.913 . . . . 14.890000000000001 108.535 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.591 0 O-C-N 121.147 -0.97 . . . . 17.350000000000001 109.575 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.785 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.937 0.875 . . . . 24.0 110.877 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.653 ' N ' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -105.49 128.64 53.67 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.57 -0.9 . . . . 23.309999999999999 108.57 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.546 ' HG3' HD21 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -111.38 151.14 28.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.988 -1.07 . . . . 40.030000000000001 109.972 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.554 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -133.71 175.86 9.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.895 . . . . 12.390000000000001 109.523 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.822 ' HB3' HD11 ' A' ' 44' ' ' LEU . 3.5 mp -127.31 155.52 43.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 17.420000000000002 109.131 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.622 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.9 m -153.73 -176.81 6.0 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.316 -0.994 . . . . 13.84 108.316 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.676 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 35.2 m-85 -130.75 102.92 6.3 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.117 -0.989 . . . . 21.140000000000001 109.561 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.061 HG22 HG22 ' A' ' 4' ' ' VAL . 78.7 t -90.8 125.94 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.07 -1.019 . . . . 10.66 110.324 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 39' ' ' ASN . 3.7 m-20 -68.51 -41.93 79.3 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.589 -0.893 . . . . 25.890000000000001 108.589 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.686 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.6 OUTLIER 47.51 48.24 16.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.798 . . . . 24.239999999999998 109.77 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.06 4.94 51.3 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.321 -1.511 . . . . 31.02 109.321 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.5 OUTLIER -104.58 95.76 6.13 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.356 -1.085 . . . . 43.229999999999997 108.47 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 39' ' ' ASN . 9.3 mt-10 -30.6 -37.31 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.41 0.624 . . . . 42.340000000000003 110.81 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -85.24 146.37 44.89 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 108.644 -0.873 . . . . 5.25 108.644 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.676 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.9 Cg_endo -76.37 137.11 18.42 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.967 1.778 . . . . 17.920000000000002 110.599 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.993 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.8 m -108.68 113.93 45.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.366 -0.833 . . . . 20.57 109.162 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.822 HD11 ' HB3' ' A' ' 32' ' ' LEU . 28.0 tp -65.63 110.28 2.7 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.368 -0.832 . . . . 20.210000000000001 109.386 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.6 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 6.6 t -115.52 165.46 10.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.518 -0.739 . . . . 10.81 109.351 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.555 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 9.8 mtpt -96.42 125.44 40.91 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.488 -0.885 . . . . 36.740000000000002 109.457 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.038 HD13 HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -117.4 136.26 55.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.31 -0.869 . . . . 19.739999999999998 109.332 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.482 ' OG1' ' CZ ' ' A' ' 80' ' ' ARG . 12.5 m -68.05 163.7 21.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.113 -0.992 . . . . 22.559999999999999 109.303 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.646 HD12 ' CD2' ' A' ' 13' ' ' PHE . 1.1 tm? -151.89 93.42 1.84 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.807 -0.812 . . . . 20.41 108.807 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.401 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -145.28 -158.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 33.990000000000002 109.823 -179.413 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 48.94 -154.18 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 54.920000000000002 109.159 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . -79.61 -2.44 88.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.445 -1.462 . . . . 36.100000000000001 109.445 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -73.41 114.28 30.17 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.286 -1.126 . . . . 54.759999999999998 110.118 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 52' ' ' GLY . 36.4 Cg_endo -80.3 153.44 21.27 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.5 2.133 . . . . 28.370000000000001 110.243 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.627 ' HB2' ' CD2' ' A' ' 13' ' ' PHE . . . -39.74 128.25 2.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.288 -0.882 . . . . 17.210000000000001 110.296 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.744 ' O ' HG21 ' A' ' 6' ' ' ILE . 86.7 m-85 -47.5 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.783 . . . . 17.190000000000001 109.009 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -48.76 175.61 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 17.82 109.589 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.5 Cg_endo -77.05 128.31 9.82 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.637 2.225 . . . . 17.280000000000001 110.192 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.06 176.73 32.46 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.614 -1.394 . . . . 17.219999999999999 109.614 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.8 mp -74.21 146.49 43.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -1.162 . . . . 19.57 108.362 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.717 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.2 m-85 -131.79 163.66 27.72 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.902 -1.124 . . . . 14.609999999999999 111.274 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.692 ' O ' HG22 ' A' ' 84' ' ' VAL . 24.1 p -146.38 120.77 9.64 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.414 -1.698 . . . . 18.359999999999999 106.414 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.976 ' CG1' HD12 ' A' ' 81' ' ' LEU . 6.2 t -49.19 168.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 C-N-CA 118.837 -1.145 . . . . 19.129999999999999 108.776 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.7 t-80 -135.37 124.53 24.46 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.393 -0.817 . . . . 20.649999999999999 109.11 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.989 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.2 OUTLIER -68.63 -5.3 19.28 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.285 -0.885 . . . . 19.649999999999999 109.572 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.5 t -55.94 -18.28 8.72 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.367 -0.975 . . . . 14.720000000000001 108.367 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -101.48 -5.53 25.12 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.525 -0.735 . . . . 11.449999999999999 110.187 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.698 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -75.36 157.9 33.57 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.919 -1.113 . . . . 14.25 108.938 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.598 ' HA ' HD21 ' B' ' 37' ' ' LEU . 20.5 mttt -146.63 164.44 32.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 32.700000000000003 109.797 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.738 HG13 HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -111.57 112.18 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 15.630000000000001 109.156 179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.5 -176.93 43.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.457 -1.457 . . . . 12.699999999999999 109.457 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.528 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.1 tm0? -90.57 22.54 3.42 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.158 -1.201 . . . . 26.289999999999999 109.367 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.25 -16.37 31.39 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.425 -0.797 . . . . 20.440000000000001 109.318 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 90.14 28.02 19.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.651 -1.38 . . . . 13.82 109.651 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' LEU . 58.0 m -161.0 124.54 3.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -1.182 . . . . 18.27 109.485 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.738 HD12 HG13 ' A' ' 70' ' ' VAL . 1.1 tp -46.94 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 12.43 109.333 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -162.5 113.57 1.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -0.923 . . . . 35.109999999999999 109.526 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.4 mt -43.14 -40.01 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.511 -0.743 . . . . 13.67 110.178 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 80' ' ' ARG . 1.6 t70 45.77 55.16 7.12 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.407 -0.96 . . . . 24.059999999999999 108.407 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 80.22 88.52 0.05 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.674 -0.861 . . . . 35.039999999999999 108.674 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.976 HD12 ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -65.46 157.87 28.32 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.752 0.787 . . . . 18.719999999999999 111.268 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 5.7 ttt180 -106.93 102.1 11.48 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.128 -1.064 . . . . 20.550000000000001 108.128 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.038 HD12 HD13 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -75.06 147.29 40.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.003 -1.061 . . . . 14.4 111.205 -178.375 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 62' ' ' THR . 33.9 m -147.85 155.56 44.4 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.094 -1.076 . . . . 17.649999999999999 108.094 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.55 144.02 83.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.091 1.861 . . . . 25.699999999999999 110.277 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -72.83 128.11 34.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 49.289999999999999 109.521 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 86' ' ' ALA . 29.7 mmtm . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.062 -0.97 . . . . 58.909999999999997 109.487 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.578 ' C ' HD22 ' A' ' 65' ' ' LEU . 1.4 pmm? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.435 -0.58 . . . . 64.909999999999997 109.435 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.989 ' N ' HD22 ' A' ' 65' ' ' LEU . 1.9 mt -58.64 85.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.842 -1.17 . . . . 33.799999999999997 107.842 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 20.7 mttt -63.63 157.99 22.48 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.804 0.812 . . . . 32.719999999999999 111.6 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.024 HG22 HG22 ' B' ' 35' ' ' VAL . 58.6 t -159.94 167.38 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.592 0.71 . . . . 14.460000000000001 109.68 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.598 ' N ' HG12 ' B' ' 4' ' ' VAL . 77.6 mt-10 -154.83 107.18 2.74 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.761 -0.829 . . . . 22.120000000000001 108.761 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.717 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -74.52 107.82 5.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 118.983 -1.087 . . . . 14.23 108.322 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.672 ' CD ' ' CD1' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.4 171.85 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.438 -0.789 . . . . 25.43 109.967 -179.064 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.5 Cg_endo -76.69 -25.68 9.06 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.598 2.199 . . . . 13.609999999999999 109.718 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.65 8.24 44.68 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.94 -0.763 . . . . 15.52 108.94 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 10.0 mm-40 -121.21 32.84 5.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.262 -0.898 . . . . 17.309999999999999 109.547 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.405 ' HB1' ' HD3' ' B' ' 58' ' ' PRO . . . -97.96 11.48 37.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.97 . . . . 24.780000000000001 110.338 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.407 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 51.0 mt-30 -138.78 138.14 37.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -0.993 . . . . 47.899999999999999 110.055 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.651 ' CD2' HD12 ' B' ' 49' ' ' LEU . 11.5 p90 -88.5 173.21 8.81 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.426 -0.796 . . . . 21.609999999999999 109.74 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 10.0 t -130.85 164.1 25.97 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.512 -0.921 . . . . 14.890000000000001 108.512 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.562 0 O-C-N 121.103 -0.998 . . . . 17.350000000000001 109.611 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.799 HD22 ' C ' ' B' ' 28' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.888 0.852 . . . . 24.0 110.896 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.66 ' N ' HD22 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -105.52 128.7 53.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.603 -0.888 . . . . 23.309999999999999 108.603 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.555 ' HG3' HD21 ' B' ' 28' ' ' LEU . 0.9 OUTLIER -111.51 151.03 29.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.992 -1.068 . . . . 40.030000000000001 109.971 -179.335 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.55 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.7 OUTLIER -133.64 175.89 9.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 12.390000000000001 109.486 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.836 ' HB3' HD11 ' B' ' 44' ' ' LEU . 3.6 mp -127.27 155.59 43.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 17.420000000000002 109.164 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.634 ' O ' HD12 ' B' ' 44' ' ' LEU . 1.9 m -153.78 -176.75 5.98 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.296 -1.001 . . . . 13.84 108.296 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' CD ' ' B' ' 7' ' ' LYS . 35.4 m-85 -130.86 102.9 6.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.164 -0.96 . . . . 21.140000000000001 109.544 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 1.024 HG22 HG22 ' B' ' 4' ' ' VAL . 78.5 t -90.78 125.96 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.004 -1.06 . . . . 10.66 110.307 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' B' ' 39' ' ' ASN . 3.8 m-20 -68.46 -41.95 79.47 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.601 -0.889 . . . . 25.890000000000001 108.601 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.688 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER 47.49 48.2 16.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.421 -0.799 . . . . 24.239999999999998 109.749 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.16 4.78 51.23 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.348 -1.501 . . . . 31.02 109.348 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.5 OUTLIER -104.44 95.72 6.12 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.33 -1.1 . . . . 43.229999999999997 108.507 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' B' ' 39' ' ' ASN . 9.3 mt-10 -30.52 -37.35 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.471 0.653 . . . . 42.340000000000003 110.858 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -85.2 146.4 45.06 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.64 -0.874 . . . . 5.2300000000000004 108.64 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.9 Cg_endo -76.37 137.09 18.4 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.958 1.772 . . . . 17.920000000000002 110.551 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.984 HG22 ' O ' ' B' ' 35' ' ' VAL . 5.9 m -108.7 114.0 45.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.362 -0.836 . . . . 20.57 109.076 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' B' ' 32' ' ' LEU . 28.8 tp -65.66 110.1 2.64 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.407 -0.808 . . . . 20.210000000000001 109.372 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.587 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 6.5 t -115.36 165.4 10.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.493 -0.755 . . . . 10.81 109.306 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.554 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 9.8 mtpt -96.31 125.52 40.87 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.538 -0.865 . . . . 36.740000000000002 109.492 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 1.021 HD13 HD12 ' B' ' 83' ' ' LEU . 0.8 OUTLIER -117.43 136.38 54.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.331 -0.856 . . . . 19.739999999999998 109.368 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.483 ' OG1' ' CZ ' ' B' ' 80' ' ' ARG . 12.6 m -68.18 163.67 22.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 22.559999999999999 109.285 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.651 HD12 ' CD2' ' B' ' 13' ' ' PHE . 1.1 tm? -151.9 93.41 1.84 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.35 -158.0 0.85 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 33.990000000000002 109.836 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 49.02 -154.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 54.920000000000002 109.162 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' B' ' 54' ' ' PRO . . . -79.62 -2.2 87.72 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.512 -1.435 . . . . 36.100000000000001 109.512 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -73.59 114.37 31.41 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.251 -1.147 . . . . 54.759999999999998 110.008 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' B' ' 52' ' ' GLY . 36.3 Cg_endo -80.29 153.33 21.27 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.512 2.141 . . . . 28.370000000000001 110.244 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.64 ' HB2' ' CD2' ' B' ' 13' ' ' PHE . . . -39.84 128.43 2.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.358 -0.839 . . . . 17.210000000000001 110.26 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.717 ' O ' HG21 ' B' ' 6' ' ' ILE . 85.2 m-85 -47.79 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.871 -0.788 . . . . 17.190000000000001 108.871 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.945 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -50.5 175.72 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.86 . . . . 17.82 109.394 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.945 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.6 Cg_endo -77.34 129.5 10.35 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.611 2.207 . . . . 17.280000000000001 110.503 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.89 177.15 30.73 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.424 -1.47 . . . . 17.219999999999999 109.424 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 4.1 mp -73.73 146.99 43.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.222 -1.163 . . . . 19.57 108.794 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.692 ' HB3' HD22 ' B' ' 83' ' ' LEU . 19.6 m-85 -132.24 163.78 27.84 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.957 -1.089 . . . . 14.609999999999999 111.319 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.685 ' O ' HG22 ' B' ' 84' ' ' VAL . 24.3 p -146.54 120.86 9.59 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.424 -1.695 . . . . 18.359999999999999 106.424 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.978 ' CG1' HD12 ' B' ' 81' ' ' LEU . 6.1 t -49.37 168.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 C-N-CA 118.82 -1.152 . . . . 19.129999999999999 108.826 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.543 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.7 t-80 -135.21 124.5 24.64 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.393 -0.817 . . . . 20.649999999999999 109.089 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.992 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -68.61 -5.4 19.75 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.244 -0.91 . . . . 19.649999999999999 109.533 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 33.4 t -55.79 -18.44 8.48 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.306 -0.998 . . . . 14.720000000000001 108.306 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -101.31 -5.92 24.8 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.544 -0.722 . . . . 11.449999999999999 110.185 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.697 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.9 m-30 -75.02 157.72 34.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.91 -1.119 . . . . 14.25 108.893 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.599 ' HA ' HD21 ' A' ' 37' ' ' LEU . 20.6 mttt -146.36 164.78 31.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -0.979 . . . . 32.700000000000003 109.815 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.724 HG13 HD12 ' B' ' 76' ' ' LEU . 0.2 OUTLIER -111.83 112.12 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.415 -0.803 . . . . 15.630000000000001 109.158 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.51 -177.0 43.03 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.481 -1.448 . . . . 12.699999999999999 109.481 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 1.1 tm0? -90.54 22.57 3.39 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.146 -1.208 . . . . 26.289999999999999 109.348 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.29 -16.36 31.31 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.46 -0.775 . . . . 20.440000000000001 109.363 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 90.39 27.62 19.73 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.665 -1.374 . . . . 13.82 109.665 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 76' ' ' LEU . 58.0 m -160.76 124.53 3.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -1.223 . . . . 18.27 109.569 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.724 HD12 HG13 ' B' ' 70' ' ' VAL . 1.1 tp -46.93 170.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 12.43 109.357 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' B' ' 76' ' ' LEU . 0.8 OUTLIER -162.48 113.58 1.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 35.109999999999999 109.553 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.4 mt -43.11 -40.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.48 -0.763 . . . . 13.67 110.212 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' B' ' 80' ' ' ARG . 1.6 t70 45.85 55.17 7.2 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.354 -0.98 . . . . 24.059999999999999 108.354 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 80.21 88.57 0.05 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.69 -0.856 . . . . 35.039999999999999 108.69 -178.81 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.978 HD12 ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -65.4 157.89 28.11 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.779 0.799 . . . . 18.719999999999999 111.267 -178.697 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 5.7 ttt180 -107.06 102.09 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.065 -1.087 . . . . 20.550000000000001 108.065 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.021 HD12 HD13 ' B' ' 47' ' ' ILE . 0.4 OUTLIER -75.04 147.45 40.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.047 -1.033 . . . . 14.4 111.162 -178.355 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.685 HG22 ' O ' ' B' ' 62' ' ' THR . 33.8 m -148.02 155.31 43.83 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 108.11 -1.07 . . . . 17.649999999999999 108.11 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.1 Cg_endo -64.33 143.95 84.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.153 1.902 . . . . 25.699999999999999 110.257 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -72.79 128.08 34.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 49.289999999999999 109.586 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' B' ' 86' ' ' ALA . 29.7 mmtm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.047 -0.978 . . . . 58.909999999999997 109.519 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.33 -0.618 . . . . 64.909999999999997 109.33 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.844 ' CA ' HD22 ' B' ' 65' ' ' LEU . 4.8 mt 73.74 75.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.162 -1.051 . . . . 33.799999999999997 108.162 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -68.99 155.35 40.49 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.756 0.788 . . . . 32.719999999999999 110.841 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.875 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -160.35 167.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.534 -0.913 . . . . 14.460000000000001 108.534 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.542 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 60.3 mt-10 -143.52 109.67 5.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 22.120000000000001 109.534 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.734 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -72.29 101.04 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.899 -1.149 . . . . 14.23 107.899 179.218 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.676 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.42 169.84 0.07 OUTLIER Pre-proline 0 N--CA 1.486 1.361 0 O-C-N 121.306 -0.871 . . . . 25.43 109.611 -179.227 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -75.3 -24.09 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.444 2.096 . . . . 13.609999999999999 109.812 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -93.31 1.39 56.99 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.094 -0.706 . . . . 15.52 109.094 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.487 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 29.3 mm-40 -120.08 39.7 3.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 17.309999999999999 109.165 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.65 22.44 15.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.119 -0.988 . . . . 24.780000000000001 110.22 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -142.72 132.71 24.33 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.054 -1.029 . . . . 47.899999999999999 108.786 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.636 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 33.3 p90 -88.56 176.88 6.95 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.013 -1.054 . . . . 21.609999999999999 109.774 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 16.1 m -130.7 153.75 48.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.674 -0.862 . . . . 14.890000000000001 108.674 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.551 0 O-C-N 121.211 -0.931 . . . . 17.350000000000001 109.439 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.547 HD22 HG22 ' A' ' 48' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.435 0.636 . . . . 24.0 109.96 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.636 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -99.05 129.92 45.35 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.451 -0.944 . . . . 23.309999999999999 108.451 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.07 152.55 33.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.998 -1.064 . . . . 40.030000000000001 109.612 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.859 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -135.24 171.54 14.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 12.390000000000001 109.897 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.838 ' HB3' HD11 ' A' ' 44' ' ' LEU . 3.3 mm? -105.89 179.13 4.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 17.420000000000002 110.252 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -173.51 158.16 3.37 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.85 -1.167 . . . . 13.84 107.85 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.676 ' CD2' ' HD3' ' A' ' 7' ' ' LYS . 20.1 m-85 -111.98 106.33 14.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.964 -1.085 . . . . 21.140000000000001 109.36 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.881 ' O ' HG22 ' A' ' 43' ' ' VAL . 25.7 t -107.4 117.59 53.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 10.66 110.627 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -95.3 41.29 1.1 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.543 -1.281 . . . . 25.890000000000001 107.543 178.248 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 38' ' ' GLY . 1.7 pp -35.19 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.377 0.608 . . . . 24.239999999999998 110.319 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.882 ' N ' HD12 ' A' ' 37' ' ' LEU . . . 165.55 50.81 0.02 OUTLIER Glycine 0 C--N 1.298 -1.576 0 C-N-CA 119.333 -1.413 . . . . 31.02 109.696 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 61.9 m-20 -126.13 18.26 7.74 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.223 -1.163 . . . . 43.229999999999997 110.101 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 51.3 mt-10 58.96 27.8 16.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 42.340000000000003 109.949 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 3.3 p-80 176.42 162.62 0.47 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.531 -0.914 . . . . 6.3700000000000001 108.531 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.651 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.7 Cg_endo -76.5 135.74 16.71 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.774 1.65 . . . . 17.920000000000002 110.231 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.938 HG21 HG21 ' B' ' 70' ' ' VAL . 2.9 m -111.1 117.31 54.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.648 -0.821 . . . . 20.57 108.994 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 32' ' ' LEU . 41.1 tp -70.75 95.94 1.18 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.292 -0.88 . . . . 20.210000000000001 109.167 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.439 HG23 HG12 ' B' ' 70' ' ' VAL . 4.4 p -105.65 161.28 5.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.6 -0.687 . . . . 10.81 109.35 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.22 -177.75 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 36.740000000000002 110.634 -179.005 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.62 HD12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -167.66 149.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.115 -1.069 . . . . 19.739999999999998 108.115 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.606 ' H ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -91.58 152.97 20.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.864 -1.148 . . . . 22.559999999999999 109.476 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -131.93 102.82 6.0 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.471 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 29.4 t70 -44.87 142.45 1.78 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 33.990000000000002 109.739 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.25 103.31 0.37 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.825 . . . . 54.920000000000002 109.322 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.1 -25.14 7.98 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.367 -1.493 . . . . 36.100000000000001 109.367 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 31.3 mt-30 -76.48 147.76 79.26 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.323 -1.104 . . . . 54.759999999999998 109.229 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.6 Cg_endo -78.12 126.13 7.62 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.662 2.241 . . . . 28.370000000000001 110.39 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.859 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -40.03 156.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.419 -0.801 . . . . 17.210000000000001 110.02 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.734 ' O ' HG21 ' A' ' 6' ' ' ILE . 74.3 m-85 -58.27 111.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 17.190000000000001 109.153 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.803 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -56.58 170.05 0.55 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 17.82 109.782 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.803 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.17 106.07 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.678 2.252 . . . . 17.280000000000001 110.392 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.11 -176.12 43.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.585 -1.406 . . . . 17.219999999999999 109.585 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -76.28 138.84 40.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -1.142 . . . . 19.57 108.613 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.679 ' HB3' HD22 ' A' ' 83' ' ' LEU . 25.5 m-85 -128.63 164.65 22.42 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.776 -1.203 . . . . 14.609999999999999 111.699 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.732 ' O ' HG22 ' A' ' 84' ' ' VAL . 47.6 p -145.46 121.89 10.99 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.268 -1.753 . . . . 18.359999999999999 106.268 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.62 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -54.41 167.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 118.632 -1.227 . . . . 19.129999999999999 108.624 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.508 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -130.12 126.57 37.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.249 -0.907 . . . . 20.649999999999999 109.501 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.841 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER -73.06 1.53 8.82 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.425 -0.797 . . . . 19.649999999999999 110.034 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 t -57.29 -19.05 19.61 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.383 -1.34 . . . . 14.720000000000001 107.383 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 69.8 m -95.12 -25.02 16.6 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.127 0.489 . . . . 11.449999999999999 110.179 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.696 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.2 m-30 -61.92 158.95 15.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.98 . . . . 14.25 109.486 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.73 176.24 12.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 32.700000000000003 109.404 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.961 HG21 HG21 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -113.44 123.37 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 15.630000000000001 109.387 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.75 -162.06 28.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.378 -1.489 . . . . 12.699999999999999 109.378 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.461 ' HB2' ' SD ' ' A' ' 77' ' ' MET . 0.3 OUTLIER 59.27 72.22 0.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -1.188 . . . . 26.289999999999999 109.311 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.3 OUTLIER 70.41 6.66 5.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 20.440000000000001 109.381 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.03 45.21 5.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.492 -1.443 . . . . 13.82 109.492 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -129.13 140.46 51.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 18.27 109.522 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.583 ' HB2' HD13 ' B' ' 81' ' ' LEU . 0.2 OUTLIER -43.69 158.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 12.43 109.355 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.52 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -165.54 104.73 0.72 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 35.109999999999999 110.112 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.829 HD12 HD12 ' B' ' 78' ' ' ILE . 1.1 mt -41.12 -64.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.613 0.721 . . . . 13.67 109.738 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 15.6 t70 84.86 -46.69 0.08 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.481 0.657 . . . . 24.059999999999999 110.003 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.581 ' O ' ' CB ' ' A' ' 67' ' ' SER . 1.9 tpm_? -171.25 66.56 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.491 -0.929 . . . . 35.039999999999999 108.491 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.62 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.3 pt? -39.58 125.7 1.79 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.659 0.742 . . . . 18.719999999999999 111.71 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -92.51 106.67 18.62 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.434 -0.95 . . . . 20.550000000000001 108.434 178.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.792 HD21 HG11 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -72.66 151.89 42.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.294 -0.879 . . . . 14.4 111.056 -178.684 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 62' ' ' THR . 33.1 m -154.08 156.4 31.9 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.011 -1.107 . . . . 17.649999999999999 108.011 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.2 Cg_endo -62.64 144.16 93.7 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.184 1.923 . . . . 25.699999999999999 110.201 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -75.91 117.04 17.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.14 -0.975 . . . . 49.289999999999999 109.557 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.99 -1.005 . . . . 58.909999999999997 109.416 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.497 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.336 -0.616 . . . . 64.909999999999997 109.336 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.841 ' CA ' HD22 ' A' ' 65' ' ' LEU . 4.8 mt 73.72 75.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.064 -1.087 . . . . 33.799999999999997 108.064 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -69.16 155.49 40.3 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.778 0.799 . . . . 32.719999999999999 110.788 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.864 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -160.45 168.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.548 -0.908 . . . . 14.460000000000001 108.548 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.536 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 60.1 mt-10 -143.79 109.75 5.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.33 -0.856 . . . . 22.120000000000001 109.536 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.722 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -72.35 100.98 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.942 -1.133 . . . . 14.23 107.942 179.254 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.676 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.37 169.78 0.07 OUTLIER Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 25.43 109.602 -179.244 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.0 Cg_endo -75.23 -24.06 12.83 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.419 2.079 . . . . 13.609999999999999 109.777 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -93.28 1.4 57.02 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.526 -0.734 . . . . 15.52 109.1 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.493 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 29.1 mm-40 -120.06 39.51 3.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.262 -0.899 . . . . 17.309999999999999 109.171 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.49 22.45 15.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 24.780000000000001 110.3 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -142.7 132.8 24.49 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.997 -1.064 . . . . 47.899999999999999 108.843 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.632 ' CD1' ' CB ' ' B' ' 29' ' ' ASN . 33.4 p90 -88.63 176.8 6.96 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.007 -1.058 . . . . 21.609999999999999 109.746 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.3 m -130.68 153.68 48.72 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.737 -0.838 . . . . 14.890000000000001 108.737 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.609 0 O-C-N 121.251 -0.906 . . . . 17.350000000000001 109.501 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.552 HD22 HG22 ' B' ' 48' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.345 0.593 . . . . 24.0 110.011 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.632 ' CB ' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -99.07 129.92 45.37 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.478 -0.934 . . . . 23.309999999999999 108.478 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.03 152.58 33.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.037 -1.04 . . . . 40.030000000000001 109.572 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.837 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -135.21 171.53 14.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.153 -0.967 . . . . 12.390000000000001 109.94 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' B' ' 44' ' ' LEU . 3.3 mm? -105.79 179.28 4.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 17.420000000000002 110.219 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -173.69 158.27 3.29 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.797 -1.186 . . . . 13.84 107.797 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.676 ' CD2' ' HD3' ' B' ' 7' ' ' LYS . 20.2 m-85 -112.13 106.4 15.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.988 -1.07 . . . . 21.140000000000001 109.309 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.867 ' O ' HG22 ' B' ' 43' ' ' VAL . 25.4 t -107.57 117.46 53.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 10.66 110.633 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.2 OUTLIER -95.21 41.34 1.1 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.433 -1.321 . . . . 25.890000000000001 107.433 178.289 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.881 HD12 ' N ' ' B' ' 38' ' ' GLY . 1.6 pp -35.29 -31.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.397 0.618 . . . . 24.239999999999998 110.284 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.881 ' N ' HD12 ' B' ' 37' ' ' LEU . . . 165.83 50.98 0.02 OUTLIER Glycine 0 C--N 1.298 -1.559 0 C-N-CA 119.286 -1.435 . . . . 31.02 109.653 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.581 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 62.1 m-20 -126.19 18.37 7.7 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.164 -1.198 . . . . 43.229999999999997 110.116 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 39' ' ' ASN . 51.2 mt-10 58.79 27.87 16.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.139 -0.976 . . . . 42.340000000000003 109.956 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 3.3 p-80 176.38 162.35 0.46 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 6.3799999999999999 108.594 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.662 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.7 Cg_endo -76.39 135.68 16.87 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.77 1.646 . . . . 17.920000000000002 110.24 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.961 HG21 HG21 ' A' ' 70' ' ' VAL . 2.9 m -111.01 117.4 54.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.358 -0.839 . . . . 20.57 108.997 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' B' ' 32' ' ' LEU . 41.8 tp -70.86 95.82 1.2 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.643 -0.823 . . . . 20.210000000000001 109.215 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.454 HG23 HG12 ' A' ' 70' ' ' VAL . 4.4 p -105.46 161.37 5.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.612 -0.68 . . . . 10.81 109.448 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.42 ' HA ' HD13 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -71.3 -177.84 1.89 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 36.740000000000002 110.552 -179.073 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.64 HD12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -167.61 149.63 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.069 -1.085 . . . . 19.739999999999998 108.069 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.587 ' H ' HD13 ' B' ' 47' ' ' ILE . 0.2 OUTLIER -91.82 153.15 19.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.839 -1.163 . . . . 22.559999999999999 109.429 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -132.21 102.96 5.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.741 -0.837 . . . . 20.41 108.741 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.441 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 29.4 t70 -45.12 142.45 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 33.990000000000002 109.898 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.1 103.41 0.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 54.920000000000002 109.319 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.93 -25.16 8.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.37 -1.492 . . . . 36.100000000000001 109.37 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.462 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 31.5 mt-30 -76.39 147.72 79.48 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.265 -1.138 . . . . 54.759999999999998 109.301 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.7 Cg_endo -78.05 126.31 7.78 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.591 2.194 . . . . 28.370000000000001 110.391 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.837 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -40.11 156.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.396 -0.815 . . . . 17.210000000000001 110.024 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.722 ' O ' HG21 ' B' ' 6' ' ' ILE . 73.3 m-85 -58.11 111.01 1.05 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.4 -0.813 . . . . 17.190000000000001 109.077 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.813 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -56.76 170.04 0.57 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 17.82 109.799 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.813 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -77.76 104.99 1.95 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.71 2.273 . . . . 17.280000000000001 110.118 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.3 -176.6 41.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.708 -1.357 . . . . 17.219999999999999 109.708 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.697 HD23 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -76.53 138.34 40.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -1.146 . . . . 19.57 108.366 179.143 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.715 ' HB3' HD22 ' B' ' 83' ' ' LEU . 25.5 m-85 -128.08 164.46 22.37 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.729 -1.232 . . . . 14.609999999999999 111.607 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.729 ' O ' HG22 ' B' ' 84' ' ' VAL . 46.9 p -145.13 122.04 11.31 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.175 -1.787 . . . . 18.359999999999999 106.175 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.621 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -54.73 167.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 118.562 -1.255 . . . . 19.129999999999999 108.594 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -130.4 126.68 37.66 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.271 -0.893 . . . . 20.649999999999999 109.49 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.844 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -73.18 1.17 9.78 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.434 -0.791 . . . . 19.649999999999999 110.014 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -56.86 -19.38 17.2 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.323 -1.362 . . . . 14.720000000000001 107.323 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 70.9 m -94.77 -25.06 16.82 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.146 0.498 . . . . 11.449999999999999 110.201 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.2 m-30 -61.93 158.59 15.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 14.25 109.466 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.4 176.29 12.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 32.700000000000003 109.407 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.938 HG21 HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -113.45 123.57 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 15.630000000000001 109.34 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.53 -162.2 29.29 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.426 -1.47 . . . . 12.699999999999999 109.426 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.3 OUTLIER 59.43 72.13 0.54 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -1.189 . . . . 26.289999999999999 109.328 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.3 OUTLIER 70.45 6.81 5.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 20.440000000000001 109.322 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.84 45.25 5.2 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.438 -1.465 . . . . 13.82 109.438 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.423 ' O ' ' C ' ' B' ' 76' ' ' LEU . 0.3 OUTLIER -129.16 140.34 51.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -1.167 . . . . 18.27 109.48 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.576 ' HB2' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -43.58 158.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -0.895 . . . . 12.43 109.376 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 0.6 OUTLIER -165.49 104.93 0.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.962 . . . . 35.109999999999999 110.083 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.829 HD12 HD12 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -41.37 -64.4 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.556 0.694 . . . . 13.67 109.682 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.545 ' N ' HG22 ' B' ' 78' ' ' ILE . 15.4 t70 84.74 -46.52 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.422 0.63 . . . . 24.059999999999999 110.007 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' B' ' 67' ' ' SER . 1.9 tpm_? -171.42 66.41 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.036 0.922 . . . . 35.039999999999999 108.517 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.621 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.2 pt? -39.41 125.65 1.71 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.653 0.739 . . . . 18.719999999999999 111.721 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.7 OUTLIER -92.48 106.59 18.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.517 -0.919 . . . . 20.550000000000001 108.517 178.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.786 HD21 HG11 ' B' ' 4' ' ' VAL . 0.6 OUTLIER -72.64 151.72 42.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.183 -0.948 . . . . 14.4 111.072 -178.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.729 HG22 ' O ' ' B' ' 62' ' ' THR . 33.4 m -153.86 156.53 32.16 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 107.959 -1.126 . . . . 17.649999999999999 107.959 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.3 Cg_endo -62.83 144.32 93.33 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.117 1.878 . . . . 25.699999999999999 110.151 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -75.96 117.03 17.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.242 -0.911 . . . . 49.289999999999999 109.617 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.009 -0.996 . . . . 58.909999999999997 109.458 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.504 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.416 -0.587 . . . . 64.909999999999997 109.416 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.751 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.7 mt -66.89 79.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.598 -1.26 . . . . 33.799999999999997 107.598 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -74.33 159.96 31.7 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.907 0.861 . . . . 32.719999999999999 110.595 -178.186 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.712 HG11 HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -162.43 167.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.437 -0.949 . . . . 14.460000000000001 108.437 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.534 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 33.2 mt-10 -142.3 112.54 7.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 22.120000000000001 109.693 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.717 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -75.25 99.52 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.815 -1.18 . . . . 14.23 107.815 179.071 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.665 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.1 mttm -53.88 165.8 0.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.357 -0.84 . . . . 25.43 109.762 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 29.8 Cg_endo -70.89 -15.61 32.85 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.922 1.748 . . . . 13.609999999999999 108.796 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.14 -2.65 49.46 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.905 -0.776 . . . . 15.52 108.905 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.583 ' OE1' HD12 ' A' ' 32' ' ' LEU . 15.7 mm-40 -129.49 43.66 3.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.205 -0.935 . . . . 17.309999999999999 109.581 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.83 20.03 16.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.05 -1.031 . . . . 24.780000000000001 110.068 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 11.5 mt-30 -135.73 140.63 44.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.121 -0.987 . . . . 47.899999999999999 109.689 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.717 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 41.3 p90 -94.78 164.01 13.12 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.201 -0.937 . . . . 21.609999999999999 109.469 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.1 m -135.07 147.26 49.54 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.341 -0.85 . . . . 14.890000000000001 109.181 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.479 0 O-C-N 121.273 -0.892 . . . . 17.350000000000001 109.364 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.381 0.61 . . . . 24.0 110.313 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.515 ' CG ' ' CD1' ' A' ' 13' ' ' PHE . 86.0 m-20 -68.59 109.99 4.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.364 -0.835 . . . . 23.309999999999999 109.041 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 18.6 mt-10 -87.01 -173.33 4.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.219 -0.925 . . . . 40.030000000000001 109.899 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.56 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 1.7 tm0? -176.33 -177.84 0.9 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.852 . . . . 12.390000000000001 109.47 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.724 ' CB ' HD11 ' A' ' 44' ' ' LEU . 13.3 mt -140.98 168.93 18.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 17.420000000000002 109.366 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -164.91 161.87 20.37 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.055 -1.091 . . . . 13.84 108.055 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.679 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 49.6 m-85 -111.44 111.72 22.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.994 -1.066 . . . . 21.140000000000001 109.716 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.672 ' CG1' HD23 ' A' ' 37' ' ' LEU . 4.6 t -106.87 140.39 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 10.66 110.871 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -111.72 39.34 2.39 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.556 -1.276 . . . . 25.890000000000001 107.556 178.526 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.809 HD21 HG22 ' B' ' 70' ' ' VAL . 1.1 pp -63.5 58.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.976 -0.452 . . . . 24.239999999999998 110.468 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 107.33 1.87 35.47 Favored Glycine 0 N--CA 1.482 1.76 0 C-N-CA 119.609 -1.282 . . . . 31.02 109.902 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 40' ' ' GLU . 1.2 m-20 -124.87 98.78 5.85 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.23 -1.159 . . . . 43.229999999999997 108.528 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -32.61 -56.85 0.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.55 0.691 . . . . 42.340000000000003 110.579 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 39' ' ' ASN . 7.2 m-70 -66.25 152.16 94.65 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 108.638 -0.875 . . . . 5.6799999999999997 108.638 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.679 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.8 Cg_endo -77.34 139.75 18.87 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.982 1.788 . . . . 17.920000000000002 110.041 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.826 HG21 HG21 ' B' ' 70' ' ' VAL . 3.4 m -112.91 115.4 49.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.317 -0.865 . . . . 20.57 109.569 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.724 HD11 ' CB ' ' A' ' 32' ' ' LEU . 59.9 tp -72.51 101.62 3.02 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.875 . . . . 20.210000000000001 109.867 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.686 HG12 ' CG1' ' B' ' 70' ' ' VAL . 2.6 m -99.82 -168.94 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.977 -0.749 . . . . 10.81 108.977 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.677 ' HA ' HD23 ' A' ' 32' ' ' LEU . 1.3 mtpp -106.57 178.61 4.51 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.507 -0.877 . . . . 36.740000000000002 110.809 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -157.64 156.47 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.242 -1.021 . . . . 19.739999999999998 108.242 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -111.46 68.57 0.67 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.12 -0.988 . . . . 22.559999999999999 109.479 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.0 HD11 ' O ' ' A' ' 53' ' ' GLN . 2.2 tm? -42.12 114.8 0.59 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.492 -0.755 . . . . 20.41 109.306 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.727 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -57.32 151.81 15.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 33.990000000000002 109.89 -179.385 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -63.53 117.5 6.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 54.920000000000002 109.223 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.62 -27.35 19.2 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.301 -1.52 . . . . 36.100000000000001 109.301 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 1.0 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -69.16 146.27 96.83 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.281 -1.129 . . . . 54.759999999999998 109.286 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.5 Cg_endo -77.52 119.76 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.577 2.184 . . . . 28.370000000000001 110.642 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.717 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -41.41 144.3 0.36 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -0.826 . . . . 17.210000000000001 110.035 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.717 ' O ' HG21 ' A' ' 6' ' ' ILE . 15.4 m-30 -45.3 108.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 17.190000000000001 109.135 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.918 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -59.04 173.87 0.43 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.056 -1.028 . . . . 17.82 109.055 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.918 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.9 Cg_endo -77.52 110.41 2.96 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.42 2.08 . . . . 17.280000000000001 110.024 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.53 -178.99 48.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.867 -1.293 . . . . 17.219999999999999 109.867 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -77.54 140.59 39.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -1.085 . . . . 19.57 108.511 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.732 ' HB3' HD22 ' A' ' 83' ' ' LEU . 17.9 m-85 -130.0 163.96 25.34 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.771 -1.205 . . . . 14.609999999999999 111.81 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.634 ' O ' HG22 ' A' ' 84' ' ' VAL . 48.9 p -145.69 121.61 10.65 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.442 -1.688 . . . . 18.359999999999999 106.442 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.587 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -51.27 167.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.792 -1.163 . . . . 19.129999999999999 109.2 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -128.25 127.47 42.88 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.833 -0.803 . . . . 20.649999999999999 108.833 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.754 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.5 OUTLIER -71.39 0.66 7.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.477 -0.764 . . . . 19.649999999999999 110.014 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 t -57.12 -17.69 11.8 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.787 -1.19 . . . . 14.720000000000001 107.787 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 16.5 m -97.81 -5.45 34.77 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.782 -0.574 . . . . 11.449999999999999 110.372 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.674 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.3 m-30 -83.6 159.77 21.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.936 -1.102 . . . . 14.25 109.771 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.589 ' HA ' HD11 ' B' ' 37' ' ' LEU . 53.7 mttm -149.11 173.25 13.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.773 . . . . 32.700000000000003 109.302 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.827 HG21 HG21 ' B' ' 43' ' ' VAL . 0.9 OUTLIER -107.28 116.12 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 15.630000000000001 108.932 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 175.93 4.86 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.779 -1.328 . . . . 12.699999999999999 109.779 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.06 12.7 8.98 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.214 -1.168 . . . . 26.289999999999999 109.763 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.457 ' O ' ' HG3' ' B' ' 46' ' ' LYS . 0.1 OUTLIER -123.25 19.37 9.84 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.532 -0.73 . . . . 20.440000000000001 109.201 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 45' ' ' VAL . . . 67.53 57.27 9.31 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.794 -1.322 . . . . 13.82 109.794 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.0 t -146.65 134.77 21.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.171 -1.193 . . . . 18.27 109.871 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.759 HD11 HD22 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -76.98 145.17 38.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 12.43 109.071 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.497 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 11.0 mtm -157.09 120.33 4.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.037 . . . . 35.109999999999999 109.926 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.833 HD12 HD12 ' B' ' 78' ' ' ILE . 3.3 mt -62.34 136.88 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 13.67 109.374 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.34 -30.41 11.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.166 -1.05 . . . . 24.059999999999999 108.166 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.6 tpm_? -176.42 71.06 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.049 -1.463 . . . . 35.039999999999999 107.049 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -30.89 118.29 0.18 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.731 0.776 . . . . 18.719999999999999 111.579 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 6.1 mtp180 -89.35 110.94 21.68 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.015 -1.106 . . . . 20.550000000000001 108.015 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -81.93 144.38 30.99 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.141 -0.975 . . . . 14.4 111.164 -178.479 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 62' ' ' THR . 11.9 m -145.98 158.91 47.96 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.705 -1.22 . . . . 17.649999999999999 107.705 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.1 Cg_endo -61.79 145.77 97.02 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.02 1.813 . . . . 25.699999999999999 110.145 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.18 119.8 17.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.156 -0.965 . . . . 49.289999999999999 109.732 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.985 -1.007 . . . . 58.909999999999997 109.411 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.496 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.432 -0.581 . . . . 64.909999999999997 109.432 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.754 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.7 mt -66.89 78.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.586 -1.265 . . . . 33.799999999999997 107.586 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -74.2 159.84 31.98 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.934 0.873 . . . . 32.719999999999999 110.595 -178.224 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.705 HG11 HD21 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -162.41 167.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.442 -0.947 . . . . 14.460000000000001 108.442 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.535 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 33.7 mt-10 -142.32 112.7 7.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 22.120000000000001 109.659 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.712 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -75.41 99.7 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.759 -1.201 . . . . 14.23 107.759 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.673 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.2 mttm -54.02 165.83 0.73 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.821 . . . . 25.43 109.785 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 29.9 Cg_endo -70.84 -15.63 33.03 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.89 1.727 . . . . 13.609999999999999 108.814 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.13 -2.66 49.47 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.858 -0.793 . . . . 15.52 108.858 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.592 ' O ' HG23 ' B' ' 6' ' ' ILE . 15.6 mm-40 -129.5 43.74 3.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 17.309999999999999 109.649 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.84 19.52 16.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.074 -1.017 . . . . 24.780000000000001 110.087 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.407 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 11.9 mt-30 -135.32 140.7 45.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.119 -0.988 . . . . 47.899999999999999 109.679 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.725 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 41.0 p90 -94.85 164.08 13.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 21.609999999999999 109.487 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 87.9 m -135.14 147.21 49.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.303 -0.873 . . . . 14.890000000000001 109.134 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.28 -0.887 . . . . 17.350000000000001 109.368 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.426 HD23 ' O ' ' B' ' 49' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.403 0.621 . . . . 24.0 110.302 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.516 ' CG ' ' CD1' ' B' ' 13' ' ' PHE . 85.2 m-20 -68.75 109.73 3.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.827 . . . . 23.309999999999999 109.082 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 18.2 mt-10 -86.69 -173.5 4.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.141 -0.974 . . . . 40.030000000000001 109.909 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.571 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 1.7 tm0? -176.12 -177.82 0.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.353 -0.842 . . . . 12.390000000000001 109.489 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.736 ' CB ' HD11 ' B' ' 44' ' ' LEU . 13.2 mt -141.1 168.73 19.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 17.420000000000002 109.33 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -164.61 162.02 21.31 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.041 -1.096 . . . . 13.84 108.041 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.677 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 49.6 m-85 -111.52 111.52 22.59 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.01 . . . . 21.140000000000001 109.698 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.681 ' CG1' HD23 ' B' ' 37' ' ' LEU . 4.6 t -106.68 140.26 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 10.66 110.92 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.9 OUTLIER -111.64 39.25 2.39 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.571 -1.27 . . . . 25.890000000000001 107.571 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.807 HD21 HG22 ' A' ' 70' ' ' VAL . 1.1 pp -63.46 58.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.973 -0.454 . . . . 24.239999999999998 110.493 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 107.14 2.21 35.95 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.868 -1.293 . . . . 31.02 109.868 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' B' ' 41' ' ' HIS . 1.2 m-20 -125.16 98.61 5.73 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.284 -1.127 . . . . 43.229999999999997 108.527 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.6 OUTLIER -32.49 -56.53 0.34 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.553 0.692 . . . . 42.340000000000003 110.678 -179.242 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' B' ' 39' ' ' ASN . 7.3 m-70 -66.53 152.21 95.21 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 108.68 -0.859 . . . . 5.6399999999999997 108.68 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.677 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.8 Cg_endo -77.34 139.56 18.71 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.038 1.825 . . . . 17.920000000000002 110.031 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.827 HG21 HG21 ' A' ' 70' ' ' VAL . 3.4 m -112.8 115.36 49.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.289 -0.882 . . . . 20.57 109.61 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.736 HD11 ' CB ' ' B' ' 32' ' ' LEU . 59.3 tp -72.43 101.8 3.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.284 -0.885 . . . . 20.210000000000001 109.827 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.684 HG12 ' CG1' ' A' ' 70' ' ' VAL . 2.6 m -100.09 -169.07 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.987 -0.746 . . . . 10.81 108.987 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.661 ' HA ' HD23 ' B' ' 32' ' ' LEU . 1.3 mtpp -106.52 178.4 4.57 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.429 -0.908 . . . . 36.740000000000002 110.765 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.583 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -157.34 156.64 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.318 -0.993 . . . . 19.739999999999998 108.318 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.421 ' O ' ' C ' ' B' ' 49' ' ' LEU . 0.3 OUTLIER -111.54 68.63 0.67 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.129 -0.982 . . . . 22.559999999999999 109.463 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.997 HD11 ' O ' ' B' ' 53' ' ' GLN . 2.2 tm? -42.24 114.54 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.586 -0.696 . . . . 20.41 109.314 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.734 ' O ' HD13 ' B' ' 49' ' ' LEU . 0.8 OUTLIER -57.05 151.77 14.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.864 . . . . 33.990000000000002 109.909 -179.435 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -63.53 117.77 7.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.378 -0.827 . . . . 54.920000000000002 109.202 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.36 -27.35 18.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.301 -1.52 . . . . 36.100000000000001 109.301 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.997 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.8 OUTLIER -69.18 146.19 96.73 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.315 -1.109 . . . . 54.759999999999998 109.346 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.8 Cg_endo -77.4 119.63 4.99 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.614 2.209 . . . . 28.370000000000001 110.714 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.725 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -41.28 144.33 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.415 -0.803 . . . . 17.210000000000001 110.004 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.712 ' O ' HG21 ' B' ' 6' ' ' ILE . 15.5 m-30 -45.51 108.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 17.190000000000001 109.166 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.887 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -58.83 173.76 0.42 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.012 -1.055 . . . . 17.82 109.008 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.887 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.59 110.73 3.01 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.444 2.096 . . . . 17.280000000000001 110.236 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.76 -178.57 48.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.817 -1.313 . . . . 17.219999999999999 109.817 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.62 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -77.42 140.96 39.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.351 -1.088 . . . . 19.57 108.601 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.721 ' HB3' HD22 ' B' ' 83' ' ' LEU . 17.9 m-85 -130.39 164.02 25.61 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.812 -1.18 . . . . 14.609999999999999 111.698 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.632 ' O ' HG22 ' B' ' 84' ' ' VAL . 51.0 p -145.73 121.83 10.78 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.473 -1.677 . . . . 18.359999999999999 106.473 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.599 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -51.63 166.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 C-N-CA 118.751 -1.179 . . . . 19.129999999999999 109.197 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -127.53 127.24 43.62 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.919 -0.771 . . . . 20.649999999999999 108.919 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.751 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -70.99 0.45 7.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.442 -0.786 . . . . 19.649999999999999 110.053 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 3.8 t -57.09 -17.36 10.16 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.821 -1.178 . . . . 14.720000000000001 107.821 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 16.2 m -98.19 -5.64 32.98 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.767 -0.583 . . . . 11.449999999999999 110.358 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.675 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.3 m-30 -83.27 159.28 21.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.895 -1.128 . . . . 14.25 109.691 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.594 ' HA ' HD11 ' A' ' 37' ' ' LEU . 53.0 mttm -148.84 173.3 13.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 32.700000000000003 109.21 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.826 HG21 HG21 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -107.32 116.01 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 15.630000000000001 108.998 179.605 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 175.87 4.88 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.809 -1.316 . . . . 12.699999999999999 109.809 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.95 12.79 8.61 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.209 -1.171 . . . . 26.289999999999999 109.748 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.469 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -123.41 19.29 9.71 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.565 -0.71 . . . . 20.440000000000001 109.234 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 45' ' ' VAL . . . 67.66 57.26 9.2 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.667 -1.373 . . . . 13.82 109.667 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.4 t -146.65 134.55 21.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -1.152 . . . . 18.27 109.86 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.755 HD11 HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -76.84 145.11 38.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 12.43 109.062 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.491 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 11.2 mtm -157.05 120.4 4.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 35.109999999999999 109.847 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 78' ' ' ILE . 3.2 mt -62.38 137.11 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 13.67 109.382 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -100.52 -30.3 11.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.164 -1.05 . . . . 24.059999999999999 108.164 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.491 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.6 tpm_? -176.5 71.18 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.045 -1.465 . . . . 35.039999999999999 107.045 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.651 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -30.99 118.32 0.18 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.723 0.773 . . . . 18.719999999999999 111.604 -177.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 6.1 mtp180 -89.36 110.79 21.55 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.074 -1.084 . . . . 20.550000000000001 108.074 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -81.78 144.37 31.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.172 -0.955 . . . . 14.4 111.217 -178.461 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.632 HG22 ' O ' ' B' ' 62' ' ' THR . 12.3 m -146.04 158.92 47.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 107.718 -1.215 . . . . 17.649999999999999 107.718 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.9 Cg_endo -61.77 145.74 97.06 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.015 1.81 . . . . 25.699999999999999 110.171 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -73.19 119.82 17.96 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.102 -0.999 . . . . 49.289999999999999 109.7 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 58.909999999999997 109.389 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.635 ' O ' HD22 ' A' ' 37' ' ' LEU . 1.2 pmm? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.321 0.582 . . . . 64.909999999999997 109.477 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.957 HG23 HD13 ' B' ' 65' ' ' LEU . 2.3 mt -74.33 66.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.102 -1.073 . . . . 33.799999999999997 108.102 178.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.645 ' C ' HG12 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -56.84 178.58 0.06 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.839 0.828 . . . . 32.719999999999999 111.097 -178.486 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.954 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 174.3 166.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.605 -0.887 . . . . 14.460000000000001 108.605 -179.872 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.567 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 25.3 mt-10 -137.6 113.79 10.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.822 -0.807 . . . . 22.120000000000001 108.822 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.764 HD11 ' SG ' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -72.53 103.81 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.472 -1.307 . . . . 14.23 107.472 179.449 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.657 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.64 171.46 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.978 -1.076 . . . . 25.43 109.638 -178.846 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.2 Cg_endo -75.05 -28.18 9.3 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.437 2.091 . . . . 13.609999999999999 110.041 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -88.03 -0.26 56.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.468 -0.77 . . . . 15.52 109.029 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.599 ' OE1' HD12 ' A' ' 32' ' ' LEU . 13.9 mm-40 -116.21 36.91 3.87 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.395 -0.816 . . . . 17.309999999999999 109.218 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.62 10.79 40.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 24.780000000000001 110.062 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.439 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 13.4 mt-30 -137.74 136.16 37.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.227 -0.921 . . . . 47.899999999999999 109.745 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.62 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 31.0 p90 -86.21 165.98 16.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.2 -0.938 . . . . 21.609999999999999 109.556 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -133.45 149.75 51.77 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.383 -0.823 . . . . 14.890000000000001 109.27 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.297 -0.877 . . . . 17.350000000000001 109.218 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.578 0.704 . . . . 24.0 110.18 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.62 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -88.09 129.45 35.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.563 -0.711 . . . . 23.309999999999999 109.77 -179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 14.7 mt-10 -115.09 162.38 17.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.302 -0.874 . . . . 40.030000000000001 109.34 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.821 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.92 -173.53 4.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.108 -0.995 . . . . 12.390000000000001 109.876 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 ' O ' ' A' ' 31' ' ' GLN . 25.1 mt -133.71 159.35 40.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 17.420000000000002 109.221 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.764 ' SG ' HD11 ' A' ' 6' ' ' ILE . 3.5 m -154.23 168.44 26.54 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.937 -1.135 . . . . 13.84 107.937 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.694 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 29.4 m-85 -120.53 105.92 11.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.951 -1.093 . . . . 21.140000000000001 109.589 -179.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 43' ' ' VAL . 39.9 t -97.8 139.69 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.002 -1.061 . . . . 10.66 111.095 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.649 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 m-20 -115.22 -140.49 0.38 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.318 -0.993 . . . . 25.890000000000001 108.318 178.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.718 ' CB ' HD21 ' B' ' 65' ' ' LEU . 0.2 OUTLIER 67.44 -68.41 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.924 -1.11 . . . . 24.239999999999998 108.47 179.467 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -78.66 -1.47 83.27 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 107.913 -2.075 . . . . 31.02 107.913 178.171 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -160.12 110.26 1.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.513 -0.992 . . . . 43.229999999999997 108.95 179.748 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 39' ' ' ASN . 2.0 mm-40 -37.68 -63.29 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.642 0.734 . . . . 42.340000000000003 109.81 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 37.3 m80 -69.0 163.95 52.08 Favored Pre-proline 0 C--N 1.293 -1.882 0 N-CA-C 108.076 -1.083 . . . . 8.0199999999999996 108.076 179.067 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.694 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -76.53 141.48 22.43 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 121.699 1.599 . . . . 17.920000000000002 109.748 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 35' ' ' VAL . 25.7 m -113.72 115.89 51.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.315 -0.866 . . . . 20.57 109.46 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.788 HD11 ' HB3' ' A' ' 32' ' ' LEU . 52.0 tp -74.23 103.39 4.63 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.366 -0.833 . . . . 20.210000000000001 109.749 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.585 HG12 HG11 ' B' ' 70' ' ' VAL . 1.3 m -107.43 176.15 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.509 -0.744 . . . . 10.81 109.172 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.28 139.85 35.37 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.314 -0.955 . . . . 36.740000000000002 109.527 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.973 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -124.02 170.59 14.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.42 -0.8 . . . . 19.739999999999998 109.261 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.683 HG21 ' NH1' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -111.77 142.53 44.0 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.175 -0.953 . . . . 22.559999999999999 109.497 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.609 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -110.41 147.48 33.93 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 20.41 108.721 179.711 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.532 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 1.0 OUTLIER -85.26 145.24 27.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 33.990000000000002 109.831 -179.332 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.19 119.82 5.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.36 -0.838 . . . . 54.920000000000002 109.614 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.79 -15.55 46.73 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.681 -1.368 . . . . 36.100000000000001 109.681 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.532 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -74.99 145.19 80.67 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.202 -1.176 . . . . 54.759999999999998 109.343 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.84 121.9 5.64 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.596 2.197 . . . . 28.370000000000001 110.74 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.816 ' HB1' HE21 ' A' ' 31' ' ' GLN . . . -38.92 149.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.501 -0.749 . . . . 17.210000000000001 110.388 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.755 ' HB3' HD13 ' A' ' 6' ' ' ILE . 89.6 m-85 -46.49 105.36 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.758 -0.83 . . . . 17.190000000000001 108.758 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -58.88 176.73 0.27 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.382 -0.824 . . . . 17.82 110.023 -179.103 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.8 Cg_endo -77.69 110.26 2.91 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.737 2.291 . . . . 17.280000000000001 110.338 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 173.65 151.94 8.54 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.563 -1.415 . . . . 17.219999999999999 109.563 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 5.1 mp -49.27 150.22 1.83 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.321 . . . . 19.57 108.779 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.954 ' CB ' HG13 ' A' ' 4' ' ' VAL . 19.1 m-85 -128.57 163.89 24.02 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.768 -1.207 . . . . 14.609999999999999 111.564 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.755 ' O ' HG22 ' A' ' 84' ' ' VAL . 55.8 p -147.69 118.73 7.69 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.411 -1.7 . . . . 18.359999999999999 106.411 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.619 HG11 ' HB2' ' A' ' 81' ' ' LEU . 8.6 t -53.33 169.86 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 C-N-CA 118.809 -1.157 . . . . 19.129999999999999 108.917 -178.294 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.577 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -128.08 120.14 26.8 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.426 -0.796 . . . . 20.649999999999999 109.066 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.954 HD13 HG23 ' B' ' 2' ' ' ILE . 0.0 OUTLIER -65.08 -8.28 15.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.727 -0.608 . . . . 19.649999999999999 109.914 -179.176 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.3 p -52.28 -17.95 1.36 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.02 -1.05 . . . . 14.720000000000001 108.402 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 2.3 m -95.94 -6.06 39.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.566 -0.709 . . . . 11.449999999999999 110.79 -179.328 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.615 ' CE1' HG12 ' A' ' 78' ' ' ILE . 1.9 m-30 -86.61 164.64 16.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.741 -1.224 . . . . 14.25 110.174 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 1.4 mtpp -159.33 178.78 9.59 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.876 -0.787 . . . . 32.700000000000003 108.876 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.812 HG21 HG21 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -118.6 114.82 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 15.630000000000001 109.38 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.46 -167.88 18.67 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.461 -1.456 . . . . 12.699999999999999 109.461 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.35 39.97 0.93 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -1.168 . . . . 26.289999999999999 109.48 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 28.3 m-85 -134.21 27.8 3.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.35 -0.844 . . . . 20.440000000000001 109.261 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 73' ' ' PHE . . . 44.7 49.01 8.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.583 -1.407 . . . . 13.82 109.583 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -149.51 145.67 26.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -1.181 . . . . 18.27 109.66 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.8 OUTLIER -88.41 149.49 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 12.43 109.119 179.72 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 54.6 mtm -157.4 137.84 12.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -0.984 . . . . 35.109999999999999 109.637 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.828 HD12 HD12 ' B' ' 78' ' ' ILE . 3.0 mt -69.98 139.59 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 13.67 110.105 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.1 -25.48 11.55 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.221 -1.029 . . . . 24.059999999999999 108.221 178.561 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.683 ' NH1' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -179.92 68.01 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.125 -1.435 . . . . 35.039999999999999 107.125 179.144 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -33.23 120.48 0.37 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.281 -0.872 . . . . 18.719999999999999 111.644 -178.247 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -91.45 113.21 25.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.922 -1.14 . . . . 20.550000000000001 107.922 178.786 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.973 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -82.55 148.85 27.82 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.028 -1.045 . . . . 14.4 110.959 -178.553 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 62' ' ' THR . 32.6 m -150.65 150.13 27.62 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 107.96 -1.126 . . . . 17.649999999999999 107.96 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.1 Cg_endo -61.37 140.89 90.46 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.164 1.91 . . . . 25.699999999999999 110.581 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.11 117.15 8.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 49.289999999999999 109.651 -178.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.005 -0.998 . . . . 58.909999999999997 109.49 179.991 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.643 ' O ' HD22 ' B' ' 37' ' ' LEU . 1.2 pmm? . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.471 -0.566 . . . . 64.909999999999997 109.471 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.954 HG23 HD13 ' A' ' 65' ' ' LEU . 2.3 mt -74.25 66.57 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.043 -1.095 . . . . 33.799999999999997 108.043 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.633 ' C ' HG12 ' B' ' 4' ' ' VAL . 0.5 OUTLIER -56.93 178.76 0.05 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.88 0.848 . . . . 32.719999999999999 110.992 -178.455 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.958 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 174.19 166.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.625 -0.879 . . . . 14.460000000000001 108.625 -179.84 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 25.2 mt-10 -137.34 113.99 10.36 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.826 -0.805 . . . . 22.120000000000001 108.826 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.768 HD11 ' SG ' ' B' ' 33' ' ' CYS . 0.1 OUTLIER -72.74 103.75 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 107.529 -1.286 . . . . 14.23 107.529 179.48 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.669 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.63 171.27 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.995 -1.065 . . . . 25.43 109.564 -178.791 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.3 Cg_endo -74.96 -28.3 9.35 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.445 2.096 . . . . 13.609999999999999 110.088 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -87.6 -0.73 57.27 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.02 -0.733 . . . . 15.52 109.02 179.021 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.579 ' OE1' HD12 ' B' ' 32' ' ' LEU . 13.6 mm-40 -115.9 37.08 3.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.342 -0.849 . . . . 17.309999999999999 109.301 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.71 10.77 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 24.780000000000001 110.004 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.438 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 13.7 mt-30 -137.62 136.14 37.23 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 47.899999999999999 109.785 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.625 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 30.8 p90 -86.15 165.97 16.14 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.248 -0.908 . . . . 21.609999999999999 109.573 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 89.7 m -133.42 149.84 51.79 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.385 -0.822 . . . . 14.890000000000001 109.234 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.479 0 O-C-N 121.251 -0.905 . . . . 17.350000000000001 109.224 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.577 0.704 . . . . 24.0 110.089 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.625 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -88.47 129.25 35.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.601 -0.687 . . . . 23.309999999999999 109.802 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 14.7 mt-10 -114.89 162.27 17.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 40.030000000000001 109.387 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.837 ' O ' HD23 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -148.76 -173.48 4.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.994 . . . . 12.390000000000001 109.892 -179.814 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.837 HD23 ' O ' ' B' ' 31' ' ' GLN . 25.3 mt -133.85 159.41 40.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 17.420000000000002 109.264 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.768 ' SG ' HD11 ' B' ' 6' ' ' ILE . 3.5 m -154.27 168.24 27.24 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.963 -1.125 . . . . 13.84 107.963 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.684 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 29.7 m-85 -120.38 105.93 11.36 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.957 -1.089 . . . . 21.140000000000001 109.652 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.827 ' O ' HG22 ' B' ' 43' ' ' VAL . 40.0 t -97.93 139.65 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.087 -1.008 . . . . 10.66 110.995 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.645 ' O ' HD12 ' B' ' 37' ' ' LEU . 4.4 m-20 -115.27 -140.46 0.38 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.292 -1.003 . . . . 25.890000000000001 108.292 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.709 ' CB ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 67.33 -68.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.925 -1.109 . . . . 24.239999999999998 108.405 179.479 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -78.6 -1.54 83.08 Favored Glycine 0 C--N 1.297 -1.587 0 N-CA-C 107.873 -2.091 . . . . 31.02 107.873 178.209 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.451 ' O ' ' C ' ' B' ' 40' ' ' GLU . 0.1 OUTLIER -160.37 110.12 1.77 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.512 -0.993 . . . . 43.229999999999997 108.869 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' B' ' 39' ' ' ASN . 2.0 mm-40 -37.37 -63.53 0.44 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.633 0.73 . . . . 42.340000000000003 109.827 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.471 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 37.9 m80 -68.89 164.1 49.99 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 108.03 -1.1 . . . . 8.0399999999999991 108.03 179.061 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.684 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.3 Cg_endo -76.51 141.53 22.54 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.722 1.615 . . . . 17.920000000000002 109.836 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.827 HG22 ' O ' ' B' ' 35' ' ' VAL . 25.5 m -113.73 115.77 50.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.255 -0.903 . . . . 20.57 109.495 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' B' ' 32' ' ' LEU . 52.1 tp -74.26 103.15 4.56 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.417 -0.802 . . . . 20.210000000000001 109.741 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.566 HG12 HG11 ' A' ' 70' ' ' VAL . 1.3 m -107.07 176.19 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.505 -0.747 . . . . 10.81 109.147 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.404 ' HA ' HD23 ' B' ' 32' ' ' LEU . 0.3 OUTLIER -100.17 139.87 35.23 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.393 -0.923 . . . . 36.740000000000002 109.526 179.627 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 1.014 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.6 OUTLIER -124.12 170.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.383 -0.823 . . . . 19.739999999999998 109.254 -179.748 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.681 HG21 ' NH1' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -111.7 142.27 44.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.206 -0.934 . . . . 22.559999999999999 109.575 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.606 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -110.21 147.54 33.58 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.285 -0.884 . . . . 20.41 108.763 179.676 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 1.0 OUTLIER -85.37 145.11 27.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.128 -0.983 . . . . 33.990000000000002 109.854 -179.355 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.85 119.84 5.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 54.920000000000002 109.595 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.74 -15.56 46.44 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.707 -1.357 . . . . 36.100000000000001 109.707 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.529 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -75.0 145.12 80.56 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 54.759999999999998 109.311 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.8 Cg_endo -77.78 121.75 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.616 2.211 . . . . 28.370000000000001 110.731 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.809 ' HB1' HE21 ' B' ' 31' ' ' GLN . . . -38.68 150.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.548 -0.72 . . . . 17.210000000000001 110.415 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.746 ' HB3' HD13 ' B' ' 6' ' ' ILE . 89.4 m-85 -46.79 105.4 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.324 -0.86 . . . . 17.190000000000001 108.724 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 1.024 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -58.83 176.89 0.26 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 17.82 110.121 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 1.024 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.78 110.26 2.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.673 2.249 . . . . 17.280000000000001 110.278 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 173.68 151.96 8.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.579 -1.408 . . . . 17.219999999999999 109.579 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.1 mp -49.25 150.1 1.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.985 -1.303 . . . . 19.57 108.724 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.958 ' CB ' HG13 ' B' ' 4' ' ' VAL . 18.7 m-85 -128.55 163.86 24.08 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.833 -1.167 . . . . 14.609999999999999 111.589 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.742 ' O ' HG22 ' B' ' 84' ' ' VAL . 53.8 p -147.6 118.71 7.73 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.481 -1.674 . . . . 18.359999999999999 106.481 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' B' ' 81' ' ' LEU . 9.2 t -53.3 169.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.811 -1.156 . . . . 19.129999999999999 108.878 -178.33 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.585 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -128.2 120.1 26.57 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.499 -0.751 . . . . 20.649999999999999 109.05 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.957 HD13 HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -64.9 -8.43 15.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.709 -0.619 . . . . 19.649999999999999 109.923 -179.151 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 96.0 p -52.05 -17.98 1.25 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.952 -1.092 . . . . 14.720000000000001 108.377 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 2.4 m -95.96 -6.59 38.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.502 -0.749 . . . . 11.449999999999999 110.776 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.631 ' CE1' HG12 ' B' ' 78' ' ' ILE . 1.8 m-30 -86.15 164.4 17.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.73 -1.231 . . . . 14.25 110.046 -179.187 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -159.09 179.06 9.38 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.82 -0.808 . . . . 32.700000000000003 108.82 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.825 HG21 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -118.73 115.13 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 15.630000000000001 109.427 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.58 -168.09 19.66 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.495 -1.442 . . . . 12.699999999999999 109.495 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.13 39.71 0.91 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.167 -1.196 . . . . 26.289999999999999 109.475 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' B' ' 73' ' ' PHE . 28.6 m-85 -133.99 28.09 3.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 20.440000000000001 109.38 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.39 49.1 8.46 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.627 -1.389 . . . . 13.82 109.627 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -149.67 145.69 26.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -1.145 . . . . 18.27 109.684 -179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.8 OUTLIER -88.58 149.62 23.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 12.43 109.072 179.734 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.492 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 54.4 mtm -157.52 138.18 13.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.123 -0.986 . . . . 35.109999999999999 109.52 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.828 HD12 HD12 ' A' ' 78' ' ' ILE . 2.9 mp -70.4 139.52 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.856 . . . . 13.67 110.134 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.84 -25.53 11.65 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.138 -1.06 . . . . 24.059999999999999 108.138 178.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.681 ' NH1' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER -179.77 68.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.186 -1.413 . . . . 35.039999999999999 107.186 179.17 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.656 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -33.21 120.28 0.36 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.311 -0.859 . . . . 18.719999999999999 111.607 -178.187 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -91.32 113.09 25.26 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.979 -1.119 . . . . 20.550000000000001 107.979 178.723 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.014 ' HB2' HD11 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -82.42 148.93 27.92 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.037 -1.039 . . . . 14.4 110.986 -178.603 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.742 HG22 ' O ' ' B' ' 62' ' ' THR . 32.5 m -150.63 150.04 27.45 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.994 -1.113 . . . . 17.649999999999999 107.994 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.0 Cg_endo -61.41 140.44 87.83 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.188 1.925 . . . . 25.699999999999999 110.6 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -65.51 117.47 8.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 49.289999999999999 109.62 -178.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.027 -0.987 . . . . 58.909999999999997 109.484 -179.98 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.358 -0.608 . . . . 64.909999999999997 109.358 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.896 ' N ' HD22 ' B' ' 65' ' ' LEU . 2.2 mt -60.4 84.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.897 -1.149 . . . . 33.799999999999997 107.897 179.069 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 1' ' ' MET . 17.4 mttt -57.85 157.14 7.92 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.847 0.832 . . . . 32.719999999999999 111.569 -177.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.057 HG22 HG22 ' A' ' 35' ' ' VAL . 59.8 t -160.52 167.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.585 0.707 . . . . 14.460000000000001 109.724 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.61 ' N ' HG12 ' A' ' 4' ' ' VAL . 38.9 mt-10 -154.09 101.44 2.41 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.771 0.796 . . . . 22.120000000000001 108.931 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -71.38 101.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.986 -1.116 . . . . 14.23 107.986 179.642 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.581 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 15.6 mmmt -50.52 163.3 0.47 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.414 -0.803 . . . . 25.43 109.252 -179.393 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.5 Cg_endo -71.98 -10.1 25.62 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.818 1.679 . . . . 13.609999999999999 109.247 179.247 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.82 12.21 31.07 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.533 -0.914 . . . . 15.52 108.533 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.529 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 7.6 mm-40 -137.08 38.45 2.54 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.31 -0.869 . . . . 17.309999999999999 109.211 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -111.96 31.48 6.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.96 . . . . 24.780000000000001 110.19 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 12.0 mt-30 -140.3 132.36 27.9 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.261 -0.9 . . . . 47.899999999999999 109.501 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.642 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 33.6 p90 -89.52 155.81 19.05 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.213 -0.93 . . . . 21.609999999999999 109.671 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.1 m -134.6 150.16 50.67 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.885 -0.783 . . . . 14.890000000000001 108.885 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.572 0 O-C-N 121.164 -0.96 . . . . 17.350000000000001 109.236 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.573 HD13 HH22 ' A' ' 80' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.447 0.642 . . . . 24.0 110.418 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.653 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -47.61 117.75 1.95 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.433 -0.792 . . . . 23.309999999999999 109.569 179.607 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -112.87 147.68 36.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.255 -0.903 . . . . 40.030000000000001 109.593 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.949 ' OE1' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -131.22 -169.71 2.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.121 -0.987 . . . . 12.390000000000001 109.341 179.843 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.971 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -128.56 177.53 6.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 17.420000000000002 109.32 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.811 ' SG ' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -172.43 162.69 5.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.053 -1.029 . . . . 13.84 108.467 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.697 ' HE1' HD13 ' A' ' 44' ' ' LEU . 4.1 m-30 -114.58 95.25 5.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.154 -0.966 . . . . 21.140000000000001 109.187 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.057 HG22 HG22 ' A' ' 4' ' ' VAL . 92.2 t -84.87 115.45 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 10.66 110.234 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 t0 -66.1 -22.67 66.41 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.381 -0.824 . . . . 25.890000000000001 108.805 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.723 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.8 OUTLIER 43.23 26.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.771 . . . . 24.239999999999998 109.567 179.965 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 58.6 22.3 52.23 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.891 -1.284 . . . . 31.02 109.891 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.546 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 19.2 p30 -100.64 27.8 5.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.983 -1.304 . . . . 43.229999999999997 110.079 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.628 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 12.2 mt-10 47.72 71.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 42.340000000000003 109.871 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.628 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER 142.92 144.46 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.287 0 N-CA-C 108.572 -0.899 . . . . 6.5700000000000003 108.572 179.451 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.681 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -79.57 142.96 16.64 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.206 1.938 . . . . 17.920000000000002 110.841 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.97 HG22 ' O ' ' A' ' 35' ' ' VAL . 6.9 m -120.52 119.3 59.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.441 -0.948 . . . . 20.57 108.441 178.469 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.971 HD11 ' HB3' ' A' ' 32' ' ' LEU . 17.7 tp -66.88 112.72 4.44 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.428 -0.795 . . . . 20.210000000000001 109.241 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 3.6 t -119.47 168.4 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.576 -0.702 . . . . 10.81 109.572 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -90.57 149.89 21.96 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.431 -0.793 . . . . 36.740000000000002 109.954 -179.776 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.861 HD11 ' CB ' ' A' ' 83' ' ' LEU . 1.6 tt -130.21 176.86 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.802 -0.814 . . . . 19.739999999999998 108.802 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.634 HG21 ' CZ ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -125.4 135.24 52.18 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.184 -0.948 . . . . 22.559999999999999 109.094 179.453 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -104.67 99.99 9.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.209 -0.932 . . . . 20.41 109.003 179.981 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.69 156.44 36.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 33.990000000000002 109.606 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.27 136.81 57.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.221 -0.924 . . . . 54.920000000000002 109.228 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.86 -35.05 3.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.321 -1.512 . . . . 36.100000000000001 109.321 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.797 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.3 mt-30 -77.32 124.04 86.98 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.243 -1.151 . . . . 54.759999999999998 109.245 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.1 Cg_endo -78.63 138.28 15.11 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.279 1.986 . . . . 28.370000000000001 110.406 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.949 ' HB1' ' OE1' ' A' ' 31' ' ' GLN . . . -35.84 138.16 0.19 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.637 -0.664 . . . . 17.210000000000001 110.424 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.7 ' HB3' HD13 ' A' ' 6' ' ' ILE . 83.7 m-85 -51.75 109.99 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 17.190000000000001 109.511 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.917 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -59.72 174.33 0.45 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.263 -0.898 . . . . 17.82 109.252 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.917 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.7 Cg_endo -77.48 110.32 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.632 2.221 . . . . 17.280000000000001 110.406 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.37 179.85 48.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.743 -1.343 . . . . 17.219999999999999 109.743 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -74.83 143.99 43.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -1.114 . . . . 19.57 108.76 179.483 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.555 ' CB ' ' HB ' ' A' ' 4' ' ' VAL . 27.0 m-85 -132.42 164.58 26.21 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.873 -1.142 . . . . 14.609999999999999 111.206 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.807 ' O ' HG22 ' A' ' 84' ' ' VAL . 31.1 p -144.11 118.96 9.9 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.925 -1.88 . . . . 18.359999999999999 105.925 178.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.743 ' HB ' HD13 ' A' ' 2' ' ' ILE . 2.6 t -52.36 166.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 C-N-CA 118.434 -1.307 . . . . 19.129999999999999 108.999 -178.077 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -129.13 128.81 44.22 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.417 -0.802 . . . . 20.649999999999999 109.3 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.906 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -71.3 0.19 8.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.691 -0.631 . . . . 19.649999999999999 110.051 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -57.25 -17.66 12.7 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.645 -1.243 . . . . 14.720000000000001 107.645 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.488 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 50.4 m -96.41 -8.38 32.52 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.782 -0.574 . . . . 11.449999999999999 110.193 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.739 ' C ' HD11 ' B' ' 37' ' ' LEU . 2.8 m-30 -77.69 155.04 31.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.052 . . . . 14.25 109.585 -178.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.467 ' HG2' ' HB2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -134.71 172.9 12.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.406 -0.809 . . . . 32.700000000000003 109.731 -179.651 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.87 HG21 HG21 ' B' ' 43' ' ' VAL . 8.7 t -124.41 133.34 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.492 -0.755 . . . . 15.630000000000001 109.376 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.26 -157.56 27.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.435 -1.466 . . . . 12.699999999999999 109.435 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' A' ' 73' ' ' PHE . 43.0 tp60 55.88 72.42 0.49 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -1.181 . . . . 26.289999999999999 109.098 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER 73.32 5.95 5.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.779 . . . . 20.440000000000001 109.402 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.481 ' O ' HG13 ' B' ' 45' ' ' VAL . . . 78.29 45.07 10.34 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.474 -1.451 . . . . 13.82 109.474 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.3 OUTLIER -127.07 119.66 27.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.144 . . . . 18.27 109.713 -179.913 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' HG11 ' B' ' 35' ' ' VAL . 0.8 OUTLIER -54.95 144.68 22.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 12.43 109.106 179.801 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 30.9 mtp -160.28 140.8 11.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 35.109999999999999 109.783 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.946 HD12 HD12 ' B' ' 78' ' ' ILE . 2.3 mp -68.56 141.66 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.816 . . . . 13.67 109.73 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 39.5 t0 -108.61 -21.26 12.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.689 -0.856 . . . . 24.059999999999999 108.689 178.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.634 ' CZ ' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER 174.22 66.76 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.1 -1.444 . . . . 35.039999999999999 107.1 179.497 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -28.3 119.7 0.11 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.257 -0.883 . . . . 18.719999999999999 111.961 -178.07 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 5.3 ttp180 -93.14 102.87 15.18 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.841 -1.17 . . . . 20.550000000000001 107.841 178.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.861 ' CB ' HD11 ' A' ' 47' ' ' ILE . 7.0 tp -74.13 149.75 40.85 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.158 -0.964 . . . . 14.4 111.184 -178.211 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 62' ' ' THR . 17.8 m -146.33 152.98 47.63 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.214 -1.032 . . . . 17.649999999999999 108.214 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 26.0 Cg_endo -64.51 142.97 80.37 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.2 1.933 . . . . 25.699999999999999 110.402 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.793 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -76.94 123.67 26.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 49.289999999999999 109.692 -178.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.003 -0.999 . . . . 58.909999999999997 109.432 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.516 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.387 -0.597 . . . . 64.909999999999997 109.387 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.906 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.2 mt -60.23 84.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.881 -1.155 . . . . 33.799999999999997 107.881 179.065 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.533 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 17.5 mttt -57.75 157.25 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.815 0.817 . . . . 32.719999999999999 111.543 -177.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.068 HG22 HG22 ' B' ' 35' ' ' VAL . 58.6 t -160.63 167.16 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.551 0.691 . . . . 14.460000000000001 109.726 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.608 ' N ' HG12 ' B' ' 4' ' ' VAL . 38.5 mt-10 -154.08 101.29 2.4 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.715 0.769 . . . . 22.120000000000001 108.963 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.694 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -71.28 101.77 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.994 -1.113 . . . . 14.23 107.994 179.664 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.565 ' HB3' ' HD2' ' B' ' 8' ' ' PRO . 15.7 mmmt -50.58 163.59 0.46 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.454 -0.779 . . . . 25.43 109.216 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.5 Cg_endo -72.23 -10.16 25.38 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.835 1.69 . . . . 13.609999999999999 109.205 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.62 12.06 31.6 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.485 -0.932 . . . . 15.52 108.485 178.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.541 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 7.7 mm-40 -136.91 38.19 2.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.869 . . . . 17.309999999999999 109.33 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.73 31.43 6.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.098 -1.001 . . . . 24.780000000000001 110.288 -179.274 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' B' ' 31' ' ' GLN . 11.9 mt-30 -140.26 132.26 27.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 47.899999999999999 109.504 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.642 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 33.0 p90 -89.33 155.75 19.15 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.249 -0.907 . . . . 21.609999999999999 109.662 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -134.63 150.27 50.65 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.83 -0.804 . . . . 14.890000000000001 108.83 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 17.350000000000001 109.209 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.58 HD13 HH22 ' B' ' 80' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.426 0.631 . . . . 24.0 110.408 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.664 ' OD1' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -47.56 117.81 1.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.434 -0.791 . . . . 23.309999999999999 109.627 179.668 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 6.4 mt-10 -112.77 148.02 35.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.218 -0.926 . . . . 40.030000000000001 109.584 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.955 ' OE1' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -131.6 -169.81 2.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.219 -0.926 . . . . 12.390000000000001 109.236 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.954 ' HB3' HD11 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -128.53 177.63 6.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.289 -0.882 . . . . 17.420000000000002 109.276 179.889 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.808 ' SG ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -172.51 162.56 5.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.992 -1.067 . . . . 13.84 108.4 -179.653 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.692 ' HE1' HD13 ' B' ' 44' ' ' LEU . 4.1 m-30 -114.51 95.36 5.22 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.125 -0.984 . . . . 21.140000000000001 109.203 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 1.068 HG22 HG22 ' B' ' 4' ' ' VAL . 92.6 t -84.92 115.41 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.028 -1.045 . . . . 10.66 110.27 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' B' ' 39' ' ' ASN . 1.1 t0 -66.0 -22.71 66.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.389 -0.819 . . . . 25.890000000000001 108.862 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.739 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER 43.23 26.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 24.239999999999998 109.55 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 58.64 22.56 53.18 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.862 -1.295 . . . . 31.02 109.862 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.542 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 19.1 p30 -100.89 27.66 5.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.016 -1.285 . . . . 43.229999999999997 110.034 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.631 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 12.2 mt-10 47.88 71.87 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 42.340000000000003 109.817 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.631 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 0.2 OUTLIER 142.89 144.44 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.196 0 N-CA-C 108.591 -0.892 . . . . 6.5599999999999996 108.591 179.48 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.674 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.7 Cg_endo -79.56 143.14 16.79 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.235 1.957 . . . . 17.920000000000002 110.762 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.987 HG22 ' O ' ' B' ' 35' ' ' VAL . 7.1 m -120.73 119.12 58.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.446 -0.946 . . . . 20.57 108.446 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.954 HD11 ' HB3' ' B' ' 32' ' ' LEU . 17.0 tp -66.71 112.96 4.48 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.413 -0.804 . . . . 20.210000000000001 109.294 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.575 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 3.7 t -119.71 168.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.552 -0.718 . . . . 10.81 109.553 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.575 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.5 OUTLIER -90.64 149.84 21.93 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.443 -0.786 . . . . 36.740000000000002 110.007 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.873 HD11 ' CB ' ' B' ' 83' ' ' LEU . 1.6 tt -130.11 176.95 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.836 -0.801 . . . . 19.739999999999998 108.836 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.648 HG21 ' CZ ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -125.57 134.94 51.78 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.228 -0.92 . . . . 22.559999999999999 109.149 179.486 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.799 HD12 ' O ' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -104.48 100.07 9.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.169 -0.957 . . . . 20.41 109.05 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.8 156.44 37.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 33.990000000000002 109.642 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.25 136.77 57.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.867 . . . . 54.920000000000002 109.245 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.76 -34.56 4.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.388 -1.485 . . . . 36.100000000000001 109.388 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.799 ' O ' HD12 ' B' ' 49' ' ' LEU . 4.3 mt-30 -77.71 123.99 86.49 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.234 -1.157 . . . . 54.759999999999998 109.202 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.476 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.8 Cg_endo -78.54 138.06 15.1 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.343 2.029 . . . . 28.370000000000001 110.478 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.955 ' HB1' ' OE1' ' B' ' 31' ' ' GLN . . . -35.62 137.78 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.384 0.612 . . . . 17.210000000000001 110.478 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.694 ' HB3' HD13 ' B' ' 6' ' ' ILE . 84.6 m-85 -51.28 109.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 17.190000000000001 109.558 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.943 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -59.72 174.25 0.46 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 17.82 109.27 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.943 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.26 109.53 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.541 2.161 . . . . 17.280000000000001 110.193 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.08 179.52 48.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.83 -1.308 . . . . 17.219999999999999 109.83 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.829 HD23 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -75.2 143.73 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -1.14 . . . . 19.57 108.474 179.263 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.561 ' CB ' HD21 ' B' ' 83' ' ' LEU . 27.0 m-85 -132.04 164.57 25.92 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.835 -1.165 . . . . 14.609999999999999 111.173 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.831 ' O ' HG22 ' B' ' 84' ' ' VAL . 31.9 p -143.99 119.0 10.0 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 105.907 -1.886 . . . . 18.359999999999999 105.907 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.752 ' HB ' HD13 ' B' ' 2' ' ' ILE . 2.5 t -52.52 166.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 C-N-CA 118.42 -1.312 . . . . 19.129999999999999 108.941 -178.136 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.512 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -129.26 128.73 43.84 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.413 -0.804 . . . . 20.649999999999999 109.287 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.896 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -71.23 0.17 8.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.621 -0.674 . . . . 19.649999999999999 110.11 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -57.2 -17.7 12.52 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.67 -1.233 . . . . 14.720000000000001 107.67 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.492 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 51.1 m -96.23 -8.78 32.03 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.773 -0.58 . . . . 11.449999999999999 110.255 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.723 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.8 m-30 -77.3 155.01 32.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.023 -1.048 . . . . 14.25 109.542 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' B' ' 79' ' ' ASP . 0.1 OUTLIER -134.83 172.58 12.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.424 -0.797 . . . . 32.700000000000003 109.703 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.851 HG21 HG21 ' A' ' 43' ' ' VAL . 9.5 t -124.14 133.31 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.462 -0.774 . . . . 15.630000000000001 109.387 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.37 -157.3 27.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.506 -1.438 . . . . 12.699999999999999 109.506 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 43.0 tp60 55.68 72.27 0.5 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -1.164 . . . . 26.289999999999999 109.131 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.1 OUTLIER 73.44 5.94 5.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 20.440000000000001 109.467 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.477 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 78.32 45.1 10.26 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.547 -1.421 . . . . 13.82 109.547 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 77' ' ' MET . 0.3 OUTLIER -127.13 119.57 26.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -1.1 . . . . 18.27 109.755 -179.916 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.548 HD13 HG11 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -54.94 144.54 22.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 12.43 109.152 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 31.1 mtp -160.14 141.1 12.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 35.109999999999999 109.749 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.946 HD12 HD12 ' A' ' 78' ' ' ILE . 2.3 mp -68.87 141.83 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 13.67 109.775 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.473 ' HB2' ' HG2' ' B' ' 69' ' ' LYS . 39.1 t0 -108.66 -21.23 12.79 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.685 -0.857 . . . . 24.059999999999999 108.685 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.648 ' CZ ' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER 174.08 66.58 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.075 -1.454 . . . . 35.039999999999999 107.075 179.541 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.653 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -28.01 119.98 0.11 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.27 -0.877 . . . . 18.719999999999999 111.893 -178.097 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 5.4 ttp180 -93.38 103.09 15.34 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.814 -1.18 . . . . 20.550000000000001 107.814 178.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.873 ' CB ' HD11 ' B' ' 47' ' ' ILE . 7.0 tp -74.35 149.59 40.5 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.113 -0.992 . . . . 14.4 111.148 -178.237 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.831 HG22 ' O ' ' B' ' 62' ' ' THR . 17.6 m -146.19 153.14 48.4 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.224 -1.028 . . . . 17.649999999999999 108.224 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 26.5 Cg_endo -64.6 143.34 81.0 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.155 1.903 . . . . 25.699999999999999 110.397 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.812 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -77.38 123.82 27.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.87 . . . . 49.289999999999999 109.643 -178.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.04 -0.981 . . . . 58.909999999999997 109.433 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 tpp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.489 -0.559 . . . . 64.909999999999997 109.489 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.764 ' N ' HD22 ' B' ' 65' ' ' LEU . 2.1 mt -59.46 84.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.962 -1.125 . . . . 33.799999999999997 107.962 179.297 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 1' ' ' MET . 15.3 mtpp -67.1 152.5 45.65 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.827 0.823 . . . . 32.719999999999999 111.306 -178.11 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.901 HG11 HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -164.15 167.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 108.381 -0.97 . . . . 14.460000000000001 108.381 179.593 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.572 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 24.3 mt-10 -141.08 118.0 11.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.336 -0.853 . . . . 22.120000000000001 109.361 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.867 HG21 ' O ' ' A' ' 56' ' ' TYR . 10.4 mm -75.71 92.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.919 -1.141 . . . . 14.23 107.919 179.163 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.671 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -44.89 171.66 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 25.43 110.19 -178.677 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -74.73 -29.28 8.89 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.481 2.121 . . . . 13.609999999999999 109.728 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -6.74 58.17 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.762 -0.829 . . . . 15.52 108.762 178.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 12.7 mm-40 -118.35 40.56 3.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.417 -0.802 . . . . 17.309999999999999 109.342 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -103.69 7.96 37.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.092 -1.005 . . . . 24.780000000000001 109.646 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.443 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 37.5 mt-30 -138.05 138.89 39.24 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.323 -0.861 . . . . 47.899999999999999 109.624 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.656 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 36.1 p90 -92.13 161.32 14.79 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.15 -0.969 . . . . 21.609999999999999 108.76 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.1 m -130.02 152.54 49.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.103 -0.998 . . . . 14.890000000000001 109.687 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.457 0 O-C-N 121.333 -0.854 . . . . 17.350000000000001 109.314 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.411 0.624 . . . . 24.0 110.451 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.626 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 98.0 m-20 -78.33 129.59 35.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.496 -0.752 . . . . 23.309999999999999 109.277 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -123.28 149.06 45.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 40.030000000000001 109.17 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.617 ' HB3' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -136.33 -170.17 2.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 12.390000000000001 109.65 -179.985 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.778 ' HB3' HD11 ' A' ' 44' ' ' LEU . 5.9 mp -132.03 174.49 10.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.327 -0.858 . . . . 17.420000000000002 109.526 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -162.69 159.37 24.29 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.258 -1.015 . . . . 13.84 108.258 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.7 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 15.0 m-85 -114.77 96.64 5.83 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.152 -0.968 . . . . 21.140000000000001 109.384 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 43' ' ' VAL . 3.0 t -105.18 127.5 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 10.66 110.461 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 16.8 p-10 -86.48 -27.54 24.01 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.496 -0.927 . . . . 25.890000000000001 108.496 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.852 ' HG ' HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER 47.4 23.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 24.239999999999998 109.625 179.775 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.27 8.03 69.05 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.976 -1.25 . . . . 31.02 109.976 179.652 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' CG ' ' O ' ' A' ' 36' ' ' ASP . 0.9 OUTLIER -87.07 19.21 3.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.094 -1.239 . . . . 43.229999999999997 110.008 -179.739 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.61 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 5.1 mt-10 45.98 72.03 0.25 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 42.340000000000003 109.862 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.61 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER 143.64 147.65 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.207 0 N-CA-C 108.6 -0.889 . . . . 6.5899999999999999 108.6 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.7 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -79.5 137.5 13.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.068 1.845 . . . . 17.920000000000002 110.542 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 35' ' ' VAL . 2.8 m -114.53 118.7 59.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.35 -0.844 . . . . 20.57 108.827 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 32' ' ' LEU . 56.7 tp -76.48 106.65 8.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.435 -0.791 . . . . 20.210000000000001 110.661 -178.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.607 HG13 HG23 ' A' ' 43' ' ' VAL . 21.2 m -115.24 -169.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.816 -0.809 . . . . 10.81 108.816 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -108.48 152.01 25.29 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.333 -0.947 . . . . 36.740000000000002 110.395 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.953 HD13 HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -141.41 126.15 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.57 -0.706 . . . . 19.739999999999998 109.141 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -64.36 147.12 53.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.062 . . . . 22.559999999999999 109.357 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.753 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.9 tm? -124.31 73.09 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 20.41 109.235 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 2.0 t70 -134.96 -175.48 3.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.916 -1.115 . . . . 33.990000000000002 109.72 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 53' ' ' GLN . 16.0 tt0 69.82 67.66 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.414 -0.804 . . . . 54.920000000000002 109.558 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 51' ' ' GLU . . . 38.17 27.85 0.04 OUTLIER Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.522 -1.031 . . . . 36.100000000000001 110.522 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 51' ' ' GLU . 3.5 mt-30 -105.96 125.58 32.8 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 120.897 -1.355 . . . . 54.759999999999998 109.913 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.528 ' C ' HD21 ' A' ' 49' ' ' LEU . 35.8 Cg_endo -78.73 146.35 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.313 2.008 . . . . 28.370000000000001 109.677 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.656 ' HB2' ' CD2' ' A' ' 13' ' ' PHE . . . -37.93 143.27 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.439 -0.788 . . . . 17.210000000000001 110.496 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.867 ' O ' HG21 ' A' ' 6' ' ' ILE . 79.5 m-85 -58.54 107.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.498 -0.751 . . . . 17.190000000000001 109.273 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.876 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.58 173.33 0.36 Allowed Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.107 -0.996 . . . . 17.82 108.983 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.876 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.8 Cg_endo -78.28 107.89 2.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.486 2.124 . . . . 17.280000000000001 110.09 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.23 179.32 47.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.963 -1.255 . . . . 17.219999999999999 109.963 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.708 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -77.12 137.74 39.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.385 -1.068 . . . . 19.57 108.642 179.203 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.937 ' HB3' HD22 ' A' ' 83' ' ' LEU . 26.9 m-85 -128.55 163.21 25.48 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.751 -1.218 . . . . 14.609999999999999 111.569 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.8 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.5 p -141.74 117.58 10.47 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.163 -1.791 . . . . 18.359999999999999 106.163 177.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.649 ' HB ' HD13 ' A' ' 2' ' ' ILE . 2.4 t -50.14 164.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 118.77 -1.172 . . . . 19.129999999999999 108.936 -178.185 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.3 t-80 -128.39 129.13 45.74 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.504 -0.747 . . . . 20.649999999999999 109.113 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.738 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER -72.59 2.19 6.88 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.519 -0.738 . . . . 19.649999999999999 109.985 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -18.91 30.66 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.002 -1.481 . . . . 14.720000000000001 107.002 178.376 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.504 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 14.7 m -96.19 -9.64 30.05 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.9 -0.5 . . . . 11.449999999999999 109.907 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.654 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.4 m-30 -78.05 154.37 31.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.112 -0.992 . . . . 14.25 109.951 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 3.8 mtmt -157.6 -178.38 7.29 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.528 -0.733 . . . . 32.700000000000003 109.182 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.565 ' CG1' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -109.96 105.82 19.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.434 -0.791 . . . . 15.630000000000001 109.132 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.22 -155.0 12.15 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.994 -1.243 . . . . 12.699999999999999 109.994 -179.5 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.401 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 5.8 tp-100 -98.55 42.47 1.09 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.321 -1.105 . . . . 26.289999999999999 109.68 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 74' ' ' GLY . 2.8 m-85 -129.22 22.14 5.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 20.440000000000001 109.625 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 73' ' ' PHE . . . 44.79 52.56 7.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.627 -1.389 . . . . 13.82 109.627 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 76' ' ' LEU . 16.8 t -176.66 130.18 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -1.116 . . . . 18.27 109.448 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.816 HD22 HD13 ' B' ' 81' ' ' LEU . 0.1 OUTLIER -44.1 160.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.907 . . . . 12.43 109.159 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.4 mtt -163.7 118.67 1.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 35.109999999999999 109.585 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.002 HD12 HD12 ' B' ' 78' ' ' ILE . 2.3 mp -54.07 138.14 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 13.67 109.324 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -105.77 -34.8 7.56 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.011 -1.107 . . . . 24.059999999999999 108.011 178.516 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.504 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.2 OUTLIER -170.12 67.07 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.169 -1.419 . . . . 35.039999999999999 107.169 178.804 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.811 HD13 HD22 ' B' ' 76' ' ' LEU . 0.7 OUTLIER -27.99 120.05 0.11 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.21 -0.905 . . . . 18.719999999999999 111.859 -178.177 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -91.61 102.06 14.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 20.550000000000001 108.545 179.063 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.953 HD12 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -70.21 140.86 52.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.369 -0.832 . . . . 14.4 110.807 -178.818 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 62' ' ' THR . 33.5 m -140.61 148.8 54.67 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.774 -1.195 . . . . 17.649999999999999 107.774 178.688 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.8 Cg_endo -63.08 141.12 82.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.05 1.834 . . . . 25.699999999999999 110.265 179.378 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.708 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -71.83 108.44 5.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.309 -0.869 . . . . 49.289999999999999 109.461 -178.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.008 -0.996 . . . . 58.909999999999997 109.438 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.3 tpp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.474 -0.565 . . . . 64.909999999999997 109.474 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.738 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.1 mt -59.41 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.033 -1.099 . . . . 33.799999999999997 108.033 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' ' 1' ' ' MET . 15.2 mtpp -67.02 152.18 46.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.841 0.829 . . . . 32.719999999999999 111.265 -178.039 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.884 HG11 HD21 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -163.8 168.18 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.462 -0.94 . . . . 14.460000000000001 108.462 179.481 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.568 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 25.2 mt-10 -141.17 118.0 11.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.337 -0.852 . . . . 22.120000000000001 109.363 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.877 HG21 ' O ' ' B' ' 56' ' ' TYR . 10.4 mm -75.85 92.53 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.869 -1.16 . . . . 14.23 107.869 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.675 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.79 171.39 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.916 . . . . 25.43 110.189 -178.735 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.5 Cg_endo -74.65 -28.83 9.5 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.462 2.108 . . . . 13.609999999999999 109.85 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.51 -6.73 58.62 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.741 -0.837 . . . . 15.52 108.741 178.874 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 12.4 mm-40 -118.28 40.26 3.23 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.418 -0.801 . . . . 17.309999999999999 109.306 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -103.62 8.98 37.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 24.780000000000001 109.711 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.45 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 37.2 mt-30 -138.99 138.68 37.47 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.286 -0.884 . . . . 47.899999999999999 109.638 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.655 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 36.1 p90 -91.92 161.32 14.87 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.176 -0.952 . . . . 21.609999999999999 108.815 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 96.7 m -130.28 152.05 50.12 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.103 -0.998 . . . . 14.890000000000001 109.667 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.463 0 O-C-N 121.395 -0.816 . . . . 17.350000000000001 109.354 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.522 0.677 . . . . 24.0 110.475 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.617 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 97.9 m-20 -77.95 130.01 36.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 23.309999999999999 109.141 179.559 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -123.58 148.95 45.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 40.030000000000001 109.047 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.612 ' HB3' HG22 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -136.24 -170.14 2.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.111 -0.993 . . . . 12.390000000000001 109.648 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.766 ' HB3' HD11 ' B' ' 44' ' ' LEU . 5.9 mp -132.19 174.35 10.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.38 -0.825 . . . . 17.420000000000002 109.455 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -162.53 159.58 24.99 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.273 -1.01 . . . . 13.84 108.273 -179.547 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.701 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 14.9 m-85 -115.06 96.52 5.73 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.204 -0.935 . . . . 21.140000000000001 109.358 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.875 ' O ' HG22 ' B' ' 43' ' ' VAL . 3.1 t -105.09 127.62 59.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.163 -0.961 . . . . 10.66 110.491 -179.495 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 16.7 p-10 -86.52 -27.43 24.01 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.512 -0.922 . . . . 25.890000000000001 108.512 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.859 ' HG ' HG12 ' B' ' 35' ' ' VAL . 0.4 OUTLIER 47.3 23.93 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 24.239999999999998 109.486 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.83 8.47 69.6 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.961 -1.256 . . . . 31.02 109.961 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.455 ' ND2' ' N ' ' B' ' 39' ' ' ASN . 1.0 OUTLIER -87.23 18.62 3.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -1.219 . . . . 43.229999999999997 109.942 -179.71 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.6 ' O ' ' CB ' ' B' ' 41' ' ' HIS . 5.3 mt-10 46.76 71.37 0.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.89 . . . . 42.340000000000003 109.822 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.6 ' CB ' ' O ' ' B' ' 40' ' ' GLU . 0.2 OUTLIER 144.09 147.77 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.251 0 N-CA-C 108.57 -0.9 . . . . 6.5 108.57 179.383 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.701 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 38.4 Cg_endo -79.38 137.37 13.18 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.148 1.899 . . . . 17.920000000000002 110.52 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.875 HG22 ' O ' ' B' ' 35' ' ' VAL . 2.8 m -114.53 118.54 58.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.331 -0.856 . . . . 20.57 108.871 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.766 HD11 ' HB3' ' B' ' 32' ' ' LEU . 56.8 tp -76.45 106.98 8.4 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.361 -0.837 . . . . 20.210000000000001 110.638 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.605 HG13 HG23 ' B' ' 43' ' ' VAL . 22.0 m -115.65 -169.55 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.862 -0.792 . . . . 10.81 108.862 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -108.22 151.8 25.44 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.334 -0.947 . . . . 36.740000000000002 110.44 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.99 HD13 HD12 ' B' ' 83' ' ' LEU . 0.9 OUTLIER -141.23 126.14 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.503 -0.748 . . . . 19.739999999999998 109.056 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -64.49 146.88 53.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.002 -1.061 . . . . 22.559999999999999 109.322 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.769 HD13 ' O ' ' B' ' 49' ' ' LEU . 2.9 tm? -123.95 73.1 1.19 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 20.41 109.281 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' B' ' 53' ' ' GLN . 1.9 t70 -134.86 -175.46 3.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.941 -1.099 . . . . 33.990000000000002 109.8 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' B' ' 53' ' ' GLN . 16.5 tt0 69.84 67.73 0.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.348 -0.845 . . . . 54.920000000000002 109.588 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 52' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' B' ' 51' ' ' GLU . . . 38.07 28.04 0.04 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.537 -1.025 . . . . 36.100000000000001 110.537 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' B' ' 51' ' ' GLU . 3.3 mt-30 -106.13 125.71 32.38 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.888 -1.36 . . . . 54.759999999999998 109.894 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.515 ' C ' HD21 ' B' ' 49' ' ' LEU . 35.4 Cg_endo -78.8 146.62 21.03 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.408 2.072 . . . . 28.370000000000001 109.68 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.655 ' HB2' ' CD2' ' B' ' 13' ' ' PHE . . . -38.24 143.37 0.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.45 -0.781 . . . . 17.210000000000001 110.479 -179.291 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.877 ' O ' HG21 ' B' ' 6' ' ' ILE . 79.9 m-85 -58.49 106.99 0.44 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.458 -0.776 . . . . 17.190000000000001 109.201 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.901 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.58 173.29 0.37 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.105 -0.997 . . . . 17.82 109.076 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.901 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.5 Cg_endo -78.05 107.12 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.491 2.127 . . . . 17.280000000000001 110.031 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.15 179.26 46.52 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.576 -1.297 . . . . 17.219999999999999 110.106 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.717 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -77.42 137.4 38.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.405 -1.056 . . . . 19.57 108.445 179.121 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.953 ' HB3' HD22 ' B' ' 83' ' ' LEU . 26.9 m-85 -128.38 163.09 25.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.691 -1.255 . . . . 14.609999999999999 111.492 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.79 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.8 p -141.57 118.01 10.86 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.145 -1.798 . . . . 18.359999999999999 106.145 177.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.638 ' HB ' HD13 ' B' ' 2' ' ' ILE . 2.4 t -50.64 165.16 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 118.74 -1.184 . . . . 19.129999999999999 108.947 -178.171 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -128.51 129.15 45.64 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.5 -0.75 . . . . 20.649999999999999 109.142 -179.293 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.764 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -72.57 2.24 6.77 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.54 -0.725 . . . . 19.649999999999999 109.964 179.777 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.21 -19.51 34.16 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.843 -1.539 . . . . 14.720000000000001 106.843 178.386 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.507 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 14.4 m -95.68 -9.49 31.84 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.931 -0.481 . . . . 11.449999999999999 110.027 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.656 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.4 m-30 -78.06 154.18 31.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.037 . . . . 14.25 109.897 -178.845 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' B' ' 68' ' ' PHE . 3.8 mtmt -157.53 -178.93 7.7 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.538 -0.726 . . . . 32.700000000000003 109.159 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.558 ' CG1' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -109.44 105.98 19.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.456 -0.778 . . . . 15.630000000000001 109.09 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.26 -154.37 11.43 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.981 -1.248 . . . . 12.699999999999999 109.981 -179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -99.08 42.22 1.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -1.09 . . . . 26.289999999999999 109.661 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -128.91 21.95 5.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.895 . . . . 20.440000000000001 109.613 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.98 52.74 7.81 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.563 -1.415 . . . . 13.82 109.563 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.422 ' O ' ' C ' ' B' ' 76' ' ' LEU . 17.0 t -176.99 129.93 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 18.27 109.435 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.811 HD22 HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -43.79 159.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.877 . . . . 12.43 109.138 179.976 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.5 mtt -163.38 118.99 1.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 35.109999999999999 109.54 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 1.002 HD12 HD12 ' A' ' 78' ' ' ILE . 2.2 mp -54.38 138.5 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.193 -0.942 . . . . 13.67 109.354 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' B' ' 67' ' ' SER . 0.2 OUTLIER -106.13 -34.73 7.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.111 -1.07 . . . . 24.059999999999999 108.111 178.515 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.507 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.2 OUTLIER -170.21 66.56 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.275 -1.38 . . . . 35.039999999999999 107.275 178.816 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.816 HD13 HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -27.62 120.04 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.113 -0.949 . . . . 18.719999999999999 111.731 -178.161 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -91.78 101.95 14.55 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 20.550000000000001 108.53 179.097 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.99 HD12 HD13 ' B' ' 47' ' ' ILE . 0.9 OUTLIER -70.27 140.67 52.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 14.4 110.84 -178.727 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.79 HG22 ' O ' ' B' ' 62' ' ' THR . 33.6 m -140.41 148.79 55.16 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.843 -1.169 . . . . 17.649999999999999 107.843 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.0 Cg_endo -63.06 141.11 82.22 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.995 1.797 . . . . 25.699999999999999 110.326 179.338 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.717 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -71.53 108.27 4.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 49.289999999999999 109.466 -178.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.035 -0.983 . . . . 58.909999999999997 109.489 179.999 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.1 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.579 -0.526 . . . . 64.909999999999997 109.579 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.704 ' N ' HD22 ' B' ' 65' ' ' LEU . 3.3 mt -64.16 78.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.592 -1.262 . . . . 33.799999999999997 107.592 178.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -71.0 177.23 3.82 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.104 0.954 . . . . 32.719999999999999 111.549 -177.771 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.024 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER 176.35 163.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.739 -0.837 . . . . 14.460000000000001 108.739 179.753 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.524 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 26.1 mt-10 -137.96 108.36 6.51 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.63 0.728 . . . . 22.120000000000001 109.093 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.705 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -71.94 100.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 C-N-CA 118.906 -1.118 . . . . 14.23 108.07 179.615 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD3' ' CG ' ' A' ' 34' ' ' TYR . 6.7 mptt -44.67 170.17 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.343 -0.848 . . . . 25.43 109.902 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 32.1 Cg_endo -73.67 -27.48 12.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.275 1.984 . . . . 13.609999999999999 109.78 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 p -86.35 -2.92 58.84 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.613 -0.884 . . . . 15.52 108.613 178.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.655 ' O ' HG23 ' A' ' 6' ' ' ILE . 6.7 mm-40 -118.75 41.29 3.05 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.429 -0.794 . . . . 17.309999999999999 109.119 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.88 14.72 29.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.076 -1.015 . . . . 24.780000000000001 109.999 -179.38 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 29.6 mt-30 -142.24 146.59 35.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.165 -0.959 . . . . 47.899999999999999 109.68 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.728 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 34.9 p90 -93.84 159.42 15.2 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.296 -0.878 . . . . 21.609999999999999 109.537 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 t -134.76 162.67 31.7 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.449 -0.945 . . . . 14.890000000000001 108.449 178.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.608 0 O-C-N 121.217 -0.927 . . . . 17.350000000000001 109.162 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.368 0.604 . . . . 24.0 110.1 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.584 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 99.1 m-20 -59.16 130.53 47.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.821 . . . . 23.309999999999999 109.48 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -121.27 152.49 38.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.944 . . . . 40.030000000000001 108.949 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.79 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -133.13 -170.93 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 12.390000000000001 109.789 -179.634 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.931 ' HB3' HD11 ' A' ' 44' ' ' LEU . 2.1 mp -130.49 174.83 9.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 17.420000000000002 108.872 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -171.85 162.88 6.22 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 13.84 108.699 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.743 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.0 m-30 -114.87 90.22 3.29 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.226 -0.921 . . . . 21.140000000000001 108.817 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.966 ' O ' HG22 ' A' ' 43' ' ' VAL . 94.0 t -89.94 119.77 37.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.197 -0.939 . . . . 10.66 110.32 -179.234 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.564 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 48.7 m-20 -68.48 -30.96 69.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.509 -0.923 . . . . 25.890000000000001 108.509 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' B' ' 69' ' ' LYS . 1.0 OUTLIER 48.17 30.98 2.35 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.503 -0.748 . . . . 24.239999999999998 109.318 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.31 9.69 64.66 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.391 -1.484 . . . . 31.02 109.391 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 1.4 m-20 -81.95 14.01 3.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -1.168 . . . . 43.229999999999997 110.659 -179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.58 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 10.0 mt-10 57.23 15.61 2.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.131 -0.981 . . . . 42.340000000000003 110.093 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 63.3 m80 -164.74 149.4 8.17 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.683 -1.228 . . . . 6.1600000000000001 107.683 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.1 Cg_endo -74.81 146.19 33.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.653 1.569 . . . . 17.920000000000002 110.631 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.966 HG22 ' O ' ' A' ' 35' ' ' VAL . 12.5 m -123.5 116.2 47.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 119.531 -0.868 . . . . 20.57 108.78 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.931 HD11 ' HB3' ' A' ' 32' ' ' LEU . 21.9 tp -68.92 104.98 2.22 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.296 -0.962 . . . . 20.210000000000001 108.678 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.516 HG22 ' O ' ' B' ' 74' ' ' GLY . 9.1 p -120.0 163.09 17.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.587 -0.695 . . . . 10.81 109.275 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' B' ' 74' ' ' GLY . 0.0 OUTLIER -82.47 157.64 23.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 36.740000000000002 110.28 -179.055 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.986 ' CD1' HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -138.7 176.38 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.282 -1.007 . . . . 19.739999999999998 108.282 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.92 144.23 42.84 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.042 -1.036 . . . . 22.559999999999999 109.38 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.755 HD13 ' O ' ' A' ' 50' ' ' ASP . 2.9 tm? -128.57 122.61 31.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.29 -0.881 . . . . 20.41 109.037 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.755 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -53.51 159.44 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 33.990000000000002 109.999 -179.279 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -70.05 108.96 4.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.403 -0.81 . . . . 54.920000000000002 109.497 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.79 -13.5 67.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.561 -1.416 . . . . 36.100000000000001 109.561 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.703 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -67.07 157.03 86.3 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.227 -1.161 . . . . 54.759999999999998 109.536 179.98 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -78.35 106.69 2.18 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.564 2.176 . . . . 28.370000000000001 110.254 179.677 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.79 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -41.95 160.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.386 -0.821 . . . . 17.210000000000001 110.028 -179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.705 ' O ' HG21 ' A' ' 6' ' ' ILE . 75.5 m-85 -58.4 104.98 0.25 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.406 -0.809 . . . . 17.190000000000001 108.838 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.44 176.14 0.24 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 17.82 109.418 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.0 Cg_endo -77.79 120.06 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.532 2.154 . . . . 17.280000000000001 110.166 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.66 177.42 39.06 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.779 -1.328 . . . . 17.219999999999999 109.779 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -72.04 149.37 44.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -1.187 . . . . 19.57 108.269 179.139 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 1.024 ' CB ' HG13 ' A' ' 4' ' ' VAL . 22.2 m-85 -133.34 163.36 29.51 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.77 -1.206 . . . . 14.609999999999999 111.705 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.732 ' O ' HG22 ' A' ' 84' ' ' VAL . 34.2 p -147.93 120.08 8.31 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.456 -1.683 . . . . 18.359999999999999 106.456 178.385 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 2' ' ' ILE . 5.7 t -51.82 170.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 C-N-CA 118.672 -1.211 . . . . 19.129999999999999 108.955 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.591 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -134.67 125.93 28.08 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.421 -0.799 . . . . 20.649999999999999 109.187 -179.237 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.737 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.6 OUTLIER -72.27 1.08 8.31 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.27 -0.894 . . . . 19.649999999999999 109.802 179.724 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.3 p -57.64 -19.17 24.55 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.521 -1.289 . . . . 14.720000000000001 107.521 178.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 9.7 m -96.76 -18.57 19.53 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.772 -0.58 . . . . 11.449999999999999 110.128 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.682 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.6 m-30 -66.29 158.48 28.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 14.25 109.346 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HA ' HD21 ' B' ' 37' ' ' LEU . 0.0 OUTLIER -140.46 178.89 7.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 32.700000000000003 109.769 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.735 HG21 HG21 ' B' ' 43' ' ' VAL . 1.7 t -126.12 129.77 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.509 -0.744 . . . . 15.630000000000001 109.495 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.21 -170.67 25.33 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.677 -1.369 . . . . 12.699999999999999 109.677 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' CB ' ' A' ' 73' ' ' PHE . 25.9 tp60 69.5 80.76 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -1.148 . . . . 26.289999999999999 109.358 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.504 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 3.0 m-85 75.34 12.03 3.32 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.424 -0.798 . . . . 20.440000000000001 109.462 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.531 ' O ' HG22 ' B' ' 45' ' ' VAL . . . 70.77 47.77 38.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.558 -1.417 . . . . 13.82 109.558 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -144.03 144.48 31.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -1.168 . . . . 18.27 109.639 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 77' ' ' MET . 1.0 OUTLIER -50.73 169.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 12.43 109.187 179.776 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 2.3 mtp -165.52 106.01 0.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 35.109999999999999 110.25 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -42.43 -63.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.513 -0.742 . . . . 13.67 109.403 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.546 ' N ' HG22 ' A' ' 78' ' ' ILE . 9.5 t70 83.34 -45.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.392 0.615 . . . . 24.059999999999999 110.039 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.7 tpm_? -174.24 66.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.113 0.958 . . . . 35.039999999999999 108.632 179.646 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.616 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.5 pt? -36.07 128.81 0.7 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.668 0.747 . . . . 18.719999999999999 111.527 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -94.52 104.67 16.62 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.248 -1.019 . . . . 20.550000000000001 108.248 178.721 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.986 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -74.23 147.26 42.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 14.4 110.898 -178.761 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 62' ' ' THR . 32.5 m -148.37 155.85 42.59 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.09 -1.078 . . . . 17.649999999999999 108.09 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.8 Cg_endo -63.08 143.6 90.85 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.105 1.87 . . . . 25.699999999999999 110.322 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.711 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -69.81 125.43 26.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.228 -0.92 . . . . 49.289999999999999 109.702 -178.657 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.2 tptp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.004 -0.998 . . . . 58.909999999999997 109.512 -179.965 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.532 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.564 -0.532 . . . . 64.909999999999997 109.564 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.737 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.3 mt -64.2 78.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 33.799999999999997 107.657 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.9 OUTLIER -70.82 177.3 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.07 0.938 . . . . 32.719999999999999 111.542 -177.754 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.034 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER 176.29 163.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.714 -0.847 . . . . 14.460000000000001 108.714 179.743 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 26.0 mt-10 -137.82 108.38 6.57 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.605 0.716 . . . . 22.120000000000001 109.103 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.701 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -71.94 100.18 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.95 -1.1 . . . . 14.23 108.075 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.583 ' HD3' ' CG ' ' B' ' 34' ' ' TYR . 6.7 mptt -44.75 170.05 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.33 -0.856 . . . . 25.43 109.898 -179.264 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.9 Cg_endo -73.59 -27.5 12.83 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.365 2.043 . . . . 13.609999999999999 109.722 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.2 p -86.39 -2.74 58.69 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.664 -0.865 . . . . 15.52 108.664 178.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.651 ' O ' HG23 ' B' ' 6' ' ' ILE . 6.7 mm-40 -118.9 41.26 3.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.399 -0.813 . . . . 17.309999999999999 109.095 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.9 14.84 28.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.123 -0.986 . . . . 24.780000000000001 109.986 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.489 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 29.7 mt-30 -142.35 146.48 35.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 47.899999999999999 109.742 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.719 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 34.5 p90 -93.79 159.32 15.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.338 -0.851 . . . . 21.609999999999999 109.615 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.3 t -134.78 162.49 32.21 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.496 -0.928 . . . . 14.890000000000001 108.496 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.298 -1.633 0 O-C-N 121.166 -0.958 . . . . 17.350000000000001 109.18 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' B' ' 28' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.384 0.612 . . . . 24.0 110.146 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.582 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 99.1 m-20 -59.06 130.58 47.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 23.309999999999999 109.439 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -121.34 152.41 39.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.948 . . . . 40.030000000000001 109.002 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.765 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -133.08 -170.8 2.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.09 -1.006 . . . . 12.390000000000001 109.84 -179.612 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.915 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.1 mp -130.61 174.76 9.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.834 -0.802 . . . . 17.420000000000002 108.834 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.54 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -171.91 162.67 6.09 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.877 -1.14 . . . . 13.84 108.725 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.738 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.0 m-30 -114.66 90.33 3.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.212 -0.93 . . . . 21.140000000000001 108.824 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.992 ' O ' HG22 ' B' ' 43' ' ' VAL . 96.0 t -90.06 119.73 37.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.181 -0.949 . . . . 10.66 110.238 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 48.7 m-20 -68.36 -31.01 70.1 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.51 -0.922 . . . . 25.890000000000001 108.51 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.538 HD21 ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER 48.27 31.03 2.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.548 -0.72 . . . . 24.239999999999998 109.252 179.804 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.28 9.52 64.28 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.438 -1.465 . . . . 31.02 109.438 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 1.4 m-20 -81.77 13.87 2.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -1.162 . . . . 43.229999999999997 110.726 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.574 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 10.0 mt-10 57.32 15.62 2.7 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.124 -0.985 . . . . 42.340000000000003 110.115 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 63.5 m80 -164.73 149.41 8.19 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 107.745 -1.206 . . . . 6.1500000000000004 107.745 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.668 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.3 Cg_endo -74.83 146.15 33.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.648 1.565 . . . . 17.920000000000002 110.628 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.992 HG22 ' O ' ' B' ' 35' ' ' VAL . 12.6 m -123.47 116.25 47.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 C-N-CA 119.495 -0.882 . . . . 20.57 108.816 179.015 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.915 HD11 ' HB3' ' B' ' 32' ' ' LEU . 21.8 tp -68.87 105.1 2.24 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.341 -0.943 . . . . 20.210000000000001 108.655 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 74' ' ' GLY . 9.1 p -120.15 163.08 18.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.534 -0.729 . . . . 10.81 109.228 -179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -82.55 157.59 23.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.394 -0.816 . . . . 36.740000000000002 110.328 -179.114 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.98 ' CD1' HD12 ' B' ' 83' ' ' LEU . 0.4 OUTLIER -138.59 176.35 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.227 -1.027 . . . . 19.739999999999998 108.227 179.447 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 144.42 42.46 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.006 -1.059 . . . . 22.559999999999999 109.405 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.764 HD13 ' O ' ' B' ' 50' ' ' ASP . 2.9 tm? -128.68 122.4 30.68 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.317 -0.865 . . . . 20.41 109.067 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.764 ' O ' HD13 ' B' ' 49' ' ' LEU . 0.1 OUTLIER -53.38 159.34 1.43 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 33.990000000000002 110.033 -179.324 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -69.95 108.95 4.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.481 -0.762 . . . . 54.920000000000002 109.487 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.81 -13.57 67.16 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.563 -1.415 . . . . 36.100000000000001 109.563 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.711 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.2 OUTLIER -67.03 157.18 85.71 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.218 -1.166 . . . . 54.759999999999998 109.487 179.962 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.0 Cg_endo -78.39 106.67 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.624 2.216 . . . . 28.370000000000001 110.257 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.765 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.0 160.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 17.210000000000001 109.976 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.701 ' O ' HG21 ' B' ' 6' ' ' ILE . 75.2 m-85 -58.92 105.56 0.33 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.347 -0.846 . . . . 17.190000000000001 108.805 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.962 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.65 176.09 0.25 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.309 -0.869 . . . . 17.82 109.275 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.962 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.3 Cg_endo -78.03 121.12 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.637 2.225 . . . . 17.280000000000001 110.445 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.94 177.88 38.41 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.657 -1.377 . . . . 17.219999999999999 109.657 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.728 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -71.73 150.0 44.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -1.182 . . . . 19.57 108.555 179.387 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 1.034 ' CB ' HG13 ' B' ' 4' ' ' VAL . 21.1 m-85 -134.02 163.31 29.85 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 120.763 -1.211 . . . . 14.609999999999999 111.702 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.736 ' O ' HG22 ' B' ' 84' ' ' VAL . 33.9 p -147.98 120.25 8.38 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.445 -1.687 . . . . 18.359999999999999 106.445 178.402 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.674 HG21 HG21 ' B' ' 2' ' ' ILE . 5.9 t -52.04 169.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 118.631 -1.228 . . . . 19.129999999999999 108.965 -178.392 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.577 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -134.43 125.86 28.34 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.453 -0.779 . . . . 20.649999999999999 109.224 -179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.704 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -72.16 0.8 8.77 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.272 -0.893 . . . . 19.649999999999999 109.755 179.791 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 94.8 p -57.34 -19.24 21.39 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 107.53 -1.285 . . . . 14.720000000000001 107.53 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 10.3 m -96.69 -18.64 19.54 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.843 -0.536 . . . . 11.449999999999999 110.143 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.675 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.6 m-30 -66.26 157.89 30.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.004 . . . . 14.25 109.331 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.531 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.94 178.91 6.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 32.700000000000003 109.837 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.729 HG21 HG21 ' A' ' 43' ' ' VAL . 1.7 t -126.06 129.78 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.759 . . . . 15.630000000000001 109.535 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' B' ' 72' ' ' GLN . . . 143.19 -170.69 25.31 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.69 -1.364 . . . . 12.699999999999999 109.69 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.5 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 25.9 tp60 69.47 80.83 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -1.159 . . . . 26.289999999999999 109.341 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.5 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 3.0 m-85 75.33 11.9 3.35 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.443 -0.785 . . . . 20.440000000000001 109.49 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.516 ' O ' HG22 ' A' ' 45' ' ' VAL . . . 70.91 47.7 37.58 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.502 -1.439 . . . . 13.82 109.502 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -144.06 144.41 31.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -1.146 . . . . 18.27 109.635 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' B' ' 77' ' ' MET . 1.0 OUTLIER -50.66 169.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 12.43 109.151 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 2.3 mtp -165.58 105.95 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 35.109999999999999 110.303 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.616 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.8 mt -42.35 -64.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.568 -0.708 . . . . 13.67 109.416 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 9.4 t70 83.51 -45.16 0.11 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.4 0.619 . . . . 24.059999999999999 110.073 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.7 tpm_? -174.32 66.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.505 -0.924 . . . . 35.039999999999999 108.505 179.653 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.626 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.5 pt? -36.17 128.81 0.72 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.703 0.763 . . . . 18.719999999999999 111.545 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -94.5 104.44 16.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.29 -1.004 . . . . 20.550000000000001 108.29 178.791 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.98 HD12 ' CD1' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -73.98 147.39 43.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.189 -0.944 . . . . 14.4 110.842 -178.753 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.736 HG22 ' O ' ' B' ' 62' ' ' THR . 32.6 m -148.66 155.64 41.58 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.046 -1.094 . . . . 17.649999999999999 108.046 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.9 Cg_endo -62.89 143.8 92.16 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.076 1.851 . . . . 25.699999999999999 110.328 179.074 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -69.96 125.63 27.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -0.907 . . . . 49.289999999999999 109.724 -178.682 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 7.2 tptp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.978 -1.01 . . . . 58.909999999999997 109.571 179.979 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 2.8 ttm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.444 -0.576 . . . . 64.909999999999997 109.444 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.739 HG12 HD13 ' B' ' 65' ' ' LEU . 3.2 mt 69.66 64.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.705 -1.22 . . . . 33.799999999999997 107.705 -178.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 26.6 mttt -54.93 162.11 1.39 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.777 0.799 . . . . 32.719999999999999 111.28 -178.196 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.05 ' CG2' HG22 ' A' ' 35' ' ' VAL . 58.6 t -160.2 167.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.534 0.683 . . . . 14.460000000000001 109.53 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.573 ' N ' HG12 ' A' ' 4' ' ' VAL . 46.8 mt-10 -152.34 106.07 3.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.544 -0.722 . . . . 22.120000000000001 109.201 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.788 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -74.64 101.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.104 -1.073 . . . . 14.23 108.104 179.505 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.645 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.78 171.22 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.403 -0.81 . . . . 25.43 109.831 -179.324 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.4 Cg_endo -74.95 -28.45 9.26 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.463 2.109 . . . . 13.609999999999999 110.131 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.7 m -92.96 4.11 54.55 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.478 -0.764 . . . . 15.52 109.127 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.535 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 18.4 mm-40 -121.03 34.1 5.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 17.309999999999999 109.352 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -106.89 18.55 21.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 24.780000000000001 110.284 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 19.2 mt-30 -137.57 129.39 28.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.067 -1.02 . . . . 47.899999999999999 109.864 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.561 ' H ' ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -77.54 -174.32 3.32 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.425 -0.797 . . . . 21.609999999999999 110.578 -179.541 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 m -158.68 145.41 17.31 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.777 -0.823 . . . . 14.890000000000001 108.777 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.534 0 O-C-N 121.244 -0.91 . . . . 17.350000000000001 109.625 -179.493 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.501 0.667 . . . . 24.0 110.096 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -74.5 111.19 9.44 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.725 -0.843 . . . . 23.309999999999999 108.725 179.602 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 14.9 mm-40 -82.63 -172.77 4.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.035 -1.04 . . . . 40.030000000000001 109.015 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.559 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -171.18 179.92 2.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.073 -1.017 . . . . 12.390000000000001 110.249 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.942 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.4 mt -140.5 148.56 41.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.579 -0.701 . . . . 17.420000000000002 109.174 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.622 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.4 m -152.04 -178.55 6.83 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.918 -1.141 . . . . 13.84 107.918 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.662 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 38.0 m-85 -128.01 106.21 8.93 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.053 -1.03 . . . . 21.140000000000001 109.395 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.05 HG22 ' CG2' ' A' ' 4' ' ' VAL . 73.8 t -98.1 141.3 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.072 -1.017 . . . . 10.66 111.168 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.1 m-20 -111.15 35.72 3.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.008 -1.108 . . . . 25.890000000000001 108.008 178.667 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.941 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.0 pt? -40.94 -25.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.658 -0.651 . . . . 24.239999999999998 110.266 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.617 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 176.8 47.33 0.06 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 108.983 -1.647 . . . . 31.02 108.983 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 38' ' ' GLY . 21.3 m120 -149.55 109.66 4.13 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.481 -1.011 . . . . 43.229999999999997 108.751 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 39' ' ' ASN . 26.0 mt-10 -34.24 -56.84 0.5 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.64 0.733 . . . . 42.340000000000003 110.128 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 50.9 m-70 -73.41 160.37 82.59 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 108.662 -0.866 . . . . 6.5700000000000003 108.662 179.394 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.662 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.3 Cg_endo -77.43 140.47 19.28 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.054 1.836 . . . . 17.920000000000002 109.87 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.925 HG22 ' O ' ' A' ' 35' ' ' VAL . 3.2 m -108.58 114.27 46.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.198 -0.939 . . . . 20.57 109.532 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.942 HD11 ' HB3' ' A' ' 32' ' ' LEU . 54.8 tp -68.01 106.94 2.51 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.388 -0.82 . . . . 20.210000000000001 109.623 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 2.1 t -110.44 169.28 3.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.48 -0.762 . . . . 10.81 109.03 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.576 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -92.93 162.89 13.89 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.33 -0.857 . . . . 36.740000000000002 110.394 -179.264 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.567 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -138.42 165.11 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.634 -0.876 . . . . 19.739999999999998 108.634 179.698 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.744 HG22 ' O ' ' A' ' 48' ' ' THR . 9.0 m -124.7 71.59 1.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 22.559999999999999 109.278 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.683 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -40.4 137.04 1.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.508 -0.745 . . . . 20.41 109.674 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.02 165.4 24.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 33.990000000000002 109.367 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.41 114.8 10.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 54.920000000000002 109.495 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.77 -6.32 64.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.685 -1.366 . . . . 36.100000000000001 109.685 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.1 mt-30 -89.06 144.45 32.7 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.128 -1.219 . . . . 54.759999999999998 109.522 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.5 Cg_endo -78.54 123.95 6.17 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.642 2.228 . . . . 28.370000000000001 110.332 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.683 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -40.41 142.74 0.38 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 17.210000000000001 110.54 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.788 ' O ' HG21 ' A' ' 6' ' ' ILE . 12.0 m-30 -45.98 104.39 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 17.190000000000001 109.153 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.774 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.35 168.64 0.36 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.992 -1.067 . . . . 17.82 109.185 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.774 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.4 Cg_endo -76.98 113.39 3.62 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.52 2.147 . . . . 17.280000000000001 110.193 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.19 -176.56 48.08 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.923 -1.271 . . . . 17.219999999999999 109.923 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -75.81 139.25 41.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -1.09 . . . . 19.57 108.406 179.121 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.7 ' HB3' HD22 ' A' ' 83' ' ' LEU . 19.0 m-85 -127.83 166.11 18.86 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.725 -1.234 . . . . 14.609999999999999 111.456 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.5 p -149.94 120.28 7.35 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.46 -1.681 . . . . 18.359999999999999 106.46 179.008 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -50.45 166.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 118.738 -1.185 . . . . 19.129999999999999 108.886 -178.362 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -125.23 123.98 40.72 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.865 -0.791 . . . . 20.649999999999999 108.865 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.745 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -69.47 -3.28 13.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.636 -0.665 . . . . 19.649999999999999 110.113 -179.187 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 t -58.83 -13.89 7.41 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.068 -1.02 . . . . 14.720000000000001 108.409 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 19.6 m -95.61 -7.72 36.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.755 . . . . 11.449999999999999 110.709 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.662 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.1 m-30 -81.25 159.16 24.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.899 -1.125 . . . . 14.25 109.882 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.565 ' HA ' HD11 ' B' ' 37' ' ' LEU . 12.0 mtmt -153.03 173.84 14.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.485 -0.76 . . . . 32.700000000000003 108.997 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.559 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.6 OUTLIER -110.68 118.08 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 15.630000000000001 109.53 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.19 -176.15 48.94 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.294 -1.523 . . . . 12.699999999999999 109.294 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.0 19.86 3.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.09 -1.241 . . . . 26.289999999999999 109.77 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 -11.39 23.5 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.511 -0.743 . . . . 20.440000000000001 109.561 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' ' OG ' ' A' ' 75' ' ' SER . . . 84.48 50.27 4.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.712 -1.355 . . . . 13.82 109.712 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -170.69 153.88 4.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -1.161 . . . . 18.27 109.553 179.933 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.742 HD23 ' N ' ' A' ' 77' ' ' MET . 10.6 tt -81.16 150.52 28.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 12.43 109.476 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.742 ' N ' HD23 ' A' ' 76' ' ' LEU . 2.2 mtt -155.78 129.19 8.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 35.109999999999999 109.355 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.883 HD12 HD12 ' B' ' 78' ' ' ILE . 3.1 mt -63.18 139.44 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 13.67 109.841 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 6.9 t0 -104.4 -18.48 14.4 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.257 -1.016 . . . . 24.059999999999999 108.257 178.448 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.4 tmm_? 172.23 71.69 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.863 -1.532 . . . . 35.039999999999999 106.863 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -34.0 119.21 0.39 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.607 0.718 . . . . 18.719999999999999 111.199 -178.05 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 5.9 mtt180 -88.75 110.07 20.69 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.466 -0.939 . . . . 20.550000000000001 108.466 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.815 HD11 HG11 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -81.13 141.63 34.06 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.187 -0.946 . . . . 14.4 110.49 -179.112 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 62' ' ' THR . 25.9 m -145.28 159.08 50.09 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.193 -1.04 . . . . 17.649999999999999 108.193 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.08 141.61 77.34 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.124 1.882 . . . . 25.699999999999999 110.206 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.663 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -67.68 122.44 18.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.096 -1.003 . . . . 49.289999999999999 109.521 -178.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.961 -1.019 . . . . 58.909999999999997 109.469 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.452 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 2.8 ttm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.446 -0.576 . . . . 64.909999999999997 109.446 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.745 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.2 mt 69.54 64.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.759 -1.2 . . . . 33.799999999999997 107.759 -178.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.534 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 26.7 mttt -54.87 162.16 1.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.823 0.821 . . . . 32.719999999999999 111.269 -178.148 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.05 ' CG2' HG22 ' B' ' 35' ' ' VAL . 58.9 t -160.19 167.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.5 0.667 . . . . 14.460000000000001 109.601 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.589 ' N ' HG12 ' B' ' 4' ' ' VAL . 46.4 mt-10 -152.26 106.2 3.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.613 0.721 . . . . 22.120000000000001 109.088 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.79 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -74.69 101.06 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.141 -1.059 . . . . 14.23 108.141 179.43 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.634 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.73 171.16 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.445 -0.785 . . . . 25.43 109.827 -179.323 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.4 Cg_endo -75.03 -28.28 9.25 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.407 2.071 . . . . 13.609999999999999 110.179 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 12.8 m -93.03 4.21 54.4 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.508 -0.745 . . . . 15.52 109.122 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 18.4 mm-40 -121.15 34.0 5.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.258 -0.901 . . . . 17.309999999999999 109.36 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.85 18.68 21.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 24.780000000000001 110.282 -179.282 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.421 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 19.1 mt-30 -137.56 129.51 28.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.057 -1.027 . . . . 47.899999999999999 109.825 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.55 ' H ' ' HB2' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -77.62 -174.45 3.42 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.395 -0.815 . . . . 21.609999999999999 110.529 -179.563 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 55.9 m -158.6 145.44 17.43 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.764 -0.828 . . . . 14.890000000000001 108.764 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.503 0 O-C-N 121.262 -0.899 . . . . 17.350000000000001 109.561 -179.468 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.461 HD23 ' O ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.493 0.663 . . . . 24.0 110.114 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.569 ' HB2' ' HB3' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -74.52 111.14 9.41 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.736 -0.838 . . . . 23.309999999999999 108.736 179.548 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 14.8 mm-40 -82.66 -172.74 4.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.035 -1.04 . . . . 40.030000000000001 108.97 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.564 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -171.21 179.96 2.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.081 -1.012 . . . . 12.390000000000001 110.3 179.848 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.952 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.4 mt -140.58 148.56 41.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.538 -0.726 . . . . 17.420000000000002 109.176 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.637 ' O ' HD12 ' B' ' 44' ' ' LEU . 2.4 m -151.96 -178.35 6.7 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.868 -1.16 . . . . 13.84 107.868 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.656 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 37.5 m-85 -128.22 106.28 8.93 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.09 -1.006 . . . . 21.140000000000001 109.3 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 1.05 HG22 ' CG2' ' B' ' 4' ' ' VAL . 73.8 t -98.14 141.27 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.127 -0.983 . . . . 10.66 111.168 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' B' ' 38' ' ' GLY . 4.1 m-20 -111.11 35.69 3.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.031 -1.1 . . . . 25.890000000000001 108.031 178.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.928 ' H ' HG12 ' B' ' 35' ' ' VAL . 2.0 pt? -40.99 -25.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.647 -0.658 . . . . 24.239999999999998 110.271 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.621 ' O ' ' ND2' ' B' ' 39' ' ' ASN . . . 176.71 47.47 0.06 OUTLIER Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.002 -1.639 . . . . 31.02 109.002 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' B' ' 38' ' ' GLY . 21.5 m120 -149.64 109.67 4.12 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.502 -0.999 . . . . 43.229999999999997 108.757 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' B' ' 39' ' ' ASN . 26.1 mt-10 -34.21 -56.86 0.5 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.692 0.758 . . . . 42.340000000000003 110.159 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 51.0 m-70 -73.41 160.48 82.35 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 108.693 -0.855 . . . . 6.5599999999999996 108.693 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.656 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.5 Cg_endo -77.46 140.34 19.11 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.098 1.865 . . . . 17.920000000000002 109.837 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.934 HG22 ' O ' ' B' ' 35' ' ' VAL . 3.2 m -108.48 114.32 46.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.168 -0.957 . . . . 20.57 109.572 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.952 HD11 ' HB3' ' B' ' 32' ' ' LEU . 54.8 tp -68.07 106.99 2.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.428 -0.795 . . . . 20.210000000000001 109.534 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 2.1 t -110.46 169.25 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 10.81 109.038 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.574 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -92.85 162.98 13.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.314 -0.866 . . . . 36.740000000000002 110.378 -179.291 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.564 ' CG2' ' HB3' ' B' ' 31' ' ' GLN . 0.4 OUTLIER -138.49 165.1 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.579 -0.897 . . . . 19.739999999999998 108.579 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.747 HG22 ' O ' ' B' ' 48' ' ' THR . 9.5 m -124.73 71.6 1.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.223 -0.923 . . . . 22.559999999999999 109.366 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.677 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -40.36 136.97 1.15 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.559 -0.713 . . . . 20.41 109.709 179.93 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.98 165.49 24.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 33.990000000000002 109.324 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.47 114.85 11.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 54.920000000000002 109.528 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.75 -6.45 64.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.665 -1.374 . . . . 36.100000000000001 109.665 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.518 ' O ' HD12 ' B' ' 49' ' ' LEU . 1.1 mt-30 -88.99 144.46 32.82 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.148 -1.207 . . . . 54.759999999999998 109.53 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.6 Cg_endo -78.54 123.87 6.14 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.62 2.213 . . . . 28.370000000000001 110.343 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.677 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -40.46 142.76 0.38 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.361 -0.837 . . . . 17.210000000000001 110.467 -179.669 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.79 ' O ' HG21 ' B' ' 6' ' ' ILE . 12.2 m-30 -46.16 104.51 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 17.190000000000001 109.246 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.768 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -53.22 168.6 0.35 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.99 -1.069 . . . . 17.82 109.084 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.768 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.8 Cg_endo -77.19 114.55 3.8 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.603 2.202 . . . . 17.280000000000001 110.458 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.12 47.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.8 -1.32 . . . . 17.219999999999999 109.8 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.661 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -75.45 139.59 42.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -1.079 . . . . 19.57 108.692 179.45 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.689 ' HB3' HD22 ' B' ' 83' ' ' LEU . 18.1 m-85 -128.25 166.04 19.34 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.765 -1.21 . . . . 14.609999999999999 111.437 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.565 ' O ' HG22 ' B' ' 84' ' ' VAL . 44.4 p -150.0 120.46 7.41 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.432 -1.692 . . . . 18.359999999999999 106.432 179.007 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -50.61 166.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 C-N-CA 118.741 -1.183 . . . . 19.129999999999999 108.908 -178.379 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -125.19 124.12 41.06 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.411 -0.806 . . . . 20.649999999999999 108.863 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.739 HD13 HG12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -69.61 -3.2 13.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.676 -0.64 . . . . 19.649999999999999 110.084 -179.166 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.7 t -58.91 -13.86 7.51 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.069 -1.019 . . . . 14.720000000000001 108.329 179.135 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 19.7 m -95.62 -7.86 36.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.756 . . . . 11.449999999999999 110.724 -179.304 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.654 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.1 m-30 -81.15 159.2 24.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.859 -1.151 . . . . 14.25 109.795 -179.027 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.566 ' HA ' HD11 ' A' ' 37' ' ' LEU . 12.0 mtmt -153.04 173.91 14.85 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.977 -0.749 . . . . 32.700000000000003 108.977 179.662 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.566 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -110.66 118.2 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 15.630000000000001 109.51 179.935 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.32 -176.22 48.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.337 -1.505 . . . . 12.699999999999999 109.337 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.93 19.87 3.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.109 -1.23 . . . . 26.289999999999999 109.793 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -11.23 23.54 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.529 -0.732 . . . . 20.440000000000001 109.573 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.414 ' C ' ' OG ' ' B' ' 75' ' ' SER . . . 84.32 50.46 4.28 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.73 -1.348 . . . . 13.82 109.73 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' B' ' 74' ' ' GLY . 0.9 OUTLIER -170.88 153.91 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -1.178 . . . . 18.27 109.614 179.889 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.742 HD23 ' N ' ' B' ' 77' ' ' MET . 10.6 tt -81.23 150.58 28.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 12.43 109.469 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.742 ' N ' HD23 ' B' ' 76' ' ' LEU . 2.2 mtt -155.88 129.14 8.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 35.109999999999999 109.402 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.883 HD12 HD12 ' A' ' 78' ' ' ILE . 3.1 mt -63.11 139.51 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 13.67 109.827 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 6.9 t0 -104.5 -18.45 14.36 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.233 -1.025 . . . . 24.059999999999999 108.233 178.448 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.4 tmm_? 172.25 71.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.893 -1.521 . . . . 35.039999999999999 106.893 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -33.98 119.11 0.39 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.643 0.735 . . . . 18.719999999999999 111.136 -178.005 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 5.9 mtt180 -88.67 110.03 20.62 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.498 -0.927 . . . . 20.550000000000001 108.498 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.836 HD11 HG11 ' B' ' 4' ' ' VAL . 0.3 OUTLIER -81.02 141.83 33.99 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.116 -0.99 . . . . 14.4 110.415 -179.069 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.565 HG22 ' O ' ' B' ' 62' ' ' THR . 25.4 m -145.59 158.86 49.46 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.185 -1.043 . . . . 17.649999999999999 108.185 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -63.93 141.57 78.16 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.078 1.852 . . . . 25.699999999999999 110.27 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.661 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -67.63 122.52 18.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.123 -0.986 . . . . 49.289999999999999 109.541 -178.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.972 -1.013 . . . . 58.909999999999997 109.498 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.499 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.358 0.599 . . . . 64.909999999999997 109.393 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.787 ' N ' HD22 ' B' ' 65' ' ' LEU . 4.3 mt 75.24 83.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.662 -1.236 . . . . 33.799999999999997 107.662 -179.086 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.516 ' C ' HG12 ' A' ' 4' ' ' VAL . 3.8 mtpp -80.55 173.16 12.88 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.133 0.968 . . . . 32.719999999999999 111.927 -177.51 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.895 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 179.77 168.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.775 -0.824 . . . . 14.460000000000001 108.775 -179.778 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 35.9 mt-10 -141.71 112.67 7.34 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.426 -0.796 . . . . 22.120000000000001 109.442 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.848 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -71.52 104.8 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.483 -1.303 . . . . 14.23 107.483 179.017 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.666 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -51.32 162.0 0.71 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.88 . . . . 25.43 110.123 -178.909 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 33.9 Cg_endo -76.68 -18.6 15.13 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.505 2.136 . . . . 13.609999999999999 109.116 179.039 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -92.12 8.38 38.18 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.682 -0.859 . . . . 15.52 108.682 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.554 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -147.74 38.97 0.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.362 -0.836 . . . . 17.309999999999999 109.246 179.326 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.11 6.9 44.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 24.780000000000001 109.756 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 29.3 mt-30 -127.29 155.64 43.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 47.899999999999999 109.282 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.757 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 37.1 p90 -96.45 160.49 14.38 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.165 -0.959 . . . . 21.609999999999999 109.406 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -127.2 160.79 30.2 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.315 -0.866 . . . . 14.890000000000001 108.8 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.299 -1.613 0 O-C-N 121.274 -0.892 . . . . 17.350000000000001 108.963 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.341 0.591 . . . . 24.0 109.637 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.571 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 85.7 m-20 -43.72 134.73 4.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 23.309999999999999 109.638 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -125.99 161.77 26.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.884 . . . . 40.030000000000001 109.163 179.942 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.97 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -140.39 -172.36 3.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 12.390000000000001 109.602 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.738 ' HB3' HD11 ' A' ' 44' ' ' LEU . 2.7 mp -130.75 171.42 13.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 17.420000000000002 109.361 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.579 ' SG ' HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -162.21 154.32 19.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.104 -0.997 . . . . 13.84 108.711 -179.613 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.699 ' CE2' HD13 ' A' ' 44' ' ' LEU . 27.1 m-85 -115.32 104.31 11.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 21.140000000000001 109.604 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.898 HG21 HD13 ' B' ' 76' ' ' LEU . 64.1 t -80.23 165.33 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.807 -1.183 . . . . 10.66 109.536 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.599 ' N ' HG12 ' A' ' 35' ' ' VAL . 6.2 m-20 -137.21 -52.87 0.68 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.299 -0.876 . . . . 25.890000000000001 109.676 -179.556 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.797 ' CG ' HD11 ' B' ' 65' ' ' LEU . 0.1 OUTLIER -42.09 -44.65 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.66 0.743 . . . . 24.239999999999998 109.11 179.919 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 39' ' ' ASN . . . -88.57 32.21 4.58 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.613 -1.395 . . . . 31.02 109.613 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 2.5 p30 161.16 117.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.384 -1.068 . . . . 43.229999999999997 109.594 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -42.5 -64.79 0.55 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 42.340000000000003 109.509 179.941 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.506 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 5.5 m-70 -68.68 163.4 55.11 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 107.96 -1.126 . . . . 3.77 107.96 179.033 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.688 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.9 Cg_endo -78.1 140.48 17.88 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.541 1.494 . . . . 17.920000000000002 109.692 -179.699 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.53 HG21 ' ND2' ' A' ' 39' ' ' ASN . 6.0 m -116.32 114.32 45.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.313 -0.867 . . . . 20.57 109.003 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.738 HD11 ' HB3' ' A' ' 32' ' ' LEU . 43.8 tp -69.75 107.73 3.61 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.347 -0.846 . . . . 20.210000000000001 109.835 -179.437 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.695 HG23 HG11 ' B' ' 70' ' ' VAL . 0.8 OUTLIER -109.13 164.19 5.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.56 -0.904 . . . . 10.81 108.56 179.635 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' HA3' ' B' ' 74' ' ' GLY . 1.0 OUTLIER -86.96 170.0 11.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.159 -0.963 . . . . 36.740000000000002 109.803 -179.67 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.635 HG22 ' CB ' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -156.6 171.65 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.347 -0.846 . . . . 19.739999999999998 109.315 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -107.82 147.8 30.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.201 -0.937 . . . . 22.559999999999999 109.45 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.639 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 1.8 tm? -129.39 112.15 13.54 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.219 -0.926 . . . . 20.41 108.778 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 53' ' ' GLN . 2.7 t70 -61.75 138.18 58.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -0.816 . . . . 33.990000000000002 110.223 -178.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.28 124.38 16.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.346 -0.847 . . . . 54.920000000000002 108.834 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.47 -31.15 8.39 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.979 -1.648 . . . . 36.100000000000001 108.979 -179.356 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.585 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -73.77 146.51 85.63 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.375 -1.074 . . . . 54.759999999999998 109.155 179.648 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.44 118.2 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.426 2.084 . . . . 28.370000000000001 109.997 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.97 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -41.58 154.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 17.210000000000001 109.711 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 6.8 m-30 -45.07 105.57 0.06 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.239 -0.913 . . . . 17.190000000000001 108.892 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.952 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -61.97 176.15 0.48 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 17.82 109.347 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.952 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.0 Cg_endo -77.61 129.97 10.43 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.602 2.202 . . . . 17.280000000000001 110.523 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.598 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 153.03 148.25 4.83 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.767 -1.333 . . . . 17.219999999999999 109.767 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.6 OUTLIER -46.78 146.23 1.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.137 -1.213 . . . . 19.57 108.838 179.481 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.895 ' CB ' HG13 ' A' ' 4' ' ' VAL . 16.3 m-85 -125.77 161.85 26.41 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.667 -1.271 . . . . 14.609999999999999 111.7 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.904 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.2 p -144.86 121.6 11.2 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.459 -1.682 . . . . 18.359999999999999 106.459 178.698 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -59.98 163.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 118.529 -1.268 . . . . 19.129999999999999 108.922 -178.504 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.473 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.2 t-80 -127.27 128.19 45.59 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.037 -0.727 . . . . 20.649999999999999 109.037 -179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.784 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -71.52 0.98 7.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.471 -0.768 . . . . 19.649999999999999 110.159 -179.833 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -20.78 6.58 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.283 -1.377 . . . . 14.720000000000001 107.283 178.647 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 5.8 m -95.11 -8.31 36.87 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.903 -0.498 . . . . 11.449999999999999 110.218 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.6 m-30 -84.73 156.87 21.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.953 -1.092 . . . . 14.25 109.336 -179.167 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HE2' ' OD2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -168.03 174.69 7.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.397 -0.814 . . . . 32.700000000000003 109.435 179.747 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.715 HG11 HG23 ' B' ' 45' ' ' VAL . 0.1 OUTLIER -103.13 109.82 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.821 . . . . 15.630000000000001 109.254 -179.965 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 72' ' ' GLN . . . -77.31 50.83 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.104 -1.199 . . . . 12.699999999999999 110.104 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER 40.05 49.39 2.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -1.094 . . . . 26.289999999999999 110.102 179.62 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 74' ' ' GLY . 1.7 m-85 -143.35 31.26 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 20.440000000000001 109.334 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.516 ' HA3' ' HG2' ' B' ' 46' ' ' LYS . . . 44.61 44.96 8.55 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.624 -1.39 . . . . 13.82 109.624 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.484 ' N ' HG22 ' B' ' 45' ' ' VAL . 46.6 m -166.57 114.27 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -1.209 . . . . 18.27 109.832 -179.925 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.862 HD13 HG21 ' B' ' 35' ' ' VAL . 0.3 OUTLIER -68.04 155.36 39.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 12.43 109.037 179.678 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.543 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 8.1 mtp -162.54 157.06 21.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 35.109999999999999 109.754 -179.743 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.759 HD12 HD12 ' B' ' 78' ' ' ILE . 3.3 mt -80.65 135.06 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 13.67 109.899 179.653 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 79' ' ' ASP . 46.9 t0 -103.18 -20.55 14.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.376 -0.972 . . . . 24.059999999999999 108.376 178.327 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 67' ' ' SER . 5.1 tmm_? 175.79 69.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.93 -1.507 . . . . 35.039999999999999 106.93 179.397 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -32.23 120.21 0.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.458 -0.792 . . . . 18.719999999999999 111.635 -177.711 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -92.12 99.44 12.24 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.322 -0.992 . . . . 20.550000000000001 108.322 178.996 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.749 HD23 ' CD2' ' A' ' 61' ' ' TYR . 1.5 tp -67.43 157.54 33.91 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.019 0.914 . . . . 14.4 111.159 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 62' ' ' THR . 21.3 m -156.55 147.98 16.9 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.818 -1.178 . . . . 17.649999999999999 107.818 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -63.12 135.24 49.87 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 121.815 1.677 . . . . 25.699999999999999 109.872 179.352 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.749 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -61.85 118.8 7.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.942 . . . . 49.289999999999999 109.792 -178.521 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.01 -0.995 . . . . 58.909999999999997 109.454 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.494 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.339 0.59 . . . . 64.909999999999997 109.425 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.784 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.2 mt 75.25 83.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.632 -1.247 . . . . 33.799999999999997 107.632 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.533 ' C ' HG12 ' B' ' 4' ' ' VAL . 3.8 mtpp -80.74 173.07 12.97 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.136 0.97 . . . . 32.719999999999999 111.957 -177.56 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.891 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 179.83 168.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.781 -0.822 . . . . 14.460000000000001 108.781 -179.773 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.582 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 36.5 mt-10 -141.54 112.65 7.39 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.401 -0.812 . . . . 22.120000000000001 109.522 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.866 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -71.5 104.72 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.475 -1.306 . . . . 14.23 107.475 179.05 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.686 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -51.32 162.05 0.7 Allowed Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.881 . . . . 25.43 110.154 -178.874 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.401 ' HD2' ' HG3' ' B' ' 7' ' ' LYS . 33.7 Cg_endo -76.54 -18.8 15.27 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.472 2.114 . . . . 13.609999999999999 109.15 178.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -92.03 8.6 36.92 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.719 -0.845 . . . . 15.52 108.719 178.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.558 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 0.0 OUTLIER -147.92 38.92 0.92 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.35 -0.844 . . . . 17.309999999999999 109.229 179.353 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.18 7.05 44.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 24.780000000000001 109.721 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.604 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 29.0 mt-30 -127.52 155.59 43.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 47.899999999999999 109.203 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.764 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 37.4 p90 -96.37 160.53 14.37 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.089 -1.007 . . . . 21.609999999999999 109.363 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -127.2 160.84 30.04 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.838 -0.801 . . . . 14.890000000000001 108.838 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.649 0 O-C-N 121.318 -0.864 . . . . 17.350000000000001 109.002 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.317 0.579 . . . . 24.0 109.681 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.576 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 85.8 m-20 -43.59 134.38 4.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 23.309999999999999 109.735 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 1.0 OUTLIER -125.65 161.74 26.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.362 -0.836 . . . . 40.030000000000001 109.192 179.889 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.96 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -140.32 -172.33 3.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.166 -0.959 . . . . 12.390000000000001 109.605 179.954 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.734 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.7 mp -130.76 171.63 12.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 17.420000000000002 109.372 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.582 ' SG ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -162.45 154.28 18.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.06 -1.025 . . . . 13.84 108.776 -179.688 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.703 ' CE2' HD13 ' B' ' 44' ' ' LEU . 27.4 m-85 -115.23 104.36 11.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 21.140000000000001 109.645 -179.653 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.862 HG21 HD13 ' A' ' 76' ' ' LEU . 63.2 t -80.32 165.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.849 -1.157 . . . . 10.66 109.509 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.617 ' N ' HG12 ' B' ' 35' ' ' VAL . 6.2 m-20 -137.24 -52.76 0.67 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.304 -0.873 . . . . 25.890000000000001 109.683 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -42.09 -44.67 3.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 24.239999999999998 109.088 179.921 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 39' ' ' ASN . . . -88.52 32.06 4.63 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.651 -1.38 . . . . 31.02 109.651 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' ASP . 2.5 p30 161.23 117.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.397 -1.06 . . . . 43.229999999999997 109.577 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.0 OUTLIER -42.45 -64.67 0.57 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.355 -0.841 . . . . 42.340000000000003 109.508 179.942 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.51 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 5.6 m-70 -68.95 163.41 56.68 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 107.97 -1.122 . . . . 3.75 107.97 179.078 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.692 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.9 Cg_endo -77.98 140.67 18.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.507 1.471 . . . . 17.920000000000002 109.702 -179.736 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.534 HG21 ' ND2' ' B' ' 39' ' ' ASN . 5.9 m -116.49 114.29 45.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.339 -0.851 . . . . 20.57 108.981 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.734 HD11 ' HB3' ' B' ' 32' ' ' LEU . 43.6 tp -69.77 107.48 3.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.379 -0.826 . . . . 20.210000000000001 109.946 -179.407 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.715 HG23 HG11 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -108.88 164.12 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.627 -0.879 . . . . 10.81 108.627 179.592 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' HA3' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -86.85 170.11 11.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.948 . . . . 36.740000000000002 109.741 -179.645 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.637 HG22 ' CB ' ' B' ' 31' ' ' GLN . 0.1 OUTLIER -156.72 171.46 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.283 -0.886 . . . . 19.739999999999998 109.379 179.861 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 18.3 m -107.5 147.71 30.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 22.559999999999999 109.442 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.64 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 1.7 tm? -129.24 112.22 13.68 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.198 -0.939 . . . . 20.41 108.781 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' B' ' 53' ' ' GLN . 2.7 t70 -61.69 138.3 58.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.827 . . . . 33.990000000000002 110.202 -179.014 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.41 124.39 17.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 54.920000000000002 108.771 179.379 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.52 -31.25 8.3 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.987 -1.645 . . . . 36.100000000000001 108.987 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.608 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.4 OUTLIER -73.61 146.45 85.94 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.35 -1.088 . . . . 54.759999999999998 109.153 179.694 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.4 Cg_endo -78.35 118.03 4.2 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.453 2.102 . . . . 28.370000000000001 109.998 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.96 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -41.49 154.81 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.454 -0.779 . . . . 17.210000000000001 109.764 -179.71 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 6.7 m-30 -44.96 105.82 0.06 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 17.190000000000001 108.769 179.737 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -62.48 176.19 0.52 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 17.82 109.439 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.7 Cg_endo -77.46 128.53 9.63 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.547 2.165 . . . . 17.280000000000001 110.152 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 59' ' ' GLY . . . . . 0.61 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 155.4 147.97 4.88 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.889 -1.284 . . . . 17.219999999999999 109.889 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.753 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.6 OUTLIER -47.43 145.69 2.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.055 -1.262 . . . . 19.57 108.527 179.209 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.891 ' CB ' HG13 ' B' ' 4' ' ' VAL . 17.0 m-85 -125.25 161.87 25.95 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.624 -1.297 . . . . 14.609999999999999 111.663 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.906 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.5 p -144.87 121.73 11.27 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.445 -1.687 . . . . 18.359999999999999 106.445 178.742 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -60.15 163.22 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 C-N-CA 118.517 -1.273 . . . . 19.129999999999999 108.974 -178.519 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.47 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -127.41 128.28 45.55 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.527 -0.733 . . . . 20.649999999999999 109.036 -179.287 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.797 HD11 ' CG ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -71.48 0.88 7.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.476 -0.765 . . . . 19.649999999999999 110.093 -179.828 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -20.89 6.15 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.268 -1.382 . . . . 14.720000000000001 107.268 178.721 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 5.6 m -95.14 -8.98 34.86 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.897 -0.502 . . . . 11.449999999999999 110.245 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.6 m-30 -84.07 156.57 22.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.945 -1.097 . . . . 14.25 109.206 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.403 ' HE2' ' OD2' ' B' ' 79' ' ' ASP . 0.3 OUTLIER -167.8 174.43 7.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.431 -0.793 . . . . 32.700000000000003 109.435 179.736 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.695 HG11 HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -102.76 109.91 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 15.630000000000001 109.273 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' B' ' 72' ' ' GLN . . . -77.44 50.58 3.2 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.143 -1.183 . . . . 12.699999999999999 110.143 -179.759 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 71' ' ' GLY . 0.4 OUTLIER 40.28 49.62 2.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.331 -1.099 . . . . 26.289999999999999 110.041 179.653 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -143.65 31.35 1.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 20.440000000000001 109.323 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.516 ' HA3' ' HG2' ' A' ' 46' ' ' LYS . . . 44.56 44.73 8.37 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.621 -1.392 . . . . 13.82 109.621 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 45' ' ' VAL . 46.6 m -166.41 114.53 0.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -1.205 . . . . 18.27 109.824 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.898 HD13 HG21 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -68.13 155.36 39.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 12.43 109.019 179.634 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 8.1 mtp -162.68 157.13 21.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 35.109999999999999 109.682 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.759 HD12 HD12 ' A' ' 78' ' ' ILE . 3.3 mt -80.78 135.36 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.442 -0.787 . . . . 13.67 109.91 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' B' ' 79' ' ' ASP . 47.2 t0 -103.19 -20.74 14.03 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.358 -0.979 . . . . 24.059999999999999 108.358 178.287 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' B' ' 67' ' ' SER . 5.1 tmm_? 175.96 69.7 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.982 -1.488 . . . . 35.039999999999999 106.982 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.643 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -32.45 120.2 0.31 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.464 -0.789 . . . . 18.719999999999999 111.684 -177.725 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -92.15 99.32 12.14 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.23 -1.026 . . . . 20.550000000000001 108.23 179.064 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.732 HD23 ' CD2' ' B' ' 61' ' ' TYR . 1.5 tp -67.4 157.62 33.68 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.034 0.921 . . . . 14.4 111.127 -178.556 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.906 HG22 ' O ' ' B' ' 62' ' ' THR . 21.2 m -156.6 148.13 16.99 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.841 -1.17 . . . . 17.649999999999999 107.841 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.5 Cg_endo -63.31 135.17 48.84 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.774 1.649 . . . . 25.699999999999999 109.88 179.383 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.753 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -61.83 118.43 7.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.318 -0.864 . . . . 49.289999999999999 109.761 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 87' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' B' ' 86' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.975 -1.012 . . . . 58.909999999999997 109.475 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.302 0.572 . . . . 64.909999999999997 109.53 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.895 ' CA ' HD22 ' B' ' 65' ' ' LEU . 5.3 mt -69.67 82.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.909 -1.145 . . . . 33.799999999999997 107.909 179.178 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.488 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 mttt -59.19 156.21 12.72 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.894 0.854 . . . . 32.719999999999999 111.531 -177.881 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 35' ' ' VAL . 49.0 t -159.57 167.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 109.19 -0.67 . . . . 14.460000000000001 109.19 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.602 ' N ' HG12 ' A' ' 4' ' ' VAL . 30.2 mt-10 -152.63 100.93 2.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.741 0.782 . . . . 22.120000000000001 109.185 -179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.644 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -66.96 103.56 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.852 -1.166 . . . . 14.23 107.852 179.493 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 2.2 mmpt? -50.18 159.23 0.84 Allowed Pre-proline 0 N--CA 1.485 1.291 0 O-C-N 121.302 -0.874 . . . . 25.43 109.66 -179.115 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.2 Cg_endo -76.16 -3.31 13.67 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.28 1.987 . . . . 13.609999999999999 109.37 179.374 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.15 -10.45 33.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.483 -0.76 . . . . 15.52 109.408 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 1.053 ' OE1' HD13 ' A' ' 32' ' ' LEU . 25.7 mm-40 -97.54 -76.34 0.52 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.293 -0.879 . . . . 17.309999999999999 108.863 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 10' ' ' GLN . . . 23.64 45.54 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.205 0.526 . . . . 24.780000000000001 111.195 179.295 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 10' ' ' GLN . 11.0 pt20 -179.04 132.42 0.12 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 47.899999999999999 109.557 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 31.9 p90 -97.45 156.27 16.55 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.953 -1.092 . . . . 21.609999999999999 109.486 179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 t -124.92 164.08 20.86 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.651 -0.87 . . . . 14.890000000000001 108.651 178.663 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.523 0 O-C-N 121.116 -0.99 . . . . 17.350000000000001 109.53 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 29' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.521 0.677 . . . . 24.0 110.657 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.63 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -42.2 159.3 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 23.309999999999999 109.942 179.686 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -156.71 137.22 13.09 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.753 -0.832 . . . . 40.030000000000001 108.753 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.844 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -120.89 -166.34 1.33 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.947 -1.095 . . . . 12.390000000000001 110.334 -179.231 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.053 HD13 ' OE1' ' A' ' 10' ' ' GLN . 4.4 mp -127.37 175.25 8.35 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.933 -0.766 . . . . 17.420000000000002 108.933 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.79 160.14 6.74 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.796 -1.19 . . . . 13.84 108.663 -179.545 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.695 ' CE1' HD13 ' A' ' 44' ' ' LEU . 2.9 m-30 -112.54 86.37 2.35 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.259 -0.9 . . . . 21.140000000000001 109.199 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 4' ' ' VAL . 59.2 t -83.11 110.37 18.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.156 -0.965 . . . . 10.66 110.227 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' LEU . 36.8 t0 -53.58 -34.79 59.61 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.779 -1.193 . . . . 25.890000000000001 107.779 178.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.748 HD11 ' C ' ' B' ' 68' ' ' PHE . 1.0 OUTLIER 41.27 34.36 0.32 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.303 0.573 . . . . 24.239999999999998 109.73 179.317 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.25 23.75 34.44 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.301 -1.52 . . . . 31.02 109.301 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.596 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 2.0 m120 -88.26 26.53 1.39 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.304 -1.116 . . . . 43.229999999999997 110.01 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.77 14.18 3.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.046 -1.034 . . . . 42.340000000000003 109.876 179.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER 175.61 167.1 0.39 Allowed Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.437 -0.949 . . . . 5.25 108.437 179.883 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 33.8 Cg_endo -75.81 145.16 28.46 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.722 1.614 . . . . 17.920000000000002 110.421 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 35' ' ' VAL . 6.6 m -119.9 119.77 61.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.482 -0.887 . . . . 20.57 109.171 179.356 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.931 HD11 ' HB3' ' A' ' 32' ' ' LEU . 14.7 tp -72.47 112.85 8.89 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.886 -0.725 . . . . 20.210000000000001 109.276 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.427 HG22 ' C ' ' B' ' 74' ' ' GLY . 1.7 p -130.78 161.51 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.386 -0.822 . . . . 10.81 109.127 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 0.6 OUTLIER -80.75 160.34 24.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.038 -1.039 . . . . 36.740000000000002 110.407 -179.094 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.815 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -140.64 161.91 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.46 -0.941 . . . . 19.739999999999998 108.46 179.353 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 143.0 28.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.97 -1.081 . . . . 22.559999999999999 109.683 -179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -114.0 146.58 39.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.366 -0.834 . . . . 20.41 108.858 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.498 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -81.33 142.88 32.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 33.990000000000002 109.538 -179.583 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.12 116.89 3.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 54.920000000000002 109.477 -179.905 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.11 -6.55 83.37 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.652 -1.379 . . . . 36.100000000000001 109.652 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.498 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -83.89 148.78 54.96 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 54.759999999999998 109.451 179.999 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.5 Cg_endo -77.01 119.47 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.617 2.211 . . . . 28.370000000000001 110.776 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.844 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.01 147.85 0.21 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 17.210000000000001 110.267 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.678 ' CD1' HG21 ' A' ' 47' ' ' ILE . 86.8 m-85 -44.07 112.09 0.36 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 17.190000000000001 109.131 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.01 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -63.92 176.58 0.63 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 17.82 109.779 -179.58 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 1.01 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -77.8 113.54 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.756 2.304 . . . . 17.280000000000001 110.433 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.8 172.84 38.83 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.389 -1.484 . . . . 17.219999999999999 109.389 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 3.3 mp -70.41 146.63 50.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 19.57 108.811 179.494 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.644 ' CE1' HD13 ' A' ' 6' ' ' ILE . 26.6 m-85 -131.24 163.59 27.45 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.945 -1.097 . . . . 14.609999999999999 110.921 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.664 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.1 p -144.4 117.17 8.72 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.066 -1.827 . . . . 18.359999999999999 106.066 178.623 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -49.81 163.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 C-N-CA 118.681 -1.208 . . . . 19.129999999999999 108.71 -178.143 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -128.3 126.62 41.16 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.409 -0.807 . . . . 20.649999999999999 109.381 -178.901 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.886 HD22 ' HA ' ' B' ' 2' ' ' ILE . 0.7 OUTLIER -74.05 2.51 8.65 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.533 -0.729 . . . . 19.649999999999999 110.054 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.9 p -58.88 -18.02 29.22 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.546 -1.279 . . . . 14.720000000000001 107.546 178.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 23.8 m -97.83 -16.4 19.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.842 -0.536 . . . . 11.449999999999999 110.151 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.728 ' C ' HD11 ' B' ' 37' ' ' LEU . 3.0 m-30 -68.14 157.3 35.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.125 -0.984 . . . . 14.25 109.441 -178.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.617 ' N ' HD11 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -150.48 -179.76 7.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.385 -0.822 . . . . 32.700000000000003 109.613 -179.995 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.632 HG21 HG21 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -120.82 110.88 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 15.630000000000001 109.121 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' N ' ' SD ' ' A' ' 77' ' ' MET . . . -81.7 -175.07 50.03 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.658 -1.377 . . . . 12.699999999999999 109.658 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.524 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.2 tm0? -89.55 20.17 4.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.152 -1.205 . . . . 26.289999999999999 109.574 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -93.73 -2.64 53.5 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.394 -0.816 . . . . 20.440000000000001 109.348 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 81.16 26.89 51.3 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.68 -1.368 . . . . 13.82 109.68 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.6 153.7 32.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.082 -1.246 . . . . 18.27 109.82 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.596 HD12 HG13 ' A' ' 70' ' ' VAL . 1.1 tp -62.24 176.81 0.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.348 -0.845 . . . . 12.43 109.664 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.488 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 2.1 ptm -167.68 100.12 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 35.109999999999999 109.691 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.606 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.9 mt -36.86 -64.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.478 0.656 . . . . 13.67 110.301 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 9.0 t0 84.53 -45.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.484 0.659 . . . . 24.059999999999999 110.014 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.8 tpm_? -173.84 67.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.147 0.975 . . . . 35.039999999999999 108.526 179.424 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.637 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.2 pt? -40.96 126.8 2.59 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.483 -0.781 . . . . 18.719999999999999 111.931 -178.696 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 1.4 ttt180 -94.11 110.4 22.11 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.693 -1.225 . . . . 20.550000000000001 107.693 178.239 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.815 ' HB2' HD11 ' A' ' 47' ' ' ILE . 11.8 tp -80.2 150.42 30.12 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.056 -1.027 . . . . 14.4 111.112 -178.148 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 62' ' ' THR . 21.2 m -147.08 157.57 46.06 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 108.161 -1.051 . . . . 17.649999999999999 108.161 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.6 Cg_endo -62.56 142.0 88.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.058 1.838 . . . . 25.699999999999999 110.321 179.11 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -76.38 116.47 17.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.229 -0.919 . . . . 49.289999999999999 109.739 -178.835 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.012 -0.995 . . . . 58.909999999999997 109.425 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.482 ' SD ' ' HB ' ' B' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.308 0.575 . . . . 64.909999999999997 109.556 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.886 ' HA ' HD22 ' A' ' 65' ' ' LEU . 5.2 mt -69.48 82.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.91 -1.144 . . . . 33.799999999999997 107.91 179.114 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.5 ' C ' HG23 ' B' ' 4' ' ' VAL . 2.3 mttt -59.12 156.4 12.12 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.915 0.864 . . . . 32.719999999999999 111.543 -178.0 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.089 HG22 HG22 ' B' ' 35' ' ' VAL . 49.2 t -159.7 167.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 109.2 -0.667 . . . . 14.460000000000001 109.2 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.604 ' N ' HG12 ' B' ' 4' ' ' VAL . 30.0 mt-10 -152.45 100.94 2.62 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.808 0.813 . . . . 22.120000000000001 109.296 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.648 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -66.92 103.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.838 -1.171 . . . . 14.23 107.838 179.454 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.567 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 2.2 mmpt? -50.08 159.39 0.8 Allowed Pre-proline 0 N--CA 1.486 1.328 0 O-C-N 121.294 -0.879 . . . . 25.43 109.69 -179.156 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.7 Cg_endo -76.26 -3.26 13.61 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.353 2.035 . . . . 13.609999999999999 109.37 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.28 -10.48 32.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.461 -0.775 . . . . 15.52 109.394 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 1.038 ' OE1' HD13 ' B' ' 32' ' ' LEU . 25.6 mm-40 -97.48 -76.45 0.52 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.282 -0.886 . . . . 17.309999999999999 108.865 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' B' ' 10' ' ' GLN . . . 23.77 45.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.164 0.507 . . . . 24.780000000000001 111.175 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' B' ' 10' ' ' GLN . 11.0 pt20 -178.94 132.28 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 47.899999999999999 109.616 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 32.5 p90 -97.21 156.35 16.45 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.954 -1.091 . . . . 21.609999999999999 109.551 179.7 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.4 t -124.97 163.94 21.21 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.656 -0.868 . . . . 14.890000000000001 108.656 178.635 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.133 -0.979 . . . . 17.350000000000001 109.538 -179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' B' ' 29' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.482 0.658 . . . . 24.0 110.612 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.623 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -42.3 159.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.471 -0.768 . . . . 23.309999999999999 109.942 179.717 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -156.77 136.99 12.82 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.764 -0.828 . . . . 40.030000000000001 108.764 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.825 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -120.77 -166.41 1.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.992 -1.068 . . . . 12.390000000000001 110.342 -179.277 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 1.038 HD13 ' OE1' ' B' ' 10' ' ' GLN . 4.4 mp -127.16 175.43 8.14 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.871 -0.788 . . . . 17.420000000000002 108.871 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.99 160.1 6.38 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.834 -1.166 . . . . 13.84 108.59 -179.549 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.701 ' CE1' HD13 ' B' ' 44' ' ' LEU . 2.9 m-30 -112.52 86.41 2.35 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 21.140000000000001 109.201 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 1.089 HG22 HG22 ' B' ' 4' ' ' VAL . 59.5 t -83.22 110.57 18.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.189 -0.944 . . . . 10.66 110.236 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' B' ' 37' ' ' LEU . 36.8 t0 -53.7 -34.74 59.78 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.79 -1.189 . . . . 25.890000000000001 107.79 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.728 HD11 ' C ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER 41.26 34.38 0.32 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.79 -0.568 . . . . 24.239999999999998 109.717 179.345 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.23 23.58 33.71 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.3 -1.52 . . . . 31.02 109.3 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.59 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 2.1 m120 -88.09 26.46 1.38 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.285 -1.126 . . . . 43.229999999999997 110.022 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.8 14.22 4.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.082 -1.011 . . . . 42.340000000000003 109.893 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 0.6 OUTLIER 175.61 167.01 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.454 -0.943 . . . . 5.2300000000000004 108.454 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.637 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 33.8 Cg_endo -75.62 145.31 29.25 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.711 1.608 . . . . 17.920000000000002 110.49 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.877 HG22 ' O ' ' B' ' 35' ' ' VAL . 6.6 m -120.03 119.94 61.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 C-N-CA 119.378 -0.929 . . . . 20.57 109.16 179.312 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.949 HD11 ' HB3' ' B' ' 32' ' ' LEU . 14.8 tp -72.76 112.92 9.24 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.93 -0.708 . . . . 20.210000000000001 109.172 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 32' ' ' LEU . 1.7 p -130.82 161.52 40.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.421 -0.799 . . . . 10.81 109.077 -179.758 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -80.74 160.31 24.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.985 . . . . 36.740000000000002 110.399 -179.093 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.798 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.5 OUTLIER -140.57 161.88 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.378 -0.971 . . . . 19.739999999999998 108.378 179.41 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.07 142.98 28.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.952 -1.092 . . . . 22.559999999999999 109.744 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.602 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -113.85 146.82 39.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 20.41 108.888 179.873 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.503 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -81.63 142.78 32.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 33.990000000000002 109.536 -179.572 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.05 117.14 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 54.920000000000002 109.417 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.12 -6.81 83.04 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.599 -1.4 . . . . 36.100000000000001 109.599 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.503 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -83.79 148.89 55.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.188 -1.183 . . . . 54.759999999999998 109.508 -179.958 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.5 Cg_endo -77.03 119.39 5.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.715 2.277 . . . . 28.370000000000001 110.761 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.825 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.0 147.69 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 17.210000000000001 110.35 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.682 ' CD1' HG21 ' B' ' 47' ' ' ILE . 86.9 m-85 -43.76 112.54 0.4 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.543 -0.723 . . . . 17.190000000000001 109.07 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.979 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -64.54 176.38 0.74 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 17.82 109.879 -179.348 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.979 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.3 112.47 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.606 2.204 . . . . 17.280000000000001 110.112 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.56 172.31 39.54 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.54 -1.424 . . . . 17.219999999999999 109.54 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 3.0 mp -70.67 146.01 50.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -1.165 . . . . 19.57 108.438 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.648 ' CE1' HD13 ' B' ' 6' ' ' ILE . 27.5 m-85 -130.69 163.51 27.08 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.909 -1.119 . . . . 14.609999999999999 110.908 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.663 ' O ' HG22 ' B' ' 84' ' ' VAL . 44.5 p -144.26 117.2 8.82 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.049 -1.834 . . . . 18.359999999999999 106.049 178.562 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -49.86 163.64 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 C-N-CA 118.644 -1.222 . . . . 19.129999999999999 108.734 -178.134 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -128.07 126.79 41.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.338 -0.851 . . . . 20.649999999999999 109.356 -178.88 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.895 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -74.22 2.48 9.02 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.533 -0.73 . . . . 19.649999999999999 110.008 -179.996 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 84.1 p -58.85 -18.03 29.04 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.512 -1.292 . . . . 14.720000000000001 107.512 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 23.7 m -97.89 -16.39 19.77 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.85 -0.531 . . . . 11.449999999999999 110.172 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.748 ' C ' HD11 ' A' ' 37' ' ' LEU . 3.0 m-30 -68.21 156.98 36.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 14.25 109.454 -178.894 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.634 ' N ' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -149.89 -179.85 7.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 32.700000000000003 109.715 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.692 HG21 HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -120.75 110.87 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 15.630000000000001 109.061 179.788 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.457 ' N ' ' SD ' ' B' ' 77' ' ' MET . . . -81.85 -174.68 49.75 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.619 -1.392 . . . . 12.699999999999999 109.619 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 1.2 tm0? -90.01 20.27 4.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.168 -1.195 . . . . 26.289999999999999 109.54 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -93.75 -2.7 53.37 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.477 -0.764 . . . . 20.440000000000001 109.349 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 80.96 27.79 48.54 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.533 -1.427 . . . . 13.82 109.533 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.34 153.52 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -1.211 . . . . 18.27 109.788 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.606 HD12 HG13 ' B' ' 70' ' ' VAL . 1.1 tp -62.12 176.83 0.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 12.43 109.584 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' B' ' 69' ' ' LYS . 2.1 ptm -167.71 99.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 35.109999999999999 109.685 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.589 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.9 mt -36.67 -64.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.511 0.672 . . . . 13.67 110.329 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 9.1 t0 84.44 -45.38 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.435 0.636 . . . . 24.059999999999999 110.061 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.9 tpm_? -173.96 67.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.155 0.978 . . . . 35.039999999999999 108.488 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.637 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.2 pt? -40.83 126.78 2.52 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.503 -0.771 . . . . 18.719999999999999 111.984 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 1.4 ttt180 -94.11 110.48 22.19 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.677 -1.231 . . . . 20.550000000000001 107.677 178.221 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.798 ' HB2' HD11 ' B' ' 47' ' ' ILE . 11.7 tp -80.28 150.39 30.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.091 -1.006 . . . . 14.4 111.166 -178.188 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.663 HG22 ' O ' ' B' ' 62' ' ' THR . 21.2 m -146.98 157.89 45.91 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 108.214 -1.032 . . . . 17.649999999999999 108.214 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.0 Cg_endo -62.77 142.1 87.7 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.015 1.81 . . . . 25.699999999999999 110.334 179.134 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -76.57 116.44 17.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.21 -0.931 . . . . 49.289999999999999 109.743 -178.786 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.994 -1.003 . . . . 58.909999999999997 109.44 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.646 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.375 0.607 . . . . 64.909999999999997 109.418 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.958 ' HA ' HD22 ' B' ' 65' ' ' LEU . 0.9 OUTLIER -68.62 73.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.664 -1.236 . . . . 33.799999999999997 107.664 178.987 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.646 ' HD3' HD21 ' A' ' 60' ' ' LEU . 1.6 mttt -62.61 157.0 21.75 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.178 0.989 . . . . 32.719999999999999 112.372 -177.669 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.976 HG22 HG22 ' A' ' 35' ' ' VAL . 60.0 t -159.44 169.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.562 -0.903 . . . . 14.460000000000001 108.562 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.606 ' N ' HG12 ' A' ' 4' ' ' VAL . 68.0 mt-10 -152.25 103.02 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.132 -0.98 . . . . 22.120000000000001 109.634 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.906 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -75.36 105.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.853 -1.166 . . . . 14.23 107.853 179.116 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.639 ' HG3' ' CD1' ' A' ' 34' ' ' TYR . 4.9 mttm -55.57 166.13 1.05 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.8 . . . . 25.43 109.704 -179.27 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.7 Cg_endo -72.19 -17.91 27.43 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.925 1.75 . . . . 13.609999999999999 108.955 179.303 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -90.78 -6.46 54.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.984 -0.747 . . . . 15.52 108.984 178.548 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 25.9 mm-40 -120.53 40.62 3.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 17.309999999999999 109.505 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -104.13 14.12 31.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.125 -0.985 . . . . 24.780000000000001 110.017 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 24.3 mt-30 -137.83 137.36 38.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 47.899999999999999 109.911 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.675 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 37.2 p90 -92.53 170.52 9.68 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.363 -0.836 . . . . 21.609999999999999 109.577 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -141.94 162.88 34.38 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.637 -0.875 . . . . 14.890000000000001 108.637 179.129 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.298 -1.632 0 O-C-N 121.194 -0.941 . . . . 17.350000000000001 109.187 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 28' ' ' LEU . 4.0 mm? . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.455 0.645 . . . . 24.0 109.984 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 95.0 m-20 -74.51 119.59 18.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.446 -0.784 . . . . 23.309999999999999 109.318 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -108.53 143.96 36.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.083 -1.011 . . . . 40.030000000000001 109.242 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.724 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -130.18 -179.9 5.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 12.390000000000001 109.548 -179.857 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.864 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.2 mp -133.78 159.15 41.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 17.420000000000002 109.795 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.61 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.7 m -152.09 177.54 10.39 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.992 -1.114 . . . . 13.84 107.992 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.674 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 51.4 m-85 -126.88 122.65 35.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.895 -1.128 . . . . 21.140000000000001 110.095 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.976 HG22 HG22 ' A' ' 4' ' ' VAL . 96.7 t -109.35 129.24 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.215 -0.928 . . . . 10.66 109.964 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -121.64 -14.68 8.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.405 -0.81 . . . . 25.890000000000001 109.81 -179.593 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.09 HD12 ' N ' ' A' ' 38' ' ' GLY . 2.6 pp -36.61 -29.74 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.653 -0.654 . . . . 24.239999999999998 110.551 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 1.09 ' N ' HD12 ' A' ' 37' ' ' LEU . . . -124.59 19.7 7.02 Favored Glycine 0 N--CA 1.482 1.734 0 N-CA-C 109.565 -1.414 . . . . 31.02 109.565 -179.012 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.599 ' ND2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -165.43 114.49 1.03 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.322 -1.105 . . . . 43.229999999999997 109.14 179.84 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 39' ' ' ASN . 39.8 mt-10 -39.08 -66.59 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.663 . . . . 42.340000000000003 109.946 -179.598 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 41' ' ' HIS . 2.1 m-70 -63.5 153.36 83.09 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 108.224 -1.028 . . . . 6.3700000000000001 108.224 179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.674 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -78.38 138.39 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.889 1.726 . . . . 17.920000000000002 110.277 -179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 43' ' ' VAL . 5.0 m -109.44 116.93 53.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.419 -0.801 . . . . 20.57 109.131 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.864 HD11 ' HB3' ' A' ' 32' ' ' LEU . 57.2 tp -71.86 108.13 4.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.276 -0.89 . . . . 20.210000000000001 109.937 -179.428 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.676 HG12 HG11 ' B' ' 70' ' ' VAL . 1.1 m -103.44 175.67 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.002 -0.74 . . . . 10.81 109.002 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -105.48 125.6 51.17 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.302 -0.959 . . . . 36.740000000000002 109.338 179.553 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.098 HD13 HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -120.9 132.33 70.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.277 -0.89 . . . . 19.739999999999998 109.602 -179.689 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 49' ' ' LEU . 60.1 m -66.63 156.71 34.41 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.246 -0.908 . . . . 22.559999999999999 109.299 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.707 HD11 ' O ' ' A' ' 53' ' ' GLN . 2.8 tm? -130.09 111.27 12.31 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.321 -0.862 . . . . 20.41 108.744 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.507 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -42.4 122.53 2.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 33.990000000000002 109.945 -179.2 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -51.02 101.67 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.353 -0.842 . . . . 54.920000000000002 109.277 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.44 -24.08 10.0 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.263 -1.535 . . . . 36.100000000000001 109.263 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.707 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -73.61 157.97 86.94 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.293 -1.122 . . . . 54.759999999999998 109.351 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -78.79 114.34 3.42 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.529 2.153 . . . . 28.370000000000001 110.142 179.546 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.724 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -38.81 142.01 0.24 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.477 -0.764 . . . . 17.210000000000001 109.888 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.906 ' O ' HG21 ' A' ' 6' ' ' ILE . 88.5 m-85 -41.9 101.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.393 -0.817 . . . . 17.190000000000001 109.408 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.795 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.72 169.36 0.21 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.16 -0.963 . . . . 17.82 109.207 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.795 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.25 122.11 6.0 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.62 2.213 . . . . 17.280000000000001 110.457 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.97 179.89 40.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.526 -1.43 . . . . 17.219999999999999 109.526 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -72.96 138.51 46.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -1.175 . . . . 19.57 108.448 179.294 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.759 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.2 m-85 -125.11 162.11 25.32 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.611 -1.306 . . . . 14.609999999999999 111.738 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 84' ' ' VAL . 58.8 p -144.74 120.62 10.62 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.505 -1.665 . . . . 18.359999999999999 106.505 179.06 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -54.6 165.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 C-N-CA 118.581 -1.248 . . . . 19.129999999999999 109.136 -178.472 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -127.55 127.07 43.3 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.523 -0.736 . . . . 20.649999999999999 109.031 -179.227 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.09 ' CD1' HD13 ' B' ' 37' ' ' LEU . 0.4 OUTLIER -69.31 -2.89 11.92 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.569 -0.707 . . . . 19.649999999999999 109.797 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 t -54.37 -19.67 5.96 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 107.775 -1.194 . . . . 14.720000000000001 107.775 179.151 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 82' ' ' ARG . 3.8 m -94.7 -8.84 36.59 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.756 -0.59 . . . . 11.449999999999999 110.188 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.685 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.3 m-30 -85.34 156.76 20.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.882 -1.136 . . . . 14.25 109.462 -179.272 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.431 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -148.52 176.54 10.23 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.054 -0.721 . . . . 32.700000000000003 109.054 179.545 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.702 HG11 HG12 ' B' ' 45' ' ' VAL . 1.7 t -127.23 118.43 49.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.302 -0.874 . . . . 15.630000000000001 109.474 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 72' ' ' GLN . . . -82.5 -99.46 0.48 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.326 -1.509 . . . . 12.699999999999999 109.326 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.589 ' O ' ' CG ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER 170.33 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -1.129 . . . . 26.289999999999999 109.565 179.754 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER 151.72 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.784 -0.821 . . . . 20.440000000000001 108.784 179.923 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -114.5 -88.06 1.56 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.442 -1.463 . . . . 13.82 109.442 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.44 ' HA ' ' HB ' ' B' ' 45' ' ' VAL . 0.2 OUTLIER 177.93 174.73 0.53 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -1.145 . . . . 18.27 109.678 -179.989 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' A' ' 77' ' ' MET . 6.3 tp -43.51 146.61 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 12.43 109.659 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.533 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 5.1 mtt -151.85 151.22 31.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 35.109999999999999 109.272 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.619 HG12 ' CE1' ' A' ' 68' ' ' PHE . 6.5 mt -76.96 137.26 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 13.67 110.308 -179.52 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -104.89 -26.73 12.09 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.931 -1.137 . . . . 24.059999999999999 107.931 178.419 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER 179.02 69.95 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.021 -1.474 . . . . 35.039999999999999 107.021 179.014 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -30.19 121.43 0.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.342 -0.845 . . . . 18.719999999999999 111.71 -178.038 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.51 ' N ' ' OG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -91.85 101.27 13.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 20.550000000000001 108.808 179.398 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.098 HD12 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -70.08 145.85 51.35 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.946 0.879 . . . . 14.4 110.883 -179.02 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 62' ' ' THR . 25.6 m -148.73 156.75 41.43 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 107.793 -1.188 . . . . 17.649999999999999 107.793 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.0 Cg_endo -63.79 140.02 71.73 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.979 1.786 . . . . 25.699999999999999 110.15 179.023 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.724 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -71.44 118.31 14.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.939 . . . . 49.289999999999999 109.64 -178.703 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.012 -0.994 . . . . 58.909999999999997 109.435 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.64 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.371 0.605 . . . . 64.909999999999997 109.408 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.95 ' HA ' HD22 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -68.73 73.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.699 -1.223 . . . . 33.799999999999997 107.699 179.028 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.647 ' HD3' HD21 ' B' ' 60' ' ' LEU . 1.5 mttt -62.63 156.82 22.29 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.157 0.979 . . . . 32.719999999999999 112.352 -177.623 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.012 HG22 HG22 ' B' ' 35' ' ' VAL . 60.4 t -159.42 168.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.552 -0.906 . . . . 14.460000000000001 108.552 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.613 ' N ' HG12 ' B' ' 4' ' ' VAL . 68.6 mt-10 -152.22 103.02 2.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 22.120000000000001 109.648 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.91 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -75.4 106.06 4.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.79 -1.189 . . . . 14.23 107.79 179.18 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.641 ' HD2' ' CE1' ' B' ' 34' ' ' TYR . 4.9 mttm -55.75 166.23 1.08 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.492 -0.755 . . . . 25.43 109.709 -179.241 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.9 Cg_endo -72.05 -18.01 27.82 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.987 1.791 . . . . 13.609999999999999 109.003 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -90.77 -6.4 54.41 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.988 -0.745 . . . . 15.52 108.988 178.64 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 26.3 mm-40 -120.68 40.73 3.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.895 . . . . 17.309999999999999 109.413 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -104.28 14.17 30.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 24.780000000000001 109.976 -179.346 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.404 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 24.7 mt-30 -137.86 137.34 38.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.148 -0.97 . . . . 47.899999999999999 109.854 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.658 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 37.2 p90 -92.47 170.59 9.64 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.398 -0.814 . . . . 21.609999999999999 109.568 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -141.91 163.02 34.03 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.57 -0.9 . . . . 14.890000000000001 108.57 179.136 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.606 0 O-C-N 121.217 -0.927 . . . . 17.350000000000001 109.18 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.435 0.636 . . . . 24.0 109.998 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.593 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 95.4 m-20 -74.71 119.44 18.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.439 -0.788 . . . . 23.309999999999999 109.33 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -108.37 144.08 36.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.069 -1.019 . . . . 40.030000000000001 109.2 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.704 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.5 OUTLIER -130.27 -179.9 5.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -0.994 . . . . 12.390000000000001 109.51 -179.902 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.3 mp -133.76 159.16 41.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 17.420000000000002 109.722 -179.782 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.614 ' O ' HD12 ' B' ' 44' ' ' LEU . 2.8 m -152.07 177.76 10.16 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.008 -1.108 . . . . 13.84 108.008 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.68 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 50.7 m-85 -127.19 122.58 34.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.881 -1.137 . . . . 21.140000000000001 110.091 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 1.012 HG22 HG22 ' B' ' 4' ' ' VAL . 96.6 t -109.27 129.16 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.234 -0.916 . . . . 10.66 109.937 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' B' ' 36' ' ' ASP . 0.4 OUTLIER -121.48 -14.68 8.19 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.432 -0.793 . . . . 25.890000000000001 109.788 -179.654 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 1.093 HD12 ' N ' ' B' ' 38' ' ' GLY . 2.6 pp -36.6 -29.7 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.654 -0.654 . . . . 24.239999999999998 110.58 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 1.093 ' N ' HD12 ' B' ' 37' ' ' LEU . . . -124.65 19.58 7.02 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 109.591 -1.404 . . . . 31.02 109.591 -178.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.605 ' ND2' HG11 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -165.43 114.68 1.03 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.38 -1.07 . . . . 43.229999999999997 109.056 179.832 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' B' ' 39' ' ' ASN . 39.9 mt-10 -39.12 -66.48 0.28 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.536 0.684 . . . . 42.340000000000003 110.057 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 41' ' ' HIS . . . . . 0.436 ' ND1' ' N ' ' B' ' 41' ' ' HIS . 2.1 m-70 -63.56 153.39 83.21 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.223 -1.029 . . . . 6.3799999999999999 108.223 179.28 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.68 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 38.2 Cg_endo -78.42 138.29 15.51 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.85 1.7 . . . . 17.920000000000002 110.241 -179.357 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.668 ' O ' HG23 ' B' ' 43' ' ' VAL . 4.8 m -109.37 116.99 53.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.423 -0.798 . . . . 20.57 109.191 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' B' ' 32' ' ' LEU . 57.0 tp -71.69 108.11 4.86 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.86 . . . . 20.210000000000001 109.982 -179.433 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.702 HG12 HG11 ' A' ' 70' ' ' VAL . 1.1 m -103.48 175.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.466 -0.771 . . . . 10.81 109.055 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -105.44 125.37 50.91 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.385 -0.926 . . . . 36.740000000000002 109.431 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 1.056 HD13 HD12 ' B' ' 83' ' ' LEU . 1.0 OUTLIER -120.72 132.39 70.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.334 -0.854 . . . . 19.739999999999998 109.608 -179.638 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.433 HG22 ' N ' ' B' ' 49' ' ' LEU . 59.8 m -66.72 156.81 34.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 22.559999999999999 109.238 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.707 HD11 ' O ' ' B' ' 53' ' ' GLN . 2.8 tm? -130.17 111.28 12.28 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.288 -0.883 . . . . 20.41 108.746 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.515 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -42.43 122.62 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 33.990000000000002 109.944 -179.124 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -51.06 101.64 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.356 -0.84 . . . . 54.920000000000002 109.322 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.47 -24.0 10.03 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.297 -1.521 . . . . 36.100000000000001 109.297 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.707 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.8 OUTLIER -73.79 157.85 86.83 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.295 -1.12 . . . . 54.759999999999998 109.362 179.883 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.7 114.47 3.46 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.518 2.145 . . . . 28.370000000000001 110.098 179.582 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.704 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -38.82 141.76 0.26 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.465 -0.772 . . . . 17.210000000000001 109.949 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.91 ' O ' HG21 ' B' ' 6' ' ' ILE . 88.7 m-85 -41.5 100.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.439 -0.788 . . . . 17.190000000000001 109.317 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -50.01 169.5 0.19 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.987 . . . . 17.82 109.287 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.6 Cg_endo -77.06 120.84 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.48 2.12 . . . . 17.280000000000001 110.188 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.35 179.07 41.59 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.69 -1.364 . . . . 17.219999999999999 109.69 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -73.18 137.98 45.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -1.153 . . . . 19.57 107.969 178.884 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.753 ' HB3' HD22 ' B' ' 83' ' ' LEU . 21.2 m-85 -124.55 162.35 24.23 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.502 -1.374 . . . . 14.609999999999999 111.703 -179.44 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.796 ' O ' HG22 ' B' ' 84' ' ' VAL . 58.1 p -144.86 120.46 10.43 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.492 -1.67 . . . . 18.359999999999999 106.492 179.08 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -54.4 166.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 C-N-CA 118.578 -1.249 . . . . 19.129999999999999 109.056 -178.451 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.484 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -128.27 127.2 42.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.033 -0.728 . . . . 20.649999999999999 109.033 -179.275 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 1.075 ' CD1' HD13 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -69.36 -2.75 11.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.514 -0.741 . . . . 19.649999999999999 109.771 -179.964 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 9.2 t -54.54 -19.52 6.04 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 107.729 -1.211 . . . . 14.720000000000001 107.729 179.119 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' B' ' 82' ' ' ARG . 3.8 m -95.1 -9.26 34.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.829 -0.544 . . . . 11.449999999999999 110.147 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.3 m-30 -84.93 155.89 21.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.878 -1.139 . . . . 14.25 109.269 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.423 ' O ' HD12 ' B' ' 76' ' ' LEU . 0.2 OUTLIER -147.77 176.56 10.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.497 -0.752 . . . . 32.700000000000003 109.016 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.676 HG11 HG12 ' A' ' 45' ' ' VAL . 1.7 t -127.13 118.63 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.867 . . . . 15.630000000000001 109.476 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' B' ' 72' ' ' GLN . . . -82.69 -99.2 0.5 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.4 -1.48 . . . . 12.699999999999999 109.4 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.579 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER 170.1 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.191 -1.181 . . . . 26.289999999999999 109.569 179.769 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.579 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 0.7 OUTLIER 151.61 -33.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.768 -0.827 . . . . 20.440000000000001 108.768 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -114.68 -87.76 1.51 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.487 -1.445 . . . . 13.82 109.487 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 177.58 174.69 0.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -1.154 . . . . 18.27 109.606 179.931 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' B' ' 77' ' ' MET . 6.3 tp -43.6 146.49 0.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 12.43 109.633 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.517 ' N ' ' HG ' ' B' ' 76' ' ' LEU . 5.0 mtt -151.74 151.34 31.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.383 -0.823 . . . . 35.109999999999999 109.13 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.628 HG12 ' CE1' ' B' ' 68' ' ' PHE . 6.5 mt -77.16 137.47 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 13.67 110.351 -179.571 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -104.84 -26.71 12.12 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.91 -1.144 . . . . 24.059999999999999 107.91 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.0 OUTLIER 178.99 70.03 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.006 -1.479 . . . . 35.039999999999999 107.006 179.054 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.645 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -30.19 121.5 0.18 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.3 -0.864 . . . . 18.719999999999999 111.697 -178.055 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.513 ' N ' ' OG ' ' B' ' 67' ' ' SER . 0.0 OUTLIER -91.84 101.45 14.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.832 -0.803 . . . . 20.550000000000001 108.832 179.37 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.056 HD12 HD13 ' B' ' 47' ' ' ILE . 0.6 OUTLIER -70.2 145.54 51.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 14.4 110.9 -179.073 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.796 HG22 ' O ' ' B' ' 62' ' ' THR . 25.8 m -148.49 156.95 42.24 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 107.714 -1.217 . . . . 17.649999999999999 107.714 179.369 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.4 Cg_endo -64.01 140.21 71.31 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.936 1.757 . . . . 25.699999999999999 110.034 179.1 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -71.55 118.29 14.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 49.289999999999999 109.693 -178.734 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.979 -1.01 . . . . 58.909999999999997 109.428 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.504 ' CG ' ' HB ' ' A' ' 62' ' ' THR . 1.5 ttp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.307 0.575 . . . . 64.909999999999997 109.565 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.908 ' CA ' HD22 ' B' ' 65' ' ' LEU . 5.2 mt -71.32 75.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.134 -1.062 . . . . 33.799999999999997 108.134 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.02 156.38 24.87 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.907 0.86 . . . . 32.719999999999999 111.155 -178.283 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.833 HG11 HD11 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -163.85 167.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.464 -0.939 . . . . 14.460000000000001 108.464 179.983 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.533 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 34.3 mt-10 -141.01 113.55 8.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 22.120000000000001 109.59 -179.66 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -72.83 103.28 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.106 -1.072 . . . . 14.23 108.106 179.346 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.597 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 24.2 mmmt -51.49 163.41 0.59 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 25.43 109.369 -179.471 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.9 Cg_endo -73.04 -12.61 25.97 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.059 1.839 . . . . 13.609999999999999 109.383 179.508 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.6 3.72 54.75 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.615 -0.883 . . . . 15.52 108.615 178.491 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.556 ' OE1' HD13 ' A' ' 32' ' ' LEU . 13.8 mm-40 -127.38 41.32 3.54 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.374 -0.829 . . . . 17.309999999999999 108.86 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -98.23 11.76 36.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 24.780000000000001 110.258 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 32.4 mt-30 -136.42 134.43 37.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.123 -0.985 . . . . 47.899999999999999 110.121 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.634 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 20.4 p90 -84.72 164.83 18.32 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.318 -0.863 . . . . 21.609999999999999 109.436 179.735 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -130.89 140.31 50.19 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.349 -0.844 . . . . 14.890000000000001 109.256 179.026 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.952 HG23 ' O ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.534 0 O-C-N 121.413 -0.805 . . . . 17.350000000000001 109.225 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.952 ' O ' HG23 ' A' ' 15' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.524 0.678 . . . . 24.0 109.997 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.634 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -103.04 131.57 49.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.461 -0.774 . . . . 23.309999999999999 109.206 -179.863 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -117.19 148.58 41.48 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.064 -1.022 . . . . 40.030000000000001 109.76 -179.762 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.789 ' HB2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -126.9 -163.91 1.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.172 -0.955 . . . . 12.390000000000001 109.496 179.729 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.013 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -136.35 177.98 7.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 17.420000000000002 109.609 -179.794 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.584 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -171.74 162.52 6.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 13.84 108.709 -179.768 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.751 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.5 m-30 -115.5 111.43 20.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.249 -0.907 . . . . 21.140000000000001 108.761 -179.848 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.832 ' O ' HG22 ' A' ' 43' ' ' VAL . 99.2 t -100.81 144.74 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.896 -1.127 . . . . 10.66 110.51 -179.602 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -125.54 -137.8 0.27 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.517 -0.92 . . . . 25.890000000000001 108.517 179.455 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.88 ' HB3' HD11 ' B' ' 65' ' ' LEU . 0.2 OUTLIER 68.48 -62.68 0.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.825 -1.172 . . . . 24.239999999999998 108.818 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -88.53 24.29 12.72 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.647 -1.781 . . . . 31.02 108.647 179.21 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.786 ' ND2' HG11 ' A' ' 43' ' ' VAL . 0.3 OUTLIER 176.39 114.41 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.548 -0.972 . . . . 43.229999999999997 108.655 -179.731 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 39' ' ' ASN . 4.3 mt-10 -38.91 -64.07 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.618 0.723 . . . . 42.340000000000003 109.995 -179.336 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -68.6 162.74 60.37 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 108.745 -0.835 . . . . 8.0199999999999996 108.745 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.647 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.5 Cg_endo -78.12 148.83 24.83 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.126 1.884 . . . . 17.920000000000002 110.307 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.965 HG21 HG21 ' B' ' 70' ' ' VAL . 18.5 m -119.74 119.53 60.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.294 -0.879 . . . . 20.57 109.262 179.363 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.013 HD11 ' HB3' ' A' ' 32' ' ' LEU . 20.6 tp -71.65 114.12 9.39 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.426 0.632 . . . . 20.210000000000001 109.557 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.482 HG23 ' N ' ' B' ' 75' ' ' SER . 3.3 p -122.09 163.05 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.455 -0.778 . . . . 10.81 109.316 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.67 173.05 12.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.919 . . . . 36.740000000000002 110.369 -179.167 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.697 HD12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -163.96 131.4 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.484 -0.932 . . . . 19.739999999999998 108.484 179.97 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.486 ' CG2' HD22 ' A' ' 28' ' ' LEU . 3.8 m -74.82 154.45 38.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.894 -1.129 . . . . 22.559999999999999 109.464 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.789 HD23 ' HB2' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -123.35 119.98 31.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -0.866 . . . . 20.41 109.037 -179.839 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.512 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -53.95 137.41 39.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 33.990000000000002 109.875 -179.455 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -57.36 118.21 4.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 54.920000000000002 109.244 179.79 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.74 -12.23 69.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.341 -1.504 . . . . 36.100000000000001 109.341 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -79.84 148.74 69.34 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.26 -1.141 . . . . 54.759999999999998 109.37 179.871 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.3 Cg_endo -77.08 121.08 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.589 2.193 . . . . 28.370000000000001 110.319 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.782 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -37.82 145.69 0.07 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.578 -0.702 . . . . 17.210000000000001 110.607 -179.597 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.697 ' CE1' HD12 ' A' ' 47' ' ' ILE . 75.2 m-85 -43.74 105.36 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.41 -0.806 . . . . 17.190000000000001 109.226 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.989 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.37 176.03 0.24 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 17.82 109.67 -179.532 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.989 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.54 115.16 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.645 2.23 . . . . 17.280000000000001 110.353 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.23 176.33 41.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.667 -1.373 . . . . 17.219999999999999 109.667 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.0 mp -73.33 145.34 46.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 19.57 108.842 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.698 ' C ' HG13 ' A' ' 4' ' ' VAL . 38.8 m-85 -132.56 162.8 30.34 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.43 1.11 . . . . 14.609999999999999 111.103 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.706 ' O ' HG22 ' A' ' 84' ' ' VAL . 38.7 p -142.32 121.83 13.27 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.945 -1.872 . . . . 18.359999999999999 105.945 178.16 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.679 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.0 t -55.26 163.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 C-N-CA 118.372 -1.331 . . . . 19.129999999999999 109.017 -177.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -123.05 130.99 53.5 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.49 -0.756 . . . . 20.649999999999999 109.383 -178.739 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.907 HD11 ' HB3' ' B' ' 37' ' ' LEU . 0.7 OUTLIER -73.87 2.85 7.61 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.475 -0.766 . . . . 19.649999999999999 109.853 179.827 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -56.2 -19.49 13.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 107.176 -1.416 . . . . 14.720000000000001 107.176 178.545 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.51 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 4.1 m -96.47 -7.01 35.9 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 116.057 -0.52 . . . . 11.449999999999999 110.212 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.686 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.1 m-30 -83.95 161.95 20.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.985 -1.072 . . . . 14.25 109.848 -178.856 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.76 170.13 22.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.453 -0.78 . . . . 32.700000000000003 109.326 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.937 HG21 ' CG2' ' B' ' 43' ' ' VAL . 0.5 OUTLIER -121.36 116.74 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 15.630000000000001 109.156 179.733 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.71 -170.82 17.73 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.763 -1.335 . . . . 12.699999999999999 109.763 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.537 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.1 tm0? -89.67 20.9 3.75 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.248 -1.148 . . . . 26.289999999999999 109.468 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 5.7 t80 -112.47 10.25 19.69 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.315 -0.866 . . . . 20.440000000000001 109.573 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' HG23 ' B' ' 45' ' ' VAL . . . 63.02 56.25 21.82 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.597 -1.401 . . . . 13.82 109.597 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.537 ' N ' HG23 ' B' ' 45' ' ' VAL . 1.4 m -157.27 120.06 3.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -1.146 . . . . 18.27 109.585 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -70.46 155.38 40.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 12.43 109.312 179.817 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 45.8 mtm -163.64 130.81 3.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 35.109999999999999 109.736 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.955 HD12 HD12 ' B' ' 78' ' ' ILE . 2.5 mp -64.64 142.0 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 13.67 109.805 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -105.59 -36.14 7.2 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.131 -1.063 . . . . 24.059999999999999 108.131 178.462 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.51 ' C ' ' HB3' ' A' ' 67' ' ' SER . 2.1 ttp180 -170.34 68.07 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 106.851 -1.537 . . . . 35.039999999999999 106.851 178.886 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.679 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -29.46 117.12 0.12 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.243 -0.889 . . . . 18.719999999999999 112.063 -177.674 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -92.21 113.0 25.15 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.004 -1.11 . . . . 20.550000000000001 108.004 178.825 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.833 HD11 HG11 ' A' ' 4' ' ' VAL . 15.3 tp -81.91 153.39 26.34 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.078 0.942 . . . . 14.4 111.023 -178.499 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 62' ' ' THR . 33.0 m -152.23 152.14 28.86 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.831 -1.174 . . . . 17.649999999999999 107.831 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.4 Cg_endo -60.99 141.54 94.77 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.019 1.812 . . . . 25.699999999999999 110.537 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.557 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.81 122.57 22.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 49.289999999999999 109.702 -178.645 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.979 -1.01 . . . . 58.909999999999997 109.446 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.507 ' CG ' ' HB ' ' B' ' 62' ' ' THR . 1.5 ttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.525 -0.546 . . . . 64.909999999999997 109.525 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.89 ' CA ' HD22 ' A' ' 65' ' ' LEU . 5.3 mt -71.68 75.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.119 -1.067 . . . . 33.799999999999997 108.119 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.01 156.19 25.39 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.917 0.865 . . . . 32.719999999999999 111.179 -178.277 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.837 HG11 HD11 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -163.67 167.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.468 -0.938 . . . . 14.460000000000001 108.468 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.544 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 34.5 mt-10 -141.04 113.63 8.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.958 . . . . 22.120000000000001 109.566 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.598 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -72.92 103.23 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.164 -1.05 . . . . 14.23 108.164 179.317 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.589 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 24.1 mmmt -51.44 163.34 0.59 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.322 -0.861 . . . . 25.43 109.338 -179.45 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.3 Cg_endo -73.05 -12.54 25.9 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.05 1.833 . . . . 13.609999999999999 109.437 179.488 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.63 3.63 54.84 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.584 -0.895 . . . . 15.52 108.584 178.467 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.57 ' OE1' HD13 ' B' ' 32' ' ' LEU . 13.7 mm-40 -127.18 41.12 3.58 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.385 -0.822 . . . . 17.309999999999999 108.898 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -98.08 11.92 36.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 24.780000000000001 110.294 -179.121 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.428 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 32.7 mt-30 -136.46 134.35 37.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.997 . . . . 47.899999999999999 110.158 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.652 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 20.6 p90 -84.7 164.8 18.36 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.355 -0.841 . . . . 21.609999999999999 109.465 179.701 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -130.86 140.34 50.22 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.39 -0.819 . . . . 14.890000000000001 109.29 179.047 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 15' ' ' THR . . . . . 0.951 HG23 ' O ' ' B' ' 28' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.527 0 O-C-N 121.333 -0.854 . . . . 17.350000000000001 109.269 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.951 ' O ' HG23 ' B' ' 15' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.469 0.652 . . . . 24.0 110.018 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.652 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -103.01 131.58 49.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.715 . . . . 23.309999999999999 109.155 -179.928 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.5 OUTLIER -117.13 148.53 41.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 40.030000000000001 109.708 -179.74 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.796 ' HB2' HD23 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -126.78 -163.84 1.28 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.173 -0.955 . . . . 12.390000000000001 109.503 179.704 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.992 ' HB3' HD11 ' B' ' 44' ' ' LEU . 0.5 OUTLIER -136.46 177.92 7.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 17.420000000000002 109.573 -179.785 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.58 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -171.69 162.56 6.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.018 -1.051 . . . . 13.84 108.718 -179.679 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.764 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.5 m-30 -115.6 111.4 20.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 21.140000000000001 108.763 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.814 ' O ' HG22 ' B' ' 43' ' ' VAL . 99.4 t -100.87 144.65 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.896 -1.128 . . . . 10.66 110.521 -179.541 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.7 OUTLIER -125.46 -137.87 0.27 Allowed 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.519 -0.919 . . . . 25.890000000000001 108.519 179.462 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.907 ' HB3' HD11 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 68.5 -62.71 0.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.877 -1.139 . . . . 24.239999999999998 108.754 -179.974 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -88.41 24.12 13.1 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 108.589 -1.804 . . . . 31.02 108.589 179.291 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.781 ' ND2' HG11 ' B' ' 43' ' ' VAL . 0.3 OUTLIER 176.48 114.39 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.588 -0.948 . . . . 43.229999999999997 108.644 -179.722 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' B' ' 39' ' ' ASN . 4.4 mt-10 -38.77 -64.21 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.511 -0.743 . . . . 42.340000000000003 109.985 -179.306 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -68.51 162.92 58.47 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 108.722 -0.844 . . . . 8.0399999999999991 108.722 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.644 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.0 Cg_endo -78.19 148.8 24.58 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.159 1.906 . . . . 17.920000000000002 110.314 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.937 ' CG2' HG21 ' A' ' 70' ' ' VAL . 18.5 m -119.71 119.66 61.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 119.575 -0.85 . . . . 20.57 109.222 179.297 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.992 HD11 ' HB3' ' B' ' 32' ' ' LEU . 20.4 tp -71.75 114.28 9.67 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.464 0.649 . . . . 20.210000000000001 109.52 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 75' ' ' SER . 3.1 p -122.18 162.78 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.478 -0.763 . . . . 10.81 109.327 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 172.95 12.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.908 . . . . 36.740000000000002 110.374 -179.163 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.7 HD12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -163.89 131.37 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.513 -0.921 . . . . 19.739999999999998 108.513 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.48 ' CG2' HD22 ' B' ' 28' ' ' LEU . 3.8 m -74.84 154.17 38.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.918 -1.114 . . . . 22.559999999999999 109.461 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.796 HD23 ' HB2' ' B' ' 31' ' ' GLN . 0.1 OUTLIER -123.09 120.1 32.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.361 -0.837 . . . . 20.41 109.059 -179.845 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -54.02 137.37 39.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 33.990000000000002 109.845 -179.391 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.28 118.36 5.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -0.865 . . . . 54.920000000000002 109.22 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 -12.21 69.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.342 -1.503 . . . . 36.100000000000001 109.342 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.516 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -79.85 148.73 69.28 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.261 -1.141 . . . . 54.759999999999998 109.361 179.92 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.4 Cg_endo -77.15 120.95 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.579 2.186 . . . . 28.370000000000001 110.367 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.791 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -37.6 145.46 0.06 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.611 -0.681 . . . . 17.210000000000001 110.68 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.7 ' CE1' HD12 ' B' ' 47' ' ' ILE . 75.5 m-85 -43.57 105.13 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.49 -0.756 . . . . 17.190000000000001 109.155 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.26 176.04 0.24 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 17.82 109.75 -179.546 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -78.38 114.48 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.678 2.252 . . . . 17.280000000000001 110.182 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.38 176.12 42.5 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.687 -1.365 . . . . 17.219999999999999 109.687 -179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 2.8 mp -73.56 145.13 45.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -1.161 . . . . 19.57 108.664 179.33 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.687 ' C ' HG13 ' B' ' 4' ' ' VAL . 38.3 m-85 -132.27 162.66 30.43 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 122.461 1.124 . . . . 14.609999999999999 111.155 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.702 ' O ' HG22 ' B' ' 84' ' ' VAL . 38.5 p -142.22 121.69 13.24 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.976 -1.861 . . . . 18.359999999999999 105.976 178.185 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.664 HG11 ' HB2' ' B' ' 81' ' ' LEU . 1.9 t -55.24 163.14 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 C-N-CA 118.37 -1.332 . . . . 19.129999999999999 109.07 -178.017 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -122.95 131.1 53.57 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.49 -0.757 . . . . 20.649999999999999 109.374 -178.716 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.908 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -73.87 2.73 7.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.561 -0.712 . . . . 19.649999999999999 109.894 179.769 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -56.13 -19.52 13.7 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.105 -1.443 . . . . 14.720000000000001 107.105 178.569 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.504 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 4.1 m -96.5 -7.35 34.92 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.896 -0.503 . . . . 11.449999999999999 110.149 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.2 m-30 -83.69 161.71 20.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.912 -1.117 . . . . 14.25 109.776 -178.848 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.62 170.15 22.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 32.700000000000003 109.28 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.965 HG21 HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -121.27 116.87 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 15.630000000000001 109.253 179.748 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.99 -170.88 19.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.73 -1.348 . . . . 12.699999999999999 109.73 -179.727 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 72' ' ' GLN . . . . . 0.534 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 1.1 tm0? -89.63 20.99 3.67 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.251 -1.147 . . . . 26.289999999999999 109.478 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' B' ' 73' ' ' PHE . 5.7 t80 -112.51 10.36 19.63 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.392 -0.817 . . . . 20.440000000000001 109.558 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.91 56.43 20.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.657 -1.377 . . . . 13.82 109.657 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.4 m -157.52 120.01 3.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -1.174 . . . . 18.27 109.616 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' B' ' 68' ' ' PHE . 0.3 OUTLIER -70.5 155.35 40.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 12.43 109.324 179.891 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 45.7 mtm -163.56 130.91 3.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 35.109999999999999 109.679 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.955 HD12 HD12 ' A' ' 78' ' ' ILE . 2.5 mp -64.78 142.25 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 13.67 109.783 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -105.73 -36.19 7.13 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.091 -1.078 . . . . 24.059999999999999 108.091 178.454 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.504 ' C ' ' HB3' ' B' ' 67' ' ' SER . 2.1 ttp180 -170.31 68.23 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.886 -1.524 . . . . 35.039999999999999 106.886 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.664 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.9 OUTLIER -29.57 117.1 0.13 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.212 -0.904 . . . . 18.719999999999999 112.104 -177.683 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.3 OUTLIER -92.18 112.94 25.07 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.051 -1.092 . . . . 20.550000000000001 108.051 178.825 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.837 HD11 HG11 ' B' ' 4' ' ' VAL . 15.3 tp -81.93 153.34 26.34 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.082 0.944 . . . . 14.4 111.008 -178.472 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.702 HG22 ' O ' ' B' ' 62' ' ' THR . 33.0 m -152.15 152.04 28.83 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.803 -1.184 . . . . 17.649999999999999 107.803 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.2 Cg_endo -60.94 141.58 94.97 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.951 1.767 . . . . 25.699999999999999 110.523 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -73.75 122.54 22.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 49.289999999999999 109.751 -178.707 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.975 -1.012 . . . . 58.909999999999997 109.442 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' C ' ' A' ' 2' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.475 -0.565 . . . . 64.909999999999997 109.475 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.833 ' N ' HD22 ' B' ' 65' ' ' LEU . 0.0 OUTLIER -43.15 131.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.614 -0.884 . . . . 33.799999999999997 108.614 179.396 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 1.3 mttp -102.82 153.78 19.84 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.117 -0.99 . . . . 32.719999999999999 110.394 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.892 HG22 HG22 ' A' ' 35' ' ' VAL . 32.7 t -159.78 166.13 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.684 0.754 . . . . 14.460000000000001 109.777 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.552 ' N ' HG12 ' A' ' 4' ' ' VAL . 32.7 mt-10 -153.05 103.06 2.7 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.684 -0.858 . . . . 22.120000000000001 108.684 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.762 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -71.84 103.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.032 -1.099 . . . . 14.23 108.032 179.837 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.647 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.63 171.19 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.446 -0.784 . . . . 25.43 109.643 -179.258 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -75.05 -22.66 14.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.334 2.023 . . . . 13.609999999999999 109.718 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.54 2.18 54.19 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.975 -0.75 . . . . 15.52 108.975 178.978 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 6' ' ' ILE . 8.7 mm-40 -121.49 40.99 3.46 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.263 -0.898 . . . . 17.309999999999999 109.205 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -109.37 12.34 24.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.16 -0.963 . . . . 24.780000000000001 109.796 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -131.7 141.63 49.61 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.509 -0.922 . . . . 47.899999999999999 108.509 179.846 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.7 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 37.1 p90 -93.68 167.65 11.52 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.019 -1.051 . . . . 21.609999999999999 109.73 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.7 m -135.1 149.96 50.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.79 -0.819 . . . . 14.890000000000001 108.79 179.159 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.512 0 O-C-N 121.212 -0.93 . . . . 17.350000000000001 109.413 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.406 0.622 . . . . 24.0 109.979 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.591 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 97.3 m-20 -69.39 129.91 41.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 23.309999999999999 109.378 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 33.9 mt-10 -112.06 163.62 14.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.148 -0.97 . . . . 40.030000000000001 109.16 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.679 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -150.7 -176.83 5.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.071 . . . . 12.390000000000001 110.038 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.865 ' HB3' HD11 ' A' ' 44' ' ' LEU . 27.9 mt -133.31 158.61 42.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.464 -0.772 . . . . 17.420000000000002 109.076 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.557 ' SG ' HD11 ' A' ' 6' ' ' ILE . 12.4 m -155.51 172.92 17.45 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.161 -1.052 . . . . 13.84 108.161 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.678 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 32.6 m-85 -121.9 104.48 9.58 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.092 -1.005 . . . . 21.140000000000001 109.176 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.892 HG22 HG22 ' A' ' 4' ' ' VAL . 42.4 t -79.8 159.55 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.096 -1.002 . . . . 10.66 110.655 -179.294 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 38' ' ' GLY . 31.6 m-20 -140.84 -147.96 0.23 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.714 -0.847 . . . . 25.890000000000001 108.714 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.973 ' CG ' HD11 ' B' ' 65' ' ' LEU . 0.2 OUTLIER 67.71 -61.89 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 24.239999999999998 109.188 -179.983 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -87.15 21.18 21.86 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.059 -1.616 . . . . 31.02 109.059 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 36' ' ' ASP . 1.5 p30 176.19 112.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -1.063 . . . . 43.229999999999997 109.324 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' ASN . 3.1 mt-10 -41.7 -63.13 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 42.340000000000003 109.955 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -65.0 154.55 86.28 Favored Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.512 -0.742 . . . . 8.3100000000000005 109.001 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.678 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.8 Cg_endo -78.26 143.92 20.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.233 1.955 . . . . 17.920000000000002 110.248 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.654 HG21 HG21 ' B' ' 70' ' ' VAL . 19.3 m -116.15 116.11 51.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.236 -0.915 . . . . 20.57 109.194 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.865 HD11 ' HB3' ' A' ' 32' ' ' LEU . 55.2 tp -73.14 102.35 3.56 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.29 -0.882 . . . . 20.210000000000001 109.683 -179.754 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.76 HG12 HG11 ' B' ' 70' ' ' VAL . 1.2 m -107.14 -178.41 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.568 -0.708 . . . . 10.81 109.164 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HA ' HD23 ' A' ' 32' ' ' LEU . 1.1 mtpt -101.07 154.3 18.83 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.569 -0.852 . . . . 36.740000000000002 109.748 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.987 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -140.55 173.45 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.336 -0.852 . . . . 19.739999999999998 109.364 -179.879 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.16 145.89 37.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.277 -0.889 . . . . 22.559999999999999 109.263 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.7 HD11 ' O ' ' A' ' 53' ' ' GLN . 3.0 tm? -127.34 126.97 43.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.315 -0.865 . . . . 20.41 109.041 -179.669 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.666 ' O ' HD13 ' A' ' 49' ' ' LEU . 3.2 m-20 -63.39 142.38 58.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 33.990000000000002 109.821 -179.417 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.66 123.63 17.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 54.920000000000002 109.295 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.23 -16.08 50.32 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.391 -1.484 . . . . 36.100000000000001 109.391 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.7 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -75.18 153.72 86.33 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.309 -1.113 . . . . 54.759999999999998 109.381 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.57 110.03 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.621 2.214 . . . . 28.370000000000001 110.334 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.7 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -41.69 151.34 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -0.829 . . . . 17.210000000000001 109.849 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.762 ' O ' HG21 ' A' ' 6' ' ' ILE . 89.8 m-85 -46.03 101.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.871 . . . . 17.190000000000001 109.072 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.9 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.07 173.6 0.17 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.907 . . . . 17.82 109.492 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.9 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.7 Cg_endo -78.13 114.62 3.61 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.682 2.255 . . . . 17.280000000000001 110.34 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.47 -178.91 45.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.695 -1.362 . . . . 17.219999999999999 109.695 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 3.4 mp -74.16 147.2 42.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -1.134 . . . . 19.57 108.717 179.45 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.676 ' HB3' HD22 ' A' ' 83' ' ' LEU . 25.7 m-85 -136.28 166.32 23.71 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 120.962 -1.086 . . . . 14.609999999999999 111.059 -179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 33.4 p -149.51 123.27 9.26 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.902 -1.888 . . . . 18.359999999999999 105.902 178.563 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.601 HG23 ' HB ' ' A' ' 2' ' ' ILE . 1.7 t -54.17 162.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 118.338 -1.345 . . . . 19.129999999999999 108.693 -178.268 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -124.83 128.14 48.24 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.393 -0.817 . . . . 20.649999999999999 109.066 -179.116 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.957 HD11 ' CG ' ' B' ' 37' ' ' LEU . 0.7 OUTLIER -72.43 2.82 5.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.463 -0.773 . . . . 19.649999999999999 110.141 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 t -56.09 -20.09 15.84 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.114 -1.439 . . . . 14.720000000000001 107.114 178.241 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.487 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 26.4 m -96.43 -8.44 32.28 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 116.126 -0.488 . . . . 11.449999999999999 110.154 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.652 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 2.2 m-30 -79.88 161.56 25.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.951 -1.093 . . . . 14.25 109.872 -178.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.514 ' NZ ' ' HB2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -165.68 174.35 9.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.795 . . . . 32.700000000000003 109.151 179.673 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.778 HG11 HG12 ' B' ' 45' ' ' VAL . 0.0 OUTLIER -100.06 104.46 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 15.630000000000001 109.466 -179.893 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.51 -168.01 37.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.595 -1.402 . . . . 12.699999999999999 109.595 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 23.32 2.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.129 -1.218 . . . . 26.289999999999999 109.888 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -93.86 -13.2 27.49 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.51 -0.744 . . . . 20.440000000000001 109.51 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 87.07 49.89 3.86 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.613 -1.395 . . . . 13.82 109.613 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 171.2 172.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -1.197 . . . . 18.27 109.645 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.551 HD13 HG11 ' B' ' 35' ' ' VAL . 14.7 tp -77.15 149.94 35.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 12.43 109.622 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 76' ' ' LEU . 8.6 mtp -155.57 135.51 12.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 35.109999999999999 109.401 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 1.011 HD12 HD12 ' B' ' 78' ' ' ILE . 2.2 mp -67.15 142.09 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 13.67 110.028 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.456 ' OD1' ' HD3' ' A' ' 69' ' ' LYS . 1.5 t70 -107.66 -41.18 5.09 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.572 -1.269 . . . . 24.059999999999999 107.572 178.014 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.487 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.3 OUTLIER -163.43 66.73 0.18 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.167 -1.42 . . . . 35.039999999999999 107.167 178.457 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.653 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -28.41 119.61 0.12 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.218 -0.901 . . . . 18.719999999999999 112.095 -177.99 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -92.98 101.14 13.48 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.296 -1.002 . . . . 20.550000000000001 108.296 178.896 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.987 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -70.72 146.51 49.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.085 -1.01 . . . . 14.4 110.943 -178.625 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 62' ' ' THR . 16.8 m -145.9 152.02 46.97 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.283 -1.006 . . . . 17.649999999999999 108.283 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 26.6 Cg_endo -64.76 144.34 83.37 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.306 2.004 . . . . 25.699999999999999 110.496 179.248 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -75.99 120.48 21.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.268 -0.895 . . . . 49.289999999999999 109.535 -179.07 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.981 -1.009 . . . . 58.909999999999997 109.463 179.979 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.458 ' O ' ' C ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.454 -0.573 . . . . 64.909999999999997 109.454 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 2' ' ' ILE . . . . . 0.837 ' CA ' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -42.87 131.68 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.701 -0.851 . . . . 33.799999999999997 108.701 179.318 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 1.4 mttp -102.84 153.73 19.9 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.122 -0.986 . . . . 32.719999999999999 110.37 -178.878 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.907 HG22 HG22 ' B' ' 35' ' ' VAL . 33.4 t -159.79 166.19 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.68 0.752 . . . . 14.460000000000001 109.75 -179.393 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.558 ' N ' HG12 ' B' ' 4' ' ' VAL . 32.5 mt-10 -153.21 102.96 2.66 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.67 -0.863 . . . . 22.120000000000001 108.67 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.768 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -71.77 103.89 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.047 -1.094 . . . . 14.23 108.047 179.769 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.658 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.68 171.23 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.366 -0.834 . . . . 25.43 109.619 -179.28 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 8' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.1 Cg_endo -74.97 -22.78 14.52 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.433 2.089 . . . . 13.609999999999999 109.759 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.6 2.32 54.12 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.977 -0.749 . . . . 15.52 108.977 179.074 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.597 ' O ' HG23 ' B' ' 6' ' ' ILE . 8.8 mm-40 -121.67 41.06 3.46 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.289 -0.882 . . . . 17.309999999999999 109.136 179.758 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -109.41 12.31 24.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.958 . . . . 24.780000000000001 109.785 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -131.52 141.8 49.81 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.198 -0.939 . . . . 47.899999999999999 108.577 179.825 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 13' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 37.2 p90 -93.96 167.45 11.6 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.011 -1.056 . . . . 21.609999999999999 109.713 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 100.0 m -134.82 150.22 50.47 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.795 -0.817 . . . . 14.890000000000001 108.795 179.156 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.468 0 O-C-N 121.204 -0.935 . . . . 17.350000000000001 109.415 -179.807 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.383 0.611 . . . . 24.0 110.024 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.576 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 97.0 m-20 -69.3 129.99 41.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 23.309999999999999 109.368 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 34.1 mt-10 -112.16 163.61 14.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.058 -1.026 . . . . 40.030000000000001 109.157 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.668 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -150.77 -176.91 5.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 12.390000000000001 110.021 -179.902 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 32' ' ' LEU . . . . . 0.887 ' HB3' HD11 ' B' ' 44' ' ' LEU . 27.9 mt -133.19 158.71 42.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.468 -0.77 . . . . 17.420000000000002 109.101 179.6 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' B' ' 6' ' ' ILE . 12.2 m -155.66 172.91 17.51 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.146 -1.057 . . . . 13.84 108.146 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.675 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 32.4 m-85 -122.01 104.57 9.61 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.051 -1.031 . . . . 21.140000000000001 109.109 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.907 HG22 HG22 ' B' ' 4' ' ' VAL . 42.4 t -79.85 159.67 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.073 -1.017 . . . . 10.66 110.686 -179.311 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' B' ' 38' ' ' GLY . 31.7 m-20 -140.89 -147.9 0.23 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.728 -0.841 . . . . 25.890000000000001 108.728 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 37' ' ' LEU . . . . . 0.957 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 67.78 -61.96 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 24.239999999999998 109.183 179.966 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 38' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -87.13 21.14 22.01 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.074 -1.61 . . . . 31.02 109.074 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 39' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' B' ' 36' ' ' ASP . 1.5 p30 176.23 112.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -1.076 . . . . 43.229999999999997 109.361 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' B' ' 39' ' ' ASN . 3.2 mt-10 -41.65 -63.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.372 -0.83 . . . . 42.340000000000003 109.898 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -65.0 154.43 86.57 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 109.002 -0.74 . . . . 8.3399999999999999 109.002 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.675 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.9 Cg_endo -78.19 143.74 20.29 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.245 1.963 . . . . 17.920000000000002 110.241 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 43' ' ' VAL . . . . . 0.632 HG21 HG21 ' A' ' 70' ' ' VAL . 19.2 m -115.97 116.22 51.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.318 -0.863 . . . . 20.57 109.15 179.673 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' B' ' 32' ' ' LEU . 54.9 tp -73.3 102.59 3.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.271 -0.893 . . . . 20.210000000000001 109.68 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.778 HG12 HG11 ' A' ' 70' ' ' VAL . 1.2 m -107.27 -178.38 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.552 -0.718 . . . . 10.81 109.23 179.797 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.645 ' HA ' HD23 ' B' ' 32' ' ' LEU . 1.1 mtpt -101.08 154.42 18.74 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.469 -0.892 . . . . 36.740000000000002 109.718 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 47' ' ' ILE . . . . . 0.994 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.5 OUTLIER -140.72 173.38 9.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.325 -0.86 . . . . 19.739999999999998 109.317 -179.894 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.14 145.85 37.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 22.559999999999999 109.274 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.677 HD11 ' O ' ' B' ' 53' ' ' GLN . 2.9 tm? -127.3 126.9 43.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.311 -0.868 . . . . 20.41 109.061 -179.678 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.658 ' O ' HD13 ' B' ' 49' ' ' LEU . 3.1 m-20 -63.34 142.27 58.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.968 . . . . 33.990000000000002 109.868 -179.441 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.42 123.78 17.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 54.920000000000002 109.395 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.0 -15.97 50.23 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.437 -1.465 . . . . 36.100000000000001 109.437 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 53' ' ' GLN . . . . . 0.677 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -75.25 153.85 86.2 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.29 -1.123 . . . . 54.759999999999998 109.469 179.943 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.2 Cg_endo -77.67 109.79 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.628 2.218 . . . . 28.370000000000001 110.383 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.701 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -41.39 150.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -0.82 . . . . 17.210000000000001 110.041 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.768 ' O ' HG21 ' B' ' 6' ' ' ILE . 90.2 m-85 -45.53 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.375 -0.828 . . . . 17.190000000000001 109.003 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 57' ' ' ALA . . . . . 0.903 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -53.02 173.56 0.17 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 17.82 109.654 -179.602 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.903 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.79 113.44 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.617 2.211 . . . . 17.280000000000001 110.077 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.4 -179.43 46.63 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.776 -1.33 . . . . 17.219999999999999 109.776 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 3.1 mp -74.47 146.8 42.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -1.167 . . . . 19.57 108.414 179.14 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.664 ' HB3' HD22 ' B' ' 83' ' ' LEU . 27.1 m-85 -135.9 166.1 24.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.956 -1.09 . . . . 14.609999999999999 110.978 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 62' ' ' THR . . . . . 0.526 ' O ' HG22 ' B' ' 84' ' ' VAL . 33.0 p -149.14 123.24 9.47 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 105.943 -1.873 . . . . 18.359999999999999 105.943 178.523 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.59 HG23 ' HB ' ' B' ' 2' ' ' ILE . 1.7 t -54.12 162.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 118.276 -1.37 . . . . 19.129999999999999 108.721 -178.243 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 64' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -124.89 128.23 48.33 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.422 -0.799 . . . . 20.649999999999999 109.06 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.973 HD11 ' CG ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -72.67 2.84 5.79 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.46 -0.775 . . . . 19.649999999999999 110.132 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.1 t -56.01 -20.08 15.2 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.099 -1.445 . . . . 14.720000000000001 107.099 178.284 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.484 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 25.8 m -96.41 -8.45 32.33 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 116.096 -0.502 . . . . 11.449999999999999 110.239 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.662 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 2.3 m-30 -79.86 161.46 25.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.004 -1.06 . . . . 14.25 109.756 -178.841 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.522 ' NZ ' ' HB2' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -165.56 174.41 9.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.455 -0.778 . . . . 32.700000000000003 109.132 179.679 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.76 HG11 HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -100.1 104.48 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 15.630000000000001 109.393 -179.93 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.45 -167.87 37.32 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.613 -1.395 . . . . 12.699999999999999 109.613 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 23.02 2.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.113 -1.228 . . . . 26.289999999999999 109.863 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -93.6 -13.35 27.78 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.493 -0.755 . . . . 20.440000000000001 109.481 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 74' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 87.26 49.9 3.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.547 -1.421 . . . . 13.82 109.547 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' B' ' 74' ' ' GLY . 0.3 OUTLIER 171.28 172.91 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -1.16 . . . . 18.27 109.588 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.622 HD13 HG11 ' A' ' 35' ' ' VAL . 14.7 tp -77.23 150.02 35.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.295 -0.878 . . . . 12.43 109.659 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' B' ' 76' ' ' LEU . 8.5 mtp -155.71 135.15 12.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 35.109999999999999 109.493 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 1.011 HD12 HD12 ' A' ' 78' ' ' ILE . 2.2 mp -66.81 142.1 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 13.67 110.116 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.455 ' OD1' ' HD3' ' B' ' 69' ' ' LYS . 1.5 t70 -107.8 -40.98 5.12 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.606 -1.257 . . . . 24.059999999999999 107.606 177.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 80' ' ' ARG . . . . . 0.484 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.3 OUTLIER -163.56 66.79 0.18 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.12 -1.437 . . . . 35.039999999999999 107.12 178.422 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.637 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -28.47 119.58 0.12 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.215 -0.902 . . . . 18.719999999999999 112.036 -178.046 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 82' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -92.94 101.12 13.46 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.268 -1.012 . . . . 20.550000000000001 108.268 178.861 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.994 ' HB2' HD11 ' B' ' 47' ' ' ILE . 0.4 OUTLIER -70.7 146.47 49.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.977 . . . . 14.4 110.91 -178.67 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.526 HG22 ' O ' ' B' ' 62' ' ' THR . 16.8 m -145.82 152.34 48.06 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.296 -1.001 . . . . 17.649999999999999 108.296 179.424 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 26.7 Cg_endo -65.05 144.45 82.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.254 1.969 . . . . 25.699999999999999 110.56 179.274 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -75.97 120.38 21.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 49.289999999999999 109.605 -179.096 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.001 -0.999 . . . . 58.909999999999997 109.471 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.634 ' SD ' HG21 ' A' ' 62' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.326 0.584 . . . . 64.909999999999997 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.964 ' HA ' HD22 ' B' ' 65' ' ' LEU . 5.5 mt -72.56 78.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.238 -1.023 . . . . 33.799999999999997 108.238 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 1.021 ' N ' HD12 ' A' ' 37' ' ' LEU . 23.0 mttp -61.85 172.26 1.37 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.715 0.769 . . . . 32.719999999999999 111.371 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.007 HG22 HG22 ' A' ' 35' ' ' VAL . 23.0 t -168.23 168.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.861 -0.792 . . . . 14.460000000000001 108.861 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.591 ' N ' HG12 ' A' ' 4' ' ' VAL . 23.4 mt-10 -147.04 104.29 3.67 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.679 -0.859 . . . . 22.120000000000001 108.679 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.626 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -69.36 104.34 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.912 -1.144 . . . . 14.23 107.912 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.653 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.47 171.13 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.083 -1.011 . . . . 25.43 109.665 -179.152 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.7 Cg_endo -76.32 -24.22 11.0 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.562 2.174 . . . . 13.609999999999999 109.899 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -94.21 4.29 54.09 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.553 -0.717 . . . . 15.52 109.258 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.832 ' OE1' HD13 ' A' ' 32' ' ' LEU . 10.6 mm-40 -117.52 34.1 5.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.27 -0.894 . . . . 17.309999999999999 109.372 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.4 11.34 33.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 24.780000000000001 110.182 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 45.2 mt-30 -138.86 132.76 31.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.007 . . . . 47.899999999999999 110.056 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.624 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 11.4 p90 -83.19 -178.36 7.07 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.402 -0.811 . . . . 21.609999999999999 109.915 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -130.4 144.67 51.54 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.752 -0.593 . . . . 14.890000000000001 109.404 179.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.2 118.91 30.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 17.350000000000001 109.222 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -129.51 138.02 51.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 34.380000000000003 109.603 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -44.7 150.38 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 38.770000000000003 109.108 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 26' ' ' TYR . . . -162.12 158.93 31.01 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.745 -1.342 . . . . 34.579999999999998 109.745 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.634 ' N ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -144.32 112.55 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.155 . . . . 41.869999999999997 108.868 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -45.78 -91.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.442 -0.786 . . . . 47.210000000000001 109.719 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 58.45 1.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 71.560000000000002 109.67 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 58.49 18.38 5.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.926 . . . . 66.599999999999994 109.418 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' HG3' ' A' ' 24' ' ' LYS . . . -99.48 -54.07 1.1 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.484 -1.446 . . . . 55.490000000000002 109.484 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' CD ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -143.87 153.02 56.95 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.278 -1.131 . . . . 44.990000000000002 109.297 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.83 132.84 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.663 2.242 . . . . 44.100000000000001 110.412 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.634 ' CE1' ' N ' ' A' ' 19' ' ' VAL . 14.7 p90 -135.64 108.5 7.57 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.204 -0.935 . . . . 32.090000000000003 109.754 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -84.92 63.32 8.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 29.25 108.893 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.719 ' CD2' HG22 ' A' ' 48' ' ' THR . 0.2 OUTLIER -55.86 165.97 0.82 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.545 -0.722 . . . . 24.0 109.946 -179.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.657 ' ND2' ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -106.07 133.27 51.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.399 -0.813 . . . . 23.309999999999999 109.342 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.81 151.76 29.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.076 -1.015 . . . . 40.030000000000001 109.62 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.675 HE21 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -133.62 -166.77 1.83 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.125 -0.984 . . . . 12.390000000000001 109.56 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.887 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -136.28 169.5 17.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.88 . . . . 17.420000000000002 109.934 -179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -158.74 164.68 35.65 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.211 -1.033 . . . . 13.84 108.211 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.665 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.8 m-85 -121.24 109.69 15.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.987 -1.07 . . . . 21.140000000000001 110.04 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.007 HG22 HG22 ' A' ' 4' ' ' VAL . 29.7 t -95.49 143.08 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 10.66 109.466 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.643 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -130.89 -24.56 2.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.146 -0.972 . . . . 25.890000000000001 110.76 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.021 HD12 ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -45.96 -16.4 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.972 -1.08 . . . . 24.239999999999998 111.384 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.596 ' H ' HD22 ' A' ' 37' ' ' LEU . . . -120.19 16.28 10.01 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 108.206 -1.957 . . . . 31.02 108.206 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.643 ' ND2' ' HA ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -178.02 115.96 0.08 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.706 -0.879 . . . . 43.229999999999997 108.828 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 39' ' ' ASN . 1.2 mp0 -36.95 -63.47 0.42 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.66 0.743 . . . . 42.340000000000003 109.978 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.8 155.87 68.52 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.449 -0.945 . . . . 2.8599999999999999 108.449 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.665 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.5 Cg_endo -77.95 141.31 18.86 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.923 1.749 . . . . 17.920000000000002 109.936 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.916 HG22 ' O ' ' A' ' 35' ' ' VAL . 29.3 m -113.72 115.33 49.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.316 -0.865 . . . . 20.57 108.957 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' A' ' 32' ' ' LEU . 54.6 tp -67.71 107.99 2.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.423 -0.798 . . . . 20.210000000000001 109.545 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.502 ' CG1' ' SG ' ' A' ' 33' ' ' CYS . 8.9 p -111.2 163.31 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.476 -0.765 . . . . 10.81 109.324 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 160.84 22.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 36.740000000000002 110.232 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.62 HD12 ' CE1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -156.31 119.68 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.798 -0.816 . . . . 19.739999999999998 108.798 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.719 HG22 ' CD2' ' A' ' 28' ' ' LEU . 1.3 m -60.17 156.03 16.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.984 -1.072 . . . . 22.559999999999999 109.757 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.579 ' HG ' ' HB3' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -131.95 109.81 10.32 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.977 -0.749 . . . . 20.41 108.977 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.541 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -63.88 145.71 55.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 33.990000000000002 109.654 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' A' ' 52' ' ' GLY . 28.9 tt0 -43.51 -87.67 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.258 -0.901 . . . . 54.920000000000002 109.661 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' N ' ' HG2' ' A' ' 51' ' ' GLU . . . -41.06 -39.07 1.93 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.889 -1.284 . . . . 36.100000000000001 109.889 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.541 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -64.11 126.11 89.51 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.095 -1.238 . . . . 54.759999999999998 109.34 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.545 ' C ' HD11 ' A' ' 49' ' ' LEU . 36.0 Cg_endo -79.62 144.86 17.93 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.401 2.067 . . . . 28.370000000000001 110.4 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.675 ' HB1' HE21 ' A' ' 31' ' ' GLN . . . -40.21 146.02 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.396 -0.815 . . . . 17.210000000000001 110.169 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.62 ' CE1' HD12 ' A' ' 47' ' ' ILE . 87.4 m-85 -53.82 111.42 0.74 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.297 -0.877 . . . . 17.190000000000001 109.222 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.027 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -66.32 -178.85 0.34 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.426 -0.796 . . . . 17.82 109.528 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 1.027 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -78.12 131.79 11.11 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.49 2.127 . . . . 17.280000000000001 110.588 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.632 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 153.91 143.01 3.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.15 -1.58 . . . . 17.219999999999999 109.15 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.438 HD23 ' CE ' ' A' ' 3' ' ' LYS . 3.8 mp -44.77 138.93 3.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.908 -1.348 . . . . 19.57 109.489 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.632 ' CD1' ' O ' ' A' ' 59' ' ' GLY . 17.9 m-85 -119.09 164.18 15.9 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.521 1.153 . . . . 14.609999999999999 111.497 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 84' ' ' VAL . 48.0 p -145.88 122.76 11.3 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.514 -1.661 . . . . 18.359999999999999 106.514 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.683 HG11 ' HB2' ' A' ' 81' ' ' LEU . 1.7 t -60.58 162.67 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 C-N-CA 118.427 -1.309 . . . . 19.129999999999999 108.72 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -120.77 130.41 54.01 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.43 -0.794 . . . . 20.649999999999999 109.248 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.97 HD22 ' HA ' ' B' ' 2' ' ' ILE . 0.9 OUTLIER -73.29 2.81 6.73 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.474 -0.766 . . . . 19.649999999999999 109.828 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -19.21 11.71 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.101 -1.444 . . . . 14.720000000000001 107.101 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.533 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 1.4 m -96.29 -6.23 38.33 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.134 -0.485 . . . . 11.449999999999999 110.391 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.699 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.2 m-30 -86.43 161.63 18.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.89 -1.131 . . . . 14.25 110.021 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -144.94 164.78 30.08 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.022 -0.733 . . . . 32.700000000000003 109.022 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.848 HG21 HG21 ' B' ' 43' ' ' VAL . 1.8 t -120.97 129.1 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 15.630000000000001 109.498 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.2 -151.52 22.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.36 -1.496 . . . . 12.699999999999999 109.36 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 0.5 OUTLIER 51.93 68.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -1.145 . . . . 26.289999999999999 109.211 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 71.07 5.62 5.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.836 . . . . 20.440000000000001 109.367 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.87 46.52 5.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.523 -1.431 . . . . 13.82 109.523 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.41 ' HB2' ' HE3' ' A' ' 77' ' ' MET . 57.7 m -125.0 116.45 22.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -1.126 . . . . 18.27 109.635 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.6 OUTLIER -59.22 147.15 36.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 12.43 109.129 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 37.8 mtt -160.12 132.32 6.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 35.109999999999999 109.725 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.86 HD12 HD12 ' B' ' 78' ' ' ILE . 2.7 mp -67.16 140.16 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.373 -0.829 . . . . 13.67 109.826 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 8.8 t70 -107.61 -10.27 15.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.324 -0.86 . . . . 24.059999999999999 108.962 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 163.94 67.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.897 -1.52 . . . . 35.039999999999999 106.897 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.683 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -31.66 118.73 0.23 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.323 -0.853 . . . . 18.719999999999999 112.199 -177.518 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.517 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -91.9 109.87 21.21 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.229 -1.026 . . . . 20.550000000000001 108.229 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.8 OUTLIER -75.63 155.19 36.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.205 -0.934 . . . . 14.4 111.382 -178.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 62' ' ' THR . 35.6 m -159.89 148.95 14.02 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 107.866 -1.161 . . . . 17.649999999999999 107.866 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 22.8 Cg_endo -61.5 139.3 81.14 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.99 1.794 . . . . 25.699999999999999 110.503 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.521 ' CA ' HG23 ' A' ' 62' ' ' THR . . . -65.66 118.1 9.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -0.921 . . . . 49.289999999999999 109.698 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.033 -0.984 . . . . 58.909999999999997 109.526 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.637 ' SD ' HG21 ' B' ' 62' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.314 0.578 . . . . 64.909999999999997 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.97 ' HA ' HD22 ' A' ' 65' ' ' LEU . 5.5 mt -72.97 78.15 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.267 -1.012 . . . . 33.799999999999997 108.267 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 1.006 ' N ' HD12 ' B' ' 37' ' ' LEU . 23.0 mttp -61.72 172.22 1.34 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.759 0.79 . . . . 32.719999999999999 111.33 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.983 HG22 HG22 ' B' ' 35' ' ' VAL . 23.1 t -168.2 168.44 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.85 -0.796 . . . . 14.460000000000001 108.85 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.601 ' N ' HG12 ' B' ' 4' ' ' VAL . 23.5 mt-10 -147.15 104.21 3.65 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.726 -0.842 . . . . 22.120000000000001 108.726 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.63 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -69.34 104.08 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.962 -1.125 . . . . 14.23 107.962 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.66 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.24 171.11 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.957 . . . . 25.43 109.682 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -76.36 -24.27 10.89 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.474 2.116 . . . . 13.609999999999999 109.847 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -94.12 4.1 54.37 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.521 -0.737 . . . . 15.52 109.224 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.818 ' OE1' HD13 ' B' ' 32' ' ' LEU . 10.5 mm-40 -117.25 33.95 5.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.262 -0.899 . . . . 17.309999999999999 109.377 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.18 11.3 32.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 24.780000000000001 110.209 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.443 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 45.1 mt-30 -138.82 132.88 31.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 47.899999999999999 110.088 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.63 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 11.4 p90 -83.26 -178.29 7.03 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.408 -0.807 . . . . 21.609999999999999 109.93 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 0.6 OUTLIER -130.48 144.65 51.54 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.738 -0.601 . . . . 14.890000000000001 109.426 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.18 118.99 30.91 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.29 -0.882 . . . . 17.350000000000001 109.199 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' B' ' 17' ' ' SER . 5.1 tpp180 -129.59 138.05 51.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 34.380000000000003 109.579 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.2 OUTLIER -44.74 150.44 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 38.770000000000003 109.082 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 26' ' ' TYR . . . -162.22 159.0 31.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.34 . . . . 34.579999999999998 109.751 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.628 ' N ' ' CE1' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -144.48 112.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.28 -1.129 . . . . 41.869999999999997 108.952 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -45.67 -91.32 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.405 -0.81 . . . . 47.210000000000001 109.752 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.32 58.53 1.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 71.560000000000002 109.613 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 58.37 18.37 5.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 66.599999999999994 109.438 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.52 -53.82 1.11 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.441 -1.464 . . . . 55.490000000000002 109.441 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.471 ' CD ' ' N ' ' B' ' 24' ' ' LYS . 0.0 OUTLIER -144.08 152.93 55.99 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.302 -1.116 . . . . 44.990000000000002 109.334 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.75 132.92 12.31 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.647 2.231 . . . . 44.100000000000001 110.434 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' B' ' 19' ' ' VAL . 14.7 p90 -135.72 108.55 7.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.181 -0.949 . . . . 32.090000000000003 109.794 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -85.06 63.43 8.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.142 -0.974 . . . . 29.25 108.884 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.728 ' CD2' HG22 ' B' ' 48' ' ' THR . 0.2 OUTLIER -55.95 165.97 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.484 -0.76 . . . . 24.0 109.919 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.654 ' ND2' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -106.03 133.27 51.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.398 -0.813 . . . . 23.309999999999999 109.298 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.79 151.98 29.7 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.037 -1.039 . . . . 40.030000000000001 109.573 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.685 HE21 ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -133.75 -166.78 1.83 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 12.390000000000001 109.573 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.888 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.0 OUTLIER -136.24 169.57 17.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.234 -0.916 . . . . 17.420000000000002 109.949 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -158.87 164.69 35.49 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.177 -1.046 . . . . 13.84 108.177 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.66 ' CD2' ' CD ' ' B' ' 7' ' ' LYS . 22.4 m-85 -121.29 109.75 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 21.140000000000001 109.989 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.983 HG22 HG22 ' B' ' 4' ' ' VAL . 31.0 t -95.64 143.05 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 10.66 109.446 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.635 ' HA ' ' ND2' ' B' ' 39' ' ' ASN . 0.5 OUTLIER -130.9 -24.51 2.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 25.890000000000001 110.8 -179.206 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 1.006 HD12 ' N ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -46.21 -16.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.002 -1.061 . . . . 24.239999999999998 111.38 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.59 ' H ' HD22 ' B' ' 37' ' ' LEU . . . -120.15 16.09 10.06 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 108.208 -1.957 . . . . 31.02 108.208 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.635 ' ND2' ' HA ' ' B' ' 36' ' ' ASP . 0.4 OUTLIER -177.9 116.03 0.08 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.686 -0.891 . . . . 43.229999999999997 108.833 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' B' ' 39' ' ' ASN . 1.1 mp0 -36.91 -63.46 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.679 0.752 . . . . 42.340000000000003 110.015 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.88 155.91 69.07 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 108.438 -0.949 . . . . 2.8599999999999999 108.438 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.658 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.6 Cg_endo -77.93 141.27 18.87 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.939 1.759 . . . . 17.920000000000002 109.894 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.927 HG22 ' O ' ' B' ' 35' ' ' VAL . 29.3 m -113.78 115.33 49.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.273 -0.892 . . . . 20.57 108.874 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.888 HD11 ' HB3' ' B' ' 32' ' ' LEU . 54.4 tp -67.59 107.9 2.68 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.397 -0.815 . . . . 20.210000000000001 109.603 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.505 ' CG1' ' SG ' ' B' ' 33' ' ' CYS . 8.9 p -111.09 163.27 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.52 -0.737 . . . . 10.81 109.369 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 160.83 21.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 36.740000000000002 110.261 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.621 HD12 ' CE1' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -156.2 119.67 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 108.801 -0.814 . . . . 19.739999999999998 108.801 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.728 HG22 ' CD2' ' B' ' 28' ' ' LEU . 1.3 m -60.23 155.64 17.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.027 . . . . 22.559999999999999 109.732 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.568 ' HG ' ' HB3' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -131.55 109.85 10.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 20.41 108.982 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.545 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -63.83 145.76 55.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 33.990000000000002 109.692 -179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' B' ' 52' ' ' GLY . 28.9 tt0 -43.66 -87.63 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.305 -0.872 . . . . 54.920000000000002 109.629 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.48 ' N ' ' HG2' ' B' ' 51' ' ' GLU . . . -41.19 -38.83 1.97 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.852 -1.299 . . . . 36.100000000000001 109.852 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.545 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -64.29 126.15 89.8 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.07 -1.253 . . . . 54.759999999999998 109.336 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.553 ' C ' HD11 ' B' ' 49' ' ' LEU . 35.9 Cg_endo -79.61 144.86 17.94 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.417 2.078 . . . . 28.370000000000001 110.421 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.685 ' HB1' HE21 ' B' ' 31' ' ' GLN . . . -40.16 145.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -0.825 . . . . 17.210000000000001 110.308 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.621 ' CE1' HD12 ' B' ' 47' ' ' ILE . 87.4 m-85 -53.35 111.73 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 17.190000000000001 109.16 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 1.004 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -67.16 -178.94 0.39 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.389 -0.82 . . . . 17.82 109.594 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 1.004 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.4 Cg_endo -77.71 130.38 10.61 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.458 2.105 . . . . 17.280000000000001 110.358 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.635 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 155.94 143.0 3.55 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.205 -1.558 . . . . 17.219999999999999 109.205 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.439 HD23 ' CE ' ' B' ' 3' ' ' LYS . 3.6 mp -45.43 138.34 4.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.426 . . . . 19.57 109.177 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' B' ' 59' ' ' GLY . 20.0 m-85 -118.43 164.26 15.52 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.49 1.138 . . . . 14.609999999999999 111.407 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.744 ' O ' HG22 ' B' ' 84' ' ' VAL . 48.9 p -145.9 122.84 11.34 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 106.386 -1.709 . . . . 18.359999999999999 106.386 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.682 HG11 ' HB2' ' B' ' 81' ' ' LEU . 1.6 t -60.44 163.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 C-N-CA 118.448 -1.301 . . . . 19.129999999999999 108.719 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.492 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -121.62 130.3 53.39 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.475 -0.765 . . . . 20.649999999999999 109.33 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 2' ' ' ILE . 0.9 OUTLIER -73.13 2.77 6.52 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.492 -0.755 . . . . 19.649999999999999 109.889 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.29 -18.97 12.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.126 -1.435 . . . . 14.720000000000001 107.126 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.537 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 1.4 m -96.35 -6.93 36.51 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 116.132 -0.485 . . . . 11.449999999999999 110.416 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.664 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.1 m-30 -85.97 161.25 19.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.851 -1.156 . . . . 14.25 109.958 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -144.57 165.1 28.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.74 . . . . 32.700000000000003 109.014 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.84 HG21 HG21 ' A' ' 43' ' ' VAL . 1.8 t -121.08 129.2 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 15.630000000000001 109.506 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.0 -151.66 22.36 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.333 -1.507 . . . . 12.699999999999999 109.333 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.6 OUTLIER 52.0 68.86 0.74 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -1.181 . . . . 26.289999999999999 109.228 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.2 OUTLIER 71.22 5.73 5.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 20.440000000000001 109.34 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.74 46.56 5.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.558 -1.417 . . . . 13.82 109.558 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 57.7 m -125.15 116.34 21.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -1.129 . . . . 18.27 109.696 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.534 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.6 OUTLIER -59.05 147.05 36.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 12.43 109.212 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.534 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 37.5 mtt -160.08 132.51 6.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.923 . . . . 35.109999999999999 109.643 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.86 HD12 HD12 ' A' ' 78' ' ' ILE . 2.7 mp -67.37 140.24 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 13.67 109.839 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 8.6 t70 -107.51 -10.27 15.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.367 -0.833 . . . . 24.059999999999999 108.966 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.537 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 163.89 67.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.923 -1.51 . . . . 35.039999999999999 106.923 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.682 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.9 OUTLIER -31.76 118.75 0.24 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.253 -0.885 . . . . 18.719999999999999 112.182 -177.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.517 ' HG3' ' NH1' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -91.88 109.94 21.28 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.194 -1.039 . . . . 20.550000000000001 108.194 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -75.65 155.28 35.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.17 -0.956 . . . . 14.4 111.384 -178.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.744 HG22 ' O ' ' B' ' 62' ' ' THR . 35.6 m -159.98 149.21 14.14 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 107.807 -1.183 . . . . 17.649999999999999 107.807 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 23.5 Cg_endo -61.76 139.13 78.74 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.024 1.816 . . . . 25.699999999999999 110.545 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.527 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -65.49 118.07 8.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 49.289999999999999 109.6 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.422 ' HD3' ' C ' ' B' ' 87' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.95 -1.024 . . . . 58.909999999999997 109.429 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.594 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.461 0.648 . . . . 64.909999999999997 109.493 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.914 HG23 ' CD1' ' B' ' 65' ' ' LEU . 3.9 mt -78.55 77.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.7 -1.222 . . . . 33.799999999999997 107.7 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.49 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -67.39 167.39 12.68 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.011 0.91 . . . . 32.719999999999999 110.848 -178.261 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.941 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -177.44 160.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.501 -0.926 . . . . 14.460000000000001 108.501 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 29.8 mt-10 -134.2 114.65 13.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.67 0.748 . . . . 22.120000000000001 109.004 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.716 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -73.74 99.28 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.788 -1.19 . . . . 14.23 107.788 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.669 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -43.95 169.92 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.335 -0.853 . . . . 25.43 109.925 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 32.5 Cg_endo -74.42 -28.31 10.4 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.469 2.112 . . . . 13.609999999999999 110.024 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.96 8.78 41.74 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.826 -0.805 . . . . 15.52 108.826 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.552 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 5.6 mm100 -125.91 22.32 7.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 17.309999999999999 109.87 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -95.77 15.23 20.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.105 -0.997 . . . . 24.780000000000001 110.162 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 60.7 mt-30 -134.9 141.09 46.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.127 -0.983 . . . . 47.899999999999999 109.754 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.744 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 45.1 p90 -93.96 153.91 17.95 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.3 -0.875 . . . . 21.609999999999999 109.32 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 m -113.11 150.45 32.11 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.331 -0.856 . . . . 14.890000000000001 108.92 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.551 HG23 ' OD1' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -104.86 121.91 44.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.289 -0.882 . . . . 17.350000000000001 109.541 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 27' ' ' SER . 0.6 OUTLIER -136.59 156.05 49.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 34.380000000000003 109.355 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 16' ' ' ARG . 94.6 p -42.43 155.25 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.428 -0.795 . . . . 38.770000000000003 109.475 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.595 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -157.42 165.72 33.49 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.199 -1.16 . . . . 34.579999999999998 110.199 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.547 ' N ' ' CE1' ' A' ' 26' ' ' TYR . 1.4 t -155.59 126.53 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.366 -1.079 . . . . 41.869999999999997 109.029 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 3.4 m -64.29 -17.27 63.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 47.210000000000001 109.716 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER 175.86 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.956 . . . . 71.560000000000002 109.712 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 0.5 OUTLIER 174.97 43.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.125 -0.984 . . . . 66.599999999999994 109.797 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.404 ' C ' ' HG3' ' A' ' 24' ' ' LYS . . . -133.3 -55.28 0.08 OUTLIER Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.022 -1.631 . . . . 55.490000000000002 109.022 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.404 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -138.18 152.14 71.11 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.478 -1.013 . . . . 44.990000000000002 108.881 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.9 Cg_endo -77.26 161.76 31.8 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.559 2.172 . . . . 44.100000000000001 110.523 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.682 ' CE1' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -157.41 50.94 0.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 32.090000000000003 110.143 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 26' ' ' TYR . 13.5 m -30.56 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.267 0.556 . . . . 29.25 110.679 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -82.8 150.18 26.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.376 -0.828 . . . . 24.0 110.094 -179.055 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.775 ' O ' HD12 ' A' ' 28' ' ' LEU . 67.4 m-20 -72.21 151.1 43.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.372 -0.83 . . . . 23.309999999999999 109.533 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.61 132.64 39.27 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.699 -0.852 . . . . 40.030000000000001 108.699 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.748 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -123.41 -174.1 2.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.071 -1.018 . . . . 12.390000000000001 110.02 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.951 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.7 mp -143.6 152.85 41.9 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.853 -0.795 . . . . 17.420000000000002 108.853 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -152.82 -177.67 6.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.974 -1.121 . . . . 13.84 107.974 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.69 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.0 m-85 -129.6 99.62 5.23 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.031 -1.043 . . . . 21.140000000000001 109.937 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.877 HG22 ' HB ' ' A' ' 4' ' ' VAL . 60.6 t -95.24 113.65 30.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.089 -1.007 . . . . 10.66 109.462 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 5.3 t70 -62.46 -28.48 69.85 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.199 -0.938 . . . . 25.890000000000001 108.572 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.684 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.7 OUTLIER 46.23 25.26 0.34 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.467 -0.77 . . . . 24.239999999999998 109.458 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.07 81.67 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.818 -1.313 . . . . 31.02 109.818 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 64.3 m-20 -86.08 15.21 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -1.209 . . . . 43.229999999999997 110.225 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 9.6 mt-10 60.73 11.52 3.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.311 -0.868 . . . . 42.340000000000003 110.36 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 71.3 m80 -161.18 152.68 16.01 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.046 -1.094 . . . . 6.3700000000000001 108.046 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.69 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -75.76 136.59 19.08 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.873 1.715 . . . . 17.920000000000002 110.397 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 35' ' ' VAL . 4.5 m -110.84 118.19 56.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.43 -0.793 . . . . 20.57 109.0 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.951 HD11 ' HB3' ' A' ' 32' ' ' LEU . 45.5 tp -73.22 104.48 4.28 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.351 -0.843 . . . . 20.210000000000001 110.255 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.618 HG13 HG23 ' A' ' 43' ' ' VAL . 32.6 m -108.46 -177.2 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.527 -0.916 . . . . 10.81 108.527 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HD2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.22 154.56 22.23 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.007 -1.077 . . . . 36.740000000000002 110.257 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.593 HG13 ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -127.18 170.1 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 109.029 -0.73 . . . . 19.739999999999998 109.029 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.523 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 3.6 m -123.01 124.0 42.16 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.356 -0.84 . . . . 22.559999999999999 108.808 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -102.53 163.83 12.0 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.331 -0.856 . . . . 20.41 109.331 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.43 167.68 9.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.897 . . . . 33.990000000000002 109.54 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -72.86 87.61 1.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 54.920000000000002 109.519 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.34 -25.84 4.48 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.514 -1.434 . . . . 36.100000000000001 109.514 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.636 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.0 mt-30 -73.7 140.97 78.66 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 54.759999999999998 109.433 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 53' ' ' GLN . 35.8 Cg_endo -79.5 118.91 3.98 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.577 2.185 . . . . 28.370000000000001 110.28 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.748 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.52 155.19 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.24 -0.912 . . . . 17.210000000000001 110.308 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.655 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 16.3 m-30 -49.86 112.14 0.62 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.531 -0.731 . . . . 17.190000000000001 109.377 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.002 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -61.72 176.43 0.44 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.138 -0.976 . . . . 17.82 109.289 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 1.002 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.7 Cg_endo -77.05 119.85 5.2 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.545 2.164 . . . . 17.280000000000001 110.221 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.42 177.54 37.86 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.835 -1.306 . . . . 17.219999999999999 109.835 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 5.2 mp -71.58 159.48 34.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 19.57 108.469 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.941 ' CB ' HG13 ' A' ' 4' ' ' VAL . 20.5 m-85 -141.8 165.1 28.41 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.849 -1.157 . . . . 14.609999999999999 111.784 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 84' ' ' VAL . 62.3 p -147.24 119.71 8.47 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.512 -1.662 . . . . 18.359999999999999 106.512 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.826 ' HB ' HD12 ' A' ' 2' ' ' ILE . 13.3 t -52.25 169.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 118.548 -1.261 . . . . 19.129999999999999 108.493 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.561 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.8 t-80 -131.33 119.64 22.01 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.36 -0.838 . . . . 20.649999999999999 108.911 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.936 HD13 HG23 ' B' ' 2' ' ' ILE . 0.0 OUTLIER -62.35 -12.44 21.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.694 -0.629 . . . . 19.649999999999999 109.641 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.2 t -46.98 -20.92 0.17 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.944 -1.097 . . . . 14.720000000000001 108.593 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 34.1 m -96.7 -7.93 32.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.496 -0.753 . . . . 11.449999999999999 111.035 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.659 ' C ' HD11 ' B' ' 37' ' ' LEU . 3.1 m-30 -81.1 161.77 23.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.617 -1.302 . . . . 14.25 109.816 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 5.1 pttm -145.74 174.75 10.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.45 -0.781 . . . . 32.700000000000003 109.663 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.816 HG21 HG21 ' B' ' 43' ' ' VAL . 2.5 t -117.19 129.2 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.419 -0.801 . . . . 15.630000000000001 109.307 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.14 168.12 35.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.479 -1.448 . . . . 12.699999999999999 109.479 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -76.74 0.55 20.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.232 -1.157 . . . . 26.289999999999999 109.733 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -26.99 23.16 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.461 -0.774 . . . . 20.440000000000001 109.21 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.77 65.31 0.76 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.492 -1.443 . . . . 13.82 109.492 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.14 133.43 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -1.107 . . . . 18.27 109.524 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 68' ' ' PHE . 2.4 tt -73.56 148.66 42.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 12.43 109.519 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 30.3 mtm -155.94 128.97 8.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 35.109999999999999 109.558 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' B' ' 78' ' ' ILE . 3.1 mt -64.72 141.0 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 13.67 109.988 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -108.25 -37.3 6.05 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.637 -1.246 . . . . 24.059999999999999 107.637 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.0 tpm_? -168.57 68.06 0.07 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.19 -1.411 . . . . 35.039999999999999 107.19 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -31.1 120.23 0.21 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.499 -0.773 . . . . 18.719999999999999 111.518 -178.276 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.539 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -90.45 103.25 15.96 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.988 -1.116 . . . . 20.550000000000001 107.988 178.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -75.83 147.33 39.21 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.934 -1.104 . . . . 14.4 111.006 -178.49 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 62' ' ' THR . 18.1 m -148.22 160.22 37.62 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 107.727 -1.212 . . . . 17.649999999999999 107.727 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.7 Cg_endo -62.32 146.63 95.75 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.036 1.824 . . . . 25.699999999999999 110.398 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -79.5 116.6 19.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.152 -0.968 . . . . 49.289999999999999 109.696 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.004 -0.998 . . . . 58.909999999999997 109.454 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.502 0.668 . . . . 64.909999999999997 109.429 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.936 HG23 HD13 ' A' ' 65' ' ' LEU . 4.0 mt -78.29 77.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.719 -1.215 . . . . 33.799999999999997 107.719 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.48 ' O ' HG13 ' B' ' 35' ' ' VAL . 0.2 OUTLIER -67.57 167.52 12.81 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.02 0.914 . . . . 32.719999999999999 110.869 -178.215 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.933 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -177.45 160.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.458 -0.942 . . . . 14.460000000000001 108.458 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.48 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 29.8 mt-10 -134.52 114.6 13.0 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.924 -0.769 . . . . 22.120000000000001 108.924 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.724 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -73.74 99.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.81 -1.182 . . . . 14.23 107.81 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.671 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.0 169.96 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.34 -0.85 . . . . 25.43 109.898 -178.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.0 Cg_endo -74.39 -28.29 10.47 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.488 2.125 . . . . 13.609999999999999 110.088 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.13 9.06 41.03 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.767 -0.827 . . . . 15.52 108.767 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.549 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 5.6 mm100 -126.13 22.34 7.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 17.309999999999999 109.864 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -95.74 15.14 20.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 24.780000000000001 110.151 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.547 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 60.4 mt-30 -134.86 141.1 46.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.038 -1.039 . . . . 47.899999999999999 109.736 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.737 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 45.1 p90 -94.03 153.91 17.92 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.257 -0.902 . . . . 21.609999999999999 109.343 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 81.1 m -113.21 150.15 32.73 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.296 -0.877 . . . . 14.890000000000001 108.955 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.551 HG23 ' OD1' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -104.61 121.86 44.42 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.33 -0.857 . . . . 17.350000000000001 109.606 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' B' ' 27' ' ' SER . 0.6 OUTLIER -136.46 156.11 49.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 34.380000000000003 109.336 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 16' ' ' ARG . 94.6 p -42.45 155.29 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.375 -0.828 . . . . 38.770000000000003 109.495 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.598 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -157.41 165.71 33.48 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.782 -1.199 . . . . 34.579999999999998 110.164 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.54 ' N ' ' CE1' ' B' ' 26' ' ' TYR . 1.4 t -155.58 126.46 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.355 -1.085 . . . . 41.869999999999997 109.09 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.41 ' O ' ' CG ' ' B' ' 21' ' ' ARG . 3.4 m -64.23 -17.22 63.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 47.210000000000001 109.709 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER 175.75 -58.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.112 -0.992 . . . . 71.560000000000002 109.698 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' B' ' 21' ' ' ARG . 0.5 OUTLIER 175.26 43.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.96 . . . . 66.599999999999994 109.749 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.403 ' C ' ' HG3' ' B' ' 24' ' ' LYS . . . -133.22 -55.39 0.08 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.043 -1.623 . . . . 55.490000000000002 109.043 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.403 ' HG3' ' C ' ' B' ' 23' ' ' GLY . 0.2 OUTLIER -138.08 152.17 71.36 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.395 -1.062 . . . . 44.990000000000002 108.847 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.9 Cg_endo -77.18 161.98 31.86 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.497 2.131 . . . . 44.100000000000001 110.562 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.694 ' CE1' HD23 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -157.61 50.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.137 -0.977 . . . . 32.090000000000003 110.066 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.485 ' C ' ' O ' ' B' ' 26' ' ' TYR . 13.4 m -30.62 83.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.346 0.593 . . . . 29.25 110.694 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.771 HD12 ' O ' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -82.81 150.26 26.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.333 -0.854 . . . . 24.0 110.031 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.771 ' O ' HD12 ' B' ' 28' ' ' LEU . 67.3 m-20 -72.16 151.18 43.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.451 -0.781 . . . . 23.309999999999999 109.499 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.63 132.67 39.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 40.030000000000001 108.704 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.756 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -123.35 -174.18 2.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.069 -1.019 . . . . 12.390000000000001 110.04 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.926 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.8 mp -143.57 152.91 41.99 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.852 -0.795 . . . . 17.420000000000002 108.852 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -152.75 -177.46 6.27 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.925 -1.139 . . . . 13.84 107.925 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.693 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 21.9 m-85 -129.78 99.71 5.23 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.056 -1.027 . . . . 21.140000000000001 109.881 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.873 HG22 ' HB ' ' B' ' 4' ' ' VAL . 62.9 t -95.35 113.74 30.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.171 -0.956 . . . . 10.66 109.435 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 5.3 t70 -62.51 -28.33 69.77 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.189 -0.945 . . . . 25.890000000000001 108.527 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.659 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER 46.25 25.27 0.34 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.516 -0.74 . . . . 24.239999999999998 109.436 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.67 14.01 81.63 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.831 -1.307 . . . . 31.02 109.831 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 64.2 m-20 -86.0 15.11 5.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -1.211 . . . . 43.229999999999997 110.325 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.578 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 9.5 mt-10 60.84 11.42 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.332 -0.855 . . . . 42.340000000000003 110.487 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 71.2 m80 -161.15 152.79 16.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.0 -1.111 . . . . 6.3799999999999999 108.0 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.693 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.4 Cg_endo -75.92 136.71 18.9 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.806 1.671 . . . . 17.920000000000002 110.442 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.857 HG22 ' O ' ' B' ' 35' ' ' VAL . 4.5 m -110.93 118.07 56.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.393 -0.817 . . . . 20.57 109.037 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.926 HD11 ' HB3' ' B' ' 32' ' ' LEU . 46.0 tp -73.21 104.38 4.24 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.392 -0.818 . . . . 20.210000000000001 110.215 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.626 HG13 HG23 ' B' ' 43' ' ' VAL . 32.5 m -108.44 -177.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.492 -0.929 . . . . 10.81 108.492 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.419 ' HD2' HD21 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -109.09 154.55 22.12 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.949 -1.101 . . . . 36.740000000000002 110.316 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.591 HG13 ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -127.21 169.96 17.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.515 -0.74 . . . . 19.739999999999998 109.105 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' B' ' 47' ' ' ILE . 3.5 m -122.78 123.99 42.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.328 -0.857 . . . . 22.559999999999999 108.838 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.643 HD12 ' O ' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -102.46 163.92 11.96 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.269 -0.894 . . . . 20.41 109.352 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.53 167.83 9.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 33.990000000000002 109.513 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -73.0 87.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 54.920000000000002 109.435 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.08 -25.96 4.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 36.100000000000001 109.568 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.643 ' O ' HD12 ' B' ' 49' ' ' LEU . 2.1 mt-30 -73.61 140.86 78.88 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.217 -1.167 . . . . 54.759999999999998 109.451 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' B' ' 55' ' ' ALA . 36.2 Cg_endo -79.48 118.71 3.95 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.526 2.151 . . . . 28.370000000000001 110.322 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.756 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.37 155.34 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 17.210000000000001 110.291 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.665 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 16.5 m-30 -50.09 111.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.449 -0.782 . . . . 17.190000000000001 109.416 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -61.4 176.37 0.42 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 17.82 109.246 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.21 121.04 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.567 2.178 . . . . 17.280000000000001 110.41 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.7 177.91 36.91 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.752 -1.339 . . . . 17.219999999999999 109.752 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.4 mp -71.36 159.64 34.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -1.13 . . . . 19.57 108.783 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.933 ' CB ' HG13 ' B' ' 4' ' ' VAL . 19.8 m-85 -142.07 165.05 28.5 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.529 1.157 . . . . 14.609999999999999 111.77 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.747 ' O ' HG22 ' B' ' 84' ' ' VAL . 60.3 p -147.28 119.82 8.51 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.554 -1.647 . . . . 18.359999999999999 106.554 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.845 ' HB ' HD12 ' B' ' 2' ' ' ILE . 13.1 t -52.26 169.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 C-N-CA 118.576 -1.25 . . . . 19.129999999999999 108.433 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.557 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.8 t-80 -131.44 119.62 21.87 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.37 -0.831 . . . . 20.649999999999999 108.987 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.914 ' CD1' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -62.25 -12.51 20.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.7 -0.625 . . . . 19.649999999999999 109.698 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.416 ' C ' ' O ' ' B' ' 65' ' ' LEU . 40.3 t -46.95 -20.48 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.933 -1.104 . . . . 14.720000000000001 108.565 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.511 ' HB2' ' HA ' ' B' ' 81' ' ' LEU . 32.6 m -97.17 -9.0 28.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -0.774 . . . . 11.449999999999999 111.032 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.684 ' C ' HD11 ' A' ' 37' ' ' LEU . 3.0 m-30 -80.22 160.97 25.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.658 -1.276 . . . . 14.25 109.743 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.52 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 4.9 pttm -144.94 175.18 10.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.369 -0.832 . . . . 32.700000000000003 109.707 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 43' ' ' VAL . 2.5 t -117.42 129.2 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.49 -0.756 . . . . 15.630000000000001 109.322 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.22 168.36 35.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.564 -1.414 . . . . 12.699999999999999 109.564 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.491 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 0.9 OUTLIER -76.93 0.61 20.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.118 -1.225 . . . . 26.289999999999999 109.686 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.37 -26.99 23.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.47 -0.769 . . . . 20.440000000000001 109.253 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.86 65.43 0.76 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.454 -1.459 . . . . 13.82 109.454 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.3 133.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -1.168 . . . . 18.27 109.53 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' B' ' 68' ' ' PHE . 2.5 tt -73.65 148.64 42.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 12.43 109.471 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.432 ' HG3' ' C ' ' B' ' 76' ' ' LEU . 30.3 mtm -155.92 128.88 8.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 35.109999999999999 109.505 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' A' ' 78' ' ' ILE . 3.0 mt -64.79 141.25 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 13.67 110.06 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -108.41 -36.95 6.1 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.581 -1.266 . . . . 24.059999999999999 107.581 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.51 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.1 tpm_? -168.91 68.12 0.07 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.184 -1.413 . . . . 35.039999999999999 107.184 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.671 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.6 OUTLIER -31.18 120.44 0.22 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.469 -0.787 . . . . 18.719999999999999 111.518 -178.218 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -90.52 103.24 15.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.959 -1.126 . . . . 20.550000000000001 107.959 178.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.665 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -75.76 147.21 39.45 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.989 -1.07 . . . . 14.4 110.966 -178.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.747 HG22 ' O ' ' B' ' 62' ' ' THR . 18.1 m -148.13 160.04 38.31 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.651 -1.24 . . . . 17.649999999999999 107.651 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.1 Cg_endo -62.17 146.51 95.99 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.974 1.783 . . . . 25.699999999999999 110.448 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.609 ' HA ' HG23 ' B' ' 62' ' ' THR . . . -79.46 116.5 19.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.146 -0.971 . . . . 49.289999999999999 109.648 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.98 -1.009 . . . . 58.909999999999997 109.474 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.524 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.433 -0.58 . . . . 64.909999999999997 109.433 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.608 HG21 HG21 ' A' ' 63' ' ' VAL . 3.7 mt -72.44 79.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.729 -1.211 . . . . 33.799999999999997 107.729 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -69.31 156.38 38.87 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.05 0.929 . . . . 32.719999999999999 111.54 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.878 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -166.01 168.01 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.18 -1.044 . . . . 14.460000000000001 108.18 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.555 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 26.3 mt-10 -143.44 112.63 6.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 22.120000000000001 109.541 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.71 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -72.37 102.72 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 C-N-CA 119.003 -1.079 . . . . 14.23 108.107 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 1.3 mmpt? -43.72 162.44 0.19 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.352 -0.842 . . . . 25.43 109.414 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.5 Cg_endo -72.7 -12.71 26.82 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.972 1.781 . . . . 13.609999999999999 109.088 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.5 t -99.13 7.15 46.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.234 -1.025 . . . . 15.52 108.234 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 1.5 mm-40 -129.47 41.27 3.48 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.846 -0.798 . . . . 17.309999999999999 108.846 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.76 3.65 39.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.122 -0.986 . . . . 24.780000000000001 110.291 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.485 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -134.84 139.64 45.22 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.129 -0.982 . . . . 47.899999999999999 108.607 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.706 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 22.3 p90 -85.62 176.97 7.88 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.035 -1.041 . . . . 21.609999999999999 109.298 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -133.98 148.2 51.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.444 -0.785 . . . . 14.890000000000001 109.099 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.32 110.78 22.08 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.336 -0.852 . . . . 17.350000000000001 109.088 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.448 ' NH1' ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -136.8 152.37 50.22 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.358 -0.839 . . . . 34.380000000000003 109.593 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 p -45.64 146.33 1.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.824 . . . . 38.770000000000003 109.378 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -145.85 166.82 27.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.17 -1.572 . . . . 34.579999999999998 109.17 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -141.3 117.14 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.069 -1.253 . . . . 41.869999999999997 109.415 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 96.6 p -55.4 90.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.348 -0.845 . . . . 47.210000000000001 109.652 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER 48.07 41.9 16.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.306 -0.871 . . . . 71.560000000000002 109.694 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 65.77 19.41 11.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 66.599999999999994 109.715 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.22 -55.48 1.27 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.175 -1.57 . . . . 55.490000000000002 109.175 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -140.76 151.33 62.73 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.429 -1.042 . . . . 44.990000000000002 108.894 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.5 Cg_endo -76.76 124.25 7.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.458 2.105 . . . . 44.100000000000001 110.696 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.8 p90 -135.45 144.23 46.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.332 -0.855 . . . . 32.090000000000003 109.789 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.32 80.64 1.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 29.25 108.679 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.571 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -94.58 168.3 10.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 24.0 110.24 -179.133 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.684 ' ND2' ' H ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -95.17 127.11 40.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.467 -0.77 . . . . 23.309999999999999 108.939 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -113.68 160.39 18.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.202 -0.936 . . . . 40.030000000000001 109.603 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.792 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -137.5 -169.41 2.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 12.390000000000001 109.123 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.973 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.1 mt -133.93 175.87 9.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 17.420000000000002 109.544 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.18 161.72 8.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.964 -1.085 . . . . 13.84 108.525 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.744 ' CE1' HD13 ' A' ' 44' ' ' LEU . 3.1 m-30 -114.34 101.34 9.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.132 -0.98 . . . . 21.140000000000001 108.828 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.878 HG22 ' HB ' ' A' ' 4' ' ' VAL . 13.9 t -107.6 148.21 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.999 -1.063 . . . . 10.66 110.029 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.942 ' O ' HD12 ' A' ' 37' ' ' LEU . 1.8 p-10 -113.86 -39.92 3.88 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.408 -0.96 . . . . 25.890000000000001 108.408 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.942 HD12 ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER 62.55 -71.01 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.731 -0.84 . . . . 24.239999999999998 108.731 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -142.59 28.0 2.2 Favored Glycine 0 C--N 1.296 -1.666 0 N-CA-C 108.238 -1.945 . . . . 31.02 108.238 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -130.89 98.97 4.76 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.593 -0.946 . . . . 43.229999999999997 108.722 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' ' 39' ' ' ASN . 3.4 mm-40 -31.36 -37.2 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.284 0.564 . . . . 42.340000000000003 111.194 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 39' ' ' ASN . 60.7 m80 -80.67 149.15 67.27 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.87 . . . . 7.0 108.973 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.633 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -78.56 149.61 24.11 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.135 1.89 . . . . 17.920000000000002 110.466 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 35' ' ' VAL . 1.8 m -121.52 119.11 58.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.393 -0.923 . . . . 20.57 109.058 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.973 HD11 ' HB3' ' A' ' 32' ' ' LEU . 15.7 tp -72.72 112.25 8.6 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.722 -0.791 . . . . 20.210000000000001 109.178 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.606 HG23 HG23 ' A' ' 43' ' ' VAL . 14.3 t -118.44 167.06 12.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.545 -0.722 . . . . 10.81 109.528 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -96.15 139.93 31.6 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.517 -0.873 . . . . 36.740000000000002 109.421 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.956 HD13 HD12 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -121.55 171.63 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.808 . . . . 19.739999999999998 109.004 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.426 ' OG1' ' HD3' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -105.56 153.59 21.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.075 -1.016 . . . . 22.559999999999999 109.691 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -136.71 105.26 5.79 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.629 -0.878 . . . . 20.41 108.629 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -70.26 143.95 51.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -0.954 . . . . 33.990000000000002 109.635 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.17 132.85 39.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 54.920000000000002 109.269 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.23 -35.58 4.79 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.452 -1.459 . . . . 36.100000000000001 109.452 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 5.1 mt-30 -79.8 138.46 54.01 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.265 -1.138 . . . . 54.759999999999998 109.341 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.3 126.13 7.48 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.509 2.139 . . . . 28.370000000000001 110.415 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.792 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -41.35 149.59 0.11 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.353 -0.842 . . . . 17.210000000000001 110.295 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.71 ' O ' HG21 ' A' ' 6' ' ' ILE . 83.1 m-85 -50.94 97.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.476 -0.765 . . . . 17.190000000000001 109.026 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.995 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.14 176.54 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.176 -0.953 . . . . 17.82 109.407 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.995 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.1 Cg_endo -76.68 131.26 12.24 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.418 2.079 . . . . 17.280000000000001 110.009 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.67 174.59 27.57 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.777 -1.329 . . . . 17.219999999999999 109.777 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.7 OUTLIER -73.7 143.12 46.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -1.114 . . . . 19.57 108.469 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.725 ' HB3' HD22 ' A' ' 83' ' ' LEU . 22.3 m-85 -127.31 162.89 25.18 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.832 -1.167 . . . . 14.609999999999999 111.548 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.8 p -143.04 121.39 12.32 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.534 -1.654 . . . . 18.359999999999999 106.534 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.834 ' CG1' HD12 ' A' ' 81' ' ' LEU . 3.3 t -52.54 166.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 C-N-CA 118.873 -1.131 . . . . 19.129999999999999 109.012 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -134.84 128.78 33.36 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.561 -0.903 . . . . 20.649999999999999 108.561 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.723 HD11 ' O ' ' B' ' 37' ' ' LEU . 1.2 pp -73.13 3.15 5.91 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.036 -1.04 . . . . 19.649999999999999 110.005 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.7 t -57.04 -19.15 17.17 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.716 -1.216 . . . . 14.720000000000001 107.716 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -101.34 -8.01 22.45 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.696 -0.628 . . . . 11.449999999999999 110.234 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.4 m-30 -74.66 155.27 37.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.836 -1.165 . . . . 14.25 108.925 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.77 176.53 12.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 32.700000000000003 109.678 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.757 HG21 HG21 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -109.45 115.77 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.392 -0.818 . . . . 15.630000000000001 109.285 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.06 179.71 10.77 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.508 -1.437 . . . . 12.699999999999999 109.508 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.402 ' C ' ' CG ' ' A' ' 73' ' ' PHE . 9.2 mm100 -88.46 42.43 1.07 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.222 -1.164 . . . . 26.289999999999999 109.298 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.402 ' CG ' ' C ' ' A' ' 72' ' ' GLN . 10.3 m-85 -148.23 34.96 0.81 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.532 -0.73 . . . . 20.440000000000001 109.384 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' HG13 ' B' ' 45' ' ' VAL . . . 48.0 58.78 6.72 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.239 -1.544 . . . . 13.82 109.239 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.435 ' HA ' HG13 ' B' ' 45' ' ' VAL . 4.2 m -156.41 136.16 12.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.335 -1.097 . . . . 18.27 109.919 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.958 HD11 HD21 ' B' ' 37' ' ' LEU . 0.3 OUTLIER -73.06 165.08 25.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.321 -0.862 . . . . 12.43 109.084 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.541 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.1 mtt -166.43 107.86 0.7 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.07 -1.019 . . . . 35.109999999999999 110.023 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.61 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -42.67 -35.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 13.67 109.588 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER 43.89 55.19 5.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 24.059999999999999 109.411 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 67' ' ' SER . 6.5 tmm_? 78.23 80.78 0.07 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.851 -0.796 . . . . 35.039999999999999 108.851 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.834 HD12 ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -55.56 149.03 14.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.768 0.794 . . . . 18.719999999999999 111.703 -178.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -99.48 103.46 15.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.094 -1.076 . . . . 20.550000000000001 108.094 178.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.956 HD12 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -75.16 151.57 38.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.185 -0.947 . . . . 14.4 111.568 -178.278 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 62' ' ' THR . 27.1 m -151.51 155.65 34.37 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.825 -1.176 . . . . 17.649999999999999 107.825 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 24.7 Cg_endo -63.42 144.23 90.3 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.146 1.898 . . . . 25.699999999999999 110.433 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.544 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -72.0 139.71 48.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.159 -0.963 . . . . 49.289999999999999 109.396 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.009 -0.996 . . . . 58.909999999999997 109.551 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.521 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.396 -0.594 . . . . 64.909999999999997 109.396 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.601 ' CA ' HD22 ' A' ' 65' ' ' LEU . 3.8 mt -72.7 79.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.664 -1.235 . . . . 33.799999999999997 107.664 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -69.59 156.13 39.41 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.055 0.931 . . . . 32.719999999999999 111.549 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.899 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -165.54 168.16 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.229 -1.026 . . . . 14.460000000000001 108.229 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.547 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 26.3 mt-10 -143.46 112.55 6.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 22.120000000000001 109.556 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.704 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -72.31 102.59 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 118.979 -1.089 . . . . 14.23 108.079 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.551 ' HB3' ' HD2' ' B' ' 8' ' ' PRO . 1.1 mmpt? -43.69 162.57 0.19 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 25.43 109.466 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.4 Cg_endo -72.65 -12.9 27.07 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.007 1.805 . . . . 13.609999999999999 109.144 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -98.99 7.15 46.28 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.26 -1.015 . . . . 15.52 108.26 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 1.5 mm-40 -129.53 41.34 3.46 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.416 -0.803 . . . . 17.309999999999999 108.885 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.92 3.88 39.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.063 -1.023 . . . . 24.780000000000001 110.264 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.464 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.9 OUTLIER -134.9 139.49 45.02 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.167 -0.958 . . . . 47.899999999999999 108.533 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.704 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 22.1 p90 -85.86 176.7 7.94 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.035 -1.041 . . . . 21.609999999999999 109.244 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -133.64 148.67 51.55 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.395 -0.816 . . . . 14.890000000000001 109.087 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.82 110.71 22.07 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.37 -0.831 . . . . 17.350000000000001 108.997 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.45 HH11 ' CG ' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -136.53 152.67 50.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.247 -0.908 . . . . 34.380000000000003 109.582 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.403 ' C ' ' O ' ' B' ' 16' ' ' ARG . 18.6 p -45.75 146.69 1.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 38.770000000000003 109.384 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -146.34 166.72 28.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.219 -1.552 . . . . 34.579999999999998 109.219 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' B' ' 24' ' ' LYS . 0.8 OUTLIER -141.15 117.36 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.015 -1.286 . . . . 41.869999999999997 109.409 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 98.2 p -55.67 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.377 -0.827 . . . . 47.210000000000001 109.677 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER 48.43 41.94 17.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.291 -0.881 . . . . 71.560000000000002 109.719 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 65.64 19.28 11.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -0.945 . . . . 66.599999999999994 109.77 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.19 -55.42 1.28 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.154 -1.578 . . . . 55.490000000000002 109.154 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' B' ' 19' ' ' VAL . 1.0 OUTLIER -140.77 151.21 62.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.377 -1.072 . . . . 44.990000000000002 108.902 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 33.9 Cg_endo -76.67 124.62 7.67 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.499 2.133 . . . . 44.100000000000001 110.619 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.582 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 6.7 p90 -136.0 144.17 45.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 32.090000000000003 109.774 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.49 80.9 1.86 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.875 . . . . 29.25 108.666 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.575 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -94.7 168.28 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 24.0 110.231 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.687 ' ND2' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -95.09 127.08 40.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.445 -0.785 . . . . 23.309999999999999 108.922 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.6 OUTLIER -113.51 160.68 18.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.175 -0.953 . . . . 40.030000000000001 109.581 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.817 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -137.83 -169.63 2.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 12.390000000000001 109.02 179.48 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.949 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.1 mt -133.81 175.85 9.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.923 . . . . 17.420000000000002 109.548 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.14 161.69 8.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.955 -1.091 . . . . 13.84 108.497 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.742 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.1 m-30 -114.41 101.58 9.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 21.140000000000001 108.739 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.899 HG22 ' HB ' ' B' ' 4' ' ' VAL . 13.5 t -107.73 148.25 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.056 -1.027 . . . . 10.66 110.125 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.94 ' O ' HD12 ' B' ' 37' ' ' LEU . 1.8 p-10 -113.95 -40.07 3.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.51 -0.922 . . . . 25.890000000000001 108.51 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.958 HD21 HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER 62.38 -70.87 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.773 -0.825 . . . . 24.239999999999998 108.773 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -142.65 27.73 2.2 Favored Glycine 0 C--N 1.296 -1.669 0 N-CA-C 108.307 -1.917 . . . . 31.02 108.307 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.0 OUTLIER -130.72 99.07 4.82 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.604 -0.939 . . . . 43.229999999999997 108.73 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' B' ' 39' ' ' ASN . 3.4 mm-40 -31.55 -37.02 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.3 0.571 . . . . 42.340000000000003 111.143 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' B' ' 39' ' ' ASN . 59.8 m80 -80.73 149.18 67.12 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 121.342 -0.849 . . . . 6.9800000000000004 109.037 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.634 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.4 Cg_endo -78.58 149.48 23.94 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.102 1.868 . . . . 17.920000000000002 110.408 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.84 HG22 ' O ' ' B' ' 35' ' ' VAL . 1.8 m -121.36 119.51 59.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.344 -0.943 . . . . 20.57 109.102 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.949 HD11 ' HB3' ' B' ' 32' ' ' LEU . 15.3 tp -73.04 111.45 8.16 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.778 -0.769 . . . . 20.210000000000001 109.105 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.608 HG23 HG23 ' B' ' 43' ' ' VAL . 12.8 t -117.7 167.16 11.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.633 -0.667 . . . . 10.81 109.449 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.564 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.9 OUTLIER -96.16 140.33 31.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.319 -0.863 . . . . 36.740000000000002 109.495 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.943 HD13 HD12 ' B' ' 83' ' ' LEU . 0.3 OUTLIER -121.96 171.81 10.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.344 -0.847 . . . . 19.739999999999998 109.076 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.423 ' OG1' ' HD3' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -105.89 153.15 22.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.051 -1.03 . . . . 22.559999999999999 109.77 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -136.36 104.99 5.79 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.684 -0.858 . . . . 20.41 108.684 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -70.01 144.5 52.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 33.990000000000002 109.665 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.58 132.88 41.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.893 . . . . 54.920000000000002 109.264 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.32 -36.09 4.44 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.398 -1.481 . . . . 36.100000000000001 109.398 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.51 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 5.0 mt-30 -79.47 138.34 55.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.27 -1.135 . . . . 54.759999999999998 109.34 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.41 126.12 7.39 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.44 2.093 . . . . 28.370000000000001 110.372 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.817 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -41.25 150.58 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.328 -0.857 . . . . 17.210000000000001 110.234 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.704 ' O ' HG21 ' B' ' 6' ' ' ILE . 82.1 m-85 -51.95 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.95 -0.759 . . . . 17.190000000000001 108.95 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.978 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -51.53 176.62 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.306 -0.871 . . . . 17.82 109.312 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.978 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -76.9 132.12 12.7 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.469 2.113 . . . . 17.280000000000001 110.328 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.99 175.15 26.66 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.676 -1.37 . . . . 17.219999999999999 109.676 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.524 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.7 OUTLIER -73.43 143.88 46.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -1.138 . . . . 19.57 108.872 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.701 ' HB3' HD22 ' B' ' 83' ' ' LEU . 21.5 m-85 -127.9 163.05 25.3 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.544 1.164 . . . . 14.609999999999999 111.556 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.69 ' O ' HG22 ' B' ' 84' ' ' VAL . 46.1 p -143.32 121.41 12.14 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.546 -1.65 . . . . 18.359999999999999 106.546 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.834 ' CG1' HD12 ' B' ' 81' ' ' LEU . 3.3 t -52.75 165.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 C-N-CA 118.88 -1.128 . . . . 19.129999999999999 109.023 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -134.02 128.55 34.56 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.59 -0.893 . . . . 20.649999999999999 108.59 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.729 HD11 ' O ' ' A' ' 37' ' ' LEU . 1.3 pp -72.74 2.95 5.68 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.061 -1.024 . . . . 19.649999999999999 110.087 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 28.6 t -56.94 -19.21 16.73 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 107.711 -1.218 . . . . 14.720000000000001 107.711 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -101.45 -7.79 22.55 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.723 -0.611 . . . . 11.449999999999999 110.166 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.641 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.3 m-30 -74.84 154.97 38.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.889 -1.132 . . . . 14.25 108.833 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.43 176.85 12.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 32.700000000000003 109.681 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -109.8 115.62 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.43 -0.794 . . . . 15.630000000000001 109.363 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.91 179.71 10.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.568 -1.413 . . . . 12.699999999999999 109.568 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.404 ' C ' ' CG ' ' B' ' 73' ' ' PHE . 9.2 mm100 -88.49 42.42 1.07 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.224 -1.162 . . . . 26.289999999999999 109.314 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.404 ' CG ' ' C ' ' B' ' 72' ' ' GLN . 9.5 m-85 -148.18 34.79 0.81 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.495 -0.753 . . . . 20.440000000000001 109.481 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.435 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 48.34 58.08 7.59 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.292 -1.523 . . . . 13.82 109.292 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.4 m -155.74 136.37 13.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.139 . . . . 18.27 109.963 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.904 HD11 HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -73.2 164.91 26.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 12.43 109.157 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.1 mtt -166.37 108.12 0.71 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.085 -1.009 . . . . 35.109999999999999 110.106 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.615 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.7 mt -42.99 -34.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 13.67 109.532 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.7 OUTLIER 43.83 55.27 5.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.832 . . . . 24.059999999999999 109.35 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 67' ' ' SER . 6.5 tmm_? 78.23 80.82 0.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.922 -0.77 . . . . 35.039999999999999 108.922 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.834 HD12 ' CG1' ' B' ' 63' ' ' VAL . 1.0 OUTLIER -55.54 149.11 14.27 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.702 0.763 . . . . 18.719999999999999 111.74 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -99.62 103.55 15.26 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.992 -1.114 . . . . 20.550000000000001 107.992 178.311 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.943 HD12 HD13 ' B' ' 47' ' ' ILE . 0.6 OUTLIER -75.22 151.55 38.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.229 -0.92 . . . . 14.4 111.609 -178.224 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.69 HG22 ' O ' ' B' ' 62' ' ' THR . 29.9 m -151.55 155.36 34.18 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 107.837 -1.171 . . . . 17.649999999999999 107.837 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 24.7 Cg_endo -63.22 144.12 91.12 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.237 1.958 . . . . 25.699999999999999 110.446 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.525 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -72.0 139.4 48.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 49.289999999999999 109.375 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.034 -0.984 . . . . 58.909999999999997 109.483 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.4 -0.593 . . . . 64.909999999999997 109.4 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.707 ' N ' HD22 ' B' ' 65' ' ' LEU . 3.0 mt -61.93 83.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.646 -1.242 . . . . 33.799999999999997 107.646 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 1' ' ' MET . 14.0 mtpt -75.93 158.05 32.47 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.952 0.882 . . . . 32.719999999999999 111.104 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.893 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -164.23 169.05 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.293 -1.002 . . . . 14.460000000000001 108.293 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 55.5 mt-10 -144.7 112.6 6.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.94 . . . . 22.120000000000001 109.47 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.746 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -72.73 101.98 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.822 -1.177 . . . . 14.23 107.822 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.656 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.69 171.22 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.304 -0.872 . . . . 25.43 109.856 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -74.8 -26.9 10.91 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.36 2.04 . . . . 13.609999999999999 109.589 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -88.02 0.08 56.39 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.987 -0.746 . . . . 15.52 108.987 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.8 mm-40 -120.42 33.87 5.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 17.309999999999999 109.475 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.95 10.79 38.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 24.780000000000001 109.958 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 15.3 mt-30 -138.93 144.99 39.29 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 47.899999999999999 109.96 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.737 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 35.4 p90 -94.3 161.52 14.21 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.323 -0.861 . . . . 21.609999999999999 109.195 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -128.92 162.82 26.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.311 -0.868 . . . . 14.890000000000001 108.808 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.658 HG22 ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -97.28 111.03 23.45 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.239 -0.913 . . . . 17.350000000000001 109.541 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -117.08 137.56 52.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -0.863 . . . . 34.380000000000003 109.087 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.4 t -50.54 90.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 38.770000000000003 109.813 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.555 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -85.44 161.76 35.77 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.304 -1.518 . . . . 34.579999999999998 109.304 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.477 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 2.1 t -132.94 123.93 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.187 -1.184 . . . . 41.869999999999997 109.386 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -64.54 89.37 0.07 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.279 -0.888 . . . . 47.210000000000001 109.632 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 20' ' ' SER . 1.2 mpt_? 43.56 53.68 5.71 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.261 -0.899 . . . . 71.560000000000002 109.749 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.72 20.77 0.79 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 66.599999999999994 109.722 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' SER . . . -99.73 -39.67 3.33 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.309 -1.516 . . . . 55.490000000000002 109.309 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 20' ' ' SER . 14.5 mttm -156.52 148.81 17.68 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.354 -1.086 . . . . 44.990000000000002 109.151 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.42 131.13 11.38 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.535 2.157 . . . . 44.100000000000001 110.5 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.604 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 5.5 p90 -144.71 139.5 27.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.182 -0.949 . . . . 32.090000000000003 109.603 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.658 ' HB2' HG22 ' A' ' 15' ' ' THR . 2.9 p -102.01 80.43 2.0 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 29.25 108.868 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.605 HD22 ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER -91.33 143.35 26.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 24.0 110.173 -179.168 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.569 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 90.7 m-20 -64.99 133.55 51.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.387 -0.821 . . . . 23.309999999999999 109.745 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.21 142.32 51.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 40.030000000000001 109.294 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.91 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -124.14 -179.04 4.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 12.390000000000001 109.303 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.9 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.1 mt -127.75 174.33 9.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 17.420000000000002 109.579 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -168.45 167.62 11.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.403 -0.962 . . . . 13.84 108.403 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.668 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 18.7 m-85 -120.88 107.38 12.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.138 -0.976 . . . . 21.140000000000001 109.545 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.927 ' O ' HG22 ' A' ' 43' ' ' VAL . 59.2 t -104.02 112.3 37.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.141 -0.974 . . . . 10.66 109.821 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.0 OUTLIER -64.0 -27.34 69.05 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.196 -1.038 . . . . 25.890000000000001 108.196 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.666 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.6 OUTLIER 48.37 30.85 2.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.602 -0.686 . . . . 24.239999999999998 109.303 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.61 9.37 78.33 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.457 -1.457 . . . . 31.02 109.457 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.615 ' OD1' HD23 ' A' ' 37' ' ' LEU . 1.9 m-20 -85.43 4.57 34.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -1.149 . . . . 43.229999999999997 110.476 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 29.6 mt-10 80.7 -42.61 0.2 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.585 -0.697 . . . . 42.340000000000003 110.567 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.521 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 47.5 m80 -107.0 155.34 39.38 Favored Pre-proline 0 C--N 1.295 -1.793 0 O-C-N 121.417 -0.802 . . . . 5.75 108.929 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.668 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -77.15 138.12 17.79 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.181 1.92 . . . . 17.920000000000002 110.542 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.927 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.6 m -111.85 117.75 55.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.369 -0.832 . . . . 20.57 108.827 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.9 HD11 ' HB3' ' A' ' 32' ' ' LEU . 67.3 tp -71.56 103.26 2.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.288 -0.882 . . . . 20.210000000000001 110.007 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 43' ' ' VAL . 3.6 m -106.42 -177.42 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.527 -0.733 . . . . 10.81 109.032 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.26 145.0 40.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.409 -0.917 . . . . 36.740000000000002 109.987 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.856 HD13 HD12 ' A' ' 83' ' ' LEU . 1.2 tt -135.9 136.47 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.418 -0.801 . . . . 19.739999999999998 109.064 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.605 ' CG2' HD22 ' A' ' 28' ' ' LEU . 11.1 m -68.67 156.01 39.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 22.559999999999999 109.57 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.641 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 2.3 tm? -129.99 114.02 15.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.282 -0.886 . . . . 20.41 109.077 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -48.85 123.56 7.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.866 . . . . 33.990000000000002 110.152 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -47.34 109.27 0.2 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.319 -0.863 . . . . 54.920000000000002 109.353 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.78 -29.65 10.55 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.429 -1.468 . . . . 36.100000000000001 109.429 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.604 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -65.2 153.68 88.89 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.23 -1.159 . . . . 54.759999999999998 109.326 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.8 Cg_endo -77.88 109.95 2.82 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.506 2.138 . . . . 28.370000000000001 110.224 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.91 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -38.63 148.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.526 -0.734 . . . . 17.210000000000001 110.218 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.746 ' O ' HG21 ' A' ' 6' ' ' ILE . 83.0 m-85 -46.0 101.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.451 -0.781 . . . . 17.190000000000001 109.355 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.845 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.63 171.02 0.17 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.907 . . . . 17.82 109.823 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.845 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -77.9 114.14 3.57 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.736 2.291 . . . . 17.280000000000001 110.117 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.65 -179.82 46.6 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.898 -1.281 . . . . 17.219999999999999 109.898 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -75.78 139.76 41.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -1.082 . . . . 19.57 108.114 179.009 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.766 ' HB3' HD22 ' A' ' 83' ' ' LEU . 18.5 m-85 -126.26 162.15 26.11 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.66 -1.275 . . . . 14.609999999999999 111.759 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.772 ' O ' HG22 ' A' ' 84' ' ' VAL . 52.8 p -142.11 122.25 13.8 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.247 -1.76 . . . . 18.359999999999999 106.247 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.598 HG21 HG21 ' A' ' 2' ' ' ILE . 2.5 t -54.38 162.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 C-N-CA 118.792 -1.163 . . . . 19.129999999999999 109.077 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.545 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.5 t-80 -130.46 129.17 42.63 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.246 -1.02 . . . . 20.649999999999999 108.246 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.711 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.5 OUTLIER -70.04 1.97 4.06 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.502 -0.749 . . . . 19.649999999999999 110.2 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.03 -20.35 9.18 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.448 -1.316 . . . . 14.720000000000001 107.448 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -97.58 -8.34 29.21 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.755 -0.591 . . . . 11.449999999999999 110.09 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -77.97 154.94 31.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.967 -1.083 . . . . 14.25 109.595 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.93 175.8 9.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 32.700000000000003 109.466 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.912 HG11 ' CG2' ' B' ' 43' ' ' VAL . 10.6 t -122.37 134.4 65.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.43 -0.794 . . . . 15.630000000000001 109.475 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.21 -160.24 28.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.382 -1.487 . . . . 12.699999999999999 109.382 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 6.2 tp60 61.67 72.73 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -1.177 . . . . 26.289999999999999 109.349 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 2.2 m-85 65.51 11.97 7.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 20.440000000000001 109.357 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' B' ' 45' ' ' VAL . . . 81.97 48.82 5.6 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.503 -1.439 . . . . 13.82 109.503 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 77' ' ' MET . 26.9 t -130.6 125.48 34.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -1.116 . . . . 18.27 109.662 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.689 ' CD1' HG22 ' A' ' 70' ' ' VAL . 3.5 tp -63.96 146.44 54.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 12.43 109.115 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.5 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 3.2 mtm -159.33 144.37 15.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 35.109999999999999 109.449 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.624 ' CG1' ' CE1' ' A' ' 68' ' ' PHE . 1.7 mp -65.14 145.48 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 13.67 109.505 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 67' ' ' SER . 4.6 t70 -103.46 -62.28 1.31 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.214 -1.402 . . . . 24.059999999999999 107.214 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.524 ' O ' ' C ' ' A' ' 81' ' ' LEU . 5.1 tmm_? -142.28 56.8 1.46 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.292 -1.003 . . . . 35.039999999999999 108.292 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.632 HD21 ' HG ' ' A' ' 83' ' ' LEU . 6.4 tt 3.43 116.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.524 -1.217 . . . . 18.719999999999999 112.849 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.545 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -99.35 96.61 7.84 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.098 -1.075 . . . . 20.550000000000001 108.098 178.299 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.856 HD12 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -77.49 150.82 34.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.982 -1.074 . . . . 14.4 111.064 -178.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 62' ' ' THR . 26.4 m -151.15 155.88 34.99 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.106 -1.072 . . . . 17.649999999999999 108.106 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.1 Cg_endo -63.86 141.9 80.06 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.053 1.836 . . . . 25.699999999999999 110.173 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.707 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -70.77 117.79 12.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.206 -0.934 . . . . 49.289999999999999 109.602 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.046 -0.978 . . . . 58.909999999999997 109.496 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.416 -0.587 . . . . 64.909999999999997 109.416 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.711 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.0 mt -62.0 83.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.644 -1.243 . . . . 33.799999999999997 107.644 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' ' 1' ' ' MET . 14.0 mtpt -75.89 158.0 32.58 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.947 0.879 . . . . 32.719999999999999 111.104 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.863 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -164.23 168.99 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.296 -1.002 . . . . 14.460000000000001 108.296 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.548 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 55.2 mt-10 -144.59 112.62 6.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.19 -0.944 . . . . 22.120000000000001 109.448 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.743 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -72.73 101.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.761 -1.2 . . . . 14.23 107.761 179.255 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.656 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.73 171.23 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.358 -0.839 . . . . 25.43 109.81 -178.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 32.6 Cg_endo -74.92 -26.82 10.72 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.331 2.021 . . . . 13.609999999999999 109.532 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -88.03 0.15 56.3 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.0 -0.741 . . . . 15.52 109.0 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.516 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.8 mm-40 -120.42 33.79 5.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 17.309999999999999 109.506 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.85 10.77 38.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.136 -0.978 . . . . 24.780000000000001 109.937 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.483 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 15.3 mt-30 -139.01 144.93 39.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.144 -0.973 . . . . 47.899999999999999 109.911 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.726 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 35.4 p90 -94.25 161.46 14.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.376 -0.827 . . . . 21.609999999999999 109.178 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 8.7 t -128.78 162.93 26.29 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.242 -0.911 . . . . 14.890000000000001 108.792 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.652 HG22 ' HB2' ' B' ' 27' ' ' SER . 0.2 OUTLIER -97.43 111.07 23.48 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.203 -0.935 . . . . 17.350000000000001 109.486 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' B' ' 18' ' ' GLY . 0.0 OUTLIER -117.12 137.66 52.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 34.380000000000003 109.093 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 28.5 t -50.6 90.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 38.770000000000003 109.835 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -85.53 161.88 35.74 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.361 -1.496 . . . . 34.579999999999998 109.361 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.474 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 2.1 t -133.07 123.84 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -1.206 . . . . 41.869999999999997 109.369 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.482 ' N ' ' O ' ' B' ' 24' ' ' LYS . 0.4 OUTLIER -64.49 89.38 0.06 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.314 -0.866 . . . . 47.210000000000001 109.681 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' B' ' 20' ' ' SER . 1.2 mpt_? 43.54 53.67 5.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.236 -0.915 . . . . 71.560000000000002 109.692 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.83 20.7 0.81 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 66.599999999999994 109.722 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.63 -39.9 3.3 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.242 -1.543 . . . . 55.490000000000002 109.242 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' B' ' 20' ' ' SER . 14.5 mttm -156.27 148.94 17.99 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.329 -1.101 . . . . 44.990000000000002 109.16 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.46 131.19 11.39 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.512 2.141 . . . . 44.100000000000001 110.532 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.6 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 5.4 p90 -144.76 139.5 27.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 32.090000000000003 109.614 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.652 ' HB2' HG22 ' B' ' 15' ' ' THR . 2.8 p -102.05 80.41 1.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 29.25 108.848 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.603 HD22 ' CG2' ' B' ' 48' ' ' THR . 0.2 OUTLIER -91.31 143.31 26.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 24.0 110.231 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.574 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 90.9 m-20 -64.94 133.6 52.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.8 . . . . 23.309999999999999 109.745 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.26 142.32 51.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 40.030000000000001 109.259 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.892 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -124.07 -179.16 4.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 12.390000000000001 109.378 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.877 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.1 mt -127.63 174.41 9.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.964 . . . . 17.420000000000002 109.511 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -168.59 167.57 11.41 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.366 -0.976 . . . . 13.84 108.366 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 18.9 m-85 -120.83 107.4 12.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.127 -0.983 . . . . 21.140000000000001 109.596 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.908 ' O ' HG22 ' B' ' 43' ' ' VAL . 59.4 t -104.04 112.29 36.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.157 -0.964 . . . . 10.66 109.834 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.0 OUTLIER -63.96 -27.41 69.12 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.155 -1.054 . . . . 25.890000000000001 108.155 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.655 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER 48.48 30.74 2.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.637 -0.664 . . . . 24.239999999999998 109.278 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.73 9.34 78.79 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.469 -1.453 . . . . 31.02 109.469 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.609 ' OD1' HD23 ' B' ' 37' ' ' LEU . 1.9 m-20 -85.39 4.5 35.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -1.165 . . . . 43.229999999999997 110.504 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' B' ' 39' ' ' ASN . 29.5 mt-10 80.67 -42.62 0.2 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.578 -0.701 . . . . 42.340000000000003 110.561 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' B' ' 36' ' ' ASP . 47.5 m80 -106.95 155.34 39.34 Favored Pre-proline 0 C--N 1.294 -1.825 0 O-C-N 121.376 -0.828 . . . . 5.7800000000000002 108.919 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.672 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.1 Cg_endo -77.2 138.21 17.78 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.12 1.88 . . . . 17.920000000000002 110.551 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.912 ' CG2' HG11 ' A' ' 70' ' ' VAL . 5.6 m -111.85 117.7 55.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.338 -0.852 . . . . 20.57 108.784 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.877 HD11 ' HB3' ' B' ' 32' ' ' LEU . 67.3 tp -71.55 103.19 2.91 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.347 -0.846 . . . . 20.210000000000001 110.032 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.565 HG13 HG23 ' B' ' 43' ' ' VAL . 3.6 m -106.34 -177.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 109.001 -0.74 . . . . 10.81 109.001 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.27 144.91 40.9 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.408 -0.917 . . . . 36.740000000000002 110.006 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.833 HD13 HD12 ' B' ' 83' ' ' LEU . 1.2 tt -135.84 136.53 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.454 -0.779 . . . . 19.739999999999998 109.068 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.603 ' CG2' HD22 ' B' ' 28' ' ' LEU . 11.0 m -68.67 156.17 38.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -0.984 . . . . 22.559999999999999 109.53 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.635 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 2.3 tm? -130.19 113.94 15.08 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.357 -0.839 . . . . 20.41 109.083 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.3 OUTLIER -48.82 123.6 7.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.873 . . . . 33.990000000000002 110.209 -179.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -47.37 109.25 0.2 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.298 -0.876 . . . . 54.920000000000002 109.394 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.83 -29.67 10.49 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.431 -1.468 . . . . 36.100000000000001 109.431 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.618 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.7 OUTLIER -65.16 153.62 88.92 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.278 -1.131 . . . . 54.759999999999998 109.311 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.5 Cg_endo -77.8 109.98 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.52 2.146 . . . . 28.370000000000001 110.214 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.892 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -38.75 148.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.526 -0.734 . . . . 17.210000000000001 110.154 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.743 ' O ' HG21 ' B' ' 6' ' ' ILE . 83.1 m-85 -46.34 102.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 17.190000000000001 109.409 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.864 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -50.82 171.01 0.17 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 17.82 109.737 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.864 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -78.17 115.31 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.768 2.312 . . . . 17.280000000000001 110.397 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.67 -179.27 45.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.747 -1.341 . . . . 17.219999999999999 109.747 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.732 HD23 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -75.44 140.4 42.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -1.102 . . . . 19.57 108.432 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.768 ' HB3' HD22 ' B' ' 83' ' ' LEU . 18.1 m-85 -126.8 162.25 26.3 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.752 -1.218 . . . . 14.609999999999999 111.764 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.767 ' O ' HG22 ' B' ' 84' ' ' VAL . 52.8 p -142.34 122.26 13.61 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.256 -1.757 . . . . 18.359999999999999 106.256 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.6 HG21 HG21 ' B' ' 2' ' ' ILE . 2.6 t -54.39 162.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 C-N-CA 118.766 -1.174 . . . . 19.129999999999999 109.077 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.552 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.5 t-80 -130.41 129.18 42.72 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.269 -1.012 . . . . 20.649999999999999 108.269 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.707 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -69.93 1.83 4.09 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.516 -0.74 . . . . 19.649999999999999 110.231 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.95 -20.35 8.8 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.419 -1.326 . . . . 14.720000000000001 107.419 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.519 ' O ' ' N ' ' B' ' 79' ' ' ASP . 0.5 OUTLIER -97.74 -8.52 28.41 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.74 -0.6 . . . . 11.449999999999999 110.062 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.666 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.8 m-30 -77.74 154.54 31.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 14.25 109.495 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.54 176.04 9.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 32.700000000000003 109.483 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.91 HG11 ' CG2' ' A' ' 43' ' ' VAL . 10.5 t -122.52 134.37 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 15.630000000000001 109.504 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.19 -160.28 28.6 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.356 -1.498 . . . . 12.699999999999999 109.356 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 6.3 tp60 61.69 72.79 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -1.164 . . . . 26.289999999999999 109.349 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 2.2 m-85 65.43 12.06 7.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 20.440000000000001 109.29 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 45' ' ' VAL . . . 81.87 48.88 5.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.495 -1.442 . . . . 13.82 109.495 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 77' ' ' MET . 27.1 t -130.59 125.38 33.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 18.27 109.659 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.692 ' CD1' HG22 ' B' ' 70' ' ' VAL . 3.4 tp -63.81 146.46 53.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 12.43 109.131 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.508 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 3.2 mtm -159.43 144.41 15.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.07 -1.019 . . . . 35.109999999999999 109.396 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.626 ' CG1' ' CE1' ' B' ' 68' ' ' PHE . 1.7 mp -65.29 145.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 13.67 109.534 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' B' ' 67' ' ' SER . 4.5 t70 -103.59 -62.07 1.34 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.238 -1.393 . . . . 24.059999999999999 107.238 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' B' ' 81' ' ' LEU . 5.1 tmm_? -142.51 56.88 1.44 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.286 -1.005 . . . . 35.039999999999999 108.286 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.641 HD21 ' HG ' ' B' ' 83' ' ' LEU . 6.5 tt 3.4 116.68 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.474 -1.239 . . . . 18.719999999999999 112.887 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.4 OUTLIER -99.41 96.51 7.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.109 -1.071 . . . . 20.550000000000001 108.109 178.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.833 HD12 HD13 ' B' ' 47' ' ' ILE . 0.9 OUTLIER -77.35 150.98 35.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.935 -1.103 . . . . 14.4 111.066 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.767 HG22 ' O ' ' B' ' 62' ' ' THR . 26.5 m -151.34 155.77 34.68 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.054 -1.091 . . . . 17.649999999999999 108.054 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.1 Cg_endo -63.73 141.91 80.94 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.055 1.837 . . . . 25.699999999999999 110.195 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.726 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -70.76 117.72 12.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.163 -0.96 . . . . 49.289999999999999 109.595 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.046 -0.978 . . . . 58.909999999999997 109.476 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.517 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.3 -0.629 . . . . 64.909999999999997 109.3 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.955 ' H ' HD22 ' B' ' 65' ' ' LEU . 1.7 mt 58.53 78.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.799 -1.186 . . . . 33.799999999999997 107.799 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -73.52 157.15 37.29 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.797 0.808 . . . . 32.719999999999999 110.672 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.876 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -164.67 159.31 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.022 -0.733 . . . . 14.460000000000001 109.022 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 5.1 mt-10 -136.34 113.6 10.68 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 22.120000000000001 109.351 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.697 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -72.36 107.26 3.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.906 -1.146 . . . . 14.23 107.906 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.603 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 4.4 mptt -50.07 172.6 0.11 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.165 -0.959 . . . . 25.43 109.999 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.8 Cg_endo -76.0 -29.23 6.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.557 2.171 . . . . 13.609999999999999 109.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 m -92.95 7.01 45.8 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.976 -0.75 . . . . 15.52 108.976 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.1 mm-40 -123.49 29.25 6.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 17.309999999999999 109.749 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.22 16.28 17.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 24.780000000000001 110.063 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 54.8 mt-30 -141.84 145.29 34.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.093 -1.004 . . . . 47.899999999999999 109.902 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.753 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 42.2 p90 -96.16 153.37 17.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.363 -0.836 . . . . 21.609999999999999 109.458 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.7 p -121.38 168.72 11.36 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.421 -0.8 . . . . 14.890000000000001 109.337 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.53 113.72 27.31 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.409 -0.807 . . . . 17.350000000000001 109.048 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HB2' ' OE1' ' A' ' 30' ' ' GLU . 25.2 mtt180 -141.62 155.11 45.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -0.883 . . . . 34.380000000000003 109.501 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' ARG . 26.6 p -42.71 133.57 3.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.39 -0.819 . . . . 38.770000000000003 109.714 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 26' ' ' TYR . . . -131.94 157.97 22.66 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.36 -1.496 . . . . 34.579999999999998 109.36 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -135.44 117.9 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.11 -1.229 . . . . 41.869999999999997 109.475 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.457 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 7.5 p -64.0 -146.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.331 -0.855 . . . . 47.210000000000001 109.183 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 22' ' ' GLN . 6.3 mtp180 -53.16 -46.64 68.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.114 -0.991 . . . . 71.560000000000002 109.155 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 2.8 pt20 164.69 46.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.429 -0.795 . . . . 66.599999999999994 109.471 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.13 -60.36 0.42 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.483 -1.447 . . . . 55.490000000000002 109.483 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.55 160.74 49.98 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.296 -1.12 . . . . 44.990000000000002 109.281 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.7 Cg_endo -77.33 80.33 2.93 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.695 2.264 . . . . 44.100000000000001 110.906 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 4.7 p90 -68.68 139.0 55.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.254 -0.904 . . . . 32.090000000000003 109.671 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.74 80.74 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 29.25 108.664 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -104.81 164.07 12.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 24.0 110.179 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.591 ' CB ' ' HB3' ' A' ' 49' ' ' LEU . 4.7 m120 -53.8 160.8 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 23.309999999999999 109.809 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 16' ' ' ARG . 7.4 mt-10 -150.04 125.45 10.19 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.44 -0.948 . . . . 40.030000000000001 108.44 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.998 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -113.6 -179.18 3.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 12.390000000000001 110.36 -178.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.922 ' HB3' HD11 ' A' ' 44' ' ' LEU . 81.2 mt -137.48 147.69 45.48 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.787 -0.819 . . . . 17.420000000000002 108.787 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.96 ' SG ' HD13 ' A' ' 47' ' ' ILE . 2.8 m -151.88 -177.53 6.19 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.802 -1.185 . . . . 13.84 107.802 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.667 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 31.6 m-85 -127.91 112.46 14.72 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.074 -1.016 . . . . 21.140000000000001 109.677 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.876 HG22 ' HB ' ' A' ' 4' ' ' VAL . 60.7 t -106.89 109.9 29.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.372 -0.931 . . . . 10.66 109.749 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 2.5 p30 -57.75 -39.4 77.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.028 -1.471 . . . . 25.890000000000001 107.028 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.754 HD11 ' CA ' ' B' ' 69' ' ' LYS . 7.3 tt 62.88 -71.2 0.05 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.831 0.824 . . . . 24.239999999999998 109.056 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.705 ' N ' HD23 ' A' ' 37' ' ' LEU . . . -178.04 41.53 0.09 OUTLIER Glycine 0 C--N 1.294 -1.791 0 N-CA-C 108.54 -1.824 . . . . 31.02 108.54 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -124.37 23.81 8.17 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.33 -1.1 . . . . 43.229999999999997 110.429 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.577 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 14.6 mt-10 50.53 19.28 0.55 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.259 -0.901 . . . . 42.340000000000003 110.729 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.577 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 98.6 m-70 -160.08 154.74 20.64 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.278 -1.008 . . . . 6.9900000000000002 108.278 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.667 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 37.4 Cg_endo -76.36 134.24 15.42 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.921 1.747 . . . . 17.920000000000002 110.556 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.817 HG23 HG23 ' A' ' 45' ' ' VAL . 3.1 m -108.76 116.69 52.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 119.509 -0.877 . . . . 20.57 108.775 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.922 HD11 ' HB3' ' A' ' 32' ' ' LEU . 64.6 tp -67.62 101.79 1.07 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.462 -0.895 . . . . 20.210000000000001 109.364 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.817 HG23 HG23 ' A' ' 43' ' ' VAL . 38.6 t -103.89 166.92 2.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.63 -0.669 . . . . 10.81 109.389 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.766 ' HA ' HD23 ' A' ' 32' ' ' LEU . 24.7 ttmt -98.64 148.78 23.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.185 -0.947 . . . . 36.740000000000002 110.198 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.96 HD13 ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -128.05 163.14 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.395 -0.816 . . . . 19.739999999999998 108.971 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.401 ' N ' HG23 ' A' ' 47' ' ' ILE . 14.9 m -111.68 135.49 52.2 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.265 -0.897 . . . . 22.559999999999999 109.161 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.62 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -112.14 151.26 29.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 20.41 109.46 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.36 -174.67 4.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 33.990000000000002 109.736 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.45 104.47 15.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.352 -0.843 . . . . 54.920000000000002 109.575 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.18 -8.29 57.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.589 -1.404 . . . . 36.100000000000001 109.589 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.42 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -78.3 143.8 65.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.172 -1.193 . . . . 54.759999999999998 109.548 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.0 Cg_endo -79.34 110.87 2.77 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.629 2.22 . . . . 28.370000000000001 110.383 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.998 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.24 160.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 17.210000000000001 110.087 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.673 ' CE2' HG12 ' A' ' 47' ' ' ILE . 11.4 m-30 -54.57 111.05 0.72 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.398 -0.814 . . . . 17.190000000000001 109.209 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.984 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -60.67 176.22 0.38 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 17.82 109.516 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.984 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.47 114.87 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.665 2.244 . . . . 17.280000000000001 110.213 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.11 179.73 43.99 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.947 -1.261 . . . . 17.219999999999999 109.947 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.718 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -75.4 146.29 40.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -1.077 . . . . 19.57 108.256 179.132 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.697 ' CE1' HD13 ' A' ' 6' ' ' ILE . 23.0 m-85 -132.28 162.92 29.81 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.692 -1.255 . . . . 14.609999999999999 111.889 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.563 ' O ' HG22 ' A' ' 84' ' ' VAL . 59.8 p -145.41 119.71 9.58 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.65 -1.611 . . . . 18.359999999999999 106.65 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.913 ' CG1' HD12 ' A' ' 81' ' ' LEU . 11.2 t -47.53 169.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 C-N-CA 119.086 -1.045 . . . . 19.129999999999999 109.266 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.577 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.7 t-80 -134.87 122.11 21.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.953 -0.758 . . . . 20.649999999999999 108.953 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.908 HD22 ' H ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -65.92 -9.22 27.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.546 -0.721 . . . . 19.649999999999999 109.348 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -53.95 -16.82 2.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.165 -0.959 . . . . 14.720000000000001 108.886 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -104.11 -6.93 20.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 11.449999999999999 111.098 -179.306 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.1 m-30 -74.21 163.25 28.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.704 -1.248 . . . . 14.25 109.663 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.674 ' CA ' HD11 ' B' ' 37' ' ' LEU . 25.2 mtmt -149.64 174.02 13.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 32.700000000000003 109.31 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 HD13 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -114.86 109.83 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 15.630000000000001 109.065 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.04 -179.45 44.34 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.554 -1.419 . . . . 12.699999999999999 109.554 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -88.43 39.21 0.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.254 -1.144 . . . . 26.289999999999999 109.524 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -112.23 11.72 20.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.801 . . . . 20.440000000000001 109.261 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 46' ' ' LYS . . . 63.69 26.62 70.03 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.341 -1.504 . . . . 13.82 109.341 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -154.17 155.33 35.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -1.133 . . . . 18.27 109.626 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 76' ' ' LEU . 1.7 tp -67.18 173.55 3.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 12.43 109.536 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.439 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 2.7 mtt -159.39 101.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 35.109999999999999 109.607 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.595 ' CG2' ' N ' ' A' ' 81' ' ' LEU . 2.7 mt -41.92 -43.33 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 13.67 109.995 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER 48.69 54.24 10.97 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.341 -0.85 . . . . 24.059999999999999 108.991 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 82.01 80.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.023 -0.732 . . . . 35.039999999999999 109.023 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.913 HD12 ' CG1' ' A' ' 63' ' ' VAL . 1.3 pt? -58.81 154.15 15.52 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.46 0.648 . . . . 18.719999999999999 110.734 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -104.89 106.11 16.45 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.693 -1.225 . . . . 20.550000000000001 107.693 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.674 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -81.51 144.4 31.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.071 -1.018 . . . . 14.4 111.482 -178.021 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 62' ' ' THR . 35.6 m -144.26 160.58 48.33 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 107.617 -1.253 . . . . 17.649999999999999 107.617 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.8 Cg_endo -62.17 147.81 94.35 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.099 1.866 . . . . 25.699999999999999 110.658 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -77.75 124.12 27.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.303 -0.873 . . . . 49.289999999999999 109.547 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.03 -0.986 . . . . 58.909999999999997 109.502 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.518 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.374 -0.602 . . . . 64.909999999999997 109.374 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.908 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.7 mt 57.8 77.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.763 -1.199 . . . . 33.799999999999997 107.763 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -73.15 157.35 37.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.791 . . . . 32.719999999999999 110.737 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.869 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -164.94 159.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.082 -0.71 . . . . 14.460000000000001 109.082 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 5.1 mt-10 -136.24 113.55 10.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.534 -0.729 . . . . 22.120000000000001 109.384 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.696 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -72.26 107.45 3.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.918 -1.142 . . . . 14.23 107.918 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.617 ' HD3' ' CD1' ' B' ' 34' ' ' TYR . 4.4 mptt -50.29 172.66 0.11 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.148 -0.97 . . . . 25.43 109.959 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -75.98 -29.53 6.66 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.618 2.212 . . . . 13.609999999999999 109.925 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.5 m -92.65 7.1 44.88 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.031 -0.729 . . . . 15.52 109.031 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.0 mm-40 -123.61 29.25 6.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 17.309999999999999 109.685 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.13 16.15 17.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.994 . . . . 24.780000000000001 110.057 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.573 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 54.6 mt-30 -141.78 145.22 34.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 47.899999999999999 109.954 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.761 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 42.4 p90 -96.05 153.64 17.67 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.378 -0.826 . . . . 21.609999999999999 109.451 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 38.5 p -121.55 168.72 11.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.437 -0.79 . . . . 14.890000000000001 109.274 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.54 113.47 26.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.447 -0.783 . . . . 17.350000000000001 109.101 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.476 ' HB2' ' OE1' ' B' ' 30' ' ' GLU . 24.7 mtt180 -141.44 154.94 45.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.256 -0.903 . . . . 34.380000000000003 109.539 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.423 ' C ' ' O ' ' B' ' 16' ' ' ARG . 27.0 p -42.6 133.54 3.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.46 -0.775 . . . . 38.770000000000003 109.735 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -131.88 157.9 22.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.32 -1.512 . . . . 34.579999999999998 109.32 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.459 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -135.34 117.89 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.111 -1.229 . . . . 41.869999999999997 109.43 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 7.4 p -63.99 -146.31 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.316 -0.865 . . . . 47.210000000000001 109.16 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.481 ' O ' ' CB ' ' B' ' 22' ' ' GLN . 6.5 mtp180 -53.28 -46.73 69.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.119 -0.988 . . . . 71.560000000000002 109.199 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' B' ' 21' ' ' ARG . 2.8 pt20 164.82 46.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.442 -0.786 . . . . 66.599999999999994 109.478 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.11 -60.38 0.42 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.464 -1.454 . . . . 55.490000000000002 109.464 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.48 160.58 50.76 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.222 -1.164 . . . . 44.990000000000002 109.323 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.7 Cg_endo -77.25 80.53 2.87 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.707 2.271 . . . . 44.100000000000001 110.864 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.597 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 4.9 p90 -68.74 138.93 55.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.232 -0.918 . . . . 32.090000000000003 109.689 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.61 80.68 1.82 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.968 . . . . 29.25 108.656 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.586 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -104.75 164.06 12.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.237 -0.915 . . . . 24.0 110.167 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.585 ' CB ' ' HB3' ' B' ' 49' ' ' LEU . 4.7 m120 -53.69 160.81 1.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 23.309999999999999 109.798 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.476 ' OE1' ' HB2' ' B' ' 16' ' ' ARG . 7.6 mt-10 -150.16 125.17 9.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.431 -0.951 . . . . 40.030000000000001 108.431 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.955 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -113.4 -179.14 3.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 12.390000000000001 110.382 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.93 ' HB3' HD11 ' B' ' 44' ' ' LEU . 81.2 mt -137.45 147.88 45.67 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.841 -0.8 . . . . 17.420000000000002 108.841 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.946 ' SG ' HD13 ' B' ' 47' ' ' ILE . 2.9 m -152.08 -177.63 6.28 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.769 -1.197 . . . . 13.84 107.769 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.668 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 31.6 m-85 -127.85 112.4 14.68 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.065 -1.022 . . . . 21.140000000000001 109.678 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.869 HG22 ' HB ' ' B' ' 4' ' ' VAL . 61.2 t -106.89 110.17 30.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.349 -0.94 . . . . 10.66 109.688 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' B' ' 38' ' ' GLY . 2.4 p30 -57.91 -39.33 77.68 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.997 -1.483 . . . . 25.890000000000001 106.997 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.721 HD23 ' N ' ' B' ' 38' ' ' GLY . 7.4 tt 62.87 -70.66 0.06 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.844 0.831 . . . . 24.239999999999998 109.046 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.721 ' N ' HD23 ' B' ' 37' ' ' LEU . . . -178.47 41.28 0.09 OUTLIER Glycine 0 C--N 1.293 -1.813 0 N-CA-C 108.554 -1.818 . . . . 31.02 108.554 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -124.17 23.72 8.33 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.281 -1.129 . . . . 43.229999999999997 110.474 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.57 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 14.1 mt-10 50.82 19.15 0.58 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.247 -0.908 . . . . 42.340000000000003 110.703 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 98.6 m-70 -160.06 154.89 20.92 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.274 -1.01 . . . . 6.9900000000000002 108.274 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.668 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 37.5 Cg_endo -76.51 134.47 15.4 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.88 1.72 . . . . 17.920000000000002 110.521 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.804 HG23 HG23 ' B' ' 45' ' ' VAL . 3.1 m -109.09 116.59 52.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 119.424 -0.91 . . . . 20.57 108.808 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.93 HD11 ' HB3' ' B' ' 32' ' ' LEU . 65.4 tp -67.48 101.83 1.04 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.457 -0.897 . . . . 20.210000000000001 109.358 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.804 HG23 HG23 ' B' ' 43' ' ' VAL . 38.0 t -103.92 167.01 2.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.602 -0.686 . . . . 10.81 109.369 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.756 ' HA ' HD23 ' B' ' 32' ' ' LEU . 24.4 ttmt -98.79 148.23 24.1 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.198 -0.939 . . . . 36.740000000000002 110.165 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.946 HD13 ' SG ' ' B' ' 33' ' ' CYS . 0.0 OUTLIER -127.47 163.09 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.383 -0.823 . . . . 19.739999999999998 108.95 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.4 ' N ' HG23 ' B' ' 47' ' ' ILE . 15.3 m -111.6 135.57 52.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.274 -0.891 . . . . 22.559999999999999 109.101 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.617 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -112.2 151.42 29.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 20.41 109.373 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.48 -174.69 4.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 33.990000000000002 109.751 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.53 104.46 16.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 54.920000000000002 109.528 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.19 -8.09 57.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.612 -1.395 . . . . 36.100000000000001 109.612 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.434 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.3 OUTLIER -78.63 143.72 63.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 54.759999999999998 109.567 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.7 Cg_endo -79.25 111.04 2.82 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.616 2.211 . . . . 28.370000000000001 110.432 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.955 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.35 160.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 17.210000000000001 110.031 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.66 ' CE2' HG12 ' B' ' 47' ' ' ILE . 11.7 m-30 -54.87 110.78 0.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 17.190000000000001 109.286 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.932 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -59.96 176.25 0.34 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 17.82 109.494 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.932 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 36.0 Cg_endo -78.79 115.83 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.713 2.276 . . . . 17.280000000000001 110.439 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.8 -179.79 43.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.833 -1.307 . . . . 17.219999999999999 109.833 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.718 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -75.37 146.55 40.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -1.103 . . . . 19.57 108.467 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.696 ' CE1' HD13 ' B' ' 6' ' ' ILE . 22.8 m-85 -132.49 162.99 29.81 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.759 -1.213 . . . . 14.609999999999999 111.92 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.566 ' O ' HG22 ' B' ' 84' ' ' VAL . 59.9 p -145.44 119.85 9.65 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.691 -1.596 . . . . 18.359999999999999 106.691 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.926 ' CG1' HD12 ' B' ' 81' ' ' LEU . 11.5 t -47.78 169.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.1 -1.04 . . . . 19.129999999999999 109.267 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.58 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.7 t-80 -134.77 122.06 21.58 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.943 -0.762 . . . . 20.649999999999999 108.943 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.955 HD22 ' H ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -65.85 -9.28 27.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.444 -0.785 . . . . 19.649999999999999 109.254 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 86.4 p -53.85 -16.82 1.97 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.13 -0.981 . . . . 14.720000000000001 108.919 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -104.33 -7.09 20.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 11.449999999999999 111.13 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.0 m-30 -74.25 162.57 28.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.651 -1.281 . . . . 14.25 109.54 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.754 ' CA ' HD11 ' A' ' 37' ' ' LEU . 25.2 mtmt -148.5 173.99 12.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 32.700000000000003 109.38 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.536 HG22 HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -114.6 109.86 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.875 . . . . 15.630000000000001 109.029 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.17 -179.45 44.15 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.587 -1.405 . . . . 12.699999999999999 109.587 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.443 ' O ' ' NE2' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -88.44 39.23 0.9 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.17 -1.194 . . . . 26.289999999999999 109.42 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -112.13 11.64 20.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 20.440000000000001 109.251 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 46' ' ' LYS . . . 63.55 27.28 70.68 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.333 -1.507 . . . . 13.82 109.333 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -154.96 155.54 34.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -1.141 . . . . 18.27 109.545 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.515 ' CD2' HG21 ' A' ' 2' ' ' ILE . 1.7 tp -67.34 173.59 3.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 12.43 109.553 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.431 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 2.8 mtt -159.53 101.69 1.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 35.109999999999999 109.551 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.595 ' CG2' ' N ' ' B' ' 81' ' ' LEU . 2.7 mt -41.88 -43.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.546 -0.721 . . . . 13.67 110.037 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.4 OUTLIER 48.66 54.32 10.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.307 -0.871 . . . . 24.059999999999999 108.985 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.546 ' CB ' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 82.18 80.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.065 -0.717 . . . . 35.039999999999999 109.065 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.926 HD12 ' CG1' ' B' ' 63' ' ' VAL . 1.3 pt? -58.69 154.03 15.4 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.472 0.653 . . . . 18.719999999999999 110.757 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.561 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -104.87 106.18 16.55 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.636 -1.246 . . . . 20.550000000000001 107.636 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.3 OUTLIER -81.5 144.45 31.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.017 -1.052 . . . . 14.4 111.475 -178.062 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.566 HG22 ' O ' ' B' ' 62' ' ' THR . 35.5 m -144.41 160.47 48.21 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 107.518 -1.289 . . . . 17.649999999999999 107.518 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.3 Cg_endo -62.17 148.02 93.98 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.07 1.847 . . . . 25.699999999999999 110.657 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -77.84 124.24 27.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.243 -0.91 . . . . 49.289999999999999 109.511 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.026 -0.988 . . . . 58.909999999999997 109.527 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.784 ' SD ' HG21 ' A' ' 62' ' ' THR . 30.9 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.495 -0.557 . . . . 64.909999999999997 109.495 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.842 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.8 mt -65.23 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.582 -1.266 . . . . 33.799999999999997 107.582 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -67.01 155.36 38.85 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.964 0.887 . . . . 32.719999999999999 111.461 -177.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.986 HG11 HD21 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -163.37 168.89 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.14 -1.059 . . . . 14.460000000000001 108.14 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.0 OUTLIER -146.28 107.54 4.21 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.105 -0.997 . . . . 22.120000000000001 109.275 -178.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.612 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -66.2 103.92 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.696 -1.224 . . . . 14.23 107.696 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.582 ' HE2' ' CE2' ' A' ' 34' ' ' TYR . 8.2 mmmt -43.61 162.26 0.19 Allowed Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.159 -0.963 . . . . 25.43 109.489 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.42 -11.96 26.93 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.945 1.763 . . . . 13.609999999999999 109.155 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.3 t -102.14 7.73 40.9 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.735 -0.839 . . . . 15.52 108.735 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.524 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 9.4 mm-40 -126.71 37.23 4.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.889 . . . . 17.309999999999999 109.247 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.64 15.95 23.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.118 -0.989 . . . . 24.780000000000001 110.165 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -136.62 143.73 43.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.116 -0.99 . . . . 47.899999999999999 108.81 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 31.6 p90 -94.0 162.63 13.81 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.121 -0.987 . . . . 21.609999999999999 109.116 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -143.71 147.17 33.85 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.256 -0.902 . . . . 14.890000000000001 109.407 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.26 110.82 22.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.348 -0.845 . . . . 17.350000000000001 109.078 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.8 90.85 0.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.194 -0.941 . . . . 34.380000000000003 109.715 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.07 161.85 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 38.770000000000003 109.861 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 26' ' ' TYR . . . 170.01 148.9 6.09 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.855 -1.698 . . . . 34.579999999999998 108.855 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.454 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -133.53 126.32 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.031 -1.276 . . . . 41.869999999999997 109.214 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 4.2 p -68.03 -32.1 72.23 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.204 -0.935 . . . . 47.210000000000001 108.759 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' O ' ' CG ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER 170.89 -60.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.051 -0.722 . . . . 71.560000000000002 109.051 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.542 ' CG ' ' O ' ' A' ' 21' ' ' ARG . 39.6 mt-30 -162.27 31.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.545 -0.722 . . . . 66.599999999999994 109.733 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -110.68 -57.11 0.5 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.548 -1.421 . . . . 55.490000000000002 109.548 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 23' ' ' GLY . 24.2 mttt -159.26 156.68 26.34 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.352 -1.087 . . . . 44.990000000000002 109.168 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.0 Cg_endo -76.83 73.87 5.15 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.559 2.173 . . . . 44.100000000000001 110.494 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.584 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 2.5 p90 -62.36 137.21 58.22 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.43 -0.793 . . . . 32.090000000000003 109.844 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.5 80.71 1.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 29.25 108.813 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -110.53 161.97 15.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 24.0 110.336 -179.183 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 95.9 m-20 -50.27 115.84 1.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.522 -0.736 . . . . 23.309999999999999 109.93 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -115.52 150.23 36.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.944 . . . . 40.030000000000001 109.019 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.568 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -125.81 -171.45 2.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.04 -1.037 . . . . 12.390000000000001 109.86 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.925 ' HB3' HD11 ' A' ' 44' ' ' LEU . 30.1 mt -128.12 176.96 7.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.482 -0.761 . . . . 17.420000000000002 109.396 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -171.39 158.02 5.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.143 -0.973 . . . . 13.84 108.438 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.745 ' HE1' HD13 ' A' ' 44' ' ' LEU . 2.9 m-30 -113.99 102.64 10.38 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.078 -1.014 . . . . 21.140000000000001 108.542 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.976 ' O ' HG22 ' A' ' 43' ' ' VAL . 38.5 t -102.41 106.74 20.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.094 -1.004 . . . . 10.66 110.273 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -61.41 -39.01 89.16 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.259 -1.386 . . . . 25.890000000000001 107.259 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.861 HD23 ' N ' ' A' ' 38' ' ' GLY . 6.9 tt 63.18 -69.36 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.675 0.75 . . . . 24.239999999999998 109.381 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.861 ' N ' HD23 ' A' ' 37' ' ' LEU . . . -178.49 42.94 0.09 OUTLIER Glycine 0 C--N 1.296 -1.674 0 N-CA-C 108.803 -1.719 . . . . 31.02 108.803 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -124.83 27.66 6.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.284 -1.127 . . . . 43.229999999999997 110.205 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.583 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 1.9 mm-40 48.67 21.2 0.39 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.17 -0.957 . . . . 42.340000000000003 110.239 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 59.4 m80 -164.57 151.39 9.72 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.196 -1.038 . . . . 6.5700000000000003 108.196 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.2 Cg_endo -76.48 144.06 25.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.08 1.853 . . . . 17.920000000000002 110.955 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.976 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.0 m -117.92 118.89 59.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.476 -0.89 . . . . 20.57 109.14 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.925 HD11 ' HB3' ' A' ' 32' ' ' LEU . 23.5 tp -68.69 110.49 4.31 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.944 -0.702 . . . . 20.210000000000001 109.155 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 16.3 t -117.02 167.38 10.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.513 -0.742 . . . . 10.81 109.497 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.567 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -90.74 162.3 14.94 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.659 -0.817 . . . . 36.740000000000002 110.216 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.054 HD13 HD12 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -152.12 161.44 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.759 -0.83 . . . . 19.739999999999998 108.759 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.67 151.83 20.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.0 -1.062 . . . . 22.559999999999999 109.762 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.716 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.7 tm? -134.22 93.62 3.1 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.434 -0.791 . . . . 20.41 108.991 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.721 ' HB3' HD22 ' A' ' 28' ' ' LEU . 2.2 p30 -154.59 174.94 14.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.934 -1.104 . . . . 33.990000000000002 110.117 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' GLN . 10.4 tt0 73.21 72.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.501 -0.749 . . . . 54.920000000000002 109.807 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 51' ' ' GLU . . . 36.45 30.06 0.03 OUTLIER Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.236 -1.146 . . . . 36.100000000000001 110.236 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.645 ' O ' HD21 ' A' ' 49' ' ' LEU . 2.4 mt-30 -107.31 131.0 22.04 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.07 -1.253 . . . . 54.759999999999998 110.061 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.3 Cg_endo -80.1 142.1 15.13 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.463 2.108 . . . . 28.370000000000001 110.004 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.701 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -41.61 141.45 0.77 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 17.210000000000001 110.015 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 84.5 m-85 -47.2 98.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 17.190000000000001 109.146 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -49.42 175.36 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 17.82 109.743 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -77.89 118.32 4.42 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.73 2.286 . . . . 17.280000000000001 110.369 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.87 171.4 34.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.473 -1.451 . . . . 17.219999999999999 109.473 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.2 mp -72.08 147.6 46.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.198 -1.177 . . . . 19.57 108.924 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.912 ' HB3' HD22 ' A' ' 83' ' ' LEU . 30.7 m-85 -132.04 163.24 28.87 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.579 1.181 . . . . 14.609999999999999 111.424 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.867 ' O ' HG22 ' A' ' 84' ' ' VAL . 20.6 p -142.17 119.35 11.43 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.616 -1.994 . . . . 18.359999999999999 105.616 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.5 t -52.42 167.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 C-N-CA 118.615 -1.234 . . . . 19.129999999999999 109.198 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.498 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.1 t-80 -129.61 128.75 43.3 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.546 -0.721 . . . . 20.649999999999999 109.123 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.855 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -70.88 -0.94 10.23 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.401 -0.812 . . . . 19.649999999999999 109.679 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 p -56.6 -19.18 14.77 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.541 -1.281 . . . . 14.720000000000001 107.541 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 39.6 m -97.02 -6.97 34.1 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.831 -0.543 . . . . 11.449999999999999 110.05 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.817 ' C ' HD11 ' B' ' 37' ' ' LEU . 3.3 m-30 -79.7 157.29 27.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 14.25 109.689 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -140.15 169.9 16.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.834 . . . . 32.700000000000003 109.488 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.778 HG21 HG21 ' B' ' 43' ' ' VAL . 2.2 t -110.08 139.52 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.912 . . . . 15.630000000000001 109.425 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.57 -157.55 23.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.341 -1.504 . . . . 12.699999999999999 109.341 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 0.0 OUTLIER 63.03 78.34 0.3 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.159 -1.2 . . . . 26.289999999999999 109.122 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.5 OUTLIER 69.48 9.39 7.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.433 -0.792 . . . . 20.440000000000001 109.472 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' O ' HG13 ' B' ' 45' ' ' VAL . . . 80.24 46.03 7.79 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.608 -1.397 . . . . 13.82 109.608 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.412 ' HA ' HG13 ' B' ' 45' ' ' VAL . 1.5 t -146.51 140.15 25.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -1.183 . . . . 18.27 109.577 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 77' ' ' MET . 1.4 tp -55.74 156.17 5.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 12.43 109.338 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 15.2 mtt -164.25 130.33 2.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 35.109999999999999 109.64 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.908 HD12 HD12 ' B' ' 78' ' ' ILE . 2.5 mp -63.72 138.49 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 13.67 109.77 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.62 -23.62 12.39 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.379 -0.971 . . . . 24.059999999999999 108.379 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 67' ' ' SER . 1.0 OUTLIER 178.44 68.04 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.03 -1.47 . . . . 35.039999999999999 107.03 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -29.05 119.68 0.13 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.274 -0.875 . . . . 18.719999999999999 111.685 -177.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -88.6 100.44 13.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 20.550000000000001 108.783 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.054 HD12 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -69.75 141.06 53.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 14.4 110.638 -179.153 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 62' ' ' THR . 27.8 m -143.22 153.5 59.83 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.71 -1.219 . . . . 17.649999999999999 107.71 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.2 Cg_endo -61.44 141.77 93.23 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.945 1.763 . . . . 25.699999999999999 110.317 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.596 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -77.95 117.78 19.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.266 -0.896 . . . . 49.289999999999999 109.682 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.993 -1.003 . . . . 58.909999999999997 109.455 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.788 ' SD ' HG21 ' B' ' 62' ' ' THR . 31.1 ttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.519 -0.548 . . . . 64.909999999999997 109.519 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.855 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.8 mt -65.28 81.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.572 -1.27 . . . . 33.799999999999997 107.572 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -67.2 155.32 39.1 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.981 0.895 . . . . 32.719999999999999 111.43 -177.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.978 HG11 HD21 ' B' ' 83' ' ' LEU . 0.1 OUTLIER -163.34 168.92 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.133 -1.062 . . . . 14.460000000000001 108.133 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 1.0 OUTLIER -146.3 107.55 4.21 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.104 -0.997 . . . . 22.120000000000001 109.258 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.606 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -66.22 104.02 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.718 -1.216 . . . . 14.23 107.718 179.024 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.586 ' HE2' ' CE2' ' B' ' 34' ' ' TYR . 8.2 mmmt -43.68 162.26 0.19 Allowed Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.147 -0.971 . . . . 25.43 109.479 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.7 Cg_endo -72.38 -12.08 27.1 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.984 1.789 . . . . 13.609999999999999 109.115 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 44.6 t -102.03 7.58 41.18 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.753 -0.832 . . . . 15.52 108.753 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.515 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 9.4 mm-40 -126.5 37.32 4.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.288 -0.882 . . . . 17.309999999999999 109.254 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.75 15.8 24.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 24.780000000000001 110.168 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.39 143.79 44.19 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.074 -1.016 . . . . 47.899999999999999 108.82 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.702 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 31.6 p90 -94.03 162.6 13.82 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.1 -1.0 . . . . 21.609999999999999 109.098 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -143.61 147.33 34.2 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.288 -0.883 . . . . 14.890000000000001 109.362 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.48 110.82 22.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.367 -0.833 . . . . 17.350000000000001 109.08 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.78 90.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 34.380000000000003 109.679 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.0 161.8 0.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.843 . . . . 38.770000000000003 109.851 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.549 ' CA ' ' O ' ' B' ' 26' ' ' TYR . . . 170.04 148.82 6.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.765 -1.734 . . . . 34.579999999999998 108.765 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.447 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.0 OUTLIER -133.43 126.39 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.048 -1.266 . . . . 41.869999999999997 109.181 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' B' ' 21' ' ' ARG . 4.2 p -68.15 -31.87 71.74 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.189 -0.944 . . . . 47.210000000000001 108.819 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER 170.79 -60.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.064 -0.717 . . . . 71.560000000000002 109.064 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.554 ' CG ' ' O ' ' B' ' 21' ' ' ARG . 39.7 mt-30 -162.35 31.39 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 66.599999999999994 109.763 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' B' ' 24' ' ' LYS . . . -110.63 -57.17 0.5 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.567 -1.413 . . . . 55.490000000000002 109.567 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' B' ' 23' ' ' GLY . 24.5 mttt -159.25 156.68 26.37 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.292 -1.123 . . . . 44.990000000000002 109.146 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.1 Cg_endo -76.8 73.84 5.15 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.535 2.157 . . . . 44.100000000000001 110.51 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 2.5 p90 -62.36 137.2 58.21 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.452 -0.78 . . . . 32.090000000000003 109.838 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.53 80.84 1.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.107 -0.996 . . . . 29.25 108.778 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.714 HD22 ' HB3' ' B' ' 50' ' ' ASP . 0.1 OUTLIER -110.61 161.98 15.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 24.0 110.312 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.622 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 95.8 m-20 -50.31 115.95 1.67 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 23.309999999999999 109.854 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -115.6 150.34 36.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.158 -0.964 . . . . 40.030000000000001 108.98 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.578 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -125.92 -171.55 2.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.013 -1.055 . . . . 12.390000000000001 109.836 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.893 ' HB3' HD11 ' B' ' 44' ' ' LEU . 30.0 mt -128.06 176.93 7.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.461 -0.774 . . . . 17.420000000000002 109.442 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -171.31 158.09 5.23 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.093 -1.004 . . . . 13.84 108.487 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.761 ' HE1' HD13 ' B' ' 44' ' ' LEU . 2.9 m-30 -114.06 102.53 10.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.148 -0.97 . . . . 21.140000000000001 108.592 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.962 ' O ' HG22 ' B' ' 43' ' ' VAL . 38.4 t -102.34 106.67 20.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.147 -1.021 . . . . 10.66 110.309 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 0.9 OUTLIER -61.17 -39.1 88.86 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.307 -1.368 . . . . 25.890000000000001 107.307 178.544 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.853 HD23 ' N ' ' B' ' 38' ' ' GLY . 6.9 tt 63.33 -69.39 0.07 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.695 0.76 . . . . 24.239999999999998 109.313 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.853 ' N ' HD23 ' B' ' 37' ' ' LEU . . . -178.52 42.97 0.09 OUTLIER Glycine 0 C--N 1.295 -1.742 0 N-CA-C 108.773 -1.731 . . . . 31.02 108.773 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -124.85 27.65 6.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.246 -1.149 . . . . 43.229999999999997 110.234 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.574 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 1.9 mm-40 48.7 21.16 0.39 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.23 -0.919 . . . . 42.340000000000003 110.25 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 59.4 m80 -164.57 151.3 9.66 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 108.2 -1.037 . . . . 6.5599999999999996 108.2 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.638 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.6 Cg_endo -76.33 143.98 25.56 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.137 1.891 . . . . 17.920000000000002 111.011 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.962 HG22 ' O ' ' B' ' 35' ' ' VAL . 5.0 m -117.87 118.8 59.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.451 -0.9 . . . . 20.57 109.098 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.893 HD11 ' HB3' ' B' ' 32' ' ' LEU . 23.4 tp -68.67 110.55 4.33 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.898 -0.721 . . . . 20.210000000000001 109.218 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.575 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 16.8 t -116.95 167.42 10.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.511 -0.743 . . . . 10.81 109.529 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -90.75 162.24 14.97 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.674 -0.81 . . . . 36.740000000000002 110.206 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 1.037 HD13 HD12 ' B' ' 83' ' ' LEU . 0.5 OUTLIER -152.06 161.5 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.706 -0.85 . . . . 19.739999999999998 108.706 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.71 151.69 20.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.969 -1.082 . . . . 22.559999999999999 109.787 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.717 HD13 ' O ' ' B' ' 49' ' ' LEU . 2.7 tm? -134.05 93.58 3.12 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.373 -0.829 . . . . 20.41 109.003 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.714 ' HB3' HD22 ' B' ' 28' ' ' LEU . 2.2 p30 -154.63 174.74 14.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.956 -1.09 . . . . 33.990000000000002 110.152 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' B' ' 53' ' ' GLN . 10.4 tt0 73.25 73.05 0.13 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 54.920000000000002 109.814 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' B' ' 51' ' ' GLU . . . 36.37 30.02 0.03 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.273 -1.131 . . . . 36.100000000000001 110.273 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.651 ' O ' HD21 ' B' ' 49' ' ' LEU . 2.4 mt-30 -107.2 130.84 22.27 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.094 -1.239 . . . . 54.759999999999998 110.084 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 36.2 Cg_endo -79.95 141.97 15.33 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.525 2.15 . . . . 28.370000000000001 109.986 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.702 ' HB2' ' CD2' ' B' ' 13' ' ' PHE . . . -41.46 141.39 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 17.210000000000001 110.031 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 83.5 m-85 -47.03 97.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.327 -0.858 . . . . 17.190000000000001 109.11 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.948 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -49.15 175.46 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 17.82 109.804 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.948 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.1 Cg_endo -77.85 117.59 4.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.651 2.234 . . . . 17.280000000000001 110.176 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.35 171.11 35.45 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.542 -1.423 . . . . 17.219999999999999 109.542 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.0 mp -72.3 147.14 46.65 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.172 -1.193 . . . . 19.57 108.711 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.93 ' HB3' HD22 ' B' ' 83' ' ' LEU . 30.6 m-85 -131.65 163.11 28.83 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 122.564 1.173 . . . . 14.609999999999999 111.446 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.85 ' O ' HG22 ' B' ' 84' ' ' VAL . 20.7 p -142.01 119.28 11.47 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 105.627 -1.99 . . . . 18.359999999999999 105.627 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.5 t -52.54 166.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 C-N-CA 118.559 -1.256 . . . . 19.129999999999999 109.208 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.488 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.1 t-80 -129.32 128.66 43.61 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.568 -0.707 . . . . 20.649999999999999 109.228 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.842 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -70.69 -1.04 10.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.457 -0.777 . . . . 19.649999999999999 109.71 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 p -56.59 -19.23 14.98 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.541 -1.281 . . . . 14.720000000000001 107.541 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 38.2 m -96.9 -7.38 33.47 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.853 -0.529 . . . . 11.449999999999999 110.131 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.822 ' C ' HD11 ' A' ' 37' ' ' LEU . 3.2 m-30 -79.32 157.06 27.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.065 -1.022 . . . . 14.25 109.642 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' B' ' 77' ' ' MET . 0.0 OUTLIER -139.96 169.68 17.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 32.700000000000003 109.484 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.751 HG21 HG21 ' A' ' 43' ' ' VAL . 2.2 t -109.88 139.57 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 15.630000000000001 109.42 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 75' ' ' SER . . . 136.59 -157.63 23.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.261 -1.536 . . . . 12.699999999999999 109.261 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.0 OUTLIER 63.08 78.32 0.3 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.188 -1.183 . . . . 26.289999999999999 109.108 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.5 OUTLIER 69.51 9.4 7.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.455 -0.778 . . . . 20.440000000000001 109.401 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 80.26 45.78 7.93 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.639 -1.384 . . . . 13.82 109.639 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.414 ' HA ' HG13 ' A' ' 45' ' ' VAL . 1.5 t -146.24 140.11 26.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -1.163 . . . . 18.27 109.603 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.525 ' O ' ' CG ' ' B' ' 77' ' ' MET . 1.4 tp -55.69 156.23 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 12.43 109.338 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.525 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 15.2 mtt -164.33 130.53 2.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 35.109999999999999 109.618 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.908 HD12 HD12 ' A' ' 78' ' ' ILE . 2.5 mp -63.97 138.57 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -0.854 . . . . 13.67 109.841 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.6 -23.76 12.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.334 -0.988 . . . . 24.059999999999999 108.334 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.9 OUTLIER 178.55 68.07 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.062 -1.459 . . . . 35.039999999999999 107.062 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.659 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.7 OUTLIER -29.15 119.66 0.13 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.297 -0.865 . . . . 18.719999999999999 111.659 -177.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -88.52 100.25 12.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.348 -0.845 . . . . 20.550000000000001 108.849 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.037 HD12 HD13 ' B' ' 47' ' ' ILE . 0.9 OUTLIER -69.74 140.93 53.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 14.4 110.626 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.85 HG22 ' O ' ' B' ' 62' ' ' THR . 27.3 m -143.08 153.33 60.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 107.756 -1.201 . . . . 17.649999999999999 107.756 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.3 Cg_endo -61.23 141.7 94.05 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.911 1.741 . . . . 25.699999999999999 110.39 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.584 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -77.89 117.81 19.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.335 -0.853 . . . . 49.289999999999999 109.687 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.04 -0.981 . . . . 58.909999999999997 109.417 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.513 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.274 0.559 . . . . 64.909999999999997 109.496 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.757 ' CA ' HD22 ' B' ' 65' ' ' LEU . 3.3 mt 70.12 78.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 107.459 -1.312 . . . . 33.799999999999997 107.459 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.521 ' C ' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -62.01 159.7 13.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.96 0.886 . . . . 32.719999999999999 111.666 -177.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.084 ' CG2' HG22 ' A' ' 35' ' ' VAL . 82.4 t -160.68 168.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.985 -0.746 . . . . 14.460000000000001 108.985 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.597 ' N ' HG12 ' A' ' 4' ' ' VAL . 30.9 mt-10 -153.29 99.7 2.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 22.120000000000001 109.463 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.995 HG21 ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -70.32 102.77 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.822 -1.177 . . . . 14.23 107.822 179.206 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 3.5 mmpt? -57.64 163.59 3.68 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 25.43 109.308 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.5 -11.94 26.75 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.98 1.787 . . . . 13.609999999999999 109.206 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -102.69 13.3 34.78 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.301 -1.0 . . . . 15.52 108.301 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.537 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 5.6 mm-40 -142.86 36.33 1.42 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.452 -0.78 . . . . 17.309999999999999 109.41 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -112.78 35.3 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.092 -1.005 . . . . 24.780000000000001 110.234 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -140.74 125.19 17.73 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.169 -0.957 . . . . 47.899999999999999 109.67 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.643 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 40.4 p90 -89.74 156.66 18.38 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.293 -0.879 . . . . 21.609999999999999 109.82 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -131.5 161.85 31.6 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.326 -0.99 . . . . 14.890000000000001 108.326 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.54 HG22 ' HB3' ' A' ' 27' ' ' SER . 0.2 OUTLIER -78.61 109.38 12.76 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.093 -1.004 . . . . 17.350000000000001 109.095 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -120.09 148.3 43.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.277 -0.89 . . . . 34.380000000000003 109.455 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 t -51.65 153.05 2.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -0.861 . . . . 38.770000000000003 109.505 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -155.45 -179.9 30.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.271 -1.531 . . . . 34.579999999999998 109.271 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -153.67 117.77 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -1.229 . . . . 41.869999999999997 109.2 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 22' ' ' GLN . 54.3 p -57.17 83.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.344 -0.847 . . . . 47.210000000000001 109.812 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER 67.79 -59.82 0.41 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.163 -0.96 . . . . 71.560000000000002 109.728 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' SER . 11.9 pt20 170.97 47.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 66.599999999999994 109.604 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.32 -55.59 0.1 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.408 -1.477 . . . . 55.490000000000002 109.408 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -135.78 150.72 72.54 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.368 -1.078 . . . . 44.990000000000002 109.259 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 35.1 Cg_endo -77.9 131.48 11.14 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.615 2.21 . . . . 44.100000000000001 110.638 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 5.5 p90 -133.09 143.28 49.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.2 -0.938 . . . . 32.090000000000003 109.749 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.54 ' HB3' HG22 ' A' ' 15' ' ' THR . 0.2 OUTLIER -102.93 81.09 1.95 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -0.888 . . . . 29.25 108.846 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -93.1 134.66 35.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.858 . . . . 24.0 110.29 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -45.77 133.97 7.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.54 -0.725 . . . . 23.309999999999999 110.082 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 35.5 mt-10 -128.53 151.69 49.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.384 -0.822 . . . . 40.030000000000001 108.816 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.927 ' OE1' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -135.62 -170.43 2.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.978 -1.076 . . . . 12.390000000000001 110.294 -179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.836 ' HB3' HD11 ' A' ' 44' ' ' LEU . 11.0 mt -126.65 173.2 9.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.733 -0.84 . . . . 17.420000000000002 108.733 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.546 ' SG ' HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -167.95 160.68 12.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.792 -1.192 . . . . 13.84 108.162 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.69 ' CE1' HD13 ' A' ' 44' ' ' LEU . 3.2 m-85 -107.59 92.17 3.96 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.136 -0.978 . . . . 21.140000000000001 109.478 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.084 HG22 ' CG2' ' A' ' 4' ' ' VAL . 37.5 t -94.59 121.74 45.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.281 -0.887 . . . . 10.66 110.17 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.746 ' C ' HD23 ' A' ' 37' ' ' LEU . 1.9 m-20 -73.35 -36.62 66.17 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.212 -1.033 . . . . 25.890000000000001 108.212 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.746 HD23 ' C ' ' A' ' 36' ' ' ASP . 1.0 OUTLIER 39.19 28.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.779 -0.575 . . . . 24.239999999999998 110.073 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 67.75 25.98 73.94 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.782 -1.327 . . . . 31.02 109.782 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 36' ' ' ASP . 1.1 t-20 -96.21 15.4 21.06 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.192 -1.181 . . . . 43.229999999999997 110.655 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 41' ' ' HIS . 1.7 mt-10 68.5 94.03 0.07 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.023 -1.048 . . . . 42.340000000000003 108.601 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.626 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 10.6 m80 86.57 167.94 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.646 -0.872 . . . . 5.0999999999999996 108.646 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 41' ' ' HIS . 34.0 Cg_endo -77.71 150.26 27.34 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.09 1.86 . . . . 17.920000000000002 111.204 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.863 HG22 ' O ' ' A' ' 35' ' ' VAL . 2.2 m -122.48 120.44 61.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.368 -0.833 . . . . 20.57 109.171 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' A' ' 32' ' ' LEU . 16.6 tp -73.79 109.62 7.44 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.295 -0.878 . . . . 20.210000000000001 108.641 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 1.6 p -123.87 160.65 27.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.438 -0.789 . . . . 10.81 109.475 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HA ' HD23 ' A' ' 32' ' ' LEU . 4.6 ttmt -77.33 164.56 25.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 36.740000000000002 110.438 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.977 HD13 HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -149.66 172.59 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.906 -0.776 . . . . 19.739999999999998 108.906 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 m -108.65 146.87 32.74 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.161 -0.962 . . . . 22.559999999999999 109.312 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.643 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -118.01 145.94 44.4 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.237 -0.914 . . . . 20.41 108.61 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.454 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -82.38 140.14 33.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.061 -1.025 . . . . 33.990000000000002 109.82 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.28 106.73 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 54.920000000000002 109.346 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.95 -12.53 57.6 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.494 . . . . 36.100000000000001 109.364 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.454 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 2.4 mt-30 -81.9 147.22 57.7 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.29 -1.124 . . . . 54.759999999999998 109.344 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.8 Cg_endo -78.15 123.23 6.05 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.593 2.195 . . . . 28.370000000000001 110.537 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.927 ' HB1' ' OE1' ' A' ' 31' ' ' GLN . . . -37.94 143.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.633 -0.667 . . . . 17.210000000000001 110.142 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.995 ' O ' HG21 ' A' ' 6' ' ' ILE . 83.9 m-85 -41.49 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.481 -0.762 . . . . 17.190000000000001 109.326 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.695 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -43.04 165.41 0.11 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 17.82 109.577 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.695 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.1 Cg_endo -77.59 105.92 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.57 2.18 . . . . 17.280000000000001 110.484 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.54 -174.25 41.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.891 -1.284 . . . . 17.219999999999999 109.891 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -76.06 142.42 41.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -1.101 . . . . 19.57 108.396 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.71 ' HB3' HD22 ' A' ' 83' ' ' LEU . 15.9 m-85 -131.74 163.69 27.62 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.767 -1.208 . . . . 14.609999999999999 111.68 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 84' ' ' VAL . 50.8 p -145.72 120.18 9.68 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.698 -1.593 . . . . 18.359999999999999 106.698 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.615 ' CG1' HD12 ' A' ' 81' ' ' LEU . 3.8 t -50.68 171.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 118.708 -1.197 . . . . 19.129999999999999 108.885 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.603 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.8 t-80 -135.08 125.37 26.3 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.337 -0.852 . . . . 20.649999999999999 109.263 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.764 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -70.4 -2.84 14.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.457 -0.777 . . . . 19.649999999999999 109.697 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -17.01 14.71 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.023 -1.102 . . . . 14.720000000000001 108.023 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -101.73 -9.66 20.65 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.726 -0.609 . . . . 11.449999999999999 110.597 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -72.31 164.14 26.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.959 -1.088 . . . . 14.25 109.992 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' A' ' 77' ' ' MET . 2.8 ptmt -146.42 177.04 9.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.947 -0.76 . . . . 32.700000000000003 108.947 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.435 HG23 HG21 ' B' ' 45' ' ' VAL . 6.2 p -126.92 158.73 37.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.272 -0.892 . . . . 15.630000000000001 109.355 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.96 -140.16 11.61 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.367 -1.493 . . . . 12.699999999999999 109.367 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 28.6 tp60 57.23 60.56 2.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.111 -1.229 . . . . 26.289999999999999 109.373 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 73.29 2.34 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.494 -0.754 . . . . 20.440000000000001 109.469 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' B' ' 46' ' ' LYS . . . 103.9 54.79 0.8 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.962 -1.255 . . . . 13.82 109.962 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.3 t -151.27 147.36 26.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -1.2 . . . . 18.27 109.776 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.638 ' HB2' HD13 ' B' ' 81' ' ' LEU . 2.6 tp -59.41 165.11 2.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 12.43 109.189 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 12.1 mtp -165.23 104.54 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.972 . . . . 35.109999999999999 110.038 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.4 mt -42.26 -63.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.509 -0.744 . . . . 13.67 109.335 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 38.0 t0 84.9 -45.5 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.387 0.613 . . . . 24.059999999999999 110.134 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.573 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.0 tmm_? -171.44 67.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.039 0.923 . . . . 35.039999999999999 108.519 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -38.06 131.19 1.12 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.603 -0.726 . . . . 18.719999999999999 111.514 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -96.47 107.0 19.34 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.923 -1.14 . . . . 20.550000000000001 107.923 178.391 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.977 HD12 HD13 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -76.9 146.84 37.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.127 -0.983 . . . . 14.4 111.221 -178.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 62' ' ' THR . 16.3 m -147.63 156.8 45.1 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.93 -1.137 . . . . 17.649999999999999 107.93 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.9 Cg_endo -64.01 142.95 83.5 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.163 1.909 . . . . 25.699999999999999 110.419 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.705 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -72.23 115.1 11.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 49.289999999999999 109.484 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.043 -0.98 . . . . 58.909999999999997 109.48 -179.942 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.43 -0.581 . . . . 64.909999999999997 109.43 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.764 ' CA ' HD22 ' A' ' 65' ' ' LEU . 3.3 mt 70.26 78.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.475 -1.306 . . . . 33.799999999999997 107.475 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 0.0 OUTLIER -61.85 159.56 13.65 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.976 0.893 . . . . 32.719999999999999 111.656 -177.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.081 ' CG2' HG22 ' B' ' 35' ' ' VAL . 84.3 t -160.52 168.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.964 -0.754 . . . . 14.460000000000001 108.964 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.618 ' N ' HG12 ' B' ' 4' ' ' VAL . 31.0 mt-10 -153.3 99.75 2.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.299 -0.876 . . . . 22.120000000000001 109.502 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.99 HG21 ' O ' ' B' ' 56' ' ' TYR . 1.0 OUTLIER -70.41 102.75 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.756 -1.201 . . . . 14.23 107.756 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.587 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 3.5 mmpt? -57.57 163.44 3.71 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.276 -0.89 . . . . 25.43 109.322 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.6 Cg_endo -72.44 -11.84 26.81 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.931 1.754 . . . . 13.609999999999999 109.182 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -102.68 13.21 35.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 15.52 108.33 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.53 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 5.6 mm-40 -142.7 36.22 1.44 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.402 -0.811 . . . . 17.309999999999999 109.452 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -112.69 35.4 3.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.986 -1.071 . . . . 24.780000000000001 110.274 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -140.8 125.09 17.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.122 -0.986 . . . . 47.899999999999999 109.588 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.644 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 40.6 p90 -89.54 157.01 18.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.313 -0.867 . . . . 21.609999999999999 109.855 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.2 t -131.89 161.53 32.79 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.327 -0.99 . . . . 14.890000000000001 108.327 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.538 HG22 ' HB3' ' B' ' 27' ' ' SER . 0.2 OUTLIER -78.32 109.46 12.48 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.09 -1.006 . . . . 17.350000000000001 109.168 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -120.29 148.24 43.97 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.31 -0.868 . . . . 34.380000000000003 109.531 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.0 t -51.56 153.12 2.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 38.770000000000003 109.466 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -155.54 -179.82 30.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.164 -1.574 . . . . 34.579999999999998 109.164 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' B' ' 21' ' ' ARG . 0.7 OUTLIER -153.77 117.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.254 . . . . 41.869999999999997 109.201 179.519 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.492 ' O ' ' N ' ' B' ' 22' ' ' GLN . 53.8 p -57.3 83.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.849 . . . . 47.210000000000001 109.832 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER 67.69 -59.78 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.216 -0.927 . . . . 71.560000000000002 109.773 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' B' ' 20' ' ' SER . 11.9 pt20 170.9 48.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 66.599999999999994 109.615 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.44 -55.55 0.1 OUTLIER Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.4 -1.48 . . . . 55.490000000000002 109.4 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -135.84 150.7 72.38 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.281 -1.129 . . . . 44.990000000000002 109.223 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.8 Cg_endo -78.0 131.54 11.08 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.532 2.154 . . . . 44.100000000000001 110.602 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' B' ' 28' ' ' LEU . 5.4 p90 -133.01 143.36 49.37 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.926 . . . . 32.090000000000003 109.807 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.538 ' HB3' HG22 ' B' ' 15' ' ' THR . 0.2 OUTLIER -103.04 81.1 1.93 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 29.25 108.809 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.592 HD23 ' O ' ' B' ' 49' ' ' LEU . 0.2 OUTLIER -93.11 134.68 35.02 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.31 -0.869 . . . . 24.0 110.329 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.627 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -45.73 134.19 7.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.561 -0.712 . . . . 23.309999999999999 110.045 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 35.4 mt-10 -128.7 151.76 49.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.322 -0.861 . . . . 40.030000000000001 108.783 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.924 ' OE1' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -135.76 -170.55 2.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.948 -1.095 . . . . 12.390000000000001 110.223 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.845 ' HB3' HD11 ' B' ' 44' ' ' LEU . 11.0 mt -126.67 173.2 9.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.692 -0.855 . . . . 17.420000000000002 108.692 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.536 ' SG ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -168.0 160.58 12.18 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.782 -1.199 . . . . 13.84 108.136 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.688 ' CE1' HD13 ' B' ' 44' ' ' LEU . 3.2 m-85 -107.47 92.41 4.06 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.082 -1.011 . . . . 21.140000000000001 109.461 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 1.081 HG22 ' CG2' ' B' ' 4' ' ' VAL . 38.5 t -94.81 121.71 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.25 -0.906 . . . . 10.66 110.112 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.742 ' C ' HD23 ' B' ' 37' ' ' LEU . 1.9 m-20 -73.35 -36.45 66.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.215 -1.031 . . . . 25.890000000000001 108.215 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.742 HD23 ' C ' ' B' ' 36' ' ' ASP . 1.0 OUTLIER 39.09 28.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.731 -0.606 . . . . 24.239999999999998 109.979 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 67.61 26.22 73.76 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.79 -1.324 . . . . 31.02 109.79 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' B' ' 36' ' ' ASP . 1.1 t-20 -96.45 15.63 20.87 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.228 -1.16 . . . . 43.229999999999997 110.568 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' B' ' 41' ' ' HIS . 1.7 mt-10 68.38 93.89 0.07 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.026 -1.046 . . . . 42.340000000000003 108.652 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.629 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 10.5 m80 86.66 168.01 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.672 -0.862 . . . . 5.1100000000000003 108.672 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.632 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 34.1 Cg_endo -77.64 150.43 27.73 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.072 1.848 . . . . 17.920000000000002 111.18 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.891 HG22 ' O ' ' B' ' 35' ' ' VAL . 2.2 m -122.66 120.41 60.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.64 -0.824 . . . . 20.57 109.128 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.845 HD11 ' HB3' ' B' ' 32' ' ' LEU . 16.7 tp -73.74 109.71 7.46 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.447 -0.901 . . . . 20.210000000000001 108.65 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' B' ' 32' ' ' LEU . 1.7 p -123.87 160.71 27.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.382 -0.824 . . . . 10.81 109.466 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.485 ' HA ' HD23 ' B' ' 32' ' ' LEU . 4.6 ttmt -77.36 164.65 25.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 36.740000000000002 110.434 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.961 HD13 HD12 ' B' ' 83' ' ' LEU . 0.4 OUTLIER -149.65 172.61 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.448 -0.782 . . . . 19.739999999999998 108.9 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.1 m -108.72 146.38 33.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.163 -0.961 . . . . 22.559999999999999 109.378 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.644 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -117.5 145.96 43.86 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.201 -0.937 . . . . 20.41 108.615 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.476 ' HB2' ' NE2' ' B' ' 53' ' ' GLN . 0.7 OUTLIER -82.42 140.03 33.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 33.990000000000002 109.81 -179.221 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.18 106.84 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 54.920000000000002 109.403 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.88 -12.44 57.69 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.363 -1.495 . . . . 36.100000000000001 109.363 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.476 ' NE2' ' HB2' ' B' ' 50' ' ' ASP . 5.0 mt-30 -82.09 147.19 56.93 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.364 -1.08 . . . . 54.759999999999998 109.359 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.6 Cg_endo -78.08 123.27 6.1 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.646 2.231 . . . . 28.370000000000001 110.469 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.924 ' HB1' ' OE1' ' B' ' 31' ' ' GLN . . . -37.88 143.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.528 -0.732 . . . . 17.210000000000001 110.19 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.99 ' O ' HG21 ' B' ' 6' ' ' ILE . 83.9 m-85 -41.41 97.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.457 -0.777 . . . . 17.190000000000001 109.259 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -42.87 165.52 0.1 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 17.82 109.582 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.67 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.43 104.97 1.97 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.562 2.175 . . . . 17.280000000000001 110.122 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.74 -175.03 41.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.946 -1.262 . . . . 17.219999999999999 109.946 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.707 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -76.31 142.07 41.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.075 -1.083 . . . . 19.57 108.075 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.693 ' HB3' HD22 ' B' ' 83' ' ' LEU . 15.5 m-85 -131.32 163.7 27.27 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.716 -1.24 . . . . 14.609999999999999 111.716 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.746 ' O ' HG22 ' B' ' 84' ' ' VAL . 50.6 p -145.64 120.09 9.68 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.61 -1.626 . . . . 18.359999999999999 106.61 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.628 ' CG1' HD12 ' B' ' 81' ' ' LEU . 3.8 t -50.64 171.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 118.78 -1.168 . . . . 19.129999999999999 108.861 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.583 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.8 t-80 -135.01 125.45 26.59 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.331 -0.856 . . . . 20.649999999999999 109.268 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.757 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -70.51 -2.91 15.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.771 . . . . 19.649999999999999 109.645 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -17.13 14.53 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.043 -1.095 . . . . 14.720000000000001 108.043 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 0.4 OUTLIER -101.63 -10.04 20.4 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.681 -0.637 . . . . 11.449999999999999 110.654 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.691 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.8 m-30 -72.05 164.12 26.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.022 -1.049 . . . . 14.25 109.943 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' B' ' 77' ' ' MET . 2.7 ptmt -146.38 177.17 9.23 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.966 -0.753 . . . . 32.700000000000003 108.966 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.459 HG23 HG21 ' A' ' 45' ' ' VAL . 6.2 p -126.99 158.72 37.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.266 -0.896 . . . . 15.630000000000001 109.348 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' B' ' 75' ' ' SER . . . 127.91 -140.13 11.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.36 -1.496 . . . . 12.699999999999999 109.36 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 28.2 tp60 57.19 60.68 2.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.11 -1.23 . . . . 26.289999999999999 109.378 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.2 OUTLIER 73.13 2.47 4.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.473 -0.767 . . . . 20.440000000000001 109.506 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 46' ' ' LYS . . . 103.78 54.77 0.8 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.975 -1.25 . . . . 13.82 109.975 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.4 ' N ' ' O ' ' B' ' 71' ' ' GLY . 48.1 t -151.34 147.51 27.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 18.27 109.827 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.633 ' HB2' HD13 ' A' ' 81' ' ' LEU . 2.6 tp -59.56 164.9 3.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.291 -0.88 . . . . 12.43 109.175 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 12.5 mtp -165.14 104.37 0.76 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.086 -1.009 . . . . 35.109999999999999 110.103 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.607 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.4 mt -42.05 -63.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 13.67 109.425 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 38.0 t0 84.94 -45.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.407 0.622 . . . . 24.059999999999999 110.108 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.0 tmm_? -171.51 67.23 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.081 0.943 . . . . 35.039999999999999 108.531 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.743 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -38.16 131.13 1.16 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.685 0.755 . . . . 18.719999999999999 111.515 -178.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -96.4 107.1 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.892 -1.151 . . . . 20.550000000000001 107.892 178.437 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.961 HD12 HD13 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -76.98 146.7 37.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 14.4 111.243 -178.317 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.746 HG22 ' O ' ' B' ' 62' ' ' THR . 16.4 m -147.49 156.64 45.59 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 107.986 -1.116 . . . . 17.649999999999999 107.986 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.4 Cg_endo -63.88 142.66 83.13 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.142 1.894 . . . . 25.699999999999999 110.515 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.707 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -72.04 115.03 10.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 49.289999999999999 109.505 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.038 -0.982 . . . . 58.909999999999997 109.499 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.57 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.306 0.574 . . . . 64.909999999999997 109.473 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.893 HD12 ' HB ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -82.65 82.57 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.109 -1.071 . . . . 33.799999999999997 108.109 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -68.04 163.59 22.0 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.112 0.958 . . . . 32.719999999999999 111.359 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.987 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -174.38 167.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.428 -0.953 . . . . 14.460000000000001 108.428 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.576 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 31.6 mt-10 -140.39 111.39 7.02 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.899 0.857 . . . . 22.120000000000001 109.347 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.844 HG21 ' O ' ' A' ' 56' ' ' TYR . 6.2 mm -73.86 89.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.279 -1.008 . . . . 14.23 108.279 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.594 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.7 mmpm? -41.99 161.89 0.15 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 25.43 109.649 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.9 Cg_endo -72.41 -12.25 27.16 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.037 1.825 . . . . 13.609999999999999 109.115 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.0 t -98.17 6.94 46.97 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.675 -0.861 . . . . 15.52 108.675 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.531 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 17.1 mm-40 -128.25 13.36 6.64 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.334 -0.854 . . . . 17.309999999999999 109.519 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -88.14 30.3 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 24.780000000000001 110.299 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.413 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 18.7 mt-30 -144.55 121.58 11.4 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.161 -0.962 . . . . 47.899999999999999 109.678 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.626 ' CD2' ' CB ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.77 -177.39 4.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.448 -0.782 . . . . 21.609999999999999 110.429 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 98.1 m -157.05 143.73 18.34 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.433 -0.792 . . . . 14.890000000000001 109.044 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -78.89 122.72 26.46 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.351 -0.843 . . . . 17.350000000000001 109.574 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 18' ' ' GLY . 6.3 mtt180 -132.95 133.89 43.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 34.380000000000003 109.35 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.71 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 38.770000000000003 109.369 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -101.67 167.63 18.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.577 -1.409 . . . . 34.579999999999998 109.577 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.5 t -141.33 119.18 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -1.157 . . . . 41.869999999999997 108.962 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 24' ' ' LYS . 6.3 m -57.45 87.75 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.305 -0.872 . . . . 47.210000000000001 109.687 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.2 mtp180 46.44 51.85 11.34 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.252 -0.905 . . . . 71.560000000000002 109.729 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 56.48 16.23 2.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 66.599999999999994 109.842 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.52 -53.85 1.77 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.142 -1.583 . . . . 55.490000000000002 109.142 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' SER . 4.4 mmtt -142.68 150.41 53.81 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.348 -1.09 . . . . 44.990000000000002 109.072 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.91 129.74 10.89 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.445 2.097 . . . . 44.100000000000001 110.483 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.615 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 8.2 p90 -144.31 135.06 24.97 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.186 -0.946 . . . . 32.090000000000003 109.561 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.458 ' HB2' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -98.32 78.51 2.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 29.25 108.611 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -83.75 161.94 20.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 24.0 110.301 -178.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.626 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -86.75 104.0 15.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.458 -0.776 . . . . 23.309999999999999 109.439 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 22.0 mt-10 -79.97 -176.53 5.53 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.039 -1.038 . . . . 40.030000000000001 109.422 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.57 ' CB ' HG22 ' A' ' 47' ' ' ILE . 3.5 mt-30 -168.38 -171.06 1.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 12.390000000000001 109.711 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.909 ' HB3' HD11 ' A' ' 44' ' ' LEU . 2.2 mp -131.39 179.08 6.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 17.420000000000002 109.634 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -172.25 159.5 4.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.935 -1.103 . . . . 13.84 109.024 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.776 ' HE1' HD13 ' A' ' 44' ' ' LEU . 2.8 m-85 -116.02 89.6 3.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 21.140000000000001 108.875 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.94 ' O ' HG22 ' A' ' 43' ' ' VAL . 98.7 t -91.73 115.86 31.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.101 -0.999 . . . . 10.66 110.233 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 73.4 m-20 -60.62 -20.34 60.41 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.178 -1.045 . . . . 25.890000000000001 108.178 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.798 HD11 ' CA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 40.65 27.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.673 -0.642 . . . . 24.239999999999998 109.922 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 61.66 27.46 68.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 120.127 -1.035 . . . . 31.02 110.539 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.56 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 8.8 p30 -106.78 22.68 15.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.677 -1.484 . . . . 43.229999999999997 110.417 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' A' ' 41' ' ' HIS . 27.6 mt-10 61.36 50.49 4.7 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.215 -0.928 . . . . 42.340000000000003 111.027 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.552 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 6.1 p80 154.68 149.45 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 108.187 -1.042 . . . . 8.3100000000000005 108.187 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.629 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.2 Cg_endo -75.88 147.21 30.46 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.947 1.765 . . . . 17.920000000000002 110.317 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 35' ' ' VAL . 14.5 m -121.36 116.68 50.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.242 -0.983 . . . . 20.57 109.069 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.909 HD11 ' HB3' ' A' ' 32' ' ' LEU . 21.9 tp -68.87 105.68 2.44 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.321 -0.952 . . . . 20.210000000000001 108.57 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' B' ' 75' ' ' SER . 0.5 OUTLIER -121.73 168.64 13.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.57 -0.706 . . . . 10.81 109.165 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -82.63 156.24 23.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 36.740000000000002 110.621 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.115 HD11 ' HB2' ' A' ' 83' ' ' LEU . 1.4 tt -143.37 161.72 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.51 -0.922 . . . . 19.739999999999998 108.51 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.573 HG21 ' CZ ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -108.67 123.88 49.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.925 -1.11 . . . . 22.559999999999999 109.423 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.912 HD11 ' O ' ' A' ' 53' ' ' GLN . 1.9 tm? -86.5 125.02 33.45 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.769 -0.826 . . . . 20.41 108.769 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -54.89 139.22 41.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 33.990000000000002 109.602 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -55.37 118.93 4.86 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.224 -0.923 . . . . 54.920000000000002 109.328 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.39 -23.1 23.62 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.544 -1.422 . . . . 36.100000000000001 109.544 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.912 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -67.0 152.14 96.35 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -1.176 . . . . 54.759999999999998 109.357 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -79.58 117.05 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.476 2.117 . . . . 28.370000000000001 110.085 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -29.71 137.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.221 0.534 . . . . 17.210000000000001 111.128 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.844 ' O ' HG21 ' A' ' 6' ' ' ILE . 99.2 m-85 -41.28 105.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.48 -0.763 . . . . 17.190000000000001 109.41 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.815 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.98 170.33 0.72 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.069 -1.019 . . . . 17.82 109.277 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.815 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.67 103.24 1.69 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.459 2.106 . . . . 17.280000000000001 110.097 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.11 -179.77 44.96 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.921 -1.272 . . . . 17.219999999999999 109.921 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.784 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -72.69 149.86 43.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.366 -1.079 . . . . 19.57 108.12 179.075 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.987 ' CB ' HG13 ' A' ' 4' ' ' VAL . 18.0 m-85 -133.92 165.23 25.5 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.692 -1.255 . . . . 14.609999999999999 111.724 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 84' ' ' VAL . 69.8 p -143.96 119.2 10.16 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.949 -1.871 . . . . 18.359999999999999 105.949 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 81' ' ' LEU . 9.8 t -53.84 165.42 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 C-N-CA 118.404 -1.318 . . . . 19.129999999999999 108.962 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.529 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -134.15 126.46 30.03 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.47 -0.937 . . . . 20.649999999999999 108.47 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' B' ' 2' ' ' ILE . 2.3 pp -72.88 2.14 7.36 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.144 -0.972 . . . . 19.649999999999999 110.246 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.32 -18.96 19.5 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.643 -1.243 . . . . 14.720000000000001 107.643 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 1.3 t -100.37 -9.36 22.33 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.72 -0.612 . . . . 11.449999999999999 110.302 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 3.9 m-30 -73.48 156.67 37.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.962 -1.086 . . . . 14.25 109.32 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.763 ' CA ' HD11 ' B' ' 37' ' ' LEU . 22.3 mtmt -152.89 167.12 30.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 32.700000000000003 109.717 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.525 HG21 HG21 ' B' ' 43' ' ' VAL . 0.5 OUTLIER -101.11 123.32 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.513 -0.921 . . . . 15.630000000000001 108.513 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 70' ' ' VAL . . . -59.81 -130.7 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.046 -1.222 . . . . 12.699999999999999 110.046 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.522 ' C ' ' CG ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -87.2 46.01 1.33 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -1.144 . . . . 26.289999999999999 108.869 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.522 ' CG ' ' C ' ' A' ' 72' ' ' GLN . 1.8 m-85 77.06 0.02 3.0 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.993 -0.743 . . . . 20.440000000000001 108.993 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.59 -66.48 2.37 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.524 -1.43 . . . . 13.82 109.524 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.476 ' HA ' HG22 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -160.6 170.18 21.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -1.165 . . . . 18.27 109.667 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.9 OUTLIER -66.79 163.6 18.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 12.43 109.433 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.537 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 15.1 mtp -165.6 127.24 1.97 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 35.109999999999999 109.401 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.2 mt -53.93 -41.3 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.306 -0.871 . . . . 13.67 109.946 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 2.1 t0 45.0 54.55 6.83 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.512 -1.292 . . . . 24.059999999999999 107.512 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.573 ' CZ ' HG21 ' A' ' 48' ' ' THR . 0.6 OUTLIER 85.56 116.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.017 -1.475 . . . . 35.039999999999999 107.017 -177.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.062 HD13 HG13 ' A' ' 63' ' ' VAL . 2.0 pp -94.63 152.02 18.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.332 -0.855 . . . . 18.719999999999999 111.274 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -101.52 95.6 6.57 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.905 -1.517 . . . . 20.550000000000001 106.905 177.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.115 ' HB2' HD11 ' A' ' 47' ' ' ILE . 2.0 tp -75.07 150.67 38.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.191 -0.943 . . . . 14.4 111.324 -177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 62' ' ' THR . 24.1 m -147.47 158.96 42.85 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.809 -1.182 . . . . 17.649999999999999 107.809 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.3 Cg_endo -63.87 145.88 90.94 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.06 1.84 . . . . 25.699999999999999 110.335 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.784 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -80.39 115.37 19.89 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.133 -0.979 . . . . 49.289999999999999 109.579 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.2 tptt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.963 -1.018 . . . . 58.909999999999997 109.486 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.567 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.461 -0.57 . . . . 64.909999999999997 109.461 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.904 HD12 ' HB ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -83.26 82.52 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.083 -1.08 . . . . 33.799999999999997 108.083 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -67.99 163.59 21.89 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.169 0.985 . . . . 32.719999999999999 111.351 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.004 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -174.38 167.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.419 -0.956 . . . . 14.460000000000001 108.419 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.565 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 31.3 mt-10 -140.27 111.5 7.13 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.866 0.841 . . . . 22.120000000000001 109.286 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.828 HG21 ' O ' ' B' ' 56' ' ' TYR . 6.2 mm -74.04 89.7 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.285 -1.006 . . . . 14.23 108.285 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.598 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.7 mmpm? -41.73 161.81 0.14 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 25.43 109.668 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.7 Cg_endo -72.44 -12.39 27.21 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.957 1.771 . . . . 13.609999999999999 109.117 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.5 t -97.94 6.9 47.17 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.655 -0.868 . . . . 15.52 108.655 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.524 ' HB3' ' HB2' ' B' ' 32' ' ' LEU . 17.0 mm-40 -128.17 13.14 6.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.316 -0.865 . . . . 17.309999999999999 109.609 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -87.92 30.13 0.87 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.973 . . . . 24.780000000000001 110.333 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 18.7 mt-30 -144.33 121.71 11.65 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.129 -0.982 . . . . 47.899999999999999 109.659 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.626 ' CD2' ' CB ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -77.84 -177.33 4.86 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.456 -0.777 . . . . 21.609999999999999 110.42 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 97.7 m -157.14 143.61 18.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.34 -0.85 . . . . 14.890000000000001 109.088 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.451 HG22 ' HB2' ' B' ' 27' ' ' SER . 0.2 OUTLIER -78.8 122.86 26.58 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.445 -0.784 . . . . 17.350000000000001 109.572 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' B' ' 18' ' ' GLY . 6.3 mtt180 -133.12 133.97 43.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 34.380000000000003 109.296 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.401 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.9 OUTLIER -45.83 98.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 38.770000000000003 109.362 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -101.59 167.72 19.06 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.624 -1.39 . . . . 34.579999999999998 109.624 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' B' ' 21' ' ' ARG . 1.4 t -141.46 119.21 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -1.128 . . . . 41.869999999999997 108.955 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.515 ' N ' ' O ' ' B' ' 24' ' ' LYS . 6.4 m -57.5 87.59 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.424 -0.797 . . . . 47.210000000000001 109.732 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' B' ' 19' ' ' VAL . 4.2 mtp180 46.64 51.78 11.79 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.262 -0.898 . . . . 71.560000000000002 109.7 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 56.49 16.39 2.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 66.599999999999994 109.792 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.61 -53.87 1.76 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.171 -1.572 . . . . 55.490000000000002 109.171 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' B' ' 20' ' ' SER . 4.4 mmtt -142.69 150.56 54.32 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.324 -1.103 . . . . 44.990000000000002 109.039 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.03 129.76 10.79 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.464 2.109 . . . . 44.100000000000001 110.505 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.625 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 8.0 p90 -144.27 135.07 25.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.201 -0.937 . . . . 32.090000000000003 109.604 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.451 ' HB2' HG22 ' B' ' 15' ' ' THR . 0.1 OUTLIER -98.28 78.52 2.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 29.25 108.609 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.61 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -83.73 162.01 20.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 24.0 110.224 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.626 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -86.82 103.79 15.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.426 -0.796 . . . . 23.309999999999999 109.465 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 21.7 mt-10 -79.77 -176.65 5.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.043 -1.035 . . . . 40.030000000000001 109.524 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.582 ' CB ' HG22 ' B' ' 47' ' ' ILE . 3.5 mt-30 -168.19 -171.12 1.44 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.209 -0.932 . . . . 12.390000000000001 109.778 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.934 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.2 mp -131.26 179.11 6.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 17.420000000000002 109.633 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.534 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -172.35 159.43 4.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.925 -1.109 . . . . 13.84 108.946 -179.435 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.758 ' HE1' HD13 ' B' ' 44' ' ' LEU . 2.8 m-85 -116.06 89.47 3.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.953 . . . . 21.140000000000001 108.911 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.946 ' O ' HG22 ' B' ' 43' ' ' VAL . 98.5 t -91.59 116.13 32.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.055 -1.028 . . . . 10.66 110.26 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 73.3 m-20 -60.92 -19.96 61.36 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.213 -1.032 . . . . 25.890000000000001 108.213 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.763 HD11 ' CA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 40.42 27.67 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.644 -0.66 . . . . 24.239999999999998 109.867 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 61.58 27.54 68.24 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.552 -1.019 . . . . 31.02 110.552 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.552 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 8.7 p30 -106.83 22.67 15.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.67 -1.488 . . . . 43.229999999999997 110.517 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.545 ' O ' ' HB3' ' B' ' 41' ' ' HIS . 27.7 mt-10 61.34 50.58 4.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.172 -0.955 . . . . 42.340000000000003 111.026 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.547 ' O ' ' HA ' ' B' ' 36' ' ' ASP . 6.1 p80 154.61 149.35 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.198 -1.038 . . . . 8.3399999999999999 108.198 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.636 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 34.9 Cg_endo -75.78 147.2 30.81 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.933 1.755 . . . . 17.920000000000002 110.33 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.946 HG22 ' O ' ' B' ' 35' ' ' VAL . 14.5 m -121.36 116.97 51.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 C-N-CA 119.282 -0.967 . . . . 20.57 109.068 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.934 HD11 ' HB3' ' B' ' 32' ' ' LEU . 22.1 tp -69.25 105.54 2.56 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.333 -0.947 . . . . 20.210000000000001 108.568 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -121.58 168.57 13.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.63 0 O-C-N 121.589 -0.694 . . . . 10.81 109.161 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.437 ' N ' HG13 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -82.49 156.23 24.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 36.740000000000002 110.605 -178.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 1.077 HD11 ' HB2' ' B' ' 83' ' ' LEU . 1.4 tt -143.42 161.62 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.464 -0.939 . . . . 19.739999999999998 108.464 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.583 HG21 ' CZ ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -108.59 123.94 49.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.958 -1.089 . . . . 22.559999999999999 109.418 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.922 HD11 ' O ' ' B' ' 53' ' ' GLN . 1.9 tm? -86.56 124.99 33.47 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.535 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.3 OUTLIER -54.85 139.27 40.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 33.990000000000002 109.666 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -55.4 118.92 4.86 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.232 -0.917 . . . . 54.920000000000002 109.31 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.34 -22.94 24.24 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.596 -1.401 . . . . 36.100000000000001 109.596 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.922 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.6 OUTLIER -67.18 152.18 96.37 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.172 -1.193 . . . . 54.759999999999998 109.29 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.506 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -79.55 117.11 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.462 2.108 . . . . 28.370000000000001 110.018 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.588 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -29.9 138.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.233 0.54 . . . . 17.210000000000001 111.068 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.828 ' O ' HG21 ' B' ' 6' ' ' ILE . 99.3 m-85 -41.33 105.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 17.190000000000001 109.591 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.792 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.46 170.32 0.63 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.09 -1.006 . . . . 17.82 109.186 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.792 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.3 Cg_endo -78.01 104.2 1.81 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.553 2.169 . . . . 17.280000000000001 110.267 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.64 -179.34 46.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.861 -1.295 . . . . 17.219999999999999 109.861 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.777 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -72.31 150.27 43.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.151 . . . . 19.57 108.449 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 1.004 ' CB ' HG13 ' B' ' 4' ' ' VAL . 16.4 m-85 -134.34 165.29 25.49 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.775 -1.203 . . . . 14.609999999999999 111.75 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.822 ' O ' HG22 ' B' ' 84' ' ' VAL . 67.1 p -144.15 119.23 10.06 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.029 -1.841 . . . . 18.359999999999999 106.029 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 1.069 HG13 HD13 ' B' ' 81' ' ' LEU . 9.7 t -53.91 165.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 C-N-CA 118.419 -1.312 . . . . 19.129999999999999 109.006 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -134.0 126.44 30.23 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.424 -0.954 . . . . 20.649999999999999 108.424 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.763 HD22 ' HA ' ' A' ' 2' ' ' ILE . 2.3 pp -72.76 1.9 7.64 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.193 -0.942 . . . . 19.649999999999999 110.197 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -19.02 16.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.575 -1.269 . . . . 14.720000000000001 107.575 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.521 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 1.3 t -100.5 -9.85 21.67 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.72 -0.613 . . . . 11.449999999999999 110.306 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.9 m-30 -72.94 156.46 38.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.979 -1.076 . . . . 14.25 109.206 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.798 ' CA ' HD11 ' A' ' 37' ' ' LEU . 22.5 mtmt -152.71 166.67 31.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 32.700000000000003 109.803 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -100.53 123.14 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.527 -0.916 . . . . 15.630000000000001 108.527 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' B' ' 70' ' ' VAL . . . -59.95 -130.71 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.016 -1.233 . . . . 12.699999999999999 110.016 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.537 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -87.1 46.25 1.36 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -1.133 . . . . 26.289999999999999 108.879 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.537 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 1.8 m-85 76.79 0.05 3.07 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.058 -0.719 . . . . 20.440000000000001 109.058 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.64 -66.28 2.45 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.612 -1.395 . . . . 13.82 109.612 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.482 ' HA ' HG22 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -160.7 170.1 21.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -1.186 . . . . 18.27 109.673 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.533 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.9 OUTLIER -66.72 163.45 19.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 12.43 109.462 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 15.2 mtp -165.59 127.42 2.0 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.892 . . . . 35.109999999999999 109.381 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.601 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.1 mt -54.22 -41.12 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 13.67 109.921 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 2.1 t0 44.92 54.67 6.66 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.442 -1.318 . . . . 24.059999999999999 107.442 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.583 ' CZ ' HG21 ' B' ' 48' ' ' THR . 0.6 OUTLIER 85.56 116.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.097 -1.445 . . . . 35.039999999999999 107.097 -177.324 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 1.069 HD13 HG13 ' B' ' 63' ' ' VAL . 2.0 pp -94.53 152.13 18.79 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 18.719999999999999 111.276 -177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.533 ' N ' HD12 ' B' ' 81' ' ' LEU . 0.0 OUTLIER -101.7 95.5 6.47 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.93 -1.507 . . . . 20.550000000000001 106.93 177.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.077 ' HB2' HD11 ' B' ' 47' ' ' ILE . 2.0 tp -75.0 150.57 38.93 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.161 -0.962 . . . . 14.4 111.335 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.822 HG22 ' O ' ' B' ' 62' ' ' THR . 24.1 m -147.47 158.64 43.31 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 107.813 -1.181 . . . . 17.649999999999999 107.813 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.0 Cg_endo -63.61 145.94 92.09 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.022 1.815 . . . . 25.699999999999999 110.357 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.777 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -80.36 115.54 19.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 49.289999999999999 109.564 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 16.2 tptt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.984 -1.008 . . . . 58.909999999999997 109.506 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.341 -0.615 . . . . 64.909999999999997 109.341 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.988 HG23 ' CD2' ' B' ' 65' ' ' LEU . 0.0 OUTLIER 56.21 88.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.933 -1.104 . . . . 33.799999999999997 108.046 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -92.77 167.12 12.08 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.341 -0.849 . . . . 32.719999999999999 110.437 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.912 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -172.67 165.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.993 -0.743 . . . . 14.460000000000001 108.993 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.561 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 34.3 mt-10 -141.74 110.37 6.09 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.908 -0.775 . . . . 22.120000000000001 108.908 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.825 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -71.85 100.81 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 119.171 -1.012 . . . . 14.23 108.401 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 3.0 mmmt -41.49 163.48 0.11 Allowed Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.462 -0.774 . . . . 25.43 109.423 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.68 -13.92 27.16 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.961 1.774 . . . . 13.609999999999999 109.224 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -96.58 5.32 51.0 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.716 -0.846 . . . . 15.52 108.716 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 9.1 mm-40 -125.93 34.9 4.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.361 -0.837 . . . . 17.309999999999999 109.355 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.95 8.46 42.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 24.780000000000001 110.014 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 41.6 mt-30 -132.14 144.47 50.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.223 -0.923 . . . . 47.899999999999999 109.516 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.72 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 30.8 p90 -91.68 164.73 13.63 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.259 -0.901 . . . . 21.609999999999999 109.407 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -137.7 152.5 49.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.29 -0.881 . . . . 14.890000000000001 109.125 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -89.99 117.16 28.58 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.242 -0.911 . . . . 17.350000000000001 109.366 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -130.35 134.68 47.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.925 . . . . 34.380000000000003 109.516 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 16' ' ' ARG . 6.3 t -44.89 113.55 0.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 38.770000000000003 109.349 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 26' ' ' TYR . . . -116.45 177.5 16.9 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.716 -1.354 . . . . 34.579999999999998 109.716 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.642 ' N ' ' CE2' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -144.81 114.7 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -1.14 . . . . 41.869999999999997 108.632 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.3 p -49.32 -91.23 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.196 -0.94 . . . . 47.210000000000001 109.685 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 18.5 ttt180 -113.71 54.47 0.74 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 71.560000000000002 109.548 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 54.63 21.4 3.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 66.599999999999994 109.531 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.85 -45.91 1.24 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.535 -1.426 . . . . 55.490000000000002 109.535 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -142.17 154.74 64.86 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.362 -1.081 . . . . 44.990000000000002 109.42 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.25 152.73 31.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.654 2.236 . . . . 44.100000000000001 110.713 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.642 ' CE2' ' N ' ' A' ' 19' ' ' VAL . 5.4 p90 -159.83 119.47 2.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 32.090000000000003 109.732 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.453 ' HB2' HG22 ' A' ' 15' ' ' THR . 0.0 OUTLIER -96.03 80.58 3.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 29.25 109.288 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -92.93 142.19 27.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 24.0 110.057 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.635 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 92.8 m-20 -52.92 118.87 4.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.844 . . . . 23.309999999999999 109.336 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 5.1 mt-10 -110.98 165.83 11.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 40.030000000000001 109.183 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.685 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -144.03 162.98 34.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.051 -1.031 . . . . 12.390000000000001 109.861 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' HD11 ' A' ' 44' ' ' LEU . 3.6 mm? -102.64 178.28 4.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.404 -0.81 . . . . 17.420000000000002 109.958 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.527 ' SG ' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -175.29 159.42 2.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.003 -1.06 . . . . 13.84 108.604 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.767 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.1 m-30 -113.96 98.04 6.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.997 . . . . 21.140000000000001 108.592 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.898 HG22 ' HB ' ' A' ' 4' ' ' VAL . 14.0 t -107.34 130.23 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 10.66 110.665 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.909 ' O ' HD12 ' A' ' 37' ' ' LEU . 12.5 p-10 -81.01 -30.18 34.99 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.124 -1.065 . . . . 25.890000000000001 108.124 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.909 HD12 ' O ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER 31.09 40.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.159 0.504 . . . . 24.239999999999998 110.993 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.722 ' C ' HD21 ' A' ' 39' ' ' ASN . . . 102.07 20.32 12.87 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.811 -1.185 . . . . 31.02 110.597 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.722 HD21 ' C ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER -135.29 103.3 5.46 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.965 -1.315 . . . . 43.229999999999997 108.223 178.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -29.54 -38.06 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.356 0.598 . . . . 42.340000000000003 111.407 -178.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 39' ' ' ASN . 40.9 m80 -89.03 153.18 49.08 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.312 -0.867 . . . . 6.5899999999999999 109.177 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 34.8 Cg_endo -76.83 148.38 28.36 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.2 1.933 . . . . 17.920000000000002 110.377 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 35' ' ' VAL . 1.8 m -119.43 119.0 59.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.185 -1.006 . . . . 20.57 109.434 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.905 HD11 ' HB3' ' A' ' 32' ' ' LEU . 18.5 tp -70.81 109.53 5.05 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.447 -0.946 . . . . 20.210000000000001 108.447 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.596 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 2.9 t -121.12 168.96 13.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.635 -0.666 . . . . 10.81 109.725 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -89.53 -175.47 4.71 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.419 -0.801 . . . . 36.740000000000002 110.251 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.687 ' CD1' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -168.85 173.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 19.739999999999998 109.144 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.47 ' N ' HG23 ' A' ' 47' ' ' ILE . 24.4 m -109.18 145.28 36.06 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.3 -0.875 . . . . 22.559999999999999 109.148 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 53' ' ' GLN . 1.8 tm? -127.76 100.31 5.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.343 -0.848 . . . . 20.41 109.052 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 53' ' ' GLN . 4.0 m-20 -41.4 129.4 3.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.394 -0.816 . . . . 33.990000000000002 110.04 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.74 100.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.303 -0.873 . . . . 54.920000000000002 109.161 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.37 -37.32 2.79 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.258 -1.537 . . . . 36.100000000000001 109.258 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.651 ' O ' HD11 ' A' ' 49' ' ' LEU . 4.3 mt-30 -64.0 151.88 88.71 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.228 -1.16 . . . . 54.759999999999998 109.048 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.6 Cg_endo -77.07 117.72 4.52 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.533 2.156 . . . . 28.370000000000001 110.439 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.72 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -40.05 148.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.522 -0.736 . . . . 17.210000000000001 109.926 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.825 ' O ' HG21 ' A' ' 6' ' ' ILE . 9.7 m-30 -48.45 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 17.190000000000001 109.6 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.942 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -48.65 174.24 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 17.82 109.307 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.942 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 36.1 Cg_endo -78.55 125.3 6.81 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.652 2.234 . . . . 17.280000000000001 110.368 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.29 -179.24 39.24 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.718 -1.23 . . . . 17.219999999999999 110.045 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -73.15 142.6 47.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.369 -1.077 . . . . 19.57 108.577 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.912 ' CB ' HG13 ' A' ' 4' ' ' VAL . 8.8 m-85 -127.24 163.49 23.78 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.65 -1.281 . . . . 14.609999999999999 111.546 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.662 ' O ' HG22 ' A' ' 84' ' ' VAL . 54.8 p -148.47 117.35 6.72 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.941 -1.503 . . . . 18.359999999999999 106.941 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.817 ' HB ' HD12 ' A' ' 2' ' ' ILE . 15.8 t -47.59 169.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 C-N-CA 119.168 -1.013 . . . . 19.129999999999999 109.106 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.55 ' N ' HG12 ' A' ' 63' ' ' VAL . 7.5 t-80 -133.72 129.72 37.13 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.834 -0.802 . . . . 20.649999999999999 108.834 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.007 ' CD2' HG23 ' B' ' 2' ' ' ILE . 0.7 OUTLIER -64.18 -10.52 23.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.511 -0.743 . . . . 19.649999999999999 109.89 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' LEU . 1.2 t -45.62 -25.93 0.54 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.589 -0.893 . . . . 14.720000000000001 108.589 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 7.2 m -98.19 -12.07 22.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.51 -0.744 . . . . 11.449999999999999 110.485 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 1.005 ' CD2' HD23 ' A' ' 65' ' ' LEU . 2.6 m-30 -80.16 153.86 28.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.845 -1.16 . . . . 14.25 109.762 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 68' ' ' PHE . 71.1 mttt -157.37 171.05 21.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.505 -0.747 . . . . 32.700000000000003 109.233 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -101.4 100.76 11.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.889 . . . . 15.630000000000001 109.124 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.68 -175.98 5.98 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.525 -1.43 . . . . 12.699999999999999 109.525 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.72 27.44 1.77 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.143 -1.21 . . . . 26.289999999999999 109.314 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 5.0 23.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.434 -0.791 . . . . 20.440000000000001 109.627 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.475 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . 67.66 49.47 49.6 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.467 -1.453 . . . . 13.82 109.467 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -170.07 148.88 3.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -1.129 . . . . 18.27 109.707 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.943 HD23 ' N ' ' A' ' 77' ' ' MET . 5.1 tt -61.16 159.1 12.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 12.43 109.278 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.943 ' N ' HD23 ' A' ' 76' ' ' LEU . 1.8 mtt -163.79 111.39 1.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.09 -1.006 . . . . 35.109999999999999 109.993 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.97 HD12 HD12 ' B' ' 78' ' ' ILE . 3.5 mt -52.77 145.87 2.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.354 -0.841 . . . . 13.67 109.647 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.577 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -126.06 53.47 1.61 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.804 -1.554 . . . . 24.059999999999999 106.804 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.58 ' H ' HG22 ' A' ' 78' ' ' ILE . 2.4 tmm_? 89.67 67.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.31 -1.367 . . . . 35.039999999999999 107.31 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -32.78 124.91 0.35 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.373 -0.831 . . . . 18.719999999999999 111.678 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.6 103.88 16.52 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.483 -1.303 . . . . 20.550000000000001 107.483 178.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.687 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -79.79 145.97 32.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.058 -1.026 . . . . 14.4 111.217 -178.021 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 62' ' ' THR . 27.2 m -146.53 158.6 46.47 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.96 -1.126 . . . . 17.649999999999999 107.96 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.16 141.07 74.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.084 1.856 . . . . 25.699999999999999 110.134 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.732 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -69.07 108.3 3.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.139 -0.976 . . . . 49.289999999999999 109.482 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.961 -1.018 . . . . 58.909999999999997 109.413 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' CG ' ' B' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.335 -0.617 . . . . 64.909999999999997 109.335 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 1.007 HG23 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 56.12 88.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.891 -1.131 . . . . 33.799999999999997 107.973 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.535 ' O ' HG13 ' B' ' 35' ' ' VAL . 0.3 OUTLIER -92.9 167.13 12.04 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.298 -0.876 . . . . 32.719999999999999 110.438 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.911 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -172.74 165.34 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.692 0.758 . . . . 14.460000000000001 108.962 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 34.3 mt-10 -141.67 110.52 6.17 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.882 -0.785 . . . . 22.120000000000001 108.882 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.827 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -71.97 101.06 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 C-N-CA 119.126 -1.03 . . . . 14.23 108.396 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.582 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 3.0 mmmt -41.61 163.61 0.11 Allowed Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.49 -0.756 . . . . 25.43 109.493 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.0 Cg_endo -72.72 -13.95 27.06 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.983 1.789 . . . . 13.609999999999999 109.201 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.6 m -96.55 5.19 51.27 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.677 -0.86 . . . . 15.52 108.677 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.535 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 9.1 mm-40 -125.9 34.94 4.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.328 -0.857 . . . . 17.309999999999999 109.412 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.92 8.46 42.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 24.780000000000001 110.026 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -132.19 144.36 50.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.272 -0.893 . . . . 47.899999999999999 109.576 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.702 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 31.0 p90 -91.6 164.78 13.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.284 -0.885 . . . . 21.609999999999999 109.385 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -137.71 152.53 49.34 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.331 -0.856 . . . . 14.890000000000001 109.11 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 27' ' ' SER . 0.2 OUTLIER -90.01 117.21 28.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 17.350000000000001 109.378 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.2 OUTLIER -130.39 134.62 47.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 34.380000000000003 109.621 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.411 ' C ' ' O ' ' B' ' 16' ' ' ARG . 6.3 t -44.8 113.63 0.59 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.912 . . . . 38.770000000000003 109.297 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' B' ' 26' ' ' TYR . . . -116.59 177.44 16.82 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.645 -1.382 . . . . 34.579999999999998 109.645 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.63 ' N ' ' CE2' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -144.8 114.76 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -1.17 . . . . 41.869999999999997 108.611 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 31.2 p -49.38 -91.18 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.227 -0.921 . . . . 47.210000000000001 109.659 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.514 ' O ' ' CG ' ' B' ' 21' ' ' ARG . 18.4 ttt180 -113.71 54.31 0.75 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 71.560000000000002 109.577 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 54.79 21.4 3.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 66.599999999999994 109.477 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.83 -46.0 1.24 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.539 -1.424 . . . . 55.490000000000002 109.539 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -142.12 154.88 65.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.244 -1.151 . . . . 44.990000000000002 109.395 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.33 152.64 30.68 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.686 2.257 . . . . 44.100000000000001 110.711 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.63 ' CE2' ' N ' ' B' ' 19' ' ' VAL . 5.4 p90 -159.78 119.48 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 32.090000000000003 109.775 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.457 ' HB2' HG22 ' B' ' 15' ' ' THR . 0.0 OUTLIER -96.07 80.54 3.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 29.25 109.33 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.588 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.3 OUTLIER -92.88 142.0 27.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 24.0 110.106 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 92.9 m-20 -52.68 118.91 3.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 23.309999999999999 109.348 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 5.1 mt-10 -111.09 165.78 11.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.051 -1.031 . . . . 40.030000000000001 109.193 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.696 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -143.96 162.94 34.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.139 -0.976 . . . . 12.390000000000001 109.798 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.935 ' HB3' HD11 ' B' ' 44' ' ' LEU . 3.6 mm? -102.67 178.07 4.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 17.420000000000002 109.91 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -175.08 159.32 2.59 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.92 -1.112 . . . . 13.84 108.619 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.769 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.1 m-30 -113.81 97.86 6.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.138 -0.976 . . . . 21.140000000000001 108.63 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.878 ' O ' HG22 ' B' ' 43' ' ' VAL . 13.9 t -107.24 130.08 59.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.106 -0.996 . . . . 10.66 110.731 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.929 ' O ' HD12 ' B' ' 37' ' ' LEU . 12.5 p-10 -80.79 -30.45 35.97 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.128 -1.064 . . . . 25.890000000000001 108.128 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.929 HD12 ' O ' ' B' ' 36' ' ' ASP . 0.4 OUTLIER 31.45 40.55 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.171 0.51 . . . . 24.239999999999998 110.953 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.704 ' C ' HD21 ' B' ' 39' ' ' ASN . . . 101.91 20.61 12.44 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.834 -1.174 . . . . 31.02 110.583 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.704 HD21 ' C ' ' B' ' 38' ' ' GLY . 0.6 OUTLIER -135.43 103.31 5.43 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.016 -1.285 . . . . 43.229999999999997 108.211 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -29.57 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.291 0.567 . . . . 42.340000000000003 111.384 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' B' ' 39' ' ' ASN . 40.9 m80 -89.14 153.13 48.82 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.375 -0.828 . . . . 6.5 109.183 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.1 Cg_endo -76.83 148.31 28.3 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.179 1.92 . . . . 17.920000000000002 110.38 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.878 HG22 ' O ' ' B' ' 35' ' ' VAL . 1.7 m -119.34 119.3 60.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.258 -0.977 . . . . 20.57 109.369 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.935 HD11 ' HB3' ' B' ' 32' ' ' LEU . 18.6 tp -71.13 109.78 5.4 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.55 -0.907 . . . . 20.210000000000001 108.55 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.612 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 3.0 t -121.38 168.84 13.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.613 -0.68 . . . . 10.81 109.776 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.584 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -89.24 -175.4 4.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.493 -0.754 . . . . 36.740000000000002 110.314 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.677 ' CD1' HD12 ' B' ' 83' ' ' LEU . 0.0 OUTLIER -168.98 173.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.3 -0.875 . . . . 19.739999999999998 109.135 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.477 ' N ' HG23 ' B' ' 47' ' ' ILE . 24.6 m -109.28 145.22 36.29 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.3 -0.875 . . . . 22.559999999999999 109.108 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.67 HD11 ' O ' ' B' ' 53' ' ' GLN . 1.8 tm? -127.73 100.35 5.92 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.871 . . . . 20.41 109.059 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' B' ' 53' ' ' GLN . 3.9 m-20 -41.44 129.42 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 33.990000000000002 110.024 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.74 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.293 -0.879 . . . . 54.920000000000002 109.152 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.25 -37.15 2.84 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.225 -1.55 . . . . 36.100000000000001 109.225 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.67 ' O ' HD11 ' B' ' 49' ' ' LEU . 4.2 mt-30 -64.2 151.91 89.43 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.223 -1.163 . . . . 54.759999999999998 109.036 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.9 Cg_endo -77.22 117.63 4.45 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.546 2.164 . . . . 28.370000000000001 110.457 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.702 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -39.72 148.0 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.523 -0.736 . . . . 17.210000000000001 110.09 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.827 ' O ' HG21 ' B' ' 6' ' ' ILE . 9.5 m-30 -47.99 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.293 -0.88 . . . . 17.190000000000001 109.595 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.919 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -47.63 174.19 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 17.82 109.486 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.919 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.8 Cg_endo -78.24 124.42 6.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.577 2.185 . . . . 17.280000000000001 110.094 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.89 -179.63 40.0 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.536 -1.316 . . . . 17.219999999999999 110.148 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -73.54 142.25 46.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -1.076 . . . . 19.57 108.33 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.911 ' CB ' HG13 ' B' ' 4' ' ' VAL . 9.2 m-85 -127.02 163.62 23.33 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.654 -1.279 . . . . 14.609999999999999 111.519 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.661 ' O ' HG22 ' B' ' 84' ' ' VAL . 55.9 p -148.4 117.42 6.77 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.002 -1.481 . . . . 18.359999999999999 107.002 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.803 ' HB ' HD12 ' B' ' 2' ' ' ILE . 16.0 t -47.62 169.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 C-N-CA 119.176 -1.01 . . . . 19.129999999999999 109.052 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.55 ' N ' HG12 ' B' ' 63' ' ' VAL . 7.6 t-80 -133.89 129.91 37.06 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.819 -0.808 . . . . 20.649999999999999 108.819 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.997 HD23 ' CD2' ' B' ' 68' ' ' PHE . 0.7 OUTLIER -64.27 -10.53 24.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.696 . . . . 19.649999999999999 109.927 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.435 ' C ' ' O ' ' B' ' 65' ' ' LEU . 1.2 t -45.56 -25.83 0.51 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.56 -0.904 . . . . 14.720000000000001 108.56 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 7.1 m -98.28 -12.37 21.64 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.727 . . . . 11.449999999999999 110.486 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.997 ' CD2' HD23 ' B' ' 65' ' ' LEU . 2.5 m-30 -80.01 153.8 28.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 14.25 109.685 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' B' ' 68' ' ' PHE . 71.1 mttt -157.43 170.73 21.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.541 -0.724 . . . . 32.700000000000003 109.199 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.596 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -101.05 100.79 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 15.630000000000001 109.034 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.77 -175.91 6.05 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.426 -1.47 . . . . 12.699999999999999 109.426 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.61 27.26 1.78 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.202 -1.175 . . . . 26.289999999999999 109.358 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.88 5.06 24.12 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.512 -0.742 . . . . 20.440000000000001 109.611 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.466 ' C ' HG13 ' A' ' 45' ' ' VAL . . . 67.36 50.0 47.7 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.41 -1.476 . . . . 13.82 109.41 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.463 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -170.37 148.94 3.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -1.135 . . . . 18.27 109.608 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.942 HD23 ' N ' ' B' ' 77' ' ' MET . 5.2 tt -61.31 159.29 12.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.927 . . . . 12.43 109.256 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.942 ' N ' HD23 ' B' ' 76' ' ' LEU . 1.8 mtt -163.97 111.36 1.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.079 -1.013 . . . . 35.109999999999999 110.026 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.97 HD12 HD12 ' A' ' 78' ' ' ILE . 3.4 mt -52.77 145.7 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 13.67 109.726 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -125.84 53.52 1.58 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.789 -1.56 . . . . 24.059999999999999 106.789 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.582 ' H ' HG22 ' B' ' 78' ' ' ILE . 2.4 tmm_? 89.63 67.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.334 -1.358 . . . . 35.039999999999999 107.334 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.668 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -32.92 124.93 0.36 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.363 -0.835 . . . . 18.719999999999999 111.661 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.54 103.86 16.5 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.451 -1.314 . . . . 20.550000000000001 107.451 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.677 HD12 ' CD1' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -79.9 145.87 32.45 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.135 -0.978 . . . . 14.4 111.25 -178.048 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.661 HG22 ' O ' ' B' ' 62' ' ' THR . 27.3 m -146.32 158.97 46.67 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 107.967 -1.123 . . . . 17.649999999999999 107.967 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -64.42 141.24 73.5 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.049 1.833 . . . . 25.699999999999999 110.152 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -69.17 108.05 3.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.223 -0.923 . . . . 49.289999999999999 109.462 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.965 -1.017 . . . . 58.909999999999997 109.489 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.434 -0.58 . . . . 64.909999999999997 109.434 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.851 ' H ' HD22 ' B' ' 65' ' ' LEU . 1.6 mt 50.32 78.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.866 -1.161 . . . . 33.799999999999997 107.866 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.26 155.93 40.13 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.712 0.767 . . . . 32.719999999999999 110.57 -178.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.814 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -165.05 165.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.553 0.692 . . . . 14.460000000000001 109.262 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.53 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 22.3 mt-10 -138.64 116.89 11.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 22.120000000000001 109.258 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.747 HG21 ' O ' ' A' ' 56' ' ' TYR . 19.4 mm -77.43 97.44 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.259 -0.901 . . . . 14.23 108.743 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.596 ' HD3' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.14 161.15 0.31 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.089 -1.007 . . . . 25.43 110.121 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.93 -29.76 5.06 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.626 2.217 . . . . 13.609999999999999 110.214 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.41 -0.85 43.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.492 -0.755 . . . . 15.52 109.131 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 9.3 pt20 -129.97 28.88 5.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 17.309999999999999 109.644 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -85.03 16.31 3.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 24.780000000000001 110.106 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -138.72 144.33 39.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.082 -1.011 . . . . 47.899999999999999 108.828 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.741 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 12.8 p90 -87.01 178.42 6.94 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.168 -0.958 . . . . 21.609999999999999 109.743 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 8.7 t -132.22 163.01 29.53 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.58 -0.896 . . . . 14.890000000000001 108.58 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -97.0 156.08 16.5 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.138 -0.977 . . . . 17.350000000000001 109.617 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.8 OUTLIER -178.23 132.81 0.14 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 34.380000000000003 109.469 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 16' ' ' ARG . 1.2 t -43.81 152.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 38.770000000000003 109.427 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 26' ' ' TYR . . . -164.52 132.11 2.61 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.671 -1.371 . . . . 34.579999999999998 109.671 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.27 125.5 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.153 -1.204 . . . . 41.869999999999997 108.808 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.532 ' CB ' ' HE2' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -64.88 -163.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.375 -0.828 . . . . 47.210000000000001 109.785 -179.053 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.05 17.07 20.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 71.560000000000002 109.361 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -114.69 2.39 14.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.286 -0.884 . . . . 66.599999999999994 109.556 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.52 8.55 67.83 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.62 -1.392 . . . . 55.490000000000002 109.62 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HE2' ' CB ' ' A' ' 20' ' ' SER . 24.0 pttt -101.96 144.68 29.07 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.181 -1.188 . . . . 44.990000000000002 109.313 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.5 151.25 25.53 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.545 2.163 . . . . 44.100000000000001 110.584 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.94 ' CE1' HD23 ' A' ' 28' ' ' LEU . 2.4 p90 -158.35 154.98 27.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 32.090000000000003 109.997 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 m -117.25 84.01 2.08 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.824 -1.176 . . . . 29.25 107.824 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.94 HD23 ' CE1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -88.43 157.17 18.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.248 -0.908 . . . . 24.0 110.292 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.786 ' N ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -93.78 131.72 38.87 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.717 -0.845 . . . . 23.309999999999999 108.717 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.893 ' HG3' HD11 ' A' ' 28' ' ' LEU . 1.8 mp0 -109.88 159.28 17.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.861 -1.149 . . . . 40.030000000000001 109.448 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.905 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -135.68 -165.33 1.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.083 -1.01 . . . . 12.390000000000001 110.04 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.896 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -134.64 178.56 6.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.721 . . . . 17.420000000000002 109.392 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' NE2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -172.93 153.74 2.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.955 -1.09 . . . . 13.84 108.893 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.753 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.1 m-30 -112.06 96.77 6.23 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.506 -0.924 . . . . 21.140000000000001 108.506 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.994 ' O ' HG22 ' A' ' 43' ' ' VAL . 85.7 t -97.12 114.92 35.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.036 -1.04 . . . . 10.66 110.118 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.6 p-10 -59.36 -32.13 69.84 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.301 -1.0 . . . . 25.890000000000001 108.301 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.7 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.7 OUTLIER 47.02 28.64 0.92 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.563 -0.711 . . . . 24.239999999999998 109.174 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.39 18.14 71.23 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.371 -1.492 . . . . 31.02 109.371 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.554 ' ND2' HD23 ' A' ' 37' ' ' LEU . 11.4 m120 -91.01 26.67 2.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -1.122 . . . . 43.229999999999997 110.367 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.527 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 1.7 mm-40 48.35 22.24 0.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.138 -0.976 . . . . 42.340000000000003 110.148 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.549 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 3.6 m80 -175.88 153.26 1.35 Allowed Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.074 -1.084 . . . . 5.3799999999999999 108.074 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.645 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.6 Cg_endo -75.73 144.09 27.56 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.923 1.749 . . . . 17.920000000000002 110.938 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.994 HG22 ' O ' ' A' ' 35' ' ' VAL . 14.4 m -119.47 118.37 57.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.735 -0.839 . . . . 20.57 108.735 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.896 HD11 ' HB3' ' A' ' 32' ' ' LEU . 18.6 tp -68.41 111.79 4.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.781 -0.768 . . . . 20.210000000000001 109.339 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 4.0 t -117.2 168.46 8.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.692 -0.63 . . . . 10.81 109.352 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 1.9 mtpt -86.63 174.92 8.57 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.238 -0.914 . . . . 36.740000000000002 110.347 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -155.4 165.25 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -0.856 . . . . 19.739999999999998 109.028 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.475 HG23 HD13 ' A' ' 28' ' ' LEU . 30.8 m -110.79 149.54 30.4 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.319 -0.863 . . . . 22.559999999999999 108.98 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -133.25 127.96 34.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 20.41 109.341 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.09 148.64 41.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 33.990000000000002 109.535 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.62 93.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 54.920000000000002 109.544 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.6 -29.39 3.81 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.722 -1.351 . . . . 36.100000000000001 109.722 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.456 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -72.9 144.87 85.91 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.177 -1.19 . . . . 54.759999999999998 109.597 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -78.2 117.48 4.12 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.696 2.264 . . . . 28.370000000000001 110.585 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.905 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.78 155.51 0.05 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.249 -0.907 . . . . 17.210000000000001 110.196 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.747 ' O ' HG21 ' A' ' 6' ' ' ILE . 15.0 m-30 -49.03 112.53 0.63 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.574 -0.704 . . . . 17.190000000000001 109.758 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.005 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -66.13 177.35 0.78 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 17.82 109.313 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 1.005 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -78.21 113.4 3.38 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.586 2.191 . . . . 17.280000000000001 110.28 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.06 177.27 43.11 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.912 -1.275 . . . . 17.219999999999999 109.912 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 4.9 mp -74.96 152.79 38.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -1.107 . . . . 19.57 108.221 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.724 ' HB3' HD22 ' A' ' 83' ' ' LEU . 17.7 m-85 -140.17 165.18 28.08 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.802 -1.186 . . . . 14.609999999999999 111.78 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.734 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.8 p -145.64 120.55 9.98 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.356 -1.72 . . . . 18.359999999999999 106.356 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.712 ' HB ' HD13 ' A' ' 2' ' ' ILE . 4.7 t -50.38 170.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 C-N-CA 118.739 -1.185 . . . . 19.129999999999999 108.791 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.589 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -130.43 122.98 28.77 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.38 -0.825 . . . . 20.649999999999999 108.942 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.852 HD22 ' H ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -66.65 -6.24 14.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.673 -0.642 . . . . 19.649999999999999 109.747 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.1 t -54.78 -15.87 2.2 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.058 -1.026 . . . . 14.720000000000001 108.565 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 35.1 m -98.79 -5.75 30.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.495 -0.753 . . . . 11.449999999999999 110.891 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.67 ' C ' HD11 ' B' ' 37' ' ' LEU . 2.8 m-30 -81.16 155.7 26.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.763 -1.211 . . . . 14.25 109.988 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.666 ' HA ' HD21 ' B' ' 37' ' ' LEU . 9.9 mtmt -143.78 171.48 14.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.501 -0.749 . . . . 32.700000000000003 109.349 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.708 HG21 HG21 ' B' ' 43' ' ' VAL . 0.5 OUTLIER -117.77 131.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 15.630000000000001 109.603 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.67 175.86 53.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.457 -1.457 . . . . 12.699999999999999 109.457 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.2 9.6 12.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.115 -1.226 . . . . 26.289999999999999 109.893 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 73' ' ' PHE . 30.1 t80 -109.62 9.65 25.07 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.57 -0.707 . . . . 20.440000000000001 109.391 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' B' ' 46' ' ' LYS . . . 70.75 71.66 0.99 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.51 -1.436 . . . . 13.82 109.51 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -165.86 112.6 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -1.153 . . . . 18.27 109.683 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.813 ' CD1' HG11 ' B' ' 35' ' ' VAL . 0.3 OUTLIER -68.51 151.36 46.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 12.43 109.169 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.518 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 7.1 mtp -163.04 139.78 7.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 35.109999999999999 109.842 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.884 HD12 HD12 ' B' ' 78' ' ' ILE . 3.4 mt -67.77 140.78 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 13.67 109.805 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.472 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 1.6 t70 -110.1 -19.24 13.12 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.389 -0.967 . . . . 24.059999999999999 108.389 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.5 OUTLIER 173.01 68.11 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.878 -1.527 . . . . 35.039999999999999 106.878 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -32.06 119.62 0.27 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.512 -0.767 . . . . 18.719999999999999 111.399 -177.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -89.66 110.05 20.97 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.844 -1.169 . . . . 20.550000000000001 107.844 178.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.724 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -82.12 143.86 31.17 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.036 -1.04 . . . . 14.4 111.101 -178.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 62' ' ' THR . 4.5 m -143.99 159.56 52.68 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.97 -1.122 . . . . 17.649999999999999 107.97 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.6 Cg_endo -63.41 147.58 93.3 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.177 1.918 . . . . 25.699999999999999 110.335 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.573 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -74.62 118.75 17.93 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.105 -0.997 . . . . 49.289999999999999 109.541 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.056 -0.973 . . . . 58.909999999999997 109.468 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.528 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.37 -0.604 . . . . 64.909999999999997 109.37 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.852 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.5 mt 50.33 78.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.806 -1.183 . . . . 33.799999999999997 107.806 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.2 156.18 39.86 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.721 0.772 . . . . 32.719999999999999 110.553 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.825 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -165.25 165.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.583 0.706 . . . . 14.460000000000001 109.283 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.526 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 22.4 mt-10 -138.57 116.92 11.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.497 -0.752 . . . . 22.120000000000001 109.333 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.754 HG21 ' O ' ' B' ' 56' ' ' TYR . 19.7 mm -77.55 97.26 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.265 -0.897 . . . . 14.23 108.754 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.585 ' HE2' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.98 161.17 0.3 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.114 -0.991 . . . . 25.43 110.145 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.02 -29.77 4.93 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.665 2.244 . . . . 13.609999999999999 110.169 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.31 -1.05 43.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.436 -0.79 . . . . 15.52 109.058 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.522 ' NE2' ' HA ' ' B' ' 33' ' ' CYS . 9.3 pt20 -129.9 29.0 5.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.861 . . . . 17.309999999999999 109.683 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -85.1 16.36 3.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 24.780000000000001 110.051 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.589 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -138.67 144.49 39.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.085 -1.009 . . . . 47.899999999999999 108.806 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.724 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 12.7 p90 -87.16 178.32 6.92 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.159 -0.963 . . . . 21.609999999999999 109.739 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 9.0 t -132.16 163.08 29.31 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.618 -0.882 . . . . 14.890000000000001 108.618 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.417 ' O ' ' HG2' ' B' ' 16' ' ' ARG . 0.2 OUTLIER -97.13 155.92 16.61 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.15 -0.969 . . . . 17.350000000000001 109.584 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.7 OUTLIER -178.13 132.64 0.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 34.380000000000003 109.429 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.429 ' C ' ' O ' ' B' ' 16' ' ' ARG . 1.2 t -43.53 152.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 38.770000000000003 109.477 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' B' ' 26' ' ' TYR . . . -164.59 132.1 2.6 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.699 -1.36 . . . . 34.579999999999998 109.699 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.33 125.47 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.15 -1.206 . . . . 41.869999999999997 108.733 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.524 ' CB ' ' HE2' ' B' ' 24' ' ' LYS . 0.3 OUTLIER -64.9 -163.08 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.374 -0.829 . . . . 47.210000000000001 109.695 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.28 17.32 20.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 71.560000000000002 109.332 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -114.91 2.57 14.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.316 -0.865 . . . . 66.599999999999994 109.521 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.34 68.4 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.648 -1.381 . . . . 55.490000000000002 109.648 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.524 ' HE2' ' CB ' ' B' ' 20' ' ' SER . 24.1 pttt -101.77 144.64 28.98 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 44.990000000000002 109.368 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 24' ' ' LYS . 35.6 Cg_endo -78.45 151.27 25.71 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.555 2.17 . . . . 44.100000000000001 110.588 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.949 ' CE1' HD23 ' B' ' 28' ' ' LEU . 2.4 p90 -158.25 155.25 28.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.2 -0.937 . . . . 32.090000000000003 109.92 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 42.9 m -117.44 83.93 2.07 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.817 -1.179 . . . . 29.25 107.817 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.949 HD23 ' CE1' ' B' ' 26' ' ' TYR . 0.7 OUTLIER -88.45 157.09 18.77 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 24.0 110.311 -178.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.781 ' N ' HD12 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -93.65 131.76 38.65 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.677 -0.86 . . . . 23.309999999999999 108.677 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.864 ' HG3' HD11 ' B' ' 28' ' ' LEU . 1.8 mp0 -110.02 159.45 17.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.958 -1.089 . . . . 40.030000000000001 109.416 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.925 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -135.81 -165.37 1.69 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.118 -0.989 . . . . 12.390000000000001 109.988 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -134.68 178.46 6.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.533 -0.729 . . . . 17.420000000000002 109.395 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.522 ' HA ' ' NE2' ' B' ' 10' ' ' GLN . 0.1 OUTLIER -172.83 153.73 2.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.002 -1.061 . . . . 13.84 108.933 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.763 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.1 m-30 -112.03 96.68 6.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.462 -0.94 . . . . 21.140000000000001 108.462 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 1.01 ' O ' HG22 ' B' ' 43' ' ' VAL . 85.3 t -96.98 115.08 35.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.066 -1.021 . . . . 10.66 110.155 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.6 p-10 -59.58 -31.86 69.84 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.311 -0.996 . . . . 25.890000000000001 108.311 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.67 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER 46.76 28.61 0.84 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.473 -0.767 . . . . 24.239999999999998 109.17 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.54 18.08 71.46 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.33 -1.508 . . . . 31.02 109.33 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.564 ' ND2' HD23 ' B' ' 37' ' ' LEU . 11.4 m120 -90.88 26.34 2.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.324 -1.103 . . . . 43.229999999999997 110.479 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.527 ' O ' ' ND1' ' B' ' 41' ' ' HIS . 1.7 mm-40 48.6 22.02 0.46 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.07 -1.019 . . . . 42.340000000000003 110.116 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.532 ' O ' ' HA ' ' B' ' 36' ' ' ASP . 3.6 m80 -175.68 153.18 1.4 Allowed Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 108.085 -1.08 . . . . 5.2999999999999998 108.085 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.643 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.5 Cg_endo -75.73 144.08 27.55 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.961 1.774 . . . . 17.920000000000002 110.884 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 1.01 HG22 ' O ' ' B' ' 35' ' ' VAL . 14.0 m -119.46 118.51 57.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.601 -0.84 . . . . 20.57 108.765 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' B' ' 32' ' ' LEU . 18.9 tp -68.56 111.67 4.88 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.848 -0.741 . . . . 20.210000000000001 109.348 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 4.3 t -117.13 168.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.643 -0.661 . . . . 10.81 109.304 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 1.9 mtpt -86.67 174.98 8.51 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.353 -0.842 . . . . 36.740000000000002 110.338 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.593 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -155.42 165.24 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.798 . . . . 19.739999999999998 109.042 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.479 HG23 HD13 ' B' ' 28' ' ' LEU . 31.2 m -110.77 149.49 30.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.371 -0.831 . . . . 22.559999999999999 108.992 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' B' ' 29' ' ' ASN . 0.3 OUTLIER -133.25 127.83 34.55 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.391 -0.818 . . . . 20.41 109.363 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.94 148.52 42.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 33.990000000000002 109.512 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.44 93.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 54.920000000000002 109.55 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.32 -29.13 3.92 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.687 -1.365 . . . . 36.100000000000001 109.687 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.454 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -73.1 144.91 85.44 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.112 -1.228 . . . . 54.759999999999998 109.515 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.4 Cg_endo -78.4 117.32 4.03 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.708 2.272 . . . . 28.370000000000001 110.591 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.925 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.52 155.7 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.18 -0.95 . . . . 17.210000000000001 110.199 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.754 ' O ' HG21 ' B' ' 6' ' ' ILE . 15.2 m-30 -49.34 112.51 0.65 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.485 -0.759 . . . . 17.190000000000001 109.876 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -65.85 177.2 0.76 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.322 -0.861 . . . . 17.82 109.258 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 36.0 Cg_endo -78.17 114.51 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.577 2.185 . . . . 17.280000000000001 110.444 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.64 177.92 42.36 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.834 -1.306 . . . . 17.219999999999999 109.834 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.0 mp -75.11 152.94 38.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -1.097 . . . . 19.57 108.396 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.726 ' HB3' HD22 ' B' ' 83' ' ' LEU . 17.6 m-85 -140.36 165.0 28.6 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.85 -1.156 . . . . 14.609999999999999 111.77 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.736 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.7 p -145.54 120.35 9.92 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.413 -1.699 . . . . 18.359999999999999 106.413 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.728 ' HB ' HD13 ' B' ' 2' ' ' ILE . 4.8 t -50.14 170.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 C-N-CA 118.836 -1.145 . . . . 19.129999999999999 108.769 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.586 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -130.53 123.13 28.91 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.391 -0.818 . . . . 20.649999999999999 108.992 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.851 HD22 ' H ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -66.61 -6.66 16.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.733 -0.605 . . . . 19.649999999999999 109.759 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 28.2 t -54.35 -16.11 2.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.984 -1.073 . . . . 14.720000000000001 108.575 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 33.0 m -98.66 -6.27 30.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.485 -0.759 . . . . 11.449999999999999 110.917 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.7 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.7 m-30 -80.69 155.47 26.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.751 -1.218 . . . . 14.25 109.844 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.656 ' HA ' HD21 ' A' ' 37' ' ' LEU . 10.0 mtmt -143.46 171.83 13.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.517 -0.739 . . . . 32.700000000000003 109.309 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.753 HG21 HG21 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -118.04 131.84 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 15.630000000000001 109.586 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.83 176.09 53.29 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.46 -1.456 . . . . 12.699999999999999 109.46 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.4 9.45 13.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.114 -1.227 . . . . 26.289999999999999 109.864 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' B' ' 73' ' ' PHE . 30.1 t80 -109.45 9.65 25.44 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.564 -0.71 . . . . 20.440000000000001 109.428 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . 70.76 71.85 0.97 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.506 -1.438 . . . . 13.82 109.506 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -165.97 112.64 0.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -1.143 . . . . 18.27 109.715 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.822 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -68.58 151.33 46.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 12.43 109.193 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 7.1 mtp -163.1 139.84 7.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 35.109999999999999 109.796 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.884 HD12 HD12 ' A' ' 78' ' ' ILE . 3.4 mt -67.94 140.97 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.349 -0.844 . . . . 13.67 109.895 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.468 ' HB2' ' HG3' ' B' ' 69' ' ' LYS . 1.6 t70 -110.18 -19.26 13.09 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.376 -0.972 . . . . 24.059999999999999 108.376 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.6 OUTLIER 173.08 68.11 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.919 -1.511 . . . . 35.039999999999999 106.919 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.659 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -32.02 119.59 0.27 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.521 -0.763 . . . . 18.719999999999999 111.447 -177.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -89.66 109.97 20.89 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.91 -1.145 . . . . 20.550000000000001 107.91 178.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.726 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -82.1 143.74 31.27 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.042 -1.036 . . . . 14.4 111.095 -178.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.736 HG22 ' O ' ' B' ' 62' ' ' THR . 4.5 m -143.86 159.66 52.74 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.949 -1.13 . . . . 17.649999999999999 107.949 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -63.55 147.84 92.78 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.115 1.877 . . . . 25.699999999999999 110.394 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.576 ' HA ' HG23 ' B' ' 62' ' ' THR . . . -74.7 118.68 17.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.13 -0.981 . . . . 49.289999999999999 109.627 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.977 -1.011 . . . . 58.909999999999997 109.482 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.5 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.531 -0.544 . . . . 64.909999999999997 109.531 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.831 ' HA ' HD21 ' B' ' 65' ' ' LEU . 2.8 mt -59.04 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.879 -1.156 . . . . 33.799999999999997 107.879 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -63.39 158.65 20.04 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.81 0.814 . . . . 32.719999999999999 111.377 -177.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.055 HG22 HG22 ' A' ' 35' ' ' VAL . 60.6 t -159.99 167.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.579 0.704 . . . . 14.460000000000001 109.583 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.607 ' N ' HG12 ' A' ' 4' ' ' VAL . 22.7 mt-10 -151.7 103.84 2.98 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.946 -0.761 . . . . 22.120000000000001 108.946 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.744 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -70.67 105.69 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.092 -1.077 . . . . 14.23 108.092 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.655 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.22 173.48 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.419 -0.801 . . . . 25.43 109.988 -178.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.1 Cg_endo -76.26 -22.12 12.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.512 2.142 . . . . 13.609999999999999 109.727 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -101.04 8.05 43.12 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.153 -0.684 . . . . 15.52 109.153 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.531 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 17.6 mm-40 -125.25 36.04 4.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.243 -0.911 . . . . 17.309999999999999 109.401 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.13 16.54 24.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 24.780000000000001 110.151 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 4.6 tt0 -137.5 130.23 30.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.099 -1.0 . . . . 47.899999999999999 108.705 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.597 ' H ' ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -76.85 -170.69 1.69 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.088 -1.007 . . . . 21.609999999999999 110.689 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -143.25 126.98 17.08 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.656 -0.653 . . . . 14.890000000000001 109.249 179.066 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.2 112.21 21.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.357 -0.84 . . . . 17.350000000000001 109.331 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 18' ' ' GLY . 6.6 tpm_? -131.82 142.32 49.69 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.295 -0.878 . . . . 34.380000000000003 109.518 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.83 87.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 38.770000000000003 109.348 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -81.91 172.2 52.86 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.653 -1.379 . . . . 34.579999999999998 109.653 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.457 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -139.16 116.96 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.301 -1.117 . . . . 41.869999999999997 108.946 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 24' ' ' LYS . 3.3 m -58.18 108.68 0.63 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.294 -0.879 . . . . 47.210000000000001 109.64 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 44.79 38.2 2.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.269 -0.895 . . . . 71.560000000000002 109.569 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 58.53 18.43 5.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 66.599999999999994 109.574 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.7 -55.94 1.05 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.457 -1.457 . . . . 55.490000000000002 109.457 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' SER . 7.5 mttt -126.93 147.99 63.67 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.301 -1.117 . . . . 44.990000000000002 109.332 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.11 129.96 9.98 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.578 2.185 . . . . 44.100000000000001 110.54 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 8.3 p90 -137.17 139.37 41.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.109 -0.995 . . . . 32.090000000000003 109.69 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.05 77.58 2.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 29.25 108.833 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.706 HD22 HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -93.08 158.95 15.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 24.0 110.145 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.586 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -99.95 117.93 35.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -0.754 . . . . 23.309999999999999 109.067 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -86.56 -173.58 4.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.054 -1.029 . . . . 40.030000000000001 109.14 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.579 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -173.48 -170.96 0.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 12.390000000000001 109.962 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' A' ' 44' ' ' LEU . 4.1 mp -145.52 169.9 17.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.473 -0.767 . . . . 17.420000000000002 109.238 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -167.99 166.95 13.01 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.223 -1.028 . . . . 13.84 108.223 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.678 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 31.9 m-85 -118.78 103.19 9.42 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.089 -1.007 . . . . 21.140000000000001 109.498 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.055 HG22 HG22 ' A' ' 4' ' ' VAL . 54.3 t -85.6 144.87 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.109 -0.994 . . . . 10.66 110.29 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.4 m-20 -128.48 -140.49 0.25 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.715 -0.846 . . . . 25.890000000000001 108.715 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.959 ' HG ' HD13 ' B' ' 65' ' ' LEU . 0.1 OUTLIER 68.39 -63.13 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.927 -1.108 . . . . 24.239999999999998 109.222 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -85.98 16.26 43.55 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.593 -1.803 . . . . 31.02 108.593 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -177.83 111.92 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.468 -1.019 . . . . 43.229999999999997 109.083 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' ASN . 1.3 mm-40 -40.78 -66.96 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.476 -0.765 . . . . 42.340000000000003 109.763 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -60.06 153.63 54.94 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 108.574 -0.899 . . . . 5.5800000000000001 108.574 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.678 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.4 Cg_endo -77.34 142.83 21.58 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.146 1.897 . . . . 17.920000000000002 110.22 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.878 HG21 HG21 ' B' ' 70' ' ' VAL . 27.5 m -113.75 113.83 45.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.32 -0.863 . . . . 20.57 109.302 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' A' ' 32' ' ' LEU . 41.0 tp -69.78 112.09 5.99 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.374 -0.829 . . . . 20.210000000000001 110.221 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.603 HG12 ' CG1' ' B' ' 70' ' ' VAL . 4.9 m -112.94 -172.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.9 -0.778 . . . . 10.81 108.9 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -111.93 154.87 24.59 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.467 -0.893 . . . . 36.740000000000002 110.329 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.583 HG13 ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -129.15 162.38 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 108.924 -0.769 . . . . 19.739999999999998 108.924 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.706 HG22 HD22 ' A' ' 28' ' ' LEU . 4.5 m -119.17 73.64 0.95 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.349 -0.844 . . . . 22.559999999999999 109.235 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -40.62 133.52 1.97 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.759 . . . . 20.41 109.663 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -55.26 -166.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 33.990000000000002 109.623 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.22 -83.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 54.920000000000002 109.725 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.24 40.85 2.28 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.623 -1.391 . . . . 36.100000000000001 109.623 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.536 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -89.93 152.63 46.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.194 -1.18 . . . . 54.759999999999998 109.635 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.14 119.25 4.58 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.813 2.342 . . . . 28.370000000000001 110.742 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.61 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -41.16 146.53 0.18 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.369 -0.832 . . . . 17.210000000000001 110.339 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.744 ' O ' HG21 ' A' ' 6' ' ' ILE . 14.7 m-30 -52.13 99.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -0.825 . . . . 17.190000000000001 109.169 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.818 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -45.61 170.75 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 17.82 109.502 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.818 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.6 108.32 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.576 2.184 . . . . 17.280000000000001 110.143 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.21 -178.12 48.63 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.958 -1.257 . . . . 17.219999999999999 109.958 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 6.4 mp -73.91 149.6 41.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -1.057 . . . . 19.57 108.641 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.745 ' HB3' HD22 ' A' ' 83' ' ' LEU . 12.1 m-85 -134.98 163.74 29.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.921 -1.112 . . . . 14.609999999999999 111.373 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.771 ' O ' HG22 ' A' ' 84' ' ' VAL . 29.2 p -145.65 119.37 9.2 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.721 -1.585 . . . . 18.359999999999999 106.721 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.578 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 18.5 t -47.81 170.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 C-N-CA 119.337 -0.945 . . . . 19.129999999999999 109.142 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.2 t-80 -133.82 126.04 29.71 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.823 -0.806 . . . . 20.649999999999999 108.823 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.939 HD13 ' HG ' ' B' ' 37' ' ' LEU . 4.6 mp -62.67 -8.0 5.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.644 -0.66 . . . . 19.649999999999999 110.432 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.407 ' OG ' ' HD3' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -47.29 -24.07 0.68 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.901 -1.124 . . . . 14.720000000000001 107.986 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 3.4 m -98.32 -13.04 20.91 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.68 -0.638 . . . . 11.449999999999999 110.673 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.673 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.6 m-30 -81.33 156.59 25.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.732 -1.23 . . . . 14.25 110.131 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -155.19 166.76 32.57 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.942 -0.762 . . . . 32.700000000000003 108.942 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.899 HG21 HG21 ' B' ' 43' ' ' VAL . 3.0 t -104.05 125.28 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -0.949 . . . . 15.630000000000001 109.227 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.6 173.62 55.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.728 -1.349 . . . . 12.699999999999999 109.728 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.0 OUTLIER -75.77 -1.14 23.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.206 -1.173 . . . . 26.289999999999999 109.83 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.07 -17.0 26.93 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.406 -0.809 . . . . 20.440000000000001 109.521 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.13 52.27 2.42 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.624 -1.391 . . . . 13.82 109.624 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.4 m -156.38 115.18 3.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -1.159 . . . . 18.27 109.507 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.754 HD12 HG11 ' B' ' 35' ' ' VAL . 7.1 tt -50.44 153.2 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 12.43 109.49 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.495 ' N ' HD23 ' A' ' 76' ' ' LEU . 25.3 mtt -161.1 123.84 3.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 35.109999999999999 109.718 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.934 HD12 HD12 ' B' ' 78' ' ' ILE . 3.1 mt -61.55 140.64 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.367 -0.833 . . . . 13.67 109.92 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 26.7 t70 -111.35 -16.95 13.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.338 -0.851 . . . . 24.059999999999999 108.972 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.505 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 169.09 63.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.577 -1.638 . . . . 35.039999999999999 106.577 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -27.2 119.59 0.09 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.665 -1.152 . . . . 18.719999999999999 112.583 -177.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.26 103.33 16.02 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.397 -1.334 . . . . 20.550000000000001 107.397 177.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.887 HD11 HG11 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -77.1 145.39 37.85 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.974 -1.079 . . . . 14.4 111.487 -177.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 62' ' ' THR . 17.8 m -144.75 160.5 47.02 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 107.835 -1.172 . . . . 17.649999999999999 107.835 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.3 Cg_endo -63.93 145.96 90.8 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.065 1.843 . . . . 25.699999999999999 110.42 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.581 ' CA ' HG23 ' A' ' 62' ' ' THR . . . -81.65 125.37 30.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.1 -1.0 . . . . 49.289999999999999 109.477 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.023 -0.989 . . . . 58.909999999999997 109.443 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.5 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.456 -0.572 . . . . 64.909999999999997 109.456 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.831 ' HA ' HD21 ' A' ' 65' ' ' LEU . 2.8 mt -59.0 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.856 -1.164 . . . . 33.799999999999997 107.856 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -63.39 158.66 20.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.803 0.811 . . . . 32.719999999999999 111.411 -177.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.12 HG22 HG22 ' B' ' 35' ' ' VAL . 61.0 t -159.99 167.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.565 0.697 . . . . 14.460000000000001 109.617 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.6 ' N ' HG12 ' B' ' 4' ' ' VAL . 22.6 mt-10 -151.8 104.02 2.98 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.924 -0.769 . . . . 22.120000000000001 108.924 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.738 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -70.82 105.63 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.069 -1.086 . . . . 14.23 108.069 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.664 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.19 173.43 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.43 -0.794 . . . . 25.43 109.974 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.0 Cg_endo -76.18 -22.26 12.98 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.484 2.122 . . . . 13.609999999999999 109.777 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -100.97 8.24 43.15 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.575 -0.703 . . . . 15.52 109.136 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 17.5 mm-40 -125.3 35.82 4.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 17.309999999999999 109.38 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.89 16.3 24.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.112 -0.992 . . . . 24.780000000000001 110.12 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 4.4 tt0 -137.25 130.39 30.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.143 -0.973 . . . . 47.899999999999999 108.7 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.599 ' H ' ' HB2' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -77.04 -170.7 1.75 Allowed 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.091 -1.005 . . . . 21.609999999999999 110.711 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -143.32 126.74 16.76 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.613 -0.679 . . . . 14.890000000000001 109.339 179.083 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.06 112.28 21.73 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.399 -0.813 . . . . 17.350000000000001 109.382 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' B' ' 18' ' ' GLY . 6.6 tpm_? -131.89 142.13 49.58 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.295 -0.878 . . . . 34.380000000000003 109.534 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.54 87.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.905 . . . . 38.770000000000003 109.35 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -82.13 172.29 52.62 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.613 -1.395 . . . . 34.579999999999998 109.613 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.456 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.6 OUTLIER -139.31 116.88 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -1.151 . . . . 41.869999999999997 108.97 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.515 ' N ' ' O ' ' B' ' 24' ' ' LYS . 3.3 m -58.05 108.74 0.63 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.307 -0.871 . . . . 47.210000000000001 109.643 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' B' ' 20' ' ' SER . 5.4 mmm180 44.75 38.18 2.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.296 -0.878 . . . . 71.560000000000002 109.575 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 58.57 18.4 5.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 66.599999999999994 109.615 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.59 -56.15 1.05 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.479 -1.449 . . . . 55.490000000000002 109.479 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' B' ' 20' ' ' SER . 7.5 mttt -126.67 147.85 62.42 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.232 -1.158 . . . . 44.990000000000002 109.299 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 24' ' ' LYS . 35.5 Cg_endo -78.03 129.76 9.93 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.564 2.176 . . . . 44.100000000000001 110.615 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 8.3 p90 -136.87 139.36 41.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 32.090000000000003 109.743 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.95 77.86 2.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.158 -0.964 . . . . 29.25 108.827 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.712 HD22 HG22 ' B' ' 48' ' ' THR . 0.0 OUTLIER -93.34 158.98 15.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 24.0 110.105 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.596 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -100.04 118.0 35.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -0.792 . . . . 23.309999999999999 109.02 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -86.61 -173.59 4.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 40.030000000000001 109.096 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.573 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -173.5 -171.04 0.65 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.153 -0.967 . . . . 12.390000000000001 109.948 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.922 ' HB3' HD11 ' B' ' 44' ' ' LEU . 4.1 mp -145.41 169.83 17.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.424 -0.798 . . . . 17.420000000000002 109.231 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -167.95 166.82 13.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.305 -0.998 . . . . 13.84 108.305 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.686 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 31.6 m-85 -118.7 103.18 9.43 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.091 -1.006 . . . . 21.140000000000001 109.478 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 1.12 HG22 HG22 ' B' ' 4' ' ' VAL . 54.6 t -85.55 144.93 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.077 -1.014 . . . . 10.66 110.228 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.5 m-20 -128.71 -140.57 0.24 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.722 -0.844 . . . . 25.890000000000001 108.722 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.939 ' HG ' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER 68.48 -63.29 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.941 -1.1 . . . . 24.239999999999998 109.263 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -85.89 16.4 42.27 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.58 -1.808 . . . . 31.02 108.58 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' B' ' 40' ' ' GLU . 0.4 OUTLIER -177.96 111.88 0.07 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.545 -0.973 . . . . 43.229999999999997 109.066 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 39' ' ' ASN . 1.3 mm-40 -40.71 -67.07 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.514 -0.741 . . . . 42.340000000000003 109.777 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -59.94 153.55 54.05 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 108.615 -0.883 . . . . 5.5599999999999996 108.615 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.686 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.4 Cg_endo -77.35 142.78 21.51 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.121 1.88 . . . . 17.920000000000002 110.323 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.899 HG21 HG21 ' A' ' 70' ' ' VAL . 27.4 m -113.7 113.68 44.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.25 -0.906 . . . . 20.57 109.412 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.922 HD11 ' HB3' ' B' ' 32' ' ' LEU . 40.1 tp -69.65 111.8 5.7 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.407 -0.808 . . . . 20.210000000000001 110.161 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.588 HG12 ' CG1' ' A' ' 70' ' ' VAL . 5.1 m -112.66 -172.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.882 -0.784 . . . . 10.81 108.882 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -111.89 155.08 24.23 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.444 -0.902 . . . . 36.740000000000002 110.311 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.591 HG13 ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -129.36 162.31 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.894 -0.78 . . . . 19.739999999999998 108.894 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.712 HG22 HD22 ' B' ' 28' ' ' LEU . 4.4 m -119.24 73.72 0.95 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.295 -0.878 . . . . 22.559999999999999 109.239 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -40.63 133.41 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.521 -0.737 . . . . 20.41 109.671 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.505 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -55.19 -166.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 33.990000000000002 109.688 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -83.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 54.920000000000002 109.745 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.22 40.62 2.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.64 -1.384 . . . . 36.100000000000001 109.64 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.539 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.1 OUTLIER -89.67 152.6 47.18 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.269 -1.136 . . . . 54.759999999999998 109.649 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.16 119.22 4.56 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.792 2.328 . . . . 28.370000000000001 110.734 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -41.11 146.1 0.19 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.356 -0.84 . . . . 17.210000000000001 110.333 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.738 ' O ' HG21 ' B' ' 6' ' ' ILE . 14.8 m-30 -51.9 100.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 17.190000000000001 109.163 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.834 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -45.9 170.83 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 17.82 109.508 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.834 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -77.69 108.45 2.56 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.562 2.174 . . . . 17.280000000000001 110.186 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.88 -178.33 48.74 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.933 -1.267 . . . . 17.219999999999999 109.933 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 6.4 mp -73.54 150.01 41.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -1.101 . . . . 19.57 108.667 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.743 ' HB3' HD22 ' B' ' 83' ' ' LEU . 12.0 m-85 -135.31 163.8 29.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.926 -1.109 . . . . 14.609999999999999 111.349 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.784 ' O ' HG22 ' B' ' 84' ' ' VAL . 29.4 p -145.73 119.47 9.22 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.67 -1.604 . . . . 18.359999999999999 106.67 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.569 HG21 HG21 ' B' ' 2' ' ' ILE . 18.6 t -47.95 170.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 C-N-CA 119.314 -0.954 . . . . 19.129999999999999 109.095 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.562 ' N ' HG12 ' B' ' 63' ' ' VAL . 2.2 t-80 -133.65 126.33 30.6 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.842 -0.799 . . . . 20.649999999999999 108.842 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.959 HD13 ' HG ' ' A' ' 37' ' ' LEU . 4.5 mp -63.0 -7.92 6.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.64 -0.662 . . . . 19.649999999999999 110.465 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.441 ' C ' ' O ' ' B' ' 65' ' ' LEU . 0.4 OUTLIER -47.17 -24.23 0.66 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.875 -1.141 . . . . 14.720000000000001 107.937 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.502 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 3.3 m -98.22 -13.27 20.92 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.774 -0.579 . . . . 11.449999999999999 110.753 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.68 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.5 m-30 -81.2 156.37 25.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.761 -1.212 . . . . 14.25 110.011 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' B' ' 77' ' ' MET . 0.0 OUTLIER -154.96 166.93 32.01 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.898 -0.778 . . . . 32.700000000000003 108.898 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.878 HG21 HG21 ' A' ' 43' ' ' VAL . 3.0 t -104.1 125.35 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 15.630000000000001 109.232 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.64 173.68 55.25 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.732 -1.347 . . . . 12.699999999999999 109.732 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.446 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 1.0 OUTLIER -75.89 -1.28 24.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.252 -1.146 . . . . 26.289999999999999 109.822 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -90.85 -17.35 26.68 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.408 -0.807 . . . . 20.440000000000001 109.52 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.54 52.42 2.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.662 -1.375 . . . . 13.82 109.662 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 57.9 m -156.59 115.33 3.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -1.163 . . . . 18.27 109.531 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.771 HD12 HG11 ' A' ' 35' ' ' VAL . 7.0 tt -50.53 152.92 1.77 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 12.43 109.447 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.489 ' N ' HD23 ' B' ' 76' ' ' LEU . 25.3 mtt -160.94 123.52 3.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 35.109999999999999 109.741 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.934 HD12 HD12 ' A' ' 78' ' ' ILE . 3.0 mt -61.32 140.71 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 13.67 109.924 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 26.6 t70 -111.24 -17.26 13.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.391 -0.818 . . . . 24.059999999999999 108.928 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.502 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 169.38 63.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.592 -1.633 . . . . 35.039999999999999 106.592 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.636 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.5 OUTLIER -27.2 119.44 0.09 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.711 -1.131 . . . . 18.719999999999999 112.576 -177.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.15 103.28 15.97 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.356 -1.349 . . . . 20.550000000000001 107.356 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.892 HD11 HG11 ' B' ' 4' ' ' VAL . 0.4 OUTLIER -77.06 145.22 38.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.905 -1.122 . . . . 14.4 111.515 -177.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.784 HG22 ' O ' ' B' ' 62' ' ' THR . 17.6 m -144.72 160.44 47.34 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.838 -1.171 . . . . 17.649999999999999 107.838 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.5 Cg_endo -63.88 146.01 91.08 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.099 1.866 . . . . 25.699999999999999 110.464 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -81.66 125.33 30.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.987 . . . . 49.289999999999999 109.528 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.987 -1.006 . . . . 58.909999999999997 109.452 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.483 ' C ' HD22 ' B' ' 65' ' ' LEU . 1.7 pmm? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.33 0.586 . . . . 64.909999999999997 109.46 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.848 ' CA ' HD22 ' B' ' 65' ' ' LEU . 3.0 mt -67.82 80.29 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.113 -1.069 . . . . 33.799999999999997 108.113 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.485 ' HB3' ' OD2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -64.35 153.9 37.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.77 0.795 . . . . 32.719999999999999 110.906 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.886 HG11 HD21 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -163.26 165.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.693 -0.854 . . . . 14.460000000000001 108.693 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 31.3 mt-10 -141.8 113.03 7.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 22.120000000000001 109.381 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.857 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -73.96 103.76 2.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 119.014 -1.075 . . . . 14.23 108.231 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.652 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.85 171.4 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.366 -0.834 . . . . 25.43 109.84 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.3 Cg_endo -76.1 -29.28 6.7 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.492 2.128 . . . . 13.609999999999999 109.803 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 t -85.12 -0.45 54.57 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.912 -0.774 . . . . 15.52 108.912 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 31.3 mm-40 -118.0 35.9 4.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.358 -0.839 . . . . 17.309999999999999 109.304 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -101.06 10.81 40.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 24.780000000000001 110.475 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.434 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -139.26 131.55 28.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.043 -1.035 . . . . 47.899999999999999 108.718 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.634 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 26.4 p90 -85.99 177.45 7.58 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.081 -1.012 . . . . 21.609999999999999 110.171 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 9.1 t -130.93 162.39 29.8 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.402 -0.962 . . . . 14.890000000000001 108.402 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 15.0 t -110.38 161.92 15.17 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.056 -1.028 . . . . 17.350000000000001 110.005 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -177.33 145.86 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.997 -0.742 . . . . 34.380000000000003 108.997 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.01 87.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 38.770000000000003 109.751 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -78.45 -174.81 44.49 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.11 -1.596 . . . . 34.579999999999998 109.11 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.484 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 1.3 t -149.58 117.79 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.26 . . . . 41.869999999999997 109.173 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.72 -95.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.386 -0.822 . . . . 47.210000000000001 109.805 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.519 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 7.9 ttp180 -119.74 51.95 1.14 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 71.560000000000002 109.606 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 21' ' ' ARG . 5.5 mt-30 67.67 13.88 9.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 66.599999999999994 109.629 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.53 -52.57 1.54 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.285 -1.526 . . . . 55.490000000000002 109.285 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -148.74 148.25 27.22 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.351 -1.088 . . . . 44.990000000000002 109.028 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 35.0 Cg_endo -77.55 138.09 16.99 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.501 2.134 . . . . 44.100000000000001 110.755 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.691 ' CD1' HD23 ' A' ' 28' ' ' LEU . 6.8 p90 -124.96 141.27 52.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.207 -0.933 . . . . 32.090000000000003 109.926 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.8 75.92 4.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.265 -1.013 . . . . 29.25 108.265 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.691 HD23 ' CD1' ' A' ' 26' ' ' TYR . 2.0 mm? -91.98 159.51 15.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.34 -0.85 . . . . 24.0 110.23 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.634 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -101.43 131.35 47.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.811 . . . . 23.309999999999999 108.894 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 87.7 mt-10 -113.98 157.98 21.76 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -0.988 . . . . 40.030000000000001 109.758 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.616 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -139.78 -167.87 2.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 12.390000000000001 109.226 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.915 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.3 mp -134.74 176.46 8.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 17.420000000000002 109.195 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.48 166.45 8.38 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.063 -1.023 . . . . 13.84 108.58 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.663 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.2 m-85 -120.15 106.11 11.63 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 21.140000000000001 109.423 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.979 ' O ' HG22 ' A' ' 43' ' ' VAL . 82.2 t -98.89 111.32 28.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.134 -0.979 . . . . 10.66 109.565 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.5 p30 -52.31 -30.2 27.14 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.192 -0.943 . . . . 25.890000000000001 108.487 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.679 HD21 ' HA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 45.29 36.92 2.47 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.48 -0.762 . . . . 24.239999999999998 109.093 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.53 18.92 39.35 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.35 -1.5 . . . . 31.02 109.35 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.493 HD22 HD23 ' A' ' 37' ' ' LEU . 11.8 m120 -92.33 25.86 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -1.113 . . . . 43.229999999999997 110.483 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 45.6 mt-10 44.3 25.68 0.13 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.065 -1.022 . . . . 42.340000000000003 109.776 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 9.9 m80 -173.03 150.8 2.02 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.952 -1.129 . . . . 2.8599999999999999 107.952 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.2 Cg_endo -75.98 136.12 18.11 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.788 1.659 . . . . 17.920000000000002 110.622 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 35' ' ' VAL . 10.3 m -112.16 115.41 49.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.564 -0.902 . . . . 20.57 108.564 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.915 HD11 ' HB3' ' A' ' 32' ' ' LEU . 47.6 tp -66.48 107.48 2.07 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.341 -0.849 . . . . 20.210000000000001 109.223 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 3.8 t -112.65 167.58 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.511 -0.743 . . . . 10.81 109.41 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -91.13 163.43 14.28 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.301 -0.874 . . . . 36.740000000000002 109.997 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.94 HD13 HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -151.43 172.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.26 -0.9 . . . . 19.739999999999998 109.289 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.842 HG21 ' NH1' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -110.09 153.64 24.38 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 22.559999999999999 109.255 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.6 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -127.55 101.58 6.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.404 -0.81 . . . . 20.41 109.057 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 2.6 t0 -44.28 144.62 0.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.853 . . . . 33.990000000000002 109.999 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -64.24 102.1 0.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 54.920000000000002 109.091 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.13 -26.19 6.82 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.02 -1.632 . . . . 36.100000000000001 109.02 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.497 ' O ' HD12 ' A' ' 49' ' ' LEU . 8.1 mt-30 -76.56 144.24 73.4 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.356 -1.085 . . . . 54.759999999999998 109.13 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -78.01 130.16 10.19 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.52 2.147 . . . . 28.370000000000001 110.518 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.616 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -39.58 141.72 0.36 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.495 -0.753 . . . . 17.210000000000001 110.082 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.857 ' O ' HG21 ' A' ' 6' ' ' ILE . 87.0 m-85 -43.23 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.407 -0.808 . . . . 17.190000000000001 109.027 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.733 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -42.71 166.16 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 17.82 109.699 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.733 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.3 Cg_endo -77.02 111.91 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.568 2.179 . . . . 17.280000000000001 110.062 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.38 -175.73 47.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.804 -1.318 . . . . 17.219999999999999 109.804 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 4.7 mp -76.09 147.48 38.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.286 -1.126 . . . . 19.57 108.706 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.768 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.7 m-85 -137.4 165.13 26.97 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.457 1.122 . . . . 14.609999999999999 111.204 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.796 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.5 p -145.43 120.57 10.13 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.066 -1.827 . . . . 18.359999999999999 106.066 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -53.95 164.97 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 118.392 -1.323 . . . . 19.129999999999999 108.877 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.433 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.3 t-80 -127.07 129.91 48.91 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.913 -0.773 . . . . 20.649999999999999 108.913 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.861 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -71.79 0.56 8.68 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.41 -0.806 . . . . 19.649999999999999 109.802 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.36 -21.06 8.49 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.252 -1.388 . . . . 14.720000000000001 107.252 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.507 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 24.4 m -95.12 -9.2 34.26 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.855 -0.528 . . . . 11.449999999999999 110.058 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.672 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.0 m-30 -78.73 156.61 28.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 14.25 109.705 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.672 ' HA ' HD21 ' B' ' 37' ' ' LEU . 12.2 mttt -146.97 173.89 12.02 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 32.700000000000003 109.356 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.614 HG22 HD13 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -111.58 111.57 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 15.630000000000001 109.433 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.22 -177.34 47.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.489 -1.444 . . . . 12.699999999999999 109.489 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.93 38.95 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.196 -1.179 . . . . 26.289999999999999 109.55 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.12 24.77 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 20.440000000000001 109.579 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.442 ' C ' HG13 ' B' ' 45' ' ' VAL . . . 50.1 58.75 8.3 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.543 -1.423 . . . . 13.82 109.543 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.25 131.83 1.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -1.114 . . . . 18.27 109.667 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.513 HD11 HD12 ' B' ' 37' ' ' LEU . 1.2 tp -69.38 153.74 43.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 12.43 109.108 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 76' ' ' LEU . 4.5 mmt -154.73 121.67 5.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.969 . . . . 35.109999999999999 109.557 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.943 HD12 HD12 ' B' ' 78' ' ' ILE . 2.6 mt -57.26 141.96 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 13.67 109.831 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -116.0 -3.32 12.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.422 -0.799 . . . . 24.059999999999999 109.034 178.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.842 ' NH1' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER 156.49 62.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.998 -1.482 . . . . 35.039999999999999 106.998 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -27.75 120.23 0.1 Allowed 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.017 -0.992 . . . . 18.719999999999999 112.141 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -91.99 102.15 14.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.67 -0.863 . . . . 20.550000000000001 108.67 179.05 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.94 HD12 HD13 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -70.37 145.26 51.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.279 -0.888 . . . . 14.4 111.281 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 62' ' ' THR . 35.2 m -146.5 151.16 42.65 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.937 -1.134 . . . . 17.649999999999999 107.937 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.3 Cg_endo -62.72 145.7 95.03 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.203 1.935 . . . . 25.699999999999999 110.464 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -78.98 115.06 18.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 49.289999999999999 109.754 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.019 -0.991 . . . . 58.909999999999997 109.431 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.478 ' C ' HD22 ' A' ' 65' ' ' LEU . 1.7 pmm? . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.36 0.6 . . . . 64.909999999999997 109.516 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.861 ' CA ' HD22 ' A' ' 65' ' ' LEU . 3.0 mt -67.91 80.13 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.12 -1.067 . . . . 33.799999999999997 108.12 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.49 ' HB3' ' OD2' ' B' ' 36' ' ' ASP . 0.0 OUTLIER -64.26 153.87 36.82 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.771 0.796 . . . . 32.719999999999999 110.87 -178.458 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.886 HG11 HD21 ' B' ' 83' ' ' LEU . 0.1 OUTLIER -163.27 165.05 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.633 -0.877 . . . . 14.460000000000001 108.633 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 31.4 mt-10 -141.75 112.87 7.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 22.120000000000001 109.478 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.844 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -73.85 103.68 2.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.999 -1.08 . . . . 14.23 108.225 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.655 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.81 171.33 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.402 -0.811 . . . . 25.43 109.852 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -76.1 -29.21 6.76 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.496 2.13 . . . . 13.609999999999999 109.856 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.3 t -85.07 -0.59 54.97 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.829 -0.804 . . . . 15.52 108.829 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 31.4 mm-40 -118.0 36.03 4.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.419 -0.801 . . . . 17.309999999999999 109.292 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -101.2 10.94 40.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.167 -0.958 . . . . 24.780000000000001 110.44 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.442 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.5 OUTLIER -139.3 131.61 28.37 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.145 -0.972 . . . . 47.899999999999999 108.672 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.634 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 26.3 p90 -86.07 177.53 7.53 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.058 -1.026 . . . . 21.609999999999999 110.052 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 9.2 t -130.98 162.38 29.88 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.392 -0.966 . . . . 14.890000000000001 108.392 178.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' B' ' 16' ' ' ARG . 15.0 t -110.4 161.96 15.14 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.127 -0.983 . . . . 17.350000000000001 109.993 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' B' ' 15' ' ' THR . 0.3 OUTLIER -177.31 145.85 0.46 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.961 -0.755 . . . . 34.380000000000003 108.961 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.99 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 38.770000000000003 109.763 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.573 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -78.49 -174.85 44.65 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.118 -1.593 . . . . 34.579999999999998 109.118 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.481 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.3 t -149.5 117.86 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -1.222 . . . . 41.869999999999997 109.139 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.83 -95.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.361 -0.837 . . . . 47.210000000000001 109.815 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.523 ' O ' ' CG ' ' B' ' 21' ' ' ARG . 8.0 ttp180 -119.79 51.9 1.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 71.560000000000002 109.636 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' B' ' 21' ' ' ARG . 5.5 mt-30 67.63 13.94 9.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 66.599999999999994 109.627 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.55 -52.66 1.53 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.257 -1.537 . . . . 55.490000000000002 109.257 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -148.64 148.34 27.79 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.345 -1.091 . . . . 44.990000000000002 109.03 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.9 Cg_endo -77.65 138.17 16.87 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.479 2.12 . . . . 44.100000000000001 110.683 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.678 ' CD1' HD23 ' B' ' 28' ' ' LEU . 6.9 p90 -125.12 141.23 52.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 32.090000000000003 109.875 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.81 75.91 4.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.25 -1.018 . . . . 29.25 108.25 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.678 HD23 ' CD1' ' B' ' 26' ' ' TYR . 2.0 mm? -91.96 159.41 15.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.373 -0.83 . . . . 24.0 110.253 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.634 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -101.37 131.22 47.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.381 -0.824 . . . . 23.309999999999999 108.892 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 87.5 mt-10 -113.89 158.03 21.61 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.109 -0.994 . . . . 40.030000000000001 109.826 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.598 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -139.84 -167.96 2.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.216 -0.928 . . . . 12.390000000000001 109.223 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.897 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.3 mp -134.68 176.58 8.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 17.420000000000002 109.235 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.56 166.51 8.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.09 -1.006 . . . . 13.84 108.543 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.67 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 22.2 m-85 -120.28 106.18 11.65 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.109 -0.994 . . . . 21.140000000000001 109.395 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.96 ' O ' HG22 ' B' ' 43' ' ' VAL . 81.8 t -98.97 111.16 27.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.121 -0.987 . . . . 10.66 109.561 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.5 p30 -52.18 -30.19 25.77 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.205 -0.935 . . . . 25.890000000000001 108.495 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.672 HD21 ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 45.26 36.93 2.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.473 -0.767 . . . . 24.239999999999998 109.065 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.49 19.03 39.49 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.386 -1.486 . . . . 31.02 109.386 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.484 HD22 HD23 ' B' ' 37' ' ' LEU . 11.7 m120 -92.39 25.93 2.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 43.229999999999997 110.539 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.575 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 45.3 mt-10 44.29 25.6 0.13 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.053 -1.029 . . . . 42.340000000000003 109.84 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 10.0 m80 -172.98 150.78 2.04 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.979 -1.119 . . . . 2.8599999999999999 107.979 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.1 Cg_endo -76.02 136.1 18.0 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.852 1.702 . . . . 17.920000000000002 110.606 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.96 HG22 ' O ' ' B' ' 35' ' ' VAL . 10.1 m -112.18 115.45 49.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.613 -0.884 . . . . 20.57 108.613 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.897 HD11 ' HB3' ' B' ' 32' ' ' LEU . 48.0 tp -66.55 107.49 2.1 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.331 -0.856 . . . . 20.210000000000001 109.299 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.592 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 4.0 t -112.65 167.66 5.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.586 -0.697 . . . . 10.81 109.469 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -91.19 163.16 14.36 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.669 -0.812 . . . . 36.740000000000002 109.97 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.975 HD13 HD12 ' B' ' 83' ' ' LEU . 0.4 OUTLIER -151.19 172.86 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.308 -0.87 . . . . 19.739999999999998 109.326 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.834 HG21 ' NH1' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -110.09 153.53 24.54 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.301 -0.874 . . . . 22.559999999999999 109.245 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.59 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -127.45 101.66 6.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 20.41 109.061 -179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.454 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 2.6 t0 -44.31 144.61 0.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.341 -0.849 . . . . 33.990000000000002 109.97 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -64.21 102.09 0.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 54.920000000000002 109.053 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.2 -26.26 6.77 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.059 -1.616 . . . . 36.100000000000001 109.059 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.498 ' O ' HD12 ' B' ' 49' ' ' LEU . 8.1 mt-30 -76.55 144.47 73.84 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.382 -1.07 . . . . 54.759999999999998 109.018 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.15 130.12 10.04 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.544 2.163 . . . . 28.370000000000001 110.517 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.598 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -39.62 141.97 0.35 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.49 -0.756 . . . . 17.210000000000001 109.99 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.844 ' O ' HG21 ' B' ' 6' ' ' ILE . 86.4 m-85 -43.61 98.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.833 . . . . 17.190000000000001 109.012 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.721 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -43.48 166.42 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.839 . . . . 17.82 109.59 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.721 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -77.54 113.0 3.44 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.625 2.217 . . . . 17.280000000000001 110.317 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.56 -175.02 46.83 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.666 -1.374 . . . . 17.219999999999999 109.666 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.0 mp -75.99 148.04 38.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -1.111 . . . . 19.57 108.995 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.781 ' HB3' HD22 ' B' ' 83' ' ' LEU . 20.7 m-85 -137.9 165.0 27.59 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.413 1.102 . . . . 14.609999999999999 111.254 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.789 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.2 p -145.46 120.61 10.13 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.127 -1.805 . . . . 18.359999999999999 106.127 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.662 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -54.02 165.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 C-N-CA 118.396 -1.321 . . . . 19.129999999999999 108.858 -178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.433 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.3 t-80 -127.01 129.96 49.09 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.97 -0.752 . . . . 20.649999999999999 108.97 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.848 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -71.87 0.54 8.89 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.377 -0.827 . . . . 19.649999999999999 109.735 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -20.94 7.9 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.263 -1.384 . . . . 14.720000000000001 107.263 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.495 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 23.9 m -95.33 -9.58 32.56 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.899 -0.5 . . . . 11.449999999999999 110.058 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.661 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.9 m-30 -78.36 156.11 29.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.124 -0.985 . . . . 14.25 109.715 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.679 ' HA ' HD21 ' A' ' 37' ' ' LEU . 12.2 mttt -146.58 173.37 12.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.805 . . . . 32.700000000000003 109.415 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.659 HG22 HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -111.08 111.63 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 15.630000000000001 109.389 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.34 -177.35 48.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.421 -1.472 . . . . 12.699999999999999 109.421 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.94 39.0 0.94 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.148 -1.207 . . . . 26.289999999999999 109.561 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.08 24.73 4.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 20.440000000000001 109.606 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.451 ' C ' HG13 ' A' ' 45' ' ' VAL . . . 50.02 59.14 7.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.519 -1.432 . . . . 13.82 109.519 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.53 131.83 1.84 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.135 . . . . 18.27 109.685 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 37' ' ' LEU . 1.2 tp -69.41 153.66 43.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.892 . . . . 12.43 109.152 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' B' ' 76' ' ' LEU . 4.5 mmt -154.74 121.77 5.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.097 -1.002 . . . . 35.109999999999999 109.573 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.943 HD12 HD12 ' A' ' 78' ' ' ILE . 2.5 mp -57.4 142.02 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -0.849 . . . . 13.67 109.819 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.7 OUTLIER -115.97 -3.39 12.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.49 -0.756 . . . . 24.059999999999999 108.997 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.834 ' NH1' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER 156.5 63.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.931 -1.507 . . . . 35.039999999999999 106.931 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.662 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.8 OUTLIER -27.89 120.33 0.11 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.001 -1.0 . . . . 18.719999999999999 112.134 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.496 ' HG3' ' NH1' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -92.04 102.08 14.63 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.675 -0.861 . . . . 20.550000000000001 108.675 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.975 HD12 HD13 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -70.39 145.39 51.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.352 -0.843 . . . . 14.4 111.345 -178.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.789 HG22 ' O ' ' B' ' 62' ' ' THR . 35.3 m -146.58 151.03 42.03 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.89 -1.152 . . . . 17.649999999999999 107.89 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.9 Cg_endo -62.53 145.71 95.44 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.181 1.92 . . . . 25.699999999999999 110.419 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -79.05 115.07 18.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 49.289999999999999 109.76 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.048 -0.977 . . . . 58.909999999999997 109.457 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.528 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.3 ttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.534 -0.543 . . . . 64.909999999999997 109.534 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.664 HG21 HG21 ' A' ' 63' ' ' VAL . 2.8 mt -61.52 82.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.962 -1.125 . . . . 33.799999999999997 107.962 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.62 ' C ' HG12 ' A' ' 4' ' ' VAL . 23.4 mttp -70.33 179.12 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.894 0.854 . . . . 32.719999999999999 111.277 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.043 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 173.56 167.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.902 -0.777 . . . . 14.460000000000001 108.902 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.576 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 79.7 mt-10 -141.31 111.17 6.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.545 -0.722 . . . . 22.120000000000001 109.259 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.834 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -72.58 105.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.545 -1.28 . . . . 14.23 107.545 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.538 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.7 mmpt? -54.14 160.36 2.43 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.118 -0.989 . . . . 25.43 109.539 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 31.8 Cg_endo -73.79 -9.25 22.31 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.057 1.838 . . . . 13.609999999999999 109.19 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.85 7.64 46.16 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.89 -0.782 . . . . 15.52 108.89 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.804 ' NE2' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -142.58 37.41 1.49 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.261 -0.899 . . . . 17.309999999999999 109.13 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.58 15.46 6.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 24.780000000000001 109.803 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.476 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -143.96 143.63 31.32 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.182 -0.949 . . . . 47.899999999999999 108.597 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.67 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 26.0 p90 -85.46 173.31 10.34 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.038 -1.039 . . . . 21.609999999999999 109.61 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 15' ' ' THR . 39.9 m -137.6 154.95 49.68 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.471 -0.768 . . . . 14.890000000000001 109.0 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 14' ' ' THR . 0.2 OUTLIER -91.46 111.03 22.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.175 -0.953 . . . . 17.350000000000001 109.506 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 17' ' ' SER . 5.7 ttt180 -136.59 149.05 47.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 34.380000000000003 109.09 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 16' ' ' ARG . 5.4 p -43.91 148.48 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 38.770000000000003 109.321 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -144.04 179.67 21.2 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.581 -1.407 . . . . 34.579999999999998 109.581 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -155.58 117.18 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -1.127 . . . . 41.869999999999997 108.795 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 22' ' ' GLN . 0.1 OUTLIER -60.33 79.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.323 -0.861 . . . . 47.210000000000001 109.632 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER 68.25 -60.18 0.42 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.166 -0.959 . . . . 71.560000000000002 109.372 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.7 pt20 175.86 43.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 66.599999999999994 109.513 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.99 -51.16 0.41 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.491 -1.444 . . . . 55.490000000000002 109.491 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 18.6 pttm -153.32 159.77 31.76 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.301 -1.117 . . . . 44.990000000000002 109.329 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.7 Cg_endo -77.26 120.94 5.5 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.596 2.197 . . . . 44.100000000000001 110.675 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 28' ' ' LEU . 4.0 p90 -126.34 139.02 53.62 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.268 -0.895 . . . . 32.090000000000003 109.627 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -103.29 80.52 1.84 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 29.25 108.846 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.667 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -102.58 134.33 46.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 24.0 110.23 -179.26 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.661 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -46.01 128.45 9.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.427 -0.796 . . . . 23.309999999999999 109.546 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -121.13 143.09 49.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.258 -0.901 . . . . 40.030000000000001 108.788 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.938 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -115.1 -167.29 1.21 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.963 -1.086 . . . . 12.390000000000001 110.149 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.886 ' HB3' HD11 ' A' ' 44' ' ' LEU . 21.1 mt -128.44 177.99 6.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.48 -0.762 . . . . 17.420000000000002 109.557 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.566 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -173.46 150.72 1.85 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.987 -1.07 . . . . 13.84 109.238 -179.461 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.762 ' HE1' HD13 ' A' ' 44' ' ' LEU . 2.9 m-85 -109.8 91.32 3.6 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.181 -1.044 . . . . 21.140000000000001 108.181 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.866 HG22 ' HB ' ' A' ' 4' ' ' VAL . 97.9 t -92.89 117.58 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.98 . . . . 10.66 110.155 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 27.6 t0 -53.56 -28.49 32.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.415 -0.957 . . . . 25.890000000000001 108.415 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.83 HD21 ' HA ' ' B' ' 69' ' ' LYS . 1.9 tt 43.25 34.47 0.71 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.498 -0.751 . . . . 24.239999999999998 109.239 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.35 23.12 52.9 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.457 -1.457 . . . . 31.02 109.457 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -97.33 26.35 4.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -1.155 . . . . 43.229999999999997 110.263 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.551 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 42.9 mt-10 49.25 21.62 0.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.134 -0.979 . . . . 42.340000000000003 109.949 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 6.0 m80 -174.71 157.11 2.23 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 108.027 -1.101 . . . . 6.1600000000000001 108.027 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.641 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.8 Cg_endo -75.6 146.14 30.24 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.019 1.813 . . . . 17.920000000000002 111.005 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.6 m -122.46 118.38 55.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.622 -0.881 . . . . 20.57 108.622 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 32' ' ' LEU . 22.4 tp -69.14 109.42 4.04 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.662 -0.815 . . . . 20.210000000000001 109.04 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.591 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 3.9 t -117.18 168.89 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.614 -0.678 . . . . 10.81 109.516 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.581 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -88.63 161.93 16.61 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.298 -0.876 . . . . 36.740000000000002 110.423 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.693 HD12 ' HE2' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -133.11 164.43 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.485 -0.932 . . . . 19.739999999999998 108.485 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -108.76 135.5 49.88 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.193 -0.942 . . . . 22.559999999999999 108.565 178.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.667 ' O ' HD23 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -123.88 123.9 41.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 20.41 109.365 -179.22 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . 1.3 t0 -71.4 142.53 50.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 33.990000000000002 109.546 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.29 107.72 0.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 54.920000000000002 109.664 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.04 -2.4 44.33 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.859 -1.296 . . . . 36.100000000000001 109.859 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.625 ' O ' HD12 ' A' ' 49' ' ' LEU . 13.2 mt-30 -89.19 144.5 32.6 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 54.759999999999998 109.525 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 55' ' ' ALA . 35.1 Cg_endo -78.38 114.78 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.643 2.229 . . . . 28.370000000000001 110.642 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.938 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -43.79 168.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.337 -0.852 . . . . 17.210000000000001 110.031 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.834 ' HB3' HD13 ' A' ' 6' ' ' ILE . 31.0 m-85 -66.14 122.85 18.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 17.190000000000001 109.657 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.997 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -74.48 179.39 1.31 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.455 -0.778 . . . . 17.82 109.808 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.997 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.9 Cg_endo -78.01 115.41 3.77 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.582 2.188 . . . . 17.280000000000001 110.436 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 166.85 142.0 3.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.317 -1.513 . . . . 17.219999999999999 109.317 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 59' ' ' GLY . 4.0 mp -42.11 144.43 0.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.153 -1.204 . . . . 19.57 109.382 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 1.043 ' CB ' HG13 ' A' ' 4' ' ' VAL . 15.1 m-85 -121.52 166.37 14.28 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.487 1.137 . . . . 14.609999999999999 111.253 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.572 HG23 ' CA ' ' A' ' 86' ' ' ALA . 39.8 p -149.35 120.54 7.79 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.505 -2.035 . . . . 18.359999999999999 105.505 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.9 t -57.89 161.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 C-N-CA 118.107 -1.437 . . . . 19.129999999999999 108.934 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 82' ' ' ARG . 5.1 t-80 -116.19 138.41 51.3 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.592 -0.693 . . . . 20.649999999999999 109.203 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.751 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.1 mt -70.71 -8.44 52.13 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.098 -0.704 . . . . 19.649999999999999 109.098 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.418 ' OG ' ' HD3' ' A' ' 82' ' ' ARG . 0.5 OUTLIER -47.93 -24.95 1.16 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.268 -1.012 . . . . 14.720000000000001 108.268 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.54 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 3.7 m -93.7 -14.77 25.96 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.825 -0.75 . . . . 11.449999999999999 109.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.756 ' HB3' HD21 ' A' ' 76' ' ' LEU . 3.5 m-30 -80.69 147.07 30.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.064 -1.022 . . . . 14.25 109.973 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.8 ' HA ' HD21 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -146.31 172.87 12.84 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.643 -0.661 . . . . 32.700000000000003 109.229 -179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.67 HG22 HD13 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -107.33 109.55 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 15.630000000000001 109.171 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.07 -173.08 49.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.582 -1.407 . . . . 12.699999999999999 109.582 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.463 ' OE1' ' N ' ' A' ' 72' ' ' GLN . 5.0 mp0 -95.87 22.98 6.72 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.261 -1.141 . . . . 26.289999999999999 108.948 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 -9.45 26.65 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.283 -0.567 . . . . 20.440000000000001 109.704 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.436 ' C ' HG13 ' B' ' 45' ' ' VAL . . . 81.5 40.41 11.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.692 -1.363 . . . . 13.82 109.692 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.499 ' HA ' ' CG1' ' B' ' 45' ' ' VAL . 4.4 m -169.18 138.54 2.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.14 . . . . 18.27 109.564 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.756 HD21 ' HB3' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -47.57 160.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 12.43 109.46 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtt -158.64 107.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 35.109999999999999 109.708 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.626 HG12 ' CD1' ' A' ' 68' ' ' PHE . 23.4 mt -60.33 138.11 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 13.67 109.815 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 12.1 t70 -103.13 -22.67 13.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.357 -0.84 . . . . 24.059999999999999 108.802 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.54 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.5 OUTLIER 171.86 66.74 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.542 -1.281 . . . . 35.039999999999999 107.542 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.892 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -21.72 119.01 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.033 -0.985 . . . . 18.719999999999999 112.264 -178.248 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -92.68 103.72 16.07 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.601 -0.888 . . . . 20.550000000000001 108.601 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.974 HD11 HG11 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -73.78 145.05 45.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.146 -0.971 . . . . 14.4 111.528 -178.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 62' ' ' THR . 2.4 m -149.64 156.25 38.85 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 107.524 -1.287 . . . . 17.649999999999999 107.524 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 24.7 Cg_endo -63.3 141.13 80.59 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 C-N-CA 121.9 1.733 . . . . 25.699999999999999 110.26 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.572 ' CA ' HG23 ' A' ' 62' ' ' THR . . . -70.66 112.13 6.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.191 -0.943 . . . . 49.289999999999999 109.5 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.045 -0.978 . . . . 58.909999999999997 109.475 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.531 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.3 ttp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.526 -0.546 . . . . 64.909999999999997 109.526 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.666 HG21 HG21 ' B' ' 63' ' ' VAL . 2.8 mt -61.56 82.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.985 -1.117 . . . . 33.799999999999997 107.985 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.635 ' C ' HG12 ' B' ' 4' ' ' VAL . 23.3 mttp -70.1 179.2 2.43 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.979 0.895 . . . . 32.719999999999999 111.284 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.046 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 173.46 167.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.865 -0.791 . . . . 14.460000000000001 108.865 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 79.6 mt-10 -141.36 111.14 6.55 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.62 0.724 . . . . 22.120000000000001 109.241 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.829 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -72.55 105.34 2.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.54 -1.281 . . . . 14.23 107.54 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.541 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.7 mmpt? -54.3 160.39 2.54 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.113 -0.992 . . . . 25.43 109.509 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.9 Cg_endo -73.75 -9.25 22.37 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.032 1.821 . . . . 13.609999999999999 109.181 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.84 7.51 46.45 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.803 -0.814 . . . . 15.52 108.803 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.795 ' NE2' HD13 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -142.63 37.6 1.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.206 -0.934 . . . . 17.309999999999999 109.093 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.7 15.34 7.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 24.780000000000001 109.831 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.467 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -143.91 143.44 31.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.216 -0.927 . . . . 47.899999999999999 108.686 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.666 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 26.3 p90 -85.24 173.22 10.55 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.036 -1.04 . . . . 21.609999999999999 109.609 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.42 HG22 ' N ' ' B' ' 15' ' ' THR . 39.9 m -137.54 155.0 49.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.48 -0.762 . . . . 14.890000000000001 108.983 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.42 ' N ' HG22 ' B' ' 14' ' ' THR . 0.2 OUTLIER -91.43 110.75 22.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.186 -0.946 . . . . 17.350000000000001 109.59 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 17' ' ' SER . 5.6 ttt180 -136.34 149.1 48.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.319 -0.863 . . . . 34.380000000000003 109.082 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.427 ' C ' ' O ' ' B' ' 16' ' ' ARG . 5.5 p -43.86 148.44 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 38.770000000000003 109.284 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -144.01 179.62 21.22 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.567 -1.413 . . . . 34.579999999999998 109.567 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' B' ' 21' ' ' ARG . 0.2 OUTLIER -155.5 117.16 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -1.138 . . . . 41.869999999999997 108.803 179.579 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.471 ' O ' ' N ' ' B' ' 22' ' ' GLN . 0.1 OUTLIER -60.28 79.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.317 -0.864 . . . . 47.210000000000001 109.562 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER 68.26 -60.22 0.42 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.164 -0.96 . . . . 71.560000000000002 109.389 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.7 pt20 175.87 43.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 66.599999999999994 109.553 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.85 -51.29 0.41 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.507 -1.437 . . . . 55.490000000000002 109.507 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.435 ' HB2' ' HD2' ' B' ' 25' ' ' PRO . 18.8 pttm -153.17 159.7 31.86 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.322 -1.105 . . . . 44.990000000000002 109.361 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.9 Cg_endo -77.26 120.74 5.43 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.667 2.245 . . . . 44.100000000000001 110.657 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.587 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 4.0 p90 -126.15 139.06 53.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.248 -0.907 . . . . 32.090000000000003 109.575 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -103.24 80.51 1.84 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 29.25 108.847 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.656 HD23 ' O ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -102.64 134.38 46.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 24.0 110.234 -179.249 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.668 ' OD1' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -46.06 128.52 9.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.401 -0.812 . . . . 23.309999999999999 109.579 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -121.2 143.11 49.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.894 . . . . 40.030000000000001 108.748 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.958 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -115.17 -167.24 1.21 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.981 -1.075 . . . . 12.390000000000001 110.132 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.908 ' HB3' HD11 ' B' ' 44' ' ' LEU . 21.0 mt -128.37 177.97 6.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.429 -0.795 . . . . 17.420000000000002 109.549 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.571 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.8 OUTLIER -173.49 150.65 1.83 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.918 -1.114 . . . . 13.84 109.265 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.772 ' HE1' HD13 ' B' ' 44' ' ' LEU . 2.9 m-85 -109.77 91.28 3.58 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.18 -1.045 . . . . 21.140000000000001 108.18 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.898 HG22 ' HB ' ' B' ' 4' ' ' VAL . 98.5 t -92.83 117.76 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.961 . . . . 10.66 110.096 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 27.6 t0 -53.71 -28.37 33.58 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.385 -0.968 . . . . 25.890000000000001 108.385 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.8 HD21 ' HA ' ' A' ' 69' ' ' LYS . 1.8 tt 43.11 34.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.572 -0.705 . . . . 24.239999999999998 109.256 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.19 23.05 51.81 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.472 -1.451 . . . . 31.02 109.472 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -97.35 26.28 4.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.217 -1.167 . . . . 43.229999999999997 110.234 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 43.0 mt-10 49.23 21.74 0.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.13 -0.981 . . . . 42.340000000000003 109.976 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 5.9 m80 -174.79 157.13 2.2 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.999 -1.111 . . . . 6.1500000000000004 107.999 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.635 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.9 Cg_endo -75.59 146.19 30.34 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.97 1.78 . . . . 17.920000000000002 110.954 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.859 HG22 ' O ' ' B' ' 35' ' ' VAL . 5.4 m -122.49 118.36 54.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.633 -0.877 . . . . 20.57 108.633 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.908 HD11 ' HB3' ' B' ' 32' ' ' LEU . 22.9 tp -69.09 109.57 4.08 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.69 -0.804 . . . . 20.210000000000001 109.096 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 3.9 t -117.37 168.86 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.529 -0.732 . . . . 10.81 109.448 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -88.52 161.9 16.72 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.351 -0.843 . . . . 36.740000000000002 110.455 -179.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.687 HD12 ' HE2' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -133.08 164.29 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.522 -0.918 . . . . 19.739999999999998 108.522 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.502 ' N ' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -108.67 135.47 49.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.242 -0.912 . . . . 22.559999999999999 108.576 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.656 ' O ' HD23 ' B' ' 28' ' ' LEU . 0.3 OUTLIER -123.92 123.89 41.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.865 . . . . 20.41 109.362 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.433 ' HB3' ' HG3' ' B' ' 53' ' ' GLN . 1.3 t0 -71.39 142.35 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 33.990000000000002 109.567 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.21 107.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 54.920000000000002 109.633 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.08 -2.41 44.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.831 -1.308 . . . . 36.100000000000001 109.831 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.628 ' O ' HD12 ' B' ' 49' ' ' LEU . 13.2 mt-30 -89.22 144.46 32.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.166 -1.197 . . . . 54.759999999999998 109.513 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.37 114.7 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.669 2.246 . . . . 28.370000000000001 110.696 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.958 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -43.69 168.67 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 17.210000000000001 110.025 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.829 ' HB3' HD13 ' B' ' 6' ' ' ILE . 30.7 m-85 -66.06 122.96 18.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 17.190000000000001 109.618 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.995 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -74.53 179.44 1.31 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.443 -0.786 . . . . 17.82 109.844 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.995 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.1 Cg_endo -78.0 115.35 3.76 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.619 2.213 . . . . 17.280000000000001 110.442 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 166.87 141.95 3.3 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.358 -1.497 . . . . 17.219999999999999 109.358 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' B' ' 59' ' ' GLY . 4.0 mp -42.04 144.26 0.47 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -1.162 . . . . 19.57 109.364 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 1.046 ' CB ' HG13 ' B' ' 4' ' ' VAL . 15.1 m-85 -121.4 166.24 14.38 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.93 -1.106 . . . . 14.609999999999999 111.34 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.571 HG23 ' CA ' ' B' ' 86' ' ' ALA . 39.2 p -149.31 120.25 7.65 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 105.485 -2.043 . . . . 18.359999999999999 105.485 177.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.925 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.8 t -57.44 161.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 C-N-CA 118.143 -1.423 . . . . 19.129999999999999 108.936 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' B' ' 82' ' ' ARG . 5.1 t-80 -116.43 138.32 51.46 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.551 -0.718 . . . . 20.649999999999999 109.245 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.754 HD23 ' CD2' ' B' ' 68' ' ' PHE . 2.1 mt -70.57 -8.47 51.77 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.065 -0.717 . . . . 19.649999999999999 109.065 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' SER . . . . . 0.42 ' OG ' ' HD3' ' B' ' 82' ' ' ARG . 0.5 OUTLIER -47.96 -24.84 1.15 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.29 -1.004 . . . . 14.720000000000001 108.29 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.538 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 3.8 m -93.78 -14.8 25.82 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.472 -0.767 . . . . 11.449999999999999 109.97 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.766 ' HB3' HD21 ' B' ' 76' ' ' LEU . 3.5 m-30 -80.71 146.44 31.06 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.081 -1.012 . . . . 14.25 109.955 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.83 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -145.72 172.62 13.02 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.651 -0.656 . . . . 32.700000000000003 109.274 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.709 HG22 HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -107.2 109.54 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 15.630000000000001 109.166 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.95 -172.88 49.12 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.593 -1.403 . . . . 12.699999999999999 109.593 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.459 ' OE1' ' N ' ' B' ' 72' ' ' GLN . 5.0 mp0 -96.05 22.83 7.06 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.215 -1.168 . . . . 26.289999999999999 108.918 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.61 -9.48 26.84 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.757 -0.589 . . . . 20.440000000000001 109.69 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.464 ' C ' HG13 ' A' ' 45' ' ' VAL . . . 81.46 41.05 10.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.578 -1.409 . . . . 13.82 109.578 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.521 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 4.3 m -169.79 138.29 1.8 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -1.153 . . . . 18.27 109.688 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.774 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -47.37 160.7 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 12.43 109.462 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtt -158.94 107.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 35.109999999999999 109.738 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.636 HG12 ' CD1' ' B' ' 68' ' ' PHE . 23.0 mt -60.26 138.4 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 13.67 109.843 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 12.1 t70 -103.37 -22.81 13.62 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.709 -0.849 . . . . 24.059999999999999 108.709 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.538 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.5 OUTLIER 172.09 66.55 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.556 -1.275 . . . . 35.039999999999999 107.556 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.925 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.7 OUTLIER -21.5 118.96 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.085 -0.961 . . . . 18.719999999999999 112.285 -178.25 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' B' ' 64' ' ' HIS . 0.3 OUTLIER -92.57 103.79 16.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 20.550000000000001 108.643 179.363 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.957 HD11 HG11 ' B' ' 4' ' ' VAL . 0.7 OUTLIER -73.85 144.93 45.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.03 -1.044 . . . . 14.4 111.469 -178.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 62' ' ' THR . 2.5 m -149.59 156.14 38.95 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.528 -1.286 . . . . 17.649999999999999 107.528 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 24.6 Cg_endo -63.26 141.08 80.73 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 121.911 1.741 . . . . 25.699999999999999 110.211 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.571 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -70.53 112.14 6.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.207 -0.933 . . . . 49.289999999999999 109.528 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.015 -0.993 . . . . 58.909999999999997 109.5 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.485 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 1.3 ttp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.457 -0.572 . . . . 64.909999999999997 109.457 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.873 ' HA ' HD22 ' B' ' 65' ' ' LEU . 6.2 mt -71.29 77.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.213 -1.032 . . . . 33.799999999999997 108.213 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 35' ' ' VAL . 54.0 mttt -63.53 155.41 29.47 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.937 0.875 . . . . 32.719999999999999 111.299 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.81 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -166.84 163.53 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.499 -0.926 . . . . 14.460000000000001 108.499 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 64.5 mt-10 -137.12 119.53 15.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.24 -0.913 . . . . 22.120000000000001 109.762 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -76.61 101.08 2.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.521 -1.288 . . . . 14.23 107.521 178.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.652 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.9 171.73 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.014 -1.054 . . . . 25.43 109.841 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -75.08 -26.06 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.49 2.126 . . . . 13.609999999999999 109.804 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.89 -0.13 56.58 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.906 -0.775 . . . . 15.52 108.906 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.479 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.5 mm-40 -120.59 37.17 4.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.346 -0.846 . . . . 17.309999999999999 109.595 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.01 8.45 44.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 24.780000000000001 110.236 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -139.71 137.89 35.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.186 -0.946 . . . . 47.899999999999999 108.677 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.667 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 30.7 p90 -84.45 173.99 10.43 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.027 -1.046 . . . . 21.609999999999999 109.459 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.7 m -142.5 151.67 41.91 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.459 -0.776 . . . . 14.890000000000001 109.115 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.03 109.87 16.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.296 -0.878 . . . . 17.350000000000001 109.23 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.61 151.76 50.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 34.380000000000003 109.33 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.68 134.9 57.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.875 . . . . 38.770000000000003 109.35 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -130.51 -170.74 12.77 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.422 -1.471 . . . . 34.579999999999998 109.422 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.52 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -155.81 121.81 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.132 . . . . 41.869999999999997 108.572 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -72.42 54.65 0.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.122 -0.986 . . . . 47.210000000000001 109.859 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 22' ' ' GLN . 0.3 OUTLIER 67.3 -60.47 0.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.171 -0.956 . . . . 71.560000000000002 109.24 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 20' ' ' SER . 17.9 mt-30 -156.67 29.92 0.32 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 66.599999999999994 109.153 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 24' ' ' LYS . . . -117.31 39.7 2.57 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.587 -1.405 . . . . 55.490000000000002 109.587 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 13.9 mttt 78.64 163.78 0.13 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.406 -1.055 . . . . 44.990000000000002 109.05 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 33.3 Cg_endo -75.96 135.89 17.89 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.464 2.109 . . . . 44.100000000000001 110.717 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.596 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.7 p90 -124.74 144.34 50.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.447 -0.783 . . . . 32.090000000000003 109.604 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.88 79.5 2.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 29.25 108.778 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.54 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -99.29 134.13 42.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 24.0 110.299 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -48.65 120.31 3.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 23.309999999999999 109.168 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 7.9 mt-10 -109.79 161.3 15.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 40.030000000000001 109.334 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.76 HE21 ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -139.91 -168.92 2.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 12.390000000000001 109.647 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.944 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.1 mt -141.44 155.28 45.88 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.684 -0.858 . . . . 17.420000000000002 108.684 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.613 ' SG ' HD11 ' A' ' 6' ' ' ILE . 2.6 m -151.64 -177.25 5.99 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.185 -1.042 . . . . 13.84 108.185 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.701 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 16.5 m-85 -131.3 103.81 6.67 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.126 -0.984 . . . . 21.140000000000001 109.785 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 43' ' ' VAL . 3.0 t -109.78 123.27 65.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.145 -0.972 . . . . 10.66 110.069 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -87.66 -36.76 17.25 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.366 -0.976 . . . . 25.890000000000001 108.366 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.791 HD21 HD11 ' B' ' 76' ' ' LEU . 0.3 OUTLIER 63.79 -71.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.541 -0.911 . . . . 24.239999999999998 108.541 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -157.19 29.17 0.52 Allowed Glycine 0 C--N 1.297 -1.633 0 N-CA-C 109.188 -1.565 . . . . 31.02 109.188 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' HIS . 1.7 m-20 -109.51 21.64 16.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -1.178 . . . . 43.229999999999997 110.229 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.579 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 3.3 mt-10 42.58 25.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.266 -0.896 . . . . 42.340000000000003 110.328 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 98.6 m-70 -160.52 152.79 17.11 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.108 -0.995 . . . . 6.9900000000000002 108.518 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.701 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -78.35 136.05 13.87 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.903 1.736 . . . . 17.920000000000002 110.411 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 35' ' ' VAL . 2.4 m -112.21 119.34 59.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.351 -0.843 . . . . 20.57 108.744 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.944 HD11 ' HB3' ' A' ' 32' ' ' LEU . 52.1 tp -75.32 103.51 5.5 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.461 -0.895 . . . . 20.210000000000001 110.018 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.737 HG13 HG23 ' A' ' 43' ' ' VAL . 29.0 m -110.53 178.48 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.643 -0.873 . . . . 10.81 108.643 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HD3' HD21 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -106.09 127.1 52.95 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.012 -1.075 . . . . 36.740000000000002 110.029 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.996 HD13 HD12 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -108.64 163.17 6.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.884 -0.784 . . . . 19.739999999999998 108.884 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 49' ' ' LEU . 56.7 m -99.59 158.99 15.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 22.559999999999999 109.539 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.799 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -130.37 105.14 7.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.198 -0.939 . . . . 20.41 109.286 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.49 142.29 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 33.990000000000002 109.501 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.14 101.58 0.3 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 54.920000000000002 109.313 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.62 -20.04 10.3 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.316 -1.514 . . . . 36.100000000000001 109.316 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 30.5 mt-30 -78.28 148.53 74.46 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.259 -1.142 . . . . 54.759999999999998 109.376 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.99 120.38 5.01 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.665 2.244 . . . . 28.370000000000001 110.619 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.799 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -38.58 143.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.506 -0.746 . . . . 17.210000000000001 110.346 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.767 ' HB3' HD13 ' A' ' 6' ' ' ILE . 86.6 m-85 -44.56 102.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.798 . . . . 17.190000000000001 108.844 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.97 176.09 0.13 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 17.82 109.955 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.8 Cg_endo -78.39 111.22 2.99 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.763 2.309 . . . . 17.280000000000001 110.27 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 175.25 163.89 28.98 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.905 -1.278 . . . . 17.219999999999999 109.905 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.751 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.5 OUTLIER -59.84 142.79 52.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.243 -1.151 . . . . 19.57 108.748 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.716 ' HB3' HD22 ' A' ' 83' ' ' LEU . 31.8 m-85 -125.9 161.07 28.3 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.718 -1.238 . . . . 14.609999999999999 111.682 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.726 ' O ' HG22 ' A' ' 84' ' ' VAL . 30.9 p -146.24 121.44 10.17 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.295 -1.743 . . . . 18.359999999999999 106.295 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.614 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.9 t -52.47 168.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.806 -1.158 . . . . 19.129999999999999 109.381 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.548 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -133.62 127.14 32.39 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.487 -0.758 . . . . 20.649999999999999 109.038 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.885 HD22 ' HA ' ' B' ' 2' ' ' ILE . 0.7 OUTLIER -71.11 0.1 8.42 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.292 -0.88 . . . . 19.649999999999999 109.997 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.3 p -55.26 -20.55 11.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.401 -1.333 . . . . 14.720000000000001 107.401 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 69.6 m -94.18 -27.35 16.24 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.835 -0.54 . . . . 11.449999999999999 109.998 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.684 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -60.82 156.27 17.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.1 -1.0 . . . . 14.25 109.127 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HE3' ' OD2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -159.1 172.31 18.35 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.385 -0.822 . . . . 32.700000000000003 109.586 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.637 HG21 HG11 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -97.45 112.19 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 15.630000000000001 109.387 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.45 -176.08 48.61 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.547 -1.421 . . . . 12.699999999999999 109.547 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -90.05 33.86 0.87 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -1.162 . . . . 26.289999999999999 109.486 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -118.74 15.36 13.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 20.440000000000001 109.628 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.06 48.96 70.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.781 -1.328 . . . . 13.82 109.781 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 77' ' ' MET . 0.0 OUTLIER -170.93 138.84 1.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -1.197 . . . . 18.27 109.416 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.8 HD11 HD21 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -45.15 163.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 12.43 109.388 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 75' ' ' SER . 6.7 mmt -154.22 100.3 2.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 35.109999999999999 109.844 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.5 mt -40.98 -61.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.511 0.672 . . . . 13.67 109.634 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 35.4 t0 81.44 -48.2 0.24 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.476 0.655 . . . . 24.059999999999999 109.958 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.0 tpm_? -172.04 66.78 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.107 0.956 . . . . 35.039999999999999 108.781 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' B' ' 76' ' ' LEU . 1.0 OUTLIER -34.84 127.06 0.51 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.499 -0.773 . . . . 18.719999999999999 111.597 -179.203 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -94.7 105.38 17.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.167 -1.049 . . . . 20.550000000000001 108.167 178.632 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.996 HD12 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -72.83 149.06 43.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 14.4 111.263 -178.425 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 62' ' ' THR . 34.3 m -150.22 150.68 29.98 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.121 -1.066 . . . . 17.649999999999999 108.121 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.2 Cg_endo -61.93 138.35 73.06 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.129 1.886 . . . . 25.699999999999999 110.241 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -66.72 116.61 7.82 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.295 -0.878 . . . . 49.289999999999999 109.684 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.001 -1.0 . . . . 58.909999999999997 109.41 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.488 ' SD ' ' HB ' ' B' ' 62' ' ' THR . 1.3 ttp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.522 -0.548 . . . . 64.909999999999997 109.522 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.885 ' HA ' HD22 ' A' ' 65' ' ' LEU . 6.3 mt -70.6 77.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.16 -1.052 . . . . 33.799999999999997 108.16 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.466 ' O ' HG13 ' B' ' 35' ' ' VAL . 53.3 mttt -63.6 155.37 29.85 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.914 0.864 . . . . 32.719999999999999 111.308 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.826 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -166.86 163.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.492 -0.929 . . . . 14.460000000000001 108.492 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 65.3 mt-10 -137.07 119.6 15.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.344 -0.847 . . . . 22.120000000000001 109.798 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.755 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -76.71 101.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.583 -1.265 . . . . 14.23 107.583 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.66 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.88 171.76 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.1 -1.0 . . . . 25.43 109.83 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.6 Cg_endo -75.07 -26.14 11.09 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.539 2.159 . . . . 13.609999999999999 109.834 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.86 -0.08 56.5 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.946 -0.761 . . . . 15.52 108.946 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.482 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.5 mm-40 -120.57 37.07 4.38 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 17.309999999999999 109.561 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.05 8.71 43.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 24.780000000000001 110.204 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.454 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -139.93 137.85 35.12 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.126 -0.984 . . . . 47.899999999999999 108.639 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 30.8 p90 -84.39 174.05 10.41 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 120.984 -1.072 . . . . 21.609999999999999 109.504 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -142.53 151.44 41.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.397 -0.814 . . . . 14.890000000000001 109.113 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.73 110.38 17.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.288 -0.883 . . . . 17.350000000000001 109.129 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.13 151.59 51.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.337 -0.852 . . . . 34.380000000000003 109.346 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.57 134.81 57.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 38.770000000000003 109.383 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -130.52 -170.63 12.74 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.398 -1.481 . . . . 34.579999999999998 109.398 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.518 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.3 OUTLIER -155.86 121.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -1.129 . . . . 41.869999999999997 108.568 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.503 ' O ' ' N ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -72.48 54.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.129 -0.982 . . . . 47.210000000000001 109.876 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.493 ' C ' ' CG ' ' B' ' 22' ' ' GLN . 0.3 OUTLIER 67.22 -60.45 0.37 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.211 -0.93 . . . . 71.560000000000002 109.24 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' B' ' 20' ' ' SER . 17.6 mt-30 -156.63 29.98 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 66.599999999999994 109.201 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' B' ' 24' ' ' LYS . . . -117.42 39.69 2.57 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.61 -1.396 . . . . 55.490000000000002 109.61 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.524 ' HB3' ' HD2' ' B' ' 25' ' ' PRO . 14.0 mttt 78.57 163.73 0.13 Allowed Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.404 -1.056 . . . . 44.990000000000002 109.038 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' B' ' 24' ' ' LYS . 33.2 Cg_endo -75.92 136.05 18.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.454 2.103 . . . . 44.100000000000001 110.701 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 6.7 p90 -124.88 144.31 50.39 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.388 -0.82 . . . . 32.090000000000003 109.596 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.79 79.49 2.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 29.25 108.735 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.549 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -99.28 134.03 42.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 24.0 110.292 -179.107 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.593 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -48.69 120.4 3.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.402 -0.811 . . . . 23.309999999999999 109.122 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 7.8 mt-10 -109.84 161.39 15.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 40.030000000000001 109.283 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.767 HE21 ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -139.9 -168.85 2.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 12.390000000000001 109.67 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.913 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.1 mt -141.55 155.19 45.79 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.717 -0.845 . . . . 17.420000000000002 108.717 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.625 ' SG ' HD11 ' B' ' 6' ' ' ILE . 2.5 m -151.63 -177.21 5.97 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.179 -1.045 . . . . 13.84 108.179 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.699 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 16.3 m-85 -131.35 103.9 6.71 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.103 -0.998 . . . . 21.140000000000001 109.692 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.854 ' O ' HG22 ' B' ' 43' ' ' VAL . 2.9 t -109.86 123.16 65.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.126 -0.984 . . . . 10.66 110.115 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.768 ' O ' HD12 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -87.45 -36.9 17.43 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.336 -0.987 . . . . 25.890000000000001 108.336 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 76' ' ' LEU . 0.3 OUTLIER 64.13 -71.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.471 -0.937 . . . . 24.239999999999998 108.471 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -157.49 29.19 0.5 Allowed Glycine 0 C--N 1.297 -1.61 0 N-CA-C 109.185 -1.566 . . . . 31.02 109.185 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' B' ' 41' ' ' HIS . 1.7 m-20 -109.49 21.53 16.9 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.117 -1.225 . . . . 43.229999999999997 110.243 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.585 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 3.2 mt-10 42.78 25.23 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 42.340000000000003 110.302 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 98.4 m-70 -160.48 152.85 17.24 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.175 -0.953 . . . . 6.9900000000000002 108.511 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.699 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 38.3 Cg_endo -78.44 135.9 13.62 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.93 1.753 . . . . 17.920000000000002 110.468 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.854 HG22 ' O ' ' B' ' 35' ' ' VAL . 2.4 m -111.88 119.34 59.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.62 -0.881 . . . . 20.57 108.62 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.913 HD11 ' HB3' ' B' ' 32' ' ' LEU . 51.4 tp -75.25 103.43 5.4 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.243 -0.91 . . . . 20.210000000000001 110.069 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.744 HG13 HG23 ' B' ' 43' ' ' VAL . 26.1 m -110.4 178.64 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.738 -0.838 . . . . 10.81 108.738 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.466 ' HD3' HD21 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -106.23 127.0 52.91 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.975 -1.09 . . . . 36.740000000000002 109.99 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 1.01 HD13 HD12 ' B' ' 83' ' ' LEU . 0.5 OUTLIER -108.48 163.3 6.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.889 -0.782 . . . . 19.739999999999998 108.889 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.431 HG22 ' N ' ' B' ' 49' ' ' LEU . 56.5 m -99.71 158.7 15.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.985 -1.072 . . . . 22.559999999999999 109.558 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -130.12 105.25 7.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 20.41 109.3 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.6 142.03 2.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 33.990000000000002 109.578 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.9 101.33 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 54.920000000000002 109.353 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.92 -19.97 10.06 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.311 -1.516 . . . . 36.100000000000001 109.311 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -78.43 148.61 74.09 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.283 -1.128 . . . . 54.759999999999998 109.436 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.9 Cg_endo -78.01 120.44 5.02 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.644 2.229 . . . . 28.370000000000001 110.587 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.768 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -38.63 143.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 17.210000000000001 110.37 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.755 ' HB3' HD13 ' B' ' 6' ' ' ILE . 86.8 m-85 -44.59 102.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 17.190000000000001 108.837 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.978 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -53.73 176.06 0.12 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 17.82 109.878 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.978 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -78.48 111.34 3.0 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.719 2.279 . . . . 17.280000000000001 110.237 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 175.24 164.15 29.39 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.918 -1.273 . . . . 17.219999999999999 109.918 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.716 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.5 OUTLIER -60.16 142.82 53.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -1.143 . . . . 19.57 108.706 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.698 ' HB3' HD22 ' B' ' 83' ' ' LEU . 31.8 m-85 -125.86 161.13 28.13 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.679 -1.263 . . . . 14.609999999999999 111.645 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.728 ' O ' HG22 ' B' ' 84' ' ' VAL . 30.8 p -146.28 121.48 10.18 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.325 -1.732 . . . . 18.359999999999999 106.325 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.9 t -52.6 168.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 C-N-CA 118.887 -1.125 . . . . 19.129999999999999 109.342 -178.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.534 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -133.61 127.26 32.64 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.508 -0.745 . . . . 20.649999999999999 109.058 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.873 HD22 ' HA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -71.38 0.38 8.33 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.263 -0.898 . . . . 19.649999999999999 109.975 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.4 p -55.32 -20.47 11.61 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.294 -1.372 . . . . 14.720000000000001 107.294 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 69.8 m -94.35 -27.23 16.2 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.864 -0.522 . . . . 11.449999999999999 109.954 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.69 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.9 m-30 -60.9 156.13 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.05 -1.031 . . . . 14.25 109.069 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.418 ' HE3' ' OD2' ' B' ' 79' ' ' ASP . 0.0 OUTLIER -159.07 172.45 18.12 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.36 -0.837 . . . . 32.700000000000003 109.595 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.78 HG21 HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -97.62 112.42 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.838 . . . . 15.630000000000001 109.392 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.52 -176.1 48.51 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.512 -1.435 . . . . 12.699999999999999 109.512 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -90.0 34.0 0.86 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.196 -1.179 . . . . 26.289999999999999 109.496 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -118.91 15.33 13.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 20.440000000000001 109.598 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.1 48.84 71.13 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.779 -1.328 . . . . 13.82 109.779 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' B' ' 77' ' ' MET . 0.0 OUTLIER -170.84 138.95 1.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -1.162 . . . . 18.27 109.403 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.791 HD11 HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -45.14 163.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 12.43 109.464 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 75' ' ' SER . 6.6 mmt -154.37 100.4 2.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 35.109999999999999 109.835 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.609 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.5 mt -41.13 -61.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.514 0.673 . . . . 13.67 109.689 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 35.5 t0 81.41 -48.28 0.24 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.485 0.66 . . . . 24.059999999999999 109.961 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.0 tpm_? -171.98 66.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.111 0.958 . . . . 35.039999999999999 108.793 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.723 HD13 ' HB2' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -34.87 127.22 0.51 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.529 -0.759 . . . . 18.719999999999999 111.604 -179.252 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -94.94 105.1 16.99 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.18 -1.044 . . . . 20.550000000000001 108.18 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.01 HD12 HD13 ' B' ' 47' ' ' ILE . 0.6 OUTLIER -72.52 149.15 44.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 14.4 111.301 -178.454 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.728 HG22 ' O ' ' B' ' 62' ' ' THR . 34.1 m -150.36 150.62 29.52 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.08 -1.081 . . . . 17.649999999999999 108.08 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.2 Cg_endo -61.94 138.41 73.39 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.04 1.827 . . . . 25.699999999999999 110.295 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.716 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -66.82 116.65 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.319 -0.863 . . . . 49.289999999999999 109.635 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.045 -0.978 . . . . 58.909999999999997 109.469 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.533 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.396 -0.594 . . . . 64.909999999999997 109.396 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.927 ' H ' HD22 ' B' ' 65' ' ' LEU . 1.1 mt 53.02 81.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.689 -1.226 . . . . 33.799999999999997 107.689 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -76.56 157.25 32.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 32.719999999999999 110.777 -178.162 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.864 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -164.07 163.38 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.022 -0.733 . . . . 14.460000000000001 109.022 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 37.5 mt-10 -138.99 114.14 9.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.486 -0.759 . . . . 22.120000000000001 109.039 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -74.36 102.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 119.201 -1.0 . . . . 14.23 108.528 179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.674 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.63 170.85 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.299 -0.875 . . . . 25.43 109.478 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.7 Cg_endo -75.92 -21.73 13.92 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.419 2.08 . . . . 13.609999999999999 109.61 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.32 5.19 50.3 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.17 -0.678 . . . . 15.52 109.17 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.524 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 19.9 mm-40 -124.15 36.04 4.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 17.309999999999999 109.64 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.57 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -105.01 15.7 27.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.062 -1.024 . . . . 24.780000000000001 110.329 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.42 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 38.9 mt-30 -133.86 135.9 44.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 47.899999999999999 109.84 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.708 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 46.9 p90 -92.63 166.66 12.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.189 -0.944 . . . . 21.609999999999999 109.492 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -140.5 145.73 37.25 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.308 -0.87 . . . . 14.890000000000001 109.124 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.24 118.02 20.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 17.350000000000001 109.553 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -130.42 145.64 51.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 34.380000000000003 109.344 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.48 117.81 3.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 38.770000000000003 109.405 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 26' ' ' TYR . . . -119.36 162.73 13.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.474 -1.45 . . . . 34.579999999999998 109.474 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.619 ' N ' ' CE1' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -143.98 113.37 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.246 . . . . 41.869999999999997 109.281 179.179 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 m -47.1 -85.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.789 . . . . 47.210000000000001 109.663 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.77 58.37 1.64 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 71.560000000000002 109.417 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 58.79 16.28 4.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.926 . . . . 66.599999999999994 109.328 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.38 -55.45 1.26 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.318 -1.513 . . . . 55.490000000000002 109.318 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -145.27 151.94 49.19 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.345 -1.091 . . . . 44.990000000000002 109.192 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.44 131.1 11.34 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.622 2.215 . . . . 44.100000000000001 110.809 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.661 ' CE2' ' HB2' ' A' ' 28' ' ' LEU . 13.9 p90 -131.44 100.08 5.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.331 -0.855 . . . . 32.090000000000003 109.736 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 m -71.5 76.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 29.25 109.136 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.661 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -87.77 142.88 27.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 24.0 110.198 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.586 ' CB ' ' CB ' ' A' ' 49' ' ' LEU . 4.3 m120 -51.08 123.2 8.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.811 . . . . 23.309999999999999 109.897 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 35.7 mp0 -98.86 155.16 17.52 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.058 -1.09 . . . . 40.030000000000001 108.058 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 1.2 tm0? -146.52 -179.96 7.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.825 -1.172 . . . . 12.390000000000001 110.384 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.89 ' HB3' HD11 ' A' ' 44' ' ' LEU . 51.0 mt -139.85 145.99 38.77 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.449 -0.782 . . . . 17.420000000000002 110.0 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.764 ' SG ' HD11 ' A' ' 47' ' ' ILE . 4.1 m -152.97 -177.12 6.09 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.148 -1.426 . . . . 13.84 107.148 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.674 ' CD2' ' HD3' ' A' ' 7' ' ' LYS . 27.3 m-85 -128.48 113.48 15.56 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.785 -1.197 . . . . 21.140000000000001 109.922 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.864 HG22 ' HB ' ' A' ' 4' ' ' VAL . 45.4 t -107.09 115.65 49.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.235 -0.916 . . . . 10.66 110.148 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 39' ' ' ASN . 54.8 m-20 -64.5 -36.55 84.55 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.806 -1.183 . . . . 25.890000000000001 107.806 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 46.41 48.21 13.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 24.239999999999998 109.893 179.303 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.04 -1.21 64.25 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.41 -1.476 . . . . 31.02 109.41 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.2 OUTLIER -105.9 95.73 6.0 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.334 -1.098 . . . . 43.229999999999997 108.342 179.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 39' ' ' ASN . 2.5 mp0 -27.33 -41.67 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.437 0.637 . . . . 42.340000000000003 111.083 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' ASN . 48.5 m80 -78.16 141.09 61.99 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 108.638 -0.875 . . . . 6.5700000000000003 108.638 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.65 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -76.23 136.72 18.29 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.898 1.732 . . . . 17.920000000000002 110.478 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.829 HG23 HG23 ' A' ' 45' ' ' VAL . 2.9 m -107.65 117.65 53.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.614 -0.884 . . . . 20.57 108.614 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.89 HD11 ' HB3' ' A' ' 32' ' ' LEU . 61.7 tp -65.8 97.82 0.36 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.514 -0.874 . . . . 20.210000000000001 109.999 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.829 HG23 HG23 ' A' ' 43' ' ' VAL . 21.0 t -99.39 168.46 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.813 -0.81 . . . . 10.81 108.813 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.576 ' N ' HG12 ' A' ' 45' ' ' VAL . 4.0 ptpp? -117.33 147.7 42.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.928 -1.108 . . . . 36.740000000000002 111.565 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.004 HG21 ' CE1' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -112.41 178.0 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.563 -0.903 . . . . 19.739999999999998 108.563 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.431 ' H ' HG22 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -126.24 74.93 1.48 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.187 -0.946 . . . . 22.559999999999999 109.46 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.627 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -42.78 150.75 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.425 -0.797 . . . . 20.41 109.22 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 26.5 t0 -123.13 148.13 46.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 33.990000000000002 109.456 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 48.31 -148.89 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.116 -0.99 . . . . 54.920000000000002 109.257 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.12 16.83 56.28 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.647 -1.381 . . . . 36.100000000000001 109.647 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -45.72 149.33 1.13 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.178 -1.189 . . . . 54.759999999999998 109.469 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.16 113.16 3.35 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.587 2.192 . . . . 28.370000000000001 110.002 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.708 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -39.4 153.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.467 -0.771 . . . . 17.210000000000001 110.25 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 1.004 ' CE1' HG21 ' A' ' 47' ' ' ILE . 84.5 m-85 -50.58 113.11 0.81 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 17.190000000000001 109.351 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.013 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -61.81 177.25 0.38 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 17.82 109.476 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 1.013 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.76 114.43 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.572 2.181 . . . . 17.280000000000001 110.398 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.0 179.88 43.98 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 17.219999999999999 109.556 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.2 mp -73.96 156.04 38.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -1.121 . . . . 19.57 108.577 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.723 ' HB3' HD22 ' A' ' 83' ' ' LEU . 26.6 m-85 -143.75 163.32 33.64 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.568 1.175 . . . . 14.609999999999999 111.577 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.773 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.5 p -145.78 123.17 11.65 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.171 -1.789 . . . . 18.359999999999999 106.171 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.8 t -54.31 169.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 C-N-CA 118.495 -1.282 . . . . 19.129999999999999 108.804 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.547 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.1 t-80 -128.11 124.5 37.11 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.861 -0.792 . . . . 20.649999999999999 108.861 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.969 HD22 ' H ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -64.91 -6.79 9.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.849 -0.532 . . . . 19.649999999999999 109.923 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.4 p -53.91 -16.19 1.72 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.93 -1.106 . . . . 14.720000000000001 108.673 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.495 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 50.1 m -99.52 -4.89 30.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.419 -0.8 . . . . 11.449999999999999 111.052 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -81.65 157.78 24.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.7 -1.25 . . . . 14.25 109.832 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.658 ' HA ' HD21 ' B' ' 37' ' ' LEU . 5.3 pttt -142.98 171.74 13.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.401 -0.812 . . . . 32.700000000000003 109.624 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.61 HG11 HG21 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -125.83 112.68 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 15.630000000000001 109.046 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.95 -173.64 20.09 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.568 -1.413 . . . . 12.699999999999999 109.568 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.477 ' N ' ' CD ' ' A' ' 72' ' ' GLN . 2.2 mp0 -89.4 34.53 0.81 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.209 -1.171 . . . . 26.289999999999999 109.508 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -133.87 24.7 3.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.405 -0.81 . . . . 20.440000000000001 109.441 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' B' ' 46' ' ' LYS . . . 51.49 56.58 14.74 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 13.82 109.635 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.7 m -148.64 105.27 3.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -1.211 . . . . 18.27 109.752 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 76' ' ' LEU . 5.0 tt -70.23 146.56 50.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 12.43 109.277 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.486 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 4.2 mtm -157.34 144.53 18.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 35.109999999999999 109.583 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.983 HD12 HD12 ' B' ' 78' ' ' ILE . 2.3 mp -69.73 141.76 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 13.67 109.615 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -107.5 -37.2 6.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.809 -1.182 . . . . 24.059999999999999 107.809 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.495 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -167.94 67.53 0.08 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.404 -1.332 . . . . 35.039999999999999 107.404 178.664 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.692 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -27.41 118.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.416 -0.811 . . . . 18.719999999999999 111.632 -178.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 20.0 tpt180 -92.09 104.58 16.95 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.066 -1.087 . . . . 20.550000000000001 108.066 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.732 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -72.64 150.7 42.78 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.052 0.929 . . . . 14.4 111.591 -178.159 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 62' ' ' THR . 34.7 m -152.07 154.36 32.42 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.741 -1.207 . . . . 17.649999999999999 107.741 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.4 Cg_endo -62.93 145.93 94.66 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.211 1.941 . . . . 25.699999999999999 110.749 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -75.24 121.85 22.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.238 -0.913 . . . . 49.289999999999999 109.525 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 tptt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.977 -1.011 . . . . 58.909999999999997 109.454 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.535 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.403 -0.591 . . . . 64.909999999999997 109.403 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.969 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.2 mt 52.83 81.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.662 -1.236 . . . . 33.799999999999997 107.662 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.417 ' O ' HG13 ' B' ' 35' ' ' VAL . 0.0 OUTLIER -76.32 157.2 32.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 32.719999999999999 110.839 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.879 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.2 OUTLIER -164.06 163.46 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.014 -0.735 . . . . 14.460000000000001 109.014 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 37.6 mt-10 -139.1 114.06 9.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 22.120000000000001 109.019 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.589 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -74.3 102.17 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 119.183 -1.007 . . . . 14.23 108.46 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.656 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.73 171.03 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.307 -0.871 . . . . 25.43 109.507 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.6 Cg_endo -75.86 -21.93 13.84 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.346 2.031 . . . . 13.609999999999999 109.678 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.18 5.33 50.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.615 -0.678 . . . . 15.52 109.222 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.511 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 19.7 mm-40 -124.23 35.97 4.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 17.309999999999999 109.637 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -104.96 15.63 27.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -0.942 . . . . 24.780000000000001 110.339 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.434 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 38.9 mt-30 -133.78 135.92 44.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.0 . . . . 47.899999999999999 109.916 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 47.0 p90 -92.62 166.68 12.37 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.168 -0.958 . . . . 21.609999999999999 109.519 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 25.0 m -140.54 145.73 37.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 14.890000000000001 109.046 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.29 118.0 20.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 17.350000000000001 109.528 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -130.3 145.68 51.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 34.380000000000003 109.404 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.54 117.82 3.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 38.770000000000003 109.378 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' B' ' 26' ' ' TYR . . . -119.45 162.75 13.67 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.42 -1.472 . . . . 34.579999999999998 109.42 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.623 ' N ' ' CE1' ' B' ' 26' ' ' TYR . 1.0 OUTLIER -144.02 113.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.115 -1.226 . . . . 41.869999999999997 109.288 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.7 m -47.17 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.743 . . . . 47.210000000000001 109.64 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.88 58.62 1.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 71.560000000000002 109.345 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 58.67 16.13 4.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.226 -0.922 . . . . 66.599999999999994 109.329 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.27 -55.31 1.28 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.325 -1.51 . . . . 55.490000000000002 109.325 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -145.35 151.94 48.87 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.251 -1.147 . . . . 44.990000000000002 109.184 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.47 131.1 11.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.607 2.205 . . . . 44.100000000000001 110.807 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.643 ' CE2' ' HB2' ' B' ' 28' ' ' LEU . 13.9 p90 -131.45 100.08 5.04 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.322 -0.861 . . . . 32.090000000000003 109.701 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.2 m -71.55 76.33 0.8 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 29.25 109.204 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.643 ' HB2' ' CE2' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -87.79 142.91 27.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.224 -0.923 . . . . 24.0 110.134 -179.346 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.589 ' CB ' ' CB ' ' B' ' 49' ' ' LEU . 4.3 m120 -51.14 123.13 8.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.462 -0.774 . . . . 23.309999999999999 109.947 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 35.6 mp0 -98.76 155.11 17.51 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.082 -1.081 . . . . 40.030000000000001 108.082 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' B' ' 10' ' ' GLN . 1.2 tm0? -146.53 -179.88 7.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.783 -1.198 . . . . 12.390000000000001 110.318 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.891 ' HB3' HD11 ' B' ' 44' ' ' LEU . 50.9 mt -139.98 145.92 38.45 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.442 -0.786 . . . . 17.420000000000002 110.019 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.763 ' SG ' HD11 ' B' ' 47' ' ' ILE . 4.1 m -152.88 -176.98 5.99 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.069 -1.456 . . . . 13.84 107.069 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.656 ' CD2' ' HD3' ' B' ' 7' ' ' LYS . 27.3 m-85 -128.61 113.41 15.39 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.867 -1.146 . . . . 21.140000000000001 109.914 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.879 HG22 ' HB ' ' B' ' 4' ' ' VAL . 45.5 t -107.09 115.83 49.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.293 -0.879 . . . . 10.66 110.126 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' B' ' 39' ' ' ASN . 55.0 m-20 -64.6 -36.48 84.37 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.806 -1.183 . . . . 25.890000000000001 107.806 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.658 HD21 ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 46.34 48.37 13.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.556 -0.715 . . . . 24.239999999999998 109.876 179.333 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.65 -0.72 64.25 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.389 -1.485 . . . . 31.02 109.389 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.2 OUTLIER -106.14 95.93 6.12 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.378 -1.072 . . . . 43.229999999999997 108.278 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' B' ' 39' ' ' ASN . 2.4 mp0 -27.55 -41.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.452 0.644 . . . . 42.340000000000003 111.126 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' B' ' 39' ' ' ASN . 48.5 m80 -78.19 141.2 62.01 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.659 -0.867 . . . . 6.5599999999999996 108.659 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.646 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.6 Cg_endo -76.3 136.7 18.13 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.909 1.739 . . . . 17.920000000000002 110.51 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.839 HG23 HG23 ' B' ' 45' ' ' VAL . 2.9 m -107.6 117.55 53.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.645 -0.872 . . . . 20.57 108.645 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.891 HD11 ' HB3' ' B' ' 32' ' ' LEU . 61.6 tp -65.75 97.79 0.35 Allowed 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.486 -0.885 . . . . 20.210000000000001 110.017 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.839 HG23 HG23 ' B' ' 43' ' ' VAL . 21.2 t -99.4 168.34 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.866 -0.79 . . . . 10.81 108.866 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.559 ' N ' HG12 ' B' ' 45' ' ' VAL . 4.0 ptpp? -117.13 147.8 42.11 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.94 -1.104 . . . . 36.740000000000002 111.59 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 1.019 HG21 ' CZ ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -112.58 177.98 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.564 -0.902 . . . . 19.739999999999998 108.564 179.191 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.435 ' H ' HG22 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -126.16 74.97 1.48 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.118 -0.989 . . . . 22.559999999999999 109.519 179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.624 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -42.85 150.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.428 -0.795 . . . . 20.41 109.129 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 53' ' ' GLN . 26.6 t0 -123.13 148.21 45.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.101 -1.0 . . . . 33.990000000000002 109.446 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 48.18 -148.8 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 54.920000000000002 109.276 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.14 16.78 56.43 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.582 -1.407 . . . . 36.100000000000001 109.582 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -45.64 149.26 1.11 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.198 -1.178 . . . . 54.759999999999998 109.523 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.06 113.19 3.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.614 2.209 . . . . 28.370000000000001 109.938 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.701 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -39.4 153.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.483 -0.761 . . . . 17.210000000000001 110.22 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 1.019 ' CZ ' HG21 ' B' ' 47' ' ' ILE . 84.8 m-85 -50.45 113.0 0.78 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.4 -0.813 . . . . 17.190000000000001 109.238 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -61.86 177.33 0.38 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 17.82 109.483 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.8 Cg_endo -77.6 113.77 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.532 2.155 . . . . 17.280000000000001 110.215 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.33 179.33 44.87 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.724 -1.35 . . . . 17.219999999999999 109.724 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.0 mp -74.06 155.87 38.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -1.173 . . . . 19.57 108.315 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.731 ' HB3' HD22 ' B' ' 83' ' ' LEU . 26.5 m-85 -143.56 163.26 33.67 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.551 1.167 . . . . 14.609999999999999 111.564 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.767 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.3 p -145.67 122.99 11.6 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.283 -1.747 . . . . 18.359999999999999 106.283 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.685 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.8 t -54.28 168.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 C-N-CA 118.497 -1.281 . . . . 19.129999999999999 108.828 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.538 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.1 t-80 -128.05 124.49 37.22 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.418 -0.801 . . . . 20.649999999999999 108.907 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.927 HD22 ' H ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -64.78 -6.9 9.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.82 -0.55 . . . . 19.649999999999999 109.903 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 13.6 p -53.86 -16.14 1.65 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.005 -1.06 . . . . 14.720000000000001 108.616 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.498 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 50.4 m -99.67 -5.32 29.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.475 -0.765 . . . . 11.449999999999999 111.002 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.637 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.8 m-30 -81.26 157.08 25.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.647 -1.283 . . . . 14.25 109.779 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.702 ' HA ' HD21 ' A' ' 37' ' ' LEU . 5.3 pttt -142.28 171.64 13.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.832 . . . . 32.700000000000003 109.66 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -125.65 112.66 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.346 -0.846 . . . . 15.630000000000001 109.092 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.02 -173.64 20.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.586 -1.406 . . . . 12.699999999999999 109.586 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' B' ' 72' ' ' GLN . 2.2 mp0 -89.3 34.5 0.8 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.214 -1.168 . . . . 26.289999999999999 109.503 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.94 24.81 3.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -0.797 . . . . 20.440000000000001 109.439 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . 51.32 56.9 12.92 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.604 -1.399 . . . . 13.82 109.604 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -149.03 105.38 3.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -1.196 . . . . 18.27 109.709 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.689 ' C ' HD23 ' B' ' 76' ' ' LEU . 5.1 tt -70.48 146.65 50.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.865 . . . . 12.43 109.257 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.506 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 4.1 mtm -157.42 144.72 18.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -0.954 . . . . 35.109999999999999 109.515 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.983 HD12 HD12 ' A' ' 78' ' ' ILE . 2.3 mp -70.06 142.12 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 13.67 109.571 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -107.69 -37.07 6.25 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.766 -1.198 . . . . 24.059999999999999 107.766 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.498 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER -168.09 67.6 0.08 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.424 -1.324 . . . . 35.039999999999999 107.424 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.685 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.6 OUTLIER -27.47 118.52 0.09 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.356 -0.838 . . . . 18.719999999999999 111.574 -178.4 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 20.0 tpt180 -91.99 104.85 17.21 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.056 -1.091 . . . . 20.550000000000001 108.056 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.731 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -72.88 150.64 42.45 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.013 0.911 . . . . 14.4 111.538 -178.15 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.767 HG22 ' O ' ' B' ' 62' ' ' THR . 34.7 m -151.99 154.42 32.62 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 107.75 -1.204 . . . . 17.649999999999999 107.75 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.1 Cg_endo -62.89 145.93 94.73 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.176 1.917 . . . . 25.699999999999999 110.774 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -75.27 121.85 22.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.242 -0.911 . . . . 49.289999999999999 109.535 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 tptt . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.017 -0.992 . . . . 58.909999999999997 109.45 -179.942 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.538 ' CG ' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.532 -0.544 . . . . 64.909999999999997 109.532 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.819 ' N ' HD22 ' B' ' 65' ' ' LEU . 3.3 mt -62.17 81.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.044 -1.095 . . . . 33.799999999999997 108.044 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.536 ' HD3' HD21 ' A' ' 60' ' ' LEU . 10.8 mttt -54.98 157.52 3.21 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.857 0.836 . . . . 32.719999999999999 111.508 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.111 HG22 HG22 ' A' ' 35' ' ' VAL . 80.8 t -161.14 166.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.719 0.771 . . . . 14.460000000000001 109.774 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.615 ' N ' HG12 ' A' ' 4' ' ' VAL . 34.1 mt-10 -152.14 105.63 3.08 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.63 -0.878 . . . . 22.120000000000001 108.63 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.766 HD11 ' SG ' ' A' ' 33' ' ' CYS . 0.3 OUTLIER -73.77 104.35 2.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 119.038 -1.065 . . . . 14.23 108.172 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.635 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.75 171.87 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 25.43 109.974 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.5 Cg_endo -75.83 -24.88 11.14 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.468 2.112 . . . . 13.609999999999999 110.211 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.0 t -93.02 0.77 57.44 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.437 -0.789 . . . . 15.52 108.887 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.518 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.6 mm-40 -116.51 43.2 2.26 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.342 -0.849 . . . . 17.309999999999999 108.932 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -108.39 10.02 27.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 24.780000000000001 110.304 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.455 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 1.4 tt0 -136.81 134.34 36.89 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.109 -0.994 . . . . 47.899999999999999 108.952 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 30.2 p90 -87.49 175.48 7.93 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.046 -1.033 . . . . 21.609999999999999 109.756 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -137.57 151.95 48.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.874 -0.787 . . . . 14.890000000000001 108.874 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.15 117.19 25.72 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.229 -0.919 . . . . 17.350000000000001 109.439 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 17' ' ' SER . 9.0 tpt180 -125.8 146.28 49.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 34.380000000000003 109.37 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.436 ' N ' ' HG3' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -62.27 95.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 38.770000000000003 109.503 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.565 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -91.02 175.71 40.11 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.498 -1.441 . . . . 34.579999999999998 109.498 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 20' ' ' SER . 1.5 t -144.73 121.96 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -1.158 . . . . 41.869999999999997 108.988 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 19' ' ' VAL . 3.4 p -51.37 -174.87 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.375 -0.828 . . . . 47.210000000000001 109.699 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' GLN . 0.2 OUTLIER -43.4 -33.58 1.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.93 . . . . 71.560000000000002 109.684 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.8 OUTLIER 163.39 46.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 66.599999999999994 109.581 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 24' ' ' LYS . . . -120.93 -59.12 0.23 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.454 -1.458 . . . . 55.490000000000002 109.454 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.489 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 22.5 mttp -149.94 163.39 24.81 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.297 -1.119 . . . . 44.990000000000002 109.475 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.6 Cg_endo -78.13 132.38 11.49 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.617 2.211 . . . . 44.100000000000001 110.083 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 10.4 p90 -122.84 138.95 54.5 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.119 -0.988 . . . . 32.090000000000003 109.622 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.45 74.71 5.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 29.25 108.972 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.583 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -85.05 169.03 14.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 24.0 109.985 -179.498 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.633 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -98.82 122.58 42.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 23.309999999999999 108.996 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.46 ' OE1' ' HD3' ' A' ' 46' ' ' LYS . 4.8 mt-10 -108.94 156.96 19.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.244 -0.91 . . . . 40.030000000000001 109.887 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.622 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -141.26 -172.85 3.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 12.390000000000001 109.419 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.929 ' HB3' HD11 ' A' ' 44' ' ' LEU . 4.7 mp -133.99 159.16 41.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 17.420000000000002 109.48 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.766 ' SG ' HD11 ' A' ' 6' ' ' ILE . 13.4 m -155.46 177.17 11.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.095 -1.003 . . . . 13.84 108.324 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.689 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 35.3 m-85 -126.65 110.98 13.77 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.093 -1.005 . . . . 21.140000000000001 108.935 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.111 HG22 HG22 ' A' ' 4' ' ' VAL . 50.9 t -89.59 151.66 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.016 -1.053 . . . . 10.66 110.378 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.2 m-20 -129.01 -145.49 0.3 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.713 -0.617 . . . . 25.890000000000001 109.348 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.861 ' HG ' HD21 ' B' ' 65' ' ' LEU . 0.3 OUTLIER 67.6 -65.33 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 24.239999999999998 109.094 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -83.39 6.13 74.07 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 109.028 -1.629 . . . . 31.02 109.028 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' A' ' 38' ' ' GLY . 4.4 m-80 -162.41 109.07 1.27 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.431 -1.041 . . . . 43.229999999999997 109.006 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' ASN . 26.0 mt-10 -39.22 -61.22 0.8 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.617 0.722 . . . . 42.340000000000003 109.632 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 22.8 m80 -71.47 164.55 56.73 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 108.174 -1.047 . . . . 8.3100000000000005 108.174 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.689 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.7 Cg_endo -78.27 140.52 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.868 1.712 . . . . 17.920000000000002 110.6 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.045 HG21 HG21 ' B' ' 70' ' ' VAL . 33.0 m -111.94 113.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.375 -0.828 . . . . 20.57 109.17 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.929 HD11 ' HB3' ' A' ' 32' ' ' LEU . 32.4 tp -67.35 110.66 3.65 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.906 . . . . 20.210000000000001 109.505 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.581 ' CG2' ' N ' ' B' ' 75' ' ' SER . 9.9 p -122.4 153.35 26.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.492 -0.755 . . . . 10.81 109.175 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 2.6 tttt -73.3 148.48 43.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 36.740000000000002 110.055 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.032 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -139.92 123.02 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.724 -0.843 . . . . 19.739999999999998 108.724 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.532 ' CG2' HD22 ' A' ' 28' ' ' LEU . 1.3 m -63.31 156.69 24.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.08 -1.013 . . . . 22.559999999999999 110.05 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.759 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -122.33 117.14 25.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.805 . . . . 20.41 108.902 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -47.13 140.25 5.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 33.990000000000002 109.812 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.85 109.49 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 54.920000000000002 109.478 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.97 -16.72 59.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.6 -1.4 . . . . 36.100000000000001 109.6 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -73.69 150.57 88.78 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.285 -1.127 . . . . 54.759999999999998 109.522 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.33 122.87 5.8 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.665 2.243 . . . . 28.370000000000001 110.184 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.759 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -40.1 147.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.396 -0.815 . . . . 17.210000000000001 110.483 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.621 ' HB3' HD13 ' A' ' 6' ' ' ILE . 89.1 m-85 -47.96 116.22 1.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.483 -0.761 . . . . 17.190000000000001 109.026 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.004 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -66.63 176.77 0.97 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 17.82 109.62 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 1.004 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -78.4 105.6 2.0 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.686 2.257 . . . . 17.280000000000001 110.261 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.49 176.69 48.16 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.99 -1.244 . . . . 17.219999999999999 109.99 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.779 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -73.5 143.59 46.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -1.111 . . . . 19.57 108.426 179.293 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.565 ' CB ' ' HB ' ' A' ' 4' ' ' VAL . 33.3 m-85 -130.29 162.73 28.33 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.773 -1.204 . . . . 14.609999999999999 111.25 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.709 ' O ' HG22 ' A' ' 84' ' ' VAL . 33.4 p -142.9 119.78 11.27 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.896 -1.89 . . . . 18.359999999999999 105.896 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.634 ' HB ' HD13 ' A' ' 2' ' ' ILE . 2.7 t -53.05 166.94 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 C-N-CA 118.59 -1.244 . . . . 19.129999999999999 109.467 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -129.36 130.46 46.08 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.545 -0.722 . . . . 20.649999999999999 109.134 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.879 HD21 ' HG ' ' B' ' 37' ' ' LEU . 0.5 OUTLIER -72.58 1.58 7.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.43 -0.794 . . . . 19.649999999999999 110.116 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -55.42 -19.25 8.69 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.496 -1.298 . . . . 14.720000000000001 107.496 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.516 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 7.1 m -99.07 -3.93 33.56 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.932 -0.48 . . . . 11.449999999999999 110.33 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.4 m-30 -85.41 157.47 20.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.863 -1.148 . . . . 14.25 110.215 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.425 ' HG2' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ptpt -154.41 174.33 15.01 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.023 -0.732 . . . . 32.700000000000003 109.023 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.05 HG21 HG21 ' B' ' 43' ' ' VAL . 1.0 OUTLIER -114.58 111.76 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 15.630000000000001 109.556 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.34 -170.25 46.59 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.315 -1.514 . . . . 12.699999999999999 109.315 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.1 tm0? -90.5 20.79 4.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.154 -1.204 . . . . 26.289999999999999 109.481 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.82 -12.74 35.44 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.501 -0.75 . . . . 20.440000000000001 109.237 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' B' ' 46' ' ' LYS . . . 85.01 35.05 13.12 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.509 -1.436 . . . . 13.82 109.509 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.547 ' N ' ' CG2' ' B' ' 45' ' ' VAL . 22.8 p -164.33 150.82 11.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -1.199 . . . . 18.27 109.647 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.688 HD22 HG21 ' B' ' 2' ' ' ILE . 16.3 tp -63.69 156.74 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.853 . . . . 12.43 109.126 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 32.0 mtt -154.95 113.43 3.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.092 -1.005 . . . . 35.109999999999999 109.749 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.96 HD12 HD12 ' B' ' 78' ' ' ILE . 2.9 mt -55.67 139.91 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.314 -0.866 . . . . 13.67 109.472 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.425 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 10.9 t70 -106.19 -27.39 11.09 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.443 -0.947 . . . . 24.059999999999999 108.443 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.516 ' C ' ' HB3' ' A' ' 67' ' ' SER . 5.7 tpm_? 179.74 67.75 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.992 -1.485 . . . . 35.039999999999999 106.992 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -29.39 118.09 0.13 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.387 -0.824 . . . . 18.719999999999999 111.913 -177.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -92.09 108.14 19.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.716 -1.216 . . . . 20.550000000000001 107.716 178.729 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.032 ' HB2' HD11 ' A' ' 47' ' ' ILE . 12.7 tp -80.25 150.42 30.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.229 -0.919 . . . . 14.4 111.093 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 62' ' ' THR . 25.0 m -147.44 152.47 42.23 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 108.039 -1.097 . . . . 17.649999999999999 108.039 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -62.37 141.58 87.72 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.103 1.868 . . . . 25.699999999999999 110.662 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.779 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.59 116.44 14.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.437 -0.789 . . . . 49.289999999999999 109.625 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.007 -0.996 . . . . 58.909999999999997 109.482 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.535 ' CG ' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.518 -0.549 . . . . 64.909999999999997 109.518 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.832 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.2 mt -62.19 81.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.993 -1.114 . . . . 33.799999999999997 107.993 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 10.8 mttt -54.83 157.37 3.16 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.877 0.846 . . . . 32.719999999999999 111.487 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.031 HG22 HG22 ' B' ' 35' ' ' VAL . 83.1 t -161.09 166.03 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.751 0.786 . . . . 14.460000000000001 109.739 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.619 ' N ' HG12 ' B' ' 4' ' ' VAL . 34.4 mt-10 -151.97 105.69 3.12 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.629 -0.878 . . . . 22.120000000000001 108.629 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.758 HD11 ' SG ' ' B' ' 33' ' ' CYS . 0.3 OUTLIER -73.77 104.55 2.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.01 -1.076 . . . . 14.23 108.178 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.641 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.83 171.9 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.442 -0.786 . . . . 25.43 109.99 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.5 Cg_endo -75.8 -25.04 11.05 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.487 2.125 . . . . 13.609999999999999 110.238 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t -92.8 0.65 57.45 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 108.938 -0.764 . . . . 15.52 108.938 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.6 mm-40 -116.43 43.25 2.24 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.345 -0.847 . . . . 17.309999999999999 108.928 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -108.4 10.09 27.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.91 . . . . 24.780000000000001 110.312 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.454 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 1.4 tt0 -136.86 134.22 36.65 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.114 -0.991 . . . . 47.899999999999999 108.943 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.629 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 30.2 p90 -87.44 175.47 7.95 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.028 -1.045 . . . . 21.609999999999999 109.74 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 59.3 m -137.48 152.04 49.11 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.845 -0.798 . . . . 14.890000000000001 108.845 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.29 117.17 25.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.256 -0.903 . . . . 17.350000000000001 109.401 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' B' ' 17' ' ' SER . 9.0 tpt180 -125.77 146.36 49.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 34.380000000000003 109.366 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.439 ' N ' ' HG3' ' B' ' 16' ' ' ARG . 0.5 OUTLIER -62.38 95.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 38.770000000000003 109.447 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -90.98 175.77 40.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.473 -1.451 . . . . 34.579999999999998 109.473 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.465 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.5 t -144.79 121.99 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.196 . . . . 41.869999999999997 109.024 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.461 ' O ' ' O ' ' B' ' 19' ' ' VAL . 3.5 p -51.41 -174.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.315 -0.866 . . . . 47.210000000000001 109.674 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 22' ' ' GLN . 0.2 OUTLIER -43.37 -33.62 1.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 71.560000000000002 109.642 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' B' ' 21' ' ' ARG . 0.8 OUTLIER 163.31 46.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 66.599999999999994 109.589 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' B' ' 24' ' ' LYS . . . -120.97 -59.05 0.23 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.514 -1.434 . . . . 55.490000000000002 109.514 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.483 ' HB3' ' HD2' ' B' ' 25' ' ' PRO . 22.4 mttp -149.97 163.36 24.91 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.296 -1.12 . . . . 44.990000000000002 109.441 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' B' ' 24' ' ' LYS . 35.0 Cg_endo -78.1 132.26 11.44 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.65 2.233 . . . . 44.100000000000001 110.039 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.6 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 10.6 p90 -122.74 139.06 54.39 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.137 -0.977 . . . . 32.090000000000003 109.662 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.57 74.93 5.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 29.25 108.954 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.584 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -85.2 168.94 14.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 24.0 109.969 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.628 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -98.75 122.53 42.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.479 -0.763 . . . . 23.309999999999999 109.035 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 4.9 mt-10 -109.0 156.79 19.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.189 -0.944 . . . . 40.030000000000001 109.911 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.623 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -141.13 -172.83 3.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 12.390000000000001 109.423 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.943 ' HB3' HD11 ' B' ' 44' ' ' LEU . 4.7 mp -133.99 159.13 41.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.154 -0.966 . . . . 17.420000000000002 109.412 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.758 ' SG ' HD11 ' B' ' 6' ' ' ILE . 13.1 m -155.41 177.21 11.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.309 -0.997 . . . . 13.84 108.309 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.684 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 34.6 m-85 -126.72 111.04 13.8 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.157 -0.964 . . . . 21.140000000000001 108.92 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 1.031 HG22 HG22 ' B' ' 4' ' ' VAL . 50.9 t -89.69 151.65 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.012 -1.055 . . . . 10.66 110.397 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.1 m-20 -128.92 -145.6 0.3 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.307 -0.627 . . . . 25.890000000000001 109.307 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.879 ' HG ' HD21 ' A' ' 65' ' ' LEU . 0.3 OUTLIER 67.65 -65.4 0.24 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.134 -0.979 . . . . 24.239999999999998 109.057 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -83.27 6.11 73.73 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.041 -1.623 . . . . 31.02 109.041 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' B' ' 38' ' ' GLY . 4.5 m-80 -162.39 109.02 1.27 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.438 -1.036 . . . . 43.229999999999997 108.986 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' B' ' 39' ' ' ASN . 26.1 mt-10 -39.08 -61.39 0.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.701 0.762 . . . . 42.340000000000003 109.573 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.461 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 22.6 m80 -71.24 164.57 56.04 Favored Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 108.256 -1.016 . . . . 8.3399999999999999 108.256 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.684 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.6 Cg_endo -78.32 140.7 17.57 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.855 1.703 . . . . 17.920000000000002 110.507 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 1.05 HG21 HG21 ' A' ' 70' ' ' VAL . 32.9 m -112.13 113.33 43.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.394 -0.816 . . . . 20.57 109.197 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.943 HD11 ' HB3' ' B' ' 32' ' ' LEU . 32.3 tp -67.46 110.72 3.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.313 -0.867 . . . . 20.210000000000001 109.616 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 75' ' ' SER . 9.9 p -122.28 153.81 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.494 -0.754 . . . . 10.81 109.108 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 2.6 tttt -73.73 148.55 42.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 36.740000000000002 110.027 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.999 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.8 OUTLIER -139.75 123.04 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.739 -0.837 . . . . 19.739999999999998 108.739 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.519 ' CG2' HD22 ' B' ' 28' ' ' LEU . 1.3 m -63.39 156.66 25.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.015 -1.053 . . . . 22.559999999999999 109.982 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.764 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -122.26 116.98 25.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.422 -0.799 . . . . 20.41 108.94 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.545 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -47.0 140.33 4.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 33.990000000000002 109.832 -179.486 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.92 109.45 0.83 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 54.920000000000002 109.478 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.99 -16.75 59.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.581 -1.408 . . . . 36.100000000000001 109.581 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.545 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.8 OUTLIER -73.7 150.47 88.71 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -1.148 . . . . 54.759999999999998 109.568 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.7 Cg_endo -78.22 122.82 5.84 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.656 2.237 . . . . 28.370000000000001 110.225 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.764 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -40.11 147.15 0.1 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 17.210000000000001 110.404 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.619 ' HB3' HD13 ' B' ' 6' ' ' ILE . 88.9 m-85 -48.13 115.59 1.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.462 -0.773 . . . . 17.190000000000001 109.171 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -65.64 176.88 0.79 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 17.82 109.583 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 36.1 Cg_endo -78.68 106.72 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.741 2.294 . . . . 17.280000000000001 110.424 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.82 176.9 48.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.876 -1.29 . . . . 17.219999999999999 109.876 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.808 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -73.37 144.14 46.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.385 -1.068 . . . . 19.57 108.632 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.571 ' CB ' ' HB ' ' B' ' 4' ' ' VAL . 33.7 m-85 -130.78 162.82 28.68 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.756 -1.215 . . . . 14.609999999999999 111.375 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.718 ' O ' HG22 ' B' ' 84' ' ' VAL . 33.2 p -143.09 119.68 11.07 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 105.975 -1.861 . . . . 18.359999999999999 105.975 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.639 ' HB ' HD13 ' B' ' 2' ' ' ILE . 2.7 t -53.12 166.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 118.575 -1.25 . . . . 19.129999999999999 109.438 -177.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -129.2 130.32 46.17 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.552 -0.718 . . . . 20.649999999999999 109.196 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.861 HD21 ' HG ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -72.47 1.69 7.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.421 -0.799 . . . . 19.649999999999999 110.092 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -55.49 -19.24 9.02 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.45 -1.315 . . . . 14.720000000000001 107.45 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.509 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 7.0 m -99.08 -3.98 33.42 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.902 -0.499 . . . . 11.449999999999999 110.351 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.659 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.3 m-30 -85.35 157.62 20.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.913 -1.117 . . . . 14.25 110.182 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.422 ' HG2' ' HB2' ' B' ' 79' ' ' ASP . 1.5 ptpt -154.57 174.17 15.32 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.991 -0.744 . . . . 32.700000000000003 108.991 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 1.045 HG21 HG21 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -114.44 111.77 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 15.630000000000001 109.55 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.2 -170.24 46.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.332 -1.507 . . . . 12.699999999999999 109.332 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 1.1 tm0? -90.65 21.17 4.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.138 -1.213 . . . . 26.289999999999999 109.458 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.16 -12.82 34.31 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.448 -0.782 . . . . 20.440000000000001 109.253 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.48 ' C ' HG22 ' A' ' 45' ' ' VAL . . . 85.15 34.72 13.82 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.546 -1.422 . . . . 13.82 109.546 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.581 ' N ' ' CG2' ' A' ' 45' ' ' VAL . 21.9 p -163.93 150.87 11.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -1.183 . . . . 18.27 109.683 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.715 HD22 HG21 ' A' ' 2' ' ' ILE . 16.3 tp -63.72 157.0 25.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 12.43 109.09 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' B' ' 76' ' ' LEU . 31.9 mtt -155.15 113.5 3.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.013 . . . . 35.109999999999999 109.679 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.96 HD12 HD12 ' A' ' 78' ' ' ILE . 2.9 mt -55.74 139.95 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 13.67 109.476 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.422 ' HB2' ' HG2' ' B' ' 69' ' ' LYS . 10.7 t70 -106.19 -27.3 11.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.417 -0.957 . . . . 24.059999999999999 108.417 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.509 ' C ' ' HB3' ' B' ' 67' ' ' SER . 5.8 tpm_? 179.65 67.78 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.956 -1.498 . . . . 35.039999999999999 106.956 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.639 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -29.34 118.13 0.13 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.349 -0.841 . . . . 18.719999999999999 111.85 -177.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -92.2 108.07 19.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.709 -1.219 . . . . 20.550000000000001 107.709 178.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.999 ' HB2' HD11 ' B' ' 47' ' ' ILE . 12.6 tp -80.13 150.26 30.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.184 -0.947 . . . . 14.4 111.07 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.718 HG22 ' O ' ' B' ' 62' ' ' THR . 25.0 m -147.32 152.58 42.9 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.111 -1.07 . . . . 17.649999999999999 108.111 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.3 Cg_endo -62.32 141.72 88.51 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.166 1.91 . . . . 25.699999999999999 110.666 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -73.69 116.54 14.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 49.289999999999999 109.497 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.959 -1.02 . . . . 58.909999999999997 109.425 179.999 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.308 0.575 . . . . 64.909999999999997 109.484 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.696 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.7 mt 69.3 72.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.975 -1.12 . . . . 33.799999999999997 107.975 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.497 ' C ' HG23 ' A' ' 4' ' ' VAL . 18.8 mttt -54.1 158.74 2.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.017 0.913 . . . . 32.719999999999999 111.461 -178.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.05 ' CG2' HG22 ' A' ' 35' ' ' VAL . 66.4 t -160.46 168.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.93 -0.766 . . . . 14.460000000000001 108.93 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.589 ' N ' HG12 ' A' ' 4' ' ' VAL . 43.1 mt-10 -154.6 103.26 2.45 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.79 0.805 . . . . 22.120000000000001 108.843 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.561 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -69.34 108.43 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.893 -1.151 . . . . 14.23 107.893 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.654 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.11 172.79 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.203 -0.936 . . . . 25.43 109.406 -179.042 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.5 Cg_endo -76.23 -21.6 13.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.475 2.117 . . . . 13.609999999999999 110.128 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.42 4.15 46.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.529 -0.732 . . . . 15.52 109.443 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.699 ' OE1' HD12 ' A' ' 32' ' ' LEU . 24.0 mm-40 -114.84 38.71 3.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 17.309999999999999 109.288 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.13 52.24 0.72 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.877 . . . . 24.780000000000001 109.738 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.63 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 5.0 pt20 -176.63 135.63 0.24 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.364 -0.835 . . . . 47.899999999999999 108.896 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.634 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 37.7 p90 -95.61 172.67 7.91 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.721 -1.237 . . . . 21.609999999999999 109.874 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 8.0 t -137.03 162.03 34.43 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.497 -0.927 . . . . 14.890000000000001 108.497 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 112.75 24.78 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.178 -0.951 . . . . 17.350000000000001 109.271 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.449 ' NH1' ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -126.15 139.39 53.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.346 -0.846 . . . . 34.380000000000003 109.424 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -44.68 152.57 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 38.770000000000003 109.456 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.589 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -158.91 167.26 34.75 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.411 -1.476 . . . . 34.579999999999998 109.411 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 23' ' ' GLY . 1.8 t -135.55 118.81 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.204 -1.174 . . . . 41.869999999999997 109.152 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 21' ' ' ARG . 2.9 p -55.49 94.09 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.459 -0.776 . . . . 47.210000000000001 109.808 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 20' ' ' SER . 29.0 mtm180 41.95 50.19 4.16 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -0.817 . . . . 71.560000000000002 109.842 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 56.98 70.02 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 66.599999999999994 109.757 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.556 ' H ' HG12 ' A' ' 19' ' ' VAL . . . -151.79 -57.87 0.01 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.016 -1.634 . . . . 55.490000000000002 109.016 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 5.5 mmtt -138.58 148.66 59.71 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.474 -1.015 . . . . 44.990000000000002 108.626 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.66 113.42 3.65 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.35 2.034 . . . . 44.100000000000001 110.368 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.997 ' CE1' HD23 ' A' ' 28' ' ' LEU . 4.6 p90 -119.89 168.83 10.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.282 -0.886 . . . . 32.090000000000003 110.007 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.01 83.65 2.17 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.85 -1.167 . . . . 29.25 107.85 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.997 HD23 ' CE1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -92.28 143.55 26.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 24.0 110.903 -178.21 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.611 ' CB ' ' CD1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -72.47 127.67 33.26 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.931 -0.766 . . . . 23.309999999999999 108.931 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.7 ' CG ' HD11 ' A' ' 28' ' ' LEU . 6.6 mt-10 -118.11 165.51 13.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.018 -1.051 . . . . 40.030000000000001 109.281 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.652 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -146.37 179.99 7.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.106 -0.996 . . . . 12.390000000000001 109.671 -179.604 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.699 HD12 ' OE1' ' A' ' 10' ' ' GLN . 39.3 mt -123.92 154.04 40.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 17.420000000000002 109.316 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 11.1 m -154.06 172.98 16.65 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.611 -1.255 . . . . 13.84 107.611 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.847 ' CE2' HD13 ' A' ' 44' ' ' LEU . 29.2 m-85 -121.45 99.03 6.24 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.951 -1.093 . . . . 21.140000000000001 109.45 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.05 HG22 ' CG2' ' A' ' 4' ' ' VAL . 61.7 t -93.73 126.16 46.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.041 -1.037 . . . . 10.66 110.602 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' GLY . 25.3 t0 -101.19 44.66 1.0 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.591 -1.263 . . . . 25.890000000000001 107.591 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.83 HD21 HG22 ' B' ' 70' ' ' VAL . 0.1 OUTLIER -35.77 -29.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.223 0.535 . . . . 24.239999999999998 110.197 -178.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.628 ' H ' HD12 ' A' ' 37' ' ' LEU . . . 160.84 52.3 0.02 OUTLIER Glycine 0 N--CA 1.479 1.535 0 N-CA-C 109.438 -1.465 . . . . 31.02 109.438 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.508 HD21 ' C ' ' A' ' 38' ' ' GLY . 5.8 m120 -126.83 17.98 7.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.07 -1.253 . . . . 43.229999999999997 110.035 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.591 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 2.6 mm-40 56.56 14.64 1.77 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.326 -0.859 . . . . 42.340000000000003 110.252 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 77.5 m-70 -162.53 161.72 19.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.326 -0.99 . . . . 6.1600000000000001 108.326 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.691 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.0 Cg_endo -78.06 136.57 14.78 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.892 1.728 . . . . 17.920000000000002 110.021 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.916 HG22 ' O ' ' A' ' 35' ' ' VAL . 3.6 m -111.34 115.24 49.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.249 -0.907 . . . . 20.57 109.453 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.847 HD13 ' CE2' ' A' ' 34' ' ' TYR . 18.9 tp -71.76 88.73 1.01 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.182 -0.949 . . . . 20.210000000000001 109.482 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.478 HG22 ' C ' ' B' ' 74' ' ' GLY . 6.1 p -103.21 152.88 5.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.632 -0.877 . . . . 10.81 108.632 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 3.7 mtpt -72.08 167.03 21.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 36.740000000000002 110.493 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.983 ' CD1' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -146.47 177.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.567 -0.901 . . . . 19.739999999999998 108.567 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.769 HG23 HD13 ' A' ' 28' ' ' LEU . 97.8 m -117.6 151.29 37.47 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.186 -0.946 . . . . 22.559999999999999 109.464 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.651 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -124.74 149.19 47.56 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.291 -1.003 . . . . 20.41 108.291 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' H ' HD13 ' A' ' 49' ' ' LEU . 23.4 t0 -106.18 143.5 34.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.078 -1.014 . . . . 33.990000000000002 110.202 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.21 127.04 14.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 54.920000000000002 109.477 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.7 -28.67 7.47 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.652 -1.379 . . . . 36.100000000000001 109.652 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.97 137.35 72.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.198 -1.178 . . . . 54.759999999999998 109.564 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.5 Cg_endo -78.58 124.2 6.26 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.413 2.075 . . . . 28.370000000000001 109.959 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.652 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -40.24 147.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.4 -0.812 . . . . 17.210000000000001 110.0 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 84.9 m-85 -45.9 105.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 17.190000000000001 109.137 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -58.1 174.79 0.32 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 17.82 109.628 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.78 114.15 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.605 2.203 . . . . 17.280000000000001 110.149 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.25 179.76 46.0 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.474 -1.45 . . . . 17.219999999999999 109.474 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.6 mp -75.4 146.31 40.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -1.217 . . . . 19.57 108.111 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.682 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.4 m-85 -133.07 167.43 20.32 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.866 -1.146 . . . . 14.609999999999999 111.591 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.642 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.8 p -150.59 119.5 6.65 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.336 -1.727 . . . . 18.359999999999999 106.336 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.602 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -52.01 164.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.374 -1.33 . . . . 19.129999999999999 108.568 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.533 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -123.47 123.89 41.65 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.397 -0.814 . . . . 20.649999999999999 109.003 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.717 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.2 OUTLIER -67.94 -4.02 11.73 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.834 -0.542 . . . . 19.649999999999999 110.209 -179.307 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.3 t -55.98 -15.86 4.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.076 -1.015 . . . . 14.720000000000001 108.449 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.49 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 16.6 m -95.76 -7.0 38.39 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.525 -0.734 . . . . 11.449999999999999 110.633 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.664 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -83.15 159.64 22.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.818 -1.176 . . . . 14.25 109.674 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.766 ' HA ' HD22 ' B' ' 37' ' ' LEU . 10.3 mtmt -157.82 172.14 19.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.49 -0.756 . . . . 32.700000000000003 109.253 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.794 HG22 HD21 ' B' ' 37' ' ' LEU . 0.0 OUTLIER -107.78 98.29 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 15.630000000000001 109.008 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.8 -149.92 4.11 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.825 -1.31 . . . . 12.699999999999999 109.825 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.3 21.04 17.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.27 -1.135 . . . . 26.289999999999999 109.685 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.09 -11.98 42.46 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.05 -0.722 . . . . 20.440000000000001 109.05 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 84.69 24.23 46.9 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.495 -1.442 . . . . 13.82 109.495 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.7 p -161.03 152.25 18.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -1.179 . . . . 18.27 109.633 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 76' ' ' LEU . 4.7 tt -62.95 149.23 45.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.319 -0.863 . . . . 12.43 109.381 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.51 ' N ' HD23 ' A' ' 76' ' ' LEU . 14.3 mtt -150.55 133.98 16.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 35.109999999999999 109.412 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' B' ' 78' ' ' ILE . 3.2 mt -66.29 139.24 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.877 . . . . 13.67 109.721 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 8.3 t70 -106.64 -19.58 13.62 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.507 -0.923 . . . . 24.059999999999999 108.507 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.49 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 172.71 68.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.198 -1.408 . . . . 35.039999999999999 107.198 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -31.63 116.88 0.19 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.693 0.758 . . . . 18.719999999999999 111.179 -178.14 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.01 104.97 17.49 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.463 -0.94 . . . . 20.550000000000001 108.463 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.983 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -73.38 144.82 46.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 14.4 111.024 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 62' ' ' THR . 27.6 m -146.72 156.61 48.32 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.956 -1.128 . . . . 17.649999999999999 107.956 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.0 Cg_endo -63.03 144.97 93.89 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.134 1.889 . . . . 25.699999999999999 110.334 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.11 115.73 12.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.135 -0.978 . . . . 49.289999999999999 109.705 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.02 -0.99 . . . . 58.909999999999997 109.531 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.534 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.399 -0.593 . . . . 64.909999999999997 109.399 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.717 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.7 mt 68.6 72.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.874 -1.158 . . . . 33.799999999999997 107.874 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.494 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 18.9 mttt -54.4 158.62 2.32 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.009 0.909 . . . . 32.719999999999999 111.412 -178.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.072 ' CG2' HG22 ' B' ' 35' ' ' VAL . 68.2 t -160.25 168.0 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.994 -0.743 . . . . 14.460000000000001 108.994 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.612 ' N ' HG12 ' B' ' 4' ' ' VAL . 42.3 mt-10 -154.02 103.09 2.54 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.418 -0.801 . . . . 22.120000000000001 108.975 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.559 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -69.18 108.53 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.934 -1.135 . . . . 14.23 107.934 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.661 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.25 172.5 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 25.43 109.36 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 35.1 Cg_endo -76.16 -21.39 13.81 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.488 2.125 . . . . 13.609999999999999 110.122 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.63 4.15 45.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.475 -0.765 . . . . 15.52 109.442 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.696 ' OE1' HD12 ' B' ' 32' ' ' LEU . 24.1 mm-40 -114.69 38.36 3.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.93 . . . . 17.309999999999999 109.187 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.14 53.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 24.780000000000001 109.709 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.614 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 4.8 pt20 -177.24 135.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.376 -0.828 . . . . 47.899999999999999 108.884 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.628 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 37.9 p90 -95.77 172.75 7.84 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.753 -1.217 . . . . 21.609999999999999 109.891 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 8.3 t -137.28 161.91 34.94 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.488 -0.93 . . . . 14.890000000000001 108.488 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.93 112.78 24.85 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.17 -0.956 . . . . 17.350000000000001 109.438 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.449 ' NH1' ' HG3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -126.21 139.27 53.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.299 -0.876 . . . . 34.380000000000003 109.378 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.6 OUTLIER -44.52 152.74 0.19 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.911 . . . . 38.770000000000003 109.403 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.576 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -159.2 167.22 34.91 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.424 -1.471 . . . . 34.579999999999998 109.424 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.566 HG12 ' H ' ' B' ' 23' ' ' GLY . 1.8 t -135.47 119.06 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.116 -1.226 . . . . 41.869999999999997 109.149 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.43 ' O ' ' C ' ' B' ' 21' ' ' ARG . 3.0 p -55.69 94.22 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.341 -0.85 . . . . 47.210000000000001 109.768 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' B' ' 20' ' ' SER . 28.4 mtm180 41.65 50.54 3.87 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.425 -0.797 . . . . 71.560000000000002 109.832 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 56.73 70.18 0.67 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 66.599999999999994 109.81 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.566 ' H ' HG12 ' B' ' 19' ' ' VAL . . . -152.1 -57.72 0.01 OUTLIER Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.048 -1.621 . . . . 55.490000000000002 109.048 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' B' ' 19' ' ' VAL . 5.5 mmtt -138.56 148.38 58.64 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.388 -1.066 . . . . 44.990000000000002 108.714 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.45 113.47 3.68 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.371 2.047 . . . . 44.100000000000001 110.403 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.982 ' CE1' HD23 ' B' ' 28' ' ' LEU . 4.3 p90 -120.16 168.49 11.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.23 -0.919 . . . . 32.090000000000003 110.081 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.68 83.82 2.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.938 -1.134 . . . . 29.25 107.938 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.982 HD23 ' CE1' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -92.4 143.42 26.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 24.0 110.846 -178.202 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.624 ' CB ' ' CD1' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -72.38 127.47 32.67 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.894 -0.78 . . . . 23.309999999999999 108.894 179.03 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.712 ' CG ' HD11 ' B' ' 28' ' ' LEU . 6.5 mt-10 -118.06 165.24 13.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.012 -1.055 . . . . 40.030000000000001 109.322 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.63 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.9 OUTLIER -146.03 -179.9 7.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.137 -0.977 . . . . 12.390000000000001 109.765 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.696 HD12 ' OE1' ' B' ' 10' ' ' GLN . 40.3 mt -124.2 153.71 41.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 17.420000000000002 109.309 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 10.3 m -153.73 172.98 16.44 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.716 -1.216 . . . . 13.84 107.716 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.829 ' CE2' HD13 ' B' ' 44' ' ' LEU . 29.3 m-85 -121.39 98.91 6.19 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.895 -1.128 . . . . 21.140000000000001 109.461 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 1.072 HG22 ' CG2' ' B' ' 4' ' ' VAL . 61.7 t -93.6 126.17 46.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.03 -1.044 . . . . 10.66 110.573 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' B' ' 38' ' ' GLY . 26.1 t0 -101.11 44.37 1.02 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.579 -1.267 . . . . 25.890000000000001 107.579 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.794 HD21 HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -35.65 -30.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.1 0.476 . . . . 24.239999999999998 110.185 -178.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.626 ' H ' HD12 ' B' ' 37' ' ' LEU . . . 161.05 51.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 109.415 -1.474 . . . . 31.02 109.415 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.501 HD21 ' C ' ' B' ' 38' ' ' GLY . 5.8 m120 -126.54 18.28 7.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.167 -1.196 . . . . 43.229999999999997 110.092 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.59 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 2.6 mm-40 56.36 14.58 1.65 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.237 -0.914 . . . . 42.340000000000003 110.302 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 77.4 m-70 -162.41 161.6 20.14 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.344 -0.984 . . . . 6.1500000000000004 108.344 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.694 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.8 Cg_endo -78.02 136.55 14.83 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.877 1.718 . . . . 17.920000000000002 109.998 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.911 HG22 ' O ' ' B' ' 35' ' ' VAL . 3.6 m -111.39 115.42 49.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.242 -0.911 . . . . 20.57 109.339 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.829 HD13 ' CE2' ' B' ' 34' ' ' TYR . 19.0 tp -71.99 88.8 1.08 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.219 -0.926 . . . . 20.210000000000001 109.503 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.42 HG22 ' C ' ' A' ' 74' ' ' GLY . 6.3 p -103.0 153.38 5.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.648 -0.871 . . . . 10.81 108.648 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 3.8 mtpt -72.32 167.44 20.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 36.740000000000002 110.428 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.975 ' CD1' HD12 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -146.94 177.12 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.628 -0.878 . . . . 19.739999999999998 108.628 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.771 HG23 HD13 ' B' ' 28' ' ' LEU . 98.5 m -117.39 151.28 37.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.123 -0.986 . . . . 22.559999999999999 109.468 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -124.88 148.86 48.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.226 -1.028 . . . . 20.41 108.226 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.465 ' H ' HD13 ' B' ' 49' ' ' LEU . 23.2 t0 -105.95 143.61 33.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 33.990000000000002 110.076 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.22 126.84 13.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.771 . . . . 54.920000000000002 109.528 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.81 -28.49 7.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.712 -1.355 . . . . 36.100000000000001 109.712 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.08 137.45 72.53 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.277 -1.131 . . . . 54.759999999999998 109.483 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.57 124.14 6.24 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.394 2.063 . . . . 28.370000000000001 109.96 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.666 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -40.29 147.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 17.210000000000001 109.913 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 84.1 m-85 -46.2 105.85 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 17.190000000000001 109.252 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.918 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.85 174.65 0.31 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 17.82 109.59 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.918 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -77.99 115.18 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.624 2.216 . . . . 17.280000000000001 110.43 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.49 -179.46 44.87 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.31 -1.516 . . . . 17.219999999999999 109.31 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 4.0 mp -75.29 146.86 40.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.134 -1.216 . . . . 19.57 108.457 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.672 ' HB3' HD22 ' B' ' 83' ' ' LEU . 19.9 m-85 -133.54 167.69 20.01 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.498 1.142 . . . . 14.609999999999999 111.452 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.646 ' O ' HG22 ' B' ' 84' ' ' VAL . 45.8 p -150.87 119.45 6.49 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.296 -1.742 . . . . 18.359999999999999 106.296 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.598 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -52.0 163.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.404 -1.318 . . . . 19.129999999999999 108.597 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -123.16 124.35 42.86 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.406 -0.809 . . . . 20.649999999999999 109.022 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.706 HD11 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -68.24 -3.95 12.47 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.879 -0.513 . . . . 19.649999999999999 110.169 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 10.4 t -55.93 -16.08 4.27 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.132 -0.98 . . . . 14.720000000000001 108.376 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.497 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 16.6 m -95.66 -6.7 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.609 -0.682 . . . . 11.449999999999999 110.707 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.665 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.9 m-30 -83.33 159.78 21.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.852 -1.155 . . . . 14.25 109.657 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.794 ' HA ' HD22 ' A' ' 37' ' ' LEU . 10.3 mtmt -158.09 171.29 20.5 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.475 -0.766 . . . . 32.700000000000003 109.269 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.83 HG22 HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -106.99 98.59 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 15.630000000000001 108.959 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.44 -150.47 4.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.707 -1.357 . . . . 12.699999999999999 109.707 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.78 21.64 16.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.238 -1.154 . . . . 26.289999999999999 109.859 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.66 -11.82 41.38 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.02 -0.733 . . . . 20.440000000000001 109.02 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.478 ' C ' HG22 ' A' ' 45' ' ' VAL . . . 84.44 24.99 44.82 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.532 -1.427 . . . . 13.82 109.532 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.7 p -161.68 152.18 17.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -1.17 . . . . 18.27 109.639 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.685 ' C ' HD23 ' B' ' 76' ' ' LEU . 4.6 tt -63.14 149.24 45.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 12.43 109.412 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.507 ' N ' HD23 ' B' ' 76' ' ' LEU . 14.4 mtt -150.44 133.69 16.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 35.109999999999999 109.502 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' A' ' 78' ' ' ILE . 3.2 mt -66.18 138.86 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 13.67 109.686 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 8.2 t70 -106.23 -19.87 13.57 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.558 -0.905 . . . . 24.059999999999999 108.558 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.497 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 173.0 68.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.208 -1.404 . . . . 35.039999999999999 107.208 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.636 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -32.03 117.04 0.21 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.672 0.748 . . . . 18.719999999999999 111.214 -178.117 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.523 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.15 105.0 17.51 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.473 -0.936 . . . . 20.550000000000001 108.473 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.975 HD12 ' CD1' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -73.34 145.05 46.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 14.4 110.96 -178.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.646 HG22 ' O ' ' B' ' 62' ' ' THR . 28.0 m -147.04 156.41 47.11 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 107.938 -1.134 . . . . 17.649999999999999 107.938 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.8 Cg_endo -62.87 144.77 94.02 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.185 1.923 . . . . 25.699999999999999 110.338 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -72.93 115.91 12.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.194 -0.941 . . . . 49.289999999999999 109.681 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' B' ' 86' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.973 -1.013 . . . . 58.909999999999997 109.528 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.598 ' C ' HD22 ' B' ' 65' ' ' LEU . 1.4 pmm? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.545 -0.539 . . . . 64.909999999999997 109.545 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.992 ' N ' HD22 ' B' ' 65' ' ' LEU . 1.8 mt -58.42 85.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.887 -1.153 . . . . 33.799999999999997 107.887 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 20.7 mttt -63.61 157.97 22.49 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.815 0.817 . . . . 32.719999999999999 111.595 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.061 HG22 HG22 ' A' ' 35' ' ' VAL . 58.8 t -160.01 167.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-O 121.609 0.719 . . . . 14.460000000000001 109.691 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.584 ' N ' HG12 ' A' ' 4' ' ' VAL . 77.3 mt-10 -154.95 107.14 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.705 -0.85 . . . . 22.120000000000001 108.705 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.744 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -74.54 107.96 5.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 118.991 -1.083 . . . . 14.23 108.3 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.675 ' CD ' ' CD1' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.44 171.85 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.449 -0.782 . . . . 25.43 110.011 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.3 Cg_endo -76.7 -25.61 9.12 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.59 2.193 . . . . 13.609999999999999 109.753 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.73 8.39 44.39 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.921 -0.77 . . . . 15.52 108.921 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.528 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 10.2 mm-40 -121.38 32.83 5.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.277 -0.889 . . . . 17.309999999999999 109.474 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.424 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -97.91 11.47 37.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.141 -0.974 . . . . 24.780000000000001 110.324 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -138.77 138.01 37.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.032 -1.042 . . . . 47.899999999999999 110.104 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.646 ' CD2' HD12 ' A' ' 49' ' ' LEU . 11.6 p90 -88.37 173.29 8.82 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.397 -0.814 . . . . 21.609999999999999 109.769 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 10.0 t -130.91 163.97 26.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.535 -0.913 . . . . 14.890000000000001 108.535 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 112.7 24.16 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.147 -0.97 . . . . 17.350000000000001 109.575 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -114.93 137.66 51.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 34.380000000000003 109.182 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 16' ' ' ARG . 3.4 m -43.98 123.73 3.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 38.770000000000003 109.411 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.576 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -133.57 144.27 16.17 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.458 -1.457 . . . . 34.579999999999998 109.458 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.541 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 1.6 t -138.88 121.73 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -1.162 . . . . 41.869999999999997 109.219 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.469 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -66.69 165.31 15.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 47.210000000000001 109.693 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -16.2 8.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 71.560000000000002 109.75 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -82.62 8.23 12.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -0.98 . . . . 66.599999999999994 109.709 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.4 3.14 85.73 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.035 -1.226 . . . . 55.490000000000002 110.035 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -89.59 140.87 28.27 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.068 -1.254 . . . . 44.990000000000002 109.252 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 36.4 Cg_endo -78.26 131.92 11.05 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.54 2.16 . . . . 44.100000000000001 110.232 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 4.9 p90 -128.02 20.97 6.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.76 -1.213 . . . . 32.090000000000003 110.92 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.572 ' C ' ' O ' ' A' ' 26' ' ' TYR . 3.4 m 12.6 61.76 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.53 0.681 . . . . 29.25 110.879 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.785 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -62.18 168.6 3.26 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.937 0.875 . . . . 24.0 110.877 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.653 ' N ' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -105.49 128.64 53.67 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.57 -0.9 . . . . 23.309999999999999 108.57 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.546 ' HG3' HD21 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -111.38 151.14 28.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.988 -1.07 . . . . 40.030000000000001 109.972 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.554 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -133.71 175.86 9.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.895 . . . . 12.390000000000001 109.523 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.822 ' HB3' HD11 ' A' ' 44' ' ' LEU . 3.5 mp -127.31 155.52 43.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 17.420000000000002 109.131 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.622 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.9 m -153.73 -176.81 6.0 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.316 -0.994 . . . . 13.84 108.316 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.676 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 35.2 m-85 -130.75 102.92 6.3 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.117 -0.989 . . . . 21.140000000000001 109.561 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.061 HG22 HG22 ' A' ' 4' ' ' VAL . 78.7 t -90.8 125.94 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.07 -1.019 . . . . 10.66 110.324 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 39' ' ' ASN . 3.7 m-20 -68.51 -41.93 79.3 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.589 -0.893 . . . . 25.890000000000001 108.589 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.686 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.6 OUTLIER 47.51 48.24 16.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.798 . . . . 24.239999999999998 109.77 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.06 4.94 51.3 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.321 -1.511 . . . . 31.02 109.321 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.5 OUTLIER -104.58 95.76 6.13 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.356 -1.085 . . . . 43.229999999999997 108.47 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 39' ' ' ASN . 9.3 mt-10 -30.6 -37.31 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.41 0.624 . . . . 42.340000000000003 110.81 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -85.24 146.37 44.89 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 108.644 -0.873 . . . . 5.25 108.644 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.676 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.9 Cg_endo -76.37 137.11 18.42 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.967 1.778 . . . . 17.920000000000002 110.599 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.993 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.8 m -108.68 113.93 45.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.366 -0.833 . . . . 20.57 109.162 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.822 HD11 ' HB3' ' A' ' 32' ' ' LEU . 28.0 tp -65.63 110.28 2.7 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.368 -0.832 . . . . 20.210000000000001 109.386 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.6 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 6.6 t -115.52 165.46 10.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.518 -0.739 . . . . 10.81 109.351 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.555 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 9.8 mtpt -96.42 125.44 40.91 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.488 -0.885 . . . . 36.740000000000002 109.457 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.038 HD13 HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -117.4 136.26 55.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.31 -0.869 . . . . 19.739999999999998 109.332 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.482 ' OG1' ' CZ ' ' A' ' 80' ' ' ARG . 12.5 m -68.05 163.7 21.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.113 -0.992 . . . . 22.559999999999999 109.303 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.646 HD12 ' CD2' ' A' ' 13' ' ' PHE . 1.1 tm? -151.89 93.42 1.84 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.807 -0.812 . . . . 20.41 108.807 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.401 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -145.28 -158.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 33.990000000000002 109.823 -179.413 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 48.94 -154.18 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 54.920000000000002 109.159 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . -79.61 -2.44 88.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.445 -1.462 . . . . 36.100000000000001 109.445 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -73.41 114.28 30.17 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.286 -1.126 . . . . 54.759999999999998 110.118 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 52' ' ' GLY . 36.4 Cg_endo -80.3 153.44 21.27 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.5 2.133 . . . . 28.370000000000001 110.243 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.627 ' HB2' ' CD2' ' A' ' 13' ' ' PHE . . . -39.74 128.25 2.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.288 -0.882 . . . . 17.210000000000001 110.296 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.744 ' O ' HG21 ' A' ' 6' ' ' ILE . 86.7 m-85 -47.5 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.783 . . . . 17.190000000000001 109.009 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -48.76 175.61 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 17.82 109.589 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.5 Cg_endo -77.05 128.31 9.82 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.637 2.225 . . . . 17.280000000000001 110.192 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.06 176.73 32.46 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.614 -1.394 . . . . 17.219999999999999 109.614 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.8 mp -74.21 146.49 43.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -1.162 . . . . 19.57 108.362 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.717 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.2 m-85 -131.79 163.66 27.72 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.902 -1.124 . . . . 14.609999999999999 111.274 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.692 ' O ' HG22 ' A' ' 84' ' ' VAL . 24.1 p -146.38 120.77 9.64 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.414 -1.698 . . . . 18.359999999999999 106.414 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.976 ' CG1' HD12 ' A' ' 81' ' ' LEU . 6.2 t -49.19 168.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 C-N-CA 118.837 -1.145 . . . . 19.129999999999999 108.776 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.7 t-80 -135.37 124.53 24.46 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.393 -0.817 . . . . 20.649999999999999 109.11 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.989 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.2 OUTLIER -68.63 -5.3 19.28 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.285 -0.885 . . . . 19.649999999999999 109.572 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.5 t -55.94 -18.28 8.72 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.367 -0.975 . . . . 14.720000000000001 108.367 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -101.48 -5.53 25.12 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.525 -0.735 . . . . 11.449999999999999 110.187 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.698 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -75.36 157.9 33.57 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.919 -1.113 . . . . 14.25 108.938 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.598 ' HA ' HD21 ' B' ' 37' ' ' LEU . 20.5 mttt -146.63 164.44 32.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 32.700000000000003 109.797 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.738 HG13 HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -111.57 112.18 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 15.630000000000001 109.156 179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.5 -176.93 43.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.457 -1.457 . . . . 12.699999999999999 109.457 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.528 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.1 tm0? -90.57 22.54 3.42 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.158 -1.201 . . . . 26.289999999999999 109.367 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.25 -16.37 31.39 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.425 -0.797 . . . . 20.440000000000001 109.318 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 90.14 28.02 19.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.651 -1.38 . . . . 13.82 109.651 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' LEU . 58.0 m -161.0 124.54 3.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -1.182 . . . . 18.27 109.485 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.738 HD12 HG13 ' A' ' 70' ' ' VAL . 1.1 tp -46.94 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 12.43 109.333 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -162.5 113.57 1.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -0.923 . . . . 35.109999999999999 109.526 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.4 mt -43.14 -40.01 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.511 -0.743 . . . . 13.67 110.178 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 80' ' ' ARG . 1.6 t70 45.77 55.16 7.12 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.407 -0.96 . . . . 24.059999999999999 108.407 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 80.22 88.52 0.05 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.674 -0.861 . . . . 35.039999999999999 108.674 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.976 HD12 ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -65.46 157.87 28.32 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.752 0.787 . . . . 18.719999999999999 111.268 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 5.7 ttt180 -106.93 102.1 11.48 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.128 -1.064 . . . . 20.550000000000001 108.128 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.038 HD12 HD13 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -75.06 147.29 40.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.003 -1.061 . . . . 14.4 111.205 -178.375 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 62' ' ' THR . 33.9 m -147.85 155.56 44.4 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.094 -1.076 . . . . 17.649999999999999 108.094 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.55 144.02 83.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.091 1.861 . . . . 25.699999999999999 110.277 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -72.83 128.11 34.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 49.289999999999999 109.521 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 86' ' ' ALA . 29.7 mmtm . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.062 -0.97 . . . . 58.909999999999997 109.487 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.578 ' C ' HD22 ' A' ' 65' ' ' LEU . 1.4 pmm? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.435 -0.58 . . . . 64.909999999999997 109.435 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.989 ' N ' HD22 ' A' ' 65' ' ' LEU . 1.9 mt -58.64 85.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.842 -1.17 . . . . 33.799999999999997 107.842 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 20.7 mttt -63.63 157.99 22.48 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.804 0.812 . . . . 32.719999999999999 111.6 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.024 HG22 HG22 ' B' ' 35' ' ' VAL . 58.6 t -159.94 167.38 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.592 0.71 . . . . 14.460000000000001 109.68 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.598 ' N ' HG12 ' B' ' 4' ' ' VAL . 77.6 mt-10 -154.83 107.18 2.74 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.761 -0.829 . . . . 22.120000000000001 108.761 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.717 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -74.52 107.82 5.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 118.983 -1.087 . . . . 14.23 108.322 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.672 ' CD ' ' CD1' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.4 171.85 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.438 -0.789 . . . . 25.43 109.967 -179.064 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.5 Cg_endo -76.69 -25.68 9.06 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.598 2.199 . . . . 13.609999999999999 109.718 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.65 8.24 44.68 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.94 -0.763 . . . . 15.52 108.94 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 10.0 mm-40 -121.21 32.84 5.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.262 -0.898 . . . . 17.309999999999999 109.547 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.405 ' HB1' ' HD3' ' B' ' 58' ' ' PRO . . . -97.96 11.48 37.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.97 . . . . 24.780000000000001 110.338 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.407 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 51.0 mt-30 -138.78 138.14 37.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -0.993 . . . . 47.899999999999999 110.055 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.651 ' CD2' HD12 ' B' ' 49' ' ' LEU . 11.5 p90 -88.5 173.21 8.81 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.426 -0.796 . . . . 21.609999999999999 109.74 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 10.0 t -130.85 164.1 25.97 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.512 -0.921 . . . . 14.890000000000001 108.512 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.02 112.75 24.28 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.103 -0.998 . . . . 17.350000000000001 109.611 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.0 OUTLIER -114.93 137.73 51.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 34.380000000000003 109.163 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.433 ' C ' ' O ' ' B' ' 16' ' ' ARG . 3.4 m -43.98 123.75 3.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 38.770000000000003 109.431 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -133.61 144.18 16.06 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.45 -1.46 . . . . 34.579999999999998 109.45 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.54 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.6 t -138.86 121.68 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -1.16 . . . . 41.869999999999997 109.23 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.466 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 0.8 OUTLIER -66.51 165.4 14.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.274 -0.891 . . . . 47.210000000000001 109.73 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -16.03 9.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.819 . . . . 71.560000000000002 109.784 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -82.75 8.27 12.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 66.599999999999994 109.702 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.36 3.18 85.62 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.997 -1.241 . . . . 55.490000000000002 109.997 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -89.62 140.93 28.22 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.235 . . . . 44.990000000000002 109.293 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 36.4 Cg_endo -78.34 131.87 10.93 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.567 2.178 . . . . 44.100000000000001 110.218 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.598 ' CD1' ' HB3' ' B' ' 28' ' ' LEU . 4.8 p90 -127.99 20.96 6.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.766 -1.209 . . . . 32.090000000000003 110.935 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.59 ' C ' ' O ' ' B' ' 26' ' ' TYR . 3.4 m 12.6 61.8 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 121.551 0.691 . . . . 29.25 110.867 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.799 HD22 ' C ' ' B' ' 28' ' ' LEU . 0.0 OUTLIER -62.22 168.67 3.24 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.888 0.852 . . . . 24.0 110.896 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.66 ' N ' HD22 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -105.52 128.7 53.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.603 -0.888 . . . . 23.309999999999999 108.603 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.555 ' HG3' HD21 ' B' ' 28' ' ' LEU . 0.9 OUTLIER -111.51 151.03 29.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.992 -1.068 . . . . 40.030000000000001 109.971 -179.335 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.55 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.7 OUTLIER -133.64 175.89 9.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 12.390000000000001 109.486 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.836 ' HB3' HD11 ' B' ' 44' ' ' LEU . 3.6 mp -127.27 155.59 43.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 17.420000000000002 109.164 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.634 ' O ' HD12 ' B' ' 44' ' ' LEU . 1.9 m -153.78 -176.75 5.98 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.296 -1.001 . . . . 13.84 108.296 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' CD ' ' B' ' 7' ' ' LYS . 35.4 m-85 -130.86 102.9 6.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.164 -0.96 . . . . 21.140000000000001 109.544 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 1.024 HG22 HG22 ' B' ' 4' ' ' VAL . 78.5 t -90.78 125.96 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.004 -1.06 . . . . 10.66 110.307 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' B' ' 39' ' ' ASN . 3.8 m-20 -68.46 -41.95 79.47 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.601 -0.889 . . . . 25.890000000000001 108.601 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.688 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER 47.49 48.2 16.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.421 -0.799 . . . . 24.239999999999998 109.749 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.16 4.78 51.23 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.348 -1.501 . . . . 31.02 109.348 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.5 OUTLIER -104.44 95.72 6.12 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.33 -1.1 . . . . 43.229999999999997 108.507 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' B' ' 39' ' ' ASN . 9.3 mt-10 -30.52 -37.35 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.471 0.653 . . . . 42.340000000000003 110.858 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -85.2 146.4 45.06 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.64 -0.874 . . . . 5.2300000000000004 108.64 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.9 Cg_endo -76.37 137.09 18.4 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.958 1.772 . . . . 17.920000000000002 110.551 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.984 HG22 ' O ' ' B' ' 35' ' ' VAL . 5.9 m -108.7 114.0 45.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.362 -0.836 . . . . 20.57 109.076 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' B' ' 32' ' ' LEU . 28.8 tp -65.66 110.1 2.64 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.407 -0.808 . . . . 20.210000000000001 109.372 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.587 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 6.5 t -115.36 165.4 10.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.493 -0.755 . . . . 10.81 109.306 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.554 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 9.8 mtpt -96.31 125.52 40.87 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.538 -0.865 . . . . 36.740000000000002 109.492 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 1.021 HD13 HD12 ' B' ' 83' ' ' LEU . 0.8 OUTLIER -117.43 136.38 54.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.331 -0.856 . . . . 19.739999999999998 109.368 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.483 ' OG1' ' CZ ' ' B' ' 80' ' ' ARG . 12.6 m -68.18 163.67 22.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 22.559999999999999 109.285 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.651 HD12 ' CD2' ' B' ' 13' ' ' PHE . 1.1 tm? -151.9 93.41 1.84 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.35 -158.0 0.85 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 33.990000000000002 109.836 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 49.02 -154.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 54.920000000000002 109.162 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' B' ' 54' ' ' PRO . . . -79.62 -2.2 87.72 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.512 -1.435 . . . . 36.100000000000001 109.512 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -73.59 114.37 31.41 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.251 -1.147 . . . . 54.759999999999998 110.008 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' B' ' 52' ' ' GLY . 36.3 Cg_endo -80.29 153.33 21.27 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.512 2.141 . . . . 28.370000000000001 110.244 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.64 ' HB2' ' CD2' ' B' ' 13' ' ' PHE . . . -39.84 128.43 2.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.358 -0.839 . . . . 17.210000000000001 110.26 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.717 ' O ' HG21 ' B' ' 6' ' ' ILE . 85.2 m-85 -47.79 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.871 -0.788 . . . . 17.190000000000001 108.871 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.945 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -50.5 175.72 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.86 . . . . 17.82 109.394 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.945 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.6 Cg_endo -77.34 129.5 10.35 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.611 2.207 . . . . 17.280000000000001 110.503 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.89 177.15 30.73 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.424 -1.47 . . . . 17.219999999999999 109.424 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 4.1 mp -73.73 146.99 43.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.222 -1.163 . . . . 19.57 108.794 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.692 ' HB3' HD22 ' B' ' 83' ' ' LEU . 19.6 m-85 -132.24 163.78 27.84 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.957 -1.089 . . . . 14.609999999999999 111.319 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.685 ' O ' HG22 ' B' ' 84' ' ' VAL . 24.3 p -146.54 120.86 9.59 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.424 -1.695 . . . . 18.359999999999999 106.424 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.978 ' CG1' HD12 ' B' ' 81' ' ' LEU . 6.1 t -49.37 168.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 C-N-CA 118.82 -1.152 . . . . 19.129999999999999 108.826 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.543 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.7 t-80 -135.21 124.5 24.64 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.393 -0.817 . . . . 20.649999999999999 109.089 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.992 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -68.61 -5.4 19.75 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.244 -0.91 . . . . 19.649999999999999 109.533 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 33.4 t -55.79 -18.44 8.48 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.306 -0.998 . . . . 14.720000000000001 108.306 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -101.31 -5.92 24.8 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.544 -0.722 . . . . 11.449999999999999 110.185 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.697 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.9 m-30 -75.02 157.72 34.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.91 -1.119 . . . . 14.25 108.893 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.599 ' HA ' HD21 ' A' ' 37' ' ' LEU . 20.6 mttt -146.36 164.78 31.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -0.979 . . . . 32.700000000000003 109.815 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.724 HG13 HD12 ' B' ' 76' ' ' LEU . 0.2 OUTLIER -111.83 112.12 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.415 -0.803 . . . . 15.630000000000001 109.158 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.51 -177.0 43.03 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.481 -1.448 . . . . 12.699999999999999 109.481 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 1.1 tm0? -90.54 22.57 3.39 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.146 -1.208 . . . . 26.289999999999999 109.348 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.29 -16.36 31.31 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.46 -0.775 . . . . 20.440000000000001 109.363 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 90.39 27.62 19.73 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.665 -1.374 . . . . 13.82 109.665 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 76' ' ' LEU . 58.0 m -160.76 124.53 3.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -1.223 . . . . 18.27 109.569 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.724 HD12 HG13 ' B' ' 70' ' ' VAL . 1.1 tp -46.93 170.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 12.43 109.357 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' B' ' 76' ' ' LEU . 0.8 OUTLIER -162.48 113.58 1.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 35.109999999999999 109.553 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.4 mt -43.11 -40.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.48 -0.763 . . . . 13.67 110.212 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' B' ' 80' ' ' ARG . 1.6 t70 45.85 55.17 7.2 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.354 -0.98 . . . . 24.059999999999999 108.354 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 80.21 88.57 0.05 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.69 -0.856 . . . . 35.039999999999999 108.69 -178.81 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.978 HD12 ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -65.4 157.89 28.11 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.779 0.799 . . . . 18.719999999999999 111.267 -178.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 5.7 ttt180 -107.06 102.09 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.065 -1.087 . . . . 20.550000000000001 108.065 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.021 HD12 HD13 ' B' ' 47' ' ' ILE . 0.4 OUTLIER -75.04 147.45 40.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.047 -1.033 . . . . 14.4 111.162 -178.355 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.685 HG22 ' O ' ' B' ' 62' ' ' THR . 33.8 m -148.02 155.31 43.83 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 108.11 -1.07 . . . . 17.649999999999999 108.11 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.1 Cg_endo -64.33 143.95 84.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.153 1.902 . . . . 25.699999999999999 110.257 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -72.79 128.08 34.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 49.289999999999999 109.586 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' B' ' 86' ' ' ALA . 29.7 mmtm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.047 -0.978 . . . . 58.909999999999997 109.519 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.33 -0.618 . . . . 64.909999999999997 109.33 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.844 ' CA ' HD22 ' B' ' 65' ' ' LEU . 4.8 mt 73.74 75.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.162 -1.051 . . . . 33.799999999999997 108.162 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -68.99 155.35 40.49 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.756 0.788 . . . . 32.719999999999999 110.841 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.875 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -160.35 167.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.534 -0.913 . . . . 14.460000000000001 108.534 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.542 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 60.3 mt-10 -143.52 109.67 5.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 22.120000000000001 109.534 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.734 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -72.29 101.04 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.899 -1.149 . . . . 14.23 107.899 179.218 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.676 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.42 169.84 0.07 OUTLIER Pre-proline 0 N--CA 1.486 1.361 0 O-C-N 121.306 -0.871 . . . . 25.43 109.611 -179.227 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -75.3 -24.09 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.444 2.096 . . . . 13.609999999999999 109.812 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -93.31 1.39 56.99 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.094 -0.706 . . . . 15.52 109.094 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.487 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 29.3 mm-40 -120.08 39.7 3.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 17.309999999999999 109.165 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.65 22.44 15.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.119 -0.988 . . . . 24.780000000000001 110.22 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -142.72 132.71 24.33 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.054 -1.029 . . . . 47.899999999999999 108.786 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.636 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 33.3 p90 -88.56 176.88 6.95 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.013 -1.054 . . . . 21.609999999999999 109.774 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 16.1 m -130.7 153.75 48.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.674 -0.862 . . . . 14.890000000000001 108.674 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.53 114.62 28.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.211 -0.931 . . . . 17.350000000000001 109.439 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' GLY . 15.1 mmt180 -134.8 143.81 47.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 34.380000000000003 109.077 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 t -51.9 89.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 38.770000000000003 109.297 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -84.54 140.82 19.23 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.692 -1.363 . . . . 34.579999999999998 109.692 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.39 123.51 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.246 -1.15 . . . . 41.869999999999997 108.837 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -55.49 -90.28 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.332 -0.855 . . . . 47.210000000000001 109.576 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -136.15 62.11 1.63 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 71.560000000000002 109.449 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 57.7 17.65 4.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 66.599999999999994 109.338 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.6 -48.26 1.31 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.541 -1.424 . . . . 55.490000000000002 109.541 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.08 150.72 21.56 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.266 -1.137 . . . . 44.990000000000002 109.37 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.28 136.13 14.06 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.598 2.199 . . . . 44.100000000000001 110.56 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 28' ' ' LEU . 4.0 p90 -136.48 136.81 39.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 32.090000000000003 109.589 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 m -102.36 79.59 1.86 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 29.25 109.26 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.596 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -96.51 161.96 13.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 24.0 109.96 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.636 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -99.05 129.92 45.35 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.451 -0.944 . . . . 23.309999999999999 108.451 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.07 152.55 33.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.998 -1.064 . . . . 40.030000000000001 109.612 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.859 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -135.24 171.54 14.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 12.390000000000001 109.897 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.838 ' HB3' HD11 ' A' ' 44' ' ' LEU . 3.3 mm? -105.89 179.13 4.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 17.420000000000002 110.252 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -173.51 158.16 3.37 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.85 -1.167 . . . . 13.84 107.85 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.676 ' CD2' ' HD3' ' A' ' 7' ' ' LYS . 20.1 m-85 -111.98 106.33 14.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.964 -1.085 . . . . 21.140000000000001 109.36 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.881 ' O ' HG22 ' A' ' 43' ' ' VAL . 25.7 t -107.4 117.59 53.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 10.66 110.627 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -95.3 41.29 1.1 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.543 -1.281 . . . . 25.890000000000001 107.543 178.248 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 38' ' ' GLY . 1.7 pp -35.19 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.377 0.608 . . . . 24.239999999999998 110.319 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.882 ' N ' HD12 ' A' ' 37' ' ' LEU . . . 165.55 50.81 0.02 OUTLIER Glycine 0 C--N 1.298 -1.576 0 C-N-CA 119.333 -1.413 . . . . 31.02 109.696 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 61.9 m-20 -126.13 18.26 7.74 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.223 -1.163 . . . . 43.229999999999997 110.101 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 51.3 mt-10 58.96 27.8 16.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 42.340000000000003 109.949 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 3.3 p-80 176.42 162.62 0.47 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.531 -0.914 . . . . 6.3700000000000001 108.531 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.651 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.7 Cg_endo -76.5 135.74 16.71 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.774 1.65 . . . . 17.920000000000002 110.231 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.938 HG21 HG21 ' B' ' 70' ' ' VAL . 2.9 m -111.1 117.31 54.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.648 -0.821 . . . . 20.57 108.994 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 32' ' ' LEU . 41.1 tp -70.75 95.94 1.18 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.292 -0.88 . . . . 20.210000000000001 109.167 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.439 HG23 HG12 ' B' ' 70' ' ' VAL . 4.4 p -105.65 161.28 5.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.6 -0.687 . . . . 10.81 109.35 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.22 -177.75 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 36.740000000000002 110.634 -179.005 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.62 HD12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -167.66 149.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.115 -1.069 . . . . 19.739999999999998 108.115 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.606 ' H ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -91.58 152.97 20.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.864 -1.148 . . . . 22.559999999999999 109.476 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -131.93 102.82 6.0 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.471 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 29.4 t70 -44.87 142.45 1.78 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 33.990000000000002 109.739 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.25 103.31 0.37 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.825 . . . . 54.920000000000002 109.322 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.1 -25.14 7.98 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.367 -1.493 . . . . 36.100000000000001 109.367 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 31.3 mt-30 -76.48 147.76 79.26 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.323 -1.104 . . . . 54.759999999999998 109.229 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.6 Cg_endo -78.12 126.13 7.62 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.662 2.241 . . . . 28.370000000000001 110.39 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.859 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -40.03 156.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.419 -0.801 . . . . 17.210000000000001 110.02 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.734 ' O ' HG21 ' A' ' 6' ' ' ILE . 74.3 m-85 -58.27 111.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 17.190000000000001 109.153 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.803 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -56.58 170.05 0.55 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 17.82 109.782 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.803 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.17 106.07 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.678 2.252 . . . . 17.280000000000001 110.392 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.11 -176.12 43.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.585 -1.406 . . . . 17.219999999999999 109.585 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -76.28 138.84 40.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -1.142 . . . . 19.57 108.613 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.679 ' HB3' HD22 ' A' ' 83' ' ' LEU . 25.5 m-85 -128.63 164.65 22.42 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.776 -1.203 . . . . 14.609999999999999 111.699 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.732 ' O ' HG22 ' A' ' 84' ' ' VAL . 47.6 p -145.46 121.89 10.99 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.268 -1.753 . . . . 18.359999999999999 106.268 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.62 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -54.41 167.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 118.632 -1.227 . . . . 19.129999999999999 108.624 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.508 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -130.12 126.57 37.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.249 -0.907 . . . . 20.649999999999999 109.501 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.841 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER -73.06 1.53 8.82 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.425 -0.797 . . . . 19.649999999999999 110.034 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 t -57.29 -19.05 19.61 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.383 -1.34 . . . . 14.720000000000001 107.383 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 69.8 m -95.12 -25.02 16.6 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.127 0.489 . . . . 11.449999999999999 110.179 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.696 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.2 m-30 -61.92 158.95 15.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.98 . . . . 14.25 109.486 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.73 176.24 12.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 32.700000000000003 109.404 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.961 HG21 HG21 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -113.44 123.37 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 15.630000000000001 109.387 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.75 -162.06 28.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.378 -1.489 . . . . 12.699999999999999 109.378 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.461 ' HB2' ' SD ' ' A' ' 77' ' ' MET . 0.3 OUTLIER 59.27 72.22 0.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -1.188 . . . . 26.289999999999999 109.311 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.3 OUTLIER 70.41 6.66 5.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 20.440000000000001 109.381 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.03 45.21 5.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.492 -1.443 . . . . 13.82 109.492 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -129.13 140.46 51.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 18.27 109.522 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.583 ' HB2' HD13 ' B' ' 81' ' ' LEU . 0.2 OUTLIER -43.69 158.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 12.43 109.355 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.52 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -165.54 104.73 0.72 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 35.109999999999999 110.112 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.829 HD12 HD12 ' B' ' 78' ' ' ILE . 1.1 mt -41.12 -64.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.613 0.721 . . . . 13.67 109.738 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 15.6 t70 84.86 -46.69 0.08 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.481 0.657 . . . . 24.059999999999999 110.003 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.581 ' O ' ' CB ' ' A' ' 67' ' ' SER . 1.9 tpm_? -171.25 66.56 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.491 -0.929 . . . . 35.039999999999999 108.491 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.62 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.3 pt? -39.58 125.7 1.79 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.659 0.742 . . . . 18.719999999999999 111.71 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -92.51 106.67 18.62 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.434 -0.95 . . . . 20.550000000000001 108.434 178.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.792 HD21 HG11 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -72.66 151.89 42.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.294 -0.879 . . . . 14.4 111.056 -178.684 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 62' ' ' THR . 33.1 m -154.08 156.4 31.9 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.011 -1.107 . . . . 17.649999999999999 108.011 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.2 Cg_endo -62.64 144.16 93.7 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.184 1.923 . . . . 25.699999999999999 110.201 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -75.91 117.04 17.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.14 -0.975 . . . . 49.289999999999999 109.557 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.99 -1.005 . . . . 58.909999999999997 109.416 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.497 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.336 -0.616 . . . . 64.909999999999997 109.336 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.841 ' CA ' HD22 ' A' ' 65' ' ' LEU . 4.8 mt 73.72 75.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.064 -1.087 . . . . 33.799999999999997 108.064 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -69.16 155.49 40.3 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.778 0.799 . . . . 32.719999999999999 110.788 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.864 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -160.45 168.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.548 -0.908 . . . . 14.460000000000001 108.548 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.536 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 60.1 mt-10 -143.79 109.75 5.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.33 -0.856 . . . . 22.120000000000001 109.536 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.722 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -72.35 100.98 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.942 -1.133 . . . . 14.23 107.942 179.254 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.676 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.37 169.78 0.07 OUTLIER Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 25.43 109.602 -179.244 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.0 Cg_endo -75.23 -24.06 12.83 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.419 2.079 . . . . 13.609999999999999 109.777 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -93.28 1.4 57.02 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.526 -0.734 . . . . 15.52 109.1 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.493 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 29.1 mm-40 -120.06 39.51 3.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.262 -0.899 . . . . 17.309999999999999 109.171 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.49 22.45 15.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 24.780000000000001 110.3 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -142.7 132.8 24.49 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.997 -1.064 . . . . 47.899999999999999 108.843 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.632 ' CD1' ' CB ' ' B' ' 29' ' ' ASN . 33.4 p90 -88.63 176.8 6.96 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.007 -1.058 . . . . 21.609999999999999 109.746 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.3 m -130.68 153.68 48.72 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.737 -0.838 . . . . 14.890000000000001 108.737 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.53 114.39 28.59 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.251 -0.906 . . . . 17.350000000000001 109.501 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' B' ' 18' ' ' GLY . 15.0 mmt180 -134.5 143.92 47.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.329 -0.857 . . . . 34.380000000000003 109.105 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.1 t -51.92 90.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 38.770000000000003 109.243 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -84.85 140.57 18.78 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.718 -1.353 . . . . 34.579999999999998 109.718 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.18 123.39 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.171 -1.194 . . . . 41.869999999999997 108.89 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -55.39 -90.15 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.37 -0.831 . . . . 47.210000000000001 109.552 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -136.3 61.96 1.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 71.560000000000002 109.495 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 57.76 17.76 4.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 66.599999999999994 109.271 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.69 -48.57 1.26 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.434 -1.467 . . . . 55.490000000000002 109.434 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.82 150.73 21.93 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.243 -1.151 . . . . 44.990000000000002 109.414 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.16 135.97 14.13 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.662 2.241 . . . . 44.100000000000001 110.658 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.591 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 4.0 p90 -136.38 136.91 40.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.228 -0.92 . . . . 32.090000000000003 109.643 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 2.6 m -102.49 79.69 1.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 29.25 109.202 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -96.55 161.96 13.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 24.0 110.011 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.632 ' CB ' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -99.07 129.92 45.37 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.478 -0.934 . . . . 23.309999999999999 108.478 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.03 152.58 33.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.037 -1.04 . . . . 40.030000000000001 109.572 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.837 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -135.21 171.53 14.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.153 -0.967 . . . . 12.390000000000001 109.94 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' B' ' 44' ' ' LEU . 3.3 mm? -105.79 179.28 4.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 17.420000000000002 110.219 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -173.69 158.27 3.29 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.797 -1.186 . . . . 13.84 107.797 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.676 ' CD2' ' HD3' ' B' ' 7' ' ' LYS . 20.2 m-85 -112.13 106.4 15.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.988 -1.07 . . . . 21.140000000000001 109.309 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.867 ' O ' HG22 ' B' ' 43' ' ' VAL . 25.4 t -107.57 117.46 53.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 10.66 110.633 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.2 OUTLIER -95.21 41.34 1.1 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.433 -1.321 . . . . 25.890000000000001 107.433 178.289 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.881 HD12 ' N ' ' B' ' 38' ' ' GLY . 1.6 pp -35.29 -31.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.397 0.618 . . . . 24.239999999999998 110.284 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.881 ' N ' HD12 ' B' ' 37' ' ' LEU . . . 165.83 50.98 0.02 OUTLIER Glycine 0 C--N 1.298 -1.559 0 C-N-CA 119.286 -1.435 . . . . 31.02 109.653 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.581 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 62.1 m-20 -126.19 18.37 7.7 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.164 -1.198 . . . . 43.229999999999997 110.116 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 39' ' ' ASN . 51.2 mt-10 58.79 27.87 16.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.139 -0.976 . . . . 42.340000000000003 109.956 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 3.3 p-80 176.38 162.35 0.46 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 6.3799999999999999 108.594 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.662 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.7 Cg_endo -76.39 135.68 16.87 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.77 1.646 . . . . 17.920000000000002 110.24 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.961 HG21 HG21 ' A' ' 70' ' ' VAL . 2.9 m -111.01 117.4 54.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.358 -0.839 . . . . 20.57 108.997 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' B' ' 32' ' ' LEU . 41.8 tp -70.86 95.82 1.2 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.643 -0.823 . . . . 20.210000000000001 109.215 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.454 HG23 HG12 ' A' ' 70' ' ' VAL . 4.4 p -105.46 161.37 5.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.612 -0.68 . . . . 10.81 109.448 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.42 ' HA ' HD13 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -71.3 -177.84 1.89 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 36.740000000000002 110.552 -179.073 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.64 HD12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -167.61 149.63 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.069 -1.085 . . . . 19.739999999999998 108.069 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.587 ' H ' HD13 ' B' ' 47' ' ' ILE . 0.2 OUTLIER -91.82 153.15 19.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.839 -1.163 . . . . 22.559999999999999 109.429 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -132.21 102.96 5.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.741 -0.837 . . . . 20.41 108.741 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.441 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 29.4 t70 -45.12 142.45 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 33.990000000000002 109.898 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.1 103.41 0.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 54.920000000000002 109.319 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.93 -25.16 8.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.37 -1.492 . . . . 36.100000000000001 109.37 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.462 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 31.5 mt-30 -76.39 147.72 79.48 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.265 -1.138 . . . . 54.759999999999998 109.301 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.7 Cg_endo -78.05 126.31 7.78 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.591 2.194 . . . . 28.370000000000001 110.391 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.837 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -40.11 156.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.396 -0.815 . . . . 17.210000000000001 110.024 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.722 ' O ' HG21 ' B' ' 6' ' ' ILE . 73.3 m-85 -58.11 111.01 1.05 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.4 -0.813 . . . . 17.190000000000001 109.077 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.813 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -56.76 170.04 0.57 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 17.82 109.799 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.813 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -77.76 104.99 1.95 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.71 2.273 . . . . 17.280000000000001 110.118 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.3 -176.6 41.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.708 -1.357 . . . . 17.219999999999999 109.708 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.697 HD23 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -76.53 138.34 40.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -1.146 . . . . 19.57 108.366 179.143 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.715 ' HB3' HD22 ' B' ' 83' ' ' LEU . 25.5 m-85 -128.08 164.46 22.37 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.729 -1.232 . . . . 14.609999999999999 111.607 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.729 ' O ' HG22 ' B' ' 84' ' ' VAL . 46.9 p -145.13 122.04 11.31 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.175 -1.787 . . . . 18.359999999999999 106.175 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.621 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -54.73 167.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 118.562 -1.255 . . . . 19.129999999999999 108.594 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -130.4 126.68 37.66 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.271 -0.893 . . . . 20.649999999999999 109.49 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.844 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -73.18 1.17 9.78 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.434 -0.791 . . . . 19.649999999999999 110.014 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -56.86 -19.38 17.2 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.323 -1.362 . . . . 14.720000000000001 107.323 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 70.9 m -94.77 -25.06 16.82 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.146 0.498 . . . . 11.449999999999999 110.201 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.2 m-30 -61.93 158.59 15.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 14.25 109.466 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.4 176.29 12.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 32.700000000000003 109.407 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.938 HG21 HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -113.45 123.57 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 15.630000000000001 109.34 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.53 -162.2 29.29 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.426 -1.47 . . . . 12.699999999999999 109.426 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.3 OUTLIER 59.43 72.13 0.54 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -1.189 . . . . 26.289999999999999 109.328 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.3 OUTLIER 70.45 6.81 5.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 20.440000000000001 109.322 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.84 45.25 5.2 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.438 -1.465 . . . . 13.82 109.438 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.423 ' O ' ' C ' ' B' ' 76' ' ' LEU . 0.3 OUTLIER -129.16 140.34 51.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -1.167 . . . . 18.27 109.48 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.576 ' HB2' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -43.58 158.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -0.895 . . . . 12.43 109.376 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 0.6 OUTLIER -165.49 104.93 0.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.962 . . . . 35.109999999999999 110.083 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.829 HD12 HD12 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -41.37 -64.4 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.556 0.694 . . . . 13.67 109.682 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.545 ' N ' HG22 ' B' ' 78' ' ' ILE . 15.4 t70 84.74 -46.52 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.422 0.63 . . . . 24.059999999999999 110.007 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' B' ' 67' ' ' SER . 1.9 tpm_? -171.42 66.41 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.036 0.922 . . . . 35.039999999999999 108.517 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.621 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.2 pt? -39.41 125.65 1.71 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.653 0.739 . . . . 18.719999999999999 111.721 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.7 OUTLIER -92.48 106.59 18.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.517 -0.919 . . . . 20.550000000000001 108.517 178.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.786 HD21 HG11 ' B' ' 4' ' ' VAL . 0.6 OUTLIER -72.64 151.72 42.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.183 -0.948 . . . . 14.4 111.072 -178.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.729 HG22 ' O ' ' B' ' 62' ' ' THR . 33.4 m -153.86 156.53 32.16 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 107.959 -1.126 . . . . 17.649999999999999 107.959 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.3 Cg_endo -62.83 144.32 93.33 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.117 1.878 . . . . 25.699999999999999 110.151 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -75.96 117.03 17.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.242 -0.911 . . . . 49.289999999999999 109.617 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.009 -0.996 . . . . 58.909999999999997 109.458 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.504 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.416 -0.587 . . . . 64.909999999999997 109.416 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.751 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.7 mt -66.89 79.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.598 -1.26 . . . . 33.799999999999997 107.598 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -74.33 159.96 31.7 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.907 0.861 . . . . 32.719999999999999 110.595 -178.186 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.712 HG11 HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -162.43 167.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.437 -0.949 . . . . 14.460000000000001 108.437 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.534 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 33.2 mt-10 -142.3 112.54 7.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 22.120000000000001 109.693 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.717 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -75.25 99.52 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.815 -1.18 . . . . 14.23 107.815 179.071 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.665 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.1 mttm -53.88 165.8 0.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.357 -0.84 . . . . 25.43 109.762 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 29.8 Cg_endo -70.89 -15.61 32.85 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.922 1.748 . . . . 13.609999999999999 108.796 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.14 -2.65 49.46 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.905 -0.776 . . . . 15.52 108.905 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.583 ' OE1' HD12 ' A' ' 32' ' ' LEU . 15.7 mm-40 -129.49 43.66 3.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.205 -0.935 . . . . 17.309999999999999 109.581 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.83 20.03 16.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.05 -1.031 . . . . 24.780000000000001 110.068 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 11.5 mt-30 -135.73 140.63 44.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.121 -0.987 . . . . 47.899999999999999 109.689 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.717 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 41.3 p90 -94.78 164.01 13.12 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.201 -0.937 . . . . 21.609999999999999 109.469 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.1 m -135.07 147.26 49.54 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.341 -0.85 . . . . 14.890000000000001 109.181 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 113.94 25.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.273 -0.892 . . . . 17.350000000000001 109.364 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 17' ' ' SER . 50.6 ttt180 -145.23 158.3 43.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 34.380000000000003 109.341 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -42.74 147.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.491 -0.756 . . . . 38.770000000000003 109.399 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -151.66 173.16 31.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.37 -1.492 . . . . 34.579999999999998 109.37 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.403 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -147.78 120.53 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.116 -1.226 . . . . 41.869999999999997 109.002 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 m -59.19 -88.71 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.338 -0.851 . . . . 47.210000000000001 109.626 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.32 63.69 1.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 71.560000000000002 109.566 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 54.46 19.27 2.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 66.599999999999994 109.498 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.06 -47.23 1.61 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.575 -1.41 . . . . 55.490000000000002 109.575 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -156.29 153.03 24.37 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.223 -1.163 . . . . 44.990000000000002 109.363 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.53 143.16 24.12 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.562 2.175 . . . . 44.100000000000001 110.701 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.591 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 2.7 p90 -146.29 136.27 23.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 32.090000000000003 109.752 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 m -105.42 80.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 29.25 108.902 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.521 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -97.18 158.48 15.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.86 . . . . 24.0 110.313 -179.071 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.515 ' CG ' ' CD1' ' A' ' 13' ' ' PHE . 86.0 m-20 -68.59 109.99 4.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.364 -0.835 . . . . 23.309999999999999 109.041 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 18.6 mt-10 -87.01 -173.33 4.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.219 -0.925 . . . . 40.030000000000001 109.899 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.56 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 1.7 tm0? -176.33 -177.84 0.9 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.852 . . . . 12.390000000000001 109.47 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.724 ' CB ' HD11 ' A' ' 44' ' ' LEU . 13.3 mt -140.98 168.93 18.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 17.420000000000002 109.366 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -164.91 161.87 20.37 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.055 -1.091 . . . . 13.84 108.055 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.679 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 49.6 m-85 -111.44 111.72 22.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.994 -1.066 . . . . 21.140000000000001 109.716 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.672 ' CG1' HD23 ' A' ' 37' ' ' LEU . 4.6 t -106.87 140.39 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 10.66 110.871 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -111.72 39.34 2.39 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.556 -1.276 . . . . 25.890000000000001 107.556 178.526 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.809 HD21 HG22 ' B' ' 70' ' ' VAL . 1.1 pp -63.5 58.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.976 -0.452 . . . . 24.239999999999998 110.468 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 107.33 1.87 35.47 Favored Glycine 0 N--CA 1.482 1.76 0 C-N-CA 119.609 -1.282 . . . . 31.02 109.902 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 40' ' ' GLU . 1.2 m-20 -124.87 98.78 5.85 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.23 -1.159 . . . . 43.229999999999997 108.528 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -32.61 -56.85 0.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.55 0.691 . . . . 42.340000000000003 110.579 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 39' ' ' ASN . 7.2 m-70 -66.25 152.16 94.65 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 108.638 -0.875 . . . . 5.6799999999999997 108.638 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.679 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.8 Cg_endo -77.34 139.75 18.87 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.982 1.788 . . . . 17.920000000000002 110.041 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.826 HG21 HG21 ' B' ' 70' ' ' VAL . 3.4 m -112.91 115.4 49.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.317 -0.865 . . . . 20.57 109.569 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.724 HD11 ' CB ' ' A' ' 32' ' ' LEU . 59.9 tp -72.51 101.62 3.02 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.875 . . . . 20.210000000000001 109.867 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.686 HG12 ' CG1' ' B' ' 70' ' ' VAL . 2.6 m -99.82 -168.94 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.977 -0.749 . . . . 10.81 108.977 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.677 ' HA ' HD23 ' A' ' 32' ' ' LEU . 1.3 mtpp -106.57 178.61 4.51 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.507 -0.877 . . . . 36.740000000000002 110.809 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -157.64 156.47 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.242 -1.021 . . . . 19.739999999999998 108.242 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -111.46 68.57 0.67 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.12 -0.988 . . . . 22.559999999999999 109.479 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.0 HD11 ' O ' ' A' ' 53' ' ' GLN . 2.2 tm? -42.12 114.8 0.59 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.492 -0.755 . . . . 20.41 109.306 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.727 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -57.32 151.81 15.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 33.990000000000002 109.89 -179.385 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -63.53 117.5 6.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 54.920000000000002 109.223 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.62 -27.35 19.2 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.301 -1.52 . . . . 36.100000000000001 109.301 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 1.0 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -69.16 146.27 96.83 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.281 -1.129 . . . . 54.759999999999998 109.286 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.5 Cg_endo -77.52 119.76 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.577 2.184 . . . . 28.370000000000001 110.642 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.717 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -41.41 144.3 0.36 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -0.826 . . . . 17.210000000000001 110.035 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.717 ' O ' HG21 ' A' ' 6' ' ' ILE . 15.4 m-30 -45.3 108.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 17.190000000000001 109.135 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.918 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -59.04 173.87 0.43 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.056 -1.028 . . . . 17.82 109.055 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.918 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.9 Cg_endo -77.52 110.41 2.96 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.42 2.08 . . . . 17.280000000000001 110.024 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.53 -178.99 48.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.867 -1.293 . . . . 17.219999999999999 109.867 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -77.54 140.59 39.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -1.085 . . . . 19.57 108.511 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.732 ' HB3' HD22 ' A' ' 83' ' ' LEU . 17.9 m-85 -130.0 163.96 25.34 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.771 -1.205 . . . . 14.609999999999999 111.81 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.634 ' O ' HG22 ' A' ' 84' ' ' VAL . 48.9 p -145.69 121.61 10.65 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.442 -1.688 . . . . 18.359999999999999 106.442 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.587 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -51.27 167.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.792 -1.163 . . . . 19.129999999999999 109.2 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -128.25 127.47 42.88 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.833 -0.803 . . . . 20.649999999999999 108.833 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.754 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.5 OUTLIER -71.39 0.66 7.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.477 -0.764 . . . . 19.649999999999999 110.014 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 t -57.12 -17.69 11.8 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.787 -1.19 . . . . 14.720000000000001 107.787 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 16.5 m -97.81 -5.45 34.77 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.782 -0.574 . . . . 11.449999999999999 110.372 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.674 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.3 m-30 -83.6 159.77 21.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.936 -1.102 . . . . 14.25 109.771 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.589 ' HA ' HD11 ' B' ' 37' ' ' LEU . 53.7 mttm -149.11 173.25 13.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.773 . . . . 32.700000000000003 109.302 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.827 HG21 HG21 ' B' ' 43' ' ' VAL . 0.9 OUTLIER -107.28 116.12 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 15.630000000000001 108.932 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 175.93 4.86 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.779 -1.328 . . . . 12.699999999999999 109.779 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.06 12.7 8.98 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.214 -1.168 . . . . 26.289999999999999 109.763 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.457 ' O ' ' HG3' ' B' ' 46' ' ' LYS . 0.1 OUTLIER -123.25 19.37 9.84 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.532 -0.73 . . . . 20.440000000000001 109.201 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 45' ' ' VAL . . . 67.53 57.27 9.31 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.794 -1.322 . . . . 13.82 109.794 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.0 t -146.65 134.77 21.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.171 -1.193 . . . . 18.27 109.871 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.759 HD11 HD22 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -76.98 145.17 38.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 12.43 109.071 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.497 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 11.0 mtm -157.09 120.33 4.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.037 . . . . 35.109999999999999 109.926 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.833 HD12 HD12 ' B' ' 78' ' ' ILE . 3.3 mt -62.34 136.88 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 13.67 109.374 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.34 -30.41 11.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.166 -1.05 . . . . 24.059999999999999 108.166 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.6 tpm_? -176.42 71.06 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.049 -1.463 . . . . 35.039999999999999 107.049 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -30.89 118.29 0.18 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.731 0.776 . . . . 18.719999999999999 111.579 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 6.1 mtp180 -89.35 110.94 21.68 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.015 -1.106 . . . . 20.550000000000001 108.015 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -81.93 144.38 30.99 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.141 -0.975 . . . . 14.4 111.164 -178.479 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 62' ' ' THR . 11.9 m -145.98 158.91 47.96 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.705 -1.22 . . . . 17.649999999999999 107.705 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.1 Cg_endo -61.79 145.77 97.02 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.02 1.813 . . . . 25.699999999999999 110.145 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.18 119.8 17.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.156 -0.965 . . . . 49.289999999999999 109.732 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.985 -1.007 . . . . 58.909999999999997 109.411 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.496 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.432 -0.581 . . . . 64.909999999999997 109.432 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.754 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.7 mt -66.89 78.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.586 -1.265 . . . . 33.799999999999997 107.586 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -74.2 159.84 31.98 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.934 0.873 . . . . 32.719999999999999 110.595 -178.224 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.705 HG11 HD21 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -162.41 167.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.442 -0.947 . . . . 14.460000000000001 108.442 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.535 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 33.7 mt-10 -142.32 112.7 7.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 22.120000000000001 109.659 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.712 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -75.41 99.7 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.759 -1.201 . . . . 14.23 107.759 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.673 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.2 mttm -54.02 165.83 0.73 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.821 . . . . 25.43 109.785 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 29.9 Cg_endo -70.84 -15.63 33.03 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.89 1.727 . . . . 13.609999999999999 108.814 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.13 -2.66 49.47 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.858 -0.793 . . . . 15.52 108.858 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.592 ' O ' HG23 ' B' ' 6' ' ' ILE . 15.6 mm-40 -129.5 43.74 3.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 17.309999999999999 109.649 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.84 19.52 16.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.074 -1.017 . . . . 24.780000000000001 110.087 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.407 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 11.9 mt-30 -135.32 140.7 45.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.119 -0.988 . . . . 47.899999999999999 109.679 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.725 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 41.0 p90 -94.85 164.08 13.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 21.609999999999999 109.487 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 87.9 m -135.14 147.21 49.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.303 -0.873 . . . . 14.890000000000001 109.134 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.37 113.92 25.64 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.28 -0.887 . . . . 17.350000000000001 109.368 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' B' ' 17' ' ' SER . 50.7 ttt180 -145.26 158.37 43.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 34.380000000000003 109.346 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.1 OUTLIER -42.62 147.97 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.432 -0.792 . . . . 38.770000000000003 109.391 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -152.02 173.18 31.27 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.414 -1.474 . . . . 34.579999999999998 109.414 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.403 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.8 OUTLIER -147.99 120.47 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.07 -1.253 . . . . 41.869999999999997 109.035 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -59.16 -88.6 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.298 -0.877 . . . . 47.210000000000001 109.652 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.45 63.54 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 71.560000000000002 109.621 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 54.54 19.52 2.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 66.599999999999994 109.392 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.18 -47.46 1.57 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.568 -1.413 . . . . 55.490000000000002 109.568 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -156.14 153.18 24.94 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.294 -1.121 . . . . 44.990000000000002 109.365 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.61 143.22 23.94 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.56 2.173 . . . . 44.100000000000001 110.745 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 2.7 p90 -146.26 136.27 23.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 32.090000000000003 109.692 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.5 m -105.34 80.91 1.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.87 . . . . 29.25 108.815 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.524 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.3 OUTLIER -97.18 158.58 15.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.915 . . . . 24.0 110.302 -179.139 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.516 ' CG ' ' CD1' ' B' ' 13' ' ' PHE . 85.2 m-20 -68.75 109.73 3.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.827 . . . . 23.309999999999999 109.082 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 18.2 mt-10 -86.69 -173.5 4.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.141 -0.974 . . . . 40.030000000000001 109.909 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.571 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 1.7 tm0? -176.12 -177.82 0.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.353 -0.842 . . . . 12.390000000000001 109.489 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.736 ' CB ' HD11 ' B' ' 44' ' ' LEU . 13.2 mt -141.1 168.73 19.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 17.420000000000002 109.33 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -164.61 162.02 21.31 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.041 -1.096 . . . . 13.84 108.041 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.677 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 49.6 m-85 -111.52 111.52 22.59 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.01 . . . . 21.140000000000001 109.698 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.681 ' CG1' HD23 ' B' ' 37' ' ' LEU . 4.6 t -106.68 140.26 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 10.66 110.92 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.9 OUTLIER -111.64 39.25 2.39 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.571 -1.27 . . . . 25.890000000000001 107.571 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.807 HD21 HG22 ' A' ' 70' ' ' VAL . 1.1 pp -63.46 58.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.973 -0.454 . . . . 24.239999999999998 110.493 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 107.14 2.21 35.95 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.868 -1.293 . . . . 31.02 109.868 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' B' ' 41' ' ' HIS . 1.2 m-20 -125.16 98.61 5.73 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.284 -1.127 . . . . 43.229999999999997 108.527 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.6 OUTLIER -32.49 -56.53 0.34 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.553 0.692 . . . . 42.340000000000003 110.678 -179.242 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' B' ' 39' ' ' ASN . 7.3 m-70 -66.53 152.21 95.21 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 108.68 -0.859 . . . . 5.6399999999999997 108.68 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.677 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.8 Cg_endo -77.34 139.56 18.71 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.038 1.825 . . . . 17.920000000000002 110.031 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.827 HG21 HG21 ' A' ' 70' ' ' VAL . 3.4 m -112.8 115.36 49.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.289 -0.882 . . . . 20.57 109.61 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.736 HD11 ' CB ' ' B' ' 32' ' ' LEU . 59.3 tp -72.43 101.8 3.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.284 -0.885 . . . . 20.210000000000001 109.827 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.684 HG12 ' CG1' ' A' ' 70' ' ' VAL . 2.6 m -100.09 -169.07 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.987 -0.746 . . . . 10.81 108.987 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.661 ' HA ' HD23 ' B' ' 32' ' ' LEU . 1.3 mtpp -106.52 178.4 4.57 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.429 -0.908 . . . . 36.740000000000002 110.765 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.583 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -157.34 156.64 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.318 -0.993 . . . . 19.739999999999998 108.318 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.421 ' O ' ' C ' ' B' ' 49' ' ' LEU . 0.3 OUTLIER -111.54 68.63 0.67 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.129 -0.982 . . . . 22.559999999999999 109.463 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.997 HD11 ' O ' ' B' ' 53' ' ' GLN . 2.2 tm? -42.24 114.54 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.586 -0.696 . . . . 20.41 109.314 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.734 ' O ' HD13 ' B' ' 49' ' ' LEU . 0.8 OUTLIER -57.05 151.77 14.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.864 . . . . 33.990000000000002 109.909 -179.435 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -63.53 117.77 7.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.378 -0.827 . . . . 54.920000000000002 109.202 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.36 -27.35 18.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.301 -1.52 . . . . 36.100000000000001 109.301 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.997 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.8 OUTLIER -69.18 146.19 96.73 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.315 -1.109 . . . . 54.759999999999998 109.346 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.8 Cg_endo -77.4 119.63 4.99 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.614 2.209 . . . . 28.370000000000001 110.714 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.725 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -41.28 144.33 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.415 -0.803 . . . . 17.210000000000001 110.004 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.712 ' O ' HG21 ' B' ' 6' ' ' ILE . 15.5 m-30 -45.51 108.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 17.190000000000001 109.166 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.887 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -58.83 173.76 0.42 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.012 -1.055 . . . . 17.82 109.008 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.887 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.59 110.73 3.01 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.444 2.096 . . . . 17.280000000000001 110.236 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.76 -178.57 48.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.817 -1.313 . . . . 17.219999999999999 109.817 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.62 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -77.42 140.96 39.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.351 -1.088 . . . . 19.57 108.601 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.721 ' HB3' HD22 ' B' ' 83' ' ' LEU . 17.9 m-85 -130.39 164.02 25.61 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.812 -1.18 . . . . 14.609999999999999 111.698 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.632 ' O ' HG22 ' B' ' 84' ' ' VAL . 51.0 p -145.73 121.83 10.78 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.473 -1.677 . . . . 18.359999999999999 106.473 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.599 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -51.63 166.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 C-N-CA 118.751 -1.179 . . . . 19.129999999999999 109.197 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -127.53 127.24 43.62 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.919 -0.771 . . . . 20.649999999999999 108.919 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.751 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -70.99 0.45 7.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.442 -0.786 . . . . 19.649999999999999 110.053 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 3.8 t -57.09 -17.36 10.16 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.821 -1.178 . . . . 14.720000000000001 107.821 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 16.2 m -98.19 -5.64 32.98 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.767 -0.583 . . . . 11.449999999999999 110.358 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.675 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.3 m-30 -83.27 159.28 21.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.895 -1.128 . . . . 14.25 109.691 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.594 ' HA ' HD11 ' A' ' 37' ' ' LEU . 53.0 mttm -148.84 173.3 13.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 32.700000000000003 109.21 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.826 HG21 HG21 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -107.32 116.01 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 15.630000000000001 108.998 179.605 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 175.87 4.88 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.809 -1.316 . . . . 12.699999999999999 109.809 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.95 12.79 8.61 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.209 -1.171 . . . . 26.289999999999999 109.748 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.469 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -123.41 19.29 9.71 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.565 -0.71 . . . . 20.440000000000001 109.234 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 45' ' ' VAL . . . 67.66 57.26 9.2 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.667 -1.373 . . . . 13.82 109.667 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.4 t -146.65 134.55 21.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -1.152 . . . . 18.27 109.86 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.755 HD11 HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -76.84 145.11 38.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 12.43 109.062 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.491 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 11.2 mtm -157.05 120.4 4.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 35.109999999999999 109.847 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 78' ' ' ILE . 3.2 mt -62.38 137.11 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 13.67 109.382 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -100.52 -30.3 11.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.164 -1.05 . . . . 24.059999999999999 108.164 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.491 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.6 tpm_? -176.5 71.18 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.045 -1.465 . . . . 35.039999999999999 107.045 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.651 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -30.99 118.32 0.18 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.723 0.773 . . . . 18.719999999999999 111.604 -177.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 6.1 mtp180 -89.36 110.79 21.55 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.074 -1.084 . . . . 20.550000000000001 108.074 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -81.78 144.37 31.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.172 -0.955 . . . . 14.4 111.217 -178.461 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.632 HG22 ' O ' ' B' ' 62' ' ' THR . 12.3 m -146.04 158.92 47.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 107.718 -1.215 . . . . 17.649999999999999 107.718 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.9 Cg_endo -61.77 145.74 97.06 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.015 1.81 . . . . 25.699999999999999 110.171 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -73.19 119.82 17.96 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.102 -0.999 . . . . 49.289999999999999 109.7 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 58.909999999999997 109.389 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.635 ' O ' HD22 ' A' ' 37' ' ' LEU . 1.2 pmm? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.321 0.582 . . . . 64.909999999999997 109.477 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.957 HG23 HD13 ' B' ' 65' ' ' LEU . 2.3 mt -74.33 66.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.102 -1.073 . . . . 33.799999999999997 108.102 178.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.645 ' C ' HG12 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -56.84 178.58 0.06 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.839 0.828 . . . . 32.719999999999999 111.097 -178.486 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.954 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 174.3 166.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.605 -0.887 . . . . 14.460000000000001 108.605 -179.872 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.567 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 25.3 mt-10 -137.6 113.79 10.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.822 -0.807 . . . . 22.120000000000001 108.822 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.764 HD11 ' SG ' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -72.53 103.81 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.472 -1.307 . . . . 14.23 107.472 179.449 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.657 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.64 171.46 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.978 -1.076 . . . . 25.43 109.638 -178.846 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.2 Cg_endo -75.05 -28.18 9.3 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.437 2.091 . . . . 13.609999999999999 110.041 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -88.03 -0.26 56.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.468 -0.77 . . . . 15.52 109.029 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.599 ' OE1' HD12 ' A' ' 32' ' ' LEU . 13.9 mm-40 -116.21 36.91 3.87 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.395 -0.816 . . . . 17.309999999999999 109.218 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.62 10.79 40.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 24.780000000000001 110.062 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.439 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 13.4 mt-30 -137.74 136.16 37.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.227 -0.921 . . . . 47.899999999999999 109.745 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.62 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 31.0 p90 -86.21 165.98 16.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.2 -0.938 . . . . 21.609999999999999 109.556 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -133.45 149.75 51.77 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.383 -0.823 . . . . 14.890000000000001 109.27 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.519 ' CG2' ' OG ' ' A' ' 27' ' ' SER . 0.2 OUTLIER -74.38 113.67 11.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.297 -0.877 . . . . 17.350000000000001 109.218 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.446 ' NH1' ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -124.3 127.18 47.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 34.380000000000003 109.627 -179.675 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 t -48.25 106.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 38.770000000000003 109.277 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.61 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -114.88 137.46 14.0 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.757 -1.337 . . . . 34.579999999999998 109.757 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.95 122.41 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.196 -1.179 . . . . 41.869999999999997 109.15 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -69.76 90.18 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.456 -0.777 . . . . 47.210000000000001 109.47 -179.45 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 22' ' ' GLN . 0.6 OUTLIER 70.81 -66.89 0.27 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.216 -0.928 . . . . 71.560000000000002 109.323 -179.9 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 5.7 pt20 174.78 48.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 66.599999999999994 109.498 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 24' ' ' LYS . . . -119.99 -60.61 0.25 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.749 -1.34 . . . . 55.490000000000002 109.749 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 23' ' ' GLY . 10.9 mttt -144.21 158.44 54.94 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.306 -1.114 . . . . 44.990000000000002 109.543 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.6 Cg_endo -77.47 82.09 2.48 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.657 2.238 . . . . 44.100000000000001 110.616 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.61 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 6.8 p90 -72.02 142.55 49.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 32.090000000000003 109.946 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.519 ' OG ' ' CG2' ' A' ' 15' ' ' THR . 0.3 OUTLIER -101.58 80.53 2.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.352 -0.842 . . . . 29.25 108.865 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -94.46 171.27 8.91 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.348 -0.845 . . . . 24.0 110.18 -179.321 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.62 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -88.09 129.45 35.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.563 -0.711 . . . . 23.309999999999999 109.77 -179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 14.7 mt-10 -115.09 162.38 17.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.302 -0.874 . . . . 40.030000000000001 109.34 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.821 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.92 -173.53 4.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.108 -0.995 . . . . 12.390000000000001 109.876 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 ' O ' ' A' ' 31' ' ' GLN . 25.1 mt -133.71 159.35 40.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 17.420000000000002 109.221 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.764 ' SG ' HD11 ' A' ' 6' ' ' ILE . 3.5 m -154.23 168.44 26.54 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.937 -1.135 . . . . 13.84 107.937 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.694 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 29.4 m-85 -120.53 105.92 11.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.951 -1.093 . . . . 21.140000000000001 109.589 -179.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 43' ' ' VAL . 39.9 t -97.8 139.69 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.002 -1.061 . . . . 10.66 111.095 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.649 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 m-20 -115.22 -140.49 0.38 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.318 -0.993 . . . . 25.890000000000001 108.318 178.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.718 ' CB ' HD21 ' B' ' 65' ' ' LEU . 0.2 OUTLIER 67.44 -68.41 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.924 -1.11 . . . . 24.239999999999998 108.47 179.467 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -78.66 -1.47 83.27 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 107.913 -2.075 . . . . 31.02 107.913 178.171 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -160.12 110.26 1.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.513 -0.992 . . . . 43.229999999999997 108.95 179.748 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 39' ' ' ASN . 2.0 mm-40 -37.68 -63.29 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.642 0.734 . . . . 42.340000000000003 109.81 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 37.3 m80 -69.0 163.95 52.08 Favored Pre-proline 0 C--N 1.293 -1.882 0 N-CA-C 108.076 -1.083 . . . . 8.0199999999999996 108.076 179.067 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.694 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -76.53 141.48 22.43 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 121.699 1.599 . . . . 17.920000000000002 109.748 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 35' ' ' VAL . 25.7 m -113.72 115.89 51.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.315 -0.866 . . . . 20.57 109.46 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.788 HD11 ' HB3' ' A' ' 32' ' ' LEU . 52.0 tp -74.23 103.39 4.63 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.366 -0.833 . . . . 20.210000000000001 109.749 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.585 HG12 HG11 ' B' ' 70' ' ' VAL . 1.3 m -107.43 176.15 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.509 -0.744 . . . . 10.81 109.172 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.28 139.85 35.37 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.314 -0.955 . . . . 36.740000000000002 109.527 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.973 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -124.02 170.59 14.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.42 -0.8 . . . . 19.739999999999998 109.261 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.683 HG21 ' NH1' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -111.77 142.53 44.0 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.175 -0.953 . . . . 22.559999999999999 109.497 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.609 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -110.41 147.48 33.93 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 20.41 108.721 179.711 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.532 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 1.0 OUTLIER -85.26 145.24 27.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 33.990000000000002 109.831 -179.332 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.19 119.82 5.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.36 -0.838 . . . . 54.920000000000002 109.614 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.79 -15.55 46.73 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.681 -1.368 . . . . 36.100000000000001 109.681 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.532 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -74.99 145.19 80.67 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.202 -1.176 . . . . 54.759999999999998 109.343 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.84 121.9 5.64 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.596 2.197 . . . . 28.370000000000001 110.74 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.816 ' HB1' HE21 ' A' ' 31' ' ' GLN . . . -38.92 149.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.501 -0.749 . . . . 17.210000000000001 110.388 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.755 ' HB3' HD13 ' A' ' 6' ' ' ILE . 89.6 m-85 -46.49 105.36 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.758 -0.83 . . . . 17.190000000000001 108.758 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -58.88 176.73 0.27 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.382 -0.824 . . . . 17.82 110.023 -179.103 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.8 Cg_endo -77.69 110.26 2.91 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.737 2.291 . . . . 17.280000000000001 110.338 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 173.65 151.94 8.54 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.563 -1.415 . . . . 17.219999999999999 109.563 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 5.1 mp -49.27 150.22 1.83 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.321 . . . . 19.57 108.779 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.954 ' CB ' HG13 ' A' ' 4' ' ' VAL . 19.1 m-85 -128.57 163.89 24.02 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.768 -1.207 . . . . 14.609999999999999 111.564 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.755 ' O ' HG22 ' A' ' 84' ' ' VAL . 55.8 p -147.69 118.73 7.69 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.411 -1.7 . . . . 18.359999999999999 106.411 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.619 HG11 ' HB2' ' A' ' 81' ' ' LEU . 8.6 t -53.33 169.86 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 C-N-CA 118.809 -1.157 . . . . 19.129999999999999 108.917 -178.294 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.577 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -128.08 120.14 26.8 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.426 -0.796 . . . . 20.649999999999999 109.066 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.954 HD13 HG23 ' B' ' 2' ' ' ILE . 0.0 OUTLIER -65.08 -8.28 15.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.727 -0.608 . . . . 19.649999999999999 109.914 -179.176 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.3 p -52.28 -17.95 1.36 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.02 -1.05 . . . . 14.720000000000001 108.402 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 2.3 m -95.94 -6.06 39.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.566 -0.709 . . . . 11.449999999999999 110.79 -179.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.615 ' CE1' HG12 ' A' ' 78' ' ' ILE . 1.9 m-30 -86.61 164.64 16.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.741 -1.224 . . . . 14.25 110.174 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 1.4 mtpp -159.33 178.78 9.59 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.876 -0.787 . . . . 32.700000000000003 108.876 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.812 HG21 HG21 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -118.6 114.82 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 15.630000000000001 109.38 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.46 -167.88 18.67 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.461 -1.456 . . . . 12.699999999999999 109.461 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.35 39.97 0.93 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -1.168 . . . . 26.289999999999999 109.48 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 28.3 m-85 -134.21 27.8 3.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.35 -0.844 . . . . 20.440000000000001 109.261 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 73' ' ' PHE . . . 44.7 49.01 8.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.583 -1.407 . . . . 13.82 109.583 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -149.51 145.67 26.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -1.181 . . . . 18.27 109.66 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.8 OUTLIER -88.41 149.49 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 12.43 109.119 179.72 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 54.6 mtm -157.4 137.84 12.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -0.984 . . . . 35.109999999999999 109.637 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.828 HD12 HD12 ' B' ' 78' ' ' ILE . 3.0 mt -69.98 139.59 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 13.67 110.105 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.1 -25.48 11.55 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.221 -1.029 . . . . 24.059999999999999 108.221 178.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.683 ' NH1' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -179.92 68.01 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.125 -1.435 . . . . 35.039999999999999 107.125 179.144 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -33.23 120.48 0.37 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.281 -0.872 . . . . 18.719999999999999 111.644 -178.247 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -91.45 113.21 25.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.922 -1.14 . . . . 20.550000000000001 107.922 178.786 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.973 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -82.55 148.85 27.82 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.028 -1.045 . . . . 14.4 110.959 -178.553 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 62' ' ' THR . 32.6 m -150.65 150.13 27.62 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 107.96 -1.126 . . . . 17.649999999999999 107.96 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.1 Cg_endo -61.37 140.89 90.46 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.164 1.91 . . . . 25.699999999999999 110.581 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.11 117.15 8.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 49.289999999999999 109.651 -178.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.005 -0.998 . . . . 58.909999999999997 109.49 179.991 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.643 ' O ' HD22 ' B' ' 37' ' ' LEU . 1.2 pmm? . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.471 -0.566 . . . . 64.909999999999997 109.471 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.954 HG23 HD13 ' A' ' 65' ' ' LEU . 2.3 mt -74.25 66.57 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.043 -1.095 . . . . 33.799999999999997 108.043 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.633 ' C ' HG12 ' B' ' 4' ' ' VAL . 0.5 OUTLIER -56.93 178.76 0.05 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.88 0.848 . . . . 32.719999999999999 110.992 -178.455 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.958 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 174.19 166.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.625 -0.879 . . . . 14.460000000000001 108.625 -179.84 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 25.2 mt-10 -137.34 113.99 10.36 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.826 -0.805 . . . . 22.120000000000001 108.826 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.768 HD11 ' SG ' ' B' ' 33' ' ' CYS . 0.1 OUTLIER -72.74 103.75 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 107.529 -1.286 . . . . 14.23 107.529 179.48 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.669 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.63 171.27 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.995 -1.065 . . . . 25.43 109.564 -178.791 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.3 Cg_endo -74.96 -28.3 9.35 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.445 2.096 . . . . 13.609999999999999 110.088 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -87.6 -0.73 57.27 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.02 -0.733 . . . . 15.52 109.02 179.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.579 ' OE1' HD12 ' B' ' 32' ' ' LEU . 13.6 mm-40 -115.9 37.08 3.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.342 -0.849 . . . . 17.309999999999999 109.301 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.71 10.77 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 24.780000000000001 110.004 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.438 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 13.7 mt-30 -137.62 136.14 37.23 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 47.899999999999999 109.785 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.625 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 30.8 p90 -86.15 165.97 16.14 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.248 -0.908 . . . . 21.609999999999999 109.573 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 89.7 m -133.42 149.84 51.79 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.385 -0.822 . . . . 14.890000000000001 109.234 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.534 ' CG2' ' OG ' ' B' ' 27' ' ' SER . 0.2 OUTLIER -74.45 113.76 12.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.251 -0.905 . . . . 17.350000000000001 109.224 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.457 ' NH1' ' CG ' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -124.28 127.27 47.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 34.380000000000003 109.606 -179.71 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.4 t -48.29 106.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.941 . . . . 38.770000000000003 109.244 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.601 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -115.14 137.39 13.89 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.751 -1.34 . . . . 34.579999999999998 109.751 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.02 122.37 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.232 -1.158 . . . . 41.869999999999997 109.127 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.445 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -69.79 89.9 0.58 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.51 -0.744 . . . . 47.210000000000001 109.525 -179.419 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' B' ' 22' ' ' GLN . 0.6 OUTLIER 70.97 -67.09 0.27 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.206 -0.934 . . . . 71.560000000000002 109.318 -179.817 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' B' ' 21' ' ' ARG . 5.6 pt20 175.05 48.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 66.599999999999994 109.431 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' B' ' 24' ' ' LYS . . . -120.12 -60.77 0.25 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.749 -1.34 . . . . 55.490000000000002 109.749 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' B' ' 23' ' ' GLY . 10.9 mttt -144.21 158.26 55.3 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.239 -1.154 . . . . 44.990000000000002 109.594 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' B' ' 24' ' ' LYS . 34.2 Cg_endo -77.2 81.92 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.742 2.295 . . . . 44.100000000000001 110.628 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.61 ' CE1' ' HB2' ' B' ' 28' ' ' LEU . 6.8 p90 -72.07 142.6 49.24 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.323 -0.86 . . . . 32.090000000000003 109.899 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.534 ' OG ' ' CG2' ' B' ' 15' ' ' THR . 0.3 OUTLIER -101.79 80.43 2.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.372 -0.83 . . . . 29.25 108.863 179.643 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.61 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -94.3 171.54 8.76 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.383 -0.823 . . . . 24.0 110.089 -179.369 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.625 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -88.47 129.25 35.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.601 -0.687 . . . . 23.309999999999999 109.802 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 14.7 mt-10 -114.89 162.27 17.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 40.030000000000001 109.387 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.837 ' O ' HD23 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -148.76 -173.48 4.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.994 . . . . 12.390000000000001 109.892 -179.814 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.837 HD23 ' O ' ' B' ' 31' ' ' GLN . 25.3 mt -133.85 159.41 40.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 17.420000000000002 109.264 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.768 ' SG ' HD11 ' B' ' 6' ' ' ILE . 3.5 m -154.27 168.24 27.24 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.963 -1.125 . . . . 13.84 107.963 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.684 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 29.7 m-85 -120.38 105.93 11.36 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.957 -1.089 . . . . 21.140000000000001 109.652 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.827 ' O ' HG22 ' B' ' 43' ' ' VAL . 40.0 t -97.93 139.65 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.087 -1.008 . . . . 10.66 110.995 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.645 ' O ' HD12 ' B' ' 37' ' ' LEU . 4.4 m-20 -115.27 -140.46 0.38 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.292 -1.003 . . . . 25.890000000000001 108.292 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.709 ' CB ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 67.33 -68.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.925 -1.109 . . . . 24.239999999999998 108.405 179.479 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -78.6 -1.54 83.08 Favored Glycine 0 C--N 1.297 -1.587 0 N-CA-C 107.873 -2.091 . . . . 31.02 107.873 178.209 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.451 ' O ' ' C ' ' B' ' 40' ' ' GLU . 0.1 OUTLIER -160.37 110.12 1.77 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.512 -0.993 . . . . 43.229999999999997 108.869 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' B' ' 39' ' ' ASN . 2.0 mm-40 -37.37 -63.53 0.44 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.633 0.73 . . . . 42.340000000000003 109.827 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.471 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 37.9 m80 -68.89 164.1 49.99 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 108.03 -1.1 . . . . 8.0399999999999991 108.03 179.061 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.684 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.3 Cg_endo -76.51 141.53 22.54 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.722 1.615 . . . . 17.920000000000002 109.836 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.827 HG22 ' O ' ' B' ' 35' ' ' VAL . 25.5 m -113.73 115.77 50.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.255 -0.903 . . . . 20.57 109.495 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' B' ' 32' ' ' LEU . 52.1 tp -74.26 103.15 4.56 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.417 -0.802 . . . . 20.210000000000001 109.741 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.566 HG12 HG11 ' A' ' 70' ' ' VAL . 1.3 m -107.07 176.19 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.505 -0.747 . . . . 10.81 109.147 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.404 ' HA ' HD23 ' B' ' 32' ' ' LEU . 0.3 OUTLIER -100.17 139.87 35.23 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.393 -0.923 . . . . 36.740000000000002 109.526 179.627 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 1.014 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.6 OUTLIER -124.12 170.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.383 -0.823 . . . . 19.739999999999998 109.254 -179.748 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.681 HG21 ' NH1' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -111.7 142.27 44.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.206 -0.934 . . . . 22.559999999999999 109.575 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.606 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -110.21 147.54 33.58 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.285 -0.884 . . . . 20.41 108.763 179.676 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 1.0 OUTLIER -85.37 145.11 27.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.128 -0.983 . . . . 33.990000000000002 109.854 -179.355 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.85 119.84 5.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 54.920000000000002 109.595 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.74 -15.56 46.44 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.707 -1.357 . . . . 36.100000000000001 109.707 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.529 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -75.0 145.12 80.56 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 54.759999999999998 109.311 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.8 Cg_endo -77.78 121.75 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.616 2.211 . . . . 28.370000000000001 110.731 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.809 ' HB1' HE21 ' B' ' 31' ' ' GLN . . . -38.68 150.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.548 -0.72 . . . . 17.210000000000001 110.415 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.746 ' HB3' HD13 ' B' ' 6' ' ' ILE . 89.4 m-85 -46.79 105.4 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.324 -0.86 . . . . 17.190000000000001 108.724 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 1.024 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -58.83 176.89 0.26 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 17.82 110.121 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 1.024 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.78 110.26 2.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.673 2.249 . . . . 17.280000000000001 110.278 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 173.68 151.96 8.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.579 -1.408 . . . . 17.219999999999999 109.579 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.1 mp -49.25 150.1 1.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.985 -1.303 . . . . 19.57 108.724 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.958 ' CB ' HG13 ' B' ' 4' ' ' VAL . 18.7 m-85 -128.55 163.86 24.08 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.833 -1.167 . . . . 14.609999999999999 111.589 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.742 ' O ' HG22 ' B' ' 84' ' ' VAL . 53.8 p -147.6 118.71 7.73 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.481 -1.674 . . . . 18.359999999999999 106.481 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' B' ' 81' ' ' LEU . 9.2 t -53.3 169.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.811 -1.156 . . . . 19.129999999999999 108.878 -178.33 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.585 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -128.2 120.1 26.57 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.499 -0.751 . . . . 20.649999999999999 109.05 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.957 HD13 HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -64.9 -8.43 15.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.709 -0.619 . . . . 19.649999999999999 109.923 -179.151 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 96.0 p -52.05 -17.98 1.25 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.952 -1.092 . . . . 14.720000000000001 108.377 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 2.4 m -95.96 -6.59 38.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.502 -0.749 . . . . 11.449999999999999 110.776 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.631 ' CE1' HG12 ' B' ' 78' ' ' ILE . 1.8 m-30 -86.15 164.4 17.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.73 -1.231 . . . . 14.25 110.046 -179.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -159.09 179.06 9.38 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.82 -0.808 . . . . 32.700000000000003 108.82 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.825 HG21 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -118.73 115.13 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 15.630000000000001 109.427 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -74.58 -168.09 19.66 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.495 -1.442 . . . . 12.699999999999999 109.495 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.13 39.71 0.91 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.167 -1.196 . . . . 26.289999999999999 109.475 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' B' ' 73' ' ' PHE . 28.6 m-85 -133.99 28.09 3.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 20.440000000000001 109.38 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.39 49.1 8.46 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.627 -1.389 . . . . 13.82 109.627 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -149.67 145.69 26.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -1.145 . . . . 18.27 109.684 -179.971 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.8 OUTLIER -88.58 149.62 23.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 12.43 109.072 179.734 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.492 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 54.4 mtm -157.52 138.18 13.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.123 -0.986 . . . . 35.109999999999999 109.52 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.828 HD12 HD12 ' A' ' 78' ' ' ILE . 2.9 mp -70.4 139.52 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.856 . . . . 13.67 110.134 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.84 -25.53 11.65 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.138 -1.06 . . . . 24.059999999999999 108.138 178.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.681 ' NH1' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER -179.77 68.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.186 -1.413 . . . . 35.039999999999999 107.186 179.17 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.656 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -33.21 120.28 0.36 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.311 -0.859 . . . . 18.719999999999999 111.607 -178.187 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -91.32 113.09 25.26 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.979 -1.119 . . . . 20.550000000000001 107.979 178.723 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.014 ' HB2' HD11 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -82.42 148.93 27.92 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.037 -1.039 . . . . 14.4 110.986 -178.603 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.742 HG22 ' O ' ' B' ' 62' ' ' THR . 32.5 m -150.63 150.04 27.45 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.994 -1.113 . . . . 17.649999999999999 107.994 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.0 Cg_endo -61.41 140.44 87.83 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.188 1.925 . . . . 25.699999999999999 110.6 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -65.51 117.47 8.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 49.289999999999999 109.62 -178.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.027 -0.987 . . . . 58.909999999999997 109.484 -179.98 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.358 -0.608 . . . . 64.909999999999997 109.358 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.896 ' N ' HD22 ' B' ' 65' ' ' LEU . 2.2 mt -60.4 84.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.897 -1.149 . . . . 33.799999999999997 107.897 179.069 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 1' ' ' MET . 17.4 mttt -57.85 157.14 7.92 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.847 0.832 . . . . 32.719999999999999 111.569 -177.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.057 HG22 HG22 ' A' ' 35' ' ' VAL . 59.8 t -160.52 167.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.585 0.707 . . . . 14.460000000000001 109.724 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.61 ' N ' HG12 ' A' ' 4' ' ' VAL . 38.9 mt-10 -154.09 101.44 2.41 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.771 0.796 . . . . 22.120000000000001 108.931 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -71.38 101.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.986 -1.116 . . . . 14.23 107.986 179.642 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.581 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 15.6 mmmt -50.52 163.3 0.47 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.414 -0.803 . . . . 25.43 109.252 -179.393 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.5 Cg_endo -71.98 -10.1 25.62 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.818 1.679 . . . . 13.609999999999999 109.247 179.247 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.82 12.21 31.07 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.533 -0.914 . . . . 15.52 108.533 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.529 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 7.6 mm-40 -137.08 38.45 2.54 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.31 -0.869 . . . . 17.309999999999999 109.211 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -111.96 31.48 6.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.96 . . . . 24.780000000000001 110.19 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 12.0 mt-30 -140.3 132.36 27.9 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.261 -0.9 . . . . 47.899999999999999 109.501 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.642 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 33.6 p90 -89.52 155.81 19.05 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.213 -0.93 . . . . 21.609999999999999 109.671 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.1 m -134.6 150.16 50.67 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.885 -0.783 . . . . 14.890000000000001 108.885 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.943 HG22 ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -82.15 108.82 15.91 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.164 -0.96 . . . . 17.350000000000001 109.236 179.93 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.482 ' NH1' ' HG3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -124.77 146.58 49.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.362 -0.836 . . . . 34.380000000000003 109.352 -179.828 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 16' ' ' ARG . 1.5 m -44.05 143.72 1.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 38.770000000000003 109.458 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -147.72 175.52 27.02 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.172 -1.571 . . . . 34.579999999999998 109.172 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -150.09 118.53 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.066 -1.255 . . . . 41.869999999999997 108.999 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 1.3 m -61.8 83.61 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.387 -0.82 . . . . 47.210000000000001 109.561 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 20' ' ' SER . 19.5 mtt180 68.37 -61.68 0.39 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.301 -0.874 . . . . 71.560000000000002 109.475 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' SER . 15.8 pt20 174.06 45.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 66.599999999999994 109.542 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.72 -56.98 0.25 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.619 -1.392 . . . . 55.490000000000002 109.619 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 5.9 pttt -143.11 158.87 57.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.303 -1.116 . . . . 44.990000000000002 109.38 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.7 Cg_endo -77.56 124.17 6.85 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.695 2.263 . . . . 44.100000000000001 110.784 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.597 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 3.8 p90 -130.14 136.35 49.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.314 -0.866 . . . . 32.090000000000003 109.601 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.943 ' HB2' HG22 ' A' ' 15' ' ' THR . 0.0 OUTLIER -104.01 80.2 1.71 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 29.25 108.684 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.573 HD13 HH22 ' A' ' 80' ' ' ARG . 0.4 OUTLIER -89.23 138.78 31.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 24.0 110.418 -179.008 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.653 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -47.61 117.75 1.95 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.433 -0.792 . . . . 23.309999999999999 109.569 179.607 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -112.87 147.68 36.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.255 -0.903 . . . . 40.030000000000001 109.593 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.949 ' OE1' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -131.22 -169.71 2.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.121 -0.987 . . . . 12.390000000000001 109.341 179.843 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.971 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -128.56 177.53 6.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 17.420000000000002 109.32 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.811 ' SG ' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -172.43 162.69 5.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.053 -1.029 . . . . 13.84 108.467 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.697 ' HE1' HD13 ' A' ' 44' ' ' LEU . 4.1 m-30 -114.58 95.25 5.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.154 -0.966 . . . . 21.140000000000001 109.187 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.057 HG22 HG22 ' A' ' 4' ' ' VAL . 92.2 t -84.87 115.45 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 10.66 110.234 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 t0 -66.1 -22.67 66.41 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.381 -0.824 . . . . 25.890000000000001 108.805 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.723 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.8 OUTLIER 43.23 26.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.771 . . . . 24.239999999999998 109.567 179.965 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 58.6 22.3 52.23 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.891 -1.284 . . . . 31.02 109.891 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.546 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 19.2 p30 -100.64 27.8 5.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.983 -1.304 . . . . 43.229999999999997 110.079 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.628 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 12.2 mt-10 47.72 71.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 42.340000000000003 109.871 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.628 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER 142.92 144.46 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.287 0 N-CA-C 108.572 -0.899 . . . . 6.5700000000000003 108.572 179.451 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.681 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -79.57 142.96 16.64 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.206 1.938 . . . . 17.920000000000002 110.841 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.97 HG22 ' O ' ' A' ' 35' ' ' VAL . 6.9 m -120.52 119.3 59.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.441 -0.948 . . . . 20.57 108.441 178.469 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.971 HD11 ' HB3' ' A' ' 32' ' ' LEU . 17.7 tp -66.88 112.72 4.44 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.428 -0.795 . . . . 20.210000000000001 109.241 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 3.6 t -119.47 168.4 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.576 -0.702 . . . . 10.81 109.572 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -90.57 149.89 21.96 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.431 -0.793 . . . . 36.740000000000002 109.954 -179.776 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.861 HD11 ' CB ' ' A' ' 83' ' ' LEU . 1.6 tt -130.21 176.86 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.802 -0.814 . . . . 19.739999999999998 108.802 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.634 HG21 ' CZ ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -125.4 135.24 52.18 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.184 -0.948 . . . . 22.559999999999999 109.094 179.453 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -104.67 99.99 9.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.209 -0.932 . . . . 20.41 109.003 179.981 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.69 156.44 36.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 33.990000000000002 109.606 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.27 136.81 57.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.221 -0.924 . . . . 54.920000000000002 109.228 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.86 -35.05 3.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.321 -1.512 . . . . 36.100000000000001 109.321 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.797 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.3 mt-30 -77.32 124.04 86.98 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.243 -1.151 . . . . 54.759999999999998 109.245 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.1 Cg_endo -78.63 138.28 15.11 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.279 1.986 . . . . 28.370000000000001 110.406 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.949 ' HB1' ' OE1' ' A' ' 31' ' ' GLN . . . -35.84 138.16 0.19 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.637 -0.664 . . . . 17.210000000000001 110.424 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.7 ' HB3' HD13 ' A' ' 6' ' ' ILE . 83.7 m-85 -51.75 109.99 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 17.190000000000001 109.511 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.917 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -59.72 174.33 0.45 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.263 -0.898 . . . . 17.82 109.252 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.917 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.7 Cg_endo -77.48 110.32 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.632 2.221 . . . . 17.280000000000001 110.406 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.37 179.85 48.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.743 -1.343 . . . . 17.219999999999999 109.743 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -74.83 143.99 43.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -1.114 . . . . 19.57 108.76 179.483 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.555 ' CB ' ' HB ' ' A' ' 4' ' ' VAL . 27.0 m-85 -132.42 164.58 26.21 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.873 -1.142 . . . . 14.609999999999999 111.206 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.807 ' O ' HG22 ' A' ' 84' ' ' VAL . 31.1 p -144.11 118.96 9.9 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.925 -1.88 . . . . 18.359999999999999 105.925 178.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.743 ' HB ' HD13 ' A' ' 2' ' ' ILE . 2.6 t -52.36 166.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 C-N-CA 118.434 -1.307 . . . . 19.129999999999999 108.999 -178.077 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -129.13 128.81 44.22 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.417 -0.802 . . . . 20.649999999999999 109.3 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.906 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -71.3 0.19 8.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.691 -0.631 . . . . 19.649999999999999 110.051 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -57.25 -17.66 12.7 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.645 -1.243 . . . . 14.720000000000001 107.645 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.488 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 50.4 m -96.41 -8.38 32.52 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.782 -0.574 . . . . 11.449999999999999 110.193 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.739 ' C ' HD11 ' B' ' 37' ' ' LEU . 2.8 m-30 -77.69 155.04 31.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.052 . . . . 14.25 109.585 -178.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.467 ' HG2' ' HB2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -134.71 172.9 12.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.406 -0.809 . . . . 32.700000000000003 109.731 -179.651 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.87 HG21 HG21 ' B' ' 43' ' ' VAL . 8.7 t -124.41 133.34 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.492 -0.755 . . . . 15.630000000000001 109.376 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.26 -157.56 27.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.435 -1.466 . . . . 12.699999999999999 109.435 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.466 ' O ' ' CB ' ' A' ' 73' ' ' PHE . 43.0 tp60 55.88 72.42 0.49 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -1.181 . . . . 26.289999999999999 109.098 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER 73.32 5.95 5.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.779 . . . . 20.440000000000001 109.402 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.481 ' O ' HG13 ' B' ' 45' ' ' VAL . . . 78.29 45.07 10.34 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.474 -1.451 . . . . 13.82 109.474 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.3 OUTLIER -127.07 119.66 27.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.144 . . . . 18.27 109.713 -179.913 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' HG11 ' B' ' 35' ' ' VAL . 0.8 OUTLIER -54.95 144.68 22.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 12.43 109.106 179.801 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 30.9 mtp -160.28 140.8 11.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 35.109999999999999 109.783 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.946 HD12 HD12 ' B' ' 78' ' ' ILE . 2.3 mp -68.56 141.66 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.816 . . . . 13.67 109.73 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 39.5 t0 -108.61 -21.26 12.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.689 -0.856 . . . . 24.059999999999999 108.689 178.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.634 ' CZ ' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER 174.22 66.76 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.1 -1.444 . . . . 35.039999999999999 107.1 179.497 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -28.3 119.7 0.11 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.257 -0.883 . . . . 18.719999999999999 111.961 -178.07 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 5.3 ttp180 -93.14 102.87 15.18 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.841 -1.17 . . . . 20.550000000000001 107.841 178.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.861 ' CB ' HD11 ' A' ' 47' ' ' ILE . 7.0 tp -74.13 149.75 40.85 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.158 -0.964 . . . . 14.4 111.184 -178.211 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 62' ' ' THR . 17.8 m -146.33 152.98 47.63 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.214 -1.032 . . . . 17.649999999999999 108.214 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 26.0 Cg_endo -64.51 142.97 80.37 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.2 1.933 . . . . 25.699999999999999 110.402 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.793 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -76.94 123.67 26.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 49.289999999999999 109.692 -178.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.003 -0.999 . . . . 58.909999999999997 109.432 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.516 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.387 -0.597 . . . . 64.909999999999997 109.387 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.906 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.2 mt -60.23 84.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.881 -1.155 . . . . 33.799999999999997 107.881 179.065 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.533 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 17.5 mttt -57.75 157.25 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.815 0.817 . . . . 32.719999999999999 111.543 -177.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.068 HG22 HG22 ' B' ' 35' ' ' VAL . 58.6 t -160.63 167.16 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.551 0.691 . . . . 14.460000000000001 109.726 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.608 ' N ' HG12 ' B' ' 4' ' ' VAL . 38.5 mt-10 -154.08 101.29 2.4 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.715 0.769 . . . . 22.120000000000001 108.963 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.694 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -71.28 101.77 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.994 -1.113 . . . . 14.23 107.994 179.664 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.565 ' HB3' ' HD2' ' B' ' 8' ' ' PRO . 15.7 mmmt -50.58 163.59 0.46 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.454 -0.779 . . . . 25.43 109.216 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.5 Cg_endo -72.23 -10.16 25.38 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.835 1.69 . . . . 13.609999999999999 109.205 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.62 12.06 31.6 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.485 -0.932 . . . . 15.52 108.485 178.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.541 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 7.7 mm-40 -136.91 38.19 2.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.869 . . . . 17.309999999999999 109.33 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.73 31.43 6.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.098 -1.001 . . . . 24.780000000000001 110.288 -179.274 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' B' ' 31' ' ' GLN . 11.9 mt-30 -140.26 132.26 27.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 47.899999999999999 109.504 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.642 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 33.0 p90 -89.33 155.75 19.15 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.249 -0.907 . . . . 21.609999999999999 109.662 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -134.63 150.27 50.65 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.83 -0.804 . . . . 14.890000000000001 108.83 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.941 HG22 ' HB2' ' B' ' 27' ' ' SER . 0.2 OUTLIER -82.17 108.7 15.83 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 17.350000000000001 109.209 179.989 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.481 ' NH1' ' HG3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -124.56 146.62 48.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 34.380000000000003 109.417 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 16' ' ' ARG . 1.5 m -44.09 143.73 1.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 38.770000000000003 109.405 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -147.74 175.56 27.01 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.154 -1.578 . . . . 34.579999999999998 109.154 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' B' ' 21' ' ' ARG . 0.5 OUTLIER -149.96 118.64 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.13 -1.217 . . . . 41.869999999999997 109.087 179.421 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.469 ' O ' ' N ' ' B' ' 22' ' ' GLN . 1.3 m -61.87 83.51 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.363 -0.836 . . . . 47.210000000000001 109.535 -179.213 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' B' ' 20' ' ' SER . 19.6 mtt180 68.45 -61.93 0.39 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.315 -0.865 . . . . 71.560000000000002 109.466 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' B' ' 20' ' ' SER . 15.8 pt20 174.27 45.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 66.599999999999994 109.585 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.71 -57.04 0.25 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.581 -1.408 . . . . 55.490000000000002 109.581 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.455 ' HB2' ' HD2' ' B' ' 25' ' ' PRO . 5.9 pttt -143.0 158.89 58.06 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 44.990000000000002 109.419 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.7 Cg_endo -77.58 124.1 6.81 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.639 2.226 . . . . 44.100000000000001 110.808 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.583 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 3.8 p90 -130.0 136.35 49.32 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.262 -0.899 . . . . 32.090000000000003 109.67 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.941 ' HB2' HG22 ' B' ' 15' ' ' THR . 0.0 OUTLIER -103.99 80.26 1.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.9 . . . . 29.25 108.623 179.651 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.58 HD13 HH22 ' B' ' 80' ' ' ARG . 0.4 OUTLIER -89.33 138.64 31.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 24.0 110.408 -178.995 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.664 ' OD1' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -47.56 117.81 1.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.434 -0.791 . . . . 23.309999999999999 109.627 179.668 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 6.4 mt-10 -112.77 148.02 35.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.218 -0.926 . . . . 40.030000000000001 109.584 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.955 ' OE1' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -131.6 -169.81 2.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.219 -0.926 . . . . 12.390000000000001 109.236 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.954 ' HB3' HD11 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -128.53 177.63 6.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.289 -0.882 . . . . 17.420000000000002 109.276 179.889 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.808 ' SG ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -172.51 162.56 5.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.992 -1.067 . . . . 13.84 108.4 -179.653 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.692 ' HE1' HD13 ' B' ' 44' ' ' LEU . 4.1 m-30 -114.51 95.36 5.22 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.125 -0.984 . . . . 21.140000000000001 109.203 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 1.068 HG22 HG22 ' B' ' 4' ' ' VAL . 92.6 t -84.92 115.41 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.028 -1.045 . . . . 10.66 110.27 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' B' ' 39' ' ' ASN . 1.1 t0 -66.0 -22.71 66.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.389 -0.819 . . . . 25.890000000000001 108.862 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.739 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER 43.23 26.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 24.239999999999998 109.55 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 58.64 22.56 53.18 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.862 -1.295 . . . . 31.02 109.862 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.542 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 19.1 p30 -100.89 27.66 5.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.016 -1.285 . . . . 43.229999999999997 110.034 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.631 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 12.2 mt-10 47.88 71.87 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 42.340000000000003 109.817 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.631 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 0.2 OUTLIER 142.89 144.44 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.196 0 N-CA-C 108.591 -0.892 . . . . 6.5599999999999996 108.591 179.48 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.674 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.7 Cg_endo -79.56 143.14 16.79 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.235 1.957 . . . . 17.920000000000002 110.762 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.987 HG22 ' O ' ' B' ' 35' ' ' VAL . 7.1 m -120.73 119.12 58.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.446 -0.946 . . . . 20.57 108.446 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.954 HD11 ' HB3' ' B' ' 32' ' ' LEU . 17.0 tp -66.71 112.96 4.48 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.413 -0.804 . . . . 20.210000000000001 109.294 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.575 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 3.7 t -119.71 168.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.552 -0.718 . . . . 10.81 109.553 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.575 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.5 OUTLIER -90.64 149.84 21.93 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.443 -0.786 . . . . 36.740000000000002 110.007 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.873 HD11 ' CB ' ' B' ' 83' ' ' LEU . 1.6 tt -130.11 176.95 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.836 -0.801 . . . . 19.739999999999998 108.836 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.648 HG21 ' CZ ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -125.57 134.94 51.78 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.228 -0.92 . . . . 22.559999999999999 109.149 179.486 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.799 HD12 ' O ' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -104.48 100.07 9.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.169 -0.957 . . . . 20.41 109.05 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.8 156.44 37.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 33.990000000000002 109.642 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.25 136.77 57.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.867 . . . . 54.920000000000002 109.245 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.76 -34.56 4.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.388 -1.485 . . . . 36.100000000000001 109.388 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.799 ' O ' HD12 ' B' ' 49' ' ' LEU . 4.3 mt-30 -77.71 123.99 86.49 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.234 -1.157 . . . . 54.759999999999998 109.202 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.476 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.8 Cg_endo -78.54 138.06 15.1 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.343 2.029 . . . . 28.370000000000001 110.478 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.955 ' HB1' ' OE1' ' B' ' 31' ' ' GLN . . . -35.62 137.78 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.384 0.612 . . . . 17.210000000000001 110.478 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.694 ' HB3' HD13 ' B' ' 6' ' ' ILE . 84.6 m-85 -51.28 109.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 17.190000000000001 109.558 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.943 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -59.72 174.25 0.46 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 17.82 109.27 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.943 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.26 109.53 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.541 2.161 . . . . 17.280000000000001 110.193 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.08 179.52 48.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.83 -1.308 . . . . 17.219999999999999 109.83 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.829 HD23 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -75.2 143.73 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -1.14 . . . . 19.57 108.474 179.263 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.561 ' CB ' HD21 ' B' ' 83' ' ' LEU . 27.0 m-85 -132.04 164.57 25.92 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.835 -1.165 . . . . 14.609999999999999 111.173 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.831 ' O ' HG22 ' B' ' 84' ' ' VAL . 31.9 p -143.99 119.0 10.0 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 105.907 -1.886 . . . . 18.359999999999999 105.907 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.752 ' HB ' HD13 ' B' ' 2' ' ' ILE . 2.5 t -52.52 166.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 C-N-CA 118.42 -1.312 . . . . 19.129999999999999 108.941 -178.136 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.512 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -129.26 128.73 43.84 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.413 -0.804 . . . . 20.649999999999999 109.287 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.896 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -71.23 0.17 8.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.621 -0.674 . . . . 19.649999999999999 110.11 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -57.2 -17.7 12.52 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.67 -1.233 . . . . 14.720000000000001 107.67 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.492 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 51.1 m -96.23 -8.78 32.03 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.773 -0.58 . . . . 11.449999999999999 110.255 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.723 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.8 m-30 -77.3 155.01 32.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.023 -1.048 . . . . 14.25 109.542 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' B' ' 79' ' ' ASP . 0.1 OUTLIER -134.83 172.58 12.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.424 -0.797 . . . . 32.700000000000003 109.703 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.851 HG21 HG21 ' A' ' 43' ' ' VAL . 9.5 t -124.14 133.31 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.462 -0.774 . . . . 15.630000000000001 109.387 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.37 -157.3 27.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.506 -1.438 . . . . 12.699999999999999 109.506 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 43.0 tp60 55.68 72.27 0.5 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -1.164 . . . . 26.289999999999999 109.131 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.1 OUTLIER 73.44 5.94 5.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 20.440000000000001 109.467 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.477 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 78.32 45.1 10.26 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.547 -1.421 . . . . 13.82 109.547 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 77' ' ' MET . 0.3 OUTLIER -127.13 119.57 26.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -1.1 . . . . 18.27 109.755 -179.916 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.548 HD13 HG11 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -54.94 144.54 22.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 12.43 109.152 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 31.1 mtp -160.14 141.1 12.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 35.109999999999999 109.749 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.946 HD12 HD12 ' A' ' 78' ' ' ILE . 2.3 mp -68.87 141.83 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 13.67 109.775 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.473 ' HB2' ' HG2' ' B' ' 69' ' ' LYS . 39.1 t0 -108.66 -21.23 12.79 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.685 -0.857 . . . . 24.059999999999999 108.685 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.648 ' CZ ' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER 174.08 66.58 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.075 -1.454 . . . . 35.039999999999999 107.075 179.541 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.653 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -28.01 119.98 0.11 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.27 -0.877 . . . . 18.719999999999999 111.893 -178.097 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 5.4 ttp180 -93.38 103.09 15.34 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.814 -1.18 . . . . 20.550000000000001 107.814 178.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.873 ' CB ' HD11 ' B' ' 47' ' ' ILE . 7.0 tp -74.35 149.59 40.5 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.113 -0.992 . . . . 14.4 111.148 -178.237 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.831 HG22 ' O ' ' B' ' 62' ' ' THR . 17.6 m -146.19 153.14 48.4 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.224 -1.028 . . . . 17.649999999999999 108.224 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 26.5 Cg_endo -64.6 143.34 81.0 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.155 1.903 . . . . 25.699999999999999 110.397 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.812 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -77.38 123.82 27.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.87 . . . . 49.289999999999999 109.643 -178.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.04 -0.981 . . . . 58.909999999999997 109.433 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 tpp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.489 -0.559 . . . . 64.909999999999997 109.489 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.764 ' N ' HD22 ' B' ' 65' ' ' LEU . 2.1 mt -59.46 84.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.962 -1.125 . . . . 33.799999999999997 107.962 179.297 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 1' ' ' MET . 15.3 mtpp -67.1 152.5 45.65 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.827 0.823 . . . . 32.719999999999999 111.306 -178.11 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.901 HG11 HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -164.15 167.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 108.381 -0.97 . . . . 14.460000000000001 108.381 179.593 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.572 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 24.3 mt-10 -141.08 118.0 11.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.336 -0.853 . . . . 22.120000000000001 109.361 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.867 HG21 ' O ' ' A' ' 56' ' ' TYR . 10.4 mm -75.71 92.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.919 -1.141 . . . . 14.23 107.919 179.163 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.671 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -44.89 171.66 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 25.43 110.19 -178.677 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -74.73 -29.28 8.89 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.481 2.121 . . . . 13.609999999999999 109.728 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -6.74 58.17 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.762 -0.829 . . . . 15.52 108.762 178.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 12.7 mm-40 -118.35 40.56 3.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.417 -0.802 . . . . 17.309999999999999 109.342 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -103.69 7.96 37.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.092 -1.005 . . . . 24.780000000000001 109.646 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.443 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 37.5 mt-30 -138.05 138.89 39.24 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.323 -0.861 . . . . 47.899999999999999 109.624 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.656 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 36.1 p90 -92.13 161.32 14.79 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.15 -0.969 . . . . 21.609999999999999 108.76 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.1 m -130.02 152.54 49.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.103 -0.998 . . . . 14.890000000000001 109.687 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.87 109.69 22.35 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.333 -0.854 . . . . 17.350000000000001 109.314 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 18' ' ' GLY . 5.0 mtp180 -123.64 152.35 42.07 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.319 -0.863 . . . . 34.380000000000003 109.06 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -57.77 84.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 38.770000000000003 109.366 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.549 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -77.68 160.43 48.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.314 -1.515 . . . . 34.579999999999998 109.314 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 1.6 t -128.76 124.1 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.116 -1.226 . . . . 41.869999999999997 108.964 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -92.14 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.23 -0.919 . . . . 47.210000000000001 109.63 -179.134 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.502 ' NH1' ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -90.14 -54.97 3.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.307 -0.87 . . . . 71.560000000000002 109.475 179.939 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.79 38.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 66.599999999999994 109.792 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -168.31 36.39 0.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.373 -1.491 . . . . 55.490000000000002 109.373 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.539 ' CG ' ' O ' ' A' ' 23' ' ' GLY . 2.8 mttp -170.36 102.15 0.43 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.495 -1.003 . . . . 44.990000000000002 108.745 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 33.5 Cg_endo -75.71 68.46 6.31 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.161 1.907 . . . . 44.100000000000001 110.805 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.2 p90 -63.05 137.67 58.33 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.349 -0.844 . . . . 32.090000000000003 109.436 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 m -99.86 78.8 2.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.124 -0.985 . . . . 29.25 108.866 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.585 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -100.4 160.75 14.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 24.0 110.451 -179.009 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.626 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 98.0 m-20 -78.33 129.59 35.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.496 -0.752 . . . . 23.309999999999999 109.277 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -123.28 149.06 45.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 40.030000000000001 109.17 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.617 ' HB3' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -136.33 -170.17 2.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 12.390000000000001 109.65 -179.985 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.778 ' HB3' HD11 ' A' ' 44' ' ' LEU . 5.9 mp -132.03 174.49 10.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.327 -0.858 . . . . 17.420000000000002 109.526 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -162.69 159.37 24.29 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.258 -1.015 . . . . 13.84 108.258 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.7 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 15.0 m-85 -114.77 96.64 5.83 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.152 -0.968 . . . . 21.140000000000001 109.384 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 43' ' ' VAL . 3.0 t -105.18 127.5 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 10.66 110.461 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 16.8 p-10 -86.48 -27.54 24.01 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.496 -0.927 . . . . 25.890000000000001 108.496 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.852 ' HG ' HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER 47.4 23.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 24.239999999999998 109.625 179.775 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.27 8.03 69.05 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.976 -1.25 . . . . 31.02 109.976 179.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' CG ' ' O ' ' A' ' 36' ' ' ASP . 0.9 OUTLIER -87.07 19.21 3.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.094 -1.239 . . . . 43.229999999999997 110.008 -179.739 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 5.1 mt-10 45.98 72.03 0.25 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 42.340000000000003 109.862 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.61 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER 143.64 147.65 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.207 0 N-CA-C 108.6 -0.889 . . . . 6.5899999999999999 108.6 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.7 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -79.5 137.5 13.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.068 1.845 . . . . 17.920000000000002 110.542 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 35' ' ' VAL . 2.8 m -114.53 118.7 59.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.35 -0.844 . . . . 20.57 108.827 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 32' ' ' LEU . 56.7 tp -76.48 106.65 8.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.435 -0.791 . . . . 20.210000000000001 110.661 -178.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.607 HG13 HG23 ' A' ' 43' ' ' VAL . 21.2 m -115.24 -169.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.816 -0.809 . . . . 10.81 108.816 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -108.48 152.01 25.29 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.333 -0.947 . . . . 36.740000000000002 110.395 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.953 HD13 HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -141.41 126.15 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.57 -0.706 . . . . 19.739999999999998 109.141 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -64.36 147.12 53.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.062 . . . . 22.559999999999999 109.357 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.753 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.9 tm? -124.31 73.09 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 20.41 109.235 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 2.0 t70 -134.96 -175.48 3.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.916 -1.115 . . . . 33.990000000000002 109.72 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 53' ' ' GLN . 16.0 tt0 69.82 67.66 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.414 -0.804 . . . . 54.920000000000002 109.558 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 51' ' ' GLU . . . 38.17 27.85 0.04 OUTLIER Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.522 -1.031 . . . . 36.100000000000001 110.522 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 51' ' ' GLU . 3.5 mt-30 -105.96 125.58 32.8 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 120.897 -1.355 . . . . 54.759999999999998 109.913 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.528 ' C ' HD21 ' A' ' 49' ' ' LEU . 35.8 Cg_endo -78.73 146.35 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.313 2.008 . . . . 28.370000000000001 109.677 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.656 ' HB2' ' CD2' ' A' ' 13' ' ' PHE . . . -37.93 143.27 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.439 -0.788 . . . . 17.210000000000001 110.496 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.867 ' O ' HG21 ' A' ' 6' ' ' ILE . 79.5 m-85 -58.54 107.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.498 -0.751 . . . . 17.190000000000001 109.273 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.876 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.58 173.33 0.36 Allowed Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.107 -0.996 . . . . 17.82 108.983 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.876 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.8 Cg_endo -78.28 107.89 2.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.486 2.124 . . . . 17.280000000000001 110.09 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.23 179.32 47.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.963 -1.255 . . . . 17.219999999999999 109.963 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.708 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -77.12 137.74 39.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.385 -1.068 . . . . 19.57 108.642 179.203 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.937 ' HB3' HD22 ' A' ' 83' ' ' LEU . 26.9 m-85 -128.55 163.21 25.48 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.751 -1.218 . . . . 14.609999999999999 111.569 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.8 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.5 p -141.74 117.58 10.47 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.163 -1.791 . . . . 18.359999999999999 106.163 177.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.649 ' HB ' HD13 ' A' ' 2' ' ' ILE . 2.4 t -50.14 164.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 118.77 -1.172 . . . . 19.129999999999999 108.936 -178.185 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.3 t-80 -128.39 129.13 45.74 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.504 -0.747 . . . . 20.649999999999999 109.113 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.738 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER -72.59 2.19 6.88 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.519 -0.738 . . . . 19.649999999999999 109.985 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -18.91 30.66 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.002 -1.481 . . . . 14.720000000000001 107.002 178.376 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.504 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 14.7 m -96.19 -9.64 30.05 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.9 -0.5 . . . . 11.449999999999999 109.907 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.654 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.4 m-30 -78.05 154.37 31.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.112 -0.992 . . . . 14.25 109.951 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 3.8 mtmt -157.6 -178.38 7.29 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.528 -0.733 . . . . 32.700000000000003 109.182 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.565 ' CG1' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -109.96 105.82 19.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.434 -0.791 . . . . 15.630000000000001 109.132 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.22 -155.0 12.15 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.994 -1.243 . . . . 12.699999999999999 109.994 -179.5 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.401 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 5.8 tp-100 -98.55 42.47 1.09 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.321 -1.105 . . . . 26.289999999999999 109.68 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 74' ' ' GLY . 2.8 m-85 -129.22 22.14 5.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 20.440000000000001 109.625 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 73' ' ' PHE . . . 44.79 52.56 7.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.627 -1.389 . . . . 13.82 109.627 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 76' ' ' LEU . 16.8 t -176.66 130.18 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -1.116 . . . . 18.27 109.448 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.816 HD22 HD13 ' B' ' 81' ' ' LEU . 0.1 OUTLIER -44.1 160.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.907 . . . . 12.43 109.159 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.4 mtt -163.7 118.67 1.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 35.109999999999999 109.585 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.002 HD12 HD12 ' B' ' 78' ' ' ILE . 2.3 mp -54.07 138.14 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 13.67 109.324 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -105.77 -34.8 7.56 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.011 -1.107 . . . . 24.059999999999999 108.011 178.516 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.504 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.2 OUTLIER -170.12 67.07 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.169 -1.419 . . . . 35.039999999999999 107.169 178.804 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.811 HD13 HD22 ' B' ' 76' ' ' LEU . 0.7 OUTLIER -27.99 120.05 0.11 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.21 -0.905 . . . . 18.719999999999999 111.859 -178.177 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -91.61 102.06 14.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 20.550000000000001 108.545 179.063 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.953 HD12 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -70.21 140.86 52.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.369 -0.832 . . . . 14.4 110.807 -178.818 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 62' ' ' THR . 33.5 m -140.61 148.8 54.67 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.774 -1.195 . . . . 17.649999999999999 107.774 178.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.8 Cg_endo -63.08 141.12 82.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.05 1.834 . . . . 25.699999999999999 110.265 179.378 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.708 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -71.83 108.44 5.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.309 -0.869 . . . . 49.289999999999999 109.461 -178.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.008 -0.996 . . . . 58.909999999999997 109.438 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.3 tpp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.474 -0.565 . . . . 64.909999999999997 109.474 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.738 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.1 mt -59.41 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.033 -1.099 . . . . 33.799999999999997 108.033 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' ' 1' ' ' MET . 15.2 mtpp -67.02 152.18 46.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.841 0.829 . . . . 32.719999999999999 111.265 -178.039 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.884 HG11 HD21 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -163.8 168.18 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.462 -0.94 . . . . 14.460000000000001 108.462 179.481 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.568 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 25.2 mt-10 -141.17 118.0 11.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.337 -0.852 . . . . 22.120000000000001 109.363 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.877 HG21 ' O ' ' B' ' 56' ' ' TYR . 10.4 mm -75.85 92.53 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.869 -1.16 . . . . 14.23 107.869 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.675 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.79 171.39 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.916 . . . . 25.43 110.189 -178.735 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.5 Cg_endo -74.65 -28.83 9.5 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.462 2.108 . . . . 13.609999999999999 109.85 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.51 -6.73 58.62 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.741 -0.837 . . . . 15.52 108.741 178.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 12.4 mm-40 -118.28 40.26 3.23 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.418 -0.801 . . . . 17.309999999999999 109.306 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -103.62 8.98 37.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 24.780000000000001 109.711 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.45 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 37.2 mt-30 -138.99 138.68 37.47 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.286 -0.884 . . . . 47.899999999999999 109.638 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.655 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 36.1 p90 -91.92 161.32 14.87 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.176 -0.952 . . . . 21.609999999999999 108.815 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 96.7 m -130.28 152.05 50.12 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.103 -0.998 . . . . 14.890000000000001 109.667 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.36 110.14 22.54 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.395 -0.816 . . . . 17.350000000000001 109.354 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' B' ' 18' ' ' GLY . 4.8 mtp180 -124.26 151.91 43.63 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.298 -0.876 . . . . 34.380000000000003 109.012 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 17.8 t -57.32 84.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 38.770000000000003 109.406 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' B' ' 25' ' ' PRO . . . -77.81 160.46 48.7 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.316 -1.514 . . . . 34.579999999999998 109.316 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' B' ' 24' ' ' LYS . 1.5 t -128.77 124.03 60.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.129 -1.218 . . . . 41.869999999999997 108.955 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -92.27 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.235 -0.916 . . . . 47.210000000000001 109.656 -179.103 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.514 ' NH1' ' HG2' ' B' ' 21' ' ' ARG . 0.0 OUTLIER -90.02 -55.02 3.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 71.560000000000002 109.403 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.98 38.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.192 -0.942 . . . . 66.599999999999994 109.812 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.547 ' O ' ' CG ' ' B' ' 24' ' ' LYS . . . -168.24 36.14 0.21 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.416 -1.474 . . . . 55.490000000000002 109.416 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' B' ' 23' ' ' GLY . 2.8 mttp -170.12 102.21 0.44 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.506 -0.996 . . . . 44.990000000000002 108.761 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 33.7 Cg_endo -75.58 68.08 6.28 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.172 1.915 . . . . 44.100000000000001 110.816 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 6.1 p90 -62.72 137.59 58.3 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.348 -0.845 . . . . 32.090000000000003 109.396 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -100.12 78.67 2.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 29.25 108.917 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.584 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -100.21 160.55 14.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 24.0 110.475 -179.005 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.617 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 97.9 m-20 -77.95 130.01 36.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 23.309999999999999 109.141 179.559 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -123.58 148.95 45.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 40.030000000000001 109.047 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.612 ' HB3' HG22 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -136.24 -170.14 2.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.111 -0.993 . . . . 12.390000000000001 109.648 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.766 ' HB3' HD11 ' B' ' 44' ' ' LEU . 5.9 mp -132.19 174.35 10.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.38 -0.825 . . . . 17.420000000000002 109.455 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -162.53 159.58 24.99 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.273 -1.01 . . . . 13.84 108.273 -179.547 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.701 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 14.9 m-85 -115.06 96.52 5.73 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.204 -0.935 . . . . 21.140000000000001 109.358 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.875 ' O ' HG22 ' B' ' 43' ' ' VAL . 3.1 t -105.09 127.62 59.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.163 -0.961 . . . . 10.66 110.491 -179.495 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 16.7 p-10 -86.52 -27.43 24.01 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.512 -0.922 . . . . 25.890000000000001 108.512 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.859 ' HG ' HG12 ' B' ' 35' ' ' VAL . 0.4 OUTLIER 47.3 23.93 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 24.239999999999998 109.486 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.83 8.47 69.6 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.961 -1.256 . . . . 31.02 109.961 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.455 ' ND2' ' N ' ' B' ' 39' ' ' ASN . 1.0 OUTLIER -87.23 18.62 3.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -1.219 . . . . 43.229999999999997 109.942 -179.71 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.6 ' O ' ' CB ' ' B' ' 41' ' ' HIS . 5.3 mt-10 46.76 71.37 0.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.89 . . . . 42.340000000000003 109.822 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.6 ' CB ' ' O ' ' B' ' 40' ' ' GLU . 0.2 OUTLIER 144.09 147.77 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.251 0 N-CA-C 108.57 -0.9 . . . . 6.5 108.57 179.383 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.701 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 38.4 Cg_endo -79.38 137.37 13.18 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.148 1.899 . . . . 17.920000000000002 110.52 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.875 HG22 ' O ' ' B' ' 35' ' ' VAL . 2.8 m -114.53 118.54 58.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.331 -0.856 . . . . 20.57 108.871 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.766 HD11 ' HB3' ' B' ' 32' ' ' LEU . 56.8 tp -76.45 106.98 8.4 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.361 -0.837 . . . . 20.210000000000001 110.638 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.605 HG13 HG23 ' B' ' 43' ' ' VAL . 22.0 m -115.65 -169.55 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.862 -0.792 . . . . 10.81 108.862 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -108.22 151.8 25.44 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.334 -0.947 . . . . 36.740000000000002 110.44 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.99 HD13 HD12 ' B' ' 83' ' ' LEU . 0.9 OUTLIER -141.23 126.14 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.503 -0.748 . . . . 19.739999999999998 109.056 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -64.49 146.88 53.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.002 -1.061 . . . . 22.559999999999999 109.322 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.769 HD13 ' O ' ' B' ' 49' ' ' LEU . 2.9 tm? -123.95 73.1 1.19 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 20.41 109.281 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' B' ' 53' ' ' GLN . 1.9 t70 -134.86 -175.46 3.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.941 -1.099 . . . . 33.990000000000002 109.8 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' B' ' 53' ' ' GLN . 16.5 tt0 69.84 67.73 0.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.348 -0.845 . . . . 54.920000000000002 109.588 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' B' ' 51' ' ' GLU . . . 38.07 28.04 0.04 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.537 -1.025 . . . . 36.100000000000001 110.537 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' B' ' 51' ' ' GLU . 3.3 mt-30 -106.13 125.71 32.38 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.888 -1.36 . . . . 54.759999999999998 109.894 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.515 ' C ' HD21 ' B' ' 49' ' ' LEU . 35.4 Cg_endo -78.8 146.62 21.03 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.408 2.072 . . . . 28.370000000000001 109.68 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.655 ' HB2' ' CD2' ' B' ' 13' ' ' PHE . . . -38.24 143.37 0.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.45 -0.781 . . . . 17.210000000000001 110.479 -179.291 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.877 ' O ' HG21 ' B' ' 6' ' ' ILE . 79.9 m-85 -58.49 106.99 0.44 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.458 -0.776 . . . . 17.190000000000001 109.201 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.901 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.58 173.29 0.37 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.105 -0.997 . . . . 17.82 109.076 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.901 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.5 Cg_endo -78.05 107.12 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.491 2.127 . . . . 17.280000000000001 110.031 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.15 179.26 46.52 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.576 -1.297 . . . . 17.219999999999999 110.106 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.717 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -77.42 137.4 38.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.405 -1.056 . . . . 19.57 108.445 179.121 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.953 ' HB3' HD22 ' B' ' 83' ' ' LEU . 26.9 m-85 -128.38 163.09 25.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.691 -1.255 . . . . 14.609999999999999 111.492 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.79 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.8 p -141.57 118.01 10.86 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.145 -1.798 . . . . 18.359999999999999 106.145 177.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.638 ' HB ' HD13 ' B' ' 2' ' ' ILE . 2.4 t -50.64 165.16 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 118.74 -1.184 . . . . 19.129999999999999 108.947 -178.171 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -128.51 129.15 45.64 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.5 -0.75 . . . . 20.649999999999999 109.142 -179.293 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.764 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -72.57 2.24 6.77 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.54 -0.725 . . . . 19.649999999999999 109.964 179.777 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.21 -19.51 34.16 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.843 -1.539 . . . . 14.720000000000001 106.843 178.386 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.507 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 14.4 m -95.68 -9.49 31.84 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.931 -0.481 . . . . 11.449999999999999 110.027 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.656 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.4 m-30 -78.06 154.18 31.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.037 . . . . 14.25 109.897 -178.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' B' ' 68' ' ' PHE . 3.8 mtmt -157.53 -178.93 7.7 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.538 -0.726 . . . . 32.700000000000003 109.159 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.558 ' CG1' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -109.44 105.98 19.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.456 -0.778 . . . . 15.630000000000001 109.09 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.26 -154.37 11.43 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.981 -1.248 . . . . 12.699999999999999 109.981 -179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -99.08 42.22 1.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -1.09 . . . . 26.289999999999999 109.661 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -128.91 21.95 5.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.895 . . . . 20.440000000000001 109.613 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.98 52.74 7.81 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.563 -1.415 . . . . 13.82 109.563 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.422 ' O ' ' C ' ' B' ' 76' ' ' LEU . 17.0 t -176.99 129.93 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 18.27 109.435 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.811 HD22 HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -43.79 159.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.877 . . . . 12.43 109.138 179.976 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.5 mtt -163.38 118.99 1.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 35.109999999999999 109.54 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 1.002 HD12 HD12 ' A' ' 78' ' ' ILE . 2.2 mp -54.38 138.5 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.193 -0.942 . . . . 13.67 109.354 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' B' ' 67' ' ' SER . 0.2 OUTLIER -106.13 -34.73 7.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.111 -1.07 . . . . 24.059999999999999 108.111 178.515 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.507 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.2 OUTLIER -170.21 66.56 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.275 -1.38 . . . . 35.039999999999999 107.275 178.816 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.816 HD13 HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -27.62 120.04 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.113 -0.949 . . . . 18.719999999999999 111.731 -178.161 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -91.78 101.95 14.55 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 20.550000000000001 108.53 179.097 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.99 HD12 HD13 ' B' ' 47' ' ' ILE . 0.9 OUTLIER -70.27 140.67 52.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 14.4 110.84 -178.727 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.79 HG22 ' O ' ' B' ' 62' ' ' THR . 33.6 m -140.41 148.79 55.16 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.843 -1.169 . . . . 17.649999999999999 107.843 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.0 Cg_endo -63.06 141.11 82.22 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.995 1.797 . . . . 25.699999999999999 110.326 179.338 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.717 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -71.53 108.27 4.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 49.289999999999999 109.466 -178.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.035 -0.983 . . . . 58.909999999999997 109.489 179.999 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.1 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.579 -0.526 . . . . 64.909999999999997 109.579 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.704 ' N ' HD22 ' B' ' 65' ' ' LEU . 3.3 mt -64.16 78.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.592 -1.262 . . . . 33.799999999999997 107.592 178.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -71.0 177.23 3.82 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.104 0.954 . . . . 32.719999999999999 111.549 -177.771 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.024 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER 176.35 163.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.739 -0.837 . . . . 14.460000000000001 108.739 179.753 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.524 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 26.1 mt-10 -137.96 108.36 6.51 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.63 0.728 . . . . 22.120000000000001 109.093 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.705 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -71.94 100.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 C-N-CA 118.906 -1.118 . . . . 14.23 108.07 179.615 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD3' ' CG ' ' A' ' 34' ' ' TYR . 6.7 mptt -44.67 170.17 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.343 -0.848 . . . . 25.43 109.902 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 32.1 Cg_endo -73.67 -27.48 12.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.275 1.984 . . . . 13.609999999999999 109.78 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 p -86.35 -2.92 58.84 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.613 -0.884 . . . . 15.52 108.613 178.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.655 ' O ' HG23 ' A' ' 6' ' ' ILE . 6.7 mm-40 -118.75 41.29 3.05 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.429 -0.794 . . . . 17.309999999999999 109.119 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.88 14.72 29.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.076 -1.015 . . . . 24.780000000000001 109.999 -179.38 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 29.6 mt-30 -142.24 146.59 35.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.165 -0.959 . . . . 47.899999999999999 109.68 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.728 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 34.9 p90 -93.84 159.42 15.2 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.296 -0.878 . . . . 21.609999999999999 109.537 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 t -134.76 162.67 31.7 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.449 -0.945 . . . . 14.890000000000001 108.449 178.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.414 HG22 ' CB ' ' A' ' 27' ' ' SER . 0.2 OUTLIER -92.8 119.17 31.87 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.217 -0.927 . . . . 17.350000000000001 109.162 -179.864 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 17' ' ' SER . 0.4 OUTLIER -145.89 84.14 1.65 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.113 -0.992 . . . . 34.380000000000003 110.024 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 16' ' ' ARG . 42.0 m 55.81 161.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 38.770000000000003 110.178 179.337 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.559 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -179.15 160.29 25.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.303 -1.519 . . . . 34.579999999999998 109.303 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -158.34 118.93 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -1.168 . . . . 41.869999999999997 109.408 179.178 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.7 m -58.54 -77.49 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.849 . . . . 47.210000000000001 109.584 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.16 60.94 1.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 71.560000000000002 109.499 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.53 23.35 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.938 . . . . 66.599999999999994 109.544 -179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.8 -43.34 1.82 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.161 -1.576 . . . . 55.490000000000002 109.161 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 158.52 31.92 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.34 -1.094 . . . . 44.990000000000002 109.01 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.1 Cg_endo -76.8 157.77 35.2 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.549 2.166 . . . . 44.100000000000001 110.765 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.917 ' CD2' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -161.37 45.27 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -0.996 . . . . 32.090000000000003 110.189 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.573 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -7.18 73.8 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 121.23 0.538 . . . . 29.25 111.717 -179.78 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.917 HD23 ' CD2' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -78.21 144.6 36.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.262 -0.899 . . . . 24.0 110.1 -179.391 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.584 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 99.1 m-20 -59.16 130.53 47.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.821 . . . . 23.309999999999999 109.48 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -121.27 152.49 38.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.944 . . . . 40.030000000000001 108.949 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.79 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -133.13 -170.93 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 12.390000000000001 109.789 -179.634 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.931 ' HB3' HD11 ' A' ' 44' ' ' LEU . 2.1 mp -130.49 174.83 9.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 17.420000000000002 108.872 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -171.85 162.88 6.22 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 13.84 108.699 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.743 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.0 m-30 -114.87 90.22 3.29 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.226 -0.921 . . . . 21.140000000000001 108.817 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.966 ' O ' HG22 ' A' ' 43' ' ' VAL . 94.0 t -89.94 119.77 37.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.197 -0.939 . . . . 10.66 110.32 -179.234 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.564 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 48.7 m-20 -68.48 -30.96 69.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.509 -0.923 . . . . 25.890000000000001 108.509 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' B' ' 69' ' ' LYS . 1.0 OUTLIER 48.17 30.98 2.35 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.503 -0.748 . . . . 24.239999999999998 109.318 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.31 9.69 64.66 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.391 -1.484 . . . . 31.02 109.391 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 1.4 m-20 -81.95 14.01 3.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -1.168 . . . . 43.229999999999997 110.659 -179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.58 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 10.0 mt-10 57.23 15.61 2.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.131 -0.981 . . . . 42.340000000000003 110.093 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 63.3 m80 -164.74 149.4 8.17 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.683 -1.228 . . . . 6.1600000000000001 107.683 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.1 Cg_endo -74.81 146.19 33.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.653 1.569 . . . . 17.920000000000002 110.631 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.966 HG22 ' O ' ' A' ' 35' ' ' VAL . 12.5 m -123.5 116.2 47.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 119.531 -0.868 . . . . 20.57 108.78 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.931 HD11 ' HB3' ' A' ' 32' ' ' LEU . 21.9 tp -68.92 104.98 2.22 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.296 -0.962 . . . . 20.210000000000001 108.678 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.516 HG22 ' O ' ' B' ' 74' ' ' GLY . 9.1 p -120.0 163.09 17.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.587 -0.695 . . . . 10.81 109.275 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' B' ' 74' ' ' GLY . 0.0 OUTLIER -82.47 157.64 23.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 36.740000000000002 110.28 -179.055 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.986 ' CD1' HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -138.7 176.38 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.282 -1.007 . . . . 19.739999999999998 108.282 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.92 144.23 42.84 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.042 -1.036 . . . . 22.559999999999999 109.38 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.755 HD13 ' O ' ' A' ' 50' ' ' ASP . 2.9 tm? -128.57 122.61 31.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.29 -0.881 . . . . 20.41 109.037 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.755 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -53.51 159.44 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 33.990000000000002 109.999 -179.279 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -70.05 108.96 4.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.403 -0.81 . . . . 54.920000000000002 109.497 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.79 -13.5 67.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.561 -1.416 . . . . 36.100000000000001 109.561 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.703 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -67.07 157.03 86.3 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.227 -1.161 . . . . 54.759999999999998 109.536 179.98 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -78.35 106.69 2.18 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.564 2.176 . . . . 28.370000000000001 110.254 179.677 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.79 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -41.95 160.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.386 -0.821 . . . . 17.210000000000001 110.028 -179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.705 ' O ' HG21 ' A' ' 6' ' ' ILE . 75.5 m-85 -58.4 104.98 0.25 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.406 -0.809 . . . . 17.190000000000001 108.838 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.44 176.14 0.24 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 17.82 109.418 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.0 Cg_endo -77.79 120.06 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.532 2.154 . . . . 17.280000000000001 110.166 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.66 177.42 39.06 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.779 -1.328 . . . . 17.219999999999999 109.779 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -72.04 149.37 44.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -1.187 . . . . 19.57 108.269 179.139 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 1.024 ' CB ' HG13 ' A' ' 4' ' ' VAL . 22.2 m-85 -133.34 163.36 29.51 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.77 -1.206 . . . . 14.609999999999999 111.705 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.732 ' O ' HG22 ' A' ' 84' ' ' VAL . 34.2 p -147.93 120.08 8.31 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.456 -1.683 . . . . 18.359999999999999 106.456 178.385 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 2' ' ' ILE . 5.7 t -51.82 170.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 C-N-CA 118.672 -1.211 . . . . 19.129999999999999 108.955 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.591 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -134.67 125.93 28.08 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.421 -0.799 . . . . 20.649999999999999 109.187 -179.237 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.737 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.6 OUTLIER -72.27 1.08 8.31 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.27 -0.894 . . . . 19.649999999999999 109.802 179.724 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.3 p -57.64 -19.17 24.55 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.521 -1.289 . . . . 14.720000000000001 107.521 178.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 9.7 m -96.76 -18.57 19.53 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.772 -0.58 . . . . 11.449999999999999 110.128 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.682 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.6 m-30 -66.29 158.48 28.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 14.25 109.346 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HA ' HD21 ' B' ' 37' ' ' LEU . 0.0 OUTLIER -140.46 178.89 7.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 32.700000000000003 109.769 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.735 HG21 HG21 ' B' ' 43' ' ' VAL . 1.7 t -126.12 129.77 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.509 -0.744 . . . . 15.630000000000001 109.495 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.21 -170.67 25.33 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.677 -1.369 . . . . 12.699999999999999 109.677 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' CB ' ' A' ' 73' ' ' PHE . 25.9 tp60 69.5 80.76 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -1.148 . . . . 26.289999999999999 109.358 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.504 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 3.0 m-85 75.34 12.03 3.32 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.424 -0.798 . . . . 20.440000000000001 109.462 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.531 ' O ' HG22 ' B' ' 45' ' ' VAL . . . 70.77 47.77 38.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.558 -1.417 . . . . 13.82 109.558 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -144.03 144.48 31.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -1.168 . . . . 18.27 109.639 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 77' ' ' MET . 1.0 OUTLIER -50.73 169.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 12.43 109.187 179.776 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 2.3 mtp -165.52 106.01 0.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 35.109999999999999 110.25 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -42.43 -63.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.513 -0.742 . . . . 13.67 109.403 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.546 ' N ' HG22 ' A' ' 78' ' ' ILE . 9.5 t70 83.34 -45.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.392 0.615 . . . . 24.059999999999999 110.039 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.7 tpm_? -174.24 66.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.113 0.958 . . . . 35.039999999999999 108.632 179.646 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.616 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.5 pt? -36.07 128.81 0.7 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.668 0.747 . . . . 18.719999999999999 111.527 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -94.52 104.67 16.62 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.248 -1.019 . . . . 20.550000000000001 108.248 178.721 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.986 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -74.23 147.26 42.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 14.4 110.898 -178.761 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 62' ' ' THR . 32.5 m -148.37 155.85 42.59 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.09 -1.078 . . . . 17.649999999999999 108.09 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.8 Cg_endo -63.08 143.6 90.85 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.105 1.87 . . . . 25.699999999999999 110.322 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.711 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -69.81 125.43 26.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.228 -0.92 . . . . 49.289999999999999 109.702 -178.657 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.2 tptp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.004 -0.998 . . . . 58.909999999999997 109.512 -179.965 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.532 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.564 -0.532 . . . . 64.909999999999997 109.564 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.737 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.3 mt -64.2 78.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 33.799999999999997 107.657 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.9 OUTLIER -70.82 177.3 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.07 0.938 . . . . 32.719999999999999 111.542 -177.754 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.034 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER 176.29 163.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.714 -0.847 . . . . 14.460000000000001 108.714 179.743 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 26.0 mt-10 -137.82 108.38 6.57 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.605 0.716 . . . . 22.120000000000001 109.103 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.701 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -71.94 100.18 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.95 -1.1 . . . . 14.23 108.075 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.583 ' HD3' ' CG ' ' B' ' 34' ' ' TYR . 6.7 mptt -44.75 170.05 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.33 -0.856 . . . . 25.43 109.898 -179.264 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.9 Cg_endo -73.59 -27.5 12.83 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.365 2.043 . . . . 13.609999999999999 109.722 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.2 p -86.39 -2.74 58.69 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.664 -0.865 . . . . 15.52 108.664 178.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.651 ' O ' HG23 ' B' ' 6' ' ' ILE . 6.7 mm-40 -118.9 41.26 3.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.399 -0.813 . . . . 17.309999999999999 109.095 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.9 14.84 28.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.123 -0.986 . . . . 24.780000000000001 109.986 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.489 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 29.7 mt-30 -142.35 146.48 35.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 47.899999999999999 109.742 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.719 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 34.5 p90 -93.79 159.32 15.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.338 -0.851 . . . . 21.609999999999999 109.615 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.3 t -134.78 162.49 32.21 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.496 -0.928 . . . . 14.890000000000001 108.496 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.405 HG22 ' CB ' ' B' ' 27' ' ' SER . 0.2 OUTLIER -92.68 119.12 31.77 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.166 -0.958 . . . . 17.350000000000001 109.18 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' B' ' 17' ' ' SER . 0.4 OUTLIER -145.88 84.22 1.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.125 -0.984 . . . . 34.380000000000003 109.953 -179.822 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.453 ' O ' ' O ' ' B' ' 16' ' ' ARG . 40.8 m 55.74 161.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 38.770000000000003 110.223 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.568 ' O ' HG22 ' B' ' 19' ' ' VAL . . . -178.95 160.24 25.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.373 -1.491 . . . . 34.579999999999998 109.373 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.568 HG22 ' O ' ' B' ' 18' ' ' GLY . 0.6 OUTLIER -158.29 118.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -1.173 . . . . 41.869999999999997 109.464 179.13 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 74.6 m -58.56 -77.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.24 -0.913 . . . . 47.210000000000001 109.617 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.23 60.83 1.47 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 71.560000000000002 109.461 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.64 23.44 0.42 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 66.599999999999994 109.54 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.92 -43.24 1.82 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.175 -1.57 . . . . 55.490000000000002 109.175 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.54 158.55 31.89 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.388 -1.066 . . . . 44.990000000000002 108.978 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.5 Cg_endo -76.77 157.83 35.32 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.555 2.17 . . . . 44.100000000000001 110.724 -179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.926 ' CD2' HD23 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -161.44 45.24 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.146 -0.971 . . . . 32.090000000000003 110.203 179.893 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.572 ' C ' ' O ' ' B' ' 26' ' ' TYR . 0.7 OUTLIER -7.13 73.8 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-O 121.256 0.55 . . . . 29.25 111.712 -179.783 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.926 HD23 ' CD2' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -78.21 144.5 36.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 24.0 110.146 -179.382 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.582 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 99.1 m-20 -59.06 130.58 47.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 23.309999999999999 109.439 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -121.34 152.41 39.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.948 . . . . 40.030000000000001 109.002 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.765 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -133.08 -170.8 2.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.09 -1.006 . . . . 12.390000000000001 109.84 -179.612 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.915 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.1 mp -130.61 174.76 9.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.834 -0.802 . . . . 17.420000000000002 108.834 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.54 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -171.91 162.67 6.09 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.877 -1.14 . . . . 13.84 108.725 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.738 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.0 m-30 -114.66 90.33 3.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.212 -0.93 . . . . 21.140000000000001 108.824 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.992 ' O ' HG22 ' B' ' 43' ' ' VAL . 96.0 t -90.06 119.73 37.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.181 -0.949 . . . . 10.66 110.238 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 48.7 m-20 -68.36 -31.01 70.1 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.51 -0.922 . . . . 25.890000000000001 108.51 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.538 HD21 ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER 48.27 31.03 2.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.548 -0.72 . . . . 24.239999999999998 109.252 179.804 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.28 9.52 64.28 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.438 -1.465 . . . . 31.02 109.438 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 1.4 m-20 -81.77 13.87 2.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -1.162 . . . . 43.229999999999997 110.726 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.574 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 10.0 mt-10 57.32 15.62 2.7 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.124 -0.985 . . . . 42.340000000000003 110.115 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 63.5 m80 -164.73 149.41 8.19 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 107.745 -1.206 . . . . 6.1500000000000004 107.745 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.668 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.3 Cg_endo -74.83 146.15 33.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.648 1.565 . . . . 17.920000000000002 110.628 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.992 HG22 ' O ' ' B' ' 35' ' ' VAL . 12.6 m -123.47 116.25 47.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 C-N-CA 119.495 -0.882 . . . . 20.57 108.816 179.015 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.915 HD11 ' HB3' ' B' ' 32' ' ' LEU . 21.8 tp -68.87 105.1 2.24 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.341 -0.943 . . . . 20.210000000000001 108.655 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 74' ' ' GLY . 9.1 p -120.15 163.08 18.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.534 -0.729 . . . . 10.81 109.228 -179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -82.55 157.59 23.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.394 -0.816 . . . . 36.740000000000002 110.328 -179.114 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.98 ' CD1' HD12 ' B' ' 83' ' ' LEU . 0.4 OUTLIER -138.59 176.35 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.227 -1.027 . . . . 19.739999999999998 108.227 179.447 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 144.42 42.46 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.006 -1.059 . . . . 22.559999999999999 109.405 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.764 HD13 ' O ' ' B' ' 50' ' ' ASP . 2.9 tm? -128.68 122.4 30.68 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.317 -0.865 . . . . 20.41 109.067 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.764 ' O ' HD13 ' B' ' 49' ' ' LEU . 0.1 OUTLIER -53.38 159.34 1.43 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 33.990000000000002 110.033 -179.324 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -69.95 108.95 4.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.481 -0.762 . . . . 54.920000000000002 109.487 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.81 -13.57 67.16 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.563 -1.415 . . . . 36.100000000000001 109.563 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.711 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.2 OUTLIER -67.03 157.18 85.71 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.218 -1.166 . . . . 54.759999999999998 109.487 179.962 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.0 Cg_endo -78.39 106.67 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.624 2.216 . . . . 28.370000000000001 110.257 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.765 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.0 160.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 17.210000000000001 109.976 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.701 ' O ' HG21 ' B' ' 6' ' ' ILE . 75.2 m-85 -58.92 105.56 0.33 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.347 -0.846 . . . . 17.190000000000001 108.805 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.962 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.65 176.09 0.25 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.309 -0.869 . . . . 17.82 109.275 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.962 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.3 Cg_endo -78.03 121.12 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.637 2.225 . . . . 17.280000000000001 110.445 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.94 177.88 38.41 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.657 -1.377 . . . . 17.219999999999999 109.657 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.728 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -71.73 150.0 44.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -1.182 . . . . 19.57 108.555 179.387 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 1.034 ' CB ' HG13 ' B' ' 4' ' ' VAL . 21.1 m-85 -134.02 163.31 29.85 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 120.763 -1.211 . . . . 14.609999999999999 111.702 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.736 ' O ' HG22 ' B' ' 84' ' ' VAL . 33.9 p -147.98 120.25 8.38 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.445 -1.687 . . . . 18.359999999999999 106.445 178.402 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.674 HG21 HG21 ' B' ' 2' ' ' ILE . 5.9 t -52.04 169.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 118.631 -1.228 . . . . 19.129999999999999 108.965 -178.392 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.577 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -134.43 125.86 28.34 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.453 -0.779 . . . . 20.649999999999999 109.224 -179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.704 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -72.16 0.8 8.77 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.272 -0.893 . . . . 19.649999999999999 109.755 179.791 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 94.8 p -57.34 -19.24 21.39 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 107.53 -1.285 . . . . 14.720000000000001 107.53 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 10.3 m -96.69 -18.64 19.54 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.843 -0.536 . . . . 11.449999999999999 110.143 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.675 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.6 m-30 -66.26 157.89 30.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.004 . . . . 14.25 109.331 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.531 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.94 178.91 6.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 32.700000000000003 109.837 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.729 HG21 HG21 ' A' ' 43' ' ' VAL . 1.7 t -126.06 129.78 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.759 . . . . 15.630000000000001 109.535 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' B' ' 72' ' ' GLN . . . 143.19 -170.69 25.31 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.69 -1.364 . . . . 12.699999999999999 109.69 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.5 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 25.9 tp60 69.47 80.83 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -1.159 . . . . 26.289999999999999 109.341 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.5 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 3.0 m-85 75.33 11.9 3.35 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.443 -0.785 . . . . 20.440000000000001 109.49 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.516 ' O ' HG22 ' A' ' 45' ' ' VAL . . . 70.91 47.7 37.58 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.502 -1.439 . . . . 13.82 109.502 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -144.06 144.41 31.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -1.146 . . . . 18.27 109.635 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' B' ' 77' ' ' MET . 1.0 OUTLIER -50.66 169.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 12.43 109.151 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 2.3 mtp -165.58 105.95 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 35.109999999999999 110.303 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.616 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.8 mt -42.35 -64.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.568 -0.708 . . . . 13.67 109.416 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 9.4 t70 83.51 -45.16 0.11 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.4 0.619 . . . . 24.059999999999999 110.073 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.7 tpm_? -174.32 66.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.505 -0.924 . . . . 35.039999999999999 108.505 179.653 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.626 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.5 pt? -36.17 128.81 0.72 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.703 0.763 . . . . 18.719999999999999 111.545 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -94.5 104.44 16.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.29 -1.004 . . . . 20.550000000000001 108.29 178.791 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.98 HD12 ' CD1' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -73.98 147.39 43.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.189 -0.944 . . . . 14.4 110.842 -178.753 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.736 HG22 ' O ' ' B' ' 62' ' ' THR . 32.6 m -148.66 155.64 41.58 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.046 -1.094 . . . . 17.649999999999999 108.046 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.9 Cg_endo -62.89 143.8 92.16 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.076 1.851 . . . . 25.699999999999999 110.328 179.074 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -69.96 125.63 27.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -0.907 . . . . 49.289999999999999 109.724 -178.682 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 7.2 tptp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.978 -1.01 . . . . 58.909999999999997 109.571 179.979 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 2.8 ttm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.444 -0.576 . . . . 64.909999999999997 109.444 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.739 HG12 HD13 ' B' ' 65' ' ' LEU . 3.2 mt 69.66 64.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.705 -1.22 . . . . 33.799999999999997 107.705 -178.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 26.6 mttt -54.93 162.11 1.39 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.777 0.799 . . . . 32.719999999999999 111.28 -178.196 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.05 ' CG2' HG22 ' A' ' 35' ' ' VAL . 58.6 t -160.2 167.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.534 0.683 . . . . 14.460000000000001 109.53 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.573 ' N ' HG12 ' A' ' 4' ' ' VAL . 46.8 mt-10 -152.34 106.07 3.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.544 -0.722 . . . . 22.120000000000001 109.201 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.788 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -74.64 101.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.104 -1.073 . . . . 14.23 108.104 179.505 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.645 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.78 171.22 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.403 -0.81 . . . . 25.43 109.831 -179.324 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.4 Cg_endo -74.95 -28.45 9.26 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.463 2.109 . . . . 13.609999999999999 110.131 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.7 m -92.96 4.11 54.55 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.478 -0.764 . . . . 15.52 109.127 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.535 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 18.4 mm-40 -121.03 34.1 5.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 17.309999999999999 109.352 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -106.89 18.55 21.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 24.780000000000001 110.284 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 19.2 mt-30 -137.57 129.39 28.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.067 -1.02 . . . . 47.899999999999999 109.864 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.561 ' H ' ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -77.54 -174.32 3.32 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.425 -0.797 . . . . 21.609999999999999 110.578 -179.541 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 m -158.68 145.41 17.31 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.777 -0.823 . . . . 14.890000000000001 108.777 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 116.82 22.55 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.244 -0.91 . . . . 17.350000000000001 109.625 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -154.8 158.26 39.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 34.380000000000003 109.28 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 16' ' ' ARG . 4.7 t -42.23 145.25 0.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.481 -0.762 . . . . 38.770000000000003 109.516 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -147.9 168.77 28.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.398 -1.481 . . . . 34.579999999999998 109.398 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.465 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 2.0 t -147.04 122.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -1.206 . . . . 41.869999999999997 109.175 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 22' ' ' GLN . 0.1 OUTLIER -57.79 -156.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.878 . . . . 47.210000000000001 109.603 -179.543 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.515 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -67.58 58.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.166 -0.959 . . . . 71.560000000000002 109.782 -179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.9 mt-30 62.86 20.84 12.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 66.599999999999994 109.584 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -98.11 -47.7 2.01 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.608 -1.397 . . . . 55.490000000000002 109.608 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 23' ' ' GLY . 19.3 mttt -158.99 159.82 29.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.269 -1.136 . . . . 44.990000000000002 109.429 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.7 Cg_endo -77.44 150.67 28.61 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.53 2.153 . . . . 44.100000000000001 110.372 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.588 ' CD1' ' HB2' ' A' ' 28' ' ' LEU . 5.1 p90 -155.39 140.54 17.48 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.199 -0.938 . . . . 32.090000000000003 109.9 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 m -102.3 79.97 1.91 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 29.25 108.677 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.588 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -105.63 173.41 6.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 24.0 110.096 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -74.5 111.19 9.44 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.725 -0.843 . . . . 23.309999999999999 108.725 179.602 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 14.9 mm-40 -82.63 -172.77 4.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.035 -1.04 . . . . 40.030000000000001 109.015 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.559 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -171.18 179.92 2.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.073 -1.017 . . . . 12.390000000000001 110.249 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.942 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.4 mt -140.5 148.56 41.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.579 -0.701 . . . . 17.420000000000002 109.174 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.622 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.4 m -152.04 -178.55 6.83 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.918 -1.141 . . . . 13.84 107.918 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.662 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 38.0 m-85 -128.01 106.21 8.93 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.053 -1.03 . . . . 21.140000000000001 109.395 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.05 HG22 ' CG2' ' A' ' 4' ' ' VAL . 73.8 t -98.1 141.3 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.072 -1.017 . . . . 10.66 111.168 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.1 m-20 -111.15 35.72 3.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.008 -1.108 . . . . 25.890000000000001 108.008 178.667 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.941 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.0 pt? -40.94 -25.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.658 -0.651 . . . . 24.239999999999998 110.266 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.617 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 176.8 47.33 0.06 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 108.983 -1.647 . . . . 31.02 108.983 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 38' ' ' GLY . 21.3 m120 -149.55 109.66 4.13 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.481 -1.011 . . . . 43.229999999999997 108.751 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 39' ' ' ASN . 26.0 mt-10 -34.24 -56.84 0.5 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.64 0.733 . . . . 42.340000000000003 110.128 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 50.9 m-70 -73.41 160.37 82.59 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 108.662 -0.866 . . . . 6.5700000000000003 108.662 179.394 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.662 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.3 Cg_endo -77.43 140.47 19.28 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.054 1.836 . . . . 17.920000000000002 109.87 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.925 HG22 ' O ' ' A' ' 35' ' ' VAL . 3.2 m -108.58 114.27 46.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.198 -0.939 . . . . 20.57 109.532 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.942 HD11 ' HB3' ' A' ' 32' ' ' LEU . 54.8 tp -68.01 106.94 2.51 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.388 -0.82 . . . . 20.210000000000001 109.623 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 2.1 t -110.44 169.28 3.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.48 -0.762 . . . . 10.81 109.03 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.576 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -92.93 162.89 13.89 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.33 -0.857 . . . . 36.740000000000002 110.394 -179.264 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.567 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -138.42 165.11 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.634 -0.876 . . . . 19.739999999999998 108.634 179.698 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.744 HG22 ' O ' ' A' ' 48' ' ' THR . 9.0 m -124.7 71.59 1.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 22.559999999999999 109.278 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.683 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -40.4 137.04 1.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.508 -0.745 . . . . 20.41 109.674 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.02 165.4 24.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 33.990000000000002 109.367 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.41 114.8 10.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 54.920000000000002 109.495 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.77 -6.32 64.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.685 -1.366 . . . . 36.100000000000001 109.685 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.1 mt-30 -89.06 144.45 32.7 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.128 -1.219 . . . . 54.759999999999998 109.522 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.5 Cg_endo -78.54 123.95 6.17 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.642 2.228 . . . . 28.370000000000001 110.332 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.683 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -40.41 142.74 0.38 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 17.210000000000001 110.54 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.788 ' O ' HG21 ' A' ' 6' ' ' ILE . 12.0 m-30 -45.98 104.39 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 17.190000000000001 109.153 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.774 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.35 168.64 0.36 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.992 -1.067 . . . . 17.82 109.185 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.774 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.4 Cg_endo -76.98 113.39 3.62 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.52 2.147 . . . . 17.280000000000001 110.193 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.19 -176.56 48.08 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.923 -1.271 . . . . 17.219999999999999 109.923 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -75.81 139.25 41.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -1.09 . . . . 19.57 108.406 179.121 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.7 ' HB3' HD22 ' A' ' 83' ' ' LEU . 19.0 m-85 -127.83 166.11 18.86 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.725 -1.234 . . . . 14.609999999999999 111.456 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.5 p -149.94 120.28 7.35 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.46 -1.681 . . . . 18.359999999999999 106.46 179.008 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -50.45 166.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 118.738 -1.185 . . . . 19.129999999999999 108.886 -178.362 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -125.23 123.98 40.72 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.865 -0.791 . . . . 20.649999999999999 108.865 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.745 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -69.47 -3.28 13.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.636 -0.665 . . . . 19.649999999999999 110.113 -179.187 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 t -58.83 -13.89 7.41 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.068 -1.02 . . . . 14.720000000000001 108.409 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 19.6 m -95.61 -7.72 36.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.755 . . . . 11.449999999999999 110.709 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.662 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.1 m-30 -81.25 159.16 24.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.899 -1.125 . . . . 14.25 109.882 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.565 ' HA ' HD11 ' B' ' 37' ' ' LEU . 12.0 mtmt -153.03 173.84 14.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.485 -0.76 . . . . 32.700000000000003 108.997 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.559 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.6 OUTLIER -110.68 118.08 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 15.630000000000001 109.53 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.19 -176.15 48.94 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.294 -1.523 . . . . 12.699999999999999 109.294 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.0 19.86 3.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.09 -1.241 . . . . 26.289999999999999 109.77 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 -11.39 23.5 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.511 -0.743 . . . . 20.440000000000001 109.561 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' ' OG ' ' A' ' 75' ' ' SER . . . 84.48 50.27 4.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.712 -1.355 . . . . 13.82 109.712 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -170.69 153.88 4.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -1.161 . . . . 18.27 109.553 179.933 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.742 HD23 ' N ' ' A' ' 77' ' ' MET . 10.6 tt -81.16 150.52 28.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 12.43 109.476 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.742 ' N ' HD23 ' A' ' 76' ' ' LEU . 2.2 mtt -155.78 129.19 8.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 35.109999999999999 109.355 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.883 HD12 HD12 ' B' ' 78' ' ' ILE . 3.1 mt -63.18 139.44 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 13.67 109.841 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 6.9 t0 -104.4 -18.48 14.4 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.257 -1.016 . . . . 24.059999999999999 108.257 178.448 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.4 tmm_? 172.23 71.69 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.863 -1.532 . . . . 35.039999999999999 106.863 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -34.0 119.21 0.39 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.607 0.718 . . . . 18.719999999999999 111.199 -178.05 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 5.9 mtt180 -88.75 110.07 20.69 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.466 -0.939 . . . . 20.550000000000001 108.466 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.815 HD11 HG11 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -81.13 141.63 34.06 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.187 -0.946 . . . . 14.4 110.49 -179.112 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 62' ' ' THR . 25.9 m -145.28 159.08 50.09 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.193 -1.04 . . . . 17.649999999999999 108.193 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.08 141.61 77.34 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.124 1.882 . . . . 25.699999999999999 110.206 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.663 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -67.68 122.44 18.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.096 -1.003 . . . . 49.289999999999999 109.521 -178.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.961 -1.019 . . . . 58.909999999999997 109.469 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.452 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 2.8 ttm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.446 -0.576 . . . . 64.909999999999997 109.446 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.745 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.2 mt 69.54 64.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.759 -1.2 . . . . 33.799999999999997 107.759 -178.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.534 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 26.7 mttt -54.87 162.16 1.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.823 0.821 . . . . 32.719999999999999 111.269 -178.148 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.05 ' CG2' HG22 ' B' ' 35' ' ' VAL . 58.9 t -160.19 167.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.5 0.667 . . . . 14.460000000000001 109.601 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.589 ' N ' HG12 ' B' ' 4' ' ' VAL . 46.4 mt-10 -152.26 106.2 3.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.613 0.721 . . . . 22.120000000000001 109.088 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.79 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -74.69 101.06 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.141 -1.059 . . . . 14.23 108.141 179.43 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.634 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.73 171.16 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.445 -0.785 . . . . 25.43 109.827 -179.323 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.4 Cg_endo -75.03 -28.28 9.25 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.407 2.071 . . . . 13.609999999999999 110.179 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 12.8 m -93.03 4.21 54.4 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.508 -0.745 . . . . 15.52 109.122 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 18.4 mm-40 -121.15 34.0 5.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.258 -0.901 . . . . 17.309999999999999 109.36 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.85 18.68 21.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 24.780000000000001 110.282 -179.282 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.421 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 19.1 mt-30 -137.56 129.51 28.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.057 -1.027 . . . . 47.899999999999999 109.825 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.55 ' H ' ' HB2' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -77.62 -174.45 3.42 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.395 -0.815 . . . . 21.609999999999999 110.529 -179.563 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 55.9 m -158.6 145.44 17.43 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.764 -0.828 . . . . 14.890000000000001 108.764 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.33 116.87 22.64 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.262 -0.899 . . . . 17.350000000000001 109.561 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.7 OUTLIER -154.81 158.34 39.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.301 -0.875 . . . . 34.380000000000003 109.315 179.857 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.442 ' C ' ' O ' ' B' ' 16' ' ' ARG . 4.8 t -42.25 145.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -0.787 . . . . 38.770000000000003 109.533 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -147.78 168.73 28.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.365 -1.494 . . . . 34.579999999999998 109.365 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.464 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 2.0 t -147.05 122.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.122 -1.223 . . . . 41.869999999999997 109.159 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.49 ' O ' ' N ' ' B' ' 22' ' ' GLN . 0.1 OUTLIER -57.78 -156.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 47.210000000000001 109.6 -179.546 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.528 ' O ' ' CG ' ' B' ' 21' ' ' ARG . 0.0 OUTLIER -67.58 58.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 71.560000000000002 109.737 -179.901 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' B' ' 20' ' ' SER . 2.9 mt-30 62.85 20.82 12.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 66.599999999999994 109.579 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' B' ' 24' ' ' LYS . . . -98.22 -47.66 2.0 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.586 -1.406 . . . . 55.490000000000002 109.586 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' B' ' 23' ' ' GLY . 19.4 mttt -159.0 159.84 29.24 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.3 -1.118 . . . . 44.990000000000002 109.345 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' B' ' 24' ' ' LYS . 34.5 Cg_endo -77.49 150.71 28.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.548 2.165 . . . . 44.100000000000001 110.35 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 5.1 p90 -155.43 140.55 17.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.155 -0.966 . . . . 32.090000000000003 109.842 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.4 m -102.3 79.95 1.9 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.885 . . . . 29.25 108.68 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -105.61 173.45 6.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.9 . . . . 24.0 110.114 -179.187 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.569 ' HB2' ' HB3' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -74.52 111.14 9.41 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.736 -0.838 . . . . 23.309999999999999 108.736 179.548 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 14.8 mm-40 -82.66 -172.74 4.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.035 -1.04 . . . . 40.030000000000001 108.97 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.564 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -171.21 179.96 2.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.081 -1.012 . . . . 12.390000000000001 110.3 179.848 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.952 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.4 mt -140.58 148.56 41.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.538 -0.726 . . . . 17.420000000000002 109.176 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.637 ' O ' HD12 ' B' ' 44' ' ' LEU . 2.4 m -151.96 -178.35 6.7 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.868 -1.16 . . . . 13.84 107.868 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.656 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 37.5 m-85 -128.22 106.28 8.93 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.09 -1.006 . . . . 21.140000000000001 109.3 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 1.05 HG22 ' CG2' ' B' ' 4' ' ' VAL . 73.8 t -98.14 141.27 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.127 -0.983 . . . . 10.66 111.168 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' B' ' 38' ' ' GLY . 4.1 m-20 -111.11 35.69 3.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.031 -1.1 . . . . 25.890000000000001 108.031 178.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.928 ' H ' HG12 ' B' ' 35' ' ' VAL . 2.0 pt? -40.99 -25.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.647 -0.658 . . . . 24.239999999999998 110.271 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.621 ' O ' ' ND2' ' B' ' 39' ' ' ASN . . . 176.71 47.47 0.06 OUTLIER Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.002 -1.639 . . . . 31.02 109.002 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.621 ' ND2' ' O ' ' B' ' 38' ' ' GLY . 21.5 m120 -149.64 109.67 4.12 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.502 -0.999 . . . . 43.229999999999997 108.757 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' B' ' 39' ' ' ASN . 26.1 mt-10 -34.21 -56.86 0.5 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.692 0.758 . . . . 42.340000000000003 110.159 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 51.0 m-70 -73.41 160.48 82.35 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 108.693 -0.855 . . . . 6.5599999999999996 108.693 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.656 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.5 Cg_endo -77.46 140.34 19.11 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.098 1.865 . . . . 17.920000000000002 109.837 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.934 HG22 ' O ' ' B' ' 35' ' ' VAL . 3.2 m -108.48 114.32 46.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.168 -0.957 . . . . 20.57 109.572 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.952 HD11 ' HB3' ' B' ' 32' ' ' LEU . 54.8 tp -68.07 106.99 2.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.428 -0.795 . . . . 20.210000000000001 109.534 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 2.1 t -110.46 169.25 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 10.81 109.038 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.574 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -92.85 162.98 13.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.314 -0.866 . . . . 36.740000000000002 110.378 -179.291 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.564 ' CG2' ' HB3' ' B' ' 31' ' ' GLN . 0.4 OUTLIER -138.49 165.1 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.579 -0.897 . . . . 19.739999999999998 108.579 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.747 HG22 ' O ' ' B' ' 48' ' ' THR . 9.5 m -124.73 71.6 1.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.223 -0.923 . . . . 22.559999999999999 109.366 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.677 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -40.36 136.97 1.15 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.559 -0.713 . . . . 20.41 109.709 179.93 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.98 165.49 24.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 33.990000000000002 109.324 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.47 114.85 11.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 54.920000000000002 109.528 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.75 -6.45 64.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.665 -1.374 . . . . 36.100000000000001 109.665 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.518 ' O ' HD12 ' B' ' 49' ' ' LEU . 1.1 mt-30 -88.99 144.46 32.82 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.148 -1.207 . . . . 54.759999999999998 109.53 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.6 Cg_endo -78.54 123.87 6.14 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.62 2.213 . . . . 28.370000000000001 110.343 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.677 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -40.46 142.76 0.38 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.361 -0.837 . . . . 17.210000000000001 110.467 -179.669 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.79 ' O ' HG21 ' B' ' 6' ' ' ILE . 12.2 m-30 -46.16 104.51 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 17.190000000000001 109.246 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.768 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -53.22 168.6 0.35 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.99 -1.069 . . . . 17.82 109.084 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.768 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.8 Cg_endo -77.19 114.55 3.8 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.603 2.202 . . . . 17.280000000000001 110.458 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.12 47.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.8 -1.32 . . . . 17.219999999999999 109.8 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.661 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -75.45 139.59 42.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -1.079 . . . . 19.57 108.692 179.45 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.689 ' HB3' HD22 ' B' ' 83' ' ' LEU . 18.1 m-85 -128.25 166.04 19.34 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.765 -1.21 . . . . 14.609999999999999 111.437 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.565 ' O ' HG22 ' B' ' 84' ' ' VAL . 44.4 p -150.0 120.46 7.41 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.432 -1.692 . . . . 18.359999999999999 106.432 179.007 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -50.61 166.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 C-N-CA 118.741 -1.183 . . . . 19.129999999999999 108.908 -178.379 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -125.19 124.12 41.06 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.411 -0.806 . . . . 20.649999999999999 108.863 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.739 HD13 HG12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -69.61 -3.2 13.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.676 -0.64 . . . . 19.649999999999999 110.084 -179.166 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.7 t -58.91 -13.86 7.51 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.069 -1.019 . . . . 14.720000000000001 108.329 179.135 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 19.7 m -95.62 -7.86 36.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.756 . . . . 11.449999999999999 110.724 -179.304 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.654 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.1 m-30 -81.15 159.2 24.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.859 -1.151 . . . . 14.25 109.795 -179.027 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.566 ' HA ' HD11 ' A' ' 37' ' ' LEU . 12.0 mtmt -153.04 173.91 14.85 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.977 -0.749 . . . . 32.700000000000003 108.977 179.662 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.566 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -110.66 118.2 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 15.630000000000001 109.51 179.935 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.32 -176.22 48.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.337 -1.505 . . . . 12.699999999999999 109.337 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.93 19.87 3.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.109 -1.23 . . . . 26.289999999999999 109.793 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -11.23 23.54 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.529 -0.732 . . . . 20.440000000000001 109.573 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.414 ' C ' ' OG ' ' B' ' 75' ' ' SER . . . 84.32 50.46 4.28 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.73 -1.348 . . . . 13.82 109.73 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' B' ' 74' ' ' GLY . 0.9 OUTLIER -170.88 153.91 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -1.178 . . . . 18.27 109.614 179.889 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.742 HD23 ' N ' ' B' ' 77' ' ' MET . 10.6 tt -81.23 150.58 28.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 12.43 109.469 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.742 ' N ' HD23 ' B' ' 76' ' ' LEU . 2.2 mtt -155.88 129.14 8.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 35.109999999999999 109.402 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.883 HD12 HD12 ' A' ' 78' ' ' ILE . 3.1 mt -63.11 139.51 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 13.67 109.827 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 6.9 t0 -104.5 -18.45 14.36 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.233 -1.025 . . . . 24.059999999999999 108.233 178.448 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.4 tmm_? 172.25 71.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.893 -1.521 . . . . 35.039999999999999 106.893 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -33.98 119.11 0.39 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.643 0.735 . . . . 18.719999999999999 111.136 -178.005 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 5.9 mtt180 -88.67 110.03 20.62 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.498 -0.927 . . . . 20.550000000000001 108.498 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.836 HD11 HG11 ' B' ' 4' ' ' VAL . 0.3 OUTLIER -81.02 141.83 33.99 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.116 -0.99 . . . . 14.4 110.415 -179.069 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.565 HG22 ' O ' ' B' ' 62' ' ' THR . 25.4 m -145.59 158.86 49.46 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.185 -1.043 . . . . 17.649999999999999 108.185 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -63.93 141.57 78.16 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.078 1.852 . . . . 25.699999999999999 110.27 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.661 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -67.63 122.52 18.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.123 -0.986 . . . . 49.289999999999999 109.541 -178.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.972 -1.013 . . . . 58.909999999999997 109.498 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.499 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.358 0.599 . . . . 64.909999999999997 109.393 . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.787 ' N ' HD22 ' B' ' 65' ' ' LEU . 4.3 mt 75.24 83.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.662 -1.236 . . . . 33.799999999999997 107.662 -179.086 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.516 ' C ' HG12 ' A' ' 4' ' ' VAL . 3.8 mtpp -80.55 173.16 12.88 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.133 0.968 . . . . 32.719999999999999 111.927 -177.51 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.895 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 179.77 168.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.775 -0.824 . . . . 14.460000000000001 108.775 -179.778 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 35.9 mt-10 -141.71 112.67 7.34 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.426 -0.796 . . . . 22.120000000000001 109.442 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.848 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -71.52 104.8 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.483 -1.303 . . . . 14.23 107.483 179.017 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.666 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -51.32 162.0 0.71 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.88 . . . . 25.43 110.123 -178.909 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 33.9 Cg_endo -76.68 -18.6 15.13 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.505 2.136 . . . . 13.609999999999999 109.116 179.039 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -92.12 8.38 38.18 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.682 -0.859 . . . . 15.52 108.682 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.554 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -147.74 38.97 0.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.362 -0.836 . . . . 17.309999999999999 109.246 179.326 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.11 6.9 44.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 24.780000000000001 109.756 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 29.3 mt-30 -127.29 155.64 43.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 47.899999999999999 109.282 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.757 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 37.1 p90 -96.45 160.49 14.38 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.165 -0.959 . . . . 21.609999999999999 109.406 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -127.2 160.79 30.2 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.315 -0.866 . . . . 14.890000000000001 108.8 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.6 107.83 20.04 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.274 -0.892 . . . . 17.350000000000001 108.963 179.849 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 18' ' ' GLY . 7.3 mmt180 -136.93 154.24 50.51 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.372 -0.83 . . . . 34.380000000000003 109.504 -179.678 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.1 m -59.81 83.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 38.770000000000003 109.468 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -76.17 132.55 12.89 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.397 -1.481 . . . . 34.579999999999998 109.397 179.741 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.401 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -101.49 124.68 55.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.267 -1.137 . . . . 41.869999999999997 108.835 179.773 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.443 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 3.9 m -69.22 -93.16 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.474 -0.766 . . . . 47.210000000000001 109.659 -179.112 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HG2' ' HG3' ' A' ' 22' ' ' GLN . 0.1 OUTLIER -91.72 -56.14 3.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 71.560000000000002 109.444 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.495 ' HG3' ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER 166.8 45.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 66.599999999999994 109.456 179.851 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -126.08 -56.98 0.15 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.545 -1.422 . . . . 55.490000000000002 109.545 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.26 150.11 74.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.258 -1.142 . . . . 44.990000000000002 109.384 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.32 79.79 3.2 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.552 2.168 . . . . 44.100000000000001 110.607 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.587 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 4.4 p90 -56.78 139.07 52.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.227 -0.92 . . . . 32.090000000000003 109.581 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.94 79.75 1.93 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 29.25 109.407 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.555 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -117.44 136.0 53.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 24.0 109.637 -179.848 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.571 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 85.7 m-20 -43.72 134.73 4.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 23.309999999999999 109.638 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -125.99 161.77 26.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.884 . . . . 40.030000000000001 109.163 179.942 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.97 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -140.39 -172.36 3.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 12.390000000000001 109.602 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.738 ' HB3' HD11 ' A' ' 44' ' ' LEU . 2.7 mp -130.75 171.42 13.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 17.420000000000002 109.361 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.579 ' SG ' HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -162.21 154.32 19.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.104 -0.997 . . . . 13.84 108.711 -179.613 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.699 ' CE2' HD13 ' A' ' 44' ' ' LEU . 27.1 m-85 -115.32 104.31 11.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 21.140000000000001 109.604 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.898 HG21 HD13 ' B' ' 76' ' ' LEU . 64.1 t -80.23 165.33 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.807 -1.183 . . . . 10.66 109.536 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.599 ' N ' HG12 ' A' ' 35' ' ' VAL . 6.2 m-20 -137.21 -52.87 0.68 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.299 -0.876 . . . . 25.890000000000001 109.676 -179.556 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.797 ' CG ' HD11 ' B' ' 65' ' ' LEU . 0.1 OUTLIER -42.09 -44.65 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.66 0.743 . . . . 24.239999999999998 109.11 179.919 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 39' ' ' ASN . . . -88.57 32.21 4.58 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.613 -1.395 . . . . 31.02 109.613 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 2.5 p30 161.16 117.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.384 -1.068 . . . . 43.229999999999997 109.594 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -42.5 -64.79 0.55 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 42.340000000000003 109.509 179.941 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.506 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 5.5 m-70 -68.68 163.4 55.11 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 107.96 -1.126 . . . . 3.77 107.96 179.033 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.688 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.9 Cg_endo -78.1 140.48 17.88 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.541 1.494 . . . . 17.920000000000002 109.692 -179.699 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.53 HG21 ' ND2' ' A' ' 39' ' ' ASN . 6.0 m -116.32 114.32 45.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.313 -0.867 . . . . 20.57 109.003 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.738 HD11 ' HB3' ' A' ' 32' ' ' LEU . 43.8 tp -69.75 107.73 3.61 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.347 -0.846 . . . . 20.210000000000001 109.835 -179.437 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.695 HG23 HG11 ' B' ' 70' ' ' VAL . 0.8 OUTLIER -109.13 164.19 5.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.56 -0.904 . . . . 10.81 108.56 179.635 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' HA3' ' B' ' 74' ' ' GLY . 1.0 OUTLIER -86.96 170.0 11.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.159 -0.963 . . . . 36.740000000000002 109.803 -179.67 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.635 HG22 ' CB ' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -156.6 171.65 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.347 -0.846 . . . . 19.739999999999998 109.315 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -107.82 147.8 30.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.201 -0.937 . . . . 22.559999999999999 109.45 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.639 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 1.8 tm? -129.39 112.15 13.54 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.219 -0.926 . . . . 20.41 108.778 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 53' ' ' GLN . 2.7 t70 -61.75 138.18 58.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -0.816 . . . . 33.990000000000002 110.223 -178.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.28 124.38 16.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.346 -0.847 . . . . 54.920000000000002 108.834 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.47 -31.15 8.39 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.979 -1.648 . . . . 36.100000000000001 108.979 -179.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.585 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -73.77 146.51 85.63 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.375 -1.074 . . . . 54.759999999999998 109.155 179.648 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.44 118.2 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.426 2.084 . . . . 28.370000000000001 109.997 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.97 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -41.58 154.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 17.210000000000001 109.711 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 6.8 m-30 -45.07 105.57 0.06 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.239 -0.913 . . . . 17.190000000000001 108.892 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.952 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -61.97 176.15 0.48 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 17.82 109.347 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.952 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.0 Cg_endo -77.61 129.97 10.43 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.602 2.202 . . . . 17.280000000000001 110.523 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.598 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 153.03 148.25 4.83 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.767 -1.333 . . . . 17.219999999999999 109.767 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.6 OUTLIER -46.78 146.23 1.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.137 -1.213 . . . . 19.57 108.838 179.481 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.895 ' CB ' HG13 ' A' ' 4' ' ' VAL . 16.3 m-85 -125.77 161.85 26.41 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.667 -1.271 . . . . 14.609999999999999 111.7 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.904 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.2 p -144.86 121.6 11.2 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.459 -1.682 . . . . 18.359999999999999 106.459 178.698 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -59.98 163.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 118.529 -1.268 . . . . 19.129999999999999 108.922 -178.504 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.473 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.2 t-80 -127.27 128.19 45.59 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.037 -0.727 . . . . 20.649999999999999 109.037 -179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.784 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -71.52 0.98 7.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.471 -0.768 . . . . 19.649999999999999 110.159 -179.833 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -20.78 6.58 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.283 -1.377 . . . . 14.720000000000001 107.283 178.647 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 5.8 m -95.11 -8.31 36.87 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.903 -0.498 . . . . 11.449999999999999 110.218 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.6 m-30 -84.73 156.87 21.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.953 -1.092 . . . . 14.25 109.336 -179.167 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HE2' ' OD2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -168.03 174.69 7.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.397 -0.814 . . . . 32.700000000000003 109.435 179.747 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.715 HG11 HG23 ' B' ' 45' ' ' VAL . 0.1 OUTLIER -103.13 109.82 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.821 . . . . 15.630000000000001 109.254 -179.965 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 72' ' ' GLN . . . -77.31 50.83 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.104 -1.199 . . . . 12.699999999999999 110.104 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 71' ' ' GLY . 0.4 OUTLIER 40.05 49.39 2.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -1.094 . . . . 26.289999999999999 110.102 179.62 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 74' ' ' GLY . 1.7 m-85 -143.35 31.26 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 20.440000000000001 109.334 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.516 ' HA3' ' HG2' ' B' ' 46' ' ' LYS . . . 44.61 44.96 8.55 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.624 -1.39 . . . . 13.82 109.624 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.484 ' N ' HG22 ' B' ' 45' ' ' VAL . 46.6 m -166.57 114.27 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -1.209 . . . . 18.27 109.832 -179.925 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.862 HD13 HG21 ' B' ' 35' ' ' VAL . 0.3 OUTLIER -68.04 155.36 39.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 12.43 109.037 179.678 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.543 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 8.1 mtp -162.54 157.06 21.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 35.109999999999999 109.754 -179.743 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.759 HD12 HD12 ' B' ' 78' ' ' ILE . 3.3 mt -80.65 135.06 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 13.67 109.899 179.653 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 79' ' ' ASP . 46.9 t0 -103.18 -20.55 14.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.376 -0.972 . . . . 24.059999999999999 108.376 178.327 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 67' ' ' SER . 5.1 tmm_? 175.79 69.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.93 -1.507 . . . . 35.039999999999999 106.93 179.397 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -32.23 120.21 0.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.458 -0.792 . . . . 18.719999999999999 111.635 -177.711 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -92.12 99.44 12.24 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.322 -0.992 . . . . 20.550000000000001 108.322 178.996 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.749 HD23 ' CD2' ' A' ' 61' ' ' TYR . 1.5 tp -67.43 157.54 33.91 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.019 0.914 . . . . 14.4 111.159 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 62' ' ' THR . 21.3 m -156.55 147.98 16.9 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.818 -1.178 . . . . 17.649999999999999 107.818 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -63.12 135.24 49.87 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 121.815 1.677 . . . . 25.699999999999999 109.872 179.352 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.749 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -61.85 118.8 7.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.942 . . . . 49.289999999999999 109.792 -178.521 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.01 -0.995 . . . . 58.909999999999997 109.454 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.494 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.339 0.59 . . . . 64.909999999999997 109.425 . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.784 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.2 mt 75.25 83.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.632 -1.247 . . . . 33.799999999999997 107.632 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.533 ' C ' HG12 ' B' ' 4' ' ' VAL . 3.8 mtpp -80.74 173.07 12.97 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.136 0.97 . . . . 32.719999999999999 111.957 -177.56 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.891 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 179.83 168.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.781 -0.822 . . . . 14.460000000000001 108.781 -179.773 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.582 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 36.5 mt-10 -141.54 112.65 7.39 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.401 -0.812 . . . . 22.120000000000001 109.522 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.866 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -71.5 104.72 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.475 -1.306 . . . . 14.23 107.475 179.05 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.686 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -51.32 162.05 0.7 Allowed Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.881 . . . . 25.43 110.154 -178.874 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.401 ' HD2' ' HG3' ' B' ' 7' ' ' LYS . 33.7 Cg_endo -76.54 -18.8 15.27 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.472 2.114 . . . . 13.609999999999999 109.15 178.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -92.03 8.6 36.92 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.719 -0.845 . . . . 15.52 108.719 178.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.558 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 0.0 OUTLIER -147.92 38.92 0.92 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.35 -0.844 . . . . 17.309999999999999 109.229 179.353 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.18 7.05 44.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 24.780000000000001 109.721 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.604 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 29.0 mt-30 -127.52 155.59 43.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 47.899999999999999 109.203 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.764 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 37.4 p90 -96.37 160.53 14.37 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.089 -1.007 . . . . 21.609999999999999 109.363 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -127.2 160.84 30.04 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.838 -0.801 . . . . 14.890000000000001 108.838 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.63 107.77 20.0 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.318 -0.864 . . . . 17.350000000000001 109.002 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' B' ' 18' ' ' GLY . 7.2 mmt180 -136.95 154.04 50.55 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.373 -0.829 . . . . 34.380000000000003 109.512 -179.712 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.1 m -59.49 83.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.372 -0.83 . . . . 38.770000000000003 109.427 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -76.35 132.5 12.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.393 -1.483 . . . . 34.579999999999998 109.393 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.403 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -101.42 124.83 55.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.169 -1.195 . . . . 41.869999999999997 108.758 179.837 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.442 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 4.0 m -69.31 -93.32 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.786 . . . . 47.210000000000001 109.544 -179.101 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.504 ' HG2' ' HG3' ' B' ' 22' ' ' GLN . 0.1 OUTLIER -91.61 -56.42 3.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.905 . . . . 71.560000000000002 109.438 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.504 ' HG3' ' HG2' ' B' ' 21' ' ' ARG . 0.0 OUTLIER 167.18 45.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 66.599999999999994 109.518 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.94 -57.2 0.15 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.588 -1.405 . . . . 55.490000000000002 109.588 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 150.08 74.68 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.249 -1.147 . . . . 44.990000000000002 109.389 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.3 79.88 3.17 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.603 2.202 . . . . 44.100000000000001 110.631 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.585 ' CE1' ' HA3' ' B' ' 18' ' ' GLY . 4.4 p90 -56.9 139.12 52.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 32.090000000000003 109.535 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.98 79.62 1.91 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 29.25 109.36 -179.864 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.55 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -117.36 135.92 53.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 24.0 109.681 -179.94 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.576 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 85.8 m-20 -43.59 134.38 4.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 23.309999999999999 109.735 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 1.0 OUTLIER -125.65 161.74 26.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.362 -0.836 . . . . 40.030000000000001 109.192 179.889 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.96 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -140.32 -172.33 3.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.166 -0.959 . . . . 12.390000000000001 109.605 179.954 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.734 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.7 mp -130.76 171.63 12.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 17.420000000000002 109.372 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.582 ' SG ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -162.45 154.28 18.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.06 -1.025 . . . . 13.84 108.776 -179.688 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.703 ' CE2' HD13 ' B' ' 44' ' ' LEU . 27.4 m-85 -115.23 104.36 11.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 21.140000000000001 109.645 -179.653 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.862 HG21 HD13 ' A' ' 76' ' ' LEU . 63.2 t -80.32 165.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.849 -1.157 . . . . 10.66 109.509 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.617 ' N ' HG12 ' B' ' 35' ' ' VAL . 6.2 m-20 -137.24 -52.76 0.67 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.304 -0.873 . . . . 25.890000000000001 109.683 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -42.09 -44.67 3.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 24.239999999999998 109.088 179.921 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 39' ' ' ASN . . . -88.52 32.06 4.63 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.651 -1.38 . . . . 31.02 109.651 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' ASP . 2.5 p30 161.23 117.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.397 -1.06 . . . . 43.229999999999997 109.577 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.0 OUTLIER -42.45 -64.67 0.57 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.355 -0.841 . . . . 42.340000000000003 109.508 179.942 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.51 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 5.6 m-70 -68.95 163.41 56.68 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 107.97 -1.122 . . . . 3.75 107.97 179.078 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.692 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.9 Cg_endo -77.98 140.67 18.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.507 1.471 . . . . 17.920000000000002 109.702 -179.736 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.534 HG21 ' ND2' ' B' ' 39' ' ' ASN . 5.9 m -116.49 114.29 45.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.339 -0.851 . . . . 20.57 108.981 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.734 HD11 ' HB3' ' B' ' 32' ' ' LEU . 43.6 tp -69.77 107.48 3.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.379 -0.826 . . . . 20.210000000000001 109.946 -179.407 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.715 HG23 HG11 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -108.88 164.12 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.627 -0.879 . . . . 10.81 108.627 179.592 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' HA3' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -86.85 170.11 11.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.948 . . . . 36.740000000000002 109.741 -179.645 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.637 HG22 ' CB ' ' B' ' 31' ' ' GLN . 0.1 OUTLIER -156.72 171.46 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.283 -0.886 . . . . 19.739999999999998 109.379 179.861 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 18.3 m -107.5 147.71 30.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 22.559999999999999 109.442 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.64 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 1.7 tm? -129.24 112.22 13.68 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.198 -0.939 . . . . 20.41 108.781 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' B' ' 53' ' ' GLN . 2.7 t70 -61.69 138.3 58.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.827 . . . . 33.990000000000002 110.202 -179.014 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.41 124.39 17.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 54.920000000000002 108.771 179.379 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.52 -31.25 8.3 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.987 -1.645 . . . . 36.100000000000001 108.987 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.608 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.4 OUTLIER -73.61 146.45 85.94 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.35 -1.088 . . . . 54.759999999999998 109.153 179.694 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.4 Cg_endo -78.35 118.03 4.2 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.453 2.102 . . . . 28.370000000000001 109.998 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.96 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -41.49 154.81 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.454 -0.779 . . . . 17.210000000000001 109.764 -179.71 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 6.7 m-30 -44.96 105.82 0.06 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 17.190000000000001 108.769 179.737 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -62.48 176.19 0.52 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 17.82 109.439 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.7 Cg_endo -77.46 128.53 9.63 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.547 2.165 . . . . 17.280000000000001 110.152 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.61 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 155.4 147.97 4.88 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.889 -1.284 . . . . 17.219999999999999 109.889 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.753 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.6 OUTLIER -47.43 145.69 2.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.055 -1.262 . . . . 19.57 108.527 179.209 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.891 ' CB ' HG13 ' B' ' 4' ' ' VAL . 17.0 m-85 -125.25 161.87 25.95 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.624 -1.297 . . . . 14.609999999999999 111.663 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.906 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.5 p -144.87 121.73 11.27 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.445 -1.687 . . . . 18.359999999999999 106.445 178.742 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -60.15 163.22 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 C-N-CA 118.517 -1.273 . . . . 19.129999999999999 108.974 -178.519 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.47 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -127.41 128.28 45.55 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.527 -0.733 . . . . 20.649999999999999 109.036 -179.287 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.797 HD11 ' CG ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -71.48 0.88 7.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.476 -0.765 . . . . 19.649999999999999 110.093 -179.828 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -20.89 6.15 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.268 -1.382 . . . . 14.720000000000001 107.268 178.721 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 5.6 m -95.14 -8.98 34.86 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.897 -0.502 . . . . 11.449999999999999 110.245 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.6 m-30 -84.07 156.57 22.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.945 -1.097 . . . . 14.25 109.206 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.403 ' HE2' ' OD2' ' B' ' 79' ' ' ASP . 0.3 OUTLIER -167.8 174.43 7.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.431 -0.793 . . . . 32.700000000000003 109.435 179.736 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.695 HG11 HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -102.76 109.91 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 15.630000000000001 109.273 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' B' ' 72' ' ' GLN . . . -77.44 50.58 3.2 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.143 -1.183 . . . . 12.699999999999999 110.143 -179.759 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 71' ' ' GLY . 0.4 OUTLIER 40.28 49.62 2.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.331 -1.099 . . . . 26.289999999999999 110.041 179.653 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -143.65 31.35 1.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 20.440000000000001 109.323 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.516 ' HA3' ' HG2' ' A' ' 46' ' ' LYS . . . 44.56 44.73 8.37 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.621 -1.392 . . . . 13.82 109.621 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 45' ' ' VAL . 46.6 m -166.41 114.53 0.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -1.205 . . . . 18.27 109.824 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.898 HD13 HG21 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -68.13 155.36 39.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 12.43 109.019 179.634 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 8.1 mtp -162.68 157.13 21.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 35.109999999999999 109.682 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.759 HD12 HD12 ' A' ' 78' ' ' ILE . 3.3 mt -80.78 135.36 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.442 -0.787 . . . . 13.67 109.91 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' B' ' 79' ' ' ASP . 47.2 t0 -103.19 -20.74 14.03 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.358 -0.979 . . . . 24.059999999999999 108.358 178.287 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' B' ' 67' ' ' SER . 5.1 tmm_? 175.96 69.7 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.982 -1.488 . . . . 35.039999999999999 106.982 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.643 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -32.45 120.2 0.31 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.464 -0.789 . . . . 18.719999999999999 111.684 -177.725 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -92.15 99.32 12.14 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.23 -1.026 . . . . 20.550000000000001 108.23 179.064 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.732 HD23 ' CD2' ' B' ' 61' ' ' TYR . 1.5 tp -67.4 157.62 33.68 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.034 0.921 . . . . 14.4 111.127 -178.556 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.906 HG22 ' O ' ' B' ' 62' ' ' THR . 21.2 m -156.6 148.13 16.99 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.841 -1.17 . . . . 17.649999999999999 107.841 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.5 Cg_endo -63.31 135.17 48.84 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.774 1.649 . . . . 25.699999999999999 109.88 179.383 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.753 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -61.83 118.43 7.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.318 -0.864 . . . . 49.289999999999999 109.761 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 87' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' B' ' 86' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.975 -1.012 . . . . 58.909999999999997 109.475 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.302 0.572 . . . . 64.909999999999997 109.53 . . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.895 ' CA ' HD22 ' B' ' 65' ' ' LEU . 5.3 mt -69.67 82.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.909 -1.145 . . . . 33.799999999999997 107.909 179.178 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.488 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 mttt -59.19 156.21 12.72 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.894 0.854 . . . . 32.719999999999999 111.531 -177.881 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 35' ' ' VAL . 49.0 t -159.57 167.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 109.19 -0.67 . . . . 14.460000000000001 109.19 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.602 ' N ' HG12 ' A' ' 4' ' ' VAL . 30.2 mt-10 -152.63 100.93 2.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.741 0.782 . . . . 22.120000000000001 109.185 -179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.644 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -66.96 103.56 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.852 -1.166 . . . . 14.23 107.852 179.493 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 2.2 mmpt? -50.18 159.23 0.84 Allowed Pre-proline 0 N--CA 1.485 1.291 0 O-C-N 121.302 -0.874 . . . . 25.43 109.66 -179.115 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.2 Cg_endo -76.16 -3.31 13.67 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.28 1.987 . . . . 13.609999999999999 109.37 179.374 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.15 -10.45 33.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.483 -0.76 . . . . 15.52 109.408 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 1.053 ' OE1' HD13 ' A' ' 32' ' ' LEU . 25.7 mm-40 -97.54 -76.34 0.52 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.293 -0.879 . . . . 17.309999999999999 108.863 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 10' ' ' GLN . . . 23.64 45.54 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.205 0.526 . . . . 24.780000000000001 111.195 179.295 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 10' ' ' GLN . 11.0 pt20 -179.04 132.42 0.12 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 47.899999999999999 109.557 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 31.9 p90 -97.45 156.27 16.55 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.953 -1.092 . . . . 21.609999999999999 109.486 179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 t -124.92 164.08 20.86 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.651 -0.87 . . . . 14.890000000000001 108.651 178.663 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.496 HG22 ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -85.81 112.13 20.82 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.116 -0.99 . . . . 17.350000000000001 109.53 -179.773 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.02 153.57 39.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 34.380000000000003 109.385 179.876 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -52.27 144.32 12.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 38.770000000000003 109.368 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -155.45 119.48 0.93 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.26 -1.536 . . . . 34.579999999999998 109.26 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.71 123.68 55.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -1.22 . . . . 41.869999999999997 109.217 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.94 -15.08 18.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 47.210000000000001 109.493 -179.517 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.492 ' HG2' ' HG2' ' A' ' 22' ' ' GLN . 2.2 ttt180 -177.6 -59.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.351 -0.843 . . . . 71.560000000000002 109.283 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER 174.93 57.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 66.599999999999994 109.471 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.78 -50.71 0.04 OUTLIER Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.582 -1.407 . . . . 55.490000000000002 109.582 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.39 108.66 59.85 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.287 -1.125 . . . . 44.990000000000002 109.377 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.79 72.07 5.26 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.173 1.915 . . . . 44.100000000000001 110.18 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.602 ' CE1' ' HB2' ' A' ' 28' ' ' LEU . 5.2 p90 -69.27 140.22 54.43 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.533 -0.729 . . . . 32.090000000000003 110.403 -179.613 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.496 ' HB2' HG22 ' A' ' 15' ' ' THR . 0.0 OUTLIER -105.54 81.46 1.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.097 -1.075 . . . . 29.25 108.097 178.922 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.602 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -90.71 138.48 31.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 24.0 110.657 -178.55 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.63 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -42.2 159.3 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 23.309999999999999 109.942 179.686 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -156.71 137.22 13.09 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.753 -0.832 . . . . 40.030000000000001 108.753 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.844 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -120.89 -166.34 1.33 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.947 -1.095 . . . . 12.390000000000001 110.334 -179.231 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.053 HD13 ' OE1' ' A' ' 10' ' ' GLN . 4.4 mp -127.37 175.25 8.35 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.933 -0.766 . . . . 17.420000000000002 108.933 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.79 160.14 6.74 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.796 -1.19 . . . . 13.84 108.663 -179.545 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.695 ' CE1' HD13 ' A' ' 44' ' ' LEU . 2.9 m-30 -112.54 86.37 2.35 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.259 -0.9 . . . . 21.140000000000001 109.199 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 4' ' ' VAL . 59.2 t -83.11 110.37 18.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.156 -0.965 . . . . 10.66 110.227 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' LEU . 36.8 t0 -53.58 -34.79 59.61 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.779 -1.193 . . . . 25.890000000000001 107.779 178.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.748 HD11 ' C ' ' B' ' 68' ' ' PHE . 1.0 OUTLIER 41.27 34.36 0.32 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.303 0.573 . . . . 24.239999999999998 109.73 179.317 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.25 23.75 34.44 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.301 -1.52 . . . . 31.02 109.301 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.596 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 2.0 m120 -88.26 26.53 1.39 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.304 -1.116 . . . . 43.229999999999997 110.01 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.77 14.18 3.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.046 -1.034 . . . . 42.340000000000003 109.876 179.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER 175.61 167.1 0.39 Allowed Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.437 -0.949 . . . . 5.25 108.437 179.883 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 33.8 Cg_endo -75.81 145.16 28.46 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.722 1.614 . . . . 17.920000000000002 110.421 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 35' ' ' VAL . 6.6 m -119.9 119.77 61.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.482 -0.887 . . . . 20.57 109.171 179.356 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.931 HD11 ' HB3' ' A' ' 32' ' ' LEU . 14.7 tp -72.47 112.85 8.89 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.886 -0.725 . . . . 20.210000000000001 109.276 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.427 HG22 ' C ' ' B' ' 74' ' ' GLY . 1.7 p -130.78 161.51 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.386 -0.822 . . . . 10.81 109.127 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 0.6 OUTLIER -80.75 160.34 24.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.038 -1.039 . . . . 36.740000000000002 110.407 -179.094 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.815 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -140.64 161.91 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.46 -0.941 . . . . 19.739999999999998 108.46 179.353 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 143.0 28.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.97 -1.081 . . . . 22.559999999999999 109.683 -179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -114.0 146.58 39.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.366 -0.834 . . . . 20.41 108.858 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.498 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -81.33 142.88 32.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 33.990000000000002 109.538 -179.583 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.12 116.89 3.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 54.920000000000002 109.477 -179.905 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.11 -6.55 83.37 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.652 -1.379 . . . . 36.100000000000001 109.652 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.498 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -83.89 148.78 54.96 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 54.759999999999998 109.451 179.999 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.5 Cg_endo -77.01 119.47 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.617 2.211 . . . . 28.370000000000001 110.776 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.844 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.01 147.85 0.21 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 17.210000000000001 110.267 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.678 ' CD1' HG21 ' A' ' 47' ' ' ILE . 86.8 m-85 -44.07 112.09 0.36 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 17.190000000000001 109.131 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.01 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -63.92 176.58 0.63 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 17.82 109.779 -179.58 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 1.01 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -77.8 113.54 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.756 2.304 . . . . 17.280000000000001 110.433 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.8 172.84 38.83 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.389 -1.484 . . . . 17.219999999999999 109.389 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 3.3 mp -70.41 146.63 50.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 19.57 108.811 179.494 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.644 ' CE1' HD13 ' A' ' 6' ' ' ILE . 26.6 m-85 -131.24 163.59 27.45 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.945 -1.097 . . . . 14.609999999999999 110.921 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.664 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.1 p -144.4 117.17 8.72 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.066 -1.827 . . . . 18.359999999999999 106.066 178.623 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -49.81 163.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 C-N-CA 118.681 -1.208 . . . . 19.129999999999999 108.71 -178.143 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -128.3 126.62 41.16 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.409 -0.807 . . . . 20.649999999999999 109.381 -178.901 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.886 HD22 ' HA ' ' B' ' 2' ' ' ILE . 0.7 OUTLIER -74.05 2.51 8.65 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.533 -0.729 . . . . 19.649999999999999 110.054 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.9 p -58.88 -18.02 29.22 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.546 -1.279 . . . . 14.720000000000001 107.546 178.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 23.8 m -97.83 -16.4 19.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.842 -0.536 . . . . 11.449999999999999 110.151 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.728 ' C ' HD11 ' B' ' 37' ' ' LEU . 3.0 m-30 -68.14 157.3 35.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.125 -0.984 . . . . 14.25 109.441 -178.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.617 ' N ' HD11 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -150.48 -179.76 7.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.385 -0.822 . . . . 32.700000000000003 109.613 -179.995 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.632 HG21 HG21 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -120.82 110.88 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 15.630000000000001 109.121 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' N ' ' SD ' ' A' ' 77' ' ' MET . . . -81.7 -175.07 50.03 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.658 -1.377 . . . . 12.699999999999999 109.658 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.524 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.2 tm0? -89.55 20.17 4.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.152 -1.205 . . . . 26.289999999999999 109.574 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -93.73 -2.64 53.5 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.394 -0.816 . . . . 20.440000000000001 109.348 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 81.16 26.89 51.3 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.68 -1.368 . . . . 13.82 109.68 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.6 153.7 32.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.082 -1.246 . . . . 18.27 109.82 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.596 HD12 HG13 ' A' ' 70' ' ' VAL . 1.1 tp -62.24 176.81 0.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.348 -0.845 . . . . 12.43 109.664 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.488 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 2.1 ptm -167.68 100.12 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 35.109999999999999 109.691 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.606 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.9 mt -36.86 -64.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.478 0.656 . . . . 13.67 110.301 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 9.0 t0 84.53 -45.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.484 0.659 . . . . 24.059999999999999 110.014 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.8 tpm_? -173.84 67.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.147 0.975 . . . . 35.039999999999999 108.526 179.424 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.637 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.2 pt? -40.96 126.8 2.59 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.483 -0.781 . . . . 18.719999999999999 111.931 -178.696 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 1.4 ttt180 -94.11 110.4 22.11 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.693 -1.225 . . . . 20.550000000000001 107.693 178.239 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.815 ' HB2' HD11 ' A' ' 47' ' ' ILE . 11.8 tp -80.2 150.42 30.12 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.056 -1.027 . . . . 14.4 111.112 -178.148 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 62' ' ' THR . 21.2 m -147.08 157.57 46.06 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 108.161 -1.051 . . . . 17.649999999999999 108.161 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.6 Cg_endo -62.56 142.0 88.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.058 1.838 . . . . 25.699999999999999 110.321 179.11 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -76.38 116.47 17.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.229 -0.919 . . . . 49.289999999999999 109.739 -178.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.012 -0.995 . . . . 58.909999999999997 109.425 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.482 ' SD ' ' HB ' ' B' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.308 0.575 . . . . 64.909999999999997 109.556 . . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.886 ' HA ' HD22 ' A' ' 65' ' ' LEU . 5.2 mt -69.48 82.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.91 -1.144 . . . . 33.799999999999997 107.91 179.114 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.5 ' C ' HG23 ' B' ' 4' ' ' VAL . 2.3 mttt -59.12 156.4 12.12 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.915 0.864 . . . . 32.719999999999999 111.543 -178.0 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.089 HG22 HG22 ' B' ' 35' ' ' VAL . 49.2 t -159.7 167.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 109.2 -0.667 . . . . 14.460000000000001 109.2 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.604 ' N ' HG12 ' B' ' 4' ' ' VAL . 30.0 mt-10 -152.45 100.94 2.62 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.808 0.813 . . . . 22.120000000000001 109.296 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.648 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -66.92 103.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.838 -1.171 . . . . 14.23 107.838 179.454 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.567 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 2.2 mmpt? -50.08 159.39 0.8 Allowed Pre-proline 0 N--CA 1.486 1.328 0 O-C-N 121.294 -0.879 . . . . 25.43 109.69 -179.156 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.7 Cg_endo -76.26 -3.26 13.61 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.353 2.035 . . . . 13.609999999999999 109.37 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.28 -10.48 32.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.461 -0.775 . . . . 15.52 109.394 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 1.038 ' OE1' HD13 ' B' ' 32' ' ' LEU . 25.6 mm-40 -97.48 -76.45 0.52 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.282 -0.886 . . . . 17.309999999999999 108.865 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' B' ' 10' ' ' GLN . . . 23.77 45.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.164 0.507 . . . . 24.780000000000001 111.175 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' B' ' 10' ' ' GLN . 11.0 pt20 -178.94 132.28 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 47.899999999999999 109.616 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 32.5 p90 -97.21 156.35 16.45 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.954 -1.091 . . . . 21.609999999999999 109.551 179.7 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.4 t -124.97 163.94 21.21 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.656 -0.868 . . . . 14.890000000000001 108.656 178.635 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.508 HG22 ' HB2' ' B' ' 27' ' ' SER . 0.2 OUTLIER -85.82 112.26 20.95 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.133 -0.979 . . . . 17.350000000000001 109.538 -179.798 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.09 153.42 39.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 34.380000000000003 109.437 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -52.11 144.24 12.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 38.770000000000003 109.424 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -155.3 119.6 0.94 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.197 -1.561 . . . . 34.579999999999998 109.197 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.86 123.66 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.107 -1.231 . . . . 41.869999999999997 109.148 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -15.2 19.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 47.210000000000001 109.488 -179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.488 ' HG2' ' HG2' ' B' ' 22' ' ' GLN . 2.1 ttt180 -177.49 -59.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.363 -0.836 . . . . 71.560000000000002 109.268 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.488 ' HG2' ' HG2' ' B' ' 21' ' ' ARG . 0.0 OUTLIER 175.08 57.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 66.599999999999994 109.435 179.768 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.8 -50.7 0.04 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.485 -1.446 . . . . 55.490000000000002 109.485 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.34 108.64 59.74 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.294 -1.121 . . . . 44.990000000000002 109.412 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.76 72.17 5.2 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.224 1.949 . . . . 44.100000000000001 110.234 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' B' ' 28' ' ' LEU . 5.4 p90 -69.34 140.44 54.31 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.565 -0.709 . . . . 32.090000000000003 110.342 -179.58 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.508 ' HB2' HG22 ' B' ' 15' ' ' THR . 0.0 OUTLIER -105.79 81.44 1.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.061 -1.088 . . . . 29.25 108.061 178.899 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -90.67 138.59 31.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 24.0 110.612 -178.504 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.623 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -42.3 159.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.471 -0.768 . . . . 23.309999999999999 109.942 179.717 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -156.77 136.99 12.82 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.764 -0.828 . . . . 40.030000000000001 108.764 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.825 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -120.77 -166.41 1.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.992 -1.068 . . . . 12.390000000000001 110.342 -179.277 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 1.038 HD13 ' OE1' ' B' ' 10' ' ' GLN . 4.4 mp -127.16 175.43 8.14 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.871 -0.788 . . . . 17.420000000000002 108.871 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.99 160.1 6.38 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.834 -1.166 . . . . 13.84 108.59 -179.549 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.701 ' CE1' HD13 ' B' ' 44' ' ' LEU . 2.9 m-30 -112.52 86.41 2.35 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 21.140000000000001 109.201 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 1.089 HG22 HG22 ' B' ' 4' ' ' VAL . 59.5 t -83.22 110.57 18.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.189 -0.944 . . . . 10.66 110.236 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' B' ' 37' ' ' LEU . 36.8 t0 -53.7 -34.74 59.78 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.79 -1.189 . . . . 25.890000000000001 107.79 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.728 HD11 ' C ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER 41.26 34.38 0.32 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.79 -0.568 . . . . 24.239999999999998 109.717 179.345 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.23 23.58 33.71 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.3 -1.52 . . . . 31.02 109.3 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.59 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 2.1 m120 -88.09 26.46 1.38 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.285 -1.126 . . . . 43.229999999999997 110.022 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.8 14.22 4.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.082 -1.011 . . . . 42.340000000000003 109.893 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 0.6 OUTLIER 175.61 167.01 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.454 -0.943 . . . . 5.2300000000000004 108.454 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.637 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 33.8 Cg_endo -75.62 145.31 29.25 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.711 1.608 . . . . 17.920000000000002 110.49 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.877 HG22 ' O ' ' B' ' 35' ' ' VAL . 6.6 m -120.03 119.94 61.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 C-N-CA 119.378 -0.929 . . . . 20.57 109.16 179.312 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.949 HD11 ' HB3' ' B' ' 32' ' ' LEU . 14.8 tp -72.76 112.92 9.24 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.93 -0.708 . . . . 20.210000000000001 109.172 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 32' ' ' LEU . 1.7 p -130.82 161.52 40.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.421 -0.799 . . . . 10.81 109.077 -179.758 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -80.74 160.31 24.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.985 . . . . 36.740000000000002 110.399 -179.093 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.798 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.5 OUTLIER -140.57 161.88 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.378 -0.971 . . . . 19.739999999999998 108.378 179.41 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.07 142.98 28.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.952 -1.092 . . . . 22.559999999999999 109.744 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.602 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -113.85 146.82 39.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 20.41 108.888 179.873 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.503 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -81.63 142.78 32.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 33.990000000000002 109.536 -179.572 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.05 117.14 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 54.920000000000002 109.417 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.12 -6.81 83.04 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.599 -1.4 . . . . 36.100000000000001 109.599 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.503 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -83.79 148.89 55.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.188 -1.183 . . . . 54.759999999999998 109.508 -179.958 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.5 Cg_endo -77.03 119.39 5.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.715 2.277 . . . . 28.370000000000001 110.761 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.825 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.0 147.69 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 17.210000000000001 110.35 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.682 ' CD1' HG21 ' B' ' 47' ' ' ILE . 86.9 m-85 -43.76 112.54 0.4 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.543 -0.723 . . . . 17.190000000000001 109.07 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.979 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -64.54 176.38 0.74 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 17.82 109.879 -179.348 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.979 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.3 112.47 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.606 2.204 . . . . 17.280000000000001 110.112 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.56 172.31 39.54 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.54 -1.424 . . . . 17.219999999999999 109.54 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 3.0 mp -70.67 146.01 50.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -1.165 . . . . 19.57 108.438 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.648 ' CE1' HD13 ' B' ' 6' ' ' ILE . 27.5 m-85 -130.69 163.51 27.08 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.909 -1.119 . . . . 14.609999999999999 110.908 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.663 ' O ' HG22 ' B' ' 84' ' ' VAL . 44.5 p -144.26 117.2 8.82 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.049 -1.834 . . . . 18.359999999999999 106.049 178.562 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -49.86 163.64 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 C-N-CA 118.644 -1.222 . . . . 19.129999999999999 108.734 -178.134 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -128.07 126.79 41.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.338 -0.851 . . . . 20.649999999999999 109.356 -178.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.895 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -74.22 2.48 9.02 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.533 -0.73 . . . . 19.649999999999999 110.008 -179.996 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 84.1 p -58.85 -18.03 29.04 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.512 -1.292 . . . . 14.720000000000001 107.512 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 23.7 m -97.89 -16.39 19.77 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.85 -0.531 . . . . 11.449999999999999 110.172 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.748 ' C ' HD11 ' A' ' 37' ' ' LEU . 3.0 m-30 -68.21 156.98 36.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 14.25 109.454 -178.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.634 ' N ' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -149.89 -179.85 7.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 32.700000000000003 109.715 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.692 HG21 HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -120.75 110.87 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 15.630000000000001 109.061 179.788 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.457 ' N ' ' SD ' ' B' ' 77' ' ' MET . . . -81.85 -174.68 49.75 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.619 -1.392 . . . . 12.699999999999999 109.619 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 1.2 tm0? -90.01 20.27 4.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.168 -1.195 . . . . 26.289999999999999 109.54 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -93.75 -2.7 53.37 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.477 -0.764 . . . . 20.440000000000001 109.349 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 80.96 27.79 48.54 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.533 -1.427 . . . . 13.82 109.533 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.34 153.52 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -1.211 . . . . 18.27 109.788 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.606 HD12 HG13 ' B' ' 70' ' ' VAL . 1.1 tp -62.12 176.83 0.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 12.43 109.584 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' B' ' 69' ' ' LYS . 2.1 ptm -167.71 99.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 35.109999999999999 109.685 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.589 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.9 mt -36.67 -64.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.511 0.672 . . . . 13.67 110.329 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 9.1 t0 84.44 -45.38 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.435 0.636 . . . . 24.059999999999999 110.061 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.9 tpm_? -173.96 67.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.155 0.978 . . . . 35.039999999999999 108.488 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.637 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.2 pt? -40.83 126.78 2.52 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.503 -0.771 . . . . 18.719999999999999 111.984 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 1.4 ttt180 -94.11 110.48 22.19 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.677 -1.231 . . . . 20.550000000000001 107.677 178.221 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.798 ' HB2' HD11 ' B' ' 47' ' ' ILE . 11.7 tp -80.28 150.39 30.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.091 -1.006 . . . . 14.4 111.166 -178.188 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.663 HG22 ' O ' ' B' ' 62' ' ' THR . 21.2 m -146.98 157.89 45.91 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 108.214 -1.032 . . . . 17.649999999999999 108.214 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.0 Cg_endo -62.77 142.1 87.7 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.015 1.81 . . . . 25.699999999999999 110.334 179.134 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -76.57 116.44 17.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.21 -0.931 . . . . 49.289999999999999 109.743 -178.786 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.994 -1.003 . . . . 58.909999999999997 109.44 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.646 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.375 0.607 . . . . 64.909999999999997 109.418 . . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.958 ' HA ' HD22 ' B' ' 65' ' ' LEU . 0.9 OUTLIER -68.62 73.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.664 -1.236 . . . . 33.799999999999997 107.664 178.987 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.646 ' HD3' HD21 ' A' ' 60' ' ' LEU . 1.6 mttt -62.61 157.0 21.75 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.178 0.989 . . . . 32.719999999999999 112.372 -177.669 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.976 HG22 HG22 ' A' ' 35' ' ' VAL . 60.0 t -159.44 169.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.562 -0.903 . . . . 14.460000000000001 108.562 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.606 ' N ' HG12 ' A' ' 4' ' ' VAL . 68.0 mt-10 -152.25 103.02 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.132 -0.98 . . . . 22.120000000000001 109.634 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.906 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -75.36 105.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.853 -1.166 . . . . 14.23 107.853 179.116 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.639 ' HG3' ' CD1' ' A' ' 34' ' ' TYR . 4.9 mttm -55.57 166.13 1.05 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.8 . . . . 25.43 109.704 -179.27 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.7 Cg_endo -72.19 -17.91 27.43 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.925 1.75 . . . . 13.609999999999999 108.955 179.303 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -90.78 -6.46 54.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.984 -0.747 . . . . 15.52 108.984 178.548 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 25.9 mm-40 -120.53 40.62 3.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 17.309999999999999 109.505 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -104.13 14.12 31.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.125 -0.985 . . . . 24.780000000000001 110.017 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 24.3 mt-30 -137.83 137.36 38.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 47.899999999999999 109.911 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.675 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 37.2 p90 -92.53 170.52 9.68 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.363 -0.836 . . . . 21.609999999999999 109.577 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -141.94 162.88 34.38 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.637 -0.875 . . . . 14.890000000000001 108.637 179.129 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.58 111.13 22.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.194 -0.941 . . . . 17.350000000000001 109.187 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -131.46 146.7 52.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.318 -0.864 . . . . 34.380000000000003 109.368 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.01 93.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 38.770000000000003 109.403 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -87.86 -178.87 47.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.402 -1.479 . . . . 34.579999999999998 109.402 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.529 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 2.0 t -138.46 125.11 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 41.869999999999997 108.37 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -73.43 54.24 0.43 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.032 -1.043 . . . . 47.210000000000001 109.638 -179.286 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.452 ' C ' ' CG ' ' A' ' 22' ' ' GLN . 0.8 OUTLIER 66.82 -59.76 0.36 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.3 -0.875 . . . . 71.560000000000002 109.267 -179.736 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 20' ' ' SER . 10.5 mt-30 -153.49 26.82 0.51 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 66.599999999999994 109.445 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 24' ' ' LYS . . . -112.29 37.85 3.5 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.275 -1.53 . . . . 55.490000000000002 109.275 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.556 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 73.54 174.92 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.546 -0.973 . . . . 44.990000000000002 109.213 -179.741 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.556 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 34.6 Cg_endo -77.29 132.83 12.79 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.592 2.195 . . . . 44.100000000000001 110.714 -179.605 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 28' ' ' LEU . 4.9 p90 -119.6 144.2 47.24 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.167 -0.958 . . . . 32.090000000000003 109.721 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.444 ' C ' HD22 ' A' ' 28' ' ' LEU . 1.1 m -96.08 78.02 3.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.189 -0.945 . . . . 29.25 108.788 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 4.0 mm? -110.66 164.5 12.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.857 . . . . 24.0 109.984 -179.178 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 95.0 m-20 -74.51 119.59 18.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.446 -0.784 . . . . 23.309999999999999 109.318 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -108.53 143.96 36.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.083 -1.011 . . . . 40.030000000000001 109.242 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.724 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -130.18 -179.9 5.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 12.390000000000001 109.548 -179.857 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.864 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.2 mp -133.78 159.15 41.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 17.420000000000002 109.795 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.61 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.7 m -152.09 177.54 10.39 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.992 -1.114 . . . . 13.84 107.992 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.674 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 51.4 m-85 -126.88 122.65 35.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.895 -1.128 . . . . 21.140000000000001 110.095 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.976 HG22 HG22 ' A' ' 4' ' ' VAL . 96.7 t -109.35 129.24 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.215 -0.928 . . . . 10.66 109.964 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -121.64 -14.68 8.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.405 -0.81 . . . . 25.890000000000001 109.81 -179.593 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.09 HD12 ' N ' ' A' ' 38' ' ' GLY . 2.6 pp -36.61 -29.74 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.653 -0.654 . . . . 24.239999999999998 110.551 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 1.09 ' N ' HD12 ' A' ' 37' ' ' LEU . . . -124.59 19.7 7.02 Favored Glycine 0 N--CA 1.482 1.734 0 N-CA-C 109.565 -1.414 . . . . 31.02 109.565 -179.012 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.599 ' ND2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -165.43 114.49 1.03 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.322 -1.105 . . . . 43.229999999999997 109.14 179.84 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 39' ' ' ASN . 39.8 mt-10 -39.08 -66.59 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.663 . . . . 42.340000000000003 109.946 -179.598 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 41' ' ' HIS . 2.1 m-70 -63.5 153.36 83.09 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 108.224 -1.028 . . . . 6.3700000000000001 108.224 179.355 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.674 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -78.38 138.39 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.889 1.726 . . . . 17.920000000000002 110.277 -179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 43' ' ' VAL . 5.0 m -109.44 116.93 53.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.419 -0.801 . . . . 20.57 109.131 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.864 HD11 ' HB3' ' A' ' 32' ' ' LEU . 57.2 tp -71.86 108.13 4.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.276 -0.89 . . . . 20.210000000000001 109.937 -179.428 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.676 HG12 HG11 ' B' ' 70' ' ' VAL . 1.1 m -103.44 175.67 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.002 -0.74 . . . . 10.81 109.002 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -105.48 125.6 51.17 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.302 -0.959 . . . . 36.740000000000002 109.338 179.553 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.098 HD13 HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -120.9 132.33 70.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.277 -0.89 . . . . 19.739999999999998 109.602 -179.689 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 49' ' ' LEU . 60.1 m -66.63 156.71 34.41 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.246 -0.908 . . . . 22.559999999999999 109.299 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.707 HD11 ' O ' ' A' ' 53' ' ' GLN . 2.8 tm? -130.09 111.27 12.31 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.321 -0.862 . . . . 20.41 108.744 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.507 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -42.4 122.53 2.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 33.990000000000002 109.945 -179.2 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -51.02 101.67 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.353 -0.842 . . . . 54.920000000000002 109.277 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.44 -24.08 10.0 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.263 -1.535 . . . . 36.100000000000001 109.263 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.707 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -73.61 157.97 86.94 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.293 -1.122 . . . . 54.759999999999998 109.351 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -78.79 114.34 3.42 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.529 2.153 . . . . 28.370000000000001 110.142 179.546 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.724 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -38.81 142.01 0.24 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.477 -0.764 . . . . 17.210000000000001 109.888 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.906 ' O ' HG21 ' A' ' 6' ' ' ILE . 88.5 m-85 -41.9 101.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.393 -0.817 . . . . 17.190000000000001 109.408 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.795 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.72 169.36 0.21 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.16 -0.963 . . . . 17.82 109.207 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.795 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.25 122.11 6.0 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.62 2.213 . . . . 17.280000000000001 110.457 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.97 179.89 40.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.526 -1.43 . . . . 17.219999999999999 109.526 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -72.96 138.51 46.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -1.175 . . . . 19.57 108.448 179.294 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.759 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.2 m-85 -125.11 162.11 25.32 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.611 -1.306 . . . . 14.609999999999999 111.738 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 84' ' ' VAL . 58.8 p -144.74 120.62 10.62 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.505 -1.665 . . . . 18.359999999999999 106.505 179.06 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -54.6 165.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 C-N-CA 118.581 -1.248 . . . . 19.129999999999999 109.136 -178.472 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -127.55 127.07 43.3 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.523 -0.736 . . . . 20.649999999999999 109.031 -179.227 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.09 ' CD1' HD13 ' B' ' 37' ' ' LEU . 0.4 OUTLIER -69.31 -2.89 11.92 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.569 -0.707 . . . . 19.649999999999999 109.797 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 t -54.37 -19.67 5.96 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 107.775 -1.194 . . . . 14.720000000000001 107.775 179.151 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 82' ' ' ARG . 3.8 m -94.7 -8.84 36.59 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.756 -0.59 . . . . 11.449999999999999 110.188 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.685 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.3 m-30 -85.34 156.76 20.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.882 -1.136 . . . . 14.25 109.462 -179.272 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.431 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -148.52 176.54 10.23 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.054 -0.721 . . . . 32.700000000000003 109.054 179.545 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.702 HG11 HG12 ' B' ' 45' ' ' VAL . 1.7 t -127.23 118.43 49.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.302 -0.874 . . . . 15.630000000000001 109.474 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 72' ' ' GLN . . . -82.5 -99.46 0.48 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.326 -1.509 . . . . 12.699999999999999 109.326 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.589 ' O ' ' CG ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER 170.33 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -1.129 . . . . 26.289999999999999 109.565 179.754 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER 151.72 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.784 -0.821 . . . . 20.440000000000001 108.784 179.923 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -114.5 -88.06 1.56 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.442 -1.463 . . . . 13.82 109.442 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.44 ' HA ' ' HB ' ' B' ' 45' ' ' VAL . 0.2 OUTLIER 177.93 174.73 0.53 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -1.145 . . . . 18.27 109.678 -179.989 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' A' ' 77' ' ' MET . 6.3 tp -43.51 146.61 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 12.43 109.659 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.533 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 5.1 mtt -151.85 151.22 31.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 35.109999999999999 109.272 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.619 HG12 ' CE1' ' A' ' 68' ' ' PHE . 6.5 mt -76.96 137.26 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 13.67 110.308 -179.52 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -104.89 -26.73 12.09 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.931 -1.137 . . . . 24.059999999999999 107.931 178.419 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER 179.02 69.95 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.021 -1.474 . . . . 35.039999999999999 107.021 179.014 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -30.19 121.43 0.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.342 -0.845 . . . . 18.719999999999999 111.71 -178.038 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.51 ' N ' ' OG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -91.85 101.27 13.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 20.550000000000001 108.808 179.398 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.098 HD12 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -70.08 145.85 51.35 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.946 0.879 . . . . 14.4 110.883 -179.02 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 62' ' ' THR . 25.6 m -148.73 156.75 41.43 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 107.793 -1.188 . . . . 17.649999999999999 107.793 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.0 Cg_endo -63.79 140.02 71.73 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.979 1.786 . . . . 25.699999999999999 110.15 179.023 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.724 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -71.44 118.31 14.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.939 . . . . 49.289999999999999 109.64 -178.703 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.012 -0.994 . . . . 58.909999999999997 109.435 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.64 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.371 0.605 . . . . 64.909999999999997 109.408 . . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.95 ' HA ' HD22 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -68.73 73.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.699 -1.223 . . . . 33.799999999999997 107.699 179.028 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.647 ' HD3' HD21 ' B' ' 60' ' ' LEU . 1.5 mttt -62.63 156.82 22.29 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.157 0.979 . . . . 32.719999999999999 112.352 -177.623 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.012 HG22 HG22 ' B' ' 35' ' ' VAL . 60.4 t -159.42 168.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.552 -0.906 . . . . 14.460000000000001 108.552 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.613 ' N ' HG12 ' B' ' 4' ' ' VAL . 68.6 mt-10 -152.22 103.02 2.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 22.120000000000001 109.648 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.91 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -75.4 106.06 4.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.79 -1.189 . . . . 14.23 107.79 179.18 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.641 ' HD2' ' CE1' ' B' ' 34' ' ' TYR . 4.9 mttm -55.75 166.23 1.08 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.492 -0.755 . . . . 25.43 109.709 -179.241 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.9 Cg_endo -72.05 -18.01 27.82 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.987 1.791 . . . . 13.609999999999999 109.003 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -90.77 -6.4 54.41 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.988 -0.745 . . . . 15.52 108.988 178.64 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 26.3 mm-40 -120.68 40.73 3.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.895 . . . . 17.309999999999999 109.413 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -104.28 14.17 30.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 24.780000000000001 109.976 -179.346 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.404 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 24.7 mt-30 -137.86 137.34 38.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.148 -0.97 . . . . 47.899999999999999 109.854 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.658 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 37.2 p90 -92.47 170.59 9.64 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.398 -0.814 . . . . 21.609999999999999 109.568 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -141.91 163.02 34.03 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.57 -0.9 . . . . 14.890000000000001 108.57 179.136 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.64 111.15 22.54 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.217 -0.927 . . . . 17.350000000000001 109.18 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -131.49 146.77 52.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.32 -0.863 . . . . 34.380000000000003 109.359 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.98 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 38.770000000000003 109.435 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.565 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -87.92 -178.96 47.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.447 -1.461 . . . . 34.579999999999998 109.447 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.526 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.9 t -138.32 125.09 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -1.155 . . . . 41.869999999999997 108.43 179.31 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.523 ' O ' ' N ' ' B' ' 22' ' ' GLN . 0.3 OUTLIER -73.5 54.35 0.45 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.066 -1.021 . . . . 47.210000000000001 109.599 -179.256 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.463 ' C ' ' CG ' ' B' ' 22' ' ' GLN . 0.7 OUTLIER 66.76 -59.86 0.36 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.266 -0.896 . . . . 71.560000000000002 109.288 -179.73 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' B' ' 20' ' ' SER . 10.4 mt-30 -153.44 26.95 0.51 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 66.599999999999994 109.472 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' B' ' 24' ' ' LYS . . . -112.43 37.94 3.45 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.219 -1.553 . . . . 55.490000000000002 109.219 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.545 ' CG ' ' HD2' ' B' ' 25' ' ' PRO . 0.0 OUTLIER 73.35 175.03 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.391 -1.064 . . . . 44.990000000000002 109.266 -179.738 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' B' ' 24' ' ' LYS . 34.2 Cg_endo -77.39 132.84 12.69 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.559 2.173 . . . . 44.100000000000001 110.737 -179.599 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' B' ' 28' ' ' LEU . 4.9 p90 -119.55 144.14 47.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.938 . . . . 32.090000000000003 109.75 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.448 ' C ' HD22 ' B' ' 28' ' ' LEU . 1.1 m -96.06 78.15 3.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 29.25 108.686 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 4.1 mm? -110.71 164.64 12.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 24.0 109.998 -179.27 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.593 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 95.4 m-20 -74.71 119.44 18.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.439 -0.788 . . . . 23.309999999999999 109.33 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -108.37 144.08 36.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.069 -1.019 . . . . 40.030000000000001 109.2 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.704 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.5 OUTLIER -130.27 -179.9 5.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -0.994 . . . . 12.390000000000001 109.51 -179.902 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.3 mp -133.76 159.16 41.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 17.420000000000002 109.722 -179.782 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.614 ' O ' HD12 ' B' ' 44' ' ' LEU . 2.8 m -152.07 177.76 10.16 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.008 -1.108 . . . . 13.84 108.008 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.68 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 50.7 m-85 -127.19 122.58 34.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.881 -1.137 . . . . 21.140000000000001 110.091 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 1.012 HG22 HG22 ' B' ' 4' ' ' VAL . 96.6 t -109.27 129.16 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.234 -0.916 . . . . 10.66 109.937 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' B' ' 36' ' ' ASP . 0.4 OUTLIER -121.48 -14.68 8.19 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.432 -0.793 . . . . 25.890000000000001 109.788 -179.654 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 1.093 HD12 ' N ' ' B' ' 38' ' ' GLY . 2.6 pp -36.6 -29.7 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.654 -0.654 . . . . 24.239999999999998 110.58 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 1.093 ' N ' HD12 ' B' ' 37' ' ' LEU . . . -124.65 19.58 7.02 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 109.591 -1.404 . . . . 31.02 109.591 -178.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.605 ' ND2' HG11 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -165.43 114.68 1.03 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.38 -1.07 . . . . 43.229999999999997 109.056 179.832 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' B' ' 39' ' ' ASN . 39.9 mt-10 -39.12 -66.48 0.28 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.536 0.684 . . . . 42.340000000000003 110.057 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 41' ' ' HIS . . . . . 0.436 ' ND1' ' N ' ' B' ' 41' ' ' HIS . 2.1 m-70 -63.56 153.39 83.21 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.223 -1.029 . . . . 6.3799999999999999 108.223 179.28 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.68 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 38.2 Cg_endo -78.42 138.29 15.51 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.85 1.7 . . . . 17.920000000000002 110.241 -179.357 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.668 ' O ' HG23 ' B' ' 43' ' ' VAL . 4.8 m -109.37 116.99 53.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.423 -0.798 . . . . 20.57 109.191 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' B' ' 32' ' ' LEU . 57.0 tp -71.69 108.11 4.86 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.86 . . . . 20.210000000000001 109.982 -179.433 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.702 HG12 HG11 ' A' ' 70' ' ' VAL . 1.1 m -103.48 175.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.466 -0.771 . . . . 10.81 109.055 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -105.44 125.37 50.91 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.385 -0.926 . . . . 36.740000000000002 109.431 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 1.056 HD13 HD12 ' B' ' 83' ' ' LEU . 1.0 OUTLIER -120.72 132.39 70.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.334 -0.854 . . . . 19.739999999999998 109.608 -179.638 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.433 HG22 ' N ' ' B' ' 49' ' ' LEU . 59.8 m -66.72 156.81 34.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 22.559999999999999 109.238 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.707 HD11 ' O ' ' B' ' 53' ' ' GLN . 2.8 tm? -130.17 111.28 12.28 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.288 -0.883 . . . . 20.41 108.746 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.515 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -42.43 122.62 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 33.990000000000002 109.944 -179.124 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -51.06 101.64 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.356 -0.84 . . . . 54.920000000000002 109.322 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.47 -24.0 10.03 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.297 -1.521 . . . . 36.100000000000001 109.297 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.707 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.8 OUTLIER -73.79 157.85 86.83 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.295 -1.12 . . . . 54.759999999999998 109.362 179.883 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.7 114.47 3.46 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.518 2.145 . . . . 28.370000000000001 110.098 179.582 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.704 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -38.82 141.76 0.26 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.465 -0.772 . . . . 17.210000000000001 109.949 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.91 ' O ' HG21 ' B' ' 6' ' ' ILE . 88.7 m-85 -41.5 100.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.439 -0.788 . . . . 17.190000000000001 109.317 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -50.01 169.5 0.19 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.987 . . . . 17.82 109.287 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.6 Cg_endo -77.06 120.84 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.48 2.12 . . . . 17.280000000000001 110.188 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.35 179.07 41.59 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.69 -1.364 . . . . 17.219999999999999 109.69 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -73.18 137.98 45.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -1.153 . . . . 19.57 107.969 178.884 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.753 ' HB3' HD22 ' B' ' 83' ' ' LEU . 21.2 m-85 -124.55 162.35 24.23 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.502 -1.374 . . . . 14.609999999999999 111.703 -179.44 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.796 ' O ' HG22 ' B' ' 84' ' ' VAL . 58.1 p -144.86 120.46 10.43 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.492 -1.67 . . . . 18.359999999999999 106.492 179.08 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -54.4 166.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 C-N-CA 118.578 -1.249 . . . . 19.129999999999999 109.056 -178.451 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.484 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -128.27 127.2 42.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.033 -0.728 . . . . 20.649999999999999 109.033 -179.275 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 1.075 ' CD1' HD13 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -69.36 -2.75 11.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.514 -0.741 . . . . 19.649999999999999 109.771 -179.964 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 9.2 t -54.54 -19.52 6.04 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 107.729 -1.211 . . . . 14.720000000000001 107.729 179.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' B' ' 82' ' ' ARG . 3.8 m -95.1 -9.26 34.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.829 -0.544 . . . . 11.449999999999999 110.147 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.3 m-30 -84.93 155.89 21.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.878 -1.139 . . . . 14.25 109.269 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.423 ' O ' HD12 ' B' ' 76' ' ' LEU . 0.2 OUTLIER -147.77 176.56 10.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.497 -0.752 . . . . 32.700000000000003 109.016 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.676 HG11 HG12 ' A' ' 45' ' ' VAL . 1.7 t -127.13 118.63 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.867 . . . . 15.630000000000001 109.476 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' B' ' 72' ' ' GLN . . . -82.69 -99.2 0.5 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.4 -1.48 . . . . 12.699999999999999 109.4 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.579 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER 170.1 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.191 -1.181 . . . . 26.289999999999999 109.569 179.769 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.579 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 0.7 OUTLIER 151.61 -33.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.768 -0.827 . . . . 20.440000000000001 108.768 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -114.68 -87.76 1.51 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.487 -1.445 . . . . 13.82 109.487 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 177.58 174.69 0.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -1.154 . . . . 18.27 109.606 179.931 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' B' ' 77' ' ' MET . 6.3 tp -43.6 146.49 0.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 12.43 109.633 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.517 ' N ' ' HG ' ' B' ' 76' ' ' LEU . 5.0 mtt -151.74 151.34 31.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.383 -0.823 . . . . 35.109999999999999 109.13 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.628 HG12 ' CE1' ' B' ' 68' ' ' PHE . 6.5 mt -77.16 137.47 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 13.67 110.351 -179.571 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -104.84 -26.71 12.12 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.91 -1.144 . . . . 24.059999999999999 107.91 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.0 OUTLIER 178.99 70.03 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.006 -1.479 . . . . 35.039999999999999 107.006 179.054 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.645 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -30.19 121.5 0.18 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.3 -0.864 . . . . 18.719999999999999 111.697 -178.055 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.513 ' N ' ' OG ' ' B' ' 67' ' ' SER . 0.0 OUTLIER -91.84 101.45 14.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.832 -0.803 . . . . 20.550000000000001 108.832 179.37 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.056 HD12 HD13 ' B' ' 47' ' ' ILE . 0.6 OUTLIER -70.2 145.54 51.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 14.4 110.9 -179.073 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.796 HG22 ' O ' ' B' ' 62' ' ' THR . 25.8 m -148.49 156.95 42.24 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 107.714 -1.217 . . . . 17.649999999999999 107.714 179.369 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.4 Cg_endo -64.01 140.21 71.31 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.936 1.757 . . . . 25.699999999999999 110.034 179.1 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -71.55 118.29 14.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 49.289999999999999 109.693 -178.734 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.979 -1.01 . . . . 58.909999999999997 109.428 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.504 ' CG ' ' HB ' ' A' ' 62' ' ' THR . 1.5 ttp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.307 0.575 . . . . 64.909999999999997 109.565 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.908 ' CA ' HD22 ' B' ' 65' ' ' LEU . 5.2 mt -71.32 75.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.134 -1.062 . . . . 33.799999999999997 108.134 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.02 156.38 24.87 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.907 0.86 . . . . 32.719999999999999 111.155 -178.283 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.833 HG11 HD11 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -163.85 167.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.464 -0.939 . . . . 14.460000000000001 108.464 179.983 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.533 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 34.3 mt-10 -141.01 113.55 8.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 22.120000000000001 109.59 -179.66 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -72.83 103.28 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.106 -1.072 . . . . 14.23 108.106 179.346 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.597 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 24.2 mmmt -51.49 163.41 0.59 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 25.43 109.369 -179.471 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.9 Cg_endo -73.04 -12.61 25.97 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.059 1.839 . . . . 13.609999999999999 109.383 179.508 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.6 3.72 54.75 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.615 -0.883 . . . . 15.52 108.615 178.491 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.556 ' OE1' HD13 ' A' ' 32' ' ' LEU . 13.8 mm-40 -127.38 41.32 3.54 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.374 -0.829 . . . . 17.309999999999999 108.86 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -98.23 11.76 36.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 24.780000000000001 110.258 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 32.4 mt-30 -136.42 134.43 37.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.123 -0.985 . . . . 47.899999999999999 110.121 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.634 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 20.4 p90 -84.72 164.83 18.32 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.318 -0.863 . . . . 21.609999999999999 109.436 179.735 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -130.89 140.31 50.19 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.349 -0.844 . . . . 14.890000000000001 109.256 179.026 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.952 HG23 ' O ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -107.35 115.39 30.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.413 -0.805 . . . . 17.350000000000001 109.225 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.461 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -129.14 72.78 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.062 -1.024 . . . . 34.380000000000003 109.663 -179.819 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER 38.65 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.331 0.586 . . . . 38.770000000000003 109.906 179.681 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -89.42 154.04 23.87 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.643 -1.383 . . . . 34.579999999999998 109.643 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.482 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 2.4 t -128.88 123.79 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -1.171 . . . . 41.869999999999997 109.012 179.595 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.409 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 3.4 m -56.47 -93.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 47.210000000000001 109.732 -179.295 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.472 ' NH1' ' HG3' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -127.82 58.91 1.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.169 -0.957 . . . . 71.560000000000002 109.482 -179.873 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 56.4 18.72 3.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 66.599999999999994 109.308 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.34 -52.49 0.63 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.418 -1.473 . . . . 55.490000000000002 109.418 179.944 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -138.48 143.04 36.78 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.344 -1.092 . . . . 44.990000000000002 109.167 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.9 145.08 19.56 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.533 2.156 . . . . 44.100000000000001 110.923 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.61 ' CE1' ' HB2' ' A' ' 28' ' ' LEU . 4.5 p90 -145.73 136.83 24.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.285 -0.884 . . . . 32.090000000000003 109.235 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 m -100.85 79.41 2.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 29.25 109.154 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.952 ' O ' HG23 ' A' ' 15' ' ' THR . 0.2 OUTLIER -92.54 169.36 10.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 24.0 109.997 -179.484 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.634 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -103.04 131.57 49.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.461 -0.774 . . . . 23.309999999999999 109.206 -179.863 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -117.19 148.58 41.48 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.064 -1.022 . . . . 40.030000000000001 109.76 -179.762 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.789 ' HB2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -126.9 -163.91 1.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.172 -0.955 . . . . 12.390000000000001 109.496 179.729 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.013 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -136.35 177.98 7.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 17.420000000000002 109.609 -179.794 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.584 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -171.74 162.52 6.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 13.84 108.709 -179.768 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.751 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.5 m-30 -115.5 111.43 20.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.249 -0.907 . . . . 21.140000000000001 108.761 -179.848 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.832 ' O ' HG22 ' A' ' 43' ' ' VAL . 99.2 t -100.81 144.74 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.896 -1.127 . . . . 10.66 110.51 -179.602 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -125.54 -137.8 0.27 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.517 -0.92 . . . . 25.890000000000001 108.517 179.455 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.88 ' HB3' HD11 ' B' ' 65' ' ' LEU . 0.2 OUTLIER 68.48 -62.68 0.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.825 -1.172 . . . . 24.239999999999998 108.818 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -88.53 24.29 12.72 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.647 -1.781 . . . . 31.02 108.647 179.21 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.786 ' ND2' HG11 ' A' ' 43' ' ' VAL . 0.3 OUTLIER 176.39 114.41 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.548 -0.972 . . . . 43.229999999999997 108.655 -179.731 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 39' ' ' ASN . 4.3 mt-10 -38.91 -64.07 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.618 0.723 . . . . 42.340000000000003 109.995 -179.336 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -68.6 162.74 60.37 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 108.745 -0.835 . . . . 8.0199999999999996 108.745 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.647 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.5 Cg_endo -78.12 148.83 24.83 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.126 1.884 . . . . 17.920000000000002 110.307 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.965 HG21 HG21 ' B' ' 70' ' ' VAL . 18.5 m -119.74 119.53 60.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.294 -0.879 . . . . 20.57 109.262 179.363 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.013 HD11 ' HB3' ' A' ' 32' ' ' LEU . 20.6 tp -71.65 114.12 9.39 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.426 0.632 . . . . 20.210000000000001 109.557 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.482 HG23 ' N ' ' B' ' 75' ' ' SER . 3.3 p -122.09 163.05 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.455 -0.778 . . . . 10.81 109.316 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.67 173.05 12.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.919 . . . . 36.740000000000002 110.369 -179.167 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.697 HD12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -163.96 131.4 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.484 -0.932 . . . . 19.739999999999998 108.484 179.97 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.486 ' CG2' HD22 ' A' ' 28' ' ' LEU . 3.8 m -74.82 154.45 38.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.894 -1.129 . . . . 22.559999999999999 109.464 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.789 HD23 ' HB2' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -123.35 119.98 31.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -0.866 . . . . 20.41 109.037 -179.839 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.512 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -53.95 137.41 39.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 33.990000000000002 109.875 -179.455 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -57.36 118.21 4.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 54.920000000000002 109.244 179.79 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.74 -12.23 69.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.341 -1.504 . . . . 36.100000000000001 109.341 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -79.84 148.74 69.34 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.26 -1.141 . . . . 54.759999999999998 109.37 179.871 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.3 Cg_endo -77.08 121.08 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.589 2.193 . . . . 28.370000000000001 110.319 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.782 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -37.82 145.69 0.07 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.578 -0.702 . . . . 17.210000000000001 110.607 -179.597 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.697 ' CE1' HD12 ' A' ' 47' ' ' ILE . 75.2 m-85 -43.74 105.36 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.41 -0.806 . . . . 17.190000000000001 109.226 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.989 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.37 176.03 0.24 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 17.82 109.67 -179.532 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.989 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.54 115.16 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.645 2.23 . . . . 17.280000000000001 110.353 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.23 176.33 41.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.667 -1.373 . . . . 17.219999999999999 109.667 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.0 mp -73.33 145.34 46.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 19.57 108.842 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.698 ' C ' HG13 ' A' ' 4' ' ' VAL . 38.8 m-85 -132.56 162.8 30.34 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.43 1.11 . . . . 14.609999999999999 111.103 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.706 ' O ' HG22 ' A' ' 84' ' ' VAL . 38.7 p -142.32 121.83 13.27 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.945 -1.872 . . . . 18.359999999999999 105.945 178.16 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.679 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.0 t -55.26 163.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 C-N-CA 118.372 -1.331 . . . . 19.129999999999999 109.017 -177.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -123.05 130.99 53.5 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.49 -0.756 . . . . 20.649999999999999 109.383 -178.739 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.907 HD11 ' HB3' ' B' ' 37' ' ' LEU . 0.7 OUTLIER -73.87 2.85 7.61 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.475 -0.766 . . . . 19.649999999999999 109.853 179.827 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -56.2 -19.49 13.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 107.176 -1.416 . . . . 14.720000000000001 107.176 178.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.51 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 4.1 m -96.47 -7.01 35.9 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 116.057 -0.52 . . . . 11.449999999999999 110.212 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.686 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.1 m-30 -83.95 161.95 20.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.985 -1.072 . . . . 14.25 109.848 -178.856 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.76 170.13 22.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.453 -0.78 . . . . 32.700000000000003 109.326 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.937 HG21 ' CG2' ' B' ' 43' ' ' VAL . 0.5 OUTLIER -121.36 116.74 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 15.630000000000001 109.156 179.733 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.71 -170.82 17.73 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.763 -1.335 . . . . 12.699999999999999 109.763 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.537 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.1 tm0? -89.67 20.9 3.75 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.248 -1.148 . . . . 26.289999999999999 109.468 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 5.7 t80 -112.47 10.25 19.69 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.315 -0.866 . . . . 20.440000000000001 109.573 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' HG23 ' B' ' 45' ' ' VAL . . . 63.02 56.25 21.82 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.597 -1.401 . . . . 13.82 109.597 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.537 ' N ' HG23 ' B' ' 45' ' ' VAL . 1.4 m -157.27 120.06 3.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -1.146 . . . . 18.27 109.585 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -70.46 155.38 40.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 12.43 109.312 179.817 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 45.8 mtm -163.64 130.81 3.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 35.109999999999999 109.736 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.955 HD12 HD12 ' B' ' 78' ' ' ILE . 2.5 mp -64.64 142.0 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 13.67 109.805 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -105.59 -36.14 7.2 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.131 -1.063 . . . . 24.059999999999999 108.131 178.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.51 ' C ' ' HB3' ' A' ' 67' ' ' SER . 2.1 ttp180 -170.34 68.07 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 106.851 -1.537 . . . . 35.039999999999999 106.851 178.886 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.679 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -29.46 117.12 0.12 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.243 -0.889 . . . . 18.719999999999999 112.063 -177.674 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -92.21 113.0 25.15 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.004 -1.11 . . . . 20.550000000000001 108.004 178.825 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.833 HD11 HG11 ' A' ' 4' ' ' VAL . 15.3 tp -81.91 153.39 26.34 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.078 0.942 . . . . 14.4 111.023 -178.499 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 62' ' ' THR . 33.0 m -152.23 152.14 28.86 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.831 -1.174 . . . . 17.649999999999999 107.831 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.4 Cg_endo -60.99 141.54 94.77 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.019 1.812 . . . . 25.699999999999999 110.537 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.557 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.81 122.57 22.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 49.289999999999999 109.702 -178.645 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.979 -1.01 . . . . 58.909999999999997 109.446 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.507 ' CG ' ' HB ' ' B' ' 62' ' ' THR . 1.5 ttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.525 -0.546 . . . . 64.909999999999997 109.525 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.89 ' CA ' HD22 ' A' ' 65' ' ' LEU . 5.3 mt -71.68 75.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.119 -1.067 . . . . 33.799999999999997 108.119 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.01 156.19 25.39 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.917 0.865 . . . . 32.719999999999999 111.179 -178.277 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.837 HG11 HD11 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -163.67 167.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.468 -0.938 . . . . 14.460000000000001 108.468 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.544 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 34.5 mt-10 -141.04 113.63 8.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.958 . . . . 22.120000000000001 109.566 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.598 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -72.92 103.23 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.164 -1.05 . . . . 14.23 108.164 179.317 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.589 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 24.1 mmmt -51.44 163.34 0.59 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.322 -0.861 . . . . 25.43 109.338 -179.45 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.3 Cg_endo -73.05 -12.54 25.9 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.05 1.833 . . . . 13.609999999999999 109.437 179.488 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.63 3.63 54.84 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.584 -0.895 . . . . 15.52 108.584 178.467 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.57 ' OE1' HD13 ' B' ' 32' ' ' LEU . 13.7 mm-40 -127.18 41.12 3.58 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.385 -0.822 . . . . 17.309999999999999 108.898 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -98.08 11.92 36.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 24.780000000000001 110.294 -179.121 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.428 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 32.7 mt-30 -136.46 134.35 37.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.997 . . . . 47.899999999999999 110.158 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.652 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 20.6 p90 -84.7 164.8 18.36 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.355 -0.841 . . . . 21.609999999999999 109.465 179.701 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -130.86 140.34 50.22 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.39 -0.819 . . . . 14.890000000000001 109.29 179.047 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 15' ' ' THR . . . . . 0.951 HG23 ' O ' ' B' ' 28' ' ' LEU . 0.4 OUTLIER -107.3 115.26 29.86 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.333 -0.854 . . . . 17.350000000000001 109.269 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 16' ' ' ARG . . . . . 0.459 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.7 OUTLIER -129.02 72.78 1.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.004 . . . . 34.380000000000003 109.711 -179.898 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 17' ' ' SER . . . . . 0.459 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.6 OUTLIER 38.62 90.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.396 0.617 . . . . 38.770000000000003 109.905 179.73 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.591 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -89.59 154.01 23.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.677 -1.369 . . . . 34.579999999999998 109.677 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.483 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 2.4 t -128.82 123.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -1.143 . . . . 41.869999999999997 109.003 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.408 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 3.4 m -56.48 -93.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.356 -0.84 . . . . 47.210000000000001 109.78 -179.386 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.462 ' NH1' ' HG3' ' B' ' 21' ' ' ARG . 0.8 OUTLIER -127.8 58.96 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.146 -0.971 . . . . 71.560000000000002 109.479 -179.87 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 56.32 18.66 3.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 66.599999999999994 109.337 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.3 -52.54 0.63 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.379 -1.489 . . . . 55.490000000000002 109.379 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -138.45 143.16 37.34 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.256 -1.144 . . . . 44.990000000000002 109.164 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.94 145.01 19.4 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.512 2.141 . . . . 44.100000000000001 110.915 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.617 ' CE1' ' HB2' ' B' ' 28' ' ' LEU . 4.4 p90 -145.66 136.81 24.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -0.872 . . . . 32.090000000000003 109.173 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.8 m -100.75 79.52 2.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.96 . . . . 29.25 109.137 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.951 ' O ' HG23 ' B' ' 15' ' ' THR . 0.2 OUTLIER -92.59 169.28 10.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.942 . . . . 24.0 110.018 -179.557 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.652 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -103.01 131.58 49.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.715 . . . . 23.309999999999999 109.155 -179.928 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.5 OUTLIER -117.13 148.53 41.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 40.030000000000001 109.708 -179.74 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.796 ' HB2' HD23 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -126.78 -163.84 1.28 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.173 -0.955 . . . . 12.390000000000001 109.503 179.704 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.992 ' HB3' HD11 ' B' ' 44' ' ' LEU . 0.5 OUTLIER -136.46 177.92 7.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 17.420000000000002 109.573 -179.785 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.58 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -171.69 162.56 6.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.018 -1.051 . . . . 13.84 108.718 -179.679 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.764 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.5 m-30 -115.6 111.4 20.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 21.140000000000001 108.763 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.814 ' O ' HG22 ' B' ' 43' ' ' VAL . 99.4 t -100.87 144.65 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.896 -1.128 . . . . 10.66 110.521 -179.541 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.7 OUTLIER -125.46 -137.87 0.27 Allowed 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.519 -0.919 . . . . 25.890000000000001 108.519 179.462 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.907 ' HB3' HD11 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 68.5 -62.71 0.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.877 -1.139 . . . . 24.239999999999998 108.754 -179.974 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -88.41 24.12 13.1 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 108.589 -1.804 . . . . 31.02 108.589 179.291 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.781 ' ND2' HG11 ' B' ' 43' ' ' VAL . 0.3 OUTLIER 176.48 114.39 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.588 -0.948 . . . . 43.229999999999997 108.644 -179.722 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' B' ' 39' ' ' ASN . 4.4 mt-10 -38.77 -64.21 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.511 -0.743 . . . . 42.340000000000003 109.985 -179.306 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -68.51 162.92 58.47 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 108.722 -0.844 . . . . 8.0399999999999991 108.722 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.644 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.0 Cg_endo -78.19 148.8 24.58 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.159 1.906 . . . . 17.920000000000002 110.314 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.937 ' CG2' HG21 ' A' ' 70' ' ' VAL . 18.5 m -119.71 119.66 61.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 119.575 -0.85 . . . . 20.57 109.222 179.297 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.992 HD11 ' HB3' ' B' ' 32' ' ' LEU . 20.4 tp -71.75 114.28 9.67 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.464 0.649 . . . . 20.210000000000001 109.52 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 75' ' ' SER . 3.1 p -122.18 162.78 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.478 -0.763 . . . . 10.81 109.327 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 172.95 12.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.908 . . . . 36.740000000000002 110.374 -179.163 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.7 HD12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -163.89 131.37 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.513 -0.921 . . . . 19.739999999999998 108.513 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.48 ' CG2' HD22 ' B' ' 28' ' ' LEU . 3.8 m -74.84 154.17 38.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.918 -1.114 . . . . 22.559999999999999 109.461 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.796 HD23 ' HB2' ' B' ' 31' ' ' GLN . 0.1 OUTLIER -123.09 120.1 32.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.361 -0.837 . . . . 20.41 109.059 -179.845 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -54.02 137.37 39.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 33.990000000000002 109.845 -179.391 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.28 118.36 5.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -0.865 . . . . 54.920000000000002 109.22 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 -12.21 69.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.342 -1.503 . . . . 36.100000000000001 109.342 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.516 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -79.85 148.73 69.28 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.261 -1.141 . . . . 54.759999999999998 109.361 179.92 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.4 Cg_endo -77.15 120.95 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.579 2.186 . . . . 28.370000000000001 110.367 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.791 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -37.6 145.46 0.06 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.611 -0.681 . . . . 17.210000000000001 110.68 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.7 ' CE1' HD12 ' B' ' 47' ' ' ILE . 75.5 m-85 -43.57 105.13 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.49 -0.756 . . . . 17.190000000000001 109.155 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.26 176.04 0.24 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 17.82 109.75 -179.546 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -78.38 114.48 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.678 2.252 . . . . 17.280000000000001 110.182 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.38 176.12 42.5 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.687 -1.365 . . . . 17.219999999999999 109.687 -179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 2.8 mp -73.56 145.13 45.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -1.161 . . . . 19.57 108.664 179.33 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.687 ' C ' HG13 ' B' ' 4' ' ' VAL . 38.3 m-85 -132.27 162.66 30.43 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 122.461 1.124 . . . . 14.609999999999999 111.155 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.702 ' O ' HG22 ' B' ' 84' ' ' VAL . 38.5 p -142.22 121.69 13.24 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.976 -1.861 . . . . 18.359999999999999 105.976 178.185 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.664 HG11 ' HB2' ' B' ' 81' ' ' LEU . 1.9 t -55.24 163.14 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 C-N-CA 118.37 -1.332 . . . . 19.129999999999999 109.07 -178.017 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -122.95 131.1 53.57 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.49 -0.757 . . . . 20.649999999999999 109.374 -178.716 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.908 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -73.87 2.73 7.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.561 -0.712 . . . . 19.649999999999999 109.894 179.769 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -56.13 -19.52 13.7 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.105 -1.443 . . . . 14.720000000000001 107.105 178.569 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.504 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 4.1 m -96.5 -7.35 34.92 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.896 -0.503 . . . . 11.449999999999999 110.149 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.2 m-30 -83.69 161.71 20.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.912 -1.117 . . . . 14.25 109.776 -178.848 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.62 170.15 22.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 32.700000000000003 109.28 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.965 HG21 HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -121.27 116.87 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 15.630000000000001 109.253 179.748 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.99 -170.88 19.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.73 -1.348 . . . . 12.699999999999999 109.73 -179.727 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 72' ' ' GLN . . . . . 0.534 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 1.1 tm0? -89.63 20.99 3.67 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.251 -1.147 . . . . 26.289999999999999 109.478 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' B' ' 73' ' ' PHE . 5.7 t80 -112.51 10.36 19.63 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.392 -0.817 . . . . 20.440000000000001 109.558 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.91 56.43 20.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.657 -1.377 . . . . 13.82 109.657 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.4 m -157.52 120.01 3.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -1.174 . . . . 18.27 109.616 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' B' ' 68' ' ' PHE . 0.3 OUTLIER -70.5 155.35 40.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 12.43 109.324 179.891 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 45.7 mtm -163.56 130.91 3.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 35.109999999999999 109.679 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.955 HD12 HD12 ' A' ' 78' ' ' ILE . 2.5 mp -64.78 142.25 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 13.67 109.783 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -105.73 -36.19 7.13 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.091 -1.078 . . . . 24.059999999999999 108.091 178.454 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.504 ' C ' ' HB3' ' B' ' 67' ' ' SER . 2.1 ttp180 -170.31 68.23 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.886 -1.524 . . . . 35.039999999999999 106.886 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.664 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.9 OUTLIER -29.57 117.1 0.13 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.212 -0.904 . . . . 18.719999999999999 112.104 -177.683 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.3 OUTLIER -92.18 112.94 25.07 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.051 -1.092 . . . . 20.550000000000001 108.051 178.825 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.837 HD11 HG11 ' B' ' 4' ' ' VAL . 15.3 tp -81.93 153.34 26.34 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.082 0.944 . . . . 14.4 111.008 -178.472 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.702 HG22 ' O ' ' B' ' 62' ' ' THR . 33.0 m -152.15 152.04 28.83 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.803 -1.184 . . . . 17.649999999999999 107.803 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.2 Cg_endo -60.94 141.58 94.97 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.951 1.767 . . . . 25.699999999999999 110.523 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -73.75 122.54 22.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 49.289999999999999 109.751 -178.707 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.975 -1.012 . . . . 58.909999999999997 109.442 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' C ' ' A' ' 2' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.475 -0.565 . . . . 64.909999999999997 109.475 . . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.833 ' N ' HD22 ' B' ' 65' ' ' LEU . 0.0 OUTLIER -43.15 131.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.614 -0.884 . . . . 33.799999999999997 108.614 179.396 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 1.3 mttp -102.82 153.78 19.84 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.117 -0.99 . . . . 32.719999999999999 110.394 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.892 HG22 HG22 ' A' ' 35' ' ' VAL . 32.7 t -159.78 166.13 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.684 0.754 . . . . 14.460000000000001 109.777 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.552 ' N ' HG12 ' A' ' 4' ' ' VAL . 32.7 mt-10 -153.05 103.06 2.7 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.684 -0.858 . . . . 22.120000000000001 108.684 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.762 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -71.84 103.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.032 -1.099 . . . . 14.23 108.032 179.837 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.647 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.63 171.19 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.446 -0.784 . . . . 25.43 109.643 -179.258 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -75.05 -22.66 14.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.334 2.023 . . . . 13.609999999999999 109.718 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.54 2.18 54.19 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.975 -0.75 . . . . 15.52 108.975 178.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 6' ' ' ILE . 8.7 mm-40 -121.49 40.99 3.46 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.263 -0.898 . . . . 17.309999999999999 109.205 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -109.37 12.34 24.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.16 -0.963 . . . . 24.780000000000001 109.796 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -131.7 141.63 49.61 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.509 -0.922 . . . . 47.899999999999999 108.509 179.846 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.7 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 37.1 p90 -93.68 167.65 11.52 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.019 -1.051 . . . . 21.609999999999999 109.73 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.7 m -135.1 149.96 50.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.79 -0.819 . . . . 14.890000000000001 108.79 179.159 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.22 111.89 19.78 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.212 -0.93 . . . . 17.350000000000001 109.413 -179.763 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.87 139.15 46.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 34.380000000000003 109.408 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.63 125.32 8.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 38.770000000000003 109.332 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -121.0 175.62 16.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.385 -1.486 . . . . 34.579999999999998 109.385 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.431 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -144.66 116.47 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.164 -1.197 . . . . 41.869999999999997 109.021 179.499 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -44.28 -86.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 47.210000000000001 109.398 -179.371 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.519 ' N ' ' OG ' ' A' ' 20' ' ' SER . 6.0 ttp180 -136.97 56.25 1.8 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 71.560000000000002 109.423 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.6 OUTLIER 69.78 16.06 7.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 66.599999999999994 109.448 -179.95 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.39 -54.87 0.93 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.505 -1.438 . . . . 55.490000000000002 109.505 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.57 149.93 29.74 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.281 -1.129 . . . . 44.990000000000002 109.393 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 35.2 Cg_endo -78.13 133.56 12.32 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.689 2.259 . . . . 44.100000000000001 110.769 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.592 ' CD1' ' HB2' ' A' ' 28' ' ' LEU . 6.9 p90 -126.7 144.31 50.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.312 -0.868 . . . . 32.090000000000003 109.441 179.796 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 m -98.98 79.41 2.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.042 . . . . 29.25 109.234 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -102.57 155.02 18.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 24.0 109.979 -179.624 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.591 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 97.3 m-20 -69.39 129.91 41.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 23.309999999999999 109.378 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 33.9 mt-10 -112.06 163.62 14.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.148 -0.97 . . . . 40.030000000000001 109.16 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.679 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -150.7 -176.83 5.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.071 . . . . 12.390000000000001 110.038 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.865 ' HB3' HD11 ' A' ' 44' ' ' LEU . 27.9 mt -133.31 158.61 42.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.464 -0.772 . . . . 17.420000000000002 109.076 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.557 ' SG ' HD11 ' A' ' 6' ' ' ILE . 12.4 m -155.51 172.92 17.45 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.161 -1.052 . . . . 13.84 108.161 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.678 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 32.6 m-85 -121.9 104.48 9.58 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.092 -1.005 . . . . 21.140000000000001 109.176 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.892 HG22 HG22 ' A' ' 4' ' ' VAL . 42.4 t -79.8 159.55 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.096 -1.002 . . . . 10.66 110.655 -179.294 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 38' ' ' GLY . 31.6 m-20 -140.84 -147.96 0.23 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.714 -0.847 . . . . 25.890000000000001 108.714 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.973 ' CG ' HD11 ' B' ' 65' ' ' LEU . 0.2 OUTLIER 67.71 -61.89 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 24.239999999999998 109.188 -179.983 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -87.15 21.18 21.86 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.059 -1.616 . . . . 31.02 109.059 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 36' ' ' ASP . 1.5 p30 176.19 112.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -1.063 . . . . 43.229999999999997 109.324 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' ASN . 3.1 mt-10 -41.7 -63.13 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 42.340000000000003 109.955 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -65.0 154.55 86.28 Favored Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.512 -0.742 . . . . 8.3100000000000005 109.001 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.678 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.8 Cg_endo -78.26 143.92 20.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.233 1.955 . . . . 17.920000000000002 110.248 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.654 HG21 HG21 ' B' ' 70' ' ' VAL . 19.3 m -116.15 116.11 51.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.236 -0.915 . . . . 20.57 109.194 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.865 HD11 ' HB3' ' A' ' 32' ' ' LEU . 55.2 tp -73.14 102.35 3.56 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.29 -0.882 . . . . 20.210000000000001 109.683 -179.754 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.76 HG12 HG11 ' B' ' 70' ' ' VAL . 1.2 m -107.14 -178.41 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.568 -0.708 . . . . 10.81 109.164 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HA ' HD23 ' A' ' 32' ' ' LEU . 1.1 mtpt -101.07 154.3 18.83 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.569 -0.852 . . . . 36.740000000000002 109.748 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.987 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -140.55 173.45 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.336 -0.852 . . . . 19.739999999999998 109.364 -179.879 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.16 145.89 37.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.277 -0.889 . . . . 22.559999999999999 109.263 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.7 HD11 ' O ' ' A' ' 53' ' ' GLN . 3.0 tm? -127.34 126.97 43.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.315 -0.865 . . . . 20.41 109.041 -179.669 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.666 ' O ' HD13 ' A' ' 49' ' ' LEU . 3.2 m-20 -63.39 142.38 58.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 33.990000000000002 109.821 -179.417 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.66 123.63 17.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 54.920000000000002 109.295 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.23 -16.08 50.32 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.391 -1.484 . . . . 36.100000000000001 109.391 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.7 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -75.18 153.72 86.33 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.309 -1.113 . . . . 54.759999999999998 109.381 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.57 110.03 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.621 2.214 . . . . 28.370000000000001 110.334 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.7 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -41.69 151.34 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -0.829 . . . . 17.210000000000001 109.849 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.762 ' O ' HG21 ' A' ' 6' ' ' ILE . 89.8 m-85 -46.03 101.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.871 . . . . 17.190000000000001 109.072 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.9 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.07 173.6 0.17 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.907 . . . . 17.82 109.492 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.9 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.7 Cg_endo -78.13 114.62 3.61 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.682 2.255 . . . . 17.280000000000001 110.34 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.47 -178.91 45.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.695 -1.362 . . . . 17.219999999999999 109.695 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 3.4 mp -74.16 147.2 42.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -1.134 . . . . 19.57 108.717 179.45 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.676 ' HB3' HD22 ' A' ' 83' ' ' LEU . 25.7 m-85 -136.28 166.32 23.71 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 120.962 -1.086 . . . . 14.609999999999999 111.059 -179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 33.4 p -149.51 123.27 9.26 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.902 -1.888 . . . . 18.359999999999999 105.902 178.563 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.601 HG23 ' HB ' ' A' ' 2' ' ' ILE . 1.7 t -54.17 162.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 118.338 -1.345 . . . . 19.129999999999999 108.693 -178.268 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -124.83 128.14 48.24 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.393 -0.817 . . . . 20.649999999999999 109.066 -179.116 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.957 HD11 ' CG ' ' B' ' 37' ' ' LEU . 0.7 OUTLIER -72.43 2.82 5.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.463 -0.773 . . . . 19.649999999999999 110.141 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 t -56.09 -20.09 15.84 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.114 -1.439 . . . . 14.720000000000001 107.114 178.241 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.487 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 26.4 m -96.43 -8.44 32.28 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 116.126 -0.488 . . . . 11.449999999999999 110.154 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.652 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 2.2 m-30 -79.88 161.56 25.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.951 -1.093 . . . . 14.25 109.872 -178.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.514 ' NZ ' ' HB2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -165.68 174.35 9.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.795 . . . . 32.700000000000003 109.151 179.673 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.778 HG11 HG12 ' B' ' 45' ' ' VAL . 0.0 OUTLIER -100.06 104.46 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 15.630000000000001 109.466 -179.893 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.51 -168.01 37.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.595 -1.402 . . . . 12.699999999999999 109.595 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 23.32 2.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.129 -1.218 . . . . 26.289999999999999 109.888 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -93.86 -13.2 27.49 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.51 -0.744 . . . . 20.440000000000001 109.51 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 87.07 49.89 3.86 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.613 -1.395 . . . . 13.82 109.613 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 171.2 172.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -1.197 . . . . 18.27 109.645 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.551 HD13 HG11 ' B' ' 35' ' ' VAL . 14.7 tp -77.15 149.94 35.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 12.43 109.622 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 76' ' ' LEU . 8.6 mtp -155.57 135.51 12.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 35.109999999999999 109.401 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 1.011 HD12 HD12 ' B' ' 78' ' ' ILE . 2.2 mp -67.15 142.09 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 13.67 110.028 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.456 ' OD1' ' HD3' ' A' ' 69' ' ' LYS . 1.5 t70 -107.66 -41.18 5.09 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.572 -1.269 . . . . 24.059999999999999 107.572 178.014 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.487 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.3 OUTLIER -163.43 66.73 0.18 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.167 -1.42 . . . . 35.039999999999999 107.167 178.457 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.653 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -28.41 119.61 0.12 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.218 -0.901 . . . . 18.719999999999999 112.095 -177.99 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -92.98 101.14 13.48 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.296 -1.002 . . . . 20.550000000000001 108.296 178.896 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.987 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -70.72 146.51 49.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.085 -1.01 . . . . 14.4 110.943 -178.625 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 62' ' ' THR . 16.8 m -145.9 152.02 46.97 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.283 -1.006 . . . . 17.649999999999999 108.283 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 26.6 Cg_endo -64.76 144.34 83.37 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.306 2.004 . . . . 25.699999999999999 110.496 179.248 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -75.99 120.48 21.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.268 -0.895 . . . . 49.289999999999999 109.535 -179.07 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.981 -1.009 . . . . 58.909999999999997 109.463 179.979 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.458 ' O ' ' C ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.454 -0.573 . . . . 64.909999999999997 109.454 . . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.837 ' CA ' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -42.87 131.68 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.701 -0.851 . . . . 33.799999999999997 108.701 179.318 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 1.4 mttp -102.84 153.73 19.9 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.122 -0.986 . . . . 32.719999999999999 110.37 -178.878 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.907 HG22 HG22 ' B' ' 35' ' ' VAL . 33.4 t -159.79 166.19 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.68 0.752 . . . . 14.460000000000001 109.75 -179.393 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.558 ' N ' HG12 ' B' ' 4' ' ' VAL . 32.5 mt-10 -153.21 102.96 2.66 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.67 -0.863 . . . . 22.120000000000001 108.67 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.768 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -71.77 103.89 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.047 -1.094 . . . . 14.23 108.047 179.769 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.658 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.68 171.23 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.366 -0.834 . . . . 25.43 109.619 -179.28 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.1 Cg_endo -74.97 -22.78 14.52 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.433 2.089 . . . . 13.609999999999999 109.759 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.6 2.32 54.12 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.977 -0.749 . . . . 15.52 108.977 179.074 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.597 ' O ' HG23 ' B' ' 6' ' ' ILE . 8.8 mm-40 -121.67 41.06 3.46 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.289 -0.882 . . . . 17.309999999999999 109.136 179.758 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -109.41 12.31 24.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.958 . . . . 24.780000000000001 109.785 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -131.52 141.8 49.81 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.198 -0.939 . . . . 47.899999999999999 108.577 179.825 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 13' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 37.2 p90 -93.96 167.45 11.6 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.011 -1.056 . . . . 21.609999999999999 109.713 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 100.0 m -134.82 150.22 50.47 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.795 -0.817 . . . . 14.890000000000001 108.795 179.156 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.53 111.91 19.93 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.204 -0.935 . . . . 17.350000000000001 109.415 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.9 139.12 45.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.299 -0.876 . . . . 34.380000000000003 109.38 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.63 125.38 8.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 38.770000000000003 109.324 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -121.0 175.75 16.13 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.396 -1.482 . . . . 34.579999999999998 109.396 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.433 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -144.75 116.47 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.118 -1.224 . . . . 41.869999999999997 108.985 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' B' ' 21' ' ' ARG . 0.3 OUTLIER -44.31 -86.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.88 . . . . 47.210000000000001 109.494 -179.404 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 21' ' ' ARG . . . . . 0.492 ' N ' ' OG ' ' B' ' 20' ' ' SER . 5.9 ttp180 -137.1 56.28 1.79 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.205 -0.934 . . . . 71.560000000000002 109.447 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 22' ' ' GLN . . . . . 0.43 ' CB ' ' O ' ' B' ' 21' ' ' ARG . 0.7 OUTLIER 69.86 15.87 7.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 66.599999999999994 109.451 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.21 -55.06 0.93 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.48 -1.448 . . . . 55.490000000000002 109.48 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 149.92 30.04 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.269 -1.136 . . . . 44.990000000000002 109.351 179.934 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 35.3 Cg_endo -78.1 133.79 12.54 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.608 2.205 . . . . 44.100000000000001 110.754 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.588 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 6.9 p90 -126.92 144.13 51.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 32.090000000000003 109.493 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -98.82 79.3 2.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.012 . . . . 29.25 109.297 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.588 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -102.46 155.04 18.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 24.0 110.024 -179.65 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.576 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 97.0 m-20 -69.3 129.99 41.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 23.309999999999999 109.368 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 34.1 mt-10 -112.16 163.61 14.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.058 -1.026 . . . . 40.030000000000001 109.157 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.668 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -150.77 -176.91 5.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 12.390000000000001 110.021 -179.902 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 32' ' ' LEU . . . . . 0.887 ' HB3' HD11 ' B' ' 44' ' ' LEU . 27.9 mt -133.19 158.71 42.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.468 -0.77 . . . . 17.420000000000002 109.101 179.6 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' B' ' 6' ' ' ILE . 12.2 m -155.66 172.91 17.51 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.146 -1.057 . . . . 13.84 108.146 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.675 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 32.4 m-85 -122.01 104.57 9.61 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.051 -1.031 . . . . 21.140000000000001 109.109 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.907 HG22 HG22 ' B' ' 4' ' ' VAL . 42.4 t -79.85 159.67 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.073 -1.017 . . . . 10.66 110.686 -179.311 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' B' ' 38' ' ' GLY . 31.7 m-20 -140.89 -147.9 0.23 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.728 -0.841 . . . . 25.890000000000001 108.728 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 37' ' ' LEU . . . . . 0.957 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 67.78 -61.96 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 24.239999999999998 109.183 179.966 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 38' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -87.13 21.14 22.01 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.074 -1.61 . . . . 31.02 109.074 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' B' ' 36' ' ' ASP . 1.5 p30 176.23 112.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -1.076 . . . . 43.229999999999997 109.361 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' B' ' 39' ' ' ASN . 3.2 mt-10 -41.65 -63.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.372 -0.83 . . . . 42.340000000000003 109.898 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -65.0 154.43 86.57 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 109.002 -0.74 . . . . 8.3399999999999999 109.002 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.675 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.9 Cg_endo -78.19 143.74 20.29 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.245 1.963 . . . . 17.920000000000002 110.241 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 43' ' ' VAL . . . . . 0.632 HG21 HG21 ' A' ' 70' ' ' VAL . 19.2 m -115.97 116.22 51.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.318 -0.863 . . . . 20.57 109.15 179.673 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' B' ' 32' ' ' LEU . 54.9 tp -73.3 102.59 3.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.271 -0.893 . . . . 20.210000000000001 109.68 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.778 HG12 HG11 ' A' ' 70' ' ' VAL . 1.2 m -107.27 -178.38 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.552 -0.718 . . . . 10.81 109.23 179.797 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.645 ' HA ' HD23 ' B' ' 32' ' ' LEU . 1.1 mtpt -101.08 154.42 18.74 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.469 -0.892 . . . . 36.740000000000002 109.718 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 47' ' ' ILE . . . . . 0.994 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.5 OUTLIER -140.72 173.38 9.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.325 -0.86 . . . . 19.739999999999998 109.317 -179.894 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.14 145.85 37.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 22.559999999999999 109.274 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.677 HD11 ' O ' ' B' ' 53' ' ' GLN . 2.9 tm? -127.3 126.9 43.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.311 -0.868 . . . . 20.41 109.061 -179.678 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.658 ' O ' HD13 ' B' ' 49' ' ' LEU . 3.1 m-20 -63.34 142.27 58.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.968 . . . . 33.990000000000002 109.868 -179.441 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.42 123.78 17.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 54.920000000000002 109.395 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.0 -15.97 50.23 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.437 -1.465 . . . . 36.100000000000001 109.437 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 53' ' ' GLN . . . . . 0.677 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -75.25 153.85 86.2 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.29 -1.123 . . . . 54.759999999999998 109.469 179.943 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.2 Cg_endo -77.67 109.79 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.628 2.218 . . . . 28.370000000000001 110.383 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.701 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -41.39 150.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -0.82 . . . . 17.210000000000001 110.041 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.768 ' O ' HG21 ' B' ' 6' ' ' ILE . 90.2 m-85 -45.53 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.375 -0.828 . . . . 17.190000000000001 109.003 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 57' ' ' ALA . . . . . 0.903 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -53.02 173.56 0.17 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 17.82 109.654 -179.602 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.903 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.79 113.44 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.617 2.211 . . . . 17.280000000000001 110.077 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.4 -179.43 46.63 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.776 -1.33 . . . . 17.219999999999999 109.776 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 3.1 mp -74.47 146.8 42.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -1.167 . . . . 19.57 108.414 179.14 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.664 ' HB3' HD22 ' B' ' 83' ' ' LEU . 27.1 m-85 -135.9 166.1 24.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.956 -1.09 . . . . 14.609999999999999 110.978 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 62' ' ' THR . . . . . 0.526 ' O ' HG22 ' B' ' 84' ' ' VAL . 33.0 p -149.14 123.24 9.47 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 105.943 -1.873 . . . . 18.359999999999999 105.943 178.523 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.59 HG23 ' HB ' ' B' ' 2' ' ' ILE . 1.7 t -54.12 162.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 118.276 -1.37 . . . . 19.129999999999999 108.721 -178.243 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 64' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -124.89 128.23 48.33 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.422 -0.799 . . . . 20.649999999999999 109.06 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.973 HD11 ' CG ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -72.67 2.84 5.79 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.46 -0.775 . . . . 19.649999999999999 110.132 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.1 t -56.01 -20.08 15.2 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.099 -1.445 . . . . 14.720000000000001 107.099 178.284 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.484 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 25.8 m -96.41 -8.45 32.33 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 116.096 -0.502 . . . . 11.449999999999999 110.239 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.662 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 2.3 m-30 -79.86 161.46 25.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.004 -1.06 . . . . 14.25 109.756 -178.841 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.522 ' NZ ' ' HB2' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -165.56 174.41 9.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.455 -0.778 . . . . 32.700000000000003 109.132 179.679 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.76 HG11 HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -100.1 104.48 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 15.630000000000001 109.393 -179.93 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.45 -167.87 37.32 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.613 -1.395 . . . . 12.699999999999999 109.613 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 23.02 2.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.113 -1.228 . . . . 26.289999999999999 109.863 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -93.6 -13.35 27.78 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.493 -0.755 . . . . 20.440000000000001 109.481 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 87.26 49.9 3.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.547 -1.421 . . . . 13.82 109.547 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' B' ' 74' ' ' GLY . 0.3 OUTLIER 171.28 172.91 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -1.16 . . . . 18.27 109.588 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.622 HD13 HG11 ' A' ' 35' ' ' VAL . 14.7 tp -77.23 150.02 35.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.295 -0.878 . . . . 12.43 109.659 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' B' ' 76' ' ' LEU . 8.5 mtp -155.71 135.15 12.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 35.109999999999999 109.493 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 1.011 HD12 HD12 ' A' ' 78' ' ' ILE . 2.2 mp -66.81 142.1 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 13.67 110.116 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.455 ' OD1' ' HD3' ' B' ' 69' ' ' LYS . 1.5 t70 -107.8 -40.98 5.12 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.606 -1.257 . . . . 24.059999999999999 107.606 177.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 80' ' ' ARG . . . . . 0.484 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.3 OUTLIER -163.56 66.79 0.18 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.12 -1.437 . . . . 35.039999999999999 107.12 178.422 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.637 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -28.47 119.58 0.12 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.215 -0.902 . . . . 18.719999999999999 112.036 -178.046 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 82' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -92.94 101.12 13.46 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.268 -1.012 . . . . 20.550000000000001 108.268 178.861 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.994 ' HB2' HD11 ' B' ' 47' ' ' ILE . 0.4 OUTLIER -70.7 146.47 49.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.977 . . . . 14.4 110.91 -178.67 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.526 HG22 ' O ' ' B' ' 62' ' ' THR . 16.8 m -145.82 152.34 48.06 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.296 -1.001 . . . . 17.649999999999999 108.296 179.424 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 26.7 Cg_endo -65.05 144.45 82.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.254 1.969 . . . . 25.699999999999999 110.56 179.274 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -75.97 120.38 21.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 49.289999999999999 109.605 -179.096 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.001 -0.999 . . . . 58.909999999999997 109.471 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.634 ' SD ' HG21 ' A' ' 62' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.326 0.584 . . . . 64.909999999999997 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.964 ' HA ' HD22 ' B' ' 65' ' ' LEU . 5.5 mt -72.56 78.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.238 -1.023 . . . . 33.799999999999997 108.238 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 1.021 ' N ' HD12 ' A' ' 37' ' ' LEU . 23.0 mttp -61.85 172.26 1.37 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.715 0.769 . . . . 32.719999999999999 111.371 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.007 HG22 HG22 ' A' ' 35' ' ' VAL . 23.0 t -168.23 168.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.861 -0.792 . . . . 14.460000000000001 108.861 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.591 ' N ' HG12 ' A' ' 4' ' ' VAL . 23.4 mt-10 -147.04 104.29 3.67 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.679 -0.859 . . . . 22.120000000000001 108.679 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.626 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -69.36 104.34 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.912 -1.144 . . . . 14.23 107.912 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.653 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.47 171.13 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.083 -1.011 . . . . 25.43 109.665 -179.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.7 Cg_endo -76.32 -24.22 11.0 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.562 2.174 . . . . 13.609999999999999 109.899 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -94.21 4.29 54.09 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.553 -0.717 . . . . 15.52 109.258 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.832 ' OE1' HD13 ' A' ' 32' ' ' LEU . 10.6 mm-40 -117.52 34.1 5.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.27 -0.894 . . . . 17.309999999999999 109.372 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.4 11.34 33.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 24.780000000000001 110.182 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 16.3 mt-30 -138.86 132.76 31.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.007 . . . . 47.899999999999999 110.056 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.624 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 11.4 p90 -83.19 -178.36 7.07 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.402 -0.811 . . . . 21.609999999999999 109.915 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -130.4 144.67 51.54 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.752 -0.593 . . . . 14.890000000000001 109.404 179.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 17.350000000000001 109.222 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.719 ' CD2' HG22 ' A' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 121.451 0.643 . . . . 24.0 109.946 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.721 HD22 HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -106.07 133.27 51.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.399 -0.813 . . . . 23.309999999999999 109.342 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.81 151.76 29.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.076 -1.015 . . . . 40.030000000000001 109.62 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.675 HE21 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -133.62 -166.77 1.83 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.125 -0.984 . . . . 12.390000000000001 109.56 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.887 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -136.28 169.5 17.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.88 . . . . 17.420000000000002 109.934 -179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -158.74 164.68 35.65 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.211 -1.033 . . . . 13.84 108.211 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.665 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.8 m-85 -121.24 109.69 15.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.987 -1.07 . . . . 21.140000000000001 110.04 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.007 HG22 HG22 ' A' ' 4' ' ' VAL . 29.7 t -95.49 143.08 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 10.66 109.466 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -130.89 -24.56 2.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.146 -0.972 . . . . 25.890000000000001 110.76 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.021 HD12 ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -45.96 -16.4 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.972 -1.08 . . . . 24.239999999999998 111.384 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.596 ' H ' HD22 ' A' ' 37' ' ' LEU . . . -120.19 16.28 10.01 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 108.206 -1.957 . . . . 31.02 108.206 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 36' ' ' ASP . 1.3 p30 -178.02 115.96 0.08 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.706 -0.879 . . . . 43.229999999999997 108.828 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 39' ' ' ASN . 1.2 mp0 -36.95 -63.47 0.42 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.66 0.743 . . . . 42.340000000000003 109.978 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.8 155.87 68.52 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.449 -0.945 . . . . 2.8599999999999999 108.449 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.665 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.5 Cg_endo -77.95 141.31 18.86 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.923 1.749 . . . . 17.920000000000002 109.936 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.916 HG22 ' O ' ' A' ' 35' ' ' VAL . 29.3 m -113.72 115.33 49.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.316 -0.865 . . . . 20.57 108.957 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' A' ' 32' ' ' LEU . 54.6 tp -67.71 107.99 2.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.423 -0.798 . . . . 20.210000000000001 109.545 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.502 ' CG1' ' SG ' ' A' ' 33' ' ' CYS . 8.9 p -111.2 163.31 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.476 -0.765 . . . . 10.81 109.324 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 160.84 22.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 36.740000000000002 110.232 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.62 HD12 ' CE1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -156.31 119.68 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.798 -0.816 . . . . 19.739999999999998 108.798 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.719 HG22 ' CD2' ' A' ' 28' ' ' LEU . 1.3 m -60.17 156.03 16.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.984 -1.072 . . . . 22.559999999999999 109.757 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.721 HD12 HD22 ' A' ' 29' ' ' ASN . 0.2 OUTLIER -131.95 109.81 10.32 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.977 -0.749 . . . . 20.41 108.977 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.541 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -63.88 145.71 55.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 33.990000000000002 109.654 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' A' ' 52' ' ' GLY . 28.9 tt0 -43.51 -87.67 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.258 -0.901 . . . . 54.920000000000002 109.661 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' N ' ' HG2' ' A' ' 51' ' ' GLU . . . -41.06 -39.07 1.93 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.889 -1.284 . . . . 36.100000000000001 109.889 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.541 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -64.11 126.11 89.51 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.095 -1.238 . . . . 54.759999999999998 109.34 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.545 ' C ' HD11 ' A' ' 49' ' ' LEU . 36.0 Cg_endo -79.62 144.86 17.93 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.401 2.067 . . . . 28.370000000000001 110.4 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.675 ' HB1' HE21 ' A' ' 31' ' ' GLN . . . -40.21 146.02 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.396 -0.815 . . . . 17.210000000000001 110.169 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.62 ' CE1' HD12 ' A' ' 47' ' ' ILE . 87.4 m-85 -53.82 111.42 0.74 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.297 -0.877 . . . . 17.190000000000001 109.222 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.027 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -66.32 -178.85 0.34 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.426 -0.796 . . . . 17.82 109.528 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 1.027 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -78.12 131.79 11.11 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.49 2.127 . . . . 17.280000000000001 110.588 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.632 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 153.91 143.01 3.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.15 -1.58 . . . . 17.219999999999999 109.15 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.438 HD23 ' CE ' ' A' ' 3' ' ' LYS . 3.8 mp -44.77 138.93 3.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.908 -1.348 . . . . 19.57 109.489 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.632 ' CD1' ' O ' ' A' ' 59' ' ' GLY . 17.9 m-85 -119.09 164.18 15.9 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.521 1.153 . . . . 14.609999999999999 111.497 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 84' ' ' VAL . 48.0 p -145.88 122.76 11.3 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.514 -1.661 . . . . 18.359999999999999 106.514 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.683 HG11 ' HB2' ' A' ' 81' ' ' LEU . 1.7 t -60.58 162.67 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 C-N-CA 118.427 -1.309 . . . . 19.129999999999999 108.72 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -120.77 130.41 54.01 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.43 -0.794 . . . . 20.649999999999999 109.248 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.97 HD22 ' HA ' ' B' ' 2' ' ' ILE . 0.9 OUTLIER -73.29 2.81 6.73 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.474 -0.766 . . . . 19.649999999999999 109.828 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -19.21 11.71 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.101 -1.444 . . . . 14.720000000000001 107.101 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.533 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 1.4 m -96.29 -6.23 38.33 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.134 -0.485 . . . . 11.449999999999999 110.391 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.699 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.2 m-30 -86.43 161.63 18.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.89 -1.131 . . . . 14.25 110.021 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -144.94 164.78 30.08 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.022 -0.733 . . . . 32.700000000000003 109.022 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.848 HG21 HG21 ' B' ' 43' ' ' VAL . 1.8 t -120.97 129.1 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 15.630000000000001 109.498 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.2 -151.52 22.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.36 -1.496 . . . . 12.699999999999999 109.36 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 0.5 OUTLIER 51.93 68.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -1.145 . . . . 26.289999999999999 109.211 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 71.07 5.62 5.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.836 . . . . 20.440000000000001 109.367 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.87 46.52 5.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.523 -1.431 . . . . 13.82 109.523 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.41 ' HB2' ' HE3' ' A' ' 77' ' ' MET . 57.7 m -125.0 116.45 22.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -1.126 . . . . 18.27 109.635 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.6 OUTLIER -59.22 147.15 36.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 12.43 109.129 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 37.8 mtt -160.12 132.32 6.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 35.109999999999999 109.725 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.86 HD12 HD12 ' B' ' 78' ' ' ILE . 2.7 mp -67.16 140.16 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.373 -0.829 . . . . 13.67 109.826 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 8.8 t70 -107.61 -10.27 15.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.324 -0.86 . . . . 24.059999999999999 108.962 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 163.94 67.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.897 -1.52 . . . . 35.039999999999999 106.897 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.683 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -31.66 118.73 0.23 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.323 -0.853 . . . . 18.719999999999999 112.199 -177.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.517 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -91.9 109.87 21.21 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.229 -1.026 . . . . 20.550000000000001 108.229 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.8 OUTLIER -75.63 155.19 36.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.205 -0.934 . . . . 14.4 111.382 -178.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 62' ' ' THR . 35.6 m -159.89 148.95 14.02 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 107.866 -1.161 . . . . 17.649999999999999 107.866 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 22.8 Cg_endo -61.5 139.3 81.14 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.99 1.794 . . . . 25.699999999999999 110.503 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.521 ' CA ' HG23 ' A' ' 62' ' ' THR . . . -65.66 118.1 9.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -0.921 . . . . 49.289999999999999 109.698 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.033 -0.984 . . . . 58.909999999999997 109.526 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.637 ' SD ' HG21 ' B' ' 62' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.314 0.578 . . . . 64.909999999999997 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.97 ' HA ' HD22 ' A' ' 65' ' ' LEU . 5.5 mt -72.97 78.15 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.267 -1.012 . . . . 33.799999999999997 108.267 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 1.006 ' N ' HD12 ' B' ' 37' ' ' LEU . 23.0 mttp -61.72 172.22 1.34 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.759 0.79 . . . . 32.719999999999999 111.33 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.983 HG22 HG22 ' B' ' 35' ' ' VAL . 23.1 t -168.2 168.44 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.85 -0.796 . . . . 14.460000000000001 108.85 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.601 ' N ' HG12 ' B' ' 4' ' ' VAL . 23.5 mt-10 -147.15 104.21 3.65 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.726 -0.842 . . . . 22.120000000000001 108.726 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.63 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -69.34 104.08 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.962 -1.125 . . . . 14.23 107.962 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.66 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.24 171.11 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.957 . . . . 25.43 109.682 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -76.36 -24.27 10.89 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.474 2.116 . . . . 13.609999999999999 109.847 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -94.12 4.1 54.37 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.521 -0.737 . . . . 15.52 109.224 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.818 ' OE1' HD13 ' B' ' 32' ' ' LEU . 10.5 mm-40 -117.25 33.95 5.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.262 -0.899 . . . . 17.309999999999999 109.377 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.18 11.3 32.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 24.780000000000001 110.209 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.443 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 16.2 mt-30 -138.82 132.88 31.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 47.899999999999999 110.088 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.63 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 11.4 p90 -83.26 -178.29 7.03 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.408 -0.807 . . . . 21.609999999999999 109.93 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 0.6 OUTLIER -130.48 144.65 51.54 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.738 -0.601 . . . . 14.890000000000001 109.426 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.461 0 O-C-N 121.29 -0.882 . . . . 17.350000000000001 109.199 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.728 ' CD2' HG22 ' B' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.486 0.66 . . . . 24.0 109.919 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.699 HD22 HD12 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -106.03 133.27 51.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.398 -0.813 . . . . 23.309999999999999 109.298 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.79 151.98 29.7 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.037 -1.039 . . . . 40.030000000000001 109.573 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.685 HE21 ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -133.75 -166.78 1.83 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 12.390000000000001 109.573 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.888 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.0 OUTLIER -136.24 169.57 17.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.234 -0.916 . . . . 17.420000000000002 109.949 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -158.87 164.69 35.49 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.177 -1.046 . . . . 13.84 108.177 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.66 ' CD2' ' CD ' ' B' ' 7' ' ' LYS . 22.4 m-85 -121.29 109.75 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 21.140000000000001 109.989 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.983 HG22 HG22 ' B' ' 4' ' ' VAL . 31.0 t -95.64 143.05 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 10.66 109.446 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 36' ' ' ASP . 0.5 OUTLIER -130.9 -24.51 2.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 25.890000000000001 110.8 -179.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 1.006 HD12 ' N ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -46.21 -16.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.002 -1.061 . . . . 24.239999999999998 111.38 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.59 ' H ' HD22 ' B' ' 37' ' ' LEU . . . -120.15 16.09 10.06 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 108.208 -1.957 . . . . 31.02 108.208 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' HA ' ' B' ' 36' ' ' ASP . 1.3 p30 -177.9 116.03 0.08 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.686 -0.891 . . . . 43.229999999999997 108.833 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' B' ' 39' ' ' ASN . 1.1 mp0 -36.91 -63.46 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.679 0.752 . . . . 42.340000000000003 110.015 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.88 155.91 69.07 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 108.438 -0.949 . . . . 2.8599999999999999 108.438 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.658 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.6 Cg_endo -77.93 141.27 18.87 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.939 1.759 . . . . 17.920000000000002 109.894 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.927 HG22 ' O ' ' B' ' 35' ' ' VAL . 29.3 m -113.78 115.33 49.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.273 -0.892 . . . . 20.57 108.874 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.888 HD11 ' HB3' ' B' ' 32' ' ' LEU . 54.4 tp -67.59 107.9 2.68 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.397 -0.815 . . . . 20.210000000000001 109.603 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.505 ' CG1' ' SG ' ' B' ' 33' ' ' CYS . 8.9 p -111.09 163.27 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.52 -0.737 . . . . 10.81 109.369 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 160.83 21.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 36.740000000000002 110.261 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.621 HD12 ' CE1' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -156.2 119.67 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 108.801 -0.814 . . . . 19.739999999999998 108.801 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.728 HG22 ' CD2' ' B' ' 28' ' ' LEU . 1.3 m -60.23 155.64 17.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.027 . . . . 22.559999999999999 109.732 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.699 HD12 HD22 ' B' ' 29' ' ' ASN . 0.2 OUTLIER -131.55 109.85 10.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 20.41 108.982 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.545 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -63.83 145.76 55.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 33.990000000000002 109.692 -179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' B' ' 52' ' ' GLY . 28.9 tt0 -43.66 -87.63 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.305 -0.872 . . . . 54.920000000000002 109.629 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.48 ' N ' ' HG2' ' B' ' 51' ' ' GLU . . . -41.19 -38.83 1.97 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.852 -1.299 . . . . 36.100000000000001 109.852 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.545 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -64.29 126.15 89.8 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.07 -1.253 . . . . 54.759999999999998 109.336 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.553 ' C ' HD11 ' B' ' 49' ' ' LEU . 35.9 Cg_endo -79.61 144.86 17.94 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.417 2.078 . . . . 28.370000000000001 110.421 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.685 ' HB1' HE21 ' B' ' 31' ' ' GLN . . . -40.16 145.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -0.825 . . . . 17.210000000000001 110.308 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.621 ' CE1' HD12 ' B' ' 47' ' ' ILE . 87.4 m-85 -53.35 111.73 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 17.190000000000001 109.16 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 1.004 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -67.16 -178.94 0.39 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.389 -0.82 . . . . 17.82 109.594 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 1.004 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.4 Cg_endo -77.71 130.38 10.61 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.458 2.105 . . . . 17.280000000000001 110.358 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.635 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 155.94 143.0 3.55 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.205 -1.558 . . . . 17.219999999999999 109.205 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.439 HD23 ' CE ' ' B' ' 3' ' ' LYS . 3.6 mp -45.43 138.34 4.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.426 . . . . 19.57 109.177 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' B' ' 59' ' ' GLY . 20.0 m-85 -118.43 164.26 15.52 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.49 1.138 . . . . 14.609999999999999 111.407 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.744 ' O ' HG22 ' B' ' 84' ' ' VAL . 48.9 p -145.9 122.84 11.34 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 106.386 -1.709 . . . . 18.359999999999999 106.386 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.682 HG11 ' HB2' ' B' ' 81' ' ' LEU . 1.6 t -60.44 163.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 C-N-CA 118.448 -1.301 . . . . 19.129999999999999 108.719 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.492 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -121.62 130.3 53.39 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.475 -0.765 . . . . 20.649999999999999 109.33 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 2' ' ' ILE . 0.9 OUTLIER -73.13 2.77 6.52 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.492 -0.755 . . . . 19.649999999999999 109.889 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.29 -18.97 12.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.126 -1.435 . . . . 14.720000000000001 107.126 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.537 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 1.4 m -96.35 -6.93 36.51 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 116.132 -0.485 . . . . 11.449999999999999 110.416 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.664 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.1 m-30 -85.97 161.25 19.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.851 -1.156 . . . . 14.25 109.958 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -144.57 165.1 28.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.74 . . . . 32.700000000000003 109.014 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.84 HG21 HG21 ' A' ' 43' ' ' VAL . 1.8 t -121.08 129.2 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 15.630000000000001 109.506 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.0 -151.66 22.36 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.333 -1.507 . . . . 12.699999999999999 109.333 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.6 OUTLIER 52.0 68.86 0.74 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -1.181 . . . . 26.289999999999999 109.228 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.2 OUTLIER 71.22 5.73 5.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 20.440000000000001 109.34 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.74 46.56 5.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.558 -1.417 . . . . 13.82 109.558 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 57.7 m -125.15 116.34 21.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -1.129 . . . . 18.27 109.696 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.534 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.6 OUTLIER -59.05 147.05 36.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 12.43 109.212 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.534 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 37.5 mtt -160.08 132.51 6.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.923 . . . . 35.109999999999999 109.643 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.86 HD12 HD12 ' A' ' 78' ' ' ILE . 2.7 mp -67.37 140.24 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 13.67 109.839 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 8.6 t70 -107.51 -10.27 15.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.367 -0.833 . . . . 24.059999999999999 108.966 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.537 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 163.89 67.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.923 -1.51 . . . . 35.039999999999999 106.923 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.682 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.9 OUTLIER -31.76 118.75 0.24 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.253 -0.885 . . . . 18.719999999999999 112.182 -177.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.517 ' HG3' ' NH1' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -91.88 109.94 21.28 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.194 -1.039 . . . . 20.550000000000001 108.194 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -75.65 155.28 35.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.17 -0.956 . . . . 14.4 111.384 -178.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.744 HG22 ' O ' ' B' ' 62' ' ' THR . 35.6 m -159.98 149.21 14.14 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 107.807 -1.183 . . . . 17.649999999999999 107.807 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 23.5 Cg_endo -61.76 139.13 78.74 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.024 1.816 . . . . 25.699999999999999 110.545 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.527 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -65.49 118.07 8.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 49.289999999999999 109.6 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.422 ' HD3' ' C ' ' B' ' 87' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.95 -1.024 . . . . 58.909999999999997 109.429 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.594 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.461 0.648 . . . . 64.909999999999997 109.493 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.914 HG23 ' CD1' ' B' ' 65' ' ' LEU . 3.9 mt -78.55 77.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.7 -1.222 . . . . 33.799999999999997 107.7 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.49 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -67.39 167.39 12.68 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.011 0.91 . . . . 32.719999999999999 110.848 -178.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.941 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -177.44 160.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.501 -0.926 . . . . 14.460000000000001 108.501 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 29.8 mt-10 -134.2 114.65 13.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.67 0.748 . . . . 22.120000000000001 109.004 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.716 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -73.74 99.28 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.788 -1.19 . . . . 14.23 107.788 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.669 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -43.95 169.92 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.335 -0.853 . . . . 25.43 109.925 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 32.5 Cg_endo -74.42 -28.31 10.4 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.469 2.112 . . . . 13.609999999999999 110.024 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.96 8.78 41.74 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.826 -0.805 . . . . 15.52 108.826 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.552 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 5.6 mm100 -125.91 22.32 7.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 17.309999999999999 109.87 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -95.77 15.23 20.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.105 -0.997 . . . . 24.780000000000001 110.162 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 60.7 mt-30 -134.9 141.09 46.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.127 -0.983 . . . . 47.899999999999999 109.754 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.744 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 45.1 p90 -93.96 153.91 17.95 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.3 -0.875 . . . . 21.609999999999999 109.32 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 m -113.11 150.45 32.11 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.331 -0.856 . . . . 14.890000000000001 108.92 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.551 HG23 ' OD1' ' A' ' 29' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.487 0 O-C-N 121.289 -0.882 . . . . 17.350000000000001 109.541 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.435 0.636 . . . . 24.0 110.094 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.775 ' O ' HD12 ' A' ' 28' ' ' LEU . 67.4 m-20 -72.21 151.1 43.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.372 -0.83 . . . . 23.309999999999999 109.533 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.61 132.64 39.27 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.699 -0.852 . . . . 40.030000000000001 108.699 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.748 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -123.41 -174.1 2.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.071 -1.018 . . . . 12.390000000000001 110.02 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.951 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.7 mp -143.6 152.85 41.9 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.853 -0.795 . . . . 17.420000000000002 108.853 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -152.82 -177.67 6.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.974 -1.121 . . . . 13.84 107.974 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.69 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.0 m-85 -129.6 99.62 5.23 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.031 -1.043 . . . . 21.140000000000001 109.937 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.877 HG22 ' HB ' ' A' ' 4' ' ' VAL . 60.6 t -95.24 113.65 30.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.089 -1.007 . . . . 10.66 109.462 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 5.3 t70 -62.46 -28.48 69.85 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.199 -0.938 . . . . 25.890000000000001 108.572 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.684 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.7 OUTLIER 46.23 25.26 0.34 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.467 -0.77 . . . . 24.239999999999998 109.458 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.07 81.67 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.818 -1.313 . . . . 31.02 109.818 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 64.3 m-20 -86.08 15.21 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -1.209 . . . . 43.229999999999997 110.225 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 9.6 mt-10 60.73 11.52 3.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.311 -0.868 . . . . 42.340000000000003 110.36 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 71.3 m80 -161.18 152.68 16.01 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.046 -1.094 . . . . 6.3700000000000001 108.046 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.69 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -75.76 136.59 19.08 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.873 1.715 . . . . 17.920000000000002 110.397 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 35' ' ' VAL . 4.5 m -110.84 118.19 56.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.43 -0.793 . . . . 20.57 109.0 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.951 HD11 ' HB3' ' A' ' 32' ' ' LEU . 45.5 tp -73.22 104.48 4.28 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.351 -0.843 . . . . 20.210000000000001 110.255 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.618 HG13 HG23 ' A' ' 43' ' ' VAL . 32.6 m -108.46 -177.2 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.527 -0.916 . . . . 10.81 108.527 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HD2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.22 154.56 22.23 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.007 -1.077 . . . . 36.740000000000002 110.257 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.593 HG13 ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -127.18 170.1 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 109.029 -0.73 . . . . 19.739999999999998 109.029 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.523 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 3.6 m -123.01 124.0 42.16 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.356 -0.84 . . . . 22.559999999999999 108.808 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -102.53 163.83 12.0 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.331 -0.856 . . . . 20.41 109.331 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.43 167.68 9.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.897 . . . . 33.990000000000002 109.54 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -72.86 87.61 1.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 54.920000000000002 109.519 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.34 -25.84 4.48 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.514 -1.434 . . . . 36.100000000000001 109.514 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.636 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.0 mt-30 -73.7 140.97 78.66 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 54.759999999999998 109.433 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 53' ' ' GLN . 35.8 Cg_endo -79.5 118.91 3.98 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.577 2.185 . . . . 28.370000000000001 110.28 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.748 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.52 155.19 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.24 -0.912 . . . . 17.210000000000001 110.308 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.655 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 16.3 m-30 -49.86 112.14 0.62 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.531 -0.731 . . . . 17.190000000000001 109.377 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.002 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -61.72 176.43 0.44 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.138 -0.976 . . . . 17.82 109.289 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 1.002 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.7 Cg_endo -77.05 119.85 5.2 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.545 2.164 . . . . 17.280000000000001 110.221 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.42 177.54 37.86 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.835 -1.306 . . . . 17.219999999999999 109.835 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 5.2 mp -71.58 159.48 34.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 19.57 108.469 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.941 ' CB ' HG13 ' A' ' 4' ' ' VAL . 20.5 m-85 -141.8 165.1 28.41 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.849 -1.157 . . . . 14.609999999999999 111.784 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 84' ' ' VAL . 62.3 p -147.24 119.71 8.47 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.512 -1.662 . . . . 18.359999999999999 106.512 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.826 ' HB ' HD12 ' A' ' 2' ' ' ILE . 13.3 t -52.25 169.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 118.548 -1.261 . . . . 19.129999999999999 108.493 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.561 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.8 t-80 -131.33 119.64 22.01 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.36 -0.838 . . . . 20.649999999999999 108.911 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.936 HD13 HG23 ' B' ' 2' ' ' ILE . 0.0 OUTLIER -62.35 -12.44 21.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.694 -0.629 . . . . 19.649999999999999 109.641 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.2 t -46.98 -20.92 0.17 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.944 -1.097 . . . . 14.720000000000001 108.593 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 34.1 m -96.7 -7.93 32.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.496 -0.753 . . . . 11.449999999999999 111.035 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.659 ' C ' HD11 ' B' ' 37' ' ' LEU . 3.1 m-30 -81.1 161.77 23.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.617 -1.302 . . . . 14.25 109.816 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 5.1 pttm -145.74 174.75 10.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.45 -0.781 . . . . 32.700000000000003 109.663 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.816 HG21 HG21 ' B' ' 43' ' ' VAL . 2.5 t -117.19 129.2 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.419 -0.801 . . . . 15.630000000000001 109.307 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.14 168.12 35.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.479 -1.448 . . . . 12.699999999999999 109.479 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -76.74 0.55 20.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.232 -1.157 . . . . 26.289999999999999 109.733 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -26.99 23.16 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.461 -0.774 . . . . 20.440000000000001 109.21 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.77 65.31 0.76 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.492 -1.443 . . . . 13.82 109.492 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.14 133.43 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -1.107 . . . . 18.27 109.524 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 68' ' ' PHE . 2.4 tt -73.56 148.66 42.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 12.43 109.519 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 30.3 mtm -155.94 128.97 8.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 35.109999999999999 109.558 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' B' ' 78' ' ' ILE . 3.1 mt -64.72 141.0 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 13.67 109.988 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -108.25 -37.3 6.05 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.637 -1.246 . . . . 24.059999999999999 107.637 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.0 tpm_? -168.57 68.06 0.07 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.19 -1.411 . . . . 35.039999999999999 107.19 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -31.1 120.23 0.21 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.499 -0.773 . . . . 18.719999999999999 111.518 -178.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.539 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -90.45 103.25 15.96 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.988 -1.116 . . . . 20.550000000000001 107.988 178.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -75.83 147.33 39.21 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.934 -1.104 . . . . 14.4 111.006 -178.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 62' ' ' THR . 18.1 m -148.22 160.22 37.62 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 107.727 -1.212 . . . . 17.649999999999999 107.727 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.7 Cg_endo -62.32 146.63 95.75 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.036 1.824 . . . . 25.699999999999999 110.398 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -79.5 116.6 19.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.152 -0.968 . . . . 49.289999999999999 109.696 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.004 -0.998 . . . . 58.909999999999997 109.454 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.502 0.668 . . . . 64.909999999999997 109.429 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.936 HG23 HD13 ' A' ' 65' ' ' LEU . 4.0 mt -78.29 77.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.719 -1.215 . . . . 33.799999999999997 107.719 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.48 ' O ' HG13 ' B' ' 35' ' ' VAL . 0.2 OUTLIER -67.57 167.52 12.81 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.02 0.914 . . . . 32.719999999999999 110.869 -178.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.933 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -177.45 160.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.458 -0.942 . . . . 14.460000000000001 108.458 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.48 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 29.8 mt-10 -134.52 114.6 13.0 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.924 -0.769 . . . . 22.120000000000001 108.924 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.724 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -73.74 99.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.81 -1.182 . . . . 14.23 107.81 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.671 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.0 169.96 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.34 -0.85 . . . . 25.43 109.898 -178.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.0 Cg_endo -74.39 -28.29 10.47 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.488 2.125 . . . . 13.609999999999999 110.088 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.13 9.06 41.03 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.767 -0.827 . . . . 15.52 108.767 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.549 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 5.6 mm100 -126.13 22.34 7.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 17.309999999999999 109.864 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -95.74 15.14 20.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 24.780000000000001 110.151 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.547 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 60.4 mt-30 -134.86 141.1 46.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.038 -1.039 . . . . 47.899999999999999 109.736 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.737 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 45.1 p90 -94.03 153.91 17.92 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.257 -0.902 . . . . 21.609999999999999 109.343 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 81.1 m -113.21 150.15 32.73 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.296 -0.877 . . . . 14.890000000000001 108.955 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . 0.551 HG23 ' OD1' ' B' ' 29' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.498 0 O-C-N 121.33 -0.857 . . . . 17.350000000000001 109.606 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.771 HD12 ' O ' ' B' ' 29' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 121.41 0.624 . . . . 24.0 110.031 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.771 ' O ' HD12 ' B' ' 28' ' ' LEU . 67.3 m-20 -72.16 151.18 43.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.451 -0.781 . . . . 23.309999999999999 109.499 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.63 132.67 39.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 40.030000000000001 108.704 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.756 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -123.35 -174.18 2.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.069 -1.019 . . . . 12.390000000000001 110.04 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.926 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.8 mp -143.57 152.91 41.99 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.852 -0.795 . . . . 17.420000000000002 108.852 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -152.75 -177.46 6.27 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.925 -1.139 . . . . 13.84 107.925 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.693 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 21.9 m-85 -129.78 99.71 5.23 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.056 -1.027 . . . . 21.140000000000001 109.881 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.873 HG22 ' HB ' ' B' ' 4' ' ' VAL . 62.9 t -95.35 113.74 30.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.171 -0.956 . . . . 10.66 109.435 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 5.3 t70 -62.51 -28.33 69.77 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.189 -0.945 . . . . 25.890000000000001 108.527 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.659 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER 46.25 25.27 0.34 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.516 -0.74 . . . . 24.239999999999998 109.436 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.67 14.01 81.63 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.831 -1.307 . . . . 31.02 109.831 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 64.2 m-20 -86.0 15.11 5.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -1.211 . . . . 43.229999999999997 110.325 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.578 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 9.5 mt-10 60.84 11.42 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.332 -0.855 . . . . 42.340000000000003 110.487 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 71.2 m80 -161.15 152.79 16.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.0 -1.111 . . . . 6.3799999999999999 108.0 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.693 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.4 Cg_endo -75.92 136.71 18.9 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.806 1.671 . . . . 17.920000000000002 110.442 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.857 HG22 ' O ' ' B' ' 35' ' ' VAL . 4.5 m -110.93 118.07 56.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.393 -0.817 . . . . 20.57 109.037 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.926 HD11 ' HB3' ' B' ' 32' ' ' LEU . 46.0 tp -73.21 104.38 4.24 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.392 -0.818 . . . . 20.210000000000001 110.215 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.626 HG13 HG23 ' B' ' 43' ' ' VAL . 32.5 m -108.44 -177.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.492 -0.929 . . . . 10.81 108.492 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.419 ' HD2' HD21 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -109.09 154.55 22.12 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.949 -1.101 . . . . 36.740000000000002 110.316 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.591 HG13 ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -127.21 169.96 17.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.515 -0.74 . . . . 19.739999999999998 109.105 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' B' ' 47' ' ' ILE . 3.5 m -122.78 123.99 42.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.328 -0.857 . . . . 22.559999999999999 108.838 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.643 HD12 ' O ' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -102.46 163.92 11.96 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.269 -0.894 . . . . 20.41 109.352 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.53 167.83 9.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 33.990000000000002 109.513 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -73.0 87.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 54.920000000000002 109.435 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.08 -25.96 4.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 36.100000000000001 109.568 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.643 ' O ' HD12 ' B' ' 49' ' ' LEU . 2.1 mt-30 -73.61 140.86 78.88 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.217 -1.167 . . . . 54.759999999999998 109.451 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' B' ' 55' ' ' ALA . 36.2 Cg_endo -79.48 118.71 3.95 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.526 2.151 . . . . 28.370000000000001 110.322 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.756 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.37 155.34 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 17.210000000000001 110.291 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.665 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 16.5 m-30 -50.09 111.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.449 -0.782 . . . . 17.190000000000001 109.416 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -61.4 176.37 0.42 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 17.82 109.246 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.21 121.04 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.567 2.178 . . . . 17.280000000000001 110.41 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.7 177.91 36.91 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.752 -1.339 . . . . 17.219999999999999 109.752 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.4 mp -71.36 159.64 34.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -1.13 . . . . 19.57 108.783 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.933 ' CB ' HG13 ' B' ' 4' ' ' VAL . 19.8 m-85 -142.07 165.05 28.5 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.529 1.157 . . . . 14.609999999999999 111.77 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.747 ' O ' HG22 ' B' ' 84' ' ' VAL . 60.3 p -147.28 119.82 8.51 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.554 -1.647 . . . . 18.359999999999999 106.554 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.845 ' HB ' HD12 ' B' ' 2' ' ' ILE . 13.1 t -52.26 169.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 C-N-CA 118.576 -1.25 . . . . 19.129999999999999 108.433 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.557 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.8 t-80 -131.44 119.62 21.87 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.37 -0.831 . . . . 20.649999999999999 108.987 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.914 ' CD1' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -62.25 -12.51 20.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.7 -0.625 . . . . 19.649999999999999 109.698 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.416 ' C ' ' O ' ' B' ' 65' ' ' LEU . 40.3 t -46.95 -20.48 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.933 -1.104 . . . . 14.720000000000001 108.565 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.511 ' HB2' ' HA ' ' B' ' 81' ' ' LEU . 32.6 m -97.17 -9.0 28.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -0.774 . . . . 11.449999999999999 111.032 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.684 ' C ' HD11 ' A' ' 37' ' ' LEU . 3.0 m-30 -80.22 160.97 25.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.658 -1.276 . . . . 14.25 109.743 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.52 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 4.9 pttm -144.94 175.18 10.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.369 -0.832 . . . . 32.700000000000003 109.707 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 43' ' ' VAL . 2.5 t -117.42 129.2 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.49 -0.756 . . . . 15.630000000000001 109.322 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.22 168.36 35.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.564 -1.414 . . . . 12.699999999999999 109.564 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.491 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 0.9 OUTLIER -76.93 0.61 20.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.118 -1.225 . . . . 26.289999999999999 109.686 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.37 -26.99 23.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.47 -0.769 . . . . 20.440000000000001 109.253 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.86 65.43 0.76 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.454 -1.459 . . . . 13.82 109.454 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.3 133.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -1.168 . . . . 18.27 109.53 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' B' ' 68' ' ' PHE . 2.5 tt -73.65 148.64 42.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 12.43 109.471 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.432 ' HG3' ' C ' ' B' ' 76' ' ' LEU . 30.3 mtm -155.92 128.88 8.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 35.109999999999999 109.505 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' A' ' 78' ' ' ILE . 3.0 mt -64.79 141.25 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 13.67 110.06 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -108.41 -36.95 6.1 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.581 -1.266 . . . . 24.059999999999999 107.581 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.51 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.1 tpm_? -168.91 68.12 0.07 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.184 -1.413 . . . . 35.039999999999999 107.184 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.671 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.6 OUTLIER -31.18 120.44 0.22 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.469 -0.787 . . . . 18.719999999999999 111.518 -178.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -90.52 103.24 15.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.959 -1.126 . . . . 20.550000000000001 107.959 178.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.665 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -75.76 147.21 39.45 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.989 -1.07 . . . . 14.4 110.966 -178.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.747 HG22 ' O ' ' B' ' 62' ' ' THR . 18.1 m -148.13 160.04 38.31 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.651 -1.24 . . . . 17.649999999999999 107.651 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.1 Cg_endo -62.17 146.51 95.99 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.974 1.783 . . . . 25.699999999999999 110.448 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.609 ' HA ' HG23 ' B' ' 62' ' ' THR . . . -79.46 116.5 19.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.146 -0.971 . . . . 49.289999999999999 109.648 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.98 -1.009 . . . . 58.909999999999997 109.474 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.524 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.433 -0.58 . . . . 64.909999999999997 109.433 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.608 HG21 HG21 ' A' ' 63' ' ' VAL . 3.7 mt -72.44 79.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.729 -1.211 . . . . 33.799999999999997 107.729 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -69.31 156.38 38.87 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.05 0.929 . . . . 32.719999999999999 111.54 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.878 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -166.01 168.01 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.18 -1.044 . . . . 14.460000000000001 108.18 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.555 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 26.3 mt-10 -143.44 112.63 6.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 22.120000000000001 109.541 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.71 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -72.37 102.72 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 C-N-CA 119.003 -1.079 . . . . 14.23 108.107 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 1.3 mmpt? -43.72 162.44 0.19 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.352 -0.842 . . . . 25.43 109.414 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.5 Cg_endo -72.7 -12.71 26.82 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.972 1.781 . . . . 13.609999999999999 109.088 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.5 t -99.13 7.15 46.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.234 -1.025 . . . . 15.52 108.234 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 1.5 mm-40 -129.47 41.27 3.48 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.846 -0.798 . . . . 17.309999999999999 108.846 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.76 3.65 39.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.122 -0.986 . . . . 24.780000000000001 110.291 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.485 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -134.84 139.64 45.22 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.129 -0.982 . . . . 47.899999999999999 108.607 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.706 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 22.3 p90 -85.62 176.97 7.88 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.035 -1.041 . . . . 21.609999999999999 109.298 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -133.98 148.2 51.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.444 -0.785 . . . . 14.890000000000001 109.099 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.594 0 O-C-N 121.336 -0.852 . . . . 17.350000000000001 109.088 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.495 0.664 . . . . 24.0 110.24 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.645 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -95.17 127.11 40.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.467 -0.77 . . . . 23.309999999999999 108.939 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -113.68 160.39 18.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.202 -0.936 . . . . 40.030000000000001 109.603 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.792 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -137.5 -169.41 2.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 12.390000000000001 109.123 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.973 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.1 mt -133.93 175.87 9.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 17.420000000000002 109.544 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.18 161.72 8.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.964 -1.085 . . . . 13.84 108.525 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.744 ' CE1' HD13 ' A' ' 44' ' ' LEU . 3.1 m-30 -114.34 101.34 9.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.132 -0.98 . . . . 21.140000000000001 108.828 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.878 HG22 ' HB ' ' A' ' 4' ' ' VAL . 13.9 t -107.6 148.21 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.999 -1.063 . . . . 10.66 110.029 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.942 ' O ' HD12 ' A' ' 37' ' ' LEU . 1.8 p-10 -113.86 -39.92 3.88 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.408 -0.96 . . . . 25.890000000000001 108.408 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.942 HD12 ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER 62.55 -71.01 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.731 -0.84 . . . . 24.239999999999998 108.731 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -142.59 28.0 2.2 Favored Glycine 0 C--N 1.296 -1.666 0 N-CA-C 108.238 -1.945 . . . . 31.02 108.238 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -130.89 98.97 4.76 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.593 -0.946 . . . . 43.229999999999997 108.722 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' ' 39' ' ' ASN . 3.4 mm-40 -31.36 -37.2 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.284 0.564 . . . . 42.340000000000003 111.194 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 39' ' ' ASN . 60.7 m80 -80.67 149.15 67.27 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.87 . . . . 7.0 108.973 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.633 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -78.56 149.61 24.11 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.135 1.89 . . . . 17.920000000000002 110.466 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 35' ' ' VAL . 1.8 m -121.52 119.11 58.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.393 -0.923 . . . . 20.57 109.058 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.973 HD11 ' HB3' ' A' ' 32' ' ' LEU . 15.7 tp -72.72 112.25 8.6 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.722 -0.791 . . . . 20.210000000000001 109.178 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.606 HG23 HG23 ' A' ' 43' ' ' VAL . 14.3 t -118.44 167.06 12.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.545 -0.722 . . . . 10.81 109.528 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -96.15 139.93 31.6 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.517 -0.873 . . . . 36.740000000000002 109.421 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.956 HD13 HD12 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -121.55 171.63 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.808 . . . . 19.739999999999998 109.004 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.426 ' OG1' ' HD3' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -105.56 153.59 21.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.075 -1.016 . . . . 22.559999999999999 109.691 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -136.71 105.26 5.79 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.629 -0.878 . . . . 20.41 108.629 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -70.26 143.95 51.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -0.954 . . . . 33.990000000000002 109.635 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.17 132.85 39.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 54.920000000000002 109.269 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.23 -35.58 4.79 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.452 -1.459 . . . . 36.100000000000001 109.452 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 5.1 mt-30 -79.8 138.46 54.01 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.265 -1.138 . . . . 54.759999999999998 109.341 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.3 126.13 7.48 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.509 2.139 . . . . 28.370000000000001 110.415 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.792 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -41.35 149.59 0.11 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.353 -0.842 . . . . 17.210000000000001 110.295 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.71 ' O ' HG21 ' A' ' 6' ' ' ILE . 83.1 m-85 -50.94 97.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.476 -0.765 . . . . 17.190000000000001 109.026 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.995 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.14 176.54 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.176 -0.953 . . . . 17.82 109.407 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.995 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.1 Cg_endo -76.68 131.26 12.24 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.418 2.079 . . . . 17.280000000000001 110.009 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.67 174.59 27.57 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.777 -1.329 . . . . 17.219999999999999 109.777 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.7 OUTLIER -73.7 143.12 46.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -1.114 . . . . 19.57 108.469 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.725 ' HB3' HD22 ' A' ' 83' ' ' LEU . 22.3 m-85 -127.31 162.89 25.18 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.832 -1.167 . . . . 14.609999999999999 111.548 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.8 p -143.04 121.39 12.32 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.534 -1.654 . . . . 18.359999999999999 106.534 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.834 ' CG1' HD12 ' A' ' 81' ' ' LEU . 3.3 t -52.54 166.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 C-N-CA 118.873 -1.131 . . . . 19.129999999999999 109.012 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -134.84 128.78 33.36 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.561 -0.903 . . . . 20.649999999999999 108.561 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.723 HD11 ' O ' ' B' ' 37' ' ' LEU . 1.2 pp -73.13 3.15 5.91 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.036 -1.04 . . . . 19.649999999999999 110.005 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.7 t -57.04 -19.15 17.17 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.716 -1.216 . . . . 14.720000000000001 107.716 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -101.34 -8.01 22.45 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.696 -0.628 . . . . 11.449999999999999 110.234 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.4 m-30 -74.66 155.27 37.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.836 -1.165 . . . . 14.25 108.925 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.77 176.53 12.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 32.700000000000003 109.678 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.757 HG21 HG21 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -109.45 115.77 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.392 -0.818 . . . . 15.630000000000001 109.285 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.06 179.71 10.77 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.508 -1.437 . . . . 12.699999999999999 109.508 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.534 ' HA ' ' NE2' ' A' ' 72' ' ' GLN . 9.2 mm-40 -88.46 42.43 1.07 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.222 -1.164 . . . . 26.289999999999999 109.298 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.402 ' CG ' ' C ' ' A' ' 72' ' ' GLN . 10.3 m-85 -148.23 34.96 0.81 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.532 -0.73 . . . . 20.440000000000001 109.384 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' HG13 ' B' ' 45' ' ' VAL . . . 48.0 58.78 6.72 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.239 -1.544 . . . . 13.82 109.239 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.435 ' HA ' HG13 ' B' ' 45' ' ' VAL . 4.2 m -156.41 136.16 12.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.335 -1.097 . . . . 18.27 109.919 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.958 HD11 HD21 ' B' ' 37' ' ' LEU . 0.3 OUTLIER -73.06 165.08 25.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.321 -0.862 . . . . 12.43 109.084 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.541 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.1 mtt -166.43 107.86 0.7 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.07 -1.019 . . . . 35.109999999999999 110.023 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.61 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -42.67 -35.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 13.67 109.588 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER 43.89 55.19 5.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 24.059999999999999 109.411 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 67' ' ' SER . 6.5 tmm_? 78.23 80.78 0.07 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.851 -0.796 . . . . 35.039999999999999 108.851 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.834 HD12 ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -55.56 149.03 14.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.768 0.794 . . . . 18.719999999999999 111.703 -178.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -99.48 103.46 15.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.094 -1.076 . . . . 20.550000000000001 108.094 178.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.956 HD12 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -75.16 151.57 38.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.185 -0.947 . . . . 14.4 111.568 -178.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 62' ' ' THR . 27.1 m -151.51 155.65 34.37 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.825 -1.176 . . . . 17.649999999999999 107.825 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 24.7 Cg_endo -63.42 144.23 90.3 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.146 1.898 . . . . 25.699999999999999 110.433 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.544 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -72.0 139.71 48.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.159 -0.963 . . . . 49.289999999999999 109.396 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.009 -0.996 . . . . 58.909999999999997 109.551 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.521 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.396 -0.594 . . . . 64.909999999999997 109.396 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.601 ' CA ' HD22 ' A' ' 65' ' ' LEU . 3.8 mt -72.7 79.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.664 -1.235 . . . . 33.799999999999997 107.664 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -69.59 156.13 39.41 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.055 0.931 . . . . 32.719999999999999 111.549 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.899 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -165.54 168.16 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.229 -1.026 . . . . 14.460000000000001 108.229 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.547 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 26.3 mt-10 -143.46 112.55 6.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 22.120000000000001 109.556 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.704 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -72.31 102.59 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 118.979 -1.089 . . . . 14.23 108.079 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.551 ' HB3' ' HD2' ' B' ' 8' ' ' PRO . 1.1 mmpt? -43.69 162.57 0.19 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 25.43 109.466 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.4 Cg_endo -72.65 -12.9 27.07 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.007 1.805 . . . . 13.609999999999999 109.144 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -98.99 7.15 46.28 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.26 -1.015 . . . . 15.52 108.26 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 1.5 mm-40 -129.53 41.34 3.46 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.416 -0.803 . . . . 17.309999999999999 108.885 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.92 3.88 39.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.063 -1.023 . . . . 24.780000000000001 110.264 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.464 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.9 OUTLIER -134.9 139.49 45.02 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.167 -0.958 . . . . 47.899999999999999 108.533 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.704 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 22.1 p90 -85.86 176.7 7.94 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.035 -1.041 . . . . 21.609999999999999 109.244 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -133.64 148.67 51.55 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.395 -0.816 . . . . 14.890000000000001 109.087 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.604 0 O-C-N 121.37 -0.831 . . . . 17.350000000000001 108.997 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.427 0.632 . . . . 24.0 110.231 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.639 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -95.09 127.08 40.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.445 -0.785 . . . . 23.309999999999999 108.922 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.6 OUTLIER -113.51 160.68 18.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.175 -0.953 . . . . 40.030000000000001 109.581 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.817 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -137.83 -169.63 2.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 12.390000000000001 109.02 179.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.949 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.1 mt -133.81 175.85 9.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.923 . . . . 17.420000000000002 109.548 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.14 161.69 8.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.955 -1.091 . . . . 13.84 108.497 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.742 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.1 m-30 -114.41 101.58 9.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 21.140000000000001 108.739 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.899 HG22 ' HB ' ' B' ' 4' ' ' VAL . 13.5 t -107.73 148.25 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.056 -1.027 . . . . 10.66 110.125 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.94 ' O ' HD12 ' B' ' 37' ' ' LEU . 1.8 p-10 -113.95 -40.07 3.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.51 -0.922 . . . . 25.890000000000001 108.51 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.958 HD21 HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER 62.38 -70.87 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.773 -0.825 . . . . 24.239999999999998 108.773 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -142.65 27.73 2.2 Favored Glycine 0 C--N 1.296 -1.669 0 N-CA-C 108.307 -1.917 . . . . 31.02 108.307 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.0 OUTLIER -130.72 99.07 4.82 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.604 -0.939 . . . . 43.229999999999997 108.73 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' B' ' 39' ' ' ASN . 3.4 mm-40 -31.55 -37.02 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.3 0.571 . . . . 42.340000000000003 111.143 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' B' ' 39' ' ' ASN . 59.8 m80 -80.73 149.18 67.12 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 121.342 -0.849 . . . . 6.9800000000000004 109.037 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.634 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.4 Cg_endo -78.58 149.48 23.94 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.102 1.868 . . . . 17.920000000000002 110.408 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.84 HG22 ' O ' ' B' ' 35' ' ' VAL . 1.8 m -121.36 119.51 59.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.344 -0.943 . . . . 20.57 109.102 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.949 HD11 ' HB3' ' B' ' 32' ' ' LEU . 15.3 tp -73.04 111.45 8.16 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.778 -0.769 . . . . 20.210000000000001 109.105 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.608 HG23 HG23 ' B' ' 43' ' ' VAL . 12.8 t -117.7 167.16 11.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.633 -0.667 . . . . 10.81 109.449 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.564 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.9 OUTLIER -96.16 140.33 31.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.319 -0.863 . . . . 36.740000000000002 109.495 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.943 HD13 HD12 ' B' ' 83' ' ' LEU . 0.3 OUTLIER -121.96 171.81 10.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.344 -0.847 . . . . 19.739999999999998 109.076 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.423 ' OG1' ' HD3' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -105.89 153.15 22.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.051 -1.03 . . . . 22.559999999999999 109.77 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -136.36 104.99 5.79 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.684 -0.858 . . . . 20.41 108.684 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -70.01 144.5 52.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 33.990000000000002 109.665 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.58 132.88 41.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.893 . . . . 54.920000000000002 109.264 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.32 -36.09 4.44 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.398 -1.481 . . . . 36.100000000000001 109.398 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.51 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 5.0 mt-30 -79.47 138.34 55.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.27 -1.135 . . . . 54.759999999999998 109.34 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.41 126.12 7.39 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.44 2.093 . . . . 28.370000000000001 110.372 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.817 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -41.25 150.58 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.328 -0.857 . . . . 17.210000000000001 110.234 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.704 ' O ' HG21 ' B' ' 6' ' ' ILE . 82.1 m-85 -51.95 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.95 -0.759 . . . . 17.190000000000001 108.95 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.978 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -51.53 176.62 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.306 -0.871 . . . . 17.82 109.312 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.978 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -76.9 132.12 12.7 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.469 2.113 . . . . 17.280000000000001 110.328 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.99 175.15 26.66 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.676 -1.37 . . . . 17.219999999999999 109.676 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.524 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.7 OUTLIER -73.43 143.88 46.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -1.138 . . . . 19.57 108.872 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.701 ' HB3' HD22 ' B' ' 83' ' ' LEU . 21.5 m-85 -127.9 163.05 25.3 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.544 1.164 . . . . 14.609999999999999 111.556 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.69 ' O ' HG22 ' B' ' 84' ' ' VAL . 46.1 p -143.32 121.41 12.14 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.546 -1.65 . . . . 18.359999999999999 106.546 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.834 ' CG1' HD12 ' B' ' 81' ' ' LEU . 3.3 t -52.75 165.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 C-N-CA 118.88 -1.128 . . . . 19.129999999999999 109.023 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -134.02 128.55 34.56 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.59 -0.893 . . . . 20.649999999999999 108.59 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.729 HD11 ' O ' ' A' ' 37' ' ' LEU . 1.3 pp -72.74 2.95 5.68 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.061 -1.024 . . . . 19.649999999999999 110.087 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 28.6 t -56.94 -19.21 16.73 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 107.711 -1.218 . . . . 14.720000000000001 107.711 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -101.45 -7.79 22.55 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.723 -0.611 . . . . 11.449999999999999 110.166 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.641 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.3 m-30 -74.84 154.97 38.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.889 -1.132 . . . . 14.25 108.833 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.43 176.85 12.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 32.700000000000003 109.681 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -109.8 115.62 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.43 -0.794 . . . . 15.630000000000001 109.363 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.91 179.71 10.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.568 -1.413 . . . . 12.699999999999999 109.568 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.537 ' HA ' ' NE2' ' B' ' 72' ' ' GLN . 8.8 mm-40 -88.49 42.42 1.07 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.224 -1.162 . . . . 26.289999999999999 109.314 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.404 ' CG ' ' C ' ' B' ' 72' ' ' GLN . 9.5 m-85 -148.18 34.79 0.81 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.495 -0.753 . . . . 20.440000000000001 109.481 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.435 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 48.34 58.08 7.59 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.292 -1.523 . . . . 13.82 109.292 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.4 m -155.74 136.37 13.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.139 . . . . 18.27 109.963 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.904 HD11 HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -73.2 164.91 26.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 12.43 109.157 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.1 mtt -166.37 108.12 0.71 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.085 -1.009 . . . . 35.109999999999999 110.106 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.615 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.7 mt -42.99 -34.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 13.67 109.532 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.7 OUTLIER 43.83 55.27 5.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.832 . . . . 24.059999999999999 109.35 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 67' ' ' SER . 6.5 tmm_? 78.23 80.82 0.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.922 -0.77 . . . . 35.039999999999999 108.922 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.834 HD12 ' CG1' ' B' ' 63' ' ' VAL . 1.0 OUTLIER -55.54 149.11 14.27 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.702 0.763 . . . . 18.719999999999999 111.74 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -99.62 103.55 15.26 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.992 -1.114 . . . . 20.550000000000001 107.992 178.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.943 HD12 HD13 ' B' ' 47' ' ' ILE . 0.6 OUTLIER -75.22 151.55 38.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.229 -0.92 . . . . 14.4 111.609 -178.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.69 HG22 ' O ' ' B' ' 62' ' ' THR . 29.9 m -151.55 155.36 34.18 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 107.837 -1.171 . . . . 17.649999999999999 107.837 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 24.7 Cg_endo -63.22 144.12 91.12 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.237 1.958 . . . . 25.699999999999999 110.446 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.525 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -72.0 139.4 48.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 49.289999999999999 109.375 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.034 -0.984 . . . . 58.909999999999997 109.483 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.4 -0.593 . . . . 64.909999999999997 109.4 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.707 ' N ' HD22 ' B' ' 65' ' ' LEU . 3.0 mt -61.93 83.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.646 -1.242 . . . . 33.799999999999997 107.646 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 1' ' ' MET . 14.0 mtpt -75.93 158.05 32.47 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.952 0.882 . . . . 32.719999999999999 111.104 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.893 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -164.23 169.05 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.293 -1.002 . . . . 14.460000000000001 108.293 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 55.5 mt-10 -144.7 112.6 6.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.94 . . . . 22.120000000000001 109.47 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.746 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -72.73 101.98 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.822 -1.177 . . . . 14.23 107.822 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.656 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.69 171.22 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.304 -0.872 . . . . 25.43 109.856 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -74.8 -26.9 10.91 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.36 2.04 . . . . 13.609999999999999 109.589 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -88.02 0.08 56.39 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.987 -0.746 . . . . 15.52 108.987 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.8 mm-40 -120.42 33.87 5.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 17.309999999999999 109.475 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.95 10.79 38.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 24.780000000000001 109.958 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 15.3 mt-30 -138.93 144.99 39.29 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 47.899999999999999 109.96 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.737 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 35.4 p90 -94.3 161.52 14.21 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.323 -0.861 . . . . 21.609999999999999 109.195 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -128.92 162.82 26.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.311 -0.868 . . . . 14.890000000000001 108.808 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.561 0 O-C-N 121.239 -0.913 . . . . 17.350000000000001 109.541 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.605 HD22 ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.462 0.649 . . . . 24.0 110.173 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.569 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 90.7 m-20 -64.99 133.55 51.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.387 -0.821 . . . . 23.309999999999999 109.745 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.21 142.32 51.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 40.030000000000001 109.294 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.91 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -124.14 -179.04 4.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 12.390000000000001 109.303 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.9 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.1 mt -127.75 174.33 9.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 17.420000000000002 109.579 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -168.45 167.62 11.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.403 -0.962 . . . . 13.84 108.403 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.668 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 18.7 m-85 -120.88 107.38 12.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.138 -0.976 . . . . 21.140000000000001 109.545 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.927 ' O ' HG22 ' A' ' 43' ' ' VAL . 59.2 t -104.02 112.3 37.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.141 -0.974 . . . . 10.66 109.821 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.0 OUTLIER -64.0 -27.34 69.05 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.196 -1.038 . . . . 25.890000000000001 108.196 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.666 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.6 OUTLIER 48.37 30.85 2.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.602 -0.686 . . . . 24.239999999999998 109.303 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.61 9.37 78.33 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.457 -1.457 . . . . 31.02 109.457 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.615 ' OD1' HD23 ' A' ' 37' ' ' LEU . 1.9 m-20 -85.43 4.57 34.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -1.149 . . . . 43.229999999999997 110.476 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 29.6 mt-10 80.7 -42.61 0.2 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.585 -0.697 . . . . 42.340000000000003 110.567 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.521 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 47.5 m80 -107.0 155.34 39.38 Favored Pre-proline 0 C--N 1.295 -1.793 0 O-C-N 121.417 -0.802 . . . . 5.75 108.929 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.668 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -77.15 138.12 17.79 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.181 1.92 . . . . 17.920000000000002 110.542 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.927 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.6 m -111.85 117.75 55.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.369 -0.832 . . . . 20.57 108.827 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.9 HD11 ' HB3' ' A' ' 32' ' ' LEU . 67.3 tp -71.56 103.26 2.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.288 -0.882 . . . . 20.210000000000001 110.007 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 43' ' ' VAL . 3.6 m -106.42 -177.42 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.527 -0.733 . . . . 10.81 109.032 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.26 145.0 40.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.409 -0.917 . . . . 36.740000000000002 109.987 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.856 HD13 HD12 ' A' ' 83' ' ' LEU . 1.2 tt -135.9 136.47 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.418 -0.801 . . . . 19.739999999999998 109.064 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.605 ' CG2' HD22 ' A' ' 28' ' ' LEU . 11.1 m -68.67 156.01 39.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 22.559999999999999 109.57 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.641 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 2.3 tm? -129.99 114.02 15.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.282 -0.886 . . . . 20.41 109.077 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -48.85 123.56 7.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.866 . . . . 33.990000000000002 110.152 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -47.34 109.27 0.2 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.319 -0.863 . . . . 54.920000000000002 109.353 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.78 -29.65 10.55 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.429 -1.468 . . . . 36.100000000000001 109.429 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.604 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -65.2 153.68 88.89 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.23 -1.159 . . . . 54.759999999999998 109.326 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.8 Cg_endo -77.88 109.95 2.82 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.506 2.138 . . . . 28.370000000000001 110.224 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.91 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -38.63 148.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.526 -0.734 . . . . 17.210000000000001 110.218 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.746 ' O ' HG21 ' A' ' 6' ' ' ILE . 83.0 m-85 -46.0 101.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.451 -0.781 . . . . 17.190000000000001 109.355 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.845 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.63 171.02 0.17 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.907 . . . . 17.82 109.823 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.845 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -77.9 114.14 3.57 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.736 2.291 . . . . 17.280000000000001 110.117 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.65 -179.82 46.6 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.898 -1.281 . . . . 17.219999999999999 109.898 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -75.78 139.76 41.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -1.082 . . . . 19.57 108.114 179.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.766 ' HB3' HD22 ' A' ' 83' ' ' LEU . 18.5 m-85 -126.26 162.15 26.11 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.66 -1.275 . . . . 14.609999999999999 111.759 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.772 ' O ' HG22 ' A' ' 84' ' ' VAL . 52.8 p -142.11 122.25 13.8 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.247 -1.76 . . . . 18.359999999999999 106.247 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.598 HG21 HG21 ' A' ' 2' ' ' ILE . 2.5 t -54.38 162.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 C-N-CA 118.792 -1.163 . . . . 19.129999999999999 109.077 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.545 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.5 t-80 -130.46 129.17 42.63 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.246 -1.02 . . . . 20.649999999999999 108.246 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.711 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.5 OUTLIER -70.04 1.97 4.06 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.502 -0.749 . . . . 19.649999999999999 110.2 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.03 -20.35 9.18 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.448 -1.316 . . . . 14.720000000000001 107.448 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -97.58 -8.34 29.21 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.755 -0.591 . . . . 11.449999999999999 110.09 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -77.97 154.94 31.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.967 -1.083 . . . . 14.25 109.595 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.93 175.8 9.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 32.700000000000003 109.466 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.912 HG11 ' CG2' ' B' ' 43' ' ' VAL . 10.6 t -122.37 134.4 65.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.43 -0.794 . . . . 15.630000000000001 109.475 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.21 -160.24 28.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.382 -1.487 . . . . 12.699999999999999 109.382 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 6.2 tp60 61.67 72.73 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -1.177 . . . . 26.289999999999999 109.349 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 2.2 m-85 65.51 11.97 7.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 20.440000000000001 109.357 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' B' ' 45' ' ' VAL . . . 81.97 48.82 5.6 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.503 -1.439 . . . . 13.82 109.503 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 77' ' ' MET . 26.9 t -130.6 125.48 34.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -1.116 . . . . 18.27 109.662 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.689 ' CD1' HG22 ' A' ' 70' ' ' VAL . 3.5 tp -63.96 146.44 54.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 12.43 109.115 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.5 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 3.2 mtm -159.33 144.37 15.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 35.109999999999999 109.449 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.624 ' CG1' ' CE1' ' A' ' 68' ' ' PHE . 1.7 mp -65.14 145.48 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 13.67 109.505 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 67' ' ' SER . 4.6 t70 -103.46 -62.28 1.31 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.214 -1.402 . . . . 24.059999999999999 107.214 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.524 ' O ' ' C ' ' A' ' 81' ' ' LEU . 5.1 tmm_? -142.28 56.8 1.46 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.292 -1.003 . . . . 35.039999999999999 108.292 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.632 HD21 ' HG ' ' A' ' 83' ' ' LEU . 6.4 tt 3.43 116.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.524 -1.217 . . . . 18.719999999999999 112.849 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.545 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -99.35 96.61 7.84 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.098 -1.075 . . . . 20.550000000000001 108.098 178.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.856 HD12 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -77.49 150.82 34.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.982 -1.074 . . . . 14.4 111.064 -178.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 62' ' ' THR . 26.4 m -151.15 155.88 34.99 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.106 -1.072 . . . . 17.649999999999999 108.106 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.1 Cg_endo -63.86 141.9 80.06 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.053 1.836 . . . . 25.699999999999999 110.173 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.707 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -70.77 117.79 12.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.206 -0.934 . . . . 49.289999999999999 109.602 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.046 -0.978 . . . . 58.909999999999997 109.496 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.416 -0.587 . . . . 64.909999999999997 109.416 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.711 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.0 mt -62.0 83.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.644 -1.243 . . . . 33.799999999999997 107.644 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' ' 1' ' ' MET . 14.0 mtpt -75.89 158.0 32.58 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.947 0.879 . . . . 32.719999999999999 111.104 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.863 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -164.23 168.99 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.296 -1.002 . . . . 14.460000000000001 108.296 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.548 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 55.2 mt-10 -144.59 112.62 6.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.19 -0.944 . . . . 22.120000000000001 109.448 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.743 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -72.73 101.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.761 -1.2 . . . . 14.23 107.761 179.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.656 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.73 171.23 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.358 -0.839 . . . . 25.43 109.81 -178.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 32.6 Cg_endo -74.92 -26.82 10.72 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.331 2.021 . . . . 13.609999999999999 109.532 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -88.03 0.15 56.3 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.0 -0.741 . . . . 15.52 109.0 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.516 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.8 mm-40 -120.42 33.79 5.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 17.309999999999999 109.506 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.85 10.77 38.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.136 -0.978 . . . . 24.780000000000001 109.937 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.483 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 15.3 mt-30 -139.01 144.93 39.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.144 -0.973 . . . . 47.899999999999999 109.911 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.726 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 35.4 p90 -94.25 161.46 14.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.376 -0.827 . . . . 21.609999999999999 109.178 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 8.7 t -128.78 162.93 26.29 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.242 -0.911 . . . . 14.890000000000001 108.792 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.563 0 O-C-N 121.203 -0.935 . . . . 17.350000000000001 109.486 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.603 HD22 ' CG2' ' B' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.43 0.633 . . . . 24.0 110.231 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.574 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 90.9 m-20 -64.94 133.6 52.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.8 . . . . 23.309999999999999 109.745 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.26 142.32 51.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 40.030000000000001 109.259 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.892 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -124.07 -179.16 4.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 12.390000000000001 109.378 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.877 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.1 mt -127.63 174.41 9.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.964 . . . . 17.420000000000002 109.511 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -168.59 167.57 11.41 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.366 -0.976 . . . . 13.84 108.366 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 18.9 m-85 -120.83 107.4 12.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.127 -0.983 . . . . 21.140000000000001 109.596 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.908 ' O ' HG22 ' B' ' 43' ' ' VAL . 59.4 t -104.04 112.29 36.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.157 -0.964 . . . . 10.66 109.834 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.0 OUTLIER -63.96 -27.41 69.12 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.155 -1.054 . . . . 25.890000000000001 108.155 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.655 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER 48.48 30.74 2.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.637 -0.664 . . . . 24.239999999999998 109.278 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.73 9.34 78.79 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.469 -1.453 . . . . 31.02 109.469 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.609 ' OD1' HD23 ' B' ' 37' ' ' LEU . 1.9 m-20 -85.39 4.5 35.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -1.165 . . . . 43.229999999999997 110.504 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' B' ' 39' ' ' ASN . 29.5 mt-10 80.67 -42.62 0.2 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.578 -0.701 . . . . 42.340000000000003 110.561 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' B' ' 36' ' ' ASP . 47.5 m80 -106.95 155.34 39.34 Favored Pre-proline 0 C--N 1.294 -1.825 0 O-C-N 121.376 -0.828 . . . . 5.7800000000000002 108.919 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.672 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.1 Cg_endo -77.2 138.21 17.78 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.12 1.88 . . . . 17.920000000000002 110.551 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.912 ' CG2' HG11 ' A' ' 70' ' ' VAL . 5.6 m -111.85 117.7 55.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.338 -0.852 . . . . 20.57 108.784 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.877 HD11 ' HB3' ' B' ' 32' ' ' LEU . 67.3 tp -71.55 103.19 2.91 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.347 -0.846 . . . . 20.210000000000001 110.032 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.565 HG13 HG23 ' B' ' 43' ' ' VAL . 3.6 m -106.34 -177.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 109.001 -0.74 . . . . 10.81 109.001 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.27 144.91 40.9 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.408 -0.917 . . . . 36.740000000000002 110.006 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.833 HD13 HD12 ' B' ' 83' ' ' LEU . 1.2 tt -135.84 136.53 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.454 -0.779 . . . . 19.739999999999998 109.068 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.603 ' CG2' HD22 ' B' ' 28' ' ' LEU . 11.0 m -68.67 156.17 38.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -0.984 . . . . 22.559999999999999 109.53 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.635 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 2.3 tm? -130.19 113.94 15.08 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.357 -0.839 . . . . 20.41 109.083 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.3 OUTLIER -48.82 123.6 7.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.873 . . . . 33.990000000000002 110.209 -179.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -47.37 109.25 0.2 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.298 -0.876 . . . . 54.920000000000002 109.394 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.83 -29.67 10.49 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.431 -1.468 . . . . 36.100000000000001 109.431 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.618 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.7 OUTLIER -65.16 153.62 88.92 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.278 -1.131 . . . . 54.759999999999998 109.311 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.5 Cg_endo -77.8 109.98 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.52 2.146 . . . . 28.370000000000001 110.214 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.892 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -38.75 148.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.526 -0.734 . . . . 17.210000000000001 110.154 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.743 ' O ' HG21 ' B' ' 6' ' ' ILE . 83.1 m-85 -46.34 102.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 17.190000000000001 109.409 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.864 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -50.82 171.01 0.17 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 17.82 109.737 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.864 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -78.17 115.31 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.768 2.312 . . . . 17.280000000000001 110.397 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.67 -179.27 45.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.747 -1.341 . . . . 17.219999999999999 109.747 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.732 HD23 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -75.44 140.4 42.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -1.102 . . . . 19.57 108.432 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.768 ' HB3' HD22 ' B' ' 83' ' ' LEU . 18.1 m-85 -126.8 162.25 26.3 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.752 -1.218 . . . . 14.609999999999999 111.764 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.767 ' O ' HG22 ' B' ' 84' ' ' VAL . 52.8 p -142.34 122.26 13.61 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.256 -1.757 . . . . 18.359999999999999 106.256 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.6 HG21 HG21 ' B' ' 2' ' ' ILE . 2.6 t -54.39 162.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 C-N-CA 118.766 -1.174 . . . . 19.129999999999999 109.077 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.552 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.5 t-80 -130.41 129.18 42.72 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.269 -1.012 . . . . 20.649999999999999 108.269 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.707 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -69.93 1.83 4.09 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.516 -0.74 . . . . 19.649999999999999 110.231 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.95 -20.35 8.8 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.419 -1.326 . . . . 14.720000000000001 107.419 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.519 ' O ' ' N ' ' B' ' 79' ' ' ASP . 0.5 OUTLIER -97.74 -8.52 28.41 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.74 -0.6 . . . . 11.449999999999999 110.062 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.666 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.8 m-30 -77.74 154.54 31.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 14.25 109.495 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.54 176.04 9.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 32.700000000000003 109.483 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.91 HG11 ' CG2' ' A' ' 43' ' ' VAL . 10.5 t -122.52 134.37 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 15.630000000000001 109.504 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.19 -160.28 28.6 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.356 -1.498 . . . . 12.699999999999999 109.356 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 6.3 tp60 61.69 72.79 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -1.164 . . . . 26.289999999999999 109.349 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 2.2 m-85 65.43 12.06 7.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 20.440000000000001 109.29 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 45' ' ' VAL . . . 81.87 48.88 5.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.495 -1.442 . . . . 13.82 109.495 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 77' ' ' MET . 27.1 t -130.59 125.38 33.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 18.27 109.659 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.692 ' CD1' HG22 ' B' ' 70' ' ' VAL . 3.4 tp -63.81 146.46 53.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 12.43 109.131 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.508 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 3.2 mtm -159.43 144.41 15.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.07 -1.019 . . . . 35.109999999999999 109.396 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.626 ' CG1' ' CE1' ' B' ' 68' ' ' PHE . 1.7 mp -65.29 145.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 13.67 109.534 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' B' ' 67' ' ' SER . 4.5 t70 -103.59 -62.07 1.34 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.238 -1.393 . . . . 24.059999999999999 107.238 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' B' ' 81' ' ' LEU . 5.1 tmm_? -142.51 56.88 1.44 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.286 -1.005 . . . . 35.039999999999999 108.286 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.641 HD21 ' HG ' ' B' ' 83' ' ' LEU . 6.5 tt 3.4 116.68 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.474 -1.239 . . . . 18.719999999999999 112.887 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.4 OUTLIER -99.41 96.51 7.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.109 -1.071 . . . . 20.550000000000001 108.109 178.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.833 HD12 HD13 ' B' ' 47' ' ' ILE . 0.9 OUTLIER -77.35 150.98 35.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.935 -1.103 . . . . 14.4 111.066 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.767 HG22 ' O ' ' B' ' 62' ' ' THR . 26.5 m -151.34 155.77 34.68 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.054 -1.091 . . . . 17.649999999999999 108.054 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.1 Cg_endo -63.73 141.91 80.94 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.055 1.837 . . . . 25.699999999999999 110.195 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.726 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -70.76 117.72 12.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.163 -0.96 . . . . 49.289999999999999 109.595 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.046 -0.978 . . . . 58.909999999999997 109.476 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.517 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.3 -0.629 . . . . 64.909999999999997 109.3 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.955 ' H ' HD22 ' B' ' 65' ' ' LEU . 1.7 mt 58.53 78.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.799 -1.186 . . . . 33.799999999999997 107.799 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -73.52 157.15 37.29 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.797 0.808 . . . . 32.719999999999999 110.672 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.876 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -164.67 159.31 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.022 -0.733 . . . . 14.460000000000001 109.022 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 5.1 mt-10 -136.34 113.6 10.68 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 22.120000000000001 109.351 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.697 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -72.36 107.26 3.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.906 -1.146 . . . . 14.23 107.906 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.603 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 4.4 mptt -50.07 172.6 0.11 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.165 -0.959 . . . . 25.43 109.999 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.8 Cg_endo -76.0 -29.23 6.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.557 2.171 . . . . 13.609999999999999 109.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 m -92.95 7.01 45.8 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.976 -0.75 . . . . 15.52 108.976 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.1 mm-40 -123.49 29.25 6.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 17.309999999999999 109.749 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.22 16.28 17.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 24.780000000000001 110.063 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 18.4 mt-30 -141.84 145.29 34.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.093 -1.004 . . . . 47.899999999999999 109.902 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.753 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 42.2 p90 -96.16 153.37 17.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.363 -0.836 . . . . 21.609999999999999 109.458 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.7 p -121.38 168.72 11.36 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.421 -0.8 . . . . 14.890000000000001 109.337 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.606 0 O-C-N 121.409 -0.807 . . . . 17.350000000000001 109.048 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.443 0.639 . . . . 24.0 110.179 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 64.1 m-20 -53.8 160.8 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 23.309999999999999 109.809 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 7.4 mt-10 -150.04 125.45 10.19 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.44 -0.948 . . . . 40.030000000000001 108.44 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.998 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -113.6 -179.18 3.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 12.390000000000001 110.36 -178.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.922 ' HB3' HD11 ' A' ' 44' ' ' LEU . 81.2 mt -137.48 147.69 45.48 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.787 -0.819 . . . . 17.420000000000002 108.787 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.96 ' SG ' HD13 ' A' ' 47' ' ' ILE . 2.8 m -151.88 -177.53 6.19 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.802 -1.185 . . . . 13.84 107.802 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.667 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 31.6 m-85 -127.91 112.46 14.72 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.074 -1.016 . . . . 21.140000000000001 109.677 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.876 HG22 ' HB ' ' A' ' 4' ' ' VAL . 60.7 t -106.89 109.9 29.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.372 -0.931 . . . . 10.66 109.749 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 2.5 p30 -57.75 -39.4 77.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.028 -1.471 . . . . 25.890000000000001 107.028 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.754 HD11 ' CA ' ' B' ' 69' ' ' LYS . 7.3 tt 62.88 -71.2 0.05 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.831 0.824 . . . . 24.239999999999998 109.056 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.705 ' N ' HD23 ' A' ' 37' ' ' LEU . . . -178.04 41.53 0.09 OUTLIER Glycine 0 C--N 1.294 -1.791 0 N-CA-C 108.54 -1.824 . . . . 31.02 108.54 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -124.37 23.81 8.17 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.33 -1.1 . . . . 43.229999999999997 110.429 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.577 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 14.6 mt-10 50.53 19.28 0.55 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.259 -0.901 . . . . 42.340000000000003 110.729 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.577 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 98.6 m-70 -160.08 154.74 20.64 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.278 -1.008 . . . . 6.9900000000000002 108.278 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.667 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 37.4 Cg_endo -76.36 134.24 15.42 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.921 1.747 . . . . 17.920000000000002 110.556 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.817 HG23 HG23 ' A' ' 45' ' ' VAL . 3.1 m -108.76 116.69 52.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 119.509 -0.877 . . . . 20.57 108.775 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.922 HD11 ' HB3' ' A' ' 32' ' ' LEU . 64.6 tp -67.62 101.79 1.07 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.462 -0.895 . . . . 20.210000000000001 109.364 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.817 HG23 HG23 ' A' ' 43' ' ' VAL . 38.6 t -103.89 166.92 2.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.63 -0.669 . . . . 10.81 109.389 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.766 ' HA ' HD23 ' A' ' 32' ' ' LEU . 24.7 ttmt -98.64 148.78 23.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.185 -0.947 . . . . 36.740000000000002 110.198 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.96 HD13 ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -128.05 163.14 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.395 -0.816 . . . . 19.739999999999998 108.971 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.401 ' N ' HG23 ' A' ' 47' ' ' ILE . 14.9 m -111.68 135.49 52.2 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.265 -0.897 . . . . 22.559999999999999 109.161 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.62 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -112.14 151.26 29.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 20.41 109.46 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.482 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -87.36 -174.67 4.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 33.990000000000002 109.736 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.45 104.47 15.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.352 -0.843 . . . . 54.920000000000002 109.575 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.18 -8.29 57.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.589 -1.404 . . . . 36.100000000000001 109.589 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.42 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -78.3 143.8 65.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.172 -1.193 . . . . 54.759999999999998 109.548 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.0 Cg_endo -79.34 110.87 2.77 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.629 2.22 . . . . 28.370000000000001 110.383 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.998 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.24 160.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 17.210000000000001 110.087 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.673 ' CE2' HG12 ' A' ' 47' ' ' ILE . 11.4 m-30 -54.57 111.05 0.72 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.398 -0.814 . . . . 17.190000000000001 109.209 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.984 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -60.67 176.22 0.38 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 17.82 109.516 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.984 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.47 114.87 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.665 2.244 . . . . 17.280000000000001 110.213 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.11 179.73 43.99 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.947 -1.261 . . . . 17.219999999999999 109.947 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.718 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -75.4 146.29 40.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -1.077 . . . . 19.57 108.256 179.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.697 ' CE1' HD13 ' A' ' 6' ' ' ILE . 23.0 m-85 -132.28 162.92 29.81 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.692 -1.255 . . . . 14.609999999999999 111.889 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.563 ' O ' HG22 ' A' ' 84' ' ' VAL . 59.8 p -145.41 119.71 9.58 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.65 -1.611 . . . . 18.359999999999999 106.65 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.913 ' CG1' HD12 ' A' ' 81' ' ' LEU . 11.2 t -47.53 169.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 C-N-CA 119.086 -1.045 . . . . 19.129999999999999 109.266 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.577 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.7 t-80 -134.87 122.11 21.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.953 -0.758 . . . . 20.649999999999999 108.953 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.908 HD22 ' H ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -65.92 -9.22 27.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.546 -0.721 . . . . 19.649999999999999 109.348 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -53.95 -16.82 2.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.165 -0.959 . . . . 14.720000000000001 108.886 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -104.11 -6.93 20.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 11.449999999999999 111.098 -179.306 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.1 m-30 -74.21 163.25 28.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.704 -1.248 . . . . 14.25 109.663 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.674 ' CA ' HD11 ' B' ' 37' ' ' LEU . 25.2 mtmt -149.64 174.02 13.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 32.700000000000003 109.31 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 HD13 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -114.86 109.83 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 15.630000000000001 109.065 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.04 -179.45 44.34 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.554 -1.419 . . . . 12.699999999999999 109.554 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -88.43 39.21 0.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.254 -1.144 . . . . 26.289999999999999 109.524 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -112.23 11.72 20.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.801 . . . . 20.440000000000001 109.261 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 46' ' ' LYS . . . 63.69 26.62 70.03 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.341 -1.504 . . . . 13.82 109.341 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -154.17 155.33 35.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -1.133 . . . . 18.27 109.626 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 76' ' ' LEU . 1.7 tp -67.18 173.55 3.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 12.43 109.536 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.439 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 2.7 mtt -159.39 101.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 35.109999999999999 109.607 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.595 ' CG2' ' N ' ' A' ' 81' ' ' LEU . 2.7 mt -41.92 -43.33 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 13.67 109.995 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER 48.69 54.24 10.97 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.341 -0.85 . . . . 24.059999999999999 108.991 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 82.01 80.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.023 -0.732 . . . . 35.039999999999999 109.023 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.913 HD12 ' CG1' ' A' ' 63' ' ' VAL . 1.3 pt? -58.81 154.15 15.52 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.46 0.648 . . . . 18.719999999999999 110.734 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -104.89 106.11 16.45 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.693 -1.225 . . . . 20.550000000000001 107.693 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.674 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -81.51 144.4 31.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.071 -1.018 . . . . 14.4 111.482 -178.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 62' ' ' THR . 35.6 m -144.26 160.58 48.33 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 107.617 -1.253 . . . . 17.649999999999999 107.617 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.8 Cg_endo -62.17 147.81 94.35 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.099 1.866 . . . . 25.699999999999999 110.658 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -77.75 124.12 27.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.303 -0.873 . . . . 49.289999999999999 109.547 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.03 -0.986 . . . . 58.909999999999997 109.502 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.518 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.374 -0.602 . . . . 64.909999999999997 109.374 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.908 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.7 mt 57.8 77.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.763 -1.199 . . . . 33.799999999999997 107.763 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -73.15 157.35 37.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.791 . . . . 32.719999999999999 110.737 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.869 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -164.94 159.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.082 -0.71 . . . . 14.460000000000001 109.082 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 5.1 mt-10 -136.24 113.55 10.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.534 -0.729 . . . . 22.120000000000001 109.384 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.696 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -72.26 107.45 3.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.918 -1.142 . . . . 14.23 107.918 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.617 ' HD3' ' CD1' ' B' ' 34' ' ' TYR . 4.4 mptt -50.29 172.66 0.11 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.148 -0.97 . . . . 25.43 109.959 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -75.98 -29.53 6.66 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.618 2.212 . . . . 13.609999999999999 109.925 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.5 m -92.65 7.1 44.88 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.031 -0.729 . . . . 15.52 109.031 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.0 mm-40 -123.61 29.25 6.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 17.309999999999999 109.685 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.13 16.15 17.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.994 . . . . 24.780000000000001 110.057 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.573 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 18.4 mt-30 -141.78 145.22 34.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 47.899999999999999 109.954 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.761 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 42.4 p90 -96.05 153.64 17.67 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.378 -0.826 . . . . 21.609999999999999 109.451 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 38.5 p -121.55 168.72 11.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.437 -0.79 . . . . 14.890000000000001 109.274 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.614 0 O-C-N 121.447 -0.783 . . . . 17.350000000000001 109.101 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.458 0.647 . . . . 24.0 110.167 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 63.2 m-20 -53.69 160.81 1.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 23.309999999999999 109.798 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' B' ' 29' ' ' ASN . 7.6 mt-10 -150.16 125.17 9.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.431 -0.951 . . . . 40.030000000000001 108.431 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.955 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -113.4 -179.14 3.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 12.390000000000001 110.382 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.93 ' HB3' HD11 ' B' ' 44' ' ' LEU . 81.2 mt -137.45 147.88 45.67 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.841 -0.8 . . . . 17.420000000000002 108.841 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.946 ' SG ' HD13 ' B' ' 47' ' ' ILE . 2.9 m -152.08 -177.63 6.28 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.769 -1.197 . . . . 13.84 107.769 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.668 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 31.6 m-85 -127.85 112.4 14.68 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.065 -1.022 . . . . 21.140000000000001 109.678 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.869 HG22 ' HB ' ' B' ' 4' ' ' VAL . 61.2 t -106.89 110.17 30.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.349 -0.94 . . . . 10.66 109.688 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' B' ' 38' ' ' GLY . 2.4 p30 -57.91 -39.33 77.68 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.997 -1.483 . . . . 25.890000000000001 106.997 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.721 HD23 ' N ' ' B' ' 38' ' ' GLY . 7.4 tt 62.87 -70.66 0.06 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.844 0.831 . . . . 24.239999999999998 109.046 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.721 ' N ' HD23 ' B' ' 37' ' ' LEU . . . -178.47 41.28 0.09 OUTLIER Glycine 0 C--N 1.293 -1.813 0 N-CA-C 108.554 -1.818 . . . . 31.02 108.554 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -124.17 23.72 8.33 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.281 -1.129 . . . . 43.229999999999997 110.474 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.57 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 14.1 mt-10 50.82 19.15 0.58 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.247 -0.908 . . . . 42.340000000000003 110.703 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 98.6 m-70 -160.06 154.89 20.92 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.274 -1.01 . . . . 6.9900000000000002 108.274 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.668 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 37.5 Cg_endo -76.51 134.47 15.4 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.88 1.72 . . . . 17.920000000000002 110.521 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.804 HG23 HG23 ' B' ' 45' ' ' VAL . 3.1 m -109.09 116.59 52.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 119.424 -0.91 . . . . 20.57 108.808 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.93 HD11 ' HB3' ' B' ' 32' ' ' LEU . 65.4 tp -67.48 101.83 1.04 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.457 -0.897 . . . . 20.210000000000001 109.358 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.804 HG23 HG23 ' B' ' 43' ' ' VAL . 38.0 t -103.92 167.01 2.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.602 -0.686 . . . . 10.81 109.369 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.756 ' HA ' HD23 ' B' ' 32' ' ' LEU . 24.4 ttmt -98.79 148.23 24.1 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.198 -0.939 . . . . 36.740000000000002 110.165 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.946 HD13 ' SG ' ' B' ' 33' ' ' CYS . 0.0 OUTLIER -127.47 163.09 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.383 -0.823 . . . . 19.739999999999998 108.95 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.4 ' N ' HG23 ' B' ' 47' ' ' ILE . 15.3 m -111.6 135.57 52.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.274 -0.891 . . . . 22.559999999999999 109.101 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.617 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -112.2 151.42 29.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 20.41 109.373 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.484 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.3 OUTLIER -87.48 -174.69 4.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 33.990000000000002 109.751 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.53 104.46 16.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 54.920000000000002 109.528 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.19 -8.09 57.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.612 -1.395 . . . . 36.100000000000001 109.612 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.434 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.3 OUTLIER -78.63 143.72 63.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 54.759999999999998 109.567 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.7 Cg_endo -79.25 111.04 2.82 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.616 2.211 . . . . 28.370000000000001 110.432 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.955 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.35 160.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 17.210000000000001 110.031 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.66 ' CE2' HG12 ' B' ' 47' ' ' ILE . 11.7 m-30 -54.87 110.78 0.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 17.190000000000001 109.286 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.932 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -59.96 176.25 0.34 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 17.82 109.494 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.932 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 36.0 Cg_endo -78.79 115.83 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.713 2.276 . . . . 17.280000000000001 110.439 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.8 -179.79 43.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.833 -1.307 . . . . 17.219999999999999 109.833 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.718 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -75.37 146.55 40.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -1.103 . . . . 19.57 108.467 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.696 ' CE1' HD13 ' B' ' 6' ' ' ILE . 22.8 m-85 -132.49 162.99 29.81 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.759 -1.213 . . . . 14.609999999999999 111.92 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.566 ' O ' HG22 ' B' ' 84' ' ' VAL . 59.9 p -145.44 119.85 9.65 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.691 -1.596 . . . . 18.359999999999999 106.691 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.926 ' CG1' HD12 ' B' ' 81' ' ' LEU . 11.5 t -47.78 169.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.1 -1.04 . . . . 19.129999999999999 109.267 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.58 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.7 t-80 -134.77 122.06 21.58 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.943 -0.762 . . . . 20.649999999999999 108.943 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.955 HD22 ' H ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -65.85 -9.28 27.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.444 -0.785 . . . . 19.649999999999999 109.254 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 86.4 p -53.85 -16.82 1.97 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.13 -0.981 . . . . 14.720000000000001 108.919 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -104.33 -7.09 20.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 11.449999999999999 111.13 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.0 m-30 -74.25 162.57 28.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.651 -1.281 . . . . 14.25 109.54 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.754 ' CA ' HD11 ' A' ' 37' ' ' LEU . 25.2 mtmt -148.5 173.99 12.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 32.700000000000003 109.38 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.536 HG22 HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -114.6 109.86 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.875 . . . . 15.630000000000001 109.029 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.17 -179.45 44.15 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.587 -1.405 . . . . 12.699999999999999 109.587 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.443 ' O ' ' NE2' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -88.44 39.23 0.9 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.17 -1.194 . . . . 26.289999999999999 109.42 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -112.13 11.64 20.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 20.440000000000001 109.251 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 46' ' ' LYS . . . 63.55 27.28 70.68 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.333 -1.507 . . . . 13.82 109.333 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -154.96 155.54 34.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -1.141 . . . . 18.27 109.545 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.515 ' CD2' HG21 ' A' ' 2' ' ' ILE . 1.7 tp -67.34 173.59 3.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 12.43 109.553 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.431 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 2.8 mtt -159.53 101.69 1.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 35.109999999999999 109.551 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.595 ' CG2' ' N ' ' B' ' 81' ' ' LEU . 2.7 mt -41.88 -43.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.546 -0.721 . . . . 13.67 110.037 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.4 OUTLIER 48.66 54.32 10.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.307 -0.871 . . . . 24.059999999999999 108.985 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.546 ' CB ' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 82.18 80.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.065 -0.717 . . . . 35.039999999999999 109.065 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.926 HD12 ' CG1' ' B' ' 63' ' ' VAL . 1.3 pt? -58.69 154.03 15.4 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.472 0.653 . . . . 18.719999999999999 110.757 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.561 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -104.87 106.18 16.55 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.636 -1.246 . . . . 20.550000000000001 107.636 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.3 OUTLIER -81.5 144.45 31.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.017 -1.052 . . . . 14.4 111.475 -178.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.566 HG22 ' O ' ' B' ' 62' ' ' THR . 35.5 m -144.41 160.47 48.21 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 107.518 -1.289 . . . . 17.649999999999999 107.518 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.3 Cg_endo -62.17 148.02 93.98 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.07 1.847 . . . . 25.699999999999999 110.657 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -77.84 124.24 27.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.243 -0.91 . . . . 49.289999999999999 109.511 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.026 -0.988 . . . . 58.909999999999997 109.527 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.784 ' SD ' HG21 ' A' ' 62' ' ' THR . 30.9 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.495 -0.557 . . . . 64.909999999999997 109.495 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.842 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.8 mt -65.23 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.582 -1.266 . . . . 33.799999999999997 107.582 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -67.01 155.36 38.85 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.964 0.887 . . . . 32.719999999999999 111.461 -177.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.986 HG11 HD21 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -163.37 168.89 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.14 -1.059 . . . . 14.460000000000001 108.14 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.0 OUTLIER -146.28 107.54 4.21 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.105 -0.997 . . . . 22.120000000000001 109.275 -178.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.612 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -66.2 103.92 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.696 -1.224 . . . . 14.23 107.696 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.582 ' HE2' ' CE2' ' A' ' 34' ' ' TYR . 8.2 mmmt -43.61 162.26 0.19 Allowed Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.159 -0.963 . . . . 25.43 109.489 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.42 -11.96 26.93 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.945 1.763 . . . . 13.609999999999999 109.155 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.3 t -102.14 7.73 40.9 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.735 -0.839 . . . . 15.52 108.735 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.524 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 9.4 mm-40 -126.71 37.23 4.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.889 . . . . 17.309999999999999 109.247 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.64 15.95 23.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.118 -0.989 . . . . 24.780000000000001 110.165 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -136.62 143.73 43.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.116 -0.99 . . . . 47.899999999999999 108.81 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 31.6 p90 -94.0 162.63 13.81 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.121 -0.987 . . . . 21.609999999999999 109.116 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -143.71 147.17 33.85 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.256 -0.902 . . . . 14.890000000000001 109.407 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 O-C-N 121.348 -0.845 . . . . 17.350000000000001 109.078 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' A' ' 50' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.501 0.667 . . . . 24.0 110.336 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 95.9 m-20 -50.27 115.84 1.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.522 -0.736 . . . . 23.309999999999999 109.93 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -115.52 150.23 36.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.944 . . . . 40.030000000000001 109.019 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.568 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -125.81 -171.45 2.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.04 -1.037 . . . . 12.390000000000001 109.86 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.925 ' HB3' HD11 ' A' ' 44' ' ' LEU . 30.1 mt -128.12 176.96 7.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.482 -0.761 . . . . 17.420000000000002 109.396 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -171.39 158.02 5.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.143 -0.973 . . . . 13.84 108.438 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.745 ' HE1' HD13 ' A' ' 44' ' ' LEU . 2.9 m-30 -113.99 102.64 10.38 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.078 -1.014 . . . . 21.140000000000001 108.542 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.976 ' O ' HG22 ' A' ' 43' ' ' VAL . 38.5 t -102.41 106.74 20.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.094 -1.004 . . . . 10.66 110.273 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -61.41 -39.01 89.16 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.259 -1.386 . . . . 25.890000000000001 107.259 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.861 HD23 ' N ' ' A' ' 38' ' ' GLY . 6.9 tt 63.18 -69.36 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.675 0.75 . . . . 24.239999999999998 109.381 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.861 ' N ' HD23 ' A' ' 37' ' ' LEU . . . -178.49 42.94 0.09 OUTLIER Glycine 0 C--N 1.296 -1.674 0 N-CA-C 108.803 -1.719 . . . . 31.02 108.803 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -124.83 27.66 6.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.284 -1.127 . . . . 43.229999999999997 110.205 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.583 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 1.9 mm-40 48.67 21.2 0.39 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.17 -0.957 . . . . 42.340000000000003 110.239 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 59.4 m80 -164.57 151.39 9.72 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.196 -1.038 . . . . 6.5700000000000003 108.196 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.2 Cg_endo -76.48 144.06 25.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.08 1.853 . . . . 17.920000000000002 110.955 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.976 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.0 m -117.92 118.89 59.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.476 -0.89 . . . . 20.57 109.14 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.925 HD11 ' HB3' ' A' ' 32' ' ' LEU . 23.5 tp -68.69 110.49 4.31 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.944 -0.702 . . . . 20.210000000000001 109.155 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 16.3 t -117.02 167.38 10.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.513 -0.742 . . . . 10.81 109.497 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.567 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -90.74 162.3 14.94 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.659 -0.817 . . . . 36.740000000000002 110.216 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.054 HD13 HD12 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -152.12 161.44 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.759 -0.83 . . . . 19.739999999999998 108.759 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.67 151.83 20.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.0 -1.062 . . . . 22.559999999999999 109.762 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.716 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.7 tm? -134.22 93.62 3.1 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.434 -0.791 . . . . 20.41 108.991 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.721 ' HB3' HD22 ' A' ' 28' ' ' LEU . 2.2 p30 -154.59 174.94 14.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.934 -1.104 . . . . 33.990000000000002 110.117 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' GLN . 10.4 tt0 73.21 72.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.501 -0.749 . . . . 54.920000000000002 109.807 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 51' ' ' GLU . . . 36.45 30.06 0.03 OUTLIER Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.236 -1.146 . . . . 36.100000000000001 110.236 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.645 ' O ' HD21 ' A' ' 49' ' ' LEU . 2.4 mt-30 -107.31 131.0 22.04 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.07 -1.253 . . . . 54.759999999999998 110.061 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.3 Cg_endo -80.1 142.1 15.13 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.463 2.108 . . . . 28.370000000000001 110.004 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.701 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -41.61 141.45 0.77 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 17.210000000000001 110.015 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 84.5 m-85 -47.2 98.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 17.190000000000001 109.146 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -49.42 175.36 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 17.82 109.743 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -77.89 118.32 4.42 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.73 2.286 . . . . 17.280000000000001 110.369 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.87 171.4 34.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.473 -1.451 . . . . 17.219999999999999 109.473 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.2 mp -72.08 147.6 46.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.198 -1.177 . . . . 19.57 108.924 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.912 ' HB3' HD22 ' A' ' 83' ' ' LEU . 30.7 m-85 -132.04 163.24 28.87 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.579 1.181 . . . . 14.609999999999999 111.424 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.867 ' O ' HG22 ' A' ' 84' ' ' VAL . 20.6 p -142.17 119.35 11.43 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.616 -1.994 . . . . 18.359999999999999 105.616 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.5 t -52.42 167.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 C-N-CA 118.615 -1.234 . . . . 19.129999999999999 109.198 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.498 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.1 t-80 -129.61 128.75 43.3 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.546 -0.721 . . . . 20.649999999999999 109.123 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.855 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -70.88 -0.94 10.23 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.401 -0.812 . . . . 19.649999999999999 109.679 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 p -56.6 -19.18 14.77 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.541 -1.281 . . . . 14.720000000000001 107.541 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 39.6 m -97.02 -6.97 34.1 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.831 -0.543 . . . . 11.449999999999999 110.05 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.817 ' C ' HD11 ' B' ' 37' ' ' LEU . 3.3 m-30 -79.7 157.29 27.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 14.25 109.689 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -140.15 169.9 16.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.834 . . . . 32.700000000000003 109.488 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.778 HG21 HG21 ' B' ' 43' ' ' VAL . 2.2 t -110.08 139.52 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.912 . . . . 15.630000000000001 109.425 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.57 -157.55 23.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.341 -1.504 . . . . 12.699999999999999 109.341 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 0.0 OUTLIER 63.03 78.34 0.3 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.159 -1.2 . . . . 26.289999999999999 109.122 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.5 OUTLIER 69.48 9.39 7.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.433 -0.792 . . . . 20.440000000000001 109.472 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' O ' HG13 ' B' ' 45' ' ' VAL . . . 80.24 46.03 7.79 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.608 -1.397 . . . . 13.82 109.608 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.412 ' HA ' HG13 ' B' ' 45' ' ' VAL . 1.5 t -146.51 140.15 25.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -1.183 . . . . 18.27 109.577 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 77' ' ' MET . 1.4 tp -55.74 156.17 5.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 12.43 109.338 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 15.2 mtt -164.25 130.33 2.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 35.109999999999999 109.64 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.908 HD12 HD12 ' B' ' 78' ' ' ILE . 2.5 mp -63.72 138.49 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 13.67 109.77 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.62 -23.62 12.39 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.379 -0.971 . . . . 24.059999999999999 108.379 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 67' ' ' SER . 1.0 OUTLIER 178.44 68.04 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.03 -1.47 . . . . 35.039999999999999 107.03 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -29.05 119.68 0.13 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.274 -0.875 . . . . 18.719999999999999 111.685 -177.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -88.6 100.44 13.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 20.550000000000001 108.783 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.054 HD12 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -69.75 141.06 53.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 14.4 110.638 -179.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 62' ' ' THR . 27.8 m -143.22 153.5 59.83 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.71 -1.219 . . . . 17.649999999999999 107.71 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.2 Cg_endo -61.44 141.77 93.23 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.945 1.763 . . . . 25.699999999999999 110.317 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.596 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -77.95 117.78 19.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.266 -0.896 . . . . 49.289999999999999 109.682 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.993 -1.003 . . . . 58.909999999999997 109.455 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.788 ' SD ' HG21 ' B' ' 62' ' ' THR . 31.1 ttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.519 -0.548 . . . . 64.909999999999997 109.519 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.855 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.8 mt -65.28 81.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.572 -1.27 . . . . 33.799999999999997 107.572 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -67.2 155.32 39.1 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.981 0.895 . . . . 32.719999999999999 111.43 -177.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.978 HG11 HD21 ' B' ' 83' ' ' LEU . 0.1 OUTLIER -163.34 168.92 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.133 -1.062 . . . . 14.460000000000001 108.133 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 1.0 OUTLIER -146.3 107.55 4.21 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.104 -0.997 . . . . 22.120000000000001 109.258 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.606 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -66.22 104.02 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.718 -1.216 . . . . 14.23 107.718 179.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.586 ' HE2' ' CE2' ' B' ' 34' ' ' TYR . 8.2 mmmt -43.68 162.26 0.19 Allowed Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.147 -0.971 . . . . 25.43 109.479 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.7 Cg_endo -72.38 -12.08 27.1 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.984 1.789 . . . . 13.609999999999999 109.115 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 44.6 t -102.03 7.58 41.18 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.753 -0.832 . . . . 15.52 108.753 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.515 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 9.4 mm-40 -126.5 37.32 4.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.288 -0.882 . . . . 17.309999999999999 109.254 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.75 15.8 24.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 24.780000000000001 110.168 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.39 143.79 44.19 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.074 -1.016 . . . . 47.899999999999999 108.82 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.702 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 31.6 p90 -94.03 162.6 13.82 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.1 -1.0 . . . . 21.609999999999999 109.098 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -143.61 147.33 34.2 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.288 -0.883 . . . . 14.890000000000001 109.362 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.489 0 O-C-N 121.367 -0.833 . . . . 17.350000000000001 109.08 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.714 HD22 ' HB3' ' B' ' 50' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.468 0.652 . . . . 24.0 110.312 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.622 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 95.8 m-20 -50.31 115.95 1.67 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 23.309999999999999 109.854 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -115.6 150.34 36.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.158 -0.964 . . . . 40.030000000000001 108.98 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.578 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -125.92 -171.55 2.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.013 -1.055 . . . . 12.390000000000001 109.836 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.893 ' HB3' HD11 ' B' ' 44' ' ' LEU . 30.0 mt -128.06 176.93 7.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.461 -0.774 . . . . 17.420000000000002 109.442 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -171.31 158.09 5.23 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.093 -1.004 . . . . 13.84 108.487 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.761 ' HE1' HD13 ' B' ' 44' ' ' LEU . 2.9 m-30 -114.06 102.53 10.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.148 -0.97 . . . . 21.140000000000001 108.592 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.962 ' O ' HG22 ' B' ' 43' ' ' VAL . 38.4 t -102.34 106.67 20.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.147 -1.021 . . . . 10.66 110.309 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 0.9 OUTLIER -61.17 -39.1 88.86 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.307 -1.368 . . . . 25.890000000000001 107.307 178.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.853 HD23 ' N ' ' B' ' 38' ' ' GLY . 6.9 tt 63.33 -69.39 0.07 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.695 0.76 . . . . 24.239999999999998 109.313 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.853 ' N ' HD23 ' B' ' 37' ' ' LEU . . . -178.52 42.97 0.09 OUTLIER Glycine 0 C--N 1.295 -1.742 0 N-CA-C 108.773 -1.731 . . . . 31.02 108.773 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -124.85 27.65 6.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.246 -1.149 . . . . 43.229999999999997 110.234 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.574 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 1.9 mm-40 48.7 21.16 0.39 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.23 -0.919 . . . . 42.340000000000003 110.25 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 59.4 m80 -164.57 151.3 9.66 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 108.2 -1.037 . . . . 6.5599999999999996 108.2 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.638 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.6 Cg_endo -76.33 143.98 25.56 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.137 1.891 . . . . 17.920000000000002 111.011 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.962 HG22 ' O ' ' B' ' 35' ' ' VAL . 5.0 m -117.87 118.8 59.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.451 -0.9 . . . . 20.57 109.098 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.893 HD11 ' HB3' ' B' ' 32' ' ' LEU . 23.4 tp -68.67 110.55 4.33 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.898 -0.721 . . . . 20.210000000000001 109.218 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.575 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 16.8 t -116.95 167.42 10.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.511 -0.743 . . . . 10.81 109.529 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -90.75 162.24 14.97 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.674 -0.81 . . . . 36.740000000000002 110.206 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 1.037 HD13 HD12 ' B' ' 83' ' ' LEU . 0.5 OUTLIER -152.06 161.5 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.706 -0.85 . . . . 19.739999999999998 108.706 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.71 151.69 20.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.969 -1.082 . . . . 22.559999999999999 109.787 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.717 HD13 ' O ' ' B' ' 49' ' ' LEU . 2.7 tm? -134.05 93.58 3.12 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.373 -0.829 . . . . 20.41 109.003 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.714 ' HB3' HD22 ' B' ' 28' ' ' LEU . 2.2 p30 -154.63 174.74 14.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.956 -1.09 . . . . 33.990000000000002 110.152 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' B' ' 53' ' ' GLN . 10.4 tt0 73.25 73.05 0.13 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 54.920000000000002 109.814 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' B' ' 51' ' ' GLU . . . 36.37 30.02 0.03 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.273 -1.131 . . . . 36.100000000000001 110.273 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.651 ' O ' HD21 ' B' ' 49' ' ' LEU . 2.4 mt-30 -107.2 130.84 22.27 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.094 -1.239 . . . . 54.759999999999998 110.084 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 36.2 Cg_endo -79.95 141.97 15.33 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.525 2.15 . . . . 28.370000000000001 109.986 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.702 ' HB2' ' CD2' ' B' ' 13' ' ' PHE . . . -41.46 141.39 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 17.210000000000001 110.031 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 83.5 m-85 -47.03 97.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.327 -0.858 . . . . 17.190000000000001 109.11 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.948 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -49.15 175.46 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 17.82 109.804 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.948 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.1 Cg_endo -77.85 117.59 4.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.651 2.234 . . . . 17.280000000000001 110.176 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.35 171.11 35.45 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.542 -1.423 . . . . 17.219999999999999 109.542 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.0 mp -72.3 147.14 46.65 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.172 -1.193 . . . . 19.57 108.711 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.93 ' HB3' HD22 ' B' ' 83' ' ' LEU . 30.6 m-85 -131.65 163.11 28.83 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 122.564 1.173 . . . . 14.609999999999999 111.446 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.85 ' O ' HG22 ' B' ' 84' ' ' VAL . 20.7 p -142.01 119.28 11.47 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 105.627 -1.99 . . . . 18.359999999999999 105.627 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.5 t -52.54 166.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 C-N-CA 118.559 -1.256 . . . . 19.129999999999999 109.208 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.488 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.1 t-80 -129.32 128.66 43.61 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.568 -0.707 . . . . 20.649999999999999 109.228 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.842 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -70.69 -1.04 10.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.457 -0.777 . . . . 19.649999999999999 109.71 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 p -56.59 -19.23 14.98 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.541 -1.281 . . . . 14.720000000000001 107.541 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 38.2 m -96.9 -7.38 33.47 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.853 -0.529 . . . . 11.449999999999999 110.131 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.822 ' C ' HD11 ' A' ' 37' ' ' LEU . 3.2 m-30 -79.32 157.06 27.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.065 -1.022 . . . . 14.25 109.642 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' B' ' 77' ' ' MET . 0.0 OUTLIER -139.96 169.68 17.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 32.700000000000003 109.484 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.751 HG21 HG21 ' A' ' 43' ' ' VAL . 2.2 t -109.88 139.57 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 15.630000000000001 109.42 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 75' ' ' SER . . . 136.59 -157.63 23.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.261 -1.536 . . . . 12.699999999999999 109.261 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.0 OUTLIER 63.08 78.32 0.3 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.188 -1.183 . . . . 26.289999999999999 109.108 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.5 OUTLIER 69.51 9.4 7.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.455 -0.778 . . . . 20.440000000000001 109.401 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 80.26 45.78 7.93 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.639 -1.384 . . . . 13.82 109.639 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.414 ' HA ' HG13 ' A' ' 45' ' ' VAL . 1.5 t -146.24 140.11 26.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -1.163 . . . . 18.27 109.603 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.525 ' O ' ' CG ' ' B' ' 77' ' ' MET . 1.4 tp -55.69 156.23 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 12.43 109.338 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.525 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 15.2 mtt -164.33 130.53 2.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 35.109999999999999 109.618 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.908 HD12 HD12 ' A' ' 78' ' ' ILE . 2.5 mp -63.97 138.57 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -0.854 . . . . 13.67 109.841 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.6 -23.76 12.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.334 -0.988 . . . . 24.059999999999999 108.334 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.9 OUTLIER 178.55 68.07 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.062 -1.459 . . . . 35.039999999999999 107.062 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.659 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.7 OUTLIER -29.15 119.66 0.13 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.297 -0.865 . . . . 18.719999999999999 111.659 -177.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -88.52 100.25 12.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.348 -0.845 . . . . 20.550000000000001 108.849 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.037 HD12 HD13 ' B' ' 47' ' ' ILE . 0.9 OUTLIER -69.74 140.93 53.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 14.4 110.626 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.85 HG22 ' O ' ' B' ' 62' ' ' THR . 27.3 m -143.08 153.33 60.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 107.756 -1.201 . . . . 17.649999999999999 107.756 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.3 Cg_endo -61.23 141.7 94.05 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.911 1.741 . . . . 25.699999999999999 110.39 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.584 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -77.89 117.81 19.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.335 -0.853 . . . . 49.289999999999999 109.687 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.04 -0.981 . . . . 58.909999999999997 109.417 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.513 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.274 0.559 . . . . 64.909999999999997 109.496 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.757 ' CA ' HD22 ' B' ' 65' ' ' LEU . 3.3 mt 70.12 78.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 107.459 -1.312 . . . . 33.799999999999997 107.459 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.521 ' C ' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -62.01 159.7 13.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.96 0.886 . . . . 32.719999999999999 111.666 -177.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.084 ' CG2' HG22 ' A' ' 35' ' ' VAL . 82.4 t -160.68 168.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.985 -0.746 . . . . 14.460000000000001 108.985 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.597 ' N ' HG12 ' A' ' 4' ' ' VAL . 30.9 mt-10 -153.29 99.7 2.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 22.120000000000001 109.463 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.995 HG21 ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -70.32 102.77 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.822 -1.177 . . . . 14.23 107.822 179.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 3.5 mmpt? -57.64 163.59 3.68 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 25.43 109.308 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.5 -11.94 26.75 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.98 1.787 . . . . 13.609999999999999 109.206 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -102.69 13.3 34.78 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.301 -1.0 . . . . 15.52 108.301 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.537 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 5.6 mm-40 -142.86 36.33 1.42 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.452 -0.78 . . . . 17.309999999999999 109.41 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -112.78 35.3 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.092 -1.005 . . . . 24.780000000000001 110.234 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -140.74 125.19 17.73 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.169 -0.957 . . . . 47.899999999999999 109.67 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.643 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 40.4 p90 -89.74 156.66 18.38 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.293 -0.879 . . . . 21.609999999999999 109.82 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -131.5 161.85 31.6 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.326 -0.99 . . . . 14.890000000000001 108.326 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.628 0 O-C-N 121.093 -1.004 . . . . 17.350000000000001 109.095 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.563 0.697 . . . . 24.0 110.29 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -45.77 133.97 7.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.54 -0.725 . . . . 23.309999999999999 110.082 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 35.5 mt-10 -128.53 151.69 49.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.384 -0.822 . . . . 40.030000000000001 108.816 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.927 ' OE1' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -135.62 -170.43 2.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.978 -1.076 . . . . 12.390000000000001 110.294 -179.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.836 ' HB3' HD11 ' A' ' 44' ' ' LEU . 11.0 mt -126.65 173.2 9.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.733 -0.84 . . . . 17.420000000000002 108.733 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.546 ' SG ' HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -167.95 160.68 12.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.792 -1.192 . . . . 13.84 108.162 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.69 ' CE1' HD13 ' A' ' 44' ' ' LEU . 3.2 m-85 -107.59 92.17 3.96 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.136 -0.978 . . . . 21.140000000000001 109.478 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.084 HG22 ' CG2' ' A' ' 4' ' ' VAL . 37.5 t -94.59 121.74 45.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.281 -0.887 . . . . 10.66 110.17 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.746 ' C ' HD23 ' A' ' 37' ' ' LEU . 1.9 m-20 -73.35 -36.62 66.17 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.212 -1.033 . . . . 25.890000000000001 108.212 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.746 HD23 ' C ' ' A' ' 36' ' ' ASP . 1.0 OUTLIER 39.19 28.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.779 -0.575 . . . . 24.239999999999998 110.073 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 67.75 25.98 73.94 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.782 -1.327 . . . . 31.02 109.782 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 36' ' ' ASP . 1.1 t-20 -96.21 15.4 21.06 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.192 -1.181 . . . . 43.229999999999997 110.655 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 41' ' ' HIS . 1.7 mt-10 68.5 94.03 0.07 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.023 -1.048 . . . . 42.340000000000003 108.601 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.626 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 10.6 m80 86.57 167.94 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.646 -0.872 . . . . 5.0999999999999996 108.646 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 41' ' ' HIS . 34.0 Cg_endo -77.71 150.26 27.34 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.09 1.86 . . . . 17.920000000000002 111.204 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.863 HG22 ' O ' ' A' ' 35' ' ' VAL . 2.2 m -122.48 120.44 61.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.368 -0.833 . . . . 20.57 109.171 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' A' ' 32' ' ' LEU . 16.6 tp -73.79 109.62 7.44 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.295 -0.878 . . . . 20.210000000000001 108.641 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 1.6 p -123.87 160.65 27.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.438 -0.789 . . . . 10.81 109.475 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HA ' HD23 ' A' ' 32' ' ' LEU . 4.6 ttmt -77.33 164.56 25.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 36.740000000000002 110.438 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.977 HD13 HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -149.66 172.59 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.906 -0.776 . . . . 19.739999999999998 108.906 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 m -108.65 146.87 32.74 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.161 -0.962 . . . . 22.559999999999999 109.312 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.643 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -118.01 145.94 44.4 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.237 -0.914 . . . . 20.41 108.61 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.475 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -82.38 140.14 33.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.061 -1.025 . . . . 33.990000000000002 109.82 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.28 106.73 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 54.920000000000002 109.346 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.95 -12.53 57.6 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.494 . . . . 36.100000000000001 109.364 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.475 ' NE2' ' HB2' ' A' ' 50' ' ' ASP . 5.1 mt-30 -81.9 147.22 57.7 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.29 -1.124 . . . . 54.759999999999998 109.344 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.8 Cg_endo -78.15 123.23 6.05 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.593 2.195 . . . . 28.370000000000001 110.537 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.927 ' HB1' ' OE1' ' A' ' 31' ' ' GLN . . . -37.94 143.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.633 -0.667 . . . . 17.210000000000001 110.142 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.995 ' O ' HG21 ' A' ' 6' ' ' ILE . 83.9 m-85 -41.49 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.481 -0.762 . . . . 17.190000000000001 109.326 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.695 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -43.04 165.41 0.11 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 17.82 109.577 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.695 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.1 Cg_endo -77.59 105.92 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.57 2.18 . . . . 17.280000000000001 110.484 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.54 -174.25 41.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.891 -1.284 . . . . 17.219999999999999 109.891 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -76.06 142.42 41.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -1.101 . . . . 19.57 108.396 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.71 ' HB3' HD22 ' A' ' 83' ' ' LEU . 15.9 m-85 -131.74 163.69 27.62 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.767 -1.208 . . . . 14.609999999999999 111.68 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 84' ' ' VAL . 50.8 p -145.72 120.18 9.68 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.698 -1.593 . . . . 18.359999999999999 106.698 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.615 ' CG1' HD12 ' A' ' 81' ' ' LEU . 3.8 t -50.68 171.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 118.708 -1.197 . . . . 19.129999999999999 108.885 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.603 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.8 t-80 -135.08 125.37 26.3 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.337 -0.852 . . . . 20.649999999999999 109.263 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.764 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -70.4 -2.84 14.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.457 -0.777 . . . . 19.649999999999999 109.697 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -17.01 14.71 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.023 -1.102 . . . . 14.720000000000001 108.023 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -101.73 -9.66 20.65 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.726 -0.609 . . . . 11.449999999999999 110.597 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -72.31 164.14 26.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.959 -1.088 . . . . 14.25 109.992 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' A' ' 77' ' ' MET . 2.8 ptmt -146.42 177.04 9.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.947 -0.76 . . . . 32.700000000000003 108.947 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.435 HG23 HG21 ' B' ' 45' ' ' VAL . 6.2 p -126.92 158.73 37.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.272 -0.892 . . . . 15.630000000000001 109.355 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.96 -140.16 11.61 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.367 -1.493 . . . . 12.699999999999999 109.367 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 28.6 tp60 57.23 60.56 2.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.111 -1.229 . . . . 26.289999999999999 109.373 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 73.29 2.34 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.494 -0.754 . . . . 20.440000000000001 109.469 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' B' ' 46' ' ' LYS . . . 103.9 54.79 0.8 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.962 -1.255 . . . . 13.82 109.962 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.3 t -151.27 147.36 26.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -1.2 . . . . 18.27 109.776 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.638 ' HB2' HD13 ' B' ' 81' ' ' LEU . 2.6 tp -59.41 165.11 2.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 12.43 109.189 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 12.1 mtp -165.23 104.54 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.972 . . . . 35.109999999999999 110.038 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.4 mt -42.26 -63.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.509 -0.744 . . . . 13.67 109.335 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 38.0 t0 84.9 -45.5 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.387 0.613 . . . . 24.059999999999999 110.134 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.573 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.0 tmm_? -171.44 67.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.039 0.923 . . . . 35.039999999999999 108.519 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -38.06 131.19 1.12 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.603 -0.726 . . . . 18.719999999999999 111.514 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -96.47 107.0 19.34 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.923 -1.14 . . . . 20.550000000000001 107.923 178.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.977 HD12 HD13 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -76.9 146.84 37.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.127 -0.983 . . . . 14.4 111.221 -178.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 62' ' ' THR . 16.3 m -147.63 156.8 45.1 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.93 -1.137 . . . . 17.649999999999999 107.93 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.9 Cg_endo -64.01 142.95 83.5 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.163 1.909 . . . . 25.699999999999999 110.419 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.705 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -72.23 115.1 11.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 49.289999999999999 109.484 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.043 -0.98 . . . . 58.909999999999997 109.48 -179.942 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.43 -0.581 . . . . 64.909999999999997 109.43 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.764 ' CA ' HD22 ' A' ' 65' ' ' LEU . 3.3 mt 70.26 78.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.475 -1.306 . . . . 33.799999999999997 107.475 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 0.0 OUTLIER -61.85 159.56 13.65 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.976 0.893 . . . . 32.719999999999999 111.656 -177.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.081 ' CG2' HG22 ' B' ' 35' ' ' VAL . 84.3 t -160.52 168.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.964 -0.754 . . . . 14.460000000000001 108.964 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.618 ' N ' HG12 ' B' ' 4' ' ' VAL . 31.0 mt-10 -153.3 99.75 2.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.299 -0.876 . . . . 22.120000000000001 109.502 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.99 HG21 ' O ' ' B' ' 56' ' ' TYR . 1.0 OUTLIER -70.41 102.75 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.756 -1.201 . . . . 14.23 107.756 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.587 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 3.5 mmpt? -57.57 163.44 3.71 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.276 -0.89 . . . . 25.43 109.322 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.6 Cg_endo -72.44 -11.84 26.81 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.931 1.754 . . . . 13.609999999999999 109.182 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -102.68 13.21 35.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 15.52 108.33 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.53 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 5.6 mm-40 -142.7 36.22 1.44 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.402 -0.811 . . . . 17.309999999999999 109.452 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -112.69 35.4 3.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.986 -1.071 . . . . 24.780000000000001 110.274 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -140.8 125.09 17.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.122 -0.986 . . . . 47.899999999999999 109.588 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.644 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 40.6 p90 -89.54 157.01 18.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.313 -0.867 . . . . 21.609999999999999 109.855 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.2 t -131.89 161.53 32.79 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.327 -0.99 . . . . 14.890000000000001 108.327 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.624 0 O-C-N 121.09 -1.006 . . . . 17.350000000000001 109.168 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.592 HD23 ' O ' ' B' ' 49' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.563 0.697 . . . . 24.0 110.329 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.627 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -45.73 134.19 7.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.561 -0.712 . . . . 23.309999999999999 110.045 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 35.4 mt-10 -128.7 151.76 49.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.322 -0.861 . . . . 40.030000000000001 108.783 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.924 ' OE1' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -135.76 -170.55 2.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.948 -1.095 . . . . 12.390000000000001 110.223 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.845 ' HB3' HD11 ' B' ' 44' ' ' LEU . 11.0 mt -126.67 173.2 9.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.692 -0.855 . . . . 17.420000000000002 108.692 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.536 ' SG ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -168.0 160.58 12.18 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.782 -1.199 . . . . 13.84 108.136 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.688 ' CE1' HD13 ' B' ' 44' ' ' LEU . 3.2 m-85 -107.47 92.41 4.06 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.082 -1.011 . . . . 21.140000000000001 109.461 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 1.081 HG22 ' CG2' ' B' ' 4' ' ' VAL . 38.5 t -94.81 121.71 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.25 -0.906 . . . . 10.66 110.112 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.742 ' C ' HD23 ' B' ' 37' ' ' LEU . 1.9 m-20 -73.35 -36.45 66.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.215 -1.031 . . . . 25.890000000000001 108.215 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.742 HD23 ' C ' ' B' ' 36' ' ' ASP . 1.0 OUTLIER 39.09 28.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.731 -0.606 . . . . 24.239999999999998 109.979 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 67.61 26.22 73.76 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.79 -1.324 . . . . 31.02 109.79 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' B' ' 36' ' ' ASP . 1.1 t-20 -96.45 15.63 20.87 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.228 -1.16 . . . . 43.229999999999997 110.568 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' B' ' 41' ' ' HIS . 1.7 mt-10 68.38 93.89 0.07 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.026 -1.046 . . . . 42.340000000000003 108.652 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.629 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 10.5 m80 86.66 168.01 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.672 -0.862 . . . . 5.1100000000000003 108.672 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.632 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 34.1 Cg_endo -77.64 150.43 27.73 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.072 1.848 . . . . 17.920000000000002 111.18 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.891 HG22 ' O ' ' B' ' 35' ' ' VAL . 2.2 m -122.66 120.41 60.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.64 -0.824 . . . . 20.57 109.128 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.845 HD11 ' HB3' ' B' ' 32' ' ' LEU . 16.7 tp -73.74 109.71 7.46 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.447 -0.901 . . . . 20.210000000000001 108.65 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' B' ' 32' ' ' LEU . 1.7 p -123.87 160.71 27.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.382 -0.824 . . . . 10.81 109.466 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.485 ' HA ' HD23 ' B' ' 32' ' ' LEU . 4.6 ttmt -77.36 164.65 25.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 36.740000000000002 110.434 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.961 HD13 HD12 ' B' ' 83' ' ' LEU . 0.4 OUTLIER -149.65 172.61 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.448 -0.782 . . . . 19.739999999999998 108.9 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.1 m -108.72 146.38 33.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.163 -0.961 . . . . 22.559999999999999 109.378 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.644 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -117.5 145.96 43.86 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.201 -0.937 . . . . 20.41 108.615 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.476 ' HB2' ' NE2' ' B' ' 53' ' ' GLN . 0.7 OUTLIER -82.42 140.03 33.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 33.990000000000002 109.81 -179.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.18 106.84 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 54.920000000000002 109.403 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.88 -12.44 57.69 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.363 -1.495 . . . . 36.100000000000001 109.363 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.476 ' NE2' ' HB2' ' B' ' 50' ' ' ASP . 5.0 mt-30 -82.09 147.19 56.93 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.364 -1.08 . . . . 54.759999999999998 109.359 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.6 Cg_endo -78.08 123.27 6.1 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.646 2.231 . . . . 28.370000000000001 110.469 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.924 ' HB1' ' OE1' ' B' ' 31' ' ' GLN . . . -37.88 143.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.528 -0.732 . . . . 17.210000000000001 110.19 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.99 ' O ' HG21 ' B' ' 6' ' ' ILE . 83.9 m-85 -41.41 97.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.457 -0.777 . . . . 17.190000000000001 109.259 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -42.87 165.52 0.1 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 17.82 109.582 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.67 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.43 104.97 1.97 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.562 2.175 . . . . 17.280000000000001 110.122 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.74 -175.03 41.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.946 -1.262 . . . . 17.219999999999999 109.946 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.707 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -76.31 142.07 41.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.075 -1.083 . . . . 19.57 108.075 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.693 ' HB3' HD22 ' B' ' 83' ' ' LEU . 15.5 m-85 -131.32 163.7 27.27 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.716 -1.24 . . . . 14.609999999999999 111.716 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.746 ' O ' HG22 ' B' ' 84' ' ' VAL . 50.6 p -145.64 120.09 9.68 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.61 -1.626 . . . . 18.359999999999999 106.61 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.628 ' CG1' HD12 ' B' ' 81' ' ' LEU . 3.8 t -50.64 171.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 118.78 -1.168 . . . . 19.129999999999999 108.861 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.583 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.8 t-80 -135.01 125.45 26.59 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.331 -0.856 . . . . 20.649999999999999 109.268 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.757 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -70.51 -2.91 15.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.771 . . . . 19.649999999999999 109.645 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -17.13 14.53 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.043 -1.095 . . . . 14.720000000000001 108.043 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 0.4 OUTLIER -101.63 -10.04 20.4 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.681 -0.637 . . . . 11.449999999999999 110.654 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.691 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.8 m-30 -72.05 164.12 26.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.022 -1.049 . . . . 14.25 109.943 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' B' ' 77' ' ' MET . 2.7 ptmt -146.38 177.17 9.23 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.966 -0.753 . . . . 32.700000000000003 108.966 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.459 HG23 HG21 ' A' ' 45' ' ' VAL . 6.2 p -126.99 158.72 37.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.266 -0.896 . . . . 15.630000000000001 109.348 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' B' ' 75' ' ' SER . . . 127.91 -140.13 11.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.36 -1.496 . . . . 12.699999999999999 109.36 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 28.2 tp60 57.19 60.68 2.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.11 -1.23 . . . . 26.289999999999999 109.378 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.2 OUTLIER 73.13 2.47 4.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.473 -0.767 . . . . 20.440000000000001 109.506 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 46' ' ' LYS . . . 103.78 54.77 0.8 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.975 -1.25 . . . . 13.82 109.975 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.4 ' N ' ' O ' ' B' ' 71' ' ' GLY . 48.1 t -151.34 147.51 27.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 18.27 109.827 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.633 ' HB2' HD13 ' A' ' 81' ' ' LEU . 2.6 tp -59.56 164.9 3.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.291 -0.88 . . . . 12.43 109.175 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 12.5 mtp -165.14 104.37 0.76 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.086 -1.009 . . . . 35.109999999999999 110.103 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.607 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.4 mt -42.05 -63.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 13.67 109.425 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 38.0 t0 84.94 -45.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.407 0.622 . . . . 24.059999999999999 110.108 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.0 tmm_? -171.51 67.23 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.081 0.943 . . . . 35.039999999999999 108.531 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.743 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -38.16 131.13 1.16 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.685 0.755 . . . . 18.719999999999999 111.515 -178.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -96.4 107.1 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.892 -1.151 . . . . 20.550000000000001 107.892 178.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.961 HD12 HD13 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -76.98 146.7 37.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 14.4 111.243 -178.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.746 HG22 ' O ' ' B' ' 62' ' ' THR . 16.4 m -147.49 156.64 45.59 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 107.986 -1.116 . . . . 17.649999999999999 107.986 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.4 Cg_endo -63.88 142.66 83.13 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.142 1.894 . . . . 25.699999999999999 110.515 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.707 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -72.04 115.03 10.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 49.289999999999999 109.505 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.038 -0.982 . . . . 58.909999999999997 109.499 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.57 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.306 0.574 . . . . 64.909999999999997 109.473 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.893 HD12 ' HB ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -82.65 82.57 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.109 -1.071 . . . . 33.799999999999997 108.109 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -68.04 163.59 22.0 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.112 0.958 . . . . 32.719999999999999 111.359 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.987 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -174.38 167.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.428 -0.953 . . . . 14.460000000000001 108.428 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.576 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 31.6 mt-10 -140.39 111.39 7.02 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.899 0.857 . . . . 22.120000000000001 109.347 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.844 HG21 ' O ' ' A' ' 56' ' ' TYR . 6.2 mm -73.86 89.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.279 -1.008 . . . . 14.23 108.279 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.594 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.7 mmpm? -41.99 161.89 0.15 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 25.43 109.649 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.9 Cg_endo -72.41 -12.25 27.16 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.037 1.825 . . . . 13.609999999999999 109.115 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.0 t -98.17 6.94 46.97 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.675 -0.861 . . . . 15.52 108.675 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.531 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 17.1 mm-40 -128.25 13.36 6.64 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.334 -0.854 . . . . 17.309999999999999 109.519 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -88.14 30.3 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 24.780000000000001 110.299 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.413 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 18.7 mt-30 -144.55 121.58 11.4 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.161 -0.962 . . . . 47.899999999999999 109.678 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.626 ' CD2' ' CB ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.77 -177.39 4.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.448 -0.782 . . . . 21.609999999999999 110.429 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 98.1 m -157.05 143.73 18.34 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.433 -0.792 . . . . 14.890000000000001 109.044 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.573 0 O-C-N 121.351 -0.843 . . . . 17.350000000000001 109.574 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.485 HD22 HG22 ' A' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.457 0.646 . . . . 24.0 110.301 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.626 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -86.75 104.0 15.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.458 -0.776 . . . . 23.309999999999999 109.439 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 22.0 mt-10 -79.97 -176.53 5.53 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.039 -1.038 . . . . 40.030000000000001 109.422 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.57 ' CB ' HG22 ' A' ' 47' ' ' ILE . 3.5 mt-30 -168.38 -171.06 1.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 12.390000000000001 109.711 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.909 ' HB3' HD11 ' A' ' 44' ' ' LEU . 2.2 mp -131.39 179.08 6.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 17.420000000000002 109.634 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -172.25 159.5 4.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.935 -1.103 . . . . 13.84 109.024 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.776 ' HE1' HD13 ' A' ' 44' ' ' LEU . 2.8 m-85 -116.02 89.6 3.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 21.140000000000001 108.875 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.94 ' O ' HG22 ' A' ' 43' ' ' VAL . 98.7 t -91.73 115.86 31.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.101 -0.999 . . . . 10.66 110.233 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 73.4 m-20 -60.62 -20.34 60.41 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.178 -1.045 . . . . 25.890000000000001 108.178 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.798 HD11 ' CA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 40.65 27.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.673 -0.642 . . . . 24.239999999999998 109.922 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 61.66 27.46 68.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 120.127 -1.035 . . . . 31.02 110.539 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.592 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 8.8 p30 -106.78 22.68 15.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.677 -1.484 . . . . 43.229999999999997 110.417 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' A' ' 41' ' ' HIS . 27.6 mt-10 61.36 50.49 4.7 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.215 -0.928 . . . . 42.340000000000003 111.027 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.592 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 2.3 p-80 154.68 149.45 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 108.187 -1.042 . . . . 8.3100000000000005 108.187 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.629 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.2 Cg_endo -75.88 147.21 30.46 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.947 1.765 . . . . 17.920000000000002 110.317 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 35' ' ' VAL . 14.5 m -121.36 116.68 50.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.242 -0.983 . . . . 20.57 109.069 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.909 HD11 ' HB3' ' A' ' 32' ' ' LEU . 21.9 tp -68.87 105.68 2.44 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.321 -0.952 . . . . 20.210000000000001 108.57 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' B' ' 75' ' ' SER . 0.5 OUTLIER -121.73 168.64 13.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.57 -0.706 . . . . 10.81 109.165 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -82.63 156.24 23.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 36.740000000000002 110.621 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.115 HD11 ' HB2' ' A' ' 83' ' ' LEU . 1.4 tt -143.37 161.72 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.51 -0.922 . . . . 19.739999999999998 108.51 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.573 HG21 ' CZ ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -108.67 123.88 49.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.925 -1.11 . . . . 22.559999999999999 109.423 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.912 HD11 ' O ' ' A' ' 53' ' ' GLN . 1.9 tm? -86.5 125.02 33.45 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.769 -0.826 . . . . 20.41 108.769 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -54.89 139.22 41.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 33.990000000000002 109.602 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -55.37 118.93 4.86 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.224 -0.923 . . . . 54.920000000000002 109.328 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.39 -23.1 23.62 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.544 -1.422 . . . . 36.100000000000001 109.544 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.912 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -67.0 152.14 96.35 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -1.176 . . . . 54.759999999999998 109.357 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -79.58 117.05 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.476 2.117 . . . . 28.370000000000001 110.085 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -29.71 137.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.221 0.534 . . . . 17.210000000000001 111.128 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.844 ' O ' HG21 ' A' ' 6' ' ' ILE . 99.2 m-85 -41.28 105.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.48 -0.763 . . . . 17.190000000000001 109.41 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.815 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.98 170.33 0.72 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.069 -1.019 . . . . 17.82 109.277 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.815 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.67 103.24 1.69 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.459 2.106 . . . . 17.280000000000001 110.097 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.11 -179.77 44.96 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.921 -1.272 . . . . 17.219999999999999 109.921 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.784 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -72.69 149.86 43.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.366 -1.079 . . . . 19.57 108.12 179.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.987 ' CB ' HG13 ' A' ' 4' ' ' VAL . 18.0 m-85 -133.92 165.23 25.5 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.692 -1.255 . . . . 14.609999999999999 111.724 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 84' ' ' VAL . 69.8 p -143.96 119.2 10.16 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.949 -1.871 . . . . 18.359999999999999 105.949 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 81' ' ' LEU . 9.8 t -53.84 165.42 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 C-N-CA 118.404 -1.318 . . . . 19.129999999999999 108.962 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.529 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -134.15 126.46 30.03 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.47 -0.937 . . . . 20.649999999999999 108.47 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' B' ' 2' ' ' ILE . 2.3 pp -72.88 2.14 7.36 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.144 -0.972 . . . . 19.649999999999999 110.246 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.32 -18.96 19.5 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.643 -1.243 . . . . 14.720000000000001 107.643 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 1.3 t -100.37 -9.36 22.33 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.72 -0.612 . . . . 11.449999999999999 110.302 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 3.9 m-30 -73.48 156.67 37.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.962 -1.086 . . . . 14.25 109.32 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.763 ' CA ' HD11 ' B' ' 37' ' ' LEU . 22.3 mtmt -152.89 167.12 30.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 32.700000000000003 109.717 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.525 HG21 HG21 ' B' ' 43' ' ' VAL . 0.5 OUTLIER -101.11 123.32 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.513 -0.921 . . . . 15.630000000000001 108.513 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 70' ' ' VAL . . . -59.81 -130.7 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.046 -1.222 . . . . 12.699999999999999 110.046 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.522 ' C ' ' CG ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -87.2 46.01 1.33 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -1.144 . . . . 26.289999999999999 108.869 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.522 ' CG ' ' C ' ' A' ' 72' ' ' GLN . 1.8 m-85 77.06 0.02 3.0 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.993 -0.743 . . . . 20.440000000000001 108.993 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.59 -66.48 2.37 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.524 -1.43 . . . . 13.82 109.524 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.476 ' HA ' HG22 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -160.6 170.18 21.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -1.165 . . . . 18.27 109.667 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.9 OUTLIER -66.79 163.6 18.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 12.43 109.433 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.537 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 15.1 mtp -165.6 127.24 1.97 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 35.109999999999999 109.401 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.2 mt -53.93 -41.3 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.306 -0.871 . . . . 13.67 109.946 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 2.1 t0 45.0 54.55 6.83 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.512 -1.292 . . . . 24.059999999999999 107.512 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.573 ' CZ ' HG21 ' A' ' 48' ' ' THR . 0.6 OUTLIER 85.56 116.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.017 -1.475 . . . . 35.039999999999999 107.017 -177.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.062 HD13 HG13 ' A' ' 63' ' ' VAL . 2.0 pp -94.63 152.02 18.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.332 -0.855 . . . . 18.719999999999999 111.274 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -101.52 95.6 6.57 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.905 -1.517 . . . . 20.550000000000001 106.905 177.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.115 ' HB2' HD11 ' A' ' 47' ' ' ILE . 2.0 tp -75.07 150.67 38.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.191 -0.943 . . . . 14.4 111.324 -177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 62' ' ' THR . 24.1 m -147.47 158.96 42.85 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.809 -1.182 . . . . 17.649999999999999 107.809 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.3 Cg_endo -63.87 145.88 90.94 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.06 1.84 . . . . 25.699999999999999 110.335 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.784 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -80.39 115.37 19.89 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.133 -0.979 . . . . 49.289999999999999 109.579 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.2 tptt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.963 -1.018 . . . . 58.909999999999997 109.486 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.567 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.461 -0.57 . . . . 64.909999999999997 109.461 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.904 HD12 ' HB ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -83.26 82.52 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.083 -1.08 . . . . 33.799999999999997 108.083 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -67.99 163.59 21.89 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.169 0.985 . . . . 32.719999999999999 111.351 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.004 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -174.38 167.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.419 -0.956 . . . . 14.460000000000001 108.419 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.565 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 31.3 mt-10 -140.27 111.5 7.13 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.866 0.841 . . . . 22.120000000000001 109.286 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.828 HG21 ' O ' ' B' ' 56' ' ' TYR . 6.2 mm -74.04 89.7 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.285 -1.006 . . . . 14.23 108.285 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.598 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.7 mmpm? -41.73 161.81 0.14 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 25.43 109.668 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.7 Cg_endo -72.44 -12.39 27.21 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.957 1.771 . . . . 13.609999999999999 109.117 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.5 t -97.94 6.9 47.17 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.655 -0.868 . . . . 15.52 108.655 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.524 ' HB3' ' HB2' ' B' ' 32' ' ' LEU . 17.0 mm-40 -128.17 13.14 6.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.316 -0.865 . . . . 17.309999999999999 109.609 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -87.92 30.13 0.87 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.973 . . . . 24.780000000000001 110.333 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 18.7 mt-30 -144.33 121.71 11.65 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.129 -0.982 . . . . 47.899999999999999 109.659 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.626 ' CD2' ' CB ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -77.84 -177.33 4.86 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.456 -0.777 . . . . 21.609999999999999 110.42 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 97.7 m -157.14 143.61 18.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.34 -0.85 . . . . 14.890000000000001 109.088 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.599 0 O-C-N 121.445 -0.784 . . . . 17.350000000000001 109.572 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.473 HD22 HG22 ' B' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.522 0.677 . . . . 24.0 110.224 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.626 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -86.82 103.79 15.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.426 -0.796 . . . . 23.309999999999999 109.465 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 21.7 mt-10 -79.77 -176.65 5.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.043 -1.035 . . . . 40.030000000000001 109.524 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.582 ' CB ' HG22 ' B' ' 47' ' ' ILE . 3.5 mt-30 -168.19 -171.12 1.44 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.209 -0.932 . . . . 12.390000000000001 109.778 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.934 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.2 mp -131.26 179.11 6.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 17.420000000000002 109.633 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.534 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -172.35 159.43 4.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.925 -1.109 . . . . 13.84 108.946 -179.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.758 ' HE1' HD13 ' B' ' 44' ' ' LEU . 2.8 m-85 -116.06 89.47 3.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.953 . . . . 21.140000000000001 108.911 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.946 ' O ' HG22 ' B' ' 43' ' ' VAL . 98.5 t -91.59 116.13 32.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.055 -1.028 . . . . 10.66 110.26 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 73.3 m-20 -60.92 -19.96 61.36 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.213 -1.032 . . . . 25.890000000000001 108.213 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.763 HD11 ' CA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 40.42 27.67 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.644 -0.66 . . . . 24.239999999999998 109.867 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 61.58 27.54 68.24 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.552 -1.019 . . . . 31.02 110.552 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.585 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 8.7 p30 -106.83 22.67 15.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.67 -1.488 . . . . 43.229999999999997 110.517 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.545 ' O ' ' HB3' ' B' ' 41' ' ' HIS . 27.7 mt-10 61.34 50.58 4.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.172 -0.955 . . . . 42.340000000000003 111.026 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 2.3 p-80 154.61 149.35 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.198 -1.038 . . . . 8.3399999999999999 108.198 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.636 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 34.9 Cg_endo -75.78 147.2 30.81 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.933 1.755 . . . . 17.920000000000002 110.33 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.946 HG22 ' O ' ' B' ' 35' ' ' VAL . 14.5 m -121.36 116.97 51.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 C-N-CA 119.282 -0.967 . . . . 20.57 109.068 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.934 HD11 ' HB3' ' B' ' 32' ' ' LEU . 22.1 tp -69.25 105.54 2.56 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.333 -0.947 . . . . 20.210000000000001 108.568 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -121.58 168.57 13.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.63 0 O-C-N 121.589 -0.694 . . . . 10.81 109.161 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.437 ' N ' HG13 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -82.49 156.23 24.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 36.740000000000002 110.605 -178.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 1.077 HD11 ' HB2' ' B' ' 83' ' ' LEU . 1.4 tt -143.42 161.62 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.464 -0.939 . . . . 19.739999999999998 108.464 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.583 HG21 ' CZ ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -108.59 123.94 49.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.958 -1.089 . . . . 22.559999999999999 109.418 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.922 HD11 ' O ' ' B' ' 53' ' ' GLN . 1.9 tm? -86.56 124.99 33.47 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.535 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.3 OUTLIER -54.85 139.27 40.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 33.990000000000002 109.666 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -55.4 118.92 4.86 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.232 -0.917 . . . . 54.920000000000002 109.31 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.34 -22.94 24.24 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.596 -1.401 . . . . 36.100000000000001 109.596 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.922 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.6 OUTLIER -67.18 152.18 96.37 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.172 -1.193 . . . . 54.759999999999998 109.29 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.506 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -79.55 117.11 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.462 2.108 . . . . 28.370000000000001 110.018 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.588 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -29.9 138.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.233 0.54 . . . . 17.210000000000001 111.068 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.828 ' O ' HG21 ' B' ' 6' ' ' ILE . 99.3 m-85 -41.33 105.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 17.190000000000001 109.591 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.792 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.46 170.32 0.63 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.09 -1.006 . . . . 17.82 109.186 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.792 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.3 Cg_endo -78.01 104.2 1.81 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.553 2.169 . . . . 17.280000000000001 110.267 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.64 -179.34 46.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.861 -1.295 . . . . 17.219999999999999 109.861 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.777 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -72.31 150.27 43.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.151 . . . . 19.57 108.449 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 1.004 ' CB ' HG13 ' B' ' 4' ' ' VAL . 16.4 m-85 -134.34 165.29 25.49 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.775 -1.203 . . . . 14.609999999999999 111.75 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.822 ' O ' HG22 ' B' ' 84' ' ' VAL . 67.1 p -144.15 119.23 10.06 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.029 -1.841 . . . . 18.359999999999999 106.029 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 1.069 HG13 HD13 ' B' ' 81' ' ' LEU . 9.7 t -53.91 165.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 C-N-CA 118.419 -1.312 . . . . 19.129999999999999 109.006 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -134.0 126.44 30.23 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.424 -0.954 . . . . 20.649999999999999 108.424 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.763 HD22 ' HA ' ' A' ' 2' ' ' ILE . 2.3 pp -72.76 1.9 7.64 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.193 -0.942 . . . . 19.649999999999999 110.197 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -19.02 16.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.575 -1.269 . . . . 14.720000000000001 107.575 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.521 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 1.3 t -100.5 -9.85 21.67 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.72 -0.613 . . . . 11.449999999999999 110.306 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.9 m-30 -72.94 156.46 38.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.979 -1.076 . . . . 14.25 109.206 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.798 ' CA ' HD11 ' A' ' 37' ' ' LEU . 22.5 mtmt -152.71 166.67 31.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 32.700000000000003 109.803 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -100.53 123.14 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.527 -0.916 . . . . 15.630000000000001 108.527 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' B' ' 70' ' ' VAL . . . -59.95 -130.71 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.016 -1.233 . . . . 12.699999999999999 110.016 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.537 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -87.1 46.25 1.36 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -1.133 . . . . 26.289999999999999 108.879 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.537 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 1.8 m-85 76.79 0.05 3.07 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.058 -0.719 . . . . 20.440000000000001 109.058 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.64 -66.28 2.45 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.612 -1.395 . . . . 13.82 109.612 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.482 ' HA ' HG22 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -160.7 170.1 21.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -1.186 . . . . 18.27 109.673 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.533 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.9 OUTLIER -66.72 163.45 19.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 12.43 109.462 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 15.2 mtp -165.59 127.42 2.0 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.892 . . . . 35.109999999999999 109.381 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.601 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.1 mt -54.22 -41.12 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 13.67 109.921 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 2.1 t0 44.92 54.67 6.66 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.442 -1.318 . . . . 24.059999999999999 107.442 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.583 ' CZ ' HG21 ' B' ' 48' ' ' THR . 0.6 OUTLIER 85.56 116.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.097 -1.445 . . . . 35.039999999999999 107.097 -177.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 1.069 HD13 HG13 ' B' ' 63' ' ' VAL . 2.0 pp -94.53 152.13 18.79 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 18.719999999999999 111.276 -177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.533 ' N ' HD12 ' B' ' 81' ' ' LEU . 0.0 OUTLIER -101.7 95.5 6.47 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.93 -1.507 . . . . 20.550000000000001 106.93 177.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.077 ' HB2' HD11 ' B' ' 47' ' ' ILE . 2.0 tp -75.0 150.57 38.93 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.161 -0.962 . . . . 14.4 111.335 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.822 HG22 ' O ' ' B' ' 62' ' ' THR . 24.1 m -147.47 158.64 43.31 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 107.813 -1.181 . . . . 17.649999999999999 107.813 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.0 Cg_endo -63.61 145.94 92.09 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.022 1.815 . . . . 25.699999999999999 110.357 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.777 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -80.36 115.54 19.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 49.289999999999999 109.564 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 16.2 tptt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.984 -1.008 . . . . 58.909999999999997 109.506 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.341 -0.615 . . . . 64.909999999999997 109.341 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.988 HG23 ' CD2' ' B' ' 65' ' ' LEU . 0.0 OUTLIER 56.21 88.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.933 -1.104 . . . . 33.799999999999997 108.046 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -92.77 167.12 12.08 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.341 -0.849 . . . . 32.719999999999999 110.437 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.912 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -172.67 165.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.993 -0.743 . . . . 14.460000000000001 108.993 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.561 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 34.3 mt-10 -141.74 110.37 6.09 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.908 -0.775 . . . . 22.120000000000001 108.908 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.825 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -71.85 100.81 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 119.171 -1.012 . . . . 14.23 108.401 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 3.0 mmmt -41.49 163.48 0.11 Allowed Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.462 -0.774 . . . . 25.43 109.423 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.68 -13.92 27.16 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.961 1.774 . . . . 13.609999999999999 109.224 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -96.58 5.32 51.0 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.716 -0.846 . . . . 15.52 108.716 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 9.1 mm-40 -125.93 34.9 4.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.361 -0.837 . . . . 17.309999999999999 109.355 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.95 8.46 42.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 24.780000000000001 110.014 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 41.6 mt-30 -132.14 144.47 50.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.223 -0.923 . . . . 47.899999999999999 109.516 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.72 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 30.8 p90 -91.68 164.73 13.63 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.259 -0.901 . . . . 21.609999999999999 109.407 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -137.7 152.5 49.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.29 -0.881 . . . . 14.890000000000001 109.125 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.473 0 O-C-N 121.242 -0.911 . . . . 17.350000000000001 109.366 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.44 HD22 HG23 ' A' ' 48' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.326 0.584 . . . . 24.0 110.057 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.635 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 92.8 m-20 -52.92 118.87 4.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.844 . . . . 23.309999999999999 109.336 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 5.1 mt-10 -110.98 165.83 11.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 40.030000000000001 109.183 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.685 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -144.03 162.98 34.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.051 -1.031 . . . . 12.390000000000001 109.861 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' HD11 ' A' ' 44' ' ' LEU . 3.6 mm? -102.64 178.28 4.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.404 -0.81 . . . . 17.420000000000002 109.958 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.527 ' SG ' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -175.29 159.42 2.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.003 -1.06 . . . . 13.84 108.604 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.767 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.1 m-30 -113.96 98.04 6.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.997 . . . . 21.140000000000001 108.592 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.898 HG22 ' HB ' ' A' ' 4' ' ' VAL . 14.0 t -107.34 130.23 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 10.66 110.665 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.909 ' O ' HD12 ' A' ' 37' ' ' LEU . 12.5 p-10 -81.01 -30.18 34.99 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.124 -1.065 . . . . 25.890000000000001 108.124 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.909 HD12 ' O ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER 31.09 40.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.159 0.504 . . . . 24.239999999999998 110.993 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' C ' ' OD1' ' A' ' 39' ' ' ASN . . . 102.07 20.32 12.87 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.811 -1.185 . . . . 31.02 110.597 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.544 ' ND2' ' CD1' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -135.29 103.3 5.46 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.965 -1.315 . . . . 43.229999999999997 108.223 178.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -29.54 -38.06 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.356 0.598 . . . . 42.340000000000003 111.407 -178.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 39' ' ' ASN . 40.9 m80 -89.03 153.18 49.08 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.312 -0.867 . . . . 6.5899999999999999 109.177 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 34.8 Cg_endo -76.83 148.38 28.36 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.2 1.933 . . . . 17.920000000000002 110.377 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 35' ' ' VAL . 1.8 m -119.43 119.0 59.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.185 -1.006 . . . . 20.57 109.434 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.905 HD11 ' HB3' ' A' ' 32' ' ' LEU . 18.5 tp -70.81 109.53 5.05 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.447 -0.946 . . . . 20.210000000000001 108.447 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.596 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 2.9 t -121.12 168.96 13.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.635 -0.666 . . . . 10.81 109.725 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -89.53 -175.47 4.71 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.419 -0.801 . . . . 36.740000000000002 110.251 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.687 ' CD1' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -168.85 173.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 19.739999999999998 109.144 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.47 ' N ' HG23 ' A' ' 47' ' ' ILE . 24.4 m -109.18 145.28 36.06 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.3 -0.875 . . . . 22.559999999999999 109.148 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 53' ' ' GLN . 1.8 tm? -127.76 100.31 5.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.343 -0.848 . . . . 20.41 109.052 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 53' ' ' GLN . 4.0 m-20 -41.4 129.4 3.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.394 -0.816 . . . . 33.990000000000002 110.04 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.74 100.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.303 -0.873 . . . . 54.920000000000002 109.161 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.37 -37.32 2.79 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.258 -1.537 . . . . 36.100000000000001 109.258 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.651 ' O ' HD11 ' A' ' 49' ' ' LEU . 4.3 mt-30 -64.0 151.88 88.71 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.228 -1.16 . . . . 54.759999999999998 109.048 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.6 Cg_endo -77.07 117.72 4.52 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.533 2.156 . . . . 28.370000000000001 110.439 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.72 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -40.05 148.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.522 -0.736 . . . . 17.210000000000001 109.926 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.825 ' O ' HG21 ' A' ' 6' ' ' ILE . 9.7 m-30 -48.45 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 17.190000000000001 109.6 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.942 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -48.65 174.24 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 17.82 109.307 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.942 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 36.1 Cg_endo -78.55 125.3 6.81 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.652 2.234 . . . . 17.280000000000001 110.368 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.29 -179.24 39.24 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.718 -1.23 . . . . 17.219999999999999 110.045 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -73.15 142.6 47.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.369 -1.077 . . . . 19.57 108.577 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.912 ' CB ' HG13 ' A' ' 4' ' ' VAL . 8.8 m-85 -127.24 163.49 23.78 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.65 -1.281 . . . . 14.609999999999999 111.546 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.662 ' O ' HG22 ' A' ' 84' ' ' VAL . 54.8 p -148.47 117.35 6.72 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.941 -1.503 . . . . 18.359999999999999 106.941 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.817 ' HB ' HD12 ' A' ' 2' ' ' ILE . 15.8 t -47.59 169.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 C-N-CA 119.168 -1.013 . . . . 19.129999999999999 109.106 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.55 ' N ' HG12 ' A' ' 63' ' ' VAL . 7.5 t-80 -133.72 129.72 37.13 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.834 -0.802 . . . . 20.649999999999999 108.834 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.007 ' CD2' HG23 ' B' ' 2' ' ' ILE . 0.7 OUTLIER -64.18 -10.52 23.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.511 -0.743 . . . . 19.649999999999999 109.89 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' LEU . 1.2 t -45.62 -25.93 0.54 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.589 -0.893 . . . . 14.720000000000001 108.589 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 7.2 m -98.19 -12.07 22.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.51 -0.744 . . . . 11.449999999999999 110.485 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 1.005 ' CD2' HD23 ' A' ' 65' ' ' LEU . 2.6 m-30 -80.16 153.86 28.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.845 -1.16 . . . . 14.25 109.762 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 68' ' ' PHE . 71.1 mttt -157.37 171.05 21.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.505 -0.747 . . . . 32.700000000000003 109.233 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -101.4 100.76 11.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.889 . . . . 15.630000000000001 109.124 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.68 -175.98 5.98 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.525 -1.43 . . . . 12.699999999999999 109.525 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -90.72 27.44 1.77 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.143 -1.21 . . . . 26.289999999999999 109.314 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 5.0 23.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.434 -0.791 . . . . 20.440000000000001 109.627 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.475 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . 67.66 49.47 49.6 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.467 -1.453 . . . . 13.82 109.467 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -170.07 148.88 3.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -1.129 . . . . 18.27 109.707 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.943 HD23 ' N ' ' A' ' 77' ' ' MET . 5.1 tt -61.16 159.1 12.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 12.43 109.278 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.943 ' N ' HD23 ' A' ' 76' ' ' LEU . 1.8 mtt -163.79 111.39 1.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.09 -1.006 . . . . 35.109999999999999 109.993 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.97 HD12 HD12 ' B' ' 78' ' ' ILE . 3.5 mt -52.77 145.87 2.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.354 -0.841 . . . . 13.67 109.647 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.577 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -126.06 53.47 1.61 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.804 -1.554 . . . . 24.059999999999999 106.804 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.58 ' H ' HG22 ' A' ' 78' ' ' ILE . 2.4 tmm_? 89.67 67.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.31 -1.367 . . . . 35.039999999999999 107.31 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -32.78 124.91 0.35 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.373 -0.831 . . . . 18.719999999999999 111.678 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.6 103.88 16.52 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.483 -1.303 . . . . 20.550000000000001 107.483 178.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.687 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -79.79 145.97 32.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.058 -1.026 . . . . 14.4 111.217 -178.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 62' ' ' THR . 27.2 m -146.53 158.6 46.47 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.96 -1.126 . . . . 17.649999999999999 107.96 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.16 141.07 74.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.084 1.856 . . . . 25.699999999999999 110.134 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.732 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -69.07 108.3 3.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.139 -0.976 . . . . 49.289999999999999 109.482 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.961 -1.018 . . . . 58.909999999999997 109.413 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' CG ' ' B' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.335 -0.617 . . . . 64.909999999999997 109.335 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 1.007 HG23 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 56.12 88.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.891 -1.131 . . . . 33.799999999999997 107.973 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.535 ' O ' HG13 ' B' ' 35' ' ' VAL . 0.3 OUTLIER -92.9 167.13 12.04 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.298 -0.876 . . . . 32.719999999999999 110.438 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.911 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -172.74 165.34 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.692 0.758 . . . . 14.460000000000001 108.962 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 34.3 mt-10 -141.67 110.52 6.17 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.882 -0.785 . . . . 22.120000000000001 108.882 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.827 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -71.97 101.06 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 C-N-CA 119.126 -1.03 . . . . 14.23 108.396 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.582 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 3.0 mmmt -41.61 163.61 0.11 Allowed Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.49 -0.756 . . . . 25.43 109.493 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.0 Cg_endo -72.72 -13.95 27.06 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.983 1.789 . . . . 13.609999999999999 109.201 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.6 m -96.55 5.19 51.27 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.677 -0.86 . . . . 15.52 108.677 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.535 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 9.1 mm-40 -125.9 34.94 4.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.328 -0.857 . . . . 17.309999999999999 109.412 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.92 8.46 42.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 24.780000000000001 110.026 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -132.19 144.36 50.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.272 -0.893 . . . . 47.899999999999999 109.576 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.702 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 31.0 p90 -91.6 164.78 13.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.284 -0.885 . . . . 21.609999999999999 109.385 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -137.71 152.53 49.34 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.331 -0.856 . . . . 14.890000000000001 109.11 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 17.350000000000001 109.378 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.437 HD22 HG23 ' B' ' 48' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.379 0.609 . . . . 24.0 110.106 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 92.9 m-20 -52.68 118.91 3.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 23.309999999999999 109.348 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 5.1 mt-10 -111.09 165.78 11.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.051 -1.031 . . . . 40.030000000000001 109.193 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.696 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -143.96 162.94 34.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.139 -0.976 . . . . 12.390000000000001 109.798 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.935 ' HB3' HD11 ' B' ' 44' ' ' LEU . 3.6 mm? -102.67 178.07 4.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 17.420000000000002 109.91 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -175.08 159.32 2.59 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.92 -1.112 . . . . 13.84 108.619 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.769 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.1 m-30 -113.81 97.86 6.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.138 -0.976 . . . . 21.140000000000001 108.63 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.878 ' O ' HG22 ' B' ' 43' ' ' VAL . 13.9 t -107.24 130.08 59.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.106 -0.996 . . . . 10.66 110.731 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.929 ' O ' HD12 ' B' ' 37' ' ' LEU . 12.5 p-10 -80.79 -30.45 35.97 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.128 -1.064 . . . . 25.890000000000001 108.128 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.929 HD12 ' O ' ' B' ' 36' ' ' ASP . 0.4 OUTLIER 31.45 40.55 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.171 0.51 . . . . 24.239999999999998 110.953 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.448 ' C ' ' OD1' ' B' ' 39' ' ' ASN . . . 101.91 20.61 12.44 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.834 -1.174 . . . . 31.02 110.583 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.549 ' ND2' ' CD1' ' B' ' 37' ' ' LEU . 1.0 OUTLIER -135.43 103.31 5.43 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.016 -1.285 . . . . 43.229999999999997 108.211 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -29.57 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.291 0.567 . . . . 42.340000000000003 111.384 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' B' ' 39' ' ' ASN . 40.9 m80 -89.14 153.13 48.82 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.375 -0.828 . . . . 6.5 109.183 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.1 Cg_endo -76.83 148.31 28.3 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.179 1.92 . . . . 17.920000000000002 110.38 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.878 HG22 ' O ' ' B' ' 35' ' ' VAL . 1.7 m -119.34 119.3 60.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.258 -0.977 . . . . 20.57 109.369 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.935 HD11 ' HB3' ' B' ' 32' ' ' LEU . 18.6 tp -71.13 109.78 5.4 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.55 -0.907 . . . . 20.210000000000001 108.55 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.612 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 3.0 t -121.38 168.84 13.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.613 -0.68 . . . . 10.81 109.776 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.584 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -89.24 -175.4 4.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.493 -0.754 . . . . 36.740000000000002 110.314 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.677 ' CD1' HD12 ' B' ' 83' ' ' LEU . 0.0 OUTLIER -168.98 173.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.3 -0.875 . . . . 19.739999999999998 109.135 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.477 ' N ' HG23 ' B' ' 47' ' ' ILE . 24.6 m -109.28 145.22 36.29 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.3 -0.875 . . . . 22.559999999999999 109.108 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.67 HD11 ' O ' ' B' ' 53' ' ' GLN . 1.8 tm? -127.73 100.35 5.92 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.871 . . . . 20.41 109.059 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' B' ' 53' ' ' GLN . 3.9 m-20 -41.44 129.42 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 33.990000000000002 110.024 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.74 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.293 -0.879 . . . . 54.920000000000002 109.152 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.25 -37.15 2.84 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.225 -1.55 . . . . 36.100000000000001 109.225 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.67 ' O ' HD11 ' B' ' 49' ' ' LEU . 4.2 mt-30 -64.2 151.91 89.43 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.223 -1.163 . . . . 54.759999999999998 109.036 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.9 Cg_endo -77.22 117.63 4.45 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.546 2.164 . . . . 28.370000000000001 110.457 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.702 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -39.72 148.0 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.523 -0.736 . . . . 17.210000000000001 110.09 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.827 ' O ' HG21 ' B' ' 6' ' ' ILE . 9.5 m-30 -47.99 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.293 -0.88 . . . . 17.190000000000001 109.595 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.919 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -47.63 174.19 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 17.82 109.486 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.919 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.8 Cg_endo -78.24 124.42 6.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.577 2.185 . . . . 17.280000000000001 110.094 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.89 -179.63 40.0 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.536 -1.316 . . . . 17.219999999999999 110.148 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -73.54 142.25 46.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -1.076 . . . . 19.57 108.33 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.911 ' CB ' HG13 ' B' ' 4' ' ' VAL . 9.2 m-85 -127.02 163.62 23.33 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.654 -1.279 . . . . 14.609999999999999 111.519 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.661 ' O ' HG22 ' B' ' 84' ' ' VAL . 55.9 p -148.4 117.42 6.77 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.002 -1.481 . . . . 18.359999999999999 107.002 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.803 ' HB ' HD12 ' B' ' 2' ' ' ILE . 16.0 t -47.62 169.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 C-N-CA 119.176 -1.01 . . . . 19.129999999999999 109.052 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.55 ' N ' HG12 ' B' ' 63' ' ' VAL . 7.6 t-80 -133.89 129.91 37.06 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.819 -0.808 . . . . 20.649999999999999 108.819 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.997 HD23 ' CD2' ' B' ' 68' ' ' PHE . 0.7 OUTLIER -64.27 -10.53 24.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.696 . . . . 19.649999999999999 109.927 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.435 ' C ' ' O ' ' B' ' 65' ' ' LEU . 1.2 t -45.56 -25.83 0.51 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.56 -0.904 . . . . 14.720000000000001 108.56 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 7.1 m -98.28 -12.37 21.64 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.727 . . . . 11.449999999999999 110.486 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.997 ' CD2' HD23 ' B' ' 65' ' ' LEU . 2.5 m-30 -80.01 153.8 28.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 14.25 109.685 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' B' ' 68' ' ' PHE . 71.1 mttt -157.43 170.73 21.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.541 -0.724 . . . . 32.700000000000003 109.199 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.596 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -101.05 100.79 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 15.630000000000001 109.034 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.77 -175.91 6.05 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.426 -1.47 . . . . 12.699999999999999 109.426 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.432 ' NE2' ' H ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.61 27.26 1.78 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.202 -1.175 . . . . 26.289999999999999 109.358 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.88 5.06 24.12 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.512 -0.742 . . . . 20.440000000000001 109.611 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.466 ' C ' HG13 ' A' ' 45' ' ' VAL . . . 67.36 50.0 47.7 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.41 -1.476 . . . . 13.82 109.41 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.463 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -170.37 148.94 3.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -1.135 . . . . 18.27 109.608 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.942 HD23 ' N ' ' B' ' 77' ' ' MET . 5.2 tt -61.31 159.29 12.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.927 . . . . 12.43 109.256 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.942 ' N ' HD23 ' B' ' 76' ' ' LEU . 1.8 mtt -163.97 111.36 1.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.079 -1.013 . . . . 35.109999999999999 110.026 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.97 HD12 HD12 ' A' ' 78' ' ' ILE . 3.4 mt -52.77 145.7 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 13.67 109.726 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -125.84 53.52 1.58 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.789 -1.56 . . . . 24.059999999999999 106.789 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.582 ' H ' HG22 ' B' ' 78' ' ' ILE . 2.4 tmm_? 89.63 67.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.334 -1.358 . . . . 35.039999999999999 107.334 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.668 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -32.92 124.93 0.36 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.363 -0.835 . . . . 18.719999999999999 111.661 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.54 103.86 16.5 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.451 -1.314 . . . . 20.550000000000001 107.451 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.677 HD12 ' CD1' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -79.9 145.87 32.45 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.135 -0.978 . . . . 14.4 111.25 -178.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.661 HG22 ' O ' ' B' ' 62' ' ' THR . 27.3 m -146.32 158.97 46.67 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 107.967 -1.123 . . . . 17.649999999999999 107.967 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -64.42 141.24 73.5 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.049 1.833 . . . . 25.699999999999999 110.152 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -69.17 108.05 3.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.223 -0.923 . . . . 49.289999999999999 109.462 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.965 -1.017 . . . . 58.909999999999997 109.489 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.434 -0.58 . . . . 64.909999999999997 109.434 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.851 ' H ' HD22 ' B' ' 65' ' ' LEU . 1.6 mt 50.32 78.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.866 -1.161 . . . . 33.799999999999997 107.866 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.26 155.93 40.13 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.712 0.767 . . . . 32.719999999999999 110.57 -178.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.814 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -165.05 165.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.553 0.692 . . . . 14.460000000000001 109.262 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.53 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 22.3 mt-10 -138.64 116.89 11.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 22.120000000000001 109.258 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.747 HG21 ' O ' ' A' ' 56' ' ' TYR . 19.4 mm -77.43 97.44 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.259 -0.901 . . . . 14.23 108.743 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.596 ' HD3' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.14 161.15 0.31 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.089 -1.007 . . . . 25.43 110.121 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.93 -29.76 5.06 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.626 2.217 . . . . 13.609999999999999 110.214 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.41 -0.85 43.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.492 -0.755 . . . . 15.52 109.131 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 9.3 pt20 -129.97 28.88 5.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 17.309999999999999 109.644 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -85.03 16.31 3.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 24.780000000000001 110.106 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -138.72 144.33 39.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.082 -1.011 . . . . 47.899999999999999 108.828 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.741 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 12.8 p90 -87.01 178.42 6.94 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.168 -0.958 . . . . 21.609999999999999 109.743 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 8.7 t -132.22 163.01 29.53 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.58 -0.896 . . . . 14.890000000000001 108.58 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.534 0 O-C-N 121.138 -0.977 . . . . 17.350000000000001 109.617 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.893 HD11 ' HG3' ' A' ' 30' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 121.497 0.665 . . . . 24.0 110.292 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.786 ' N ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -93.78 131.72 38.87 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.717 -0.845 . . . . 23.309999999999999 108.717 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.893 ' HG3' HD11 ' A' ' 28' ' ' LEU . 1.8 mp0 -109.88 159.28 17.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.861 -1.149 . . . . 40.030000000000001 109.448 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.905 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -135.68 -165.33 1.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.083 -1.01 . . . . 12.390000000000001 110.04 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.896 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -134.64 178.56 6.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.721 . . . . 17.420000000000002 109.392 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' NE2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -172.93 153.74 2.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.955 -1.09 . . . . 13.84 108.893 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.753 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.1 m-30 -112.06 96.77 6.23 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.506 -0.924 . . . . 21.140000000000001 108.506 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.994 ' O ' HG22 ' A' ' 43' ' ' VAL . 85.7 t -97.12 114.92 35.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.036 -1.04 . . . . 10.66 110.118 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.6 p-10 -59.36 -32.13 69.84 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.301 -1.0 . . . . 25.890000000000001 108.301 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.7 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.7 OUTLIER 47.02 28.64 0.92 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.563 -0.711 . . . . 24.239999999999998 109.174 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.39 18.14 71.23 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.371 -1.492 . . . . 31.02 109.371 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.562 HD21 HD22 ' A' ' 37' ' ' LEU . 92.6 m-20 -91.01 26.67 2.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -1.122 . . . . 43.229999999999997 110.367 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.527 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 1.7 mm-40 48.35 22.24 0.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.138 -0.976 . . . . 42.340000000000003 110.148 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.549 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 3.6 m80 -175.88 153.26 1.35 Allowed Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.074 -1.084 . . . . 5.3799999999999999 108.074 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.645 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.6 Cg_endo -75.73 144.09 27.56 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.923 1.749 . . . . 17.920000000000002 110.938 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.994 HG22 ' O ' ' A' ' 35' ' ' VAL . 14.4 m -119.47 118.37 57.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.735 -0.839 . . . . 20.57 108.735 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.896 HD11 ' HB3' ' A' ' 32' ' ' LEU . 18.6 tp -68.41 111.79 4.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.781 -0.768 . . . . 20.210000000000001 109.339 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 4.0 t -117.2 168.46 8.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.692 -0.63 . . . . 10.81 109.352 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 1.9 mtpt -86.63 174.92 8.57 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.238 -0.914 . . . . 36.740000000000002 110.347 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -155.4 165.25 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -0.856 . . . . 19.739999999999998 109.028 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.475 HG23 HD13 ' A' ' 28' ' ' LEU . 30.8 m -110.79 149.54 30.4 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.319 -0.863 . . . . 22.559999999999999 108.98 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -133.25 127.96 34.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 20.41 109.341 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.09 148.64 41.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 33.990000000000002 109.535 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.62 93.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 54.920000000000002 109.544 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.6 -29.39 3.81 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.722 -1.351 . . . . 36.100000000000001 109.722 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.456 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -72.9 144.87 85.91 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.177 -1.19 . . . . 54.759999999999998 109.597 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -78.2 117.48 4.12 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.696 2.264 . . . . 28.370000000000001 110.585 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.905 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.78 155.51 0.05 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.249 -0.907 . . . . 17.210000000000001 110.196 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.747 ' O ' HG21 ' A' ' 6' ' ' ILE . 15.0 m-30 -49.03 112.53 0.63 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.574 -0.704 . . . . 17.190000000000001 109.758 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.005 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -66.13 177.35 0.78 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 17.82 109.313 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 1.005 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -78.21 113.4 3.38 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.586 2.191 . . . . 17.280000000000001 110.28 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.06 177.27 43.11 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.912 -1.275 . . . . 17.219999999999999 109.912 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 4.9 mp -74.96 152.79 38.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -1.107 . . . . 19.57 108.221 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.724 ' HB3' HD22 ' A' ' 83' ' ' LEU . 17.7 m-85 -140.17 165.18 28.08 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.802 -1.186 . . . . 14.609999999999999 111.78 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.734 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.8 p -145.64 120.55 9.98 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.356 -1.72 . . . . 18.359999999999999 106.356 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.712 ' HB ' HD13 ' A' ' 2' ' ' ILE . 4.7 t -50.38 170.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 C-N-CA 118.739 -1.185 . . . . 19.129999999999999 108.791 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.589 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -130.43 122.98 28.77 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.38 -0.825 . . . . 20.649999999999999 108.942 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.852 HD22 ' H ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -66.65 -6.24 14.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.673 -0.642 . . . . 19.649999999999999 109.747 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.1 t -54.78 -15.87 2.2 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.058 -1.026 . . . . 14.720000000000001 108.565 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 35.1 m -98.79 -5.75 30.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.495 -0.753 . . . . 11.449999999999999 110.891 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.67 ' C ' HD11 ' B' ' 37' ' ' LEU . 2.8 m-30 -81.16 155.7 26.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.763 -1.211 . . . . 14.25 109.988 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.666 ' HA ' HD21 ' B' ' 37' ' ' LEU . 9.9 mtmt -143.78 171.48 14.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.501 -0.749 . . . . 32.700000000000003 109.349 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.708 HG21 HG21 ' B' ' 43' ' ' VAL . 0.5 OUTLIER -117.77 131.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 15.630000000000001 109.603 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.67 175.86 53.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.457 -1.457 . . . . 12.699999999999999 109.457 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.2 9.6 12.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.115 -1.226 . . . . 26.289999999999999 109.893 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 73' ' ' PHE . 30.1 t80 -109.62 9.65 25.07 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.57 -0.707 . . . . 20.440000000000001 109.391 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' B' ' 46' ' ' LYS . . . 70.75 71.66 0.99 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.51 -1.436 . . . . 13.82 109.51 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -165.86 112.6 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -1.153 . . . . 18.27 109.683 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.813 ' CD1' HG11 ' B' ' 35' ' ' VAL . 0.3 OUTLIER -68.51 151.36 46.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 12.43 109.169 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.518 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 7.1 mtp -163.04 139.78 7.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 35.109999999999999 109.842 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.884 HD12 HD12 ' B' ' 78' ' ' ILE . 3.4 mt -67.77 140.78 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 13.67 109.805 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.472 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 1.6 t70 -110.1 -19.24 13.12 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.389 -0.967 . . . . 24.059999999999999 108.389 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.5 OUTLIER 173.01 68.11 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.878 -1.527 . . . . 35.039999999999999 106.878 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -32.06 119.62 0.27 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.512 -0.767 . . . . 18.719999999999999 111.399 -177.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -89.66 110.05 20.97 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.844 -1.169 . . . . 20.550000000000001 107.844 178.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.724 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -82.12 143.86 31.17 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.036 -1.04 . . . . 14.4 111.101 -178.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 62' ' ' THR . 4.5 m -143.99 159.56 52.68 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.97 -1.122 . . . . 17.649999999999999 107.97 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.6 Cg_endo -63.41 147.58 93.3 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.177 1.918 . . . . 25.699999999999999 110.335 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.573 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -74.62 118.75 17.93 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.105 -0.997 . . . . 49.289999999999999 109.541 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.056 -0.973 . . . . 58.909999999999997 109.468 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.528 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.37 -0.604 . . . . 64.909999999999997 109.37 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.852 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.5 mt 50.33 78.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.806 -1.183 . . . . 33.799999999999997 107.806 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.2 156.18 39.86 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.721 0.772 . . . . 32.719999999999999 110.553 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.825 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -165.25 165.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.583 0.706 . . . . 14.460000000000001 109.283 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.526 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 22.4 mt-10 -138.57 116.92 11.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.497 -0.752 . . . . 22.120000000000001 109.333 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.754 HG21 ' O ' ' B' ' 56' ' ' TYR . 19.7 mm -77.55 97.26 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.265 -0.897 . . . . 14.23 108.754 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.585 ' HE2' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.98 161.17 0.3 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.114 -0.991 . . . . 25.43 110.145 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.02 -29.77 4.93 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.665 2.244 . . . . 13.609999999999999 110.169 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.31 -1.05 43.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.436 -0.79 . . . . 15.52 109.058 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.522 ' NE2' ' HA ' ' B' ' 33' ' ' CYS . 9.3 pt20 -129.9 29.0 5.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.861 . . . . 17.309999999999999 109.683 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -85.1 16.36 3.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 24.780000000000001 110.051 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.589 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -138.67 144.49 39.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.085 -1.009 . . . . 47.899999999999999 108.806 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.724 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 12.7 p90 -87.16 178.32 6.92 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.159 -0.963 . . . . 21.609999999999999 109.739 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 9.0 t -132.16 163.08 29.31 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.618 -0.882 . . . . 14.890000000000001 108.618 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.568 0 O-C-N 121.15 -0.969 . . . . 17.350000000000001 109.584 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.864 HD11 ' HG3' ' B' ' 30' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 121.522 0.677 . . . . 24.0 110.311 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.781 ' N ' HD12 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -93.65 131.76 38.65 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.677 -0.86 . . . . 23.309999999999999 108.677 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.864 ' HG3' HD11 ' B' ' 28' ' ' LEU . 1.8 mp0 -110.02 159.45 17.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.958 -1.089 . . . . 40.030000000000001 109.416 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.925 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -135.81 -165.37 1.69 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.118 -0.989 . . . . 12.390000000000001 109.988 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -134.68 178.46 6.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.533 -0.729 . . . . 17.420000000000002 109.395 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.522 ' HA ' ' NE2' ' B' ' 10' ' ' GLN . 0.1 OUTLIER -172.83 153.73 2.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.002 -1.061 . . . . 13.84 108.933 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.763 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.1 m-30 -112.03 96.68 6.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.462 -0.94 . . . . 21.140000000000001 108.462 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 1.01 ' O ' HG22 ' B' ' 43' ' ' VAL . 85.3 t -96.98 115.08 35.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.066 -1.021 . . . . 10.66 110.155 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.6 p-10 -59.58 -31.86 69.84 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.311 -0.996 . . . . 25.890000000000001 108.311 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.67 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER 46.76 28.61 0.84 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.473 -0.767 . . . . 24.239999999999998 109.17 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.54 18.08 71.46 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.33 -1.508 . . . . 31.02 109.33 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.581 HD21 HD22 ' B' ' 37' ' ' LEU . 92.7 m-20 -90.88 26.34 2.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.324 -1.103 . . . . 43.229999999999997 110.479 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.527 ' O ' ' ND1' ' B' ' 41' ' ' HIS . 1.7 mm-40 48.6 22.02 0.46 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.07 -1.019 . . . . 42.340000000000003 110.116 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.532 ' O ' ' HA ' ' B' ' 36' ' ' ASP . 3.6 m80 -175.68 153.18 1.4 Allowed Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 108.085 -1.08 . . . . 5.2999999999999998 108.085 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.643 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.5 Cg_endo -75.73 144.08 27.55 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.961 1.774 . . . . 17.920000000000002 110.884 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 1.01 HG22 ' O ' ' B' ' 35' ' ' VAL . 14.0 m -119.46 118.51 57.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.601 -0.84 . . . . 20.57 108.765 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' B' ' 32' ' ' LEU . 18.9 tp -68.56 111.67 4.88 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.848 -0.741 . . . . 20.210000000000001 109.348 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 4.3 t -117.13 168.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.643 -0.661 . . . . 10.81 109.304 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 1.9 mtpt -86.67 174.98 8.51 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.353 -0.842 . . . . 36.740000000000002 110.338 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.593 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -155.42 165.24 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.798 . . . . 19.739999999999998 109.042 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.479 HG23 HD13 ' B' ' 28' ' ' LEU . 31.2 m -110.77 149.49 30.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.371 -0.831 . . . . 22.559999999999999 108.992 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' B' ' 29' ' ' ASN . 0.3 OUTLIER -133.25 127.83 34.55 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.391 -0.818 . . . . 20.41 109.363 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.94 148.52 42.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 33.990000000000002 109.512 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.44 93.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 54.920000000000002 109.55 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.32 -29.13 3.92 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.687 -1.365 . . . . 36.100000000000001 109.687 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.454 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -73.1 144.91 85.44 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.112 -1.228 . . . . 54.759999999999998 109.515 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.4 Cg_endo -78.4 117.32 4.03 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.708 2.272 . . . . 28.370000000000001 110.591 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.925 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.52 155.7 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.18 -0.95 . . . . 17.210000000000001 110.199 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.754 ' O ' HG21 ' B' ' 6' ' ' ILE . 15.2 m-30 -49.34 112.51 0.65 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.485 -0.759 . . . . 17.190000000000001 109.876 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -65.85 177.2 0.76 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.322 -0.861 . . . . 17.82 109.258 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 36.0 Cg_endo -78.17 114.51 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.577 2.185 . . . . 17.280000000000001 110.444 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.64 177.92 42.36 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.834 -1.306 . . . . 17.219999999999999 109.834 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.0 mp -75.11 152.94 38.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -1.097 . . . . 19.57 108.396 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.726 ' HB3' HD22 ' B' ' 83' ' ' LEU . 17.6 m-85 -140.36 165.0 28.6 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.85 -1.156 . . . . 14.609999999999999 111.77 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.736 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.7 p -145.54 120.35 9.92 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.413 -1.699 . . . . 18.359999999999999 106.413 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.728 ' HB ' HD13 ' B' ' 2' ' ' ILE . 4.8 t -50.14 170.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 C-N-CA 118.836 -1.145 . . . . 19.129999999999999 108.769 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.586 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -130.53 123.13 28.91 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.391 -0.818 . . . . 20.649999999999999 108.992 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.851 HD22 ' H ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -66.61 -6.66 16.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.733 -0.605 . . . . 19.649999999999999 109.759 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 28.2 t -54.35 -16.11 2.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.984 -1.073 . . . . 14.720000000000001 108.575 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 33.0 m -98.66 -6.27 30.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.485 -0.759 . . . . 11.449999999999999 110.917 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.7 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.7 m-30 -80.69 155.47 26.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.751 -1.218 . . . . 14.25 109.844 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.656 ' HA ' HD21 ' A' ' 37' ' ' LEU . 10.0 mtmt -143.46 171.83 13.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.517 -0.739 . . . . 32.700000000000003 109.309 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.753 HG21 HG21 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -118.04 131.84 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 15.630000000000001 109.586 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.83 176.09 53.29 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.46 -1.456 . . . . 12.699999999999999 109.46 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.4 9.45 13.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.114 -1.227 . . . . 26.289999999999999 109.864 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' B' ' 73' ' ' PHE . 30.1 t80 -109.45 9.65 25.44 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.564 -0.71 . . . . 20.440000000000001 109.428 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . 70.76 71.85 0.97 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.506 -1.438 . . . . 13.82 109.506 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -165.97 112.64 0.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -1.143 . . . . 18.27 109.715 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.822 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -68.58 151.33 46.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 12.43 109.193 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 7.1 mtp -163.1 139.84 7.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 35.109999999999999 109.796 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.884 HD12 HD12 ' A' ' 78' ' ' ILE . 3.4 mt -67.94 140.97 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.349 -0.844 . . . . 13.67 109.895 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.468 ' HB2' ' HG3' ' B' ' 69' ' ' LYS . 1.6 t70 -110.18 -19.26 13.09 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.376 -0.972 . . . . 24.059999999999999 108.376 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.6 OUTLIER 173.08 68.11 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.919 -1.511 . . . . 35.039999999999999 106.919 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.659 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -32.02 119.59 0.27 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.521 -0.763 . . . . 18.719999999999999 111.447 -177.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -89.66 109.97 20.89 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.91 -1.145 . . . . 20.550000000000001 107.91 178.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.726 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -82.1 143.74 31.27 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.042 -1.036 . . . . 14.4 111.095 -178.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.736 HG22 ' O ' ' B' ' 62' ' ' THR . 4.5 m -143.86 159.66 52.74 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.949 -1.13 . . . . 17.649999999999999 107.949 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -63.55 147.84 92.78 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.115 1.877 . . . . 25.699999999999999 110.394 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.576 ' HA ' HG23 ' B' ' 62' ' ' THR . . . -74.7 118.68 17.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.13 -0.981 . . . . 49.289999999999999 109.627 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.977 -1.011 . . . . 58.909999999999997 109.482 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.5 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.531 -0.544 . . . . 64.909999999999997 109.531 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.831 ' HA ' HD21 ' B' ' 65' ' ' LEU . 2.8 mt -59.04 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.879 -1.156 . . . . 33.799999999999997 107.879 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -63.39 158.65 20.04 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.81 0.814 . . . . 32.719999999999999 111.377 -177.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.055 HG22 HG22 ' A' ' 35' ' ' VAL . 60.6 t -159.99 167.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.579 0.704 . . . . 14.460000000000001 109.583 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.607 ' N ' HG12 ' A' ' 4' ' ' VAL . 22.7 mt-10 -151.7 103.84 2.98 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.946 -0.761 . . . . 22.120000000000001 108.946 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.744 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -70.67 105.69 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.092 -1.077 . . . . 14.23 108.092 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.655 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.22 173.48 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.419 -0.801 . . . . 25.43 109.988 -178.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.1 Cg_endo -76.26 -22.12 12.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.512 2.142 . . . . 13.609999999999999 109.727 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -101.04 8.05 43.12 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.153 -0.684 . . . . 15.52 109.153 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.531 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 17.6 mm-40 -125.25 36.04 4.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.243 -0.911 . . . . 17.309999999999999 109.401 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.13 16.54 24.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 24.780000000000001 110.151 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 4.6 tt0 -137.5 130.23 30.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.099 -1.0 . . . . 47.899999999999999 108.705 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.597 ' H ' ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -76.85 -170.69 1.69 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.088 -1.007 . . . . 21.609999999999999 110.689 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -143.25 126.98 17.08 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.656 -0.653 . . . . 14.890000000000001 109.249 179.066 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.469 0 O-C-N 121.357 -0.84 . . . . 17.350000000000001 109.331 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.706 HD22 HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.389 0.614 . . . . 24.0 110.145 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.586 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -99.95 117.93 35.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -0.754 . . . . 23.309999999999999 109.067 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -86.56 -173.58 4.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.054 -1.029 . . . . 40.030000000000001 109.14 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.579 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -173.48 -170.96 0.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 12.390000000000001 109.962 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' A' ' 44' ' ' LEU . 4.1 mp -145.52 169.9 17.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.473 -0.767 . . . . 17.420000000000002 109.238 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -167.99 166.95 13.01 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.223 -1.028 . . . . 13.84 108.223 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.678 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 31.9 m-85 -118.78 103.19 9.42 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.089 -1.007 . . . . 21.140000000000001 109.498 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.055 HG22 HG22 ' A' ' 4' ' ' VAL . 54.3 t -85.6 144.87 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.109 -0.994 . . . . 10.66 110.29 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.4 m-20 -128.48 -140.49 0.25 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.715 -0.846 . . . . 25.890000000000001 108.715 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.959 ' HG ' HD13 ' B' ' 65' ' ' LEU . 0.1 OUTLIER 68.39 -63.13 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.927 -1.108 . . . . 24.239999999999998 109.222 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -85.98 16.26 43.55 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.593 -1.803 . . . . 31.02 108.593 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -177.83 111.92 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.468 -1.019 . . . . 43.229999999999997 109.083 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' ASN . 1.3 mm-40 -40.78 -66.96 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.476 -0.765 . . . . 42.340000000000003 109.763 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -60.06 153.63 54.94 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 108.574 -0.899 . . . . 5.5800000000000001 108.574 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.678 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.4 Cg_endo -77.34 142.83 21.58 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.146 1.897 . . . . 17.920000000000002 110.22 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.878 HG21 HG21 ' B' ' 70' ' ' VAL . 27.5 m -113.75 113.83 45.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.32 -0.863 . . . . 20.57 109.302 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' A' ' 32' ' ' LEU . 41.0 tp -69.78 112.09 5.99 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.374 -0.829 . . . . 20.210000000000001 110.221 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.603 HG12 ' CG1' ' B' ' 70' ' ' VAL . 4.9 m -112.94 -172.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.9 -0.778 . . . . 10.81 108.9 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -111.93 154.87 24.59 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.467 -0.893 . . . . 36.740000000000002 110.329 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.583 HG13 ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -129.15 162.38 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 108.924 -0.769 . . . . 19.739999999999998 108.924 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.706 HG22 HD22 ' A' ' 28' ' ' LEU . 4.5 m -119.17 73.64 0.95 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.349 -0.844 . . . . 22.559999999999999 109.235 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -40.62 133.52 1.97 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.759 . . . . 20.41 109.663 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -55.26 -166.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 33.990000000000002 109.623 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.22 -83.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 54.920000000000002 109.725 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.24 40.85 2.28 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.623 -1.391 . . . . 36.100000000000001 109.623 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.536 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -89.93 152.63 46.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.194 -1.18 . . . . 54.759999999999998 109.635 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.14 119.25 4.58 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.813 2.342 . . . . 28.370000000000001 110.742 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.61 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -41.16 146.53 0.18 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.369 -0.832 . . . . 17.210000000000001 110.339 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.744 ' O ' HG21 ' A' ' 6' ' ' ILE . 14.7 m-30 -52.13 99.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -0.825 . . . . 17.190000000000001 109.169 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.818 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -45.61 170.75 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 17.82 109.502 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.818 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.6 108.32 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.576 2.184 . . . . 17.280000000000001 110.143 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.21 -178.12 48.63 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.958 -1.257 . . . . 17.219999999999999 109.958 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 6.4 mp -73.91 149.6 41.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -1.057 . . . . 19.57 108.641 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.745 ' HB3' HD22 ' A' ' 83' ' ' LEU . 12.1 m-85 -134.98 163.74 29.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.921 -1.112 . . . . 14.609999999999999 111.373 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.771 ' O ' HG22 ' A' ' 84' ' ' VAL . 29.2 p -145.65 119.37 9.2 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.721 -1.585 . . . . 18.359999999999999 106.721 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.578 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 18.5 t -47.81 170.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 C-N-CA 119.337 -0.945 . . . . 19.129999999999999 109.142 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.2 t-80 -133.82 126.04 29.71 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.823 -0.806 . . . . 20.649999999999999 108.823 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.939 HD13 ' HG ' ' B' ' 37' ' ' LEU . 4.6 mp -62.67 -8.0 5.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.644 -0.66 . . . . 19.649999999999999 110.432 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.407 ' OG ' ' HD3' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -47.29 -24.07 0.68 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.901 -1.124 . . . . 14.720000000000001 107.986 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 3.4 m -98.32 -13.04 20.91 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.68 -0.638 . . . . 11.449999999999999 110.673 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.673 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.6 m-30 -81.33 156.59 25.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.732 -1.23 . . . . 14.25 110.131 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -155.19 166.76 32.57 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.942 -0.762 . . . . 32.700000000000003 108.942 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.899 HG21 HG21 ' B' ' 43' ' ' VAL . 3.0 t -104.05 125.28 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -0.949 . . . . 15.630000000000001 109.227 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.6 173.62 55.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.728 -1.349 . . . . 12.699999999999999 109.728 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.0 OUTLIER -75.77 -1.14 23.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.206 -1.173 . . . . 26.289999999999999 109.83 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.07 -17.0 26.93 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.406 -0.809 . . . . 20.440000000000001 109.521 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.13 52.27 2.42 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.624 -1.391 . . . . 13.82 109.624 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.4 m -156.38 115.18 3.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -1.159 . . . . 18.27 109.507 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.754 HD12 HG11 ' B' ' 35' ' ' VAL . 7.1 tt -50.44 153.2 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 12.43 109.49 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.495 ' N ' HD23 ' A' ' 76' ' ' LEU . 25.3 mtt -161.1 123.84 3.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 35.109999999999999 109.718 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.934 HD12 HD12 ' B' ' 78' ' ' ILE . 3.1 mt -61.55 140.64 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.367 -0.833 . . . . 13.67 109.92 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 26.7 t70 -111.35 -16.95 13.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.338 -0.851 . . . . 24.059999999999999 108.972 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.505 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 169.09 63.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.577 -1.638 . . . . 35.039999999999999 106.577 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -27.2 119.59 0.09 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.665 -1.152 . . . . 18.719999999999999 112.583 -177.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.26 103.33 16.02 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.397 -1.334 . . . . 20.550000000000001 107.397 177.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.887 HD11 HG11 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -77.1 145.39 37.85 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.974 -1.079 . . . . 14.4 111.487 -177.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 62' ' ' THR . 17.8 m -144.75 160.5 47.02 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 107.835 -1.172 . . . . 17.649999999999999 107.835 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.3 Cg_endo -63.93 145.96 90.8 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.065 1.843 . . . . 25.699999999999999 110.42 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.581 ' CA ' HG23 ' A' ' 62' ' ' THR . . . -81.65 125.37 30.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.1 -1.0 . . . . 49.289999999999999 109.477 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.023 -0.989 . . . . 58.909999999999997 109.443 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.5 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.456 -0.572 . . . . 64.909999999999997 109.456 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.831 ' HA ' HD21 ' A' ' 65' ' ' LEU . 2.8 mt -59.0 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.856 -1.164 . . . . 33.799999999999997 107.856 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -63.39 158.66 20.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.803 0.811 . . . . 32.719999999999999 111.411 -177.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.12 HG22 HG22 ' B' ' 35' ' ' VAL . 61.0 t -159.99 167.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.565 0.697 . . . . 14.460000000000001 109.617 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.6 ' N ' HG12 ' B' ' 4' ' ' VAL . 22.6 mt-10 -151.8 104.02 2.98 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.924 -0.769 . . . . 22.120000000000001 108.924 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.738 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -70.82 105.63 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.069 -1.086 . . . . 14.23 108.069 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.664 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.19 173.43 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.43 -0.794 . . . . 25.43 109.974 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.0 Cg_endo -76.18 -22.26 12.98 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.484 2.122 . . . . 13.609999999999999 109.777 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -100.97 8.24 43.15 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.575 -0.703 . . . . 15.52 109.136 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 17.5 mm-40 -125.3 35.82 4.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 17.309999999999999 109.38 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.89 16.3 24.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.112 -0.992 . . . . 24.780000000000001 110.12 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 4.4 tt0 -137.25 130.39 30.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.143 -0.973 . . . . 47.899999999999999 108.7 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.599 ' H ' ' HB2' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -77.04 -170.7 1.75 Allowed 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.091 -1.005 . . . . 21.609999999999999 110.711 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -143.32 126.74 16.76 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.613 -0.679 . . . . 14.890000000000001 109.339 179.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.487 0 O-C-N 121.399 -0.813 . . . . 17.350000000000001 109.382 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.712 HD22 HG22 ' B' ' 48' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.425 0.631 . . . . 24.0 110.105 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.596 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -100.04 118.0 35.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -0.792 . . . . 23.309999999999999 109.02 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -86.61 -173.59 4.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 40.030000000000001 109.096 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.573 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -173.5 -171.04 0.65 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.153 -0.967 . . . . 12.390000000000001 109.948 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.922 ' HB3' HD11 ' B' ' 44' ' ' LEU . 4.1 mp -145.41 169.83 17.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.424 -0.798 . . . . 17.420000000000002 109.231 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -167.95 166.82 13.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.305 -0.998 . . . . 13.84 108.305 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.686 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 31.6 m-85 -118.7 103.18 9.43 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.091 -1.006 . . . . 21.140000000000001 109.478 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 1.12 HG22 HG22 ' B' ' 4' ' ' VAL . 54.6 t -85.55 144.93 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.077 -1.014 . . . . 10.66 110.228 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.5 m-20 -128.71 -140.57 0.24 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.722 -0.844 . . . . 25.890000000000001 108.722 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.939 ' HG ' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER 68.48 -63.29 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.941 -1.1 . . . . 24.239999999999998 109.263 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -85.89 16.4 42.27 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.58 -1.808 . . . . 31.02 108.58 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' B' ' 40' ' ' GLU . 0.4 OUTLIER -177.96 111.88 0.07 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.545 -0.973 . . . . 43.229999999999997 109.066 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 39' ' ' ASN . 1.3 mm-40 -40.71 -67.07 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.514 -0.741 . . . . 42.340000000000003 109.777 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -59.94 153.55 54.05 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 108.615 -0.883 . . . . 5.5599999999999996 108.615 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.686 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.4 Cg_endo -77.35 142.78 21.51 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.121 1.88 . . . . 17.920000000000002 110.323 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.899 HG21 HG21 ' A' ' 70' ' ' VAL . 27.4 m -113.7 113.68 44.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.25 -0.906 . . . . 20.57 109.412 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.922 HD11 ' HB3' ' B' ' 32' ' ' LEU . 40.1 tp -69.65 111.8 5.7 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.407 -0.808 . . . . 20.210000000000001 110.161 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.588 HG12 ' CG1' ' A' ' 70' ' ' VAL . 5.1 m -112.66 -172.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.882 -0.784 . . . . 10.81 108.882 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -111.89 155.08 24.23 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.444 -0.902 . . . . 36.740000000000002 110.311 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.591 HG13 ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -129.36 162.31 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.894 -0.78 . . . . 19.739999999999998 108.894 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.712 HG22 HD22 ' B' ' 28' ' ' LEU . 4.4 m -119.24 73.72 0.95 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.295 -0.878 . . . . 22.559999999999999 109.239 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -40.63 133.41 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.521 -0.737 . . . . 20.41 109.671 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.505 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -55.19 -166.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 33.990000000000002 109.688 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -83.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 54.920000000000002 109.745 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.22 40.62 2.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.64 -1.384 . . . . 36.100000000000001 109.64 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.539 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.1 OUTLIER -89.67 152.6 47.18 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.269 -1.136 . . . . 54.759999999999998 109.649 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.16 119.22 4.56 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.792 2.328 . . . . 28.370000000000001 110.734 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -41.11 146.1 0.19 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.356 -0.84 . . . . 17.210000000000001 110.333 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.738 ' O ' HG21 ' B' ' 6' ' ' ILE . 14.8 m-30 -51.9 100.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 17.190000000000001 109.163 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.834 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -45.9 170.83 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 17.82 109.508 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.834 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -77.69 108.45 2.56 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.562 2.174 . . . . 17.280000000000001 110.186 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.88 -178.33 48.74 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.933 -1.267 . . . . 17.219999999999999 109.933 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 6.4 mp -73.54 150.01 41.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -1.101 . . . . 19.57 108.667 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.743 ' HB3' HD22 ' B' ' 83' ' ' LEU . 12.0 m-85 -135.31 163.8 29.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.926 -1.109 . . . . 14.609999999999999 111.349 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.784 ' O ' HG22 ' B' ' 84' ' ' VAL . 29.4 p -145.73 119.47 9.22 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.67 -1.604 . . . . 18.359999999999999 106.67 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.569 HG21 HG21 ' B' ' 2' ' ' ILE . 18.6 t -47.95 170.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 C-N-CA 119.314 -0.954 . . . . 19.129999999999999 109.095 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.562 ' N ' HG12 ' B' ' 63' ' ' VAL . 2.2 t-80 -133.65 126.33 30.6 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.842 -0.799 . . . . 20.649999999999999 108.842 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.959 HD13 ' HG ' ' A' ' 37' ' ' LEU . 4.5 mp -63.0 -7.92 6.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.64 -0.662 . . . . 19.649999999999999 110.465 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.441 ' C ' ' O ' ' B' ' 65' ' ' LEU . 0.4 OUTLIER -47.17 -24.23 0.66 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.875 -1.141 . . . . 14.720000000000001 107.937 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.502 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 3.3 m -98.22 -13.27 20.92 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.774 -0.579 . . . . 11.449999999999999 110.753 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.68 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.5 m-30 -81.2 156.37 25.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.761 -1.212 . . . . 14.25 110.011 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' B' ' 77' ' ' MET . 0.0 OUTLIER -154.96 166.93 32.01 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.898 -0.778 . . . . 32.700000000000003 108.898 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.878 HG21 HG21 ' A' ' 43' ' ' VAL . 3.0 t -104.1 125.35 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 15.630000000000001 109.232 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.64 173.68 55.25 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.732 -1.347 . . . . 12.699999999999999 109.732 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.446 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 1.0 OUTLIER -75.89 -1.28 24.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.252 -1.146 . . . . 26.289999999999999 109.822 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -90.85 -17.35 26.68 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.408 -0.807 . . . . 20.440000000000001 109.52 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.54 52.42 2.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.662 -1.375 . . . . 13.82 109.662 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 57.9 m -156.59 115.33 3.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -1.163 . . . . 18.27 109.531 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.771 HD12 HG11 ' A' ' 35' ' ' VAL . 7.0 tt -50.53 152.92 1.77 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 12.43 109.447 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.489 ' N ' HD23 ' B' ' 76' ' ' LEU . 25.3 mtt -160.94 123.52 3.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 35.109999999999999 109.741 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.934 HD12 HD12 ' A' ' 78' ' ' ILE . 3.0 mt -61.32 140.71 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 13.67 109.924 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 26.6 t70 -111.24 -17.26 13.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.391 -0.818 . . . . 24.059999999999999 108.928 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.502 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 169.38 63.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.592 -1.633 . . . . 35.039999999999999 106.592 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.636 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.5 OUTLIER -27.2 119.44 0.09 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.711 -1.131 . . . . 18.719999999999999 112.576 -177.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.15 103.28 15.97 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.356 -1.349 . . . . 20.550000000000001 107.356 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.892 HD11 HG11 ' B' ' 4' ' ' VAL . 0.4 OUTLIER -77.06 145.22 38.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.905 -1.122 . . . . 14.4 111.515 -177.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.784 HG22 ' O ' ' B' ' 62' ' ' THR . 17.6 m -144.72 160.44 47.34 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.838 -1.171 . . . . 17.649999999999999 107.838 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.5 Cg_endo -63.88 146.01 91.08 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.099 1.866 . . . . 25.699999999999999 110.464 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -81.66 125.33 30.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.987 . . . . 49.289999999999999 109.528 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.987 -1.006 . . . . 58.909999999999997 109.452 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.483 ' C ' HD22 ' B' ' 65' ' ' LEU . 1.7 pmm? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.33 0.586 . . . . 64.909999999999997 109.46 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.848 ' CA ' HD22 ' B' ' 65' ' ' LEU . 3.0 mt -67.82 80.29 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.113 -1.069 . . . . 33.799999999999997 108.113 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.485 ' HB3' ' OD2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -64.35 153.9 37.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.77 0.795 . . . . 32.719999999999999 110.906 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.886 HG11 HD21 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -163.26 165.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.693 -0.854 . . . . 14.460000000000001 108.693 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 31.3 mt-10 -141.8 113.03 7.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 22.120000000000001 109.381 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.857 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -73.96 103.76 2.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 119.014 -1.075 . . . . 14.23 108.231 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.652 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.85 171.4 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.366 -0.834 . . . . 25.43 109.84 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.3 Cg_endo -76.1 -29.28 6.7 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.492 2.128 . . . . 13.609999999999999 109.803 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 t -85.12 -0.45 54.57 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.912 -0.774 . . . . 15.52 108.912 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 4.0 mm100 -118.0 35.9 4.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.358 -0.839 . . . . 17.309999999999999 109.304 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -101.06 10.81 40.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 24.780000000000001 110.475 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.434 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -139.26 131.55 28.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.043 -1.035 . . . . 47.899999999999999 108.718 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.634 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 26.4 p90 -85.99 177.45 7.58 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.081 -1.012 . . . . 21.609999999999999 110.171 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 9.1 t -130.93 162.39 29.8 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.402 -0.962 . . . . 14.890000000000001 108.402 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.3 -1.575 0 O-C-N 121.056 -1.028 . . . . 17.350000000000001 110.005 -179.561 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 28' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 121.475 0.655 . . . . 24.0 110.23 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.634 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -101.43 131.35 47.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.811 . . . . 23.309999999999999 108.894 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 87.7 mt-10 -113.98 157.98 21.76 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -0.988 . . . . 40.030000000000001 109.758 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.616 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -139.78 -167.87 2.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 12.390000000000001 109.226 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.915 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.3 mp -134.74 176.46 8.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 17.420000000000002 109.195 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.48 166.45 8.38 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.063 -1.023 . . . . 13.84 108.58 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.663 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.2 m-85 -120.15 106.11 11.63 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 21.140000000000001 109.423 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.979 ' O ' HG22 ' A' ' 43' ' ' VAL . 82.2 t -98.89 111.32 28.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.134 -0.979 . . . . 10.66 109.565 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.5 p30 -52.31 -30.2 27.14 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.192 -0.943 . . . . 25.890000000000001 108.487 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.701 HD22 HD21 ' A' ' 39' ' ' ASN . 0.9 OUTLIER 45.29 36.92 2.47 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.48 -0.762 . . . . 24.239999999999998 109.093 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.53 18.92 39.35 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.35 -1.5 . . . . 31.02 109.35 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.701 HD21 HD22 ' A' ' 37' ' ' LEU . 90.3 m-20 -92.33 25.86 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -1.113 . . . . 43.229999999999997 110.483 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.563 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 45.6 mt-10 44.3 25.68 0.13 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.065 -1.022 . . . . 42.340000000000003 109.776 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 9.9 m80 -173.03 150.8 2.02 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.952 -1.129 . . . . 2.8599999999999999 107.952 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.2 Cg_endo -75.98 136.12 18.11 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.788 1.659 . . . . 17.920000000000002 110.622 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 35' ' ' VAL . 10.3 m -112.16 115.41 49.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.564 -0.902 . . . . 20.57 108.564 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.915 HD11 ' HB3' ' A' ' 32' ' ' LEU . 47.6 tp -66.48 107.48 2.07 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.341 -0.849 . . . . 20.210000000000001 109.223 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 3.8 t -112.65 167.58 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.511 -0.743 . . . . 10.81 109.41 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -91.13 163.43 14.28 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.301 -0.874 . . . . 36.740000000000002 109.997 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.94 HD13 HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -151.43 172.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.26 -0.9 . . . . 19.739999999999998 109.289 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.842 HG21 ' NH1' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -110.09 153.64 24.38 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 22.559999999999999 109.255 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.6 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -127.55 101.58 6.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.404 -0.81 . . . . 20.41 109.057 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 2.6 t0 -44.28 144.62 0.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.853 . . . . 33.990000000000002 109.999 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -64.24 102.1 0.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 54.920000000000002 109.091 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.13 -26.19 6.82 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.02 -1.632 . . . . 36.100000000000001 109.02 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.497 ' O ' HD12 ' A' ' 49' ' ' LEU . 8.1 mt-30 -76.56 144.24 73.4 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.356 -1.085 . . . . 54.759999999999998 109.13 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -78.01 130.16 10.19 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.52 2.147 . . . . 28.370000000000001 110.518 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.616 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -39.58 141.72 0.36 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.495 -0.753 . . . . 17.210000000000001 110.082 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.857 ' O ' HG21 ' A' ' 6' ' ' ILE . 87.0 m-85 -43.23 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.407 -0.808 . . . . 17.190000000000001 109.027 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.733 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -42.71 166.16 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 17.82 109.699 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.733 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.3 Cg_endo -77.02 111.91 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.568 2.179 . . . . 17.280000000000001 110.062 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.38 -175.73 47.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.804 -1.318 . . . . 17.219999999999999 109.804 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 4.7 mp -76.09 147.48 38.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.286 -1.126 . . . . 19.57 108.706 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.768 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.7 m-85 -137.4 165.13 26.97 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.457 1.122 . . . . 14.609999999999999 111.204 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.796 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.5 p -145.43 120.57 10.13 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.066 -1.827 . . . . 18.359999999999999 106.066 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -53.95 164.97 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 118.392 -1.323 . . . . 19.129999999999999 108.877 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.433 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.3 t-80 -127.07 129.91 48.91 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.913 -0.773 . . . . 20.649999999999999 108.913 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.861 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -71.79 0.56 8.68 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.41 -0.806 . . . . 19.649999999999999 109.802 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.36 -21.06 8.49 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.252 -1.388 . . . . 14.720000000000001 107.252 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.507 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 24.4 m -95.12 -9.2 34.26 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.855 -0.528 . . . . 11.449999999999999 110.058 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.672 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.0 m-30 -78.73 156.61 28.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 14.25 109.705 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.672 ' HA ' HD21 ' B' ' 37' ' ' LEU . 12.2 mttt -146.97 173.89 12.02 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 32.700000000000003 109.356 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.614 HG22 HD13 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -111.58 111.57 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 15.630000000000001 109.433 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.22 -177.34 47.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.489 -1.444 . . . . 12.699999999999999 109.489 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.93 38.95 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.196 -1.179 . . . . 26.289999999999999 109.55 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.12 24.77 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 20.440000000000001 109.579 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.442 ' C ' HG13 ' B' ' 45' ' ' VAL . . . 50.1 58.75 8.3 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.543 -1.423 . . . . 13.82 109.543 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.25 131.83 1.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -1.114 . . . . 18.27 109.667 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.513 HD11 HD12 ' B' ' 37' ' ' LEU . 1.2 tp -69.38 153.74 43.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 12.43 109.108 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 76' ' ' LEU . 4.5 mmt -154.73 121.67 5.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.969 . . . . 35.109999999999999 109.557 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.943 HD12 HD12 ' B' ' 78' ' ' ILE . 2.6 mt -57.26 141.96 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 13.67 109.831 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -116.0 -3.32 12.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.422 -0.799 . . . . 24.059999999999999 109.034 178.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.842 ' NH1' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER 156.49 62.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.998 -1.482 . . . . 35.039999999999999 106.998 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -27.75 120.23 0.1 Allowed 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.017 -0.992 . . . . 18.719999999999999 112.141 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -91.99 102.15 14.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.67 -0.863 . . . . 20.550000000000001 108.67 179.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.94 HD12 HD13 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -70.37 145.26 51.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.279 -0.888 . . . . 14.4 111.281 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 62' ' ' THR . 35.2 m -146.5 151.16 42.65 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.937 -1.134 . . . . 17.649999999999999 107.937 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.3 Cg_endo -62.72 145.7 95.03 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.203 1.935 . . . . 25.699999999999999 110.464 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -78.98 115.06 18.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 49.289999999999999 109.754 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.019 -0.991 . . . . 58.909999999999997 109.431 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.478 ' C ' HD22 ' A' ' 65' ' ' LEU . 1.7 pmm? . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.36 0.6 . . . . 64.909999999999997 109.516 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.861 ' CA ' HD22 ' A' ' 65' ' ' LEU . 3.0 mt -67.91 80.13 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.12 -1.067 . . . . 33.799999999999997 108.12 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.49 ' HB3' ' OD2' ' B' ' 36' ' ' ASP . 0.0 OUTLIER -64.26 153.87 36.82 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.771 0.796 . . . . 32.719999999999999 110.87 -178.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.886 HG11 HD21 ' B' ' 83' ' ' LEU . 0.1 OUTLIER -163.27 165.05 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.633 -0.877 . . . . 14.460000000000001 108.633 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 31.4 mt-10 -141.75 112.87 7.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 22.120000000000001 109.478 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.844 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -73.85 103.68 2.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.999 -1.08 . . . . 14.23 108.225 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.655 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.81 171.33 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.402 -0.811 . . . . 25.43 109.852 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -76.1 -29.21 6.76 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.496 2.13 . . . . 13.609999999999999 109.856 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.3 t -85.07 -0.59 54.97 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.829 -0.804 . . . . 15.52 108.829 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 4.1 mm100 -118.0 36.03 4.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.419 -0.801 . . . . 17.309999999999999 109.292 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -101.2 10.94 40.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.167 -0.958 . . . . 24.780000000000001 110.44 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.442 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.5 OUTLIER -139.3 131.61 28.37 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.145 -0.972 . . . . 47.899999999999999 108.672 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.634 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 26.3 p90 -86.07 177.53 7.53 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.058 -1.026 . . . . 21.609999999999999 110.052 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 9.2 t -130.98 162.38 29.88 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.392 -0.966 . . . . 14.890000000000001 108.392 178.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 C--N 1.299 -1.592 0 O-C-N 121.127 -0.983 . . . . 17.350000000000001 109.993 -179.613 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.45 ' HA ' HD13 ' B' ' 28' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.467 0.651 . . . . 24.0 110.253 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.634 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -101.37 131.22 47.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.381 -0.824 . . . . 23.309999999999999 108.892 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 87.5 mt-10 -113.89 158.03 21.61 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.109 -0.994 . . . . 40.030000000000001 109.826 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.598 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -139.84 -167.96 2.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.216 -0.928 . . . . 12.390000000000001 109.223 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.897 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.3 mp -134.68 176.58 8.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 17.420000000000002 109.235 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.56 166.51 8.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.09 -1.006 . . . . 13.84 108.543 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.67 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 22.2 m-85 -120.28 106.18 11.65 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.109 -0.994 . . . . 21.140000000000001 109.395 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.96 ' O ' HG22 ' B' ' 43' ' ' VAL . 81.8 t -98.97 111.16 27.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.121 -0.987 . . . . 10.66 109.561 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.5 p30 -52.18 -30.19 25.77 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.205 -0.935 . . . . 25.890000000000001 108.495 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.676 HD22 HD21 ' B' ' 39' ' ' ASN . 0.9 OUTLIER 45.26 36.93 2.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.473 -0.767 . . . . 24.239999999999998 109.065 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.49 19.03 39.49 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.386 -1.486 . . . . 31.02 109.386 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.676 HD21 HD22 ' B' ' 37' ' ' LEU . 90.1 m-20 -92.39 25.93 2.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 43.229999999999997 110.539 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.575 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 45.3 mt-10 44.29 25.6 0.13 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.053 -1.029 . . . . 42.340000000000003 109.84 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 10.0 m80 -172.98 150.78 2.04 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.979 -1.119 . . . . 2.8599999999999999 107.979 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.1 Cg_endo -76.02 136.1 18.0 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.852 1.702 . . . . 17.920000000000002 110.606 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.96 HG22 ' O ' ' B' ' 35' ' ' VAL . 10.1 m -112.18 115.45 49.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.613 -0.884 . . . . 20.57 108.613 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.897 HD11 ' HB3' ' B' ' 32' ' ' LEU . 48.0 tp -66.55 107.49 2.1 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.331 -0.856 . . . . 20.210000000000001 109.299 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.592 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 4.0 t -112.65 167.66 5.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.586 -0.697 . . . . 10.81 109.469 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -91.19 163.16 14.36 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.669 -0.812 . . . . 36.740000000000002 109.97 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.975 HD13 HD12 ' B' ' 83' ' ' LEU . 0.4 OUTLIER -151.19 172.86 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.308 -0.87 . . . . 19.739999999999998 109.326 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.834 HG21 ' NH1' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -110.09 153.53 24.54 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.301 -0.874 . . . . 22.559999999999999 109.245 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.59 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -127.45 101.66 6.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 20.41 109.061 -179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.454 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 2.6 t0 -44.31 144.61 0.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.341 -0.849 . . . . 33.990000000000002 109.97 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -64.21 102.09 0.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 54.920000000000002 109.053 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.2 -26.26 6.77 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.059 -1.616 . . . . 36.100000000000001 109.059 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.498 ' O ' HD12 ' B' ' 49' ' ' LEU . 8.1 mt-30 -76.55 144.47 73.84 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.382 -1.07 . . . . 54.759999999999998 109.018 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.15 130.12 10.04 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.544 2.163 . . . . 28.370000000000001 110.517 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.598 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -39.62 141.97 0.35 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.49 -0.756 . . . . 17.210000000000001 109.99 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.844 ' O ' HG21 ' B' ' 6' ' ' ILE . 86.4 m-85 -43.61 98.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.833 . . . . 17.190000000000001 109.012 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.721 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -43.48 166.42 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.839 . . . . 17.82 109.59 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.721 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -77.54 113.0 3.44 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.625 2.217 . . . . 17.280000000000001 110.317 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.56 -175.02 46.83 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.666 -1.374 . . . . 17.219999999999999 109.666 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.0 mp -75.99 148.04 38.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -1.111 . . . . 19.57 108.995 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.781 ' HB3' HD22 ' B' ' 83' ' ' LEU . 20.7 m-85 -137.9 165.0 27.59 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.413 1.102 . . . . 14.609999999999999 111.254 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.789 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.2 p -145.46 120.61 10.13 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.127 -1.805 . . . . 18.359999999999999 106.127 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.662 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -54.02 165.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 C-N-CA 118.396 -1.321 . . . . 19.129999999999999 108.858 -178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.433 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.3 t-80 -127.01 129.96 49.09 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.97 -0.752 . . . . 20.649999999999999 108.97 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.848 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -71.87 0.54 8.89 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.377 -0.827 . . . . 19.649999999999999 109.735 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -20.94 7.9 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.263 -1.384 . . . . 14.720000000000001 107.263 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.495 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 23.9 m -95.33 -9.58 32.56 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.899 -0.5 . . . . 11.449999999999999 110.058 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.661 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.9 m-30 -78.36 156.11 29.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.124 -0.985 . . . . 14.25 109.715 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.679 ' HA ' HD21 ' A' ' 37' ' ' LEU . 12.2 mttt -146.58 173.37 12.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.805 . . . . 32.700000000000003 109.415 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.659 HG22 HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -111.08 111.63 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 15.630000000000001 109.389 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.34 -177.35 48.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.421 -1.472 . . . . 12.699999999999999 109.421 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.94 39.0 0.94 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.148 -1.207 . . . . 26.289999999999999 109.561 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.08 24.73 4.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 20.440000000000001 109.606 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.451 ' C ' HG13 ' A' ' 45' ' ' VAL . . . 50.02 59.14 7.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.519 -1.432 . . . . 13.82 109.519 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.53 131.83 1.84 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.135 . . . . 18.27 109.685 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 37' ' ' LEU . 1.2 tp -69.41 153.66 43.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.892 . . . . 12.43 109.152 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' B' ' 76' ' ' LEU . 4.5 mmt -154.74 121.77 5.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.097 -1.002 . . . . 35.109999999999999 109.573 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.943 HD12 HD12 ' A' ' 78' ' ' ILE . 2.5 mp -57.4 142.02 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -0.849 . . . . 13.67 109.819 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.7 OUTLIER -115.97 -3.39 12.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.49 -0.756 . . . . 24.059999999999999 108.997 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.834 ' NH1' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER 156.5 63.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.931 -1.507 . . . . 35.039999999999999 106.931 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.662 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.8 OUTLIER -27.89 120.33 0.11 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.001 -1.0 . . . . 18.719999999999999 112.134 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.496 ' HG3' ' NH1' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -92.04 102.08 14.63 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.675 -0.861 . . . . 20.550000000000001 108.675 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.975 HD12 HD13 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -70.39 145.39 51.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.352 -0.843 . . . . 14.4 111.345 -178.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.789 HG22 ' O ' ' B' ' 62' ' ' THR . 35.3 m -146.58 151.03 42.03 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.89 -1.152 . . . . 17.649999999999999 107.89 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.9 Cg_endo -62.53 145.71 95.44 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.181 1.92 . . . . 25.699999999999999 110.419 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -79.05 115.07 18.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 49.289999999999999 109.76 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.048 -0.977 . . . . 58.909999999999997 109.457 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.528 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.3 ttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.534 -0.543 . . . . 64.909999999999997 109.534 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.664 HG21 HG21 ' A' ' 63' ' ' VAL . 2.8 mt -61.52 82.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.962 -1.125 . . . . 33.799999999999997 107.962 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.62 ' C ' HG12 ' A' ' 4' ' ' VAL . 23.4 mttp -70.33 179.12 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.894 0.854 . . . . 32.719999999999999 111.277 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.043 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 173.56 167.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.902 -0.777 . . . . 14.460000000000001 108.902 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.576 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 79.7 mt-10 -141.31 111.17 6.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.545 -0.722 . . . . 22.120000000000001 109.259 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.834 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -72.58 105.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.545 -1.28 . . . . 14.23 107.545 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.538 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.7 mmpt? -54.14 160.36 2.43 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.118 -0.989 . . . . 25.43 109.539 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 31.8 Cg_endo -73.79 -9.25 22.31 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.057 1.838 . . . . 13.609999999999999 109.19 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.85 7.64 46.16 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.89 -0.782 . . . . 15.52 108.89 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.654 ' OE1' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -142.58 37.41 1.49 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.261 -0.899 . . . . 17.309999999999999 109.13 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.58 15.46 6.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 24.780000000000001 109.803 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.476 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -143.96 143.63 31.32 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.182 -0.949 . . . . 47.899999999999999 108.597 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.67 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 26.0 p90 -85.46 173.31 10.34 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.038 -1.039 . . . . 21.609999999999999 109.61 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 15' ' ' THR . 39.9 m -137.6 154.95 49.68 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.471 -0.768 . . . . 14.890000000000001 109.0 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.175 -0.953 . . . . 17.350000000000001 109.506 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.667 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.424 0.63 . . . . 24.0 110.23 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.661 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -46.01 128.45 9.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.427 -0.796 . . . . 23.309999999999999 109.546 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -121.13 143.09 49.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.258 -0.901 . . . . 40.030000000000001 108.788 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.938 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -115.1 -167.29 1.21 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.963 -1.086 . . . . 12.390000000000001 110.149 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.886 ' HB3' HD11 ' A' ' 44' ' ' LEU . 21.1 mt -128.44 177.99 6.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.48 -0.762 . . . . 17.420000000000002 109.557 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.566 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -173.46 150.72 1.85 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.987 -1.07 . . . . 13.84 109.238 -179.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.762 ' HE1' HD13 ' A' ' 44' ' ' LEU . 2.9 m-85 -109.8 91.32 3.6 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.181 -1.044 . . . . 21.140000000000001 108.181 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.866 HG22 ' HB ' ' A' ' 4' ' ' VAL . 97.9 t -92.89 117.58 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.98 . . . . 10.66 110.155 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 27.6 t0 -53.56 -28.49 32.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.415 -0.957 . . . . 25.890000000000001 108.415 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.83 HD21 ' HA ' ' B' ' 69' ' ' LYS . 1.9 tt 43.25 34.47 0.71 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.498 -0.751 . . . . 24.239999999999998 109.239 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.35 23.12 52.9 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.457 -1.457 . . . . 31.02 109.457 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.736 HD21 HD22 ' A' ' 37' ' ' LEU . 98.6 m-20 -97.33 26.35 4.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -1.155 . . . . 43.229999999999997 110.263 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.551 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 42.9 mt-10 49.25 21.62 0.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.134 -0.979 . . . . 42.340000000000003 109.949 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 6.0 m80 -174.71 157.11 2.23 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 108.027 -1.101 . . . . 6.1600000000000001 108.027 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.641 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.8 Cg_endo -75.6 146.14 30.24 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.019 1.813 . . . . 17.920000000000002 111.005 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.6 m -122.46 118.38 55.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.622 -0.881 . . . . 20.57 108.622 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 32' ' ' LEU . 22.4 tp -69.14 109.42 4.04 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.662 -0.815 . . . . 20.210000000000001 109.04 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.591 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 3.9 t -117.18 168.89 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.614 -0.678 . . . . 10.81 109.516 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.581 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -88.63 161.93 16.61 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.298 -0.876 . . . . 36.740000000000002 110.423 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.693 HD12 ' HE2' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -133.11 164.43 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.485 -0.932 . . . . 19.739999999999998 108.485 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -108.76 135.5 49.88 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.193 -0.942 . . . . 22.559999999999999 108.565 178.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.667 ' O ' HD23 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -123.88 123.9 41.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 20.41 109.365 -179.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . 1.3 t0 -71.4 142.53 50.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 33.990000000000002 109.546 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.29 107.72 0.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 54.920000000000002 109.664 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.04 -2.4 44.33 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.859 -1.296 . . . . 36.100000000000001 109.859 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.625 ' O ' HD12 ' A' ' 49' ' ' LEU . 13.2 mt-30 -89.19 144.5 32.6 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 54.759999999999998 109.525 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 55' ' ' ALA . 35.1 Cg_endo -78.38 114.78 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.643 2.229 . . . . 28.370000000000001 110.642 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.938 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -43.79 168.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.337 -0.852 . . . . 17.210000000000001 110.031 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.834 ' HB3' HD13 ' A' ' 6' ' ' ILE . 31.0 m-85 -66.14 122.85 18.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 17.190000000000001 109.657 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.997 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -74.48 179.39 1.31 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.455 -0.778 . . . . 17.82 109.808 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.997 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.9 Cg_endo -78.01 115.41 3.77 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.582 2.188 . . . . 17.280000000000001 110.436 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 166.85 142.0 3.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.317 -1.513 . . . . 17.219999999999999 109.317 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 59' ' ' GLY . 4.0 mp -42.11 144.43 0.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.153 -1.204 . . . . 19.57 109.382 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 1.043 ' CB ' HG13 ' A' ' 4' ' ' VAL . 15.1 m-85 -121.52 166.37 14.28 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.487 1.137 . . . . 14.609999999999999 111.253 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.572 HG23 ' CA ' ' A' ' 86' ' ' ALA . 39.8 p -149.35 120.54 7.79 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.505 -2.035 . . . . 18.359999999999999 105.505 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.9 t -57.89 161.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 C-N-CA 118.107 -1.437 . . . . 19.129999999999999 108.934 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 82' ' ' ARG . 5.1 t-80 -116.19 138.41 51.3 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.592 -0.693 . . . . 20.649999999999999 109.203 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.751 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.1 mt -70.71 -8.44 52.13 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.098 -0.704 . . . . 19.649999999999999 109.098 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.418 ' OG ' ' HD3' ' A' ' 82' ' ' ARG . 0.5 OUTLIER -47.93 -24.95 1.16 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.268 -1.012 . . . . 14.720000000000001 108.268 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.54 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 3.7 m -93.7 -14.77 25.96 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.825 -0.75 . . . . 11.449999999999999 109.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.756 ' HB3' HD21 ' A' ' 76' ' ' LEU . 3.5 m-30 -80.69 147.07 30.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.064 -1.022 . . . . 14.25 109.973 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.8 ' HA ' HD21 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -146.31 172.87 12.84 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.643 -0.661 . . . . 32.700000000000003 109.229 -179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.67 HG22 HD13 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -107.33 109.55 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 15.630000000000001 109.171 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.07 -173.08 49.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.582 -1.407 . . . . 12.699999999999999 109.582 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 72' ' ' GLN . 0.6 OUTLIER -95.87 22.98 6.72 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.261 -1.141 . . . . 26.289999999999999 108.948 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 -9.45 26.65 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.283 -0.567 . . . . 20.440000000000001 109.704 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.436 ' C ' HG13 ' B' ' 45' ' ' VAL . . . 81.5 40.41 11.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.692 -1.363 . . . . 13.82 109.692 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.499 ' HA ' ' CG1' ' B' ' 45' ' ' VAL . 4.4 m -169.18 138.54 2.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.14 . . . . 18.27 109.564 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.756 HD21 ' HB3' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -47.57 160.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 12.43 109.46 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtt -158.64 107.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 35.109999999999999 109.708 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.626 HG12 ' CD1' ' A' ' 68' ' ' PHE . 23.4 mt -60.33 138.11 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 13.67 109.815 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 12.1 t70 -103.13 -22.67 13.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.357 -0.84 . . . . 24.059999999999999 108.802 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.54 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.5 OUTLIER 171.86 66.74 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.542 -1.281 . . . . 35.039999999999999 107.542 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.892 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -21.72 119.01 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.033 -0.985 . . . . 18.719999999999999 112.264 -178.248 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -92.68 103.72 16.07 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.601 -0.888 . . . . 20.550000000000001 108.601 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.974 HD11 HG11 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -73.78 145.05 45.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.146 -0.971 . . . . 14.4 111.528 -178.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 62' ' ' THR . 2.4 m -149.64 156.25 38.85 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 107.524 -1.287 . . . . 17.649999999999999 107.524 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 24.7 Cg_endo -63.3 141.13 80.59 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 C-N-CA 121.9 1.733 . . . . 25.699999999999999 110.26 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.572 ' CA ' HG23 ' A' ' 62' ' ' THR . . . -70.66 112.13 6.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.191 -0.943 . . . . 49.289999999999999 109.5 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.045 -0.978 . . . . 58.909999999999997 109.475 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.531 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.3 ttp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.526 -0.546 . . . . 64.909999999999997 109.526 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.666 HG21 HG21 ' B' ' 63' ' ' VAL . 2.8 mt -61.56 82.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.985 -1.117 . . . . 33.799999999999997 107.985 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.635 ' C ' HG12 ' B' ' 4' ' ' VAL . 23.3 mttp -70.1 179.2 2.43 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.979 0.895 . . . . 32.719999999999999 111.284 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.046 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 173.46 167.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.865 -0.791 . . . . 14.460000000000001 108.865 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 79.6 mt-10 -141.36 111.14 6.55 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.62 0.724 . . . . 22.120000000000001 109.241 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.829 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -72.55 105.34 2.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.54 -1.281 . . . . 14.23 107.54 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.541 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.7 mmpt? -54.3 160.39 2.54 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.113 -0.992 . . . . 25.43 109.509 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.9 Cg_endo -73.75 -9.25 22.37 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.032 1.821 . . . . 13.609999999999999 109.181 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.84 7.51 46.45 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.803 -0.814 . . . . 15.52 108.803 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.645 ' OE1' HD13 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -142.63 37.6 1.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.206 -0.934 . . . . 17.309999999999999 109.093 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.7 15.34 7.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 24.780000000000001 109.831 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.467 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -143.91 143.44 31.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.216 -0.927 . . . . 47.899999999999999 108.686 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.666 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 26.3 p90 -85.24 173.22 10.55 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.036 -1.04 . . . . 21.609999999999999 109.609 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.42 HG22 ' N ' ' B' ' 15' ' ' THR . 39.9 m -137.54 155.0 49.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.48 -0.762 . . . . 14.890000000000001 108.983 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . 0.42 ' N ' HG22 ' B' ' 14' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.461 0 O-C-N 121.186 -0.946 . . . . 17.350000000000001 109.59 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.656 HD23 ' O ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.454 0.645 . . . . 24.0 110.234 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.668 ' OD1' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -46.06 128.52 9.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.401 -0.812 . . . . 23.309999999999999 109.579 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -121.2 143.11 49.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.894 . . . . 40.030000000000001 108.748 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.958 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -115.17 -167.24 1.21 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.981 -1.075 . . . . 12.390000000000001 110.132 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.908 ' HB3' HD11 ' B' ' 44' ' ' LEU . 21.0 mt -128.37 177.97 6.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.429 -0.795 . . . . 17.420000000000002 109.549 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.571 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.8 OUTLIER -173.49 150.65 1.83 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.918 -1.114 . . . . 13.84 109.265 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.772 ' HE1' HD13 ' B' ' 44' ' ' LEU . 2.9 m-85 -109.77 91.28 3.58 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.18 -1.045 . . . . 21.140000000000001 108.18 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.898 HG22 ' HB ' ' B' ' 4' ' ' VAL . 98.5 t -92.83 117.76 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.961 . . . . 10.66 110.096 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 27.6 t0 -53.71 -28.37 33.58 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.385 -0.968 . . . . 25.890000000000001 108.385 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.8 HD21 ' HA ' ' A' ' 69' ' ' LYS . 1.8 tt 43.11 34.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.572 -0.705 . . . . 24.239999999999998 109.256 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.19 23.05 51.81 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.472 -1.451 . . . . 31.02 109.472 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.739 HD21 HD22 ' B' ' 37' ' ' LEU . 99.0 m-20 -97.35 26.28 4.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.217 -1.167 . . . . 43.229999999999997 110.234 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 43.0 mt-10 49.23 21.74 0.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.13 -0.981 . . . . 42.340000000000003 109.976 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 5.9 m80 -174.79 157.13 2.2 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.999 -1.111 . . . . 6.1500000000000004 107.999 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.635 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.9 Cg_endo -75.59 146.19 30.34 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.97 1.78 . . . . 17.920000000000002 110.954 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.859 HG22 ' O ' ' B' ' 35' ' ' VAL . 5.4 m -122.49 118.36 54.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.633 -0.877 . . . . 20.57 108.633 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.908 HD11 ' HB3' ' B' ' 32' ' ' LEU . 22.9 tp -69.09 109.57 4.08 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.69 -0.804 . . . . 20.210000000000001 109.096 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 3.9 t -117.37 168.86 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.529 -0.732 . . . . 10.81 109.448 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -88.52 161.9 16.72 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.351 -0.843 . . . . 36.740000000000002 110.455 -179.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.687 HD12 ' HE2' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -133.08 164.29 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.522 -0.918 . . . . 19.739999999999998 108.522 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.502 ' N ' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -108.67 135.47 49.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.242 -0.912 . . . . 22.559999999999999 108.576 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.656 ' O ' HD23 ' B' ' 28' ' ' LEU . 0.3 OUTLIER -123.92 123.89 41.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.865 . . . . 20.41 109.362 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.433 ' HB3' ' HG3' ' B' ' 53' ' ' GLN . 1.3 t0 -71.39 142.35 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 33.990000000000002 109.567 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.21 107.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 54.920000000000002 109.633 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.08 -2.41 44.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.831 -1.308 . . . . 36.100000000000001 109.831 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.628 ' O ' HD12 ' B' ' 49' ' ' LEU . 13.2 mt-30 -89.22 144.46 32.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.166 -1.197 . . . . 54.759999999999998 109.513 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.37 114.7 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.669 2.246 . . . . 28.370000000000001 110.696 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.958 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -43.69 168.67 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 17.210000000000001 110.025 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.829 ' HB3' HD13 ' B' ' 6' ' ' ILE . 30.7 m-85 -66.06 122.96 18.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 17.190000000000001 109.618 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.995 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -74.53 179.44 1.31 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.443 -0.786 . . . . 17.82 109.844 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.995 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.1 Cg_endo -78.0 115.35 3.76 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.619 2.213 . . . . 17.280000000000001 110.442 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 166.87 141.95 3.3 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.358 -1.497 . . . . 17.219999999999999 109.358 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' B' ' 59' ' ' GLY . 4.0 mp -42.04 144.26 0.47 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -1.162 . . . . 19.57 109.364 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 1.046 ' CB ' HG13 ' B' ' 4' ' ' VAL . 15.1 m-85 -121.4 166.24 14.38 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.93 -1.106 . . . . 14.609999999999999 111.34 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.571 HG23 ' CA ' ' B' ' 86' ' ' ALA . 39.2 p -149.31 120.25 7.65 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 105.485 -2.043 . . . . 18.359999999999999 105.485 177.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.925 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.8 t -57.44 161.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 C-N-CA 118.143 -1.423 . . . . 19.129999999999999 108.936 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' B' ' 82' ' ' ARG . 5.1 t-80 -116.43 138.32 51.46 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.551 -0.718 . . . . 20.649999999999999 109.245 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.754 HD23 ' CD2' ' B' ' 68' ' ' PHE . 2.1 mt -70.57 -8.47 51.77 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.065 -0.717 . . . . 19.649999999999999 109.065 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . 0.42 ' OG ' ' HD3' ' B' ' 82' ' ' ARG . 0.5 OUTLIER -47.96 -24.84 1.15 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.29 -1.004 . . . . 14.720000000000001 108.29 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.538 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 3.8 m -93.78 -14.8 25.82 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.472 -0.767 . . . . 11.449999999999999 109.97 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.766 ' HB3' HD21 ' B' ' 76' ' ' LEU . 3.5 m-30 -80.71 146.44 31.06 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.081 -1.012 . . . . 14.25 109.955 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.83 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -145.72 172.62 13.02 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.651 -0.656 . . . . 32.700000000000003 109.274 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.709 HG22 HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -107.2 109.54 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 15.630000000000001 109.166 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.95 -172.88 49.12 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.593 -1.403 . . . . 12.699999999999999 109.593 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.605 ' NE2' ' N ' ' B' ' 72' ' ' GLN . 0.6 OUTLIER -96.05 22.83 7.06 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.215 -1.168 . . . . 26.289999999999999 108.918 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.61 -9.48 26.84 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.757 -0.589 . . . . 20.440000000000001 109.69 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.464 ' C ' HG13 ' A' ' 45' ' ' VAL . . . 81.46 41.05 10.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.578 -1.409 . . . . 13.82 109.578 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.521 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 4.3 m -169.79 138.29 1.8 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -1.153 . . . . 18.27 109.688 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.774 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -47.37 160.7 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 12.43 109.462 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtt -158.94 107.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 35.109999999999999 109.738 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.636 HG12 ' CD1' ' B' ' 68' ' ' PHE . 23.0 mt -60.26 138.4 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 13.67 109.843 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 12.1 t70 -103.37 -22.81 13.62 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.709 -0.849 . . . . 24.059999999999999 108.709 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.538 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.5 OUTLIER 172.09 66.55 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.556 -1.275 . . . . 35.039999999999999 107.556 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.925 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.7 OUTLIER -21.5 118.96 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.085 -0.961 . . . . 18.719999999999999 112.285 -178.25 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' B' ' 64' ' ' HIS . 0.3 OUTLIER -92.57 103.79 16.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 20.550000000000001 108.643 179.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.957 HD11 HG11 ' B' ' 4' ' ' VAL . 0.7 OUTLIER -73.85 144.93 45.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.03 -1.044 . . . . 14.4 111.469 -178.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 62' ' ' THR . 2.5 m -149.59 156.14 38.95 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.528 -1.286 . . . . 17.649999999999999 107.528 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 24.6 Cg_endo -63.26 141.08 80.73 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 121.911 1.741 . . . . 25.699999999999999 110.211 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.571 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -70.53 112.14 6.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.207 -0.933 . . . . 49.289999999999999 109.528 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.015 -0.993 . . . . 58.909999999999997 109.5 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.485 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 1.3 ttp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.457 -0.572 . . . . 64.909999999999997 109.457 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.873 ' HA ' HD22 ' B' ' 65' ' ' LEU . 6.2 mt -71.29 77.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.213 -1.032 . . . . 33.799999999999997 108.213 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 35' ' ' VAL . 54.0 mttt -63.53 155.41 29.47 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.937 0.875 . . . . 32.719999999999999 111.299 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.81 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -166.84 163.53 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.499 -0.926 . . . . 14.460000000000001 108.499 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 64.5 mt-10 -137.12 119.53 15.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.24 -0.913 . . . . 22.120000000000001 109.762 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -76.61 101.08 2.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.521 -1.288 . . . . 14.23 107.521 178.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.652 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.9 171.73 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.014 -1.054 . . . . 25.43 109.841 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -75.08 -26.06 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.49 2.126 . . . . 13.609999999999999 109.804 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.89 -0.13 56.58 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.906 -0.775 . . . . 15.52 108.906 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.479 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.5 mm-40 -120.59 37.17 4.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.346 -0.846 . . . . 17.309999999999999 109.595 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.01 8.45 44.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 24.780000000000001 110.236 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -139.71 137.89 35.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.186 -0.946 . . . . 47.899999999999999 108.677 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.667 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 30.7 p90 -84.45 173.99 10.43 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.027 -1.046 . . . . 21.609999999999999 109.459 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.7 m -142.5 151.67 41.91 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.459 -0.776 . . . . 14.890000000000001 109.115 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.497 0 O-C-N 121.296 -0.878 . . . . 17.350000000000001 109.23 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.359 0.6 . . . . 24.0 110.299 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -48.65 120.31 3.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 23.309999999999999 109.168 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 7.9 mt-10 -109.79 161.3 15.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 40.030000000000001 109.334 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.76 HE21 ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -139.91 -168.92 2.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 12.390000000000001 109.647 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.944 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.1 mt -141.44 155.28 45.88 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.684 -0.858 . . . . 17.420000000000002 108.684 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.613 ' SG ' HD11 ' A' ' 6' ' ' ILE . 2.6 m -151.64 -177.25 5.99 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.185 -1.042 . . . . 13.84 108.185 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.701 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 16.5 m-85 -131.3 103.81 6.67 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.126 -0.984 . . . . 21.140000000000001 109.785 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 43' ' ' VAL . 3.0 t -109.78 123.27 65.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.145 -0.972 . . . . 10.66 110.069 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -87.66 -36.76 17.25 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.366 -0.976 . . . . 25.890000000000001 108.366 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.791 HD21 HD11 ' B' ' 76' ' ' LEU . 0.3 OUTLIER 63.79 -71.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.541 -0.911 . . . . 24.239999999999998 108.541 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -157.19 29.17 0.52 Allowed Glycine 0 C--N 1.297 -1.633 0 N-CA-C 109.188 -1.565 . . . . 31.02 109.188 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' HIS . 1.7 m-20 -109.51 21.64 16.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -1.178 . . . . 43.229999999999997 110.229 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.579 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 3.3 mt-10 42.58 25.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.266 -0.896 . . . . 42.340000000000003 110.328 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 98.6 m-70 -160.52 152.79 17.11 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.108 -0.995 . . . . 6.9900000000000002 108.518 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.701 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -78.35 136.05 13.87 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.903 1.736 . . . . 17.920000000000002 110.411 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 35' ' ' VAL . 2.4 m -112.21 119.34 59.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.351 -0.843 . . . . 20.57 108.744 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.944 HD11 ' HB3' ' A' ' 32' ' ' LEU . 52.1 tp -75.32 103.51 5.5 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.461 -0.895 . . . . 20.210000000000001 110.018 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.737 HG13 HG23 ' A' ' 43' ' ' VAL . 29.0 m -110.53 178.48 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.643 -0.873 . . . . 10.81 108.643 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HD3' HD21 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -106.09 127.1 52.95 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.012 -1.075 . . . . 36.740000000000002 110.029 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.996 HD13 HD12 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -108.64 163.17 6.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.884 -0.784 . . . . 19.739999999999998 108.884 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 49' ' ' LEU . 56.7 m -99.59 158.99 15.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 22.559999999999999 109.539 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.799 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -130.37 105.14 7.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.198 -0.939 . . . . 20.41 109.286 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.49 142.29 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 33.990000000000002 109.501 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.14 101.58 0.3 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 54.920000000000002 109.313 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.62 -20.04 10.3 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.316 -1.514 . . . . 36.100000000000001 109.316 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 30.5 mt-30 -78.28 148.53 74.46 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.259 -1.142 . . . . 54.759999999999998 109.376 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.99 120.38 5.01 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.665 2.244 . . . . 28.370000000000001 110.619 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.799 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -38.58 143.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.506 -0.746 . . . . 17.210000000000001 110.346 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.767 ' HB3' HD13 ' A' ' 6' ' ' ILE . 86.6 m-85 -44.56 102.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.798 . . . . 17.190000000000001 108.844 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.97 176.09 0.13 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 17.82 109.955 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.8 Cg_endo -78.39 111.22 2.99 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.763 2.309 . . . . 17.280000000000001 110.27 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 175.25 163.89 28.98 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.905 -1.278 . . . . 17.219999999999999 109.905 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.751 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.5 OUTLIER -59.84 142.79 52.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.243 -1.151 . . . . 19.57 108.748 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.716 ' HB3' HD22 ' A' ' 83' ' ' LEU . 31.8 m-85 -125.9 161.07 28.3 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.718 -1.238 . . . . 14.609999999999999 111.682 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.726 ' O ' HG22 ' A' ' 84' ' ' VAL . 30.9 p -146.24 121.44 10.17 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.295 -1.743 . . . . 18.359999999999999 106.295 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.614 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.9 t -52.47 168.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.806 -1.158 . . . . 19.129999999999999 109.381 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.548 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -133.62 127.14 32.39 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.487 -0.758 . . . . 20.649999999999999 109.038 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.885 HD22 ' HA ' ' B' ' 2' ' ' ILE . 0.7 OUTLIER -71.11 0.1 8.42 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.292 -0.88 . . . . 19.649999999999999 109.997 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.3 p -55.26 -20.55 11.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.401 -1.333 . . . . 14.720000000000001 107.401 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 69.6 m -94.18 -27.35 16.24 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.835 -0.54 . . . . 11.449999999999999 109.998 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.684 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -60.82 156.27 17.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.1 -1.0 . . . . 14.25 109.127 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HE3' ' OD2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -159.1 172.31 18.35 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.385 -0.822 . . . . 32.700000000000003 109.586 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.637 HG21 HG11 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -97.45 112.19 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 15.630000000000001 109.387 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.45 -176.08 48.61 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.547 -1.421 . . . . 12.699999999999999 109.547 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -90.05 33.86 0.87 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -1.162 . . . . 26.289999999999999 109.486 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -118.74 15.36 13.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 20.440000000000001 109.628 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.06 48.96 70.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.781 -1.328 . . . . 13.82 109.781 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 77' ' ' MET . 0.0 OUTLIER -170.93 138.84 1.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -1.197 . . . . 18.27 109.416 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.8 HD11 HD21 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -45.15 163.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 12.43 109.388 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 75' ' ' SER . 6.7 mmt -154.22 100.3 2.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 35.109999999999999 109.844 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.5 mt -40.98 -61.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.511 0.672 . . . . 13.67 109.634 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 35.4 t0 81.44 -48.2 0.24 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.476 0.655 . . . . 24.059999999999999 109.958 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.0 tpm_? -172.04 66.78 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.107 0.956 . . . . 35.039999999999999 108.781 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' B' ' 76' ' ' LEU . 1.0 OUTLIER -34.84 127.06 0.51 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.499 -0.773 . . . . 18.719999999999999 111.597 -179.203 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -94.7 105.38 17.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.167 -1.049 . . . . 20.550000000000001 108.167 178.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.996 HD12 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -72.83 149.06 43.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 14.4 111.263 -178.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 62' ' ' THR . 34.3 m -150.22 150.68 29.98 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.121 -1.066 . . . . 17.649999999999999 108.121 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.2 Cg_endo -61.93 138.35 73.06 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.129 1.886 . . . . 25.699999999999999 110.241 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -66.72 116.61 7.82 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.295 -0.878 . . . . 49.289999999999999 109.684 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.001 -1.0 . . . . 58.909999999999997 109.41 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.488 ' SD ' ' HB ' ' B' ' 62' ' ' THR . 1.3 ttp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.522 -0.548 . . . . 64.909999999999997 109.522 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.885 ' HA ' HD22 ' A' ' 65' ' ' LEU . 6.3 mt -70.6 77.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.16 -1.052 . . . . 33.799999999999997 108.16 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.466 ' O ' HG13 ' B' ' 35' ' ' VAL . 53.3 mttt -63.6 155.37 29.85 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.914 0.864 . . . . 32.719999999999999 111.308 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.826 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -166.86 163.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.492 -0.929 . . . . 14.460000000000001 108.492 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 65.3 mt-10 -137.07 119.6 15.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.344 -0.847 . . . . 22.120000000000001 109.798 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.755 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -76.71 101.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.583 -1.265 . . . . 14.23 107.583 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.66 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.88 171.76 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.1 -1.0 . . . . 25.43 109.83 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.6 Cg_endo -75.07 -26.14 11.09 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.539 2.159 . . . . 13.609999999999999 109.834 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.86 -0.08 56.5 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.946 -0.761 . . . . 15.52 108.946 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.482 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.5 mm-40 -120.57 37.07 4.38 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 17.309999999999999 109.561 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.05 8.71 43.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 24.780000000000001 110.204 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.454 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -139.93 137.85 35.12 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.126 -0.984 . . . . 47.899999999999999 108.639 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 30.8 p90 -84.39 174.05 10.41 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 120.984 -1.072 . . . . 21.609999999999999 109.504 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -142.53 151.44 41.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.397 -0.814 . . . . 14.890000000000001 109.113 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.536 0 O-C-N 121.288 -0.883 . . . . 17.350000000000001 109.129 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.349 0.595 . . . . 24.0 110.292 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.593 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -48.69 120.4 3.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.402 -0.811 . . . . 23.309999999999999 109.122 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 7.8 mt-10 -109.84 161.39 15.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 40.030000000000001 109.283 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.767 HE21 ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -139.9 -168.85 2.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 12.390000000000001 109.67 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.913 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.1 mt -141.55 155.19 45.79 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.717 -0.845 . . . . 17.420000000000002 108.717 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.625 ' SG ' HD11 ' B' ' 6' ' ' ILE . 2.5 m -151.63 -177.21 5.97 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.179 -1.045 . . . . 13.84 108.179 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.699 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 16.3 m-85 -131.35 103.9 6.71 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.103 -0.998 . . . . 21.140000000000001 109.692 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.854 ' O ' HG22 ' B' ' 43' ' ' VAL . 2.9 t -109.86 123.16 65.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.126 -0.984 . . . . 10.66 110.115 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.768 ' O ' HD12 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -87.45 -36.9 17.43 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.336 -0.987 . . . . 25.890000000000001 108.336 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 76' ' ' LEU . 0.3 OUTLIER 64.13 -71.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.471 -0.937 . . . . 24.239999999999998 108.471 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -157.49 29.19 0.5 Allowed Glycine 0 C--N 1.297 -1.61 0 N-CA-C 109.185 -1.566 . . . . 31.02 109.185 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' B' ' 41' ' ' HIS . 1.7 m-20 -109.49 21.53 16.9 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.117 -1.225 . . . . 43.229999999999997 110.243 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.585 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 3.2 mt-10 42.78 25.23 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 42.340000000000003 110.302 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 98.4 m-70 -160.48 152.85 17.24 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.175 -0.953 . . . . 6.9900000000000002 108.511 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.699 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 38.3 Cg_endo -78.44 135.9 13.62 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.93 1.753 . . . . 17.920000000000002 110.468 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.854 HG22 ' O ' ' B' ' 35' ' ' VAL . 2.4 m -111.88 119.34 59.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.62 -0.881 . . . . 20.57 108.62 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.913 HD11 ' HB3' ' B' ' 32' ' ' LEU . 51.4 tp -75.25 103.43 5.4 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.243 -0.91 . . . . 20.210000000000001 110.069 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.744 HG13 HG23 ' B' ' 43' ' ' VAL . 26.1 m -110.4 178.64 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.738 -0.838 . . . . 10.81 108.738 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.466 ' HD3' HD21 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -106.23 127.0 52.91 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.975 -1.09 . . . . 36.740000000000002 109.99 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 1.01 HD13 HD12 ' B' ' 83' ' ' LEU . 0.5 OUTLIER -108.48 163.3 6.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.889 -0.782 . . . . 19.739999999999998 108.889 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.431 HG22 ' N ' ' B' ' 49' ' ' LEU . 56.5 m -99.71 158.7 15.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.985 -1.072 . . . . 22.559999999999999 109.558 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -130.12 105.25 7.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 20.41 109.3 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.6 142.03 2.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 33.990000000000002 109.578 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.9 101.33 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 54.920000000000002 109.353 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.92 -19.97 10.06 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.311 -1.516 . . . . 36.100000000000001 109.311 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -78.43 148.61 74.09 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.283 -1.128 . . . . 54.759999999999998 109.436 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.9 Cg_endo -78.01 120.44 5.02 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.644 2.229 . . . . 28.370000000000001 110.587 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.768 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -38.63 143.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 17.210000000000001 110.37 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.755 ' HB3' HD13 ' B' ' 6' ' ' ILE . 86.8 m-85 -44.59 102.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 17.190000000000001 108.837 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.978 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -53.73 176.06 0.12 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 17.82 109.878 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.978 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -78.48 111.34 3.0 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.719 2.279 . . . . 17.280000000000001 110.237 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 175.24 164.15 29.39 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.918 -1.273 . . . . 17.219999999999999 109.918 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.716 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.5 OUTLIER -60.16 142.82 53.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -1.143 . . . . 19.57 108.706 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.698 ' HB3' HD22 ' B' ' 83' ' ' LEU . 31.8 m-85 -125.86 161.13 28.13 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.679 -1.263 . . . . 14.609999999999999 111.645 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.728 ' O ' HG22 ' B' ' 84' ' ' VAL . 30.8 p -146.28 121.48 10.18 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.325 -1.732 . . . . 18.359999999999999 106.325 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.9 t -52.6 168.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 C-N-CA 118.887 -1.125 . . . . 19.129999999999999 109.342 -178.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.534 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -133.61 127.26 32.64 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.508 -0.745 . . . . 20.649999999999999 109.058 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.873 HD22 ' HA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -71.38 0.38 8.33 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.263 -0.898 . . . . 19.649999999999999 109.975 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.4 p -55.32 -20.47 11.61 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.294 -1.372 . . . . 14.720000000000001 107.294 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 69.8 m -94.35 -27.23 16.2 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.864 -0.522 . . . . 11.449999999999999 109.954 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.69 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.9 m-30 -60.9 156.13 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.05 -1.031 . . . . 14.25 109.069 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.418 ' HE3' ' OD2' ' B' ' 79' ' ' ASP . 0.0 OUTLIER -159.07 172.45 18.12 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.36 -0.837 . . . . 32.700000000000003 109.595 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.78 HG21 HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -97.62 112.42 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.838 . . . . 15.630000000000001 109.392 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.52 -176.1 48.51 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.512 -1.435 . . . . 12.699999999999999 109.512 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.438 ' NE2' ' H ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.0 34.0 0.86 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.196 -1.179 . . . . 26.289999999999999 109.496 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -118.91 15.33 13.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 20.440000000000001 109.598 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.1 48.84 71.13 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.779 -1.328 . . . . 13.82 109.779 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' B' ' 77' ' ' MET . 0.0 OUTLIER -170.84 138.95 1.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -1.162 . . . . 18.27 109.403 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.791 HD11 HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -45.14 163.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 12.43 109.464 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 75' ' ' SER . 6.6 mmt -154.37 100.4 2.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 35.109999999999999 109.835 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.609 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.5 mt -41.13 -61.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.514 0.673 . . . . 13.67 109.689 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 35.5 t0 81.41 -48.28 0.24 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.485 0.66 . . . . 24.059999999999999 109.961 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.0 tpm_? -171.98 66.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.111 0.958 . . . . 35.039999999999999 108.793 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.723 HD13 ' HB2' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -34.87 127.22 0.51 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.529 -0.759 . . . . 18.719999999999999 111.604 -179.252 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -94.94 105.1 16.99 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.18 -1.044 . . . . 20.550000000000001 108.18 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.01 HD12 HD13 ' B' ' 47' ' ' ILE . 0.6 OUTLIER -72.52 149.15 44.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 14.4 111.301 -178.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.728 HG22 ' O ' ' B' ' 62' ' ' THR . 34.1 m -150.36 150.62 29.52 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.08 -1.081 . . . . 17.649999999999999 108.08 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.2 Cg_endo -61.94 138.41 73.39 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.04 1.827 . . . . 25.699999999999999 110.295 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.716 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -66.82 116.65 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.319 -0.863 . . . . 49.289999999999999 109.635 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.045 -0.978 . . . . 58.909999999999997 109.469 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.533 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.396 -0.594 . . . . 64.909999999999997 109.396 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.927 ' H ' HD22 ' B' ' 65' ' ' LEU . 1.1 mt 53.02 81.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.689 -1.226 . . . . 33.799999999999997 107.689 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -76.56 157.25 32.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 32.719999999999999 110.777 -178.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.864 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -164.07 163.38 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.022 -0.733 . . . . 14.460000000000001 109.022 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 37.5 mt-10 -138.99 114.14 9.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.486 -0.759 . . . . 22.120000000000001 109.039 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -74.36 102.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 119.201 -1.0 . . . . 14.23 108.528 179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.674 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.63 170.85 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.299 -0.875 . . . . 25.43 109.478 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.7 Cg_endo -75.92 -21.73 13.92 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.419 2.08 . . . . 13.609999999999999 109.61 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.32 5.19 50.3 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.17 -0.678 . . . . 15.52 109.17 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.524 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 19.9 mm-40 -124.15 36.04 4.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 17.309999999999999 109.64 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.57 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -105.01 15.7 27.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.062 -1.024 . . . . 24.780000000000001 110.329 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.42 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 38.9 mt-30 -133.86 135.9 44.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 47.899999999999999 109.84 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.708 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 46.9 p90 -92.63 166.66 12.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.189 -0.944 . . . . 21.609999999999999 109.492 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -140.5 145.73 37.25 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.308 -0.87 . . . . 14.890000000000001 109.124 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 17.350000000000001 109.553 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.43 0.634 . . . . 24.0 110.198 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.586 ' CB ' ' CB ' ' A' ' 49' ' ' LEU . 69.5 m-20 -51.08 123.2 8.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.811 . . . . 23.309999999999999 109.897 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 35.7 mp0 -98.86 155.16 17.52 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.058 -1.09 . . . . 40.030000000000001 108.058 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 1.2 tm0? -146.52 -179.96 7.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.825 -1.172 . . . . 12.390000000000001 110.384 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.89 ' HB3' HD11 ' A' ' 44' ' ' LEU . 51.0 mt -139.85 145.99 38.77 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.449 -0.782 . . . . 17.420000000000002 110.0 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.764 ' SG ' HD11 ' A' ' 47' ' ' ILE . 4.1 m -152.97 -177.12 6.09 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.148 -1.426 . . . . 13.84 107.148 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.674 ' CD2' ' HD3' ' A' ' 7' ' ' LYS . 27.3 m-85 -128.48 113.48 15.56 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.785 -1.197 . . . . 21.140000000000001 109.922 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.864 HG22 ' HB ' ' A' ' 4' ' ' VAL . 45.4 t -107.09 115.65 49.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.235 -0.916 . . . . 10.66 110.148 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 39' ' ' ASN . 54.8 m-20 -64.5 -36.55 84.55 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.806 -1.183 . . . . 25.890000000000001 107.806 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 46.41 48.21 13.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 24.239999999999998 109.893 179.303 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.04 -1.21 64.25 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.41 -1.476 . . . . 31.02 109.41 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.2 OUTLIER -105.9 95.73 6.0 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.334 -1.098 . . . . 43.229999999999997 108.342 179.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 39' ' ' ASN . 2.5 mp0 -27.33 -41.67 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.437 0.637 . . . . 42.340000000000003 111.083 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' ASN . 48.5 m80 -78.16 141.09 61.99 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 108.638 -0.875 . . . . 6.5700000000000003 108.638 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.65 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -76.23 136.72 18.29 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.898 1.732 . . . . 17.920000000000002 110.478 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.829 HG23 HG23 ' A' ' 45' ' ' VAL . 2.9 m -107.65 117.65 53.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.614 -0.884 . . . . 20.57 108.614 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.89 HD11 ' HB3' ' A' ' 32' ' ' LEU . 61.7 tp -65.8 97.82 0.36 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.514 -0.874 . . . . 20.210000000000001 109.999 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.829 HG23 HG23 ' A' ' 43' ' ' VAL . 21.0 t -99.39 168.46 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.813 -0.81 . . . . 10.81 108.813 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.576 ' N ' HG12 ' A' ' 45' ' ' VAL . 4.0 ptpp? -117.33 147.7 42.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.928 -1.108 . . . . 36.740000000000002 111.565 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.004 HG21 ' CE1' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -112.41 178.0 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.563 -0.903 . . . . 19.739999999999998 108.563 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.431 ' H ' HG22 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -126.24 74.93 1.48 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.187 -0.946 . . . . 22.559999999999999 109.46 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.627 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -42.78 150.75 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.425 -0.797 . . . . 20.41 109.22 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 26.5 t0 -123.13 148.13 46.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 33.990000000000002 109.456 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 48.31 -148.89 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.116 -0.99 . . . . 54.920000000000002 109.257 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.12 16.83 56.28 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.647 -1.381 . . . . 36.100000000000001 109.647 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -45.72 149.33 1.13 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.178 -1.189 . . . . 54.759999999999998 109.469 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.16 113.16 3.35 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.587 2.192 . . . . 28.370000000000001 110.002 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.708 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -39.4 153.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.467 -0.771 . . . . 17.210000000000001 110.25 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 1.004 ' CE1' HG21 ' A' ' 47' ' ' ILE . 84.5 m-85 -50.58 113.11 0.81 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 17.190000000000001 109.351 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.013 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -61.81 177.25 0.38 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 17.82 109.476 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 1.013 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.76 114.43 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.572 2.181 . . . . 17.280000000000001 110.398 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.0 179.88 43.98 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 17.219999999999999 109.556 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.2 mp -73.96 156.04 38.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -1.121 . . . . 19.57 108.577 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.723 ' HB3' HD22 ' A' ' 83' ' ' LEU . 26.6 m-85 -143.75 163.32 33.64 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.568 1.175 . . . . 14.609999999999999 111.577 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.773 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.5 p -145.78 123.17 11.65 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.171 -1.789 . . . . 18.359999999999999 106.171 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.8 t -54.31 169.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 C-N-CA 118.495 -1.282 . . . . 19.129999999999999 108.804 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.547 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.1 t-80 -128.11 124.5 37.11 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.861 -0.792 . . . . 20.649999999999999 108.861 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.969 HD22 ' H ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -64.91 -6.79 9.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.849 -0.532 . . . . 19.649999999999999 109.923 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.4 p -53.91 -16.19 1.72 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.93 -1.106 . . . . 14.720000000000001 108.673 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.495 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 50.1 m -99.52 -4.89 30.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.419 -0.8 . . . . 11.449999999999999 111.052 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -81.65 157.78 24.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.7 -1.25 . . . . 14.25 109.832 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.658 ' HA ' HD21 ' B' ' 37' ' ' LEU . 5.3 pttt -142.98 171.74 13.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.401 -0.812 . . . . 32.700000000000003 109.624 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.61 HG11 HG21 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -125.83 112.68 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 15.630000000000001 109.046 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.479 ' C ' ' NE2' ' A' ' 72' ' ' GLN . . . -71.95 -173.64 20.09 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.568 -1.413 . . . . 12.699999999999999 109.568 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.48 ' NE2' ' N ' ' A' ' 72' ' ' GLN . 0.8 OUTLIER -89.4 34.53 0.81 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.209 -1.171 . . . . 26.289999999999999 109.508 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -133.87 24.7 3.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.405 -0.81 . . . . 20.440000000000001 109.441 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' B' ' 46' ' ' LYS . . . 51.49 56.58 14.74 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 13.82 109.635 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.7 m -148.64 105.27 3.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -1.211 . . . . 18.27 109.752 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 76' ' ' LEU . 5.0 tt -70.23 146.56 50.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 12.43 109.277 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.486 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 4.2 mtm -157.34 144.53 18.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 35.109999999999999 109.583 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.983 HD12 HD12 ' B' ' 78' ' ' ILE . 2.3 mp -69.73 141.76 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 13.67 109.615 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -107.5 -37.2 6.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.809 -1.182 . . . . 24.059999999999999 107.809 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.495 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -167.94 67.53 0.08 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.404 -1.332 . . . . 35.039999999999999 107.404 178.664 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.692 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -27.41 118.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.416 -0.811 . . . . 18.719999999999999 111.632 -178.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 20.0 tpt180 -92.09 104.58 16.95 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.066 -1.087 . . . . 20.550000000000001 108.066 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.732 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -72.64 150.7 42.78 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.052 0.929 . . . . 14.4 111.591 -178.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 62' ' ' THR . 34.7 m -152.07 154.36 32.42 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.741 -1.207 . . . . 17.649999999999999 107.741 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.4 Cg_endo -62.93 145.93 94.66 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.211 1.941 . . . . 25.699999999999999 110.749 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -75.24 121.85 22.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.238 -0.913 . . . . 49.289999999999999 109.525 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 tptt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.977 -1.011 . . . . 58.909999999999997 109.454 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.535 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.403 -0.591 . . . . 64.909999999999997 109.403 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.969 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.2 mt 52.83 81.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.662 -1.236 . . . . 33.799999999999997 107.662 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.417 ' O ' HG13 ' B' ' 35' ' ' VAL . 0.0 OUTLIER -76.32 157.2 32.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 32.719999999999999 110.839 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.879 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.2 OUTLIER -164.06 163.46 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.014 -0.735 . . . . 14.460000000000001 109.014 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 37.6 mt-10 -139.1 114.06 9.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 22.120000000000001 109.019 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.589 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -74.3 102.17 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 119.183 -1.007 . . . . 14.23 108.46 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.656 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.73 171.03 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.307 -0.871 . . . . 25.43 109.507 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.6 Cg_endo -75.86 -21.93 13.84 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.346 2.031 . . . . 13.609999999999999 109.678 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.18 5.33 50.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.615 -0.678 . . . . 15.52 109.222 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.511 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 19.7 mm-40 -124.23 35.97 4.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 17.309999999999999 109.637 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -104.96 15.63 27.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -0.942 . . . . 24.780000000000001 110.339 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.434 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 38.9 mt-30 -133.78 135.92 44.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.0 . . . . 47.899999999999999 109.916 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 47.0 p90 -92.62 166.68 12.37 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.168 -0.958 . . . . 21.609999999999999 109.519 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 25.0 m -140.54 145.73 37.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 14.890000000000001 109.046 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 17.350000000000001 109.528 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.406 ' HB3' HG22 ' B' ' 48' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.395 0.616 . . . . 24.0 110.134 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.589 ' CB ' ' CB ' ' B' ' 49' ' ' LEU . 69.6 m-20 -51.14 123.13 8.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.462 -0.774 . . . . 23.309999999999999 109.947 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 35.6 mp0 -98.76 155.11 17.51 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.082 -1.081 . . . . 40.030000000000001 108.082 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' B' ' 10' ' ' GLN . 1.2 tm0? -146.53 -179.88 7.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.783 -1.198 . . . . 12.390000000000001 110.318 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.891 ' HB3' HD11 ' B' ' 44' ' ' LEU . 50.9 mt -139.98 145.92 38.45 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.442 -0.786 . . . . 17.420000000000002 110.019 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.763 ' SG ' HD11 ' B' ' 47' ' ' ILE . 4.1 m -152.88 -176.98 5.99 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.069 -1.456 . . . . 13.84 107.069 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.656 ' CD2' ' HD3' ' B' ' 7' ' ' LYS . 27.3 m-85 -128.61 113.41 15.39 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.867 -1.146 . . . . 21.140000000000001 109.914 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.879 HG22 ' HB ' ' B' ' 4' ' ' VAL . 45.5 t -107.09 115.83 49.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.293 -0.879 . . . . 10.66 110.126 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' B' ' 39' ' ' ASN . 55.0 m-20 -64.6 -36.48 84.37 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.806 -1.183 . . . . 25.890000000000001 107.806 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.658 HD21 ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 46.34 48.37 13.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.556 -0.715 . . . . 24.239999999999998 109.876 179.333 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.65 -0.72 64.25 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.389 -1.485 . . . . 31.02 109.389 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.2 OUTLIER -106.14 95.93 6.12 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.378 -1.072 . . . . 43.229999999999997 108.278 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' B' ' 39' ' ' ASN . 2.4 mp0 -27.55 -41.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.452 0.644 . . . . 42.340000000000003 111.126 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' B' ' 39' ' ' ASN . 48.5 m80 -78.19 141.2 62.01 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.659 -0.867 . . . . 6.5599999999999996 108.659 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.646 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.6 Cg_endo -76.3 136.7 18.13 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.909 1.739 . . . . 17.920000000000002 110.51 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.839 HG23 HG23 ' B' ' 45' ' ' VAL . 2.9 m -107.6 117.55 53.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.645 -0.872 . . . . 20.57 108.645 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.891 HD11 ' HB3' ' B' ' 32' ' ' LEU . 61.6 tp -65.75 97.79 0.35 Allowed 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.486 -0.885 . . . . 20.210000000000001 110.017 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.839 HG23 HG23 ' B' ' 43' ' ' VAL . 21.2 t -99.4 168.34 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.866 -0.79 . . . . 10.81 108.866 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.559 ' N ' HG12 ' B' ' 45' ' ' VAL . 4.0 ptpp? -117.13 147.8 42.11 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.94 -1.104 . . . . 36.740000000000002 111.59 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 1.019 HG21 ' CZ ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -112.58 177.98 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.564 -0.902 . . . . 19.739999999999998 108.564 179.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.435 ' H ' HG22 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -126.16 74.97 1.48 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.118 -0.989 . . . . 22.559999999999999 109.519 179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.624 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -42.85 150.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.428 -0.795 . . . . 20.41 109.129 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 53' ' ' GLN . 26.6 t0 -123.13 148.21 45.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.101 -1.0 . . . . 33.990000000000002 109.446 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 48.18 -148.8 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 54.920000000000002 109.276 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.14 16.78 56.43 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.582 -1.407 . . . . 36.100000000000001 109.582 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -45.64 149.26 1.11 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.198 -1.178 . . . . 54.759999999999998 109.523 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.06 113.19 3.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.614 2.209 . . . . 28.370000000000001 109.938 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.701 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -39.4 153.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.483 -0.761 . . . . 17.210000000000001 110.22 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 1.019 ' CZ ' HG21 ' B' ' 47' ' ' ILE . 84.8 m-85 -50.45 113.0 0.78 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.4 -0.813 . . . . 17.190000000000001 109.238 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -61.86 177.33 0.38 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 17.82 109.483 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.8 Cg_endo -77.6 113.77 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.532 2.155 . . . . 17.280000000000001 110.215 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.33 179.33 44.87 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.724 -1.35 . . . . 17.219999999999999 109.724 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.0 mp -74.06 155.87 38.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -1.173 . . . . 19.57 108.315 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.731 ' HB3' HD22 ' B' ' 83' ' ' LEU . 26.5 m-85 -143.56 163.26 33.67 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.551 1.167 . . . . 14.609999999999999 111.564 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.767 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.3 p -145.67 122.99 11.6 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.283 -1.747 . . . . 18.359999999999999 106.283 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.685 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.8 t -54.28 168.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 C-N-CA 118.497 -1.281 . . . . 19.129999999999999 108.828 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.538 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.1 t-80 -128.05 124.49 37.22 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.418 -0.801 . . . . 20.649999999999999 108.907 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.927 HD22 ' H ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -64.78 -6.9 9.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.82 -0.55 . . . . 19.649999999999999 109.903 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 13.6 p -53.86 -16.14 1.65 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.005 -1.06 . . . . 14.720000000000001 108.616 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.498 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 50.4 m -99.67 -5.32 29.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.475 -0.765 . . . . 11.449999999999999 111.002 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.637 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.8 m-30 -81.26 157.08 25.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.647 -1.283 . . . . 14.25 109.779 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.702 ' HA ' HD21 ' A' ' 37' ' ' LEU . 5.3 pttt -142.28 171.64 13.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.832 . . . . 32.700000000000003 109.66 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -125.65 112.66 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.346 -0.846 . . . . 15.630000000000001 109.092 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.472 ' C ' ' NE2' ' B' ' 72' ' ' GLN . . . -72.02 -173.64 20.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.586 -1.406 . . . . 12.699999999999999 109.586 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.482 ' NE2' ' N ' ' B' ' 72' ' ' GLN . 0.8 OUTLIER -89.3 34.5 0.8 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.214 -1.168 . . . . 26.289999999999999 109.503 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.94 24.81 3.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -0.797 . . . . 20.440000000000001 109.439 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . 51.32 56.9 12.92 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.604 -1.399 . . . . 13.82 109.604 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -149.03 105.38 3.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -1.196 . . . . 18.27 109.709 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.689 ' C ' HD23 ' B' ' 76' ' ' LEU . 5.1 tt -70.48 146.65 50.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.865 . . . . 12.43 109.257 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.506 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 4.1 mtm -157.42 144.72 18.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -0.954 . . . . 35.109999999999999 109.515 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.983 HD12 HD12 ' A' ' 78' ' ' ILE . 2.3 mp -70.06 142.12 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 13.67 109.571 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -107.69 -37.07 6.25 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.766 -1.198 . . . . 24.059999999999999 107.766 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.498 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER -168.09 67.6 0.08 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.424 -1.324 . . . . 35.039999999999999 107.424 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.685 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.6 OUTLIER -27.47 118.52 0.09 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.356 -0.838 . . . . 18.719999999999999 111.574 -178.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 20.0 tpt180 -91.99 104.85 17.21 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.056 -1.091 . . . . 20.550000000000001 108.056 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.731 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -72.88 150.64 42.45 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.013 0.911 . . . . 14.4 111.538 -178.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.767 HG22 ' O ' ' B' ' 62' ' ' THR . 34.7 m -151.99 154.42 32.62 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 107.75 -1.204 . . . . 17.649999999999999 107.75 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.1 Cg_endo -62.89 145.93 94.73 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.176 1.917 . . . . 25.699999999999999 110.774 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -75.27 121.85 22.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.242 -0.911 . . . . 49.289999999999999 109.535 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 tptt . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.017 -0.992 . . . . 58.909999999999997 109.45 -179.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.538 ' CG ' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.532 -0.544 . . . . 64.909999999999997 109.532 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.819 ' N ' HD22 ' B' ' 65' ' ' LEU . 3.3 mt -62.17 81.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.044 -1.095 . . . . 33.799999999999997 108.044 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.536 ' HD3' HD21 ' A' ' 60' ' ' LEU . 10.8 mttt -54.98 157.52 3.21 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.857 0.836 . . . . 32.719999999999999 111.508 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.111 HG22 HG22 ' A' ' 35' ' ' VAL . 80.8 t -161.14 166.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.719 0.771 . . . . 14.460000000000001 109.774 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.615 ' N ' HG12 ' A' ' 4' ' ' VAL . 34.1 mt-10 -152.14 105.63 3.08 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.63 -0.878 . . . . 22.120000000000001 108.63 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.766 HD11 ' SG ' ' A' ' 33' ' ' CYS . 0.3 OUTLIER -73.77 104.35 2.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 119.038 -1.065 . . . . 14.23 108.172 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.635 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.75 171.87 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 25.43 109.974 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.5 Cg_endo -75.83 -24.88 11.14 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.468 2.112 . . . . 13.609999999999999 110.211 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.0 t -93.02 0.77 57.44 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.437 -0.789 . . . . 15.52 108.887 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.518 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.6 mm-40 -116.51 43.2 2.26 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.342 -0.849 . . . . 17.309999999999999 108.932 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -108.39 10.02 27.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 24.780000000000001 110.304 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.455 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 1.4 tt0 -136.81 134.34 36.89 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.109 -0.994 . . . . 47.899999999999999 108.952 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 30.2 p90 -87.49 175.48 7.93 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.046 -1.033 . . . . 21.609999999999999 109.756 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -137.57 151.95 48.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.874 -0.787 . . . . 14.890000000000001 108.874 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.531 0 O-C-N 121.229 -0.919 . . . . 17.350000000000001 109.439 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.532 HD22 ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.462 0.649 . . . . 24.0 109.985 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.633 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -98.82 122.58 42.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 23.309999999999999 108.996 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.46 ' OE1' ' HD3' ' A' ' 46' ' ' LYS . 4.8 mt-10 -108.94 156.96 19.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.244 -0.91 . . . . 40.030000000000001 109.887 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.622 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -141.26 -172.85 3.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 12.390000000000001 109.419 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.929 ' HB3' HD11 ' A' ' 44' ' ' LEU . 4.7 mp -133.99 159.16 41.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 17.420000000000002 109.48 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.766 ' SG ' HD11 ' A' ' 6' ' ' ILE . 13.4 m -155.46 177.17 11.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.095 -1.003 . . . . 13.84 108.324 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.689 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 35.3 m-85 -126.65 110.98 13.77 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.093 -1.005 . . . . 21.140000000000001 108.935 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.111 HG22 HG22 ' A' ' 4' ' ' VAL . 50.9 t -89.59 151.66 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.016 -1.053 . . . . 10.66 110.378 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.2 m-20 -129.01 -145.49 0.3 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.713 -0.617 . . . . 25.890000000000001 109.348 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.861 ' HG ' HD21 ' B' ' 65' ' ' LEU . 0.3 OUTLIER 67.6 -65.33 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 24.239999999999998 109.094 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -83.39 6.13 74.07 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 109.028 -1.629 . . . . 31.02 109.028 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' A' ' 38' ' ' GLY . 4.4 m-80 -162.41 109.07 1.27 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.431 -1.041 . . . . 43.229999999999997 109.006 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' ASN . 26.0 mt-10 -39.22 -61.22 0.8 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.617 0.722 . . . . 42.340000000000003 109.632 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 22.8 m80 -71.47 164.55 56.73 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 108.174 -1.047 . . . . 8.3100000000000005 108.174 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.689 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.7 Cg_endo -78.27 140.52 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.868 1.712 . . . . 17.920000000000002 110.6 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.045 HG21 HG21 ' B' ' 70' ' ' VAL . 33.0 m -111.94 113.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.375 -0.828 . . . . 20.57 109.17 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.929 HD11 ' HB3' ' A' ' 32' ' ' LEU . 32.4 tp -67.35 110.66 3.65 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.906 . . . . 20.210000000000001 109.505 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.581 ' CG2' ' N ' ' B' ' 75' ' ' SER . 9.9 p -122.4 153.35 26.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.492 -0.755 . . . . 10.81 109.175 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 2.6 tttt -73.3 148.48 43.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 36.740000000000002 110.055 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.032 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -139.92 123.02 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.724 -0.843 . . . . 19.739999999999998 108.724 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.532 ' CG2' HD22 ' A' ' 28' ' ' LEU . 1.3 m -63.31 156.69 24.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.08 -1.013 . . . . 22.559999999999999 110.05 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.759 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -122.33 117.14 25.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.805 . . . . 20.41 108.902 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -47.13 140.25 5.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 33.990000000000002 109.812 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.85 109.49 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 54.920000000000002 109.478 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.97 -16.72 59.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.6 -1.4 . . . . 36.100000000000001 109.6 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -73.69 150.57 88.78 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.285 -1.127 . . . . 54.759999999999998 109.522 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.33 122.87 5.8 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.665 2.243 . . . . 28.370000000000001 110.184 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.759 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -40.1 147.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.396 -0.815 . . . . 17.210000000000001 110.483 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.621 ' HB3' HD13 ' A' ' 6' ' ' ILE . 89.1 m-85 -47.96 116.22 1.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.483 -0.761 . . . . 17.190000000000001 109.026 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.004 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -66.63 176.77 0.97 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 17.82 109.62 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 1.004 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -78.4 105.6 2.0 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.686 2.257 . . . . 17.280000000000001 110.261 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.49 176.69 48.16 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.99 -1.244 . . . . 17.219999999999999 109.99 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.779 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -73.5 143.59 46.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -1.111 . . . . 19.57 108.426 179.293 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.565 ' CB ' ' HB ' ' A' ' 4' ' ' VAL . 33.3 m-85 -130.29 162.73 28.33 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.773 -1.204 . . . . 14.609999999999999 111.25 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.709 ' O ' HG22 ' A' ' 84' ' ' VAL . 33.4 p -142.9 119.78 11.27 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.896 -1.89 . . . . 18.359999999999999 105.896 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.634 ' HB ' HD13 ' A' ' 2' ' ' ILE . 2.7 t -53.05 166.94 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 C-N-CA 118.59 -1.244 . . . . 19.129999999999999 109.467 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -129.36 130.46 46.08 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.545 -0.722 . . . . 20.649999999999999 109.134 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.879 HD21 ' HG ' ' B' ' 37' ' ' LEU . 0.5 OUTLIER -72.58 1.58 7.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.43 -0.794 . . . . 19.649999999999999 110.116 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -55.42 -19.25 8.69 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.496 -1.298 . . . . 14.720000000000001 107.496 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.516 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 7.1 m -99.07 -3.93 33.56 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.932 -0.48 . . . . 11.449999999999999 110.33 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.4 m-30 -85.41 157.47 20.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.863 -1.148 . . . . 14.25 110.215 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.425 ' HG2' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ptpt -154.41 174.33 15.01 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.023 -0.732 . . . . 32.700000000000003 109.023 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.05 HG21 HG21 ' B' ' 43' ' ' VAL . 1.0 OUTLIER -114.58 111.76 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 15.630000000000001 109.556 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.34 -170.25 46.59 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.315 -1.514 . . . . 12.699999999999999 109.315 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -90.5 20.79 4.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.154 -1.204 . . . . 26.289999999999999 109.481 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.82 -12.74 35.44 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.501 -0.75 . . . . 20.440000000000001 109.237 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' B' ' 46' ' ' LYS . . . 85.01 35.05 13.12 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.509 -1.436 . . . . 13.82 109.509 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.547 ' N ' ' CG2' ' B' ' 45' ' ' VAL . 22.8 p -164.33 150.82 11.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -1.199 . . . . 18.27 109.647 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.688 HD22 HG21 ' B' ' 2' ' ' ILE . 16.3 tp -63.69 156.74 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.853 . . . . 12.43 109.126 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 32.0 mtt -154.95 113.43 3.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.092 -1.005 . . . . 35.109999999999999 109.749 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.96 HD12 HD12 ' B' ' 78' ' ' ILE . 2.9 mt -55.67 139.91 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.314 -0.866 . . . . 13.67 109.472 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.425 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 10.9 t70 -106.19 -27.39 11.09 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.443 -0.947 . . . . 24.059999999999999 108.443 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.516 ' C ' ' HB3' ' A' ' 67' ' ' SER . 5.7 tpm_? 179.74 67.75 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.992 -1.485 . . . . 35.039999999999999 106.992 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -29.39 118.09 0.13 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.387 -0.824 . . . . 18.719999999999999 111.913 -177.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -92.09 108.14 19.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.716 -1.216 . . . . 20.550000000000001 107.716 178.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.032 ' HB2' HD11 ' A' ' 47' ' ' ILE . 12.7 tp -80.25 150.42 30.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.229 -0.919 . . . . 14.4 111.093 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 62' ' ' THR . 25.0 m -147.44 152.47 42.23 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 108.039 -1.097 . . . . 17.649999999999999 108.039 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -62.37 141.58 87.72 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.103 1.868 . . . . 25.699999999999999 110.662 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.779 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.59 116.44 14.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.437 -0.789 . . . . 49.289999999999999 109.625 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.007 -0.996 . . . . 58.909999999999997 109.482 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.535 ' CG ' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.518 -0.549 . . . . 64.909999999999997 109.518 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.832 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.2 mt -62.19 81.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.993 -1.114 . . . . 33.799999999999997 107.993 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 10.8 mttt -54.83 157.37 3.16 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.877 0.846 . . . . 32.719999999999999 111.487 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.031 HG22 HG22 ' B' ' 35' ' ' VAL . 83.1 t -161.09 166.03 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.751 0.786 . . . . 14.460000000000001 109.739 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.619 ' N ' HG12 ' B' ' 4' ' ' VAL . 34.4 mt-10 -151.97 105.69 3.12 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.629 -0.878 . . . . 22.120000000000001 108.629 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.758 HD11 ' SG ' ' B' ' 33' ' ' CYS . 0.3 OUTLIER -73.77 104.55 2.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.01 -1.076 . . . . 14.23 108.178 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.641 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.83 171.9 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.442 -0.786 . . . . 25.43 109.99 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.5 Cg_endo -75.8 -25.04 11.05 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.487 2.125 . . . . 13.609999999999999 110.238 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t -92.8 0.65 57.45 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 108.938 -0.764 . . . . 15.52 108.938 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.6 mm-40 -116.43 43.25 2.24 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.345 -0.847 . . . . 17.309999999999999 108.928 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -108.4 10.09 27.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.91 . . . . 24.780000000000001 110.312 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.454 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 1.4 tt0 -136.86 134.22 36.65 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.114 -0.991 . . . . 47.899999999999999 108.943 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.629 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 30.2 p90 -87.44 175.47 7.95 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.028 -1.045 . . . . 21.609999999999999 109.74 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 59.3 m -137.48 152.04 49.11 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.845 -0.798 . . . . 14.890000000000001 108.845 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.494 0 O-C-N 121.256 -0.903 . . . . 17.350000000000001 109.401 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.519 HD22 ' CG2' ' B' ' 48' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.478 0.656 . . . . 24.0 109.969 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.628 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -98.75 122.53 42.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.479 -0.763 . . . . 23.309999999999999 109.035 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 4.9 mt-10 -109.0 156.79 19.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.189 -0.944 . . . . 40.030000000000001 109.911 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.623 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -141.13 -172.83 3.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 12.390000000000001 109.423 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.943 ' HB3' HD11 ' B' ' 44' ' ' LEU . 4.7 mp -133.99 159.13 41.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.154 -0.966 . . . . 17.420000000000002 109.412 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.758 ' SG ' HD11 ' B' ' 6' ' ' ILE . 13.1 m -155.41 177.21 11.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.309 -0.997 . . . . 13.84 108.309 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.684 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 34.6 m-85 -126.72 111.04 13.8 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.157 -0.964 . . . . 21.140000000000001 108.92 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 1.031 HG22 HG22 ' B' ' 4' ' ' VAL . 50.9 t -89.69 151.65 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.012 -1.055 . . . . 10.66 110.397 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.1 m-20 -128.92 -145.6 0.3 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.307 -0.627 . . . . 25.890000000000001 109.307 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.879 ' HG ' HD21 ' A' ' 65' ' ' LEU . 0.3 OUTLIER 67.65 -65.4 0.24 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.134 -0.979 . . . . 24.239999999999998 109.057 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -83.27 6.11 73.73 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.041 -1.623 . . . . 31.02 109.041 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' B' ' 38' ' ' GLY . 4.5 m-80 -162.39 109.02 1.27 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.438 -1.036 . . . . 43.229999999999997 108.986 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' B' ' 39' ' ' ASN . 26.1 mt-10 -39.08 -61.39 0.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.701 0.762 . . . . 42.340000000000003 109.573 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.461 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 22.6 m80 -71.24 164.57 56.04 Favored Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 108.256 -1.016 . . . . 8.3399999999999999 108.256 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.684 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.6 Cg_endo -78.32 140.7 17.57 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.855 1.703 . . . . 17.920000000000002 110.507 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 1.05 HG21 HG21 ' A' ' 70' ' ' VAL . 32.9 m -112.13 113.33 43.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.394 -0.816 . . . . 20.57 109.197 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.943 HD11 ' HB3' ' B' ' 32' ' ' LEU . 32.3 tp -67.46 110.72 3.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.313 -0.867 . . . . 20.210000000000001 109.616 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 75' ' ' SER . 9.9 p -122.28 153.81 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.494 -0.754 . . . . 10.81 109.108 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 2.6 tttt -73.73 148.55 42.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 36.740000000000002 110.027 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.999 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.8 OUTLIER -139.75 123.04 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.739 -0.837 . . . . 19.739999999999998 108.739 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.519 ' CG2' HD22 ' B' ' 28' ' ' LEU . 1.3 m -63.39 156.66 25.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.015 -1.053 . . . . 22.559999999999999 109.982 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.764 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -122.26 116.98 25.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.422 -0.799 . . . . 20.41 108.94 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.545 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -47.0 140.33 4.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 33.990000000000002 109.832 -179.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.92 109.45 0.83 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 54.920000000000002 109.478 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.99 -16.75 59.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.581 -1.408 . . . . 36.100000000000001 109.581 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.545 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.8 OUTLIER -73.7 150.47 88.71 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -1.148 . . . . 54.759999999999998 109.568 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.7 Cg_endo -78.22 122.82 5.84 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.656 2.237 . . . . 28.370000000000001 110.225 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.764 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -40.11 147.15 0.1 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 17.210000000000001 110.404 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.619 ' HB3' HD13 ' B' ' 6' ' ' ILE . 88.9 m-85 -48.13 115.59 1.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.462 -0.773 . . . . 17.190000000000001 109.171 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -65.64 176.88 0.79 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 17.82 109.583 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 36.1 Cg_endo -78.68 106.72 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.741 2.294 . . . . 17.280000000000001 110.424 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.82 176.9 48.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.876 -1.29 . . . . 17.219999999999999 109.876 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.808 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -73.37 144.14 46.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.385 -1.068 . . . . 19.57 108.632 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.571 ' CB ' ' HB ' ' B' ' 4' ' ' VAL . 33.7 m-85 -130.78 162.82 28.68 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.756 -1.215 . . . . 14.609999999999999 111.375 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.718 ' O ' HG22 ' B' ' 84' ' ' VAL . 33.2 p -143.09 119.68 11.07 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 105.975 -1.861 . . . . 18.359999999999999 105.975 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.639 ' HB ' HD13 ' B' ' 2' ' ' ILE . 2.7 t -53.12 166.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 118.575 -1.25 . . . . 19.129999999999999 109.438 -177.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -129.2 130.32 46.17 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.552 -0.718 . . . . 20.649999999999999 109.196 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.861 HD21 ' HG ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -72.47 1.69 7.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.421 -0.799 . . . . 19.649999999999999 110.092 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -55.49 -19.24 9.02 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.45 -1.315 . . . . 14.720000000000001 107.45 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.509 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 7.0 m -99.08 -3.98 33.42 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.902 -0.499 . . . . 11.449999999999999 110.351 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.659 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.3 m-30 -85.35 157.62 20.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.913 -1.117 . . . . 14.25 110.182 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.422 ' HG2' ' HB2' ' B' ' 79' ' ' ASP . 1.5 ptpt -154.57 174.17 15.32 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.991 -0.744 . . . . 32.700000000000003 108.991 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 1.045 HG21 HG21 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -114.44 111.77 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 15.630000000000001 109.55 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.2 -170.24 46.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.332 -1.507 . . . . 12.699999999999999 109.332 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.65 21.17 4.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.138 -1.213 . . . . 26.289999999999999 109.458 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.16 -12.82 34.31 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.448 -0.782 . . . . 20.440000000000001 109.253 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.48 ' C ' HG22 ' A' ' 45' ' ' VAL . . . 85.15 34.72 13.82 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.546 -1.422 . . . . 13.82 109.546 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.581 ' N ' ' CG2' ' A' ' 45' ' ' VAL . 21.9 p -163.93 150.87 11.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -1.183 . . . . 18.27 109.683 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.715 HD22 HG21 ' A' ' 2' ' ' ILE . 16.3 tp -63.72 157.0 25.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 12.43 109.09 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' B' ' 76' ' ' LEU . 31.9 mtt -155.15 113.5 3.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.013 . . . . 35.109999999999999 109.679 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.96 HD12 HD12 ' A' ' 78' ' ' ILE . 2.9 mt -55.74 139.95 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 13.67 109.476 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.422 ' HB2' ' HG2' ' B' ' 69' ' ' LYS . 10.7 t70 -106.19 -27.3 11.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.417 -0.957 . . . . 24.059999999999999 108.417 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.509 ' C ' ' HB3' ' B' ' 67' ' ' SER . 5.8 tpm_? 179.65 67.78 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.956 -1.498 . . . . 35.039999999999999 106.956 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.639 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -29.34 118.13 0.13 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.349 -0.841 . . . . 18.719999999999999 111.85 -177.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -92.2 108.07 19.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.709 -1.219 . . . . 20.550000000000001 107.709 178.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.999 ' HB2' HD11 ' B' ' 47' ' ' ILE . 12.6 tp -80.13 150.26 30.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.184 -0.947 . . . . 14.4 111.07 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.718 HG22 ' O ' ' B' ' 62' ' ' THR . 25.0 m -147.32 152.58 42.9 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.111 -1.07 . . . . 17.649999999999999 108.111 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.3 Cg_endo -62.32 141.72 88.51 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.166 1.91 . . . . 25.699999999999999 110.666 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -73.69 116.54 14.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 49.289999999999999 109.497 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.959 -1.02 . . . . 58.909999999999997 109.425 179.999 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.308 0.575 . . . . 64.909999999999997 109.484 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.696 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.7 mt 69.3 72.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.975 -1.12 . . . . 33.799999999999997 107.975 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.497 ' C ' HG23 ' A' ' 4' ' ' VAL . 18.8 mttt -54.1 158.74 2.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.017 0.913 . . . . 32.719999999999999 111.461 -178.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.05 ' CG2' HG22 ' A' ' 35' ' ' VAL . 66.4 t -160.46 168.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.93 -0.766 . . . . 14.460000000000001 108.93 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.589 ' N ' HG12 ' A' ' 4' ' ' VAL . 43.1 mt-10 -154.6 103.26 2.45 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.79 0.805 . . . . 22.120000000000001 108.843 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.561 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -69.34 108.43 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.893 -1.151 . . . . 14.23 107.893 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.654 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.11 172.79 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.203 -0.936 . . . . 25.43 109.406 -179.042 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.5 Cg_endo -76.23 -21.6 13.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.475 2.117 . . . . 13.609999999999999 110.128 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.42 4.15 46.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.529 -0.732 . . . . 15.52 109.443 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.699 ' OE1' HD12 ' A' ' 32' ' ' LEU . 24.0 mm-40 -114.84 38.71 3.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 17.309999999999999 109.288 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.13 52.24 0.72 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.877 . . . . 24.780000000000001 109.738 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.63 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 5.0 pt20 -176.63 135.63 0.24 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.364 -0.835 . . . . 47.899999999999999 108.896 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.634 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 37.7 p90 -95.61 172.67 7.91 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.721 -1.237 . . . . 21.609999999999999 109.874 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 8.0 t -137.03 162.03 34.43 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.497 -0.927 . . . . 14.890000000000001 108.497 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.623 0 O-C-N 121.178 -0.951 . . . . 17.350000000000001 109.271 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.772 ' C ' HD12 ' A' ' 28' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.523 0.678 . . . . 24.0 110.903 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.611 ' CB ' ' CD1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -72.47 127.67 33.26 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.931 -0.766 . . . . 23.309999999999999 108.931 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.7 ' CG ' HD11 ' A' ' 28' ' ' LEU . 6.6 mt-10 -118.11 165.51 13.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.018 -1.051 . . . . 40.030000000000001 109.281 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.652 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -146.37 179.99 7.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.106 -0.996 . . . . 12.390000000000001 109.671 -179.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.699 HD12 ' OE1' ' A' ' 10' ' ' GLN . 39.3 mt -123.92 154.04 40.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 17.420000000000002 109.316 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 11.1 m -154.06 172.98 16.65 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.611 -1.255 . . . . 13.84 107.611 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.847 ' CE2' HD13 ' A' ' 44' ' ' LEU . 29.2 m-85 -121.45 99.03 6.24 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.951 -1.093 . . . . 21.140000000000001 109.45 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.05 HG22 ' CG2' ' A' ' 4' ' ' VAL . 61.7 t -93.73 126.16 46.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.041 -1.037 . . . . 10.66 110.602 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' GLY . 25.3 t0 -101.19 44.66 1.0 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.591 -1.263 . . . . 25.890000000000001 107.591 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.83 HD21 HG22 ' B' ' 70' ' ' VAL . 0.1 OUTLIER -35.77 -29.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.223 0.535 . . . . 24.239999999999998 110.197 -178.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.628 ' H ' HD12 ' A' ' 37' ' ' LEU . . . 160.84 52.3 0.02 OUTLIER Glycine 0 N--CA 1.479 1.535 0 N-CA-C 109.438 -1.465 . . . . 31.02 109.438 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.47 HD22 HG11 ' A' ' 43' ' ' VAL . 37.3 m-20 -126.83 17.98 7.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.07 -1.253 . . . . 43.229999999999997 110.035 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.591 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 2.6 mm-40 56.56 14.64 1.77 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.326 -0.859 . . . . 42.340000000000003 110.252 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 77.5 m-70 -162.53 161.72 19.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.326 -0.99 . . . . 6.1600000000000001 108.326 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.691 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.0 Cg_endo -78.06 136.57 14.78 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.892 1.728 . . . . 17.920000000000002 110.021 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.916 HG22 ' O ' ' A' ' 35' ' ' VAL . 3.6 m -111.34 115.24 49.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.249 -0.907 . . . . 20.57 109.453 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.847 HD13 ' CE2' ' A' ' 34' ' ' TYR . 18.9 tp -71.76 88.73 1.01 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.182 -0.949 . . . . 20.210000000000001 109.482 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.478 HG22 ' C ' ' B' ' 74' ' ' GLY . 6.1 p -103.21 152.88 5.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.632 -0.877 . . . . 10.81 108.632 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 3.7 mtpt -72.08 167.03 21.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 36.740000000000002 110.493 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.983 ' CD1' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -146.47 177.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.567 -0.901 . . . . 19.739999999999998 108.567 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.769 HG23 HD13 ' A' ' 28' ' ' LEU . 97.8 m -117.6 151.29 37.47 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.186 -0.946 . . . . 22.559999999999999 109.464 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.651 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -124.74 149.19 47.56 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.291 -1.003 . . . . 20.41 108.291 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' H ' HD13 ' A' ' 49' ' ' LEU . 23.4 t0 -106.18 143.5 34.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.078 -1.014 . . . . 33.990000000000002 110.202 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.21 127.04 14.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 54.920000000000002 109.477 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.7 -28.67 7.47 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.652 -1.379 . . . . 36.100000000000001 109.652 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.97 137.35 72.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.198 -1.178 . . . . 54.759999999999998 109.564 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.5 Cg_endo -78.58 124.2 6.26 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.413 2.075 . . . . 28.370000000000001 109.959 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.652 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -40.24 147.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.4 -0.812 . . . . 17.210000000000001 110.0 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 84.9 m-85 -45.9 105.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 17.190000000000001 109.137 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -58.1 174.79 0.32 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 17.82 109.628 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.78 114.15 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.605 2.203 . . . . 17.280000000000001 110.149 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.25 179.76 46.0 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.474 -1.45 . . . . 17.219999999999999 109.474 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.6 mp -75.4 146.31 40.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -1.217 . . . . 19.57 108.111 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.682 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.4 m-85 -133.07 167.43 20.32 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.866 -1.146 . . . . 14.609999999999999 111.591 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.642 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.8 p -150.59 119.5 6.65 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.336 -1.727 . . . . 18.359999999999999 106.336 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.602 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -52.01 164.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.374 -1.33 . . . . 19.129999999999999 108.568 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.533 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -123.47 123.89 41.65 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.397 -0.814 . . . . 20.649999999999999 109.003 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.717 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.2 OUTLIER -67.94 -4.02 11.73 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.834 -0.542 . . . . 19.649999999999999 110.209 -179.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.3 t -55.98 -15.86 4.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.076 -1.015 . . . . 14.720000000000001 108.449 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.49 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 16.6 m -95.76 -7.0 38.39 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.525 -0.734 . . . . 11.449999999999999 110.633 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.664 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -83.15 159.64 22.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.818 -1.176 . . . . 14.25 109.674 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.766 ' HA ' HD22 ' B' ' 37' ' ' LEU . 10.3 mtmt -157.82 172.14 19.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.49 -0.756 . . . . 32.700000000000003 109.253 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.794 HG22 HD21 ' B' ' 37' ' ' LEU . 0.0 OUTLIER -107.78 98.29 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 15.630000000000001 109.008 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.8 -149.92 4.11 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.825 -1.31 . . . . 12.699999999999999 109.825 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.3 21.04 17.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.27 -1.135 . . . . 26.289999999999999 109.685 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.09 -11.98 42.46 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.05 -0.722 . . . . 20.440000000000001 109.05 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 84.69 24.23 46.9 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.495 -1.442 . . . . 13.82 109.495 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.7 p -161.03 152.25 18.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -1.179 . . . . 18.27 109.633 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 76' ' ' LEU . 4.7 tt -62.95 149.23 45.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.319 -0.863 . . . . 12.43 109.381 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.51 ' N ' HD23 ' A' ' 76' ' ' LEU . 14.3 mtt -150.55 133.98 16.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 35.109999999999999 109.412 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' B' ' 78' ' ' ILE . 3.2 mt -66.29 139.24 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.877 . . . . 13.67 109.721 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 8.3 t70 -106.64 -19.58 13.62 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.507 -0.923 . . . . 24.059999999999999 108.507 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.49 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 172.71 68.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.198 -1.408 . . . . 35.039999999999999 107.198 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -31.63 116.88 0.19 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.693 0.758 . . . . 18.719999999999999 111.179 -178.14 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.01 104.97 17.49 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.463 -0.94 . . . . 20.550000000000001 108.463 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.983 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -73.38 144.82 46.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 14.4 111.024 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 62' ' ' THR . 27.6 m -146.72 156.61 48.32 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.956 -1.128 . . . . 17.649999999999999 107.956 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.0 Cg_endo -63.03 144.97 93.89 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.134 1.889 . . . . 25.699999999999999 110.334 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.11 115.73 12.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.135 -0.978 . . . . 49.289999999999999 109.705 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.02 -0.99 . . . . 58.909999999999997 109.531 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.534 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.399 -0.593 . . . . 64.909999999999997 109.399 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.717 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.7 mt 68.6 72.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.874 -1.158 . . . . 33.799999999999997 107.874 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.494 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 18.9 mttt -54.4 158.62 2.32 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.009 0.909 . . . . 32.719999999999999 111.412 -178.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.072 ' CG2' HG22 ' B' ' 35' ' ' VAL . 68.2 t -160.25 168.0 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.994 -0.743 . . . . 14.460000000000001 108.994 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.612 ' N ' HG12 ' B' ' 4' ' ' VAL . 42.3 mt-10 -154.02 103.09 2.54 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.418 -0.801 . . . . 22.120000000000001 108.975 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.559 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -69.18 108.53 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.934 -1.135 . . . . 14.23 107.934 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.661 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.25 172.5 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 25.43 109.36 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 35.1 Cg_endo -76.16 -21.39 13.81 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.488 2.125 . . . . 13.609999999999999 110.122 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.63 4.15 45.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.475 -0.765 . . . . 15.52 109.442 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.696 ' OE1' HD12 ' B' ' 32' ' ' LEU . 24.1 mm-40 -114.69 38.36 3.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.93 . . . . 17.309999999999999 109.187 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.14 53.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 24.780000000000001 109.709 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.614 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 4.8 pt20 -177.24 135.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.376 -0.828 . . . . 47.899999999999999 108.884 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.628 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 37.9 p90 -95.77 172.75 7.84 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.753 -1.217 . . . . 21.609999999999999 109.891 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 8.3 t -137.28 161.91 34.94 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.488 -0.93 . . . . 14.890000000000001 108.488 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.615 0 O-C-N 121.17 -0.956 . . . . 17.350000000000001 109.438 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.774 ' C ' HD12 ' B' ' 28' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.577 0.703 . . . . 24.0 110.846 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.624 ' CB ' ' CD1' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -72.38 127.47 32.67 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.894 -0.78 . . . . 23.309999999999999 108.894 179.03 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.712 ' CG ' HD11 ' B' ' 28' ' ' LEU . 6.5 mt-10 -118.06 165.24 13.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.012 -1.055 . . . . 40.030000000000001 109.322 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.63 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.9 OUTLIER -146.03 -179.9 7.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.137 -0.977 . . . . 12.390000000000001 109.765 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.696 HD12 ' OE1' ' B' ' 10' ' ' GLN . 40.3 mt -124.2 153.71 41.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 17.420000000000002 109.309 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 10.3 m -153.73 172.98 16.44 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.716 -1.216 . . . . 13.84 107.716 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.829 ' CE2' HD13 ' B' ' 44' ' ' LEU . 29.3 m-85 -121.39 98.91 6.19 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.895 -1.128 . . . . 21.140000000000001 109.461 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 1.072 HG22 ' CG2' ' B' ' 4' ' ' VAL . 61.7 t -93.6 126.17 46.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.03 -1.044 . . . . 10.66 110.573 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' B' ' 38' ' ' GLY . 26.1 t0 -101.11 44.37 1.02 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.579 -1.267 . . . . 25.890000000000001 107.579 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.794 HD21 HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -35.65 -30.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.1 0.476 . . . . 24.239999999999998 110.185 -178.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.626 ' H ' HD12 ' B' ' 37' ' ' LEU . . . 161.05 51.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 109.415 -1.474 . . . . 31.02 109.415 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.459 HD22 HG11 ' B' ' 43' ' ' VAL . 37.7 m-20 -126.54 18.28 7.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.167 -1.196 . . . . 43.229999999999997 110.092 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.59 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 2.6 mm-40 56.36 14.58 1.65 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.237 -0.914 . . . . 42.340000000000003 110.302 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 77.4 m-70 -162.41 161.6 20.14 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.344 -0.984 . . . . 6.1500000000000004 108.344 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.694 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.8 Cg_endo -78.02 136.55 14.83 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.877 1.718 . . . . 17.920000000000002 109.998 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.911 HG22 ' O ' ' B' ' 35' ' ' VAL . 3.6 m -111.39 115.42 49.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.242 -0.911 . . . . 20.57 109.339 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.829 HD13 ' CE2' ' B' ' 34' ' ' TYR . 19.0 tp -71.99 88.8 1.08 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.219 -0.926 . . . . 20.210000000000001 109.503 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.42 HG22 ' C ' ' A' ' 74' ' ' GLY . 6.3 p -103.0 153.38 5.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.648 -0.871 . . . . 10.81 108.648 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 3.8 mtpt -72.32 167.44 20.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 36.740000000000002 110.428 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.975 ' CD1' HD12 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -146.94 177.12 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.628 -0.878 . . . . 19.739999999999998 108.628 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.771 HG23 HD13 ' B' ' 28' ' ' LEU . 98.5 m -117.39 151.28 37.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.123 -0.986 . . . . 22.559999999999999 109.468 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -124.88 148.86 48.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.226 -1.028 . . . . 20.41 108.226 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.465 ' H ' HD13 ' B' ' 49' ' ' LEU . 23.2 t0 -105.95 143.61 33.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 33.990000000000002 110.076 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.22 126.84 13.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.771 . . . . 54.920000000000002 109.528 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.81 -28.49 7.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.712 -1.355 . . . . 36.100000000000001 109.712 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.08 137.45 72.53 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.277 -1.131 . . . . 54.759999999999998 109.483 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.57 124.14 6.24 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.394 2.063 . . . . 28.370000000000001 109.96 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.666 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -40.29 147.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 17.210000000000001 109.913 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 84.1 m-85 -46.2 105.85 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 17.190000000000001 109.252 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.918 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.85 174.65 0.31 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 17.82 109.59 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.918 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -77.99 115.18 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.624 2.216 . . . . 17.280000000000001 110.43 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.49 -179.46 44.87 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.31 -1.516 . . . . 17.219999999999999 109.31 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 4.0 mp -75.29 146.86 40.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.134 -1.216 . . . . 19.57 108.457 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.672 ' HB3' HD22 ' B' ' 83' ' ' LEU . 19.9 m-85 -133.54 167.69 20.01 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.498 1.142 . . . . 14.609999999999999 111.452 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.646 ' O ' HG22 ' B' ' 84' ' ' VAL . 45.8 p -150.87 119.45 6.49 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.296 -1.742 . . . . 18.359999999999999 106.296 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.598 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -52.0 163.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.404 -1.318 . . . . 19.129999999999999 108.597 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -123.16 124.35 42.86 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.406 -0.809 . . . . 20.649999999999999 109.022 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.706 HD11 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -68.24 -3.95 12.47 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.879 -0.513 . . . . 19.649999999999999 110.169 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 10.4 t -55.93 -16.08 4.27 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.132 -0.98 . . . . 14.720000000000001 108.376 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.497 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 16.6 m -95.66 -6.7 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.609 -0.682 . . . . 11.449999999999999 110.707 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.665 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.9 m-30 -83.33 159.78 21.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.852 -1.155 . . . . 14.25 109.657 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.794 ' HA ' HD22 ' A' ' 37' ' ' LEU . 10.3 mtmt -158.09 171.29 20.5 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.475 -0.766 . . . . 32.700000000000003 109.269 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.83 HG22 HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -106.99 98.59 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 15.630000000000001 108.959 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.44 -150.47 4.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.707 -1.357 . . . . 12.699999999999999 109.707 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.78 21.64 16.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.238 -1.154 . . . . 26.289999999999999 109.859 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.66 -11.82 41.38 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.02 -0.733 . . . . 20.440000000000001 109.02 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.478 ' C ' HG22 ' A' ' 45' ' ' VAL . . . 84.44 24.99 44.82 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.532 -1.427 . . . . 13.82 109.532 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.7 p -161.68 152.18 17.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -1.17 . . . . 18.27 109.639 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.685 ' C ' HD23 ' B' ' 76' ' ' LEU . 4.6 tt -63.14 149.24 45.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 12.43 109.412 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.507 ' N ' HD23 ' B' ' 76' ' ' LEU . 14.4 mtt -150.44 133.69 16.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 35.109999999999999 109.502 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' A' ' 78' ' ' ILE . 3.2 mt -66.18 138.86 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 13.67 109.686 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 8.2 t70 -106.23 -19.87 13.57 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.558 -0.905 . . . . 24.059999999999999 108.558 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.497 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 173.0 68.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.208 -1.404 . . . . 35.039999999999999 107.208 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.636 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -32.03 117.04 0.21 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.672 0.748 . . . . 18.719999999999999 111.214 -178.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.523 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.15 105.0 17.51 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.473 -0.936 . . . . 20.550000000000001 108.473 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.975 HD12 ' CD1' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -73.34 145.05 46.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 14.4 110.96 -178.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.646 HG22 ' O ' ' B' ' 62' ' ' THR . 28.0 m -147.04 156.41 47.11 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 107.938 -1.134 . . . . 17.649999999999999 107.938 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.8 Cg_endo -62.87 144.77 94.02 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.185 1.923 . . . . 25.699999999999999 110.338 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -72.93 115.91 12.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.194 -0.941 . . . . 49.289999999999999 109.681 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' B' ' 86' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.973 -1.013 . . . . 58.909999999999997 109.528 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.598 ' C ' HD22 ' B' ' 65' ' ' LEU . 1.4 pmm? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.545 -0.539 . . . . 64.909999999999997 109.545 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.992 ' N ' HD22 ' B' ' 65' ' ' LEU . 1.8 mt -58.42 85.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.887 -1.153 . . . . 33.799999999999997 107.887 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 20.7 mttt -63.61 157.97 22.49 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.815 0.817 . . . . 32.719999999999999 111.595 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.061 HG22 HG22 ' A' ' 35' ' ' VAL . 58.8 t -160.01 167.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-O 121.609 0.719 . . . . 14.460000000000001 109.691 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.584 ' N ' HG12 ' A' ' 4' ' ' VAL . 77.3 mt-10 -154.95 107.14 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.705 -0.85 . . . . 22.120000000000001 108.705 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.744 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -74.54 107.96 5.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 118.991 -1.083 . . . . 14.23 108.3 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.675 ' CD ' ' CD1' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.44 171.85 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.449 -0.782 . . . . 25.43 110.011 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.3 Cg_endo -76.7 -25.61 9.12 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.59 2.193 . . . . 13.609999999999999 109.753 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.73 8.39 44.39 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.921 -0.77 . . . . 15.52 108.921 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.528 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 10.2 mm-40 -121.38 32.83 5.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.277 -0.889 . . . . 17.309999999999999 109.474 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.424 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -97.91 11.47 37.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.141 -0.974 . . . . 24.780000000000001 110.324 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -138.77 138.01 37.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.032 -1.042 . . . . 47.899999999999999 110.104 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.646 ' CD2' HD12 ' A' ' 49' ' ' LEU . 11.6 p90 -88.37 173.29 8.82 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.397 -0.814 . . . . 21.609999999999999 109.769 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 10.0 t -130.91 163.97 26.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.535 -0.913 . . . . 14.890000000000001 108.535 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.591 0 O-C-N 121.147 -0.97 . . . . 17.350000000000001 109.575 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.785 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.937 0.875 . . . . 24.0 110.877 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.653 ' N ' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -105.49 128.64 53.67 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.57 -0.9 . . . . 23.309999999999999 108.57 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.546 ' HG3' HD21 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -111.38 151.14 28.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.988 -1.07 . . . . 40.030000000000001 109.972 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.554 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -133.71 175.86 9.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.895 . . . . 12.390000000000001 109.523 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.822 ' HB3' HD11 ' A' ' 44' ' ' LEU . 3.5 mp -127.31 155.52 43.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 17.420000000000002 109.131 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.622 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.9 m -153.73 -176.81 6.0 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.316 -0.994 . . . . 13.84 108.316 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.676 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 35.2 m-85 -130.75 102.92 6.3 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.117 -0.989 . . . . 21.140000000000001 109.561 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.061 HG22 HG22 ' A' ' 4' ' ' VAL . 78.7 t -90.8 125.94 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.07 -1.019 . . . . 10.66 110.324 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 39' ' ' ASN . 3.7 m-20 -68.51 -41.93 79.3 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.589 -0.893 . . . . 25.890000000000001 108.589 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.686 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.6 OUTLIER 47.51 48.24 16.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.798 . . . . 24.239999999999998 109.77 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.06 4.94 51.3 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.321 -1.511 . . . . 31.02 109.321 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.5 OUTLIER -104.58 95.76 6.13 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.356 -1.085 . . . . 43.229999999999997 108.47 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 39' ' ' ASN . 9.3 mt-10 -30.6 -37.31 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.41 0.624 . . . . 42.340000000000003 110.81 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -85.24 146.37 44.89 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 108.644 -0.873 . . . . 5.25 108.644 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.676 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.9 Cg_endo -76.37 137.11 18.42 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.967 1.778 . . . . 17.920000000000002 110.599 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.993 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.8 m -108.68 113.93 45.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.366 -0.833 . . . . 20.57 109.162 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.822 HD11 ' HB3' ' A' ' 32' ' ' LEU . 28.0 tp -65.63 110.28 2.7 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.368 -0.832 . . . . 20.210000000000001 109.386 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.6 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 6.6 t -115.52 165.46 10.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.518 -0.739 . . . . 10.81 109.351 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.555 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 9.8 mtpt -96.42 125.44 40.91 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.488 -0.885 . . . . 36.740000000000002 109.457 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.038 HD13 HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -117.4 136.26 55.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.31 -0.869 . . . . 19.739999999999998 109.332 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.482 ' OG1' ' CZ ' ' A' ' 80' ' ' ARG . 12.5 m -68.05 163.7 21.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.113 -0.992 . . . . 22.559999999999999 109.303 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.646 HD12 ' CD2' ' A' ' 13' ' ' PHE . 1.1 tm? -151.89 93.42 1.84 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.807 -0.812 . . . . 20.41 108.807 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.401 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -145.28 -158.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 33.990000000000002 109.823 -179.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 48.94 -154.18 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 54.920000000000002 109.159 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . -79.61 -2.44 88.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.445 -1.462 . . . . 36.100000000000001 109.445 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -73.41 114.28 30.17 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.286 -1.126 . . . . 54.759999999999998 110.118 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 52' ' ' GLY . 36.4 Cg_endo -80.3 153.44 21.27 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.5 2.133 . . . . 28.370000000000001 110.243 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.627 ' HB2' ' CD2' ' A' ' 13' ' ' PHE . . . -39.74 128.25 2.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.288 -0.882 . . . . 17.210000000000001 110.296 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.744 ' O ' HG21 ' A' ' 6' ' ' ILE . 86.7 m-85 -47.5 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.783 . . . . 17.190000000000001 109.009 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -48.76 175.61 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 17.82 109.589 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.5 Cg_endo -77.05 128.31 9.82 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.637 2.225 . . . . 17.280000000000001 110.192 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.06 176.73 32.46 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.614 -1.394 . . . . 17.219999999999999 109.614 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.8 mp -74.21 146.49 43.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -1.162 . . . . 19.57 108.362 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.717 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.2 m-85 -131.79 163.66 27.72 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.902 -1.124 . . . . 14.609999999999999 111.274 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.692 ' O ' HG22 ' A' ' 84' ' ' VAL . 24.1 p -146.38 120.77 9.64 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.414 -1.698 . . . . 18.359999999999999 106.414 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.976 ' CG1' HD12 ' A' ' 81' ' ' LEU . 6.2 t -49.19 168.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 C-N-CA 118.837 -1.145 . . . . 19.129999999999999 108.776 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.7 t-80 -135.37 124.53 24.46 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.393 -0.817 . . . . 20.649999999999999 109.11 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.989 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.2 OUTLIER -68.63 -5.3 19.28 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.285 -0.885 . . . . 19.649999999999999 109.572 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.5 t -55.94 -18.28 8.72 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.367 -0.975 . . . . 14.720000000000001 108.367 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -101.48 -5.53 25.12 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.525 -0.735 . . . . 11.449999999999999 110.187 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.698 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -75.36 157.9 33.57 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.919 -1.113 . . . . 14.25 108.938 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.598 ' HA ' HD21 ' B' ' 37' ' ' LEU . 20.5 mttt -146.63 164.44 32.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 32.700000000000003 109.797 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.738 HG13 HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -111.57 112.18 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 15.630000000000001 109.156 179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.5 -176.93 43.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.457 -1.457 . . . . 12.699999999999999 109.457 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.528 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -90.57 22.54 3.42 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.158 -1.201 . . . . 26.289999999999999 109.367 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.25 -16.37 31.39 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.425 -0.797 . . . . 20.440000000000001 109.318 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 90.14 28.02 19.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.651 -1.38 . . . . 13.82 109.651 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' LEU . 58.0 m -161.0 124.54 3.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -1.182 . . . . 18.27 109.485 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.738 HD12 HG13 ' A' ' 70' ' ' VAL . 1.1 tp -46.94 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 12.43 109.333 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -162.5 113.57 1.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -0.923 . . . . 35.109999999999999 109.526 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.4 mt -43.14 -40.01 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.511 -0.743 . . . . 13.67 110.178 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 80' ' ' ARG . 1.6 t70 45.77 55.16 7.12 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.407 -0.96 . . . . 24.059999999999999 108.407 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 80.22 88.52 0.05 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.674 -0.861 . . . . 35.039999999999999 108.674 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.976 HD12 ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -65.46 157.87 28.32 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.752 0.787 . . . . 18.719999999999999 111.268 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 5.7 ttt180 -106.93 102.1 11.48 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.128 -1.064 . . . . 20.550000000000001 108.128 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.038 HD12 HD13 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -75.06 147.29 40.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.003 -1.061 . . . . 14.4 111.205 -178.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 62' ' ' THR . 33.9 m -147.85 155.56 44.4 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.094 -1.076 . . . . 17.649999999999999 108.094 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.55 144.02 83.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.091 1.861 . . . . 25.699999999999999 110.277 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -72.83 128.11 34.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 49.289999999999999 109.521 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 86' ' ' ALA . 29.7 mmtm . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.062 -0.97 . . . . 58.909999999999997 109.487 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.578 ' C ' HD22 ' A' ' 65' ' ' LEU . 1.4 pmm? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.435 -0.58 . . . . 64.909999999999997 109.435 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.989 ' N ' HD22 ' A' ' 65' ' ' LEU . 1.9 mt -58.64 85.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.842 -1.17 . . . . 33.799999999999997 107.842 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 20.7 mttt -63.63 157.99 22.48 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.804 0.812 . . . . 32.719999999999999 111.6 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.024 HG22 HG22 ' B' ' 35' ' ' VAL . 58.6 t -159.94 167.38 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.592 0.71 . . . . 14.460000000000001 109.68 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.598 ' N ' HG12 ' B' ' 4' ' ' VAL . 77.6 mt-10 -154.83 107.18 2.74 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.761 -0.829 . . . . 22.120000000000001 108.761 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.717 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -74.52 107.82 5.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 118.983 -1.087 . . . . 14.23 108.322 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.672 ' CD ' ' CD1' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.4 171.85 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.438 -0.789 . . . . 25.43 109.967 -179.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.5 Cg_endo -76.69 -25.68 9.06 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.598 2.199 . . . . 13.609999999999999 109.718 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.65 8.24 44.68 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.94 -0.763 . . . . 15.52 108.94 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 10.0 mm-40 -121.21 32.84 5.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.262 -0.898 . . . . 17.309999999999999 109.547 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.405 ' HB1' ' HD3' ' B' ' 58' ' ' PRO . . . -97.96 11.48 37.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.97 . . . . 24.780000000000001 110.338 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.407 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 11.6 mt-30 -138.78 138.14 37.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -0.993 . . . . 47.899999999999999 110.055 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.651 ' CD2' HD12 ' B' ' 49' ' ' LEU . 11.5 p90 -88.5 173.21 8.81 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.426 -0.796 . . . . 21.609999999999999 109.74 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 10.0 t -130.85 164.1 25.97 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.512 -0.921 . . . . 14.890000000000001 108.512 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.562 0 O-C-N 121.103 -0.998 . . . . 17.350000000000001 109.611 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.799 HD22 ' C ' ' B' ' 28' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.888 0.852 . . . . 24.0 110.896 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.66 ' N ' HD22 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -105.52 128.7 53.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.603 -0.888 . . . . 23.309999999999999 108.603 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.555 ' HG3' HD21 ' B' ' 28' ' ' LEU . 0.9 OUTLIER -111.51 151.03 29.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.992 -1.068 . . . . 40.030000000000001 109.971 -179.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.55 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.7 OUTLIER -133.64 175.89 9.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 12.390000000000001 109.486 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.836 ' HB3' HD11 ' B' ' 44' ' ' LEU . 3.6 mp -127.27 155.59 43.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 17.420000000000002 109.164 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.634 ' O ' HD12 ' B' ' 44' ' ' LEU . 1.9 m -153.78 -176.75 5.98 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.296 -1.001 . . . . 13.84 108.296 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' CD ' ' B' ' 7' ' ' LYS . 35.4 m-85 -130.86 102.9 6.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.164 -0.96 . . . . 21.140000000000001 109.544 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 1.024 HG22 HG22 ' B' ' 4' ' ' VAL . 78.5 t -90.78 125.96 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.004 -1.06 . . . . 10.66 110.307 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' B' ' 39' ' ' ASN . 3.8 m-20 -68.46 -41.95 79.47 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.601 -0.889 . . . . 25.890000000000001 108.601 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.688 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER 47.49 48.2 16.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.421 -0.799 . . . . 24.239999999999998 109.749 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.16 4.78 51.23 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.348 -1.501 . . . . 31.02 109.348 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.5 OUTLIER -104.44 95.72 6.12 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.33 -1.1 . . . . 43.229999999999997 108.507 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' B' ' 39' ' ' ASN . 9.3 mt-10 -30.52 -37.35 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.471 0.653 . . . . 42.340000000000003 110.858 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -85.2 146.4 45.06 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.64 -0.874 . . . . 5.2300000000000004 108.64 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.9 Cg_endo -76.37 137.09 18.4 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.958 1.772 . . . . 17.920000000000002 110.551 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.984 HG22 ' O ' ' B' ' 35' ' ' VAL . 5.9 m -108.7 114.0 45.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.362 -0.836 . . . . 20.57 109.076 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' B' ' 32' ' ' LEU . 28.8 tp -65.66 110.1 2.64 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.407 -0.808 . . . . 20.210000000000001 109.372 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.587 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 6.5 t -115.36 165.4 10.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.493 -0.755 . . . . 10.81 109.306 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.554 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 9.8 mtpt -96.31 125.52 40.87 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.538 -0.865 . . . . 36.740000000000002 109.492 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 1.021 HD13 HD12 ' B' ' 83' ' ' LEU . 0.8 OUTLIER -117.43 136.38 54.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.331 -0.856 . . . . 19.739999999999998 109.368 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.483 ' OG1' ' CZ ' ' B' ' 80' ' ' ARG . 12.6 m -68.18 163.67 22.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 22.559999999999999 109.285 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.651 HD12 ' CD2' ' B' ' 13' ' ' PHE . 1.1 tm? -151.9 93.41 1.84 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.35 -158.0 0.85 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 33.990000000000002 109.836 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 49.02 -154.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 54.920000000000002 109.162 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' B' ' 54' ' ' PRO . . . -79.62 -2.2 87.72 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.512 -1.435 . . . . 36.100000000000001 109.512 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -73.59 114.37 31.41 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.251 -1.147 . . . . 54.759999999999998 110.008 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' B' ' 52' ' ' GLY . 36.3 Cg_endo -80.29 153.33 21.27 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.512 2.141 . . . . 28.370000000000001 110.244 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.64 ' HB2' ' CD2' ' B' ' 13' ' ' PHE . . . -39.84 128.43 2.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.358 -0.839 . . . . 17.210000000000001 110.26 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.717 ' O ' HG21 ' B' ' 6' ' ' ILE . 85.2 m-85 -47.79 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.871 -0.788 . . . . 17.190000000000001 108.871 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.945 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -50.5 175.72 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.86 . . . . 17.82 109.394 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.945 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.6 Cg_endo -77.34 129.5 10.35 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.611 2.207 . . . . 17.280000000000001 110.503 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.89 177.15 30.73 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.424 -1.47 . . . . 17.219999999999999 109.424 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 4.1 mp -73.73 146.99 43.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.222 -1.163 . . . . 19.57 108.794 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.692 ' HB3' HD22 ' B' ' 83' ' ' LEU . 19.6 m-85 -132.24 163.78 27.84 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.957 -1.089 . . . . 14.609999999999999 111.319 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.685 ' O ' HG22 ' B' ' 84' ' ' VAL . 24.3 p -146.54 120.86 9.59 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.424 -1.695 . . . . 18.359999999999999 106.424 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.978 ' CG1' HD12 ' B' ' 81' ' ' LEU . 6.1 t -49.37 168.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 C-N-CA 118.82 -1.152 . . . . 19.129999999999999 108.826 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.543 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.7 t-80 -135.21 124.5 24.64 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.393 -0.817 . . . . 20.649999999999999 109.089 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.992 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -68.61 -5.4 19.75 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.244 -0.91 . . . . 19.649999999999999 109.533 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 33.4 t -55.79 -18.44 8.48 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.306 -0.998 . . . . 14.720000000000001 108.306 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -101.31 -5.92 24.8 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.544 -0.722 . . . . 11.449999999999999 110.185 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.697 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.9 m-30 -75.02 157.72 34.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.91 -1.119 . . . . 14.25 108.893 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.599 ' HA ' HD21 ' A' ' 37' ' ' LEU . 20.6 mttt -146.36 164.78 31.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -0.979 . . . . 32.700000000000003 109.815 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.724 HG13 HD12 ' B' ' 76' ' ' LEU . 0.2 OUTLIER -111.83 112.12 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.415 -0.803 . . . . 15.630000000000001 109.158 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.51 -177.0 43.03 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.481 -1.448 . . . . 12.699999999999999 109.481 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.54 22.57 3.39 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.146 -1.208 . . . . 26.289999999999999 109.348 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.29 -16.36 31.31 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.46 -0.775 . . . . 20.440000000000001 109.363 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 90.39 27.62 19.73 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.665 -1.374 . . . . 13.82 109.665 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 76' ' ' LEU . 58.0 m -160.76 124.53 3.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -1.223 . . . . 18.27 109.569 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.724 HD12 HG13 ' B' ' 70' ' ' VAL . 1.1 tp -46.93 170.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 12.43 109.357 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' B' ' 76' ' ' LEU . 0.8 OUTLIER -162.48 113.58 1.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 35.109999999999999 109.553 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.4 mt -43.11 -40.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.48 -0.763 . . . . 13.67 110.212 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' B' ' 80' ' ' ARG . 1.6 t70 45.85 55.17 7.2 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.354 -0.98 . . . . 24.059999999999999 108.354 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 80.21 88.57 0.05 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.69 -0.856 . . . . 35.039999999999999 108.69 -178.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.978 HD12 ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -65.4 157.89 28.11 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.779 0.799 . . . . 18.719999999999999 111.267 -178.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 5.7 ttt180 -107.06 102.09 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.065 -1.087 . . . . 20.550000000000001 108.065 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.021 HD12 HD13 ' B' ' 47' ' ' ILE . 0.4 OUTLIER -75.04 147.45 40.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.047 -1.033 . . . . 14.4 111.162 -178.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.685 HG22 ' O ' ' B' ' 62' ' ' THR . 33.8 m -148.02 155.31 43.83 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 108.11 -1.07 . . . . 17.649999999999999 108.11 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.1 Cg_endo -64.33 143.95 84.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.153 1.902 . . . . 25.699999999999999 110.257 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -72.79 128.08 34.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 49.289999999999999 109.586 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' B' ' 86' ' ' ALA . 29.7 mmtm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.047 -0.978 . . . . 58.909999999999997 109.519 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.33 -0.618 . . . . 64.909999999999997 109.33 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.844 ' CA ' HD22 ' B' ' 65' ' ' LEU . 4.8 mt 73.74 75.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.162 -1.051 . . . . 33.799999999999997 108.162 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -68.99 155.35 40.49 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.756 0.788 . . . . 32.719999999999999 110.841 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.875 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -160.35 167.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.534 -0.913 . . . . 14.460000000000001 108.534 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.542 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 60.3 mt-10 -143.52 109.67 5.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 22.120000000000001 109.534 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.734 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -72.29 101.04 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.899 -1.149 . . . . 14.23 107.899 179.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.676 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.42 169.84 0.07 OUTLIER Pre-proline 0 N--CA 1.486 1.361 0 O-C-N 121.306 -0.871 . . . . 25.43 109.611 -179.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -75.3 -24.09 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.444 2.096 . . . . 13.609999999999999 109.812 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -93.31 1.39 56.99 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.094 -0.706 . . . . 15.52 109.094 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.487 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 29.3 mm-40 -120.08 39.7 3.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 17.309999999999999 109.165 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.65 22.44 15.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.119 -0.988 . . . . 24.780000000000001 110.22 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -142.72 132.71 24.33 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.054 -1.029 . . . . 47.899999999999999 108.786 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.636 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 33.3 p90 -88.56 176.88 6.95 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.013 -1.054 . . . . 21.609999999999999 109.774 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 16.1 m -130.7 153.75 48.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.674 -0.862 . . . . 14.890000000000001 108.674 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.551 0 O-C-N 121.211 -0.931 . . . . 17.350000000000001 109.439 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.547 HD22 HG22 ' A' ' 48' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.435 0.636 . . . . 24.0 109.96 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.636 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -99.05 129.92 45.35 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.451 -0.944 . . . . 23.309999999999999 108.451 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.07 152.55 33.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.998 -1.064 . . . . 40.030000000000001 109.612 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.859 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -135.24 171.54 14.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 12.390000000000001 109.897 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.838 ' HB3' HD11 ' A' ' 44' ' ' LEU . 3.3 mm? -105.89 179.13 4.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 17.420000000000002 110.252 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -173.51 158.16 3.37 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.85 -1.167 . . . . 13.84 107.85 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.676 ' CD2' ' HD3' ' A' ' 7' ' ' LYS . 20.1 m-85 -111.98 106.33 14.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.964 -1.085 . . . . 21.140000000000001 109.36 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.881 ' O ' HG22 ' A' ' 43' ' ' VAL . 25.7 t -107.4 117.59 53.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 10.66 110.627 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -95.3 41.29 1.1 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.543 -1.281 . . . . 25.890000000000001 107.543 178.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 38' ' ' GLY . 1.7 pp -35.19 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.377 0.608 . . . . 24.239999999999998 110.319 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.882 ' N ' HD12 ' A' ' 37' ' ' LEU . . . 165.55 50.81 0.02 OUTLIER Glycine 0 C--N 1.298 -1.576 0 C-N-CA 119.333 -1.413 . . . . 31.02 109.696 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 61.9 m-20 -126.13 18.26 7.74 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.223 -1.163 . . . . 43.229999999999997 110.101 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 51.3 mt-10 58.96 27.8 16.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 42.340000000000003 109.949 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 3.3 p-80 176.42 162.62 0.47 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.531 -0.914 . . . . 6.3700000000000001 108.531 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.651 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.7 Cg_endo -76.5 135.74 16.71 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.774 1.65 . . . . 17.920000000000002 110.231 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.938 HG21 HG21 ' B' ' 70' ' ' VAL . 2.9 m -111.1 117.31 54.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.648 -0.821 . . . . 20.57 108.994 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 32' ' ' LEU . 41.1 tp -70.75 95.94 1.18 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.292 -0.88 . . . . 20.210000000000001 109.167 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.439 HG23 HG12 ' B' ' 70' ' ' VAL . 4.4 p -105.65 161.28 5.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.6 -0.687 . . . . 10.81 109.35 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.22 -177.75 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 36.740000000000002 110.634 -179.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.62 HD12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -167.66 149.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.115 -1.069 . . . . 19.739999999999998 108.115 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.606 ' H ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -91.58 152.97 20.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.864 -1.148 . . . . 22.559999999999999 109.476 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -131.93 102.82 6.0 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.471 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 29.4 t70 -44.87 142.45 1.78 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 33.990000000000002 109.739 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.25 103.31 0.37 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.825 . . . . 54.920000000000002 109.322 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.1 -25.14 7.98 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.367 -1.493 . . . . 36.100000000000001 109.367 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 31.3 mt-30 -76.48 147.76 79.26 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.323 -1.104 . . . . 54.759999999999998 109.229 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.6 Cg_endo -78.12 126.13 7.62 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.662 2.241 . . . . 28.370000000000001 110.39 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.859 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -40.03 156.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.419 -0.801 . . . . 17.210000000000001 110.02 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.734 ' O ' HG21 ' A' ' 6' ' ' ILE . 74.3 m-85 -58.27 111.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 17.190000000000001 109.153 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.803 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -56.58 170.05 0.55 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 17.82 109.782 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.803 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.17 106.07 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.678 2.252 . . . . 17.280000000000001 110.392 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.11 -176.12 43.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.585 -1.406 . . . . 17.219999999999999 109.585 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -76.28 138.84 40.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -1.142 . . . . 19.57 108.613 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.679 ' HB3' HD22 ' A' ' 83' ' ' LEU . 25.5 m-85 -128.63 164.65 22.42 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.776 -1.203 . . . . 14.609999999999999 111.699 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.732 ' O ' HG22 ' A' ' 84' ' ' VAL . 47.6 p -145.46 121.89 10.99 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.268 -1.753 . . . . 18.359999999999999 106.268 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.62 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -54.41 167.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 118.632 -1.227 . . . . 19.129999999999999 108.624 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.508 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -130.12 126.57 37.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.249 -0.907 . . . . 20.649999999999999 109.501 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.841 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER -73.06 1.53 8.82 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.425 -0.797 . . . . 19.649999999999999 110.034 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 t -57.29 -19.05 19.61 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.383 -1.34 . . . . 14.720000000000001 107.383 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 69.8 m -95.12 -25.02 16.6 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.127 0.489 . . . . 11.449999999999999 110.179 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.696 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.2 m-30 -61.92 158.95 15.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.98 . . . . 14.25 109.486 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.73 176.24 12.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 32.700000000000003 109.404 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.961 HG21 HG21 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -113.44 123.37 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 15.630000000000001 109.387 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.75 -162.06 28.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.378 -1.489 . . . . 12.699999999999999 109.378 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.461 ' HB2' ' SD ' ' A' ' 77' ' ' MET . 0.3 OUTLIER 59.27 72.22 0.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -1.188 . . . . 26.289999999999999 109.311 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.3 OUTLIER 70.41 6.66 5.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 20.440000000000001 109.381 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.03 45.21 5.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.492 -1.443 . . . . 13.82 109.492 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -129.13 140.46 51.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 18.27 109.522 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.583 ' HB2' HD13 ' B' ' 81' ' ' LEU . 0.2 OUTLIER -43.69 158.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 12.43 109.355 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.52 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -165.54 104.73 0.72 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 35.109999999999999 110.112 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.829 HD12 HD12 ' B' ' 78' ' ' ILE . 1.1 mt -41.12 -64.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.613 0.721 . . . . 13.67 109.738 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 15.6 t70 84.86 -46.69 0.08 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.481 0.657 . . . . 24.059999999999999 110.003 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.581 ' O ' ' CB ' ' A' ' 67' ' ' SER . 1.9 tpm_? -171.25 66.56 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.491 -0.929 . . . . 35.039999999999999 108.491 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.62 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.3 pt? -39.58 125.7 1.79 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.659 0.742 . . . . 18.719999999999999 111.71 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -92.51 106.67 18.62 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.434 -0.95 . . . . 20.550000000000001 108.434 178.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.792 HD21 HG11 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -72.66 151.89 42.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.294 -0.879 . . . . 14.4 111.056 -178.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 62' ' ' THR . 33.1 m -154.08 156.4 31.9 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.011 -1.107 . . . . 17.649999999999999 108.011 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.2 Cg_endo -62.64 144.16 93.7 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.184 1.923 . . . . 25.699999999999999 110.201 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -75.91 117.04 17.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.14 -0.975 . . . . 49.289999999999999 109.557 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.99 -1.005 . . . . 58.909999999999997 109.416 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.497 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.336 -0.616 . . . . 64.909999999999997 109.336 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.841 ' CA ' HD22 ' A' ' 65' ' ' LEU . 4.8 mt 73.72 75.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.064 -1.087 . . . . 33.799999999999997 108.064 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -69.16 155.49 40.3 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.778 0.799 . . . . 32.719999999999999 110.788 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.864 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -160.45 168.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.548 -0.908 . . . . 14.460000000000001 108.548 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.536 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 60.1 mt-10 -143.79 109.75 5.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.33 -0.856 . . . . 22.120000000000001 109.536 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.722 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -72.35 100.98 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.942 -1.133 . . . . 14.23 107.942 179.254 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.676 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.37 169.78 0.07 OUTLIER Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 25.43 109.602 -179.244 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.0 Cg_endo -75.23 -24.06 12.83 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.419 2.079 . . . . 13.609999999999999 109.777 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -93.28 1.4 57.02 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.526 -0.734 . . . . 15.52 109.1 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.493 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 29.1 mm-40 -120.06 39.51 3.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.262 -0.899 . . . . 17.309999999999999 109.171 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.49 22.45 15.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 24.780000000000001 110.3 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -142.7 132.8 24.49 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.997 -1.064 . . . . 47.899999999999999 108.843 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.632 ' CD1' ' CB ' ' B' ' 29' ' ' ASN . 33.4 p90 -88.63 176.8 6.96 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.007 -1.058 . . . . 21.609999999999999 109.746 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.3 m -130.68 153.68 48.72 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.737 -0.838 . . . . 14.890000000000001 108.737 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.299 -1.609 0 O-C-N 121.251 -0.906 . . . . 17.350000000000001 109.501 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.552 HD22 HG22 ' B' ' 48' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.345 0.593 . . . . 24.0 110.011 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.632 ' CB ' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -99.07 129.92 45.37 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.478 -0.934 . . . . 23.309999999999999 108.478 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.03 152.58 33.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.037 -1.04 . . . . 40.030000000000001 109.572 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.837 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -135.21 171.53 14.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.153 -0.967 . . . . 12.390000000000001 109.94 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' B' ' 44' ' ' LEU . 3.3 mm? -105.79 179.28 4.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 17.420000000000002 110.219 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -173.69 158.27 3.29 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.797 -1.186 . . . . 13.84 107.797 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.676 ' CD2' ' HD3' ' B' ' 7' ' ' LYS . 20.2 m-85 -112.13 106.4 15.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.988 -1.07 . . . . 21.140000000000001 109.309 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.867 ' O ' HG22 ' B' ' 43' ' ' VAL . 25.4 t -107.57 117.46 53.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 10.66 110.633 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.2 OUTLIER -95.21 41.34 1.1 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.433 -1.321 . . . . 25.890000000000001 107.433 178.289 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.881 HD12 ' N ' ' B' ' 38' ' ' GLY . 1.6 pp -35.29 -31.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.397 0.618 . . . . 24.239999999999998 110.284 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.881 ' N ' HD12 ' B' ' 37' ' ' LEU . . . 165.83 50.98 0.02 OUTLIER Glycine 0 C--N 1.298 -1.559 0 C-N-CA 119.286 -1.435 . . . . 31.02 109.653 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.581 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 62.1 m-20 -126.19 18.37 7.7 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.164 -1.198 . . . . 43.229999999999997 110.116 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 39' ' ' ASN . 51.2 mt-10 58.79 27.87 16.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.139 -0.976 . . . . 42.340000000000003 109.956 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 3.3 p-80 176.38 162.35 0.46 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 6.3799999999999999 108.594 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.662 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.7 Cg_endo -76.39 135.68 16.87 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.77 1.646 . . . . 17.920000000000002 110.24 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.961 HG21 HG21 ' A' ' 70' ' ' VAL . 2.9 m -111.01 117.4 54.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.358 -0.839 . . . . 20.57 108.997 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' B' ' 32' ' ' LEU . 41.8 tp -70.86 95.82 1.2 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.643 -0.823 . . . . 20.210000000000001 109.215 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.454 HG23 HG12 ' A' ' 70' ' ' VAL . 4.4 p -105.46 161.37 5.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.612 -0.68 . . . . 10.81 109.448 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.42 ' HA ' HD13 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -71.3 -177.84 1.89 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 36.740000000000002 110.552 -179.073 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.64 HD12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -167.61 149.63 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.069 -1.085 . . . . 19.739999999999998 108.069 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.587 ' H ' HD13 ' B' ' 47' ' ' ILE . 0.2 OUTLIER -91.82 153.15 19.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.839 -1.163 . . . . 22.559999999999999 109.429 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -132.21 102.96 5.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.741 -0.837 . . . . 20.41 108.741 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.441 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 29.4 t70 -45.12 142.45 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 33.990000000000002 109.898 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.1 103.41 0.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 54.920000000000002 109.319 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.93 -25.16 8.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.37 -1.492 . . . . 36.100000000000001 109.37 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.462 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 31.5 mt-30 -76.39 147.72 79.48 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.265 -1.138 . . . . 54.759999999999998 109.301 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.7 Cg_endo -78.05 126.31 7.78 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.591 2.194 . . . . 28.370000000000001 110.391 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.837 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -40.11 156.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.396 -0.815 . . . . 17.210000000000001 110.024 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.722 ' O ' HG21 ' B' ' 6' ' ' ILE . 73.3 m-85 -58.11 111.01 1.05 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.4 -0.813 . . . . 17.190000000000001 109.077 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.813 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -56.76 170.04 0.57 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 17.82 109.799 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.813 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -77.76 104.99 1.95 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.71 2.273 . . . . 17.280000000000001 110.118 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.3 -176.6 41.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.708 -1.357 . . . . 17.219999999999999 109.708 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.697 HD23 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -76.53 138.34 40.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -1.146 . . . . 19.57 108.366 179.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.715 ' HB3' HD22 ' B' ' 83' ' ' LEU . 25.5 m-85 -128.08 164.46 22.37 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.729 -1.232 . . . . 14.609999999999999 111.607 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.729 ' O ' HG22 ' B' ' 84' ' ' VAL . 46.9 p -145.13 122.04 11.31 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.175 -1.787 . . . . 18.359999999999999 106.175 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.621 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -54.73 167.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 118.562 -1.255 . . . . 19.129999999999999 108.594 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -130.4 126.68 37.66 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.271 -0.893 . . . . 20.649999999999999 109.49 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.844 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -73.18 1.17 9.78 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.434 -0.791 . . . . 19.649999999999999 110.014 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -56.86 -19.38 17.2 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.323 -1.362 . . . . 14.720000000000001 107.323 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 70.9 m -94.77 -25.06 16.82 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.146 0.498 . . . . 11.449999999999999 110.201 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.2 m-30 -61.93 158.59 15.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 14.25 109.466 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.4 176.29 12.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 32.700000000000003 109.407 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.938 HG21 HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -113.45 123.57 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 15.630000000000001 109.34 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.53 -162.2 29.29 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.426 -1.47 . . . . 12.699999999999999 109.426 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.3 OUTLIER 59.43 72.13 0.54 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -1.189 . . . . 26.289999999999999 109.328 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.3 OUTLIER 70.45 6.81 5.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 20.440000000000001 109.322 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.84 45.25 5.2 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.438 -1.465 . . . . 13.82 109.438 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.423 ' O ' ' C ' ' B' ' 76' ' ' LEU . 0.3 OUTLIER -129.16 140.34 51.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -1.167 . . . . 18.27 109.48 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.576 ' HB2' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -43.58 158.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -0.895 . . . . 12.43 109.376 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 0.6 OUTLIER -165.49 104.93 0.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.962 . . . . 35.109999999999999 110.083 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.829 HD12 HD12 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -41.37 -64.4 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.556 0.694 . . . . 13.67 109.682 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.545 ' N ' HG22 ' B' ' 78' ' ' ILE . 15.4 t70 84.74 -46.52 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.422 0.63 . . . . 24.059999999999999 110.007 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' B' ' 67' ' ' SER . 1.9 tpm_? -171.42 66.41 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.036 0.922 . . . . 35.039999999999999 108.517 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.621 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.2 pt? -39.41 125.65 1.71 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.653 0.739 . . . . 18.719999999999999 111.721 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.7 OUTLIER -92.48 106.59 18.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.517 -0.919 . . . . 20.550000000000001 108.517 178.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.786 HD21 HG11 ' B' ' 4' ' ' VAL . 0.6 OUTLIER -72.64 151.72 42.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.183 -0.948 . . . . 14.4 111.072 -178.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.729 HG22 ' O ' ' B' ' 62' ' ' THR . 33.4 m -153.86 156.53 32.16 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 107.959 -1.126 . . . . 17.649999999999999 107.959 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.3 Cg_endo -62.83 144.32 93.33 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.117 1.878 . . . . 25.699999999999999 110.151 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -75.96 117.03 17.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.242 -0.911 . . . . 49.289999999999999 109.617 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.009 -0.996 . . . . 58.909999999999997 109.458 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.504 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.416 -0.587 . . . . 64.909999999999997 109.416 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.751 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.7 mt -66.89 79.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.598 -1.26 . . . . 33.799999999999997 107.598 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -74.33 159.96 31.7 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.907 0.861 . . . . 32.719999999999999 110.595 -178.186 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.712 HG11 HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -162.43 167.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.437 -0.949 . . . . 14.460000000000001 108.437 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.534 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 33.2 mt-10 -142.3 112.54 7.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 22.120000000000001 109.693 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.717 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -75.25 99.52 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.815 -1.18 . . . . 14.23 107.815 179.071 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.665 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.1 mttm -53.88 165.8 0.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.357 -0.84 . . . . 25.43 109.762 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 29.8 Cg_endo -70.89 -15.61 32.85 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.922 1.748 . . . . 13.609999999999999 108.796 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.14 -2.65 49.46 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.905 -0.776 . . . . 15.52 108.905 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.73 ' NE2' HD12 ' A' ' 32' ' ' LEU . 1.5 mm100 -129.49 43.66 3.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.205 -0.935 . . . . 17.309999999999999 109.581 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.83 20.03 16.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.05 -1.031 . . . . 24.780000000000001 110.068 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 11.5 mt-30 -135.73 140.63 44.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.121 -0.987 . . . . 47.899999999999999 109.689 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.717 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 41.3 p90 -94.78 164.01 13.12 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.201 -0.937 . . . . 21.609999999999999 109.469 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.1 m -135.07 147.26 49.54 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.341 -0.85 . . . . 14.890000000000001 109.181 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.479 0 O-C-N 121.273 -0.892 . . . . 17.350000000000001 109.364 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.381 0.61 . . . . 24.0 110.313 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.515 ' CG ' ' CD1' ' A' ' 13' ' ' PHE . 86.0 m-20 -68.59 109.99 4.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.364 -0.835 . . . . 23.309999999999999 109.041 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 18.6 mt-10 -87.01 -173.33 4.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.219 -0.925 . . . . 40.030000000000001 109.899 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.56 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 1.7 tm0? -176.33 -177.84 0.9 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.852 . . . . 12.390000000000001 109.47 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.73 HD12 ' NE2' ' A' ' 10' ' ' GLN . 13.3 mt -140.98 168.93 18.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 17.420000000000002 109.366 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -164.91 161.87 20.37 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.055 -1.091 . . . . 13.84 108.055 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.679 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 49.6 m-85 -111.44 111.72 22.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.994 -1.066 . . . . 21.140000000000001 109.716 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.672 ' CG1' HD23 ' A' ' 37' ' ' LEU . 4.6 t -106.87 140.39 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 10.66 110.871 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -111.72 39.34 2.39 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.556 -1.276 . . . . 25.890000000000001 107.556 178.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.809 HD21 HG22 ' B' ' 70' ' ' VAL . 1.1 pp -63.5 58.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.976 -0.452 . . . . 24.239999999999998 110.468 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 107.33 1.87 35.47 Favored Glycine 0 N--CA 1.482 1.76 0 C-N-CA 119.609 -1.282 . . . . 31.02 109.902 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 40' ' ' GLU . 1.2 m-20 -124.87 98.78 5.85 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.23 -1.159 . . . . 43.229999999999997 108.528 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -32.61 -56.85 0.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.55 0.691 . . . . 42.340000000000003 110.579 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 39' ' ' ASN . 7.2 m-70 -66.25 152.16 94.65 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 108.638 -0.875 . . . . 5.6799999999999997 108.638 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.679 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.8 Cg_endo -77.34 139.75 18.87 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.982 1.788 . . . . 17.920000000000002 110.041 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.826 HG21 HG21 ' B' ' 70' ' ' VAL . 3.4 m -112.91 115.4 49.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.317 -0.865 . . . . 20.57 109.569 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.724 HD11 ' CB ' ' A' ' 32' ' ' LEU . 59.9 tp -72.51 101.62 3.02 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.875 . . . . 20.210000000000001 109.867 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.686 HG12 ' CG1' ' B' ' 70' ' ' VAL . 2.6 m -99.82 -168.94 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.977 -0.749 . . . . 10.81 108.977 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.677 ' HA ' HD23 ' A' ' 32' ' ' LEU . 1.3 mtpp -106.57 178.61 4.51 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.507 -0.877 . . . . 36.740000000000002 110.809 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -157.64 156.47 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.242 -1.021 . . . . 19.739999999999998 108.242 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -111.46 68.57 0.67 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.12 -0.988 . . . . 22.559999999999999 109.479 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.0 HD11 ' O ' ' A' ' 53' ' ' GLN . 2.2 tm? -42.12 114.8 0.59 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.492 -0.755 . . . . 20.41 109.306 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.727 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -57.32 151.81 15.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 33.990000000000002 109.89 -179.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -63.53 117.5 6.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 54.920000000000002 109.223 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.62 -27.35 19.2 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.301 -1.52 . . . . 36.100000000000001 109.301 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 1.0 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.16 146.27 96.83 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.281 -1.129 . . . . 54.759999999999998 109.286 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.5 Cg_endo -77.52 119.76 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.577 2.184 . . . . 28.370000000000001 110.642 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.717 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -41.41 144.3 0.36 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -0.826 . . . . 17.210000000000001 110.035 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.717 ' O ' HG21 ' A' ' 6' ' ' ILE . 15.4 m-30 -45.3 108.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 17.190000000000001 109.135 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.918 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -59.04 173.87 0.43 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.056 -1.028 . . . . 17.82 109.055 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.918 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.9 Cg_endo -77.52 110.41 2.96 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.42 2.08 . . . . 17.280000000000001 110.024 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.53 -178.99 48.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.867 -1.293 . . . . 17.219999999999999 109.867 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -77.54 140.59 39.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -1.085 . . . . 19.57 108.511 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.732 ' HB3' HD22 ' A' ' 83' ' ' LEU . 17.9 m-85 -130.0 163.96 25.34 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.771 -1.205 . . . . 14.609999999999999 111.81 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.634 ' O ' HG22 ' A' ' 84' ' ' VAL . 48.9 p -145.69 121.61 10.65 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.442 -1.688 . . . . 18.359999999999999 106.442 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.587 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -51.27 167.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.792 -1.163 . . . . 19.129999999999999 109.2 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -128.25 127.47 42.88 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.833 -0.803 . . . . 20.649999999999999 108.833 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.754 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.5 OUTLIER -71.39 0.66 7.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.477 -0.764 . . . . 19.649999999999999 110.014 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 t -57.12 -17.69 11.8 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.787 -1.19 . . . . 14.720000000000001 107.787 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 16.5 m -97.81 -5.45 34.77 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.782 -0.574 . . . . 11.449999999999999 110.372 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.674 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.3 m-30 -83.6 159.77 21.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.936 -1.102 . . . . 14.25 109.771 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.589 ' HA ' HD11 ' B' ' 37' ' ' LEU . 53.7 mttm -149.11 173.25 13.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.773 . . . . 32.700000000000003 109.302 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.827 HG21 HG21 ' B' ' 43' ' ' VAL . 0.9 OUTLIER -107.28 116.12 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 15.630000000000001 108.932 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 175.93 4.86 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.779 -1.328 . . . . 12.699999999999999 109.779 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.06 12.7 8.98 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.214 -1.168 . . . . 26.289999999999999 109.763 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.457 ' O ' ' HG3' ' B' ' 46' ' ' LYS . 0.1 OUTLIER -123.25 19.37 9.84 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.532 -0.73 . . . . 20.440000000000001 109.201 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 45' ' ' VAL . . . 67.53 57.27 9.31 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.794 -1.322 . . . . 13.82 109.794 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.0 t -146.65 134.77 21.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.171 -1.193 . . . . 18.27 109.871 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.759 HD11 HD22 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -76.98 145.17 38.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 12.43 109.071 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.497 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 11.0 mtm -157.09 120.33 4.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.037 . . . . 35.109999999999999 109.926 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.833 HD12 HD12 ' B' ' 78' ' ' ILE . 3.3 mt -62.34 136.88 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 13.67 109.374 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.34 -30.41 11.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.166 -1.05 . . . . 24.059999999999999 108.166 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.6 tpm_? -176.42 71.06 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.049 -1.463 . . . . 35.039999999999999 107.049 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -30.89 118.29 0.18 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.731 0.776 . . . . 18.719999999999999 111.579 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 6.1 mtp180 -89.35 110.94 21.68 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.015 -1.106 . . . . 20.550000000000001 108.015 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -81.93 144.38 30.99 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.141 -0.975 . . . . 14.4 111.164 -178.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 62' ' ' THR . 11.9 m -145.98 158.91 47.96 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.705 -1.22 . . . . 17.649999999999999 107.705 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.1 Cg_endo -61.79 145.77 97.02 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.02 1.813 . . . . 25.699999999999999 110.145 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.18 119.8 17.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.156 -0.965 . . . . 49.289999999999999 109.732 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.985 -1.007 . . . . 58.909999999999997 109.411 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.496 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.432 -0.581 . . . . 64.909999999999997 109.432 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.754 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.7 mt -66.89 78.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.586 -1.265 . . . . 33.799999999999997 107.586 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -74.2 159.84 31.98 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.934 0.873 . . . . 32.719999999999999 110.595 -178.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.705 HG11 HD21 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -162.41 167.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.442 -0.947 . . . . 14.460000000000001 108.442 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.535 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 33.7 mt-10 -142.32 112.7 7.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 22.120000000000001 109.659 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.712 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -75.41 99.7 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.759 -1.201 . . . . 14.23 107.759 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.673 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.2 mttm -54.02 165.83 0.73 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.821 . . . . 25.43 109.785 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 29.9 Cg_endo -70.84 -15.63 33.03 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.89 1.727 . . . . 13.609999999999999 108.814 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.13 -2.66 49.47 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.858 -0.793 . . . . 15.52 108.858 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.739 ' NE2' HD12 ' B' ' 32' ' ' LEU . 1.5 mm100 -129.5 43.74 3.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 17.309999999999999 109.649 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.84 19.52 16.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.074 -1.017 . . . . 24.780000000000001 110.087 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.407 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 11.9 mt-30 -135.32 140.7 45.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.119 -0.988 . . . . 47.899999999999999 109.679 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.725 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 41.0 p90 -94.85 164.08 13.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 21.609999999999999 109.487 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 87.9 m -135.14 147.21 49.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.303 -0.873 . . . . 14.890000000000001 109.134 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.28 -0.887 . . . . 17.350000000000001 109.368 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.426 HD23 ' O ' ' B' ' 49' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.403 0.621 . . . . 24.0 110.302 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.516 ' CG ' ' CD1' ' B' ' 13' ' ' PHE . 85.2 m-20 -68.75 109.73 3.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.827 . . . . 23.309999999999999 109.082 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 18.2 mt-10 -86.69 -173.5 4.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.141 -0.974 . . . . 40.030000000000001 109.909 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.571 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 1.7 tm0? -176.12 -177.82 0.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.353 -0.842 . . . . 12.390000000000001 109.489 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.739 HD12 ' NE2' ' B' ' 10' ' ' GLN . 13.2 mt -141.1 168.73 19.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 17.420000000000002 109.33 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -164.61 162.02 21.31 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.041 -1.096 . . . . 13.84 108.041 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.677 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 49.6 m-85 -111.52 111.52 22.59 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.01 . . . . 21.140000000000001 109.698 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.681 ' CG1' HD23 ' B' ' 37' ' ' LEU . 4.6 t -106.68 140.26 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 10.66 110.92 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.9 OUTLIER -111.64 39.25 2.39 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.571 -1.27 . . . . 25.890000000000001 107.571 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.807 HD21 HG22 ' A' ' 70' ' ' VAL . 1.1 pp -63.46 58.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.973 -0.454 . . . . 24.239999999999998 110.493 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 107.14 2.21 35.95 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.868 -1.293 . . . . 31.02 109.868 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' B' ' 41' ' ' HIS . 1.2 m-20 -125.16 98.61 5.73 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.284 -1.127 . . . . 43.229999999999997 108.527 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.6 OUTLIER -32.49 -56.53 0.34 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.553 0.692 . . . . 42.340000000000003 110.678 -179.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' B' ' 39' ' ' ASN . 7.3 m-70 -66.53 152.21 95.21 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 108.68 -0.859 . . . . 5.6399999999999997 108.68 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.677 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.8 Cg_endo -77.34 139.56 18.71 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.038 1.825 . . . . 17.920000000000002 110.031 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.827 HG21 HG21 ' A' ' 70' ' ' VAL . 3.4 m -112.8 115.36 49.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.289 -0.882 . . . . 20.57 109.61 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.736 HD11 ' CB ' ' B' ' 32' ' ' LEU . 59.3 tp -72.43 101.8 3.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.284 -0.885 . . . . 20.210000000000001 109.827 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.684 HG12 ' CG1' ' A' ' 70' ' ' VAL . 2.6 m -100.09 -169.07 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.987 -0.746 . . . . 10.81 108.987 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.661 ' HA ' HD23 ' B' ' 32' ' ' LEU . 1.3 mtpp -106.52 178.4 4.57 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.429 -0.908 . . . . 36.740000000000002 110.765 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.583 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -157.34 156.64 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.318 -0.993 . . . . 19.739999999999998 108.318 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.421 ' O ' ' C ' ' B' ' 49' ' ' LEU . 0.3 OUTLIER -111.54 68.63 0.67 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.129 -0.982 . . . . 22.559999999999999 109.463 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.997 HD11 ' O ' ' B' ' 53' ' ' GLN . 2.2 tm? -42.24 114.54 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.586 -0.696 . . . . 20.41 109.314 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.734 ' O ' HD13 ' B' ' 49' ' ' LEU . 0.8 OUTLIER -57.05 151.77 14.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.864 . . . . 33.990000000000002 109.909 -179.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -63.53 117.77 7.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.378 -0.827 . . . . 54.920000000000002 109.202 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.36 -27.35 18.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.301 -1.52 . . . . 36.100000000000001 109.301 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.997 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.3 OUTLIER -69.18 146.19 96.73 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.315 -1.109 . . . . 54.759999999999998 109.346 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.8 Cg_endo -77.4 119.63 4.99 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.614 2.209 . . . . 28.370000000000001 110.714 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.725 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -41.28 144.33 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.415 -0.803 . . . . 17.210000000000001 110.004 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.712 ' O ' HG21 ' B' ' 6' ' ' ILE . 15.5 m-30 -45.51 108.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 17.190000000000001 109.166 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.887 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -58.83 173.76 0.42 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.012 -1.055 . . . . 17.82 109.008 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.887 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.59 110.73 3.01 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.444 2.096 . . . . 17.280000000000001 110.236 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.76 -178.57 48.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.817 -1.313 . . . . 17.219999999999999 109.817 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.62 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -77.42 140.96 39.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.351 -1.088 . . . . 19.57 108.601 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.721 ' HB3' HD22 ' B' ' 83' ' ' LEU . 17.9 m-85 -130.39 164.02 25.61 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.812 -1.18 . . . . 14.609999999999999 111.698 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.632 ' O ' HG22 ' B' ' 84' ' ' VAL . 51.0 p -145.73 121.83 10.78 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.473 -1.677 . . . . 18.359999999999999 106.473 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.599 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -51.63 166.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 C-N-CA 118.751 -1.179 . . . . 19.129999999999999 109.197 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -127.53 127.24 43.62 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.919 -0.771 . . . . 20.649999999999999 108.919 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.751 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -70.99 0.45 7.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.442 -0.786 . . . . 19.649999999999999 110.053 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 3.8 t -57.09 -17.36 10.16 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.821 -1.178 . . . . 14.720000000000001 107.821 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 16.2 m -98.19 -5.64 32.98 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.767 -0.583 . . . . 11.449999999999999 110.358 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.675 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.3 m-30 -83.27 159.28 21.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.895 -1.128 . . . . 14.25 109.691 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.594 ' HA ' HD11 ' A' ' 37' ' ' LEU . 53.0 mttm -148.84 173.3 13.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 32.700000000000003 109.21 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.826 HG21 HG21 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -107.32 116.01 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 15.630000000000001 108.998 179.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 175.87 4.88 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.809 -1.316 . . . . 12.699999999999999 109.809 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.95 12.79 8.61 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.209 -1.171 . . . . 26.289999999999999 109.748 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.469 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -123.41 19.29 9.71 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.565 -0.71 . . . . 20.440000000000001 109.234 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 45' ' ' VAL . . . 67.66 57.26 9.2 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.667 -1.373 . . . . 13.82 109.667 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.4 t -146.65 134.55 21.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -1.152 . . . . 18.27 109.86 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.755 HD11 HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -76.84 145.11 38.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 12.43 109.062 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.491 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 11.2 mtm -157.05 120.4 4.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 35.109999999999999 109.847 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 78' ' ' ILE . 3.2 mt -62.38 137.11 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 13.67 109.382 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -100.52 -30.3 11.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.164 -1.05 . . . . 24.059999999999999 108.164 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.491 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.6 tpm_? -176.5 71.18 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.045 -1.465 . . . . 35.039999999999999 107.045 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.651 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -30.99 118.32 0.18 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.723 0.773 . . . . 18.719999999999999 111.604 -177.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 6.1 mtp180 -89.36 110.79 21.55 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.074 -1.084 . . . . 20.550000000000001 108.074 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -81.78 144.37 31.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.172 -0.955 . . . . 14.4 111.217 -178.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.632 HG22 ' O ' ' B' ' 62' ' ' THR . 12.3 m -146.04 158.92 47.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 107.718 -1.215 . . . . 17.649999999999999 107.718 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.9 Cg_endo -61.77 145.74 97.06 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.015 1.81 . . . . 25.699999999999999 110.171 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -73.19 119.82 17.96 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.102 -0.999 . . . . 49.289999999999999 109.7 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 58.909999999999997 109.389 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.635 ' O ' HD22 ' A' ' 37' ' ' LEU . 1.2 pmm? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.321 0.582 . . . . 64.909999999999997 109.477 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.957 HG23 HD13 ' B' ' 65' ' ' LEU . 2.3 mt -74.33 66.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.102 -1.073 . . . . 33.799999999999997 108.102 178.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.645 ' C ' HG12 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -56.84 178.58 0.06 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.839 0.828 . . . . 32.719999999999999 111.097 -178.486 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.954 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 174.3 166.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.605 -0.887 . . . . 14.460000000000001 108.605 -179.872 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.567 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 25.3 mt-10 -137.6 113.79 10.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.822 -0.807 . . . . 22.120000000000001 108.822 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.764 HD11 ' SG ' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -72.53 103.81 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.472 -1.307 . . . . 14.23 107.472 179.449 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.657 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.64 171.46 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.978 -1.076 . . . . 25.43 109.638 -178.846 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.2 Cg_endo -75.05 -28.18 9.3 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.437 2.091 . . . . 13.609999999999999 110.041 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -88.03 -0.26 56.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.468 -0.77 . . . . 15.52 109.029 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.599 ' OE1' HD12 ' A' ' 32' ' ' LEU . 13.9 mm-40 -116.21 36.91 3.87 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.395 -0.816 . . . . 17.309999999999999 109.218 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.62 10.79 40.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 24.780000000000001 110.062 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.439 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 13.4 mt-30 -137.74 136.16 37.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.227 -0.921 . . . . 47.899999999999999 109.745 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.62 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 31.0 p90 -86.21 165.98 16.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.2 -0.938 . . . . 21.609999999999999 109.556 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -133.45 149.75 51.77 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.383 -0.823 . . . . 14.890000000000001 109.27 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.297 -0.877 . . . . 17.350000000000001 109.218 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.578 0.704 . . . . 24.0 110.18 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.62 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -88.09 129.45 35.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.563 -0.711 . . . . 23.309999999999999 109.77 -179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 14.7 mt-10 -115.09 162.38 17.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.302 -0.874 . . . . 40.030000000000001 109.34 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.821 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.92 -173.53 4.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.108 -0.995 . . . . 12.390000000000001 109.876 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 ' O ' ' A' ' 31' ' ' GLN . 25.1 mt -133.71 159.35 40.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 17.420000000000002 109.221 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.764 ' SG ' HD11 ' A' ' 6' ' ' ILE . 3.5 m -154.23 168.44 26.54 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.937 -1.135 . . . . 13.84 107.937 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.694 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 29.4 m-85 -120.53 105.92 11.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.951 -1.093 . . . . 21.140000000000001 109.589 -179.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 43' ' ' VAL . 39.9 t -97.8 139.69 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.002 -1.061 . . . . 10.66 111.095 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.649 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 m-20 -115.22 -140.49 0.38 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.318 -0.993 . . . . 25.890000000000001 108.318 178.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.718 ' CB ' HD21 ' B' ' 65' ' ' LEU . 0.2 OUTLIER 67.44 -68.41 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.924 -1.11 . . . . 24.239999999999998 108.47 179.467 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -78.66 -1.47 83.27 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 107.913 -2.075 . . . . 31.02 107.913 178.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -160.12 110.26 1.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.513 -0.992 . . . . 43.229999999999997 108.95 179.748 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 39' ' ' ASN . 2.0 mm-40 -37.68 -63.29 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.642 0.734 . . . . 42.340000000000003 109.81 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 37.3 m80 -69.0 163.95 52.08 Favored Pre-proline 0 C--N 1.293 -1.882 0 N-CA-C 108.076 -1.083 . . . . 8.0199999999999996 108.076 179.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.694 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -76.53 141.48 22.43 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 121.699 1.599 . . . . 17.920000000000002 109.748 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 35' ' ' VAL . 25.7 m -113.72 115.89 51.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.315 -0.866 . . . . 20.57 109.46 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.788 HD11 ' HB3' ' A' ' 32' ' ' LEU . 52.0 tp -74.23 103.39 4.63 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.366 -0.833 . . . . 20.210000000000001 109.749 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.585 HG12 HG11 ' B' ' 70' ' ' VAL . 1.3 m -107.43 176.15 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.509 -0.744 . . . . 10.81 109.172 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.28 139.85 35.37 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.314 -0.955 . . . . 36.740000000000002 109.527 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.973 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -124.02 170.59 14.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.42 -0.8 . . . . 19.739999999999998 109.261 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.683 HG21 ' NH1' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -111.77 142.53 44.0 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.175 -0.953 . . . . 22.559999999999999 109.497 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.609 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -110.41 147.48 33.93 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 20.41 108.721 179.711 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.532 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 1.0 OUTLIER -85.26 145.24 27.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 33.990000000000002 109.831 -179.332 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.19 119.82 5.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.36 -0.838 . . . . 54.920000000000002 109.614 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.79 -15.55 46.73 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.681 -1.368 . . . . 36.100000000000001 109.681 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.532 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -74.99 145.19 80.67 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.202 -1.176 . . . . 54.759999999999998 109.343 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.84 121.9 5.64 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.596 2.197 . . . . 28.370000000000001 110.74 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.816 ' HB1' HE21 ' A' ' 31' ' ' GLN . . . -38.92 149.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.501 -0.749 . . . . 17.210000000000001 110.388 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.755 ' HB3' HD13 ' A' ' 6' ' ' ILE . 89.6 m-85 -46.49 105.36 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.758 -0.83 . . . . 17.190000000000001 108.758 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -58.88 176.73 0.27 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.382 -0.824 . . . . 17.82 110.023 -179.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.8 Cg_endo -77.69 110.26 2.91 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.737 2.291 . . . . 17.280000000000001 110.338 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 173.65 151.94 8.54 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.563 -1.415 . . . . 17.219999999999999 109.563 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 5.1 mp -49.27 150.22 1.83 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.321 . . . . 19.57 108.779 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.954 ' CB ' HG13 ' A' ' 4' ' ' VAL . 19.1 m-85 -128.57 163.89 24.02 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.768 -1.207 . . . . 14.609999999999999 111.564 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.755 ' O ' HG22 ' A' ' 84' ' ' VAL . 55.8 p -147.69 118.73 7.69 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.411 -1.7 . . . . 18.359999999999999 106.411 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.619 HG11 ' HB2' ' A' ' 81' ' ' LEU . 8.6 t -53.33 169.86 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 C-N-CA 118.809 -1.157 . . . . 19.129999999999999 108.917 -178.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.577 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -128.08 120.14 26.8 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.426 -0.796 . . . . 20.649999999999999 109.066 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.954 HD13 HG23 ' B' ' 2' ' ' ILE . 0.0 OUTLIER -65.08 -8.28 15.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.727 -0.608 . . . . 19.649999999999999 109.914 -179.176 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.3 p -52.28 -17.95 1.36 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.02 -1.05 . . . . 14.720000000000001 108.402 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 2.3 m -95.94 -6.06 39.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.566 -0.709 . . . . 11.449999999999999 110.79 -179.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.615 ' CE1' HG12 ' A' ' 78' ' ' ILE . 1.9 m-30 -86.61 164.64 16.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.741 -1.224 . . . . 14.25 110.174 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 1.4 mtpp -159.33 178.78 9.59 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.876 -0.787 . . . . 32.700000000000003 108.876 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.812 HG21 HG21 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -118.6 114.82 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 15.630000000000001 109.38 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.472 ' C ' ' NE2' ' A' ' 72' ' ' GLN . . . -74.46 -167.88 18.67 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.461 -1.456 . . . . 12.699999999999999 109.461 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.543 ' NE2' ' N ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -88.35 39.97 0.93 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -1.168 . . . . 26.289999999999999 109.48 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 28.3 m-85 -134.21 27.8 3.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.35 -0.844 . . . . 20.440000000000001 109.261 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 73' ' ' PHE . . . 44.7 49.01 8.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.583 -1.407 . . . . 13.82 109.583 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -149.51 145.67 26.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -1.181 . . . . 18.27 109.66 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.8 OUTLIER -88.41 149.49 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 12.43 109.119 179.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 54.6 mtm -157.4 137.84 12.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -0.984 . . . . 35.109999999999999 109.637 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.828 HD12 HD12 ' B' ' 78' ' ' ILE . 3.0 mt -69.98 139.59 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 13.67 110.105 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.1 -25.48 11.55 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.221 -1.029 . . . . 24.059999999999999 108.221 178.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.683 ' NH1' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -179.92 68.01 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.125 -1.435 . . . . 35.039999999999999 107.125 179.144 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -33.23 120.48 0.37 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.281 -0.872 . . . . 18.719999999999999 111.644 -178.247 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -91.45 113.21 25.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.922 -1.14 . . . . 20.550000000000001 107.922 178.786 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.973 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -82.55 148.85 27.82 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.028 -1.045 . . . . 14.4 110.959 -178.553 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 62' ' ' THR . 32.6 m -150.65 150.13 27.62 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 107.96 -1.126 . . . . 17.649999999999999 107.96 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.1 Cg_endo -61.37 140.89 90.46 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.164 1.91 . . . . 25.699999999999999 110.581 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.11 117.15 8.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 49.289999999999999 109.651 -178.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.005 -0.998 . . . . 58.909999999999997 109.49 179.991 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.643 ' O ' HD22 ' B' ' 37' ' ' LEU . 1.2 pmm? . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.471 -0.566 . . . . 64.909999999999997 109.471 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.954 HG23 HD13 ' A' ' 65' ' ' LEU . 2.3 mt -74.25 66.57 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.043 -1.095 . . . . 33.799999999999997 108.043 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.633 ' C ' HG12 ' B' ' 4' ' ' VAL . 0.5 OUTLIER -56.93 178.76 0.05 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.88 0.848 . . . . 32.719999999999999 110.992 -178.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.958 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 174.19 166.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.625 -0.879 . . . . 14.460000000000001 108.625 -179.84 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 25.2 mt-10 -137.34 113.99 10.36 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.826 -0.805 . . . . 22.120000000000001 108.826 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.768 HD11 ' SG ' ' B' ' 33' ' ' CYS . 0.1 OUTLIER -72.74 103.75 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 107.529 -1.286 . . . . 14.23 107.529 179.48 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.669 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.63 171.27 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.995 -1.065 . . . . 25.43 109.564 -178.791 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.3 Cg_endo -74.96 -28.3 9.35 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.445 2.096 . . . . 13.609999999999999 110.088 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -87.6 -0.73 57.27 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.02 -0.733 . . . . 15.52 109.02 179.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.579 ' OE1' HD12 ' B' ' 32' ' ' LEU . 13.6 mm-40 -115.9 37.08 3.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.342 -0.849 . . . . 17.309999999999999 109.301 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.71 10.77 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 24.780000000000001 110.004 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.438 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 13.7 mt-30 -137.62 136.14 37.23 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 47.899999999999999 109.785 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.625 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 30.8 p90 -86.15 165.97 16.14 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.248 -0.908 . . . . 21.609999999999999 109.573 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 89.7 m -133.42 149.84 51.79 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.385 -0.822 . . . . 14.890000000000001 109.234 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.479 0 O-C-N 121.251 -0.905 . . . . 17.350000000000001 109.224 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.577 0.704 . . . . 24.0 110.089 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.625 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -88.47 129.25 35.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.601 -0.687 . . . . 23.309999999999999 109.802 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 14.7 mt-10 -114.89 162.27 17.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 40.030000000000001 109.387 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.837 ' O ' HD23 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -148.76 -173.48 4.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.994 . . . . 12.390000000000001 109.892 -179.814 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.837 HD23 ' O ' ' B' ' 31' ' ' GLN . 25.3 mt -133.85 159.41 40.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 17.420000000000002 109.264 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.768 ' SG ' HD11 ' B' ' 6' ' ' ILE . 3.5 m -154.27 168.24 27.24 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.963 -1.125 . . . . 13.84 107.963 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.684 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 29.7 m-85 -120.38 105.93 11.36 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.957 -1.089 . . . . 21.140000000000001 109.652 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.827 ' O ' HG22 ' B' ' 43' ' ' VAL . 40.0 t -97.93 139.65 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.087 -1.008 . . . . 10.66 110.995 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.645 ' O ' HD12 ' B' ' 37' ' ' LEU . 4.4 m-20 -115.27 -140.46 0.38 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.292 -1.003 . . . . 25.890000000000001 108.292 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.709 ' CB ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 67.33 -68.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.925 -1.109 . . . . 24.239999999999998 108.405 179.479 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -78.6 -1.54 83.08 Favored Glycine 0 C--N 1.297 -1.587 0 N-CA-C 107.873 -2.091 . . . . 31.02 107.873 178.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.451 ' O ' ' C ' ' B' ' 40' ' ' GLU . 0.1 OUTLIER -160.37 110.12 1.77 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.512 -0.993 . . . . 43.229999999999997 108.869 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' B' ' 39' ' ' ASN . 2.0 mm-40 -37.37 -63.53 0.44 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.633 0.73 . . . . 42.340000000000003 109.827 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.471 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 37.9 m80 -68.89 164.1 49.99 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 108.03 -1.1 . . . . 8.0399999999999991 108.03 179.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.684 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.3 Cg_endo -76.51 141.53 22.54 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.722 1.615 . . . . 17.920000000000002 109.836 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.827 HG22 ' O ' ' B' ' 35' ' ' VAL . 25.5 m -113.73 115.77 50.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.255 -0.903 . . . . 20.57 109.495 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' B' ' 32' ' ' LEU . 52.1 tp -74.26 103.15 4.56 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.417 -0.802 . . . . 20.210000000000001 109.741 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.566 HG12 HG11 ' A' ' 70' ' ' VAL . 1.3 m -107.07 176.19 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.505 -0.747 . . . . 10.81 109.147 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.404 ' HA ' HD23 ' B' ' 32' ' ' LEU . 0.3 OUTLIER -100.17 139.87 35.23 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.393 -0.923 . . . . 36.740000000000002 109.526 179.627 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 1.014 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.6 OUTLIER -124.12 170.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.383 -0.823 . . . . 19.739999999999998 109.254 -179.748 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.681 HG21 ' NH1' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -111.7 142.27 44.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.206 -0.934 . . . . 22.559999999999999 109.575 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.606 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -110.21 147.54 33.58 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.285 -0.884 . . . . 20.41 108.763 179.676 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 1.0 OUTLIER -85.37 145.11 27.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.128 -0.983 . . . . 33.990000000000002 109.854 -179.355 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.85 119.84 5.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 54.920000000000002 109.595 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.74 -15.56 46.44 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.707 -1.357 . . . . 36.100000000000001 109.707 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.529 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -75.0 145.12 80.56 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 54.759999999999998 109.311 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.8 Cg_endo -77.78 121.75 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.616 2.211 . . . . 28.370000000000001 110.731 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.809 ' HB1' HE21 ' B' ' 31' ' ' GLN . . . -38.68 150.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.548 -0.72 . . . . 17.210000000000001 110.415 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.746 ' HB3' HD13 ' B' ' 6' ' ' ILE . 89.4 m-85 -46.79 105.4 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.324 -0.86 . . . . 17.190000000000001 108.724 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 1.024 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -58.83 176.89 0.26 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 17.82 110.121 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 1.024 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.78 110.26 2.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.673 2.249 . . . . 17.280000000000001 110.278 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 173.68 151.96 8.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.579 -1.408 . . . . 17.219999999999999 109.579 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.1 mp -49.25 150.1 1.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.985 -1.303 . . . . 19.57 108.724 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.958 ' CB ' HG13 ' B' ' 4' ' ' VAL . 18.7 m-85 -128.55 163.86 24.08 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.833 -1.167 . . . . 14.609999999999999 111.589 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.742 ' O ' HG22 ' B' ' 84' ' ' VAL . 53.8 p -147.6 118.71 7.73 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.481 -1.674 . . . . 18.359999999999999 106.481 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' B' ' 81' ' ' LEU . 9.2 t -53.3 169.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.811 -1.156 . . . . 19.129999999999999 108.878 -178.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.585 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -128.2 120.1 26.57 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.499 -0.751 . . . . 20.649999999999999 109.05 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.957 HD13 HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -64.9 -8.43 15.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.709 -0.619 . . . . 19.649999999999999 109.923 -179.151 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 96.0 p -52.05 -17.98 1.25 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.952 -1.092 . . . . 14.720000000000001 108.377 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 2.4 m -95.96 -6.59 38.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.502 -0.749 . . . . 11.449999999999999 110.776 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.631 ' CE1' HG12 ' B' ' 78' ' ' ILE . 1.8 m-30 -86.15 164.4 17.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.73 -1.231 . . . . 14.25 110.046 -179.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -159.09 179.06 9.38 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.82 -0.808 . . . . 32.700000000000003 108.82 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.825 HG21 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -118.73 115.13 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 15.630000000000001 109.427 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.483 ' C ' ' NE2' ' B' ' 72' ' ' GLN . . . -74.58 -168.09 19.66 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.495 -1.442 . . . . 12.699999999999999 109.495 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.55 ' NE2' ' N ' ' B' ' 72' ' ' GLN . 0.6 OUTLIER -88.13 39.71 0.91 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.167 -1.196 . . . . 26.289999999999999 109.475 179.937 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' B' ' 73' ' ' PHE . 28.6 m-85 -133.99 28.09 3.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 20.440000000000001 109.38 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.39 49.1 8.46 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.627 -1.389 . . . . 13.82 109.627 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -149.67 145.69 26.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -1.145 . . . . 18.27 109.684 -179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.8 OUTLIER -88.58 149.62 23.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 12.43 109.072 179.734 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.492 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 54.4 mtm -157.52 138.18 13.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.123 -0.986 . . . . 35.109999999999999 109.52 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.828 HD12 HD12 ' A' ' 78' ' ' ILE . 2.9 mp -70.4 139.52 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.856 . . . . 13.67 110.134 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.84 -25.53 11.65 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.138 -1.06 . . . . 24.059999999999999 108.138 178.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.681 ' NH1' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER -179.77 68.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.186 -1.413 . . . . 35.039999999999999 107.186 179.17 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.656 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -33.21 120.28 0.36 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.311 -0.859 . . . . 18.719999999999999 111.607 -178.187 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -91.32 113.09 25.26 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.979 -1.119 . . . . 20.550000000000001 107.979 178.723 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.014 ' HB2' HD11 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -82.42 148.93 27.92 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.037 -1.039 . . . . 14.4 110.986 -178.603 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.742 HG22 ' O ' ' B' ' 62' ' ' THR . 32.5 m -150.63 150.04 27.45 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.994 -1.113 . . . . 17.649999999999999 107.994 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.0 Cg_endo -61.41 140.44 87.83 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.188 1.925 . . . . 25.699999999999999 110.6 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -65.51 117.47 8.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 49.289999999999999 109.62 -178.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.027 -0.987 . . . . 58.909999999999997 109.484 -179.98 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.358 -0.608 . . . . 64.909999999999997 109.358 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.896 ' N ' HD22 ' B' ' 65' ' ' LEU . 2.2 mt -60.4 84.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.897 -1.149 . . . . 33.799999999999997 107.897 179.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 1' ' ' MET . 17.4 mttt -57.85 157.14 7.92 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.847 0.832 . . . . 32.719999999999999 111.569 -177.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.057 HG22 HG22 ' A' ' 35' ' ' VAL . 59.8 t -160.52 167.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.585 0.707 . . . . 14.460000000000001 109.724 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.61 ' N ' HG12 ' A' ' 4' ' ' VAL . 38.9 mt-10 -154.09 101.44 2.41 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.771 0.796 . . . . 22.120000000000001 108.931 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -71.38 101.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.986 -1.116 . . . . 14.23 107.986 179.642 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.581 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 15.6 mmmt -50.52 163.3 0.47 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.414 -0.803 . . . . 25.43 109.252 -179.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.5 Cg_endo -71.98 -10.1 25.62 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.818 1.679 . . . . 13.609999999999999 109.247 179.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.82 12.21 31.07 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.533 -0.914 . . . . 15.52 108.533 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.529 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 7.6 mm-40 -137.08 38.45 2.54 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.31 -0.869 . . . . 17.309999999999999 109.211 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -111.96 31.48 6.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.96 . . . . 24.780000000000001 110.19 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 12.0 mt-30 -140.3 132.36 27.9 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.261 -0.9 . . . . 47.899999999999999 109.501 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.642 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 33.6 p90 -89.52 155.81 19.05 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.213 -0.93 . . . . 21.609999999999999 109.671 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.1 m -134.6 150.16 50.67 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.885 -0.783 . . . . 14.890000000000001 108.885 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.572 0 O-C-N 121.164 -0.96 . . . . 17.350000000000001 109.236 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.573 HD13 HH22 ' A' ' 80' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.447 0.642 . . . . 24.0 110.418 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.653 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -47.61 117.75 1.95 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.433 -0.792 . . . . 23.309999999999999 109.569 179.607 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -112.87 147.68 36.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.255 -0.903 . . . . 40.030000000000001 109.593 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.949 ' OE1' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -131.22 -169.71 2.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.121 -0.987 . . . . 12.390000000000001 109.341 179.843 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.971 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -128.56 177.53 6.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 17.420000000000002 109.32 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.811 ' SG ' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -172.43 162.69 5.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.053 -1.029 . . . . 13.84 108.467 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.697 ' HE1' HD13 ' A' ' 44' ' ' LEU . 4.1 m-30 -114.58 95.25 5.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.154 -0.966 . . . . 21.140000000000001 109.187 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.057 HG22 HG22 ' A' ' 4' ' ' VAL . 92.2 t -84.87 115.45 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 10.66 110.234 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 t0 -66.1 -22.67 66.41 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.381 -0.824 . . . . 25.890000000000001 108.805 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.723 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.8 OUTLIER 43.23 26.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.771 . . . . 24.239999999999998 109.567 179.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 58.6 22.3 52.23 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.891 -1.284 . . . . 31.02 109.891 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.546 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 19.2 p30 -100.64 27.8 5.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.983 -1.304 . . . . 43.229999999999997 110.079 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.628 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 12.2 mt-10 47.72 71.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 42.340000000000003 109.871 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.628 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER 142.92 144.46 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.287 0 N-CA-C 108.572 -0.899 . . . . 6.5700000000000003 108.572 179.451 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.681 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -79.57 142.96 16.64 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.206 1.938 . . . . 17.920000000000002 110.841 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.97 HG22 ' O ' ' A' ' 35' ' ' VAL . 6.9 m -120.52 119.3 59.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.441 -0.948 . . . . 20.57 108.441 178.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.971 HD11 ' HB3' ' A' ' 32' ' ' LEU . 17.7 tp -66.88 112.72 4.44 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.428 -0.795 . . . . 20.210000000000001 109.241 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 3.6 t -119.47 168.4 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.576 -0.702 . . . . 10.81 109.572 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -90.57 149.89 21.96 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.431 -0.793 . . . . 36.740000000000002 109.954 -179.776 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.861 HD11 ' CB ' ' A' ' 83' ' ' LEU . 1.6 tt -130.21 176.86 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.802 -0.814 . . . . 19.739999999999998 108.802 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.634 HG21 ' CZ ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -125.4 135.24 52.18 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.184 -0.948 . . . . 22.559999999999999 109.094 179.453 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -104.67 99.99 9.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.209 -0.932 . . . . 20.41 109.003 179.981 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.69 156.44 36.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 33.990000000000002 109.606 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.27 136.81 57.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.221 -0.924 . . . . 54.920000000000002 109.228 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.86 -35.05 3.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.321 -1.512 . . . . 36.100000000000001 109.321 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.797 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.3 mt-30 -77.32 124.04 86.98 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.243 -1.151 . . . . 54.759999999999998 109.245 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.1 Cg_endo -78.63 138.28 15.11 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.279 1.986 . . . . 28.370000000000001 110.406 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.949 ' HB1' ' OE1' ' A' ' 31' ' ' GLN . . . -35.84 138.16 0.19 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.637 -0.664 . . . . 17.210000000000001 110.424 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.7 ' HB3' HD13 ' A' ' 6' ' ' ILE . 83.7 m-85 -51.75 109.99 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 17.190000000000001 109.511 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.917 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -59.72 174.33 0.45 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.263 -0.898 . . . . 17.82 109.252 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.917 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.7 Cg_endo -77.48 110.32 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.632 2.221 . . . . 17.280000000000001 110.406 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.37 179.85 48.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.743 -1.343 . . . . 17.219999999999999 109.743 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -74.83 143.99 43.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -1.114 . . . . 19.57 108.76 179.483 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.555 ' CB ' ' HB ' ' A' ' 4' ' ' VAL . 27.0 m-85 -132.42 164.58 26.21 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.873 -1.142 . . . . 14.609999999999999 111.206 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.807 ' O ' HG22 ' A' ' 84' ' ' VAL . 31.1 p -144.11 118.96 9.9 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.925 -1.88 . . . . 18.359999999999999 105.925 178.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.743 ' HB ' HD13 ' A' ' 2' ' ' ILE . 2.6 t -52.36 166.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 C-N-CA 118.434 -1.307 . . . . 19.129999999999999 108.999 -178.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -129.13 128.81 44.22 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.417 -0.802 . . . . 20.649999999999999 109.3 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.906 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -71.3 0.19 8.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.691 -0.631 . . . . 19.649999999999999 110.051 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -57.25 -17.66 12.7 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.645 -1.243 . . . . 14.720000000000001 107.645 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.488 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 50.4 m -96.41 -8.38 32.52 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.782 -0.574 . . . . 11.449999999999999 110.193 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.739 ' C ' HD11 ' B' ' 37' ' ' LEU . 2.8 m-30 -77.69 155.04 31.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.052 . . . . 14.25 109.585 -178.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.467 ' HG2' ' HB2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -134.71 172.9 12.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.406 -0.809 . . . . 32.700000000000003 109.731 -179.651 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.87 HG21 HG21 ' B' ' 43' ' ' VAL . 8.7 t -124.41 133.34 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.492 -0.755 . . . . 15.630000000000001 109.376 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.26 -157.56 27.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.435 -1.466 . . . . 12.699999999999999 109.435 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.511 ' HA ' ' NE2' ' A' ' 72' ' ' GLN . 6.5 tp-100 55.88 72.42 0.49 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -1.181 . . . . 26.289999999999999 109.098 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER 73.32 5.95 5.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.779 . . . . 20.440000000000001 109.402 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.481 ' O ' HG13 ' B' ' 45' ' ' VAL . . . 78.29 45.07 10.34 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.474 -1.451 . . . . 13.82 109.474 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.3 OUTLIER -127.07 119.66 27.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.144 . . . . 18.27 109.713 -179.913 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' HG11 ' B' ' 35' ' ' VAL . 0.8 OUTLIER -54.95 144.68 22.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 12.43 109.106 179.801 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 30.9 mtp -160.28 140.8 11.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 35.109999999999999 109.783 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.946 HD12 HD12 ' B' ' 78' ' ' ILE . 2.3 mp -68.56 141.66 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.816 . . . . 13.67 109.73 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 39.5 t0 -108.61 -21.26 12.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.689 -0.856 . . . . 24.059999999999999 108.689 178.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.634 ' CZ ' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER 174.22 66.76 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.1 -1.444 . . . . 35.039999999999999 107.1 179.497 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -28.3 119.7 0.11 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.257 -0.883 . . . . 18.719999999999999 111.961 -178.07 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 5.3 ttp180 -93.14 102.87 15.18 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.841 -1.17 . . . . 20.550000000000001 107.841 178.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.861 ' CB ' HD11 ' A' ' 47' ' ' ILE . 7.0 tp -74.13 149.75 40.85 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.158 -0.964 . . . . 14.4 111.184 -178.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 62' ' ' THR . 17.8 m -146.33 152.98 47.63 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.214 -1.032 . . . . 17.649999999999999 108.214 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 26.0 Cg_endo -64.51 142.97 80.37 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.2 1.933 . . . . 25.699999999999999 110.402 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.793 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -76.94 123.67 26.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 49.289999999999999 109.692 -178.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.003 -0.999 . . . . 58.909999999999997 109.432 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.516 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.387 -0.597 . . . . 64.909999999999997 109.387 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.906 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.2 mt -60.23 84.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.881 -1.155 . . . . 33.799999999999997 107.881 179.065 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.533 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 17.5 mttt -57.75 157.25 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.815 0.817 . . . . 32.719999999999999 111.543 -177.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.068 HG22 HG22 ' B' ' 35' ' ' VAL . 58.6 t -160.63 167.16 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.551 0.691 . . . . 14.460000000000001 109.726 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.608 ' N ' HG12 ' B' ' 4' ' ' VAL . 38.5 mt-10 -154.08 101.29 2.4 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.715 0.769 . . . . 22.120000000000001 108.963 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.694 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -71.28 101.77 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.994 -1.113 . . . . 14.23 107.994 179.664 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.565 ' HB3' ' HD2' ' B' ' 8' ' ' PRO . 15.7 mmmt -50.58 163.59 0.46 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.454 -0.779 . . . . 25.43 109.216 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.5 Cg_endo -72.23 -10.16 25.38 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.835 1.69 . . . . 13.609999999999999 109.205 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.62 12.06 31.6 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.485 -0.932 . . . . 15.52 108.485 178.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.541 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 7.7 mm-40 -136.91 38.19 2.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.869 . . . . 17.309999999999999 109.33 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.73 31.43 6.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.098 -1.001 . . . . 24.780000000000001 110.288 -179.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' B' ' 31' ' ' GLN . 11.9 mt-30 -140.26 132.26 27.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 47.899999999999999 109.504 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.642 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 33.0 p90 -89.33 155.75 19.15 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.249 -0.907 . . . . 21.609999999999999 109.662 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -134.63 150.27 50.65 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.83 -0.804 . . . . 14.890000000000001 108.83 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 17.350000000000001 109.209 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.58 HD13 HH22 ' B' ' 80' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.426 0.631 . . . . 24.0 110.408 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.664 ' OD1' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -47.56 117.81 1.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.434 -0.791 . . . . 23.309999999999999 109.627 179.668 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 6.4 mt-10 -112.77 148.02 35.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.218 -0.926 . . . . 40.030000000000001 109.584 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.955 ' OE1' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -131.6 -169.81 2.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.219 -0.926 . . . . 12.390000000000001 109.236 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.954 ' HB3' HD11 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -128.53 177.63 6.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.289 -0.882 . . . . 17.420000000000002 109.276 179.889 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.808 ' SG ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -172.51 162.56 5.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.992 -1.067 . . . . 13.84 108.4 -179.653 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.692 ' HE1' HD13 ' B' ' 44' ' ' LEU . 4.1 m-30 -114.51 95.36 5.22 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.125 -0.984 . . . . 21.140000000000001 109.203 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 1.068 HG22 HG22 ' B' ' 4' ' ' VAL . 92.6 t -84.92 115.41 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.028 -1.045 . . . . 10.66 110.27 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' B' ' 39' ' ' ASN . 1.1 t0 -66.0 -22.71 66.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.389 -0.819 . . . . 25.890000000000001 108.862 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.739 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER 43.23 26.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 24.239999999999998 109.55 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 58.64 22.56 53.18 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.862 -1.295 . . . . 31.02 109.862 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.542 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 19.1 p30 -100.89 27.66 5.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.016 -1.285 . . . . 43.229999999999997 110.034 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.631 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 12.2 mt-10 47.88 71.87 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 42.340000000000003 109.817 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.631 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 0.2 OUTLIER 142.89 144.44 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.196 0 N-CA-C 108.591 -0.892 . . . . 6.5599999999999996 108.591 179.48 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.674 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.7 Cg_endo -79.56 143.14 16.79 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.235 1.957 . . . . 17.920000000000002 110.762 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.987 HG22 ' O ' ' B' ' 35' ' ' VAL . 7.1 m -120.73 119.12 58.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.446 -0.946 . . . . 20.57 108.446 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.954 HD11 ' HB3' ' B' ' 32' ' ' LEU . 17.0 tp -66.71 112.96 4.48 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.413 -0.804 . . . . 20.210000000000001 109.294 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.575 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 3.7 t -119.71 168.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.552 -0.718 . . . . 10.81 109.553 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.575 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.5 OUTLIER -90.64 149.84 21.93 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.443 -0.786 . . . . 36.740000000000002 110.007 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.873 HD11 ' CB ' ' B' ' 83' ' ' LEU . 1.6 tt -130.11 176.95 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.836 -0.801 . . . . 19.739999999999998 108.836 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.648 HG21 ' CZ ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -125.57 134.94 51.78 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.228 -0.92 . . . . 22.559999999999999 109.149 179.486 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.799 HD12 ' O ' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -104.48 100.07 9.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.169 -0.957 . . . . 20.41 109.05 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.8 156.44 37.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 33.990000000000002 109.642 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.25 136.77 57.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.867 . . . . 54.920000000000002 109.245 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.76 -34.56 4.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.388 -1.485 . . . . 36.100000000000001 109.388 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.799 ' O ' HD12 ' B' ' 49' ' ' LEU . 4.3 mt-30 -77.71 123.99 86.49 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.234 -1.157 . . . . 54.759999999999998 109.202 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.476 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.8 Cg_endo -78.54 138.06 15.1 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.343 2.029 . . . . 28.370000000000001 110.478 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.955 ' HB1' ' OE1' ' B' ' 31' ' ' GLN . . . -35.62 137.78 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.384 0.612 . . . . 17.210000000000001 110.478 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.694 ' HB3' HD13 ' B' ' 6' ' ' ILE . 84.6 m-85 -51.28 109.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 17.190000000000001 109.558 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.943 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -59.72 174.25 0.46 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 17.82 109.27 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.943 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.26 109.53 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.541 2.161 . . . . 17.280000000000001 110.193 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.08 179.52 48.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.83 -1.308 . . . . 17.219999999999999 109.83 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.829 HD23 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -75.2 143.73 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -1.14 . . . . 19.57 108.474 179.263 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.561 ' CB ' HD21 ' B' ' 83' ' ' LEU . 27.0 m-85 -132.04 164.57 25.92 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.835 -1.165 . . . . 14.609999999999999 111.173 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.831 ' O ' HG22 ' B' ' 84' ' ' VAL . 31.9 p -143.99 119.0 10.0 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 105.907 -1.886 . . . . 18.359999999999999 105.907 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.752 ' HB ' HD13 ' B' ' 2' ' ' ILE . 2.5 t -52.52 166.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 C-N-CA 118.42 -1.312 . . . . 19.129999999999999 108.941 -178.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.512 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -129.26 128.73 43.84 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.413 -0.804 . . . . 20.649999999999999 109.287 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.896 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -71.23 0.17 8.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.621 -0.674 . . . . 19.649999999999999 110.11 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -57.2 -17.7 12.52 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.67 -1.233 . . . . 14.720000000000001 107.67 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.492 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 51.1 m -96.23 -8.78 32.03 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.773 -0.58 . . . . 11.449999999999999 110.255 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.723 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.8 m-30 -77.3 155.01 32.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.023 -1.048 . . . . 14.25 109.542 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' B' ' 79' ' ' ASP . 0.1 OUTLIER -134.83 172.58 12.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.424 -0.797 . . . . 32.700000000000003 109.703 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.851 HG21 HG21 ' A' ' 43' ' ' VAL . 9.5 t -124.14 133.31 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.462 -0.774 . . . . 15.630000000000001 109.387 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.37 -157.3 27.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.506 -1.438 . . . . 12.699999999999999 109.506 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.533 ' HA ' ' NE2' ' B' ' 72' ' ' GLN . 6.5 tp-100 55.68 72.27 0.5 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -1.164 . . . . 26.289999999999999 109.131 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.1 OUTLIER 73.44 5.94 5.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 20.440000000000001 109.467 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.477 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 78.32 45.1 10.26 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.547 -1.421 . . . . 13.82 109.547 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 77' ' ' MET . 0.3 OUTLIER -127.13 119.57 26.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -1.1 . . . . 18.27 109.755 -179.916 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.548 HD13 HG11 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -54.94 144.54 22.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 12.43 109.152 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 31.1 mtp -160.14 141.1 12.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 35.109999999999999 109.749 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.946 HD12 HD12 ' A' ' 78' ' ' ILE . 2.3 mp -68.87 141.83 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 13.67 109.775 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.473 ' HB2' ' HG2' ' B' ' 69' ' ' LYS . 39.1 t0 -108.66 -21.23 12.79 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.685 -0.857 . . . . 24.059999999999999 108.685 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.648 ' CZ ' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER 174.08 66.58 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.075 -1.454 . . . . 35.039999999999999 107.075 179.541 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.653 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -28.01 119.98 0.11 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.27 -0.877 . . . . 18.719999999999999 111.893 -178.097 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 5.4 ttp180 -93.38 103.09 15.34 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.814 -1.18 . . . . 20.550000000000001 107.814 178.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.873 ' CB ' HD11 ' B' ' 47' ' ' ILE . 7.0 tp -74.35 149.59 40.5 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.113 -0.992 . . . . 14.4 111.148 -178.237 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.831 HG22 ' O ' ' B' ' 62' ' ' THR . 17.6 m -146.19 153.14 48.4 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.224 -1.028 . . . . 17.649999999999999 108.224 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 26.5 Cg_endo -64.6 143.34 81.0 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.155 1.903 . . . . 25.699999999999999 110.397 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.812 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -77.38 123.82 27.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.87 . . . . 49.289999999999999 109.643 -178.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.04 -0.981 . . . . 58.909999999999997 109.433 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 tpp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.489 -0.559 . . . . 64.909999999999997 109.489 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.764 ' N ' HD22 ' B' ' 65' ' ' LEU . 2.1 mt -59.46 84.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.962 -1.125 . . . . 33.799999999999997 107.962 179.297 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 1' ' ' MET . 15.3 mtpp -67.1 152.5 45.65 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.827 0.823 . . . . 32.719999999999999 111.306 -178.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.901 HG11 HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -164.15 167.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 108.381 -0.97 . . . . 14.460000000000001 108.381 179.593 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.572 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 24.3 mt-10 -141.08 118.0 11.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.336 -0.853 . . . . 22.120000000000001 109.361 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.867 HG21 ' O ' ' A' ' 56' ' ' TYR . 10.4 mm -75.71 92.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.919 -1.141 . . . . 14.23 107.919 179.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.671 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -44.89 171.66 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 25.43 110.19 -178.677 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -74.73 -29.28 8.89 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.481 2.121 . . . . 13.609999999999999 109.728 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -6.74 58.17 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.762 -0.829 . . . . 15.52 108.762 178.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 1.3 mm100 -118.35 40.56 3.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.417 -0.802 . . . . 17.309999999999999 109.342 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -103.69 7.96 37.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.092 -1.005 . . . . 24.780000000000001 109.646 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.443 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 37.5 mt-30 -138.05 138.89 39.24 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.323 -0.861 . . . . 47.899999999999999 109.624 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.656 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 36.1 p90 -92.13 161.32 14.79 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.15 -0.969 . . . . 21.609999999999999 108.76 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.1 m -130.02 152.54 49.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.103 -0.998 . . . . 14.890000000000001 109.687 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.457 0 O-C-N 121.333 -0.854 . . . . 17.350000000000001 109.314 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.411 0.624 . . . . 24.0 110.451 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.626 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 98.0 m-20 -78.33 129.59 35.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.496 -0.752 . . . . 23.309999999999999 109.277 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -123.28 149.06 45.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 40.030000000000001 109.17 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.617 ' HB3' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -136.33 -170.17 2.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 12.390000000000001 109.65 -179.985 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.778 ' HB3' HD11 ' A' ' 44' ' ' LEU . 5.9 mp -132.03 174.49 10.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.327 -0.858 . . . . 17.420000000000002 109.526 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -162.69 159.37 24.29 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.258 -1.015 . . . . 13.84 108.258 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.7 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 15.0 m-85 -114.77 96.64 5.83 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.152 -0.968 . . . . 21.140000000000001 109.384 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 43' ' ' VAL . 3.0 t -105.18 127.5 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 10.66 110.461 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 16.8 p-10 -86.48 -27.54 24.01 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.496 -0.927 . . . . 25.890000000000001 108.496 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.852 ' HG ' HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER 47.4 23.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 24.239999999999998 109.625 179.775 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.27 8.03 69.05 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.976 -1.25 . . . . 31.02 109.976 179.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' CG ' ' O ' ' A' ' 36' ' ' ASP . 1.7 m-20 -87.07 19.21 3.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.094 -1.239 . . . . 43.229999999999997 110.008 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.61 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 5.1 mt-10 45.98 72.03 0.25 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 42.340000000000003 109.862 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.61 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER 143.64 147.65 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.207 0 N-CA-C 108.6 -0.889 . . . . 6.5899999999999999 108.6 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.7 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -79.5 137.5 13.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.068 1.845 . . . . 17.920000000000002 110.542 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 35' ' ' VAL . 2.8 m -114.53 118.7 59.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.35 -0.844 . . . . 20.57 108.827 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 32' ' ' LEU . 56.7 tp -76.48 106.65 8.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.435 -0.791 . . . . 20.210000000000001 110.661 -178.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.607 HG13 HG23 ' A' ' 43' ' ' VAL . 21.2 m -115.24 -169.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.816 -0.809 . . . . 10.81 108.816 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -108.48 152.01 25.29 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.333 -0.947 . . . . 36.740000000000002 110.395 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.953 HD13 HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -141.41 126.15 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.57 -0.706 . . . . 19.739999999999998 109.141 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -64.36 147.12 53.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.062 . . . . 22.559999999999999 109.357 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.753 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.9 tm? -124.31 73.09 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 20.41 109.235 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 2.0 t70 -134.96 -175.48 3.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.916 -1.115 . . . . 33.990000000000002 109.72 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 53' ' ' GLN . 16.0 tt0 69.82 67.66 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.414 -0.804 . . . . 54.920000000000002 109.558 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 51' ' ' GLU . . . 38.17 27.85 0.04 OUTLIER Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.522 -1.031 . . . . 36.100000000000001 110.522 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 51' ' ' GLU . 3.5 mt-30 -105.96 125.58 32.8 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 120.897 -1.355 . . . . 54.759999999999998 109.913 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.528 ' C ' HD21 ' A' ' 49' ' ' LEU . 35.8 Cg_endo -78.73 146.35 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.313 2.008 . . . . 28.370000000000001 109.677 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.656 ' HB2' ' CD2' ' A' ' 13' ' ' PHE . . . -37.93 143.27 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.439 -0.788 . . . . 17.210000000000001 110.496 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.867 ' O ' HG21 ' A' ' 6' ' ' ILE . 79.5 m-85 -58.54 107.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.498 -0.751 . . . . 17.190000000000001 109.273 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.876 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.58 173.33 0.36 Allowed Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.107 -0.996 . . . . 17.82 108.983 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.876 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.8 Cg_endo -78.28 107.89 2.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.486 2.124 . . . . 17.280000000000001 110.09 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.23 179.32 47.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.963 -1.255 . . . . 17.219999999999999 109.963 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.708 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -77.12 137.74 39.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.385 -1.068 . . . . 19.57 108.642 179.203 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.937 ' HB3' HD22 ' A' ' 83' ' ' LEU . 26.9 m-85 -128.55 163.21 25.48 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.751 -1.218 . . . . 14.609999999999999 111.569 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.8 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.5 p -141.74 117.58 10.47 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.163 -1.791 . . . . 18.359999999999999 106.163 177.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.649 ' HB ' HD13 ' A' ' 2' ' ' ILE . 2.4 t -50.14 164.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 118.77 -1.172 . . . . 19.129999999999999 108.936 -178.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.3 t-80 -128.39 129.13 45.74 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.504 -0.747 . . . . 20.649999999999999 109.113 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.738 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER -72.59 2.19 6.88 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.519 -0.738 . . . . 19.649999999999999 109.985 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -18.91 30.66 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.002 -1.481 . . . . 14.720000000000001 107.002 178.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.504 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 14.7 m -96.19 -9.64 30.05 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.9 -0.5 . . . . 11.449999999999999 109.907 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.654 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.4 m-30 -78.05 154.37 31.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.112 -0.992 . . . . 14.25 109.951 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 3.8 mtmt -157.6 -178.38 7.29 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.528 -0.733 . . . . 32.700000000000003 109.182 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.565 ' CG1' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -109.96 105.82 19.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.434 -0.791 . . . . 15.630000000000001 109.132 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.22 -155.0 12.15 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.994 -1.243 . . . . 12.699999999999999 109.994 -179.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' HA ' ' NE2' ' A' ' 72' ' ' GLN . 12.6 tp60 -98.55 42.47 1.09 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.321 -1.105 . . . . 26.289999999999999 109.68 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 74' ' ' GLY . 2.8 m-85 -129.22 22.14 5.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 20.440000000000001 109.625 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 73' ' ' PHE . . . 44.79 52.56 7.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.627 -1.389 . . . . 13.82 109.627 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 76' ' ' LEU . 16.8 t -176.66 130.18 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -1.116 . . . . 18.27 109.448 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.816 HD22 HD13 ' B' ' 81' ' ' LEU . 0.1 OUTLIER -44.1 160.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.907 . . . . 12.43 109.159 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.4 mtt -163.7 118.67 1.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 35.109999999999999 109.585 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.002 HD12 HD12 ' B' ' 78' ' ' ILE . 2.3 mp -54.07 138.14 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 13.67 109.324 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -105.77 -34.8 7.56 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.011 -1.107 . . . . 24.059999999999999 108.011 178.516 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.504 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.2 OUTLIER -170.12 67.07 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.169 -1.419 . . . . 35.039999999999999 107.169 178.804 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.811 HD13 HD22 ' B' ' 76' ' ' LEU . 0.7 OUTLIER -27.99 120.05 0.11 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.21 -0.905 . . . . 18.719999999999999 111.859 -178.177 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -91.61 102.06 14.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 20.550000000000001 108.545 179.063 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.953 HD12 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -70.21 140.86 52.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.369 -0.832 . . . . 14.4 110.807 -178.818 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 62' ' ' THR . 33.5 m -140.61 148.8 54.67 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.774 -1.195 . . . . 17.649999999999999 107.774 178.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.8 Cg_endo -63.08 141.12 82.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.05 1.834 . . . . 25.699999999999999 110.265 179.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.708 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -71.83 108.44 5.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.309 -0.869 . . . . 49.289999999999999 109.461 -178.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.008 -0.996 . . . . 58.909999999999997 109.438 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.3 tpp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.474 -0.565 . . . . 64.909999999999997 109.474 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.738 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.1 mt -59.41 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.033 -1.099 . . . . 33.799999999999997 108.033 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' ' 1' ' ' MET . 15.2 mtpp -67.02 152.18 46.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.841 0.829 . . . . 32.719999999999999 111.265 -178.039 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.884 HG11 HD21 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -163.8 168.18 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.462 -0.94 . . . . 14.460000000000001 108.462 179.481 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.568 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 25.2 mt-10 -141.17 118.0 11.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.337 -0.852 . . . . 22.120000000000001 109.363 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.877 HG21 ' O ' ' B' ' 56' ' ' TYR . 10.4 mm -75.85 92.53 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.869 -1.16 . . . . 14.23 107.869 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.675 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.79 171.39 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.916 . . . . 25.43 110.189 -178.735 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.5 Cg_endo -74.65 -28.83 9.5 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.462 2.108 . . . . 13.609999999999999 109.85 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.51 -6.73 58.62 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.741 -0.837 . . . . 15.52 108.741 178.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 1.2 mm100 -118.28 40.26 3.23 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.418 -0.801 . . . . 17.309999999999999 109.306 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -103.62 8.98 37.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 24.780000000000001 109.711 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.45 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 37.2 mt-30 -138.99 138.68 37.47 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.286 -0.884 . . . . 47.899999999999999 109.638 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.655 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 36.1 p90 -91.92 161.32 14.87 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.176 -0.952 . . . . 21.609999999999999 108.815 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 96.7 m -130.28 152.05 50.12 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.103 -0.998 . . . . 14.890000000000001 109.667 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.463 0 O-C-N 121.395 -0.816 . . . . 17.350000000000001 109.354 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.522 0.677 . . . . 24.0 110.475 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.617 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 97.9 m-20 -77.95 130.01 36.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 23.309999999999999 109.141 179.559 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -123.58 148.95 45.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 40.030000000000001 109.047 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.612 ' HB3' HG22 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -136.24 -170.14 2.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.111 -0.993 . . . . 12.390000000000001 109.648 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.766 ' HB3' HD11 ' B' ' 44' ' ' LEU . 5.9 mp -132.19 174.35 10.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.38 -0.825 . . . . 17.420000000000002 109.455 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -162.53 159.58 24.99 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.273 -1.01 . . . . 13.84 108.273 -179.547 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.701 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 14.9 m-85 -115.06 96.52 5.73 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.204 -0.935 . . . . 21.140000000000001 109.358 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.875 ' O ' HG22 ' B' ' 43' ' ' VAL . 3.1 t -105.09 127.62 59.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.163 -0.961 . . . . 10.66 110.491 -179.495 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 16.7 p-10 -86.52 -27.43 24.01 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.512 -0.922 . . . . 25.890000000000001 108.512 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.859 ' HG ' HG12 ' B' ' 35' ' ' VAL . 0.4 OUTLIER 47.3 23.93 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 24.239999999999998 109.486 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.83 8.47 69.6 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.961 -1.256 . . . . 31.02 109.961 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.447 ' CG ' ' O ' ' B' ' 36' ' ' ASP . 2.1 m-20 -87.23 18.62 3.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -1.219 . . . . 43.229999999999997 109.942 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.6 ' O ' ' CB ' ' B' ' 41' ' ' HIS . 5.3 mt-10 46.76 71.37 0.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.89 . . . . 42.340000000000003 109.822 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.6 ' CB ' ' O ' ' B' ' 40' ' ' GLU . 0.2 OUTLIER 144.09 147.77 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.251 0 N-CA-C 108.57 -0.9 . . . . 6.5 108.57 179.383 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.701 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 38.4 Cg_endo -79.38 137.37 13.18 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.148 1.899 . . . . 17.920000000000002 110.52 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.875 HG22 ' O ' ' B' ' 35' ' ' VAL . 2.8 m -114.53 118.54 58.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.331 -0.856 . . . . 20.57 108.871 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.766 HD11 ' HB3' ' B' ' 32' ' ' LEU . 56.8 tp -76.45 106.98 8.4 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.361 -0.837 . . . . 20.210000000000001 110.638 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.605 HG13 HG23 ' B' ' 43' ' ' VAL . 22.0 m -115.65 -169.55 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.862 -0.792 . . . . 10.81 108.862 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -108.22 151.8 25.44 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.334 -0.947 . . . . 36.740000000000002 110.44 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.99 HD13 HD12 ' B' ' 83' ' ' LEU . 0.9 OUTLIER -141.23 126.14 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.503 -0.748 . . . . 19.739999999999998 109.056 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -64.49 146.88 53.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.002 -1.061 . . . . 22.559999999999999 109.322 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.769 HD13 ' O ' ' B' ' 49' ' ' LEU . 2.9 tm? -123.95 73.1 1.19 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 20.41 109.281 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' B' ' 53' ' ' GLN . 1.9 t70 -134.86 -175.46 3.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.941 -1.099 . . . . 33.990000000000002 109.8 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' B' ' 53' ' ' GLN . 16.5 tt0 69.84 67.73 0.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.348 -0.845 . . . . 54.920000000000002 109.588 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' B' ' 51' ' ' GLU . . . 38.07 28.04 0.04 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.537 -1.025 . . . . 36.100000000000001 110.537 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' B' ' 51' ' ' GLU . 3.3 mt-30 -106.13 125.71 32.38 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.888 -1.36 . . . . 54.759999999999998 109.894 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.515 ' C ' HD21 ' B' ' 49' ' ' LEU . 35.4 Cg_endo -78.8 146.62 21.03 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.408 2.072 . . . . 28.370000000000001 109.68 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.655 ' HB2' ' CD2' ' B' ' 13' ' ' PHE . . . -38.24 143.37 0.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.45 -0.781 . . . . 17.210000000000001 110.479 -179.291 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.877 ' O ' HG21 ' B' ' 6' ' ' ILE . 79.9 m-85 -58.49 106.99 0.44 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.458 -0.776 . . . . 17.190000000000001 109.201 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.901 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.58 173.29 0.37 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.105 -0.997 . . . . 17.82 109.076 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.901 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.5 Cg_endo -78.05 107.12 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.491 2.127 . . . . 17.280000000000001 110.031 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.15 179.26 46.52 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.576 -1.297 . . . . 17.219999999999999 110.106 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.717 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -77.42 137.4 38.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.405 -1.056 . . . . 19.57 108.445 179.121 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.953 ' HB3' HD22 ' B' ' 83' ' ' LEU . 26.9 m-85 -128.38 163.09 25.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.691 -1.255 . . . . 14.609999999999999 111.492 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.79 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.8 p -141.57 118.01 10.86 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.145 -1.798 . . . . 18.359999999999999 106.145 177.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.638 ' HB ' HD13 ' B' ' 2' ' ' ILE . 2.4 t -50.64 165.16 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 118.74 -1.184 . . . . 19.129999999999999 108.947 -178.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -128.51 129.15 45.64 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.5 -0.75 . . . . 20.649999999999999 109.142 -179.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.764 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -72.57 2.24 6.77 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.54 -0.725 . . . . 19.649999999999999 109.964 179.777 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.21 -19.51 34.16 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.843 -1.539 . . . . 14.720000000000001 106.843 178.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.507 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 14.4 m -95.68 -9.49 31.84 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.931 -0.481 . . . . 11.449999999999999 110.027 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.656 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.4 m-30 -78.06 154.18 31.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.037 . . . . 14.25 109.897 -178.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' B' ' 68' ' ' PHE . 3.8 mtmt -157.53 -178.93 7.7 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.538 -0.726 . . . . 32.700000000000003 109.159 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.558 ' CG1' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -109.44 105.98 19.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.456 -0.778 . . . . 15.630000000000001 109.09 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.26 -154.37 11.43 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.981 -1.248 . . . . 12.699999999999999 109.981 -179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.502 ' HA ' ' NE2' ' B' ' 72' ' ' GLN . 12.5 tp60 -99.08 42.22 1.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -1.09 . . . . 26.289999999999999 109.661 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -128.91 21.95 5.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.895 . . . . 20.440000000000001 109.613 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.98 52.74 7.81 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.563 -1.415 . . . . 13.82 109.563 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.422 ' O ' ' C ' ' B' ' 76' ' ' LEU . 17.0 t -176.99 129.93 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 18.27 109.435 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.811 HD22 HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -43.79 159.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.877 . . . . 12.43 109.138 179.976 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.5 mtt -163.38 118.99 1.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 35.109999999999999 109.54 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 1.002 HD12 HD12 ' A' ' 78' ' ' ILE . 2.2 mp -54.38 138.5 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.193 -0.942 . . . . 13.67 109.354 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' B' ' 67' ' ' SER . 0.2 OUTLIER -106.13 -34.73 7.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.111 -1.07 . . . . 24.059999999999999 108.111 178.515 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.507 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.2 OUTLIER -170.21 66.56 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.275 -1.38 . . . . 35.039999999999999 107.275 178.816 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.816 HD13 HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -27.62 120.04 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.113 -0.949 . . . . 18.719999999999999 111.731 -178.161 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -91.78 101.95 14.55 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 20.550000000000001 108.53 179.097 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.99 HD12 HD13 ' B' ' 47' ' ' ILE . 0.9 OUTLIER -70.27 140.67 52.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 14.4 110.84 -178.727 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.79 HG22 ' O ' ' B' ' 62' ' ' THR . 33.6 m -140.41 148.79 55.16 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.843 -1.169 . . . . 17.649999999999999 107.843 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.0 Cg_endo -63.06 141.11 82.22 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.995 1.797 . . . . 25.699999999999999 110.326 179.338 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.717 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -71.53 108.27 4.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 49.289999999999999 109.466 -178.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.035 -0.983 . . . . 58.909999999999997 109.489 179.999 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.1 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.579 -0.526 . . . . 64.909999999999997 109.579 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.704 ' N ' HD22 ' B' ' 65' ' ' LEU . 3.3 mt -64.16 78.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.592 -1.262 . . . . 33.799999999999997 107.592 178.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -71.0 177.23 3.82 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.104 0.954 . . . . 32.719999999999999 111.549 -177.771 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.024 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER 176.35 163.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.739 -0.837 . . . . 14.460000000000001 108.739 179.753 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.524 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 26.1 mt-10 -137.96 108.36 6.51 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.63 0.728 . . . . 22.120000000000001 109.093 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.705 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -71.94 100.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 C-N-CA 118.906 -1.118 . . . . 14.23 108.07 179.615 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD3' ' CG ' ' A' ' 34' ' ' TYR . 6.7 mptt -44.67 170.17 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.343 -0.848 . . . . 25.43 109.902 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 32.1 Cg_endo -73.67 -27.48 12.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.275 1.984 . . . . 13.609999999999999 109.78 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 p -86.35 -2.92 58.84 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.613 -0.884 . . . . 15.52 108.613 178.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.655 ' O ' HG23 ' A' ' 6' ' ' ILE . 6.7 mm-40 -118.75 41.29 3.05 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.429 -0.794 . . . . 17.309999999999999 109.119 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.88 14.72 29.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.076 -1.015 . . . . 24.780000000000001 109.999 -179.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 29.6 mt-30 -142.24 146.59 35.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.165 -0.959 . . . . 47.899999999999999 109.68 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.728 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 34.9 p90 -93.84 159.42 15.2 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.296 -0.878 . . . . 21.609999999999999 109.537 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 t -134.76 162.67 31.7 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.449 -0.945 . . . . 14.890000000000001 108.449 178.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.608 0 O-C-N 121.217 -0.927 . . . . 17.350000000000001 109.162 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.368 0.604 . . . . 24.0 110.1 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.584 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 99.1 m-20 -59.16 130.53 47.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.821 . . . . 23.309999999999999 109.48 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -121.27 152.49 38.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.944 . . . . 40.030000000000001 108.949 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.79 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -133.13 -170.93 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 12.390000000000001 109.789 -179.634 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.931 ' HB3' HD11 ' A' ' 44' ' ' LEU . 2.1 mp -130.49 174.83 9.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 17.420000000000002 108.872 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -171.85 162.88 6.22 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 13.84 108.699 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.743 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.0 m-30 -114.87 90.22 3.29 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.226 -0.921 . . . . 21.140000000000001 108.817 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.966 ' O ' HG22 ' A' ' 43' ' ' VAL . 94.0 t -89.94 119.77 37.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.197 -0.939 . . . . 10.66 110.32 -179.234 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.564 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 48.7 m-20 -68.48 -30.96 69.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.509 -0.923 . . . . 25.890000000000001 108.509 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' B' ' 69' ' ' LYS . 1.0 OUTLIER 48.17 30.98 2.35 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.503 -0.748 . . . . 24.239999999999998 109.318 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.31 9.69 64.66 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.391 -1.484 . . . . 31.02 109.391 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 1.4 m-20 -81.95 14.01 3.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -1.168 . . . . 43.229999999999997 110.659 -179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.58 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 10.0 mt-10 57.23 15.61 2.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.131 -0.981 . . . . 42.340000000000003 110.093 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 63.3 m80 -164.74 149.4 8.17 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.683 -1.228 . . . . 6.1600000000000001 107.683 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.1 Cg_endo -74.81 146.19 33.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.653 1.569 . . . . 17.920000000000002 110.631 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.966 HG22 ' O ' ' A' ' 35' ' ' VAL . 12.5 m -123.5 116.2 47.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 119.531 -0.868 . . . . 20.57 108.78 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.931 HD11 ' HB3' ' A' ' 32' ' ' LEU . 21.9 tp -68.92 104.98 2.22 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.296 -0.962 . . . . 20.210000000000001 108.678 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.516 HG22 ' O ' ' B' ' 74' ' ' GLY . 9.1 p -120.0 163.09 17.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.587 -0.695 . . . . 10.81 109.275 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' B' ' 74' ' ' GLY . 0.0 OUTLIER -82.47 157.64 23.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 36.740000000000002 110.28 -179.055 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.986 ' CD1' HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -138.7 176.38 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.282 -1.007 . . . . 19.739999999999998 108.282 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.92 144.23 42.84 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.042 -1.036 . . . . 22.559999999999999 109.38 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.755 HD13 ' O ' ' A' ' 50' ' ' ASP . 2.9 tm? -128.57 122.61 31.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.29 -0.881 . . . . 20.41 109.037 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.755 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -53.51 159.44 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 33.990000000000002 109.999 -179.279 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -70.05 108.96 4.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.403 -0.81 . . . . 54.920000000000002 109.497 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.79 -13.5 67.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.561 -1.416 . . . . 36.100000000000001 109.561 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.703 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -67.07 157.03 86.3 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.227 -1.161 . . . . 54.759999999999998 109.536 179.98 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -78.35 106.69 2.18 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.564 2.176 . . . . 28.370000000000001 110.254 179.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.79 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -41.95 160.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.386 -0.821 . . . . 17.210000000000001 110.028 -179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.705 ' O ' HG21 ' A' ' 6' ' ' ILE . 75.5 m-85 -58.4 104.98 0.25 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.406 -0.809 . . . . 17.190000000000001 108.838 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.44 176.14 0.24 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 17.82 109.418 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.0 Cg_endo -77.79 120.06 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.532 2.154 . . . . 17.280000000000001 110.166 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.66 177.42 39.06 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.779 -1.328 . . . . 17.219999999999999 109.779 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -72.04 149.37 44.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -1.187 . . . . 19.57 108.269 179.139 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 1.024 ' CB ' HG13 ' A' ' 4' ' ' VAL . 22.2 m-85 -133.34 163.36 29.51 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.77 -1.206 . . . . 14.609999999999999 111.705 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.732 ' O ' HG22 ' A' ' 84' ' ' VAL . 34.2 p -147.93 120.08 8.31 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.456 -1.683 . . . . 18.359999999999999 106.456 178.385 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 2' ' ' ILE . 5.7 t -51.82 170.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 C-N-CA 118.672 -1.211 . . . . 19.129999999999999 108.955 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.591 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -134.67 125.93 28.08 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.421 -0.799 . . . . 20.649999999999999 109.187 -179.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.737 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.6 OUTLIER -72.27 1.08 8.31 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.27 -0.894 . . . . 19.649999999999999 109.802 179.724 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.3 p -57.64 -19.17 24.55 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.521 -1.289 . . . . 14.720000000000001 107.521 178.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 9.7 m -96.76 -18.57 19.53 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.772 -0.58 . . . . 11.449999999999999 110.128 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.682 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.6 m-30 -66.29 158.48 28.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 14.25 109.346 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HA ' HD21 ' B' ' 37' ' ' LEU . 0.0 OUTLIER -140.46 178.89 7.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 32.700000000000003 109.769 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.735 HG21 HG21 ' B' ' 43' ' ' VAL . 1.7 t -126.12 129.77 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.509 -0.744 . . . . 15.630000000000001 109.495 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.21 -170.67 25.33 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.677 -1.369 . . . . 12.699999999999999 109.677 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' CB ' ' A' ' 73' ' ' PHE . 25.9 tp60 69.5 80.76 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -1.148 . . . . 26.289999999999999 109.358 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.504 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 3.0 m-85 75.34 12.03 3.32 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.424 -0.798 . . . . 20.440000000000001 109.462 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.531 ' O ' HG22 ' B' ' 45' ' ' VAL . . . 70.77 47.77 38.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.558 -1.417 . . . . 13.82 109.558 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -144.03 144.48 31.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -1.168 . . . . 18.27 109.639 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 77' ' ' MET . 1.0 OUTLIER -50.73 169.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 12.43 109.187 179.776 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 2.3 mtp -165.52 106.01 0.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 35.109999999999999 110.25 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -42.43 -63.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.513 -0.742 . . . . 13.67 109.403 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.546 ' N ' HG22 ' A' ' 78' ' ' ILE . 9.5 t70 83.34 -45.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.392 0.615 . . . . 24.059999999999999 110.039 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.7 tpm_? -174.24 66.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.113 0.958 . . . . 35.039999999999999 108.632 179.646 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.616 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.5 pt? -36.07 128.81 0.7 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.668 0.747 . . . . 18.719999999999999 111.527 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -94.52 104.67 16.62 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.248 -1.019 . . . . 20.550000000000001 108.248 178.721 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.986 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -74.23 147.26 42.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 14.4 110.898 -178.761 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 62' ' ' THR . 32.5 m -148.37 155.85 42.59 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.09 -1.078 . . . . 17.649999999999999 108.09 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.8 Cg_endo -63.08 143.6 90.85 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.105 1.87 . . . . 25.699999999999999 110.322 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.711 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -69.81 125.43 26.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.228 -0.92 . . . . 49.289999999999999 109.702 -178.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.2 tptp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.004 -0.998 . . . . 58.909999999999997 109.512 -179.965 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.532 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.564 -0.532 . . . . 64.909999999999997 109.564 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.737 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.3 mt -64.2 78.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 33.799999999999997 107.657 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.9 OUTLIER -70.82 177.3 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.07 0.938 . . . . 32.719999999999999 111.542 -177.754 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.034 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER 176.29 163.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.714 -0.847 . . . . 14.460000000000001 108.714 179.743 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 26.0 mt-10 -137.82 108.38 6.57 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.605 0.716 . . . . 22.120000000000001 109.103 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.701 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -71.94 100.18 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.95 -1.1 . . . . 14.23 108.075 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.583 ' HD3' ' CG ' ' B' ' 34' ' ' TYR . 6.7 mptt -44.75 170.05 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.33 -0.856 . . . . 25.43 109.898 -179.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.9 Cg_endo -73.59 -27.5 12.83 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.365 2.043 . . . . 13.609999999999999 109.722 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.2 p -86.39 -2.74 58.69 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.664 -0.865 . . . . 15.52 108.664 178.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.651 ' O ' HG23 ' B' ' 6' ' ' ILE . 6.7 mm-40 -118.9 41.26 3.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.399 -0.813 . . . . 17.309999999999999 109.095 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.9 14.84 28.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.123 -0.986 . . . . 24.780000000000001 109.986 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.489 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 29.7 mt-30 -142.35 146.48 35.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 47.899999999999999 109.742 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.719 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 34.5 p90 -93.79 159.32 15.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.338 -0.851 . . . . 21.609999999999999 109.615 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.3 t -134.78 162.49 32.21 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.496 -0.928 . . . . 14.890000000000001 108.496 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.298 -1.633 0 O-C-N 121.166 -0.958 . . . . 17.350000000000001 109.18 -179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' B' ' 28' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 121.384 0.612 . . . . 24.0 110.146 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.582 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 99.1 m-20 -59.06 130.58 47.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 23.309999999999999 109.439 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -121.34 152.41 39.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.948 . . . . 40.030000000000001 109.002 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.765 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -133.08 -170.8 2.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.09 -1.006 . . . . 12.390000000000001 109.84 -179.612 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.915 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.1 mp -130.61 174.76 9.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.834 -0.802 . . . . 17.420000000000002 108.834 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.54 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -171.91 162.67 6.09 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.877 -1.14 . . . . 13.84 108.725 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.738 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.0 m-30 -114.66 90.33 3.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.212 -0.93 . . . . 21.140000000000001 108.824 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.992 ' O ' HG22 ' B' ' 43' ' ' VAL . 96.0 t -90.06 119.73 37.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.181 -0.949 . . . . 10.66 110.238 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 48.7 m-20 -68.36 -31.01 70.1 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.51 -0.922 . . . . 25.890000000000001 108.51 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.538 HD21 ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER 48.27 31.03 2.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.548 -0.72 . . . . 24.239999999999998 109.252 179.804 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.28 9.52 64.28 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.438 -1.465 . . . . 31.02 109.438 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 1.4 m-20 -81.77 13.87 2.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -1.162 . . . . 43.229999999999997 110.726 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.574 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 10.0 mt-10 57.32 15.62 2.7 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.124 -0.985 . . . . 42.340000000000003 110.115 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 63.5 m80 -164.73 149.41 8.19 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 107.745 -1.206 . . . . 6.1500000000000004 107.745 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.668 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.3 Cg_endo -74.83 146.15 33.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.648 1.565 . . . . 17.920000000000002 110.628 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.992 HG22 ' O ' ' B' ' 35' ' ' VAL . 12.6 m -123.47 116.25 47.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 C-N-CA 119.495 -0.882 . . . . 20.57 108.816 179.015 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.915 HD11 ' HB3' ' B' ' 32' ' ' LEU . 21.8 tp -68.87 105.1 2.24 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.341 -0.943 . . . . 20.210000000000001 108.655 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 74' ' ' GLY . 9.1 p -120.15 163.08 18.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.534 -0.729 . . . . 10.81 109.228 -179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -82.55 157.59 23.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.394 -0.816 . . . . 36.740000000000002 110.328 -179.114 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.98 ' CD1' HD12 ' B' ' 83' ' ' LEU . 0.4 OUTLIER -138.59 176.35 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.227 -1.027 . . . . 19.739999999999998 108.227 179.447 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 144.42 42.46 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.006 -1.059 . . . . 22.559999999999999 109.405 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.764 HD13 ' O ' ' B' ' 50' ' ' ASP . 2.9 tm? -128.68 122.4 30.68 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.317 -0.865 . . . . 20.41 109.067 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.764 ' O ' HD13 ' B' ' 49' ' ' LEU . 0.1 OUTLIER -53.38 159.34 1.43 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 33.990000000000002 110.033 -179.324 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -69.95 108.95 4.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.481 -0.762 . . . . 54.920000000000002 109.487 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.81 -13.57 67.16 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.563 -1.415 . . . . 36.100000000000001 109.563 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.711 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.2 OUTLIER -67.03 157.18 85.71 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.218 -1.166 . . . . 54.759999999999998 109.487 179.962 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.0 Cg_endo -78.39 106.67 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.624 2.216 . . . . 28.370000000000001 110.257 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.765 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.0 160.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 17.210000000000001 109.976 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.701 ' O ' HG21 ' B' ' 6' ' ' ILE . 75.2 m-85 -58.92 105.56 0.33 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.347 -0.846 . . . . 17.190000000000001 108.805 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.962 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.65 176.09 0.25 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.309 -0.869 . . . . 17.82 109.275 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.962 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.3 Cg_endo -78.03 121.12 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.637 2.225 . . . . 17.280000000000001 110.445 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.94 177.88 38.41 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.657 -1.377 . . . . 17.219999999999999 109.657 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.728 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -71.73 150.0 44.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -1.182 . . . . 19.57 108.555 179.387 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 1.034 ' CB ' HG13 ' B' ' 4' ' ' VAL . 21.1 m-85 -134.02 163.31 29.85 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 120.763 -1.211 . . . . 14.609999999999999 111.702 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.736 ' O ' HG22 ' B' ' 84' ' ' VAL . 33.9 p -147.98 120.25 8.38 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.445 -1.687 . . . . 18.359999999999999 106.445 178.402 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.674 HG21 HG21 ' B' ' 2' ' ' ILE . 5.9 t -52.04 169.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 118.631 -1.228 . . . . 19.129999999999999 108.965 -178.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.577 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -134.43 125.86 28.34 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.453 -0.779 . . . . 20.649999999999999 109.224 -179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.704 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -72.16 0.8 8.77 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.272 -0.893 . . . . 19.649999999999999 109.755 179.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 94.8 p -57.34 -19.24 21.39 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 107.53 -1.285 . . . . 14.720000000000001 107.53 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 10.3 m -96.69 -18.64 19.54 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.843 -0.536 . . . . 11.449999999999999 110.143 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.675 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.6 m-30 -66.26 157.89 30.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.004 . . . . 14.25 109.331 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.531 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.94 178.91 6.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 32.700000000000003 109.837 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.729 HG21 HG21 ' A' ' 43' ' ' VAL . 1.7 t -126.06 129.78 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.759 . . . . 15.630000000000001 109.535 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' B' ' 72' ' ' GLN . . . 143.19 -170.69 25.31 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.69 -1.364 . . . . 12.699999999999999 109.69 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.5 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 25.9 tp60 69.47 80.83 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -1.159 . . . . 26.289999999999999 109.341 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.5 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 3.0 m-85 75.33 11.9 3.35 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.443 -0.785 . . . . 20.440000000000001 109.49 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.516 ' O ' HG22 ' A' ' 45' ' ' VAL . . . 70.91 47.7 37.58 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.502 -1.439 . . . . 13.82 109.502 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -144.06 144.41 31.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -1.146 . . . . 18.27 109.635 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' B' ' 77' ' ' MET . 1.0 OUTLIER -50.66 169.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 12.43 109.151 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 2.3 mtp -165.58 105.95 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 35.109999999999999 110.303 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.616 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.8 mt -42.35 -64.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.568 -0.708 . . . . 13.67 109.416 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 9.4 t70 83.51 -45.16 0.11 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.4 0.619 . . . . 24.059999999999999 110.073 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.7 tpm_? -174.32 66.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.505 -0.924 . . . . 35.039999999999999 108.505 179.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.626 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.5 pt? -36.17 128.81 0.72 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.703 0.763 . . . . 18.719999999999999 111.545 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -94.5 104.44 16.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.29 -1.004 . . . . 20.550000000000001 108.29 178.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.98 HD12 ' CD1' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -73.98 147.39 43.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.189 -0.944 . . . . 14.4 110.842 -178.753 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.736 HG22 ' O ' ' B' ' 62' ' ' THR . 32.6 m -148.66 155.64 41.58 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.046 -1.094 . . . . 17.649999999999999 108.046 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.9 Cg_endo -62.89 143.8 92.16 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.076 1.851 . . . . 25.699999999999999 110.328 179.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -69.96 125.63 27.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -0.907 . . . . 49.289999999999999 109.724 -178.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 7.2 tptp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.978 -1.01 . . . . 58.909999999999997 109.571 179.979 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 2.8 ttm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.444 -0.576 . . . . 64.909999999999997 109.444 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.739 HG12 HD13 ' B' ' 65' ' ' LEU . 3.2 mt 69.66 64.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.705 -1.22 . . . . 33.799999999999997 107.705 -178.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 26.6 mttt -54.93 162.11 1.39 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.777 0.799 . . . . 32.719999999999999 111.28 -178.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.05 ' CG2' HG22 ' A' ' 35' ' ' VAL . 58.6 t -160.2 167.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.534 0.683 . . . . 14.460000000000001 109.53 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.573 ' N ' HG12 ' A' ' 4' ' ' VAL . 46.8 mt-10 -152.34 106.07 3.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.544 -0.722 . . . . 22.120000000000001 109.201 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.788 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -74.64 101.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.104 -1.073 . . . . 14.23 108.104 179.505 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.645 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.78 171.22 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.403 -0.81 . . . . 25.43 109.831 -179.324 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.4 Cg_endo -74.95 -28.45 9.26 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.463 2.109 . . . . 13.609999999999999 110.131 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.7 m -92.96 4.11 54.55 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.478 -0.764 . . . . 15.52 109.127 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.535 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 18.4 mm-40 -121.03 34.1 5.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 17.309999999999999 109.352 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -106.89 18.55 21.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 24.780000000000001 110.284 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 19.2 mt-30 -137.57 129.39 28.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.067 -1.02 . . . . 47.899999999999999 109.864 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.561 ' H ' ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -77.54 -174.32 3.32 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.425 -0.797 . . . . 21.609999999999999 110.578 -179.541 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 m -158.68 145.41 17.31 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.777 -0.823 . . . . 14.890000000000001 108.777 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.534 0 O-C-N 121.244 -0.91 . . . . 17.350000000000001 109.625 -179.493 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.501 0.667 . . . . 24.0 110.096 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -74.5 111.19 9.44 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.725 -0.843 . . . . 23.309999999999999 108.725 179.602 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 14.9 mm-40 -82.63 -172.77 4.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.035 -1.04 . . . . 40.030000000000001 109.015 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.559 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -171.18 179.92 2.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.073 -1.017 . . . . 12.390000000000001 110.249 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.942 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.4 mt -140.5 148.56 41.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.579 -0.701 . . . . 17.420000000000002 109.174 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.622 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.4 m -152.04 -178.55 6.83 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.918 -1.141 . . . . 13.84 107.918 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.662 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 38.0 m-85 -128.01 106.21 8.93 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.053 -1.03 . . . . 21.140000000000001 109.395 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.05 HG22 ' CG2' ' A' ' 4' ' ' VAL . 73.8 t -98.1 141.3 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.072 -1.017 . . . . 10.66 111.168 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.1 m-20 -111.15 35.72 3.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.008 -1.108 . . . . 25.890000000000001 108.008 178.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.941 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.0 pt? -40.94 -25.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.658 -0.651 . . . . 24.239999999999998 110.266 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 39' ' ' ASN . . . 176.8 47.33 0.06 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 108.983 -1.647 . . . . 31.02 108.983 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.75 HD22 HG11 ' A' ' 43' ' ' VAL . 74.3 m-20 -149.55 109.66 4.13 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.481 -1.011 . . . . 43.229999999999997 108.751 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 39' ' ' ASN . 26.0 mt-10 -34.24 -56.84 0.5 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.64 0.733 . . . . 42.340000000000003 110.128 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 50.9 m-70 -73.41 160.37 82.59 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 108.662 -0.866 . . . . 6.5700000000000003 108.662 179.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.662 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.3 Cg_endo -77.43 140.47 19.28 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.054 1.836 . . . . 17.920000000000002 109.87 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.925 HG22 ' O ' ' A' ' 35' ' ' VAL . 3.2 m -108.58 114.27 46.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.198 -0.939 . . . . 20.57 109.532 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.942 HD11 ' HB3' ' A' ' 32' ' ' LEU . 54.8 tp -68.01 106.94 2.51 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.388 -0.82 . . . . 20.210000000000001 109.623 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 2.1 t -110.44 169.28 3.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.48 -0.762 . . . . 10.81 109.03 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.576 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -92.93 162.89 13.89 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.33 -0.857 . . . . 36.740000000000002 110.394 -179.264 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.567 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -138.42 165.11 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.634 -0.876 . . . . 19.739999999999998 108.634 179.698 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.744 HG22 ' O ' ' A' ' 48' ' ' THR . 9.0 m -124.7 71.59 1.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 22.559999999999999 109.278 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.683 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -40.4 137.04 1.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.508 -0.745 . . . . 20.41 109.674 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -78.02 165.4 24.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 33.990000000000002 109.367 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.41 114.8 10.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 54.920000000000002 109.495 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.77 -6.32 64.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.685 -1.366 . . . . 36.100000000000001 109.685 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.1 mt-30 -89.06 144.45 32.7 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.128 -1.219 . . . . 54.759999999999998 109.522 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.5 Cg_endo -78.54 123.95 6.17 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.642 2.228 . . . . 28.370000000000001 110.332 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.683 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -40.41 142.74 0.38 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 17.210000000000001 110.54 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.788 ' O ' HG21 ' A' ' 6' ' ' ILE . 12.0 m-30 -45.98 104.39 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 17.190000000000001 109.153 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.774 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.35 168.64 0.36 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.992 -1.067 . . . . 17.82 109.185 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.774 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.4 Cg_endo -76.98 113.39 3.62 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.52 2.147 . . . . 17.280000000000001 110.193 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.19 -176.56 48.08 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.923 -1.271 . . . . 17.219999999999999 109.923 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -75.81 139.25 41.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -1.09 . . . . 19.57 108.406 179.121 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.7 ' HB3' HD22 ' A' ' 83' ' ' LEU . 19.0 m-85 -127.83 166.11 18.86 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.725 -1.234 . . . . 14.609999999999999 111.456 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.5 p -149.94 120.28 7.35 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.46 -1.681 . . . . 18.359999999999999 106.46 179.008 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -50.45 166.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 118.738 -1.185 . . . . 19.129999999999999 108.886 -178.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -125.23 123.98 40.72 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.865 -0.791 . . . . 20.649999999999999 108.865 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.745 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -69.47 -3.28 13.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.636 -0.665 . . . . 19.649999999999999 110.113 -179.187 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 t -58.83 -13.89 7.41 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.068 -1.02 . . . . 14.720000000000001 108.409 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 19.6 m -95.61 -7.72 36.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.755 . . . . 11.449999999999999 110.709 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.662 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.1 m-30 -81.25 159.16 24.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.899 -1.125 . . . . 14.25 109.882 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.565 ' HA ' HD11 ' B' ' 37' ' ' LEU . 12.0 mtmt -153.03 173.84 14.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.485 -0.76 . . . . 32.700000000000003 108.997 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.559 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.6 OUTLIER -110.68 118.08 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 15.630000000000001 109.53 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.19 -176.15 48.94 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.294 -1.523 . . . . 12.699999999999999 109.294 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.0 19.86 3.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.09 -1.241 . . . . 26.289999999999999 109.77 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 -11.39 23.5 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.511 -0.743 . . . . 20.440000000000001 109.561 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' ' OG ' ' A' ' 75' ' ' SER . . . 84.48 50.27 4.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.712 -1.355 . . . . 13.82 109.712 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -170.69 153.88 4.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -1.161 . . . . 18.27 109.553 179.933 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.742 HD23 ' N ' ' A' ' 77' ' ' MET . 10.6 tt -81.16 150.52 28.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 12.43 109.476 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.742 ' N ' HD23 ' A' ' 76' ' ' LEU . 2.2 mtt -155.78 129.19 8.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 35.109999999999999 109.355 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.883 HD12 HD12 ' B' ' 78' ' ' ILE . 3.1 mt -63.18 139.44 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 13.67 109.841 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 6.9 t0 -104.4 -18.48 14.4 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.257 -1.016 . . . . 24.059999999999999 108.257 178.448 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.4 tmm_? 172.23 71.69 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.863 -1.532 . . . . 35.039999999999999 106.863 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -34.0 119.21 0.39 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.607 0.718 . . . . 18.719999999999999 111.199 -178.05 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 5.9 mtt180 -88.75 110.07 20.69 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.466 -0.939 . . . . 20.550000000000001 108.466 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.815 HD11 HG11 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -81.13 141.63 34.06 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.187 -0.946 . . . . 14.4 110.49 -179.112 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 62' ' ' THR . 25.9 m -145.28 159.08 50.09 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.193 -1.04 . . . . 17.649999999999999 108.193 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.08 141.61 77.34 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.124 1.882 . . . . 25.699999999999999 110.206 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.663 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -67.68 122.44 18.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.096 -1.003 . . . . 49.289999999999999 109.521 -178.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.961 -1.019 . . . . 58.909999999999997 109.469 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.452 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 2.8 ttm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.446 -0.576 . . . . 64.909999999999997 109.446 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.745 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.2 mt 69.54 64.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.759 -1.2 . . . . 33.799999999999997 107.759 -178.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.534 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 26.7 mttt -54.87 162.16 1.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.823 0.821 . . . . 32.719999999999999 111.269 -178.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.05 ' CG2' HG22 ' B' ' 35' ' ' VAL . 58.9 t -160.19 167.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.5 0.667 . . . . 14.460000000000001 109.601 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.589 ' N ' HG12 ' B' ' 4' ' ' VAL . 46.4 mt-10 -152.26 106.2 3.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.613 0.721 . . . . 22.120000000000001 109.088 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.79 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -74.69 101.06 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.141 -1.059 . . . . 14.23 108.141 179.43 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.634 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.73 171.16 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.445 -0.785 . . . . 25.43 109.827 -179.323 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.4 Cg_endo -75.03 -28.28 9.25 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.407 2.071 . . . . 13.609999999999999 110.179 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 12.8 m -93.03 4.21 54.4 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.508 -0.745 . . . . 15.52 109.122 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 18.4 mm-40 -121.15 34.0 5.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.258 -0.901 . . . . 17.309999999999999 109.36 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.85 18.68 21.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 24.780000000000001 110.282 -179.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.421 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 19.1 mt-30 -137.56 129.51 28.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.057 -1.027 . . . . 47.899999999999999 109.825 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.55 ' H ' ' HB2' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -77.62 -174.45 3.42 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.395 -0.815 . . . . 21.609999999999999 110.529 -179.563 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 55.9 m -158.6 145.44 17.43 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.764 -0.828 . . . . 14.890000000000001 108.764 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.503 0 O-C-N 121.262 -0.899 . . . . 17.350000000000001 109.561 -179.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.461 HD23 ' O ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.493 0.663 . . . . 24.0 110.114 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.569 ' HB2' ' HB3' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -74.52 111.14 9.41 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.736 -0.838 . . . . 23.309999999999999 108.736 179.548 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 14.8 mm-40 -82.66 -172.74 4.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.035 -1.04 . . . . 40.030000000000001 108.97 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.564 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -171.21 179.96 2.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.081 -1.012 . . . . 12.390000000000001 110.3 179.848 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.952 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.4 mt -140.58 148.56 41.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.538 -0.726 . . . . 17.420000000000002 109.176 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.637 ' O ' HD12 ' B' ' 44' ' ' LEU . 2.4 m -151.96 -178.35 6.7 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.868 -1.16 . . . . 13.84 107.868 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.656 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 37.5 m-85 -128.22 106.28 8.93 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.09 -1.006 . . . . 21.140000000000001 109.3 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 1.05 HG22 ' CG2' ' B' ' 4' ' ' VAL . 73.8 t -98.14 141.27 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.127 -0.983 . . . . 10.66 111.168 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' B' ' 38' ' ' GLY . 4.1 m-20 -111.11 35.69 3.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.031 -1.1 . . . . 25.890000000000001 108.031 178.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.928 ' H ' HG12 ' B' ' 35' ' ' VAL . 2.0 pt? -40.99 -25.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.647 -0.658 . . . . 24.239999999999998 110.271 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 176.71 47.47 0.06 OUTLIER Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.002 -1.639 . . . . 31.02 109.002 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.744 HD22 HG11 ' B' ' 43' ' ' VAL . 74.5 m-20 -149.64 109.67 4.12 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.502 -0.999 . . . . 43.229999999999997 108.757 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' B' ' 39' ' ' ASN . 26.1 mt-10 -34.21 -56.86 0.5 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.692 0.758 . . . . 42.340000000000003 110.159 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 51.0 m-70 -73.41 160.48 82.35 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 108.693 -0.855 . . . . 6.5599999999999996 108.693 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.656 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.5 Cg_endo -77.46 140.34 19.11 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.098 1.865 . . . . 17.920000000000002 109.837 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.934 HG22 ' O ' ' B' ' 35' ' ' VAL . 3.2 m -108.48 114.32 46.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.168 -0.957 . . . . 20.57 109.572 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.952 HD11 ' HB3' ' B' ' 32' ' ' LEU . 54.8 tp -68.07 106.99 2.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.428 -0.795 . . . . 20.210000000000001 109.534 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 2.1 t -110.46 169.25 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 10.81 109.038 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.574 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -92.85 162.98 13.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.314 -0.866 . . . . 36.740000000000002 110.378 -179.291 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.564 ' CG2' ' HB3' ' B' ' 31' ' ' GLN . 0.4 OUTLIER -138.49 165.1 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.579 -0.897 . . . . 19.739999999999998 108.579 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.747 HG22 ' O ' ' B' ' 48' ' ' THR . 9.5 m -124.73 71.6 1.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.223 -0.923 . . . . 22.559999999999999 109.366 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.677 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -40.36 136.97 1.15 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.559 -0.713 . . . . 20.41 109.709 179.93 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.45 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.4 OUTLIER -77.98 165.49 24.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 33.990000000000002 109.324 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.47 114.85 11.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 54.920000000000002 109.528 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.75 -6.45 64.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.665 -1.374 . . . . 36.100000000000001 109.665 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.518 ' O ' HD12 ' B' ' 49' ' ' LEU . 1.1 mt-30 -88.99 144.46 32.82 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.148 -1.207 . . . . 54.759999999999998 109.53 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.6 Cg_endo -78.54 123.87 6.14 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.62 2.213 . . . . 28.370000000000001 110.343 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.677 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -40.46 142.76 0.38 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.361 -0.837 . . . . 17.210000000000001 110.467 -179.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.79 ' O ' HG21 ' B' ' 6' ' ' ILE . 12.2 m-30 -46.16 104.51 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 17.190000000000001 109.246 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.768 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -53.22 168.6 0.35 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.99 -1.069 . . . . 17.82 109.084 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.768 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.8 Cg_endo -77.19 114.55 3.8 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.603 2.202 . . . . 17.280000000000001 110.458 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.12 47.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.8 -1.32 . . . . 17.219999999999999 109.8 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.661 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -75.45 139.59 42.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -1.079 . . . . 19.57 108.692 179.45 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.689 ' HB3' HD22 ' B' ' 83' ' ' LEU . 18.1 m-85 -128.25 166.04 19.34 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.765 -1.21 . . . . 14.609999999999999 111.437 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.565 ' O ' HG22 ' B' ' 84' ' ' VAL . 44.4 p -150.0 120.46 7.41 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.432 -1.692 . . . . 18.359999999999999 106.432 179.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -50.61 166.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 C-N-CA 118.741 -1.183 . . . . 19.129999999999999 108.908 -178.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -125.19 124.12 41.06 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.411 -0.806 . . . . 20.649999999999999 108.863 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.739 HD13 HG12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -69.61 -3.2 13.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.676 -0.64 . . . . 19.649999999999999 110.084 -179.166 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.7 t -58.91 -13.86 7.51 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.069 -1.019 . . . . 14.720000000000001 108.329 179.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 19.7 m -95.62 -7.86 36.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.756 . . . . 11.449999999999999 110.724 -179.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.654 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.1 m-30 -81.15 159.2 24.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.859 -1.151 . . . . 14.25 109.795 -179.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.566 ' HA ' HD11 ' A' ' 37' ' ' LEU . 12.0 mtmt -153.04 173.91 14.85 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.977 -0.749 . . . . 32.700000000000003 108.977 179.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.566 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -110.66 118.2 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 15.630000000000001 109.51 179.935 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.32 -176.22 48.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.337 -1.505 . . . . 12.699999999999999 109.337 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.93 19.87 3.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.109 -1.23 . . . . 26.289999999999999 109.793 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -11.23 23.54 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.529 -0.732 . . . . 20.440000000000001 109.573 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.414 ' C ' ' OG ' ' B' ' 75' ' ' SER . . . 84.32 50.46 4.28 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.73 -1.348 . . . . 13.82 109.73 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' B' ' 74' ' ' GLY . 0.9 OUTLIER -170.88 153.91 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -1.178 . . . . 18.27 109.614 179.889 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.742 HD23 ' N ' ' B' ' 77' ' ' MET . 10.6 tt -81.23 150.58 28.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 12.43 109.469 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.742 ' N ' HD23 ' B' ' 76' ' ' LEU . 2.2 mtt -155.88 129.14 8.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 35.109999999999999 109.402 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.883 HD12 HD12 ' A' ' 78' ' ' ILE . 3.1 mt -63.11 139.51 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 13.67 109.827 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 6.9 t0 -104.5 -18.45 14.36 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.233 -1.025 . . . . 24.059999999999999 108.233 178.448 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.4 tmm_? 172.25 71.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.893 -1.521 . . . . 35.039999999999999 106.893 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -33.98 119.11 0.39 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.643 0.735 . . . . 18.719999999999999 111.136 -178.005 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 5.9 mtt180 -88.67 110.03 20.62 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.498 -0.927 . . . . 20.550000000000001 108.498 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.836 HD11 HG11 ' B' ' 4' ' ' VAL . 0.3 OUTLIER -81.02 141.83 33.99 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.116 -0.99 . . . . 14.4 110.415 -179.069 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.565 HG22 ' O ' ' B' ' 62' ' ' THR . 25.4 m -145.59 158.86 49.46 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.185 -1.043 . . . . 17.649999999999999 108.185 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -63.93 141.57 78.16 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.078 1.852 . . . . 25.699999999999999 110.27 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.661 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -67.63 122.52 18.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.123 -0.986 . . . . 49.289999999999999 109.541 -178.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.972 -1.013 . . . . 58.909999999999997 109.498 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.499 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.358 0.599 . . . . 64.909999999999997 109.393 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.787 ' N ' HD22 ' B' ' 65' ' ' LEU . 4.3 mt 75.24 83.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.662 -1.236 . . . . 33.799999999999997 107.662 -179.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.516 ' C ' HG12 ' A' ' 4' ' ' VAL . 3.8 mtpp -80.55 173.16 12.88 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.133 0.968 . . . . 32.719999999999999 111.927 -177.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.895 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 179.77 168.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.775 -0.824 . . . . 14.460000000000001 108.775 -179.778 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 35.9 mt-10 -141.71 112.67 7.34 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.426 -0.796 . . . . 22.120000000000001 109.442 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.848 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -71.52 104.8 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.483 -1.303 . . . . 14.23 107.483 179.017 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.666 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -51.32 162.0 0.71 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.88 . . . . 25.43 110.123 -178.909 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 33.9 Cg_endo -76.68 -18.6 15.13 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.505 2.136 . . . . 13.609999999999999 109.116 179.039 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -92.12 8.38 38.18 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.682 -0.859 . . . . 15.52 108.682 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.554 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -147.74 38.97 0.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.362 -0.836 . . . . 17.309999999999999 109.246 179.326 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.11 6.9 44.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 24.780000000000001 109.756 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 29.3 mt-30 -127.29 155.64 43.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 47.899999999999999 109.282 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.757 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 37.1 p90 -96.45 160.49 14.38 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.165 -0.959 . . . . 21.609999999999999 109.406 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -127.2 160.79 30.2 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.315 -0.866 . . . . 14.890000000000001 108.8 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.299 -1.613 0 O-C-N 121.274 -0.892 . . . . 17.350000000000001 108.963 179.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.341 0.591 . . . . 24.0 109.637 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.571 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 85.7 m-20 -43.72 134.73 4.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 23.309999999999999 109.638 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -125.99 161.77 26.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.884 . . . . 40.030000000000001 109.163 179.942 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.97 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -140.39 -172.36 3.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 12.390000000000001 109.602 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.738 ' HB3' HD11 ' A' ' 44' ' ' LEU . 2.7 mp -130.75 171.42 13.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 17.420000000000002 109.361 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.579 ' SG ' HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -162.21 154.32 19.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.104 -0.997 . . . . 13.84 108.711 -179.613 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.699 ' CE2' HD13 ' A' ' 44' ' ' LEU . 27.1 m-85 -115.32 104.31 11.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 21.140000000000001 109.604 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.898 HG21 HD13 ' B' ' 76' ' ' LEU . 64.1 t -80.23 165.33 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.807 -1.183 . . . . 10.66 109.536 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.599 ' N ' HG12 ' A' ' 35' ' ' VAL . 6.2 m-20 -137.21 -52.87 0.68 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.299 -0.876 . . . . 25.890000000000001 109.676 -179.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.797 ' CG ' HD11 ' B' ' 65' ' ' LEU . 0.1 OUTLIER -42.09 -44.65 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.66 0.743 . . . . 24.239999999999998 109.11 179.919 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 39' ' ' ASN . . . -88.57 32.21 4.58 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.613 -1.395 . . . . 31.02 109.613 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 2.5 p30 161.16 117.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.384 -1.068 . . . . 43.229999999999997 109.594 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -42.5 -64.79 0.55 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 42.340000000000003 109.509 179.941 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.506 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 5.5 m-70 -68.68 163.4 55.11 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 107.96 -1.126 . . . . 3.77 107.96 179.033 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.688 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.9 Cg_endo -78.1 140.48 17.88 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.541 1.494 . . . . 17.920000000000002 109.692 -179.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.53 HG21 ' ND2' ' A' ' 39' ' ' ASN . 6.0 m -116.32 114.32 45.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.313 -0.867 . . . . 20.57 109.003 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.738 HD11 ' HB3' ' A' ' 32' ' ' LEU . 43.8 tp -69.75 107.73 3.61 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.347 -0.846 . . . . 20.210000000000001 109.835 -179.437 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.695 HG23 HG11 ' B' ' 70' ' ' VAL . 0.8 OUTLIER -109.13 164.19 5.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.56 -0.904 . . . . 10.81 108.56 179.635 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' HA3' ' B' ' 74' ' ' GLY . 1.0 OUTLIER -86.96 170.0 11.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.159 -0.963 . . . . 36.740000000000002 109.803 -179.67 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.635 HG22 ' CB ' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -156.6 171.65 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.347 -0.846 . . . . 19.739999999999998 109.315 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -107.82 147.8 30.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.201 -0.937 . . . . 22.559999999999999 109.45 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.639 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 1.8 tm? -129.39 112.15 13.54 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.219 -0.926 . . . . 20.41 108.778 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 53' ' ' GLN . 2.7 t70 -61.75 138.18 58.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -0.816 . . . . 33.990000000000002 110.223 -178.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.28 124.38 16.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.346 -0.847 . . . . 54.920000000000002 108.834 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.47 -31.15 8.39 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.979 -1.648 . . . . 36.100000000000001 108.979 -179.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.585 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -73.77 146.51 85.63 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.375 -1.074 . . . . 54.759999999999998 109.155 179.648 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.44 118.2 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.426 2.084 . . . . 28.370000000000001 109.997 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.97 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -41.58 154.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 17.210000000000001 109.711 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 6.8 m-30 -45.07 105.57 0.06 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.239 -0.913 . . . . 17.190000000000001 108.892 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.952 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -61.97 176.15 0.48 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 17.82 109.347 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.952 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.0 Cg_endo -77.61 129.97 10.43 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.602 2.202 . . . . 17.280000000000001 110.523 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.598 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 153.03 148.25 4.83 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.767 -1.333 . . . . 17.219999999999999 109.767 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.6 OUTLIER -46.78 146.23 1.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.137 -1.213 . . . . 19.57 108.838 179.481 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.895 ' CB ' HG13 ' A' ' 4' ' ' VAL . 16.3 m-85 -125.77 161.85 26.41 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.667 -1.271 . . . . 14.609999999999999 111.7 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.904 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.2 p -144.86 121.6 11.2 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.459 -1.682 . . . . 18.359999999999999 106.459 178.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -59.98 163.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 118.529 -1.268 . . . . 19.129999999999999 108.922 -178.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.473 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.2 t-80 -127.27 128.19 45.59 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.037 -0.727 . . . . 20.649999999999999 109.037 -179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.784 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -71.52 0.98 7.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.471 -0.768 . . . . 19.649999999999999 110.159 -179.833 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -20.78 6.58 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.283 -1.377 . . . . 14.720000000000001 107.283 178.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 5.8 m -95.11 -8.31 36.87 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.903 -0.498 . . . . 11.449999999999999 110.218 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.6 m-30 -84.73 156.87 21.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.953 -1.092 . . . . 14.25 109.336 -179.167 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HE2' ' OD2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -168.03 174.69 7.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.397 -0.814 . . . . 32.700000000000003 109.435 179.747 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.715 HG11 HG23 ' B' ' 45' ' ' VAL . 0.1 OUTLIER -103.13 109.82 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.821 . . . . 15.630000000000001 109.254 -179.965 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 72' ' ' GLN . . . -77.31 50.83 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.104 -1.199 . . . . 12.699999999999999 110.104 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER 40.05 49.39 2.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -1.094 . . . . 26.289999999999999 110.102 179.62 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 74' ' ' GLY . 1.7 m-85 -143.35 31.26 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 20.440000000000001 109.334 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.516 ' HA3' ' HG2' ' B' ' 46' ' ' LYS . . . 44.61 44.96 8.55 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.624 -1.39 . . . . 13.82 109.624 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.484 ' N ' HG22 ' B' ' 45' ' ' VAL . 46.6 m -166.57 114.27 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -1.209 . . . . 18.27 109.832 -179.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.862 HD13 HG21 ' B' ' 35' ' ' VAL . 0.3 OUTLIER -68.04 155.36 39.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 12.43 109.037 179.678 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.543 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 8.1 mtp -162.54 157.06 21.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 35.109999999999999 109.754 -179.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.759 HD12 HD12 ' B' ' 78' ' ' ILE . 3.3 mt -80.65 135.06 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 13.67 109.899 179.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 79' ' ' ASP . 46.9 t0 -103.18 -20.55 14.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.376 -0.972 . . . . 24.059999999999999 108.376 178.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 67' ' ' SER . 5.1 tmm_? 175.79 69.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.93 -1.507 . . . . 35.039999999999999 106.93 179.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -32.23 120.21 0.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.458 -0.792 . . . . 18.719999999999999 111.635 -177.711 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -92.12 99.44 12.24 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.322 -0.992 . . . . 20.550000000000001 108.322 178.996 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.749 HD23 ' CD2' ' A' ' 61' ' ' TYR . 1.5 tp -67.43 157.54 33.91 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.019 0.914 . . . . 14.4 111.159 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 62' ' ' THR . 21.3 m -156.55 147.98 16.9 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.818 -1.178 . . . . 17.649999999999999 107.818 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -63.12 135.24 49.87 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 121.815 1.677 . . . . 25.699999999999999 109.872 179.352 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.749 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -61.85 118.8 7.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.942 . . . . 49.289999999999999 109.792 -178.521 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.01 -0.995 . . . . 58.909999999999997 109.454 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.494 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.339 0.59 . . . . 64.909999999999997 109.425 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.784 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.2 mt 75.25 83.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.632 -1.247 . . . . 33.799999999999997 107.632 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.533 ' C ' HG12 ' B' ' 4' ' ' VAL . 3.8 mtpp -80.74 173.07 12.97 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.136 0.97 . . . . 32.719999999999999 111.957 -177.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.891 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 179.83 168.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.781 -0.822 . . . . 14.460000000000001 108.781 -179.773 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.582 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 36.5 mt-10 -141.54 112.65 7.39 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.401 -0.812 . . . . 22.120000000000001 109.522 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.866 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -71.5 104.72 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.475 -1.306 . . . . 14.23 107.475 179.05 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.686 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -51.32 162.05 0.7 Allowed Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.881 . . . . 25.43 110.154 -178.874 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.401 ' HD2' ' HG3' ' B' ' 7' ' ' LYS . 33.7 Cg_endo -76.54 -18.8 15.27 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.472 2.114 . . . . 13.609999999999999 109.15 178.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -92.03 8.6 36.92 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.719 -0.845 . . . . 15.52 108.719 178.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.558 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 0.0 OUTLIER -147.92 38.92 0.92 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.35 -0.844 . . . . 17.309999999999999 109.229 179.353 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.18 7.05 44.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 24.780000000000001 109.721 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.604 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 29.0 mt-30 -127.52 155.59 43.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 47.899999999999999 109.203 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.764 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 37.4 p90 -96.37 160.53 14.37 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.089 -1.007 . . . . 21.609999999999999 109.363 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -127.2 160.84 30.04 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.838 -0.801 . . . . 14.890000000000001 108.838 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.649 0 O-C-N 121.318 -0.864 . . . . 17.350000000000001 109.002 179.81 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.317 0.579 . . . . 24.0 109.681 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.576 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 85.8 m-20 -43.59 134.38 4.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 23.309999999999999 109.735 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 1.0 OUTLIER -125.65 161.74 26.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.362 -0.836 . . . . 40.030000000000001 109.192 179.889 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.96 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -140.32 -172.33 3.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.166 -0.959 . . . . 12.390000000000001 109.605 179.954 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.734 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.7 mp -130.76 171.63 12.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 17.420000000000002 109.372 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.582 ' SG ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -162.45 154.28 18.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.06 -1.025 . . . . 13.84 108.776 -179.688 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.703 ' CE2' HD13 ' B' ' 44' ' ' LEU . 27.4 m-85 -115.23 104.36 11.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 21.140000000000001 109.645 -179.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.862 HG21 HD13 ' A' ' 76' ' ' LEU . 63.2 t -80.32 165.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.849 -1.157 . . . . 10.66 109.509 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.617 ' N ' HG12 ' B' ' 35' ' ' VAL . 6.2 m-20 -137.24 -52.76 0.67 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.304 -0.873 . . . . 25.890000000000001 109.683 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -42.09 -44.67 3.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 24.239999999999998 109.088 179.921 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 39' ' ' ASN . . . -88.52 32.06 4.63 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.651 -1.38 . . . . 31.02 109.651 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' ASP . 2.5 p30 161.23 117.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.397 -1.06 . . . . 43.229999999999997 109.577 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.0 OUTLIER -42.45 -64.67 0.57 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.355 -0.841 . . . . 42.340000000000003 109.508 179.942 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.51 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 5.6 m-70 -68.95 163.41 56.68 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 107.97 -1.122 . . . . 3.75 107.97 179.078 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.692 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.9 Cg_endo -77.98 140.67 18.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.507 1.471 . . . . 17.920000000000002 109.702 -179.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.534 HG21 ' ND2' ' B' ' 39' ' ' ASN . 5.9 m -116.49 114.29 45.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.339 -0.851 . . . . 20.57 108.981 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.734 HD11 ' HB3' ' B' ' 32' ' ' LEU . 43.6 tp -69.77 107.48 3.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.379 -0.826 . . . . 20.210000000000001 109.946 -179.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.715 HG23 HG11 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -108.88 164.12 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.627 -0.879 . . . . 10.81 108.627 179.592 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' HA3' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -86.85 170.11 11.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.948 . . . . 36.740000000000002 109.741 -179.645 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.637 HG22 ' CB ' ' B' ' 31' ' ' GLN . 0.1 OUTLIER -156.72 171.46 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.283 -0.886 . . . . 19.739999999999998 109.379 179.861 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 18.3 m -107.5 147.71 30.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 22.559999999999999 109.442 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.64 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 1.7 tm? -129.24 112.22 13.68 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.198 -0.939 . . . . 20.41 108.781 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' B' ' 53' ' ' GLN . 2.7 t70 -61.69 138.3 58.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.827 . . . . 33.990000000000002 110.202 -179.014 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.41 124.39 17.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 54.920000000000002 108.771 179.379 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.52 -31.25 8.3 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.987 -1.645 . . . . 36.100000000000001 108.987 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.608 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.4 OUTLIER -73.61 146.45 85.94 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.35 -1.088 . . . . 54.759999999999998 109.153 179.694 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.4 Cg_endo -78.35 118.03 4.2 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.453 2.102 . . . . 28.370000000000001 109.998 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.96 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -41.49 154.81 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.454 -0.779 . . . . 17.210000000000001 109.764 -179.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 6.7 m-30 -44.96 105.82 0.06 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 17.190000000000001 108.769 179.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -62.48 176.19 0.52 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 17.82 109.439 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.7 Cg_endo -77.46 128.53 9.63 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.547 2.165 . . . . 17.280000000000001 110.152 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.61 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 155.4 147.97 4.88 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.889 -1.284 . . . . 17.219999999999999 109.889 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.753 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.6 OUTLIER -47.43 145.69 2.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.055 -1.262 . . . . 19.57 108.527 179.209 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.891 ' CB ' HG13 ' B' ' 4' ' ' VAL . 17.0 m-85 -125.25 161.87 25.95 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.624 -1.297 . . . . 14.609999999999999 111.663 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.906 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.5 p -144.87 121.73 11.27 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.445 -1.687 . . . . 18.359999999999999 106.445 178.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -60.15 163.22 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 C-N-CA 118.517 -1.273 . . . . 19.129999999999999 108.974 -178.519 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.47 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -127.41 128.28 45.55 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.527 -0.733 . . . . 20.649999999999999 109.036 -179.287 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.797 HD11 ' CG ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -71.48 0.88 7.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.476 -0.765 . . . . 19.649999999999999 110.093 -179.828 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -20.89 6.15 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.268 -1.382 . . . . 14.720000000000001 107.268 178.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 5.6 m -95.14 -8.98 34.86 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.897 -0.502 . . . . 11.449999999999999 110.245 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.6 m-30 -84.07 156.57 22.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.945 -1.097 . . . . 14.25 109.206 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.403 ' HE2' ' OD2' ' B' ' 79' ' ' ASP . 0.3 OUTLIER -167.8 174.43 7.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.431 -0.793 . . . . 32.700000000000003 109.435 179.736 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.695 HG11 HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -102.76 109.91 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 15.630000000000001 109.273 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' B' ' 72' ' ' GLN . . . -77.44 50.58 3.2 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.143 -1.183 . . . . 12.699999999999999 110.143 -179.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 71' ' ' GLY . 0.0 OUTLIER 40.28 49.62 2.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.331 -1.099 . . . . 26.289999999999999 110.041 179.653 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -143.65 31.35 1.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 20.440000000000001 109.323 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.516 ' HA3' ' HG2' ' A' ' 46' ' ' LYS . . . 44.56 44.73 8.37 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.621 -1.392 . . . . 13.82 109.621 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 45' ' ' VAL . 46.6 m -166.41 114.53 0.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -1.205 . . . . 18.27 109.824 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.898 HD13 HG21 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -68.13 155.36 39.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 12.43 109.019 179.634 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 8.1 mtp -162.68 157.13 21.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 35.109999999999999 109.682 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.759 HD12 HD12 ' A' ' 78' ' ' ILE . 3.3 mt -80.78 135.36 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.442 -0.787 . . . . 13.67 109.91 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' B' ' 79' ' ' ASP . 47.2 t0 -103.19 -20.74 14.03 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.358 -0.979 . . . . 24.059999999999999 108.358 178.287 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' B' ' 67' ' ' SER . 5.1 tmm_? 175.96 69.7 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.982 -1.488 . . . . 35.039999999999999 106.982 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.643 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -32.45 120.2 0.31 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.464 -0.789 . . . . 18.719999999999999 111.684 -177.725 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -92.15 99.32 12.14 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.23 -1.026 . . . . 20.550000000000001 108.23 179.064 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.732 HD23 ' CD2' ' B' ' 61' ' ' TYR . 1.5 tp -67.4 157.62 33.68 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.034 0.921 . . . . 14.4 111.127 -178.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.906 HG22 ' O ' ' B' ' 62' ' ' THR . 21.2 m -156.6 148.13 16.99 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.841 -1.17 . . . . 17.649999999999999 107.841 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.5 Cg_endo -63.31 135.17 48.84 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.774 1.649 . . . . 25.699999999999999 109.88 179.383 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.753 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -61.83 118.43 7.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.318 -0.864 . . . . 49.289999999999999 109.761 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' B' ' 86' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.975 -1.012 . . . . 58.909999999999997 109.475 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.302 0.572 . . . . 64.909999999999997 109.53 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.895 ' CA ' HD22 ' B' ' 65' ' ' LEU . 5.3 mt -69.67 82.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.909 -1.145 . . . . 33.799999999999997 107.909 179.178 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.488 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 mttt -59.19 156.21 12.72 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.894 0.854 . . . . 32.719999999999999 111.531 -177.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 35' ' ' VAL . 49.0 t -159.57 167.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 109.19 -0.67 . . . . 14.460000000000001 109.19 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.602 ' N ' HG12 ' A' ' 4' ' ' VAL . 30.2 mt-10 -152.63 100.93 2.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.741 0.782 . . . . 22.120000000000001 109.185 -179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.644 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -66.96 103.56 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.852 -1.166 . . . . 14.23 107.852 179.493 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 2.2 mmpt? -50.18 159.23 0.84 Allowed Pre-proline 0 N--CA 1.485 1.291 0 O-C-N 121.302 -0.874 . . . . 25.43 109.66 -179.115 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.2 Cg_endo -76.16 -3.31 13.67 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.28 1.987 . . . . 13.609999999999999 109.37 179.374 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.15 -10.45 33.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.483 -0.76 . . . . 15.52 109.408 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 1.053 ' OE1' HD13 ' A' ' 32' ' ' LEU . 25.7 mm-40 -97.54 -76.34 0.52 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.293 -0.879 . . . . 17.309999999999999 108.863 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 10' ' ' GLN . . . 23.64 45.54 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.205 0.526 . . . . 24.780000000000001 111.195 179.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.2 pt20 -179.04 132.42 0.12 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 47.899999999999999 109.557 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 31.9 p90 -97.45 156.27 16.55 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.953 -1.092 . . . . 21.609999999999999 109.486 179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 t -124.92 164.08 20.86 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.651 -0.87 . . . . 14.890000000000001 108.651 178.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.523 0 O-C-N 121.116 -0.99 . . . . 17.350000000000001 109.53 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 29' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.521 0.677 . . . . 24.0 110.657 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.63 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -42.2 159.3 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 23.309999999999999 109.942 179.686 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -156.71 137.22 13.09 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.753 -0.832 . . . . 40.030000000000001 108.753 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.844 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -120.89 -166.34 1.33 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.947 -1.095 . . . . 12.390000000000001 110.334 -179.231 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.053 HD13 ' OE1' ' A' ' 10' ' ' GLN . 4.4 mp -127.37 175.25 8.35 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.933 -0.766 . . . . 17.420000000000002 108.933 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.79 160.14 6.74 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.796 -1.19 . . . . 13.84 108.663 -179.545 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.695 ' CE1' HD13 ' A' ' 44' ' ' LEU . 2.9 m-30 -112.54 86.37 2.35 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.259 -0.9 . . . . 21.140000000000001 109.199 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 4' ' ' VAL . 59.2 t -83.11 110.37 18.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.156 -0.965 . . . . 10.66 110.227 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' LEU . 36.8 t0 -53.58 -34.79 59.61 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.779 -1.193 . . . . 25.890000000000001 107.779 178.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.748 HD11 ' C ' ' B' ' 68' ' ' PHE . 1.0 OUTLIER 41.27 34.36 0.32 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.303 0.573 . . . . 24.239999999999998 109.73 179.317 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.25 23.75 34.44 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.301 -1.52 . . . . 31.02 109.301 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.854 HD22 HG11 ' A' ' 43' ' ' VAL . 43.3 m-20 -88.26 26.53 1.39 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.304 -1.116 . . . . 43.229999999999997 110.01 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.77 14.18 3.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.046 -1.034 . . . . 42.340000000000003 109.876 179.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER 175.61 167.1 0.39 Allowed Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.437 -0.949 . . . . 5.25 108.437 179.883 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 33.8 Cg_endo -75.81 145.16 28.46 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.722 1.614 . . . . 17.920000000000002 110.421 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 35' ' ' VAL . 6.6 m -119.9 119.77 61.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.482 -0.887 . . . . 20.57 109.171 179.356 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.931 HD11 ' HB3' ' A' ' 32' ' ' LEU . 14.7 tp -72.47 112.85 8.89 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.886 -0.725 . . . . 20.210000000000001 109.276 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.427 HG22 ' C ' ' B' ' 74' ' ' GLY . 1.7 p -130.78 161.51 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.386 -0.822 . . . . 10.81 109.127 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 0.6 OUTLIER -80.75 160.34 24.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.038 -1.039 . . . . 36.740000000000002 110.407 -179.094 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.815 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -140.64 161.91 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.46 -0.941 . . . . 19.739999999999998 108.46 179.353 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 143.0 28.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.97 -1.081 . . . . 22.559999999999999 109.683 -179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -114.0 146.58 39.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.366 -0.834 . . . . 20.41 108.858 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.498 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -81.33 142.88 32.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 33.990000000000002 109.538 -179.583 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.12 116.89 3.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 54.920000000000002 109.477 -179.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.11 -6.55 83.37 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.652 -1.379 . . . . 36.100000000000001 109.652 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.498 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -83.89 148.78 54.96 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 54.759999999999998 109.451 179.999 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.5 Cg_endo -77.01 119.47 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.617 2.211 . . . . 28.370000000000001 110.776 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.844 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.01 147.85 0.21 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 17.210000000000001 110.267 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.678 ' CD1' HG21 ' A' ' 47' ' ' ILE . 86.8 m-85 -44.07 112.09 0.36 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 17.190000000000001 109.131 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.01 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -63.92 176.58 0.63 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 17.82 109.779 -179.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 1.01 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -77.8 113.54 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.756 2.304 . . . . 17.280000000000001 110.433 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.8 172.84 38.83 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.389 -1.484 . . . . 17.219999999999999 109.389 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 3.3 mp -70.41 146.63 50.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 19.57 108.811 179.494 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.644 ' CE1' HD13 ' A' ' 6' ' ' ILE . 26.6 m-85 -131.24 163.59 27.45 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.945 -1.097 . . . . 14.609999999999999 110.921 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.664 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.1 p -144.4 117.17 8.72 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.066 -1.827 . . . . 18.359999999999999 106.066 178.623 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -49.81 163.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 C-N-CA 118.681 -1.208 . . . . 19.129999999999999 108.71 -178.143 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -128.3 126.62 41.16 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.409 -0.807 . . . . 20.649999999999999 109.381 -178.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.886 HD22 ' HA ' ' B' ' 2' ' ' ILE . 0.7 OUTLIER -74.05 2.51 8.65 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.533 -0.729 . . . . 19.649999999999999 110.054 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.9 p -58.88 -18.02 29.22 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.546 -1.279 . . . . 14.720000000000001 107.546 178.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 23.8 m -97.83 -16.4 19.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.842 -0.536 . . . . 11.449999999999999 110.151 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.728 ' C ' HD11 ' B' ' 37' ' ' LEU . 3.0 m-30 -68.14 157.3 35.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.125 -0.984 . . . . 14.25 109.441 -178.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.617 ' N ' HD11 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -150.48 -179.76 7.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.385 -0.822 . . . . 32.700000000000003 109.613 -179.995 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.632 HG21 HG21 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -120.82 110.88 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 15.630000000000001 109.121 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.458 ' N ' ' SD ' ' A' ' 77' ' ' MET . . . -81.7 -175.07 50.03 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.658 -1.377 . . . . 12.699999999999999 109.658 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.524 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -89.55 20.17 4.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.152 -1.205 . . . . 26.289999999999999 109.574 -179.974 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -93.73 -2.64 53.5 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.394 -0.816 . . . . 20.440000000000001 109.348 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 81.16 26.89 51.3 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.68 -1.368 . . . . 13.82 109.68 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.6 153.7 32.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.082 -1.246 . . . . 18.27 109.82 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.596 HD12 HG13 ' A' ' 70' ' ' VAL . 1.1 tp -62.24 176.81 0.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.348 -0.845 . . . . 12.43 109.664 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.488 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 2.1 ptm -167.68 100.12 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 35.109999999999999 109.691 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.606 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.9 mt -36.86 -64.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.478 0.656 . . . . 13.67 110.301 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 9.0 t0 84.53 -45.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.484 0.659 . . . . 24.059999999999999 110.014 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.8 tpm_? -173.84 67.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.147 0.975 . . . . 35.039999999999999 108.526 179.424 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.637 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.2 pt? -40.96 126.8 2.59 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.483 -0.781 . . . . 18.719999999999999 111.931 -178.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 1.4 ttt180 -94.11 110.4 22.11 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.693 -1.225 . . . . 20.550000000000001 107.693 178.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.815 ' HB2' HD11 ' A' ' 47' ' ' ILE . 11.8 tp -80.2 150.42 30.12 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.056 -1.027 . . . . 14.4 111.112 -178.148 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 62' ' ' THR . 21.2 m -147.08 157.57 46.06 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 108.161 -1.051 . . . . 17.649999999999999 108.161 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.6 Cg_endo -62.56 142.0 88.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.058 1.838 . . . . 25.699999999999999 110.321 179.11 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -76.38 116.47 17.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.229 -0.919 . . . . 49.289999999999999 109.739 -178.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.012 -0.995 . . . . 58.909999999999997 109.425 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.482 ' SD ' ' HB ' ' B' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.308 0.575 . . . . 64.909999999999997 109.556 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.886 ' HA ' HD22 ' A' ' 65' ' ' LEU . 5.2 mt -69.48 82.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.91 -1.144 . . . . 33.799999999999997 107.91 179.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.5 ' C ' HG23 ' B' ' 4' ' ' VAL . 2.3 mttt -59.12 156.4 12.12 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.915 0.864 . . . . 32.719999999999999 111.543 -178.0 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.089 HG22 HG22 ' B' ' 35' ' ' VAL . 49.2 t -159.7 167.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 109.2 -0.667 . . . . 14.460000000000001 109.2 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.604 ' N ' HG12 ' B' ' 4' ' ' VAL . 30.0 mt-10 -152.45 100.94 2.62 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.808 0.813 . . . . 22.120000000000001 109.296 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.648 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -66.92 103.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.838 -1.171 . . . . 14.23 107.838 179.454 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.567 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 2.2 mmpt? -50.08 159.39 0.8 Allowed Pre-proline 0 N--CA 1.486 1.328 0 O-C-N 121.294 -0.879 . . . . 25.43 109.69 -179.156 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.7 Cg_endo -76.26 -3.26 13.61 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.353 2.035 . . . . 13.609999999999999 109.37 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.28 -10.48 32.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.461 -0.775 . . . . 15.52 109.394 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 1.038 ' OE1' HD13 ' B' ' 32' ' ' LEU . 25.6 mm-40 -97.48 -76.45 0.52 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.282 -0.886 . . . . 17.309999999999999 108.865 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' B' ' 10' ' ' GLN . . . 23.77 45.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.164 0.507 . . . . 24.780000000000001 111.175 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' B' ' 10' ' ' GLN . 1.2 pt20 -178.94 132.28 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 47.899999999999999 109.616 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 32.5 p90 -97.21 156.35 16.45 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.954 -1.091 . . . . 21.609999999999999 109.551 179.7 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.4 t -124.97 163.94 21.21 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.656 -0.868 . . . . 14.890000000000001 108.656 178.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.133 -0.979 . . . . 17.350000000000001 109.538 -179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' B' ' 29' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.482 0.658 . . . . 24.0 110.612 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.623 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -42.3 159.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.471 -0.768 . . . . 23.309999999999999 109.942 179.717 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -156.77 136.99 12.82 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.764 -0.828 . . . . 40.030000000000001 108.764 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.825 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -120.77 -166.41 1.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.992 -1.068 . . . . 12.390000000000001 110.342 -179.277 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 1.038 HD13 ' OE1' ' B' ' 10' ' ' GLN . 4.4 mp -127.16 175.43 8.14 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.871 -0.788 . . . . 17.420000000000002 108.871 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.99 160.1 6.38 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.834 -1.166 . . . . 13.84 108.59 -179.549 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.701 ' CE1' HD13 ' B' ' 44' ' ' LEU . 2.9 m-30 -112.52 86.41 2.35 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 21.140000000000001 109.201 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 1.089 HG22 HG22 ' B' ' 4' ' ' VAL . 59.5 t -83.22 110.57 18.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.189 -0.944 . . . . 10.66 110.236 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' B' ' 37' ' ' LEU . 36.8 t0 -53.7 -34.74 59.78 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.79 -1.189 . . . . 25.890000000000001 107.79 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.728 HD11 ' C ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER 41.26 34.38 0.32 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.79 -0.568 . . . . 24.239999999999998 109.717 179.345 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.23 23.58 33.71 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.3 -1.52 . . . . 31.02 109.3 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.837 HD22 HG11 ' B' ' 43' ' ' VAL . 45.1 m-20 -88.09 26.46 1.38 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.285 -1.126 . . . . 43.229999999999997 110.022 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.8 14.22 4.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.082 -1.011 . . . . 42.340000000000003 109.893 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 0.6 OUTLIER 175.61 167.01 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.454 -0.943 . . . . 5.2300000000000004 108.454 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.637 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 33.8 Cg_endo -75.62 145.31 29.25 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.711 1.608 . . . . 17.920000000000002 110.49 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.877 HG22 ' O ' ' B' ' 35' ' ' VAL . 6.6 m -120.03 119.94 61.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 C-N-CA 119.378 -0.929 . . . . 20.57 109.16 179.312 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.949 HD11 ' HB3' ' B' ' 32' ' ' LEU . 14.8 tp -72.76 112.92 9.24 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.93 -0.708 . . . . 20.210000000000001 109.172 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 32' ' ' LEU . 1.7 p -130.82 161.52 40.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.421 -0.799 . . . . 10.81 109.077 -179.758 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -80.74 160.31 24.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.985 . . . . 36.740000000000002 110.399 -179.093 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.798 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.5 OUTLIER -140.57 161.88 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.378 -0.971 . . . . 19.739999999999998 108.378 179.41 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.07 142.98 28.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.952 -1.092 . . . . 22.559999999999999 109.744 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.602 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -113.85 146.82 39.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 20.41 108.888 179.873 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.503 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -81.63 142.78 32.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 33.990000000000002 109.536 -179.572 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.05 117.14 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 54.920000000000002 109.417 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.12 -6.81 83.04 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.599 -1.4 . . . . 36.100000000000001 109.599 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.503 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -83.79 148.89 55.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.188 -1.183 . . . . 54.759999999999998 109.508 -179.958 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.5 Cg_endo -77.03 119.39 5.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.715 2.277 . . . . 28.370000000000001 110.761 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.825 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.0 147.69 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 17.210000000000001 110.35 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.682 ' CD1' HG21 ' B' ' 47' ' ' ILE . 86.9 m-85 -43.76 112.54 0.4 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.543 -0.723 . . . . 17.190000000000001 109.07 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.979 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -64.54 176.38 0.74 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 17.82 109.879 -179.348 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.979 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.3 112.47 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.606 2.204 . . . . 17.280000000000001 110.112 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.56 172.31 39.54 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.54 -1.424 . . . . 17.219999999999999 109.54 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 3.0 mp -70.67 146.01 50.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -1.165 . . . . 19.57 108.438 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.648 ' CE1' HD13 ' B' ' 6' ' ' ILE . 27.5 m-85 -130.69 163.51 27.08 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.909 -1.119 . . . . 14.609999999999999 110.908 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.663 ' O ' HG22 ' B' ' 84' ' ' VAL . 44.5 p -144.26 117.2 8.82 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.049 -1.834 . . . . 18.359999999999999 106.049 178.562 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -49.86 163.64 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 C-N-CA 118.644 -1.222 . . . . 19.129999999999999 108.734 -178.134 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -128.07 126.79 41.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.338 -0.851 . . . . 20.649999999999999 109.356 -178.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.895 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -74.22 2.48 9.02 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.533 -0.73 . . . . 19.649999999999999 110.008 -179.996 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 84.1 p -58.85 -18.03 29.04 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.512 -1.292 . . . . 14.720000000000001 107.512 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 23.7 m -97.89 -16.39 19.77 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.85 -0.531 . . . . 11.449999999999999 110.172 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.748 ' C ' HD11 ' A' ' 37' ' ' LEU . 3.0 m-30 -68.21 156.98 36.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 14.25 109.454 -178.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.634 ' N ' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -149.89 -179.85 7.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 32.700000000000003 109.715 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.692 HG21 HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -120.75 110.87 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 15.630000000000001 109.061 179.788 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.457 ' N ' ' SD ' ' B' ' 77' ' ' MET . . . -81.85 -174.68 49.75 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.619 -1.392 . . . . 12.699999999999999 109.619 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.01 20.27 4.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.168 -1.195 . . . . 26.289999999999999 109.54 -179.932 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -93.75 -2.7 53.37 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.477 -0.764 . . . . 20.440000000000001 109.349 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 80.96 27.79 48.54 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.533 -1.427 . . . . 13.82 109.533 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.34 153.52 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -1.211 . . . . 18.27 109.788 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.606 HD12 HG13 ' B' ' 70' ' ' VAL . 1.1 tp -62.12 176.83 0.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 12.43 109.584 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' B' ' 69' ' ' LYS . 2.1 ptm -167.71 99.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 35.109999999999999 109.685 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.589 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.9 mt -36.67 -64.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.511 0.672 . . . . 13.67 110.329 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 9.1 t0 84.44 -45.38 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.435 0.636 . . . . 24.059999999999999 110.061 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.9 tpm_? -173.96 67.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.155 0.978 . . . . 35.039999999999999 108.488 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.637 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.2 pt? -40.83 126.78 2.52 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.503 -0.771 . . . . 18.719999999999999 111.984 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 1.4 ttt180 -94.11 110.48 22.19 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.677 -1.231 . . . . 20.550000000000001 107.677 178.221 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.798 ' HB2' HD11 ' B' ' 47' ' ' ILE . 11.7 tp -80.28 150.39 30.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.091 -1.006 . . . . 14.4 111.166 -178.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.663 HG22 ' O ' ' B' ' 62' ' ' THR . 21.2 m -146.98 157.89 45.91 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 108.214 -1.032 . . . . 17.649999999999999 108.214 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.0 Cg_endo -62.77 142.1 87.7 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.015 1.81 . . . . 25.699999999999999 110.334 179.134 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -76.57 116.44 17.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.21 -0.931 . . . . 49.289999999999999 109.743 -178.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.994 -1.003 . . . . 58.909999999999997 109.44 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.646 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.375 0.607 . . . . 64.909999999999997 109.418 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.958 ' HA ' HD22 ' B' ' 65' ' ' LEU . 0.9 OUTLIER -68.62 73.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.664 -1.236 . . . . 33.799999999999997 107.664 178.987 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.646 ' HD3' HD21 ' A' ' 60' ' ' LEU . 1.6 mttt -62.61 157.0 21.75 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.178 0.989 . . . . 32.719999999999999 112.372 -177.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.976 HG22 HG22 ' A' ' 35' ' ' VAL . 60.0 t -159.44 169.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.562 -0.903 . . . . 14.460000000000001 108.562 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.606 ' N ' HG12 ' A' ' 4' ' ' VAL . 68.0 mt-10 -152.25 103.02 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.132 -0.98 . . . . 22.120000000000001 109.634 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.906 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -75.36 105.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.853 -1.166 . . . . 14.23 107.853 179.116 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.639 ' HG3' ' CD1' ' A' ' 34' ' ' TYR . 4.9 mttm -55.57 166.13 1.05 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.8 . . . . 25.43 109.704 -179.27 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.7 Cg_endo -72.19 -17.91 27.43 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.925 1.75 . . . . 13.609999999999999 108.955 179.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -90.78 -6.46 54.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.984 -0.747 . . . . 15.52 108.984 178.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 2.4 mm100 -120.53 40.62 3.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 17.309999999999999 109.505 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -104.13 14.12 31.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.125 -0.985 . . . . 24.780000000000001 110.017 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 24.3 mt-30 -137.83 137.36 38.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 47.899999999999999 109.911 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.675 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 37.2 p90 -92.53 170.52 9.68 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.363 -0.836 . . . . 21.609999999999999 109.577 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -141.94 162.88 34.38 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.637 -0.875 . . . . 14.890000000000001 108.637 179.129 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.298 -1.632 0 O-C-N 121.194 -0.941 . . . . 17.350000000000001 109.187 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 28' ' ' LEU . 4.0 mm? . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.455 0.645 . . . . 24.0 109.984 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 95.0 m-20 -74.51 119.59 18.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.446 -0.784 . . . . 23.309999999999999 109.318 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -108.53 143.96 36.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.083 -1.011 . . . . 40.030000000000001 109.242 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.724 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -130.18 -179.9 5.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 12.390000000000001 109.548 -179.857 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.864 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.2 mp -133.78 159.15 41.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 17.420000000000002 109.795 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.61 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.7 m -152.09 177.54 10.39 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.992 -1.114 . . . . 13.84 107.992 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.674 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 51.4 m-85 -126.88 122.65 35.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.895 -1.128 . . . . 21.140000000000001 110.095 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.976 HG22 HG22 ' A' ' 4' ' ' VAL . 96.7 t -109.35 129.24 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.215 -0.928 . . . . 10.66 109.964 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -121.64 -14.68 8.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.405 -0.81 . . . . 25.890000000000001 109.81 -179.593 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.09 HD12 ' N ' ' A' ' 38' ' ' GLY . 2.6 pp -36.61 -29.74 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.653 -0.654 . . . . 24.239999999999998 110.551 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 1.09 ' N ' HD12 ' A' ' 37' ' ' LEU . . . -124.59 19.7 7.02 Favored Glycine 0 N--CA 1.482 1.734 0 N-CA-C 109.565 -1.414 . . . . 31.02 109.565 -179.012 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.599 ' ND2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -165.43 114.49 1.03 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.322 -1.105 . . . . 43.229999999999997 109.14 179.84 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 39' ' ' ASN . 39.8 mt-10 -39.08 -66.59 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.663 . . . . 42.340000000000003 109.946 -179.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 41' ' ' HIS . 2.1 m-70 -63.5 153.36 83.09 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 108.224 -1.028 . . . . 6.3700000000000001 108.224 179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.674 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -78.38 138.39 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.889 1.726 . . . . 17.920000000000002 110.277 -179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 43' ' ' VAL . 5.0 m -109.44 116.93 53.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.419 -0.801 . . . . 20.57 109.131 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.864 HD11 ' HB3' ' A' ' 32' ' ' LEU . 57.2 tp -71.86 108.13 4.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.276 -0.89 . . . . 20.210000000000001 109.937 -179.428 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.676 HG12 HG11 ' B' ' 70' ' ' VAL . 1.1 m -103.44 175.67 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.002 -0.74 . . . . 10.81 109.002 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -105.48 125.6 51.17 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.302 -0.959 . . . . 36.740000000000002 109.338 179.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.098 HD13 HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -120.9 132.33 70.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.277 -0.89 . . . . 19.739999999999998 109.602 -179.689 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 49' ' ' LEU . 60.1 m -66.63 156.71 34.41 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.246 -0.908 . . . . 22.559999999999999 109.299 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.707 HD11 ' O ' ' A' ' 53' ' ' GLN . 2.8 tm? -130.09 111.27 12.31 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.321 -0.862 . . . . 20.41 108.744 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.507 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -42.4 122.53 2.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 33.990000000000002 109.945 -179.2 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -51.02 101.67 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.353 -0.842 . . . . 54.920000000000002 109.277 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.44 -24.08 10.0 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.263 -1.535 . . . . 36.100000000000001 109.263 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.707 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -73.61 157.97 86.94 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.293 -1.122 . . . . 54.759999999999998 109.351 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -78.79 114.34 3.42 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.529 2.153 . . . . 28.370000000000001 110.142 179.546 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.724 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -38.81 142.01 0.24 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.477 -0.764 . . . . 17.210000000000001 109.888 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.906 ' O ' HG21 ' A' ' 6' ' ' ILE . 88.5 m-85 -41.9 101.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.393 -0.817 . . . . 17.190000000000001 109.408 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.795 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.72 169.36 0.21 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.16 -0.963 . . . . 17.82 109.207 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.795 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.25 122.11 6.0 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.62 2.213 . . . . 17.280000000000001 110.457 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.97 179.89 40.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.526 -1.43 . . . . 17.219999999999999 109.526 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -72.96 138.51 46.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -1.175 . . . . 19.57 108.448 179.294 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.759 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.2 m-85 -125.11 162.11 25.32 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.611 -1.306 . . . . 14.609999999999999 111.738 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 84' ' ' VAL . 58.8 p -144.74 120.62 10.62 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.505 -1.665 . . . . 18.359999999999999 106.505 179.06 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -54.6 165.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 C-N-CA 118.581 -1.248 . . . . 19.129999999999999 109.136 -178.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -127.55 127.07 43.3 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.523 -0.736 . . . . 20.649999999999999 109.031 -179.227 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.09 ' CD1' HD13 ' B' ' 37' ' ' LEU . 0.4 OUTLIER -69.31 -2.89 11.92 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.569 -0.707 . . . . 19.649999999999999 109.797 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 t -54.37 -19.67 5.96 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 107.775 -1.194 . . . . 14.720000000000001 107.775 179.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 82' ' ' ARG . 3.8 m -94.7 -8.84 36.59 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.756 -0.59 . . . . 11.449999999999999 110.188 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.685 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.3 m-30 -85.34 156.76 20.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.882 -1.136 . . . . 14.25 109.462 -179.272 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.431 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -148.52 176.54 10.23 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.054 -0.721 . . . . 32.700000000000003 109.054 179.545 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.702 HG11 HG12 ' B' ' 45' ' ' VAL . 1.7 t -127.23 118.43 49.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.302 -0.874 . . . . 15.630000000000001 109.474 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 72' ' ' GLN . . . -82.5 -99.46 0.48 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.326 -1.509 . . . . 12.699999999999999 109.326 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.589 ' O ' ' CG ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER 170.33 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -1.129 . . . . 26.289999999999999 109.565 179.754 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER 151.72 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.784 -0.821 . . . . 20.440000000000001 108.784 179.923 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -114.5 -88.06 1.56 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.442 -1.463 . . . . 13.82 109.442 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.44 ' HA ' ' HB ' ' B' ' 45' ' ' VAL . 0.2 OUTLIER 177.93 174.73 0.53 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -1.145 . . . . 18.27 109.678 -179.989 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' A' ' 77' ' ' MET . 6.3 tp -43.51 146.61 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 12.43 109.659 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.533 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 5.1 mtt -151.85 151.22 31.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 35.109999999999999 109.272 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.619 HG12 ' CE1' ' A' ' 68' ' ' PHE . 6.5 mt -76.96 137.26 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 13.67 110.308 -179.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -104.89 -26.73 12.09 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.931 -1.137 . . . . 24.059999999999999 107.931 178.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER 179.02 69.95 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.021 -1.474 . . . . 35.039999999999999 107.021 179.014 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -30.19 121.43 0.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.342 -0.845 . . . . 18.719999999999999 111.71 -178.038 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.51 ' N ' ' OG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -91.85 101.27 13.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 20.550000000000001 108.808 179.398 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.098 HD12 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -70.08 145.85 51.35 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.946 0.879 . . . . 14.4 110.883 -179.02 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 62' ' ' THR . 25.6 m -148.73 156.75 41.43 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 107.793 -1.188 . . . . 17.649999999999999 107.793 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.0 Cg_endo -63.79 140.02 71.73 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.979 1.786 . . . . 25.699999999999999 110.15 179.023 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.724 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -71.44 118.31 14.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.939 . . . . 49.289999999999999 109.64 -178.703 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.012 -0.994 . . . . 58.909999999999997 109.435 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.64 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.371 0.605 . . . . 64.909999999999997 109.408 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.95 ' HA ' HD22 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -68.73 73.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.699 -1.223 . . . . 33.799999999999997 107.699 179.028 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.647 ' HD3' HD21 ' B' ' 60' ' ' LEU . 1.5 mttt -62.63 156.82 22.29 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.157 0.979 . . . . 32.719999999999999 112.352 -177.623 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.012 HG22 HG22 ' B' ' 35' ' ' VAL . 60.4 t -159.42 168.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.552 -0.906 . . . . 14.460000000000001 108.552 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.613 ' N ' HG12 ' B' ' 4' ' ' VAL . 68.6 mt-10 -152.22 103.02 2.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 22.120000000000001 109.648 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.91 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -75.4 106.06 4.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.79 -1.189 . . . . 14.23 107.79 179.18 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.641 ' HD2' ' CE1' ' B' ' 34' ' ' TYR . 4.9 mttm -55.75 166.23 1.08 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.492 -0.755 . . . . 25.43 109.709 -179.241 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.9 Cg_endo -72.05 -18.01 27.82 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.987 1.791 . . . . 13.609999999999999 109.003 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -90.77 -6.4 54.41 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.988 -0.745 . . . . 15.52 108.988 178.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 2.5 mm100 -120.68 40.73 3.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.895 . . . . 17.309999999999999 109.413 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -104.28 14.17 30.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 24.780000000000001 109.976 -179.346 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.404 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 24.7 mt-30 -137.86 137.34 38.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.148 -0.97 . . . . 47.899999999999999 109.854 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.658 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 37.2 p90 -92.47 170.59 9.64 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.398 -0.814 . . . . 21.609999999999999 109.568 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -141.91 163.02 34.03 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.57 -0.9 . . . . 14.890000000000001 108.57 179.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.299 -1.606 0 O-C-N 121.217 -0.927 . . . . 17.350000000000001 109.18 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.435 0.636 . . . . 24.0 109.998 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.593 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 95.4 m-20 -74.71 119.44 18.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.439 -0.788 . . . . 23.309999999999999 109.33 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -108.37 144.08 36.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.069 -1.019 . . . . 40.030000000000001 109.2 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.704 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.5 OUTLIER -130.27 -179.9 5.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -0.994 . . . . 12.390000000000001 109.51 -179.902 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.3 mp -133.76 159.16 41.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 17.420000000000002 109.722 -179.782 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.614 ' O ' HD12 ' B' ' 44' ' ' LEU . 2.8 m -152.07 177.76 10.16 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.008 -1.108 . . . . 13.84 108.008 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.68 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 50.7 m-85 -127.19 122.58 34.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.881 -1.137 . . . . 21.140000000000001 110.091 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 1.012 HG22 HG22 ' B' ' 4' ' ' VAL . 96.6 t -109.27 129.16 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.234 -0.916 . . . . 10.66 109.937 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' B' ' 36' ' ' ASP . 0.4 OUTLIER -121.48 -14.68 8.19 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.432 -0.793 . . . . 25.890000000000001 109.788 -179.654 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 1.093 HD12 ' N ' ' B' ' 38' ' ' GLY . 2.6 pp -36.6 -29.7 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.654 -0.654 . . . . 24.239999999999998 110.58 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 1.093 ' N ' HD12 ' B' ' 37' ' ' LEU . . . -124.65 19.58 7.02 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 109.591 -1.404 . . . . 31.02 109.591 -178.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.605 ' ND2' HG11 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -165.43 114.68 1.03 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.38 -1.07 . . . . 43.229999999999997 109.056 179.832 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' B' ' 39' ' ' ASN . 39.9 mt-10 -39.12 -66.48 0.28 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.536 0.684 . . . . 42.340000000000003 110.057 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . 0.436 ' ND1' ' N ' ' B' ' 41' ' ' HIS . 2.1 m-70 -63.56 153.39 83.21 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.223 -1.029 . . . . 6.3799999999999999 108.223 179.28 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.68 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 38.2 Cg_endo -78.42 138.29 15.51 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.85 1.7 . . . . 17.920000000000002 110.241 -179.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.668 ' O ' HG23 ' B' ' 43' ' ' VAL . 4.8 m -109.37 116.99 53.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.423 -0.798 . . . . 20.57 109.191 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' B' ' 32' ' ' LEU . 57.0 tp -71.69 108.11 4.86 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.86 . . . . 20.210000000000001 109.982 -179.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.702 HG12 HG11 ' A' ' 70' ' ' VAL . 1.1 m -103.48 175.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.466 -0.771 . . . . 10.81 109.055 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -105.44 125.37 50.91 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.385 -0.926 . . . . 36.740000000000002 109.431 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 1.056 HD13 HD12 ' B' ' 83' ' ' LEU . 1.0 OUTLIER -120.72 132.39 70.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.334 -0.854 . . . . 19.739999999999998 109.608 -179.638 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.433 HG22 ' N ' ' B' ' 49' ' ' LEU . 59.8 m -66.72 156.81 34.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 22.559999999999999 109.238 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.707 HD11 ' O ' ' B' ' 53' ' ' GLN . 2.8 tm? -130.17 111.28 12.28 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.288 -0.883 . . . . 20.41 108.746 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.515 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -42.43 122.62 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 33.990000000000002 109.944 -179.124 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -51.06 101.64 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.356 -0.84 . . . . 54.920000000000002 109.322 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.47 -24.0 10.03 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.297 -1.521 . . . . 36.100000000000001 109.297 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.707 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.8 OUTLIER -73.79 157.85 86.83 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.295 -1.12 . . . . 54.759999999999998 109.362 179.883 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.7 114.47 3.46 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.518 2.145 . . . . 28.370000000000001 110.098 179.582 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.704 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -38.82 141.76 0.26 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.465 -0.772 . . . . 17.210000000000001 109.949 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.91 ' O ' HG21 ' B' ' 6' ' ' ILE . 88.7 m-85 -41.5 100.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.439 -0.788 . . . . 17.190000000000001 109.317 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -50.01 169.5 0.19 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.987 . . . . 17.82 109.287 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.6 Cg_endo -77.06 120.84 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.48 2.12 . . . . 17.280000000000001 110.188 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.35 179.07 41.59 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.69 -1.364 . . . . 17.219999999999999 109.69 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -73.18 137.98 45.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -1.153 . . . . 19.57 107.969 178.884 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.753 ' HB3' HD22 ' B' ' 83' ' ' LEU . 21.2 m-85 -124.55 162.35 24.23 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.502 -1.374 . . . . 14.609999999999999 111.703 -179.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.796 ' O ' HG22 ' B' ' 84' ' ' VAL . 58.1 p -144.86 120.46 10.43 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.492 -1.67 . . . . 18.359999999999999 106.492 179.08 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -54.4 166.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 C-N-CA 118.578 -1.249 . . . . 19.129999999999999 109.056 -178.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.484 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -128.27 127.2 42.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.033 -0.728 . . . . 20.649999999999999 109.033 -179.275 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 1.075 ' CD1' HD13 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -69.36 -2.75 11.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.514 -0.741 . . . . 19.649999999999999 109.771 -179.964 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 9.2 t -54.54 -19.52 6.04 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 107.729 -1.211 . . . . 14.720000000000001 107.729 179.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' B' ' 82' ' ' ARG . 3.8 m -95.1 -9.26 34.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.829 -0.544 . . . . 11.449999999999999 110.147 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.3 m-30 -84.93 155.89 21.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.878 -1.139 . . . . 14.25 109.269 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.423 ' O ' HD12 ' B' ' 76' ' ' LEU . 0.2 OUTLIER -147.77 176.56 10.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.497 -0.752 . . . . 32.700000000000003 109.016 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.676 HG11 HG12 ' A' ' 45' ' ' VAL . 1.7 t -127.13 118.63 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.867 . . . . 15.630000000000001 109.476 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' B' ' 72' ' ' GLN . . . -82.69 -99.2 0.5 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.4 -1.48 . . . . 12.699999999999999 109.4 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.579 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER 170.1 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.191 -1.181 . . . . 26.289999999999999 109.569 179.769 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.579 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 0.7 OUTLIER 151.61 -33.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.768 -0.827 . . . . 20.440000000000001 108.768 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -114.68 -87.76 1.51 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.487 -1.445 . . . . 13.82 109.487 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 177.58 174.69 0.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -1.154 . . . . 18.27 109.606 179.931 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' B' ' 77' ' ' MET . 6.3 tp -43.6 146.49 0.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 12.43 109.633 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.517 ' N ' ' HG ' ' B' ' 76' ' ' LEU . 5.0 mtt -151.74 151.34 31.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.383 -0.823 . . . . 35.109999999999999 109.13 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.628 HG12 ' CE1' ' B' ' 68' ' ' PHE . 6.5 mt -77.16 137.47 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 13.67 110.351 -179.571 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -104.84 -26.71 12.12 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.91 -1.144 . . . . 24.059999999999999 107.91 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.0 OUTLIER 178.99 70.03 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.006 -1.479 . . . . 35.039999999999999 107.006 179.054 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.645 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -30.19 121.5 0.18 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.3 -0.864 . . . . 18.719999999999999 111.697 -178.055 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.513 ' N ' ' OG ' ' B' ' 67' ' ' SER . 0.0 OUTLIER -91.84 101.45 14.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.832 -0.803 . . . . 20.550000000000001 108.832 179.37 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.056 HD12 HD13 ' B' ' 47' ' ' ILE . 0.6 OUTLIER -70.2 145.54 51.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 14.4 110.9 -179.073 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.796 HG22 ' O ' ' B' ' 62' ' ' THR . 25.8 m -148.49 156.95 42.24 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 107.714 -1.217 . . . . 17.649999999999999 107.714 179.369 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.4 Cg_endo -64.01 140.21 71.31 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.936 1.757 . . . . 25.699999999999999 110.034 179.1 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -71.55 118.29 14.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 49.289999999999999 109.693 -178.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.979 -1.01 . . . . 58.909999999999997 109.428 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.504 ' CG ' ' HB ' ' A' ' 62' ' ' THR . 1.5 ttp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.307 0.575 . . . . 64.909999999999997 109.565 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.908 ' CA ' HD22 ' B' ' 65' ' ' LEU . 5.2 mt -71.32 75.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.134 -1.062 . . . . 33.799999999999997 108.134 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.02 156.38 24.87 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.907 0.86 . . . . 32.719999999999999 111.155 -178.283 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.833 HG11 HD11 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -163.85 167.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.464 -0.939 . . . . 14.460000000000001 108.464 179.983 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.533 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 34.3 mt-10 -141.01 113.55 8.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 22.120000000000001 109.59 -179.66 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -72.83 103.28 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.106 -1.072 . . . . 14.23 108.106 179.346 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.597 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 24.2 mmmt -51.49 163.41 0.59 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 25.43 109.369 -179.471 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.9 Cg_endo -73.04 -12.61 25.97 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.059 1.839 . . . . 13.609999999999999 109.383 179.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.6 3.72 54.75 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.615 -0.883 . . . . 15.52 108.615 178.491 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.556 ' OE1' HD13 ' A' ' 32' ' ' LEU . 13.8 mm-40 -127.38 41.32 3.54 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.374 -0.829 . . . . 17.309999999999999 108.86 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -98.23 11.76 36.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 24.780000000000001 110.258 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 32.4 mt-30 -136.42 134.43 37.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.123 -0.985 . . . . 47.899999999999999 110.121 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.634 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 20.4 p90 -84.72 164.83 18.32 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.318 -0.863 . . . . 21.609999999999999 109.436 179.735 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -130.89 140.31 50.19 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.349 -0.844 . . . . 14.890000000000001 109.256 179.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.952 HG23 ' O ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.534 0 O-C-N 121.413 -0.805 . . . . 17.350000000000001 109.225 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.952 ' O ' HG23 ' A' ' 15' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.524 0.678 . . . . 24.0 109.997 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.634 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -103.04 131.57 49.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.461 -0.774 . . . . 23.309999999999999 109.206 -179.863 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -117.19 148.58 41.48 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.064 -1.022 . . . . 40.030000000000001 109.76 -179.762 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.789 ' HB2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -126.9 -163.91 1.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.172 -0.955 . . . . 12.390000000000001 109.496 179.729 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.013 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -136.35 177.98 7.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 17.420000000000002 109.609 -179.794 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.584 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -171.74 162.52 6.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 13.84 108.709 -179.768 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.751 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.5 m-30 -115.5 111.43 20.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.249 -0.907 . . . . 21.140000000000001 108.761 -179.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.832 ' O ' HG22 ' A' ' 43' ' ' VAL . 99.2 t -100.81 144.74 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.896 -1.127 . . . . 10.66 110.51 -179.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -125.54 -137.8 0.27 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.517 -0.92 . . . . 25.890000000000001 108.517 179.455 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.88 ' HB3' HD11 ' B' ' 65' ' ' LEU . 0.2 OUTLIER 68.48 -62.68 0.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.825 -1.172 . . . . 24.239999999999998 108.818 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -88.53 24.29 12.72 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.647 -1.781 . . . . 31.02 108.647 179.21 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.786 ' ND2' HG11 ' A' ' 43' ' ' VAL . 0.3 OUTLIER 176.39 114.41 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.548 -0.972 . . . . 43.229999999999997 108.655 -179.731 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 39' ' ' ASN . 4.3 mt-10 -38.91 -64.07 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.618 0.723 . . . . 42.340000000000003 109.995 -179.336 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -68.6 162.74 60.37 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 108.745 -0.835 . . . . 8.0199999999999996 108.745 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.647 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.5 Cg_endo -78.12 148.83 24.83 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.126 1.884 . . . . 17.920000000000002 110.307 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.965 HG21 HG21 ' B' ' 70' ' ' VAL . 18.5 m -119.74 119.53 60.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.294 -0.879 . . . . 20.57 109.262 179.363 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.013 HD11 ' HB3' ' A' ' 32' ' ' LEU . 20.6 tp -71.65 114.12 9.39 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.426 0.632 . . . . 20.210000000000001 109.557 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.482 HG23 ' N ' ' B' ' 75' ' ' SER . 3.3 p -122.09 163.05 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.455 -0.778 . . . . 10.81 109.316 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.67 173.05 12.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.919 . . . . 36.740000000000002 110.369 -179.167 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.697 HD12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -163.96 131.4 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.484 -0.932 . . . . 19.739999999999998 108.484 179.97 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.486 ' CG2' HD22 ' A' ' 28' ' ' LEU . 3.8 m -74.82 154.45 38.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.894 -1.129 . . . . 22.559999999999999 109.464 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.789 HD23 ' HB2' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -123.35 119.98 31.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -0.866 . . . . 20.41 109.037 -179.839 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.512 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -53.95 137.41 39.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 33.990000000000002 109.875 -179.455 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -57.36 118.21 4.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 54.920000000000002 109.244 179.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.74 -12.23 69.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.341 -1.504 . . . . 36.100000000000001 109.341 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -79.84 148.74 69.34 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.26 -1.141 . . . . 54.759999999999998 109.37 179.871 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.3 Cg_endo -77.08 121.08 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.589 2.193 . . . . 28.370000000000001 110.319 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.782 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -37.82 145.69 0.07 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.578 -0.702 . . . . 17.210000000000001 110.607 -179.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.697 ' CE1' HD12 ' A' ' 47' ' ' ILE . 75.2 m-85 -43.74 105.36 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.41 -0.806 . . . . 17.190000000000001 109.226 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.989 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.37 176.03 0.24 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 17.82 109.67 -179.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.989 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.54 115.16 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.645 2.23 . . . . 17.280000000000001 110.353 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.23 176.33 41.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.667 -1.373 . . . . 17.219999999999999 109.667 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.0 mp -73.33 145.34 46.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 19.57 108.842 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.698 ' C ' HG13 ' A' ' 4' ' ' VAL . 38.8 m-85 -132.56 162.8 30.34 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.43 1.11 . . . . 14.609999999999999 111.103 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.706 ' O ' HG22 ' A' ' 84' ' ' VAL . 38.7 p -142.32 121.83 13.27 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.945 -1.872 . . . . 18.359999999999999 105.945 178.16 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.679 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.0 t -55.26 163.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 C-N-CA 118.372 -1.331 . . . . 19.129999999999999 109.017 -177.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -123.05 130.99 53.5 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.49 -0.756 . . . . 20.649999999999999 109.383 -178.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.907 HD11 ' HB3' ' B' ' 37' ' ' LEU . 0.7 OUTLIER -73.87 2.85 7.61 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.475 -0.766 . . . . 19.649999999999999 109.853 179.827 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -56.2 -19.49 13.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 107.176 -1.416 . . . . 14.720000000000001 107.176 178.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.51 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 4.1 m -96.47 -7.01 35.9 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 116.057 -0.52 . . . . 11.449999999999999 110.212 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.686 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.1 m-30 -83.95 161.95 20.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.985 -1.072 . . . . 14.25 109.848 -178.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.76 170.13 22.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.453 -0.78 . . . . 32.700000000000003 109.326 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.937 HG21 ' CG2' ' B' ' 43' ' ' VAL . 0.5 OUTLIER -121.36 116.74 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 15.630000000000001 109.156 179.733 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.71 -170.82 17.73 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.763 -1.335 . . . . 12.699999999999999 109.763 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.537 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -89.67 20.9 3.75 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.248 -1.148 . . . . 26.289999999999999 109.468 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 5.7 t80 -112.47 10.25 19.69 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.315 -0.866 . . . . 20.440000000000001 109.573 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' HG23 ' B' ' 45' ' ' VAL . . . 63.02 56.25 21.82 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.597 -1.401 . . . . 13.82 109.597 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.537 ' N ' HG23 ' B' ' 45' ' ' VAL . 1.4 m -157.27 120.06 3.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -1.146 . . . . 18.27 109.585 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -70.46 155.38 40.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 12.43 109.312 179.817 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 45.8 mtm -163.64 130.81 3.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 35.109999999999999 109.736 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.955 HD12 HD12 ' B' ' 78' ' ' ILE . 2.5 mp -64.64 142.0 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 13.67 109.805 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -105.59 -36.14 7.2 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.131 -1.063 . . . . 24.059999999999999 108.131 178.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.51 ' C ' ' HB3' ' A' ' 67' ' ' SER . 2.1 ttp180 -170.34 68.07 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 106.851 -1.537 . . . . 35.039999999999999 106.851 178.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.679 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -29.46 117.12 0.12 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.243 -0.889 . . . . 18.719999999999999 112.063 -177.674 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -92.21 113.0 25.15 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.004 -1.11 . . . . 20.550000000000001 108.004 178.825 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.833 HD11 HG11 ' A' ' 4' ' ' VAL . 15.3 tp -81.91 153.39 26.34 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.078 0.942 . . . . 14.4 111.023 -178.499 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 62' ' ' THR . 33.0 m -152.23 152.14 28.86 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.831 -1.174 . . . . 17.649999999999999 107.831 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.4 Cg_endo -60.99 141.54 94.77 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.019 1.812 . . . . 25.699999999999999 110.537 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.557 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.81 122.57 22.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 49.289999999999999 109.702 -178.645 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.979 -1.01 . . . . 58.909999999999997 109.446 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.507 ' CG ' ' HB ' ' B' ' 62' ' ' THR . 1.5 ttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.525 -0.546 . . . . 64.909999999999997 109.525 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.89 ' CA ' HD22 ' A' ' 65' ' ' LEU . 5.3 mt -71.68 75.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.119 -1.067 . . . . 33.799999999999997 108.119 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.01 156.19 25.39 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.917 0.865 . . . . 32.719999999999999 111.179 -178.277 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.837 HG11 HD11 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -163.67 167.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.468 -0.938 . . . . 14.460000000000001 108.468 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.544 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 34.5 mt-10 -141.04 113.63 8.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.958 . . . . 22.120000000000001 109.566 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.598 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -72.92 103.23 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.164 -1.05 . . . . 14.23 108.164 179.317 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.589 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 24.1 mmmt -51.44 163.34 0.59 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.322 -0.861 . . . . 25.43 109.338 -179.45 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.3 Cg_endo -73.05 -12.54 25.9 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.05 1.833 . . . . 13.609999999999999 109.437 179.488 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.63 3.63 54.84 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.584 -0.895 . . . . 15.52 108.584 178.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.57 ' OE1' HD13 ' B' ' 32' ' ' LEU . 13.7 mm-40 -127.18 41.12 3.58 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.385 -0.822 . . . . 17.309999999999999 108.898 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -98.08 11.92 36.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 24.780000000000001 110.294 -179.121 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.428 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 32.7 mt-30 -136.46 134.35 37.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.997 . . . . 47.899999999999999 110.158 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.652 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 20.6 p90 -84.7 164.8 18.36 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.355 -0.841 . . . . 21.609999999999999 109.465 179.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -130.86 140.34 50.22 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.39 -0.819 . . . . 14.890000000000001 109.29 179.047 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . 0.951 HG23 ' O ' ' B' ' 28' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.527 0 O-C-N 121.333 -0.854 . . . . 17.350000000000001 109.269 179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.951 ' O ' HG23 ' B' ' 15' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.469 0.652 . . . . 24.0 110.018 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.652 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -103.01 131.58 49.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.715 . . . . 23.309999999999999 109.155 -179.928 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.5 OUTLIER -117.13 148.53 41.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 40.030000000000001 109.708 -179.74 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.796 ' HB2' HD23 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -126.78 -163.84 1.28 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.173 -0.955 . . . . 12.390000000000001 109.503 179.704 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.992 ' HB3' HD11 ' B' ' 44' ' ' LEU . 0.5 OUTLIER -136.46 177.92 7.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 17.420000000000002 109.573 -179.785 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.58 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -171.69 162.56 6.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.018 -1.051 . . . . 13.84 108.718 -179.679 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.764 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.5 m-30 -115.6 111.4 20.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 21.140000000000001 108.763 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.814 ' O ' HG22 ' B' ' 43' ' ' VAL . 99.4 t -100.87 144.65 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.896 -1.128 . . . . 10.66 110.521 -179.541 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.7 OUTLIER -125.46 -137.87 0.27 Allowed 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.519 -0.919 . . . . 25.890000000000001 108.519 179.462 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.907 ' HB3' HD11 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 68.5 -62.71 0.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.877 -1.139 . . . . 24.239999999999998 108.754 -179.974 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -88.41 24.12 13.1 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 108.589 -1.804 . . . . 31.02 108.589 179.291 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.781 ' ND2' HG11 ' B' ' 43' ' ' VAL . 0.3 OUTLIER 176.48 114.39 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.588 -0.948 . . . . 43.229999999999997 108.644 -179.722 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' B' ' 39' ' ' ASN . 4.4 mt-10 -38.77 -64.21 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.511 -0.743 . . . . 42.340000000000003 109.985 -179.306 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -68.51 162.92 58.47 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 108.722 -0.844 . . . . 8.0399999999999991 108.722 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.644 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.0 Cg_endo -78.19 148.8 24.58 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.159 1.906 . . . . 17.920000000000002 110.314 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.937 ' CG2' HG21 ' A' ' 70' ' ' VAL . 18.5 m -119.71 119.66 61.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 119.575 -0.85 . . . . 20.57 109.222 179.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.992 HD11 ' HB3' ' B' ' 32' ' ' LEU . 20.4 tp -71.75 114.28 9.67 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.464 0.649 . . . . 20.210000000000001 109.52 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 75' ' ' SER . 3.1 p -122.18 162.78 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.478 -0.763 . . . . 10.81 109.327 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 172.95 12.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.908 . . . . 36.740000000000002 110.374 -179.163 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.7 HD12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -163.89 131.37 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.513 -0.921 . . . . 19.739999999999998 108.513 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.48 ' CG2' HD22 ' B' ' 28' ' ' LEU . 3.8 m -74.84 154.17 38.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.918 -1.114 . . . . 22.559999999999999 109.461 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.796 HD23 ' HB2' ' B' ' 31' ' ' GLN . 0.1 OUTLIER -123.09 120.1 32.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.361 -0.837 . . . . 20.41 109.059 -179.845 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -54.02 137.37 39.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 33.990000000000002 109.845 -179.391 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.28 118.36 5.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -0.865 . . . . 54.920000000000002 109.22 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 -12.21 69.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.342 -1.503 . . . . 36.100000000000001 109.342 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.516 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -79.85 148.73 69.28 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.261 -1.141 . . . . 54.759999999999998 109.361 179.92 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.4 Cg_endo -77.15 120.95 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.579 2.186 . . . . 28.370000000000001 110.367 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.791 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -37.6 145.46 0.06 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.611 -0.681 . . . . 17.210000000000001 110.68 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.7 ' CE1' HD12 ' B' ' 47' ' ' ILE . 75.5 m-85 -43.57 105.13 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.49 -0.756 . . . . 17.190000000000001 109.155 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.26 176.04 0.24 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 17.82 109.75 -179.546 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -78.38 114.48 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.678 2.252 . . . . 17.280000000000001 110.182 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.38 176.12 42.5 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.687 -1.365 . . . . 17.219999999999999 109.687 -179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 2.8 mp -73.56 145.13 45.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -1.161 . . . . 19.57 108.664 179.33 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.687 ' C ' HG13 ' B' ' 4' ' ' VAL . 38.3 m-85 -132.27 162.66 30.43 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 122.461 1.124 . . . . 14.609999999999999 111.155 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.702 ' O ' HG22 ' B' ' 84' ' ' VAL . 38.5 p -142.22 121.69 13.24 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.976 -1.861 . . . . 18.359999999999999 105.976 178.185 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.664 HG11 ' HB2' ' B' ' 81' ' ' LEU . 1.9 t -55.24 163.14 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 C-N-CA 118.37 -1.332 . . . . 19.129999999999999 109.07 -178.017 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -122.95 131.1 53.57 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.49 -0.757 . . . . 20.649999999999999 109.374 -178.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.908 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -73.87 2.73 7.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.561 -0.712 . . . . 19.649999999999999 109.894 179.769 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -56.13 -19.52 13.7 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.105 -1.443 . . . . 14.720000000000001 107.105 178.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.504 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 4.1 m -96.5 -7.35 34.92 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.896 -0.503 . . . . 11.449999999999999 110.149 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.2 m-30 -83.69 161.71 20.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.912 -1.117 . . . . 14.25 109.776 -178.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.62 170.15 22.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 32.700000000000003 109.28 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.965 HG21 HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -121.27 116.87 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 15.630000000000001 109.253 179.748 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.99 -170.88 19.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.73 -1.348 . . . . 12.699999999999999 109.73 -179.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . 0.534 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -89.63 20.99 3.67 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.251 -1.147 . . . . 26.289999999999999 109.478 -179.882 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' B' ' 73' ' ' PHE . 5.7 t80 -112.51 10.36 19.63 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.392 -0.817 . . . . 20.440000000000001 109.558 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.91 56.43 20.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.657 -1.377 . . . . 13.82 109.657 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.4 m -157.52 120.01 3.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -1.174 . . . . 18.27 109.616 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' B' ' 68' ' ' PHE . 0.3 OUTLIER -70.5 155.35 40.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 12.43 109.324 179.891 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 45.7 mtm -163.56 130.91 3.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 35.109999999999999 109.679 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.955 HD12 HD12 ' A' ' 78' ' ' ILE . 2.5 mp -64.78 142.25 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 13.67 109.783 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -105.73 -36.19 7.13 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.091 -1.078 . . . . 24.059999999999999 108.091 178.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.504 ' C ' ' HB3' ' B' ' 67' ' ' SER . 2.1 ttp180 -170.31 68.23 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.886 -1.524 . . . . 35.039999999999999 106.886 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.664 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.9 OUTLIER -29.57 117.1 0.13 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.212 -0.904 . . . . 18.719999999999999 112.104 -177.683 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.3 OUTLIER -92.18 112.94 25.07 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.051 -1.092 . . . . 20.550000000000001 108.051 178.825 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.837 HD11 HG11 ' B' ' 4' ' ' VAL . 15.3 tp -81.93 153.34 26.34 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.082 0.944 . . . . 14.4 111.008 -178.472 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.702 HG22 ' O ' ' B' ' 62' ' ' THR . 33.0 m -152.15 152.04 28.83 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.803 -1.184 . . . . 17.649999999999999 107.803 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.2 Cg_endo -60.94 141.58 94.97 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.951 1.767 . . . . 25.699999999999999 110.523 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -73.75 122.54 22.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 49.289999999999999 109.751 -178.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.975 -1.012 . . . . 58.909999999999997 109.442 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' C ' ' A' ' 2' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.475 -0.565 . . . . 64.909999999999997 109.475 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.833 ' N ' HD22 ' B' ' 65' ' ' LEU . 0.0 OUTLIER -43.15 131.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.614 -0.884 . . . . 33.799999999999997 108.614 179.396 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 1.3 mttp -102.82 153.78 19.84 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.117 -0.99 . . . . 32.719999999999999 110.394 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.892 HG22 HG22 ' A' ' 35' ' ' VAL . 32.7 t -159.78 166.13 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.684 0.754 . . . . 14.460000000000001 109.777 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.552 ' N ' HG12 ' A' ' 4' ' ' VAL . 32.7 mt-10 -153.05 103.06 2.7 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.684 -0.858 . . . . 22.120000000000001 108.684 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.762 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -71.84 103.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.032 -1.099 . . . . 14.23 108.032 179.837 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.647 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.63 171.19 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.446 -0.784 . . . . 25.43 109.643 -179.258 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -75.05 -22.66 14.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.334 2.023 . . . . 13.609999999999999 109.718 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.54 2.18 54.19 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.975 -0.75 . . . . 15.52 108.975 178.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 6' ' ' ILE . 8.7 mm-40 -121.49 40.99 3.46 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.263 -0.898 . . . . 17.309999999999999 109.205 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -109.37 12.34 24.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.16 -0.963 . . . . 24.780000000000001 109.796 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -131.7 141.63 49.61 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.509 -0.922 . . . . 47.899999999999999 108.509 179.846 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.7 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 37.1 p90 -93.68 167.65 11.52 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.019 -1.051 . . . . 21.609999999999999 109.73 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.7 m -135.1 149.96 50.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.79 -0.819 . . . . 14.890000000000001 108.79 179.159 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.512 0 O-C-N 121.212 -0.93 . . . . 17.350000000000001 109.413 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.406 0.622 . . . . 24.0 109.979 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.591 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 97.3 m-20 -69.39 129.91 41.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 23.309999999999999 109.378 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 33.9 mt-10 -112.06 163.62 14.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.148 -0.97 . . . . 40.030000000000001 109.16 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.679 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -150.7 -176.83 5.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.071 . . . . 12.390000000000001 110.038 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.865 ' HB3' HD11 ' A' ' 44' ' ' LEU . 27.9 mt -133.31 158.61 42.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.464 -0.772 . . . . 17.420000000000002 109.076 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.557 ' SG ' HD11 ' A' ' 6' ' ' ILE . 12.4 m -155.51 172.92 17.45 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.161 -1.052 . . . . 13.84 108.161 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.678 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 32.6 m-85 -121.9 104.48 9.58 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.092 -1.005 . . . . 21.140000000000001 109.176 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.892 HG22 HG22 ' A' ' 4' ' ' VAL . 42.4 t -79.8 159.55 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.096 -1.002 . . . . 10.66 110.655 -179.294 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 38' ' ' GLY . 31.6 m-20 -140.84 -147.96 0.23 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.714 -0.847 . . . . 25.890000000000001 108.714 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.973 ' CG ' HD11 ' B' ' 65' ' ' LEU . 0.2 OUTLIER 67.71 -61.89 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 24.239999999999998 109.188 -179.983 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -87.15 21.18 21.86 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.059 -1.616 . . . . 31.02 109.059 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 36' ' ' ASP . 1.5 p30 176.19 112.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -1.063 . . . . 43.229999999999997 109.324 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' ASN . 3.1 mt-10 -41.7 -63.13 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 42.340000000000003 109.955 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -65.0 154.55 86.28 Favored Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.512 -0.742 . . . . 8.3100000000000005 109.001 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.678 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.8 Cg_endo -78.26 143.92 20.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.233 1.955 . . . . 17.920000000000002 110.248 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.654 HG21 HG21 ' B' ' 70' ' ' VAL . 19.3 m -116.15 116.11 51.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.236 -0.915 . . . . 20.57 109.194 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.865 HD11 ' HB3' ' A' ' 32' ' ' LEU . 55.2 tp -73.14 102.35 3.56 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.29 -0.882 . . . . 20.210000000000001 109.683 -179.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.76 HG12 HG11 ' B' ' 70' ' ' VAL . 1.2 m -107.14 -178.41 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.568 -0.708 . . . . 10.81 109.164 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HA ' HD23 ' A' ' 32' ' ' LEU . 1.1 mtpt -101.07 154.3 18.83 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.569 -0.852 . . . . 36.740000000000002 109.748 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.987 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -140.55 173.45 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.336 -0.852 . . . . 19.739999999999998 109.364 -179.879 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.16 145.89 37.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.277 -0.889 . . . . 22.559999999999999 109.263 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.7 HD11 ' O ' ' A' ' 53' ' ' GLN . 3.0 tm? -127.34 126.97 43.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.315 -0.865 . . . . 20.41 109.041 -179.669 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.666 ' O ' HD13 ' A' ' 49' ' ' LEU . 3.2 m-20 -63.39 142.38 58.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 33.990000000000002 109.821 -179.417 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.66 123.63 17.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 54.920000000000002 109.295 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.23 -16.08 50.32 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.391 -1.484 . . . . 36.100000000000001 109.391 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.7 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -75.18 153.72 86.33 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.309 -1.113 . . . . 54.759999999999998 109.381 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.57 110.03 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.621 2.214 . . . . 28.370000000000001 110.334 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.7 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -41.69 151.34 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -0.829 . . . . 17.210000000000001 109.849 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.762 ' O ' HG21 ' A' ' 6' ' ' ILE . 89.8 m-85 -46.03 101.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.871 . . . . 17.190000000000001 109.072 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.9 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.07 173.6 0.17 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.907 . . . . 17.82 109.492 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.9 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.7 Cg_endo -78.13 114.62 3.61 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.682 2.255 . . . . 17.280000000000001 110.34 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.47 -178.91 45.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.695 -1.362 . . . . 17.219999999999999 109.695 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 3.4 mp -74.16 147.2 42.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -1.134 . . . . 19.57 108.717 179.45 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.676 ' HB3' HD22 ' A' ' 83' ' ' LEU . 25.7 m-85 -136.28 166.32 23.71 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 120.962 -1.086 . . . . 14.609999999999999 111.059 -179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 33.4 p -149.51 123.27 9.26 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.902 -1.888 . . . . 18.359999999999999 105.902 178.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.601 HG23 ' HB ' ' A' ' 2' ' ' ILE . 1.7 t -54.17 162.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 118.338 -1.345 . . . . 19.129999999999999 108.693 -178.268 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -124.83 128.14 48.24 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.393 -0.817 . . . . 20.649999999999999 109.066 -179.116 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.957 HD11 ' CG ' ' B' ' 37' ' ' LEU . 0.7 OUTLIER -72.43 2.82 5.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.463 -0.773 . . . . 19.649999999999999 110.141 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 t -56.09 -20.09 15.84 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.114 -1.439 . . . . 14.720000000000001 107.114 178.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.487 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 26.4 m -96.43 -8.44 32.28 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 116.126 -0.488 . . . . 11.449999999999999 110.154 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.652 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 2.2 m-30 -79.88 161.56 25.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.951 -1.093 . . . . 14.25 109.872 -178.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.514 ' NZ ' ' HB2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -165.68 174.35 9.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.795 . . . . 32.700000000000003 109.151 179.673 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.778 HG11 HG12 ' B' ' 45' ' ' VAL . 0.0 OUTLIER -100.06 104.46 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 15.630000000000001 109.466 -179.893 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.51 -168.01 37.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.595 -1.402 . . . . 12.699999999999999 109.595 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 23.32 2.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.129 -1.218 . . . . 26.289999999999999 109.888 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -93.86 -13.2 27.49 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.51 -0.744 . . . . 20.440000000000001 109.51 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 87.07 49.89 3.86 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.613 -1.395 . . . . 13.82 109.613 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 171.2 172.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -1.197 . . . . 18.27 109.645 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.551 HD13 HG11 ' B' ' 35' ' ' VAL . 14.7 tp -77.15 149.94 35.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 12.43 109.622 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 76' ' ' LEU . 8.6 mtp -155.57 135.51 12.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 35.109999999999999 109.401 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 1.011 HD12 HD12 ' B' ' 78' ' ' ILE . 2.2 mp -67.15 142.09 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 13.67 110.028 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.456 ' OD1' ' HD3' ' A' ' 69' ' ' LYS . 1.5 t70 -107.66 -41.18 5.09 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.572 -1.269 . . . . 24.059999999999999 107.572 178.014 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.487 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.3 OUTLIER -163.43 66.73 0.18 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.167 -1.42 . . . . 35.039999999999999 107.167 178.457 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.653 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -28.41 119.61 0.12 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.218 -0.901 . . . . 18.719999999999999 112.095 -177.99 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -92.98 101.14 13.48 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.296 -1.002 . . . . 20.550000000000001 108.296 178.896 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.987 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -70.72 146.51 49.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.085 -1.01 . . . . 14.4 110.943 -178.625 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 62' ' ' THR . 16.8 m -145.9 152.02 46.97 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.283 -1.006 . . . . 17.649999999999999 108.283 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 26.6 Cg_endo -64.76 144.34 83.37 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.306 2.004 . . . . 25.699999999999999 110.496 179.248 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -75.99 120.48 21.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.268 -0.895 . . . . 49.289999999999999 109.535 -179.07 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.981 -1.009 . . . . 58.909999999999997 109.463 179.979 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.458 ' O ' ' C ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.454 -0.573 . . . . 64.909999999999997 109.454 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 2' ' ' ILE . . . . . 0.837 ' CA ' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -42.87 131.68 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.701 -0.851 . . . . 33.799999999999997 108.701 179.318 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 1.4 mttp -102.84 153.73 19.9 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.122 -0.986 . . . . 32.719999999999999 110.37 -178.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.907 HG22 HG22 ' B' ' 35' ' ' VAL . 33.4 t -159.79 166.19 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.68 0.752 . . . . 14.460000000000001 109.75 -179.393 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.558 ' N ' HG12 ' B' ' 4' ' ' VAL . 32.5 mt-10 -153.21 102.96 2.66 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.67 -0.863 . . . . 22.120000000000001 108.67 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.768 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -71.77 103.89 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.047 -1.094 . . . . 14.23 108.047 179.769 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.658 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.68 171.23 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.366 -0.834 . . . . 25.43 109.619 -179.28 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.1 Cg_endo -74.97 -22.78 14.52 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.433 2.089 . . . . 13.609999999999999 109.759 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.6 2.32 54.12 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.977 -0.749 . . . . 15.52 108.977 179.074 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.597 ' O ' HG23 ' B' ' 6' ' ' ILE . 8.8 mm-40 -121.67 41.06 3.46 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.289 -0.882 . . . . 17.309999999999999 109.136 179.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -109.41 12.31 24.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.958 . . . . 24.780000000000001 109.785 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -131.52 141.8 49.81 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.198 -0.939 . . . . 47.899999999999999 108.577 179.825 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 37.2 p90 -93.96 167.45 11.6 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.011 -1.056 . . . . 21.609999999999999 109.713 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 100.0 m -134.82 150.22 50.47 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.795 -0.817 . . . . 14.890000000000001 108.795 179.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.468 0 O-C-N 121.204 -0.935 . . . . 17.350000000000001 109.415 -179.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.383 0.611 . . . . 24.0 110.024 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.576 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 97.0 m-20 -69.3 129.99 41.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 23.309999999999999 109.368 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 34.1 mt-10 -112.16 163.61 14.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.058 -1.026 . . . . 40.030000000000001 109.157 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.668 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -150.77 -176.91 5.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 12.390000000000001 110.021 -179.902 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 32' ' ' LEU . . . . . 0.887 ' HB3' HD11 ' B' ' 44' ' ' LEU . 27.9 mt -133.19 158.71 42.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.468 -0.77 . . . . 17.420000000000002 109.101 179.6 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' B' ' 6' ' ' ILE . 12.2 m -155.66 172.91 17.51 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.146 -1.057 . . . . 13.84 108.146 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.675 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 32.4 m-85 -122.01 104.57 9.61 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.051 -1.031 . . . . 21.140000000000001 109.109 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.907 HG22 HG22 ' B' ' 4' ' ' VAL . 42.4 t -79.85 159.67 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.073 -1.017 . . . . 10.66 110.686 -179.311 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' B' ' 38' ' ' GLY . 31.7 m-20 -140.89 -147.9 0.23 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.728 -0.841 . . . . 25.890000000000001 108.728 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 37' ' ' LEU . . . . . 0.957 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 67.78 -61.96 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 24.239999999999998 109.183 179.966 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -87.13 21.14 22.01 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.074 -1.61 . . . . 31.02 109.074 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 39' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' B' ' 36' ' ' ASP . 1.5 p30 176.23 112.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -1.076 . . . . 43.229999999999997 109.361 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' B' ' 39' ' ' ASN . 3.2 mt-10 -41.65 -63.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.372 -0.83 . . . . 42.340000000000003 109.898 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -65.0 154.43 86.57 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 109.002 -0.74 . . . . 8.3399999999999999 109.002 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.675 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.9 Cg_endo -78.19 143.74 20.29 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.245 1.963 . . . . 17.920000000000002 110.241 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 43' ' ' VAL . . . . . 0.632 HG21 HG21 ' A' ' 70' ' ' VAL . 19.2 m -115.97 116.22 51.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.318 -0.863 . . . . 20.57 109.15 179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' B' ' 32' ' ' LEU . 54.9 tp -73.3 102.59 3.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.271 -0.893 . . . . 20.210000000000001 109.68 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.778 HG12 HG11 ' A' ' 70' ' ' VAL . 1.2 m -107.27 -178.38 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.552 -0.718 . . . . 10.81 109.23 179.797 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.645 ' HA ' HD23 ' B' ' 32' ' ' LEU . 1.1 mtpt -101.08 154.42 18.74 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.469 -0.892 . . . . 36.740000000000002 109.718 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 47' ' ' ILE . . . . . 0.994 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.5 OUTLIER -140.72 173.38 9.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.325 -0.86 . . . . 19.739999999999998 109.317 -179.894 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.14 145.85 37.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 22.559999999999999 109.274 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.677 HD11 ' O ' ' B' ' 53' ' ' GLN . 2.9 tm? -127.3 126.9 43.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.311 -0.868 . . . . 20.41 109.061 -179.678 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.658 ' O ' HD13 ' B' ' 49' ' ' LEU . 3.1 m-20 -63.34 142.27 58.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.968 . . . . 33.990000000000002 109.868 -179.441 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.42 123.78 17.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 54.920000000000002 109.395 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.0 -15.97 50.23 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.437 -1.465 . . . . 36.100000000000001 109.437 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 53' ' ' GLN . . . . . 0.677 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -75.25 153.85 86.2 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.29 -1.123 . . . . 54.759999999999998 109.469 179.943 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.2 Cg_endo -77.67 109.79 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.628 2.218 . . . . 28.370000000000001 110.383 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.701 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -41.39 150.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -0.82 . . . . 17.210000000000001 110.041 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.768 ' O ' HG21 ' B' ' 6' ' ' ILE . 90.2 m-85 -45.53 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.375 -0.828 . . . . 17.190000000000001 109.003 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 57' ' ' ALA . . . . . 0.903 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -53.02 173.56 0.17 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 17.82 109.654 -179.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.903 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.79 113.44 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.617 2.211 . . . . 17.280000000000001 110.077 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.4 -179.43 46.63 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.776 -1.33 . . . . 17.219999999999999 109.776 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 3.1 mp -74.47 146.8 42.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -1.167 . . . . 19.57 108.414 179.14 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.664 ' HB3' HD22 ' B' ' 83' ' ' LEU . 27.1 m-85 -135.9 166.1 24.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.956 -1.09 . . . . 14.609999999999999 110.978 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 62' ' ' THR . . . . . 0.526 ' O ' HG22 ' B' ' 84' ' ' VAL . 33.0 p -149.14 123.24 9.47 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 105.943 -1.873 . . . . 18.359999999999999 105.943 178.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.59 HG23 ' HB ' ' B' ' 2' ' ' ILE . 1.7 t -54.12 162.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 118.276 -1.37 . . . . 19.129999999999999 108.721 -178.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 64' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -124.89 128.23 48.33 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.422 -0.799 . . . . 20.649999999999999 109.06 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.973 HD11 ' CG ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -72.67 2.84 5.79 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.46 -0.775 . . . . 19.649999999999999 110.132 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.1 t -56.01 -20.08 15.2 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.099 -1.445 . . . . 14.720000000000001 107.099 178.284 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.484 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 25.8 m -96.41 -8.45 32.33 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 116.096 -0.502 . . . . 11.449999999999999 110.239 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.662 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 2.3 m-30 -79.86 161.46 25.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.004 -1.06 . . . . 14.25 109.756 -178.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.522 ' NZ ' ' HB2' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -165.56 174.41 9.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.455 -0.778 . . . . 32.700000000000003 109.132 179.679 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.76 HG11 HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -100.1 104.48 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 15.630000000000001 109.393 -179.93 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.45 -167.87 37.32 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.613 -1.395 . . . . 12.699999999999999 109.613 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 23.02 2.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.113 -1.228 . . . . 26.289999999999999 109.863 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -93.6 -13.35 27.78 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.493 -0.755 . . . . 20.440000000000001 109.481 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 74' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 87.26 49.9 3.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.547 -1.421 . . . . 13.82 109.547 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' B' ' 74' ' ' GLY . 0.3 OUTLIER 171.28 172.91 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -1.16 . . . . 18.27 109.588 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.622 HD13 HG11 ' A' ' 35' ' ' VAL . 14.7 tp -77.23 150.02 35.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.295 -0.878 . . . . 12.43 109.659 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' B' ' 76' ' ' LEU . 8.5 mtp -155.71 135.15 12.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 35.109999999999999 109.493 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 1.011 HD12 HD12 ' A' ' 78' ' ' ILE . 2.2 mp -66.81 142.1 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 13.67 110.116 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.455 ' OD1' ' HD3' ' B' ' 69' ' ' LYS . 1.5 t70 -107.8 -40.98 5.12 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.606 -1.257 . . . . 24.059999999999999 107.606 177.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 80' ' ' ARG . . . . . 0.484 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.3 OUTLIER -163.56 66.79 0.18 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.12 -1.437 . . . . 35.039999999999999 107.12 178.422 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.637 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -28.47 119.58 0.12 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.215 -0.902 . . . . 18.719999999999999 112.036 -178.046 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 82' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -92.94 101.12 13.46 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.268 -1.012 . . . . 20.550000000000001 108.268 178.861 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.994 ' HB2' HD11 ' B' ' 47' ' ' ILE . 0.4 OUTLIER -70.7 146.47 49.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.977 . . . . 14.4 110.91 -178.67 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.526 HG22 ' O ' ' B' ' 62' ' ' THR . 16.8 m -145.82 152.34 48.06 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.296 -1.001 . . . . 17.649999999999999 108.296 179.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 26.7 Cg_endo -65.05 144.45 82.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.254 1.969 . . . . 25.699999999999999 110.56 179.274 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -75.97 120.38 21.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 49.289999999999999 109.605 -179.096 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.001 -0.999 . . . . 58.909999999999997 109.471 -179.945 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.634 ' SD ' HG21 ' A' ' 62' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.326 0.584 . . . . 64.909999999999997 109.458 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.964 ' HA ' HD22 ' B' ' 65' ' ' LEU . 5.5 mt -72.56 78.25 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.238 -1.023 . . . . 33.799999999999997 108.238 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 1.021 ' N ' HD12 ' A' ' 37' ' ' LEU . 23.0 mttp -61.85 172.26 1.37 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.715 0.769 . . . . 32.719999999999999 111.371 -178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.007 HG22 HG22 ' A' ' 35' ' ' VAL . 23.0 t -168.23 168.36 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.861 -0.792 . . . . 14.460000000000001 108.861 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.591 ' N ' HG12 ' A' ' 4' ' ' VAL . 23.4 mt-10 -147.04 104.29 3.67 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.679 -0.859 . . . . 22.120000000000001 108.679 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.626 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -69.36 104.34 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.912 -1.144 . . . . 14.23 107.912 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.653 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.47 171.13 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.083 -1.011 . . . . 25.43 109.665 -179.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.7 Cg_endo -76.32 -24.22 11.0 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.562 2.174 . . . . 13.609999999999999 109.899 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -94.21 4.29 54.09 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.553 -0.717 . . . . 15.52 109.258 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.832 ' OE1' HD13 ' A' ' 32' ' ' LEU . 10.6 mm-40 -117.52 34.1 5.3 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.27 -0.894 . . . . 17.309999999999999 109.372 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.4 11.34 33.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 24.780000000000001 110.182 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 16.3 mt-30 -138.86 132.76 31.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.007 . . . . 47.899999999999999 110.056 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.624 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 11.4 p90 -83.19 -178.36 7.07 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.402 -0.811 . . . . 21.609999999999999 109.915 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -130.4 144.67 51.54 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.752 -0.593 . . . . 14.890000000000001 109.404 179.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.2 118.91 30.85 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 17.350000000000001 109.222 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 tpp180 -129.51 138.02 51.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 34.380000000000003 109.603 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -44.7 150.38 0.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 38.770000000000003 109.108 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 26' ' ' TYR . . . -162.12 158.93 31.01 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.745 -1.342 . . . . 34.579999999999998 109.745 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.634 ' N ' ' CE1' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -144.32 112.55 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.155 . . . . 41.869999999999997 108.868 179.295 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -45.78 -91.26 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.442 -0.786 . . . . 47.210000000000001 109.719 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 58.45 1.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 71.560000000000002 109.67 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 58.49 18.38 5.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.218 -0.926 . . . . 66.599999999999994 109.418 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' HG3' ' A' ' 24' ' ' LYS . . . -99.48 -54.07 1.1 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.484 -1.446 . . . . 55.490000000000002 109.484 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' CD ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -143.87 153.02 56.95 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.278 -1.131 . . . . 44.990000000000002 109.297 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.83 132.84 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.663 2.242 . . . . 44.100000000000001 110.412 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.634 ' CE1' ' N ' ' A' ' 19' ' ' VAL . 14.7 p90 -135.64 108.5 7.57 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.204 -0.935 . . . . 32.090000000000003 109.754 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -84.92 63.32 8.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 29.25 108.893 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.719 ' CD2' HG22 ' A' ' 48' ' ' THR . 0.2 OUTLIER -55.86 165.97 0.82 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.545 -0.722 . . . . 24.0 109.946 -179.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.721 HD22 HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -106.07 133.27 51.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.399 -0.813 . . . . 23.309999999999999 109.342 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.81 151.76 29.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.076 -1.015 . . . . 40.030000000000001 109.62 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.675 HE21 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -133.62 -166.77 1.83 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.125 -0.984 . . . . 12.390000000000001 109.56 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.887 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -136.28 169.5 17.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.88 . . . . 17.420000000000002 109.934 -179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -158.74 164.68 35.65 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.211 -1.033 . . . . 13.84 108.211 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.665 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.8 m-85 -121.24 109.69 15.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.987 -1.07 . . . . 21.140000000000001 110.04 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.007 HG22 HG22 ' A' ' 4' ' ' VAL . 29.7 t -95.49 143.08 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 10.66 109.466 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -130.89 -24.56 2.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.146 -0.972 . . . . 25.890000000000001 110.76 -179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.021 HD12 ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -45.96 -16.4 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.972 -1.08 . . . . 24.239999999999998 111.384 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.596 ' H ' HD22 ' A' ' 37' ' ' LEU . . . -120.19 16.28 10.01 Favored Glycine 0 N--CA 1.482 1.729 0 N-CA-C 108.206 -1.957 . . . . 31.02 108.206 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 36' ' ' ASP . 1.3 p30 -178.02 115.96 0.08 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.706 -0.879 . . . . 43.229999999999997 108.828 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 39' ' ' ASN . 1.2 mp0 -36.95 -63.47 0.42 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.66 0.743 . . . . 42.340000000000003 109.978 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.8 155.87 68.52 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 108.449 -0.945 . . . . 2.8599999999999999 108.449 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.665 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.5 Cg_endo -77.95 141.31 18.86 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.923 1.749 . . . . 17.920000000000002 109.936 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.916 HG22 ' O ' ' A' ' 35' ' ' VAL . 29.3 m -113.72 115.33 49.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 121.316 -0.865 . . . . 20.57 108.957 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' A' ' 32' ' ' LEU . 54.6 tp -67.71 107.99 2.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.423 -0.798 . . . . 20.210000000000001 109.545 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.502 ' CG1' ' SG ' ' A' ' 33' ' ' CYS . 8.9 p -111.2 163.31 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.476 -0.765 . . . . 10.81 109.324 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.92 160.84 22.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.92 . . . . 36.740000000000002 110.232 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.62 HD12 ' CE1' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -156.31 119.68 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.798 -0.816 . . . . 19.739999999999998 108.798 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.719 HG22 ' CD2' ' A' ' 28' ' ' LEU . 1.3 m -60.17 156.03 16.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.984 -1.072 . . . . 22.559999999999999 109.757 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.721 HD12 HD22 ' A' ' 29' ' ' ASN . 0.2 OUTLIER -131.95 109.81 10.32 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.977 -0.749 . . . . 20.41 108.977 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.541 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -63.88 145.71 55.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 33.990000000000002 109.654 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' A' ' 52' ' ' GLY . 28.9 tt0 -43.51 -87.67 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.258 -0.901 . . . . 54.920000000000002 109.661 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' N ' ' HG2' ' A' ' 51' ' ' GLU . . . -41.06 -39.07 1.93 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.889 -1.284 . . . . 36.100000000000001 109.889 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.541 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -64.11 126.11 89.51 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.095 -1.238 . . . . 54.759999999999998 109.34 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.545 ' C ' HD11 ' A' ' 49' ' ' LEU . 36.0 Cg_endo -79.62 144.86 17.93 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.401 2.067 . . . . 28.370000000000001 110.4 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.675 ' HB1' HE21 ' A' ' 31' ' ' GLN . . . -40.21 146.02 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.396 -0.815 . . . . 17.210000000000001 110.169 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.62 ' CE1' HD12 ' A' ' 47' ' ' ILE . 87.4 m-85 -53.82 111.42 0.74 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.297 -0.877 . . . . 17.190000000000001 109.222 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.027 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -66.32 -178.85 0.34 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.426 -0.796 . . . . 17.82 109.528 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 1.027 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -78.12 131.79 11.11 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.49 2.127 . . . . 17.280000000000001 110.588 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.632 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 153.91 143.01 3.58 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.15 -1.58 . . . . 17.219999999999999 109.15 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.438 HD23 ' CE ' ' A' ' 3' ' ' LYS . 3.8 mp -44.77 138.93 3.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.908 -1.348 . . . . 19.57 109.489 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.632 ' CD1' ' O ' ' A' ' 59' ' ' GLY . 17.9 m-85 -119.09 164.18 15.9 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 122.521 1.153 . . . . 14.609999999999999 111.497 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 84' ' ' VAL . 48.0 p -145.88 122.76 11.3 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.514 -1.661 . . . . 18.359999999999999 106.514 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.683 HG11 ' HB2' ' A' ' 81' ' ' LEU . 1.7 t -60.58 162.67 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 C-N-CA 118.427 -1.309 . . . . 19.129999999999999 108.72 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.489 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -120.77 130.41 54.01 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 121.43 -0.794 . . . . 20.649999999999999 109.248 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.97 HD22 ' HA ' ' B' ' 2' ' ' ILE . 0.9 OUTLIER -73.29 2.81 6.73 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.474 -0.766 . . . . 19.649999999999999 109.828 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.0 -19.21 11.71 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.101 -1.444 . . . . 14.720000000000001 107.101 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.533 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 1.4 m -96.29 -6.23 38.33 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.134 -0.485 . . . . 11.449999999999999 110.391 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.699 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.2 m-30 -86.43 161.63 18.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.89 -1.131 . . . . 14.25 110.021 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -144.94 164.78 30.08 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.022 -0.733 . . . . 32.700000000000003 109.022 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.848 HG21 HG21 ' B' ' 43' ' ' VAL . 1.8 t -120.97 129.1 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 15.630000000000001 109.498 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.2 -151.52 22.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.36 -1.496 . . . . 12.699999999999999 109.36 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 0.5 OUTLIER 51.93 68.98 0.72 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -1.145 . . . . 26.289999999999999 109.211 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.471 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 71.07 5.62 5.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.363 -0.836 . . . . 20.440000000000001 109.367 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.87 46.52 5.08 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.523 -1.431 . . . . 13.82 109.523 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.41 ' HB2' ' HE3' ' A' ' 77' ' ' MET . 57.7 m -125.0 116.45 22.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -1.126 . . . . 18.27 109.635 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.6 OUTLIER -59.22 147.15 36.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 12.43 109.129 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 37.8 mtt -160.12 132.32 6.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 35.109999999999999 109.725 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.86 HD12 HD12 ' B' ' 78' ' ' ILE . 2.7 mp -67.16 140.16 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.373 -0.829 . . . . 13.67 109.826 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 8.8 t70 -107.61 -10.27 15.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.324 -0.86 . . . . 24.059999999999999 108.962 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 163.94 67.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 106.897 -1.52 . . . . 35.039999999999999 106.897 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.683 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -31.66 118.73 0.23 Allowed 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.323 -0.853 . . . . 18.719999999999999 112.199 -177.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.517 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -91.9 109.87 21.21 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.229 -1.026 . . . . 20.550000000000001 108.229 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.8 OUTLIER -75.63 155.19 36.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.205 -0.934 . . . . 14.4 111.382 -178.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 62' ' ' THR . 35.6 m -159.89 148.95 14.02 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 107.866 -1.161 . . . . 17.649999999999999 107.866 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 22.8 Cg_endo -61.5 139.3 81.14 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.99 1.794 . . . . 25.699999999999999 110.503 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.521 ' CA ' HG23 ' A' ' 62' ' ' THR . . . -65.66 118.1 9.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -0.921 . . . . 49.289999999999999 109.698 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.033 -0.984 . . . . 58.909999999999997 109.526 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.637 ' SD ' HG21 ' B' ' 62' ' ' THR . 3.5 ptm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.314 0.578 . . . . 64.909999999999997 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.97 ' HA ' HD22 ' A' ' 65' ' ' LEU . 5.5 mt -72.97 78.15 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.267 -1.012 . . . . 33.799999999999997 108.267 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 1.006 ' N ' HD12 ' B' ' 37' ' ' LEU . 23.0 mttp -61.72 172.22 1.34 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.759 0.79 . . . . 32.719999999999999 111.33 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.983 HG22 HG22 ' B' ' 35' ' ' VAL . 23.1 t -168.2 168.44 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.85 -0.796 . . . . 14.460000000000001 108.85 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.601 ' N ' HG12 ' B' ' 4' ' ' VAL . 23.5 mt-10 -147.15 104.21 3.65 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.726 -0.842 . . . . 22.120000000000001 108.726 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.63 ' O ' HG22 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -69.34 104.08 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.962 -1.125 . . . . 14.23 107.962 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.66 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.24 171.11 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.168 -0.957 . . . . 25.43 109.682 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -76.36 -24.27 10.89 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.474 2.116 . . . . 13.609999999999999 109.847 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -94.12 4.1 54.37 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.521 -0.737 . . . . 15.52 109.224 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.818 ' OE1' HD13 ' B' ' 32' ' ' LEU . 10.5 mm-40 -117.25 33.95 5.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.262 -0.899 . . . . 17.309999999999999 109.377 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.18 11.3 32.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 24.780000000000001 110.209 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.443 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 16.2 mt-30 -138.82 132.88 31.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 47.899999999999999 110.088 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.63 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 11.4 p90 -83.26 -178.29 7.03 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.408 -0.807 . . . . 21.609999999999999 109.93 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 0.6 OUTLIER -130.48 144.65 51.54 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.738 -0.601 . . . . 14.890000000000001 109.426 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.18 118.99 30.91 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.29 -0.882 . . . . 17.350000000000001 109.199 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' B' ' 17' ' ' SER . 5.1 tpp180 -129.59 138.05 51.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 34.380000000000003 109.579 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.2 OUTLIER -44.74 150.44 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 38.770000000000003 109.082 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 26' ' ' TYR . . . -162.22 159.0 31.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.751 -1.34 . . . . 34.579999999999998 109.751 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.628 ' N ' ' CE1' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -144.48 112.37 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.28 -1.129 . . . . 41.869999999999997 108.952 179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -45.67 -91.32 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.405 -0.81 . . . . 47.210000000000001 109.752 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.32 58.53 1.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.228 -0.92 . . . . 71.560000000000002 109.613 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 58.37 18.37 5.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.913 . . . . 66.599999999999994 109.438 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.52 -53.82 1.11 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.441 -1.464 . . . . 55.490000000000002 109.441 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.471 ' CD ' ' N ' ' B' ' 24' ' ' LYS . 0.0 OUTLIER -144.08 152.93 55.99 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.302 -1.116 . . . . 44.990000000000002 109.334 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.75 132.92 12.31 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.647 2.231 . . . . 44.100000000000001 110.434 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.628 ' CE1' ' N ' ' B' ' 19' ' ' VAL . 14.7 p90 -135.72 108.55 7.56 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.181 -0.949 . . . . 32.090000000000003 109.794 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 1.4 m -85.06 63.43 8.11 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.142 -0.974 . . . . 29.25 108.884 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.728 ' CD2' HG22 ' B' ' 48' ' ' THR . 0.2 OUTLIER -55.95 165.97 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.484 -0.76 . . . . 24.0 109.919 -179.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.699 HD22 HD12 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -106.03 133.27 51.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.398 -0.813 . . . . 23.309999999999999 109.298 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -112.79 151.98 29.7 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.037 -1.039 . . . . 40.030000000000001 109.573 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.685 HE21 ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -133.75 -166.78 1.83 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.161 -0.962 . . . . 12.390000000000001 109.573 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.888 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.0 OUTLIER -136.24 169.57 17.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.234 -0.916 . . . . 17.420000000000002 109.949 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -158.87 164.69 35.49 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.177 -1.046 . . . . 13.84 108.177 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.66 ' CD2' ' CD ' ' B' ' 7' ' ' LYS . 22.4 m-85 -121.29 109.75 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.991 -1.068 . . . . 21.140000000000001 109.989 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.983 HG22 HG22 ' B' ' 4' ' ' VAL . 31.0 t -95.64 143.05 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 10.66 109.446 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' B' ' 36' ' ' ASP . 0.5 OUTLIER -130.9 -24.51 2.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 25.890000000000001 110.8 -179.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 1.006 HD12 ' N ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -46.21 -16.2 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.002 -1.061 . . . . 24.239999999999998 111.38 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.59 ' H ' HD22 ' B' ' 37' ' ' LEU . . . -120.15 16.09 10.06 Favored Glycine 0 N--CA 1.481 1.637 0 N-CA-C 108.208 -1.957 . . . . 31.02 108.208 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' HA ' ' B' ' 36' ' ' ASP . 1.3 p30 -177.9 116.03 0.08 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.686 -0.891 . . . . 43.229999999999997 108.833 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' B' ' 39' ' ' ASN . 1.1 mp0 -36.91 -63.46 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.679 0.752 . . . . 42.340000000000003 110.015 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.88 155.91 69.07 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 108.438 -0.949 . . . . 2.8599999999999999 108.438 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.658 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.6 Cg_endo -77.93 141.27 18.87 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.939 1.759 . . . . 17.920000000000002 109.894 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.927 HG22 ' O ' ' B' ' 35' ' ' VAL . 29.3 m -113.78 115.33 49.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 121.273 -0.892 . . . . 20.57 108.874 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.888 HD11 ' HB3' ' B' ' 32' ' ' LEU . 54.4 tp -67.59 107.9 2.68 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.397 -0.815 . . . . 20.210000000000001 109.603 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.505 ' CG1' ' SG ' ' B' ' 33' ' ' CYS . 8.9 p -111.09 163.27 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.52 -0.737 . . . . 10.81 109.369 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.97 160.83 21.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 36.740000000000002 110.261 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.621 HD12 ' CE1' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -156.2 119.67 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 108.801 -0.814 . . . . 19.739999999999998 108.801 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.728 HG22 ' CD2' ' B' ' 28' ' ' LEU . 1.3 m -60.23 155.64 17.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.056 -1.027 . . . . 22.559999999999999 109.732 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.699 HD12 HD22 ' B' ' 29' ' ' ASN . 0.2 OUTLIER -131.55 109.85 10.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 20.41 108.982 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.545 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -63.83 145.76 55.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 33.990000000000002 109.692 -179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' B' ' 52' ' ' GLY . 28.9 tt0 -43.66 -87.63 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.305 -0.872 . . . . 54.920000000000002 109.629 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.48 ' N ' ' HG2' ' B' ' 51' ' ' GLU . . . -41.19 -38.83 1.97 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.852 -1.299 . . . . 36.100000000000001 109.852 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.545 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -64.29 126.15 89.8 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.07 -1.253 . . . . 54.759999999999998 109.336 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.553 ' C ' HD11 ' B' ' 49' ' ' LEU . 35.9 Cg_endo -79.61 144.86 17.94 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.417 2.078 . . . . 28.370000000000001 110.421 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.685 ' HB1' HE21 ' B' ' 31' ' ' GLN . . . -40.16 145.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.379 -0.825 . . . . 17.210000000000001 110.308 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.621 ' CE1' HD12 ' B' ' 47' ' ' ILE . 87.4 m-85 -53.35 111.73 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 17.190000000000001 109.16 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 1.004 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -67.16 -178.94 0.39 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.389 -0.82 . . . . 17.82 109.594 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 1.004 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.4 Cg_endo -77.71 130.38 10.61 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.458 2.105 . . . . 17.280000000000001 110.358 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.635 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 155.94 143.0 3.55 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.205 -1.558 . . . . 17.219999999999999 109.205 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.439 HD23 ' CE ' ' B' ' 3' ' ' LYS . 3.6 mp -45.43 138.34 4.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.426 . . . . 19.57 109.177 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' B' ' 59' ' ' GLY . 20.0 m-85 -118.43 164.26 15.52 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.49 1.138 . . . . 14.609999999999999 111.407 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.744 ' O ' HG22 ' B' ' 84' ' ' VAL . 48.9 p -145.9 122.84 11.34 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 106.386 -1.709 . . . . 18.359999999999999 106.386 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.682 HG11 ' HB2' ' B' ' 81' ' ' LEU . 1.6 t -60.44 163.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 C-N-CA 118.448 -1.301 . . . . 19.129999999999999 108.719 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.492 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -121.62 130.3 53.39 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.475 -0.765 . . . . 20.649999999999999 109.33 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 2' ' ' ILE . 0.9 OUTLIER -73.13 2.77 6.52 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.492 -0.755 . . . . 19.649999999999999 109.889 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.29 -18.97 12.22 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 107.126 -1.435 . . . . 14.720000000000001 107.126 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.537 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 1.4 m -96.35 -6.93 36.51 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 116.132 -0.485 . . . . 11.449999999999999 110.416 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.664 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.1 m-30 -85.97 161.25 19.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.851 -1.156 . . . . 14.25 109.958 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 11.9 mtmt -144.57 165.1 28.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.74 . . . . 32.700000000000003 109.014 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.84 HG21 HG21 ' A' ' 43' ' ' VAL . 1.8 t -121.08 129.2 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 15.630000000000001 109.506 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 160.0 -151.66 22.36 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.333 -1.507 . . . . 12.699999999999999 109.333 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.6 OUTLIER 52.0 68.86 0.74 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -1.181 . . . . 26.289999999999999 109.228 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.2 OUTLIER 71.22 5.73 5.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.386 -0.821 . . . . 20.440000000000001 109.34 -179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.74 46.56 5.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.558 -1.417 . . . . 13.82 109.558 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 57.7 m -125.15 116.34 21.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -1.129 . . . . 18.27 109.696 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.534 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.6 OUTLIER -59.05 147.05 36.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 12.43 109.212 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.534 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 37.5 mtt -160.08 132.51 6.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.923 . . . . 35.109999999999999 109.643 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.86 HD12 HD12 ' A' ' 78' ' ' ILE . 2.7 mp -67.37 140.24 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 13.67 109.839 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 8.6 t70 -107.51 -10.27 15.75 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.367 -0.833 . . . . 24.059999999999999 108.966 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.537 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 163.89 67.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.923 -1.51 . . . . 35.039999999999999 106.923 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.682 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.9 OUTLIER -31.76 118.75 0.24 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.253 -0.885 . . . . 18.719999999999999 112.182 -177.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.517 ' HG3' ' NH1' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -91.88 109.94 21.28 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.194 -1.039 . . . . 20.550000000000001 108.194 178.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -75.65 155.28 35.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.17 -0.956 . . . . 14.4 111.384 -178.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.744 HG22 ' O ' ' B' ' 62' ' ' THR . 35.6 m -159.98 149.21 14.14 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 107.807 -1.183 . . . . 17.649999999999999 107.807 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 23.5 Cg_endo -61.76 139.13 78.74 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.024 1.816 . . . . 25.699999999999999 110.545 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.527 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -65.49 118.07 8.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.252 -0.905 . . . . 49.289999999999999 109.6 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.422 ' HD3' ' C ' ' B' ' 87' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.95 -1.024 . . . . 58.909999999999997 109.429 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.594 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.461 0.648 . . . . 64.909999999999997 109.493 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.914 HG23 ' CD1' ' B' ' 65' ' ' LEU . 3.9 mt -78.55 77.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.7 -1.222 . . . . 33.799999999999997 107.7 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.49 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -67.39 167.39 12.68 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.011 0.91 . . . . 32.719999999999999 110.848 -178.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.941 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -177.44 160.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.501 -0.926 . . . . 14.460000000000001 108.501 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 29.8 mt-10 -134.2 114.65 13.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.67 0.748 . . . . 22.120000000000001 109.004 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.716 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -73.74 99.28 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 107.788 -1.19 . . . . 14.23 107.788 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.669 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -43.95 169.92 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.335 -0.853 . . . . 25.43 109.925 -179.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 32.5 Cg_endo -74.42 -28.31 10.4 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.469 2.112 . . . . 13.609999999999999 110.024 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.96 8.78 41.74 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.826 -0.805 . . . . 15.52 108.826 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.552 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 5.6 mm100 -125.91 22.32 7.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -0.883 . . . . 17.309999999999999 109.87 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -95.77 15.23 20.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.105 -0.997 . . . . 24.780000000000001 110.162 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 60.7 mt-30 -134.9 141.09 46.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.127 -0.983 . . . . 47.899999999999999 109.754 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.744 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 45.1 p90 -93.96 153.91 17.95 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.3 -0.875 . . . . 21.609999999999999 109.32 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 m -113.11 150.45 32.11 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.331 -0.856 . . . . 14.890000000000001 108.92 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.551 HG23 ' OD1' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -104.86 121.91 44.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.289 -0.882 . . . . 17.350000000000001 109.541 -179.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 27' ' ' SER . 0.6 OUTLIER -136.59 156.05 49.09 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 34.380000000000003 109.355 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 16' ' ' ARG . 94.6 p -42.43 155.25 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.428 -0.795 . . . . 38.770000000000003 109.475 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.595 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -157.42 165.72 33.49 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.199 -1.16 . . . . 34.579999999999998 110.199 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.547 ' N ' ' CE1' ' A' ' 26' ' ' TYR . 1.4 t -155.59 126.53 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.366 -1.079 . . . . 41.869999999999997 109.029 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 3.4 m -64.29 -17.27 63.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 47.210000000000001 109.716 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 20' ' ' SER . 0.0 OUTLIER 175.86 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.956 . . . . 71.560000000000002 109.712 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 0.5 OUTLIER 174.97 43.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.125 -0.984 . . . . 66.599999999999994 109.797 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.404 ' C ' ' HG3' ' A' ' 24' ' ' LYS . . . -133.3 -55.28 0.08 OUTLIER Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.022 -1.631 . . . . 55.490000000000002 109.022 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.404 ' HG3' ' C ' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -138.18 152.14 71.11 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.478 -1.013 . . . . 44.990000000000002 108.881 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.9 Cg_endo -77.26 161.76 31.8 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.559 2.172 . . . . 44.100000000000001 110.523 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.682 ' CE1' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -157.41 50.94 0.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.079 -1.013 . . . . 32.090000000000003 110.143 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 26' ' ' TYR . 13.5 m -30.56 82.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.267 0.556 . . . . 29.25 110.679 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -82.8 150.18 26.77 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.376 -0.828 . . . . 24.0 110.094 -179.055 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.775 ' O ' HD12 ' A' ' 28' ' ' LEU . 67.4 m-20 -72.21 151.1 43.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.372 -0.83 . . . . 23.309999999999999 109.533 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.61 132.64 39.27 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.699 -0.852 . . . . 40.030000000000001 108.699 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.748 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -123.41 -174.1 2.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.071 -1.018 . . . . 12.390000000000001 110.02 -179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.951 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.7 mp -143.6 152.85 41.9 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.853 -0.795 . . . . 17.420000000000002 108.853 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -152.82 -177.67 6.41 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.974 -1.121 . . . . 13.84 107.974 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.69 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.0 m-85 -129.6 99.62 5.23 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.031 -1.043 . . . . 21.140000000000001 109.937 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.877 HG22 ' HB ' ' A' ' 4' ' ' VAL . 60.6 t -95.24 113.65 30.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 121.089 -1.007 . . . . 10.66 109.462 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 5.3 t70 -62.46 -28.48 69.85 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.199 -0.938 . . . . 25.890000000000001 108.572 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.684 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.7 OUTLIER 46.23 25.26 0.34 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.467 -0.77 . . . . 24.239999999999998 109.458 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.72 14.07 81.67 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 109.818 -1.313 . . . . 31.02 109.818 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 64.3 m-20 -86.08 15.21 5.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.144 -1.209 . . . . 43.229999999999997 110.225 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.582 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 9.6 mt-10 60.73 11.52 3.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.311 -0.868 . . . . 42.340000000000003 110.36 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 71.3 m80 -161.18 152.68 16.01 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.046 -1.094 . . . . 6.3700000000000001 108.046 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.69 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -75.76 136.59 19.08 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.873 1.715 . . . . 17.920000000000002 110.397 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 35' ' ' VAL . 4.5 m -110.84 118.19 56.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 O-C-N 121.43 -0.793 . . . . 20.57 109.0 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.951 HD11 ' HB3' ' A' ' 32' ' ' LEU . 45.5 tp -73.22 104.48 4.28 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.351 -0.843 . . . . 20.210000000000001 110.255 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.618 HG13 HG23 ' A' ' 43' ' ' VAL . 32.6 m -108.46 -177.2 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 108.527 -0.916 . . . . 10.81 108.527 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HD2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.22 154.56 22.23 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.007 -1.077 . . . . 36.740000000000002 110.257 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.593 HG13 ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -127.18 170.1 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 109.029 -0.73 . . . . 19.739999999999998 109.029 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.523 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 3.6 m -123.01 124.0 42.16 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.356 -0.84 . . . . 22.559999999999999 108.808 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -102.53 163.83 12.0 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.331 -0.856 . . . . 20.41 109.331 -179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.43 167.68 9.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.897 . . . . 33.990000000000002 109.54 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -72.86 87.61 1.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 54.920000000000002 109.519 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.34 -25.84 4.48 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.514 -1.434 . . . . 36.100000000000001 109.514 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.636 ' O ' HD12 ' A' ' 49' ' ' LEU . 2.0 mt-30 -73.7 140.97 78.66 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 54.759999999999998 109.433 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 53' ' ' GLN . 35.8 Cg_endo -79.5 118.91 3.98 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.577 2.185 . . . . 28.370000000000001 110.28 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.748 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.52 155.19 0.05 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.24 -0.912 . . . . 17.210000000000001 110.308 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.655 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 16.3 m-30 -49.86 112.14 0.62 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.531 -0.731 . . . . 17.190000000000001 109.377 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.002 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -61.72 176.43 0.44 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.138 -0.976 . . . . 17.82 109.289 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 1.002 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.7 Cg_endo -77.05 119.85 5.2 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.545 2.164 . . . . 17.280000000000001 110.221 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.42 177.54 37.86 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.835 -1.306 . . . . 17.219999999999999 109.835 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 5.2 mp -71.58 159.48 34.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 19.57 108.469 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.941 ' CB ' HG13 ' A' ' 4' ' ' VAL . 20.5 m-85 -141.8 165.1 28.41 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.849 -1.157 . . . . 14.609999999999999 111.784 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 84' ' ' VAL . 62.3 p -147.24 119.71 8.47 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.512 -1.662 . . . . 18.359999999999999 106.512 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.826 ' HB ' HD12 ' A' ' 2' ' ' ILE . 13.3 t -52.25 169.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 118.548 -1.261 . . . . 19.129999999999999 108.493 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.561 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.8 t-80 -131.33 119.64 22.01 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.36 -0.838 . . . . 20.649999999999999 108.911 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.936 HD13 HG23 ' B' ' 2' ' ' ILE . 0.0 OUTLIER -62.35 -12.44 21.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.694 -0.629 . . . . 19.649999999999999 109.641 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.2 t -46.98 -20.92 0.17 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.944 -1.097 . . . . 14.720000000000001 108.593 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 34.1 m -96.7 -7.93 32.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.496 -0.753 . . . . 11.449999999999999 111.035 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.659 ' C ' HD11 ' B' ' 37' ' ' LEU . 3.1 m-30 -81.1 161.77 23.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.617 -1.302 . . . . 14.25 109.816 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HA ' ' CD2' ' B' ' 37' ' ' LEU . 5.1 pttm -145.74 174.75 10.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.45 -0.781 . . . . 32.700000000000003 109.663 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.816 HG21 HG21 ' B' ' 43' ' ' VAL . 2.5 t -117.19 129.2 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.419 -0.801 . . . . 15.630000000000001 109.307 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.14 168.12 35.03 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.479 -1.448 . . . . 12.699999999999999 109.479 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -76.74 0.55 20.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.232 -1.157 . . . . 26.289999999999999 109.733 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -26.99 23.16 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.461 -0.774 . . . . 20.440000000000001 109.21 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.77 65.31 0.76 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.492 -1.443 . . . . 13.82 109.492 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.14 133.43 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.319 -1.107 . . . . 18.27 109.524 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 68' ' ' PHE . 2.4 tt -73.56 148.66 42.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 12.43 109.519 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.445 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 30.3 mtm -155.94 128.97 8.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 35.109999999999999 109.558 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' B' ' 78' ' ' ILE . 3.1 mt -64.72 141.0 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 13.67 109.988 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -108.25 -37.3 6.05 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.637 -1.246 . . . . 24.059999999999999 107.637 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.0 tpm_? -168.57 68.06 0.07 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.19 -1.411 . . . . 35.039999999999999 107.19 178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -31.1 120.23 0.21 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.499 -0.773 . . . . 18.719999999999999 111.518 -178.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.539 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -90.45 103.25 15.96 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.988 -1.116 . . . . 20.550000000000001 107.988 178.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -75.83 147.33 39.21 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.934 -1.104 . . . . 14.4 111.006 -178.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 62' ' ' THR . 18.1 m -148.22 160.22 37.62 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 107.727 -1.212 . . . . 17.649999999999999 107.727 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.7 Cg_endo -62.32 146.63 95.75 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.036 1.824 . . . . 25.699999999999999 110.398 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -79.5 116.6 19.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.152 -0.968 . . . . 49.289999999999999 109.696 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.004 -0.998 . . . . 58.909999999999997 109.454 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.502 0.668 . . . . 64.909999999999997 109.429 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.936 HG23 HD13 ' A' ' 65' ' ' LEU . 4.0 mt -78.29 77.7 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 107.719 -1.215 . . . . 33.799999999999997 107.719 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.48 ' O ' HG13 ' B' ' 35' ' ' VAL . 0.2 OUTLIER -67.57 167.52 12.81 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.02 0.914 . . . . 32.719999999999999 110.869 -178.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.933 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -177.45 160.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.458 -0.942 . . . . 14.460000000000001 108.458 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.48 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 29.8 mt-10 -134.52 114.6 13.0 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.924 -0.769 . . . . 22.120000000000001 108.924 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.724 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -73.74 99.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 107.81 -1.182 . . . . 14.23 107.81 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.671 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.0 169.96 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.34 -0.85 . . . . 25.43 109.898 -178.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.0 Cg_endo -74.39 -28.29 10.47 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.488 2.125 . . . . 13.609999999999999 110.088 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.13 9.06 41.03 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.767 -0.827 . . . . 15.52 108.767 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.549 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 5.6 mm100 -126.13 22.34 7.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 17.309999999999999 109.864 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -95.74 15.14 20.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 24.780000000000001 110.151 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.547 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 60.4 mt-30 -134.86 141.1 46.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.038 -1.039 . . . . 47.899999999999999 109.736 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.737 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 45.1 p90 -94.03 153.91 17.92 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.257 -0.902 . . . . 21.609999999999999 109.343 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 81.1 m -113.21 150.15 32.73 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.296 -0.877 . . . . 14.890000000000001 108.955 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.551 HG23 ' OD1' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -104.61 121.86 44.42 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.33 -0.857 . . . . 17.350000000000001 109.606 -179.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' B' ' 27' ' ' SER . 0.6 OUTLIER -136.46 156.11 49.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 34.380000000000003 109.336 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 16' ' ' ARG . 94.6 p -42.45 155.29 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.375 -0.828 . . . . 38.770000000000003 109.495 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.598 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -157.41 165.71 33.48 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.782 -1.199 . . . . 34.579999999999998 110.164 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.54 ' N ' ' CE1' ' B' ' 26' ' ' TYR . 1.4 t -155.58 126.46 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.355 -1.085 . . . . 41.869999999999997 109.09 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.41 ' O ' ' CG ' ' B' ' 21' ' ' ARG . 3.4 m -64.23 -17.22 63.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 47.210000000000001 109.709 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' B' ' 20' ' ' SER . 0.0 OUTLIER 175.75 -58.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.112 -0.992 . . . . 71.560000000000002 109.698 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' B' ' 21' ' ' ARG . 0.5 OUTLIER 175.26 43.55 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.96 . . . . 66.599999999999994 109.749 179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.403 ' C ' ' HG3' ' B' ' 24' ' ' LYS . . . -133.22 -55.39 0.08 OUTLIER Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.043 -1.623 . . . . 55.490000000000002 109.043 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.403 ' HG3' ' C ' ' B' ' 23' ' ' GLY . 0.2 OUTLIER -138.08 152.17 71.36 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.395 -1.062 . . . . 44.990000000000002 108.847 179.431 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.9 Cg_endo -77.18 161.98 31.86 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.497 2.131 . . . . 44.100000000000001 110.562 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.694 ' CE1' HD23 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -157.61 50.89 0.44 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.137 -0.977 . . . . 32.090000000000003 110.066 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.485 ' C ' ' O ' ' B' ' 26' ' ' TYR . 13.4 m -30.62 83.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.346 0.593 . . . . 29.25 110.694 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.771 HD12 ' O ' ' B' ' 29' ' ' ASN . 0.8 OUTLIER -82.81 150.26 26.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.333 -0.854 . . . . 24.0 110.031 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.771 ' O ' HD12 ' B' ' 28' ' ' LEU . 67.3 m-20 -72.16 151.18 43.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.451 -0.781 . . . . 23.309999999999999 109.499 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -134.63 132.67 39.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 40.030000000000001 108.704 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.756 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -123.35 -174.18 2.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.069 -1.019 . . . . 12.390000000000001 110.04 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.926 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.8 mp -143.57 152.91 41.99 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.852 -0.795 . . . . 17.420000000000002 108.852 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.8 OUTLIER -152.75 -177.46 6.27 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.925 -1.139 . . . . 13.84 107.925 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.693 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 21.9 m-85 -129.78 99.71 5.23 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.056 -1.027 . . . . 21.140000000000001 109.881 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.873 HG22 ' HB ' ' B' ' 4' ' ' VAL . 62.9 t -95.35 113.74 30.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.171 -0.956 . . . . 10.66 109.435 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 5.3 t70 -62.51 -28.33 69.77 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.189 -0.945 . . . . 25.890000000000001 108.527 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.659 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER 46.25 25.27 0.34 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.516 -0.74 . . . . 24.239999999999998 109.436 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.67 14.01 81.63 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 109.831 -1.307 . . . . 31.02 109.831 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 64.2 m-20 -86.0 15.11 5.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -1.211 . . . . 43.229999999999997 110.325 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.578 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 9.5 mt-10 60.84 11.42 3.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.332 -0.855 . . . . 42.340000000000003 110.487 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.578 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 71.2 m80 -161.15 152.79 16.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.0 -1.111 . . . . 6.3799999999999999 108.0 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.693 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.4 Cg_endo -75.92 136.71 18.9 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.806 1.671 . . . . 17.920000000000002 110.442 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.857 HG22 ' O ' ' B' ' 35' ' ' VAL . 4.5 m -110.93 118.07 56.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.393 -0.817 . . . . 20.57 109.037 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.926 HD11 ' HB3' ' B' ' 32' ' ' LEU . 46.0 tp -73.21 104.38 4.24 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.392 -0.818 . . . . 20.210000000000001 110.215 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.626 HG13 HG23 ' B' ' 43' ' ' VAL . 32.5 m -108.44 -177.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.492 -0.929 . . . . 10.81 108.492 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.419 ' HD2' HD21 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -109.09 154.55 22.12 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.949 -1.101 . . . . 36.740000000000002 110.316 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.591 HG13 ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -127.21 169.96 17.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.515 -0.74 . . . . 19.739999999999998 109.105 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.519 ' N ' ' CG2' ' B' ' 47' ' ' ILE . 3.5 m -122.78 123.99 42.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.328 -0.857 . . . . 22.559999999999999 108.838 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.643 HD12 ' O ' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -102.46 163.92 11.96 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.269 -0.894 . . . . 20.41 109.352 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.53 167.83 9.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.923 . . . . 33.990000000000002 109.513 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -73.0 87.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 54.920000000000002 109.435 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.08 -25.96 4.53 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.568 -1.413 . . . . 36.100000000000001 109.568 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.643 ' O ' HD12 ' B' ' 49' ' ' LEU . 2.1 mt-30 -73.61 140.86 78.88 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.217 -1.167 . . . . 54.759999999999998 109.451 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.42 ' O ' ' C ' ' B' ' 55' ' ' ALA . 36.2 Cg_endo -79.48 118.71 3.95 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.526 2.151 . . . . 28.370000000000001 110.322 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.756 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.37 155.34 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.279 -0.888 . . . . 17.210000000000001 110.291 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.665 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 16.5 m-30 -50.09 111.97 0.6 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.449 -0.782 . . . . 17.190000000000001 109.416 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -61.4 176.37 0.42 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 17.82 109.246 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.21 121.04 5.56 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.567 2.178 . . . . 17.280000000000001 110.41 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 163.7 177.91 36.91 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.752 -1.339 . . . . 17.219999999999999 109.752 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.4 mp -71.36 159.64 34.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -1.13 . . . . 19.57 108.783 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.933 ' CB ' HG13 ' B' ' 4' ' ' VAL . 19.8 m-85 -142.07 165.05 28.5 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.529 1.157 . . . . 14.609999999999999 111.77 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.747 ' O ' HG22 ' B' ' 84' ' ' VAL . 60.3 p -147.28 119.82 8.51 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 106.554 -1.647 . . . . 18.359999999999999 106.554 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.845 ' HB ' HD12 ' B' ' 2' ' ' ILE . 13.1 t -52.26 169.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 C-N-CA 118.576 -1.25 . . . . 19.129999999999999 108.433 -178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.557 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.8 t-80 -131.44 119.62 21.87 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.37 -0.831 . . . . 20.649999999999999 108.987 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.914 ' CD1' HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -62.25 -12.51 20.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.7 -0.625 . . . . 19.649999999999999 109.698 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.416 ' C ' ' O ' ' B' ' 65' ' ' LEU . 40.3 t -46.95 -20.48 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.933 -1.104 . . . . 14.720000000000001 108.565 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.511 ' HB2' ' HA ' ' B' ' 81' ' ' LEU . 32.6 m -97.17 -9.0 28.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.462 -0.774 . . . . 11.449999999999999 111.032 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.684 ' C ' HD11 ' A' ' 37' ' ' LEU . 3.0 m-30 -80.22 160.97 25.42 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.658 -1.276 . . . . 14.25 109.743 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.52 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 4.9 pttm -144.94 175.18 10.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.369 -0.832 . . . . 32.700000000000003 109.707 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 43' ' ' VAL . 2.5 t -117.42 129.2 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.49 -0.756 . . . . 15.630000000000001 109.322 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.22 168.36 35.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.564 -1.414 . . . . 12.699999999999999 109.564 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.491 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 0.9 OUTLIER -76.93 0.61 20.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.118 -1.225 . . . . 26.289999999999999 109.686 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.37 -26.99 23.07 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.47 -0.769 . . . . 20.440000000000001 109.253 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.86 65.43 0.76 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.454 -1.459 . . . . 13.82 109.454 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.3 133.42 0.84 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -1.168 . . . . 18.27 109.53 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' B' ' 68' ' ' PHE . 2.5 tt -73.65 148.64 42.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.201 -0.937 . . . . 12.43 109.471 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.432 ' HG3' ' C ' ' B' ' 76' ' ' LEU . 30.3 mtm -155.92 128.88 8.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 35.109999999999999 109.505 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' A' ' 78' ' ' ILE . 3.0 mt -64.79 141.25 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.247 -0.908 . . . . 13.67 110.06 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -108.41 -36.95 6.1 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.581 -1.266 . . . . 24.059999999999999 107.581 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.51 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.1 tpm_? -168.91 68.12 0.07 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.184 -1.413 . . . . 35.039999999999999 107.184 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.671 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.6 OUTLIER -31.18 120.44 0.22 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.469 -0.787 . . . . 18.719999999999999 111.518 -178.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -90.52 103.24 15.95 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.959 -1.126 . . . . 20.550000000000001 107.959 178.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.665 ' HB3' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -75.76 147.21 39.45 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.989 -1.07 . . . . 14.4 110.966 -178.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.747 HG22 ' O ' ' B' ' 62' ' ' THR . 18.1 m -148.13 160.04 38.31 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 107.651 -1.24 . . . . 17.649999999999999 107.651 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.1 Cg_endo -62.17 146.51 95.99 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.974 1.783 . . . . 25.699999999999999 110.448 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.609 ' HA ' HG23 ' B' ' 62' ' ' THR . . . -79.46 116.5 19.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.146 -0.971 . . . . 49.289999999999999 109.648 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.98 -1.009 . . . . 58.909999999999997 109.474 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.524 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.433 -0.58 . . . . 64.909999999999997 109.433 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.608 HG21 HG21 ' A' ' 63' ' ' VAL . 3.7 mt -72.44 79.22 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.729 -1.211 . . . . 33.799999999999997 107.729 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 mttt -69.31 156.38 38.87 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 122.05 0.929 . . . . 32.719999999999999 111.54 -177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.878 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -166.01 168.01 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.18 -1.044 . . . . 14.460000000000001 108.18 179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.555 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 26.3 mt-10 -143.44 112.63 6.75 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 22.120000000000001 109.541 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.71 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -72.37 102.72 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 C-N-CA 119.003 -1.079 . . . . 14.23 108.107 179.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 1.3 mmpt? -43.72 162.44 0.19 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.352 -0.842 . . . . 25.43 109.414 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.5 Cg_endo -72.7 -12.71 26.82 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.972 1.781 . . . . 13.609999999999999 109.088 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.5 t -99.13 7.15 46.1 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.234 -1.025 . . . . 15.52 108.234 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 1.5 mm-40 -129.47 41.27 3.48 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.846 -0.798 . . . . 17.309999999999999 108.846 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.76 3.65 39.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.122 -0.986 . . . . 24.780000000000001 110.291 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.485 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -134.84 139.64 45.22 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.129 -0.982 . . . . 47.899999999999999 108.607 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.706 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 22.3 p90 -85.62 176.97 7.88 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.035 -1.041 . . . . 21.609999999999999 109.298 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.0 m -133.98 148.2 51.1 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.444 -0.785 . . . . 14.890000000000001 109.099 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.32 110.78 22.08 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.336 -0.852 . . . . 17.350000000000001 109.088 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.448 ' NH1' ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -136.8 152.37 50.22 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.358 -0.839 . . . . 34.380000000000003 109.593 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.3 p -45.64 146.33 1.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.824 . . . . 38.770000000000003 109.378 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -145.85 166.82 27.82 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.17 -1.572 . . . . 34.579999999999998 109.17 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -141.3 117.14 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.069 -1.253 . . . . 41.869999999999997 109.415 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 96.6 p -55.4 90.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.348 -0.845 . . . . 47.210000000000001 109.652 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER 48.07 41.9 16.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.306 -0.871 . . . . 71.560000000000002 109.694 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 65.77 19.41 11.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 66.599999999999994 109.715 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.22 -55.48 1.27 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.175 -1.57 . . . . 55.490000000000002 109.175 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -140.76 151.33 62.73 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.429 -1.042 . . . . 44.990000000000002 108.894 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.5 Cg_endo -76.76 124.25 7.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.458 2.105 . . . . 44.100000000000001 110.696 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.8 p90 -135.45 144.23 46.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.332 -0.855 . . . . 32.090000000000003 109.789 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.32 80.64 1.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 29.25 108.679 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.571 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -94.58 168.3 10.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.885 . . . . 24.0 110.24 -179.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.645 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -95.17 127.11 40.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.467 -0.77 . . . . 23.309999999999999 108.939 179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -113.68 160.39 18.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.202 -0.936 . . . . 40.030000000000001 109.603 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.792 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -137.5 -169.41 2.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.901 . . . . 12.390000000000001 109.123 179.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.973 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.1 mt -133.93 175.87 9.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 17.420000000000002 109.544 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.18 161.72 8.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.964 -1.085 . . . . 13.84 108.525 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.744 ' CE1' HD13 ' A' ' 44' ' ' LEU . 3.1 m-30 -114.34 101.34 9.07 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.132 -0.98 . . . . 21.140000000000001 108.828 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.878 HG22 ' HB ' ' A' ' 4' ' ' VAL . 13.9 t -107.6 148.21 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.999 -1.063 . . . . 10.66 110.029 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.942 ' O ' HD12 ' A' ' 37' ' ' LEU . 1.8 p-10 -113.86 -39.92 3.88 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.408 -0.96 . . . . 25.890000000000001 108.408 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.942 HD12 ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER 62.55 -71.01 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.731 -0.84 . . . . 24.239999999999998 108.731 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -142.59 28.0 2.2 Favored Glycine 0 C--N 1.296 -1.666 0 N-CA-C 108.238 -1.945 . . . . 31.02 108.238 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -130.89 98.97 4.76 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.593 -0.946 . . . . 43.229999999999997 108.722 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' ' 39' ' ' ASN . 3.4 mm-40 -31.36 -37.2 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.284 0.564 . . . . 42.340000000000003 111.194 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 39' ' ' ASN . 60.7 m80 -80.67 149.15 67.27 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.307 -0.87 . . . . 7.0 108.973 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.633 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -78.56 149.61 24.11 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.135 1.89 . . . . 17.920000000000002 110.466 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.86 HG22 ' O ' ' A' ' 35' ' ' VAL . 1.8 m -121.52 119.11 58.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.393 -0.923 . . . . 20.57 109.058 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.973 HD11 ' HB3' ' A' ' 32' ' ' LEU . 15.7 tp -72.72 112.25 8.6 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.722 -0.791 . . . . 20.210000000000001 109.178 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.606 HG23 HG23 ' A' ' 43' ' ' VAL . 14.3 t -118.44 167.06 12.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.545 -0.722 . . . . 10.81 109.528 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -96.15 139.93 31.6 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.517 -0.873 . . . . 36.740000000000002 109.421 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.956 HD13 HD12 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -121.55 171.63 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.408 -0.808 . . . . 19.739999999999998 109.004 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.426 ' OG1' ' HD3' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -105.56 153.59 21.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.075 -1.016 . . . . 22.559999999999999 109.691 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -136.71 105.26 5.79 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.629 -0.878 . . . . 20.41 108.629 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -70.26 143.95 51.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -0.954 . . . . 33.990000000000002 109.635 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.17 132.85 39.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 54.920000000000002 109.269 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.23 -35.58 4.79 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.452 -1.459 . . . . 36.100000000000001 109.452 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 5.1 mt-30 -79.8 138.46 54.01 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.265 -1.138 . . . . 54.759999999999998 109.341 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.3 126.13 7.48 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.509 2.139 . . . . 28.370000000000001 110.415 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.792 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -41.35 149.59 0.11 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.353 -0.842 . . . . 17.210000000000001 110.295 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.71 ' O ' HG21 ' A' ' 6' ' ' ILE . 83.1 m-85 -50.94 97.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.476 -0.765 . . . . 17.190000000000001 109.026 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.995 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.14 176.54 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.176 -0.953 . . . . 17.82 109.407 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.995 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.1 Cg_endo -76.68 131.26 12.24 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.418 2.079 . . . . 17.280000000000001 110.009 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.67 174.59 27.57 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.777 -1.329 . . . . 17.219999999999999 109.777 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.7 OUTLIER -73.7 143.12 46.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.306 -1.114 . . . . 19.57 108.469 179.242 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.725 ' HB3' HD22 ' A' ' 83' ' ' LEU . 22.3 m-85 -127.31 162.89 25.18 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 120.832 -1.167 . . . . 14.609999999999999 111.548 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.676 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.8 p -143.04 121.39 12.32 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.534 -1.654 . . . . 18.359999999999999 106.534 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.834 ' CG1' HD12 ' A' ' 81' ' ' LEU . 3.3 t -52.54 166.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 C-N-CA 118.873 -1.131 . . . . 19.129999999999999 109.012 -178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -134.84 128.78 33.36 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.561 -0.903 . . . . 20.649999999999999 108.561 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.723 HD11 ' O ' ' B' ' 37' ' ' LEU . 1.2 pp -73.13 3.15 5.91 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.036 -1.04 . . . . 19.649999999999999 110.005 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.7 t -57.04 -19.15 17.17 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 107.716 -1.216 . . . . 14.720000000000001 107.716 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.529 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -101.34 -8.01 22.45 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.696 -0.628 . . . . 11.449999999999999 110.234 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.4 m-30 -74.66 155.27 37.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.836 -1.165 . . . . 14.25 108.925 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.77 176.53 12.46 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 32.700000000000003 109.678 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.757 HG21 HG21 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -109.45 115.77 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.392 -0.818 . . . . 15.630000000000001 109.285 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.06 179.71 10.77 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.508 -1.437 . . . . 12.699999999999999 109.508 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.534 ' HA ' ' NE2' ' A' ' 72' ' ' GLN . 9.2 mm-40 -88.46 42.43 1.07 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.222 -1.164 . . . . 26.289999999999999 109.298 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.402 ' CG ' ' C ' ' A' ' 72' ' ' GLN . 10.3 m-85 -148.23 34.96 0.81 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.532 -0.73 . . . . 20.440000000000001 109.384 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' HG13 ' B' ' 45' ' ' VAL . . . 48.0 58.78 6.72 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.239 -1.544 . . . . 13.82 109.239 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.435 ' HA ' HG13 ' B' ' 45' ' ' VAL . 4.2 m -156.41 136.16 12.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.335 -1.097 . . . . 18.27 109.919 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.958 HD11 HD21 ' B' ' 37' ' ' LEU . 0.3 OUTLIER -73.06 165.08 25.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.321 -0.862 . . . . 12.43 109.084 179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.541 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.1 mtt -166.43 107.86 0.7 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.07 -1.019 . . . . 35.109999999999999 110.023 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.61 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -42.67 -35.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.514 -0.741 . . . . 13.67 109.588 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER 43.89 55.19 5.36 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 24.059999999999999 109.411 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 67' ' ' SER . 6.5 tmm_? 78.23 80.78 0.07 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.851 -0.796 . . . . 35.039999999999999 108.851 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.834 HD12 ' CG1' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -55.56 149.03 14.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.768 0.794 . . . . 18.719999999999999 111.703 -178.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -99.48 103.46 15.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.094 -1.076 . . . . 20.550000000000001 108.094 178.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.956 HD12 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -75.16 151.57 38.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.185 -0.947 . . . . 14.4 111.568 -178.278 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 62' ' ' THR . 27.1 m -151.51 155.65 34.37 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 107.825 -1.176 . . . . 17.649999999999999 107.825 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 24.7 Cg_endo -63.42 144.23 90.3 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.146 1.898 . . . . 25.699999999999999 110.433 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.544 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -72.0 139.71 48.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.159 -0.963 . . . . 49.289999999999999 109.396 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.009 -0.996 . . . . 58.909999999999997 109.551 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.521 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.396 -0.594 . . . . 64.909999999999997 109.396 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.601 ' CA ' HD22 ' A' ' 65' ' ' LEU . 3.8 mt -72.7 79.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.664 -1.235 . . . . 33.799999999999997 107.664 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -69.59 156.13 39.41 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.055 0.931 . . . . 32.719999999999999 111.549 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.899 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -165.54 168.16 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.229 -1.026 . . . . 14.460000000000001 108.229 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.547 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 26.3 mt-10 -143.46 112.55 6.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 22.120000000000001 109.556 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.704 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -72.31 102.59 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 118.979 -1.089 . . . . 14.23 108.079 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.551 ' HB3' ' HD2' ' B' ' 8' ' ' PRO . 1.1 mmpt? -43.69 162.57 0.19 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 25.43 109.466 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.4 Cg_endo -72.65 -12.9 27.07 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.007 1.805 . . . . 13.609999999999999 109.144 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -98.99 7.15 46.28 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.26 -1.015 . . . . 15.52 108.26 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 1.5 mm-40 -129.53 41.34 3.46 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.416 -0.803 . . . . 17.309999999999999 108.885 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.92 3.88 39.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.063 -1.023 . . . . 24.780000000000001 110.264 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.464 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.9 OUTLIER -134.9 139.49 45.02 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.167 -0.958 . . . . 47.899999999999999 108.533 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.704 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 22.1 p90 -85.86 176.7 7.94 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.035 -1.041 . . . . 21.609999999999999 109.244 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 24.4 m -133.64 148.67 51.55 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.395 -0.816 . . . . 14.890000000000001 109.087 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.82 110.71 22.07 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.37 -0.831 . . . . 17.350000000000001 108.997 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.45 HH11 ' CG ' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -136.53 152.67 50.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.247 -0.908 . . . . 34.380000000000003 109.582 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.403 ' C ' ' O ' ' B' ' 16' ' ' ARG . 18.6 p -45.75 146.69 1.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 38.770000000000003 109.384 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -146.34 166.72 28.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.219 -1.552 . . . . 34.579999999999998 109.219 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' B' ' 24' ' ' LYS . 0.8 OUTLIER -141.15 117.36 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.015 -1.286 . . . . 41.869999999999997 109.409 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.423 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 98.2 p -55.67 89.81 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.377 -0.827 . . . . 47.210000000000001 109.677 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER 48.43 41.94 17.56 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.291 -0.881 . . . . 71.560000000000002 109.719 179.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 65.64 19.28 11.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -0.945 . . . . 66.599999999999994 109.77 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.19 -55.42 1.28 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.154 -1.578 . . . . 55.490000000000002 109.154 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' B' ' 19' ' ' VAL . 1.0 OUTLIER -140.77 151.21 62.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.377 -1.072 . . . . 44.990000000000002 108.902 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 33.9 Cg_endo -76.67 124.62 7.67 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.499 2.133 . . . . 44.100000000000001 110.619 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.582 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 6.7 p90 -136.0 144.17 45.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.849 . . . . 32.090000000000003 109.774 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.49 80.9 1.86 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.875 . . . . 29.25 108.666 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.575 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -94.7 168.28 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 24.0 110.231 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.639 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -95.09 127.08 40.87 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.445 -0.785 . . . . 23.309999999999999 108.922 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.6 OUTLIER -113.51 160.68 18.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.175 -0.953 . . . . 40.030000000000001 109.581 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.817 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -137.83 -169.63 2.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 12.390000000000001 109.02 179.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.949 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.1 mt -133.81 175.85 9.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.224 -0.923 . . . . 17.420000000000002 109.548 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.14 161.69 8.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.955 -1.091 . . . . 13.84 108.497 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.742 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.1 m-30 -114.41 101.58 9.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.172 -0.955 . . . . 21.140000000000001 108.739 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.899 HG22 ' HB ' ' B' ' 4' ' ' VAL . 13.5 t -107.73 148.25 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.056 -1.027 . . . . 10.66 110.125 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.94 ' O ' HD12 ' B' ' 37' ' ' LEU . 1.8 p-10 -113.95 -40.07 3.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.51 -0.922 . . . . 25.890000000000001 108.51 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.958 HD21 HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER 62.38 -70.87 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.773 -0.825 . . . . 24.239999999999998 108.773 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -142.65 27.73 2.2 Favored Glycine 0 C--N 1.296 -1.669 0 N-CA-C 108.307 -1.917 . . . . 31.02 108.307 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.0 OUTLIER -130.72 99.07 4.82 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.604 -0.939 . . . . 43.229999999999997 108.73 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' B' ' 39' ' ' ASN . 3.4 mm-40 -31.55 -37.02 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.3 0.571 . . . . 42.340000000000003 111.143 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.484 ' N ' ' O ' ' B' ' 39' ' ' ASN . 59.8 m80 -80.73 149.18 67.12 Favored Pre-proline 0 C--N 1.296 -1.744 0 O-C-N 121.342 -0.849 . . . . 6.9800000000000004 109.037 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.634 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.4 Cg_endo -78.58 149.48 23.94 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.102 1.868 . . . . 17.920000000000002 110.408 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.84 HG22 ' O ' ' B' ' 35' ' ' VAL . 1.8 m -121.36 119.51 59.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.344 -0.943 . . . . 20.57 109.102 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.949 HD11 ' HB3' ' B' ' 32' ' ' LEU . 15.3 tp -73.04 111.45 8.16 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.778 -0.769 . . . . 20.210000000000001 109.105 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.608 HG23 HG23 ' B' ' 43' ' ' VAL . 12.8 t -117.7 167.16 11.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.633 -0.667 . . . . 10.81 109.449 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.564 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.9 OUTLIER -96.16 140.33 31.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.319 -0.863 . . . . 36.740000000000002 109.495 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.943 HD13 HD12 ' B' ' 83' ' ' LEU . 0.3 OUTLIER -121.96 171.81 10.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.344 -0.847 . . . . 19.739999999999998 109.076 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.423 ' OG1' ' HD3' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -105.89 153.15 22.36 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.051 -1.03 . . . . 22.559999999999999 109.77 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' B' ' 29' ' ' ASN . 0.2 OUTLIER -136.36 104.99 5.79 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.684 -0.858 . . . . 20.41 108.684 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -70.01 144.5 52.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 33.990000000000002 109.665 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.58 132.88 41.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.893 . . . . 54.920000000000002 109.264 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.32 -36.09 4.44 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.398 -1.481 . . . . 36.100000000000001 109.398 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.51 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 5.0 mt-30 -79.47 138.34 55.26 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.27 -1.135 . . . . 54.759999999999998 109.34 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.41 126.12 7.39 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.44 2.093 . . . . 28.370000000000001 110.372 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.817 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -41.25 150.58 0.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.328 -0.857 . . . . 17.210000000000001 110.234 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.704 ' O ' HG21 ' B' ' 6' ' ' ILE . 82.1 m-85 -51.95 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.95 -0.759 . . . . 17.190000000000001 108.95 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.978 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -51.53 176.62 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.306 -0.871 . . . . 17.82 109.312 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.978 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -76.9 132.12 12.7 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.469 2.113 . . . . 17.280000000000001 110.328 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.99 175.15 26.66 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.676 -1.37 . . . . 17.219999999999999 109.676 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.524 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.7 OUTLIER -73.43 143.88 46.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.265 -1.138 . . . . 19.57 108.872 179.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.701 ' HB3' HD22 ' B' ' 83' ' ' LEU . 21.5 m-85 -127.9 163.05 25.3 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.544 1.164 . . . . 14.609999999999999 111.556 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.69 ' O ' HG22 ' B' ' 84' ' ' VAL . 46.1 p -143.32 121.41 12.14 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.546 -1.65 . . . . 18.359999999999999 106.546 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.834 ' CG1' HD12 ' B' ' 81' ' ' LEU . 3.3 t -52.75 165.7 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 C-N-CA 118.88 -1.128 . . . . 19.129999999999999 109.023 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -134.02 128.55 34.56 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.59 -0.893 . . . . 20.649999999999999 108.59 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.729 HD11 ' O ' ' A' ' 37' ' ' LEU . 1.3 pp -72.74 2.95 5.68 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.061 -1.024 . . . . 19.649999999999999 110.087 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 28.6 t -56.94 -19.21 16.73 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 107.711 -1.218 . . . . 14.720000000000001 107.711 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.537 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -101.45 -7.79 22.55 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.723 -0.611 . . . . 11.449999999999999 110.166 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.641 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.3 m-30 -74.84 154.97 38.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.889 -1.132 . . . . 14.25 108.833 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.43 176.85 12.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.186 -0.946 . . . . 32.700000000000003 109.681 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -109.8 115.62 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.43 -0.794 . . . . 15.630000000000001 109.363 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.91 179.71 10.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.568 -1.413 . . . . 12.699999999999999 109.568 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.537 ' HA ' ' NE2' ' B' ' 72' ' ' GLN . 8.8 mm-40 -88.49 42.42 1.07 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.224 -1.162 . . . . 26.289999999999999 109.314 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.404 ' CG ' ' C ' ' B' ' 72' ' ' GLN . 9.5 m-85 -148.18 34.79 0.81 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.495 -0.753 . . . . 20.440000000000001 109.481 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.435 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 48.34 58.08 7.59 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.292 -1.523 . . . . 13.82 109.292 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.4 m -155.74 136.37 13.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.139 . . . . 18.27 109.963 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.904 HD11 HD21 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -73.2 164.91 26.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 12.43 109.157 179.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.1 mtt -166.37 108.12 0.71 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.085 -1.009 . . . . 35.109999999999999 110.106 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.615 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.7 mt -42.99 -34.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 13.67 109.532 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.7 OUTLIER 43.83 55.27 5.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -0.832 . . . . 24.059999999999999 109.35 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 67' ' ' SER . 6.5 tmm_? 78.23 80.82 0.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.922 -0.77 . . . . 35.039999999999999 108.922 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.834 HD12 ' CG1' ' B' ' 63' ' ' VAL . 1.0 OUTLIER -55.54 149.11 14.27 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.702 0.763 . . . . 18.719999999999999 111.74 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -99.62 103.55 15.26 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.992 -1.114 . . . . 20.550000000000001 107.992 178.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.943 HD12 HD13 ' B' ' 47' ' ' ILE . 0.6 OUTLIER -75.22 151.55 38.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.229 -0.92 . . . . 14.4 111.609 -178.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.69 HG22 ' O ' ' B' ' 62' ' ' THR . 29.9 m -151.55 155.36 34.18 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 107.837 -1.171 . . . . 17.649999999999999 107.837 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 24.7 Cg_endo -63.22 144.12 91.12 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.237 1.958 . . . . 25.699999999999999 110.446 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.525 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -72.0 139.4 48.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 49.289999999999999 109.375 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.034 -0.984 . . . . 58.909999999999997 109.483 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.4 -0.593 . . . . 64.909999999999997 109.4 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.707 ' N ' HD22 ' B' ' 65' ' ' LEU . 3.0 mt -61.93 83.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.646 -1.242 . . . . 33.799999999999997 107.646 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 1' ' ' MET . 14.0 mtpt -75.93 158.05 32.47 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.952 0.882 . . . . 32.719999999999999 111.104 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.893 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -164.23 169.05 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.293 -1.002 . . . . 14.460000000000001 108.293 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.557 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 55.5 mt-10 -144.7 112.6 6.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.94 . . . . 22.120000000000001 109.47 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.746 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -72.73 101.98 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.822 -1.177 . . . . 14.23 107.822 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.656 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.69 171.22 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.304 -0.872 . . . . 25.43 109.856 -178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -74.8 -26.9 10.91 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.36 2.04 . . . . 13.609999999999999 109.589 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -88.02 0.08 56.39 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.987 -0.746 . . . . 15.52 108.987 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.8 mm-40 -120.42 33.87 5.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 17.309999999999999 109.475 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.95 10.79 38.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 24.780000000000001 109.958 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 15.3 mt-30 -138.93 144.99 39.29 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 47.899999999999999 109.96 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.737 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 35.4 p90 -94.3 161.52 14.21 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.323 -0.861 . . . . 21.609999999999999 109.195 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -128.92 162.82 26.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.311 -0.868 . . . . 14.890000000000001 108.808 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.658 HG22 ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -97.28 111.03 23.45 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.239 -0.913 . . . . 17.350000000000001 109.541 -179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -117.08 137.56 52.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.319 -0.863 . . . . 34.380000000000003 109.087 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.4 t -50.54 90.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 38.770000000000003 109.813 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.555 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -85.44 161.76 35.77 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.304 -1.518 . . . . 34.579999999999998 109.304 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.477 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 2.1 t -132.94 123.93 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.187 -1.184 . . . . 41.869999999999997 109.386 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -64.54 89.37 0.07 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.279 -0.888 . . . . 47.210000000000001 109.632 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 20' ' ' SER . 1.2 mpt_? 43.56 53.68 5.71 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.261 -0.899 . . . . 71.560000000000002 109.749 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.72 20.77 0.79 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 66.599999999999994 109.722 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' SER . . . -99.73 -39.67 3.33 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.309 -1.516 . . . . 55.490000000000002 109.309 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 20' ' ' SER . 14.5 mttm -156.52 148.81 17.68 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.354 -1.086 . . . . 44.990000000000002 109.151 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.42 131.13 11.38 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.535 2.157 . . . . 44.100000000000001 110.5 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.604 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 5.5 p90 -144.71 139.5 27.96 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.182 -0.949 . . . . 32.090000000000003 109.603 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.658 ' HB2' HG22 ' A' ' 15' ' ' THR . 2.9 p -102.01 80.43 2.0 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 29.25 108.868 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.605 HD22 ' CG2' ' A' ' 48' ' ' THR . 0.2 OUTLIER -91.33 143.35 26.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 24.0 110.173 -179.168 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.569 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 90.7 m-20 -64.99 133.55 51.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.387 -0.821 . . . . 23.309999999999999 109.745 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.21 142.32 51.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 40.030000000000001 109.294 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.91 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -124.14 -179.04 4.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 12.390000000000001 109.303 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.9 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.1 mt -127.75 174.33 9.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 17.420000000000002 109.579 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -168.45 167.62 11.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.403 -0.962 . . . . 13.84 108.403 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.668 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 18.7 m-85 -120.88 107.38 12.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.138 -0.976 . . . . 21.140000000000001 109.545 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.927 ' O ' HG22 ' A' ' 43' ' ' VAL . 59.2 t -104.02 112.3 37.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.141 -0.974 . . . . 10.66 109.821 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.0 OUTLIER -64.0 -27.34 69.05 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.196 -1.038 . . . . 25.890000000000001 108.196 179.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.666 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.6 OUTLIER 48.37 30.85 2.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.602 -0.686 . . . . 24.239999999999998 109.303 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.61 9.37 78.33 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.457 -1.457 . . . . 31.02 109.457 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.615 ' OD1' HD23 ' A' ' 37' ' ' LEU . 1.9 m-20 -85.43 4.57 34.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.247 -1.149 . . . . 43.229999999999997 110.476 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 29.6 mt-10 80.7 -42.61 0.2 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.585 -0.697 . . . . 42.340000000000003 110.567 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.521 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 47.5 m80 -107.0 155.34 39.38 Favored Pre-proline 0 C--N 1.295 -1.793 0 O-C-N 121.417 -0.802 . . . . 5.75 108.929 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.668 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -77.15 138.12 17.79 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.181 1.92 . . . . 17.920000000000002 110.542 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.927 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.6 m -111.85 117.75 55.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.369 -0.832 . . . . 20.57 108.827 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.9 HD11 ' HB3' ' A' ' 32' ' ' LEU . 67.3 tp -71.56 103.26 2.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.288 -0.882 . . . . 20.210000000000001 110.007 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 43' ' ' VAL . 3.6 m -106.42 -177.42 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.527 -0.733 . . . . 10.81 109.032 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.26 145.0 40.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.409 -0.917 . . . . 36.740000000000002 109.987 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.856 HD13 HD12 ' A' ' 83' ' ' LEU . 1.2 tt -135.9 136.47 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.418 -0.801 . . . . 19.739999999999998 109.064 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.605 ' CG2' HD22 ' A' ' 28' ' ' LEU . 11.1 m -68.67 156.01 39.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 22.559999999999999 109.57 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.641 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 2.3 tm? -129.99 114.02 15.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.282 -0.886 . . . . 20.41 109.077 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -48.85 123.56 7.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.866 . . . . 33.990000000000002 110.152 -179.244 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -47.34 109.27 0.2 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.319 -0.863 . . . . 54.920000000000002 109.353 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.78 -29.65 10.55 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.429 -1.468 . . . . 36.100000000000001 109.429 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.604 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -65.2 153.68 88.89 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.23 -1.159 . . . . 54.759999999999998 109.326 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.8 Cg_endo -77.88 109.95 2.82 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.506 2.138 . . . . 28.370000000000001 110.224 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.91 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -38.63 148.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.526 -0.734 . . . . 17.210000000000001 110.218 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.746 ' O ' HG21 ' A' ' 6' ' ' ILE . 83.0 m-85 -46.0 101.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.451 -0.781 . . . . 17.190000000000001 109.355 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.845 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.63 171.02 0.17 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.907 . . . . 17.82 109.823 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.845 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -77.9 114.14 3.57 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.736 2.291 . . . . 17.280000000000001 110.117 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.65 -179.82 46.6 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.898 -1.281 . . . . 17.219999999999999 109.898 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -75.78 139.76 41.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -1.082 . . . . 19.57 108.114 179.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.766 ' HB3' HD22 ' A' ' 83' ' ' LEU . 18.5 m-85 -126.26 162.15 26.11 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.66 -1.275 . . . . 14.609999999999999 111.759 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.772 ' O ' HG22 ' A' ' 84' ' ' VAL . 52.8 p -142.11 122.25 13.8 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.247 -1.76 . . . . 18.359999999999999 106.247 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.598 HG21 HG21 ' A' ' 2' ' ' ILE . 2.5 t -54.38 162.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 C-N-CA 118.792 -1.163 . . . . 19.129999999999999 109.077 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.545 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.5 t-80 -130.46 129.17 42.63 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.246 -1.02 . . . . 20.649999999999999 108.246 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.711 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.5 OUTLIER -70.04 1.97 4.06 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.502 -0.749 . . . . 19.649999999999999 110.2 -179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.03 -20.35 9.18 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.448 -1.316 . . . . 14.720000000000001 107.448 178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.5 OUTLIER -97.58 -8.34 29.21 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.755 -0.591 . . . . 11.449999999999999 110.09 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -77.97 154.94 31.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.967 -1.083 . . . . 14.25 109.595 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.93 175.8 9.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -0.792 . . . . 32.700000000000003 109.466 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.912 HG11 ' CG2' ' B' ' 43' ' ' VAL . 10.6 t -122.37 134.4 65.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.43 -0.794 . . . . 15.630000000000001 109.475 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.21 -160.24 28.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.382 -1.487 . . . . 12.699999999999999 109.382 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 6.2 tp60 61.67 72.73 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -1.177 . . . . 26.289999999999999 109.349 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 2.2 m-85 65.51 11.97 7.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 20.440000000000001 109.357 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' B' ' 45' ' ' VAL . . . 81.97 48.82 5.6 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.503 -1.439 . . . . 13.82 109.503 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 77' ' ' MET . 26.9 t -130.6 125.48 34.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -1.116 . . . . 18.27 109.662 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.689 ' CD1' HG22 ' A' ' 70' ' ' VAL . 3.5 tp -63.96 146.44 54.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 12.43 109.115 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.5 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 3.2 mtm -159.33 144.37 15.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.133 -0.979 . . . . 35.109999999999999 109.449 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.624 ' CG1' ' CE1' ' A' ' 68' ' ' PHE . 1.7 mp -65.14 145.48 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 13.67 109.505 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.508 ' N ' ' O ' ' A' ' 67' ' ' SER . 4.6 t70 -103.46 -62.28 1.31 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.214 -1.402 . . . . 24.059999999999999 107.214 178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.524 ' O ' ' C ' ' A' ' 81' ' ' LEU . 5.1 tmm_? -142.28 56.8 1.46 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.292 -1.003 . . . . 35.039999999999999 108.292 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.632 HD21 ' HG ' ' A' ' 83' ' ' LEU . 6.4 tt 3.43 116.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.524 -1.217 . . . . 18.719999999999999 112.849 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.545 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -99.35 96.61 7.84 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.098 -1.075 . . . . 20.550000000000001 108.098 178.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.856 HD12 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -77.49 150.82 34.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.982 -1.074 . . . . 14.4 111.064 -178.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 62' ' ' THR . 26.4 m -151.15 155.88 34.99 Favored Pre-proline 0 C--N 1.303 -1.437 0 N-CA-C 108.106 -1.072 . . . . 17.649999999999999 108.106 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.1 Cg_endo -63.86 141.9 80.06 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.053 1.836 . . . . 25.699999999999999 110.173 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.707 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -70.77 117.79 12.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.206 -0.934 . . . . 49.289999999999999 109.602 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.046 -0.978 . . . . 58.909999999999997 109.496 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.518 ' O ' ' N ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.416 -0.587 . . . . 64.909999999999997 109.416 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.711 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.0 mt -62.0 83.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 107.644 -1.243 . . . . 33.799999999999997 107.644 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' B' ' 1' ' ' MET . 14.0 mtpt -75.89 158.0 32.58 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.947 0.879 . . . . 32.719999999999999 111.104 -177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.863 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -164.23 168.99 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.296 -1.002 . . . . 14.460000000000001 108.296 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.548 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 55.2 mt-10 -144.59 112.62 6.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.19 -0.944 . . . . 22.120000000000001 109.448 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.743 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -72.73 101.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.761 -1.2 . . . . 14.23 107.761 179.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.656 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.73 171.23 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.358 -0.839 . . . . 25.43 109.81 -178.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 32.6 Cg_endo -74.92 -26.82 10.72 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.331 2.021 . . . . 13.609999999999999 109.532 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -88.03 0.15 56.3 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.0 -0.741 . . . . 15.52 109.0 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.516 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.8 mm-40 -120.42 33.79 5.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 17.309999999999999 109.506 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.85 10.77 38.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.136 -0.978 . . . . 24.780000000000001 109.937 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.483 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 15.3 mt-30 -139.01 144.93 39.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.144 -0.973 . . . . 47.899999999999999 109.911 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.726 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 35.4 p90 -94.25 161.46 14.24 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.376 -0.827 . . . . 21.609999999999999 109.178 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 8.7 t -128.78 162.93 26.29 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.242 -0.911 . . . . 14.890000000000001 108.792 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.652 HG22 ' HB2' ' B' ' 27' ' ' SER . 0.2 OUTLIER -97.43 111.07 23.48 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.203 -0.935 . . . . 17.350000000000001 109.486 -179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' B' ' 18' ' ' GLY . 0.0 OUTLIER -117.12 137.66 52.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -0.895 . . . . 34.380000000000003 109.093 179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 28.5 t -50.6 90.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 38.770000000000003 109.835 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -85.53 161.88 35.74 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.361 -1.496 . . . . 34.579999999999998 109.361 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.474 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 2.1 t -133.07 123.84 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.15 -1.206 . . . . 41.869999999999997 109.369 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.482 ' N ' ' O ' ' B' ' 24' ' ' LYS . 0.4 OUTLIER -64.49 89.38 0.06 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.314 -0.866 . . . . 47.210000000000001 109.681 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' B' ' 20' ' ' SER . 1.2 mpt_? 43.54 53.67 5.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.236 -0.915 . . . . 71.560000000000002 109.692 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.83 20.7 0.81 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 66.599999999999994 109.722 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.63 -39.9 3.3 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.242 -1.543 . . . . 55.490000000000002 109.242 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' B' ' 20' ' ' SER . 14.5 mttm -156.27 148.94 17.99 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.329 -1.101 . . . . 44.990000000000002 109.16 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.46 131.19 11.39 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.512 2.141 . . . . 44.100000000000001 110.532 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.6 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 5.4 p90 -144.76 139.5 27.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 32.090000000000003 109.614 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.652 ' HB2' HG22 ' B' ' 15' ' ' THR . 2.8 p -102.05 80.41 1.99 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 29.25 108.848 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.603 HD22 ' CG2' ' B' ' 48' ' ' THR . 0.2 OUTLIER -91.31 143.31 26.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 24.0 110.231 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.574 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 90.9 m-20 -64.94 133.6 52.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.421 -0.8 . . . . 23.309999999999999 109.745 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -124.26 142.32 51.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 40.030000000000001 109.259 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.892 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -124.07 -179.16 4.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 12.390000000000001 109.378 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.877 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.1 mt -127.63 174.41 9.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.157 -0.964 . . . . 17.420000000000002 109.511 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -168.59 167.57 11.41 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.366 -0.976 . . . . 13.84 108.366 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 18.9 m-85 -120.83 107.4 12.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.127 -0.983 . . . . 21.140000000000001 109.596 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.908 ' O ' HG22 ' B' ' 43' ' ' VAL . 59.4 t -104.04 112.29 36.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.157 -0.964 . . . . 10.66 109.834 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.0 OUTLIER -63.96 -27.41 69.12 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.155 -1.054 . . . . 25.890000000000001 108.155 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.655 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER 48.48 30.74 2.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.637 -0.664 . . . . 24.239999999999998 109.278 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.73 9.34 78.79 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.469 -1.453 . . . . 31.02 109.469 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.609 ' OD1' HD23 ' B' ' 37' ' ' LEU . 1.9 m-20 -85.39 4.5 35.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -1.165 . . . . 43.229999999999997 110.504 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' B' ' 39' ' ' ASN . 29.5 mt-10 80.67 -42.62 0.2 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.578 -0.701 . . . . 42.340000000000003 110.561 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' B' ' 36' ' ' ASP . 47.5 m80 -106.95 155.34 39.34 Favored Pre-proline 0 C--N 1.294 -1.825 0 O-C-N 121.376 -0.828 . . . . 5.7800000000000002 108.919 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.672 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.1 Cg_endo -77.2 138.21 17.78 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.12 1.88 . . . . 17.920000000000002 110.551 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.912 ' CG2' HG11 ' A' ' 70' ' ' VAL . 5.6 m -111.85 117.7 55.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.338 -0.852 . . . . 20.57 108.784 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.877 HD11 ' HB3' ' B' ' 32' ' ' LEU . 67.3 tp -71.55 103.19 2.91 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.347 -0.846 . . . . 20.210000000000001 110.032 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.565 HG13 HG23 ' B' ' 43' ' ' VAL . 3.6 m -106.34 -177.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 109.001 -0.74 . . . . 10.81 109.001 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.27 144.91 40.9 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.408 -0.917 . . . . 36.740000000000002 110.006 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.833 HD13 HD12 ' B' ' 83' ' ' LEU . 1.2 tt -135.84 136.53 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.454 -0.779 . . . . 19.739999999999998 109.068 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.603 ' CG2' HD22 ' B' ' 28' ' ' LEU . 11.0 m -68.67 156.17 38.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.125 -0.984 . . . . 22.559999999999999 109.53 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.635 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 2.3 tm? -130.19 113.94 15.08 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.357 -0.839 . . . . 20.41 109.083 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.3 OUTLIER -48.82 123.6 7.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.873 . . . . 33.990000000000002 110.209 -179.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -47.37 109.25 0.2 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.298 -0.876 . . . . 54.920000000000002 109.394 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.83 -29.67 10.49 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.431 -1.468 . . . . 36.100000000000001 109.431 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.618 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.7 OUTLIER -65.16 153.62 88.92 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.278 -1.131 . . . . 54.759999999999998 109.311 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.5 Cg_endo -77.8 109.98 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.52 2.146 . . . . 28.370000000000001 110.214 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.892 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -38.75 148.58 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.526 -0.734 . . . . 17.210000000000001 110.154 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.743 ' O ' HG21 ' B' ' 6' ' ' ILE . 83.1 m-85 -46.34 102.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.404 -0.81 . . . . 17.190000000000001 109.409 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.864 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -50.82 171.01 0.17 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 17.82 109.737 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.864 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -78.17 115.31 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.768 2.312 . . . . 17.280000000000001 110.397 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.67 -179.27 45.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.747 -1.341 . . . . 17.219999999999999 109.747 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.732 HD23 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -75.44 140.4 42.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -1.102 . . . . 19.57 108.432 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.768 ' HB3' HD22 ' B' ' 83' ' ' LEU . 18.1 m-85 -126.8 162.25 26.3 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.752 -1.218 . . . . 14.609999999999999 111.764 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.767 ' O ' HG22 ' B' ' 84' ' ' VAL . 52.8 p -142.34 122.26 13.61 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.256 -1.757 . . . . 18.359999999999999 106.256 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.6 HG21 HG21 ' B' ' 2' ' ' ILE . 2.6 t -54.39 162.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 C-N-CA 118.766 -1.174 . . . . 19.129999999999999 109.077 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.552 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.5 t-80 -130.41 129.18 42.72 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.269 -1.012 . . . . 20.649999999999999 108.269 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.707 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -69.93 1.83 4.09 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.516 -0.74 . . . . 19.649999999999999 110.231 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.95 -20.35 8.8 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.419 -1.326 . . . . 14.720000000000001 107.419 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.519 ' O ' ' N ' ' B' ' 79' ' ' ASP . 0.5 OUTLIER -97.74 -8.52 28.41 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.74 -0.6 . . . . 11.449999999999999 110.062 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.666 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.8 m-30 -77.74 154.54 31.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 14.25 109.495 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.54 176.04 9.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 32.700000000000003 109.483 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.91 HG11 ' CG2' ' A' ' 43' ' ' VAL . 10.5 t -122.52 134.37 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 15.630000000000001 109.504 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.19 -160.28 28.6 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.356 -1.498 . . . . 12.699999999999999 109.356 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 6.3 tp60 61.69 72.79 0.5 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -1.164 . . . . 26.289999999999999 109.349 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 2.2 m-85 65.43 12.06 7.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 20.440000000000001 109.29 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 45' ' ' VAL . . . 81.87 48.88 5.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.495 -1.442 . . . . 13.82 109.495 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 77' ' ' MET . 27.1 t -130.59 125.38 33.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -1.129 . . . . 18.27 109.659 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.692 ' CD1' HG22 ' B' ' 70' ' ' VAL . 3.4 tp -63.81 146.46 53.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 12.43 109.131 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.508 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 3.2 mtm -159.43 144.41 15.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.07 -1.019 . . . . 35.109999999999999 109.396 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.626 ' CG1' ' CE1' ' B' ' 68' ' ' PHE . 1.7 mp -65.29 145.69 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 13.67 109.534 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' B' ' 67' ' ' SER . 4.5 t70 -103.59 -62.07 1.34 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.238 -1.393 . . . . 24.059999999999999 107.238 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' B' ' 81' ' ' LEU . 5.1 tmm_? -142.51 56.88 1.44 Allowed 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.286 -1.005 . . . . 35.039999999999999 108.286 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.641 HD21 ' HG ' ' B' ' 83' ' ' LEU . 6.5 tt 3.4 116.68 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.474 -1.239 . . . . 18.719999999999999 112.887 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.4 OUTLIER -99.41 96.51 7.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.109 -1.071 . . . . 20.550000000000001 108.109 178.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.833 HD12 HD13 ' B' ' 47' ' ' ILE . 0.9 OUTLIER -77.35 150.98 35.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.935 -1.103 . . . . 14.4 111.066 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.767 HG22 ' O ' ' B' ' 62' ' ' THR . 26.5 m -151.34 155.77 34.68 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.054 -1.091 . . . . 17.649999999999999 108.054 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.1 Cg_endo -63.73 141.91 80.94 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.055 1.837 . . . . 25.699999999999999 110.195 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.726 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -70.76 117.72 12.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.163 -0.96 . . . . 49.289999999999999 109.595 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.046 -0.978 . . . . 58.909999999999997 109.476 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.517 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.3 -0.629 . . . . 64.909999999999997 109.3 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.955 ' H ' HD22 ' B' ' 65' ' ' LEU . 1.7 mt 58.53 78.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.799 -1.186 . . . . 33.799999999999997 107.799 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -73.52 157.15 37.29 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.797 0.808 . . . . 32.719999999999999 110.672 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.876 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -164.67 159.31 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.022 -0.733 . . . . 14.460000000000001 109.022 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 5.1 mt-10 -136.34 113.6 10.68 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.498 -0.751 . . . . 22.120000000000001 109.351 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.697 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -72.36 107.26 3.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.906 -1.146 . . . . 14.23 107.906 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.603 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 4.4 mptt -50.07 172.6 0.11 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.165 -0.959 . . . . 25.43 109.999 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.8 Cg_endo -76.0 -29.23 6.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.557 2.171 . . . . 13.609999999999999 109.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.8 m -92.95 7.01 45.8 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.976 -0.75 . . . . 15.52 108.976 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.1 mm-40 -123.49 29.25 6.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.309 -0.869 . . . . 17.309999999999999 109.749 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.22 16.28 17.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 24.780000000000001 110.063 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.563 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 18.4 mt-30 -141.84 145.29 34.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.093 -1.004 . . . . 47.899999999999999 109.902 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.753 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 42.2 p90 -96.16 153.37 17.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.363 -0.836 . . . . 21.609999999999999 109.458 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.7 p -121.38 168.72 11.36 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.421 -0.8 . . . . 14.890000000000001 109.337 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.53 113.72 27.31 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.409 -0.807 . . . . 17.350000000000001 109.048 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.472 ' HB2' ' OE1' ' A' ' 30' ' ' GLU . 25.2 mtt180 -141.62 155.11 45.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.287 -0.883 . . . . 34.380000000000003 109.501 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' ARG . 26.6 p -42.71 133.57 3.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.39 -0.819 . . . . 38.770000000000003 109.714 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 26' ' ' TYR . . . -131.94 157.97 22.66 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.36 -1.496 . . . . 34.579999999999998 109.36 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -135.44 117.9 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.11 -1.229 . . . . 41.869999999999997 109.475 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.457 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 7.5 p -64.0 -146.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.331 -0.855 . . . . 47.210000000000001 109.183 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 22' ' ' GLN . 6.3 mtp180 -53.16 -46.64 68.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.114 -0.991 . . . . 71.560000000000002 109.155 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.466 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 2.8 pt20 164.69 46.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.429 -0.795 . . . . 66.599999999999994 109.471 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.13 -60.36 0.42 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.483 -1.447 . . . . 55.490000000000002 109.483 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.55 160.74 49.98 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.296 -1.12 . . . . 44.990000000000002 109.281 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.7 Cg_endo -77.33 80.33 2.93 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.695 2.264 . . . . 44.100000000000001 110.906 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.594 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 4.7 p90 -68.68 139.0 55.4 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.254 -0.904 . . . . 32.090000000000003 109.671 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.74 80.74 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 29.25 108.664 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -104.81 164.07 12.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 24.0 110.179 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 64.1 m-20 -53.8 160.8 1.29 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 23.309999999999999 109.809 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.472 ' OE1' ' HB2' ' A' ' 16' ' ' ARG . 7.4 mt-10 -150.04 125.45 10.19 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.44 -0.948 . . . . 40.030000000000001 108.44 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.998 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -113.6 -179.18 3.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.025 -1.047 . . . . 12.390000000000001 110.36 -178.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.922 ' HB3' HD11 ' A' ' 44' ' ' LEU . 81.2 mt -137.48 147.69 45.48 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.787 -0.819 . . . . 17.420000000000002 108.787 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.96 ' SG ' HD13 ' A' ' 47' ' ' ILE . 2.8 m -151.88 -177.53 6.19 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.802 -1.185 . . . . 13.84 107.802 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.667 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 31.6 m-85 -127.91 112.46 14.72 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.074 -1.016 . . . . 21.140000000000001 109.677 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.876 HG22 ' HB ' ' A' ' 4' ' ' VAL . 60.7 t -106.89 109.9 29.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.372 -0.931 . . . . 10.66 109.749 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 2.5 p30 -57.75 -39.4 77.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.028 -1.471 . . . . 25.890000000000001 107.028 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.754 HD11 ' CA ' ' B' ' 69' ' ' LYS . 7.3 tt 62.88 -71.2 0.05 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.831 0.824 . . . . 24.239999999999998 109.056 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.705 ' N ' HD23 ' A' ' 37' ' ' LEU . . . -178.04 41.53 0.09 OUTLIER Glycine 0 C--N 1.294 -1.791 0 N-CA-C 108.54 -1.824 . . . . 31.02 108.54 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -124.37 23.81 8.17 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.33 -1.1 . . . . 43.229999999999997 110.429 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.577 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 14.6 mt-10 50.53 19.28 0.55 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.259 -0.901 . . . . 42.340000000000003 110.729 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.577 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 98.6 m-70 -160.08 154.74 20.64 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 108.278 -1.008 . . . . 6.9900000000000002 108.278 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.667 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 37.4 Cg_endo -76.36 134.24 15.42 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 121.921 1.747 . . . . 17.920000000000002 110.556 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.817 HG23 HG23 ' A' ' 45' ' ' VAL . 3.1 m -108.76 116.69 52.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 119.509 -0.877 . . . . 20.57 108.775 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.922 HD11 ' HB3' ' A' ' 32' ' ' LEU . 64.6 tp -67.62 101.79 1.07 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.462 -0.895 . . . . 20.210000000000001 109.364 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.817 HG23 HG23 ' A' ' 43' ' ' VAL . 38.6 t -103.89 166.92 2.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.63 -0.669 . . . . 10.81 109.389 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.766 ' HA ' HD23 ' A' ' 32' ' ' LEU . 24.7 ttmt -98.64 148.78 23.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.185 -0.947 . . . . 36.740000000000002 110.198 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.96 HD13 ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -128.05 163.14 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.395 -0.816 . . . . 19.739999999999998 108.971 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.401 ' N ' HG23 ' A' ' 47' ' ' ILE . 14.9 m -111.68 135.49 52.2 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.265 -0.897 . . . . 22.559999999999999 109.161 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.62 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -112.14 151.26 29.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 20.41 109.46 -179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.482 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -87.36 -174.67 4.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 33.990000000000002 109.736 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.45 104.47 15.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.352 -0.843 . . . . 54.920000000000002 109.575 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.18 -8.29 57.23 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.589 -1.404 . . . . 36.100000000000001 109.589 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.42 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -78.3 143.8 65.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.172 -1.193 . . . . 54.759999999999998 109.548 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.0 Cg_endo -79.34 110.87 2.77 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.629 2.22 . . . . 28.370000000000001 110.383 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.998 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.24 160.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 17.210000000000001 110.087 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.673 ' CE2' HG12 ' A' ' 47' ' ' ILE . 11.4 m-30 -54.57 111.05 0.72 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.398 -0.814 . . . . 17.190000000000001 109.209 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.984 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -60.67 176.22 0.38 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.285 -0.884 . . . . 17.82 109.516 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.984 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.47 114.87 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.665 2.244 . . . . 17.280000000000001 110.213 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.11 179.73 43.99 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.947 -1.261 . . . . 17.219999999999999 109.947 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.718 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -75.4 146.29 40.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -1.077 . . . . 19.57 108.256 179.132 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.697 ' CE1' HD13 ' A' ' 6' ' ' ILE . 23.0 m-85 -132.28 162.92 29.81 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.692 -1.255 . . . . 14.609999999999999 111.889 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.563 ' O ' HG22 ' A' ' 84' ' ' VAL . 59.8 p -145.41 119.71 9.58 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.65 -1.611 . . . . 18.359999999999999 106.65 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.913 ' CG1' HD12 ' A' ' 81' ' ' LEU . 11.2 t -47.53 169.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 C-N-CA 119.086 -1.045 . . . . 19.129999999999999 109.266 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.577 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.7 t-80 -134.87 122.11 21.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.953 -0.758 . . . . 20.649999999999999 108.953 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.908 HD22 ' H ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -65.92 -9.22 27.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.546 -0.721 . . . . 19.649999999999999 109.348 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -53.95 -16.82 2.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.165 -0.959 . . . . 14.720000000000001 108.886 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -104.11 -6.93 20.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 11.449999999999999 111.098 -179.306 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.605 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.1 m-30 -74.21 163.25 28.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.704 -1.248 . . . . 14.25 109.663 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.674 ' CA ' HD11 ' B' ' 37' ' ' LEU . 25.2 mtmt -149.64 174.02 13.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 32.700000000000003 109.31 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG22 HD13 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -114.86 109.83 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 15.630000000000001 109.065 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.04 -179.45 44.34 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.554 -1.419 . . . . 12.699999999999999 109.554 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.419 ' O ' ' NE2' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -88.43 39.21 0.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.254 -1.144 . . . . 26.289999999999999 109.524 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -112.23 11.72 20.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.419 -0.801 . . . . 20.440000000000001 109.261 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 46' ' ' LYS . . . 63.69 26.62 70.03 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.341 -1.504 . . . . 13.82 109.341 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -154.17 155.33 35.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.273 -1.133 . . . . 18.27 109.626 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' A' ' 76' ' ' LEU . 1.7 tp -67.18 173.55 3.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 12.43 109.536 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.439 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 2.7 mtt -159.39 101.92 1.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 35.109999999999999 109.607 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.595 ' CG2' ' N ' ' A' ' 81' ' ' LEU . 2.7 mt -41.92 -43.33 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.545 -0.722 . . . . 13.67 109.995 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.543 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER 48.69 54.24 10.97 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.341 -0.85 . . . . 24.059999999999999 108.991 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' CB ' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 82.01 80.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.023 -0.732 . . . . 35.039999999999999 109.023 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.913 HD12 ' CG1' ' A' ' 63' ' ' VAL . 1.3 pt? -58.81 154.15 15.52 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.46 0.648 . . . . 18.719999999999999 110.734 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -104.89 106.11 16.45 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.693 -1.225 . . . . 20.550000000000001 107.693 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.674 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.3 OUTLIER -81.51 144.4 31.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.071 -1.018 . . . . 14.4 111.482 -178.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 62' ' ' THR . 35.6 m -144.26 160.58 48.33 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 107.617 -1.253 . . . . 17.649999999999999 107.617 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.8 Cg_endo -62.17 147.81 94.35 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.099 1.866 . . . . 25.699999999999999 110.658 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -77.75 124.12 27.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.303 -0.873 . . . . 49.289999999999999 109.547 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.03 -0.986 . . . . 58.909999999999997 109.502 179.92 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.518 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.374 -0.602 . . . . 64.909999999999997 109.374 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.908 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.7 mt 57.8 77.9 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 107.763 -1.199 . . . . 33.799999999999997 107.763 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -73.15 157.35 37.39 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.435 -0.791 . . . . 32.719999999999999 110.737 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.869 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -164.94 159.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.082 -0.71 . . . . 14.460000000000001 109.082 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 5.1 mt-10 -136.24 113.55 10.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.534 -0.729 . . . . 22.120000000000001 109.384 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.696 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -72.26 107.45 3.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.918 -1.142 . . . . 14.23 107.918 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.617 ' HD3' ' CD1' ' B' ' 34' ' ' TYR . 4.4 mptt -50.29 172.66 0.11 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.148 -0.97 . . . . 25.43 109.959 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -75.98 -29.53 6.66 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.618 2.212 . . . . 13.609999999999999 109.925 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.5 m -92.65 7.1 44.88 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.031 -0.729 . . . . 15.52 109.031 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.0 mm-40 -123.61 29.25 6.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.306 -0.871 . . . . 17.309999999999999 109.685 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.13 16.15 17.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.994 . . . . 24.780000000000001 110.057 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.573 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 18.4 mt-30 -141.78 145.22 34.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 47.899999999999999 109.954 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.761 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 42.4 p90 -96.05 153.64 17.67 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.378 -0.826 . . . . 21.609999999999999 109.451 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 38.5 p -121.55 168.72 11.42 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.437 -0.79 . . . . 14.890000000000001 109.274 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.54 113.47 26.86 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.447 -0.783 . . . . 17.350000000000001 109.101 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.476 ' HB2' ' OE1' ' B' ' 30' ' ' GLU . 24.7 mtt180 -141.44 154.94 45.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.256 -0.903 . . . . 34.380000000000003 109.539 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.423 ' C ' ' O ' ' B' ' 16' ' ' ARG . 27.0 p -42.6 133.54 3.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.46 -0.775 . . . . 38.770000000000003 109.735 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -131.88 157.9 22.62 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.32 -1.512 . . . . 34.579999999999998 109.32 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.459 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -135.34 117.89 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.111 -1.229 . . . . 41.869999999999997 109.43 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.451 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 7.4 p -63.99 -146.31 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.316 -0.865 . . . . 47.210000000000001 109.16 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.481 ' O ' ' CB ' ' B' ' 22' ' ' GLN . 6.5 mtp180 -53.28 -46.73 69.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.119 -0.988 . . . . 71.560000000000002 109.199 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.481 ' CB ' ' O ' ' B' ' 21' ' ' ARG . 2.8 pt20 164.82 46.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.442 -0.786 . . . . 66.599999999999994 109.478 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -113.11 -60.38 0.42 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.464 -1.454 . . . . 55.490000000000002 109.464 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -143.48 160.58 50.76 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.222 -1.164 . . . . 44.990000000000002 109.323 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.7 Cg_endo -77.25 80.53 2.87 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.707 2.271 . . . . 44.100000000000001 110.864 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.597 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 4.9 p90 -68.74 138.93 55.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.232 -0.918 . . . . 32.090000000000003 109.689 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.61 80.68 1.82 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.968 . . . . 29.25 108.656 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.586 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -104.75 164.06 12.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.237 -0.915 . . . . 24.0 110.167 -179.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 63.2 m-20 -53.69 160.81 1.24 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.459 -0.776 . . . . 23.309999999999999 109.798 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.476 ' OE1' ' HB2' ' B' ' 16' ' ' ARG . 7.6 mt-10 -150.16 125.17 9.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.431 -0.951 . . . . 40.030000000000001 108.431 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.955 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -113.4 -179.14 3.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.159 -0.963 . . . . 12.390000000000001 110.382 -178.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.93 ' HB3' HD11 ' B' ' 44' ' ' LEU . 81.2 mt -137.45 147.88 45.67 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.841 -0.8 . . . . 17.420000000000002 108.841 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.946 ' SG ' HD13 ' B' ' 47' ' ' ILE . 2.9 m -152.08 -177.63 6.28 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.769 -1.197 . . . . 13.84 107.769 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.668 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 31.6 m-85 -127.85 112.4 14.68 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.065 -1.022 . . . . 21.140000000000001 109.678 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.869 HG22 ' HB ' ' B' ' 4' ' ' VAL . 61.2 t -106.89 110.17 30.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.349 -0.94 . . . . 10.66 109.688 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' B' ' 38' ' ' GLY . 2.4 p30 -57.91 -39.33 77.68 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.997 -1.483 . . . . 25.890000000000001 106.997 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.721 HD23 ' N ' ' B' ' 38' ' ' GLY . 7.4 tt 62.87 -70.66 0.06 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.844 0.831 . . . . 24.239999999999998 109.046 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.721 ' N ' HD23 ' B' ' 37' ' ' LEU . . . -178.47 41.28 0.09 OUTLIER Glycine 0 C--N 1.293 -1.813 0 N-CA-C 108.554 -1.818 . . . . 31.02 108.554 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -124.17 23.72 8.33 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.281 -1.129 . . . . 43.229999999999997 110.474 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.57 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 14.1 mt-10 50.82 19.15 0.58 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.247 -0.908 . . . . 42.340000000000003 110.703 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 98.6 m-70 -160.06 154.89 20.92 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 108.274 -1.01 . . . . 6.9900000000000002 108.274 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.668 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 37.5 Cg_endo -76.51 134.47 15.4 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.88 1.72 . . . . 17.920000000000002 110.521 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.804 HG23 HG23 ' B' ' 45' ' ' VAL . 3.1 m -109.09 116.59 52.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 C-N-CA 119.424 -0.91 . . . . 20.57 108.808 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.93 HD11 ' HB3' ' B' ' 32' ' ' LEU . 65.4 tp -67.48 101.83 1.04 Allowed 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.457 -0.897 . . . . 20.210000000000001 109.358 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.804 HG23 HG23 ' B' ' 43' ' ' VAL . 38.0 t -103.92 167.01 2.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.602 -0.686 . . . . 10.81 109.369 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.756 ' HA ' HD23 ' B' ' 32' ' ' LEU . 24.4 ttmt -98.79 148.23 24.1 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.198 -0.939 . . . . 36.740000000000002 110.165 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.946 HD13 ' SG ' ' B' ' 33' ' ' CYS . 0.0 OUTLIER -127.47 163.09 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.383 -0.823 . . . . 19.739999999999998 108.95 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.4 ' N ' HG23 ' B' ' 47' ' ' ILE . 15.3 m -111.6 135.57 52.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.274 -0.891 . . . . 22.559999999999999 109.101 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.617 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -112.2 151.42 29.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -0.962 . . . . 20.41 109.373 -179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.484 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.3 OUTLIER -87.48 -174.69 4.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.909 . . . . 33.990000000000002 109.751 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.53 104.46 16.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 54.920000000000002 109.528 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.19 -8.09 57.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.612 -1.395 . . . . 36.100000000000001 109.612 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.434 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.3 OUTLIER -78.63 143.72 63.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 54.759999999999998 109.567 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.7 Cg_endo -79.25 111.04 2.82 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.616 2.211 . . . . 28.370000000000001 110.432 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.955 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.35 160.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 17.210000000000001 110.031 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.66 ' CE2' HG12 ' B' ' 47' ' ' ILE . 11.7 m-30 -54.87 110.78 0.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.369 -0.832 . . . . 17.190000000000001 109.286 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.932 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -59.96 176.25 0.34 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.326 -0.859 . . . . 17.82 109.494 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.932 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 36.0 Cg_endo -78.79 115.83 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.713 2.276 . . . . 17.280000000000001 110.439 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.8 -179.79 43.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.833 -1.307 . . . . 17.219999999999999 109.833 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.718 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -75.37 146.55 40.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -1.103 . . . . 19.57 108.467 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.696 ' CE1' HD13 ' B' ' 6' ' ' ILE . 22.8 m-85 -132.49 162.99 29.81 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.759 -1.213 . . . . 14.609999999999999 111.92 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.566 ' O ' HG22 ' B' ' 84' ' ' VAL . 59.9 p -145.44 119.85 9.65 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.691 -1.596 . . . . 18.359999999999999 106.691 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.926 ' CG1' HD12 ' B' ' 81' ' ' LEU . 11.5 t -47.78 169.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.1 -1.04 . . . . 19.129999999999999 109.267 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.58 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.7 t-80 -134.77 122.06 21.58 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.943 -0.762 . . . . 20.649999999999999 108.943 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.955 HD22 ' H ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -65.85 -9.28 27.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.444 -0.785 . . . . 19.649999999999999 109.254 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 86.4 p -53.85 -16.82 1.97 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.13 -0.981 . . . . 14.720000000000001 108.919 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.528 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -104.33 -7.09 20.22 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 11.449999999999999 111.13 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.0 m-30 -74.25 162.57 28.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.651 -1.281 . . . . 14.25 109.54 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.754 ' CA ' HD11 ' A' ' 37' ' ' LEU . 25.2 mtmt -148.5 173.99 12.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.809 . . . . 32.700000000000003 109.38 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.536 HG22 HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -114.6 109.86 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.875 . . . . 15.630000000000001 109.029 179.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.17 -179.45 44.15 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.587 -1.405 . . . . 12.699999999999999 109.587 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.443 ' O ' ' NE2' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -88.44 39.23 0.9 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.17 -1.194 . . . . 26.289999999999999 109.42 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -112.13 11.64 20.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 20.440000000000001 109.251 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 46' ' ' LYS . . . 63.55 27.28 70.68 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.333 -1.507 . . . . 13.82 109.333 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -154.96 155.54 34.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -1.141 . . . . 18.27 109.545 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.515 ' CD2' HG21 ' A' ' 2' ' ' ILE . 1.7 tp -67.34 173.59 3.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 12.43 109.553 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.431 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 2.8 mtt -159.53 101.69 1.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 35.109999999999999 109.551 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.595 ' CG2' ' N ' ' B' ' 81' ' ' LEU . 2.7 mt -41.88 -43.07 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.546 -0.721 . . . . 13.67 110.037 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.4 OUTLIER 48.66 54.32 10.8 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.307 -0.871 . . . . 24.059999999999999 108.985 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.546 ' CB ' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 82.18 80.32 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.065 -0.717 . . . . 35.039999999999999 109.065 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.926 HD12 ' CG1' ' B' ' 63' ' ' VAL . 1.3 pt? -58.69 154.03 15.4 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.472 0.653 . . . . 18.719999999999999 110.757 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.561 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -104.87 106.18 16.55 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.636 -1.246 . . . . 20.550000000000001 107.636 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.3 OUTLIER -81.5 144.45 31.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.017 -1.052 . . . . 14.4 111.475 -178.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.566 HG22 ' O ' ' B' ' 62' ' ' THR . 35.5 m -144.41 160.47 48.21 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 107.518 -1.289 . . . . 17.649999999999999 107.518 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.3 Cg_endo -62.17 148.02 93.98 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.07 1.847 . . . . 25.699999999999999 110.657 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -77.84 124.24 27.74 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.243 -0.91 . . . . 49.289999999999999 109.511 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.026 -0.988 . . . . 58.909999999999997 109.527 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.784 ' SD ' HG21 ' A' ' 62' ' ' THR . 30.9 ttp . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.495 -0.557 . . . . 64.909999999999997 109.495 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.842 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.8 mt -65.23 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.582 -1.266 . . . . 33.799999999999997 107.582 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -67.01 155.36 38.85 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.964 0.887 . . . . 32.719999999999999 111.461 -177.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.986 HG11 HD21 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -163.37 168.89 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.14 -1.059 . . . . 14.460000000000001 108.14 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.0 OUTLIER -146.28 107.54 4.21 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.105 -0.997 . . . . 22.120000000000001 109.275 -178.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.612 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -66.2 103.92 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.696 -1.224 . . . . 14.23 107.696 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.582 ' HE2' ' CE2' ' A' ' 34' ' ' TYR . 8.2 mmmt -43.61 162.26 0.19 Allowed Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.159 -0.963 . . . . 25.43 109.489 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.42 -11.96 26.93 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.945 1.763 . . . . 13.609999999999999 109.155 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.3 t -102.14 7.73 40.9 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.735 -0.839 . . . . 15.52 108.735 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.524 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 9.4 mm-40 -126.71 37.23 4.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.889 . . . . 17.309999999999999 109.247 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.64 15.95 23.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.118 -0.989 . . . . 24.780000000000001 110.165 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -136.62 143.73 43.7 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.116 -0.99 . . . . 47.899999999999999 108.81 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 31.6 p90 -94.0 162.63 13.81 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.121 -0.987 . . . . 21.609999999999999 109.116 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -143.71 147.17 33.85 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.256 -0.902 . . . . 14.890000000000001 109.407 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.26 110.82 22.12 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.348 -0.845 . . . . 17.350000000000001 109.078 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.8 90.85 0.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.194 -0.941 . . . . 34.380000000000003 109.715 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.07 161.85 0.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 38.770000000000003 109.861 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 26' ' ' TYR . . . 170.01 148.9 6.09 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.855 -1.698 . . . . 34.579999999999998 108.855 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.454 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -133.53 126.32 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.031 -1.276 . . . . 41.869999999999997 109.214 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 4.2 p -68.03 -32.1 72.23 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.204 -0.935 . . . . 47.210000000000001 108.759 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' O ' ' CG ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER 170.89 -60.19 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 109.051 -0.722 . . . . 71.560000000000002 109.051 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.542 ' CG ' ' O ' ' A' ' 21' ' ' ARG . 39.6 mt-30 -162.27 31.43 0.11 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.545 -0.722 . . . . 66.599999999999994 109.733 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -110.68 -57.11 0.5 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.548 -1.421 . . . . 55.490000000000002 109.548 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.526 ' CG ' ' O ' ' A' ' 23' ' ' GLY . 24.2 mttt -159.26 156.68 26.34 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.352 -1.087 . . . . 44.990000000000002 109.168 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.0 Cg_endo -76.83 73.87 5.15 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.559 2.173 . . . . 44.100000000000001 110.494 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.584 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 2.5 p90 -62.36 137.21 58.22 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.43 -0.793 . . . . 32.090000000000003 109.844 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.5 80.71 1.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 29.25 108.813 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -110.53 161.97 15.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.182 -0.949 . . . . 24.0 110.336 -179.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.63 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 95.9 m-20 -50.27 115.84 1.61 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.522 -0.736 . . . . 23.309999999999999 109.93 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -115.52 150.23 36.89 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.189 -0.944 . . . . 40.030000000000001 109.019 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.568 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -125.81 -171.45 2.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.04 -1.037 . . . . 12.390000000000001 109.86 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.925 ' HB3' HD11 ' A' ' 44' ' ' LEU . 30.1 mt -128.12 176.96 7.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.482 -0.761 . . . . 17.420000000000002 109.396 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -171.39 158.02 5.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.143 -0.973 . . . . 13.84 108.438 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.745 ' HE1' HD13 ' A' ' 44' ' ' LEU . 2.9 m-30 -113.99 102.64 10.38 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.078 -1.014 . . . . 21.140000000000001 108.542 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.976 ' O ' HG22 ' A' ' 43' ' ' VAL . 38.5 t -102.41 106.74 20.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.094 -1.004 . . . . 10.66 110.273 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -61.41 -39.01 89.16 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.259 -1.386 . . . . 25.890000000000001 107.259 178.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.861 HD23 ' N ' ' A' ' 38' ' ' GLY . 6.9 tt 63.18 -69.36 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.675 0.75 . . . . 24.239999999999998 109.381 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.861 ' N ' HD23 ' A' ' 37' ' ' LEU . . . -178.49 42.94 0.09 OUTLIER Glycine 0 C--N 1.296 -1.674 0 N-CA-C 108.803 -1.719 . . . . 31.02 108.803 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -124.83 27.66 6.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.284 -1.127 . . . . 43.229999999999997 110.205 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.583 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 1.9 mm-40 48.67 21.2 0.39 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.17 -0.957 . . . . 42.340000000000003 110.239 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 59.4 m80 -164.57 151.39 9.72 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.196 -1.038 . . . . 6.5700000000000003 108.196 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.2 Cg_endo -76.48 144.06 25.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.08 1.853 . . . . 17.920000000000002 110.955 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.976 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.0 m -117.92 118.89 59.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.476 -0.89 . . . . 20.57 109.14 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.925 HD11 ' HB3' ' A' ' 32' ' ' LEU . 23.5 tp -68.69 110.49 4.31 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.944 -0.702 . . . . 20.210000000000001 109.155 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.567 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 16.3 t -117.02 167.38 10.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.513 -0.742 . . . . 10.81 109.497 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.567 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -90.74 162.3 14.94 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.659 -0.817 . . . . 36.740000000000002 110.216 -179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.054 HD13 HD12 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -152.12 161.44 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.759 -0.83 . . . . 19.739999999999998 108.759 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.67 151.83 20.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.0 -1.062 . . . . 22.559999999999999 109.762 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.716 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.7 tm? -134.22 93.62 3.1 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.434 -0.791 . . . . 20.41 108.991 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.721 ' HB3' HD22 ' A' ' 28' ' ' LEU . 2.2 p30 -154.59 174.94 14.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.934 -1.104 . . . . 33.990000000000002 110.117 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' GLN . 10.4 tt0 73.21 72.91 0.13 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.501 -0.749 . . . . 54.920000000000002 109.807 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 51' ' ' GLU . . . 36.45 30.06 0.03 OUTLIER Glycine 0 N--CA 1.497 2.756 0 N-CA-C 110.236 -1.146 . . . . 36.100000000000001 110.236 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.645 ' O ' HD21 ' A' ' 49' ' ' LEU . 2.4 mt-30 -107.31 131.0 22.04 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.07 -1.253 . . . . 54.759999999999998 110.061 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ALA . 36.3 Cg_endo -80.1 142.1 15.13 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.463 2.108 . . . . 28.370000000000001 110.004 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.701 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -41.61 141.45 0.77 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 17.210000000000001 110.015 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 84.5 m-85 -47.2 98.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 17.190000000000001 109.146 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -49.42 175.36 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 17.82 109.743 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -77.89 118.32 4.42 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.73 2.286 . . . . 17.280000000000001 110.369 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.87 171.4 34.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.473 -1.451 . . . . 17.219999999999999 109.473 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.2 mp -72.08 147.6 46.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.198 -1.177 . . . . 19.57 108.924 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.912 ' HB3' HD22 ' A' ' 83' ' ' LEU . 30.7 m-85 -132.04 163.24 28.87 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 122.579 1.181 . . . . 14.609999999999999 111.424 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.867 ' O ' HG22 ' A' ' 84' ' ' VAL . 20.6 p -142.17 119.35 11.43 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.616 -1.994 . . . . 18.359999999999999 105.616 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.64 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.5 t -52.42 167.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 C-N-CA 118.615 -1.234 . . . . 19.129999999999999 109.198 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.498 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.1 t-80 -129.61 128.75 43.3 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.546 -0.721 . . . . 20.649999999999999 109.123 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.855 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -70.88 -0.94 10.23 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.401 -0.812 . . . . 19.649999999999999 109.679 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 p -56.6 -19.18 14.77 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.541 -1.281 . . . . 14.720000000000001 107.541 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 39.6 m -97.02 -6.97 34.1 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.831 -0.543 . . . . 11.449999999999999 110.05 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.817 ' C ' HD11 ' B' ' 37' ' ' LEU . 3.3 m-30 -79.7 157.29 27.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 14.25 109.689 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -140.15 169.9 16.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.365 -0.834 . . . . 32.700000000000003 109.488 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.778 HG21 HG21 ' B' ' 43' ' ' VAL . 2.2 t -110.08 139.52 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.912 . . . . 15.630000000000001 109.425 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.57 -157.55 23.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.341 -1.504 . . . . 12.699999999999999 109.341 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 0.0 OUTLIER 63.03 78.34 0.3 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.159 -1.2 . . . . 26.289999999999999 109.122 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.5 OUTLIER 69.48 9.39 7.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.433 -0.792 . . . . 20.440000000000001 109.472 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' O ' HG13 ' B' ' 45' ' ' VAL . . . 80.24 46.03 7.79 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.608 -1.397 . . . . 13.82 109.608 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.412 ' HA ' HG13 ' B' ' 45' ' ' VAL . 1.5 t -146.51 140.15 25.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.189 -1.183 . . . . 18.27 109.577 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 77' ' ' MET . 1.4 tp -55.74 156.17 5.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 12.43 109.338 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 15.2 mtt -164.25 130.33 2.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.924 . . . . 35.109999999999999 109.64 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.908 HD12 HD12 ' B' ' 78' ' ' ILE . 2.5 mp -63.72 138.49 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 13.67 109.77 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.62 -23.62 12.39 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.379 -0.971 . . . . 24.059999999999999 108.379 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 67' ' ' SER . 1.0 OUTLIER 178.44 68.04 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.03 -1.47 . . . . 35.039999999999999 107.03 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -29.05 119.68 0.13 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.274 -0.875 . . . . 18.719999999999999 111.685 -177.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.475 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -88.6 100.44 13.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 20.550000000000001 108.783 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.054 HD12 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -69.75 141.06 53.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 14.4 110.638 -179.153 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 62' ' ' THR . 27.8 m -143.22 153.5 59.83 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.71 -1.219 . . . . 17.649999999999999 107.71 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.2 Cg_endo -61.44 141.77 93.23 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 C-N-CA 121.945 1.763 . . . . 25.699999999999999 110.317 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.596 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -77.95 117.78 19.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.266 -0.896 . . . . 49.289999999999999 109.682 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.993 -1.003 . . . . 58.909999999999997 109.455 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.788 ' SD ' HG21 ' B' ' 62' ' ' THR . 31.1 ttp . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.519 -0.548 . . . . 64.909999999999997 109.519 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.855 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.8 mt -65.28 81.85 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 107.572 -1.27 . . . . 33.799999999999997 107.572 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -67.2 155.32 39.1 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.981 0.895 . . . . 32.719999999999999 111.43 -177.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.978 HG11 HD21 ' B' ' 83' ' ' LEU . 0.1 OUTLIER -163.34 168.92 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.133 -1.062 . . . . 14.460000000000001 108.133 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.554 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 1.0 OUTLIER -146.3 107.55 4.21 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.104 -0.997 . . . . 22.120000000000001 109.258 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.606 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -66.22 104.02 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.718 -1.216 . . . . 14.23 107.718 179.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.586 ' HE2' ' CE2' ' B' ' 34' ' ' TYR . 8.2 mmmt -43.68 162.26 0.19 Allowed Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.147 -0.971 . . . . 25.43 109.479 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.7 Cg_endo -72.38 -12.08 27.1 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.984 1.789 . . . . 13.609999999999999 109.115 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 44.6 t -102.03 7.58 41.18 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.753 -0.832 . . . . 15.52 108.753 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.515 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 9.4 mm-40 -126.5 37.32 4.33 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.288 -0.882 . . . . 17.309999999999999 109.254 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.75 15.8 24.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 24.780000000000001 110.168 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.39 143.79 44.19 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.074 -1.016 . . . . 47.899999999999999 108.82 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.702 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 31.6 p90 -94.03 162.6 13.82 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.1 -1.0 . . . . 21.609999999999999 109.098 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -143.61 147.33 34.2 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.288 -0.883 . . . . 14.890000000000001 109.362 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.48 110.82 22.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.367 -0.833 . . . . 17.350000000000001 109.08 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.78 90.9 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 34.380000000000003 109.679 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.0 161.8 0.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.843 . . . . 38.770000000000003 109.851 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.549 ' CA ' ' O ' ' B' ' 26' ' ' TYR . . . 170.04 148.82 6.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.765 -1.734 . . . . 34.579999999999998 108.765 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.447 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.0 OUTLIER -133.43 126.39 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.048 -1.266 . . . . 41.869999999999997 109.181 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' B' ' 21' ' ' ARG . 4.2 p -68.15 -31.87 71.74 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.189 -0.944 . . . . 47.210000000000001 108.819 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.554 ' O ' ' CG ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER 170.79 -60.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.064 -0.717 . . . . 71.560000000000002 109.064 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.554 ' CG ' ' O ' ' B' ' 21' ' ' ARG . 39.7 mt-30 -162.35 31.39 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 66.599999999999994 109.763 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' B' ' 24' ' ' LYS . . . -110.63 -57.17 0.5 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.567 -1.413 . . . . 55.490000000000002 109.567 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' B' ' 23' ' ' GLY . 24.5 mttt -159.25 156.68 26.37 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.292 -1.123 . . . . 44.990000000000002 109.146 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.1 Cg_endo -76.8 73.84 5.15 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.535 2.157 . . . . 44.100000000000001 110.51 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 2.5 p90 -62.36 137.2 58.21 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.452 -0.78 . . . . 32.090000000000003 109.838 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.53 80.84 1.61 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.107 -0.996 . . . . 29.25 108.778 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.714 HD22 ' HB3' ' B' ' 50' ' ' ASP . 0.1 OUTLIER -110.61 161.98 15.18 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 24.0 110.312 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.622 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 95.8 m-20 -50.31 115.95 1.67 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.49 -0.756 . . . . 23.309999999999999 109.854 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -115.6 150.34 36.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.158 -0.964 . . . . 40.030000000000001 108.98 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.578 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.0 OUTLIER -125.92 -171.55 2.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.013 -1.055 . . . . 12.390000000000001 109.836 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.893 ' HB3' HD11 ' B' ' 44' ' ' LEU . 30.0 mt -128.06 176.93 7.25 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.461 -0.774 . . . . 17.420000000000002 109.442 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -171.31 158.09 5.23 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.093 -1.004 . . . . 13.84 108.487 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.761 ' HE1' HD13 ' B' ' 44' ' ' LEU . 2.9 m-30 -114.06 102.53 10.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.148 -0.97 . . . . 21.140000000000001 108.592 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.962 ' O ' HG22 ' B' ' 43' ' ' VAL . 38.4 t -102.34 106.67 20.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 C-N-CA 119.147 -1.021 . . . . 10.66 110.309 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 0.9 OUTLIER -61.17 -39.1 88.86 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.307 -1.368 . . . . 25.890000000000001 107.307 178.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.853 HD23 ' N ' ' B' ' 38' ' ' GLY . 6.9 tt 63.33 -69.39 0.07 Allowed 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.695 0.76 . . . . 24.239999999999998 109.313 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.853 ' N ' HD23 ' B' ' 37' ' ' LEU . . . -178.52 42.97 0.09 OUTLIER Glycine 0 C--N 1.295 -1.742 0 N-CA-C 108.773 -1.731 . . . . 31.02 108.773 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -124.85 27.65 6.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.246 -1.149 . . . . 43.229999999999997 110.234 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.574 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 1.9 mm-40 48.7 21.16 0.39 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.23 -0.919 . . . . 42.340000000000003 110.25 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 59.4 m80 -164.57 151.3 9.66 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 108.2 -1.037 . . . . 6.5599999999999996 108.2 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.638 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.6 Cg_endo -76.33 143.98 25.56 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.137 1.891 . . . . 17.920000000000002 111.011 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.962 HG22 ' O ' ' B' ' 35' ' ' VAL . 5.0 m -117.87 118.8 59.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.451 -0.9 . . . . 20.57 109.098 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.893 HD11 ' HB3' ' B' ' 32' ' ' LEU . 23.4 tp -68.67 110.55 4.33 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.898 -0.721 . . . . 20.210000000000001 109.218 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.575 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 16.8 t -116.95 167.42 10.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.511 -0.743 . . . . 10.81 109.529 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -90.75 162.24 14.97 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.674 -0.81 . . . . 36.740000000000002 110.206 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 1.037 HD13 HD12 ' B' ' 83' ' ' LEU . 0.5 OUTLIER -152.06 161.5 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.706 -0.85 . . . . 19.739999999999998 108.706 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.71 151.69 20.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.969 -1.082 . . . . 22.559999999999999 109.787 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.717 HD13 ' O ' ' B' ' 49' ' ' LEU . 2.7 tm? -134.05 93.58 3.12 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.373 -0.829 . . . . 20.41 109.003 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.714 ' HB3' HD22 ' B' ' 28' ' ' LEU . 2.2 p30 -154.63 174.74 14.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.956 -1.09 . . . . 33.990000000000002 110.152 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' B' ' 53' ' ' GLN . 10.4 tt0 73.25 73.05 0.13 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 54.920000000000002 109.814 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' B' ' 51' ' ' GLU . . . 36.37 30.02 0.03 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.273 -1.131 . . . . 36.100000000000001 110.273 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.651 ' O ' HD21 ' B' ' 49' ' ' LEU . 2.4 mt-30 -107.2 130.84 22.27 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.094 -1.239 . . . . 54.759999999999998 110.084 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 36.2 Cg_endo -79.95 141.97 15.33 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.525 2.15 . . . . 28.370000000000001 109.986 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.702 ' HB2' ' CD2' ' B' ' 13' ' ' PHE . . . -41.46 141.39 0.74 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 17.210000000000001 110.031 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 83.5 m-85 -47.03 97.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.327 -0.858 . . . . 17.190000000000001 109.11 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.948 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -49.15 175.46 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 17.82 109.804 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.948 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.1 Cg_endo -77.85 117.59 4.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.651 2.234 . . . . 17.280000000000001 110.176 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.35 171.11 35.45 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.542 -1.423 . . . . 17.219999999999999 109.542 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.0 mp -72.3 147.14 46.65 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.172 -1.193 . . . . 19.57 108.711 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.93 ' HB3' HD22 ' B' ' 83' ' ' LEU . 30.6 m-85 -131.65 163.11 28.83 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 122.564 1.173 . . . . 14.609999999999999 111.446 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.85 ' O ' HG22 ' B' ' 84' ' ' VAL . 20.7 p -142.01 119.28 11.47 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 105.627 -1.99 . . . . 18.359999999999999 105.627 177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.5 t -52.54 166.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 C-N-CA 118.559 -1.256 . . . . 19.129999999999999 109.208 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.488 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.1 t-80 -129.32 128.66 43.61 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.568 -0.707 . . . . 20.649999999999999 109.228 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.842 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -70.69 -1.04 10.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.457 -0.777 . . . . 19.649999999999999 109.71 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 p -56.59 -19.23 14.98 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.541 -1.281 . . . . 14.720000000000001 107.541 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 38.2 m -96.9 -7.38 33.47 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.853 -0.529 . . . . 11.449999999999999 110.131 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.822 ' C ' HD11 ' A' ' 37' ' ' LEU . 3.2 m-30 -79.32 157.06 27.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.065 -1.022 . . . . 14.25 109.642 -179.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' B' ' 77' ' ' MET . 0.0 OUTLIER -139.96 169.68 17.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 32.700000000000003 109.484 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.751 HG21 HG21 ' A' ' 43' ' ' VAL . 2.2 t -109.88 139.57 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 15.630000000000001 109.42 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' B' ' 75' ' ' SER . . . 136.59 -157.63 23.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.261 -1.536 . . . . 12.699999999999999 109.261 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.0 OUTLIER 63.08 78.32 0.3 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.188 -1.183 . . . . 26.289999999999999 109.108 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.5 OUTLIER 69.51 9.4 7.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.455 -0.778 . . . . 20.440000000000001 109.401 -179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 80.26 45.78 7.93 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.639 -1.384 . . . . 13.82 109.639 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.414 ' HA ' HG13 ' A' ' 45' ' ' VAL . 1.5 t -146.24 140.11 26.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -1.163 . . . . 18.27 109.603 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.525 ' O ' ' CG ' ' B' ' 77' ' ' MET . 1.4 tp -55.69 156.23 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 12.43 109.338 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.525 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 15.2 mtt -164.33 130.53 2.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 35.109999999999999 109.618 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.908 HD12 HD12 ' A' ' 78' ' ' ILE . 2.5 mp -63.97 138.57 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.333 -0.854 . . . . 13.67 109.841 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.6 -23.76 12.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.334 -0.988 . . . . 24.059999999999999 108.334 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.9 OUTLIER 178.55 68.07 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.062 -1.459 . . . . 35.039999999999999 107.062 179.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.659 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.7 OUTLIER -29.15 119.66 0.13 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.297 -0.865 . . . . 18.719999999999999 111.659 -177.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -88.52 100.25 12.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.348 -0.845 . . . . 20.550000000000001 108.849 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.037 HD12 HD13 ' B' ' 47' ' ' ILE . 0.9 OUTLIER -69.74 140.93 53.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 14.4 110.626 -179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.85 HG22 ' O ' ' B' ' 62' ' ' THR . 27.3 m -143.08 153.33 60.08 Favored Pre-proline 0 C--N 1.3 -1.574 0 N-CA-C 107.756 -1.201 . . . . 17.649999999999999 107.756 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.583 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.3 Cg_endo -61.23 141.7 94.05 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 121.911 1.741 . . . . 25.699999999999999 110.39 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.584 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -77.89 117.81 19.6 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.335 -0.853 . . . . 49.289999999999999 109.687 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.04 -0.981 . . . . 58.909999999999997 109.417 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.513 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.274 0.559 . . . . 64.909999999999997 109.496 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.757 ' CA ' HD22 ' B' ' 65' ' ' LEU . 3.3 mt 70.12 78.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 107.459 -1.312 . . . . 33.799999999999997 107.459 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.521 ' C ' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -62.01 159.7 13.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.96 0.886 . . . . 32.719999999999999 111.666 -177.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.084 ' CG2' HG22 ' A' ' 35' ' ' VAL . 82.4 t -160.68 168.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.985 -0.746 . . . . 14.460000000000001 108.985 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.597 ' N ' HG12 ' A' ' 4' ' ' VAL . 30.9 mt-10 -153.29 99.7 2.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 22.120000000000001 109.463 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.995 HG21 ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -70.32 102.77 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 107.822 -1.177 . . . . 14.23 107.822 179.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 3.5 mmpt? -57.64 163.59 3.68 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 25.43 109.308 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.5 -11.94 26.75 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 121.98 1.787 . . . . 13.609999999999999 109.206 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -102.69 13.3 34.78 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.301 -1.0 . . . . 15.52 108.301 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.537 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 5.6 mm-40 -142.86 36.33 1.42 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.452 -0.78 . . . . 17.309999999999999 109.41 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -112.78 35.3 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.092 -1.005 . . . . 24.780000000000001 110.234 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -140.74 125.19 17.73 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.169 -0.957 . . . . 47.899999999999999 109.67 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.643 ' CD2' ' HG ' ' A' ' 49' ' ' LEU . 40.4 p90 -89.74 156.66 18.38 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.293 -0.879 . . . . 21.609999999999999 109.82 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -131.5 161.85 31.6 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.326 -0.99 . . . . 14.890000000000001 108.326 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.54 HG22 ' HB3' ' A' ' 27' ' ' SER . 0.2 OUTLIER -78.61 109.38 12.76 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.093 -1.004 . . . . 17.350000000000001 109.095 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -120.09 148.3 43.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.277 -0.89 . . . . 34.380000000000003 109.455 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 t -51.65 153.05 2.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -0.861 . . . . 38.770000000000003 109.505 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -155.45 -179.9 30.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.271 -1.531 . . . . 34.579999999999998 109.271 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER -153.67 117.77 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -1.229 . . . . 41.869999999999997 109.2 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 22' ' ' GLN . 54.3 p -57.17 83.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.344 -0.847 . . . . 47.210000000000001 109.812 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER 67.79 -59.82 0.41 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.163 -0.96 . . . . 71.560000000000002 109.728 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 20' ' ' SER . 11.9 pt20 170.97 47.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 66.599999999999994 109.604 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.32 -55.59 0.1 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.408 -1.477 . . . . 55.490000000000002 109.408 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -135.78 150.72 72.54 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.368 -1.078 . . . . 44.990000000000002 109.259 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 35.1 Cg_endo -77.9 131.48 11.14 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.615 2.21 . . . . 44.100000000000001 110.638 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.584 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 5.5 p90 -133.09 143.28 49.21 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.2 -0.938 . . . . 32.090000000000003 109.749 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.54 ' HB3' HG22 ' A' ' 15' ' ' THR . 0.2 OUTLIER -102.93 81.09 1.95 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -0.888 . . . . 29.25 108.846 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -93.1 134.66 35.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.326 -0.858 . . . . 24.0 110.29 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -45.77 133.97 7.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.54 -0.725 . . . . 23.309999999999999 110.082 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 35.5 mt-10 -128.53 151.69 49.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.384 -0.822 . . . . 40.030000000000001 108.816 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.927 ' OE1' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -135.62 -170.43 2.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.978 -1.076 . . . . 12.390000000000001 110.294 -179.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.836 ' HB3' HD11 ' A' ' 44' ' ' LEU . 11.0 mt -126.65 173.2 9.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.733 -0.84 . . . . 17.420000000000002 108.733 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.546 ' SG ' HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -167.95 160.68 12.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.792 -1.192 . . . . 13.84 108.162 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.69 ' CE1' HD13 ' A' ' 44' ' ' LEU . 3.2 m-85 -107.59 92.17 3.96 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.136 -0.978 . . . . 21.140000000000001 109.478 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.084 HG22 ' CG2' ' A' ' 4' ' ' VAL . 37.5 t -94.59 121.74 45.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.281 -0.887 . . . . 10.66 110.17 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.746 ' C ' HD23 ' A' ' 37' ' ' LEU . 1.9 m-20 -73.35 -36.62 66.17 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.212 -1.033 . . . . 25.890000000000001 108.212 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.746 HD23 ' C ' ' A' ' 36' ' ' ASP . 1.0 OUTLIER 39.19 28.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.779 -0.575 . . . . 24.239999999999998 110.073 179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 67.75 25.98 73.94 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.782 -1.327 . . . . 31.02 109.782 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 36' ' ' ASP . 1.1 t-20 -96.21 15.4 21.06 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.192 -1.181 . . . . 43.229999999999997 110.655 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 41' ' ' HIS . 1.7 mt-10 68.5 94.03 0.07 Allowed 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.023 -1.048 . . . . 42.340000000000003 108.601 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.626 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 10.6 m80 86.57 167.94 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.875 0 N-CA-C 108.646 -0.872 . . . . 5.0999999999999996 108.646 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 41' ' ' HIS . 34.0 Cg_endo -77.71 150.26 27.34 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 122.09 1.86 . . . . 17.920000000000002 111.204 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.863 HG22 ' O ' ' A' ' 35' ' ' VAL . 2.2 m -122.48 120.44 61.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.368 -0.833 . . . . 20.57 109.171 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' A' ' 32' ' ' LEU . 16.6 tp -73.79 109.62 7.44 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.295 -0.878 . . . . 20.210000000000001 108.641 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 1.6 p -123.87 160.65 27.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.438 -0.789 . . . . 10.81 109.475 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HA ' HD23 ' A' ' 32' ' ' LEU . 4.6 ttmt -77.33 164.56 25.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 36.740000000000002 110.438 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.977 HD13 HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -149.66 172.59 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.906 -0.776 . . . . 19.739999999999998 108.906 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.2 m -108.65 146.87 32.74 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.161 -0.962 . . . . 22.559999999999999 109.312 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.643 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -118.01 145.94 44.4 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.237 -0.914 . . . . 20.41 108.61 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.475 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -82.38 140.14 33.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.061 -1.025 . . . . 33.990000000000002 109.82 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.28 106.73 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 54.920000000000002 109.346 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.95 -12.53 57.6 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.364 -1.494 . . . . 36.100000000000001 109.364 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.475 ' NE2' ' HB2' ' A' ' 50' ' ' ASP . 5.1 mt-30 -81.9 147.22 57.7 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.29 -1.124 . . . . 54.759999999999998 109.344 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.8 Cg_endo -78.15 123.23 6.05 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.593 2.195 . . . . 28.370000000000001 110.537 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.927 ' HB1' ' OE1' ' A' ' 31' ' ' GLN . . . -37.94 143.93 0.11 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.633 -0.667 . . . . 17.210000000000001 110.142 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.995 ' O ' HG21 ' A' ' 6' ' ' ILE . 83.9 m-85 -41.49 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.481 -0.762 . . . . 17.190000000000001 109.326 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.695 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -43.04 165.41 0.11 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 17.82 109.577 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.695 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.1 Cg_endo -77.59 105.92 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.57 2.18 . . . . 17.280000000000001 110.484 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.54 -174.25 41.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.891 -1.284 . . . . 17.219999999999999 109.891 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -76.06 142.42 41.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -1.101 . . . . 19.57 108.396 179.289 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.71 ' HB3' HD22 ' A' ' 83' ' ' LEU . 15.9 m-85 -131.74 163.69 27.62 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.767 -1.208 . . . . 14.609999999999999 111.68 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 84' ' ' VAL . 50.8 p -145.72 120.18 9.68 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 106.698 -1.593 . . . . 18.359999999999999 106.698 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.615 ' CG1' HD12 ' A' ' 81' ' ' LEU . 3.8 t -50.68 171.1 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 118.708 -1.197 . . . . 19.129999999999999 108.885 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.603 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.8 t-80 -135.08 125.37 26.3 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.337 -0.852 . . . . 20.649999999999999 109.263 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.764 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -70.4 -2.84 14.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.457 -0.777 . . . . 19.649999999999999 109.697 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -17.01 14.71 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.023 -1.102 . . . . 14.720000000000001 108.023 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 0.4 OUTLIER -101.73 -9.66 20.65 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.726 -0.609 . . . . 11.449999999999999 110.597 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.693 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -72.31 164.14 26.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.959 -1.088 . . . . 14.25 109.992 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' A' ' 77' ' ' MET . 2.8 ptmt -146.42 177.04 9.34 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.947 -0.76 . . . . 32.700000000000003 108.947 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.435 HG23 HG21 ' B' ' 45' ' ' VAL . 6.2 p -126.92 158.73 37.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.272 -0.892 . . . . 15.630000000000001 109.355 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.96 -140.16 11.61 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.367 -1.493 . . . . 12.699999999999999 109.367 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' A' ' 73' ' ' PHE . 28.6 tp60 57.23 60.56 2.89 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.111 -1.229 . . . . 26.289999999999999 109.373 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.481 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.2 OUTLIER 73.29 2.34 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.494 -0.754 . . . . 20.440000000000001 109.469 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' B' ' 46' ' ' LYS . . . 103.9 54.79 0.8 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.962 -1.255 . . . . 13.82 109.962 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.3 t -151.27 147.36 26.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -1.2 . . . . 18.27 109.776 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.638 ' HB2' HD13 ' B' ' 81' ' ' LEU . 2.6 tp -59.41 165.11 2.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -0.92 . . . . 12.43 109.189 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 12.1 mtp -165.23 104.54 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.972 . . . . 35.109999999999999 110.038 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.4 mt -42.26 -63.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.509 -0.744 . . . . 13.67 109.335 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 38.0 t0 84.9 -45.5 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.387 0.613 . . . . 24.059999999999999 110.134 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.573 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.0 tmm_? -171.44 67.27 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.039 0.923 . . . . 35.039999999999999 108.519 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.74 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -38.06 131.19 1.12 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.603 -0.726 . . . . 18.719999999999999 111.514 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -96.47 107.0 19.34 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.923 -1.14 . . . . 20.550000000000001 107.923 178.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.977 HD12 HD13 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -76.9 146.84 37.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.127 -0.983 . . . . 14.4 111.221 -178.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 62' ' ' THR . 16.3 m -147.63 156.8 45.1 Favored Pre-proline 0 C--N 1.303 -1.456 0 N-CA-C 107.93 -1.137 . . . . 17.649999999999999 107.93 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.9 Cg_endo -64.01 142.95 83.5 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.163 1.909 . . . . 25.699999999999999 110.419 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.705 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -72.23 115.1 11.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.199 -0.938 . . . . 49.289999999999999 109.484 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.043 -0.98 . . . . 58.909999999999997 109.48 -179.942 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.43 -0.581 . . . . 64.909999999999997 109.43 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.764 ' CA ' HD22 ' A' ' 65' ' ' LEU . 3.3 mt 70.26 78.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.475 -1.306 . . . . 33.799999999999997 107.475 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 0.0 OUTLIER -61.85 159.56 13.65 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.976 0.893 . . . . 32.719999999999999 111.656 -177.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.081 ' CG2' HG22 ' B' ' 35' ' ' VAL . 84.3 t -160.52 168.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 108.964 -0.754 . . . . 14.460000000000001 108.964 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.618 ' N ' HG12 ' B' ' 4' ' ' VAL . 31.0 mt-10 -153.3 99.75 2.39 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.299 -0.876 . . . . 22.120000000000001 109.502 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.99 HG21 ' O ' ' B' ' 56' ' ' TYR . 1.0 OUTLIER -70.41 102.75 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 107.756 -1.201 . . . . 14.23 107.756 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.587 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 3.5 mmpt? -57.57 163.44 3.71 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.276 -0.89 . . . . 25.43 109.322 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.6 Cg_endo -72.44 -11.84 26.81 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.931 1.754 . . . . 13.609999999999999 109.182 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 28.8 t -102.68 13.21 35.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.33 -0.989 . . . . 15.52 108.33 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.53 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 5.6 mm-40 -142.7 36.22 1.44 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.402 -0.811 . . . . 17.309999999999999 109.452 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -112.69 35.4 3.88 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.986 -1.071 . . . . 24.780000000000001 110.274 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -140.8 125.09 17.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.122 -0.986 . . . . 47.899999999999999 109.588 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.644 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 40.6 p90 -89.54 157.01 18.25 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.313 -0.867 . . . . 21.609999999999999 109.855 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.2 t -131.89 161.53 32.79 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.327 -0.99 . . . . 14.890000000000001 108.327 178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.538 HG22 ' HB3' ' B' ' 27' ' ' SER . 0.2 OUTLIER -78.32 109.46 12.48 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.09 -1.006 . . . . 17.350000000000001 109.168 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -120.29 148.24 43.97 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.31 -0.868 . . . . 34.380000000000003 109.531 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 6.0 t -51.56 153.12 2.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 38.770000000000003 109.466 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -155.54 -179.82 30.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.164 -1.574 . . . . 34.579999999999998 109.164 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' B' ' 21' ' ' ARG . 0.7 OUTLIER -153.77 117.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.254 . . . . 41.869999999999997 109.201 179.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.492 ' O ' ' N ' ' B' ' 22' ' ' GLN . 53.8 p -57.3 83.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.342 -0.849 . . . . 47.210000000000001 109.832 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER 67.69 -59.78 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.216 -0.927 . . . . 71.560000000000002 109.773 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' B' ' 20' ' ' SER . 11.9 pt20 170.9 48.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 66.599999999999994 109.615 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.44 -55.55 0.1 OUTLIER Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.4 -1.48 . . . . 55.490000000000002 109.4 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -135.84 150.7 72.38 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.281 -1.129 . . . . 44.990000000000002 109.223 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.8 Cg_endo -78.0 131.54 11.08 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.532 2.154 . . . . 44.100000000000001 110.602 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' B' ' 28' ' ' LEU . 5.4 p90 -133.01 143.36 49.37 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.219 -0.926 . . . . 32.090000000000003 109.807 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.538 ' HB3' HG22 ' B' ' 15' ' ' THR . 0.2 OUTLIER -103.04 81.1 1.93 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 29.25 108.809 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.592 HD23 ' O ' ' B' ' 49' ' ' LEU . 0.2 OUTLIER -93.11 134.68 35.02 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.31 -0.869 . . . . 24.0 110.329 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.627 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -45.73 134.19 7.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.561 -0.712 . . . . 23.309999999999999 110.045 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 35.4 mt-10 -128.7 151.76 49.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.322 -0.861 . . . . 40.030000000000001 108.783 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.924 ' OE1' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -135.76 -170.55 2.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.948 -1.095 . . . . 12.390000000000001 110.223 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.845 ' HB3' HD11 ' B' ' 44' ' ' LEU . 11.0 mt -126.67 173.2 9.67 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.692 -0.855 . . . . 17.420000000000002 108.692 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.536 ' SG ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -168.0 160.58 12.18 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.782 -1.199 . . . . 13.84 108.136 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.688 ' CE1' HD13 ' B' ' 44' ' ' LEU . 3.2 m-85 -107.47 92.41 4.06 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.082 -1.011 . . . . 21.140000000000001 109.461 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 1.081 HG22 ' CG2' ' B' ' 4' ' ' VAL . 38.5 t -94.81 121.71 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.25 -0.906 . . . . 10.66 110.112 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.742 ' C ' HD23 ' B' ' 37' ' ' LEU . 1.9 m-20 -73.35 -36.45 66.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.215 -1.031 . . . . 25.890000000000001 108.215 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.742 HD23 ' C ' ' B' ' 36' ' ' ASP . 1.0 OUTLIER 39.09 28.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.731 -0.606 . . . . 24.239999999999998 109.979 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 67.61 26.22 73.76 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.79 -1.324 . . . . 31.02 109.79 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' B' ' 36' ' ' ASP . 1.1 t-20 -96.45 15.63 20.87 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.228 -1.16 . . . . 43.229999999999997 110.568 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' B' ' 41' ' ' HIS . 1.7 mt-10 68.38 93.89 0.07 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.026 -1.046 . . . . 42.340000000000003 108.652 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.629 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 10.5 m80 86.66 168.01 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 108.672 -0.862 . . . . 5.1100000000000003 108.672 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.632 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 34.1 Cg_endo -77.64 150.43 27.73 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.072 1.848 . . . . 17.920000000000002 111.18 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.891 HG22 ' O ' ' B' ' 35' ' ' VAL . 2.2 m -122.66 120.41 60.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.64 -0.824 . . . . 20.57 109.128 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.845 HD11 ' HB3' ' B' ' 32' ' ' LEU . 16.7 tp -73.74 109.71 7.46 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.447 -0.901 . . . . 20.210000000000001 108.65 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' B' ' 32' ' ' LEU . 1.7 p -123.87 160.71 27.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.382 -0.824 . . . . 10.81 109.466 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.485 ' HA ' HD23 ' B' ' 32' ' ' LEU . 4.6 ttmt -77.36 164.65 25.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.196 -0.94 . . . . 36.740000000000002 110.434 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.961 HD13 HD12 ' B' ' 83' ' ' LEU . 0.4 OUTLIER -149.65 172.61 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.448 -0.782 . . . . 19.739999999999998 108.9 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.1 m -108.72 146.38 33.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.163 -0.961 . . . . 22.559999999999999 109.378 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.644 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -117.5 145.96 43.86 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.201 -0.937 . . . . 20.41 108.615 179.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.476 ' HB2' ' NE2' ' B' ' 53' ' ' GLN . 0.7 OUTLIER -82.42 140.03 33.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 33.990000000000002 109.81 -179.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.18 106.84 0.22 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.319 -0.863 . . . . 54.920000000000002 109.403 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.88 -12.44 57.69 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.363 -1.495 . . . . 36.100000000000001 109.363 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.476 ' NE2' ' HB2' ' B' ' 50' ' ' ASP . 5.0 mt-30 -82.09 147.19 56.93 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.364 -1.08 . . . . 54.759999999999998 109.359 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.6 Cg_endo -78.08 123.27 6.1 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.646 2.231 . . . . 28.370000000000001 110.469 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.924 ' HB1' ' OE1' ' B' ' 31' ' ' GLN . . . -37.88 143.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.528 -0.732 . . . . 17.210000000000001 110.19 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.99 ' O ' HG21 ' B' ' 6' ' ' ILE . 83.9 m-85 -41.41 97.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.457 -0.777 . . . . 17.190000000000001 109.259 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -42.87 165.52 0.1 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 17.82 109.582 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.67 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.43 104.97 1.97 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.562 2.175 . . . . 17.280000000000001 110.122 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.74 -175.03 41.12 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.946 -1.262 . . . . 17.219999999999999 109.946 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.707 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -76.31 142.07 41.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.075 -1.083 . . . . 19.57 108.075 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.693 ' HB3' HD22 ' B' ' 83' ' ' LEU . 15.5 m-85 -131.32 163.7 27.27 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 120.716 -1.24 . . . . 14.609999999999999 111.716 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.746 ' O ' HG22 ' B' ' 84' ' ' VAL . 50.6 p -145.64 120.09 9.68 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.61 -1.626 . . . . 18.359999999999999 106.61 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.628 ' CG1' HD12 ' B' ' 81' ' ' LEU . 3.8 t -50.64 171.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 118.78 -1.168 . . . . 19.129999999999999 108.861 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.583 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.8 t-80 -135.01 125.45 26.59 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.331 -0.856 . . . . 20.649999999999999 109.268 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.757 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -70.51 -2.91 15.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.771 . . . . 19.649999999999999 109.645 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -17.13 14.53 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.043 -1.095 . . . . 14.720000000000001 108.043 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 0.4 OUTLIER -101.63 -10.04 20.4 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.681 -0.637 . . . . 11.449999999999999 110.654 -179.505 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.691 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.8 m-30 -72.05 164.12 26.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.022 -1.049 . . . . 14.25 109.943 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' B' ' 77' ' ' MET . 2.7 ptmt -146.38 177.17 9.23 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.966 -0.753 . . . . 32.700000000000003 108.966 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.459 HG23 HG21 ' A' ' 45' ' ' VAL . 6.2 p -126.99 158.72 37.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.266 -0.896 . . . . 15.630000000000001 109.348 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' B' ' 75' ' ' SER . . . 127.91 -140.13 11.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.36 -1.496 . . . . 12.699999999999999 109.36 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.491 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 28.2 tp60 57.19 60.68 2.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.11 -1.23 . . . . 26.289999999999999 109.378 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.491 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.2 OUTLIER 73.13 2.47 4.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.473 -0.767 . . . . 20.440000000000001 109.506 -179.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 46' ' ' LYS . . . 103.78 54.77 0.8 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.975 -1.25 . . . . 13.82 109.975 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.4 ' N ' ' O ' ' B' ' 71' ' ' GLY . 48.1 t -151.34 147.51 27.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -1.18 . . . . 18.27 109.827 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.633 ' HB2' HD13 ' A' ' 81' ' ' LEU . 2.6 tp -59.56 164.9 3.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.291 -0.88 . . . . 12.43 109.175 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 12.5 mtp -165.14 104.37 0.76 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.086 -1.009 . . . . 35.109999999999999 110.103 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.607 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.4 mt -42.05 -63.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 13.67 109.425 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.548 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 38.0 t0 84.94 -45.37 0.07 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.407 0.622 . . . . 24.059999999999999 110.108 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.0 tmm_? -171.51 67.23 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.081 0.943 . . . . 35.039999999999999 108.531 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.743 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -38.16 131.13 1.16 Allowed 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.685 0.755 . . . . 18.719999999999999 111.515 -178.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -96.4 107.1 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.892 -1.151 . . . . 20.550000000000001 107.892 178.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.961 HD12 HD13 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -76.98 146.7 37.29 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 14.4 111.243 -178.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.746 HG22 ' O ' ' B' ' 62' ' ' THR . 16.4 m -147.49 156.64 45.59 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 107.986 -1.116 . . . . 17.649999999999999 107.986 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.4 Cg_endo -63.88 142.66 83.13 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.142 1.894 . . . . 25.699999999999999 110.515 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.707 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -72.04 115.03 10.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.167 -0.958 . . . . 49.289999999999999 109.505 -179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.038 -0.982 . . . . 58.909999999999997 109.499 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.57 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.306 0.574 . . . . 64.909999999999997 109.473 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.893 HD12 ' HB ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -82.65 82.57 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.109 -1.071 . . . . 33.799999999999997 108.109 179.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -68.04 163.59 22.0 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.112 0.958 . . . . 32.719999999999999 111.359 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.987 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -174.38 167.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.428 -0.953 . . . . 14.460000000000001 108.428 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.576 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 31.6 mt-10 -140.39 111.39 7.02 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.899 0.857 . . . . 22.120000000000001 109.347 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.844 HG21 ' O ' ' A' ' 56' ' ' TYR . 6.2 mm -73.86 89.99 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.279 -1.008 . . . . 14.23 108.279 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.594 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.7 mmpm? -41.99 161.89 0.15 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 25.43 109.649 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.9 Cg_endo -72.41 -12.25 27.16 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.037 1.825 . . . . 13.609999999999999 109.115 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.0 t -98.17 6.94 46.97 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.675 -0.861 . . . . 15.52 108.675 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.531 ' HG2' ' HB2' ' A' ' 7' ' ' LYS . 17.1 mm-40 -128.25 13.36 6.64 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.334 -0.854 . . . . 17.309999999999999 109.519 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -88.14 30.3 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 24.780000000000001 110.299 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.413 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 18.7 mt-30 -144.55 121.58 11.4 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.161 -0.962 . . . . 47.899999999999999 109.678 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.626 ' CD2' ' CB ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.77 -177.39 4.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.448 -0.782 . . . . 21.609999999999999 110.429 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 98.1 m -157.05 143.73 18.34 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.433 -0.792 . . . . 14.890000000000001 109.044 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -78.89 122.72 26.46 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.351 -0.843 . . . . 17.350000000000001 109.574 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' A' ' 18' ' ' GLY . 6.3 mtt180 -132.95 133.89 43.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.284 -0.885 . . . . 34.380000000000003 109.35 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.71 98.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 38.770000000000003 109.369 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -101.67 167.63 18.9 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.577 -1.409 . . . . 34.579999999999998 109.577 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.5 t -141.33 119.18 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -1.157 . . . . 41.869999999999997 108.962 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 24' ' ' LYS . 6.3 m -57.45 87.75 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.305 -0.872 . . . . 47.210000000000001 109.687 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.2 mtp180 46.44 51.85 11.34 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.252 -0.905 . . . . 71.560000000000002 109.729 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 56.48 16.23 2.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 66.599999999999994 109.842 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.52 -53.85 1.77 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.142 -1.583 . . . . 55.490000000000002 109.142 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 20' ' ' SER . 4.4 mmtt -142.68 150.41 53.81 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.348 -1.09 . . . . 44.990000000000002 109.072 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.91 129.74 10.89 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.445 2.097 . . . . 44.100000000000001 110.483 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.615 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 8.2 p90 -144.31 135.06 24.97 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.186 -0.946 . . . . 32.090000000000003 109.561 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.458 ' HB2' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -98.32 78.51 2.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 29.25 108.611 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -83.75 161.94 20.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 24.0 110.301 -178.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.626 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -86.75 104.0 15.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.458 -0.776 . . . . 23.309999999999999 109.439 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 22.0 mt-10 -79.97 -176.53 5.53 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.039 -1.038 . . . . 40.030000000000001 109.422 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.57 ' CB ' HG22 ' A' ' 47' ' ' ILE . 3.5 mt-30 -168.38 -171.06 1.38 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.217 -0.927 . . . . 12.390000000000001 109.711 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.909 ' HB3' HD11 ' A' ' 44' ' ' LEU . 2.2 mp -131.39 179.08 6.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 17.420000000000002 109.634 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -172.25 159.5 4.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.935 -1.103 . . . . 13.84 109.024 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.776 ' HE1' HD13 ' A' ' 44' ' ' LEU . 2.8 m-85 -116.02 89.6 3.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 21.140000000000001 108.875 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.94 ' O ' HG22 ' A' ' 43' ' ' VAL . 98.7 t -91.73 115.86 31.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.101 -0.999 . . . . 10.66 110.233 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 73.4 m-20 -60.62 -20.34 60.41 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.178 -1.045 . . . . 25.890000000000001 108.178 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.798 HD11 ' CA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 40.65 27.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.673 -0.642 . . . . 24.239999999999998 109.922 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 61.66 27.46 68.26 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 120.127 -1.035 . . . . 31.02 110.539 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.592 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 8.8 p30 -106.78 22.68 15.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.677 -1.484 . . . . 43.229999999999997 110.417 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.544 ' O ' ' HB3' ' A' ' 41' ' ' HIS . 27.6 mt-10 61.36 50.49 4.7 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.215 -0.928 . . . . 42.340000000000003 111.027 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.592 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 2.3 p-80 154.68 149.45 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 108.187 -1.042 . . . . 8.3100000000000005 108.187 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.629 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.2 Cg_endo -75.88 147.21 30.46 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.947 1.765 . . . . 17.920000000000002 110.317 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 35' ' ' VAL . 14.5 m -121.36 116.68 50.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.242 -0.983 . . . . 20.57 109.069 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.909 HD11 ' HB3' ' A' ' 32' ' ' LEU . 21.9 tp -68.87 105.68 2.44 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.321 -0.952 . . . . 20.210000000000001 108.57 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' B' ' 75' ' ' SER . 0.5 OUTLIER -121.73 168.64 13.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.57 -0.706 . . . . 10.81 109.165 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' N ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -82.63 156.24 23.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 36.740000000000002 110.621 -178.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.115 HD11 ' HB2' ' A' ' 83' ' ' LEU . 1.4 tt -143.37 161.72 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.51 -0.922 . . . . 19.739999999999998 108.51 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.573 HG21 ' CZ ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -108.67 123.88 49.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.925 -1.11 . . . . 22.559999999999999 109.423 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.912 HD11 ' O ' ' A' ' 53' ' ' GLN . 1.9 tm? -86.5 125.02 33.45 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.769 -0.826 . . . . 20.41 108.769 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -54.89 139.22 41.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 33.990000000000002 109.602 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -55.37 118.93 4.86 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.224 -0.923 . . . . 54.920000000000002 109.328 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.39 -23.1 23.62 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.544 -1.422 . . . . 36.100000000000001 109.544 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.912 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -67.0 152.14 96.35 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.2 -1.176 . . . . 54.759999999999998 109.357 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -79.58 117.05 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.476 2.117 . . . . 28.370000000000001 110.085 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HA ' ' CD2' ' A' ' 49' ' ' LEU . . . -29.71 137.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.221 0.534 . . . . 17.210000000000001 111.128 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.844 ' O ' HG21 ' A' ' 6' ' ' ILE . 99.2 m-85 -41.28 105.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.48 -0.763 . . . . 17.190000000000001 109.41 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.815 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.98 170.33 0.72 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.069 -1.019 . . . . 17.82 109.277 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.815 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.67 103.24 1.69 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.459 2.106 . . . . 17.280000000000001 110.097 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -174.11 -179.77 44.96 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.921 -1.272 . . . . 17.219999999999999 109.921 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.784 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -72.69 149.86 43.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.366 -1.079 . . . . 19.57 108.12 179.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.987 ' CB ' HG13 ' A' ' 4' ' ' VAL . 18.0 m-85 -133.92 165.23 25.5 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 120.692 -1.255 . . . . 14.609999999999999 111.724 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 84' ' ' VAL . 69.8 p -143.96 119.2 10.16 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.949 -1.871 . . . . 18.359999999999999 105.949 178.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 81' ' ' LEU . 9.8 t -53.84 165.42 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 C-N-CA 118.404 -1.318 . . . . 19.129999999999999 108.962 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.529 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -134.15 126.46 30.03 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.47 -0.937 . . . . 20.649999999999999 108.47 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' B' ' 2' ' ' ILE . 2.3 pp -72.88 2.14 7.36 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.144 -0.972 . . . . 19.649999999999999 110.246 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.32 -18.96 19.5 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.643 -1.243 . . . . 14.720000000000001 107.643 178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 1.3 t -100.37 -9.36 22.33 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.72 -0.612 . . . . 11.449999999999999 110.302 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 3.9 m-30 -73.48 156.67 37.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.962 -1.086 . . . . 14.25 109.32 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.763 ' CA ' HD11 ' B' ' 37' ' ' LEU . 22.3 mtmt -152.89 167.12 30.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 32.700000000000003 109.717 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.525 HG21 HG21 ' B' ' 43' ' ' VAL . 0.5 OUTLIER -101.11 123.32 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.513 -0.921 . . . . 15.630000000000001 108.513 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 70' ' ' VAL . . . -59.81 -130.7 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.046 -1.222 . . . . 12.699999999999999 110.046 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.522 ' C ' ' CG ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -87.2 46.01 1.33 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.255 -1.144 . . . . 26.289999999999999 108.869 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.522 ' CG ' ' C ' ' A' ' 72' ' ' GLN . 1.8 m-85 77.06 0.02 3.0 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.993 -0.743 . . . . 20.440000000000001 108.993 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.59 -66.48 2.37 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.524 -1.43 . . . . 13.82 109.524 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.476 ' HA ' HG22 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -160.6 170.18 21.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -1.165 . . . . 18.27 109.667 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.9 OUTLIER -66.79 163.6 18.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 12.43 109.433 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.537 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 15.1 mtp -165.6 127.24 1.97 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 35.109999999999999 109.401 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.2 mt -53.93 -41.3 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.306 -0.871 . . . . 13.67 109.946 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 2.1 t0 45.0 54.55 6.83 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.512 -1.292 . . . . 24.059999999999999 107.512 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.573 ' CZ ' HG21 ' A' ' 48' ' ' THR . 0.6 OUTLIER 85.56 116.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.017 -1.475 . . . . 35.039999999999999 107.017 -177.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.062 HD13 HG13 ' A' ' 63' ' ' VAL . 2.0 pp -94.63 152.02 18.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.332 -0.855 . . . . 18.719999999999999 111.274 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -101.52 95.6 6.57 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.905 -1.517 . . . . 20.550000000000001 106.905 177.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.115 ' HB2' HD11 ' A' ' 47' ' ' ILE . 2.0 tp -75.07 150.67 38.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.191 -0.943 . . . . 14.4 111.324 -177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.824 HG22 ' O ' ' A' ' 62' ' ' THR . 24.1 m -147.47 158.96 42.85 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 107.809 -1.182 . . . . 17.649999999999999 107.809 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.3 Cg_endo -63.87 145.88 90.94 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.06 1.84 . . . . 25.699999999999999 110.335 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.784 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -80.39 115.37 19.89 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.133 -0.979 . . . . 49.289999999999999 109.579 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.2 tptt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.963 -1.018 . . . . 58.909999999999997 109.486 -180.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.567 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.461 -0.57 . . . . 64.909999999999997 109.461 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.904 HD12 ' HB ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -83.26 82.52 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.083 -1.08 . . . . 33.799999999999997 108.083 179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -67.99 163.59 21.89 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.169 0.985 . . . . 32.719999999999999 111.351 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.004 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -174.38 167.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.419 -0.956 . . . . 14.460000000000001 108.419 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.565 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 31.3 mt-10 -140.27 111.5 7.13 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.866 0.841 . . . . 22.120000000000001 109.286 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.828 HG21 ' O ' ' B' ' 56' ' ' TYR . 6.2 mm -74.04 89.7 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.285 -1.006 . . . . 14.23 108.285 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.598 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.7 mmpm? -41.73 161.81 0.14 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 25.43 109.668 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.7 Cg_endo -72.44 -12.39 27.21 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.957 1.771 . . . . 13.609999999999999 109.117 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 19.5 t -97.94 6.9 47.17 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.655 -0.868 . . . . 15.52 108.655 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.524 ' HB3' ' HB2' ' B' ' 32' ' ' LEU . 17.0 mm-40 -128.17 13.14 6.67 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.316 -0.865 . . . . 17.309999999999999 109.609 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -87.92 30.13 0.87 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.144 -0.973 . . . . 24.780000000000001 110.333 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 18.7 mt-30 -144.33 121.71 11.65 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.129 -0.982 . . . . 47.899999999999999 109.659 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.626 ' CD2' ' CB ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -77.84 -177.33 4.86 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.456 -0.777 . . . . 21.609999999999999 110.42 -179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 97.7 m -157.14 143.61 18.13 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.34 -0.85 . . . . 14.890000000000001 109.088 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.451 HG22 ' HB2' ' B' ' 27' ' ' SER . 0.2 OUTLIER -78.8 122.86 26.58 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.445 -0.784 . . . . 17.350000000000001 109.572 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' B' ' 18' ' ' GLY . 6.3 mtt180 -133.12 133.97 43.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 34.380000000000003 109.296 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.401 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.9 OUTLIER -45.83 98.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 38.770000000000003 109.362 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -101.59 167.72 19.06 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.624 -1.39 . . . . 34.579999999999998 109.624 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' B' ' 21' ' ' ARG . 1.4 t -141.46 119.21 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -1.128 . . . . 41.869999999999997 108.955 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.515 ' N ' ' O ' ' B' ' 24' ' ' LYS . 6.4 m -57.5 87.59 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.424 -0.797 . . . . 47.210000000000001 109.732 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' B' ' 19' ' ' VAL . 4.2 mtp180 46.64 51.78 11.79 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.262 -0.898 . . . . 71.560000000000002 109.7 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 56.49 16.39 2.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.207 -0.933 . . . . 66.599999999999994 109.792 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.61 -53.87 1.76 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.171 -1.572 . . . . 55.490000000000002 109.171 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' B' ' 20' ' ' SER . 4.4 mmtt -142.69 150.56 54.32 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.324 -1.103 . . . . 44.990000000000002 109.039 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.03 129.76 10.79 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.464 2.109 . . . . 44.100000000000001 110.505 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.625 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 8.0 p90 -144.27 135.07 25.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.201 -0.937 . . . . 32.090000000000003 109.604 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.451 ' HB2' HG22 ' B' ' 15' ' ' THR . 0.1 OUTLIER -98.28 78.52 2.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 29.25 108.609 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.61 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -83.73 162.01 20.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 24.0 110.224 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.626 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -86.82 103.79 15.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.426 -0.796 . . . . 23.309999999999999 109.465 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 21.7 mt-10 -79.77 -176.65 5.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.043 -1.035 . . . . 40.030000000000001 109.524 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.582 ' CB ' HG22 ' B' ' 47' ' ' ILE . 3.5 mt-30 -168.19 -171.12 1.44 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.209 -0.932 . . . . 12.390000000000001 109.778 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.934 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.2 mp -131.26 179.11 6.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 17.420000000000002 109.633 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.534 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -172.35 159.43 4.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.925 -1.109 . . . . 13.84 108.946 -179.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.758 ' HE1' HD13 ' B' ' 44' ' ' LEU . 2.8 m-85 -116.06 89.47 3.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.953 . . . . 21.140000000000001 108.911 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.946 ' O ' HG22 ' B' ' 43' ' ' VAL . 98.5 t -91.59 116.13 32.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 O-C-N 121.055 -1.028 . . . . 10.66 110.26 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.547 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 73.3 m-20 -60.92 -19.96 61.36 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.213 -1.032 . . . . 25.890000000000001 108.213 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.763 HD11 ' CA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 40.42 27.67 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.644 -0.66 . . . . 24.239999999999998 109.867 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 61.58 27.54 68.24 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.552 -1.019 . . . . 31.02 110.552 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.585 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 8.7 p30 -106.83 22.67 15.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.67 -1.488 . . . . 43.229999999999997 110.517 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.545 ' O ' ' HB3' ' B' ' 41' ' ' HIS . 27.7 mt-10 61.34 50.58 4.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.172 -0.955 . . . . 42.340000000000003 111.026 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.585 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 2.3 p-80 154.61 149.35 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.198 -1.038 . . . . 8.3399999999999999 108.198 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.636 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 34.9 Cg_endo -75.78 147.2 30.81 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.933 1.755 . . . . 17.920000000000002 110.33 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.946 HG22 ' O ' ' B' ' 35' ' ' VAL . 14.5 m -121.36 116.97 51.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 C-N-CA 119.282 -0.967 . . . . 20.57 109.068 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.934 HD11 ' HB3' ' B' ' 32' ' ' LEU . 22.1 tp -69.25 105.54 2.56 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.333 -0.947 . . . . 20.210000000000001 108.568 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -121.58 168.57 13.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.63 0 O-C-N 121.589 -0.694 . . . . 10.81 109.161 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.437 ' N ' HG13 ' B' ' 45' ' ' VAL . 0.2 OUTLIER -82.49 156.23 24.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 36.740000000000002 110.605 -178.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 1.077 HD11 ' HB2' ' B' ' 83' ' ' LEU . 1.4 tt -143.42 161.62 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.464 -0.939 . . . . 19.739999999999998 108.464 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.583 HG21 ' CZ ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -108.59 123.94 49.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.958 -1.089 . . . . 22.559999999999999 109.418 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.922 HD11 ' O ' ' B' ' 53' ' ' GLN . 1.9 tm? -86.56 124.99 33.47 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.535 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.3 OUTLIER -54.85 139.27 40.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 33.990000000000002 109.666 -179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -55.4 118.92 4.86 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.232 -0.917 . . . . 54.920000000000002 109.31 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.34 -22.94 24.24 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.596 -1.401 . . . . 36.100000000000001 109.596 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.922 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.6 OUTLIER -67.18 152.18 96.37 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.172 -1.193 . . . . 54.759999999999998 109.29 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.506 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -79.55 117.11 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.462 2.108 . . . . 28.370000000000001 110.018 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.588 ' HA ' ' CD2' ' B' ' 49' ' ' LEU . . . -29.9 138.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.233 0.54 . . . . 17.210000000000001 111.068 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.828 ' O ' HG21 ' B' ' 6' ' ' ILE . 99.3 m-85 -41.33 105.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 17.190000000000001 109.591 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.792 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.46 170.32 0.63 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.09 -1.006 . . . . 17.82 109.186 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.792 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.3 Cg_endo -78.01 104.2 1.81 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.553 2.169 . . . . 17.280000000000001 110.267 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.64 -179.34 46.1 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.861 -1.295 . . . . 17.219999999999999 109.861 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.777 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -72.31 150.27 43.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -1.151 . . . . 19.57 108.449 179.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 1.004 ' CB ' HG13 ' B' ' 4' ' ' VAL . 16.4 m-85 -134.34 165.29 25.49 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.775 -1.203 . . . . 14.609999999999999 111.75 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.822 ' O ' HG22 ' B' ' 84' ' ' VAL . 67.1 p -144.15 119.23 10.06 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.029 -1.841 . . . . 18.359999999999999 106.029 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 1.069 HG13 HD13 ' B' ' 81' ' ' LEU . 9.7 t -53.91 165.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 C-N-CA 118.419 -1.312 . . . . 19.129999999999999 109.006 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -134.0 126.44 30.23 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.424 -0.954 . . . . 20.649999999999999 108.424 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.763 HD22 ' HA ' ' A' ' 2' ' ' ILE . 2.3 pp -72.76 1.9 7.64 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.193 -0.942 . . . . 19.649999999999999 110.197 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -19.02 16.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.575 -1.269 . . . . 14.720000000000001 107.575 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.521 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 1.3 t -100.5 -9.85 21.67 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.72 -0.613 . . . . 11.449999999999999 110.306 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.65 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 3.9 m-30 -72.94 156.46 38.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.979 -1.076 . . . . 14.25 109.206 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.798 ' CA ' HD11 ' A' ' 37' ' ' LEU . 22.5 mtmt -152.71 166.67 31.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 32.700000000000003 109.803 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.553 HG21 HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -100.53 123.14 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.527 -0.916 . . . . 15.630000000000001 108.527 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' B' ' 70' ' ' VAL . . . -59.95 -130.71 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.016 -1.233 . . . . 12.699999999999999 110.016 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.537 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -87.1 46.25 1.36 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -1.133 . . . . 26.289999999999999 108.879 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.537 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 1.8 m-85 76.79 0.05 3.07 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.058 -0.719 . . . . 20.440000000000001 109.058 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.64 -66.28 2.45 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.612 -1.395 . . . . 13.82 109.612 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.482 ' HA ' HG22 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -160.7 170.1 21.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.184 -1.186 . . . . 18.27 109.673 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.533 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.9 OUTLIER -66.72 163.45 19.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -0.886 . . . . 12.43 109.462 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 15.2 mtp -165.59 127.42 2.0 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.892 . . . . 35.109999999999999 109.381 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.601 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.1 mt -54.22 -41.12 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 13.67 109.921 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.567 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 2.1 t0 44.92 54.67 6.66 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 107.442 -1.318 . . . . 24.059999999999999 107.442 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.583 ' CZ ' HG21 ' B' ' 48' ' ' THR . 0.6 OUTLIER 85.56 116.77 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.097 -1.445 . . . . 35.039999999999999 107.097 -177.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 1.069 HD13 HG13 ' B' ' 63' ' ' VAL . 2.0 pp -94.53 152.13 18.79 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.318 -0.864 . . . . 18.719999999999999 111.276 -177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.533 ' N ' HD12 ' B' ' 81' ' ' LEU . 0.0 OUTLIER -101.7 95.5 6.47 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.93 -1.507 . . . . 20.550000000000001 106.93 177.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.077 ' HB2' HD11 ' B' ' 47' ' ' ILE . 2.0 tp -75.0 150.57 38.93 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.161 -0.962 . . . . 14.4 111.335 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.822 HG22 ' O ' ' B' ' 62' ' ' THR . 24.1 m -147.47 158.64 43.31 Favored Pre-proline 0 C--N 1.301 -1.532 0 N-CA-C 107.813 -1.181 . . . . 17.649999999999999 107.813 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.0 Cg_endo -63.61 145.94 92.09 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.022 1.815 . . . . 25.699999999999999 110.357 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.777 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -80.36 115.54 19.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.198 -0.939 . . . . 49.289999999999999 109.564 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 16.2 tptt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.984 -1.008 . . . . 58.909999999999997 109.506 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.341 -0.615 . . . . 64.909999999999997 109.341 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.988 HG23 ' CD2' ' B' ' 65' ' ' LEU . 0.0 OUTLIER 56.21 88.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.933 -1.104 . . . . 33.799999999999997 108.046 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -92.77 167.12 12.08 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.341 -0.849 . . . . 32.719999999999999 110.437 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.912 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -172.67 165.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.993 -0.743 . . . . 14.460000000000001 108.993 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.561 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 34.3 mt-10 -141.74 110.37 6.09 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.908 -0.775 . . . . 22.120000000000001 108.908 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.825 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -71.85 100.81 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 C-N-CA 119.171 -1.012 . . . . 14.23 108.401 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 3.0 mmmt -41.49 163.48 0.11 Allowed Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.462 -0.774 . . . . 25.43 109.423 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.8 Cg_endo -72.68 -13.92 27.16 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.961 1.774 . . . . 13.609999999999999 109.224 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.4 m -96.58 5.32 51.0 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.716 -0.846 . . . . 15.52 108.716 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.523 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 9.1 mm-40 -125.93 34.9 4.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.361 -0.837 . . . . 17.309999999999999 109.355 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.95 8.46 42.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 24.780000000000001 110.014 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 41.6 mt-30 -132.14 144.47 50.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.223 -0.923 . . . . 47.899999999999999 109.516 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.72 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 30.8 p90 -91.68 164.73 13.63 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.259 -0.901 . . . . 21.609999999999999 109.407 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -137.7 152.5 49.33 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.29 -0.881 . . . . 14.890000000000001 109.125 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -89.99 117.16 28.58 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.242 -0.911 . . . . 17.350000000000001 109.366 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -130.35 134.68 47.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.925 . . . . 34.380000000000003 109.516 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 16' ' ' ARG . 6.3 t -44.89 113.55 0.58 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 38.770000000000003 109.349 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 26' ' ' TYR . . . -116.45 177.5 16.9 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.716 -1.354 . . . . 34.579999999999998 109.716 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.642 ' N ' ' CE2' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -144.81 114.7 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -1.14 . . . . 41.869999999999997 108.632 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.3 p -49.32 -91.23 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.196 -0.94 . . . . 47.210000000000001 109.685 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.505 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 18.5 ttt180 -113.71 54.47 0.74 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 71.560000000000002 109.548 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 54.63 21.4 3.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 66.599999999999994 109.531 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.85 -45.91 1.24 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.535 -1.426 . . . . 55.490000000000002 109.535 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -142.17 154.74 64.86 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.362 -1.081 . . . . 44.990000000000002 109.42 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.25 152.73 31.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.654 2.236 . . . . 44.100000000000001 110.713 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.642 ' CE2' ' N ' ' A' ' 19' ' ' VAL . 5.4 p90 -159.83 119.47 2.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 32.090000000000003 109.732 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.453 ' HB2' HG22 ' A' ' 15' ' ' THR . 0.0 OUTLIER -96.03 80.58 3.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 29.25 109.288 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -92.93 142.19 27.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 24.0 110.057 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.635 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 92.8 m-20 -52.92 118.87 4.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.844 . . . . 23.309999999999999 109.336 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 5.1 mt-10 -110.98 165.83 11.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 40.030000000000001 109.183 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.685 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -144.03 162.98 34.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.051 -1.031 . . . . 12.390000000000001 109.861 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' HD11 ' A' ' 44' ' ' LEU . 3.6 mm? -102.64 178.28 4.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.404 -0.81 . . . . 17.420000000000002 109.958 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.527 ' SG ' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -175.29 159.42 2.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.003 -1.06 . . . . 13.84 108.604 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.767 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.1 m-30 -113.96 98.04 6.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.997 . . . . 21.140000000000001 108.592 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.898 HG22 ' HB ' ' A' ' 4' ' ' VAL . 14.0 t -107.34 130.23 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 10.66 110.665 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.909 ' O ' HD12 ' A' ' 37' ' ' LEU . 12.5 p-10 -81.01 -30.18 34.99 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.124 -1.065 . . . . 25.890000000000001 108.124 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.909 HD12 ' O ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER 31.09 40.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.159 0.504 . . . . 24.239999999999998 110.993 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' C ' ' OD1' ' A' ' 39' ' ' ASN . . . 102.07 20.32 12.87 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 119.811 -1.185 . . . . 31.02 110.597 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.544 ' ND2' ' CD1' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -135.29 103.3 5.46 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.965 -1.315 . . . . 43.229999999999997 108.223 178.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -29.54 -38.06 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.356 0.598 . . . . 42.340000000000003 111.407 -178.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 39' ' ' ASN . 40.9 m80 -89.03 153.18 49.08 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.312 -0.867 . . . . 6.5899999999999999 109.177 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 34.8 Cg_endo -76.83 148.38 28.36 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.2 1.933 . . . . 17.920000000000002 110.377 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 35' ' ' VAL . 1.8 m -119.43 119.0 59.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.185 -1.006 . . . . 20.57 109.434 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.905 HD11 ' HB3' ' A' ' 32' ' ' LEU . 18.5 tp -70.81 109.53 5.05 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.447 -0.946 . . . . 20.210000000000001 108.447 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.596 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 2.9 t -121.12 168.96 13.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.635 -0.666 . . . . 10.81 109.725 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -89.53 -175.47 4.71 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.419 -0.801 . . . . 36.740000000000002 110.251 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.687 ' CD1' HD12 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -168.85 173.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.3 -0.875 . . . . 19.739999999999998 109.144 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.47 ' N ' HG23 ' A' ' 47' ' ' ILE . 24.4 m -109.18 145.28 36.06 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.3 -0.875 . . . . 22.559999999999999 109.148 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 53' ' ' GLN . 1.8 tm? -127.76 100.31 5.9 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.343 -0.848 . . . . 20.41 109.052 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 53' ' ' GLN . 4.0 m-20 -41.4 129.4 3.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.394 -0.816 . . . . 33.990000000000002 110.04 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.74 100.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.303 -0.873 . . . . 54.920000000000002 109.161 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.37 -37.32 2.79 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.258 -1.537 . . . . 36.100000000000001 109.258 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.651 ' O ' HD11 ' A' ' 49' ' ' LEU . 4.3 mt-30 -64.0 151.88 88.71 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.228 -1.16 . . . . 54.759999999999998 109.048 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.6 Cg_endo -77.07 117.72 4.52 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.533 2.156 . . . . 28.370000000000001 110.439 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.72 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -40.05 148.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.522 -0.736 . . . . 17.210000000000001 109.926 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.825 ' O ' HG21 ' A' ' 6' ' ' ILE . 9.7 m-30 -48.45 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 17.190000000000001 109.6 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.942 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -48.65 174.24 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 17.82 109.307 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.942 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 36.1 Cg_endo -78.55 125.3 6.81 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.652 2.234 . . . . 17.280000000000001 110.368 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.29 -179.24 39.24 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 119.718 -1.23 . . . . 17.219999999999999 110.045 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.732 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -73.15 142.6 47.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.369 -1.077 . . . . 19.57 108.577 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.912 ' CB ' HG13 ' A' ' 4' ' ' VAL . 8.8 m-85 -127.24 163.49 23.78 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.65 -1.281 . . . . 14.609999999999999 111.546 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.662 ' O ' HG22 ' A' ' 84' ' ' VAL . 54.8 p -148.47 117.35 6.72 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.941 -1.503 . . . . 18.359999999999999 106.941 179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.817 ' HB ' HD12 ' A' ' 2' ' ' ILE . 15.8 t -47.59 169.12 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 C-N-CA 119.168 -1.013 . . . . 19.129999999999999 109.106 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.55 ' N ' HG12 ' A' ' 63' ' ' VAL . 7.5 t-80 -133.72 129.72 37.13 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.834 -0.802 . . . . 20.649999999999999 108.834 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.007 ' CD2' HG23 ' B' ' 2' ' ' ILE . 0.7 OUTLIER -64.18 -10.52 23.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.511 -0.743 . . . . 19.649999999999999 109.89 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' LEU . 1.2 t -45.62 -25.93 0.54 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.589 -0.893 . . . . 14.720000000000001 108.589 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 7.2 m -98.19 -12.07 22.08 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.51 -0.744 . . . . 11.449999999999999 110.485 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 1.005 ' CD2' HD23 ' A' ' 65' ' ' LEU . 2.6 m-30 -80.16 153.86 28.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.845 -1.16 . . . . 14.25 109.762 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' A' ' 68' ' ' PHE . 71.1 mttt -157.37 171.05 21.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.505 -0.747 . . . . 32.700000000000003 109.233 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -101.4 100.76 11.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.277 -0.889 . . . . 15.630000000000001 109.124 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.68 -175.98 5.98 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.525 -1.43 . . . . 12.699999999999999 109.525 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -90.72 27.44 1.77 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.143 -1.21 . . . . 26.289999999999999 109.314 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 5.0 23.64 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.434 -0.791 . . . . 20.440000000000001 109.627 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.475 ' O ' ' OG ' ' A' ' 75' ' ' SER . . . 67.66 49.47 49.6 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.467 -1.453 . . . . 13.82 109.467 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -170.07 148.88 3.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -1.129 . . . . 18.27 109.707 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.943 HD23 ' N ' ' A' ' 77' ' ' MET . 5.1 tt -61.16 159.1 12.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 12.43 109.278 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.943 ' N ' HD23 ' A' ' 76' ' ' LEU . 1.8 mtt -163.79 111.39 1.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.09 -1.006 . . . . 35.109999999999999 109.993 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.97 HD12 HD12 ' B' ' 78' ' ' ILE . 3.5 mt -52.77 145.87 2.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.354 -0.841 . . . . 13.67 109.647 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.577 ' O ' ' CB ' ' A' ' 80' ' ' ARG . 0.3 OUTLIER -126.06 53.47 1.61 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 106.804 -1.554 . . . . 24.059999999999999 106.804 178.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.58 ' H ' HG22 ' A' ' 78' ' ' ILE . 2.4 tmm_? 89.67 67.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.31 -1.367 . . . . 35.039999999999999 107.31 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -32.78 124.91 0.35 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.373 -0.831 . . . . 18.719999999999999 111.678 -178.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.6 103.88 16.52 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.483 -1.303 . . . . 20.550000000000001 107.483 178.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.687 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -79.79 145.97 32.55 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.058 -1.026 . . . . 14.4 111.217 -178.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 62' ' ' THR . 27.2 m -146.53 158.6 46.47 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.96 -1.126 . . . . 17.649999999999999 107.96 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.16 141.07 74.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.084 1.856 . . . . 25.699999999999999 110.134 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.732 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -69.07 108.3 3.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.139 -0.976 . . . . 49.289999999999999 109.482 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.961 -1.018 . . . . 58.909999999999997 109.413 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' CG ' ' B' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.335 -0.617 . . . . 64.909999999999997 109.335 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 1.007 HG23 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 56.12 88.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 120.891 -1.131 . . . . 33.799999999999997 107.973 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.535 ' O ' HG13 ' B' ' 35' ' ' VAL . 0.3 OUTLIER -92.9 167.13 12.04 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.298 -0.876 . . . . 32.719999999999999 110.438 -178.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.911 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER -172.74 165.34 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.692 0.758 . . . . 14.460000000000001 108.962 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.56 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 34.3 mt-10 -141.67 110.52 6.17 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.882 -0.785 . . . . 22.120000000000001 108.882 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.827 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -71.97 101.06 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 C-N-CA 119.126 -1.03 . . . . 14.23 108.396 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.582 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 3.0 mmmt -41.61 163.61 0.11 Allowed Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.49 -0.756 . . . . 25.43 109.493 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.0 Cg_endo -72.72 -13.95 27.06 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 121.983 1.789 . . . . 13.609999999999999 109.201 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 13.6 m -96.55 5.19 51.27 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.677 -0.86 . . . . 15.52 108.677 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.535 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 9.1 mm-40 -125.9 34.94 4.78 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.328 -0.857 . . . . 17.309999999999999 109.412 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.92 8.46 42.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 24.780000000000001 110.026 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -132.19 144.36 50.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.272 -0.893 . . . . 47.899999999999999 109.576 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.702 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 31.0 p90 -91.6 164.78 13.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.284 -0.885 . . . . 21.609999999999999 109.385 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 97.5 m -137.71 152.53 49.34 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.331 -0.856 . . . . 14.890000000000001 109.11 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.457 HG22 ' HB2' ' B' ' 27' ' ' SER . 0.2 OUTLIER -90.01 117.21 28.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 17.350000000000001 109.378 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.2 OUTLIER -130.39 134.62 47.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 34.380000000000003 109.621 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.411 ' C ' ' O ' ' B' ' 16' ' ' ARG . 6.3 t -44.8 113.63 0.59 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.912 . . . . 38.770000000000003 109.297 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' B' ' 26' ' ' TYR . . . -116.59 177.44 16.82 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.645 -1.382 . . . . 34.579999999999998 109.645 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.63 ' N ' ' CE2' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -144.8 114.76 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.21 -1.17 . . . . 41.869999999999997 108.611 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 31.2 p -49.38 -91.18 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.227 -0.921 . . . . 47.210000000000001 109.659 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.514 ' O ' ' CG ' ' B' ' 21' ' ' ARG . 18.4 ttt180 -113.71 54.31 0.75 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 71.560000000000002 109.577 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 54.79 21.4 3.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 66.599999999999994 109.477 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.83 -46.0 1.24 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.539 -1.424 . . . . 55.490000000000002 109.539 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -142.12 154.88 65.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.244 -1.151 . . . . 44.990000000000002 109.395 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.33 152.64 30.68 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.686 2.257 . . . . 44.100000000000001 110.711 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.63 ' CE2' ' N ' ' B' ' 19' ' ' VAL . 5.4 p90 -159.78 119.48 2.92 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 32.090000000000003 109.775 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.457 ' HB2' HG22 ' B' ' 15' ' ' THR . 0.0 OUTLIER -96.07 80.54 3.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 29.25 109.33 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.588 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.3 OUTLIER -92.88 142.0 27.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 24.0 110.106 -179.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.629 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 92.9 m-20 -52.68 118.91 3.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 23.309999999999999 109.348 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 5.1 mt-10 -111.09 165.78 11.6 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.051 -1.031 . . . . 40.030000000000001 109.193 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.696 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -143.96 162.94 34.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.139 -0.976 . . . . 12.390000000000001 109.798 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.935 ' HB3' HD11 ' B' ' 44' ' ' LEU . 3.6 mm? -102.67 178.07 4.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 17.420000000000002 109.91 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' CD1' ' B' ' 47' ' ' ILE . 0.1 OUTLIER -175.08 159.32 2.59 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.92 -1.112 . . . . 13.84 108.619 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.769 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.1 m-30 -113.81 97.86 6.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.138 -0.976 . . . . 21.140000000000001 108.63 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.878 ' O ' HG22 ' B' ' 43' ' ' VAL . 13.9 t -107.24 130.08 59.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.106 -0.996 . . . . 10.66 110.731 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.929 ' O ' HD12 ' B' ' 37' ' ' LEU . 12.5 p-10 -80.79 -30.45 35.97 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.128 -1.064 . . . . 25.890000000000001 108.128 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.929 HD12 ' O ' ' B' ' 36' ' ' ASP . 0.4 OUTLIER 31.45 40.55 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.171 0.51 . . . . 24.239999999999998 110.953 179.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.448 ' C ' ' OD1' ' B' ' 39' ' ' ASN . . . 101.91 20.61 12.44 Favored Glycine 0 N--CA 1.485 1.946 0 C-N-CA 119.834 -1.174 . . . . 31.02 110.583 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.549 ' ND2' ' CD1' ' B' ' 37' ' ' LEU . 1.0 OUTLIER -135.43 103.31 5.43 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.016 -1.285 . . . . 43.229999999999997 108.211 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.49 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -29.57 -37.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.291 0.567 . . . . 42.340000000000003 111.384 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' B' ' 39' ' ' ASN . 40.9 m80 -89.14 153.13 48.82 Favored Pre-proline 0 C--N 1.294 -1.828 0 O-C-N 121.375 -0.828 . . . . 6.5 109.183 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.1 Cg_endo -76.83 148.31 28.3 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.179 1.92 . . . . 17.920000000000002 110.38 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.878 HG22 ' O ' ' B' ' 35' ' ' VAL . 1.7 m -119.34 119.3 60.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 119.258 -0.977 . . . . 20.57 109.369 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.935 HD11 ' HB3' ' B' ' 32' ' ' LEU . 18.6 tp -71.13 109.78 5.4 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.55 -0.907 . . . . 20.210000000000001 108.55 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.612 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 3.0 t -121.38 168.84 13.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.613 -0.68 . . . . 10.81 109.776 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.584 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -89.24 -175.4 4.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.493 -0.754 . . . . 36.740000000000002 110.314 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.677 ' CD1' HD12 ' B' ' 83' ' ' LEU . 0.0 OUTLIER -168.98 173.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.3 -0.875 . . . . 19.739999999999998 109.135 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.477 ' N ' HG23 ' B' ' 47' ' ' ILE . 24.6 m -109.28 145.22 36.29 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.3 -0.875 . . . . 22.559999999999999 109.108 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.67 HD11 ' O ' ' B' ' 53' ' ' GLN . 1.8 tm? -127.73 100.35 5.92 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.871 . . . . 20.41 109.059 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' B' ' 53' ' ' GLN . 3.9 m-20 -41.44 129.42 3.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 33.990000000000002 110.024 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -51.74 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.293 -0.879 . . . . 54.920000000000002 109.152 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.25 -37.15 2.84 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.225 -1.55 . . . . 36.100000000000001 109.225 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.67 ' O ' HD11 ' B' ' 49' ' ' LEU . 4.2 mt-30 -64.2 151.91 89.43 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.223 -1.163 . . . . 54.759999999999998 109.036 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.9 Cg_endo -77.22 117.63 4.45 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.546 2.164 . . . . 28.370000000000001 110.457 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.702 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -39.72 148.0 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.523 -0.736 . . . . 17.210000000000001 110.09 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.827 ' O ' HG21 ' B' ' 6' ' ' ILE . 9.5 m-30 -47.99 93.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.293 -0.88 . . . . 17.190000000000001 109.595 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.919 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -47.63 174.19 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 17.82 109.486 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.919 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.8 Cg_endo -78.24 124.42 6.57 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.577 2.185 . . . . 17.280000000000001 110.094 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.89 -179.63 40.0 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.536 -1.316 . . . . 17.219999999999999 110.148 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -73.54 142.25 46.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -1.076 . . . . 19.57 108.33 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.911 ' CB ' HG13 ' B' ' 4' ' ' VAL . 9.2 m-85 -127.02 163.62 23.33 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.654 -1.279 . . . . 14.609999999999999 111.519 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.661 ' O ' HG22 ' B' ' 84' ' ' VAL . 55.9 p -148.4 117.42 6.77 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.002 -1.481 . . . . 18.359999999999999 107.002 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.803 ' HB ' HD12 ' B' ' 2' ' ' ILE . 16.0 t -47.62 169.29 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 C-N-CA 119.176 -1.01 . . . . 19.129999999999999 109.052 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.55 ' N ' HG12 ' B' ' 63' ' ' VAL . 7.6 t-80 -133.89 129.91 37.06 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.819 -0.808 . . . . 20.649999999999999 108.819 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.997 HD23 ' CD2' ' B' ' 68' ' ' PHE . 0.7 OUTLIER -64.27 -10.53 24.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.587 -0.696 . . . . 19.649999999999999 109.927 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.435 ' C ' ' O ' ' B' ' 65' ' ' LEU . 1.2 t -45.56 -25.83 0.51 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.56 -0.904 . . . . 14.720000000000001 108.56 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 7.1 m -98.28 -12.37 21.64 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.727 . . . . 11.449999999999999 110.486 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.997 ' CD2' HD23 ' B' ' 65' ' ' LEU . 2.5 m-30 -80.01 153.8 28.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.758 -1.214 . . . . 14.25 109.685 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.463 ' CG ' ' O ' ' B' ' 68' ' ' PHE . 71.1 mttt -157.43 170.73 21.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.541 -0.724 . . . . 32.700000000000003 109.199 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.596 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -101.05 100.79 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 15.630000000000001 109.034 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.77 -175.91 6.05 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.426 -1.47 . . . . 12.699999999999999 109.426 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.432 ' NE2' ' H ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.61 27.26 1.78 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.202 -1.175 . . . . 26.289999999999999 109.358 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.88 5.06 24.12 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.512 -0.742 . . . . 20.440000000000001 109.611 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.466 ' C ' HG13 ' A' ' 45' ' ' VAL . . . 67.36 50.0 47.7 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.41 -1.476 . . . . 13.82 109.41 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.463 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -170.37 148.94 3.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -1.135 . . . . 18.27 109.608 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.942 HD23 ' N ' ' B' ' 77' ' ' MET . 5.2 tt -61.31 159.29 12.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.218 -0.927 . . . . 12.43 109.256 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.942 ' N ' HD23 ' B' ' 76' ' ' LEU . 1.8 mtt -163.97 111.36 1.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.079 -1.013 . . . . 35.109999999999999 110.026 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.97 HD12 HD12 ' A' ' 78' ' ' ILE . 3.4 mt -52.77 145.7 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 13.67 109.726 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.3 OUTLIER -125.84 53.52 1.58 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.789 -1.56 . . . . 24.059999999999999 106.789 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.582 ' H ' HG22 ' B' ' 78' ' ' ILE . 2.4 tmm_? 89.63 67.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.334 -1.358 . . . . 35.039999999999999 107.334 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.668 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -32.92 124.93 0.36 Allowed 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.363 -0.835 . . . . 18.719999999999999 111.661 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.54 103.86 16.5 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.451 -1.314 . . . . 20.550000000000001 107.451 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.677 HD12 ' CD1' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -79.9 145.87 32.45 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.135 -0.978 . . . . 14.4 111.25 -178.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.661 HG22 ' O ' ' B' ' 62' ' ' THR . 27.3 m -146.32 158.97 46.67 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 107.967 -1.123 . . . . 17.649999999999999 107.967 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -64.42 141.24 73.5 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.049 1.833 . . . . 25.699999999999999 110.152 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -69.17 108.05 3.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.223 -0.923 . . . . 49.289999999999999 109.462 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.965 -1.017 . . . . 58.909999999999997 109.489 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.434 -0.58 . . . . 64.909999999999997 109.434 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.851 ' H ' HD22 ' B' ' 65' ' ' LEU . 1.6 mt 50.32 78.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.866 -1.161 . . . . 33.799999999999997 107.866 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.26 155.93 40.13 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.712 0.767 . . . . 32.719999999999999 110.57 -178.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.814 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -165.05 165.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.553 0.692 . . . . 14.460000000000001 109.262 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.53 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 22.3 mt-10 -138.64 116.89 11.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.557 -0.715 . . . . 22.120000000000001 109.258 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.747 HG21 ' O ' ' A' ' 56' ' ' TYR . 19.4 mm -77.43 97.44 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 O-C-N 121.259 -0.901 . . . . 14.23 108.743 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.596 ' HD3' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.14 161.15 0.31 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.089 -1.007 . . . . 25.43 110.121 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.93 -29.76 5.06 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.626 2.217 . . . . 13.609999999999999 110.214 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.41 -0.85 43.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.492 -0.755 . . . . 15.52 109.131 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 9.3 pt20 -129.97 28.88 5.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.311 -0.868 . . . . 17.309999999999999 109.644 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -85.03 16.31 3.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.17 -0.956 . . . . 24.780000000000001 110.106 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -138.72 144.33 39.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.082 -1.011 . . . . 47.899999999999999 108.828 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.741 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 12.8 p90 -87.01 178.42 6.94 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.168 -0.958 . . . . 21.609999999999999 109.743 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 8.7 t -132.22 163.01 29.53 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.58 -0.896 . . . . 14.890000000000001 108.58 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -97.0 156.08 16.5 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.138 -0.977 . . . . 17.350000000000001 109.617 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.8 OUTLIER -178.23 132.81 0.14 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 34.380000000000003 109.469 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 16' ' ' ARG . 1.2 t -43.81 152.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -0.878 . . . . 38.770000000000003 109.427 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 26' ' ' TYR . . . -164.52 132.11 2.61 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.671 -1.371 . . . . 34.579999999999998 109.671 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.27 125.5 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.153 -1.204 . . . . 41.869999999999997 108.808 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.532 ' CB ' ' HE2' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -64.88 -163.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.375 -0.828 . . . . 47.210000000000001 109.785 -179.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.05 17.07 20.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.335 -0.853 . . . . 71.560000000000002 109.361 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -114.69 2.39 14.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.286 -0.884 . . . . 66.599999999999994 109.556 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.52 8.55 67.83 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.62 -1.392 . . . . 55.490000000000002 109.62 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.532 ' HE2' ' CB ' ' A' ' 20' ' ' SER . 24.0 pttt -101.96 144.68 29.07 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.181 -1.188 . . . . 44.990000000000002 109.313 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.5 151.25 25.53 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.545 2.163 . . . . 44.100000000000001 110.584 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.94 ' CE1' HD23 ' A' ' 28' ' ' LEU . 2.4 p90 -158.35 154.98 27.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 32.090000000000003 109.997 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 m -117.25 84.01 2.08 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.824 -1.176 . . . . 29.25 107.824 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.94 HD23 ' CE1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -88.43 157.17 18.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.248 -0.908 . . . . 24.0 110.292 -178.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.786 ' N ' HD12 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -93.78 131.72 38.87 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.717 -0.845 . . . . 23.309999999999999 108.717 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.893 ' HG3' HD11 ' A' ' 28' ' ' LEU . 1.8 mp0 -109.88 159.28 17.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.861 -1.149 . . . . 40.030000000000001 109.448 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.905 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -135.68 -165.33 1.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.083 -1.01 . . . . 12.390000000000001 110.04 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.896 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -134.64 178.56 6.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.547 -0.721 . . . . 17.420000000000002 109.392 -179.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HA ' ' NE2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -172.93 153.74 2.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.955 -1.09 . . . . 13.84 108.893 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.753 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.1 m-30 -112.06 96.77 6.23 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.506 -0.924 . . . . 21.140000000000001 108.506 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.994 ' O ' HG22 ' A' ' 43' ' ' VAL . 85.7 t -97.12 114.92 35.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.036 -1.04 . . . . 10.66 110.118 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.6 p-10 -59.36 -32.13 69.84 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.301 -1.0 . . . . 25.890000000000001 108.301 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.7 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.7 OUTLIER 47.02 28.64 0.92 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.563 -0.711 . . . . 24.239999999999998 109.174 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.39 18.14 71.23 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.371 -1.492 . . . . 31.02 109.371 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.562 HD21 HD22 ' A' ' 37' ' ' LEU . 92.6 m-20 -91.01 26.67 2.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -1.122 . . . . 43.229999999999997 110.367 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.527 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 1.7 mm-40 48.35 22.24 0.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.138 -0.976 . . . . 42.340000000000003 110.148 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.549 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 3.6 m80 -175.88 153.26 1.35 Allowed Pre-proline 0 N--CA 1.493 1.716 0 N-CA-C 108.074 -1.084 . . . . 5.3799999999999999 108.074 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.645 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.6 Cg_endo -75.73 144.09 27.56 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.923 1.749 . . . . 17.920000000000002 110.938 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.994 HG22 ' O ' ' A' ' 35' ' ' VAL . 14.4 m -119.47 118.37 57.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.735 -0.839 . . . . 20.57 108.735 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.896 HD11 ' HB3' ' A' ' 32' ' ' LEU . 18.6 tp -68.41 111.79 4.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.781 -0.768 . . . . 20.210000000000001 109.339 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.572 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 4.0 t -117.2 168.46 8.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.692 -0.63 . . . . 10.81 109.352 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 1.9 mtpt -86.63 174.92 8.57 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.238 -0.914 . . . . 36.740000000000002 110.347 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -155.4 165.25 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.331 -0.856 . . . . 19.739999999999998 109.028 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.475 HG23 HD13 ' A' ' 28' ' ' LEU . 30.8 m -110.79 149.54 30.4 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.319 -0.863 . . . . 22.559999999999999 108.98 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 29' ' ' ASN . 0.3 OUTLIER -133.25 127.96 34.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.355 -0.841 . . . . 20.41 109.341 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.09 148.64 41.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 33.990000000000002 109.535 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.62 93.55 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 54.920000000000002 109.544 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.6 -29.39 3.81 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.722 -1.351 . . . . 36.100000000000001 109.722 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.456 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -72.9 144.87 85.91 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.177 -1.19 . . . . 54.759999999999998 109.597 -179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -78.2 117.48 4.12 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.696 2.264 . . . . 28.370000000000001 110.585 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.905 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.78 155.51 0.05 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.249 -0.907 . . . . 17.210000000000001 110.196 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.747 ' O ' HG21 ' A' ' 6' ' ' ILE . 15.0 m-30 -49.03 112.53 0.63 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.574 -0.704 . . . . 17.190000000000001 109.758 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.005 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -66.13 177.35 0.78 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 17.82 109.313 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 1.005 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -78.21 113.4 3.38 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.586 2.191 . . . . 17.280000000000001 110.28 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.06 177.27 43.11 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.912 -1.275 . . . . 17.219999999999999 109.912 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 4.9 mp -74.96 152.79 38.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.317 -1.107 . . . . 19.57 108.221 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.724 ' HB3' HD22 ' A' ' 83' ' ' LEU . 17.7 m-85 -140.17 165.18 28.08 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 120.802 -1.186 . . . . 14.609999999999999 111.78 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.734 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.8 p -145.64 120.55 9.98 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.356 -1.72 . . . . 18.359999999999999 106.356 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.712 ' HB ' HD13 ' A' ' 2' ' ' ILE . 4.7 t -50.38 170.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.172 0 C-N-CA 118.739 -1.185 . . . . 19.129999999999999 108.791 -178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.589 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -130.43 122.98 28.77 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.38 -0.825 . . . . 20.649999999999999 108.942 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.852 HD22 ' H ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -66.65 -6.24 14.72 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.673 -0.642 . . . . 19.649999999999999 109.747 -179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.1 t -54.78 -15.87 2.2 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.058 -1.026 . . . . 14.720000000000001 108.565 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 35.1 m -98.79 -5.75 30.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.495 -0.753 . . . . 11.449999999999999 110.891 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.67 ' C ' HD11 ' B' ' 37' ' ' LEU . 2.8 m-30 -81.16 155.7 26.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.763 -1.211 . . . . 14.25 109.988 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.666 ' HA ' HD21 ' B' ' 37' ' ' LEU . 9.9 mtmt -143.78 171.48 14.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.501 -0.749 . . . . 32.700000000000003 109.349 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.708 HG21 HG21 ' B' ' 43' ' ' VAL . 0.5 OUTLIER -117.77 131.84 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 15.630000000000001 109.603 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.67 175.86 53.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.457 -1.457 . . . . 12.699999999999999 109.457 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.2 9.6 12.41 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.115 -1.226 . . . . 26.289999999999999 109.893 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.474 ' CG ' ' O ' ' A' ' 73' ' ' PHE . 30.1 t80 -109.62 9.65 25.07 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.57 -0.707 . . . . 20.440000000000001 109.391 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' B' ' 46' ' ' LYS . . . 70.75 71.66 0.99 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.51 -1.436 . . . . 13.82 109.51 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -165.86 112.6 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -1.153 . . . . 18.27 109.683 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.813 ' CD1' HG11 ' B' ' 35' ' ' VAL . 0.3 OUTLIER -68.51 151.36 46.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 12.43 109.169 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.518 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 7.1 mtp -163.04 139.78 7.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 35.109999999999999 109.842 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.884 HD12 HD12 ' B' ' 78' ' ' ILE . 3.4 mt -67.77 140.78 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.398 -0.814 . . . . 13.67 109.805 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.472 ' HB2' ' HG3' ' A' ' 69' ' ' LYS . 1.6 t70 -110.1 -19.24 13.12 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.389 -0.967 . . . . 24.059999999999999 108.389 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.5 OUTLIER 173.01 68.11 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.878 -1.527 . . . . 35.039999999999999 106.878 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -32.06 119.62 0.27 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.512 -0.767 . . . . 18.719999999999999 111.399 -177.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -89.66 110.05 20.97 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.844 -1.169 . . . . 20.550000000000001 107.844 178.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.724 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -82.12 143.86 31.17 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.036 -1.04 . . . . 14.4 111.101 -178.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 62' ' ' THR . 4.5 m -143.99 159.56 52.68 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.97 -1.122 . . . . 17.649999999999999 107.97 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.6 Cg_endo -63.41 147.58 93.3 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.177 1.918 . . . . 25.699999999999999 110.335 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.573 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -74.62 118.75 17.93 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.105 -0.997 . . . . 49.289999999999999 109.541 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.056 -0.973 . . . . 58.909999999999997 109.468 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.528 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.37 -0.604 . . . . 64.909999999999997 109.37 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.852 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.5 mt 50.33 78.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.806 -1.183 . . . . 33.799999999999997 107.806 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.2 156.18 39.86 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.721 0.772 . . . . 32.719999999999999 110.553 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.825 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -165.25 165.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.583 0.706 . . . . 14.460000000000001 109.283 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.526 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 22.4 mt-10 -138.57 116.92 11.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.497 -0.752 . . . . 22.120000000000001 109.333 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.754 HG21 ' O ' ' B' ' 56' ' ' TYR . 19.7 mm -77.55 97.26 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.265 -0.897 . . . . 14.23 108.754 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.585 ' HE2' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.98 161.17 0.3 Allowed Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.114 -0.991 . . . . 25.43 110.145 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -77.02 -29.77 4.93 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.665 2.244 . . . . 13.609999999999999 110.169 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.31 -1.05 43.73 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.436 -0.79 . . . . 15.52 109.058 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.522 ' NE2' ' HA ' ' B' ' 33' ' ' CYS . 9.3 pt20 -129.9 29.0 5.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.861 . . . . 17.309999999999999 109.683 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -85.1 16.36 3.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 24.780000000000001 110.051 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.589 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -138.67 144.49 39.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.085 -1.009 . . . . 47.899999999999999 108.806 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.724 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 12.7 p90 -87.16 178.32 6.92 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.159 -0.963 . . . . 21.609999999999999 109.739 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 9.0 t -132.16 163.08 29.31 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.618 -0.882 . . . . 14.890000000000001 108.618 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.417 ' O ' ' HG2' ' B' ' 16' ' ' ARG . 0.2 OUTLIER -97.13 155.92 16.61 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.15 -0.969 . . . . 17.350000000000001 109.584 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.7 OUTLIER -178.13 132.64 0.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 34.380000000000003 109.429 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.429 ' C ' ' O ' ' B' ' 16' ' ' ARG . 1.2 t -43.53 152.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 38.770000000000003 109.477 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.576 ' O ' ' CD2' ' B' ' 26' ' ' TYR . . . -164.59 132.1 2.6 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.699 -1.36 . . . . 34.579999999999998 109.699 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 1.7 t -103.33 125.47 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.15 -1.206 . . . . 41.869999999999997 108.733 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.524 ' CB ' ' HE2' ' B' ' 24' ' ' LYS . 0.3 OUTLIER -64.9 -163.08 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.374 -0.829 . . . . 47.210000000000001 109.695 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.28 17.32 20.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 71.560000000000002 109.332 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -114.91 2.57 14.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.316 -0.865 . . . . 66.599999999999994 109.521 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.38 8.34 68.4 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.648 -1.381 . . . . 55.490000000000002 109.648 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.524 ' HE2' ' CB ' ' B' ' 20' ' ' SER . 24.1 pttt -101.77 144.64 28.98 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.189 -1.183 . . . . 44.990000000000002 109.368 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' B' ' 24' ' ' LYS . 35.6 Cg_endo -78.45 151.27 25.71 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.555 2.17 . . . . 44.100000000000001 110.588 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.949 ' CE1' HD23 ' B' ' 28' ' ' LEU . 2.4 p90 -158.25 155.25 28.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.2 -0.937 . . . . 32.090000000000003 109.92 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 42.9 m -117.44 83.93 2.07 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.817 -1.179 . . . . 29.25 107.817 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.949 HD23 ' CE1' ' B' ' 26' ' ' TYR . 0.7 OUTLIER -88.45 157.09 18.77 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 24.0 110.311 -178.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.781 ' N ' HD12 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -93.65 131.76 38.65 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.677 -0.86 . . . . 23.309999999999999 108.677 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.864 ' HG3' HD11 ' B' ' 28' ' ' LEU . 1.8 mp0 -110.02 159.45 17.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.958 -1.089 . . . . 40.030000000000001 109.416 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.925 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -135.81 -165.37 1.69 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.118 -0.989 . . . . 12.390000000000001 109.988 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' B' ' 44' ' ' LEU . 0.4 OUTLIER -134.68 178.46 6.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.533 -0.729 . . . . 17.420000000000002 109.395 -179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.522 ' HA ' ' NE2' ' B' ' 10' ' ' GLN . 0.1 OUTLIER -172.83 153.73 2.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.002 -1.061 . . . . 13.84 108.933 -179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.763 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.1 m-30 -112.03 96.68 6.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.462 -0.94 . . . . 21.140000000000001 108.462 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 1.01 ' O ' HG22 ' B' ' 43' ' ' VAL . 85.3 t -96.98 115.08 35.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.066 -1.021 . . . . 10.66 110.155 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.532 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.6 p-10 -59.58 -31.86 69.84 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.311 -0.996 . . . . 25.890000000000001 108.311 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.67 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.7 OUTLIER 46.76 28.61 0.84 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.473 -0.767 . . . . 24.239999999999998 109.17 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.54 18.08 71.46 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.33 -1.508 . . . . 31.02 109.33 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.581 HD21 HD22 ' B' ' 37' ' ' LEU . 92.7 m-20 -90.88 26.34 2.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.324 -1.103 . . . . 43.229999999999997 110.479 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.527 ' O ' ' ND1' ' B' ' 41' ' ' HIS . 1.7 mm-40 48.6 22.02 0.46 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.07 -1.019 . . . . 42.340000000000003 110.116 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.532 ' O ' ' HA ' ' B' ' 36' ' ' ASP . 3.6 m80 -175.68 153.18 1.4 Allowed Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 108.085 -1.08 . . . . 5.2999999999999998 108.085 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.643 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.5 Cg_endo -75.73 144.08 27.55 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.961 1.774 . . . . 17.920000000000002 110.884 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 1.01 HG22 ' O ' ' B' ' 35' ' ' VAL . 14.0 m -119.46 118.51 57.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 C-N-CA 119.601 -0.84 . . . . 20.57 108.765 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' B' ' 32' ' ' LEU . 18.9 tp -68.56 111.67 4.88 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.848 -0.741 . . . . 20.210000000000001 109.348 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.577 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 4.3 t -117.13 168.55 8.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.643 -0.661 . . . . 10.81 109.304 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 1.9 mtpt -86.67 174.98 8.51 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.353 -0.842 . . . . 36.740000000000002 110.338 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.593 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -155.42 165.24 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.424 -0.798 . . . . 19.739999999999998 109.042 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.479 HG23 HD13 ' B' ' 28' ' ' LEU . 31.2 m -110.77 149.49 30.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.371 -0.831 . . . . 22.559999999999999 108.992 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' B' ' 29' ' ' ASN . 0.3 OUTLIER -133.25 127.83 34.55 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.391 -0.818 . . . . 20.41 109.363 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.94 148.52 42.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 33.990000000000002 109.512 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.44 93.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 54.920000000000002 109.55 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.32 -29.13 3.92 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.687 -1.365 . . . . 36.100000000000001 109.687 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.454 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -73.1 144.91 85.44 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.112 -1.228 . . . . 54.759999999999998 109.515 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.4 Cg_endo -78.4 117.32 4.03 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.708 2.272 . . . . 28.370000000000001 110.591 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.925 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.52 155.7 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.18 -0.95 . . . . 17.210000000000001 110.199 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.754 ' O ' HG21 ' B' ' 6' ' ' ILE . 15.2 m-30 -49.34 112.51 0.65 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.485 -0.759 . . . . 17.190000000000001 109.876 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -65.85 177.2 0.76 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.322 -0.861 . . . . 17.82 109.258 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 36.0 Cg_endo -78.17 114.51 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.577 2.185 . . . . 17.280000000000001 110.444 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.64 177.92 42.36 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.834 -1.306 . . . . 17.219999999999999 109.834 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.0 mp -75.11 152.94 38.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -1.097 . . . . 19.57 108.396 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.726 ' HB3' HD22 ' B' ' 83' ' ' LEU . 17.6 m-85 -140.36 165.0 28.6 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.85 -1.156 . . . . 14.609999999999999 111.77 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.736 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.7 p -145.54 120.35 9.92 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 106.413 -1.699 . . . . 18.359999999999999 106.413 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.728 ' HB ' HD13 ' B' ' 2' ' ' ILE . 4.8 t -50.14 170.33 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 C-N-CA 118.836 -1.145 . . . . 19.129999999999999 108.769 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.586 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -130.53 123.13 28.91 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.391 -0.818 . . . . 20.649999999999999 108.992 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.851 HD22 ' H ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -66.61 -6.66 16.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.733 -0.605 . . . . 19.649999999999999 109.759 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 28.2 t -54.35 -16.11 2.02 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.984 -1.073 . . . . 14.720000000000001 108.575 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 33.0 m -98.66 -6.27 30.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.485 -0.759 . . . . 11.449999999999999 110.917 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.7 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.7 m-30 -80.69 155.47 26.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.751 -1.218 . . . . 14.25 109.844 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.656 ' HA ' HD21 ' A' ' 37' ' ' LEU . 10.0 mtmt -143.46 171.83 13.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.517 -0.739 . . . . 32.700000000000003 109.309 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.753 HG21 HG21 ' A' ' 43' ' ' VAL . 0.4 OUTLIER -118.04 131.84 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.283 -0.886 . . . . 15.630000000000001 109.586 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.83 176.09 53.29 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.46 -1.456 . . . . 12.699999999999999 109.46 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.4 9.45 13.23 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.114 -1.227 . . . . 26.289999999999999 109.864 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' B' ' 73' ' ' PHE . 30.1 t80 -109.45 9.65 25.44 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.564 -0.71 . . . . 20.440000000000001 109.428 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . 70.76 71.85 0.97 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.506 -1.438 . . . . 13.82 109.506 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.5 m -165.97 112.64 0.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -1.143 . . . . 18.27 109.715 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.822 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -68.58 151.33 46.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 12.43 109.193 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.517 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 7.1 mtp -163.1 139.84 7.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 35.109999999999999 109.796 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.884 HD12 HD12 ' A' ' 78' ' ' ILE . 3.4 mt -67.94 140.97 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.349 -0.844 . . . . 13.67 109.895 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.468 ' HB2' ' HG3' ' B' ' 69' ' ' LYS . 1.6 t70 -110.18 -19.26 13.09 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.376 -0.972 . . . . 24.059999999999999 108.376 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.6 OUTLIER 173.08 68.11 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.919 -1.511 . . . . 35.039999999999999 106.919 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.659 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -32.02 119.59 0.27 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.521 -0.763 . . . . 18.719999999999999 111.447 -177.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -89.66 109.97 20.89 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.91 -1.145 . . . . 20.550000000000001 107.91 178.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.726 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -82.1 143.74 31.27 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.042 -1.036 . . . . 14.4 111.095 -178.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.736 HG22 ' O ' ' B' ' 62' ' ' THR . 4.5 m -143.86 159.66 52.74 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.949 -1.13 . . . . 17.649999999999999 107.949 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -63.55 147.84 92.78 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.115 1.877 . . . . 25.699999999999999 110.394 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.576 ' HA ' HG23 ' B' ' 62' ' ' THR . . . -74.7 118.68 17.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.13 -0.981 . . . . 49.289999999999999 109.627 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.977 -1.011 . . . . 58.909999999999997 109.482 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.5 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.531 -0.544 . . . . 64.909999999999997 109.531 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.831 ' HA ' HD21 ' B' ' 65' ' ' LEU . 2.8 mt -59.04 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.879 -1.156 . . . . 33.799999999999997 107.879 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -63.39 158.65 20.04 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.81 0.814 . . . . 32.719999999999999 111.377 -177.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.055 HG22 HG22 ' A' ' 35' ' ' VAL . 60.6 t -159.99 167.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-O 121.579 0.704 . . . . 14.460000000000001 109.583 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.607 ' N ' HG12 ' A' ' 4' ' ' VAL . 22.7 mt-10 -151.7 103.84 2.98 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.946 -0.761 . . . . 22.120000000000001 108.946 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.744 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -70.67 105.69 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.092 -1.077 . . . . 14.23 108.092 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.655 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.22 173.48 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.419 -0.801 . . . . 25.43 109.988 -178.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.1 Cg_endo -76.26 -22.12 12.96 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.512 2.142 . . . . 13.609999999999999 109.727 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -101.04 8.05 43.12 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.153 -0.684 . . . . 15.52 109.153 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.531 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 17.6 mm-40 -125.25 36.04 4.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.243 -0.911 . . . . 17.309999999999999 109.401 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.13 16.54 24.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.098 -1.001 . . . . 24.780000000000001 110.151 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 4.6 tt0 -137.5 130.23 30.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.099 -1.0 . . . . 47.899999999999999 108.705 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.597 ' H ' ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -76.85 -170.69 1.69 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.088 -1.007 . . . . 21.609999999999999 110.689 -179.478 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -143.25 126.98 17.08 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.656 -0.653 . . . . 14.890000000000001 109.249 179.066 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.2 112.21 21.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.357 -0.84 . . . . 17.350000000000001 109.331 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' A' ' 18' ' ' GLY . 6.6 tpm_? -131.82 142.32 49.69 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.295 -0.878 . . . . 34.380000000000003 109.518 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.83 87.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 38.770000000000003 109.348 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -81.91 172.2 52.86 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.653 -1.379 . . . . 34.579999999999998 109.653 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.457 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -139.16 116.96 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.301 -1.117 . . . . 41.869999999999997 108.946 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 24' ' ' LYS . 3.3 m -58.18 108.68 0.63 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.294 -0.879 . . . . 47.210000000000001 109.64 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 44.79 38.2 2.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.269 -0.895 . . . . 71.560000000000002 109.569 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 58.53 18.43 5.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.233 -0.917 . . . . 66.599999999999994 109.574 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.7 -55.94 1.05 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.457 -1.457 . . . . 55.490000000000002 109.457 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' SER . 7.5 mttt -126.93 147.99 63.67 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.301 -1.117 . . . . 44.990000000000002 109.332 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.11 129.96 9.98 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.578 2.185 . . . . 44.100000000000001 110.54 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 8.3 p90 -137.17 139.37 41.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.109 -0.995 . . . . 32.090000000000003 109.69 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.05 77.58 2.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 29.25 108.833 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.706 HD22 HG22 ' A' ' 48' ' ' THR . 0.0 OUTLIER -93.08 158.95 15.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 24.0 110.145 -179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.586 ' CB ' ' CD2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -99.95 117.93 35.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -0.754 . . . . 23.309999999999999 109.067 179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -86.56 -173.58 4.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.054 -1.029 . . . . 40.030000000000001 109.14 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.579 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -173.48 -170.96 0.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.126 -0.984 . . . . 12.390000000000001 109.962 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' A' ' 44' ' ' LEU . 4.1 mp -145.52 169.9 17.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.473 -0.767 . . . . 17.420000000000002 109.238 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -167.99 166.95 13.01 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.223 -1.028 . . . . 13.84 108.223 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.678 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 31.9 m-85 -118.78 103.19 9.42 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.089 -1.007 . . . . 21.140000000000001 109.498 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.055 HG22 HG22 ' A' ' 4' ' ' VAL . 54.3 t -85.6 144.87 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.109 -0.994 . . . . 10.66 110.29 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.4 m-20 -128.48 -140.49 0.25 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.715 -0.846 . . . . 25.890000000000001 108.715 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.959 ' HG ' HD13 ' B' ' 65' ' ' LEU . 0.1 OUTLIER 68.39 -63.13 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.927 -1.108 . . . . 24.239999999999998 109.222 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -85.98 16.26 43.55 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.593 -1.803 . . . . 31.02 108.593 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -177.83 111.92 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.468 -1.019 . . . . 43.229999999999997 109.083 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.432 ' C ' ' O ' ' A' ' 39' ' ' ASN . 1.3 mm-40 -40.78 -66.96 0.27 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.476 -0.765 . . . . 42.340000000000003 109.763 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -60.06 153.63 54.94 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 108.574 -0.899 . . . . 5.5800000000000001 108.574 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.678 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.4 Cg_endo -77.34 142.83 21.58 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.146 1.897 . . . . 17.920000000000002 110.22 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.878 HG21 HG21 ' B' ' 70' ' ' VAL . 27.5 m -113.75 113.83 45.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.32 -0.863 . . . . 20.57 109.302 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' A' ' 32' ' ' LEU . 41.0 tp -69.78 112.09 5.99 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.374 -0.829 . . . . 20.210000000000001 110.221 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.603 HG12 ' CG1' ' B' ' 70' ' ' VAL . 4.9 m -112.94 -172.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.9 -0.778 . . . . 10.81 108.9 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -111.93 154.87 24.59 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.467 -0.893 . . . . 36.740000000000002 110.329 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.583 HG13 ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -129.15 162.38 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 108.924 -0.769 . . . . 19.739999999999998 108.924 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.706 HG22 HD22 ' A' ' 28' ' ' LEU . 4.5 m -119.17 73.64 0.95 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.349 -0.844 . . . . 22.559999999999999 109.235 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -40.62 133.52 1.97 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.485 -0.759 . . . . 20.41 109.663 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.7 OUTLIER -55.26 -166.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.885 . . . . 33.990000000000002 109.623 -179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.22 -83.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 54.920000000000002 109.725 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.24 40.85 2.28 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.623 -1.391 . . . . 36.100000000000001 109.623 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.536 ' O ' HD12 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -89.93 152.63 46.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.194 -1.18 . . . . 54.759999999999998 109.635 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.14 119.25 4.58 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.813 2.342 . . . . 28.370000000000001 110.742 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.61 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -41.16 146.53 0.18 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.369 -0.832 . . . . 17.210000000000001 110.339 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.744 ' O ' HG21 ' A' ' 6' ' ' ILE . 14.7 m-30 -52.13 99.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -0.825 . . . . 17.190000000000001 109.169 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.818 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -45.61 170.75 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 17.82 109.502 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.818 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.6 108.32 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.576 2.184 . . . . 17.280000000000001 110.143 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.21 -178.12 48.63 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.958 -1.257 . . . . 17.219999999999999 109.958 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.58 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 6.4 mp -73.91 149.6 41.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.402 -1.057 . . . . 19.57 108.641 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.745 ' HB3' HD22 ' A' ' 83' ' ' LEU . 12.1 m-85 -134.98 163.74 29.19 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.921 -1.112 . . . . 14.609999999999999 111.373 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.771 ' O ' HG22 ' A' ' 84' ' ' VAL . 29.2 p -145.65 119.37 9.2 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 106.721 -1.585 . . . . 18.359999999999999 106.721 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.578 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 18.5 t -47.81 170.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 C-N-CA 119.337 -0.945 . . . . 19.129999999999999 109.142 -178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.2 t-80 -133.82 126.04 29.71 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.823 -0.806 . . . . 20.649999999999999 108.823 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.939 HD13 ' HG ' ' B' ' 37' ' ' LEU . 4.6 mp -62.67 -8.0 5.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.644 -0.66 . . . . 19.649999999999999 110.432 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.407 ' OG ' ' HD3' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -47.29 -24.07 0.68 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.901 -1.124 . . . . 14.720000000000001 107.986 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 3.4 m -98.32 -13.04 20.91 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.68 -0.638 . . . . 11.449999999999999 110.673 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.673 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.6 m-30 -81.33 156.59 25.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.732 -1.23 . . . . 14.25 110.131 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 77' ' ' MET . 0.0 OUTLIER -155.19 166.76 32.57 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.942 -0.762 . . . . 32.700000000000003 108.942 179.301 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.899 HG21 HG21 ' B' ' 43' ' ' VAL . 3.0 t -104.05 125.28 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.181 -0.949 . . . . 15.630000000000001 109.227 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.6 173.62 55.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.728 -1.349 . . . . 12.699999999999999 109.728 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.454 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.0 OUTLIER -75.77 -1.14 23.6 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.206 -1.173 . . . . 26.289999999999999 109.83 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.07 -17.0 26.93 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.406 -0.809 . . . . 20.440000000000001 109.521 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.13 52.27 2.42 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.624 -1.391 . . . . 13.82 109.624 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.4 m -156.38 115.18 3.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -1.159 . . . . 18.27 109.507 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.754 HD12 HG11 ' B' ' 35' ' ' VAL . 7.1 tt -50.44 153.2 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 12.43 109.49 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.495 ' N ' HD23 ' A' ' 76' ' ' LEU . 25.3 mtt -161.1 123.84 3.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 35.109999999999999 109.718 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.934 HD12 HD12 ' B' ' 78' ' ' ILE . 3.1 mt -61.55 140.64 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.367 -0.833 . . . . 13.67 109.92 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 26.7 t70 -111.35 -16.95 13.25 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.338 -0.851 . . . . 24.059999999999999 108.972 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.505 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 169.09 63.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.577 -1.638 . . . . 35.039999999999999 106.577 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -27.2 119.59 0.09 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.665 -1.152 . . . . 18.719999999999999 112.583 -177.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.26 103.33 16.02 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.397 -1.334 . . . . 20.550000000000001 107.397 177.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.887 HD11 HG11 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -77.1 145.39 37.85 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.974 -1.079 . . . . 14.4 111.487 -177.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 62' ' ' THR . 17.8 m -144.75 160.5 47.02 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 107.835 -1.172 . . . . 17.649999999999999 107.835 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.3 Cg_endo -63.93 145.96 90.8 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.065 1.843 . . . . 25.699999999999999 110.42 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.581 ' CA ' HG23 ' A' ' 62' ' ' THR . . . -81.65 125.37 30.48 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.1 -1.0 . . . . 49.289999999999999 109.477 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.023 -0.989 . . . . 58.909999999999997 109.443 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.53 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.5 ttm . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.456 -0.572 . . . . 64.909999999999997 109.456 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.831 ' HA ' HD21 ' A' ' 65' ' ' LEU . 2.8 mt -59.0 86.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 107.856 -1.164 . . . . 33.799999999999997 107.856 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.4 OUTLIER -63.39 158.66 20.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.803 0.811 . . . . 32.719999999999999 111.411 -177.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.12 HG22 HG22 ' B' ' 35' ' ' VAL . 61.0 t -159.99 167.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.565 0.697 . . . . 14.460000000000001 109.617 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.6 ' N ' HG12 ' B' ' 4' ' ' VAL . 22.6 mt-10 -151.8 104.02 2.98 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.924 -0.769 . . . . 22.120000000000001 108.924 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.738 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -70.82 105.63 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.069 -1.086 . . . . 14.23 108.069 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.664 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.19 173.43 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.43 -0.794 . . . . 25.43 109.974 -178.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.485 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.0 Cg_endo -76.18 -22.26 12.98 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.484 2.122 . . . . 13.609999999999999 109.777 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -100.97 8.24 43.15 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.575 -0.703 . . . . 15.52 109.136 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 17.5 mm-40 -125.3 35.82 4.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 17.309999999999999 109.38 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.89 16.3 24.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.112 -0.992 . . . . 24.780000000000001 110.12 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.432 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 4.4 tt0 -137.25 130.39 30.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.143 -0.973 . . . . 47.899999999999999 108.7 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.599 ' H ' ' HB2' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -77.04 -170.7 1.75 Allowed 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.091 -1.005 . . . . 21.609999999999999 110.711 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -143.32 126.74 16.76 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.613 -0.679 . . . . 14.890000000000001 109.339 179.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.06 112.28 21.73 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.399 -0.813 . . . . 17.350000000000001 109.382 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.499 ' O ' ' N ' ' B' ' 18' ' ' GLY . 6.6 tpm_? -131.89 142.13 49.58 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.295 -0.878 . . . . 34.380000000000003 109.534 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.54 87.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.905 . . . . 38.770000000000003 109.35 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -82.13 172.29 52.62 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.613 -1.395 . . . . 34.579999999999998 109.613 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.456 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.6 OUTLIER -139.31 116.88 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -1.151 . . . . 41.869999999999997 108.97 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.515 ' N ' ' O ' ' B' ' 24' ' ' LYS . 3.3 m -58.05 108.74 0.63 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.307 -0.871 . . . . 47.210000000000001 109.643 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' B' ' 20' ' ' SER . 5.4 mmm180 44.75 38.18 2.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.296 -0.878 . . . . 71.560000000000002 109.575 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 58.57 18.4 5.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 66.599999999999994 109.615 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.59 -56.15 1.05 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.479 -1.449 . . . . 55.490000000000002 109.479 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' B' ' 20' ' ' SER . 7.5 mttt -126.67 147.85 62.42 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.232 -1.158 . . . . 44.990000000000002 109.299 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 24' ' ' LYS . 35.5 Cg_endo -78.03 129.76 9.93 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.564 2.176 . . . . 44.100000000000001 110.615 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 8.3 p90 -136.87 139.36 41.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 32.090000000000003 109.743 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.95 77.86 2.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.158 -0.964 . . . . 29.25 108.827 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.712 HD22 HG22 ' B' ' 48' ' ' THR . 0.0 OUTLIER -93.34 158.98 15.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 24.0 110.105 -179.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.596 ' CB ' ' CD2' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -100.04 118.0 35.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.433 -0.792 . . . . 23.309999999999999 109.02 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -86.61 -173.59 4.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 40.030000000000001 109.096 179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.573 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -173.5 -171.04 0.65 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.153 -0.967 . . . . 12.390000000000001 109.948 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.922 ' HB3' HD11 ' B' ' 44' ' ' LEU . 4.1 mp -145.41 169.83 17.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.424 -0.798 . . . . 17.420000000000002 109.231 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -167.95 166.82 13.14 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.305 -0.998 . . . . 13.84 108.305 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.686 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 31.6 m-85 -118.7 103.18 9.43 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.091 -1.006 . . . . 21.140000000000001 109.478 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 1.12 HG22 HG22 ' B' ' 4' ' ' VAL . 54.6 t -85.55 144.93 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.077 -1.014 . . . . 10.66 110.228 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.5 m-20 -128.71 -140.57 0.24 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.722 -0.844 . . . . 25.890000000000001 108.722 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.939 ' HG ' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER 68.48 -63.29 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.941 -1.1 . . . . 24.239999999999998 109.263 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -85.89 16.4 42.27 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 108.58 -1.808 . . . . 31.02 108.58 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' B' ' 40' ' ' GLU . 0.4 OUTLIER -177.96 111.88 0.07 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.545 -0.973 . . . . 43.229999999999997 109.066 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' B' ' 39' ' ' ASN . 1.3 mm-40 -40.71 -67.07 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.514 -0.741 . . . . 42.340000000000003 109.777 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -59.94 153.55 54.05 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 108.615 -0.883 . . . . 5.5599999999999996 108.615 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.686 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.4 Cg_endo -77.35 142.78 21.51 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.121 1.88 . . . . 17.920000000000002 110.323 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.899 HG21 HG21 ' A' ' 70' ' ' VAL . 27.4 m -113.7 113.68 44.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.25 -0.906 . . . . 20.57 109.412 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.922 HD11 ' HB3' ' B' ' 32' ' ' LEU . 40.1 tp -69.65 111.8 5.7 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.407 -0.808 . . . . 20.210000000000001 110.161 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.588 HG12 ' CG1' ' A' ' 70' ' ' VAL . 5.1 m -112.66 -172.17 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.882 -0.784 . . . . 10.81 108.882 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -111.89 155.08 24.23 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.444 -0.902 . . . . 36.740000000000002 110.311 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.591 HG13 ' CE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -129.36 162.31 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.894 -0.78 . . . . 19.739999999999998 108.894 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.712 HG22 HD22 ' B' ' 28' ' ' LEU . 4.4 m -119.24 73.72 0.95 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.295 -0.878 . . . . 22.559999999999999 109.239 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -40.63 133.41 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.521 -0.737 . . . . 20.41 109.671 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.505 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.7 OUTLIER -55.19 -166.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 33.990000000000002 109.688 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -83.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 54.920000000000002 109.745 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.22 40.62 2.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.64 -1.384 . . . . 36.100000000000001 109.64 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.539 ' O ' HD12 ' B' ' 49' ' ' LEU . 0.1 OUTLIER -89.67 152.6 47.18 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.269 -1.136 . . . . 54.759999999999998 109.649 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.16 119.22 4.56 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.792 2.328 . . . . 28.370000000000001 110.734 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -41.11 146.1 0.19 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.356 -0.84 . . . . 17.210000000000001 110.333 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.738 ' O ' HG21 ' B' ' 6' ' ' ILE . 14.8 m-30 -51.9 100.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.365 -0.834 . . . . 17.190000000000001 109.163 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.834 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -45.9 170.83 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 17.82 109.508 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.834 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -77.69 108.45 2.56 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.562 2.174 . . . . 17.280000000000001 110.186 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.88 -178.33 48.74 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.933 -1.267 . . . . 17.219999999999999 109.933 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 6.4 mp -73.54 150.01 41.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.328 -1.101 . . . . 19.57 108.667 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.743 ' HB3' HD22 ' B' ' 83' ' ' LEU . 12.0 m-85 -135.31 163.8 29.18 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.926 -1.109 . . . . 14.609999999999999 111.349 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.784 ' O ' HG22 ' B' ' 84' ' ' VAL . 29.4 p -145.73 119.47 9.22 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.67 -1.604 . . . . 18.359999999999999 106.67 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.569 HG21 HG21 ' B' ' 2' ' ' ILE . 18.6 t -47.95 170.25 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 C-N-CA 119.314 -0.954 . . . . 19.129999999999999 109.095 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.562 ' N ' HG12 ' B' ' 63' ' ' VAL . 2.2 t-80 -133.65 126.33 30.6 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.842 -0.799 . . . . 20.649999999999999 108.842 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.959 HD13 ' HG ' ' A' ' 37' ' ' LEU . 4.5 mp -63.0 -7.92 6.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.64 -0.662 . . . . 19.649999999999999 110.465 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.441 ' C ' ' O ' ' B' ' 65' ' ' LEU . 0.4 OUTLIER -47.17 -24.23 0.66 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.875 -1.141 . . . . 14.720000000000001 107.937 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.502 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 3.3 m -98.22 -13.27 20.92 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.774 -0.579 . . . . 11.449999999999999 110.753 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.68 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.5 m-30 -81.2 156.37 25.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.761 -1.212 . . . . 14.25 110.011 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' B' ' 77' ' ' MET . 0.0 OUTLIER -154.96 166.93 32.01 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.898 -0.778 . . . . 32.700000000000003 108.898 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.878 HG21 HG21 ' A' ' 43' ' ' VAL . 3.0 t -104.1 125.35 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 15.630000000000001 109.232 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.64 173.68 55.25 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.732 -1.347 . . . . 12.699999999999999 109.732 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.446 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 1.0 OUTLIER -75.89 -1.28 24.67 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.252 -1.146 . . . . 26.289999999999999 109.822 -179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -90.85 -17.35 26.68 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.408 -0.807 . . . . 20.440000000000001 109.52 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.54 52.42 2.32 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.662 -1.375 . . . . 13.82 109.662 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 57.9 m -156.59 115.33 3.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.223 -1.163 . . . . 18.27 109.531 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.771 HD12 HG11 ' A' ' 35' ' ' VAL . 7.0 tt -50.53 152.92 1.77 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 12.43 109.447 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.489 ' N ' HD23 ' B' ' 76' ' ' LEU . 25.3 mtt -160.94 123.52 3.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 35.109999999999999 109.741 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.934 HD12 HD12 ' A' ' 78' ' ' ILE . 3.0 mt -61.32 140.71 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.401 -0.812 . . . . 13.67 109.924 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 26.6 t70 -111.24 -17.26 13.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.391 -0.818 . . . . 24.059999999999999 108.928 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.502 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 169.38 63.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.592 -1.633 . . . . 35.039999999999999 106.592 179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.636 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.5 OUTLIER -27.2 119.44 0.09 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.711 -1.131 . . . . 18.719999999999999 112.576 -177.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.15 103.28 15.97 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.356 -1.349 . . . . 20.550000000000001 107.356 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.892 HD11 HG11 ' B' ' 4' ' ' VAL . 0.4 OUTLIER -77.06 145.22 38.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.905 -1.122 . . . . 14.4 111.515 -177.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.784 HG22 ' O ' ' B' ' 62' ' ' THR . 17.6 m -144.72 160.44 47.34 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.838 -1.171 . . . . 17.649999999999999 107.838 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.5 Cg_endo -63.88 146.01 91.08 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.099 1.866 . . . . 25.699999999999999 110.464 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.587 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -81.66 125.33 30.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.987 . . . . 49.289999999999999 109.528 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.987 -1.006 . . . . 58.909999999999997 109.452 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.483 ' C ' HD22 ' B' ' 65' ' ' LEU . 1.7 pmm? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.33 0.586 . . . . 64.909999999999997 109.46 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.848 ' CA ' HD22 ' B' ' 65' ' ' LEU . 3.0 mt -67.82 80.29 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.113 -1.069 . . . . 33.799999999999997 108.113 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.485 ' HB3' ' OD2' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -64.35 153.9 37.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.77 0.795 . . . . 32.719999999999999 110.906 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.886 HG11 HD21 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -163.26 165.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.693 -0.854 . . . . 14.460000000000001 108.693 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 31.3 mt-10 -141.8 113.03 7.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 22.120000000000001 109.381 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.857 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -73.96 103.76 2.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 119.014 -1.075 . . . . 14.23 108.231 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.652 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.85 171.4 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.366 -0.834 . . . . 25.43 109.84 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.3 Cg_endo -76.1 -29.28 6.7 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.492 2.128 . . . . 13.609999999999999 109.803 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 t -85.12 -0.45 54.57 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.912 -0.774 . . . . 15.52 108.912 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.534 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 4.0 mm100 -118.0 35.9 4.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.358 -0.839 . . . . 17.309999999999999 109.304 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -101.06 10.81 40.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 24.780000000000001 110.475 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.434 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -139.26 131.55 28.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.043 -1.035 . . . . 47.899999999999999 108.718 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.634 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 26.4 p90 -85.99 177.45 7.58 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.081 -1.012 . . . . 21.609999999999999 110.171 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 9.1 t -130.93 162.39 29.8 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.402 -0.962 . . . . 14.890000000000001 108.402 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' A' ' 16' ' ' ARG . 15.0 t -110.38 161.92 15.17 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.056 -1.028 . . . . 17.350000000000001 110.005 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -177.33 145.86 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.997 -0.742 . . . . 34.380000000000003 108.997 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.01 87.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.204 -0.935 . . . . 38.770000000000003 109.751 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -78.45 -174.81 44.49 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.11 -1.596 . . . . 34.579999999999998 109.11 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.484 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 1.3 t -149.58 117.79 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.26 . . . . 41.869999999999997 109.173 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.72 -95.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.386 -0.822 . . . . 47.210000000000001 109.805 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.519 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 7.9 ttp180 -119.74 51.95 1.14 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.093 -1.004 . . . . 71.560000000000002 109.606 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' A' ' 21' ' ' ARG . 5.5 mt-30 67.67 13.88 9.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 66.599999999999994 109.629 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.53 -52.57 1.54 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.285 -1.526 . . . . 55.490000000000002 109.285 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -148.74 148.25 27.22 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.351 -1.088 . . . . 44.990000000000002 109.028 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 35.0 Cg_endo -77.55 138.09 16.99 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.501 2.134 . . . . 44.100000000000001 110.755 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.691 ' CD1' HD23 ' A' ' 28' ' ' LEU . 6.8 p90 -124.96 141.27 52.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.207 -0.933 . . . . 32.090000000000003 109.926 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.8 75.92 4.25 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.265 -1.013 . . . . 29.25 108.265 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.691 HD23 ' CD1' ' A' ' 26' ' ' TYR . 2.0 mm? -91.98 159.51 15.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.34 -0.85 . . . . 24.0 110.23 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.634 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -101.43 131.35 47.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.811 . . . . 23.309999999999999 108.894 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 87.7 mt-10 -113.98 157.98 21.76 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.119 -0.988 . . . . 40.030000000000001 109.758 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.616 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -139.78 -167.87 2.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 12.390000000000001 109.226 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.915 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.3 mp -134.74 176.46 8.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 17.420000000000002 109.195 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.48 166.45 8.38 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.063 -1.023 . . . . 13.84 108.58 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.663 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 22.2 m-85 -120.15 106.11 11.63 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 21.140000000000001 109.423 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.979 ' O ' HG22 ' A' ' 43' ' ' VAL . 82.2 t -98.89 111.32 28.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.134 -0.979 . . . . 10.66 109.565 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 1.5 p30 -52.31 -30.2 27.14 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.192 -0.943 . . . . 25.890000000000001 108.487 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.701 HD22 HD21 ' A' ' 39' ' ' ASN . 0.9 OUTLIER 45.29 36.92 2.47 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.48 -0.762 . . . . 24.239999999999998 109.093 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.53 18.92 39.35 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.35 -1.5 . . . . 31.02 109.35 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.701 HD21 HD22 ' A' ' 37' ' ' LEU . 90.3 m-20 -92.33 25.86 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.308 -1.113 . . . . 43.229999999999997 110.483 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.563 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 45.6 mt-10 44.3 25.68 0.13 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.065 -1.022 . . . . 42.340000000000003 109.776 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.563 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 9.9 m80 -173.03 150.8 2.02 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.952 -1.129 . . . . 2.8599999999999999 107.952 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.2 Cg_endo -75.98 136.12 18.11 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.788 1.659 . . . . 17.920000000000002 110.622 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.979 HG22 ' O ' ' A' ' 35' ' ' VAL . 10.3 m -112.16 115.41 49.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.564 -0.902 . . . . 20.57 108.564 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.915 HD11 ' HB3' ' A' ' 32' ' ' LEU . 47.6 tp -66.48 107.48 2.07 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.341 -0.849 . . . . 20.210000000000001 109.223 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.571 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 3.8 t -112.65 167.58 5.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.511 -0.743 . . . . 10.81 109.41 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -91.13 163.43 14.28 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.301 -0.874 . . . . 36.740000000000002 109.997 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.94 HD13 HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -151.43 172.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.26 -0.9 . . . . 19.739999999999998 109.289 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.842 HG21 ' NH1' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -110.09 153.64 24.38 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 22.559999999999999 109.255 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.6 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -127.55 101.58 6.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.404 -0.81 . . . . 20.41 109.057 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 2.6 t0 -44.28 144.62 0.95 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.853 . . . . 33.990000000000002 109.999 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -64.24 102.1 0.48 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 54.920000000000002 109.091 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.13 -26.19 6.82 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.02 -1.632 . . . . 36.100000000000001 109.02 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.497 ' O ' HD12 ' A' ' 49' ' ' LEU . 8.1 mt-30 -76.56 144.24 73.4 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.356 -1.085 . . . . 54.759999999999998 109.13 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -78.01 130.16 10.19 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.52 2.147 . . . . 28.370000000000001 110.518 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.616 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -39.58 141.72 0.36 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.495 -0.753 . . . . 17.210000000000001 110.082 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.857 ' O ' HG21 ' A' ' 6' ' ' ILE . 87.0 m-85 -43.23 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.407 -0.808 . . . . 17.190000000000001 109.027 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.733 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -42.71 166.16 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 17.82 109.699 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.733 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.3 Cg_endo -77.02 111.91 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.568 2.179 . . . . 17.280000000000001 110.062 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.38 -175.73 47.58 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.804 -1.318 . . . . 17.219999999999999 109.804 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 4.7 mp -76.09 147.48 38.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.286 -1.126 . . . . 19.57 108.706 179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.768 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.7 m-85 -137.4 165.13 26.97 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.457 1.122 . . . . 14.609999999999999 111.204 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.796 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.5 p -145.43 120.57 10.13 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 106.066 -1.827 . . . . 18.359999999999999 106.066 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -53.95 164.97 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 118.392 -1.323 . . . . 19.129999999999999 108.877 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.433 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.3 t-80 -127.07 129.91 48.91 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.913 -0.773 . . . . 20.649999999999999 108.913 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.861 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -71.79 0.56 8.68 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.41 -0.806 . . . . 19.649999999999999 109.802 179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.36 -21.06 8.49 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.252 -1.388 . . . . 14.720000000000001 107.252 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.507 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 24.4 m -95.12 -9.2 34.26 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.855 -0.528 . . . . 11.449999999999999 110.058 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.672 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.0 m-30 -78.73 156.61 28.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 14.25 109.705 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.672 ' HA ' HD21 ' B' ' 37' ' ' LEU . 12.2 mttt -146.97 173.89 12.02 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.367 -0.833 . . . . 32.700000000000003 109.356 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.614 HG22 HD13 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -111.58 111.57 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 15.630000000000001 109.433 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.22 -177.34 47.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.489 -1.444 . . . . 12.699999999999999 109.489 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.93 38.95 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.196 -1.179 . . . . 26.289999999999999 109.55 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.12 24.77 4.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 20.440000000000001 109.579 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.442 ' C ' HG13 ' B' ' 45' ' ' VAL . . . 50.1 58.75 8.3 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.543 -1.423 . . . . 13.82 109.543 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.25 131.83 1.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.306 -1.114 . . . . 18.27 109.667 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.513 HD11 HD12 ' B' ' 37' ' ' LEU . 1.2 tp -69.38 153.74 43.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.903 . . . . 12.43 109.108 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' A' ' 76' ' ' LEU . 4.5 mmt -154.73 121.67 5.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -0.969 . . . . 35.109999999999999 109.557 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.943 HD12 HD12 ' B' ' 78' ' ' ILE . 2.6 mt -57.26 141.96 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.302 -0.874 . . . . 13.67 109.831 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -116.0 -3.32 12.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.422 -0.799 . . . . 24.059999999999999 109.034 178.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.842 ' NH1' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER 156.49 62.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 106.998 -1.482 . . . . 35.039999999999999 106.998 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -27.75 120.23 0.1 Allowed 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.017 -0.992 . . . . 18.719999999999999 112.141 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HG3' ' NH1' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -91.99 102.15 14.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.67 -0.863 . . . . 20.550000000000001 108.67 179.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.94 HD12 HD13 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -70.37 145.26 51.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.279 -0.888 . . . . 14.4 111.281 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 62' ' ' THR . 35.2 m -146.5 151.16 42.65 Favored Pre-proline 0 C--N 1.302 -1.459 0 N-CA-C 107.937 -1.134 . . . . 17.649999999999999 107.937 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.3 Cg_endo -62.72 145.7 95.03 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.203 1.935 . . . . 25.699999999999999 110.464 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -78.98 115.06 18.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 49.289999999999999 109.754 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.019 -0.991 . . . . 58.909999999999997 109.431 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.478 ' C ' HD22 ' A' ' 65' ' ' LEU . 1.7 pmm? . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.36 0.6 . . . . 64.909999999999997 109.516 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.861 ' CA ' HD22 ' A' ' 65' ' ' LEU . 3.0 mt -67.91 80.13 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.12 -1.067 . . . . 33.799999999999997 108.12 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.49 ' HB3' ' OD2' ' B' ' 36' ' ' ASP . 0.0 OUTLIER -64.26 153.87 36.82 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.771 0.796 . . . . 32.719999999999999 110.87 -178.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.886 HG11 HD21 ' B' ' 83' ' ' LEU . 0.1 OUTLIER -163.27 165.05 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.633 -0.877 . . . . 14.460000000000001 108.633 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 31.4 mt-10 -141.75 112.87 7.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.343 -0.848 . . . . 22.120000000000001 109.478 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.844 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -73.85 103.68 2.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.999 -1.08 . . . . 14.23 108.225 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.655 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.81 171.33 0.07 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.402 -0.811 . . . . 25.43 109.852 -179.275 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 34.4 Cg_endo -76.1 -29.21 6.76 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.496 2.13 . . . . 13.609999999999999 109.856 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 4.3 t -85.07 -0.59 54.97 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.829 -0.804 . . . . 15.52 108.829 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 4.1 mm100 -118.0 36.03 4.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.419 -0.801 . . . . 17.309999999999999 109.292 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -101.2 10.94 40.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.167 -0.958 . . . . 24.780000000000001 110.44 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.442 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.5 OUTLIER -139.3 131.61 28.37 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.145 -0.972 . . . . 47.899999999999999 108.672 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.634 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 26.3 p90 -86.07 177.53 7.53 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.058 -1.026 . . . . 21.609999999999999 110.052 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 9.2 t -130.98 162.38 29.88 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.392 -0.966 . . . . 14.890000000000001 108.392 178.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' B' ' 16' ' ' ARG . 15.0 t -110.4 161.96 15.14 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.127 -0.983 . . . . 17.350000000000001 109.993 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' B' ' 15' ' ' THR . 0.3 OUTLIER -177.31 145.85 0.46 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.961 -0.755 . . . . 34.380000000000003 108.961 179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.99 87.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 38.770000000000003 109.763 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.573 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -78.49 -174.85 44.65 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.118 -1.593 . . . . 34.579999999999998 109.118 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.481 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.3 t -149.5 117.86 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -1.222 . . . . 41.869999999999997 109.139 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.83 -95.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.361 -0.837 . . . . 47.210000000000001 109.815 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.523 ' O ' ' CG ' ' B' ' 21' ' ' ARG . 8.0 ttp180 -119.79 51.9 1.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 71.560000000000002 109.636 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' B' ' 21' ' ' ARG . 5.5 mt-30 67.63 13.94 9.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 66.599999999999994 109.627 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.55 -52.66 1.53 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.257 -1.537 . . . . 55.490000000000002 109.257 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -148.64 148.34 27.79 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.345 -1.091 . . . . 44.990000000000002 109.03 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.9 Cg_endo -77.65 138.17 16.87 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.479 2.12 . . . . 44.100000000000001 110.683 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.678 ' CD1' HD23 ' B' ' 28' ' ' LEU . 6.9 p90 -125.12 141.23 52.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.215 -0.928 . . . . 32.090000000000003 109.875 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.81 75.91 4.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.25 -1.018 . . . . 29.25 108.25 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.678 HD23 ' CD1' ' B' ' 26' ' ' TYR . 2.0 mm? -91.96 159.41 15.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.373 -0.83 . . . . 24.0 110.253 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.634 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -101.37 131.22 47.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.381 -0.824 . . . . 23.309999999999999 108.892 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 87.5 mt-10 -113.89 158.03 21.61 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.109 -0.994 . . . . 40.030000000000001 109.826 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.598 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -139.84 -167.96 2.4 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.216 -0.928 . . . . 12.390000000000001 109.223 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.897 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.3 mp -134.68 176.58 8.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 17.420000000000002 109.235 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.56 166.51 8.22 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.09 -1.006 . . . . 13.84 108.543 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.67 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 22.2 m-85 -120.28 106.18 11.65 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.109 -0.994 . . . . 21.140000000000001 109.395 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.96 ' O ' HG22 ' B' ' 43' ' ' VAL . 81.8 t -98.97 111.16 27.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.121 -0.987 . . . . 10.66 109.561 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 1.5 p30 -52.18 -30.19 25.77 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.205 -0.935 . . . . 25.890000000000001 108.495 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.676 HD22 HD21 ' B' ' 39' ' ' ASN . 0.9 OUTLIER 45.26 36.93 2.44 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.473 -0.767 . . . . 24.239999999999998 109.065 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.49 19.03 39.49 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.386 -1.486 . . . . 31.02 109.386 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.676 HD21 HD22 ' B' ' 37' ' ' LEU . 90.1 m-20 -92.39 25.93 2.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 43.229999999999997 110.539 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.575 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 45.3 mt-10 44.29 25.6 0.13 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.053 -1.029 . . . . 42.340000000000003 109.84 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 10.0 m80 -172.98 150.78 2.04 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 107.979 -1.119 . . . . 2.8599999999999999 107.979 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.1 Cg_endo -76.02 136.1 18.0 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.852 1.702 . . . . 17.920000000000002 110.606 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.96 HG22 ' O ' ' B' ' 35' ' ' VAL . 10.1 m -112.18 115.45 49.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.613 -0.884 . . . . 20.57 108.613 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.897 HD11 ' HB3' ' B' ' 32' ' ' LEU . 48.0 tp -66.55 107.49 2.1 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.331 -0.856 . . . . 20.210000000000001 109.299 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.592 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 4.0 t -112.65 167.66 5.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.586 -0.697 . . . . 10.81 109.469 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.577 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -91.19 163.16 14.36 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.669 -0.812 . . . . 36.740000000000002 109.97 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.975 HD13 HD12 ' B' ' 83' ' ' LEU . 0.4 OUTLIER -151.19 172.86 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.308 -0.87 . . . . 19.739999999999998 109.326 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.834 HG21 ' NH1' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -110.09 153.53 24.54 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.301 -0.874 . . . . 22.559999999999999 109.245 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.59 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -127.45 101.66 6.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 20.41 109.061 -179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.454 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 2.6 t0 -44.31 144.61 0.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.341 -0.849 . . . . 33.990000000000002 109.97 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -64.21 102.09 0.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 54.920000000000002 109.053 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.2 -26.26 6.77 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.059 -1.616 . . . . 36.100000000000001 109.059 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.498 ' O ' HD12 ' B' ' 49' ' ' LEU . 8.1 mt-30 -76.55 144.47 73.84 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.382 -1.07 . . . . 54.759999999999998 109.018 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.15 130.12 10.04 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.544 2.163 . . . . 28.370000000000001 110.517 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.598 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -39.62 141.97 0.35 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.49 -0.756 . . . . 17.210000000000001 109.99 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.844 ' O ' HG21 ' B' ' 6' ' ' ILE . 86.4 m-85 -43.61 98.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.368 -0.833 . . . . 17.190000000000001 109.012 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.721 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -43.48 166.42 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.839 . . . . 17.82 109.59 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.721 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -77.54 113.0 3.44 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.625 2.217 . . . . 17.280000000000001 110.317 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.56 -175.02 46.83 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.666 -1.374 . . . . 17.219999999999999 109.666 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.0 mp -75.99 148.04 38.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -1.111 . . . . 19.57 108.995 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.781 ' HB3' HD22 ' B' ' 83' ' ' LEU . 20.7 m-85 -137.9 165.0 27.59 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.413 1.102 . . . . 14.609999999999999 111.254 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.789 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.2 p -145.46 120.61 10.13 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.127 -1.805 . . . . 18.359999999999999 106.127 178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.662 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -54.02 165.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 C-N-CA 118.396 -1.321 . . . . 19.129999999999999 108.858 -178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.433 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.3 t-80 -127.01 129.96 49.09 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.97 -0.752 . . . . 20.649999999999999 108.97 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.848 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -71.87 0.54 8.89 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.377 -0.827 . . . . 19.649999999999999 109.735 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -20.94 7.9 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.263 -1.384 . . . . 14.720000000000001 107.263 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.495 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 23.9 m -95.33 -9.58 32.56 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.899 -0.5 . . . . 11.449999999999999 110.058 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.661 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.9 m-30 -78.36 156.11 29.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.124 -0.985 . . . . 14.25 109.715 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.679 ' HA ' HD21 ' A' ' 37' ' ' LEU . 12.2 mttt -146.58 173.37 12.39 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.411 -0.805 . . . . 32.700000000000003 109.415 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.659 HG22 HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -111.08 111.63 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -0.869 . . . . 15.630000000000001 109.389 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.34 -177.35 48.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.421 -1.472 . . . . 12.699999999999999 109.421 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.94 39.0 0.94 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.148 -1.207 . . . . 26.289999999999999 109.561 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -133.08 24.73 4.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 20.440000000000001 109.606 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.451 ' C ' HG13 ' A' ' 45' ' ' VAL . . . 50.02 59.14 7.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.519 -1.432 . . . . 13.82 109.519 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.53 131.83 1.84 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -1.135 . . . . 18.27 109.685 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 37' ' ' LEU . 1.2 tp -69.41 153.66 43.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -0.892 . . . . 12.43 109.152 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.448 ' SD ' ' O ' ' B' ' 76' ' ' LEU . 4.5 mmt -154.74 121.77 5.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.097 -1.002 . . . . 35.109999999999999 109.573 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.943 HD12 HD12 ' A' ' 78' ' ' ILE . 2.5 mp -57.4 142.02 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.342 -0.849 . . . . 13.67 109.819 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' B' ' 80' ' ' ARG . 0.7 OUTLIER -115.97 -3.39 12.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.49 -0.756 . . . . 24.059999999999999 108.997 178.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.834 ' NH1' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER 156.5 63.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.931 -1.507 . . . . 35.039999999999999 106.931 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.662 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.8 OUTLIER -27.89 120.33 0.11 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.001 -1.0 . . . . 18.719999999999999 112.134 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.496 ' HG3' ' NH1' ' B' ' 82' ' ' ARG . 0.0 OUTLIER -92.04 102.08 14.63 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.675 -0.861 . . . . 20.550000000000001 108.675 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.975 HD12 HD13 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -70.39 145.39 51.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.352 -0.843 . . . . 14.4 111.345 -178.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.789 HG22 ' O ' ' B' ' 62' ' ' THR . 35.3 m -146.58 151.03 42.03 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.89 -1.152 . . . . 17.649999999999999 107.89 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.9 Cg_endo -62.53 145.71 95.44 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.181 1.92 . . . . 25.699999999999999 110.419 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -79.05 115.07 18.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.23 -0.919 . . . . 49.289999999999999 109.76 -178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.048 -0.977 . . . . 58.909999999999997 109.457 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.528 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.3 ttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.534 -0.543 . . . . 64.909999999999997 109.534 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.664 HG21 HG21 ' A' ' 63' ' ' VAL . 2.8 mt -61.52 82.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.962 -1.125 . . . . 33.799999999999997 107.962 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.62 ' C ' HG12 ' A' ' 4' ' ' VAL . 23.4 mttp -70.33 179.12 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.894 0.854 . . . . 32.719999999999999 111.277 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.043 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 173.56 167.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.902 -0.777 . . . . 14.460000000000001 108.902 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.576 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 79.7 mt-10 -141.31 111.17 6.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.545 -0.722 . . . . 22.120000000000001 109.259 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.834 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -72.58 105.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.545 -1.28 . . . . 14.23 107.545 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.538 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.7 mmpt? -54.14 160.36 2.43 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.118 -0.989 . . . . 25.43 109.539 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 31.8 Cg_endo -73.79 -9.25 22.31 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.057 1.838 . . . . 13.609999999999999 109.19 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.85 7.64 46.16 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.89 -0.782 . . . . 15.52 108.89 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.654 ' OE1' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -142.58 37.41 1.49 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.261 -0.899 . . . . 17.309999999999999 109.13 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.58 15.46 6.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 24.780000000000001 109.803 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.476 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -143.96 143.63 31.32 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.182 -0.949 . . . . 47.899999999999999 108.597 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.67 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 26.0 p90 -85.46 173.31 10.34 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.038 -1.039 . . . . 21.609999999999999 109.61 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 15' ' ' THR . 39.9 m -137.6 154.95 49.68 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.471 -0.768 . . . . 14.890000000000001 109.0 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 14' ' ' THR . 0.2 OUTLIER -91.46 111.03 22.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.175 -0.953 . . . . 17.350000000000001 109.506 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 17' ' ' SER . 5.7 ttt180 -136.59 149.05 47.85 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.842 . . . . 34.380000000000003 109.09 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 16' ' ' ARG . 5.4 p -43.91 148.48 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 38.770000000000003 109.321 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -144.04 179.67 21.2 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.581 -1.407 . . . . 34.579999999999998 109.581 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -155.58 117.18 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -1.127 . . . . 41.869999999999997 108.795 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 22' ' ' GLN . 0.1 OUTLIER -60.33 79.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.323 -0.861 . . . . 47.210000000000001 109.632 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.5 OUTLIER 68.25 -60.18 0.42 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.166 -0.959 . . . . 71.560000000000002 109.372 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' A' ' 20' ' ' SER . 1.7 pt20 175.86 43.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 66.599999999999994 109.513 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.99 -51.16 0.41 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.491 -1.444 . . . . 55.490000000000002 109.491 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.436 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 18.6 pttm -153.32 159.77 31.76 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.301 -1.117 . . . . 44.990000000000002 109.329 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.7 Cg_endo -77.26 120.94 5.5 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.596 2.197 . . . . 44.100000000000001 110.675 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 28' ' ' LEU . 4.0 p90 -126.34 139.02 53.62 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.268 -0.895 . . . . 32.090000000000003 109.627 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -103.29 80.52 1.84 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 29.25 108.846 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.667 HD23 ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -102.58 134.33 46.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 24.0 110.23 -179.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.661 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -46.01 128.45 9.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.427 -0.796 . . . . 23.309999999999999 109.546 179.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -121.13 143.09 49.28 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.258 -0.901 . . . . 40.030000000000001 108.788 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.938 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -115.1 -167.29 1.21 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.963 -1.086 . . . . 12.390000000000001 110.149 -179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.886 ' HB3' HD11 ' A' ' 44' ' ' LEU . 21.1 mt -128.44 177.99 6.6 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.48 -0.762 . . . . 17.420000000000002 109.557 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.566 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -173.46 150.72 1.85 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.987 -1.07 . . . . 13.84 109.238 -179.461 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.762 ' HE1' HD13 ' A' ' 44' ' ' LEU . 2.9 m-85 -109.8 91.32 3.6 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.181 -1.044 . . . . 21.140000000000001 108.181 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.866 HG22 ' HB ' ' A' ' 4' ' ' VAL . 97.9 t -92.89 117.58 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.98 . . . . 10.66 110.155 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 27.6 t0 -53.56 -28.49 32.18 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.415 -0.957 . . . . 25.890000000000001 108.415 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.83 HD21 ' HA ' ' B' ' 69' ' ' LYS . 1.9 tt 43.25 34.47 0.71 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.498 -0.751 . . . . 24.239999999999998 109.239 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.35 23.12 52.9 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.457 -1.457 . . . . 31.02 109.457 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.736 HD21 HD22 ' A' ' 37' ' ' LEU . 98.6 m-20 -97.33 26.35 4.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -1.155 . . . . 43.229999999999997 110.263 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.551 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 42.9 mt-10 49.25 21.62 0.56 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.134 -0.979 . . . . 42.340000000000003 109.949 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 6.0 m80 -174.71 157.11 2.23 Favored Pre-proline 0 N--CA 1.494 1.738 0 N-CA-C 108.027 -1.101 . . . . 6.1600000000000001 108.027 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.641 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.8 Cg_endo -75.6 146.14 30.24 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.019 1.813 . . . . 17.920000000000002 111.005 -179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.846 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.6 m -122.46 118.38 55.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 108.622 -0.881 . . . . 20.57 108.622 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 32' ' ' LEU . 22.4 tp -69.14 109.42 4.04 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.662 -0.815 . . . . 20.210000000000001 109.04 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.591 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 3.9 t -117.18 168.89 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.614 -0.678 . . . . 10.81 109.516 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.581 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -88.63 161.93 16.61 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.298 -0.876 . . . . 36.740000000000002 110.423 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.693 HD12 ' HE2' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -133.11 164.43 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.485 -0.932 . . . . 19.739999999999998 108.485 179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.51 ' N ' ' CG2' ' A' ' 47' ' ' ILE . 0.3 OUTLIER -108.76 135.5 49.88 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.193 -0.942 . . . . 22.559999999999999 108.565 178.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.667 ' O ' HD23 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -123.88 123.9 41.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 20.41 109.365 -179.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . 1.3 t0 -71.4 142.53 50.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 33.990000000000002 109.546 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -50.29 107.72 0.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 54.920000000000002 109.664 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.04 -2.4 44.33 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.859 -1.296 . . . . 36.100000000000001 109.859 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.625 ' O ' HD12 ' A' ' 49' ' ' LEU . 13.2 mt-30 -89.19 144.5 32.6 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 54.759999999999998 109.525 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 55' ' ' ALA . 35.1 Cg_endo -78.38 114.78 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.643 2.229 . . . . 28.370000000000001 110.642 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.938 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -43.79 168.74 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.337 -0.852 . . . . 17.210000000000001 110.031 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.834 ' HB3' HD13 ' A' ' 6' ' ' ILE . 31.0 m-85 -66.14 122.85 18.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 17.190000000000001 109.657 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.997 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -74.48 179.39 1.31 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.455 -0.778 . . . . 17.82 109.808 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.997 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.9 Cg_endo -78.01 115.41 3.77 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.582 2.188 . . . . 17.280000000000001 110.436 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 166.85 142.0 3.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.317 -1.513 . . . . 17.219999999999999 109.317 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 59' ' ' GLY . 4.0 mp -42.11 144.43 0.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.153 -1.204 . . . . 19.57 109.382 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 1.043 ' CB ' HG13 ' A' ' 4' ' ' VAL . 15.1 m-85 -121.52 166.37 14.28 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.487 1.137 . . . . 14.609999999999999 111.253 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.572 HG23 ' CA ' ' A' ' 86' ' ' ALA . 39.8 p -149.35 120.54 7.79 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.505 -2.035 . . . . 18.359999999999999 105.505 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.892 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.9 t -57.89 161.37 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 C-N-CA 118.107 -1.437 . . . . 19.129999999999999 108.934 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 82' ' ' ARG . 5.1 t-80 -116.19 138.41 51.3 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.592 -0.693 . . . . 20.649999999999999 109.203 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.751 HD23 ' CD2' ' A' ' 68' ' ' PHE . 2.1 mt -70.71 -8.44 52.13 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.098 -0.704 . . . . 19.649999999999999 109.098 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.418 ' OG ' ' HD3' ' A' ' 82' ' ' ARG . 0.5 OUTLIER -47.93 -24.95 1.16 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.268 -1.012 . . . . 14.720000000000001 108.268 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.54 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 3.7 m -93.7 -14.77 25.96 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.825 -0.75 . . . . 11.449999999999999 109.943 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.756 ' HB3' HD21 ' A' ' 76' ' ' LEU . 3.5 m-30 -80.69 147.07 30.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.064 -1.022 . . . . 14.25 109.973 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.8 ' HA ' HD21 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -146.31 172.87 12.84 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.643 -0.661 . . . . 32.700000000000003 109.229 -179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.67 HG22 HD13 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -107.33 109.55 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 15.630000000000001 109.171 179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.07 -173.08 49.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.582 -1.407 . . . . 12.699999999999999 109.582 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 72' ' ' GLN . 0.6 OUTLIER -95.87 22.98 6.72 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.261 -1.141 . . . . 26.289999999999999 108.948 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 -9.45 26.65 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 120.283 -0.567 . . . . 20.440000000000001 109.704 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.436 ' C ' HG13 ' B' ' 45' ' ' VAL . . . 81.5 40.41 11.09 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.692 -1.363 . . . . 13.82 109.692 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.499 ' HA ' ' CG1' ' B' ' 45' ' ' VAL . 4.4 m -169.18 138.54 2.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.14 . . . . 18.27 109.564 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.756 HD21 ' HB3' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -47.57 160.49 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 12.43 109.46 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtt -158.64 107.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 35.109999999999999 109.708 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.626 HG12 ' CD1' ' A' ' 68' ' ' PHE . 23.4 mt -60.33 138.11 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.831 . . . . 13.67 109.815 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 12.1 t70 -103.13 -22.67 13.73 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.357 -0.84 . . . . 24.059999999999999 108.802 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.54 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.5 OUTLIER 171.86 66.74 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.542 -1.281 . . . . 35.039999999999999 107.542 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.892 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -21.72 119.01 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.033 -0.985 . . . . 18.719999999999999 112.264 -178.248 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -92.68 103.72 16.07 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.601 -0.888 . . . . 20.550000000000001 108.601 179.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.974 HD11 HG11 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -73.78 145.05 45.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.146 -0.971 . . . . 14.4 111.528 -178.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 62' ' ' THR . 2.4 m -149.64 156.25 38.85 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 107.524 -1.287 . . . . 17.649999999999999 107.524 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 24.7 Cg_endo -63.3 141.13 80.59 Favored 'Trans proline' 0 C--N 1.302 -1.921 0 C-N-CA 121.9 1.733 . . . . 25.699999999999999 110.26 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.572 ' CA ' HG23 ' A' ' 62' ' ' THR . . . -70.66 112.13 6.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.191 -0.943 . . . . 49.289999999999999 109.5 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.045 -0.978 . . . . 58.909999999999997 109.475 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.531 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.3 ttp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.526 -0.546 . . . . 64.909999999999997 109.526 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.666 HG21 HG21 ' B' ' 63' ' ' VAL . 2.8 mt -61.56 82.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.985 -1.117 . . . . 33.799999999999997 107.985 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.635 ' C ' HG12 ' B' ' 4' ' ' VAL . 23.3 mttp -70.1 179.2 2.43 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.979 0.895 . . . . 32.719999999999999 111.284 -178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.046 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 173.46 167.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.865 -0.791 . . . . 14.460000000000001 108.865 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 79.6 mt-10 -141.36 111.14 6.55 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.62 0.724 . . . . 22.120000000000001 109.241 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.829 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -72.55 105.34 2.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.54 -1.281 . . . . 14.23 107.54 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.541 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.7 mmpt? -54.3 160.39 2.54 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.113 -0.992 . . . . 25.43 109.509 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.9 Cg_endo -73.75 -9.25 22.37 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.032 1.821 . . . . 13.609999999999999 109.181 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.84 7.51 46.45 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.803 -0.814 . . . . 15.52 108.803 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.645 ' OE1' HD13 ' B' ' 44' ' ' LEU . 0.0 OUTLIER -142.63 37.6 1.48 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.206 -0.934 . . . . 17.309999999999999 109.093 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.7 15.34 7.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 24.780000000000001 109.831 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.467 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -143.91 143.44 31.27 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.216 -0.927 . . . . 47.899999999999999 108.686 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.666 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 26.3 p90 -85.24 173.22 10.55 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.036 -1.04 . . . . 21.609999999999999 109.609 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.42 HG22 ' N ' ' B' ' 15' ' ' THR . 39.9 m -137.54 155.0 49.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.48 -0.762 . . . . 14.890000000000001 108.983 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.42 ' N ' HG22 ' B' ' 14' ' ' THR . 0.2 OUTLIER -91.43 110.75 22.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.186 -0.946 . . . . 17.350000000000001 109.59 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 17' ' ' SER . 5.6 ttt180 -136.34 149.1 48.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.319 -0.863 . . . . 34.380000000000003 109.082 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.427 ' C ' ' O ' ' B' ' 16' ' ' ARG . 5.5 p -43.86 148.44 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 38.770000000000003 109.284 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -144.01 179.62 21.22 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.567 -1.413 . . . . 34.579999999999998 109.567 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' B' ' 21' ' ' ARG . 0.2 OUTLIER -155.5 117.16 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -1.138 . . . . 41.869999999999997 108.803 179.579 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.471 ' O ' ' N ' ' B' ' 22' ' ' GLN . 0.1 OUTLIER -60.28 79.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.317 -0.864 . . . . 47.210000000000001 109.562 -179.202 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' B' ' 19' ' ' VAL . 0.5 OUTLIER 68.26 -60.22 0.42 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.164 -0.96 . . . . 71.560000000000002 109.389 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' B' ' 20' ' ' SER . 1.7 pt20 175.87 43.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 66.599999999999994 109.553 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.85 -51.29 0.41 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.507 -1.437 . . . . 55.490000000000002 109.507 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.435 ' HB2' ' HD2' ' B' ' 25' ' ' PRO . 18.8 pttm -153.17 159.7 31.86 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.322 -1.105 . . . . 44.990000000000002 109.361 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.9 Cg_endo -77.26 120.74 5.43 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.667 2.245 . . . . 44.100000000000001 110.657 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.587 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 4.0 p90 -126.15 139.06 53.67 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.248 -0.907 . . . . 32.090000000000003 109.575 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 1.1 m -103.24 80.51 1.84 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 29.25 108.847 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.656 HD23 ' O ' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -102.64 134.38 46.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 24.0 110.234 -179.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.668 ' OD1' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -46.06 128.52 9.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.401 -0.812 . . . . 23.309999999999999 109.579 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -121.2 143.11 49.31 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.894 . . . . 40.030000000000001 108.748 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.958 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -115.17 -167.24 1.21 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.981 -1.075 . . . . 12.390000000000001 110.132 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.908 ' HB3' HD11 ' B' ' 44' ' ' LEU . 21.0 mt -128.37 177.97 6.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.429 -0.795 . . . . 17.420000000000002 109.549 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.571 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.8 OUTLIER -173.49 150.65 1.83 Allowed 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.918 -1.114 . . . . 13.84 109.265 -179.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.772 ' HE1' HD13 ' B' ' 44' ' ' LEU . 2.9 m-85 -109.77 91.28 3.58 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.18 -1.045 . . . . 21.140000000000001 108.18 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.898 HG22 ' HB ' ' B' ' 4' ' ' VAL . 98.5 t -92.83 117.76 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.961 . . . . 10.66 110.096 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 27.6 t0 -53.71 -28.37 33.58 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.385 -0.968 . . . . 25.890000000000001 108.385 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.8 HD21 ' HA ' ' A' ' 69' ' ' LYS . 1.8 tt 43.11 34.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.572 -0.705 . . . . 24.239999999999998 109.256 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.19 23.05 51.81 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.472 -1.451 . . . . 31.02 109.472 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.739 HD21 HD22 ' B' ' 37' ' ' LEU . 99.0 m-20 -97.35 26.28 4.98 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.217 -1.167 . . . . 43.229999999999997 110.234 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.559 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 43.0 mt-10 49.23 21.74 0.57 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.13 -0.981 . . . . 42.340000000000003 109.976 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 5.9 m80 -174.79 157.13 2.2 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.999 -1.111 . . . . 6.1500000000000004 107.999 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.635 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.9 Cg_endo -75.59 146.19 30.34 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.97 1.78 . . . . 17.920000000000002 110.954 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.859 HG22 ' O ' ' B' ' 35' ' ' VAL . 5.4 m -122.49 118.36 54.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.633 -0.877 . . . . 20.57 108.633 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.908 HD11 ' HB3' ' B' ' 32' ' ' LEU . 22.9 tp -69.09 109.57 4.08 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.69 -0.804 . . . . 20.210000000000001 109.096 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 3.9 t -117.37 168.86 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.529 -0.732 . . . . 10.81 109.448 -179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -88.52 161.9 16.72 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.351 -0.843 . . . . 36.740000000000002 110.455 -179.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.687 HD12 ' HE2' ' B' ' 56' ' ' TYR . 0.9 OUTLIER -133.08 164.29 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.522 -0.918 . . . . 19.739999999999998 108.522 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.502 ' N ' ' CG2' ' B' ' 47' ' ' ILE . 0.3 OUTLIER -108.67 135.47 49.85 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.242 -0.912 . . . . 22.559999999999999 108.576 178.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.656 ' O ' HD23 ' B' ' 28' ' ' LEU . 0.3 OUTLIER -123.92 123.89 41.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.315 -0.865 . . . . 20.41 109.362 -179.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.433 ' HB3' ' HG3' ' B' ' 53' ' ' GLN . 1.3 t0 -71.39 142.35 50.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 33.990000000000002 109.567 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.21 107.67 0.17 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 54.920000000000002 109.633 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 104.08 -2.41 44.19 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.831 -1.308 . . . . 36.100000000000001 109.831 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.628 ' O ' HD12 ' B' ' 49' ' ' LEU . 13.2 mt-30 -89.22 144.46 32.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.166 -1.197 . . . . 54.759999999999998 109.513 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.37 114.7 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.669 2.246 . . . . 28.370000000000001 110.696 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.958 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -43.69 168.67 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.309 -0.869 . . . . 17.210000000000001 110.025 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.829 ' HB3' HD13 ' B' ' 6' ' ' ILE . 30.7 m-85 -66.06 122.96 18.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 17.190000000000001 109.618 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.995 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -74.53 179.44 1.31 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.443 -0.786 . . . . 17.82 109.844 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.995 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.1 Cg_endo -78.0 115.35 3.76 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.619 2.213 . . . . 17.280000000000001 110.442 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 166.87 141.95 3.3 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.358 -1.497 . . . . 17.219999999999999 109.358 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' B' ' 59' ' ' GLY . 4.0 mp -42.04 144.26 0.47 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.225 -1.162 . . . . 19.57 109.364 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 1.046 ' CB ' HG13 ' B' ' 4' ' ' VAL . 15.1 m-85 -121.4 166.24 14.38 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.93 -1.106 . . . . 14.609999999999999 111.34 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.571 HG23 ' CA ' ' B' ' 86' ' ' ALA . 39.2 p -149.31 120.25 7.65 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 105.485 -2.043 . . . . 18.359999999999999 105.485 177.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.925 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.8 t -57.44 161.56 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 C-N-CA 118.143 -1.423 . . . . 19.129999999999999 108.936 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' B' ' 82' ' ' ARG . 5.1 t-80 -116.43 138.32 51.46 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.551 -0.718 . . . . 20.649999999999999 109.245 -178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.754 HD23 ' CD2' ' B' ' 68' ' ' PHE . 2.1 mt -70.57 -8.47 51.77 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.065 -0.717 . . . . 19.649999999999999 109.065 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . 0.42 ' OG ' ' HD3' ' B' ' 82' ' ' ARG . 0.5 OUTLIER -47.96 -24.84 1.15 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.29 -1.004 . . . . 14.720000000000001 108.29 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.538 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 3.8 m -93.78 -14.8 25.82 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.472 -0.767 . . . . 11.449999999999999 109.97 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.766 ' HB3' HD21 ' B' ' 76' ' ' LEU . 3.5 m-30 -80.71 146.44 31.06 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.081 -1.012 . . . . 14.25 109.955 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.83 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -145.72 172.62 13.02 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.651 -0.656 . . . . 32.700000000000003 109.274 -179.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.709 HG22 HD13 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -107.2 109.54 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 15.630000000000001 109.166 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -82.95 -172.88 49.12 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.593 -1.403 . . . . 12.699999999999999 109.593 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.605 ' NE2' ' N ' ' B' ' 72' ' ' GLN . 0.6 OUTLIER -96.05 22.83 7.06 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.215 -1.168 . . . . 26.289999999999999 108.918 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.61 -9.48 26.84 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.757 -0.589 . . . . 20.440000000000001 109.69 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.464 ' C ' HG13 ' A' ' 45' ' ' VAL . . . 81.46 41.05 10.32 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.578 -1.409 . . . . 13.82 109.578 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.521 ' HA ' ' CG1' ' A' ' 45' ' ' VAL . 4.3 m -169.79 138.29 1.8 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -1.153 . . . . 18.27 109.688 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.774 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -47.37 160.7 0.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.261 -0.899 . . . . 12.43 109.462 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 2.6 mtt -158.94 107.57 1.89 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 35.109999999999999 109.738 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.636 HG12 ' CD1' ' B' ' 68' ' ' PHE . 23.0 mt -60.26 138.4 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.347 -0.846 . . . . 13.67 109.843 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 12.1 t70 -103.37 -22.81 13.62 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.709 -0.849 . . . . 24.059999999999999 108.709 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.538 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.5 OUTLIER 172.09 66.55 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.556 -1.275 . . . . 35.039999999999999 107.556 179.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.925 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.7 OUTLIER -21.5 118.96 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 115.085 -0.961 . . . . 18.719999999999999 112.285 -178.25 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' B' ' 64' ' ' HIS . 0.3 OUTLIER -92.57 103.79 16.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.879 . . . . 20.550000000000001 108.643 179.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.957 HD11 HG11 ' B' ' 4' ' ' VAL . 0.7 OUTLIER -73.85 144.93 45.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.03 -1.044 . . . . 14.4 111.469 -178.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 62' ' ' THR . 2.5 m -149.59 156.14 38.95 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 107.528 -1.286 . . . . 17.649999999999999 107.528 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' B' ' 61' ' ' TYR . 24.6 Cg_endo -63.26 141.08 80.73 Favored 'Trans proline' 0 C--N 1.303 -1.866 0 C-N-CA 121.911 1.741 . . . . 25.699999999999999 110.211 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.571 ' CA ' HG23 ' B' ' 62' ' ' THR . . . -70.53 112.14 6.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.207 -0.933 . . . . 49.289999999999999 109.528 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.015 -0.993 . . . . 58.909999999999997 109.5 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.485 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 1.3 ttp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.457 -0.572 . . . . 64.909999999999997 109.457 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.873 ' HA ' HD22 ' B' ' 65' ' ' LEU . 6.2 mt -71.29 77.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 108.213 -1.032 . . . . 33.799999999999997 108.213 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' O ' HG13 ' A' ' 35' ' ' VAL . 54.0 mttt -63.53 155.41 29.47 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.937 0.875 . . . . 32.719999999999999 111.299 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.81 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -166.84 163.53 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.499 -0.926 . . . . 14.460000000000001 108.499 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 64.5 mt-10 -137.12 119.53 15.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.24 -0.913 . . . . 22.120000000000001 109.762 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -76.61 101.08 2.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.521 -1.288 . . . . 14.23 107.521 178.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.652 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.9 171.73 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.014 -1.054 . . . . 25.43 109.841 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -75.08 -26.06 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.49 2.126 . . . . 13.609999999999999 109.804 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.89 -0.13 56.58 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.906 -0.775 . . . . 15.52 108.906 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.479 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 6.5 mm-40 -120.59 37.17 4.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.346 -0.846 . . . . 17.309999999999999 109.595 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.01 8.45 44.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 24.780000000000001 110.236 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -139.71 137.89 35.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.186 -0.946 . . . . 47.899999999999999 108.677 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.667 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 30.7 p90 -84.45 173.99 10.43 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.027 -1.046 . . . . 21.609999999999999 109.459 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.7 m -142.5 151.67 41.91 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.459 -0.776 . . . . 14.890000000000001 109.115 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.03 109.87 16.75 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.296 -0.878 . . . . 17.350000000000001 109.23 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.61 151.76 50.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 34.380000000000003 109.33 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.68 134.9 57.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.875 . . . . 38.770000000000003 109.35 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -130.51 -170.74 12.77 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.422 -1.471 . . . . 34.579999999999998 109.422 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.52 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -155.81 121.81 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.132 . . . . 41.869999999999997 108.572 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -72.42 54.65 0.33 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.122 -0.986 . . . . 47.210000000000001 109.859 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 22' ' ' GLN . 0.3 OUTLIER 67.3 -60.47 0.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.171 -0.956 . . . . 71.560000000000002 109.24 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 20' ' ' SER . 17.9 mt-30 -156.67 29.92 0.32 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.356 -0.84 . . . . 66.599999999999994 109.153 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 24' ' ' LYS . . . -117.31 39.7 2.57 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.587 -1.405 . . . . 55.490000000000002 109.587 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 13.9 mttt 78.64 163.78 0.13 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.406 -1.055 . . . . 44.990000000000002 109.05 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 33.3 Cg_endo -75.96 135.89 17.89 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.464 2.109 . . . . 44.100000000000001 110.717 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.596 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.7 p90 -124.74 144.34 50.29 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.447 -0.783 . . . . 32.090000000000003 109.604 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.88 79.5 2.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -0.947 . . . . 29.25 108.778 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.54 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -99.29 134.13 42.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 24.0 110.299 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -48.65 120.31 3.68 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 23.309999999999999 109.168 179.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 7.9 mt-10 -109.79 161.3 15.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 40.030000000000001 109.334 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.76 HE21 ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -139.91 -168.92 2.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 12.390000000000001 109.647 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.944 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.1 mt -141.44 155.28 45.88 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.684 -0.858 . . . . 17.420000000000002 108.684 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.613 ' SG ' HD11 ' A' ' 6' ' ' ILE . 2.6 m -151.64 -177.25 5.99 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.185 -1.042 . . . . 13.84 108.185 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.701 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 16.5 m-85 -131.3 103.81 6.67 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.126 -0.984 . . . . 21.140000000000001 109.785 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 43' ' ' VAL . 3.0 t -109.78 123.27 65.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.145 -0.972 . . . . 10.66 110.069 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.755 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -87.66 -36.76 17.25 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.366 -0.976 . . . . 25.890000000000001 108.366 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.791 HD21 HD11 ' B' ' 76' ' ' LEU . 0.3 OUTLIER 63.79 -71.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.541 -0.911 . . . . 24.239999999999998 108.541 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -157.19 29.17 0.52 Allowed Glycine 0 C--N 1.297 -1.633 0 N-CA-C 109.188 -1.565 . . . . 31.02 109.188 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 41' ' ' HIS . 1.7 m-20 -109.51 21.64 16.75 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.197 -1.178 . . . . 43.229999999999997 110.229 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.579 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 3.3 mt-10 42.58 25.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.266 -0.896 . . . . 42.340000000000003 110.328 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.579 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 98.6 m-70 -160.52 152.79 17.11 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.108 -0.995 . . . . 6.9900000000000002 108.518 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.701 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -78.35 136.05 13.87 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.903 1.736 . . . . 17.920000000000002 110.411 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 35' ' ' VAL . 2.4 m -112.21 119.34 59.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 O-C-N 121.351 -0.843 . . . . 20.57 108.744 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.944 HD11 ' HB3' ' A' ' 32' ' ' LEU . 52.1 tp -75.32 103.51 5.5 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.461 -0.895 . . . . 20.210000000000001 110.018 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.737 HG13 HG23 ' A' ' 43' ' ' VAL . 29.0 m -110.53 178.48 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.643 -0.873 . . . . 10.81 108.643 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HD3' HD21 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -106.09 127.1 52.95 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 119.012 -1.075 . . . . 36.740000000000002 110.029 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.996 HD13 HD12 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -108.64 163.17 6.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.884 -0.784 . . . . 19.739999999999998 108.884 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 49' ' ' LEU . 56.7 m -99.59 158.99 15.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 22.559999999999999 109.539 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.799 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -130.37 105.14 7.69 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.198 -0.939 . . . . 20.41 109.286 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.49 142.29 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 33.990000000000002 109.501 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.14 101.58 0.3 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 54.920000000000002 109.313 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.62 -20.04 10.3 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.316 -1.514 . . . . 36.100000000000001 109.316 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 30.5 mt-30 -78.28 148.53 74.46 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.259 -1.142 . . . . 54.759999999999998 109.376 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.99 120.38 5.01 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.665 2.244 . . . . 28.370000000000001 110.619 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.799 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -38.58 143.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.506 -0.746 . . . . 17.210000000000001 110.346 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.767 ' HB3' HD13 ' A' ' 6' ' ' ILE . 86.6 m-85 -44.56 102.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.844 -0.798 . . . . 17.190000000000001 108.844 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.97 176.09 0.13 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 17.82 109.955 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.8 Cg_endo -78.39 111.22 2.99 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.763 2.309 . . . . 17.280000000000001 110.27 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 175.25 163.89 28.98 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.905 -1.278 . . . . 17.219999999999999 109.905 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.751 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.5 OUTLIER -59.84 142.79 52.8 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.243 -1.151 . . . . 19.57 108.748 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.716 ' HB3' HD22 ' A' ' 83' ' ' LEU . 31.8 m-85 -125.9 161.07 28.3 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.718 -1.238 . . . . 14.609999999999999 111.682 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.726 ' O ' HG22 ' A' ' 84' ' ' VAL . 30.9 p -146.24 121.44 10.17 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.295 -1.743 . . . . 18.359999999999999 106.295 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.614 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.9 t -52.47 168.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.806 -1.158 . . . . 19.129999999999999 109.381 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.548 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -133.62 127.14 32.39 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.487 -0.758 . . . . 20.649999999999999 109.038 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.885 HD22 ' HA ' ' B' ' 2' ' ' ILE . 0.7 OUTLIER -71.11 0.1 8.42 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.292 -0.88 . . . . 19.649999999999999 109.997 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.3 p -55.26 -20.55 11.39 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.401 -1.333 . . . . 14.720000000000001 107.401 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 69.6 m -94.18 -27.35 16.24 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.835 -0.54 . . . . 11.449999999999999 109.998 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.684 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -60.82 156.27 17.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.1 -1.0 . . . . 14.25 109.127 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HE3' ' OD2' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -159.1 172.31 18.35 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.385 -0.822 . . . . 32.700000000000003 109.586 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.637 HG21 HG11 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -97.45 112.19 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 15.630000000000001 109.387 -179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.45 -176.08 48.61 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.547 -1.421 . . . . 12.699999999999999 109.547 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.44 ' NE2' ' H ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -90.05 33.86 0.87 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.224 -1.162 . . . . 26.289999999999999 109.486 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -118.74 15.36 13.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 20.440000000000001 109.628 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.06 48.96 70.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.781 -1.328 . . . . 13.82 109.781 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 77' ' ' MET . 0.0 OUTLIER -170.93 138.84 1.36 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.166 -1.197 . . . . 18.27 109.416 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.8 HD11 HD21 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -45.15 163.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 12.43 109.388 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 75' ' ' SER . 6.7 mmt -154.22 100.3 2.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 35.109999999999999 109.844 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.592 HG12 ' CE1' ' A' ' 68' ' ' PHE . 2.5 mt -40.98 -61.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 CA-C-O 121.511 0.672 . . . . 13.67 109.634 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 35.4 t0 81.44 -48.2 0.24 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.476 0.655 . . . . 24.059999999999999 109.958 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.559 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.0 tpm_? -172.04 66.78 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.107 0.956 . . . . 35.039999999999999 108.781 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.732 HD13 ' HB2' ' B' ' 76' ' ' LEU . 1.0 OUTLIER -34.84 127.06 0.51 Allowed 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.499 -0.773 . . . . 18.719999999999999 111.597 -179.203 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -94.7 105.38 17.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.167 -1.049 . . . . 20.550000000000001 108.167 178.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.996 HD12 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -72.83 149.06 43.9 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 14.4 111.263 -178.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 62' ' ' THR . 34.3 m -150.22 150.68 29.98 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 108.121 -1.066 . . . . 17.649999999999999 108.121 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.2 Cg_endo -61.93 138.35 73.06 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.129 1.886 . . . . 25.699999999999999 110.241 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -66.72 116.61 7.82 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.295 -0.878 . . . . 49.289999999999999 109.684 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.001 -1.0 . . . . 58.909999999999997 109.41 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.488 ' SD ' ' HB ' ' B' ' 62' ' ' THR . 1.3 ttp . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.522 -0.548 . . . . 64.909999999999997 109.522 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.885 ' HA ' HD22 ' A' ' 65' ' ' LEU . 6.3 mt -70.6 77.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.16 -1.052 . . . . 33.799999999999997 108.16 179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.466 ' O ' HG13 ' B' ' 35' ' ' VAL . 53.3 mttt -63.6 155.37 29.85 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.914 0.864 . . . . 32.719999999999999 111.308 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.826 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -166.86 163.46 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.492 -0.929 . . . . 14.460000000000001 108.492 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 65.3 mt-10 -137.07 119.6 15.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.344 -0.847 . . . . 22.120000000000001 109.798 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.755 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.1 OUTLIER -76.71 101.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.583 -1.265 . . . . 14.23 107.583 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.66 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.88 171.76 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.1 -1.0 . . . . 25.43 109.83 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.6 Cg_endo -75.07 -26.14 11.09 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.539 2.159 . . . . 13.609999999999999 109.834 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.86 -0.08 56.5 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.946 -0.761 . . . . 15.52 108.946 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.482 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 6.5 mm-40 -120.57 37.07 4.38 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 17.309999999999999 109.561 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.05 8.71 43.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 24.780000000000001 110.204 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.454 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -139.93 137.85 35.12 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.126 -0.984 . . . . 47.899999999999999 108.639 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 30.8 p90 -84.39 174.05 10.41 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 120.984 -1.072 . . . . 21.609999999999999 109.504 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 91.6 m -142.53 151.44 41.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.397 -0.814 . . . . 14.890000000000001 109.113 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.73 110.38 17.01 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.288 -0.883 . . . . 17.350000000000001 109.129 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.13 151.59 51.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.337 -0.852 . . . . 34.380000000000003 109.346 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.57 134.81 57.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 38.770000000000003 109.383 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -130.52 -170.63 12.74 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.398 -1.481 . . . . 34.579999999999998 109.398 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.518 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.3 OUTLIER -155.86 121.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -1.129 . . . . 41.869999999999997 108.568 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.503 ' O ' ' N ' ' B' ' 22' ' ' GLN . 0.0 OUTLIER -72.48 54.71 0.33 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.129 -0.982 . . . . 47.210000000000001 109.876 -179.112 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.493 ' C ' ' CG ' ' B' ' 22' ' ' GLN . 0.3 OUTLIER 67.22 -60.45 0.37 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.211 -0.93 . . . . 71.560000000000002 109.24 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' B' ' 20' ' ' SER . 17.6 mt-30 -156.63 29.98 0.32 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.378 -0.826 . . . . 66.599999999999994 109.201 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' B' ' 24' ' ' LYS . . . -117.42 39.69 2.57 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.61 -1.396 . . . . 55.490000000000002 109.61 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.524 ' HB3' ' HD2' ' B' ' 25' ' ' PRO . 14.0 mttt 78.57 163.73 0.13 Allowed Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.404 -1.056 . . . . 44.990000000000002 109.038 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' B' ' 24' ' ' LYS . 33.2 Cg_endo -75.92 136.05 18.14 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.454 2.103 . . . . 44.100000000000001 110.701 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 6.7 p90 -124.88 144.31 50.39 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.388 -0.82 . . . . 32.090000000000003 109.596 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.79 79.49 2.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 29.25 108.735 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.549 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -99.28 134.03 42.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.235 -0.916 . . . . 24.0 110.292 -179.107 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.593 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -48.69 120.4 3.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.402 -0.811 . . . . 23.309999999999999 109.122 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 7.8 mt-10 -109.84 161.39 15.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.225 -0.922 . . . . 40.030000000000001 109.283 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.767 HE21 ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -139.9 -168.85 2.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 12.390000000000001 109.67 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.913 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.1 mt -141.55 155.19 45.79 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.717 -0.845 . . . . 17.420000000000002 108.717 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.625 ' SG ' HD11 ' B' ' 6' ' ' ILE . 2.5 m -151.63 -177.21 5.97 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.179 -1.045 . . . . 13.84 108.179 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.699 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 16.3 m-85 -131.35 103.9 6.71 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.103 -0.998 . . . . 21.140000000000001 109.692 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.854 ' O ' HG22 ' B' ' 43' ' ' VAL . 2.9 t -109.86 123.16 65.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.126 -0.984 . . . . 10.66 110.115 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.768 ' O ' HD12 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -87.45 -36.9 17.43 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.336 -0.987 . . . . 25.890000000000001 108.336 179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.8 HD21 HD11 ' A' ' 76' ' ' LEU . 0.3 OUTLIER 64.13 -71.18 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.471 -0.937 . . . . 24.239999999999998 108.471 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -157.49 29.19 0.5 Allowed Glycine 0 C--N 1.297 -1.61 0 N-CA-C 109.185 -1.566 . . . . 31.02 109.185 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' B' ' 41' ' ' HIS . 1.7 m-20 -109.49 21.53 16.9 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.117 -1.225 . . . . 43.229999999999997 110.243 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.585 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 3.2 mt-10 42.78 25.23 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 42.340000000000003 110.302 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 98.4 m-70 -160.48 152.85 17.24 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.175 -0.953 . . . . 6.9900000000000002 108.511 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.699 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 38.3 Cg_endo -78.44 135.9 13.62 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.93 1.753 . . . . 17.920000000000002 110.468 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.854 HG22 ' O ' ' B' ' 35' ' ' VAL . 2.4 m -111.88 119.34 59.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 108.62 -0.881 . . . . 20.57 108.62 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.913 HD11 ' HB3' ' B' ' 32' ' ' LEU . 51.4 tp -75.25 103.43 5.4 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.243 -0.91 . . . . 20.210000000000001 110.069 -179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.744 HG13 HG23 ' B' ' 43' ' ' VAL . 26.1 m -110.4 178.64 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.738 -0.838 . . . . 10.81 108.738 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.466 ' HD3' HD21 ' B' ' 32' ' ' LEU . 0.1 OUTLIER -106.23 127.0 52.91 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.975 -1.09 . . . . 36.740000000000002 109.99 179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 1.01 HD13 HD12 ' B' ' 83' ' ' LEU . 0.5 OUTLIER -108.48 163.3 6.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.889 -0.782 . . . . 19.739999999999998 108.889 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.431 HG22 ' N ' ' B' ' 49' ' ' LEU . 56.5 m -99.71 158.7 15.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.985 -1.072 . . . . 22.559999999999999 109.558 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.1 OUTLIER -130.12 105.25 7.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 20.41 109.3 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.6 142.03 2.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.317 -0.864 . . . . 33.990000000000002 109.578 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.9 101.33 0.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 54.920000000000002 109.353 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.92 -19.97 10.06 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.311 -1.516 . . . . 36.100000000000001 109.311 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -78.43 148.61 74.09 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.283 -1.128 . . . . 54.759999999999998 109.436 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.9 Cg_endo -78.01 120.44 5.02 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.644 2.229 . . . . 28.370000000000001 110.587 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.768 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -38.63 143.47 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 17.210000000000001 110.37 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.755 ' HB3' HD13 ' B' ' 6' ' ' ILE . 86.8 m-85 -44.59 102.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.37 -0.831 . . . . 17.190000000000001 108.837 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.978 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -53.73 176.06 0.12 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.398 -0.814 . . . . 17.82 109.878 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.978 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -78.48 111.34 3.0 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.719 2.279 . . . . 17.280000000000001 110.237 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 175.24 164.15 29.39 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.918 -1.273 . . . . 17.219999999999999 109.918 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.716 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.5 OUTLIER -60.16 142.82 53.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.256 -1.143 . . . . 19.57 108.706 179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.698 ' HB3' HD22 ' B' ' 83' ' ' LEU . 31.8 m-85 -125.86 161.13 28.13 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.679 -1.263 . . . . 14.609999999999999 111.645 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.728 ' O ' HG22 ' B' ' 84' ' ' VAL . 30.8 p -146.28 121.48 10.18 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.325 -1.732 . . . . 18.359999999999999 106.325 178.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.9 t -52.6 168.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 C-N-CA 118.887 -1.125 . . . . 19.129999999999999 109.342 -178.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.534 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -133.61 127.26 32.64 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.508 -0.745 . . . . 20.649999999999999 109.058 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.873 HD22 ' HA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -71.38 0.38 8.33 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.263 -0.898 . . . . 19.649999999999999 109.975 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 2.4 p -55.32 -20.47 11.61 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.294 -1.372 . . . . 14.720000000000001 107.294 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 69.8 m -94.35 -27.23 16.2 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.864 -0.522 . . . . 11.449999999999999 109.954 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.69 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.9 m-30 -60.9 156.13 18.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.05 -1.031 . . . . 14.25 109.069 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.418 ' HE3' ' OD2' ' B' ' 79' ' ' ASP . 0.0 OUTLIER -159.07 172.45 18.12 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.36 -0.837 . . . . 32.700000000000003 109.595 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.78 HG21 HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -97.62 112.42 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.36 -0.838 . . . . 15.630000000000001 109.392 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.52 -176.1 48.51 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.512 -1.435 . . . . 12.699999999999999 109.512 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.438 ' NE2' ' H ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.0 34.0 0.86 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.196 -1.179 . . . . 26.289999999999999 109.496 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -118.91 15.33 13.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -0.857 . . . . 20.440000000000001 109.598 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.1 48.84 71.13 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.779 -1.328 . . . . 13.82 109.779 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.474 ' O ' ' HG2' ' B' ' 77' ' ' MET . 0.0 OUTLIER -170.84 138.95 1.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -1.162 . . . . 18.27 109.403 179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.791 HD11 HD21 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -45.14 163.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.228 -0.92 . . . . 12.43 109.464 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' B' ' 75' ' ' SER . 6.6 mmt -154.37 100.4 2.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 35.109999999999999 109.835 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.609 HG12 ' CE1' ' B' ' 68' ' ' PHE . 2.5 mt -41.13 -61.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.514 0.673 . . . . 13.67 109.689 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 35.5 t0 81.41 -48.28 0.24 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.485 0.66 . . . . 24.059999999999999 109.961 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.557 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.0 tpm_? -171.98 66.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 122.111 0.958 . . . . 35.039999999999999 108.793 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.723 HD13 ' HB2' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -34.87 127.22 0.51 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.529 -0.759 . . . . 18.719999999999999 111.604 -179.252 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -94.94 105.1 16.99 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.18 -1.044 . . . . 20.550000000000001 108.18 178.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.01 HD12 HD13 ' B' ' 47' ' ' ILE . 0.6 OUTLIER -72.52 149.15 44.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 14.4 111.301 -178.454 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.728 HG22 ' O ' ' B' ' 62' ' ' THR . 34.1 m -150.36 150.62 29.52 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.08 -1.081 . . . . 17.649999999999999 108.08 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.2 Cg_endo -61.94 138.41 73.39 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.04 1.827 . . . . 25.699999999999999 110.295 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.716 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -66.82 116.65 7.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.319 -0.863 . . . . 49.289999999999999 109.635 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.045 -0.978 . . . . 58.909999999999997 109.469 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.533 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.396 -0.594 . . . . 64.909999999999997 109.396 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.927 ' H ' HD22 ' B' ' 65' ' ' LEU . 1.1 mt 53.02 81.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 107.689 -1.226 . . . . 33.799999999999997 107.689 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -76.56 157.25 32.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 32.719999999999999 110.777 -178.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.864 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -164.07 163.38 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.022 -0.733 . . . . 14.460000000000001 109.022 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 37.5 mt-10 -138.99 114.14 9.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.486 -0.759 . . . . 22.120000000000001 109.039 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -74.36 102.02 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 119.201 -1.0 . . . . 14.23 108.528 179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.674 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.63 170.85 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.299 -0.875 . . . . 25.43 109.478 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.7 Cg_endo -75.92 -21.73 13.92 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.419 2.08 . . . . 13.609999999999999 109.61 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.32 5.19 50.3 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.17 -0.678 . . . . 15.52 109.17 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.524 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 19.9 mm-40 -124.15 36.04 4.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 17.309999999999999 109.64 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.57 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -105.01 15.7 27.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.062 -1.024 . . . . 24.780000000000001 110.329 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.42 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 38.9 mt-30 -133.86 135.9 44.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.034 -1.041 . . . . 47.899999999999999 109.84 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.708 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 46.9 p90 -92.63 166.66 12.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.189 -0.944 . . . . 21.609999999999999 109.492 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -140.5 145.73 37.25 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.308 -0.87 . . . . 14.890000000000001 109.124 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.24 118.02 20.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 17.350000000000001 109.553 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -130.42 145.64 51.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 34.380000000000003 109.344 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.48 117.81 3.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 38.770000000000003 109.405 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 26' ' ' TYR . . . -119.36 162.73 13.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.474 -1.45 . . . . 34.579999999999998 109.474 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.619 ' N ' ' CE1' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -143.98 113.37 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.246 . . . . 41.869999999999997 109.281 179.179 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.7 m -47.1 -85.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.789 . . . . 47.210000000000001 109.663 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.77 58.37 1.64 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 71.560000000000002 109.417 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 58.79 16.28 4.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.219 -0.926 . . . . 66.599999999999994 109.328 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.38 -55.45 1.26 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.318 -1.513 . . . . 55.490000000000002 109.318 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -145.27 151.94 49.19 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.345 -1.091 . . . . 44.990000000000002 109.192 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.44 131.1 11.34 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.622 2.215 . . . . 44.100000000000001 110.809 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.661 ' CE2' ' HB2' ' A' ' 28' ' ' LEU . 13.9 p90 -131.44 100.08 5.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.331 -0.855 . . . . 32.090000000000003 109.736 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 m -71.5 76.37 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 29.25 109.136 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.661 ' HB2' ' CE2' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -87.77 142.88 27.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 24.0 110.198 -179.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.586 ' CB ' ' CB ' ' A' ' 49' ' ' LEU . 69.5 m-20 -51.08 123.2 8.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.403 -0.811 . . . . 23.309999999999999 109.897 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 35.7 mp0 -98.86 155.16 17.52 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.058 -1.09 . . . . 40.030000000000001 108.058 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.524 ' NE2' ' O ' ' A' ' 10' ' ' GLN . 1.2 tm0? -146.52 -179.96 7.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.825 -1.172 . . . . 12.390000000000001 110.384 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.89 ' HB3' HD11 ' A' ' 44' ' ' LEU . 51.0 mt -139.85 145.99 38.77 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.449 -0.782 . . . . 17.420000000000002 110.0 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.764 ' SG ' HD11 ' A' ' 47' ' ' ILE . 4.1 m -152.97 -177.12 6.09 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.148 -1.426 . . . . 13.84 107.148 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.674 ' CD2' ' HD3' ' A' ' 7' ' ' LYS . 27.3 m-85 -128.48 113.48 15.56 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.785 -1.197 . . . . 21.140000000000001 109.922 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.864 HG22 ' HB ' ' A' ' 4' ' ' VAL . 45.4 t -107.09 115.65 49.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.235 -0.916 . . . . 10.66 110.148 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 39' ' ' ASN . 54.8 m-20 -64.5 -36.55 84.55 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.806 -1.183 . . . . 25.890000000000001 107.806 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.702 HD21 ' HA ' ' B' ' 69' ' ' LYS . 0.9 OUTLIER 46.41 48.21 13.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 24.239999999999998 109.893 179.303 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.04 -1.21 64.25 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.41 -1.476 . . . . 31.02 109.41 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.2 OUTLIER -105.9 95.73 6.0 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.334 -1.098 . . . . 43.229999999999997 108.342 179.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.519 ' C ' ' O ' ' A' ' 39' ' ' ASN . 2.5 mp0 -27.33 -41.67 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.437 0.637 . . . . 42.340000000000003 111.083 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 39' ' ' ASN . 48.5 m80 -78.16 141.09 61.99 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 108.638 -0.875 . . . . 6.5700000000000003 108.638 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.65 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -76.23 136.72 18.29 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.898 1.732 . . . . 17.920000000000002 110.478 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.829 HG23 HG23 ' A' ' 45' ' ' VAL . 2.9 m -107.65 117.65 53.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.614 -0.884 . . . . 20.57 108.614 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.89 HD11 ' HB3' ' A' ' 32' ' ' LEU . 61.7 tp -65.8 97.82 0.36 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.514 -0.874 . . . . 20.210000000000001 109.999 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.829 HG23 HG23 ' A' ' 43' ' ' VAL . 21.0 t -99.39 168.46 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.813 -0.81 . . . . 10.81 108.813 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.576 ' N ' HG12 ' A' ' 45' ' ' VAL . 4.0 ptpp? -117.33 147.7 42.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.928 -1.108 . . . . 36.740000000000002 111.565 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.004 HG21 ' CE1' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -112.41 178.0 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.563 -0.903 . . . . 19.739999999999998 108.563 179.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.431 ' H ' HG22 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -126.24 74.93 1.48 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.187 -0.946 . . . . 22.559999999999999 109.46 179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.627 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -42.78 150.75 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.425 -0.797 . . . . 20.41 109.22 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 26.5 t0 -123.13 148.13 46.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 33.990000000000002 109.456 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 48.31 -148.89 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.116 -0.99 . . . . 54.920000000000002 109.257 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.12 16.83 56.28 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.647 -1.381 . . . . 36.100000000000001 109.647 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -45.72 149.33 1.13 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.178 -1.189 . . . . 54.759999999999998 109.469 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.4 Cg_endo -78.16 113.16 3.35 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.587 2.192 . . . . 28.370000000000001 110.002 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.708 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -39.4 153.48 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.467 -0.771 . . . . 17.210000000000001 110.25 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 1.004 ' CE1' HG21 ' A' ' 47' ' ' ILE . 84.5 m-85 -50.58 113.11 0.81 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 17.190000000000001 109.351 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.013 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -61.81 177.25 0.38 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 17.82 109.476 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 1.013 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.76 114.43 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.572 2.181 . . . . 17.280000000000001 110.398 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.0 179.88 43.98 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 17.219999999999999 109.556 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 6.2 mp -73.96 156.04 38.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -1.121 . . . . 19.57 108.577 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.723 ' HB3' HD22 ' A' ' 83' ' ' LEU . 26.6 m-85 -143.75 163.32 33.64 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.568 1.175 . . . . 14.609999999999999 111.577 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.773 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.5 p -145.78 123.17 11.65 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.171 -1.789 . . . . 18.359999999999999 106.171 178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.8 t -54.31 169.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 C-N-CA 118.495 -1.282 . . . . 19.129999999999999 108.804 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.547 ' H ' HG12 ' A' ' 63' ' ' VAL . 2.1 t-80 -128.11 124.5 37.11 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.861 -0.792 . . . . 20.649999999999999 108.861 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.969 HD22 ' H ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -64.91 -6.79 9.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.849 -0.532 . . . . 19.649999999999999 109.923 -179.36 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.4 p -53.91 -16.19 1.72 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.93 -1.106 . . . . 14.720000000000001 108.673 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.495 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 50.1 m -99.52 -4.89 30.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.419 -0.8 . . . . 11.449999999999999 111.052 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.636 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -81.65 157.78 24.54 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.7 -1.25 . . . . 14.25 109.832 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.658 ' HA ' HD21 ' B' ' 37' ' ' LEU . 5.3 pttt -142.98 171.74 13.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.401 -0.812 . . . . 32.700000000000003 109.624 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.61 HG11 HG21 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -125.83 112.68 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 15.630000000000001 109.046 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.479 ' C ' ' NE2' ' A' ' 72' ' ' GLN . . . -71.95 -173.64 20.09 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.568 -1.413 . . . . 12.699999999999999 109.568 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.48 ' NE2' ' N ' ' A' ' 72' ' ' GLN . 0.8 OUTLIER -89.4 34.53 0.81 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.209 -1.171 . . . . 26.289999999999999 109.508 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -133.87 24.7 3.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.405 -0.81 . . . . 20.440000000000001 109.441 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.488 ' O ' ' HG2' ' B' ' 46' ' ' LYS . . . 51.49 56.58 14.74 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.635 -1.386 . . . . 13.82 109.635 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.7 m -148.64 105.27 3.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -1.211 . . . . 18.27 109.752 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.679 ' C ' HD23 ' A' ' 76' ' ' LEU . 5.0 tt -70.23 146.56 50.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 12.43 109.277 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.486 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 4.2 mtm -157.34 144.53 18.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.185 -0.947 . . . . 35.109999999999999 109.583 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.983 HD12 HD12 ' B' ' 78' ' ' ILE . 2.3 mp -69.73 141.76 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -0.905 . . . . 13.67 109.615 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -107.5 -37.2 6.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.809 -1.182 . . . . 24.059999999999999 107.809 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.495 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER -167.94 67.53 0.08 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.404 -1.332 . . . . 35.039999999999999 107.404 178.664 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.692 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.6 OUTLIER -27.41 118.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.416 -0.811 . . . . 18.719999999999999 111.632 -178.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 20.0 tpt180 -92.09 104.58 16.95 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.066 -1.087 . . . . 20.550000000000001 108.066 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.732 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.6 OUTLIER -72.64 150.7 42.78 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.052 0.929 . . . . 14.4 111.591 -178.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 62' ' ' THR . 34.7 m -152.07 154.36 32.42 Favored Pre-proline 0 C--N 1.304 -1.383 0 N-CA-C 107.741 -1.207 . . . . 17.649999999999999 107.741 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.4 Cg_endo -62.93 145.93 94.66 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.211 1.941 . . . . 25.699999999999999 110.749 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -75.24 121.85 22.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.238 -0.913 . . . . 49.289999999999999 109.525 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 tptt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.977 -1.011 . . . . 58.909999999999997 109.454 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.535 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.403 -0.591 . . . . 64.909999999999997 109.403 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.969 ' H ' HD22 ' A' ' 65' ' ' LEU . 1.2 mt 52.83 81.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.662 -1.236 . . . . 33.799999999999997 107.662 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.417 ' O ' HG13 ' B' ' 35' ' ' VAL . 0.0 OUTLIER -76.32 157.2 32.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 32.719999999999999 110.839 -178.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.879 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.2 OUTLIER -164.06 163.46 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 109.014 -0.735 . . . . 14.460000000000001 109.014 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' B' ' 34' ' ' TYR . 37.6 mt-10 -139.1 114.06 9.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.486 -0.759 . . . . 22.120000000000001 109.019 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.589 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -74.3 102.17 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 119.183 -1.007 . . . . 14.23 108.46 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.656 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.73 171.03 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.307 -0.871 . . . . 25.43 109.507 -179.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.6 Cg_endo -75.86 -21.93 13.84 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.346 2.031 . . . . 13.609999999999999 109.678 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.18 5.33 50.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.615 -0.678 . . . . 15.52 109.222 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.511 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 19.7 mm-40 -124.23 35.97 4.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 17.309999999999999 109.637 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -104.96 15.63 27.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.193 -0.942 . . . . 24.780000000000001 110.339 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.434 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 38.9 mt-30 -133.78 135.92 44.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.0 . . . . 47.899999999999999 109.916 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 47.0 p90 -92.62 166.68 12.37 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.168 -0.958 . . . . 21.609999999999999 109.519 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 25.0 m -140.54 145.73 37.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.822 . . . . 14.890000000000001 109.046 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.29 118.0 20.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 17.350000000000001 109.528 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -130.3 145.68 51.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 34.380000000000003 109.404 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.54 117.82 3.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 38.770000000000003 109.378 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' B' ' 26' ' ' TYR . . . -119.45 162.75 13.67 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.42 -1.472 . . . . 34.579999999999998 109.42 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.623 ' N ' ' CE1' ' B' ' 26' ' ' TYR . 1.0 OUTLIER -144.02 113.43 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.115 -1.226 . . . . 41.869999999999997 109.288 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.7 m -47.17 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.512 -0.743 . . . . 47.210000000000001 109.64 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.88 58.62 1.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.303 -0.873 . . . . 71.560000000000002 109.345 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 58.67 16.13 4.16 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.226 -0.922 . . . . 66.599999999999994 109.329 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.27 -55.31 1.28 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.325 -1.51 . . . . 55.490000000000002 109.325 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -145.35 151.94 48.87 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.251 -1.147 . . . . 44.990000000000002 109.184 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.47 131.1 11.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.607 2.205 . . . . 44.100000000000001 110.807 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.643 ' CE2' ' HB2' ' B' ' 28' ' ' LEU . 13.9 p90 -131.45 100.08 5.04 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.322 -0.861 . . . . 32.090000000000003 109.701 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.2 m -71.55 76.33 0.8 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 29.25 109.204 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.643 ' HB2' ' CE2' ' B' ' 26' ' ' TYR . 0.5 OUTLIER -87.79 142.91 27.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.224 -0.923 . . . . 24.0 110.134 -179.346 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.589 ' CB ' ' CB ' ' B' ' 49' ' ' LEU . 69.6 m-20 -51.14 123.13 8.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.462 -0.774 . . . . 23.309999999999999 109.947 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 35.6 mp0 -98.76 155.11 17.51 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.082 -1.081 . . . . 40.030000000000001 108.082 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' B' ' 10' ' ' GLN . 1.2 tm0? -146.53 -179.88 7.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.783 -1.198 . . . . 12.390000000000001 110.318 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.891 ' HB3' HD11 ' B' ' 44' ' ' LEU . 50.9 mt -139.98 145.92 38.45 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.442 -0.786 . . . . 17.420000000000002 110.019 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.763 ' SG ' HD11 ' B' ' 47' ' ' ILE . 4.1 m -152.88 -176.98 5.99 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.069 -1.456 . . . . 13.84 107.069 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.656 ' CD2' ' HD3' ' B' ' 7' ' ' LYS . 27.3 m-85 -128.61 113.41 15.39 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.867 -1.146 . . . . 21.140000000000001 109.914 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.879 HG22 ' HB ' ' B' ' 4' ' ' VAL . 45.5 t -107.09 115.83 49.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.293 -0.879 . . . . 10.66 110.126 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' B' ' 39' ' ' ASN . 55.0 m-20 -64.6 -36.48 84.37 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.806 -1.183 . . . . 25.890000000000001 107.806 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.658 HD21 ' HA ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER 46.34 48.37 13.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.556 -0.715 . . . . 24.239999999999998 109.876 179.333 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.65 -0.72 64.25 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.389 -1.485 . . . . 31.02 109.389 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.2 OUTLIER -106.14 95.93 6.12 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.378 -1.072 . . . . 43.229999999999997 108.278 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.494 ' C ' ' O ' ' B' ' 39' ' ' ASN . 2.4 mp0 -27.55 -41.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.452 0.644 . . . . 42.340000000000003 111.126 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' B' ' 39' ' ' ASN . 48.5 m80 -78.19 141.2 62.01 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.659 -0.867 . . . . 6.5599999999999996 108.659 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.646 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.6 Cg_endo -76.3 136.7 18.13 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 121.909 1.739 . . . . 17.920000000000002 110.51 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.839 HG23 HG23 ' B' ' 45' ' ' VAL . 2.9 m -107.6 117.55 53.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.645 -0.872 . . . . 20.57 108.645 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.891 HD11 ' HB3' ' B' ' 32' ' ' LEU . 61.6 tp -65.75 97.79 0.35 Allowed 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.486 -0.885 . . . . 20.210000000000001 110.017 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.839 HG23 HG23 ' B' ' 43' ' ' VAL . 21.2 t -99.4 168.34 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.866 -0.79 . . . . 10.81 108.866 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.559 ' N ' HG12 ' B' ' 45' ' ' VAL . 4.0 ptpp? -117.13 147.8 42.11 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 118.94 -1.104 . . . . 36.740000000000002 111.59 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 1.019 HG21 ' CZ ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -112.58 177.98 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.564 -0.902 . . . . 19.739999999999998 108.564 179.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.435 ' H ' HG22 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -126.16 74.97 1.48 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.118 -0.989 . . . . 22.559999999999999 109.519 179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.624 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.3 OUTLIER -42.85 150.74 0.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.428 -0.795 . . . . 20.41 109.129 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 53' ' ' GLN . 26.6 t0 -123.13 148.21 45.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.101 -1.0 . . . . 33.990000000000002 109.446 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 48.18 -148.8 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 54.920000000000002 109.276 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.14 16.78 56.43 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.582 -1.407 . . . . 36.100000000000001 109.582 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -45.64 149.26 1.11 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.198 -1.178 . . . . 54.759999999999998 109.523 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.1 Cg_endo -78.06 113.19 3.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.614 2.209 . . . . 28.370000000000001 109.938 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.701 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -39.4 153.44 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.483 -0.761 . . . . 17.210000000000001 110.22 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 1.019 ' CZ ' HG21 ' B' ' 47' ' ' ILE . 84.8 m-85 -50.45 113.0 0.78 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.4 -0.813 . . . . 17.190000000000001 109.238 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -61.86 177.33 0.38 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 17.82 109.483 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.8 Cg_endo -77.6 113.77 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.532 2.155 . . . . 17.280000000000001 110.215 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.33 179.33 44.87 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.724 -1.35 . . . . 17.219999999999999 109.724 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 6.0 mp -74.06 155.87 38.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -1.173 . . . . 19.57 108.315 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.731 ' HB3' HD22 ' B' ' 83' ' ' LEU . 26.5 m-85 -143.56 163.26 33.67 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.551 1.167 . . . . 14.609999999999999 111.564 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.767 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.3 p -145.67 122.99 11.6 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.283 -1.747 . . . . 18.359999999999999 106.283 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.685 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.8 t -54.28 168.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 C-N-CA 118.497 -1.281 . . . . 19.129999999999999 108.828 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.538 ' H ' HG12 ' B' ' 63' ' ' VAL . 2.1 t-80 -128.05 124.49 37.22 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.418 -0.801 . . . . 20.649999999999999 108.907 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.927 HD22 ' H ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -64.78 -6.9 9.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.82 -0.55 . . . . 19.649999999999999 109.903 -179.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 13.6 p -53.86 -16.14 1.65 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.005 -1.06 . . . . 14.720000000000001 108.616 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.498 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 50.4 m -99.67 -5.32 29.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.475 -0.765 . . . . 11.449999999999999 111.002 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.637 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.8 m-30 -81.26 157.08 25.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.647 -1.283 . . . . 14.25 109.779 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.702 ' HA ' HD21 ' A' ' 37' ' ' LEU . 5.3 pttt -142.28 171.64 13.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.368 -0.832 . . . . 32.700000000000003 109.66 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.66 HG11 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -125.65 112.66 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.346 -0.846 . . . . 15.630000000000001 109.092 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.472 ' C ' ' NE2' ' B' ' 72' ' ' GLN . . . -72.02 -173.64 20.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.586 -1.406 . . . . 12.699999999999999 109.586 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.482 ' NE2' ' N ' ' B' ' 72' ' ' GLN . 0.8 OUTLIER -89.3 34.5 0.8 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.214 -1.168 . . . . 26.289999999999999 109.503 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.94 24.81 3.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -0.797 . . . . 20.440000000000001 109.439 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.485 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . 51.32 56.9 12.92 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.604 -1.399 . . . . 13.82 109.604 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 2.6 m -149.03 105.38 3.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -1.196 . . . . 18.27 109.709 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.689 ' C ' HD23 ' B' ' 76' ' ' LEU . 5.1 tt -70.48 146.65 50.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.865 . . . . 12.43 109.257 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.506 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 4.1 mtm -157.42 144.72 18.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.173 -0.954 . . . . 35.109999999999999 109.515 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.983 HD12 HD12 ' A' ' 78' ' ' ILE . 2.3 mp -70.06 142.12 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 13.67 109.571 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -107.69 -37.07 6.25 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.766 -1.198 . . . . 24.059999999999999 107.766 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.498 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER -168.09 67.6 0.08 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.424 -1.324 . . . . 35.039999999999999 107.424 178.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.685 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.6 OUTLIER -27.47 118.52 0.09 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.356 -0.838 . . . . 18.719999999999999 111.574 -178.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.522 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 20.0 tpt180 -91.99 104.85 17.21 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.056 -1.091 . . . . 20.550000000000001 108.056 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.731 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -72.88 150.64 42.45 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.013 0.911 . . . . 14.4 111.538 -178.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.767 HG22 ' O ' ' B' ' 62' ' ' THR . 34.7 m -151.99 154.42 32.62 Favored Pre-proline 0 C--N 1.305 -1.367 0 N-CA-C 107.75 -1.204 . . . . 17.649999999999999 107.75 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.1 Cg_endo -62.89 145.93 94.73 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.176 1.917 . . . . 25.699999999999999 110.774 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -75.27 121.85 22.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.242 -0.911 . . . . 49.289999999999999 109.535 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 29.7 tptt . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.017 -0.992 . . . . 58.909999999999997 109.45 -179.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.538 ' CG ' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.532 -0.544 . . . . 64.909999999999997 109.532 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.819 ' N ' HD22 ' B' ' 65' ' ' LEU . 3.3 mt -62.17 81.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.044 -1.095 . . . . 33.799999999999997 108.044 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.536 ' HD3' HD21 ' A' ' 60' ' ' LEU . 10.8 mttt -54.98 157.52 3.21 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.857 0.836 . . . . 32.719999999999999 111.508 -177.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.111 HG22 HG22 ' A' ' 35' ' ' VAL . 80.8 t -161.14 166.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 121.719 0.771 . . . . 14.460000000000001 109.774 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.615 ' N ' HG12 ' A' ' 4' ' ' VAL . 34.1 mt-10 -152.14 105.63 3.08 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.63 -0.878 . . . . 22.120000000000001 108.63 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.766 HD11 ' SG ' ' A' ' 33' ' ' CYS . 0.3 OUTLIER -73.77 104.35 2.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 119.038 -1.065 . . . . 14.23 108.172 179.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.635 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.75 171.87 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.426 -0.796 . . . . 25.43 109.974 -179.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.5 Cg_endo -75.83 -24.88 11.14 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.468 2.112 . . . . 13.609999999999999 110.211 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.0 t -93.02 0.77 57.44 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.437 -0.789 . . . . 15.52 108.887 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.518 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 13.6 mm-40 -116.51 43.2 2.26 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.342 -0.849 . . . . 17.309999999999999 108.932 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -108.39 10.02 27.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 24.780000000000001 110.304 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.455 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 1.4 tt0 -136.81 134.34 36.89 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.109 -0.994 . . . . 47.899999999999999 108.952 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 30.2 p90 -87.49 175.48 7.93 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.046 -1.033 . . . . 21.609999999999999 109.756 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.6 m -137.57 151.95 48.91 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.874 -0.787 . . . . 14.890000000000001 108.874 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.15 117.19 25.72 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.229 -0.919 . . . . 17.350000000000001 109.439 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 17' ' ' SER . 9.0 tpt180 -125.8 146.28 49.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -0.908 . . . . 34.380000000000003 109.37 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.436 ' N ' ' HG3' ' A' ' 16' ' ' ARG . 0.5 OUTLIER -62.27 95.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 38.770000000000003 109.503 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.565 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -91.02 175.71 40.11 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.498 -1.441 . . . . 34.579999999999998 109.498 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.473 ' O ' ' O ' ' A' ' 20' ' ' SER . 1.5 t -144.73 121.96 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -1.158 . . . . 41.869999999999997 108.988 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 19' ' ' VAL . 3.4 p -51.37 -174.87 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.375 -0.828 . . . . 47.210000000000001 109.699 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 22' ' ' GLN . 0.2 OUTLIER -43.4 -33.58 1.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.213 -0.93 . . . . 71.560000000000002 109.684 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.8 OUTLIER 163.39 46.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.294 -0.879 . . . . 66.599999999999994 109.581 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 24' ' ' LYS . . . -120.93 -59.12 0.23 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.454 -1.458 . . . . 55.490000000000002 109.454 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.489 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 22.5 mttp -149.94 163.39 24.81 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.297 -1.119 . . . . 44.990000000000002 109.475 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.6 Cg_endo -78.13 132.38 11.49 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.617 2.211 . . . . 44.100000000000001 110.083 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 10.4 p90 -122.84 138.95 54.5 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.119 -0.988 . . . . 32.090000000000003 109.622 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.45 74.71 5.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.206 -0.934 . . . . 29.25 108.972 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.583 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -85.05 169.03 14.35 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 24.0 109.985 -179.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.633 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -98.82 122.58 42.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.46 -0.775 . . . . 23.309999999999999 108.996 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.46 ' OE1' ' HD3' ' A' ' 46' ' ' LYS . 4.8 mt-10 -108.94 156.96 19.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.244 -0.91 . . . . 40.030000000000001 109.887 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.622 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -141.26 -172.85 3.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 12.390000000000001 109.419 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.929 ' HB3' HD11 ' A' ' 44' ' ' LEU . 4.7 mp -133.99 159.16 41.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 17.420000000000002 109.48 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.766 ' SG ' HD11 ' A' ' 6' ' ' ILE . 13.4 m -155.46 177.17 11.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.095 -1.003 . . . . 13.84 108.324 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.689 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 35.3 m-85 -126.65 110.98 13.77 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.093 -1.005 . . . . 21.140000000000001 108.935 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.111 HG22 HG22 ' A' ' 4' ' ' VAL . 50.9 t -89.59 151.66 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.016 -1.053 . . . . 10.66 110.378 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 38' ' ' GLY . 1.2 m-20 -129.01 -145.49 0.3 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.713 -0.617 . . . . 25.890000000000001 109.348 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.861 ' HG ' HD21 ' B' ' 65' ' ' LEU . 0.3 OUTLIER 67.6 -65.33 0.24 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.185 -0.947 . . . . 24.239999999999998 109.094 -179.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -83.39 6.13 74.07 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 109.028 -1.629 . . . . 31.02 109.028 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' A' ' 38' ' ' GLY . 4.4 m-80 -162.41 109.07 1.27 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.431 -1.041 . . . . 43.229999999999997 109.006 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' ASN . 26.0 mt-10 -39.22 -61.22 0.8 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.617 0.722 . . . . 42.340000000000003 109.632 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 22.8 m80 -71.47 164.55 56.73 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 108.174 -1.047 . . . . 8.3100000000000005 108.174 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.689 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.7 Cg_endo -78.27 140.52 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 121.868 1.712 . . . . 17.920000000000002 110.6 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.045 HG21 HG21 ' B' ' 70' ' ' VAL . 33.0 m -111.94 113.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.375 -0.828 . . . . 20.57 109.17 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.929 HD11 ' HB3' ' A' ' 32' ' ' LEU . 32.4 tp -67.35 110.66 3.65 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.906 . . . . 20.210000000000001 109.505 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.581 ' CG2' ' N ' ' B' ' 75' ' ' SER . 9.9 p -122.4 153.35 26.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.492 -0.755 . . . . 10.81 109.175 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' HD3' ' OE1' ' A' ' 30' ' ' GLU . 2.6 tttt -73.3 148.48 43.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.218 -0.926 . . . . 36.740000000000002 110.055 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.032 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.8 OUTLIER -139.92 123.02 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.724 -0.843 . . . . 19.739999999999998 108.724 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.532 ' CG2' HD22 ' A' ' 28' ' ' LEU . 1.3 m -63.31 156.69 24.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.08 -1.013 . . . . 22.559999999999999 110.05 -179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.759 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -122.33 117.14 25.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.805 . . . . 20.41 108.902 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.538 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -47.13 140.25 5.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.221 -0.924 . . . . 33.990000000000002 109.812 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.85 109.49 0.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.379 -0.826 . . . . 54.920000000000002 109.478 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.97 -16.72 59.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.6 -1.4 . . . . 36.100000000000001 109.6 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.538 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -73.69 150.57 88.78 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.285 -1.127 . . . . 54.759999999999998 109.522 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.33 122.87 5.8 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.665 2.243 . . . . 28.370000000000001 110.184 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.759 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -40.1 147.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.396 -0.815 . . . . 17.210000000000001 110.483 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.621 ' HB3' HD13 ' A' ' 6' ' ' ILE . 89.1 m-85 -47.96 116.22 1.44 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.483 -0.761 . . . . 17.190000000000001 109.026 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.004 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -66.63 176.77 0.97 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 17.82 109.62 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 1.004 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.4 Cg_endo -78.4 105.6 2.0 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.686 2.257 . . . . 17.280000000000001 110.261 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.49 176.69 48.16 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.99 -1.244 . . . . 17.219999999999999 109.99 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.779 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -73.5 143.59 46.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -1.111 . . . . 19.57 108.426 179.293 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.565 ' CB ' ' HB ' ' A' ' 4' ' ' VAL . 33.3 m-85 -130.29 162.73 28.33 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.773 -1.204 . . . . 14.609999999999999 111.25 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.709 ' O ' HG22 ' A' ' 84' ' ' VAL . 33.4 p -142.9 119.78 11.27 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.896 -1.89 . . . . 18.359999999999999 105.896 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.634 ' HB ' HD13 ' A' ' 2' ' ' ILE . 2.7 t -53.05 166.94 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 C-N-CA 118.59 -1.244 . . . . 19.129999999999999 109.467 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -129.36 130.46 46.08 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.545 -0.722 . . . . 20.649999999999999 109.134 -178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.879 HD21 ' HG ' ' B' ' 37' ' ' LEU . 0.5 OUTLIER -72.58 1.58 7.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.43 -0.794 . . . . 19.649999999999999 110.116 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -55.42 -19.25 8.69 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 107.496 -1.298 . . . . 14.720000000000001 107.496 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.516 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 7.1 m -99.07 -3.93 33.56 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.932 -0.48 . . . . 11.449999999999999 110.33 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.66 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.4 m-30 -85.41 157.47 20.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.863 -1.148 . . . . 14.25 110.215 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.425 ' HG2' ' HB2' ' A' ' 79' ' ' ASP . 1.5 ptpt -154.41 174.33 15.01 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 109.023 -0.732 . . . . 32.700000000000003 109.023 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.05 HG21 HG21 ' B' ' 43' ' ' VAL . 1.0 OUTLIER -114.58 111.76 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.192 -0.943 . . . . 15.630000000000001 109.556 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.34 -170.25 46.59 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.315 -1.514 . . . . 12.699999999999999 109.315 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -90.5 20.79 4.31 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.154 -1.204 . . . . 26.289999999999999 109.481 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -90.82 -12.74 35.44 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.501 -0.75 . . . . 20.440000000000001 109.237 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' B' ' 46' ' ' LYS . . . 85.01 35.05 13.12 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.509 -1.436 . . . . 13.82 109.509 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.547 ' N ' ' CG2' ' B' ' 45' ' ' VAL . 22.8 p -164.33 150.82 11.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -1.199 . . . . 18.27 109.647 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.688 HD22 HG21 ' B' ' 2' ' ' ILE . 16.3 tp -63.69 156.74 26.03 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.853 . . . . 12.43 109.126 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 32.0 mtt -154.95 113.43 3.53 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.092 -1.005 . . . . 35.109999999999999 109.749 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.96 HD12 HD12 ' B' ' 78' ' ' ILE . 2.9 mt -55.67 139.91 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.314 -0.866 . . . . 13.67 109.472 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.425 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 10.9 t70 -106.19 -27.39 11.09 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.443 -0.947 . . . . 24.059999999999999 108.443 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.516 ' C ' ' HB3' ' A' ' 67' ' ' SER . 5.7 tpm_? 179.74 67.75 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.992 -1.485 . . . . 35.039999999999999 106.992 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.643 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -29.39 118.09 0.13 Allowed 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.387 -0.824 . . . . 18.719999999999999 111.913 -177.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -92.09 108.14 19.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.716 -1.216 . . . . 20.550000000000001 107.716 178.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.032 ' HB2' HD11 ' A' ' 47' ' ' ILE . 12.7 tp -80.25 150.42 30.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.229 -0.919 . . . . 14.4 111.093 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 62' ' ' THR . 25.0 m -147.44 152.47 42.23 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 108.039 -1.097 . . . . 17.649999999999999 108.039 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -62.37 141.58 87.72 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.103 1.868 . . . . 25.699999999999999 110.662 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.779 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.59 116.44 14.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.437 -0.789 . . . . 49.289999999999999 109.625 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.007 -0.996 . . . . 58.909999999999997 109.482 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.535 ' CG ' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.518 -0.549 . . . . 64.909999999999997 109.518 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.832 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.2 mt -62.19 81.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 107.993 -1.114 . . . . 33.799999999999997 107.993 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 10.8 mttt -54.83 157.37 3.16 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.877 0.846 . . . . 32.719999999999999 111.487 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.031 HG22 HG22 ' B' ' 35' ' ' VAL . 83.1 t -161.09 166.03 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.751 0.786 . . . . 14.460000000000001 109.739 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.619 ' N ' HG12 ' B' ' 4' ' ' VAL . 34.4 mt-10 -151.97 105.69 3.12 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.629 -0.878 . . . . 22.120000000000001 108.629 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.758 HD11 ' SG ' ' B' ' 33' ' ' CYS . 0.3 OUTLIER -73.77 104.55 2.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 C-N-CA 119.01 -1.076 . . . . 14.23 108.178 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.641 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.83 171.9 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.442 -0.786 . . . . 25.43 109.99 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.5 Cg_endo -75.8 -25.04 11.05 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.487 2.125 . . . . 13.609999999999999 110.238 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 14.3 t -92.8 0.65 57.45 Favored 'General case' 0 C--N 1.298 -1.63 0 N-CA-C 108.938 -0.764 . . . . 15.52 108.938 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 13.6 mm-40 -116.43 43.25 2.24 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.345 -0.847 . . . . 17.309999999999999 108.928 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -108.4 10.09 27.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.91 . . . . 24.780000000000001 110.312 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.454 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 1.4 tt0 -136.86 134.22 36.65 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.114 -0.991 . . . . 47.899999999999999 108.943 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.629 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 30.2 p90 -87.44 175.47 7.95 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.028 -1.045 . . . . 21.609999999999999 109.74 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 59.3 m -137.48 152.04 49.11 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.845 -0.798 . . . . 14.890000000000001 108.845 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.29 117.17 25.88 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.256 -0.903 . . . . 17.350000000000001 109.401 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' B' ' 17' ' ' SER . 9.0 tpt180 -125.77 146.36 49.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 34.380000000000003 109.366 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.439 ' N ' ' HG3' ' B' ' 16' ' ' ARG . 0.5 OUTLIER -62.38 95.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 38.770000000000003 109.447 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -90.98 175.77 40.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.473 -1.451 . . . . 34.579999999999998 109.473 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.465 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.5 t -144.79 121.99 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.196 . . . . 41.869999999999997 109.024 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.461 ' O ' ' O ' ' B' ' 19' ' ' VAL . 3.5 p -51.41 -174.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.315 -0.866 . . . . 47.210000000000001 109.674 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 22' ' ' GLN . 0.2 OUTLIER -43.37 -33.62 1.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 71.560000000000002 109.642 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' B' ' 21' ' ' ARG . 0.8 OUTLIER 163.31 46.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 66.599999999999994 109.589 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' B' ' 24' ' ' LYS . . . -120.97 -59.05 0.23 Allowed Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.514 -1.434 . . . . 55.490000000000002 109.514 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.483 ' HB3' ' HD2' ' B' ' 25' ' ' PRO . 22.4 mttp -149.97 163.36 24.91 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.296 -1.12 . . . . 44.990000000000002 109.441 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' B' ' 24' ' ' LYS . 35.0 Cg_endo -78.1 132.26 11.44 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.65 2.233 . . . . 44.100000000000001 110.039 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.6 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 10.6 p90 -122.74 139.06 54.39 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.137 -0.977 . . . . 32.090000000000003 109.662 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.57 74.93 5.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 29.25 108.954 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.584 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -85.2 168.94 14.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 24.0 109.969 -179.488 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.628 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -98.75 122.53 42.09 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.479 -0.763 . . . . 23.309999999999999 109.035 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 4.9 mt-10 -109.0 156.79 19.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.189 -0.944 . . . . 40.030000000000001 109.911 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.623 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -141.13 -172.83 3.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 12.390000000000001 109.423 179.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.943 ' HB3' HD11 ' B' ' 44' ' ' LEU . 4.7 mp -133.99 159.13 41.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.154 -0.966 . . . . 17.420000000000002 109.412 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.758 ' SG ' HD11 ' B' ' 6' ' ' ILE . 13.1 m -155.41 177.21 11.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.309 -0.997 . . . . 13.84 108.309 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.684 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 34.6 m-85 -126.72 111.04 13.8 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.157 -0.964 . . . . 21.140000000000001 108.92 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 1.031 HG22 HG22 ' B' ' 4' ' ' VAL . 50.9 t -89.69 151.65 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.012 -1.055 . . . . 10.66 110.397 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' B' ' 38' ' ' GLY . 1.1 m-20 -128.92 -145.6 0.3 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.307 -0.627 . . . . 25.890000000000001 109.307 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.879 ' HG ' HD21 ' A' ' 65' ' ' LEU . 0.3 OUTLIER 67.65 -65.4 0.24 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.134 -0.979 . . . . 24.239999999999998 109.057 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -83.27 6.11 73.73 Favored Glycine 0 N--CA 1.483 1.805 0 N-CA-C 109.041 -1.623 . . . . 31.02 109.041 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' B' ' 38' ' ' GLY . 4.5 m-80 -162.39 109.02 1.27 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.438 -1.036 . . . . 43.229999999999997 108.986 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' B' ' 39' ' ' ASN . 26.1 mt-10 -39.08 -61.39 0.76 Allowed 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.701 0.762 . . . . 42.340000000000003 109.573 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.461 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 22.6 m80 -71.24 164.57 56.04 Favored Pre-proline 0 C--N 1.295 -1.771 0 N-CA-C 108.256 -1.016 . . . . 8.3399999999999999 108.256 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.684 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.6 Cg_endo -78.32 140.7 17.57 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.855 1.703 . . . . 17.920000000000002 110.507 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 1.05 HG21 HG21 ' A' ' 70' ' ' VAL . 32.9 m -112.13 113.33 43.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.394 -0.816 . . . . 20.57 109.197 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.943 HD11 ' HB3' ' B' ' 32' ' ' LEU . 32.3 tp -67.46 110.72 3.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.313 -0.867 . . . . 20.210000000000001 109.616 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 75' ' ' SER . 9.9 p -122.28 153.81 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.494 -0.754 . . . . 10.81 109.108 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 2.6 tttt -73.73 148.55 42.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 36.740000000000002 110.027 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.999 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.8 OUTLIER -139.75 123.04 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.739 -0.837 . . . . 19.739999999999998 108.739 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.519 ' CG2' HD22 ' B' ' 28' ' ' LEU . 1.3 m -63.39 156.66 25.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.015 -1.053 . . . . 22.559999999999999 109.982 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.764 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -122.26 116.98 25.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.422 -0.799 . . . . 20.41 108.94 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.545 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -47.0 140.33 4.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.146 -0.971 . . . . 33.990000000000002 109.832 -179.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -58.92 109.45 0.83 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 54.920000000000002 109.478 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.99 -16.75 59.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.581 -1.408 . . . . 36.100000000000001 109.581 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.545 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.8 OUTLIER -73.7 150.47 88.71 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.248 -1.148 . . . . 54.759999999999998 109.568 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.7 Cg_endo -78.22 122.82 5.84 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.656 2.237 . . . . 28.370000000000001 110.225 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.764 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -40.11 147.15 0.1 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 17.210000000000001 110.404 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.619 ' HB3' HD13 ' B' ' 6' ' ' ILE . 88.9 m-85 -48.13 115.59 1.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.462 -0.773 . . . . 17.190000000000001 109.171 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -65.64 176.88 0.79 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 17.82 109.583 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 36.1 Cg_endo -78.68 106.72 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.741 2.294 . . . . 17.280000000000001 110.424 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -178.82 176.9 48.27 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.876 -1.29 . . . . 17.219999999999999 109.876 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.808 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -73.37 144.14 46.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.385 -1.068 . . . . 19.57 108.632 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.571 ' CB ' ' HB ' ' B' ' 4' ' ' VAL . 33.7 m-85 -130.78 162.82 28.68 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.756 -1.215 . . . . 14.609999999999999 111.375 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.718 ' O ' HG22 ' B' ' 84' ' ' VAL . 33.2 p -143.09 119.68 11.07 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 105.975 -1.861 . . . . 18.359999999999999 105.975 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.639 ' HB ' HD13 ' B' ' 2' ' ' ILE . 2.7 t -53.12 166.71 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 118.575 -1.25 . . . . 19.129999999999999 109.438 -177.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -129.2 130.32 46.17 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.552 -0.718 . . . . 20.649999999999999 109.196 -178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.861 HD21 ' HG ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -72.47 1.69 7.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.421 -0.799 . . . . 19.649999999999999 110.092 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -55.49 -19.24 9.02 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.45 -1.315 . . . . 14.720000000000001 107.45 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.509 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 7.0 m -99.08 -3.98 33.42 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.902 -0.499 . . . . 11.449999999999999 110.351 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.659 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.3 m-30 -85.35 157.62 20.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.913 -1.117 . . . . 14.25 110.182 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.422 ' HG2' ' HB2' ' B' ' 79' ' ' ASP . 1.5 ptpt -154.57 174.17 15.32 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.991 -0.744 . . . . 32.700000000000003 108.991 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 1.045 HG21 HG21 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -114.44 111.77 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 15.630000000000001 109.55 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.2 -170.24 46.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.332 -1.507 . . . . 12.699999999999999 109.332 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.65 21.17 4.16 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.138 -1.213 . . . . 26.289999999999999 109.458 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.16 -12.82 34.31 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.448 -0.782 . . . . 20.440000000000001 109.253 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.48 ' C ' HG22 ' A' ' 45' ' ' VAL . . . 85.15 34.72 13.82 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.546 -1.422 . . . . 13.82 109.546 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.581 ' N ' ' CG2' ' A' ' 45' ' ' VAL . 21.9 p -163.93 150.87 11.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -1.183 . . . . 18.27 109.683 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.715 HD22 HG21 ' A' ' 2' ' ' ILE . 16.3 tp -63.72 157.0 25.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 12.43 109.09 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' B' ' 76' ' ' LEU . 31.9 mtt -155.15 113.5 3.49 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.013 . . . . 35.109999999999999 109.679 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.96 HD12 HD12 ' A' ' 78' ' ' ILE . 2.9 mt -55.74 139.95 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.862 . . . . 13.67 109.476 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.422 ' HB2' ' HG2' ' B' ' 69' ' ' LYS . 10.7 t70 -106.19 -27.3 11.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.417 -0.957 . . . . 24.059999999999999 108.417 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.509 ' C ' ' HB3' ' B' ' 67' ' ' SER . 5.8 tpm_? 179.65 67.78 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 106.956 -1.498 . . . . 35.039999999999999 106.956 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.639 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -29.34 118.13 0.13 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.349 -0.841 . . . . 18.719999999999999 111.85 -177.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.525 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.1 OUTLIER -92.2 108.07 19.67 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.709 -1.219 . . . . 20.550000000000001 107.709 178.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.999 ' HB2' HD11 ' B' ' 47' ' ' ILE . 12.6 tp -80.13 150.26 30.28 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.184 -0.947 . . . . 14.4 111.07 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.718 HG22 ' O ' ' B' ' 62' ' ' THR . 25.0 m -147.32 152.58 42.9 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 108.111 -1.07 . . . . 17.649999999999999 108.111 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.3 Cg_endo -62.32 141.72 88.51 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.166 1.91 . . . . 25.699999999999999 110.666 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -73.69 116.54 14.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 49.289999999999999 109.497 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.959 -1.02 . . . . 58.909999999999997 109.425 179.999 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' A' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.308 0.575 . . . . 64.909999999999997 109.484 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.696 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.7 mt 69.3 72.64 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.975 -1.12 . . . . 33.799999999999997 107.975 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.497 ' C ' HG23 ' A' ' 4' ' ' VAL . 18.8 mttt -54.1 158.74 2.08 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.017 0.913 . . . . 32.719999999999999 111.461 -178.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.05 ' CG2' HG22 ' A' ' 35' ' ' VAL . 66.4 t -160.46 168.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.93 -0.766 . . . . 14.460000000000001 108.93 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.589 ' N ' HG12 ' A' ' 4' ' ' VAL . 43.1 mt-10 -154.6 103.26 2.45 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.79 0.805 . . . . 22.120000000000001 108.843 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.561 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -69.34 108.43 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 107.893 -1.151 . . . . 14.23 107.893 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.654 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -47.11 172.79 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.203 -0.936 . . . . 25.43 109.406 -179.042 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.5 Cg_endo -76.23 -21.6 13.49 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.475 2.117 . . . . 13.609999999999999 110.128 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.42 4.15 46.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.529 -0.732 . . . . 15.52 109.443 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.699 ' OE1' HD12 ' A' ' 32' ' ' LEU . 24.0 mm-40 -114.84 38.71 3.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.169 -0.957 . . . . 17.309999999999999 109.288 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.13 52.24 0.72 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.296 -0.877 . . . . 24.780000000000001 109.738 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.63 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 5.0 pt20 -176.63 135.63 0.24 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.364 -0.835 . . . . 47.899999999999999 108.896 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.634 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 37.7 p90 -95.61 172.67 7.91 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.721 -1.237 . . . . 21.609999999999999 109.874 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 8.0 t -137.03 162.03 34.43 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.497 -0.927 . . . . 14.890000000000001 108.497 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 112.75 24.78 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.178 -0.951 . . . . 17.350000000000001 109.271 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.449 ' NH1' ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -126.15 139.39 53.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.346 -0.846 . . . . 34.380000000000003 109.424 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -44.68 152.57 0.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 38.770000000000003 109.456 -179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.589 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -158.91 167.26 34.75 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.411 -1.476 . . . . 34.579999999999998 109.411 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 23' ' ' GLY . 1.8 t -135.55 118.81 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.204 -1.174 . . . . 41.869999999999997 109.152 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 21' ' ' ARG . 2.9 p -55.49 94.09 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.459 -0.776 . . . . 47.210000000000001 109.808 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 20' ' ' SER . 29.0 mtm180 41.95 50.19 4.16 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -0.817 . . . . 71.560000000000002 109.842 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 56.98 70.02 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 66.599999999999994 109.757 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.556 ' H ' HG12 ' A' ' 19' ' ' VAL . . . -151.79 -57.87 0.01 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.016 -1.634 . . . . 55.490000000000002 109.016 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 5.5 mmtt -138.58 148.66 59.71 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.474 -1.015 . . . . 44.990000000000002 108.626 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.66 113.42 3.65 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.35 2.034 . . . . 44.100000000000001 110.368 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.997 ' CE1' HD23 ' A' ' 28' ' ' LEU . 4.6 p90 -119.89 168.83 10.73 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.282 -0.886 . . . . 32.090000000000003 110.007 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.01 83.65 2.17 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.85 -1.167 . . . . 29.25 107.85 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.997 HD23 ' CE1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -92.28 143.55 26.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 24.0 110.903 -178.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.611 ' CB ' ' CD1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -72.47 127.67 33.26 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.931 -0.766 . . . . 23.309999999999999 108.931 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.7 ' CG ' HD11 ' A' ' 28' ' ' LEU . 6.6 mt-10 -118.11 165.51 13.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.018 -1.051 . . . . 40.030000000000001 109.281 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.652 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.9 OUTLIER -146.37 179.99 7.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.106 -0.996 . . . . 12.390000000000001 109.671 -179.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.699 HD12 ' OE1' ' A' ' 10' ' ' GLN . 39.3 mt -123.92 154.04 40.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 17.420000000000002 109.316 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 11.1 m -154.06 172.98 16.65 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.611 -1.255 . . . . 13.84 107.611 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.847 ' CE2' HD13 ' A' ' 44' ' ' LEU . 29.2 m-85 -121.45 99.03 6.24 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.951 -1.093 . . . . 21.140000000000001 109.45 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.05 HG22 ' CG2' ' A' ' 4' ' ' VAL . 61.7 t -93.73 126.16 46.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.041 -1.037 . . . . 10.66 110.602 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' GLY . 25.3 t0 -101.19 44.66 1.0 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.591 -1.263 . . . . 25.890000000000001 107.591 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.83 HD21 HG22 ' B' ' 70' ' ' VAL . 0.1 OUTLIER -35.77 -29.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.223 0.535 . . . . 24.239999999999998 110.197 -178.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.628 ' H ' HD12 ' A' ' 37' ' ' LEU . . . 160.84 52.3 0.02 OUTLIER Glycine 0 N--CA 1.479 1.535 0 N-CA-C 109.438 -1.465 . . . . 31.02 109.438 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.47 HD22 HG11 ' A' ' 43' ' ' VAL . 37.3 m-20 -126.83 17.98 7.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.07 -1.253 . . . . 43.229999999999997 110.035 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.591 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 2.6 mm-40 56.56 14.64 1.77 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.326 -0.859 . . . . 42.340000000000003 110.252 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 77.5 m-70 -162.53 161.72 19.71 Favored Pre-proline 0 N--CA 1.492 1.632 0 N-CA-C 108.326 -0.99 . . . . 6.1600000000000001 108.326 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.691 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.0 Cg_endo -78.06 136.57 14.78 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 121.892 1.728 . . . . 17.920000000000002 110.021 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.916 HG22 ' O ' ' A' ' 35' ' ' VAL . 3.6 m -111.34 115.24 49.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.249 -0.907 . . . . 20.57 109.453 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.847 HD13 ' CE2' ' A' ' 34' ' ' TYR . 18.9 tp -71.76 88.73 1.01 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.182 -0.949 . . . . 20.210000000000001 109.482 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.478 HG22 ' C ' ' B' ' 74' ' ' GLY . 6.1 p -103.21 152.88 5.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.632 -0.877 . . . . 10.81 108.632 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 3.7 mtpt -72.08 167.03 21.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.133 -0.979 . . . . 36.740000000000002 110.493 -178.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.983 ' CD1' HD12 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -146.47 177.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.567 -0.901 . . . . 19.739999999999998 108.567 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.769 HG23 HD13 ' A' ' 28' ' ' LEU . 97.8 m -117.6 151.29 37.47 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.186 -0.946 . . . . 22.559999999999999 109.464 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.651 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -124.74 149.19 47.56 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.291 -1.003 . . . . 20.41 108.291 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' H ' HD13 ' A' ' 49' ' ' LEU . 23.4 t0 -106.18 143.5 34.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.078 -1.014 . . . . 33.990000000000002 110.202 -179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.21 127.04 14.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.471 -0.768 . . . . 54.920000000000002 109.477 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.7 -28.67 7.47 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.652 -1.379 . . . . 36.100000000000001 109.652 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.97 137.35 72.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.198 -1.178 . . . . 54.759999999999998 109.564 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.5 Cg_endo -78.58 124.2 6.26 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.413 2.075 . . . . 28.370000000000001 109.959 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.652 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -40.24 147.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.4 -0.812 . . . . 17.210000000000001 110.0 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.646 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 84.9 m-85 -45.9 105.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.861 . . . . 17.190000000000001 109.137 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -58.1 174.79 0.32 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 17.82 109.628 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.78 114.15 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.605 2.203 . . . . 17.280000000000001 110.149 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.25 179.76 46.0 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.474 -1.45 . . . . 17.219999999999999 109.474 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.6 mp -75.4 146.31 40.9 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -1.217 . . . . 19.57 108.111 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.682 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.4 m-85 -133.07 167.43 20.32 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.866 -1.146 . . . . 14.609999999999999 111.591 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.642 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.8 p -150.59 119.5 6.65 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.336 -1.727 . . . . 18.359999999999999 106.336 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.602 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -52.01 164.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.374 -1.33 . . . . 19.129999999999999 108.568 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.533 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -123.47 123.89 41.65 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.397 -0.814 . . . . 20.649999999999999 109.003 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.717 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.2 OUTLIER -67.94 -4.02 11.73 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.834 -0.542 . . . . 19.649999999999999 110.209 -179.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.3 t -55.98 -15.86 4.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.076 -1.015 . . . . 14.720000000000001 108.449 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.49 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 16.6 m -95.76 -7.0 38.39 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.525 -0.734 . . . . 11.449999999999999 110.633 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.664 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.9 m-30 -83.15 159.64 22.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.818 -1.176 . . . . 14.25 109.674 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.766 ' HA ' HD22 ' B' ' 37' ' ' LEU . 10.3 mtmt -157.82 172.14 19.03 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.49 -0.756 . . . . 32.700000000000003 109.253 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.794 HG22 HD21 ' B' ' 37' ' ' LEU . 0.0 OUTLIER -107.78 98.29 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 15.630000000000001 109.008 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -77.8 -149.92 4.11 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.825 -1.31 . . . . 12.699999999999999 109.825 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.3 21.04 17.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.27 -1.135 . . . . 26.289999999999999 109.685 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.09 -11.98 42.46 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 109.05 -0.722 . . . . 20.440000000000001 109.05 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 84.69 24.23 46.9 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.495 -1.442 . . . . 13.82 109.495 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.7 p -161.03 152.25 18.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -1.179 . . . . 18.27 109.633 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.675 ' C ' HD23 ' A' ' 76' ' ' LEU . 4.7 tt -62.95 149.23 45.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.319 -0.863 . . . . 12.43 109.381 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.51 ' N ' HD23 ' A' ' 76' ' ' LEU . 14.3 mtt -150.55 133.98 16.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 35.109999999999999 109.412 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' B' ' 78' ' ' ILE . 3.2 mt -66.29 139.24 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.877 . . . . 13.67 109.721 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 8.3 t70 -106.64 -19.58 13.62 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.507 -0.923 . . . . 24.059999999999999 108.507 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.49 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.0 OUTLIER 172.71 68.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.198 -1.408 . . . . 35.039999999999999 107.198 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -31.63 116.88 0.19 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.693 0.758 . . . . 18.719999999999999 111.179 -178.14 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.533 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -90.01 104.97 17.49 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.463 -0.94 . . . . 20.550000000000001 108.463 179.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.983 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -73.38 144.82 46.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 14.4 111.024 -178.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 62' ' ' THR . 27.6 m -146.72 156.61 48.32 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.956 -1.128 . . . . 17.649999999999999 107.956 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.0 Cg_endo -63.03 144.97 93.89 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.134 1.889 . . . . 25.699999999999999 110.334 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.11 115.73 12.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.135 -0.978 . . . . 49.289999999999999 109.705 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.02 -0.99 . . . . 58.909999999999997 109.531 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.534 ' HG3' ' CG2' ' B' ' 62' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.399 -0.593 . . . . 64.909999999999997 109.399 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.717 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.7 mt 68.6 72.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.874 -1.158 . . . . 33.799999999999997 107.874 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.494 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 18.9 mttt -54.4 158.62 2.32 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.009 0.909 . . . . 32.719999999999999 111.412 -178.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.072 ' CG2' HG22 ' B' ' 35' ' ' VAL . 68.2 t -160.25 168.0 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.994 -0.743 . . . . 14.460000000000001 108.994 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.612 ' N ' HG12 ' B' ' 4' ' ' VAL . 42.3 mt-10 -154.02 103.09 2.54 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.418 -0.801 . . . . 22.120000000000001 108.975 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.559 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -69.18 108.53 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.934 -1.135 . . . . 14.23 107.934 179.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.661 ' CD ' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -47.25 172.5 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 25.43 109.36 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.457 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 35.1 Cg_endo -76.16 -21.39 13.81 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.488 2.125 . . . . 13.609999999999999 110.122 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.63 4.15 45.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.475 -0.765 . . . . 15.52 109.442 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.696 ' OE1' HD12 ' B' ' 32' ' ' LEU . 24.1 mm-40 -114.69 38.36 3.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.93 . . . . 17.309999999999999 109.187 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.14 53.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 24.780000000000001 109.709 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.614 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 4.8 pt20 -177.24 135.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.376 -0.828 . . . . 47.899999999999999 108.884 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.628 ' CD2' ' HG ' ' B' ' 49' ' ' LEU . 37.9 p90 -95.77 172.75 7.84 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.753 -1.217 . . . . 21.609999999999999 109.891 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 8.3 t -137.28 161.91 34.94 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.488 -0.93 . . . . 14.890000000000001 108.488 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.93 112.78 24.85 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.17 -0.956 . . . . 17.350000000000001 109.438 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.449 ' NH1' ' HG3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -126.21 139.27 53.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.299 -0.876 . . . . 34.380000000000003 109.378 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.413 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.6 OUTLIER -44.52 152.74 0.19 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.243 -0.911 . . . . 38.770000000000003 109.403 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.576 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -159.2 167.22 34.91 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.424 -1.471 . . . . 34.579999999999998 109.424 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.566 HG12 ' H ' ' B' ' 23' ' ' GLY . 1.8 t -135.47 119.06 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.116 -1.226 . . . . 41.869999999999997 109.149 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.43 ' O ' ' C ' ' B' ' 21' ' ' ARG . 3.0 p -55.69 94.22 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.341 -0.85 . . . . 47.210000000000001 109.768 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' B' ' 20' ' ' SER . 28.4 mtm180 41.65 50.54 3.87 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.425 -0.797 . . . . 71.560000000000002 109.832 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 56.73 70.18 0.67 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 66.599999999999994 109.81 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.566 ' H ' HG12 ' B' ' 19' ' ' VAL . . . -152.1 -57.72 0.01 OUTLIER Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.048 -1.621 . . . . 55.490000000000002 109.048 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' B' ' 19' ' ' VAL . 5.5 mmtt -138.56 148.38 58.64 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.388 -1.066 . . . . 44.990000000000002 108.714 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.45 113.47 3.68 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.371 2.047 . . . . 44.100000000000001 110.403 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.982 ' CE1' HD23 ' B' ' 28' ' ' LEU . 4.3 p90 -120.16 168.49 11.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.23 -0.919 . . . . 32.090000000000003 110.081 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.68 83.82 2.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.938 -1.134 . . . . 29.25 107.938 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.982 HD23 ' CE1' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -92.4 143.42 26.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 24.0 110.846 -178.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.624 ' CB ' ' CD1' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -72.38 127.47 32.67 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.894 -0.78 . . . . 23.309999999999999 108.894 179.03 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.712 ' CG ' HD11 ' B' ' 28' ' ' LEU . 6.5 mt-10 -118.06 165.24 13.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.012 -1.055 . . . . 40.030000000000001 109.322 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.63 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.9 OUTLIER -146.03 -179.9 7.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.137 -0.977 . . . . 12.390000000000001 109.765 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.696 HD12 ' OE1' ' B' ' 10' ' ' GLN . 40.3 mt -124.2 153.71 41.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 17.420000000000002 109.309 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 10.3 m -153.73 172.98 16.44 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.716 -1.216 . . . . 13.84 107.716 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.829 ' CE2' HD13 ' B' ' 44' ' ' LEU . 29.3 m-85 -121.39 98.91 6.19 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.895 -1.128 . . . . 21.140000000000001 109.461 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 1.072 HG22 ' CG2' ' B' ' 4' ' ' VAL . 61.7 t -93.6 126.17 46.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.03 -1.044 . . . . 10.66 110.573 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' B' ' 38' ' ' GLY . 26.1 t0 -101.11 44.37 1.02 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.579 -1.267 . . . . 25.890000000000001 107.579 178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.794 HD21 HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -35.65 -30.02 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.1 0.476 . . . . 24.239999999999998 110.185 -178.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.626 ' H ' HD12 ' B' ' 37' ' ' LEU . . . 161.05 51.75 0.02 OUTLIER Glycine 0 N--CA 1.479 1.5 0 N-CA-C 109.415 -1.474 . . . . 31.02 109.415 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.459 HD22 HG11 ' B' ' 43' ' ' VAL . 37.7 m-20 -126.54 18.28 7.48 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.167 -1.196 . . . . 43.229999999999997 110.092 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.59 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 2.6 mm-40 56.36 14.58 1.65 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.237 -0.914 . . . . 42.340000000000003 110.302 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 77.4 m-70 -162.41 161.6 20.14 Favored Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 108.344 -0.984 . . . . 6.1500000000000004 108.344 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.694 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.8 Cg_endo -78.02 136.55 14.83 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.877 1.718 . . . . 17.920000000000002 109.998 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.911 HG22 ' O ' ' B' ' 35' ' ' VAL . 3.6 m -111.39 115.42 49.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.242 -0.911 . . . . 20.57 109.339 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.829 HD13 ' CE2' ' B' ' 34' ' ' TYR . 19.0 tp -71.99 88.8 1.08 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.219 -0.926 . . . . 20.210000000000001 109.503 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.42 HG22 ' C ' ' A' ' 74' ' ' GLY . 6.3 p -103.0 153.38 5.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.648 -0.871 . . . . 10.81 108.648 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 3.8 mtpt -72.32 167.44 20.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.093 -1.004 . . . . 36.740000000000002 110.428 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.975 ' CD1' HD12 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -146.94 177.12 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.628 -0.878 . . . . 19.739999999999998 108.628 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.771 HG23 HD13 ' B' ' 28' ' ' LEU . 98.5 m -117.39 151.28 37.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.123 -0.986 . . . . 22.559999999999999 109.468 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -124.88 148.86 48.06 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.226 -1.028 . . . . 20.41 108.226 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.465 ' H ' HD13 ' B' ' 49' ' ' LEU . 23.2 t0 -105.95 143.61 33.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.089 -1.007 . . . . 33.990000000000002 110.076 -179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.22 126.84 13.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.771 . . . . 54.920000000000002 109.528 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.81 -28.49 7.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.712 -1.355 . . . . 36.100000000000001 109.712 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.08 137.45 72.53 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.277 -1.131 . . . . 54.759999999999998 109.483 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.57 124.14 6.24 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.394 2.063 . . . . 28.370000000000001 109.96 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.666 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -40.29 147.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.449 -0.782 . . . . 17.210000000000001 109.913 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 84.1 m-85 -46.2 105.85 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 17.190000000000001 109.252 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.918 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.85 174.65 0.31 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 17.82 109.59 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.918 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.6 Cg_endo -77.99 115.18 3.74 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.624 2.216 . . . . 17.280000000000001 110.43 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.49 -179.46 44.87 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.31 -1.516 . . . . 17.219999999999999 109.31 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 4.0 mp -75.29 146.86 40.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.134 -1.216 . . . . 19.57 108.457 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.672 ' HB3' HD22 ' B' ' 83' ' ' LEU . 19.9 m-85 -133.54 167.69 20.01 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 122.498 1.142 . . . . 14.609999999999999 111.452 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.646 ' O ' HG22 ' B' ' 84' ' ' VAL . 45.8 p -150.87 119.45 6.49 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.296 -1.742 . . . . 18.359999999999999 106.296 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.598 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -52.0 163.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.404 -1.318 . . . . 19.129999999999999 108.597 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -123.16 124.35 42.86 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.406 -0.809 . . . . 20.649999999999999 109.022 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.706 HD11 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -68.24 -3.95 12.47 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.879 -0.513 . . . . 19.649999999999999 110.169 -179.339 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 10.4 t -55.93 -16.08 4.27 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.132 -0.98 . . . . 14.720000000000001 108.376 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.497 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 16.6 m -95.66 -6.7 39.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.609 -0.682 . . . . 11.449999999999999 110.707 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.665 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.9 m-30 -83.33 159.78 21.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.852 -1.155 . . . . 14.25 109.657 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.794 ' HA ' HD22 ' A' ' 37' ' ' LEU . 10.3 mtmt -158.09 171.29 20.5 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.475 -0.766 . . . . 32.700000000000003 109.269 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.83 HG22 HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -106.99 98.59 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.357 -0.84 . . . . 15.630000000000001 108.959 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -78.44 -150.47 4.91 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.707 -1.357 . . . . 12.699999999999999 109.707 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.78 21.64 16.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.238 -1.154 . . . . 26.289999999999999 109.859 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.66 -11.82 41.38 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.02 -0.733 . . . . 20.440000000000001 109.02 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.478 ' C ' HG22 ' A' ' 45' ' ' VAL . . . 84.44 24.99 44.82 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.532 -1.427 . . . . 13.82 109.532 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 4.7 p -161.68 152.18 17.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.211 -1.17 . . . . 18.27 109.639 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.685 ' C ' HD23 ' B' ' 76' ' ' LEU . 4.6 tt -63.14 149.24 45.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 12.43 109.412 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.507 ' N ' HD23 ' B' ' 76' ' ' LEU . 14.4 mtt -150.44 133.69 16.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 35.109999999999999 109.502 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.964 HD12 HD12 ' A' ' 78' ' ' ILE . 3.2 mt -66.18 138.86 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.292 -0.88 . . . . 13.67 109.686 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 8.2 t70 -106.23 -19.87 13.57 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.558 -0.905 . . . . 24.059999999999999 108.558 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.497 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.0 OUTLIER 173.0 68.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.208 -1.404 . . . . 35.039999999999999 107.208 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.636 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -32.03 117.04 0.21 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.672 0.748 . . . . 18.719999999999999 111.214 -178.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.523 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -90.15 105.0 17.51 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.473 -0.936 . . . . 20.550000000000001 108.473 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.975 HD12 ' CD1' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -73.34 145.05 46.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 14.4 110.96 -178.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.646 HG22 ' O ' ' B' ' 62' ' ' THR . 28.0 m -147.04 156.41 47.11 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 107.938 -1.134 . . . . 17.649999999999999 107.938 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.8 Cg_endo -62.87 144.77 94.02 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.185 1.923 . . . . 25.699999999999999 110.338 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -72.93 115.91 12.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.194 -0.941 . . . . 49.289999999999999 109.681 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.424 ' CB ' ' O ' ' B' ' 86' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.973 -1.013 . . . . 58.909999999999997 109.528 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.598 ' C ' HD22 ' B' ' 65' ' ' LEU . 1.4 pmm? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.545 -0.539 . . . . 64.909999999999997 109.545 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.992 ' N ' HD22 ' B' ' 65' ' ' LEU . 1.8 mt -58.42 85.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.887 -1.153 . . . . 33.799999999999997 107.887 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 20.7 mttt -63.61 157.97 22.49 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.815 0.817 . . . . 32.719999999999999 111.595 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.061 HG22 HG22 ' A' ' 35' ' ' VAL . 58.8 t -160.01 167.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-O 121.609 0.719 . . . . 14.460000000000001 109.691 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.584 ' N ' HG12 ' A' ' 4' ' ' VAL . 77.3 mt-10 -154.95 107.14 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.705 -0.85 . . . . 22.120000000000001 108.705 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.744 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -74.54 107.96 5.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 C-N-CA 118.991 -1.083 . . . . 14.23 108.3 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.675 ' CD ' ' CD1' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.44 171.85 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.449 -0.782 . . . . 25.43 110.011 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 34.3 Cg_endo -76.7 -25.61 9.12 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.59 2.193 . . . . 13.609999999999999 109.753 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.73 8.39 44.39 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.921 -0.77 . . . . 15.52 108.921 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.528 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 10.2 mm-40 -121.38 32.83 5.75 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.277 -0.889 . . . . 17.309999999999999 109.474 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.424 ' HB1' ' HD3' ' A' ' 58' ' ' PRO . . . -97.91 11.47 37.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.141 -0.974 . . . . 24.780000000000001 110.324 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -138.77 138.01 37.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.032 -1.042 . . . . 47.899999999999999 110.104 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.646 ' CD2' HD12 ' A' ' 49' ' ' LEU . 11.6 p90 -88.37 173.29 8.82 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.397 -0.814 . . . . 21.609999999999999 109.769 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 10.0 t -130.91 163.97 26.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.535 -0.913 . . . . 14.890000000000001 108.535 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.91 112.7 24.16 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.147 -0.97 . . . . 17.350000000000001 109.575 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -114.93 137.66 51.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 34.380000000000003 109.182 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 16' ' ' ARG . 3.4 m -43.98 123.73 3.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 38.770000000000003 109.411 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.576 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -133.57 144.27 16.17 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.458 -1.457 . . . . 34.579999999999998 109.458 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.541 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 1.6 t -138.88 121.73 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -1.162 . . . . 41.869999999999997 109.219 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.469 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -66.69 165.31 15.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.311 -0.868 . . . . 47.210000000000001 109.693 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -16.2 8.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -0.829 . . . . 71.560000000000002 109.75 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -82.62 8.23 12.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.132 -0.98 . . . . 66.599999999999994 109.709 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.4 3.14 85.73 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.035 -1.226 . . . . 55.490000000000002 110.035 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -89.59 140.87 28.27 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.068 -1.254 . . . . 44.990000000000002 109.252 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 36.4 Cg_endo -78.26 131.92 11.05 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.54 2.16 . . . . 44.100000000000001 110.232 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 4.9 p90 -128.02 20.97 6.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.76 -1.213 . . . . 32.090000000000003 110.92 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.572 ' C ' ' O ' ' A' ' 26' ' ' TYR . 3.4 m 12.6 61.76 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.53 0.681 . . . . 29.25 110.879 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.785 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -62.18 168.6 3.26 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.937 0.875 . . . . 24.0 110.877 -178.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.653 ' N ' HD22 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -105.49 128.64 53.67 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.57 -0.9 . . . . 23.309999999999999 108.57 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.546 ' HG3' HD21 ' A' ' 28' ' ' LEU . 0.9 OUTLIER -111.38 151.14 28.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.988 -1.07 . . . . 40.030000000000001 109.972 -179.372 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.554 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -133.71 175.86 9.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.269 -0.895 . . . . 12.390000000000001 109.523 179.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.822 ' HB3' HD11 ' A' ' 44' ' ' LEU . 3.5 mp -127.31 155.52 43.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 17.420000000000002 109.131 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.622 ' O ' HD12 ' A' ' 44' ' ' LEU . 1.9 m -153.73 -176.81 6.0 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.316 -0.994 . . . . 13.84 108.316 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.676 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 35.2 m-85 -130.75 102.92 6.3 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.117 -0.989 . . . . 21.140000000000001 109.561 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.061 HG22 HG22 ' A' ' 4' ' ' VAL . 78.7 t -90.8 125.94 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.07 -1.019 . . . . 10.66 110.324 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 39' ' ' ASN . 3.7 m-20 -68.51 -41.93 79.3 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.589 -0.893 . . . . 25.890000000000001 108.589 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.686 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.6 OUTLIER 47.51 48.24 16.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.798 . . . . 24.239999999999998 109.77 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.06 4.94 51.3 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.321 -1.511 . . . . 31.02 109.321 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 41' ' ' HIS . 0.5 OUTLIER -104.58 95.76 6.13 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.356 -1.085 . . . . 43.229999999999997 108.47 179.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 39' ' ' ASN . 9.3 mt-10 -30.6 -37.31 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.41 0.624 . . . . 42.340000000000003 110.81 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -85.24 146.37 44.89 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 108.644 -0.873 . . . . 5.25 108.644 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.676 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.9 Cg_endo -76.37 137.11 18.42 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.967 1.778 . . . . 17.920000000000002 110.599 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.993 HG22 ' O ' ' A' ' 35' ' ' VAL . 5.8 m -108.68 113.93 45.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.366 -0.833 . . . . 20.57 109.162 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.822 HD11 ' HB3' ' A' ' 32' ' ' LEU . 28.0 tp -65.63 110.28 2.7 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.368 -0.832 . . . . 20.210000000000001 109.386 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.6 ' CG2' ' CG1' ' B' ' 70' ' ' VAL . 6.6 t -115.52 165.46 10.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.518 -0.739 . . . . 10.81 109.351 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.555 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 9.8 mtpt -96.42 125.44 40.91 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.488 -0.885 . . . . 36.740000000000002 109.457 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.038 HD13 HD12 ' A' ' 83' ' ' LEU . 0.8 OUTLIER -117.4 136.26 55.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.31 -0.869 . . . . 19.739999999999998 109.332 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.482 ' OG1' ' CZ ' ' A' ' 80' ' ' ARG . 12.5 m -68.05 163.7 21.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.113 -0.992 . . . . 22.559999999999999 109.303 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.646 HD12 ' CD2' ' A' ' 13' ' ' PHE . 1.1 tm? -151.89 93.42 1.84 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.807 -0.812 . . . . 20.41 108.807 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.401 ' HA ' ' ND2' ' A' ' 29' ' ' ASN . 0.2 OUTLIER -145.28 -158.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.194 -0.941 . . . . 33.990000000000002 109.823 -179.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 48.94 -154.18 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 54.920000000000002 109.159 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . -79.61 -2.44 88.01 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.445 -1.462 . . . . 36.100000000000001 109.445 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -73.41 114.28 30.17 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 121.286 -1.126 . . . . 54.759999999999998 110.118 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 52' ' ' GLY . 36.4 Cg_endo -80.3 153.44 21.27 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.5 2.133 . . . . 28.370000000000001 110.243 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.627 ' HB2' ' CD2' ' A' ' 13' ' ' PHE . . . -39.74 128.25 2.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.288 -0.882 . . . . 17.210000000000001 110.296 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.744 ' O ' HG21 ' A' ' 6' ' ' ILE . 86.7 m-85 -47.5 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.783 . . . . 17.190000000000001 109.009 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -48.76 175.61 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.217 -0.927 . . . . 17.82 109.589 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.5 Cg_endo -77.05 128.31 9.82 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.637 2.225 . . . . 17.280000000000001 110.192 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.06 176.73 32.46 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.614 -1.394 . . . . 17.219999999999999 109.614 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.8 mp -74.21 146.49 43.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -1.162 . . . . 19.57 108.362 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.717 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.2 m-85 -131.79 163.66 27.72 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.902 -1.124 . . . . 14.609999999999999 111.274 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.692 ' O ' HG22 ' A' ' 84' ' ' VAL . 24.1 p -146.38 120.77 9.64 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.414 -1.698 . . . . 18.359999999999999 106.414 178.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.976 ' CG1' HD12 ' A' ' 81' ' ' LEU . 6.2 t -49.19 168.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 C-N-CA 118.837 -1.145 . . . . 19.129999999999999 108.776 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.536 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 1.7 t-80 -135.37 124.53 24.46 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.393 -0.817 . . . . 20.649999999999999 109.11 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.989 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.2 OUTLIER -68.63 -5.3 19.28 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.285 -0.885 . . . . 19.649999999999999 109.572 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.5 t -55.94 -18.28 8.72 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.367 -0.975 . . . . 14.720000000000001 108.367 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -101.48 -5.53 25.12 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.525 -0.735 . . . . 11.449999999999999 110.187 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.698 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.9 m-30 -75.36 157.9 33.57 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.919 -1.113 . . . . 14.25 108.938 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.598 ' HA ' HD21 ' B' ' 37' ' ' LEU . 20.5 mttt -146.63 164.44 32.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 32.700000000000003 109.797 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.738 HG13 HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -111.57 112.18 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.382 -0.824 . . . . 15.630000000000001 109.156 179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.5 -176.93 43.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.457 -1.457 . . . . 12.699999999999999 109.457 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.528 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -90.57 22.54 3.42 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.158 -1.201 . . . . 26.289999999999999 109.367 -179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.25 -16.37 31.39 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.425 -0.797 . . . . 20.440000000000001 109.318 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 90.14 28.02 19.07 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.651 -1.38 . . . . 13.82 109.651 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 76' ' ' LEU . 58.0 m -161.0 124.54 3.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -1.182 . . . . 18.27 109.485 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.738 HD12 HG13 ' A' ' 70' ' ' VAL . 1.1 tp -46.94 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 12.43 109.333 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -162.5 113.57 1.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -0.923 . . . . 35.109999999999999 109.526 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' A' ' 68' ' ' PHE . 3.4 mt -43.14 -40.01 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.511 -0.743 . . . . 13.67 110.178 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 80' ' ' ARG . 1.6 t70 45.77 55.16 7.12 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.407 -0.96 . . . . 24.059999999999999 108.407 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER 80.22 88.52 0.05 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.674 -0.861 . . . . 35.039999999999999 108.674 -178.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.976 HD12 ' CG1' ' A' ' 63' ' ' VAL . 0.8 OUTLIER -65.46 157.87 28.32 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.752 0.787 . . . . 18.719999999999999 111.268 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 5.7 ttt180 -106.93 102.1 11.48 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.128 -1.064 . . . . 20.550000000000001 108.128 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.038 HD12 HD13 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -75.06 147.29 40.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.003 -1.061 . . . . 14.4 111.205 -178.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 62' ' ' THR . 33.9 m -147.85 155.56 44.4 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.094 -1.076 . . . . 17.649999999999999 108.094 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.558 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.55 144.02 83.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.091 1.861 . . . . 25.699999999999999 110.277 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -72.83 128.11 34.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.239 -0.913 . . . . 49.289999999999999 109.521 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 86' ' ' ALA . 29.7 mmtm . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.062 -0.97 . . . . 58.909999999999997 109.487 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.578 ' C ' HD22 ' A' ' 65' ' ' LEU . 1.4 pmm? . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.435 -0.58 . . . . 64.909999999999997 109.435 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.989 ' N ' HD22 ' A' ' 65' ' ' LEU . 1.9 mt -58.64 85.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.842 -1.17 . . . . 33.799999999999997 107.842 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.53 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 20.7 mttt -63.63 157.99 22.48 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.804 0.812 . . . . 32.719999999999999 111.6 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.024 HG22 HG22 ' B' ' 35' ' ' VAL . 58.6 t -159.94 167.38 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.592 0.71 . . . . 14.460000000000001 109.68 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.598 ' N ' HG12 ' B' ' 4' ' ' VAL . 77.6 mt-10 -154.83 107.18 2.74 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.761 -0.829 . . . . 22.120000000000001 108.761 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.717 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -74.52 107.82 5.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 C-N-CA 118.983 -1.087 . . . . 14.23 108.322 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.672 ' CD ' ' CD1' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.4 171.85 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.438 -0.789 . . . . 25.43 109.967 -179.064 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 34.5 Cg_endo -76.69 -25.68 9.06 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.598 2.199 . . . . 13.609999999999999 109.718 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.65 8.24 44.68 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.94 -0.763 . . . . 15.52 108.94 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 10.0 mm-40 -121.21 32.84 5.76 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.262 -0.898 . . . . 17.309999999999999 109.547 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.405 ' HB1' ' HD3' ' B' ' 58' ' ' PRO . . . -97.96 11.48 37.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.97 . . . . 24.780000000000001 110.338 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.407 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 11.6 mt-30 -138.78 138.14 37.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -0.993 . . . . 47.899999999999999 110.055 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.651 ' CD2' HD12 ' B' ' 49' ' ' LEU . 11.5 p90 -88.5 173.21 8.81 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.426 -0.796 . . . . 21.609999999999999 109.74 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 10.0 t -130.85 164.1 25.97 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.512 -0.921 . . . . 14.890000000000001 108.512 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.02 112.75 24.28 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.103 -0.998 . . . . 17.350000000000001 109.611 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.0 OUTLIER -114.93 137.73 51.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 34.380000000000003 109.163 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.433 ' C ' ' O ' ' B' ' 16' ' ' ARG . 3.4 m -43.98 123.75 3.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 38.770000000000003 109.431 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -133.61 144.18 16.06 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.45 -1.46 . . . . 34.579999999999998 109.45 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.54 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.6 t -138.86 121.68 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -1.16 . . . . 41.869999999999997 109.23 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.466 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 0.8 OUTLIER -66.51 165.4 14.56 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.274 -0.891 . . . . 47.210000000000001 109.73 -179.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -16.03 9.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.819 . . . . 71.560000000000002 109.784 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -82.75 8.27 12.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 66.599999999999994 109.702 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.36 3.18 85.62 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.997 -1.241 . . . . 55.490000000000002 109.997 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 19' ' ' VAL . 0.0 OUTLIER -89.62 140.93 28.22 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.235 . . . . 44.990000000000002 109.293 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 36.4 Cg_endo -78.34 131.87 10.93 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.567 2.178 . . . . 44.100000000000001 110.218 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.598 ' CD1' ' HB3' ' B' ' 28' ' ' LEU . 4.8 p90 -127.99 20.96 6.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.766 -1.209 . . . . 32.090000000000003 110.935 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.59 ' C ' ' O ' ' B' ' 26' ' ' TYR . 3.4 m 12.6 61.8 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 CA-C-O 121.551 0.691 . . . . 29.25 110.867 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.799 HD22 ' C ' ' B' ' 28' ' ' LEU . 0.0 OUTLIER -62.22 168.67 3.24 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.888 0.852 . . . . 24.0 110.896 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.66 ' N ' HD22 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -105.52 128.7 53.72 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.603 -0.888 . . . . 23.309999999999999 108.603 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.555 ' HG3' HD21 ' B' ' 28' ' ' LEU . 0.9 OUTLIER -111.51 151.03 29.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.992 -1.068 . . . . 40.030000000000001 109.971 -179.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.55 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.7 OUTLIER -133.64 175.89 9.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.295 -0.878 . . . . 12.390000000000001 109.486 179.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.836 ' HB3' HD11 ' B' ' 44' ' ' LEU . 3.6 mp -127.27 155.59 43.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 17.420000000000002 109.164 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.634 ' O ' HD12 ' B' ' 44' ' ' LEU . 1.9 m -153.78 -176.75 5.98 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.296 -1.001 . . . . 13.84 108.296 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.672 ' CD1' ' CD ' ' B' ' 7' ' ' LYS . 35.4 m-85 -130.86 102.9 6.27 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.164 -0.96 . . . . 21.140000000000001 109.544 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 1.024 HG22 HG22 ' B' ' 4' ' ' VAL . 78.5 t -90.78 125.96 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.004 -1.06 . . . . 10.66 110.307 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' B' ' 39' ' ' ASN . 3.8 m-20 -68.46 -41.95 79.47 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.601 -0.889 . . . . 25.890000000000001 108.601 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.688 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER 47.49 48.2 16.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.421 -0.799 . . . . 24.239999999999998 109.749 179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.16 4.78 51.23 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.348 -1.501 . . . . 31.02 109.348 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' B' ' 41' ' ' HIS . 0.5 OUTLIER -104.44 95.72 6.12 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.33 -1.1 . . . . 43.229999999999997 108.507 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' B' ' 39' ' ' ASN . 9.3 mt-10 -30.52 -37.35 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.471 0.653 . . . . 42.340000000000003 110.858 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' B' ' 39' ' ' ASN . 0.3 OUTLIER -85.2 146.4 45.06 Favored Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 108.64 -0.874 . . . . 5.2300000000000004 108.64 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.9 Cg_endo -76.37 137.09 18.4 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 121.958 1.772 . . . . 17.920000000000002 110.551 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.984 HG22 ' O ' ' B' ' 35' ' ' VAL . 5.9 m -108.7 114.0 45.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.362 -0.836 . . . . 20.57 109.076 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' B' ' 32' ' ' LEU . 28.8 tp -65.66 110.1 2.64 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.407 -0.808 . . . . 20.210000000000001 109.372 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.587 ' CG2' ' CG1' ' A' ' 70' ' ' VAL . 6.5 t -115.36 165.4 10.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.493 -0.755 . . . . 10.81 109.306 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.554 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 9.8 mtpt -96.31 125.52 40.87 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.538 -0.865 . . . . 36.740000000000002 109.492 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 1.021 HD13 HD12 ' B' ' 83' ' ' LEU . 0.8 OUTLIER -117.43 136.38 54.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.331 -0.856 . . . . 19.739999999999998 109.368 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.483 ' OG1' ' CZ ' ' B' ' 80' ' ' ARG . 12.6 m -68.18 163.67 22.14 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.131 -0.981 . . . . 22.559999999999999 109.285 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.651 HD12 ' CD2' ' B' ' 13' ' ' PHE . 1.1 tm? -151.9 93.41 1.84 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.35 -158.0 0.85 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 33.990000000000002 109.836 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 49.02 -154.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.912 . . . . 54.920000000000002 109.162 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' B' ' 54' ' ' PRO . . . -79.62 -2.2 87.72 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.512 -1.435 . . . . 36.100000000000001 109.512 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -73.59 114.37 31.41 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.251 -1.147 . . . . 54.759999999999998 110.008 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' B' ' 52' ' ' GLY . 36.3 Cg_endo -80.29 153.33 21.27 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.512 2.141 . . . . 28.370000000000001 110.244 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.64 ' HB2' ' CD2' ' B' ' 13' ' ' PHE . . . -39.84 128.43 2.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.358 -0.839 . . . . 17.210000000000001 110.26 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.717 ' O ' HG21 ' B' ' 6' ' ' ILE . 85.2 m-85 -47.79 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.871 -0.788 . . . . 17.190000000000001 108.871 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.945 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -50.5 175.72 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.86 . . . . 17.82 109.394 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.945 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.6 Cg_endo -77.34 129.5 10.35 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.611 2.207 . . . . 17.280000000000001 110.503 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.89 177.15 30.73 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.424 -1.47 . . . . 17.219999999999999 109.424 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 4.1 mp -73.73 146.99 43.97 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.222 -1.163 . . . . 19.57 108.794 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.692 ' HB3' HD22 ' B' ' 83' ' ' LEU . 19.6 m-85 -132.24 163.78 27.84 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.957 -1.089 . . . . 14.609999999999999 111.319 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.685 ' O ' HG22 ' B' ' 84' ' ' VAL . 24.3 p -146.54 120.86 9.59 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.424 -1.695 . . . . 18.359999999999999 106.424 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.978 ' CG1' HD12 ' B' ' 81' ' ' LEU . 6.1 t -49.37 168.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 C-N-CA 118.82 -1.152 . . . . 19.129999999999999 108.826 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.543 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.7 t-80 -135.21 124.5 24.64 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.393 -0.817 . . . . 20.649999999999999 109.089 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.992 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -68.61 -5.4 19.75 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.244 -0.91 . . . . 19.649999999999999 109.533 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 33.4 t -55.79 -18.44 8.48 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.306 -0.998 . . . . 14.720000000000001 108.306 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -101.31 -5.92 24.8 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.544 -0.722 . . . . 11.449999999999999 110.185 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.697 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.9 m-30 -75.02 157.72 34.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.91 -1.119 . . . . 14.25 108.893 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.599 ' HA ' HD21 ' A' ' 37' ' ' LEU . 20.6 mttt -146.36 164.78 31.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -0.979 . . . . 32.700000000000003 109.815 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.724 HG13 HD12 ' B' ' 76' ' ' LEU . 0.2 OUTLIER -111.83 112.12 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.415 -0.803 . . . . 15.630000000000001 109.158 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -91.51 -177.0 43.03 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.481 -1.448 . . . . 12.699999999999999 109.481 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.54 22.57 3.39 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.146 -1.208 . . . . 26.289999999999999 109.348 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.29 -16.36 31.31 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.46 -0.775 . . . . 20.440000000000001 109.363 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 90.39 27.62 19.73 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.665 -1.374 . . . . 13.82 109.665 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 76' ' ' LEU . 58.0 m -160.76 124.53 3.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -1.223 . . . . 18.27 109.569 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.724 HD12 HG13 ' B' ' 70' ' ' VAL . 1.1 tp -46.93 170.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 12.43 109.357 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' B' ' 76' ' ' LEU . 0.8 OUTLIER -162.48 113.58 1.56 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.174 -0.954 . . . . 35.109999999999999 109.553 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.602 HG12 ' CE1' ' B' ' 68' ' ' PHE . 3.4 mt -43.11 -40.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.48 -0.763 . . . . 13.67 110.212 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' B' ' 80' ' ' ARG . 1.6 t70 45.85 55.17 7.2 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.354 -0.98 . . . . 24.059999999999999 108.354 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' B' ' 79' ' ' ASP . 0.0 OUTLIER 80.21 88.57 0.05 Allowed 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.69 -0.856 . . . . 35.039999999999999 108.69 -178.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.978 HD12 ' CG1' ' B' ' 63' ' ' VAL . 0.8 OUTLIER -65.4 157.89 28.11 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.779 0.799 . . . . 18.719999999999999 111.267 -178.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 5.7 ttt180 -107.06 102.09 11.46 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.065 -1.087 . . . . 20.550000000000001 108.065 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.021 HD12 HD13 ' B' ' 47' ' ' ILE . 0.4 OUTLIER -75.04 147.45 40.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.047 -1.033 . . . . 14.4 111.162 -178.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.685 HG22 ' O ' ' B' ' 62' ' ' THR . 33.8 m -148.02 155.31 43.83 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 108.11 -1.07 . . . . 17.649999999999999 108.11 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.563 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.1 Cg_endo -64.33 143.95 84.52 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.153 1.902 . . . . 25.699999999999999 110.257 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -72.79 128.08 34.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 49.289999999999999 109.586 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' B' ' 86' ' ' ALA . 29.7 mmtm . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.047 -0.978 . . . . 58.909999999999997 109.519 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.33 -0.618 . . . . 64.909999999999997 109.33 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.844 ' CA ' HD22 ' B' ' 65' ' ' LEU . 4.8 mt 73.74 75.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.162 -1.051 . . . . 33.799999999999997 108.162 -178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -68.99 155.35 40.49 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.756 0.788 . . . . 32.719999999999999 110.841 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.875 ' HB ' HG22 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -160.35 167.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.534 -0.913 . . . . 14.460000000000001 108.534 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.542 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 60.3 mt-10 -143.52 109.67 5.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 22.120000000000001 109.534 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.734 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -72.29 101.04 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 107.899 -1.149 . . . . 14.23 107.899 179.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.676 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.42 169.84 0.07 OUTLIER Pre-proline 0 N--CA 1.486 1.361 0 O-C-N 121.306 -0.871 . . . . 25.43 109.611 -179.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -75.3 -24.09 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.444 2.096 . . . . 13.609999999999999 109.812 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -93.31 1.39 56.99 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.094 -0.706 . . . . 15.52 109.094 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.487 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 29.3 mm-40 -120.08 39.7 3.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 17.309999999999999 109.165 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.65 22.44 15.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.119 -0.988 . . . . 24.780000000000001 110.22 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -142.72 132.71 24.33 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.054 -1.029 . . . . 47.899999999999999 108.786 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.636 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 33.3 p90 -88.56 176.88 6.95 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.013 -1.054 . . . . 21.609999999999999 109.774 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 16.1 m -130.7 153.75 48.65 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.674 -0.862 . . . . 14.890000000000001 108.674 178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.53 114.62 28.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.211 -0.931 . . . . 17.350000000000001 109.439 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' GLY . 15.1 mmt180 -134.8 143.81 47.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 34.380000000000003 109.077 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 t -51.9 89.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 38.770000000000003 109.297 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -84.54 140.82 19.23 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.692 -1.363 . . . . 34.579999999999998 109.692 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.39 123.51 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.246 -1.15 . . . . 41.869999999999997 108.837 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -55.49 -90.28 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.332 -0.855 . . . . 47.210000000000001 109.576 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -136.15 62.11 1.63 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 71.560000000000002 109.449 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 57.7 17.65 4.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 66.599999999999994 109.338 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.6 -48.26 1.31 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.541 -1.424 . . . . 55.490000000000002 109.541 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.08 150.72 21.56 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.266 -1.137 . . . . 44.990000000000002 109.37 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.28 136.13 14.06 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.598 2.199 . . . . 44.100000000000001 110.56 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.596 ' CE1' ' HB2' ' A' ' 28' ' ' LEU . 4.0 p90 -136.48 136.81 39.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 32.090000000000003 109.589 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 m -102.36 79.59 1.86 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -0.874 . . . . 29.25 109.26 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.596 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -96.51 161.96 13.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -0.918 . . . . 24.0 109.96 -179.571 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.636 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -99.05 129.92 45.35 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.451 -0.944 . . . . 23.309999999999999 108.451 179.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.07 152.55 33.39 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.998 -1.064 . . . . 40.030000000000001 109.612 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.859 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -135.24 171.54 14.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.116 -0.99 . . . . 12.390000000000001 109.897 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.838 ' HB3' HD11 ' A' ' 44' ' ' LEU . 3.3 mm? -105.89 179.13 4.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 17.420000000000002 110.252 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -173.51 158.16 3.37 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.85 -1.167 . . . . 13.84 107.85 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.676 ' CD2' ' HD3' ' A' ' 7' ' ' LYS . 20.1 m-85 -111.98 106.33 14.98 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.964 -1.085 . . . . 21.140000000000001 109.36 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.881 ' O ' HG22 ' A' ' 43' ' ' VAL . 25.7 t -107.4 117.59 53.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 10.66 110.627 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -95.3 41.29 1.1 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.543 -1.281 . . . . 25.890000000000001 107.543 178.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.882 HD12 ' N ' ' A' ' 38' ' ' GLY . 1.7 pp -35.19 -30.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.377 0.608 . . . . 24.239999999999998 110.319 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.882 ' N ' HD12 ' A' ' 37' ' ' LEU . . . 165.55 50.81 0.02 OUTLIER Glycine 0 C--N 1.298 -1.576 0 C-N-CA 119.333 -1.413 . . . . 31.02 109.696 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.591 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 61.9 m-20 -126.13 18.26 7.74 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.223 -1.163 . . . . 43.229999999999997 110.101 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 51.3 mt-10 58.96 27.8 16.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.135 -0.978 . . . . 42.340000000000003 109.949 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 3.3 p-80 176.42 162.62 0.47 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.531 -0.914 . . . . 6.3700000000000001 108.531 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.651 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.7 Cg_endo -76.5 135.74 16.71 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.774 1.65 . . . . 17.920000000000002 110.231 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.938 HG21 HG21 ' B' ' 70' ' ' VAL . 2.9 m -111.1 117.31 54.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.648 -0.821 . . . . 20.57 108.994 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 32' ' ' LEU . 41.1 tp -70.75 95.94 1.18 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.292 -0.88 . . . . 20.210000000000001 109.167 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.439 HG23 HG12 ' B' ' 70' ' ' VAL . 4.4 p -105.65 161.28 5.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.6 -0.687 . . . . 10.81 109.35 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HA ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.22 -177.75 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 36.740000000000002 110.634 -179.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.62 HD12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -167.66 149.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.115 -1.069 . . . . 19.739999999999998 108.115 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.606 ' H ' HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -91.58 152.97 20.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.864 -1.148 . . . . 22.559999999999999 109.476 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.614 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -131.93 102.82 6.0 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.803 -0.814 . . . . 20.41 108.803 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.471 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 29.4 t70 -44.87 142.45 1.78 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 33.990000000000002 109.739 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.25 103.31 0.37 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.381 -0.825 . . . . 54.920000000000002 109.322 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 119.1 -25.14 7.98 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.367 -1.493 . . . . 36.100000000000001 109.367 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' O ' ' CD1' ' A' ' 49' ' ' LEU . 31.3 mt-30 -76.48 147.76 79.26 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.323 -1.104 . . . . 54.759999999999998 109.229 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.6 Cg_endo -78.12 126.13 7.62 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.662 2.241 . . . . 28.370000000000001 110.39 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.859 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -40.03 156.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.419 -0.801 . . . . 17.210000000000001 110.02 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.734 ' O ' HG21 ' A' ' 6' ' ' ILE . 74.3 m-85 -58.27 111.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 17.190000000000001 109.153 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.803 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -56.58 170.05 0.55 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.264 -0.898 . . . . 17.82 109.782 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.803 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.17 106.07 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.678 2.252 . . . . 17.280000000000001 110.392 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.11 -176.12 43.13 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.585 -1.406 . . . . 17.219999999999999 109.585 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -76.28 138.84 40.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -1.142 . . . . 19.57 108.613 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.679 ' HB3' HD22 ' A' ' 83' ' ' LEU . 25.5 m-85 -128.63 164.65 22.42 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.776 -1.203 . . . . 14.609999999999999 111.699 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.732 ' O ' HG22 ' A' ' 84' ' ' VAL . 47.6 p -145.46 121.89 10.99 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 106.268 -1.753 . . . . 18.359999999999999 106.268 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.62 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -54.41 167.16 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 118.632 -1.227 . . . . 19.129999999999999 108.624 -178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.508 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -130.12 126.57 37.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.249 -0.907 . . . . 20.649999999999999 109.501 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.841 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER -73.06 1.53 8.82 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.425 -0.797 . . . . 19.649999999999999 110.034 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.4 t -57.29 -19.05 19.61 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.383 -1.34 . . . . 14.720000000000001 107.383 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.581 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 69.8 m -95.12 -25.02 16.6 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.127 0.489 . . . . 11.449999999999999 110.179 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.696 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.2 m-30 -61.92 158.95 15.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.131 -0.98 . . . . 14.25 109.486 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.73 176.24 12.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 32.700000000000003 109.404 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.961 HG21 HG21 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -113.44 123.37 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 15.630000000000001 109.387 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.75 -162.06 28.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.378 -1.489 . . . . 12.699999999999999 109.378 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.461 ' HB2' ' SD ' ' A' ' 77' ' ' MET . 0.3 OUTLIER 59.27 72.22 0.54 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -1.188 . . . . 26.289999999999999 109.311 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 0.3 OUTLIER 70.41 6.66 5.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 20.440000000000001 109.381 -179.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.03 45.21 5.16 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.492 -1.443 . . . . 13.82 109.492 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -129.13 140.46 51.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -1.177 . . . . 18.27 109.522 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.583 ' HB2' HD13 ' B' ' 81' ' ' LEU . 0.2 OUTLIER -43.69 158.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 12.43 109.355 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.52 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -165.54 104.73 0.72 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 35.109999999999999 110.112 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.829 HD12 HD12 ' B' ' 78' ' ' ILE . 1.1 mt -41.12 -64.53 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.613 0.721 . . . . 13.67 109.738 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.562 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 15.6 t70 84.86 -46.69 0.08 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.481 0.657 . . . . 24.059999999999999 110.003 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.581 ' O ' ' CB ' ' A' ' 67' ' ' SER . 1.9 tpm_? -171.25 66.56 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.491 -0.929 . . . . 35.039999999999999 108.491 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.62 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.3 pt? -39.58 125.7 1.79 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.659 0.742 . . . . 18.719999999999999 111.71 -178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.508 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -92.51 106.67 18.62 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.434 -0.95 . . . . 20.550000000000001 108.434 178.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.792 HD21 HG11 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -72.66 151.89 42.01 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.294 -0.879 . . . . 14.4 111.056 -178.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 62' ' ' THR . 33.1 m -154.08 156.4 31.9 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.011 -1.107 . . . . 17.649999999999999 108.011 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.2 Cg_endo -62.64 144.16 93.7 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.184 1.923 . . . . 25.699999999999999 110.201 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -75.91 117.04 17.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.14 -0.975 . . . . 49.289999999999999 109.557 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.99 -1.005 . . . . 58.909999999999997 109.416 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.497 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.336 -0.616 . . . . 64.909999999999997 109.336 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.841 ' CA ' HD22 ' A' ' 65' ' ' LEU . 4.8 mt 73.72 75.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.064 -1.087 . . . . 33.799999999999997 108.064 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -69.16 155.49 40.3 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.778 0.799 . . . . 32.719999999999999 110.788 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.864 ' HB ' HG22 ' B' ' 35' ' ' VAL . 0.1 OUTLIER -160.45 168.14 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.548 -0.908 . . . . 14.460000000000001 108.548 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.536 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 60.1 mt-10 -143.79 109.75 5.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.33 -0.856 . . . . 22.120000000000001 109.536 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.722 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -72.35 100.98 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 107.942 -1.133 . . . . 14.23 107.942 179.254 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.676 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.37 169.78 0.07 OUTLIER Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 25.43 109.602 -179.244 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.0 Cg_endo -75.23 -24.06 12.83 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.419 2.079 . . . . 13.609999999999999 109.777 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -93.28 1.4 57.02 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.526 -0.734 . . . . 15.52 109.1 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.493 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 29.1 mm-40 -120.06 39.51 3.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.262 -0.899 . . . . 17.309999999999999 109.171 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.49 22.45 15.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.143 -0.973 . . . . 24.780000000000001 110.3 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.448 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -142.7 132.8 24.49 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.997 -1.064 . . . . 47.899999999999999 108.843 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.632 ' CD1' ' CB ' ' B' ' 29' ' ' ASN . 33.4 p90 -88.63 176.8 6.96 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.007 -1.058 . . . . 21.609999999999999 109.746 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.3 m -130.68 153.68 48.72 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.737 -0.838 . . . . 14.890000000000001 108.737 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.53 114.39 28.59 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.251 -0.906 . . . . 17.350000000000001 109.501 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' B' ' 18' ' ' GLY . 15.0 mmt180 -134.5 143.92 47.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.329 -0.857 . . . . 34.380000000000003 109.105 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 3.1 t -51.92 90.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 38.770000000000003 109.243 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.582 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -84.85 140.57 18.78 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.718 -1.353 . . . . 34.579999999999998 109.718 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.18 123.39 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.171 -1.194 . . . . 41.869999999999997 108.89 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -55.39 -90.15 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.37 -0.831 . . . . 47.210000000000001 109.552 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -136.3 61.96 1.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 71.560000000000002 109.495 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 57.76 17.76 4.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 66.599999999999994 109.271 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.69 -48.57 1.26 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.434 -1.467 . . . . 55.490000000000002 109.434 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.82 150.73 21.93 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.243 -1.151 . . . . 44.990000000000002 109.414 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.16 135.97 14.13 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.662 2.241 . . . . 44.100000000000001 110.658 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.591 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 4.0 p90 -136.38 136.91 40.01 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.228 -0.92 . . . . 32.090000000000003 109.643 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 2.6 m -102.49 79.69 1.85 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 29.25 109.202 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -96.55 161.96 13.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 24.0 110.011 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.632 ' CB ' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -99.07 129.92 45.37 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.478 -0.934 . . . . 23.309999999999999 108.478 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.03 152.58 33.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.037 -1.04 . . . . 40.030000000000001 109.572 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.837 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -135.21 171.53 14.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.153 -0.967 . . . . 12.390000000000001 109.94 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' B' ' 44' ' ' LEU . 3.3 mm? -105.79 179.28 4.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 17.420000000000002 110.219 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -173.69 158.27 3.29 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.797 -1.186 . . . . 13.84 107.797 179.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.676 ' CD2' ' HD3' ' B' ' 7' ' ' LYS . 20.2 m-85 -112.13 106.4 15.0 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.988 -1.07 . . . . 21.140000000000001 109.309 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.867 ' O ' HG22 ' B' ' 43' ' ' VAL . 25.4 t -107.57 117.46 53.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 10.66 110.633 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.2 OUTLIER -95.21 41.34 1.1 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.433 -1.321 . . . . 25.890000000000001 107.433 178.289 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.881 HD12 ' N ' ' B' ' 38' ' ' GLY . 1.6 pp -35.29 -31.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.397 0.618 . . . . 24.239999999999998 110.284 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.881 ' N ' HD12 ' B' ' 37' ' ' LEU . . . 165.83 50.98 0.02 OUTLIER Glycine 0 C--N 1.298 -1.559 0 C-N-CA 119.286 -1.435 . . . . 31.02 109.653 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.581 ' O ' ' CE1' ' B' ' 41' ' ' HIS . 62.1 m-20 -126.19 18.37 7.7 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.164 -1.198 . . . . 43.229999999999997 110.116 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 39' ' ' ASN . 51.2 mt-10 58.79 27.87 16.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.139 -0.976 . . . . 42.340000000000003 109.956 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.581 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 3.3 p-80 176.38 162.35 0.46 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 6.3799999999999999 108.594 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.662 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.7 Cg_endo -76.39 135.68 16.87 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.77 1.646 . . . . 17.920000000000002 110.24 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.961 HG21 HG21 ' A' ' 70' ' ' VAL . 2.9 m -111.01 117.4 54.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.358 -0.839 . . . . 20.57 108.997 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' B' ' 32' ' ' LEU . 41.8 tp -70.86 95.82 1.2 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.643 -0.823 . . . . 20.210000000000001 109.215 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.454 HG23 HG12 ' A' ' 70' ' ' VAL . 4.4 p -105.46 161.37 5.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.612 -0.68 . . . . 10.81 109.448 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.42 ' HA ' HD13 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -71.3 -177.84 1.89 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 36.740000000000002 110.552 -179.073 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.64 HD12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -167.61 149.63 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.069 -1.085 . . . . 19.739999999999998 108.069 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.587 ' H ' HD13 ' B' ' 47' ' ' ILE . 0.2 OUTLIER -91.82 153.15 19.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.839 -1.163 . . . . 22.559999999999999 109.429 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -132.21 102.96 5.99 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.741 -0.837 . . . . 20.41 108.741 -179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.441 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 29.4 t70 -45.12 142.45 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.289 -0.882 . . . . 33.990000000000002 109.898 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.1 103.41 0.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 54.920000000000002 109.319 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 118.93 -25.16 8.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.37 -1.492 . . . . 36.100000000000001 109.37 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.462 ' O ' ' CD1' ' B' ' 49' ' ' LEU . 31.5 mt-30 -76.39 147.72 79.48 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.265 -1.138 . . . . 54.759999999999998 109.301 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.456 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.7 Cg_endo -78.05 126.31 7.78 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.591 2.194 . . . . 28.370000000000001 110.391 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.837 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -40.11 156.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.396 -0.815 . . . . 17.210000000000001 110.024 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.722 ' O ' HG21 ' B' ' 6' ' ' ILE . 73.3 m-85 -58.11 111.01 1.05 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.4 -0.813 . . . . 17.190000000000001 109.077 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.813 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -56.76 170.04 0.57 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 17.82 109.799 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.813 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -77.76 104.99 1.95 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.71 2.273 . . . . 17.280000000000001 110.118 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.3 -176.6 41.93 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.708 -1.357 . . . . 17.219999999999999 109.708 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.697 HD23 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -76.53 138.34 40.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -1.146 . . . . 19.57 108.366 179.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.715 ' HB3' HD22 ' B' ' 83' ' ' LEU . 25.5 m-85 -128.08 164.46 22.37 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.729 -1.232 . . . . 14.609999999999999 111.607 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.729 ' O ' HG22 ' B' ' 84' ' ' VAL . 46.9 p -145.13 122.04 11.31 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.175 -1.787 . . . . 18.359999999999999 106.175 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.621 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -54.73 167.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 118.562 -1.255 . . . . 19.129999999999999 108.594 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 1.9 t-80 -130.4 126.68 37.66 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.271 -0.893 . . . . 20.649999999999999 109.49 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.844 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -73.18 1.17 9.78 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.434 -0.791 . . . . 19.649999999999999 110.014 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -56.86 -19.38 17.2 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 107.323 -1.362 . . . . 14.720000000000001 107.323 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 70.9 m -94.77 -25.06 16.82 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.146 0.498 . . . . 11.449999999999999 110.201 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.694 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.2 m-30 -61.93 158.59 15.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 14.25 109.466 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.4 176.29 12.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.393 -0.817 . . . . 32.700000000000003 109.407 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.938 HG21 HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -113.45 123.57 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.327 -0.858 . . . . 15.630000000000001 109.34 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.53 -162.2 29.29 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.426 -1.47 . . . . 12.699999999999999 109.426 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' B' ' 73' ' ' PHE . 0.3 OUTLIER 59.43 72.13 0.54 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -1.189 . . . . 26.289999999999999 109.328 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.3 OUTLIER 70.45 6.81 5.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 20.440000000000001 109.322 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.84 45.25 5.2 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.438 -1.465 . . . . 13.82 109.438 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.423 ' O ' ' C ' ' B' ' 76' ' ' LEU . 0.3 OUTLIER -129.16 140.34 51.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -1.167 . . . . 18.27 109.48 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.576 ' HB2' HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -43.58 158.36 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.268 -0.895 . . . . 12.43 109.376 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 0.6 OUTLIER -165.49 104.93 0.73 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.962 . . . . 35.109999999999999 110.083 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.829 HD12 HD12 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -41.37 -64.4 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.556 0.694 . . . . 13.67 109.682 179.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.545 ' N ' HG22 ' B' ' 78' ' ' ILE . 15.4 t70 84.74 -46.52 0.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.422 0.63 . . . . 24.059999999999999 110.007 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.574 ' O ' ' CB ' ' B' ' 67' ' ' SER . 1.9 tpm_? -171.42 66.41 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.036 0.922 . . . . 35.039999999999999 108.517 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.621 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.2 pt? -39.41 125.65 1.71 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 121.653 0.739 . . . . 18.719999999999999 111.721 -178.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.7 OUTLIER -92.48 106.59 18.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.517 -0.919 . . . . 20.550000000000001 108.517 178.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.786 HD21 HG11 ' B' ' 4' ' ' VAL . 0.6 OUTLIER -72.64 151.72 42.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.183 -0.948 . . . . 14.4 111.072 -178.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.729 HG22 ' O ' ' B' ' 62' ' ' THR . 33.4 m -153.86 156.53 32.16 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 107.959 -1.126 . . . . 17.649999999999999 107.959 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.3 Cg_endo -62.83 144.32 93.33 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.117 1.878 . . . . 25.699999999999999 110.151 178.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -75.96 117.03 17.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.242 -0.911 . . . . 49.289999999999999 109.617 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.009 -0.996 . . . . 58.909999999999997 109.458 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.504 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.416 -0.587 . . . . 64.909999999999997 109.416 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.751 ' CA ' HD22 ' B' ' 65' ' ' LEU . 2.7 mt -66.89 79.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.598 -1.26 . . . . 33.799999999999997 107.598 178.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -74.33 159.96 31.7 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.907 0.861 . . . . 32.719999999999999 110.595 -178.186 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.712 HG11 HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -162.43 167.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 108.437 -0.949 . . . . 14.460000000000001 108.437 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.534 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 33.2 mt-10 -142.3 112.54 7.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 22.120000000000001 109.693 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.717 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.7 OUTLIER -75.25 99.52 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 107.815 -1.18 . . . . 14.23 107.815 179.071 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.665 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 1.1 mttm -53.88 165.8 0.71 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.357 -0.84 . . . . 25.43 109.762 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 29.8 Cg_endo -70.89 -15.61 32.85 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.922 1.748 . . . . 13.609999999999999 108.796 179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.14 -2.65 49.46 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.905 -0.776 . . . . 15.52 108.905 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.73 ' NE2' HD12 ' A' ' 32' ' ' LEU . 1.5 mm100 -129.49 43.66 3.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.205 -0.935 . . . . 17.309999999999999 109.581 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.83 20.03 16.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.05 -1.031 . . . . 24.780000000000001 110.068 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 11.5 mt-30 -135.73 140.63 44.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.121 -0.987 . . . . 47.899999999999999 109.689 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.717 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 41.3 p90 -94.78 164.01 13.12 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.201 -0.937 . . . . 21.609999999999999 109.469 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.1 m -135.07 147.26 49.54 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.341 -0.85 . . . . 14.890000000000001 109.181 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 113.94 25.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.273 -0.892 . . . . 17.350000000000001 109.364 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 17' ' ' SER . 50.6 ttt180 -145.23 158.3 43.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.889 . . . . 34.380000000000003 109.341 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -42.74 147.61 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.491 -0.756 . . . . 38.770000000000003 109.399 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -151.66 173.16 31.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.37 -1.492 . . . . 34.579999999999998 109.37 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.403 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -147.78 120.53 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.116 -1.226 . . . . 41.869999999999997 109.002 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 m -59.19 -88.71 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.338 -0.851 . . . . 47.210000000000001 109.626 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.32 63.69 1.42 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 71.560000000000002 109.566 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 54.46 19.27 2.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 66.599999999999994 109.498 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.06 -47.23 1.61 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.575 -1.41 . . . . 55.490000000000002 109.575 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -156.29 153.03 24.37 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.223 -1.163 . . . . 44.990000000000002 109.363 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.53 143.16 24.12 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.562 2.175 . . . . 44.100000000000001 110.701 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.591 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 2.7 p90 -146.29 136.27 23.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 32.090000000000003 109.752 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 m -105.42 80.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 29.25 108.902 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.521 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -97.18 158.48 15.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.323 -0.86 . . . . 24.0 110.313 -179.071 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.515 ' CG ' ' CD1' ' A' ' 13' ' ' PHE . 86.0 m-20 -68.59 109.99 4.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.364 -0.835 . . . . 23.309999999999999 109.041 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 18.6 mt-10 -87.01 -173.33 4.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.219 -0.925 . . . . 40.030000000000001 109.899 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.56 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 1.7 tm0? -176.33 -177.84 0.9 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.336 -0.852 . . . . 12.390000000000001 109.47 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.73 HD12 ' NE2' ' A' ' 10' ' ' GLN . 13.3 mt -140.98 168.93 18.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 17.420000000000002 109.366 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -164.91 161.87 20.37 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.055 -1.091 . . . . 13.84 108.055 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.679 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 49.6 m-85 -111.44 111.72 22.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.994 -1.066 . . . . 21.140000000000001 109.716 -179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.672 ' CG1' HD23 ' A' ' 37' ' ' LEU . 4.6 t -106.87 140.39 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 10.66 110.871 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -111.72 39.34 2.39 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.556 -1.276 . . . . 25.890000000000001 107.556 178.526 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.809 HD21 HG22 ' B' ' 70' ' ' VAL . 1.1 pp -63.5 58.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.976 -0.452 . . . . 24.239999999999998 110.468 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 107.33 1.87 35.47 Favored Glycine 0 N--CA 1.482 1.76 0 C-N-CA 119.609 -1.282 . . . . 31.02 109.902 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 40' ' ' GLU . 1.2 m-20 -124.87 98.78 5.85 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.23 -1.159 . . . . 43.229999999999997 108.528 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.487 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -32.61 -56.85 0.36 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.55 0.691 . . . . 42.340000000000003 110.579 -179.23 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 39' ' ' ASN . 7.2 m-70 -66.25 152.16 94.65 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 108.638 -0.875 . . . . 5.6799999999999997 108.638 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.679 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.8 Cg_endo -77.34 139.75 18.87 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.982 1.788 . . . . 17.920000000000002 110.041 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.826 HG21 HG21 ' B' ' 70' ' ' VAL . 3.4 m -112.91 115.4 49.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.317 -0.865 . . . . 20.57 109.569 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.724 HD11 ' CB ' ' A' ' 32' ' ' LEU . 59.9 tp -72.51 101.62 3.02 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.875 . . . . 20.210000000000001 109.867 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.686 HG12 ' CG1' ' B' ' 70' ' ' VAL . 2.6 m -99.82 -168.94 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.977 -0.749 . . . . 10.81 108.977 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.677 ' HA ' HD23 ' A' ' 32' ' ' LEU . 1.3 mtpp -106.57 178.61 4.51 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.507 -0.877 . . . . 36.740000000000002 110.809 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.596 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -157.64 156.47 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.242 -1.021 . . . . 19.739999999999998 108.242 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.427 ' O ' ' C ' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -111.46 68.57 0.67 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.12 -0.988 . . . . 22.559999999999999 109.479 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.0 HD11 ' O ' ' A' ' 53' ' ' GLN . 2.2 tm? -42.12 114.8 0.59 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.492 -0.755 . . . . 20.41 109.306 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.727 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -57.32 151.81 15.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 33.990000000000002 109.89 -179.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -63.53 117.5 6.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 54.920000000000002 109.223 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.62 -27.35 19.2 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.301 -1.52 . . . . 36.100000000000001 109.301 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 1.0 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -69.16 146.27 96.83 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.281 -1.129 . . . . 54.759999999999998 109.286 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.5 Cg_endo -77.52 119.76 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.577 2.184 . . . . 28.370000000000001 110.642 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.717 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -41.41 144.3 0.36 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -0.826 . . . . 17.210000000000001 110.035 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.717 ' O ' HG21 ' A' ' 6' ' ' ILE . 15.4 m-30 -45.3 108.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 17.190000000000001 109.135 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.918 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -59.04 173.87 0.43 Allowed Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.056 -1.028 . . . . 17.82 109.055 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.918 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.9 Cg_endo -77.52 110.41 2.96 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.42 2.08 . . . . 17.280000000000001 110.024 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.53 -178.99 48.72 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.867 -1.293 . . . . 17.219999999999999 109.867 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -77.54 140.59 39.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.356 -1.085 . . . . 19.57 108.511 179.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.732 ' HB3' HD22 ' A' ' 83' ' ' LEU . 17.9 m-85 -130.0 163.96 25.34 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.771 -1.205 . . . . 14.609999999999999 111.81 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.634 ' O ' HG22 ' A' ' 84' ' ' VAL . 48.9 p -145.69 121.61 10.65 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.442 -1.688 . . . . 18.359999999999999 106.442 178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.587 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -51.27 167.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 C-N-CA 118.792 -1.163 . . . . 19.129999999999999 109.2 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -128.25 127.47 42.88 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.833 -0.803 . . . . 20.649999999999999 108.833 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.754 HD22 ' CA ' ' B' ' 2' ' ' ILE . 0.5 OUTLIER -71.39 0.66 7.68 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.477 -0.764 . . . . 19.649999999999999 110.014 -179.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.6 t -57.12 -17.69 11.8 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.787 -1.19 . . . . 14.720000000000001 107.787 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 16.5 m -97.81 -5.45 34.77 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.782 -0.574 . . . . 11.449999999999999 110.372 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.674 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.3 m-30 -83.6 159.77 21.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.936 -1.102 . . . . 14.25 109.771 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.589 ' HA ' HD11 ' B' ' 37' ' ' LEU . 53.7 mttm -149.11 173.25 13.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.773 . . . . 32.700000000000003 109.302 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.827 HG21 HG21 ' B' ' 43' ' ' VAL . 0.9 OUTLIER -107.28 116.12 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 15.630000000000001 108.932 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 175.93 4.86 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.779 -1.328 . . . . 12.699999999999999 109.779 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.06 12.7 8.98 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.214 -1.168 . . . . 26.289999999999999 109.763 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.457 ' O ' ' HG3' ' B' ' 46' ' ' LYS . 0.1 OUTLIER -123.25 19.37 9.84 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.532 -0.73 . . . . 20.440000000000001 109.201 179.626 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 45' ' ' VAL . . . 67.53 57.27 9.31 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.794 -1.322 . . . . 13.82 109.794 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.0 t -146.65 134.77 21.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.171 -1.193 . . . . 18.27 109.871 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.759 HD11 HD22 ' B' ' 37' ' ' LEU . 0.2 OUTLIER -76.98 145.17 38.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 12.43 109.071 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.497 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 11.0 mtm -157.09 120.33 4.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.037 . . . . 35.109999999999999 109.926 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.833 HD12 HD12 ' B' ' 78' ' ' ILE . 3.3 mt -62.34 136.88 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 13.67 109.374 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.34 -30.41 11.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.166 -1.05 . . . . 24.059999999999999 108.166 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.6 tpm_? -176.42 71.06 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.049 -1.463 . . . . 35.039999999999999 107.049 179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -30.89 118.29 0.18 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.731 0.776 . . . . 18.719999999999999 111.579 -177.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 6.1 mtp180 -89.35 110.94 21.68 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.015 -1.106 . . . . 20.550000000000001 108.015 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.732 HD22 ' HB3' ' A' ' 61' ' ' TYR . 0.4 OUTLIER -81.93 144.38 30.99 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.141 -0.975 . . . . 14.4 111.164 -178.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 62' ' ' THR . 11.9 m -145.98 158.91 47.96 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.705 -1.22 . . . . 17.649999999999999 107.705 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.1 Cg_endo -61.79 145.77 97.02 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.02 1.813 . . . . 25.699999999999999 110.145 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.18 119.8 17.92 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.156 -0.965 . . . . 49.289999999999999 109.732 -178.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.985 -1.007 . . . . 58.909999999999997 109.411 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.496 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.432 -0.581 . . . . 64.909999999999997 109.432 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.754 ' CA ' HD22 ' A' ' 65' ' ' LEU . 2.7 mt -66.89 78.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.586 -1.265 . . . . 33.799999999999997 107.586 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -74.2 159.84 31.98 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.934 0.873 . . . . 32.719999999999999 110.595 -178.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.705 HG11 HD21 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -162.41 167.93 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.442 -0.947 . . . . 14.460000000000001 108.442 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.535 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 33.7 mt-10 -142.32 112.7 7.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 22.120000000000001 109.659 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.712 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.7 OUTLIER -75.41 99.7 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.759 -1.201 . . . . 14.23 107.759 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.673 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 1.2 mttm -54.02 165.83 0.73 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.821 . . . . 25.43 109.785 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 29.9 Cg_endo -70.84 -15.63 33.03 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.89 1.727 . . . . 13.609999999999999 108.814 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.13 -2.66 49.47 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.858 -0.793 . . . . 15.52 108.858 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.739 ' NE2' HD12 ' B' ' 32' ' ' LEU . 1.5 mm100 -129.5 43.74 3.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 17.309999999999999 109.649 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.84 19.52 16.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.074 -1.017 . . . . 24.780000000000001 110.087 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.407 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 11.9 mt-30 -135.32 140.7 45.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.119 -0.988 . . . . 47.899999999999999 109.679 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.725 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 41.0 p90 -94.85 164.08 13.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 21.609999999999999 109.487 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 87.9 m -135.14 147.21 49.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.303 -0.873 . . . . 14.890000000000001 109.134 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.37 113.92 25.64 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.28 -0.887 . . . . 17.350000000000001 109.368 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' B' ' 17' ' ' SER . 50.7 ttt180 -145.26 158.37 43.84 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 34.380000000000003 109.346 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.1 OUTLIER -42.62 147.97 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.432 -0.792 . . . . 38.770000000000003 109.391 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -152.02 173.18 31.27 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.414 -1.474 . . . . 34.579999999999998 109.414 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.403 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.8 OUTLIER -147.99 120.47 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.07 -1.253 . . . . 41.869999999999997 109.035 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 2.3 m -59.16 -88.6 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.298 -0.877 . . . . 47.210000000000001 109.652 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.45 63.54 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 71.560000000000002 109.621 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 54.54 19.52 2.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 66.599999999999994 109.392 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.18 -47.46 1.57 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.568 -1.413 . . . . 55.490000000000002 109.568 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -156.14 153.18 24.94 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.294 -1.121 . . . . 44.990000000000002 109.365 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.61 143.22 23.94 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.56 2.173 . . . . 44.100000000000001 110.745 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.575 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 2.7 p90 -146.26 136.27 23.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 32.090000000000003 109.692 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.5 m -105.34 80.91 1.64 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.309 -0.87 . . . . 29.25 108.815 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.524 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.3 OUTLIER -97.18 158.58 15.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.915 . . . . 24.0 110.302 -179.139 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.516 ' CG ' ' CD1' ' B' ' 13' ' ' PHE . 85.2 m-20 -68.75 109.73 3.98 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.827 . . . . 23.309999999999999 109.082 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' B' ' 13' ' ' PHE . 18.2 mt-10 -86.69 -173.5 4.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.141 -0.974 . . . . 40.030000000000001 109.909 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.571 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 1.7 tm0? -176.12 -177.82 0.94 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.353 -0.842 . . . . 12.390000000000001 109.489 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.739 HD12 ' NE2' ' B' ' 10' ' ' GLN . 13.2 mt -141.1 168.73 19.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 17.420000000000002 109.33 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -164.61 162.02 21.31 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.041 -1.096 . . . . 13.84 108.041 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.677 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 49.6 m-85 -111.52 111.52 22.59 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.01 . . . . 21.140000000000001 109.698 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.681 ' CG1' HD23 ' B' ' 37' ' ' LEU . 4.6 t -106.68 140.26 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 10.66 110.92 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.9 OUTLIER -111.64 39.25 2.39 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.571 -1.27 . . . . 25.890000000000001 107.571 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.807 HD21 HG22 ' A' ' 70' ' ' VAL . 1.1 pp -63.46 58.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.973 -0.454 . . . . 24.239999999999998 110.493 -178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 107.14 2.21 35.95 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 109.868 -1.293 . . . . 31.02 109.868 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.47 ' O ' ' O ' ' B' ' 41' ' ' HIS . 1.2 m-20 -125.16 98.61 5.73 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.284 -1.127 . . . . 43.229999999999997 108.527 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.6 OUTLIER -32.49 -56.53 0.34 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.553 0.692 . . . . 42.340000000000003 110.678 -179.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' B' ' 39' ' ' ASN . 7.3 m-70 -66.53 152.21 95.21 Favored Pre-proline 0 C--N 1.294 -1.839 0 N-CA-C 108.68 -0.859 . . . . 5.6399999999999997 108.68 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.677 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.8 Cg_endo -77.34 139.56 18.71 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.038 1.825 . . . . 17.920000000000002 110.031 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.827 HG21 HG21 ' A' ' 70' ' ' VAL . 3.4 m -112.8 115.36 49.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.289 -0.882 . . . . 20.57 109.61 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.736 HD11 ' CB ' ' B' ' 32' ' ' LEU . 59.3 tp -72.43 101.8 3.02 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.284 -0.885 . . . . 20.210000000000001 109.827 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.684 HG12 ' CG1' ' A' ' 70' ' ' VAL . 2.6 m -100.09 -169.07 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.987 -0.746 . . . . 10.81 108.987 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.661 ' HA ' HD23 ' B' ' 32' ' ' LEU . 1.3 mtpp -106.52 178.4 4.57 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.429 -0.908 . . . . 36.740000000000002 110.765 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.583 ' CD1' ' CE2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -157.34 156.64 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.318 -0.993 . . . . 19.739999999999998 108.318 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.421 ' O ' ' C ' ' B' ' 49' ' ' LEU . 0.3 OUTLIER -111.54 68.63 0.67 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.129 -0.982 . . . . 22.559999999999999 109.463 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.997 HD11 ' O ' ' B' ' 53' ' ' GLN . 2.2 tm? -42.24 114.54 0.57 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.586 -0.696 . . . . 20.41 109.314 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.734 ' O ' HD13 ' B' ' 49' ' ' LEU . 0.8 OUTLIER -57.05 151.77 14.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.864 . . . . 33.990000000000002 109.909 -179.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -63.53 117.77 7.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.378 -0.827 . . . . 54.920000000000002 109.202 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.36 -27.35 18.98 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.301 -1.52 . . . . 36.100000000000001 109.301 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.997 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.3 OUTLIER -69.18 146.19 96.73 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.315 -1.109 . . . . 54.759999999999998 109.346 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.8 Cg_endo -77.4 119.63 4.99 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.614 2.209 . . . . 28.370000000000001 110.714 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.725 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -41.28 144.33 0.34 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.415 -0.803 . . . . 17.210000000000001 110.004 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.712 ' O ' HG21 ' B' ' 6' ' ' ILE . 15.5 m-30 -45.51 108.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 17.190000000000001 109.166 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.887 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -58.83 173.76 0.42 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.012 -1.055 . . . . 17.82 109.008 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.887 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.59 110.73 3.01 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.444 2.096 . . . . 17.280000000000001 110.236 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.76 -178.57 48.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.817 -1.313 . . . . 17.219999999999999 109.817 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.62 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -77.42 140.96 39.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.351 -1.088 . . . . 19.57 108.601 179.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.721 ' HB3' HD22 ' B' ' 83' ' ' LEU . 17.9 m-85 -130.39 164.02 25.61 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.812 -1.18 . . . . 14.609999999999999 111.698 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.632 ' O ' HG22 ' B' ' 84' ' ' VAL . 51.0 p -145.73 121.83 10.78 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.473 -1.677 . . . . 18.359999999999999 106.473 178.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.599 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -51.63 166.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 C-N-CA 118.751 -1.179 . . . . 19.129999999999999 109.197 -178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -127.53 127.24 43.62 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.919 -0.771 . . . . 20.649999999999999 108.919 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.751 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -70.99 0.45 7.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.442 -0.786 . . . . 19.649999999999999 110.053 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 3.8 t -57.09 -17.36 10.16 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.821 -1.178 . . . . 14.720000000000001 107.821 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 16.2 m -98.19 -5.64 32.98 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.767 -0.583 . . . . 11.449999999999999 110.358 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.675 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.3 m-30 -83.27 159.28 21.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.895 -1.128 . . . . 14.25 109.691 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.594 ' HA ' HD11 ' A' ' 37' ' ' LEU . 53.0 mttm -148.84 173.3 13.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.429 -0.794 . . . . 32.700000000000003 109.21 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.826 HG21 HG21 ' A' ' 43' ' ' VAL . 0.9 OUTLIER -107.32 116.01 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -0.902 . . . . 15.630000000000001 108.998 179.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 175.87 4.88 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.809 -1.316 . . . . 12.699999999999999 109.809 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.95 12.79 8.61 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.209 -1.171 . . . . 26.289999999999999 109.748 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.469 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -123.41 19.29 9.71 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.565 -0.71 . . . . 20.440000000000001 109.234 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 45' ' ' VAL . . . 67.66 57.26 9.2 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.667 -1.373 . . . . 13.82 109.667 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.4 t -146.65 134.55 21.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -1.152 . . . . 18.27 109.86 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.755 HD11 HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -76.84 145.11 38.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 12.43 109.062 179.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.491 ' CG ' ' C ' ' B' ' 76' ' ' LEU . 11.2 mtm -157.05 120.4 4.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.055 -1.028 . . . . 35.109999999999999 109.847 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.833 HD12 HD12 ' A' ' 78' ' ' ILE . 3.2 mt -62.38 137.11 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.919 . . . . 13.67 109.382 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -100.52 -30.3 11.87 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.164 -1.05 . . . . 24.059999999999999 108.164 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.491 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.6 tpm_? -176.5 71.18 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.045 -1.465 . . . . 35.039999999999999 107.045 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.651 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -30.99 118.32 0.18 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.723 0.773 . . . . 18.719999999999999 111.604 -177.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.528 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 6.1 mtp180 -89.36 110.79 21.55 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.074 -1.084 . . . . 20.550000000000001 108.074 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.721 HD22 ' HB3' ' B' ' 61' ' ' TYR . 0.4 OUTLIER -81.78 144.37 31.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.172 -0.955 . . . . 14.4 111.217 -178.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.632 HG22 ' O ' ' B' ' 62' ' ' THR . 12.3 m -146.04 158.92 47.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 107.718 -1.215 . . . . 17.649999999999999 107.718 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.9 Cg_endo -61.77 145.74 97.06 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.015 1.81 . . . . 25.699999999999999 110.171 178.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -73.19 119.82 17.96 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.102 -0.999 . . . . 49.289999999999999 109.7 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 58.909999999999997 109.389 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.635 ' O ' HD22 ' A' ' 37' ' ' LEU . 1.2 pmm? . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.321 0.582 . . . . 64.909999999999997 109.477 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.957 HG23 HD13 ' B' ' 65' ' ' LEU . 2.3 mt -74.33 66.52 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.102 -1.073 . . . . 33.799999999999997 108.102 178.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.645 ' C ' HG12 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -56.84 178.58 0.06 Allowed 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.839 0.828 . . . . 32.719999999999999 111.097 -178.486 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.954 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 174.3 166.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.605 -0.887 . . . . 14.460000000000001 108.605 -179.872 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.567 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 25.3 mt-10 -137.6 113.79 10.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.822 -0.807 . . . . 22.120000000000001 108.822 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.764 HD11 ' SG ' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -72.53 103.81 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.472 -1.307 . . . . 14.23 107.472 179.449 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.657 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -46.64 171.46 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 120.978 -1.076 . . . . 25.43 109.638 -178.846 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.2 Cg_endo -75.05 -28.18 9.3 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.437 2.091 . . . . 13.609999999999999 110.041 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -88.03 -0.26 56.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.468 -0.77 . . . . 15.52 109.029 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.599 ' OE1' HD12 ' A' ' 32' ' ' LEU . 13.9 mm-40 -116.21 36.91 3.87 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.395 -0.816 . . . . 17.309999999999999 109.218 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.62 10.79 40.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.943 . . . . 24.780000000000001 110.062 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.439 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 13.4 mt-30 -137.74 136.16 37.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.227 -0.921 . . . . 47.899999999999999 109.745 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.62 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 31.0 p90 -86.21 165.98 16.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.2 -0.938 . . . . 21.609999999999999 109.556 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.5 m -133.45 149.75 51.77 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.383 -0.823 . . . . 14.890000000000001 109.27 179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.519 ' CG2' ' OG ' ' A' ' 27' ' ' SER . 0.2 OUTLIER -74.38 113.67 11.88 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.297 -0.877 . . . . 17.350000000000001 109.218 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.446 ' NH1' ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -124.3 127.18 47.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 34.380000000000003 109.627 -179.675 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 t -48.25 106.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 38.770000000000003 109.277 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.61 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -114.88 137.46 14.0 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.757 -1.337 . . . . 34.579999999999998 109.757 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.5 t -99.95 122.41 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.196 -1.179 . . . . 41.869999999999997 109.15 179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.451 ' O ' ' CB ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -69.76 90.18 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.456 -0.777 . . . . 47.210000000000001 109.47 -179.45 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.456 ' O ' ' HB3' ' A' ' 22' ' ' GLN . 0.6 OUTLIER 70.81 -66.89 0.27 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.216 -0.928 . . . . 71.560000000000002 109.323 -179.9 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 5.7 pt20 174.78 48.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 66.599999999999994 109.498 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 24' ' ' LYS . . . -119.99 -60.61 0.25 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.749 -1.34 . . . . 55.490000000000002 109.749 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 23' ' ' GLY . 10.9 mttt -144.21 158.44 54.94 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.306 -1.114 . . . . 44.990000000000002 109.543 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.6 Cg_endo -77.47 82.09 2.48 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.657 2.238 . . . . 44.100000000000001 110.616 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.61 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 6.8 p90 -72.02 142.55 49.31 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.345 -0.847 . . . . 32.090000000000003 109.946 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.519 ' OG ' ' CG2' ' A' ' 15' ' ' THR . 0.3 OUTLIER -101.58 80.53 2.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.352 -0.842 . . . . 29.25 108.865 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.606 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -94.46 171.27 8.91 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.348 -0.845 . . . . 24.0 110.18 -179.321 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.62 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -88.09 129.45 35.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.563 -0.711 . . . . 23.309999999999999 109.77 -179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 14.7 mt-10 -115.09 162.38 17.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.302 -0.874 . . . . 40.030000000000001 109.34 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.821 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.92 -173.53 4.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.108 -0.995 . . . . 12.390000000000001 109.876 -179.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 ' O ' ' A' ' 31' ' ' GLN . 25.1 mt -133.71 159.35 40.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 17.420000000000002 109.221 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.764 ' SG ' HD11 ' A' ' 6' ' ' ILE . 3.5 m -154.23 168.44 26.54 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.937 -1.135 . . . . 13.84 107.937 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.694 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 29.4 m-85 -120.53 105.92 11.3 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.951 -1.093 . . . . 21.140000000000001 109.589 -179.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 43' ' ' VAL . 39.9 t -97.8 139.69 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.002 -1.061 . . . . 10.66 111.095 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.649 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 m-20 -115.22 -140.49 0.38 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.318 -0.993 . . . . 25.890000000000001 108.318 178.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.718 ' CB ' HD21 ' B' ' 65' ' ' LEU . 0.2 OUTLIER 67.44 -68.41 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.924 -1.11 . . . . 24.239999999999998 108.47 179.467 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -78.66 -1.47 83.27 Favored Glycine 0 C--N 1.296 -1.646 0 N-CA-C 107.913 -2.075 . . . . 31.02 107.913 178.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -160.12 110.26 1.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.513 -0.992 . . . . 43.229999999999997 108.95 179.748 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.465 ' C ' ' O ' ' A' ' 39' ' ' ASN . 2.0 mm-40 -37.68 -63.29 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.642 0.734 . . . . 42.340000000000003 109.81 -179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 37.3 m80 -69.0 163.95 52.08 Favored Pre-proline 0 C--N 1.293 -1.882 0 N-CA-C 108.076 -1.083 . . . . 8.0199999999999996 108.076 179.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.694 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.1 Cg_endo -76.53 141.48 22.43 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 121.699 1.599 . . . . 17.920000000000002 109.748 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 35' ' ' VAL . 25.7 m -113.72 115.89 51.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.315 -0.866 . . . . 20.57 109.46 -179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.788 HD11 ' HB3' ' A' ' 32' ' ' LEU . 52.0 tp -74.23 103.39 4.63 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.366 -0.833 . . . . 20.210000000000001 109.749 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.585 HG12 HG11 ' B' ' 70' ' ' VAL . 1.3 m -107.43 176.15 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.509 -0.744 . . . . 10.81 109.172 179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.28 139.85 35.37 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.314 -0.955 . . . . 36.740000000000002 109.527 179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.973 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -124.02 170.59 14.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.42 -0.8 . . . . 19.739999999999998 109.261 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.683 HG21 ' NH1' ' A' ' 80' ' ' ARG . 0.2 OUTLIER -111.77 142.53 44.0 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.175 -0.953 . . . . 22.559999999999999 109.497 179.789 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.609 ' HG ' ' CD2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -110.41 147.48 33.93 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 20.41 108.721 179.711 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.532 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 1.0 OUTLIER -85.26 145.24 27.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.195 -0.941 . . . . 33.990000000000002 109.831 -179.332 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.19 119.82 5.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.36 -0.838 . . . . 54.920000000000002 109.614 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.79 -15.55 46.73 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.681 -1.368 . . . . 36.100000000000001 109.681 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.532 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -74.99 145.19 80.67 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.202 -1.176 . . . . 54.759999999999998 109.343 179.921 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.84 121.9 5.64 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.596 2.197 . . . . 28.370000000000001 110.74 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.816 ' HB1' HE21 ' A' ' 31' ' ' GLN . . . -38.92 149.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.501 -0.749 . . . . 17.210000000000001 110.388 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.755 ' HB3' HD13 ' A' ' 6' ' ' ILE . 89.6 m-85 -46.49 105.36 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.758 -0.83 . . . . 17.190000000000001 108.758 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -58.88 176.73 0.27 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.382 -0.824 . . . . 17.82 110.023 -179.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.8 Cg_endo -77.69 110.26 2.91 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.737 2.291 . . . . 17.280000000000001 110.338 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 173.65 151.94 8.54 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.563 -1.415 . . . . 17.219999999999999 109.563 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 5.1 mp -49.27 150.22 1.83 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.954 -1.321 . . . . 19.57 108.779 179.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.954 ' CB ' HG13 ' A' ' 4' ' ' VAL . 19.1 m-85 -128.57 163.89 24.02 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 120.768 -1.207 . . . . 14.609999999999999 111.564 -179.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.755 ' O ' HG22 ' A' ' 84' ' ' VAL . 55.8 p -147.69 118.73 7.69 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.411 -1.7 . . . . 18.359999999999999 106.411 178.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.619 HG11 ' HB2' ' A' ' 81' ' ' LEU . 8.6 t -53.33 169.86 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 C-N-CA 118.809 -1.157 . . . . 19.129999999999999 108.917 -178.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.577 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -128.08 120.14 26.8 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.426 -0.796 . . . . 20.649999999999999 109.066 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.954 HD13 HG23 ' B' ' 2' ' ' ILE . 0.0 OUTLIER -65.08 -8.28 15.78 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.727 -0.608 . . . . 19.649999999999999 109.914 -179.176 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 97.3 p -52.28 -17.95 1.36 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.02 -1.05 . . . . 14.720000000000001 108.402 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 2.3 m -95.94 -6.06 39.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.566 -0.709 . . . . 11.449999999999999 110.79 -179.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.615 ' CE1' HG12 ' A' ' 78' ' ' ILE . 1.9 m-30 -86.61 164.64 16.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.741 -1.224 . . . . 14.25 110.174 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 1.4 mtpp -159.33 178.78 9.59 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.876 -0.787 . . . . 32.700000000000003 108.876 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.812 HG21 HG21 ' B' ' 43' ' ' VAL . 0.2 OUTLIER -118.6 114.82 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.324 -0.86 . . . . 15.630000000000001 109.38 179.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.472 ' C ' ' NE2' ' A' ' 72' ' ' GLN . . . -74.46 -167.88 18.67 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.461 -1.456 . . . . 12.699999999999999 109.461 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.543 ' NE2' ' N ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -88.35 39.97 0.93 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.215 -1.168 . . . . 26.289999999999999 109.48 -179.909 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 28.3 m-85 -134.21 27.8 3.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.35 -0.844 . . . . 20.440000000000001 109.261 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 73' ' ' PHE . . . 44.7 49.01 8.96 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.583 -1.407 . . . . 13.82 109.583 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -149.51 145.67 26.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.192 -1.181 . . . . 18.27 109.66 179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 77' ' ' MET . 0.8 OUTLIER -88.41 149.49 23.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 12.43 109.119 179.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.497 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 54.6 mtm -157.4 137.84 12.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -0.984 . . . . 35.109999999999999 109.637 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.828 HD12 HD12 ' B' ' 78' ' ' ILE . 3.0 mt -69.98 139.59 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.354 -0.841 . . . . 13.67 110.105 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.1 -25.48 11.55 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.221 -1.029 . . . . 24.059999999999999 108.221 178.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.683 ' NH1' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -179.92 68.01 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.125 -1.435 . . . . 35.039999999999999 107.125 179.144 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -33.23 120.48 0.37 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.281 -0.872 . . . . 18.719999999999999 111.644 -178.247 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -91.45 113.21 25.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.922 -1.14 . . . . 20.550000000000001 107.922 178.786 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.973 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -82.55 148.85 27.82 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.028 -1.045 . . . . 14.4 110.959 -178.553 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 62' ' ' THR . 32.6 m -150.65 150.13 27.62 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 107.96 -1.126 . . . . 17.649999999999999 107.96 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.1 Cg_endo -61.37 140.89 90.46 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.164 1.91 . . . . 25.699999999999999 110.581 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.11 117.15 8.02 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 49.289999999999999 109.651 -178.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.005 -0.998 . . . . 58.909999999999997 109.49 179.991 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.643 ' O ' HD22 ' B' ' 37' ' ' LEU . 1.2 pmm? . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.471 -0.566 . . . . 64.909999999999997 109.471 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.954 HG23 HD13 ' A' ' 65' ' ' LEU . 2.3 mt -74.25 66.57 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.043 -1.095 . . . . 33.799999999999997 108.043 178.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.633 ' C ' HG12 ' B' ' 4' ' ' VAL . 0.5 OUTLIER -56.93 178.76 0.05 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.88 0.848 . . . . 32.719999999999999 110.992 -178.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.958 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 174.19 166.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.625 -0.879 . . . . 14.460000000000001 108.625 -179.84 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.558 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 25.2 mt-10 -137.34 113.99 10.36 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.826 -0.805 . . . . 22.120000000000001 108.826 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.768 HD11 ' SG ' ' B' ' 33' ' ' CYS . 0.1 OUTLIER -72.74 103.75 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 107.529 -1.286 . . . . 14.23 107.529 179.48 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.669 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -46.63 171.27 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.995 -1.065 . . . . 25.43 109.564 -178.791 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.3 Cg_endo -74.96 -28.3 9.35 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.445 2.096 . . . . 13.609999999999999 110.088 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -87.6 -0.73 57.27 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.02 -0.733 . . . . 15.52 109.02 179.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.579 ' OE1' HD12 ' B' ' 32' ' ' LEU . 13.6 mm-40 -115.9 37.08 3.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.342 -0.849 . . . . 17.309999999999999 109.301 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.71 10.77 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 24.780000000000001 110.004 -179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.438 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 13.7 mt-30 -137.62 136.14 37.23 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.14 -0.975 . . . . 47.899999999999999 109.785 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.625 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 30.8 p90 -86.15 165.97 16.14 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.248 -0.908 . . . . 21.609999999999999 109.573 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 89.7 m -133.42 149.84 51.79 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.385 -0.822 . . . . 14.890000000000001 109.234 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.534 ' CG2' ' OG ' ' B' ' 27' ' ' SER . 0.2 OUTLIER -74.45 113.76 12.06 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.251 -0.905 . . . . 17.350000000000001 109.224 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.457 ' NH1' ' CG ' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -124.28 127.27 47.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 34.380000000000003 109.606 -179.71 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 4.4 t -48.29 106.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.941 . . . . 38.770000000000003 109.244 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.601 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -115.14 137.39 13.89 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.751 -1.34 . . . . 34.579999999999998 109.751 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 1.5 t -100.02 122.37 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.232 -1.158 . . . . 41.869999999999997 109.127 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.445 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -69.79 89.9 0.58 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.51 -0.744 . . . . 47.210000000000001 109.525 -179.419 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' B' ' 22' ' ' GLN . 0.6 OUTLIER 70.97 -67.09 0.27 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.206 -0.934 . . . . 71.560000000000002 109.318 -179.817 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.451 ' HB3' ' O ' ' B' ' 21' ' ' ARG . 5.6 pt20 175.05 48.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 66.599999999999994 109.431 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' B' ' 24' ' ' LYS . . . -120.12 -60.77 0.25 Allowed Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.749 -1.34 . . . . 55.490000000000002 109.749 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' B' ' 23' ' ' GLY . 10.9 mttt -144.21 158.26 55.3 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.239 -1.154 . . . . 44.990000000000002 109.594 -179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' B' ' 24' ' ' LYS . 34.2 Cg_endo -77.2 81.92 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.742 2.295 . . . . 44.100000000000001 110.628 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.61 ' CE1' ' HB2' ' B' ' 28' ' ' LEU . 6.8 p90 -72.07 142.6 49.24 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.323 -0.86 . . . . 32.090000000000003 109.899 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.534 ' OG ' ' CG2' ' B' ' 15' ' ' THR . 0.3 OUTLIER -101.79 80.43 2.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.372 -0.83 . . . . 29.25 108.863 179.643 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.61 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -94.3 171.54 8.76 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.383 -0.823 . . . . 24.0 110.089 -179.369 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.625 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -88.47 129.25 35.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.601 -0.687 . . . . 23.309999999999999 109.802 -179.837 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 14.7 mt-10 -114.89 162.27 17.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.891 . . . . 40.030000000000001 109.387 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.837 ' O ' HD23 ' B' ' 32' ' ' LEU . 0.0 OUTLIER -148.76 -173.48 4.36 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.994 . . . . 12.390000000000001 109.892 -179.814 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.837 HD23 ' O ' ' B' ' 31' ' ' GLN . 25.3 mt -133.85 159.41 40.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.378 -0.826 . . . . 17.420000000000002 109.264 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.768 ' SG ' HD11 ' B' ' 6' ' ' ILE . 3.5 m -154.27 168.24 27.24 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.963 -1.125 . . . . 13.84 107.963 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.684 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 29.7 m-85 -120.38 105.93 11.36 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.957 -1.089 . . . . 21.140000000000001 109.652 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.827 ' O ' HG22 ' B' ' 43' ' ' VAL . 40.0 t -97.93 139.65 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.087 -1.008 . . . . 10.66 110.995 -179.086 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.645 ' O ' HD12 ' B' ' 37' ' ' LEU . 4.4 m-20 -115.27 -140.46 0.38 Allowed 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.292 -1.003 . . . . 25.890000000000001 108.292 179.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.709 ' CB ' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 67.33 -68.25 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.925 -1.109 . . . . 24.239999999999998 108.405 179.479 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -78.6 -1.54 83.08 Favored Glycine 0 C--N 1.297 -1.587 0 N-CA-C 107.873 -2.091 . . . . 31.02 107.873 178.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.451 ' O ' ' C ' ' B' ' 40' ' ' GLU . 0.1 OUTLIER -160.37 110.12 1.77 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.512 -0.993 . . . . 43.229999999999997 108.869 179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' B' ' 39' ' ' ASN . 2.0 mm-40 -37.37 -63.53 0.44 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.633 0.73 . . . . 42.340000000000003 109.827 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.471 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 37.9 m80 -68.89 164.1 49.99 Favored Pre-proline 0 C--N 1.293 -1.85 0 N-CA-C 108.03 -1.1 . . . . 8.0399999999999991 108.03 179.061 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.684 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.3 Cg_endo -76.51 141.53 22.54 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.722 1.615 . . . . 17.920000000000002 109.836 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.827 HG22 ' O ' ' B' ' 35' ' ' VAL . 25.5 m -113.73 115.77 50.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.255 -0.903 . . . . 20.57 109.495 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' B' ' 32' ' ' LEU . 52.1 tp -74.26 103.15 4.56 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.417 -0.802 . . . . 20.210000000000001 109.741 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.566 HG12 HG11 ' A' ' 70' ' ' VAL . 1.3 m -107.07 176.19 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.505 -0.747 . . . . 10.81 109.147 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.404 ' HA ' HD23 ' B' ' 32' ' ' LEU . 0.3 OUTLIER -100.17 139.87 35.23 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.393 -0.923 . . . . 36.740000000000002 109.526 179.627 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 1.014 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.6 OUTLIER -124.12 170.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.383 -0.823 . . . . 19.739999999999998 109.254 -179.748 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.681 HG21 ' NH1' ' B' ' 80' ' ' ARG . 0.2 OUTLIER -111.7 142.27 44.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.206 -0.934 . . . . 22.559999999999999 109.575 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.606 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -110.21 147.54 33.58 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.285 -0.884 . . . . 20.41 108.763 179.676 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 1.0 OUTLIER -85.37 145.11 27.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.128 -0.983 . . . . 33.990000000000002 109.854 -179.355 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.85 119.84 5.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 54.920000000000002 109.595 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.74 -15.56 46.44 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.707 -1.357 . . . . 36.100000000000001 109.707 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.529 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -75.0 145.12 80.56 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 54.759999999999998 109.311 179.987 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.8 Cg_endo -77.78 121.75 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.616 2.211 . . . . 28.370000000000001 110.731 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.809 ' HB1' HE21 ' B' ' 31' ' ' GLN . . . -38.68 150.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.548 -0.72 . . . . 17.210000000000001 110.415 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.746 ' HB3' HD13 ' B' ' 6' ' ' ILE . 89.4 m-85 -46.79 105.4 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.324 -0.86 . . . . 17.190000000000001 108.724 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 1.024 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -58.83 176.89 0.26 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.383 -0.823 . . . . 17.82 110.121 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 1.024 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.78 110.26 2.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.673 2.249 . . . . 17.280000000000001 110.278 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 173.68 151.96 8.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.579 -1.408 . . . . 17.219999999999999 109.579 -179.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 5.1 mp -49.25 150.1 1.86 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.985 -1.303 . . . . 19.57 108.724 179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.958 ' CB ' HG13 ' B' ' 4' ' ' VAL . 18.7 m-85 -128.55 163.86 24.08 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.833 -1.167 . . . . 14.609999999999999 111.589 -179.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.742 ' O ' HG22 ' B' ' 84' ' ' VAL . 53.8 p -147.6 118.71 7.73 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 106.481 -1.674 . . . . 18.359999999999999 106.481 178.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' B' ' 81' ' ' LEU . 9.2 t -53.3 169.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 118.811 -1.156 . . . . 19.129999999999999 108.878 -178.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.585 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -128.2 120.1 26.57 Favored 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.499 -0.751 . . . . 20.649999999999999 109.05 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.957 HD13 HG23 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -64.9 -8.43 15.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.709 -0.619 . . . . 19.649999999999999 109.923 -179.151 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 96.0 p -52.05 -17.98 1.25 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.952 -1.092 . . . . 14.720000000000001 108.377 179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' B' ' 80' ' ' ARG . 2.4 m -95.96 -6.59 38.64 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.502 -0.749 . . . . 11.449999999999999 110.776 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.631 ' CE1' HG12 ' B' ' 78' ' ' ILE . 1.8 m-30 -86.15 164.4 17.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.73 -1.231 . . . . 14.25 110.046 -179.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -159.09 179.06 9.38 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.82 -0.808 . . . . 32.700000000000003 108.82 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.825 HG21 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -118.73 115.13 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.244 -0.91 . . . . 15.630000000000001 109.427 179.939 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.483 ' C ' ' NE2' ' B' ' 72' ' ' GLN . . . -74.58 -168.09 19.66 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.495 -1.442 . . . . 12.699999999999999 109.495 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.55 ' NE2' ' N ' ' B' ' 72' ' ' GLN . 0.6 OUTLIER -88.13 39.71 0.91 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.167 -1.196 . . . . 26.289999999999999 109.475 179.937 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' B' ' 73' ' ' PHE . 28.6 m-85 -133.99 28.09 3.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 20.440000000000001 109.38 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.39 49.1 8.46 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.627 -1.389 . . . . 13.82 109.627 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -149.67 145.69 26.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -1.145 . . . . 18.27 109.684 -179.971 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' B' ' 77' ' ' MET . 0.8 OUTLIER -88.58 149.62 23.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.887 . . . . 12.43 109.072 179.734 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.492 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 54.4 mtm -157.52 138.18 13.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.123 -0.986 . . . . 35.109999999999999 109.52 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.828 HD12 HD12 ' A' ' 78' ' ' ILE . 2.9 mp -70.4 139.52 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.331 -0.856 . . . . 13.67 110.134 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.84 -25.53 11.65 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.138 -1.06 . . . . 24.059999999999999 108.138 178.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.681 ' NH1' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER -179.77 68.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.186 -1.413 . . . . 35.039999999999999 107.186 179.17 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.656 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -33.21 120.28 0.36 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.311 -0.859 . . . . 18.719999999999999 111.607 -178.187 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -91.32 113.09 25.26 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.979 -1.119 . . . . 20.550000000000001 107.979 178.723 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.014 ' HB2' HD11 ' B' ' 47' ' ' ILE . 0.5 OUTLIER -82.42 148.93 27.92 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.037 -1.039 . . . . 14.4 110.986 -178.603 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.742 HG22 ' O ' ' B' ' 62' ' ' THR . 32.5 m -150.63 150.04 27.45 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 107.994 -1.113 . . . . 17.649999999999999 107.994 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.0 Cg_endo -61.41 140.44 87.83 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.188 1.925 . . . . 25.699999999999999 110.6 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -65.51 117.47 8.06 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 49.289999999999999 109.62 -178.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.027 -0.987 . . . . 58.909999999999997 109.484 -179.98 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.358 -0.608 . . . . 64.909999999999997 109.358 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.896 ' N ' HD22 ' B' ' 65' ' ' LEU . 2.2 mt -60.4 84.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 107.897 -1.149 . . . . 33.799999999999997 107.897 179.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 1' ' ' MET . 17.4 mttt -57.85 157.14 7.92 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.847 0.832 . . . . 32.719999999999999 111.569 -177.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.057 HG22 HG22 ' A' ' 35' ' ' VAL . 59.8 t -160.52 167.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.585 0.707 . . . . 14.460000000000001 109.724 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.61 ' N ' HG12 ' A' ' 4' ' ' VAL . 38.9 mt-10 -154.09 101.44 2.41 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.771 0.796 . . . . 22.120000000000001 108.931 179.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.7 HD13 ' HB3' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -71.38 101.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.986 -1.116 . . . . 14.23 107.986 179.642 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.581 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 15.6 mmmt -50.52 163.3 0.47 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.414 -0.803 . . . . 25.43 109.252 -179.393 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.5 Cg_endo -71.98 -10.1 25.62 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.818 1.679 . . . . 13.609999999999999 109.247 179.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.82 12.21 31.07 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.533 -0.914 . . . . 15.52 108.533 178.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.529 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 7.6 mm-40 -137.08 38.45 2.54 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.31 -0.869 . . . . 17.309999999999999 109.211 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -111.96 31.48 6.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.165 -0.96 . . . . 24.780000000000001 110.19 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 12.0 mt-30 -140.3 132.36 27.9 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.261 -0.9 . . . . 47.899999999999999 109.501 179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.642 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 33.6 p90 -89.52 155.81 19.05 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.213 -0.93 . . . . 21.609999999999999 109.671 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.1 m -134.6 150.16 50.67 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.885 -0.783 . . . . 14.890000000000001 108.885 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.943 HG22 ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -82.15 108.82 15.91 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.164 -0.96 . . . . 17.350000000000001 109.236 179.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.482 ' NH1' ' HG3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -124.77 146.58 49.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.362 -0.836 . . . . 34.380000000000003 109.352 -179.828 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 16' ' ' ARG . 1.5 m -44.05 143.72 1.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 38.770000000000003 109.458 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -147.72 175.52 27.02 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.172 -1.571 . . . . 34.579999999999998 109.172 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.5 OUTLIER -150.09 118.53 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.066 -1.255 . . . . 41.869999999999997 108.999 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 21' ' ' ARG . 1.3 m -61.8 83.61 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.387 -0.82 . . . . 47.210000000000001 109.561 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 20' ' ' SER . 19.5 mtt180 68.37 -61.68 0.39 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.301 -0.874 . . . . 71.560000000000002 109.475 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' SER . 15.8 pt20 174.06 45.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 66.599999999999994 109.542 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.72 -56.98 0.25 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.619 -1.392 . . . . 55.490000000000002 109.619 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 5.9 pttt -143.11 158.87 57.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.303 -1.116 . . . . 44.990000000000002 109.38 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.7 Cg_endo -77.56 124.17 6.85 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.695 2.263 . . . . 44.100000000000001 110.784 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.597 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 3.8 p90 -130.14 136.35 49.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.314 -0.866 . . . . 32.090000000000003 109.601 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.943 ' HB2' HG22 ' A' ' 15' ' ' THR . 0.0 OUTLIER -104.01 80.2 1.71 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.88 . . . . 29.25 108.684 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.573 HD13 HH22 ' A' ' 80' ' ' ARG . 0.4 OUTLIER -89.23 138.78 31.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 24.0 110.418 -179.008 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.653 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -47.61 117.75 1.95 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.433 -0.792 . . . . 23.309999999999999 109.569 179.607 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -112.87 147.68 36.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.255 -0.903 . . . . 40.030000000000001 109.593 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.949 ' OE1' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -131.22 -169.71 2.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.121 -0.987 . . . . 12.390000000000001 109.341 179.843 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.971 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -128.56 177.53 6.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.857 . . . . 17.420000000000002 109.32 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.811 ' SG ' HD12 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -172.43 162.69 5.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.053 -1.029 . . . . 13.84 108.467 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.697 ' HE1' HD13 ' A' ' 44' ' ' LEU . 4.1 m-30 -114.58 95.25 5.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.154 -0.966 . . . . 21.140000000000001 109.187 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.057 HG22 HG22 ' A' ' 4' ' ' VAL . 92.2 t -84.87 115.45 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 10.66 110.234 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 t0 -66.1 -22.67 66.41 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.381 -0.824 . . . . 25.890000000000001 108.805 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.723 HD11 ' C ' ' B' ' 68' ' ' PHE . 0.8 OUTLIER 43.23 26.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.467 -0.771 . . . . 24.239999999999998 109.567 179.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . 58.6 22.3 52.23 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.891 -1.284 . . . . 31.02 109.891 179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.546 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 19.2 p30 -100.64 27.8 5.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.983 -1.304 . . . . 43.229999999999997 110.079 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.628 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 12.2 mt-10 47.72 71.81 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.886 . . . . 42.340000000000003 109.871 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.628 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER 142.92 144.46 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.287 0 N-CA-C 108.572 -0.899 . . . . 6.5700000000000003 108.572 179.451 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.681 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 36.6 Cg_endo -79.57 142.96 16.64 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.206 1.938 . . . . 17.920000000000002 110.841 -179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.97 HG22 ' O ' ' A' ' 35' ' ' VAL . 6.9 m -120.52 119.3 59.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 108.441 -0.948 . . . . 20.57 108.441 178.469 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.971 HD11 ' HB3' ' A' ' 32' ' ' LEU . 17.7 tp -66.88 112.72 4.44 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.428 -0.795 . . . . 20.210000000000001 109.241 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.585 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 3.6 t -119.47 168.4 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.576 -0.702 . . . . 10.81 109.572 -179.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -90.57 149.89 21.96 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.431 -0.793 . . . . 36.740000000000002 109.954 -179.776 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.861 HD11 ' CB ' ' A' ' 83' ' ' LEU . 1.6 tt -130.21 176.86 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.802 -0.814 . . . . 19.739999999999998 108.802 179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.634 HG21 ' CZ ' ' A' ' 80' ' ' ARG . 0.1 OUTLIER -125.4 135.24 52.18 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.184 -0.948 . . . . 22.559999999999999 109.094 179.453 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -104.67 99.99 9.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.209 -0.932 . . . . 20.41 109.003 179.981 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.69 156.44 36.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 33.990000000000002 109.606 -179.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.27 136.81 57.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.221 -0.924 . . . . 54.920000000000002 109.228 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.86 -35.05 3.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.321 -1.512 . . . . 36.100000000000001 109.321 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.797 ' O ' HD12 ' A' ' 49' ' ' LEU . 4.3 mt-30 -77.32 124.04 86.98 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.243 -1.151 . . . . 54.759999999999998 109.245 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.1 Cg_endo -78.63 138.28 15.11 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.279 1.986 . . . . 28.370000000000001 110.406 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.949 ' HB1' ' OE1' ' A' ' 31' ' ' GLN . . . -35.84 138.16 0.19 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.637 -0.664 . . . . 17.210000000000001 110.424 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.7 ' HB3' HD13 ' A' ' 6' ' ' ILE . 83.7 m-85 -51.75 109.99 0.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.321 -0.862 . . . . 17.190000000000001 109.511 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.917 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -59.72 174.33 0.45 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.263 -0.898 . . . . 17.82 109.252 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.917 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.7 Cg_endo -77.48 110.32 2.95 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.632 2.221 . . . . 17.280000000000001 110.406 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.37 179.85 48.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.743 -1.343 . . . . 17.219999999999999 109.743 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -74.83 143.99 43.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -1.114 . . . . 19.57 108.76 179.483 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.555 ' CB ' ' HB ' ' A' ' 4' ' ' VAL . 27.0 m-85 -132.42 164.58 26.21 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.873 -1.142 . . . . 14.609999999999999 111.206 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.807 ' O ' HG22 ' A' ' 84' ' ' VAL . 31.1 p -144.11 118.96 9.9 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.925 -1.88 . . . . 18.359999999999999 105.925 178.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.743 ' HB ' HD13 ' A' ' 2' ' ' ILE . 2.6 t -52.36 166.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 C-N-CA 118.434 -1.307 . . . . 19.129999999999999 108.999 -178.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -129.13 128.81 44.22 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.417 -0.802 . . . . 20.649999999999999 109.3 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.906 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -71.3 0.19 8.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.691 -0.631 . . . . 19.649999999999999 110.051 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -57.25 -17.66 12.7 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 107.645 -1.243 . . . . 14.720000000000001 107.645 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.488 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 50.4 m -96.41 -8.38 32.52 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.782 -0.574 . . . . 11.449999999999999 110.193 -179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.739 ' C ' HD11 ' B' ' 37' ' ' LEU . 2.8 m-30 -77.69 155.04 31.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.052 . . . . 14.25 109.585 -178.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.467 ' HG2' ' HB2' ' A' ' 79' ' ' ASP . 0.1 OUTLIER -134.71 172.9 12.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.406 -0.809 . . . . 32.700000000000003 109.731 -179.651 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.87 HG21 HG21 ' B' ' 43' ' ' VAL . 8.7 t -124.41 133.34 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.492 -0.755 . . . . 15.630000000000001 109.376 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.26 -157.56 27.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.435 -1.466 . . . . 12.699999999999999 109.435 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.511 ' HA ' ' NE2' ' A' ' 72' ' ' GLN . 6.5 tp-100 55.88 72.42 0.49 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -1.181 . . . . 26.289999999999999 109.098 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 0.1 OUTLIER 73.32 5.95 5.09 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.453 -0.779 . . . . 20.440000000000001 109.402 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.481 ' O ' HG13 ' B' ' 45' ' ' VAL . . . 78.29 45.07 10.34 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.474 -1.451 . . . . 13.82 109.474 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.3 OUTLIER -127.07 119.66 27.1 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -1.144 . . . . 18.27 109.713 -179.913 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' HG11 ' B' ' 35' ' ' VAL . 0.8 OUTLIER -54.95 144.68 22.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 12.43 109.106 179.801 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 30.9 mtp -160.28 140.8 11.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 35.109999999999999 109.783 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.946 HD12 HD12 ' B' ' 78' ' ' ILE . 2.3 mp -68.56 141.66 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.816 . . . . 13.67 109.73 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 69' ' ' LYS . 39.5 t0 -108.61 -21.26 12.78 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.689 -0.856 . . . . 24.059999999999999 108.689 178.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.634 ' CZ ' HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER 174.22 66.76 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.1 -1.444 . . . . 35.039999999999999 107.1 179.497 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -28.3 119.7 0.11 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.257 -0.883 . . . . 18.719999999999999 111.961 -178.07 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 5.3 ttp180 -93.14 102.87 15.18 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.841 -1.17 . . . . 20.550000000000001 107.841 178.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.861 ' CB ' HD11 ' A' ' 47' ' ' ILE . 7.0 tp -74.13 149.75 40.85 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.158 -0.964 . . . . 14.4 111.184 -178.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 62' ' ' THR . 17.8 m -146.33 152.98 47.63 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.214 -1.032 . . . . 17.649999999999999 108.214 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 26.0 Cg_endo -64.51 142.97 80.37 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.2 1.933 . . . . 25.699999999999999 110.402 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.793 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -76.94 123.67 26.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 49.289999999999999 109.692 -178.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.003 -0.999 . . . . 58.909999999999997 109.432 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.516 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.4 pmm? . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.387 -0.597 . . . . 64.909999999999997 109.387 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.906 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.2 mt -60.23 84.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.881 -1.155 . . . . 33.799999999999997 107.881 179.065 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.533 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 17.5 mttt -57.75 157.25 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.815 0.817 . . . . 32.719999999999999 111.543 -177.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.068 HG22 HG22 ' B' ' 35' ' ' VAL . 58.6 t -160.63 167.16 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.551 0.691 . . . . 14.460000000000001 109.726 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.608 ' N ' HG12 ' B' ' 4' ' ' VAL . 38.5 mt-10 -154.08 101.29 2.4 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.715 0.769 . . . . 22.120000000000001 108.963 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.694 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -71.28 101.77 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 107.994 -1.113 . . . . 14.23 107.994 179.664 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.565 ' HB3' ' HD2' ' B' ' 8' ' ' PRO . 15.7 mmmt -50.58 163.59 0.46 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.454 -0.779 . . . . 25.43 109.216 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.5 Cg_endo -72.23 -10.16 25.38 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.835 1.69 . . . . 13.609999999999999 109.205 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.62 12.06 31.6 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.485 -0.932 . . . . 15.52 108.485 178.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.541 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 7.7 mm-40 -136.91 38.19 2.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.309 -0.869 . . . . 17.309999999999999 109.33 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.73 31.43 6.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.098 -1.001 . . . . 24.780000000000001 110.288 -179.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' B' ' 31' ' ' GLN . 11.9 mt-30 -140.26 132.26 27.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 47.899999999999999 109.504 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.642 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 33.0 p90 -89.33 155.75 19.15 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.249 -0.907 . . . . 21.609999999999999 109.662 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -134.63 150.27 50.65 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.83 -0.804 . . . . 14.890000000000001 108.83 179.442 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.941 HG22 ' HB2' ' B' ' 27' ' ' SER . 0.2 OUTLIER -82.17 108.7 15.83 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 17.350000000000001 109.209 179.989 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.481 ' NH1' ' HG3' ' B' ' 16' ' ' ARG . 0.0 OUTLIER -124.56 146.62 48.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 34.380000000000003 109.417 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.414 ' C ' ' O ' ' B' ' 16' ' ' ARG . 1.5 m -44.09 143.73 1.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 38.770000000000003 109.405 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -147.74 175.56 27.01 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.154 -1.578 . . . . 34.579999999999998 109.154 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' B' ' 21' ' ' ARG . 0.5 OUTLIER -149.96 118.64 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.13 -1.217 . . . . 41.869999999999997 109.087 179.421 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.469 ' O ' ' N ' ' B' ' 22' ' ' GLN . 1.3 m -61.87 83.51 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.363 -0.836 . . . . 47.210000000000001 109.535 -179.213 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' B' ' 20' ' ' SER . 19.6 mtt180 68.45 -61.93 0.39 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.315 -0.865 . . . . 71.560000000000002 109.466 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' B' ' 20' ' ' SER . 15.8 pt20 174.27 45.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 66.599999999999994 109.585 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -119.71 -57.04 0.25 Allowed Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.581 -1.408 . . . . 55.490000000000002 109.581 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.455 ' HB2' ' HD2' ' B' ' 25' ' ' PRO . 5.9 pttt -143.0 158.89 58.06 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.246 -1.149 . . . . 44.990000000000002 109.419 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.7 Cg_endo -77.58 124.1 6.81 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.639 2.226 . . . . 44.100000000000001 110.808 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.583 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 3.8 p90 -130.0 136.35 49.32 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.262 -0.899 . . . . 32.090000000000003 109.67 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.941 ' HB2' HG22 ' B' ' 15' ' ' THR . 0.0 OUTLIER -103.99 80.26 1.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.9 . . . . 29.25 108.623 179.651 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.58 HD13 HH22 ' B' ' 80' ' ' ARG . 0.4 OUTLIER -89.33 138.64 31.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 24.0 110.408 -178.995 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.664 ' OD1' ' N ' ' B' ' 29' ' ' ASN . 0.0 OUTLIER -47.56 117.81 1.97 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.434 -0.791 . . . . 23.309999999999999 109.627 179.668 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 6.4 mt-10 -112.77 148.02 35.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.218 -0.926 . . . . 40.030000000000001 109.584 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.955 ' OE1' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -131.6 -169.81 2.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.219 -0.926 . . . . 12.390000000000001 109.236 179.86 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.954 ' HB3' HD11 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -128.53 177.63 6.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.289 -0.882 . . . . 17.420000000000002 109.276 179.889 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.808 ' SG ' HD12 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -172.51 162.56 5.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.992 -1.067 . . . . 13.84 108.4 -179.653 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.692 ' HE1' HD13 ' B' ' 44' ' ' LEU . 4.1 m-30 -114.51 95.36 5.22 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.125 -0.984 . . . . 21.140000000000001 109.203 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 1.068 HG22 HG22 ' B' ' 4' ' ' VAL . 92.6 t -84.92 115.41 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.028 -1.045 . . . . 10.66 110.27 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' B' ' 39' ' ' ASN . 1.1 t0 -66.0 -22.71 66.47 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.389 -0.819 . . . . 25.890000000000001 108.862 179.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.739 HD11 ' C ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER 43.23 26.69 0.1 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.813 . . . . 24.239999999999998 109.55 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 58.64 22.56 53.18 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.862 -1.295 . . . . 31.02 109.862 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.542 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 19.1 p30 -100.89 27.66 5.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.016 -1.285 . . . . 43.229999999999997 110.034 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.631 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 12.2 mt-10 47.88 71.87 0.31 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 42.340000000000003 109.817 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.631 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 0.2 OUTLIER 142.89 144.44 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.196 0 N-CA-C 108.591 -0.892 . . . . 6.5599999999999996 108.591 179.48 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.674 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.7 Cg_endo -79.56 143.14 16.79 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.235 1.957 . . . . 17.920000000000002 110.762 -179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.987 HG22 ' O ' ' B' ' 35' ' ' VAL . 7.1 m -120.73 119.12 58.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.446 -0.946 . . . . 20.57 108.446 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.954 HD11 ' HB3' ' B' ' 32' ' ' LEU . 17.0 tp -66.71 112.96 4.48 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.413 -0.804 . . . . 20.210000000000001 109.294 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.575 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 3.7 t -119.71 168.43 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.552 -0.718 . . . . 10.81 109.553 -179.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.575 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.5 OUTLIER -90.64 149.84 21.93 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.443 -0.786 . . . . 36.740000000000002 110.007 -179.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.873 HD11 ' CB ' ' B' ' 83' ' ' LEU . 1.6 tt -130.11 176.95 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.836 -0.801 . . . . 19.739999999999998 108.836 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.648 HG21 ' CZ ' ' B' ' 80' ' ' ARG . 0.1 OUTLIER -125.57 134.94 51.78 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.228 -0.92 . . . . 22.559999999999999 109.149 179.486 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.799 HD12 ' O ' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -104.48 100.07 9.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.169 -0.957 . . . . 20.41 109.05 179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.8 156.44 37.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 33.990000000000002 109.642 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -58.25 136.77 57.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.312 -0.867 . . . . 54.920000000000002 109.245 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.76 -34.56 4.01 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.388 -1.485 . . . . 36.100000000000001 109.388 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.799 ' O ' HD12 ' B' ' 49' ' ' LEU . 4.3 mt-30 -77.71 123.99 86.49 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.234 -1.157 . . . . 54.759999999999998 109.202 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.476 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.8 Cg_endo -78.54 138.06 15.1 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.343 2.029 . . . . 28.370000000000001 110.478 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.955 ' HB1' ' OE1' ' B' ' 31' ' ' GLN . . . -35.62 137.78 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.384 0.612 . . . . 17.210000000000001 110.478 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.694 ' HB3' HD13 ' B' ' 6' ' ' ILE . 84.6 m-85 -51.28 109.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 17.190000000000001 109.558 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.943 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -59.72 174.25 0.46 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 17.82 109.27 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.943 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.26 109.53 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.541 2.161 . . . . 17.280000000000001 110.193 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.08 179.52 48.88 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.83 -1.308 . . . . 17.219999999999999 109.83 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.829 HD23 ' O ' ' B' ' 4' ' ' VAL . 0.4 OUTLIER -75.2 143.73 43.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -1.14 . . . . 19.57 108.474 179.263 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.561 ' CB ' HD21 ' B' ' 83' ' ' LEU . 27.0 m-85 -132.04 164.57 25.92 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.835 -1.165 . . . . 14.609999999999999 111.173 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.831 ' O ' HG22 ' B' ' 84' ' ' VAL . 31.9 p -143.99 119.0 10.0 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 105.907 -1.886 . . . . 18.359999999999999 105.907 178.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.752 ' HB ' HD13 ' B' ' 2' ' ' ILE . 2.5 t -52.52 166.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 C-N-CA 118.42 -1.312 . . . . 19.129999999999999 108.941 -178.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.512 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -129.26 128.73 43.84 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.413 -0.804 . . . . 20.649999999999999 109.287 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.896 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.4 OUTLIER -71.23 0.17 8.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.621 -0.674 . . . . 19.649999999999999 110.11 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.9 t -57.2 -17.7 12.52 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.67 -1.233 . . . . 14.720000000000001 107.67 179.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.492 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 51.1 m -96.23 -8.78 32.03 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.773 -0.58 . . . . 11.449999999999999 110.255 -179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.723 ' C ' HD11 ' A' ' 37' ' ' LEU . 2.8 m-30 -77.3 155.01 32.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.023 -1.048 . . . . 14.25 109.542 -178.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' B' ' 79' ' ' ASP . 0.1 OUTLIER -134.83 172.58 12.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.424 -0.797 . . . . 32.700000000000003 109.703 -179.57 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.851 HG21 HG21 ' A' ' 43' ' ' VAL . 9.5 t -124.14 133.31 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.462 -0.774 . . . . 15.630000000000001 109.387 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.37 -157.3 27.35 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.506 -1.438 . . . . 12.699999999999999 109.506 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.533 ' HA ' ' NE2' ' B' ' 72' ' ' GLN . 6.5 tp-100 55.68 72.27 0.5 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -1.164 . . . . 26.289999999999999 109.131 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' B' ' 72' ' ' GLN . 0.1 OUTLIER 73.44 5.94 5.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.489 -0.757 . . . . 20.440000000000001 109.467 -179.697 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.477 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 78.32 45.1 10.26 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.547 -1.421 . . . . 13.82 109.547 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 77' ' ' MET . 0.3 OUTLIER -127.13 119.57 26.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -1.1 . . . . 18.27 109.755 -179.916 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.548 HD13 HG11 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -54.94 144.54 22.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 12.43 109.152 179.784 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.53 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 31.1 mtp -160.14 141.1 12.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 35.109999999999999 109.749 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.946 HD12 HD12 ' A' ' 78' ' ' ILE . 2.3 mp -68.87 141.83 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 13.67 109.775 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.473 ' HB2' ' HG2' ' B' ' 69' ' ' LYS . 39.1 t0 -108.66 -21.23 12.79 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.685 -0.857 . . . . 24.059999999999999 108.685 178.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.648 ' CZ ' HG21 ' B' ' 48' ' ' THR . 0.0 OUTLIER 174.08 66.58 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.075 -1.454 . . . . 35.039999999999999 107.075 179.541 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.653 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -28.01 119.98 0.11 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.27 -0.877 . . . . 18.719999999999999 111.893 -178.097 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 5.4 ttp180 -93.38 103.09 15.34 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.814 -1.18 . . . . 20.550000000000001 107.814 178.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.873 ' CB ' HD11 ' B' ' 47' ' ' ILE . 7.0 tp -74.35 149.59 40.5 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.113 -0.992 . . . . 14.4 111.148 -178.237 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.831 HG22 ' O ' ' B' ' 62' ' ' THR . 17.6 m -146.19 153.14 48.4 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.224 -1.028 . . . . 17.649999999999999 108.224 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 26.5 Cg_endo -64.6 143.34 81.0 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.155 1.903 . . . . 25.699999999999999 110.397 179.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.812 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -77.38 123.82 27.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.309 -0.87 . . . . 49.289999999999999 109.643 -178.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.04 -0.981 . . . . 58.909999999999997 109.433 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.4 tpp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.489 -0.559 . . . . 64.909999999999997 109.489 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.764 ' N ' HD22 ' B' ' 65' ' ' LEU . 2.1 mt -59.46 84.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 107.962 -1.125 . . . . 33.799999999999997 107.962 179.297 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 1' ' ' MET . 15.3 mtpp -67.1 152.5 45.65 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.827 0.823 . . . . 32.719999999999999 111.306 -178.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.901 HG11 HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -164.15 167.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 108.381 -0.97 . . . . 14.460000000000001 108.381 179.593 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.572 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 24.3 mt-10 -141.08 118.0 11.13 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.336 -0.853 . . . . 22.120000000000001 109.361 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.867 HG21 ' O ' ' A' ' 56' ' ' TYR . 10.4 mm -75.71 92.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 107.919 -1.141 . . . . 14.23 107.919 179.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.671 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -44.89 171.66 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 25.43 110.19 -178.677 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' A' ' 7' ' ' LYS . 33.3 Cg_endo -74.73 -29.28 8.89 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.481 2.121 . . . . 13.609999999999999 109.728 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -6.74 58.17 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.762 -0.829 . . . . 15.52 108.762 178.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 1.3 mm100 -118.35 40.56 3.16 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.417 -0.802 . . . . 17.309999999999999 109.342 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 56' ' ' TYR . . . -103.69 7.96 37.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.092 -1.005 . . . . 24.780000000000001 109.646 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.443 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 37.5 mt-30 -138.05 138.89 39.24 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.323 -0.861 . . . . 47.899999999999999 109.624 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.656 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 36.1 p90 -92.13 161.32 14.79 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.15 -0.969 . . . . 21.609999999999999 108.76 179.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.1 m -130.02 152.54 49.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.103 -0.998 . . . . 14.890000000000001 109.687 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.87 109.69 22.35 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.333 -0.854 . . . . 17.350000000000001 109.314 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 18' ' ' GLY . 5.0 mtp180 -123.64 152.35 42.07 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.319 -0.863 . . . . 34.380000000000003 109.06 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -57.77 84.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 38.770000000000003 109.366 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.549 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -77.68 160.43 48.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.314 -1.515 . . . . 34.579999999999998 109.314 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 24' ' ' LYS . 1.6 t -128.76 124.1 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.116 -1.226 . . . . 41.869999999999997 108.964 179.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.47 -92.14 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.23 -0.919 . . . . 47.210000000000001 109.63 -179.134 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.502 ' NH1' ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -90.14 -54.97 3.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.307 -0.87 . . . . 71.560000000000002 109.475 179.939 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.79 38.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 66.599999999999994 109.792 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.539 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -168.31 36.39 0.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.373 -1.491 . . . . 55.490000000000002 109.373 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.539 ' CG ' ' O ' ' A' ' 23' ' ' GLY . 2.8 mttp -170.36 102.15 0.43 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.495 -1.003 . . . . 44.990000000000002 108.745 -179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 33.5 Cg_endo -75.71 68.46 6.31 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.161 1.907 . . . . 44.100000000000001 110.805 -179.573 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' A' ' 26' ' ' TYR . 6.2 p90 -63.05 137.67 58.33 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.349 -0.844 . . . . 32.090000000000003 109.436 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 m -99.86 78.8 2.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.124 -0.985 . . . . 29.25 108.866 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.585 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -100.4 160.75 14.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 24.0 110.451 -179.009 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.626 ' ND2' ' CE1' ' A' ' 13' ' ' PHE . 98.0 m-20 -78.33 129.59 35.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.496 -0.752 . . . . 23.309999999999999 109.277 179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -123.28 149.06 45.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 40.030000000000001 109.17 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.617 ' HB3' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -136.33 -170.17 2.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 12.390000000000001 109.65 -179.985 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.778 ' HB3' HD11 ' A' ' 44' ' ' LEU . 5.9 mp -132.03 174.49 10.13 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.327 -0.858 . . . . 17.420000000000002 109.526 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -162.69 159.37 24.29 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.258 -1.015 . . . . 13.84 108.258 -179.587 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.7 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 15.0 m-85 -114.77 96.64 5.83 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.152 -0.968 . . . . 21.140000000000001 109.384 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.876 ' O ' HG22 ' A' ' 43' ' ' VAL . 3.0 t -105.18 127.5 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 10.66 110.461 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 16.8 p-10 -86.48 -27.54 24.01 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.496 -0.927 . . . . 25.890000000000001 108.496 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.852 ' HG ' HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER 47.4 23.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.398 -0.814 . . . . 24.239999999999998 109.625 179.775 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.27 8.03 69.05 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.976 -1.25 . . . . 31.02 109.976 179.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' CG ' ' O ' ' A' ' 36' ' ' ASP . 1.7 m-20 -87.07 19.21 3.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.094 -1.239 . . . . 43.229999999999997 110.008 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 5.1 mt-10 45.98 72.03 0.25 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.905 . . . . 42.340000000000003 109.862 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.61 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER 143.64 147.65 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.207 0 N-CA-C 108.6 -0.889 . . . . 6.5899999999999999 108.6 179.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.7 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -79.5 137.5 13.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.068 1.845 . . . . 17.920000000000002 110.542 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.876 HG22 ' O ' ' A' ' 35' ' ' VAL . 2.8 m -114.53 118.7 59.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 O-C-N 121.35 -0.844 . . . . 20.57 108.827 179.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.778 HD11 ' HB3' ' A' ' 32' ' ' LEU . 56.7 tp -76.48 106.65 8.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.435 -0.791 . . . . 20.210000000000001 110.661 -178.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.607 HG13 HG23 ' A' ' 43' ' ' VAL . 21.2 m -115.24 -169.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.816 -0.809 . . . . 10.81 108.816 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -108.48 152.01 25.29 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.333 -0.947 . . . . 36.740000000000002 110.395 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.953 HD13 HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -141.41 126.15 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.57 -0.706 . . . . 19.739999999999998 109.141 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -64.36 147.12 53.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.062 . . . . 22.559999999999999 109.357 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.753 HD13 ' O ' ' A' ' 49' ' ' LEU . 2.9 tm? -124.31 73.09 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 20.41 109.235 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 2.0 t70 -134.96 -175.48 3.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.916 -1.115 . . . . 33.990000000000002 109.72 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 53' ' ' GLN . 16.0 tt0 69.82 67.66 0.23 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.414 -0.804 . . . . 54.920000000000002 109.558 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 51' ' ' GLU . . . 38.17 27.85 0.04 OUTLIER Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.522 -1.031 . . . . 36.100000000000001 110.522 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 51' ' ' GLU . 3.5 mt-30 -105.96 125.58 32.8 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 120.897 -1.355 . . . . 54.759999999999998 109.913 -179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.528 ' C ' HD21 ' A' ' 49' ' ' LEU . 35.8 Cg_endo -78.73 146.35 21.0 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.313 2.008 . . . . 28.370000000000001 109.677 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.656 ' HB2' ' CD2' ' A' ' 13' ' ' PHE . . . -37.93 143.27 0.12 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.439 -0.788 . . . . 17.210000000000001 110.496 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.867 ' O ' HG21 ' A' ' 6' ' ' ILE . 79.5 m-85 -58.54 107.16 0.47 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.498 -0.751 . . . . 17.190000000000001 109.273 179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.876 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.58 173.33 0.36 Allowed Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 121.107 -0.996 . . . . 17.82 108.983 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.876 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.8 Cg_endo -78.28 107.89 2.39 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.486 2.124 . . . . 17.280000000000001 110.09 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -176.23 179.32 47.37 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.963 -1.255 . . . . 17.219999999999999 109.963 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.708 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -77.12 137.74 39.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.385 -1.068 . . . . 19.57 108.642 179.203 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.937 ' HB3' HD22 ' A' ' 83' ' ' LEU . 26.9 m-85 -128.55 163.21 25.48 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.751 -1.218 . . . . 14.609999999999999 111.569 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.8 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.5 p -141.74 117.58 10.47 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.163 -1.791 . . . . 18.359999999999999 106.163 177.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.649 ' HB ' HD13 ' A' ' 2' ' ' ILE . 2.4 t -50.14 164.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 118.77 -1.172 . . . . 19.129999999999999 108.936 -178.185 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.3 t-80 -128.39 129.13 45.74 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.504 -0.747 . . . . 20.649999999999999 109.113 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.738 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER -72.59 2.19 6.88 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.519 -0.738 . . . . 19.649999999999999 109.985 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.31 -18.91 30.66 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 107.002 -1.481 . . . . 14.720000000000001 107.002 178.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.504 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 14.7 m -96.19 -9.64 30.05 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.9 -0.5 . . . . 11.449999999999999 109.907 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.654 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 3.4 m-30 -78.05 154.37 31.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.112 -0.992 . . . . 14.25 109.951 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 68' ' ' PHE . 3.8 mtmt -157.6 -178.38 7.29 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.528 -0.733 . . . . 32.700000000000003 109.182 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.565 ' CG1' ' CG1' ' B' ' 45' ' ' VAL . 0.0 OUTLIER -109.96 105.82 19.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.434 -0.791 . . . . 15.630000000000001 109.132 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.22 -155.0 12.15 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.994 -1.243 . . . . 12.699999999999999 109.994 -179.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' HA ' ' NE2' ' A' ' 72' ' ' GLN . 12.6 tp60 -98.55 42.47 1.09 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.321 -1.105 . . . . 26.289999999999999 109.68 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 74' ' ' GLY . 2.8 m-85 -129.22 22.14 5.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.162 -0.961 . . . . 20.440000000000001 109.625 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 73' ' ' PHE . . . 44.79 52.56 7.69 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.627 -1.389 . . . . 13.82 109.627 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 76' ' ' LEU . 16.8 t -176.66 130.18 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -1.116 . . . . 18.27 109.448 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.816 HD22 HD13 ' B' ' 81' ' ' LEU . 0.1 OUTLIER -44.1 160.15 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.907 . . . . 12.43 109.159 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 1.4 mtt -163.7 118.67 1.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 35.109999999999999 109.585 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.002 HD12 HD12 ' B' ' 78' ' ' ILE . 2.3 mp -54.07 138.14 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.214 -0.929 . . . . 13.67 109.324 179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -105.77 -34.8 7.56 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.011 -1.107 . . . . 24.059999999999999 108.011 178.516 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.504 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.2 OUTLIER -170.12 67.07 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.169 -1.419 . . . . 35.039999999999999 107.169 178.804 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.811 HD13 HD22 ' B' ' 76' ' ' LEU . 0.7 OUTLIER -27.99 120.05 0.11 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.21 -0.905 . . . . 18.719999999999999 111.859 -178.177 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -91.61 102.06 14.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 20.550000000000001 108.545 179.063 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.953 HD12 HD13 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -70.21 140.86 52.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.369 -0.832 . . . . 14.4 110.807 -178.818 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 62' ' ' THR . 33.5 m -140.61 148.8 54.67 Favored Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.774 -1.195 . . . . 17.649999999999999 107.774 178.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.8 Cg_endo -63.08 141.12 82.12 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.05 1.834 . . . . 25.699999999999999 110.265 179.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.708 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -71.83 108.44 5.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.309 -0.869 . . . . 49.289999999999999 109.461 -178.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.008 -0.996 . . . . 58.909999999999997 109.438 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.524 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.3 tpp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.474 -0.565 . . . . 64.909999999999997 109.474 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.738 ' N ' HD22 ' A' ' 65' ' ' LEU . 2.1 mt -59.41 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.033 -1.099 . . . . 33.799999999999997 108.033 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' B' ' 1' ' ' MET . 15.2 mtpp -67.02 152.18 46.26 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.841 0.829 . . . . 32.719999999999999 111.265 -178.039 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.884 HG11 HD21 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -163.8 168.18 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.462 -0.94 . . . . 14.460000000000001 108.462 179.481 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.568 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 25.2 mt-10 -141.17 118.0 11.08 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.337 -0.852 . . . . 22.120000000000001 109.363 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.877 HG21 ' O ' ' B' ' 56' ' ' TYR . 10.4 mm -75.85 92.53 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.869 -1.16 . . . . 14.23 107.869 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.675 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -44.79 171.39 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.234 -0.916 . . . . 25.43 110.189 -178.735 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' B' ' 7' ' ' LYS . 33.5 Cg_endo -74.65 -28.83 9.5 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.462 2.108 . . . . 13.609999999999999 109.85 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.51 -6.73 58.62 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.741 -0.837 . . . . 15.52 108.741 178.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 1.2 mm100 -118.28 40.26 3.23 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.418 -0.801 . . . . 17.309999999999999 109.306 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 56' ' ' TYR . . . -103.62 8.98 37.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 24.780000000000001 109.711 -179.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.45 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 37.2 mt-30 -138.99 138.68 37.47 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.286 -0.884 . . . . 47.899999999999999 109.638 179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.655 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 36.1 p90 -91.92 161.32 14.87 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.176 -0.952 . . . . 21.609999999999999 108.815 179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 96.7 m -130.28 152.05 50.12 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.103 -0.998 . . . . 14.890000000000001 109.667 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.36 110.14 22.54 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.395 -0.816 . . . . 17.350000000000001 109.354 179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' B' ' 18' ' ' GLY . 4.8 mtp180 -124.26 151.91 43.63 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.298 -0.876 . . . . 34.380000000000003 109.012 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 17.8 t -57.32 84.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 38.770000000000003 109.406 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' B' ' 25' ' ' PRO . . . -77.81 160.46 48.7 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.316 -1.514 . . . . 34.579999999999998 109.316 179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' B' ' 24' ' ' LYS . 1.5 t -128.77 124.03 60.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.129 -1.218 . . . . 41.869999999999997 108.955 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -92.27 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.235 -0.916 . . . . 47.210000000000001 109.656 -179.103 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.514 ' NH1' ' HG2' ' B' ' 21' ' ' ARG . 0.0 OUTLIER -90.02 -55.02 3.78 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 71.560000000000002 109.403 179.862 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.98 38.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.192 -0.942 . . . . 66.599999999999994 109.812 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.547 ' O ' ' CG ' ' B' ' 24' ' ' LYS . . . -168.24 36.14 0.21 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.416 -1.474 . . . . 55.490000000000002 109.416 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' B' ' 23' ' ' GLY . 2.8 mttp -170.12 102.21 0.44 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.506 -0.996 . . . . 44.990000000000002 108.761 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 33.7 Cg_endo -75.58 68.08 6.28 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.172 1.915 . . . . 44.100000000000001 110.816 -179.534 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.612 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 6.1 p90 -62.72 137.59 58.3 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.348 -0.845 . . . . 32.090000000000003 109.396 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -100.12 78.67 2.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 29.25 108.917 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.584 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -100.21 160.55 14.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 24.0 110.475 -179.005 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.617 ' ND2' ' CE1' ' B' ' 13' ' ' PHE . 97.9 m-20 -77.95 130.01 36.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.393 -0.817 . . . . 23.309999999999999 109.141 179.559 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -123.58 148.95 45.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.043 -1.036 . . . . 40.030000000000001 109.047 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.612 ' HB3' HG22 ' B' ' 47' ' ' ILE . 0.0 OUTLIER -136.24 -170.14 2.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.111 -0.993 . . . . 12.390000000000001 109.648 -179.989 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.766 ' HB3' HD11 ' B' ' 44' ' ' LEU . 5.9 mp -132.19 174.35 10.31 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.38 -0.825 . . . . 17.420000000000002 109.455 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -162.53 159.58 24.99 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.273 -1.01 . . . . 13.84 108.273 -179.547 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.701 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 14.9 m-85 -115.06 96.52 5.73 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.204 -0.935 . . . . 21.140000000000001 109.358 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.875 ' O ' HG22 ' B' ' 43' ' ' VAL . 3.1 t -105.09 127.62 59.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.163 -0.961 . . . . 10.66 110.491 -179.495 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 16.7 p-10 -86.52 -27.43 24.01 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.512 -0.922 . . . . 25.890000000000001 108.512 179.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.859 ' HG ' HG12 ' B' ' 35' ' ' VAL . 0.4 OUTLIER 47.3 23.93 0.39 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.336 -0.852 . . . . 24.239999999999998 109.486 179.801 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.83 8.47 69.6 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.961 -1.256 . . . . 31.02 109.961 179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.447 ' CG ' ' O ' ' B' ' 36' ' ' ASP . 2.1 m-20 -87.23 18.62 3.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -1.219 . . . . 43.229999999999997 109.942 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.6 ' O ' ' CB ' ' B' ' 41' ' ' HIS . 5.3 mt-10 46.76 71.37 0.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.89 . . . . 42.340000000000003 109.822 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.6 ' CB ' ' O ' ' B' ' 40' ' ' GLU . 0.2 OUTLIER 144.09 147.77 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.251 0 N-CA-C 108.57 -0.9 . . . . 6.5 108.57 179.383 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.701 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 38.4 Cg_endo -79.38 137.37 13.18 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.148 1.899 . . . . 17.920000000000002 110.52 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.875 HG22 ' O ' ' B' ' 35' ' ' VAL . 2.8 m -114.53 118.54 58.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.331 -0.856 . . . . 20.57 108.871 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.766 HD11 ' HB3' ' B' ' 32' ' ' LEU . 56.8 tp -76.45 106.98 8.4 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.361 -0.837 . . . . 20.210000000000001 110.638 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.605 HG13 HG23 ' B' ' 43' ' ' VAL . 22.0 m -115.65 -169.55 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.862 -0.792 . . . . 10.81 108.862 179.12 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -108.22 151.8 25.44 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 119.334 -0.947 . . . . 36.740000000000002 110.44 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.99 HD13 HD12 ' B' ' 83' ' ' LEU . 0.9 OUTLIER -141.23 126.14 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.503 -0.748 . . . . 19.739999999999998 109.056 -179.889 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -64.49 146.88 53.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.002 -1.061 . . . . 22.559999999999999 109.322 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.769 HD13 ' O ' ' B' ' 49' ' ' LEU . 2.9 tm? -123.95 73.1 1.19 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 20.41 109.281 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' B' ' 53' ' ' GLN . 1.9 t70 -134.86 -175.46 3.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.941 -1.099 . . . . 33.990000000000002 109.8 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' B' ' 53' ' ' GLN . 16.5 tt0 69.84 67.73 0.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.348 -0.845 . . . . 54.920000000000002 109.588 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' B' ' 51' ' ' GLU . . . 38.07 28.04 0.04 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.537 -1.025 . . . . 36.100000000000001 110.537 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.497 ' N ' ' O ' ' B' ' 51' ' ' GLU . 3.3 mt-30 -106.13 125.71 32.38 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 120.888 -1.36 . . . . 54.759999999999998 109.894 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.515 ' C ' HD21 ' B' ' 49' ' ' LEU . 35.4 Cg_endo -78.8 146.62 21.03 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.408 2.072 . . . . 28.370000000000001 109.68 179.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.655 ' HB2' ' CD2' ' B' ' 13' ' ' PHE . . . -38.24 143.37 0.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.45 -0.781 . . . . 17.210000000000001 110.479 -179.291 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.877 ' O ' HG21 ' B' ' 6' ' ' ILE . 79.9 m-85 -58.49 106.99 0.44 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.458 -0.776 . . . . 17.190000000000001 109.201 179.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.901 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.58 173.29 0.37 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.105 -0.997 . . . . 17.82 109.076 -179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.901 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.5 Cg_endo -78.05 107.12 2.27 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.491 2.127 . . . . 17.280000000000001 110.031 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . -175.15 179.26 46.52 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 119.576 -1.297 . . . . 17.219999999999999 110.106 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.717 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -77.42 137.4 38.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.405 -1.056 . . . . 19.57 108.445 179.121 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.953 ' HB3' HD22 ' B' ' 83' ' ' LEU . 26.9 m-85 -128.38 163.09 25.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.691 -1.255 . . . . 14.609999999999999 111.492 -179.616 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.79 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.8 p -141.57 118.01 10.86 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 106.145 -1.798 . . . . 18.359999999999999 106.145 177.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.638 ' HB ' HD13 ' B' ' 2' ' ' ILE . 2.4 t -50.64 165.16 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 C-N-CA 118.74 -1.184 . . . . 19.129999999999999 108.947 -178.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -128.51 129.15 45.64 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.5 -0.75 . . . . 20.649999999999999 109.142 -179.293 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.764 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -72.57 2.24 6.77 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.54 -0.725 . . . . 19.649999999999999 109.964 179.777 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.21 -19.51 34.16 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.843 -1.539 . . . . 14.720000000000001 106.843 178.386 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.507 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 14.4 m -95.68 -9.49 31.84 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 121.931 -0.481 . . . . 11.449999999999999 110.027 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.656 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 3.4 m-30 -78.06 154.18 31.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.037 . . . . 14.25 109.897 -178.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' B' ' 68' ' ' PHE . 3.8 mtmt -157.53 -178.93 7.7 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.538 -0.726 . . . . 32.700000000000003 109.159 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.558 ' CG1' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -109.44 105.98 19.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.456 -0.778 . . . . 15.630000000000001 109.09 179.879 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -81.26 -154.37 11.43 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.981 -1.248 . . . . 12.699999999999999 109.981 -179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.502 ' HA ' ' NE2' ' B' ' 72' ' ' GLN . 12.5 tp60 -99.08 42.22 1.11 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -1.09 . . . . 26.289999999999999 109.661 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -128.91 21.95 5.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.895 . . . . 20.440000000000001 109.613 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 44.98 52.74 7.81 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.563 -1.415 . . . . 13.82 109.563 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.422 ' O ' ' C ' ' B' ' 76' ' ' LEU . 17.0 t -176.99 129.93 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -1.099 . . . . 18.27 109.435 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.811 HD22 HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -43.79 159.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.877 . . . . 12.43 109.138 179.976 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.508 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 1.5 mtt -163.38 118.99 1.7 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 35.109999999999999 109.54 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 1.002 HD12 HD12 ' A' ' 78' ' ' ILE . 2.2 mp -54.38 138.5 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.193 -0.942 . . . . 13.67 109.354 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' B' ' 67' ' ' SER . 0.2 OUTLIER -106.13 -34.73 7.44 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.111 -1.07 . . . . 24.059999999999999 108.111 178.515 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.507 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.2 OUTLIER -170.21 66.56 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.275 -1.38 . . . . 35.039999999999999 107.275 178.816 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.816 HD13 HD22 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -27.62 120.04 0.1 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.113 -0.949 . . . . 18.719999999999999 111.731 -178.161 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -91.78 101.95 14.55 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.53 -0.915 . . . . 20.550000000000001 108.53 179.097 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.99 HD12 HD13 ' B' ' 47' ' ' ILE . 0.9 OUTLIER -70.27 140.67 52.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 14.4 110.84 -178.727 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.79 HG22 ' O ' ' B' ' 62' ' ' THR . 33.6 m -140.41 148.79 55.16 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.843 -1.169 . . . . 17.649999999999999 107.843 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.0 Cg_endo -63.06 141.11 82.22 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.995 1.797 . . . . 25.699999999999999 110.326 179.338 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.717 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -71.53 108.27 4.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 49.289999999999999 109.466 -178.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.035 -0.983 . . . . 58.909999999999997 109.489 179.999 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 3' ' ' LYS . 1.1 ttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.579 -0.526 . . . . 64.909999999999997 109.579 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.704 ' N ' HD22 ' B' ' 65' ' ' LEU . 3.3 mt -64.16 78.78 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.592 -1.262 . . . . 33.799999999999997 107.592 178.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.9 OUTLIER -71.0 177.23 3.82 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.104 0.954 . . . . 32.719999999999999 111.549 -177.771 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.024 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.5 OUTLIER 176.35 163.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.739 -0.837 . . . . 14.460000000000001 108.739 179.753 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.524 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 26.1 mt-10 -137.96 108.36 6.51 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.63 0.728 . . . . 22.120000000000001 109.093 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.705 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -71.94 100.23 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 C-N-CA 118.906 -1.118 . . . . 14.23 108.07 179.615 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.584 ' HD3' ' CG ' ' A' ' 34' ' ' TYR . 6.7 mptt -44.67 170.17 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.343 -0.848 . . . . 25.43 109.902 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 32.1 Cg_endo -73.67 -27.48 12.69 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.275 1.984 . . . . 13.609999999999999 109.78 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 p -86.35 -2.92 58.84 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.613 -0.884 . . . . 15.52 108.613 178.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.655 ' O ' HG23 ' A' ' 6' ' ' ILE . 6.7 mm-40 -118.75 41.29 3.05 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.429 -0.794 . . . . 17.309999999999999 109.119 179.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.88 14.72 29.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.076 -1.015 . . . . 24.780000000000001 109.999 -179.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.481 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 29.6 mt-30 -142.24 146.59 35.32 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.165 -0.959 . . . . 47.899999999999999 109.68 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.728 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 34.9 p90 -93.84 159.42 15.2 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.296 -0.878 . . . . 21.609999999999999 109.537 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 t -134.76 162.67 31.7 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.449 -0.945 . . . . 14.890000000000001 108.449 178.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.414 HG22 ' CB ' ' A' ' 27' ' ' SER . 0.2 OUTLIER -92.8 119.17 31.87 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.217 -0.927 . . . . 17.350000000000001 109.162 -179.864 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 17' ' ' SER . 0.4 OUTLIER -145.89 84.14 1.65 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.113 -0.992 . . . . 34.380000000000003 110.024 -179.848 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 16' ' ' ARG . 42.0 m 55.81 161.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -0.83 . . . . 38.770000000000003 110.178 179.337 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.559 ' O ' HG22 ' A' ' 19' ' ' VAL . . . -179.15 160.29 25.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.303 -1.519 . . . . 34.579999999999998 109.303 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -158.34 118.93 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.215 -1.168 . . . . 41.869999999999997 109.408 179.178 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.7 m -58.54 -77.49 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.341 -0.849 . . . . 47.210000000000001 109.584 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.16 60.94 1.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 71.560000000000002 109.499 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.53 23.35 0.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.938 . . . . 66.599999999999994 109.544 -179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.8 -43.34 1.82 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.161 -1.576 . . . . 55.490000000000002 109.161 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 158.52 31.92 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.34 -1.094 . . . . 44.990000000000002 109.01 179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 34.1 Cg_endo -76.8 157.77 35.2 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.549 2.166 . . . . 44.100000000000001 110.765 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.917 ' CD2' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -161.37 45.27 0.17 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.106 -0.996 . . . . 32.090000000000003 110.189 179.96 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.573 ' C ' ' O ' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -7.18 73.8 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 121.23 0.538 . . . . 29.25 111.717 -179.78 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.917 HD23 ' CD2' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -78.21 144.6 36.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.262 -0.899 . . . . 24.0 110.1 -179.391 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.584 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 99.1 m-20 -59.16 130.53 47.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.821 . . . . 23.309999999999999 109.48 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -121.27 152.49 38.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.944 . . . . 40.030000000000001 108.949 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.79 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -133.13 -170.93 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.028 -1.045 . . . . 12.390000000000001 109.789 -179.634 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.931 ' HB3' HD11 ' A' ' 44' ' ' LEU . 2.1 mp -130.49 174.83 9.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.428 -0.795 . . . . 17.420000000000002 108.872 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -171.85 162.88 6.22 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 13.84 108.699 -179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.743 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.0 m-30 -114.87 90.22 3.29 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.226 -0.921 . . . . 21.140000000000001 108.817 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.966 ' O ' HG22 ' A' ' 43' ' ' VAL . 94.0 t -89.94 119.77 37.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.197 -0.939 . . . . 10.66 110.32 -179.234 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.564 ' HA ' ' O ' ' A' ' 41' ' ' HIS . 48.7 m-20 -68.48 -30.96 69.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.509 -0.923 . . . . 25.890000000000001 108.509 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' B' ' 69' ' ' LYS . 1.0 OUTLIER 48.17 30.98 2.35 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.503 -0.748 . . . . 24.239999999999998 109.318 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.31 9.69 64.66 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.391 -1.484 . . . . 31.02 109.391 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 37' ' ' LEU . 1.4 m-20 -81.95 14.01 3.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -1.168 . . . . 43.229999999999997 110.659 -179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.58 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 10.0 mt-10 57.23 15.61 2.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.131 -0.981 . . . . 42.340000000000003 110.093 179.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 40' ' ' GLU . 63.3 m80 -164.74 149.4 8.17 Favored Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 107.683 -1.228 . . . . 6.1600000000000001 107.683 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.663 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.1 Cg_endo -74.81 146.19 33.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.653 1.569 . . . . 17.920000000000002 110.631 -179.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.966 HG22 ' O ' ' A' ' 35' ' ' VAL . 12.5 m -123.5 116.2 47.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 119.531 -0.868 . . . . 20.57 108.78 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.931 HD11 ' HB3' ' A' ' 32' ' ' LEU . 21.9 tp -68.92 104.98 2.22 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.296 -0.962 . . . . 20.210000000000001 108.678 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.516 HG22 ' O ' ' B' ' 74' ' ' GLY . 9.1 p -120.0 163.09 17.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.587 -0.695 . . . . 10.81 109.275 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' B' ' 74' ' ' GLY . 0.0 OUTLIER -82.47 157.64 23.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 36.740000000000002 110.28 -179.055 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.986 ' CD1' HD12 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -138.7 176.38 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.282 -1.007 . . . . 19.739999999999998 108.282 179.345 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.92 144.23 42.84 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.042 -1.036 . . . . 22.559999999999999 109.38 179.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.755 HD13 ' O ' ' A' ' 50' ' ' ASP . 2.9 tm? -128.57 122.61 31.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.29 -0.881 . . . . 20.41 109.037 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.755 ' O ' HD13 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -53.51 159.44 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 33.990000000000002 109.999 -179.279 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -70.05 108.96 4.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.403 -0.81 . . . . 54.920000000000002 109.497 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.79 -13.5 67.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.561 -1.416 . . . . 36.100000000000001 109.561 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.703 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -67.07 157.03 86.3 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.227 -1.161 . . . . 54.759999999999998 109.536 179.98 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -78.35 106.69 2.18 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.564 2.176 . . . . 28.370000000000001 110.254 179.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.79 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -41.95 160.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.386 -0.821 . . . . 17.210000000000001 110.028 -179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.705 ' O ' HG21 ' A' ' 6' ' ' ILE . 75.5 m-85 -58.4 104.98 0.25 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.406 -0.809 . . . . 17.190000000000001 108.838 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.44 176.14 0.24 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.098 -1.001 . . . . 17.82 109.418 -179.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.0 Cg_endo -77.79 120.06 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.532 2.154 . . . . 17.280000000000001 110.166 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.66 177.42 39.06 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.779 -1.328 . . . . 17.219999999999999 109.779 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -72.04 149.37 44.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -1.187 . . . . 19.57 108.269 179.139 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 1.024 ' CB ' HG13 ' A' ' 4' ' ' VAL . 22.2 m-85 -133.34 163.36 29.51 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.77 -1.206 . . . . 14.609999999999999 111.705 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.732 ' O ' HG22 ' A' ' 84' ' ' VAL . 34.2 p -147.93 120.08 8.31 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.456 -1.683 . . . . 18.359999999999999 106.456 178.385 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.674 HG21 HG21 ' A' ' 2' ' ' ILE . 5.7 t -51.82 170.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 C-N-CA 118.672 -1.211 . . . . 19.129999999999999 108.955 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.591 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t-80 -134.67 125.93 28.08 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.421 -0.799 . . . . 20.649999999999999 109.187 -179.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.737 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.6 OUTLIER -72.27 1.08 8.31 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.27 -0.894 . . . . 19.649999999999999 109.802 179.724 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.3 p -57.64 -19.17 24.55 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 107.521 -1.289 . . . . 14.720000000000001 107.521 178.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 9.7 m -96.76 -18.57 19.53 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.772 -0.58 . . . . 11.449999999999999 110.128 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.682 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.6 m-30 -66.29 158.48 28.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.134 -0.979 . . . . 14.25 109.346 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.538 ' HA ' HD21 ' B' ' 37' ' ' LEU . 0.0 OUTLIER -140.46 178.89 7.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.858 . . . . 32.700000000000003 109.769 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.735 HG21 HG21 ' B' ' 43' ' ' VAL . 1.7 t -126.12 129.77 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.509 -0.744 . . . . 15.630000000000001 109.495 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.21 -170.67 25.33 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.677 -1.369 . . . . 12.699999999999999 109.677 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' CB ' ' A' ' 73' ' ' PHE . 25.9 tp60 69.5 80.76 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.249 -1.148 . . . . 26.289999999999999 109.358 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.504 ' CB ' ' O ' ' A' ' 72' ' ' GLN . 3.0 m-85 75.34 12.03 3.32 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.424 -0.798 . . . . 20.440000000000001 109.462 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.531 ' O ' HG22 ' B' ' 45' ' ' VAL . . . 70.77 47.77 38.35 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.558 -1.417 . . . . 13.82 109.558 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -144.03 144.48 31.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.215 -1.168 . . . . 18.27 109.639 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' ' CG ' ' A' ' 77' ' ' MET . 1.0 OUTLIER -50.73 169.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 12.43 109.187 179.776 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.522 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 2.3 mtp -165.52 106.01 0.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 35.109999999999999 110.25 -179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.594 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.7 mt -42.43 -63.94 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.513 -0.742 . . . . 13.67 109.403 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.546 ' N ' HG22 ' A' ' 78' ' ' ILE . 9.5 t70 83.34 -45.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.392 0.615 . . . . 24.059999999999999 110.039 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.556 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.7 tpm_? -174.24 66.35 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.113 0.958 . . . . 35.039999999999999 108.632 179.646 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.616 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.5 pt? -36.07 128.81 0.7 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.668 0.747 . . . . 18.719999999999999 111.527 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -94.52 104.67 16.62 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.248 -1.019 . . . . 20.550000000000001 108.248 178.721 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.986 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -74.23 147.26 42.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 14.4 110.898 -178.761 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 62' ' ' THR . 32.5 m -148.37 155.85 42.59 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 108.09 -1.078 . . . . 17.649999999999999 108.09 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.8 Cg_endo -63.08 143.6 90.85 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.105 1.87 . . . . 25.699999999999999 110.322 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.711 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -69.81 125.43 26.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.228 -0.92 . . . . 49.289999999999999 109.702 -178.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.2 tptp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.004 -0.998 . . . . 58.909999999999997 109.512 -179.965 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.532 ' O ' ' N ' ' B' ' 3' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.564 -0.532 . . . . 64.909999999999997 109.564 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.737 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.3 mt -64.2 78.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 33.799999999999997 107.657 178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.9 OUTLIER -70.82 177.3 3.68 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 122.07 0.938 . . . . 32.719999999999999 111.542 -177.754 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.034 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.5 OUTLIER 176.29 163.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.714 -0.847 . . . . 14.460000000000001 108.714 179.743 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.537 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 26.0 mt-10 -137.82 108.38 6.57 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.605 0.716 . . . . 22.120000000000001 109.103 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.701 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -71.94 100.18 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.95 -1.1 . . . . 14.23 108.075 179.585 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.583 ' HD3' ' CG ' ' B' ' 34' ' ' TYR . 6.7 mptt -44.75 170.05 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.33 -0.856 . . . . 25.43 109.898 -179.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.9 Cg_endo -73.59 -27.5 12.83 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.365 2.043 . . . . 13.609999999999999 109.722 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.2 p -86.39 -2.74 58.69 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.664 -0.865 . . . . 15.52 108.664 178.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.651 ' O ' HG23 ' B' ' 6' ' ' ILE . 6.7 mm-40 -118.9 41.26 3.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.399 -0.813 . . . . 17.309999999999999 109.095 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.9 14.84 28.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.123 -0.986 . . . . 24.780000000000001 109.986 -179.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.489 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 29.7 mt-30 -142.35 146.48 35.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 47.899999999999999 109.742 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.719 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 34.5 p90 -93.79 159.32 15.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.338 -0.851 . . . . 21.609999999999999 109.615 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 7.3 t -134.78 162.49 32.21 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.496 -0.928 . . . . 14.890000000000001 108.496 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.405 HG22 ' CB ' ' B' ' 27' ' ' SER . 0.2 OUTLIER -92.68 119.12 31.77 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.166 -0.958 . . . . 17.350000000000001 109.18 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' B' ' 17' ' ' SER . 0.4 OUTLIER -145.88 84.22 1.66 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.125 -0.984 . . . . 34.380000000000003 109.953 -179.822 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.453 ' O ' ' O ' ' B' ' 16' ' ' ARG . 40.8 m 55.74 161.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.366 -0.834 . . . . 38.770000000000003 110.223 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.568 ' O ' HG22 ' B' ' 19' ' ' VAL . . . -178.95 160.24 25.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.373 -1.491 . . . . 34.579999999999998 109.373 -179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.568 HG22 ' O ' ' B' ' 18' ' ' GLY . 0.6 OUTLIER -158.29 118.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -1.173 . . . . 41.869999999999997 109.464 179.13 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 74.6 m -58.56 -77.45 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.24 -0.913 . . . . 47.210000000000001 109.617 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.23 60.83 1.47 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 71.560000000000002 109.461 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 47.64 23.44 0.42 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.936 . . . . 66.599999999999994 109.54 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.92 -43.24 1.82 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.175 -1.57 . . . . 55.490000000000002 109.175 179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.54 158.55 31.89 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.388 -1.066 . . . . 44.990000000000002 108.978 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 34.5 Cg_endo -76.77 157.83 35.32 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.555 2.17 . . . . 44.100000000000001 110.724 -179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.926 ' CD2' HD23 ' B' ' 28' ' ' LEU . 0.0 OUTLIER -161.44 45.24 0.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.146 -0.971 . . . . 32.090000000000003 110.203 179.893 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.572 ' C ' ' O ' ' B' ' 26' ' ' TYR . 0.7 OUTLIER -7.13 73.8 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 CA-C-O 121.256 0.55 . . . . 29.25 111.712 -179.783 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.926 HD23 ' CD2' ' B' ' 26' ' ' TYR . 0.2 OUTLIER -78.21 144.5 36.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.239 -0.913 . . . . 24.0 110.146 -179.382 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.582 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 99.1 m-20 -59.06 130.58 47.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 23.309999999999999 109.439 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -121.34 152.41 39.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.948 . . . . 40.030000000000001 109.002 179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.765 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -133.08 -170.8 2.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.09 -1.006 . . . . 12.390000000000001 109.84 -179.612 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.915 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.1 mp -130.61 174.76 9.59 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.834 -0.802 . . . . 17.420000000000002 108.834 179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.54 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -171.91 162.67 6.09 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.877 -1.14 . . . . 13.84 108.725 -179.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.738 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.0 m-30 -114.66 90.33 3.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.212 -0.93 . . . . 21.140000000000001 108.824 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.992 ' O ' HG22 ' B' ' 43' ' ' VAL . 96.0 t -90.06 119.73 37.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.181 -0.949 . . . . 10.66 110.238 -179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' B' ' 41' ' ' HIS . 48.7 m-20 -68.36 -31.01 70.1 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.51 -0.922 . . . . 25.890000000000001 108.51 179.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.538 HD21 ' HA ' ' A' ' 69' ' ' LYS . 1.0 OUTLIER 48.27 31.03 2.45 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.548 -0.72 . . . . 24.239999999999998 109.252 179.804 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.28 9.52 64.28 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.438 -1.465 . . . . 31.02 109.438 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' B' ' 37' ' ' LEU . 1.4 m-20 -81.77 13.87 2.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -1.162 . . . . 43.229999999999997 110.726 -179.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.574 ' O ' ' CG ' ' B' ' 41' ' ' HIS . 10.0 mt-10 57.32 15.62 2.7 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.124 -0.985 . . . . 42.340000000000003 110.115 179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' B' ' 40' ' ' GLU . 63.5 m80 -164.73 149.41 8.19 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 107.745 -1.206 . . . . 6.1500000000000004 107.745 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.668 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 35.3 Cg_endo -74.83 146.15 33.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 121.648 1.565 . . . . 17.920000000000002 110.628 -179.296 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.992 HG22 ' O ' ' B' ' 35' ' ' VAL . 12.6 m -123.47 116.25 47.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 C-N-CA 119.495 -0.882 . . . . 20.57 108.816 179.015 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.915 HD11 ' HB3' ' B' ' 32' ' ' LEU . 21.8 tp -68.87 105.1 2.24 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.341 -0.943 . . . . 20.210000000000001 108.655 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 74' ' ' GLY . 9.1 p -120.15 163.08 18.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 121.534 -0.729 . . . . 10.81 109.228 -179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -82.55 157.59 23.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.394 -0.816 . . . . 36.740000000000002 110.328 -179.114 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.98 ' CD1' HD12 ' B' ' 83' ' ' LEU . 0.4 OUTLIER -138.59 176.35 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.227 -1.027 . . . . 19.739999999999998 108.227 179.447 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 144.42 42.46 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.006 -1.059 . . . . 22.559999999999999 109.405 179.689 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.764 HD13 ' O ' ' B' ' 50' ' ' ASP . 2.9 tm? -128.68 122.4 30.68 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.317 -0.865 . . . . 20.41 109.067 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.764 ' O ' HD13 ' B' ' 49' ' ' LEU . 0.1 OUTLIER -53.38 159.34 1.43 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 33.990000000000002 110.033 -179.324 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -69.95 108.95 4.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.481 -0.762 . . . . 54.920000000000002 109.487 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.81 -13.57 67.16 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.563 -1.415 . . . . 36.100000000000001 109.563 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.711 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.2 OUTLIER -67.03 157.18 85.71 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.218 -1.166 . . . . 54.759999999999998 109.487 179.962 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.0 Cg_endo -78.39 106.67 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.624 2.216 . . . . 28.370000000000001 110.257 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.765 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.0 160.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 17.210000000000001 109.976 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.701 ' O ' HG21 ' B' ' 6' ' ' ILE . 75.2 m-85 -58.92 105.56 0.33 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.347 -0.846 . . . . 17.190000000000001 108.805 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.962 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.65 176.09 0.25 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.309 -0.869 . . . . 17.82 109.275 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.962 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.3 Cg_endo -78.03 121.12 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.637 2.225 . . . . 17.280000000000001 110.445 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 165.94 177.88 38.41 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.657 -1.377 . . . . 17.219999999999999 109.657 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.728 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.3 OUTLIER -71.73 150.0 44.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -1.182 . . . . 19.57 108.555 179.387 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 1.034 ' CB ' HG13 ' B' ' 4' ' ' VAL . 21.1 m-85 -134.02 163.31 29.85 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 120.763 -1.211 . . . . 14.609999999999999 111.702 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.736 ' O ' HG22 ' B' ' 84' ' ' VAL . 33.9 p -147.98 120.25 8.38 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.445 -1.687 . . . . 18.359999999999999 106.445 178.402 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.674 HG21 HG21 ' B' ' 2' ' ' ILE . 5.9 t -52.04 169.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 118.631 -1.228 . . . . 19.129999999999999 108.965 -178.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.577 ' H ' HG12 ' B' ' 63' ' ' VAL . 1.9 t-80 -134.43 125.86 28.34 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.453 -0.779 . . . . 20.649999999999999 109.224 -179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.704 HD22 ' N ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -72.16 0.8 8.77 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.272 -0.893 . . . . 19.649999999999999 109.755 179.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 94.8 p -57.34 -19.24 21.39 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 107.53 -1.285 . . . . 14.720000000000001 107.53 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 10.3 m -96.69 -18.64 19.54 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.843 -0.536 . . . . 11.449999999999999 110.143 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.675 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.6 m-30 -66.26 157.89 30.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.094 -1.004 . . . . 14.25 109.331 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.531 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -139.94 178.91 6.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 32.700000000000003 109.837 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.729 HG21 HG21 ' A' ' 43' ' ' VAL . 1.7 t -126.06 129.78 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.759 . . . . 15.630000000000001 109.535 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' B' ' 72' ' ' GLN . . . 143.19 -170.69 25.31 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.69 -1.364 . . . . 12.699999999999999 109.69 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.5 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 25.9 tp60 69.47 80.83 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -1.159 . . . . 26.289999999999999 109.341 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.5 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 3.0 m-85 75.33 11.9 3.35 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.443 -0.785 . . . . 20.440000000000001 109.49 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.516 ' O ' HG22 ' A' ' 45' ' ' VAL . . . 70.91 47.7 37.58 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.502 -1.439 . . . . 13.82 109.502 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -144.06 144.41 31.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.252 -1.146 . . . . 18.27 109.635 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' B' ' 77' ' ' MET . 1.0 OUTLIER -50.66 169.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 12.43 109.151 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.527 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 2.3 mtp -165.58 105.95 0.74 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 35.109999999999999 110.303 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.616 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.8 mt -42.35 -64.07 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.568 -0.708 . . . . 13.67 109.416 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 9.4 t70 83.51 -45.16 0.11 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.4 0.619 . . . . 24.059999999999999 110.073 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.7 tpm_? -174.32 66.45 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.505 -0.924 . . . . 35.039999999999999 108.505 179.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.626 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.5 pt? -36.17 128.81 0.72 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.703 0.763 . . . . 18.719999999999999 111.545 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.477 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -94.5 104.44 16.39 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.29 -1.004 . . . . 20.550000000000001 108.29 178.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.98 HD12 ' CD1' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -73.98 147.39 43.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.189 -0.944 . . . . 14.4 110.842 -178.753 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.736 HG22 ' O ' ' B' ' 62' ' ' THR . 32.6 m -148.66 155.64 41.58 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.046 -1.094 . . . . 17.649999999999999 108.046 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.9 Cg_endo -62.89 143.8 92.16 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.076 1.851 . . . . 25.699999999999999 110.328 179.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -69.96 125.63 27.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -0.907 . . . . 49.289999999999999 109.724 -178.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 7.2 tptp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.978 -1.01 . . . . 58.909999999999997 109.571 179.979 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 2.8 ttm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.444 -0.576 . . . . 64.909999999999997 109.444 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.739 HG12 HD13 ' B' ' 65' ' ' LEU . 3.2 mt 69.66 64.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.705 -1.22 . . . . 33.799999999999997 107.705 -178.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.531 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 26.6 mttt -54.93 162.11 1.39 Allowed 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.777 0.799 . . . . 32.719999999999999 111.28 -178.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.05 ' CG2' HG22 ' A' ' 35' ' ' VAL . 58.6 t -160.2 167.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 121.534 0.683 . . . . 14.460000000000001 109.53 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.573 ' N ' HG12 ' A' ' 4' ' ' VAL . 46.8 mt-10 -152.34 106.07 3.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.544 -0.722 . . . . 22.120000000000001 109.201 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.788 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -74.64 101.12 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.104 -1.073 . . . . 14.23 108.104 179.505 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.645 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.78 171.22 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.403 -0.81 . . . . 25.43 109.831 -179.324 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.4 Cg_endo -74.95 -28.45 9.26 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.463 2.109 . . . . 13.609999999999999 110.131 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.7 m -92.96 4.11 54.55 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.478 -0.764 . . . . 15.52 109.127 179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.535 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 18.4 mm-40 -121.03 34.1 5.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.309 -0.869 . . . . 17.309999999999999 109.352 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -106.89 18.55 21.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 24.780000000000001 110.284 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 19.2 mt-30 -137.57 129.39 28.69 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.067 -1.02 . . . . 47.899999999999999 109.864 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.561 ' H ' ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -77.54 -174.32 3.32 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.425 -0.797 . . . . 21.609999999999999 110.578 -179.541 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 m -158.68 145.41 17.31 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.777 -0.823 . . . . 14.890000000000001 108.777 179.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.2 116.82 22.55 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.244 -0.91 . . . . 17.350000000000001 109.625 -179.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -154.8 158.26 39.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 34.380000000000003 109.28 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 16' ' ' ARG . 4.7 t -42.23 145.25 0.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.481 -0.762 . . . . 38.770000000000003 109.516 -179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -147.9 168.77 28.74 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.398 -1.481 . . . . 34.579999999999998 109.398 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.465 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 2.0 t -147.04 122.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.15 -1.206 . . . . 41.869999999999997 109.175 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 22' ' ' GLN . 0.1 OUTLIER -57.79 -156.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.878 . . . . 47.210000000000001 109.603 -179.543 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.515 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -67.58 58.91 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.166 -0.959 . . . . 71.560000000000002 109.782 -179.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.469 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.9 mt-30 62.86 20.84 12.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 66.599999999999994 109.584 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 24' ' ' LYS . . . -98.11 -47.7 2.01 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.608 -1.397 . . . . 55.490000000000002 109.608 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 23' ' ' GLY . 19.3 mttt -158.99 159.82 29.25 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.269 -1.136 . . . . 44.990000000000002 109.429 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.7 Cg_endo -77.44 150.67 28.61 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.53 2.153 . . . . 44.100000000000001 110.372 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.588 ' CD1' ' HB2' ' A' ' 28' ' ' LEU . 5.1 p90 -155.39 140.54 17.48 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.199 -0.938 . . . . 32.090000000000003 109.9 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 m -102.3 79.97 1.91 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 29.25 108.677 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.588 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -105.63 173.41 6.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 24.0 110.096 -179.195 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.589 ' HB2' ' HB3' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -74.5 111.19 9.44 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.725 -0.843 . . . . 23.309999999999999 108.725 179.602 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 14.9 mm-40 -82.63 -172.77 4.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.035 -1.04 . . . . 40.030000000000001 109.015 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.559 ' HB3' ' CG2' ' A' ' 47' ' ' ILE . 0.5 OUTLIER -171.18 179.92 2.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.073 -1.017 . . . . 12.390000000000001 110.249 179.811 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.942 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.4 mt -140.5 148.56 41.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.579 -0.701 . . . . 17.420000000000002 109.174 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.622 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.4 m -152.04 -178.55 6.83 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.918 -1.141 . . . . 13.84 107.918 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.662 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 38.0 m-85 -128.01 106.21 8.93 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.053 -1.03 . . . . 21.140000000000001 109.395 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.05 HG22 ' CG2' ' A' ' 4' ' ' VAL . 73.8 t -98.1 141.3 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.072 -1.017 . . . . 10.66 111.168 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 38' ' ' GLY . 4.1 m-20 -111.15 35.72 3.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.008 -1.108 . . . . 25.890000000000001 108.008 178.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.941 ' H ' HG12 ' A' ' 35' ' ' VAL . 2.0 pt? -40.94 -25.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.658 -0.651 . . . . 24.239999999999998 110.266 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 39' ' ' ASN . . . 176.8 47.33 0.06 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 108.983 -1.647 . . . . 31.02 108.983 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.75 HD22 HG11 ' A' ' 43' ' ' VAL . 74.3 m-20 -149.55 109.66 4.13 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.481 -1.011 . . . . 43.229999999999997 108.751 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 39' ' ' ASN . 26.0 mt-10 -34.24 -56.84 0.5 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.64 0.733 . . . . 42.340000000000003 110.128 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 50.9 m-70 -73.41 160.37 82.59 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 108.662 -0.866 . . . . 6.5700000000000003 108.662 179.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.662 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 36.3 Cg_endo -77.43 140.47 19.28 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.054 1.836 . . . . 17.920000000000002 109.87 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.925 HG22 ' O ' ' A' ' 35' ' ' VAL . 3.2 m -108.58 114.27 46.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.198 -0.939 . . . . 20.57 109.532 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.942 HD11 ' HB3' ' A' ' 32' ' ' LEU . 54.8 tp -68.01 106.94 2.51 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.388 -0.82 . . . . 20.210000000000001 109.623 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' ' 46' ' ' LYS . 2.1 t -110.44 169.28 3.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.48 -0.762 . . . . 10.81 109.03 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.576 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -92.93 162.89 13.89 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.33 -0.857 . . . . 36.740000000000002 110.394 -179.264 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.567 ' CD1' ' CE2' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -138.42 165.11 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.634 -0.876 . . . . 19.739999999999998 108.634 179.698 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.744 HG22 ' O ' ' A' ' 48' ' ' THR . 9.0 m -124.7 71.59 1.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 22.559999999999999 109.278 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.683 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -40.4 137.04 1.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.508 -0.745 . . . . 20.41 109.674 179.906 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' O ' ' ND2' ' A' ' 29' ' ' ASN . 0.4 OUTLIER -78.02 165.4 24.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 33.990000000000002 109.367 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.41 114.8 10.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 54.920000000000002 109.495 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.77 -6.32 64.64 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.685 -1.366 . . . . 36.100000000000001 109.685 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.519 ' O ' HD12 ' A' ' 49' ' ' LEU . 1.1 mt-30 -89.06 144.45 32.7 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.128 -1.219 . . . . 54.759999999999998 109.522 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.5 Cg_endo -78.54 123.95 6.17 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.642 2.228 . . . . 28.370000000000001 110.332 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.683 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -40.41 142.74 0.38 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 17.210000000000001 110.54 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.788 ' O ' HG21 ' A' ' 6' ' ' ILE . 12.0 m-30 -45.98 104.39 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 17.190000000000001 109.153 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.774 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.35 168.64 0.36 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.992 -1.067 . . . . 17.82 109.185 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.774 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 34.4 Cg_endo -76.98 113.39 3.62 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.52 2.147 . . . . 17.280000000000001 110.193 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.19 -176.56 48.08 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.923 -1.271 . . . . 17.219999999999999 109.923 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -75.81 139.25 41.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -1.09 . . . . 19.57 108.406 179.121 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.7 ' HB3' HD22 ' A' ' 83' ' ' LEU . 19.0 m-85 -127.83 166.11 18.86 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 120.725 -1.234 . . . . 14.609999999999999 111.456 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.561 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.5 p -149.94 120.28 7.35 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.46 -1.681 . . . . 18.359999999999999 106.46 179.008 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -50.45 166.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 118.738 -1.185 . . . . 19.129999999999999 108.886 -178.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -125.23 123.98 40.72 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.865 -0.791 . . . . 20.649999999999999 108.865 -179.492 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.745 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.0 OUTLIER -69.47 -3.28 13.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.636 -0.665 . . . . 19.649999999999999 110.113 -179.187 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.7 t -58.83 -13.89 7.41 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.068 -1.02 . . . . 14.720000000000001 108.409 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 19.6 m -95.61 -7.72 36.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.491 -0.755 . . . . 11.449999999999999 110.709 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.662 ' CE1' HG12 ' A' ' 78' ' ' ILE . 2.1 m-30 -81.25 159.16 24.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.899 -1.125 . . . . 14.25 109.882 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.565 ' HA ' HD11 ' B' ' 37' ' ' LEU . 12.0 mtmt -153.03 173.84 14.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.485 -0.76 . . . . 32.700000000000003 108.997 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.559 ' CG1' ' CG2' ' B' ' 45' ' ' VAL . 0.6 OUTLIER -110.68 118.08 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 15.630000000000001 109.53 179.948 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.19 -176.15 48.94 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.294 -1.523 . . . . 12.699999999999999 109.294 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.0 19.86 3.92 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.09 -1.241 . . . . 26.289999999999999 109.77 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.72 -11.39 23.5 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.511 -0.743 . . . . 20.440000000000001 109.561 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' ' OG ' ' A' ' 75' ' ' SER . . . 84.48 50.27 4.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.712 -1.355 . . . . 13.82 109.712 179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.428 ' OG ' ' C ' ' A' ' 74' ' ' GLY . 0.9 OUTLIER -170.69 153.88 4.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -1.161 . . . . 18.27 109.553 179.933 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.742 HD23 ' N ' ' A' ' 77' ' ' MET . 10.6 tt -81.16 150.52 28.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 12.43 109.476 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.742 ' N ' HD23 ' A' ' 76' ' ' LEU . 2.2 mtt -155.78 129.19 8.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 35.109999999999999 109.355 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.883 HD12 HD12 ' B' ' 78' ' ' ILE . 3.1 mt -63.18 139.44 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 13.67 109.841 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 6.9 t0 -104.4 -18.48 14.4 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.257 -1.016 . . . . 24.059999999999999 108.257 178.448 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 67' ' ' SER . 2.4 tmm_? 172.23 71.69 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.863 -1.532 . . . . 35.039999999999999 106.863 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -34.0 119.21 0.39 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.607 0.718 . . . . 18.719999999999999 111.199 -178.05 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' HIS . 5.9 mtt180 -88.75 110.07 20.69 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.466 -0.939 . . . . 20.550000000000001 108.466 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.815 HD11 HG11 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -81.13 141.63 34.06 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.187 -0.946 . . . . 14.4 110.49 -179.112 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 62' ' ' THR . 25.9 m -145.28 159.08 50.09 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.193 -1.04 . . . . 17.649999999999999 108.193 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.4 Cg_endo -64.08 141.61 77.34 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.124 1.882 . . . . 25.699999999999999 110.206 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.663 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -67.68 122.44 18.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.096 -1.003 . . . . 49.289999999999999 109.521 -178.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.961 -1.019 . . . . 58.909999999999997 109.469 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.452 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 2.8 ttm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.446 -0.576 . . . . 64.909999999999997 109.446 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.745 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.2 mt 69.54 64.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 107.759 -1.2 . . . . 33.799999999999997 107.759 -178.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.534 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 26.7 mttt -54.87 162.16 1.35 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.823 0.821 . . . . 32.719999999999999 111.269 -178.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.05 ' CG2' HG22 ' B' ' 35' ' ' VAL . 58.9 t -160.19 167.4 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.5 0.667 . . . . 14.460000000000001 109.601 -179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.589 ' N ' HG12 ' B' ' 4' ' ' VAL . 46.4 mt-10 -152.26 106.2 3.13 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.613 0.721 . . . . 22.120000000000001 109.088 -179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.79 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -74.69 101.06 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.141 -1.059 . . . . 14.23 108.141 179.43 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.634 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.73 171.16 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.445 -0.785 . . . . 25.43 109.827 -179.323 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.4 Cg_endo -75.03 -28.28 9.25 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.407 2.071 . . . . 13.609999999999999 110.179 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 12.8 m -93.03 4.21 54.4 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.508 -0.745 . . . . 15.52 109.122 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.521 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 18.4 mm-40 -121.15 34.0 5.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.258 -0.901 . . . . 17.309999999999999 109.36 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.85 18.68 21.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.179 -0.951 . . . . 24.780000000000001 110.282 -179.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.421 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 19.1 mt-30 -137.56 129.51 28.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.057 -1.027 . . . . 47.899999999999999 109.825 179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.55 ' H ' ' HB2' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -77.62 -174.45 3.42 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.395 -0.815 . . . . 21.609999999999999 110.529 -179.563 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 55.9 m -158.6 145.44 17.43 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.764 -0.828 . . . . 14.890000000000001 108.764 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.33 116.87 22.64 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.262 -0.899 . . . . 17.350000000000001 109.561 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.7 OUTLIER -154.81 158.34 39.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.301 -0.875 . . . . 34.380000000000003 109.315 179.857 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.442 ' C ' ' O ' ' B' ' 16' ' ' ARG . 4.8 t -42.25 145.05 0.41 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -0.787 . . . . 38.770000000000003 109.533 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -147.78 168.73 28.66 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.365 -1.494 . . . . 34.579999999999998 109.365 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.464 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 2.0 t -147.05 122.25 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.122 -1.223 . . . . 41.869999999999997 109.159 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.49 ' O ' ' N ' ' B' ' 22' ' ' GLN . 0.1 OUTLIER -57.78 -156.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 47.210000000000001 109.6 -179.546 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.528 ' O ' ' CG ' ' B' ' 21' ' ' ARG . 0.0 OUTLIER -67.58 58.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 71.560000000000002 109.737 -179.901 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' B' ' 20' ' ' SER . 2.9 mt-30 62.85 20.82 12.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.139 -0.976 . . . . 66.599999999999994 109.579 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' B' ' 24' ' ' LYS . . . -98.22 -47.66 2.0 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.586 -1.406 . . . . 55.490000000000002 109.586 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' B' ' 23' ' ' GLY . 19.4 mttt -159.0 159.84 29.24 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.3 -1.118 . . . . 44.990000000000002 109.345 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' B' ' 24' ' ' LYS . 34.5 Cg_endo -77.49 150.71 28.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.548 2.165 . . . . 44.100000000000001 110.35 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.589 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 5.1 p90 -155.43 140.55 17.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.155 -0.966 . . . . 32.090000000000003 109.842 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.4 m -102.3 79.95 1.9 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.285 -0.885 . . . . 29.25 108.68 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.578 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -105.61 173.45 6.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.9 . . . . 24.0 110.114 -179.187 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.569 ' HB2' ' HB3' ' B' ' 49' ' ' LEU . 0.0 OUTLIER -74.52 111.14 9.41 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.736 -0.838 . . . . 23.309999999999999 108.736 179.548 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 14.8 mm-40 -82.66 -172.74 4.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.035 -1.04 . . . . 40.030000000000001 108.97 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.564 ' HB3' ' CG2' ' B' ' 47' ' ' ILE . 0.5 OUTLIER -171.21 179.96 2.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.081 -1.012 . . . . 12.390000000000001 110.3 179.848 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.952 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.4 mt -140.58 148.56 41.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.538 -0.726 . . . . 17.420000000000002 109.176 179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.637 ' O ' HD12 ' B' ' 44' ' ' LEU . 2.4 m -151.96 -178.35 6.7 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.868 -1.16 . . . . 13.84 107.868 179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.656 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 37.5 m-85 -128.22 106.28 8.93 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.09 -1.006 . . . . 21.140000000000001 109.3 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 1.05 HG22 ' CG2' ' B' ' 4' ' ' VAL . 73.8 t -98.14 141.27 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.127 -0.983 . . . . 10.66 111.168 -179.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' B' ' 38' ' ' GLY . 4.1 m-20 -111.11 35.69 3.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.031 -1.1 . . . . 25.890000000000001 108.031 178.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.928 ' H ' HG12 ' B' ' 35' ' ' VAL . 2.0 pt? -40.99 -25.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.647 -0.658 . . . . 24.239999999999998 110.271 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . 176.71 47.47 0.06 OUTLIER Glycine 0 N--CA 1.479 1.529 0 N-CA-C 109.002 -1.639 . . . . 31.02 109.002 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.744 HD22 HG11 ' B' ' 43' ' ' VAL . 74.5 m-20 -149.64 109.67 4.12 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.502 -0.999 . . . . 43.229999999999997 108.757 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' B' ' 39' ' ' ASN . 26.1 mt-10 -34.21 -56.86 0.5 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.692 0.758 . . . . 42.340000000000003 110.159 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 51.0 m-70 -73.41 160.48 82.35 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 108.693 -0.855 . . . . 6.5599999999999996 108.693 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.656 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 36.5 Cg_endo -77.46 140.34 19.11 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.098 1.865 . . . . 17.920000000000002 109.837 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.934 HG22 ' O ' ' B' ' 35' ' ' VAL . 3.2 m -108.48 114.32 46.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.168 -0.957 . . . . 20.57 109.572 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.952 HD11 ' HB3' ' B' ' 32' ' ' LEU . 54.8 tp -68.07 106.99 2.56 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.428 -0.795 . . . . 20.210000000000001 109.534 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' B' ' 46' ' ' LYS . 2.1 t -110.46 169.25 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 10.81 109.038 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.574 ' N ' ' CG1' ' B' ' 45' ' ' VAL . 0.2 OUTLIER -92.85 162.98 13.88 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.314 -0.866 . . . . 36.740000000000002 110.378 -179.291 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.564 ' CG2' ' HB3' ' B' ' 31' ' ' GLN . 0.4 OUTLIER -138.49 165.1 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.579 -0.897 . . . . 19.739999999999998 108.579 179.685 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.747 HG22 ' O ' ' B' ' 48' ' ' THR . 9.5 m -124.73 71.6 1.17 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.223 -0.923 . . . . 22.559999999999999 109.366 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.677 HD21 ' HA ' ' B' ' 55' ' ' ALA . 0.2 OUTLIER -40.36 136.97 1.15 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.559 -0.713 . . . . 20.41 109.709 179.93 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.45 ' O ' ' ND2' ' B' ' 29' ' ' ASN . 0.4 OUTLIER -77.98 165.49 24.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 33.990000000000002 109.324 179.803 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.47 114.85 11.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 54.920000000000002 109.528 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.75 -6.45 64.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.665 -1.374 . . . . 36.100000000000001 109.665 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.518 ' O ' HD12 ' B' ' 49' ' ' LEU . 1.1 mt-30 -88.99 144.46 32.82 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.148 -1.207 . . . . 54.759999999999998 109.53 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.6 Cg_endo -78.54 123.87 6.14 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.62 2.213 . . . . 28.370000000000001 110.343 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.677 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -40.46 142.76 0.38 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.361 -0.837 . . . . 17.210000000000001 110.467 -179.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.79 ' O ' HG21 ' B' ' 6' ' ' ILE . 12.2 m-30 -46.16 104.51 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 17.190000000000001 109.246 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.768 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -53.22 168.6 0.35 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 120.99 -1.069 . . . . 17.82 109.084 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.768 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.8 Cg_endo -77.19 114.55 3.8 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.603 2.202 . . . . 17.280000000000001 110.458 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.12 47.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.8 -1.32 . . . . 17.219999999999999 109.8 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.661 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -75.45 139.59 42.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.366 -1.079 . . . . 19.57 108.692 179.45 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.689 ' HB3' HD22 ' B' ' 83' ' ' LEU . 18.1 m-85 -128.25 166.04 19.34 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.765 -1.21 . . . . 14.609999999999999 111.437 -179.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.565 ' O ' HG22 ' B' ' 84' ' ' VAL . 44.4 p -150.0 120.46 7.41 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.432 -1.692 . . . . 18.359999999999999 106.432 179.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -50.61 166.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 C-N-CA 118.741 -1.183 . . . . 19.129999999999999 108.908 -178.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -125.19 124.12 41.06 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.411 -0.806 . . . . 20.649999999999999 108.863 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.739 HD13 HG12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -69.61 -3.2 13.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.676 -0.64 . . . . 19.649999999999999 110.084 -179.166 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 6.7 t -58.91 -13.86 7.51 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.069 -1.019 . . . . 14.720000000000001 108.329 179.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.513 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 19.7 m -95.62 -7.86 36.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.756 . . . . 11.449999999999999 110.724 -179.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.654 ' CE1' HG12 ' B' ' 78' ' ' ILE . 2.1 m-30 -81.15 159.2 24.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.859 -1.151 . . . . 14.25 109.795 -179.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.566 ' HA ' HD11 ' A' ' 37' ' ' LEU . 12.0 mtmt -153.04 173.91 14.85 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.977 -0.749 . . . . 32.700000000000003 108.977 179.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.566 ' CG1' ' CG2' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -110.66 118.2 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 15.630000000000001 109.51 179.935 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.32 -176.22 48.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.337 -1.505 . . . . 12.699999999999999 109.337 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.93 19.87 3.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.109 -1.23 . . . . 26.289999999999999 109.793 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -11.23 23.54 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.529 -0.732 . . . . 20.440000000000001 109.573 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.414 ' C ' ' OG ' ' B' ' 75' ' ' SER . . . 84.32 50.46 4.28 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.73 -1.348 . . . . 13.82 109.73 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' B' ' 74' ' ' GLY . 0.9 OUTLIER -170.88 153.91 4.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -1.178 . . . . 18.27 109.614 179.889 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.742 HD23 ' N ' ' B' ' 77' ' ' MET . 10.6 tt -81.23 150.58 28.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 12.43 109.469 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.742 ' N ' HD23 ' B' ' 76' ' ' LEU . 2.2 mtt -155.88 129.14 8.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 35.109999999999999 109.402 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.883 HD12 HD12 ' A' ' 78' ' ' ILE . 3.1 mt -63.11 139.51 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 13.67 109.827 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' B' ' 80' ' ' ARG . 6.9 t0 -104.5 -18.45 14.36 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.233 -1.025 . . . . 24.059999999999999 108.233 178.448 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.513 ' O ' ' CB ' ' B' ' 67' ' ' SER . 2.4 tmm_? 172.25 71.69 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.893 -1.521 . . . . 35.039999999999999 106.893 179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -33.98 119.11 0.39 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.643 0.735 . . . . 18.719999999999999 111.136 -178.005 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' B' ' 64' ' ' HIS . 5.9 mtt180 -88.67 110.03 20.62 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.498 -0.927 . . . . 20.550000000000001 108.498 179.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.836 HD11 HG11 ' B' ' 4' ' ' VAL . 0.3 OUTLIER -81.02 141.83 33.99 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.116 -0.99 . . . . 14.4 110.415 -179.069 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.565 HG22 ' O ' ' B' ' 62' ' ' THR . 25.4 m -145.59 158.86 49.46 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.185 -1.043 . . . . 17.649999999999999 108.185 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.2 Cg_endo -63.93 141.57 78.16 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.078 1.852 . . . . 25.699999999999999 110.27 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.661 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -67.63 122.52 18.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.123 -0.986 . . . . 49.289999999999999 109.541 -178.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.972 -1.013 . . . . 58.909999999999997 109.498 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.499 ' HG3' ' HB ' ' A' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.358 0.599 . . . . 64.909999999999997 109.393 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.787 ' N ' HD22 ' B' ' 65' ' ' LEU . 4.3 mt 75.24 83.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 107.662 -1.236 . . . . 33.799999999999997 107.662 -179.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.516 ' C ' HG12 ' A' ' 4' ' ' VAL . 3.8 mtpp -80.55 173.16 12.88 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.133 0.968 . . . . 32.719999999999999 111.927 -177.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.895 HG13 ' CB ' ' A' ' 61' ' ' TYR . 0.2 OUTLIER 179.77 168.31 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.775 -0.824 . . . . 14.460000000000001 108.775 -179.778 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.563 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 35.9 mt-10 -141.71 112.67 7.34 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.426 -0.796 . . . . 22.120000000000001 109.442 -179.835 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.848 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -71.52 104.8 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 107.483 -1.303 . . . . 14.23 107.483 179.017 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.666 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -51.32 162.0 0.71 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.88 . . . . 25.43 110.123 -178.909 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HD2' ' HG3' ' A' ' 7' ' ' LYS . 33.9 Cg_endo -76.68 -18.6 15.13 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.505 2.136 . . . . 13.609999999999999 109.116 179.039 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -92.12 8.38 38.18 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.682 -0.859 . . . . 15.52 108.682 178.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.554 ' CG ' ' HB2' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -147.74 38.97 0.94 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.362 -0.836 . . . . 17.309999999999999 109.246 179.326 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.11 6.9 44.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 24.780000000000001 109.756 -179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 29.3 mt-30 -127.29 155.64 43.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 47.899999999999999 109.282 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.757 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 37.1 p90 -96.45 160.49 14.38 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.165 -0.959 . . . . 21.609999999999999 109.406 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -127.2 160.79 30.2 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.315 -0.866 . . . . 14.890000000000001 108.8 179.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.6 107.83 20.04 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.274 -0.892 . . . . 17.350000000000001 108.963 179.849 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 18' ' ' GLY . 7.3 mmt180 -136.93 154.24 50.51 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.372 -0.83 . . . . 34.380000000000003 109.504 -179.678 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.1 m -59.81 83.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 38.770000000000003 109.468 -179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.587 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -76.17 132.55 12.89 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.397 -1.481 . . . . 34.579999999999998 109.397 179.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.401 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -101.49 124.68 55.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.267 -1.137 . . . . 41.869999999999997 108.835 179.773 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.443 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 3.9 m -69.22 -93.16 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.474 -0.766 . . . . 47.210000000000001 109.659 -179.112 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' HG2' ' HG3' ' A' ' 22' ' ' GLN . 0.1 OUTLIER -91.72 -56.14 3.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 71.560000000000002 109.444 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.495 ' HG3' ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER 166.8 45.51 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 66.599999999999994 109.456 179.851 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -126.08 -56.98 0.15 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.545 -1.422 . . . . 55.490000000000002 109.545 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.26 150.11 74.4 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.258 -1.142 . . . . 44.990000000000002 109.384 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.32 79.79 3.2 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.552 2.168 . . . . 44.100000000000001 110.607 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.587 ' CE1' ' HA3' ' A' ' 18' ' ' GLY . 4.4 p90 -56.78 139.07 52.14 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.227 -0.92 . . . . 32.090000000000003 109.581 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.94 79.75 1.93 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 29.25 109.407 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.555 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -117.44 136.0 53.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 24.0 109.637 -179.848 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.571 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 85.7 m-20 -43.72 134.73 4.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.305 -0.872 . . . . 23.309999999999999 109.638 179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -125.99 161.77 26.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.286 -0.884 . . . . 40.030000000000001 109.163 179.942 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.97 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -140.39 -172.36 3.41 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 12.390000000000001 109.602 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.738 ' HB3' HD11 ' A' ' 44' ' ' LEU . 2.7 mp -130.75 171.42 13.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 17.420000000000002 109.361 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.579 ' SG ' HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -162.21 154.32 19.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.104 -0.997 . . . . 13.84 108.711 -179.613 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.699 ' CE2' HD13 ' A' ' 44' ' ' LEU . 27.1 m-85 -115.32 104.31 11.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 21.140000000000001 109.604 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.898 HG21 HD13 ' B' ' 76' ' ' LEU . 64.1 t -80.23 165.33 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.807 -1.183 . . . . 10.66 109.536 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.599 ' N ' HG12 ' A' ' 35' ' ' VAL . 6.2 m-20 -137.21 -52.87 0.68 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.299 -0.876 . . . . 25.890000000000001 109.676 -179.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.797 ' CG ' HD11 ' B' ' 65' ' ' LEU . 0.1 OUTLIER -42.09 -44.65 3.7 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.66 0.743 . . . . 24.239999999999998 109.11 179.919 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 39' ' ' ASN . . . -88.57 32.21 4.58 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.613 -1.395 . . . . 31.02 109.613 -179.866 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 2.5 p30 161.16 117.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.384 -1.068 . . . . 43.229999999999997 109.594 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -42.5 -64.79 0.55 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 42.340000000000003 109.509 179.941 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.506 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 5.5 m-70 -68.68 163.4 55.11 Favored Pre-proline 0 C--N 1.295 -1.792 0 N-CA-C 107.96 -1.126 . . . . 3.77 107.96 179.033 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.688 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.9 Cg_endo -78.1 140.48 17.88 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 121.541 1.494 . . . . 17.920000000000002 109.692 -179.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.53 HG21 ' ND2' ' A' ' 39' ' ' ASN . 6.0 m -116.32 114.32 45.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.313 -0.867 . . . . 20.57 109.003 179.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.738 HD11 ' HB3' ' A' ' 32' ' ' LEU . 43.8 tp -69.75 107.73 3.61 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.347 -0.846 . . . . 20.210000000000001 109.835 -179.437 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.695 HG23 HG11 ' B' ' 70' ' ' VAL . 0.8 OUTLIER -109.13 164.19 5.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.56 -0.904 . . . . 10.81 108.56 179.635 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' HA3' ' B' ' 74' ' ' GLY . 1.0 OUTLIER -86.96 170.0 11.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.159 -0.963 . . . . 36.740000000000002 109.803 -179.67 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.635 HG22 ' CB ' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -156.6 171.65 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.347 -0.846 . . . . 19.739999999999998 109.315 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -107.82 147.8 30.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.201 -0.937 . . . . 22.559999999999999 109.45 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.639 ' CD1' ' CD2' ' A' ' 13' ' ' PHE . 1.8 tm? -129.39 112.15 13.54 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.219 -0.926 . . . . 20.41 108.778 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 53' ' ' GLN . 2.7 t70 -61.75 138.18 58.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.395 -0.816 . . . . 33.990000000000002 110.223 -178.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.28 124.38 16.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.346 -0.847 . . . . 54.920000000000002 108.834 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.47 -31.15 8.39 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.979 -1.648 . . . . 36.100000000000001 108.979 -179.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.585 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -73.77 146.51 85.63 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.375 -1.074 . . . . 54.759999999999998 109.155 179.648 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.3 Cg_endo -78.44 118.2 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.426 2.084 . . . . 28.370000000000001 109.997 179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.97 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -41.58 154.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 17.210000000000001 109.711 -179.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.662 ' CE2' ' HB3' ' A' ' 83' ' ' LEU . 6.8 m-30 -45.07 105.57 0.06 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.239 -0.913 . . . . 17.190000000000001 108.892 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.952 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -61.97 176.15 0.48 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 17.82 109.347 -179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.952 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.0 Cg_endo -77.61 129.97 10.43 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.602 2.202 . . . . 17.280000000000001 110.523 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.598 ' O ' ' CD1' ' A' ' 61' ' ' TYR . . . 153.03 148.25 4.83 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.767 -1.333 . . . . 17.219999999999999 109.767 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.749 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.6 OUTLIER -46.78 146.23 1.67 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.137 -1.213 . . . . 19.57 108.838 179.481 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.895 ' CB ' HG13 ' A' ' 4' ' ' VAL . 16.3 m-85 -125.77 161.85 26.41 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.667 -1.271 . . . . 14.609999999999999 111.7 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.904 ' O ' HG22 ' A' ' 84' ' ' VAL . 43.2 p -144.86 121.6 11.2 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.459 -1.682 . . . . 18.359999999999999 106.459 178.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.575 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -59.98 163.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 C-N-CA 118.529 -1.268 . . . . 19.129999999999999 108.922 -178.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.473 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.2 t-80 -127.27 128.19 45.59 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.037 -0.727 . . . . 20.649999999999999 109.037 -179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.784 HD22 ' N ' ' B' ' 2' ' ' ILE . 0.4 OUTLIER -71.52 0.98 7.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.471 -0.768 . . . . 19.649999999999999 110.159 -179.833 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -20.78 6.58 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.283 -1.377 . . . . 14.720000000000001 107.283 178.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 5.8 m -95.11 -8.31 36.87 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.903 -0.498 . . . . 11.449999999999999 110.218 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.6 m-30 -84.73 156.87 21.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.953 -1.092 . . . . 14.25 109.336 -179.167 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HE2' ' OD2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -168.03 174.69 7.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.397 -0.814 . . . . 32.700000000000003 109.435 179.747 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.715 HG11 HG23 ' B' ' 45' ' ' VAL . 0.1 OUTLIER -103.13 109.82 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.387 -0.821 . . . . 15.630000000000001 109.254 -179.965 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 72' ' ' GLN . . . -77.31 50.83 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.104 -1.199 . . . . 12.699999999999999 110.104 -179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER 40.05 49.39 2.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.34 -1.094 . . . . 26.289999999999999 110.102 179.62 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 74' ' ' GLY . 1.7 m-85 -143.35 31.26 1.36 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 20.440000000000001 109.334 179.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.516 ' HA3' ' HG2' ' B' ' 46' ' ' LYS . . . 44.61 44.96 8.55 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.624 -1.39 . . . . 13.82 109.624 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.484 ' N ' HG22 ' B' ' 45' ' ' VAL . 46.6 m -166.57 114.27 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -1.209 . . . . 18.27 109.832 -179.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.862 HD13 HG21 ' B' ' 35' ' ' VAL . 0.3 OUTLIER -68.04 155.36 39.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 12.43 109.037 179.678 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.543 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 8.1 mtp -162.54 157.06 21.66 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 35.109999999999999 109.754 -179.743 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.759 HD12 HD12 ' B' ' 78' ' ' ILE . 3.3 mt -80.65 135.06 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.367 -0.833 . . . . 13.67 109.899 179.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 79' ' ' ASP . 46.9 t0 -103.18 -20.55 14.1 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.376 -0.972 . . . . 24.059999999999999 108.376 178.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 67' ' ' SER . 5.1 tmm_? 175.79 69.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.93 -1.507 . . . . 35.039999999999999 106.93 179.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -32.23 120.21 0.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.458 -0.792 . . . . 18.719999999999999 111.635 -177.711 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.473 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -92.12 99.44 12.24 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.322 -0.992 . . . . 20.550000000000001 108.322 178.996 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.749 HD23 ' CD2' ' A' ' 61' ' ' TYR . 1.5 tp -67.43 157.54 33.91 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.019 0.914 . . . . 14.4 111.159 -178.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.904 HG22 ' O ' ' A' ' 62' ' ' THR . 21.3 m -156.55 147.98 16.9 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 107.818 -1.178 . . . . 17.649999999999999 107.818 179.498 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 24.1 Cg_endo -63.12 135.24 49.87 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 121.815 1.677 . . . . 25.699999999999999 109.872 179.352 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.749 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -61.85 118.8 7.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.942 . . . . 49.289999999999999 109.792 -178.521 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.01 -0.995 . . . . 58.909999999999997 109.454 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.494 ' HG3' ' HB ' ' B' ' 62' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.339 0.59 . . . . 64.909999999999997 109.425 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.784 ' N ' HD22 ' A' ' 65' ' ' LEU . 4.2 mt 75.25 83.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.632 -1.247 . . . . 33.799999999999997 107.632 -179.07 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.533 ' C ' HG12 ' B' ' 4' ' ' VAL . 3.8 mtpp -80.74 173.07 12.97 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.136 0.97 . . . . 32.719999999999999 111.957 -177.56 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.891 HG13 ' CB ' ' B' ' 61' ' ' TYR . 0.2 OUTLIER 179.83 168.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.781 -0.822 . . . . 14.460000000000001 108.781 -179.773 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.582 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 36.5 mt-10 -141.54 112.65 7.39 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.401 -0.812 . . . . 22.120000000000001 109.522 -179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.866 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.6 OUTLIER -71.5 104.72 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.475 -1.306 . . . . 14.23 107.475 179.05 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.686 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -51.32 162.05 0.7 Allowed Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.881 . . . . 25.43 110.154 -178.874 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.401 ' HD2' ' HG3' ' B' ' 7' ' ' LYS . 33.7 Cg_endo -76.54 -18.8 15.27 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.472 2.114 . . . . 13.609999999999999 109.15 178.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -92.03 8.6 36.92 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.719 -0.845 . . . . 15.52 108.719 178.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.558 ' CG ' ' HB2' ' B' ' 7' ' ' LYS . 0.0 OUTLIER -147.92 38.92 0.92 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.35 -0.844 . . . . 17.309999999999999 109.229 179.353 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.18 7.05 44.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.318 -0.864 . . . . 24.780000000000001 109.721 -179.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.604 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 29.0 mt-30 -127.52 155.59 43.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 47.899999999999999 109.203 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.764 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 37.4 p90 -96.37 160.53 14.37 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.089 -1.007 . . . . 21.609999999999999 109.363 -179.847 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -127.2 160.84 30.04 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.838 -0.801 . . . . 14.890000000000001 108.838 179.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.63 107.77 20.0 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.318 -0.864 . . . . 17.350000000000001 109.002 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' B' ' 18' ' ' GLY . 7.2 mmt180 -136.95 154.04 50.55 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.373 -0.829 . . . . 34.380000000000003 109.512 -179.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 2.1 m -59.49 83.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.372 -0.83 . . . . 38.770000000000003 109.427 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -76.35 132.5 12.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.393 -1.483 . . . . 34.579999999999998 109.393 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.403 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -101.42 124.83 55.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.169 -1.195 . . . . 41.869999999999997 108.758 179.837 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.442 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 4.0 m -69.31 -93.32 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.786 . . . . 47.210000000000001 109.544 -179.101 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.504 ' HG2' ' HG3' ' B' ' 22' ' ' GLN . 0.1 OUTLIER -91.61 -56.42 3.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.905 . . . . 71.560000000000002 109.438 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.504 ' HG3' ' HG2' ' B' ' 21' ' ' ARG . 0.0 OUTLIER 167.18 45.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 66.599999999999994 109.518 179.809 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.94 -57.2 0.15 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.588 -1.405 . . . . 55.490000000000002 109.588 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.92 150.08 74.68 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.249 -1.147 . . . . 44.990000000000002 109.389 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.3 79.88 3.17 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.603 2.202 . . . . 44.100000000000001 110.631 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.585 ' CE1' ' HA3' ' B' ' 18' ' ' GLY . 4.4 p90 -56.9 139.12 52.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 32.090000000000003 109.535 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.98 79.62 1.91 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 29.25 109.36 -179.864 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.55 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.0 OUTLIER -117.36 135.92 53.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 24.0 109.681 -179.94 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.576 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 85.8 m-20 -43.59 134.38 4.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 23.309999999999999 109.735 179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 1.0 OUTLIER -125.65 161.74 26.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.362 -0.836 . . . . 40.030000000000001 109.192 179.889 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.96 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -140.32 -172.33 3.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.166 -0.959 . . . . 12.390000000000001 109.605 179.954 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.734 ' HB3' HD11 ' B' ' 44' ' ' LEU . 2.7 mp -130.76 171.63 12.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 17.420000000000002 109.372 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.582 ' SG ' HD13 ' B' ' 47' ' ' ILE . 0.1 OUTLIER -162.45 154.28 18.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.06 -1.025 . . . . 13.84 108.776 -179.688 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.703 ' CE2' HD13 ' B' ' 44' ' ' LEU . 27.4 m-85 -115.23 104.36 11.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 21.140000000000001 109.645 -179.653 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.862 HG21 HD13 ' A' ' 76' ' ' LEU . 63.2 t -80.32 165.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.849 -1.157 . . . . 10.66 109.509 179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.617 ' N ' HG12 ' B' ' 35' ' ' VAL . 6.2 m-20 -137.24 -52.76 0.67 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.304 -0.873 . . . . 25.890000000000001 109.683 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -42.09 -44.67 3.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 24.239999999999998 109.088 179.921 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 39' ' ' ASN . . . -88.52 32.06 4.63 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.651 -1.38 . . . . 31.02 109.651 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' B' ' 36' ' ' ASP . 2.5 p30 161.23 117.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.397 -1.06 . . . . 43.229999999999997 109.577 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' B' ' 39' ' ' ASN . 0.0 OUTLIER -42.45 -64.67 0.57 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.355 -0.841 . . . . 42.340000000000003 109.508 179.942 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.51 ' HB3' ' HD2' ' B' ' 42' ' ' PRO . 5.6 m-70 -68.95 163.41 56.68 Favored Pre-proline 0 C--N 1.296 -1.759 0 N-CA-C 107.97 -1.122 . . . . 3.75 107.97 179.078 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.692 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.9 Cg_endo -77.98 140.67 18.28 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.507 1.471 . . . . 17.920000000000002 109.702 -179.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.534 HG21 ' ND2' ' B' ' 39' ' ' ASN . 5.9 m -116.49 114.29 45.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 O-C-N 121.339 -0.851 . . . . 20.57 108.981 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.734 HD11 ' HB3' ' B' ' 32' ' ' LEU . 43.6 tp -69.77 107.48 3.52 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.379 -0.826 . . . . 20.210000000000001 109.946 -179.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.715 HG23 HG11 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -108.88 164.12 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 108.627 -0.879 . . . . 10.81 108.627 179.592 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.516 ' HG2' ' HA3' ' A' ' 74' ' ' GLY . 1.0 OUTLIER -86.85 170.11 11.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.948 . . . . 36.740000000000002 109.741 -179.645 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.637 HG22 ' CB ' ' B' ' 31' ' ' GLN . 0.1 OUTLIER -156.72 171.46 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 121.283 -0.886 . . . . 19.739999999999998 109.379 179.861 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 18.3 m -107.5 147.71 30.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 22.559999999999999 109.442 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.64 ' CD1' ' CD2' ' B' ' 13' ' ' PHE . 1.7 tm? -129.24 112.22 13.68 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.198 -0.939 . . . . 20.41 108.781 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' B' ' 53' ' ' GLN . 2.7 t70 -61.69 138.3 58.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.378 -0.827 . . . . 33.990000000000002 110.202 -179.014 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.41 124.39 17.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.347 -0.846 . . . . 54.920000000000002 108.771 179.379 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.52 -31.25 8.3 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.987 -1.645 . . . . 36.100000000000001 108.987 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.608 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.4 OUTLIER -73.61 146.45 85.94 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.35 -1.088 . . . . 54.759999999999998 109.153 179.694 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.4 Cg_endo -78.35 118.03 4.2 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.453 2.102 . . . . 28.370000000000001 109.998 179.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.96 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -41.49 154.81 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.454 -0.779 . . . . 17.210000000000001 109.764 -179.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.666 ' CE2' ' HB3' ' B' ' 83' ' ' LEU . 6.7 m-30 -44.96 105.82 0.06 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 17.190000000000001 108.769 179.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -62.48 176.19 0.52 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.925 . . . . 17.82 109.439 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.7 Cg_endo -77.46 128.53 9.63 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.547 2.165 . . . . 17.280000000000001 110.152 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.61 ' O ' ' CD1' ' B' ' 61' ' ' TYR . . . 155.4 147.97 4.88 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.889 -1.284 . . . . 17.219999999999999 109.889 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.753 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.6 OUTLIER -47.43 145.69 2.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.055 -1.262 . . . . 19.57 108.527 179.209 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.891 ' CB ' HG13 ' B' ' 4' ' ' VAL . 17.0 m-85 -125.25 161.87 25.95 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 120.624 -1.297 . . . . 14.609999999999999 111.663 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.906 ' O ' HG22 ' B' ' 84' ' ' VAL . 43.5 p -144.87 121.73 11.27 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.445 -1.687 . . . . 18.359999999999999 106.445 178.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -60.15 163.22 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 C-N-CA 118.517 -1.273 . . . . 19.129999999999999 108.974 -178.519 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.47 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.2 t-80 -127.41 128.28 45.55 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.527 -0.733 . . . . 20.649999999999999 109.036 -179.287 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.797 HD11 ' CG ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -71.48 0.88 7.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.476 -0.765 . . . . 19.649999999999999 110.093 -179.828 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -20.89 6.15 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.268 -1.382 . . . . 14.720000000000001 107.268 178.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 5.6 m -95.14 -8.98 34.86 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.897 -0.502 . . . . 11.449999999999999 110.245 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.6 m-30 -84.07 156.57 22.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.945 -1.097 . . . . 14.25 109.206 -179.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.403 ' HE2' ' OD2' ' B' ' 79' ' ' ASP . 0.3 OUTLIER -167.8 174.43 7.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.431 -0.793 . . . . 32.700000000000003 109.435 179.736 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.695 HG11 HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -102.76 109.91 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.321 -0.862 . . . . 15.630000000000001 109.273 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' B' ' 72' ' ' GLN . . . -77.44 50.58 3.2 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.143 -1.183 . . . . 12.699999999999999 110.143 -179.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 71' ' ' GLY . 0.0 OUTLIER 40.28 49.62 2.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.331 -1.099 . . . . 26.289999999999999 110.041 179.653 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -143.65 31.35 1.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.312 -0.868 . . . . 20.440000000000001 109.323 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.516 ' HA3' ' HG2' ' A' ' 46' ' ' LYS . . . 44.56 44.73 8.37 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.621 -1.392 . . . . 13.82 109.621 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 45' ' ' VAL . 46.6 m -166.41 114.53 0.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -1.205 . . . . 18.27 109.824 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.898 HD13 HG21 ' A' ' 35' ' ' VAL . 0.3 OUTLIER -68.13 155.36 39.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 12.43 109.019 179.634 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.54 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 8.1 mtp -162.68 157.13 21.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 35.109999999999999 109.682 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.759 HD12 HD12 ' A' ' 78' ' ' ILE . 3.3 mt -80.78 135.36 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.442 -0.787 . . . . 13.67 109.91 179.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' B' ' 79' ' ' ASP . 47.2 t0 -103.19 -20.74 14.03 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.358 -0.979 . . . . 24.059999999999999 108.358 178.287 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' B' ' 67' ' ' SER . 5.1 tmm_? 175.96 69.7 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 106.982 -1.488 . . . . 35.039999999999999 106.982 179.402 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.643 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -32.45 120.2 0.31 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.464 -0.789 . . . . 18.719999999999999 111.684 -177.725 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -92.15 99.32 12.14 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.23 -1.026 . . . . 20.550000000000001 108.23 179.064 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.732 HD23 ' CD2' ' B' ' 61' ' ' TYR . 1.5 tp -67.4 157.62 33.68 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.034 0.921 . . . . 14.4 111.127 -178.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.906 HG22 ' O ' ' B' ' 62' ' ' THR . 21.2 m -156.6 148.13 16.99 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.841 -1.17 . . . . 17.649999999999999 107.841 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 23.5 Cg_endo -63.31 135.17 48.84 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 C-N-CA 121.774 1.649 . . . . 25.699999999999999 109.88 179.383 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.753 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -61.83 118.43 7.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.318 -0.864 . . . . 49.289999999999999 109.761 -178.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . 0.404 ' O ' ' O ' ' B' ' 86' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.975 -1.012 . . . . 58.909999999999997 109.475 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' HB ' ' A' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.302 0.572 . . . . 64.909999999999997 109.53 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.895 ' CA ' HD22 ' B' ' 65' ' ' LEU . 5.3 mt -69.67 82.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.909 -1.145 . . . . 33.799999999999997 107.909 179.178 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.488 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 mttt -59.19 156.21 12.72 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.894 0.854 . . . . 32.719999999999999 111.531 -177.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 35' ' ' VAL . 49.0 t -159.57 167.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 109.19 -0.67 . . . . 14.460000000000001 109.19 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.602 ' N ' HG12 ' A' ' 4' ' ' VAL . 30.2 mt-10 -152.63 100.93 2.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.741 0.782 . . . . 22.120000000000001 109.185 -179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.644 HD13 ' CE1' ' A' ' 61' ' ' TYR . 0.5 OUTLIER -66.96 103.56 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.852 -1.166 . . . . 14.23 107.852 179.493 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 34' ' ' TYR . 2.2 mmpt? -50.18 159.23 0.84 Allowed Pre-proline 0 N--CA 1.485 1.291 0 O-C-N 121.302 -0.874 . . . . 25.43 109.66 -179.115 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 34.2 Cg_endo -76.16 -3.31 13.67 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.28 1.987 . . . . 13.609999999999999 109.37 179.374 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.15 -10.45 33.17 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.483 -0.76 . . . . 15.52 109.408 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 1.053 ' OE1' HD13 ' A' ' 32' ' ' LEU . 25.7 mm-40 -97.54 -76.34 0.52 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.293 -0.879 . . . . 17.309999999999999 108.863 179.604 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 10' ' ' GLN . . . 23.64 45.54 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 121.205 0.526 . . . . 24.780000000000001 111.195 179.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 10' ' ' GLN . 1.2 pt20 -179.04 132.42 0.12 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.225 -0.922 . . . . 47.899999999999999 109.557 -179.783 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 31.9 p90 -97.45 156.27 16.55 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.953 -1.092 . . . . 21.609999999999999 109.486 179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 t -124.92 164.08 20.86 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.651 -0.87 . . . . 14.890000000000001 108.651 178.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.496 HG22 ' HB2' ' A' ' 27' ' ' SER . 0.2 OUTLIER -85.81 112.13 20.82 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.116 -0.99 . . . . 17.350000000000001 109.53 -179.773 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.02 153.57 39.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 34.380000000000003 109.385 179.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -52.27 144.32 12.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -0.875 . . . . 38.770000000000003 109.368 -179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.581 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -155.45 119.48 0.93 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.26 -1.536 . . . . 34.579999999999998 109.26 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.71 123.68 55.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -1.22 . . . . 41.869999999999997 109.217 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.94 -15.08 18.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.419 -0.801 . . . . 47.210000000000001 109.493 -179.517 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.492 ' HG2' ' HG2' ' A' ' 22' ' ' GLN . 2.2 ttt180 -177.6 -59.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.351 -0.843 . . . . 71.560000000000002 109.283 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER 174.93 57.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 66.599999999999994 109.471 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.78 -50.71 0.04 OUTLIER Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.582 -1.407 . . . . 55.490000000000002 109.582 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.39 108.66 59.85 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.287 -1.125 . . . . 44.990000000000002 109.377 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.79 72.07 5.26 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.173 1.915 . . . . 44.100000000000001 110.18 179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.602 ' CE1' ' HB2' ' A' ' 28' ' ' LEU . 5.2 p90 -69.27 140.22 54.43 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.533 -0.729 . . . . 32.090000000000003 110.403 -179.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.496 ' HB2' HG22 ' A' ' 15' ' ' THR . 0.0 OUTLIER -105.54 81.46 1.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.097 -1.075 . . . . 29.25 108.097 178.922 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.602 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -90.71 138.48 31.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 24.0 110.657 -178.55 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.63 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -42.2 159.3 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 23.309999999999999 109.942 179.686 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -156.71 137.22 13.09 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.753 -0.832 . . . . 40.030000000000001 108.753 179.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.844 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -120.89 -166.34 1.33 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.947 -1.095 . . . . 12.390000000000001 110.334 -179.231 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.053 HD13 ' OE1' ' A' ' 10' ' ' GLN . 4.4 mp -127.37 175.25 8.35 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.933 -0.766 . . . . 17.420000000000002 108.933 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -170.79 160.14 6.74 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 120.796 -1.19 . . . . 13.84 108.663 -179.545 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.695 ' CE1' HD13 ' A' ' 44' ' ' LEU . 2.9 m-30 -112.54 86.37 2.35 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.259 -0.9 . . . . 21.140000000000001 109.199 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.056 HG22 HG22 ' A' ' 4' ' ' VAL . 59.2 t -83.11 110.37 18.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.156 -0.965 . . . . 10.66 110.227 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 37' ' ' LEU . 36.8 t0 -53.58 -34.79 59.61 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.779 -1.193 . . . . 25.890000000000001 107.779 178.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.748 HD11 ' C ' ' B' ' 68' ' ' PHE . 1.0 OUTLIER 41.27 34.36 0.32 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.303 0.573 . . . . 24.239999999999998 109.73 179.317 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.25 23.75 34.44 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.301 -1.52 . . . . 31.02 109.301 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.854 HD22 HG11 ' A' ' 43' ' ' VAL . 43.3 m-20 -88.26 26.53 1.39 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.304 -1.116 . . . . 43.229999999999997 110.01 -179.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.77 14.18 3.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.046 -1.034 . . . . 42.340000000000003 109.876 179.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER 175.61 167.1 0.39 Allowed Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.437 -0.949 . . . . 5.25 108.437 179.883 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 33.8 Cg_endo -75.81 145.16 28.46 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.722 1.614 . . . . 17.920000000000002 110.421 -179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.875 HG22 ' O ' ' A' ' 35' ' ' VAL . 6.6 m -119.9 119.77 61.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.482 -0.887 . . . . 20.57 109.171 179.356 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.931 HD11 ' HB3' ' A' ' 32' ' ' LEU . 14.7 tp -72.47 112.85 8.89 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.886 -0.725 . . . . 20.210000000000001 109.276 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.427 HG22 ' C ' ' B' ' 74' ' ' GLY . 1.7 p -130.78 161.51 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.386 -0.822 . . . . 10.81 109.127 -179.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' B' ' 74' ' ' GLY . 0.6 OUTLIER -80.75 160.34 24.93 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.038 -1.039 . . . . 36.740000000000002 110.407 -179.094 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.815 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -140.64 161.91 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.46 -0.941 . . . . 19.739999999999998 108.46 179.353 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.01 143.0 28.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.97 -1.081 . . . . 22.559999999999999 109.683 -179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -114.0 146.58 39.96 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.366 -0.834 . . . . 20.41 108.858 179.85 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.498 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -81.33 142.88 32.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 33.990000000000002 109.538 -179.583 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.12 116.89 3.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -0.903 . . . . 54.920000000000002 109.477 -179.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.11 -6.55 83.37 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.652 -1.379 . . . . 36.100000000000001 109.652 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.498 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -83.89 148.78 54.96 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.182 -1.187 . . . . 54.759999999999998 109.451 179.999 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.5 Cg_endo -77.01 119.47 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.617 2.211 . . . . 28.370000000000001 110.776 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.844 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -42.01 147.85 0.21 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 17.210000000000001 110.267 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.678 ' CD1' HG21 ' A' ' 47' ' ' ILE . 86.8 m-85 -44.07 112.09 0.36 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.53 -0.731 . . . . 17.190000000000001 109.131 179.619 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.01 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -63.92 176.58 0.63 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 17.82 109.779 -179.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 1.01 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -77.8 113.54 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.756 2.304 . . . . 17.280000000000001 110.433 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.8 172.84 38.83 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.389 -1.484 . . . . 17.219999999999999 109.389 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 3.3 mp -70.41 146.63 50.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -1.173 . . . . 19.57 108.811 179.494 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.644 ' CE1' HD13 ' A' ' 6' ' ' ILE . 26.6 m-85 -131.24 163.59 27.45 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.945 -1.097 . . . . 14.609999999999999 110.921 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.664 ' O ' HG22 ' A' ' 84' ' ' VAL . 44.1 p -144.4 117.17 8.72 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 106.066 -1.827 . . . . 18.359999999999999 106.066 178.623 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' A' ' 81' ' ' LEU . 2.4 t -49.81 163.95 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.282 0 C-N-CA 118.681 -1.208 . . . . 19.129999999999999 108.71 -178.143 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.532 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.0 t-80 -128.3 126.62 41.16 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.409 -0.807 . . . . 20.649999999999999 109.381 -178.901 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.886 HD22 ' HA ' ' B' ' 2' ' ' ILE . 0.7 OUTLIER -74.05 2.51 8.65 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.533 -0.729 . . . . 19.649999999999999 110.054 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.9 p -58.88 -18.02 29.22 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.546 -1.279 . . . . 14.720000000000001 107.546 178.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 80' ' ' ARG . 23.8 m -97.83 -16.4 19.83 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.842 -0.536 . . . . 11.449999999999999 110.151 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.728 ' C ' HD11 ' B' ' 37' ' ' LEU . 3.0 m-30 -68.14 157.3 35.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.125 -0.984 . . . . 14.25 109.441 -178.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.617 ' N ' HD11 ' B' ' 37' ' ' LEU . 0.1 OUTLIER -150.48 -179.76 7.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.385 -0.822 . . . . 32.700000000000003 109.613 -179.995 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.632 HG21 HG21 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -120.82 110.88 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.505 -0.747 . . . . 15.630000000000001 109.121 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.458 ' N ' ' SD ' ' A' ' 77' ' ' MET . . . -81.7 -175.07 50.03 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.658 -1.377 . . . . 12.699999999999999 109.658 -179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.524 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -89.55 20.17 4.12 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.152 -1.205 . . . . 26.289999999999999 109.574 -179.974 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -93.73 -2.64 53.5 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.394 -0.816 . . . . 20.440000000000001 109.348 179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 81.16 26.89 51.3 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.68 -1.368 . . . . 13.82 109.68 179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.6 153.7 32.83 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.082 -1.246 . . . . 18.27 109.82 -179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.596 HD12 HG13 ' A' ' 70' ' ' VAL . 1.1 tp -62.24 176.81 0.55 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.348 -0.845 . . . . 12.43 109.664 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.488 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 2.1 ptm -167.68 100.12 0.48 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.319 -0.863 . . . . 35.109999999999999 109.691 179.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.606 HG12 ' CE1' ' A' ' 68' ' ' PHE . 1.9 mt -36.86 -64.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 121.478 0.656 . . . . 13.67 110.301 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.557 ' CB ' ' O ' ' A' ' 78' ' ' ILE . 9.0 t0 84.53 -45.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.484 0.659 . . . . 24.059999999999999 110.014 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.552 ' O ' ' CB ' ' A' ' 67' ' ' SER . 3.8 tpm_? -173.84 67.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.147 0.975 . . . . 35.039999999999999 108.526 179.424 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.637 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 1.2 pt? -40.96 126.8 2.59 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.483 -0.781 . . . . 18.719999999999999 111.931 -178.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 1.4 ttt180 -94.11 110.4 22.11 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.693 -1.225 . . . . 20.550000000000001 107.693 178.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.815 ' HB2' HD11 ' A' ' 47' ' ' ILE . 11.8 tp -80.2 150.42 30.12 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.056 -1.027 . . . . 14.4 111.112 -178.148 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 62' ' ' THR . 21.2 m -147.08 157.57 46.06 Favored Pre-proline 0 C--N 1.305 -1.328 0 N-CA-C 108.161 -1.051 . . . . 17.649999999999999 108.161 179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 23.6 Cg_endo -62.56 142.0 88.35 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.058 1.838 . . . . 25.699999999999999 110.321 179.11 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -76.38 116.47 17.1 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.229 -0.919 . . . . 49.289999999999999 109.739 -178.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.012 -0.995 . . . . 58.909999999999997 109.425 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.482 ' SD ' ' HB ' ' B' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.308 0.575 . . . . 64.909999999999997 109.556 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.886 ' HA ' HD22 ' A' ' 65' ' ' LEU . 5.2 mt -69.48 82.44 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.91 -1.144 . . . . 33.799999999999997 107.91 179.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.5 ' C ' HG23 ' B' ' 4' ' ' VAL . 2.3 mttt -59.12 156.4 12.12 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.915 0.864 . . . . 32.719999999999999 111.543 -178.0 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.089 HG22 HG22 ' B' ' 35' ' ' VAL . 49.2 t -159.7 167.07 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 109.2 -0.667 . . . . 14.460000000000001 109.2 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.604 ' N ' HG12 ' B' ' 4' ' ' VAL . 30.0 mt-10 -152.45 100.94 2.62 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.808 0.813 . . . . 22.120000000000001 109.296 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.648 HD13 ' CE1' ' B' ' 61' ' ' TYR . 0.5 OUTLIER -66.92 103.46 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 107.838 -1.171 . . . . 14.23 107.838 179.454 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.567 ' HD2' ' CE2' ' B' ' 34' ' ' TYR . 2.2 mmpt? -50.08 159.39 0.8 Allowed Pre-proline 0 N--CA 1.486 1.328 0 O-C-N 121.294 -0.879 . . . . 25.43 109.69 -179.156 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.7 Cg_endo -76.26 -3.26 13.61 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.353 2.035 . . . . 13.609999999999999 109.37 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.28 -10.48 32.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.461 -0.775 . . . . 15.52 109.394 179.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 1.038 ' OE1' HD13 ' B' ' 32' ' ' LEU . 25.6 mm-40 -97.48 -76.45 0.52 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.282 -0.886 . . . . 17.309999999999999 108.865 179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' B' ' 10' ' ' GLN . . . 23.77 45.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.164 0.507 . . . . 24.780000000000001 111.175 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' B' ' 10' ' ' GLN . 1.2 pt20 -178.94 132.28 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 47.899999999999999 109.616 -179.762 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.646 ' CD2' ' HB2' ' B' ' 55' ' ' ALA . 32.5 p90 -97.21 156.35 16.45 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.954 -1.091 . . . . 21.609999999999999 109.551 179.7 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 9.4 t -124.97 163.94 21.21 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.656 -0.868 . . . . 14.890000000000001 108.656 178.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.508 HG22 ' HB2' ' B' ' 27' ' ' SER . 0.2 OUTLIER -85.82 112.26 20.95 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.133 -0.979 . . . . 17.350000000000001 109.538 -179.798 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.09 153.42 39.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 34.380000000000003 109.437 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -52.11 144.24 12.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 38.770000000000003 109.424 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -155.3 119.6 0.94 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.197 -1.561 . . . . 34.579999999999998 109.197 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 t -101.86 123.66 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.107 -1.231 . . . . 41.869999999999997 109.148 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.86 -15.2 19.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.811 . . . . 47.210000000000001 109.488 -179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.488 ' HG2' ' HG2' ' B' ' 22' ' ' GLN . 2.1 ttt180 -177.49 -59.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.363 -0.836 . . . . 71.560000000000002 109.268 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.488 ' HG2' ' HG2' ' B' ' 21' ' ' ARG . 0.0 OUTLIER 175.08 57.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 66.599999999999994 109.435 179.768 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.8 -50.7 0.04 OUTLIER Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.485 -1.446 . . . . 55.490000000000002 109.485 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.34 108.64 59.74 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.294 -1.121 . . . . 44.990000000000002 109.412 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.76 72.17 5.2 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.224 1.949 . . . . 44.100000000000001 110.234 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.593 ' CE1' ' HB2' ' B' ' 28' ' ' LEU . 5.4 p90 -69.34 140.44 54.31 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.565 -0.709 . . . . 32.090000000000003 110.342 -179.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.508 ' HB2' HG22 ' B' ' 15' ' ' THR . 0.0 OUTLIER -105.79 81.44 1.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.061 -1.088 . . . . 29.25 108.061 178.899 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.593 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -90.67 138.59 31.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.377 -0.827 . . . . 24.0 110.612 -178.504 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.623 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.1 OUTLIER -42.3 159.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.471 -0.768 . . . . 23.309999999999999 109.942 179.717 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -156.77 136.99 12.82 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.764 -0.828 . . . . 40.030000000000001 108.764 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.825 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -120.77 -166.41 1.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.992 -1.068 . . . . 12.390000000000001 110.342 -179.277 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 1.038 HD13 ' OE1' ' B' ' 10' ' ' GLN . 4.4 mp -127.16 175.43 8.14 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.871 -0.788 . . . . 17.420000000000002 108.871 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 0.1 OUTLIER -170.99 160.1 6.38 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.834 -1.166 . . . . 13.84 108.59 -179.549 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.701 ' CE1' HD13 ' B' ' 44' ' ' LEU . 2.9 m-30 -112.52 86.41 2.35 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.257 -0.902 . . . . 21.140000000000001 109.201 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 1.089 HG22 HG22 ' B' ' 4' ' ' VAL . 59.5 t -83.22 110.57 18.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.189 -0.944 . . . . 10.66 110.236 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.425 ' O ' ' C ' ' B' ' 37' ' ' LEU . 36.8 t0 -53.7 -34.74 59.78 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.79 -1.189 . . . . 25.890000000000001 107.79 179.007 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.728 HD11 ' C ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER 41.26 34.38 0.32 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.79 -0.568 . . . . 24.239999999999998 109.717 179.345 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.23 23.58 33.71 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.3 -1.52 . . . . 31.02 109.3 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.837 HD22 HG11 ' B' ' 43' ' ' VAL . 45.1 m-20 -88.09 26.46 1.38 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.285 -1.126 . . . . 43.229999999999997 110.022 -179.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 59.8 14.22 4.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.082 -1.011 . . . . 42.340000000000003 109.893 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.59 ' CE1' ' O ' ' B' ' 39' ' ' ASN . 0.6 OUTLIER 175.61 167.01 0.39 Allowed Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.454 -0.943 . . . . 5.2300000000000004 108.454 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.637 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 33.8 Cg_endo -75.62 145.31 29.25 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.711 1.608 . . . . 17.920000000000002 110.49 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.877 HG22 ' O ' ' B' ' 35' ' ' VAL . 6.6 m -120.03 119.94 61.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 C-N-CA 119.378 -0.929 . . . . 20.57 109.16 179.312 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.949 HD11 ' HB3' ' B' ' 32' ' ' LEU . 14.8 tp -72.76 112.92 9.24 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.93 -0.708 . . . . 20.210000000000001 109.172 -179.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 32' ' ' LEU . 1.7 p -130.82 161.52 40.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.421 -0.799 . . . . 10.81 109.077 -179.758 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -80.74 160.31 24.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.985 . . . . 36.740000000000002 110.399 -179.093 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.798 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.5 OUTLIER -140.57 161.88 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.378 -0.971 . . . . 19.739999999999998 108.378 179.41 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.07 142.98 28.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.952 -1.092 . . . . 22.559999999999999 109.744 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.602 ' HG ' ' CD2' ' B' ' 13' ' ' PHE . 0.2 OUTLIER -113.85 146.82 39.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.391 -0.818 . . . . 20.41 108.888 179.873 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.503 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -81.63 142.78 32.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.068 -1.02 . . . . 33.990000000000002 109.536 -179.572 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.05 117.14 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 54.920000000000002 109.417 -179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.12 -6.81 83.04 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.599 -1.4 . . . . 36.100000000000001 109.599 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.503 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.0 OUTLIER -83.79 148.89 55.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.188 -1.183 . . . . 54.759999999999998 109.508 -179.958 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.418 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.5 Cg_endo -77.03 119.39 5.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.715 2.277 . . . . 28.370000000000001 110.761 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.825 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -42.0 147.69 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 17.210000000000001 110.35 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.682 ' CD1' HG21 ' B' ' 47' ' ' ILE . 86.9 m-85 -43.76 112.54 0.4 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.543 -0.723 . . . . 17.190000000000001 109.07 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.979 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -64.54 176.38 0.74 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 17.82 109.879 -179.348 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.979 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.0 Cg_endo -77.3 112.47 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.606 2.204 . . . . 17.280000000000001 110.112 179.745 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.56 172.31 39.54 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.54 -1.424 . . . . 17.219999999999999 109.54 -179.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 3.0 mp -70.67 146.01 50.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -1.165 . . . . 19.57 108.438 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.648 ' CE1' HD13 ' B' ' 6' ' ' ILE . 27.5 m-85 -130.69 163.51 27.08 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.909 -1.119 . . . . 14.609999999999999 110.908 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.663 ' O ' HG22 ' B' ' 84' ' ' VAL . 44.5 p -144.26 117.2 8.82 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.049 -1.834 . . . . 18.359999999999999 106.049 178.562 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' B' ' 81' ' ' LEU . 2.4 t -49.86 163.64 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 C-N-CA 118.644 -1.222 . . . . 19.129999999999999 108.734 -178.134 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.0 t-80 -128.07 126.79 41.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.338 -0.851 . . . . 20.649999999999999 109.356 -178.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.895 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.8 OUTLIER -74.22 2.48 9.02 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.533 -0.73 . . . . 19.649999999999999 110.008 -179.996 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 84.1 p -58.85 -18.03 29.04 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 107.512 -1.292 . . . . 14.720000000000001 107.512 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' B' ' 80' ' ' ARG . 23.7 m -97.89 -16.39 19.77 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.85 -0.531 . . . . 11.449999999999999 110.172 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.748 ' C ' HD11 ' A' ' 37' ' ' LEU . 3.0 m-30 -68.21 156.98 36.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.071 -1.018 . . . . 14.25 109.454 -178.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.634 ' N ' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -149.89 -179.85 7.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -0.877 . . . . 32.700000000000003 109.715 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.692 HG21 HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -120.75 110.87 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.482 -0.761 . . . . 15.630000000000001 109.061 179.788 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.457 ' N ' ' SD ' ' B' ' 77' ' ' MET . . . -81.85 -174.68 49.75 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.619 -1.392 . . . . 12.699999999999999 109.619 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -90.01 20.27 4.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.168 -1.195 . . . . 26.289999999999999 109.54 -179.932 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -93.75 -2.7 53.37 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.477 -0.764 . . . . 20.440000000000001 109.349 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 80.96 27.79 48.54 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.533 -1.427 . . . . 13.82 109.533 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.34 153.52 31.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -1.211 . . . . 18.27 109.788 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.606 HD12 HG13 ' B' ' 70' ' ' VAL . 1.1 tp -62.12 176.83 0.53 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.366 -0.834 . . . . 12.43 109.584 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' B' ' 69' ' ' LYS . 2.1 ptm -167.71 99.96 0.48 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 35.109999999999999 109.685 179.809 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.589 HG12 ' CE1' ' B' ' 68' ' ' PHE . 1.9 mt -36.67 -64.9 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.511 0.672 . . . . 13.67 110.329 179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' B' ' 78' ' ' ILE . 9.1 t0 84.44 -45.38 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.435 0.636 . . . . 24.059999999999999 110.061 -179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.553 ' O ' ' CB ' ' B' ' 67' ' ' SER . 3.9 tpm_? -173.96 67.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.155 0.978 . . . . 35.039999999999999 108.488 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.637 ' HB2' ' CG1' ' B' ' 63' ' ' VAL . 1.2 pt? -40.83 126.78 2.52 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.503 -0.771 . . . . 18.719999999999999 111.984 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 1.4 ttt180 -94.11 110.48 22.19 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.677 -1.231 . . . . 20.550000000000001 107.677 178.221 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.798 ' HB2' HD11 ' B' ' 47' ' ' ILE . 11.7 tp -80.28 150.39 30.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.091 -1.006 . . . . 14.4 111.166 -178.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.663 HG22 ' O ' ' B' ' 62' ' ' THR . 21.2 m -146.98 157.89 45.91 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 108.214 -1.032 . . . . 17.649999999999999 108.214 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 24.0 Cg_endo -62.77 142.1 87.7 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.015 1.81 . . . . 25.699999999999999 110.334 179.134 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -76.57 116.44 17.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.21 -0.931 . . . . 49.289999999999999 109.743 -178.786 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.994 -1.003 . . . . 58.909999999999997 109.44 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.646 ' SD ' HG21 ' A' ' 62' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.375 0.607 . . . . 64.909999999999997 109.418 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.958 ' HA ' HD22 ' B' ' 65' ' ' LEU . 0.9 OUTLIER -68.62 73.54 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.664 -1.236 . . . . 33.799999999999997 107.664 178.987 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.646 ' HD3' HD21 ' A' ' 60' ' ' LEU . 1.6 mttt -62.61 157.0 21.75 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.178 0.989 . . . . 32.719999999999999 112.372 -177.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.976 HG22 HG22 ' A' ' 35' ' ' VAL . 60.0 t -159.44 169.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.562 -0.903 . . . . 14.460000000000001 108.562 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.606 ' N ' HG12 ' A' ' 4' ' ' VAL . 68.0 mt-10 -152.25 103.02 2.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.132 -0.98 . . . . 22.120000000000001 109.634 -179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.906 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.6 OUTLIER -75.36 105.89 4.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.853 -1.166 . . . . 14.23 107.853 179.116 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.639 ' HG3' ' CD1' ' A' ' 34' ' ' TYR . 4.9 mttm -55.57 166.13 1.05 Allowed Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.421 -0.8 . . . . 25.43 109.704 -179.27 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.7 Cg_endo -72.19 -17.91 27.43 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.925 1.75 . . . . 13.609999999999999 108.955 179.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -90.78 -6.46 54.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.984 -0.747 . . . . 15.52 108.984 178.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.522 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 2.4 mm100 -120.53 40.62 3.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 17.309999999999999 109.505 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -104.13 14.12 31.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.125 -0.985 . . . . 24.780000000000001 110.017 -179.434 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 24.3 mt-30 -137.83 137.36 38.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.228 -0.92 . . . . 47.899999999999999 109.911 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.675 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 37.2 p90 -92.53 170.52 9.68 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.363 -0.836 . . . . 21.609999999999999 109.577 179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -141.94 162.88 34.38 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.637 -0.875 . . . . 14.890000000000001 108.637 179.129 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.58 111.13 22.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.194 -0.941 . . . . 17.350000000000001 109.187 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -131.46 146.7 52.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.318 -0.864 . . . . 34.380000000000003 109.368 -179.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.01 93.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 38.770000000000003 109.403 -179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -87.86 -178.87 47.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.402 -1.479 . . . . 34.579999999999998 109.402 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.529 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 2.0 t -138.46 125.11 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 41.869999999999997 108.37 179.291 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -73.43 54.24 0.43 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.032 -1.043 . . . . 47.210000000000001 109.638 -179.286 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.452 ' C ' ' CG ' ' A' ' 22' ' ' GLN . 0.8 OUTLIER 66.82 -59.76 0.36 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.3 -0.875 . . . . 71.560000000000002 109.267 -179.736 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 20' ' ' SER . 10.5 mt-30 -153.49 26.82 0.51 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 66.599999999999994 109.445 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 24' ' ' LYS . . . -112.29 37.85 3.5 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.275 -1.53 . . . . 55.490000000000002 109.275 179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.556 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 73.54 174.92 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.546 -0.973 . . . . 44.990000000000002 109.213 -179.741 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.556 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 34.6 Cg_endo -77.29 132.83 12.79 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.592 2.195 . . . . 44.100000000000001 110.714 -179.605 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 28' ' ' LEU . 4.9 p90 -119.6 144.2 47.24 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.167 -0.958 . . . . 32.090000000000003 109.721 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.444 ' C ' HD22 ' A' ' 28' ' ' LEU . 1.1 m -96.08 78.02 3.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.189 -0.945 . . . . 29.25 108.788 179.521 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 26' ' ' TYR . 4.0 mm? -110.66 164.5 12.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.857 . . . . 24.0 109.984 -179.178 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.587 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 95.0 m-20 -74.51 119.59 18.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.446 -0.784 . . . . 23.309999999999999 109.318 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -108.53 143.96 36.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.083 -1.011 . . . . 40.030000000000001 109.242 179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.724 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.5 OUTLIER -130.18 -179.9 5.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 12.390000000000001 109.548 -179.857 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.864 ' HB3' HD11 ' A' ' 44' ' ' LEU . 1.2 mp -133.78 159.15 41.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.244 -0.91 . . . . 17.420000000000002 109.795 -179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.61 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.7 m -152.09 177.54 10.39 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.992 -1.114 . . . . 13.84 107.992 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.674 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 51.4 m-85 -126.88 122.65 35.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.895 -1.128 . . . . 21.140000000000001 110.095 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.976 HG22 HG22 ' A' ' 4' ' ' VAL . 96.7 t -109.35 129.24 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.215 -0.928 . . . . 10.66 109.964 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -121.64 -14.68 8.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.405 -0.81 . . . . 25.890000000000001 109.81 -179.593 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.09 HD12 ' N ' ' A' ' 38' ' ' GLY . 2.6 pp -36.61 -29.74 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.653 -0.654 . . . . 24.239999999999998 110.551 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 1.09 ' N ' HD12 ' A' ' 37' ' ' LEU . . . -124.59 19.7 7.02 Favored Glycine 0 N--CA 1.482 1.734 0 N-CA-C 109.565 -1.414 . . . . 31.02 109.565 -179.012 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.599 ' ND2' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -165.43 114.49 1.03 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.322 -1.105 . . . . 43.229999999999997 109.14 179.84 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 39' ' ' ASN . 39.8 mt-10 -39.08 -66.59 0.27 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.663 . . . . 42.340000000000003 109.946 -179.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 41' ' ' HIS . 2.1 m-70 -63.5 153.36 83.09 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 108.224 -1.028 . . . . 6.3700000000000001 108.224 179.355 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.674 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 38.2 Cg_endo -78.38 138.39 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 121.889 1.726 . . . . 17.920000000000002 110.277 -179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 43' ' ' VAL . 5.0 m -109.44 116.93 53.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.419 -0.801 . . . . 20.57 109.131 179.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.864 HD11 ' HB3' ' A' ' 32' ' ' LEU . 57.2 tp -71.86 108.13 4.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.276 -0.89 . . . . 20.210000000000001 109.937 -179.428 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.676 HG12 HG11 ' B' ' 70' ' ' VAL . 1.1 m -103.44 175.67 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.002 -0.74 . . . . 10.81 109.002 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -105.48 125.6 51.17 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.302 -0.959 . . . . 36.740000000000002 109.338 179.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.098 HD13 HD12 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -120.9 132.33 70.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.277 -0.89 . . . . 19.739999999999998 109.602 -179.689 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 49' ' ' LEU . 60.1 m -66.63 156.71 34.41 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.246 -0.908 . . . . 22.559999999999999 109.299 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.707 HD11 ' O ' ' A' ' 53' ' ' GLN . 2.8 tm? -130.09 111.27 12.31 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.321 -0.862 . . . . 20.41 108.744 -179.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.507 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -42.4 122.53 2.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.232 -0.918 . . . . 33.990000000000002 109.945 -179.2 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -51.02 101.67 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.353 -0.842 . . . . 54.920000000000002 109.277 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.44 -24.08 10.0 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.263 -1.535 . . . . 36.100000000000001 109.263 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.707 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.8 OUTLIER -73.61 157.97 86.94 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.293 -1.122 . . . . 54.759999999999998 109.351 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.7 Cg_endo -78.79 114.34 3.42 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.529 2.153 . . . . 28.370000000000001 110.142 179.546 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.724 ' HB1' ' HG3' ' A' ' 31' ' ' GLN . . . -38.81 142.01 0.24 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.477 -0.764 . . . . 17.210000000000001 109.888 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.906 ' O ' HG21 ' A' ' 6' ' ' ILE . 88.5 m-85 -41.9 101.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.393 -0.817 . . . . 17.190000000000001 109.408 -179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.795 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -50.72 169.36 0.21 Allowed Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.16 -0.963 . . . . 17.82 109.207 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.795 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.2 Cg_endo -77.25 122.11 6.0 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.62 2.213 . . . . 17.280000000000001 110.457 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.97 179.89 40.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.526 -1.43 . . . . 17.219999999999999 109.526 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -72.96 138.51 46.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -1.175 . . . . 19.57 108.448 179.294 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.759 ' HB3' HD22 ' A' ' 83' ' ' LEU . 20.2 m-85 -125.11 162.11 25.32 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.611 -1.306 . . . . 14.609999999999999 111.738 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 84' ' ' VAL . 58.8 p -144.74 120.62 10.62 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 106.505 -1.665 . . . . 18.359999999999999 106.505 179.06 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.617 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.2 t -54.6 165.79 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 C-N-CA 118.581 -1.248 . . . . 19.129999999999999 109.136 -178.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -127.55 127.07 43.3 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.523 -0.736 . . . . 20.649999999999999 109.031 -179.227 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.09 ' CD1' HD13 ' B' ' 37' ' ' LEU . 0.4 OUTLIER -69.31 -2.89 11.92 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.569 -0.707 . . . . 19.649999999999999 109.797 -179.921 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 t -54.37 -19.67 5.96 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 107.775 -1.194 . . . . 14.720000000000001 107.775 179.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 82' ' ' ARG . 3.8 m -94.7 -8.84 36.59 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.756 -0.59 . . . . 11.449999999999999 110.188 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.685 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 1.3 m-30 -85.34 156.76 20.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.882 -1.136 . . . . 14.25 109.462 -179.272 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.431 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -148.52 176.54 10.23 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.054 -0.721 . . . . 32.700000000000003 109.054 179.545 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.702 HG11 HG12 ' B' ' 45' ' ' VAL . 1.7 t -127.23 118.43 49.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.302 -0.874 . . . . 15.630000000000001 109.474 179.864 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.494 ' O ' ' CG ' ' A' ' 72' ' ' GLN . . . -82.5 -99.46 0.48 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.326 -1.509 . . . . 12.699999999999999 109.326 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.589 ' O ' ' CG ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER 170.33 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -1.129 . . . . 26.289999999999999 109.565 179.754 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER 151.72 -33.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.784 -0.821 . . . . 20.440000000000001 108.784 179.923 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -114.5 -88.06 1.56 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.442 -1.463 . . . . 13.82 109.442 179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.44 ' HA ' ' HB ' ' B' ' 45' ' ' VAL . 0.2 OUTLIER 177.93 174.73 0.53 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -1.145 . . . . 18.27 109.678 -179.989 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' A' ' 77' ' ' MET . 6.3 tp -43.51 146.61 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.819 . . . . 12.43 109.659 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.533 ' N ' ' HG ' ' A' ' 76' ' ' LEU . 5.1 mtt -151.85 151.22 31.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 35.109999999999999 109.272 179.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.619 HG12 ' CE1' ' A' ' 68' ' ' PHE . 6.5 mt -76.96 137.26 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 13.67 110.308 -179.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -104.89 -26.73 12.09 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.931 -1.137 . . . . 24.059999999999999 107.931 178.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER 179.02 69.95 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.021 -1.474 . . . . 35.039999999999999 107.021 179.014 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -30.19 121.43 0.18 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.342 -0.845 . . . . 18.719999999999999 111.71 -178.038 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.51 ' N ' ' OG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -91.85 101.27 13.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.385 -0.822 . . . . 20.550000000000001 108.808 179.398 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.098 HD12 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -70.08 145.85 51.35 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.946 0.879 . . . . 14.4 110.883 -179.02 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 62' ' ' THR . 25.6 m -148.73 156.75 41.43 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 107.793 -1.188 . . . . 17.649999999999999 107.793 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 25.0 Cg_endo -63.79 140.02 71.73 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 121.979 1.786 . . . . 25.699999999999999 110.15 179.023 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.724 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -71.44 118.31 14.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.939 . . . . 49.289999999999999 109.64 -178.703 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.012 -0.994 . . . . 58.909999999999997 109.435 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.64 ' SD ' HG21 ' B' ' 62' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.371 0.605 . . . . 64.909999999999997 109.408 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.95 ' HA ' HD22 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -68.73 73.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.699 -1.223 . . . . 33.799999999999997 107.699 179.028 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.647 ' HD3' HD21 ' B' ' 60' ' ' LEU . 1.5 mttt -62.63 156.82 22.29 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.157 0.979 . . . . 32.719999999999999 112.352 -177.623 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.012 HG22 HG22 ' B' ' 35' ' ' VAL . 60.4 t -159.42 168.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.552 -0.906 . . . . 14.460000000000001 108.552 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.613 ' N ' HG12 ' B' ' 4' ' ' VAL . 68.6 mt-10 -152.22 103.02 2.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 22.120000000000001 109.648 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.91 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.6 OUTLIER -75.4 106.06 4.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.79 -1.189 . . . . 14.23 107.79 179.18 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.641 ' HD2' ' CE1' ' B' ' 34' ' ' TYR . 4.9 mttm -55.75 166.23 1.08 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.492 -0.755 . . . . 25.43 109.709 -179.241 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 30.9 Cg_endo -72.05 -18.01 27.82 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.987 1.791 . . . . 13.609999999999999 109.003 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 3.0 t -90.77 -6.4 54.41 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.988 -0.745 . . . . 15.52 108.988 178.64 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' O ' ' NE2' ' B' ' 31' ' ' GLN . 2.5 mm100 -120.68 40.73 3.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.269 -0.895 . . . . 17.309999999999999 109.413 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -104.28 14.17 30.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.14 -0.975 . . . . 24.780000000000001 109.976 -179.346 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.404 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 24.7 mt-30 -137.86 137.34 38.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.148 -0.97 . . . . 47.899999999999999 109.854 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.658 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 37.2 p90 -92.47 170.59 9.64 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.398 -0.814 . . . . 21.609999999999999 109.568 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -141.91 163.02 34.03 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.57 -0.9 . . . . 14.890000000000001 108.57 179.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.64 111.15 22.54 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.217 -0.927 . . . . 17.350000000000001 109.18 179.95 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -131.49 146.77 52.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.32 -0.863 . . . . 34.380000000000003 109.359 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.98 93.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.283 -0.885 . . . . 38.770000000000003 109.435 -179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.565 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -87.92 -178.96 47.51 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.447 -1.461 . . . . 34.579999999999998 109.447 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.526 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 1.9 t -138.32 125.09 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -1.155 . . . . 41.869999999999997 108.43 179.31 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.523 ' O ' ' N ' ' B' ' 22' ' ' GLN . 0.3 OUTLIER -73.5 54.35 0.45 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.066 -1.021 . . . . 47.210000000000001 109.599 -179.256 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.463 ' C ' ' CG ' ' B' ' 22' ' ' GLN . 0.7 OUTLIER 66.76 -59.86 0.36 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.266 -0.896 . . . . 71.560000000000002 109.288 -179.73 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' B' ' 20' ' ' SER . 10.4 mt-30 -153.44 26.95 0.51 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 66.599999999999994 109.472 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' B' ' 24' ' ' LYS . . . -112.43 37.94 3.45 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.219 -1.553 . . . . 55.490000000000002 109.219 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.545 ' CG ' ' HD2' ' B' ' 25' ' ' PRO . 0.0 OUTLIER 73.35 175.03 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.391 -1.064 . . . . 44.990000000000002 109.266 -179.738 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' B' ' 24' ' ' LYS . 34.2 Cg_endo -77.39 132.84 12.69 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.559 2.173 . . . . 44.100000000000001 110.737 -179.599 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' B' ' 28' ' ' LEU . 4.9 p90 -119.55 144.14 47.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.938 . . . . 32.090000000000003 109.75 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.448 ' C ' HD22 ' B' ' 28' ' ' LEU . 1.1 m -96.06 78.15 3.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.216 -0.928 . . . . 29.25 108.686 179.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.599 ' HB2' ' CE1' ' B' ' 26' ' ' TYR . 4.1 mm? -110.71 164.64 12.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 24.0 109.998 -179.27 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.593 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 95.4 m-20 -74.71 119.44 18.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.439 -0.788 . . . . 23.309999999999999 109.33 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -108.37 144.08 36.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.069 -1.019 . . . . 40.030000000000001 109.2 179.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.704 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.5 OUTLIER -130.27 -179.9 5.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -0.994 . . . . 12.390000000000001 109.51 -179.902 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' B' ' 44' ' ' LEU . 1.3 mp -133.76 159.16 41.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 17.420000000000002 109.722 -179.782 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.614 ' O ' HD12 ' B' ' 44' ' ' LEU . 2.8 m -152.07 177.76 10.16 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.008 -1.108 . . . . 13.84 108.008 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.68 ' CD2' ' HB2' ' B' ' 42' ' ' PRO . 50.7 m-85 -127.19 122.58 34.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.881 -1.137 . . . . 21.140000000000001 110.091 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 1.012 HG22 HG22 ' B' ' 4' ' ' VAL . 96.6 t -109.27 129.16 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.234 -0.916 . . . . 10.66 109.937 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' B' ' 36' ' ' ASP . 0.4 OUTLIER -121.48 -14.68 8.19 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.432 -0.793 . . . . 25.890000000000001 109.788 -179.654 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 1.093 HD12 ' N ' ' B' ' 38' ' ' GLY . 2.6 pp -36.6 -29.7 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.654 -0.654 . . . . 24.239999999999998 110.58 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 1.093 ' N ' HD12 ' B' ' 37' ' ' LEU . . . -124.65 19.58 7.02 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 109.591 -1.404 . . . . 31.02 109.591 -178.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.605 ' ND2' HG11 ' B' ' 43' ' ' VAL . 0.1 OUTLIER -165.43 114.68 1.03 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.38 -1.07 . . . . 43.229999999999997 109.056 179.832 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' B' ' 39' ' ' ASN . 39.9 mt-10 -39.12 -66.48 0.28 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.536 0.684 . . . . 42.340000000000003 110.057 -179.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . 0.436 ' ND1' ' N ' ' B' ' 41' ' ' HIS . 2.1 m-70 -63.56 153.39 83.21 Favored Pre-proline 0 C--N 1.295 -1.789 0 N-CA-C 108.223 -1.029 . . . . 6.3799999999999999 108.223 179.28 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.68 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 38.2 Cg_endo -78.42 138.29 15.51 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 121.85 1.7 . . . . 17.920000000000002 110.241 -179.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.668 ' O ' HG23 ' B' ' 43' ' ' VAL . 4.8 m -109.37 116.99 53.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 O-C-N 121.423 -0.798 . . . . 20.57 109.191 179.48 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' B' ' 32' ' ' LEU . 57.0 tp -71.69 108.11 4.86 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.86 . . . . 20.210000000000001 109.982 -179.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.702 HG12 HG11 ' A' ' 70' ' ' VAL . 1.1 m -103.48 175.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.466 -0.771 . . . . 10.81 109.055 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -105.44 125.37 50.91 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.385 -0.926 . . . . 36.740000000000002 109.431 179.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 1.056 HD13 HD12 ' B' ' 83' ' ' LEU . 1.0 OUTLIER -120.72 132.39 70.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 121.334 -0.854 . . . . 19.739999999999998 109.608 -179.638 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.433 HG22 ' N ' ' B' ' 49' ' ' LEU . 59.8 m -66.72 156.81 34.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 22.559999999999999 109.238 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.707 HD11 ' O ' ' B' ' 53' ' ' GLN . 2.8 tm? -130.17 111.28 12.28 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.288 -0.883 . . . . 20.41 108.746 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.515 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -42.43 122.62 2.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.926 . . . . 33.990000000000002 109.944 -179.124 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -51.06 101.64 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.356 -0.84 . . . . 54.920000000000002 109.322 179.816 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.47 -24.0 10.03 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.297 -1.521 . . . . 36.100000000000001 109.297 -179.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.707 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.8 OUTLIER -73.79 157.85 86.83 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.295 -1.12 . . . . 54.759999999999998 109.362 179.883 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.5 Cg_endo -78.7 114.47 3.46 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.518 2.145 . . . . 28.370000000000001 110.098 179.582 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.704 ' HB1' ' HG3' ' B' ' 31' ' ' GLN . . . -38.82 141.76 0.26 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.465 -0.772 . . . . 17.210000000000001 109.949 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.91 ' O ' HG21 ' B' ' 6' ' ' ILE . 88.7 m-85 -41.5 100.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.439 -0.788 . . . . 17.190000000000001 109.317 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.807 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -50.01 169.5 0.19 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.122 -0.987 . . . . 17.82 109.287 -179.833 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.807 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.6 Cg_endo -77.06 120.84 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.48 2.12 . . . . 17.280000000000001 110.188 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.35 179.07 41.59 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.69 -1.364 . . . . 17.219999999999999 109.69 -179.636 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 0.4 OUTLIER -73.18 137.98 45.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.241 -1.153 . . . . 19.57 107.969 178.884 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.753 ' HB3' HD22 ' B' ' 83' ' ' LEU . 21.2 m-85 -124.55 162.35 24.23 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.502 -1.374 . . . . 14.609999999999999 111.703 -179.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.796 ' O ' HG22 ' B' ' 84' ' ' VAL . 58.1 p -144.86 120.46 10.43 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.492 -1.67 . . . . 18.359999999999999 106.492 179.08 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.636 HG11 ' HB2' ' B' ' 81' ' ' LEU . 2.2 t -54.4 166.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 C-N-CA 118.578 -1.249 . . . . 19.129999999999999 109.056 -178.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.484 ' HB2' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -128.27 127.2 42.34 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.033 -0.728 . . . . 20.649999999999999 109.033 -179.275 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 1.075 ' CD1' HD13 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -69.36 -2.75 11.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.514 -0.741 . . . . 19.649999999999999 109.771 -179.964 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 9.2 t -54.54 -19.52 6.04 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 107.729 -1.211 . . . . 14.720000000000001 107.729 179.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' B' ' 82' ' ' ARG . 3.8 m -95.1 -9.26 34.13 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.829 -0.544 . . . . 11.449999999999999 110.147 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.671 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 1.3 m-30 -84.93 155.89 21.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.878 -1.139 . . . . 14.25 109.269 -179.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.423 ' O ' HD12 ' B' ' 76' ' ' LEU . 0.2 OUTLIER -147.77 176.56 10.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.497 -0.752 . . . . 32.700000000000003 109.016 179.613 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.676 HG11 HG12 ' A' ' 45' ' ' VAL . 1.7 t -127.13 118.63 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.867 . . . . 15.630000000000001 109.476 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.513 ' O ' ' CG ' ' B' ' 72' ' ' GLN . . . -82.69 -99.2 0.5 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.4 -1.48 . . . . 12.699999999999999 109.4 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.579 ' O ' ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER 170.1 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.191 -1.181 . . . . 26.289999999999999 109.569 179.769 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.579 ' CB ' ' O ' ' B' ' 72' ' ' GLN . 0.7 OUTLIER 151.61 -33.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.768 -0.827 . . . . 20.440000000000001 108.768 179.946 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -114.68 -87.76 1.51 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.487 -1.445 . . . . 13.82 109.487 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.455 ' HA ' ' HB ' ' A' ' 45' ' ' VAL . 0.2 OUTLIER 177.58 174.69 0.48 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -1.154 . . . . 18.27 109.606 179.931 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' B' ' 77' ' ' MET . 6.3 tp -43.6 146.49 0.52 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 12.43 109.633 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.517 ' N ' ' HG ' ' B' ' 76' ' ' LEU . 5.0 mtt -151.74 151.34 31.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.383 -0.823 . . . . 35.109999999999999 109.13 179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.628 HG12 ' CE1' ' B' ' 68' ' ' PHE . 6.5 mt -77.16 137.47 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 13.67 110.351 -179.571 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -104.84 -26.71 12.12 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.91 -1.144 . . . . 24.059999999999999 107.91 178.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' B' ' 67' ' ' SER . 0.0 OUTLIER 178.99 70.03 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.006 -1.479 . . . . 35.039999999999999 107.006 179.054 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.645 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.9 OUTLIER -30.19 121.5 0.18 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.3 -0.864 . . . . 18.719999999999999 111.697 -178.055 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.513 ' N ' ' OG ' ' B' ' 67' ' ' SER . 0.0 OUTLIER -91.84 101.45 14.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.832 -0.803 . . . . 20.550000000000001 108.832 179.37 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.056 HD12 HD13 ' B' ' 47' ' ' ILE . 0.6 OUTLIER -70.2 145.54 51.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.236 -0.915 . . . . 14.4 110.9 -179.073 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.796 HG22 ' O ' ' B' ' 62' ' ' THR . 25.8 m -148.49 156.95 42.24 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 107.714 -1.217 . . . . 17.649999999999999 107.714 179.369 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 25.4 Cg_endo -64.01 140.21 71.31 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 121.936 1.757 . . . . 25.699999999999999 110.034 179.1 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.715 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -71.55 118.29 14.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 49.289999999999999 109.693 -178.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.979 -1.01 . . . . 58.909999999999997 109.428 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.504 ' CG ' ' HB ' ' A' ' 62' ' ' THR . 1.5 ttp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.307 0.575 . . . . 64.909999999999997 109.565 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.908 ' CA ' HD22 ' B' ' 65' ' ' LEU . 5.2 mt -71.32 75.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.134 -1.062 . . . . 33.799999999999997 108.134 179.282 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.02 156.38 24.87 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.907 0.86 . . . . 32.719999999999999 111.155 -178.283 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.833 HG11 HD11 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -163.85 167.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.464 -0.939 . . . . 14.460000000000001 108.464 179.983 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.533 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 34.3 mt-10 -141.01 113.55 8.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 22.120000000000001 109.59 -179.66 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -72.83 103.28 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.106 -1.072 . . . . 14.23 108.106 179.346 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.597 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 24.2 mmmt -51.49 163.41 0.59 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.283 -0.886 . . . . 25.43 109.369 -179.471 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 30.9 Cg_endo -73.04 -12.61 25.97 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.059 1.839 . . . . 13.609999999999999 109.383 179.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.6 3.72 54.75 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.615 -0.883 . . . . 15.52 108.615 178.491 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.556 ' OE1' HD13 ' A' ' 32' ' ' LEU . 13.8 mm-40 -127.38 41.32 3.54 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.374 -0.829 . . . . 17.309999999999999 108.86 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -98.23 11.76 36.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 24.780000000000001 110.258 -179.095 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' A' ' 55' ' ' ALA . 32.4 mt-30 -136.42 134.43 37.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.123 -0.985 . . . . 47.899999999999999 110.121 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.634 ' CD1' ' HB3' ' A' ' 29' ' ' ASN . 20.4 p90 -84.72 164.83 18.32 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.318 -0.863 . . . . 21.609999999999999 109.436 179.735 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.7 m -130.89 140.31 50.19 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.349 -0.844 . . . . 14.890000000000001 109.256 179.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.952 HG23 ' O ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -107.35 115.39 30.08 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.413 -0.805 . . . . 17.350000000000001 109.225 -179.94 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.461 ' O ' ' C ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -129.14 72.78 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.062 -1.024 . . . . 34.380000000000003 109.663 -179.819 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER 38.65 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.331 0.586 . . . . 38.770000000000003 109.906 179.681 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 26' ' ' TYR . . . -89.42 154.04 23.87 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.643 -1.383 . . . . 34.579999999999998 109.643 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.482 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 2.4 t -128.88 123.79 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -1.171 . . . . 41.869999999999997 109.012 179.595 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.409 ' N ' ' CD2' ' A' ' 26' ' ' TYR . 3.4 m -56.47 -93.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.35 -0.844 . . . . 47.210000000000001 109.732 -179.295 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.472 ' NH1' ' HG3' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -127.82 58.91 1.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.169 -0.957 . . . . 71.560000000000002 109.482 -179.873 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 56.4 18.72 3.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 66.599999999999994 109.308 -179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.34 -52.49 0.63 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.418 -1.473 . . . . 55.490000000000002 109.418 179.944 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -138.48 143.04 36.78 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.344 -1.092 . . . . 44.990000000000002 109.167 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.9 145.08 19.56 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.533 2.156 . . . . 44.100000000000001 110.923 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.61 ' CE1' ' HB2' ' A' ' 28' ' ' LEU . 4.5 p90 -145.73 136.83 24.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.285 -0.884 . . . . 32.090000000000003 109.235 179.469 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 m -100.85 79.41 2.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 29.25 109.154 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.952 ' O ' HG23 ' A' ' 15' ' ' THR . 0.2 OUTLIER -92.54 169.36 10.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 24.0 109.997 -179.484 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.634 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -103.04 131.57 49.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.461 -0.774 . . . . 23.309999999999999 109.206 -179.863 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -117.19 148.58 41.48 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.064 -1.022 . . . . 40.030000000000001 109.76 -179.762 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.789 ' HB2' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -126.9 -163.91 1.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.172 -0.955 . . . . 12.390000000000001 109.496 179.729 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.013 ' HB3' HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -136.35 177.98 7.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 17.420000000000002 109.609 -179.794 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.584 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -171.74 162.52 6.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 13.84 108.709 -179.768 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.751 ' HE1' HD13 ' A' ' 44' ' ' LEU . 3.5 m-30 -115.5 111.43 20.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.249 -0.907 . . . . 21.140000000000001 108.761 -179.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.832 ' O ' HG22 ' A' ' 43' ' ' VAL . 99.2 t -100.81 144.74 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.896 -1.127 . . . . 10.66 110.51 -179.602 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 38' ' ' GLY . 0.7 OUTLIER -125.54 -137.8 0.27 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.517 -0.92 . . . . 25.890000000000001 108.517 179.455 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.88 ' HB3' HD11 ' B' ' 65' ' ' LEU . 0.2 OUTLIER 68.48 -62.68 0.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.825 -1.172 . . . . 24.239999999999998 108.818 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -88.53 24.29 12.72 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.647 -1.781 . . . . 31.02 108.647 179.21 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.786 ' ND2' HG11 ' A' ' 43' ' ' VAL . 0.3 OUTLIER 176.39 114.41 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.548 -0.972 . . . . 43.229999999999997 108.655 -179.731 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' ' 39' ' ' ASN . 4.3 mt-10 -38.91 -64.07 0.48 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.618 0.723 . . . . 42.340000000000003 109.995 -179.336 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -68.6 162.74 60.37 Favored Pre-proline 0 C--N 1.292 -1.915 0 N-CA-C 108.745 -0.835 . . . . 8.0199999999999996 108.745 179.536 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.647 ' HB2' ' CD2' ' A' ' 34' ' ' TYR . 35.5 Cg_endo -78.12 148.83 24.83 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.126 1.884 . . . . 17.920000000000002 110.307 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.965 HG21 HG21 ' B' ' 70' ' ' VAL . 18.5 m -119.74 119.53 60.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 O-C-N 121.294 -0.879 . . . . 20.57 109.262 179.363 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.013 HD11 ' HB3' ' A' ' 32' ' ' LEU . 20.6 tp -71.65 114.12 9.39 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.426 0.632 . . . . 20.210000000000001 109.557 -179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.482 HG23 ' N ' ' B' ' 75' ' ' SER . 3.3 p -122.09 163.05 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.455 -0.778 . . . . 10.81 109.316 -179.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.67 173.05 12.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.229 -0.919 . . . . 36.740000000000002 110.369 -179.167 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.697 HD12 ' CE1' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -163.96 131.4 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.484 -0.932 . . . . 19.739999999999998 108.484 179.97 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.486 ' CG2' HD22 ' A' ' 28' ' ' LEU . 3.8 m -74.82 154.45 38.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.894 -1.129 . . . . 22.559999999999999 109.464 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.789 HD23 ' HB2' ' A' ' 31' ' ' GLN . 0.1 OUTLIER -123.35 119.98 31.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.315 -0.866 . . . . 20.41 109.037 -179.839 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.512 ' CB ' ' HB2' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -53.95 137.41 39.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 33.990000000000002 109.875 -179.455 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -57.36 118.21 4.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.345 -0.847 . . . . 54.920000000000002 109.244 179.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.74 -12.23 69.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.341 -1.504 . . . . 36.100000000000001 109.341 -179.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -79.84 148.74 69.34 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.26 -1.141 . . . . 54.759999999999998 109.37 179.871 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 55' ' ' ALA . 34.3 Cg_endo -77.08 121.08 5.63 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.589 2.193 . . . . 28.370000000000001 110.319 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.782 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -37.82 145.69 0.07 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.578 -0.702 . . . . 17.210000000000001 110.607 -179.597 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.697 ' CE1' HD12 ' A' ' 47' ' ' ILE . 75.2 m-85 -43.74 105.36 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.41 -0.806 . . . . 17.190000000000001 109.226 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.989 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -57.37 176.03 0.24 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 17.82 109.67 -179.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.989 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.5 Cg_endo -78.54 115.16 3.6 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.645 2.23 . . . . 17.280000000000001 110.353 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.23 176.33 41.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.667 -1.373 . . . . 17.219999999999999 109.667 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 3.0 mp -73.33 145.34 46.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -1.159 . . . . 19.57 108.842 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.698 ' C ' HG13 ' A' ' 4' ' ' VAL . 38.8 m-85 -132.56 162.8 30.34 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.43 1.11 . . . . 14.609999999999999 111.103 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.706 ' O ' HG22 ' A' ' 84' ' ' VAL . 38.7 p -142.32 121.83 13.27 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.945 -1.872 . . . . 18.359999999999999 105.945 178.16 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.679 HG11 ' HB2' ' A' ' 81' ' ' LEU . 2.0 t -55.26 163.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 C-N-CA 118.372 -1.331 . . . . 19.129999999999999 109.017 -177.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.4 t-80 -123.05 130.99 53.5 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.49 -0.756 . . . . 20.649999999999999 109.383 -178.739 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.907 HD11 ' HB3' ' B' ' 37' ' ' LEU . 0.7 OUTLIER -73.87 2.85 7.61 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.475 -0.766 . . . . 19.649999999999999 109.853 179.827 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t -56.2 -19.49 13.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 107.176 -1.416 . . . . 14.720000000000001 107.176 178.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.51 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 4.1 m -96.47 -7.01 35.9 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 116.057 -0.52 . . . . 11.449999999999999 110.212 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.686 ' CD2' ' HB2' ' A' ' 65' ' ' LEU . 2.1 m-30 -83.95 161.95 20.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.985 -1.072 . . . . 14.25 109.848 -178.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.76 170.13 22.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.453 -0.78 . . . . 32.700000000000003 109.326 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.937 HG21 ' CG2' ' B' ' 43' ' ' VAL . 0.5 OUTLIER -121.36 116.74 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.202 -0.936 . . . . 15.630000000000001 109.156 179.733 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.71 -170.82 17.73 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.763 -1.335 . . . . 12.699999999999999 109.763 -179.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.537 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -89.67 20.9 3.75 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.248 -1.148 . . . . 26.289999999999999 109.468 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.411 ' O ' ' CD1' ' A' ' 73' ' ' PHE . 5.7 t80 -112.47 10.25 19.69 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.315 -0.866 . . . . 20.440000000000001 109.573 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' C ' HG23 ' B' ' 45' ' ' VAL . . . 63.02 56.25 21.82 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.597 -1.401 . . . . 13.82 109.597 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.537 ' N ' HG23 ' B' ' 45' ' ' VAL . 1.4 m -157.27 120.06 3.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -1.146 . . . . 18.27 109.585 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -70.46 155.38 40.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.95 . . . . 12.43 109.312 179.817 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 45.8 mtm -163.64 130.81 3.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 35.109999999999999 109.736 -179.89 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.955 HD12 HD12 ' B' ' 78' ' ' ILE . 2.5 mp -64.64 142.0 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 13.67 109.805 179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -105.59 -36.14 7.2 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.131 -1.063 . . . . 24.059999999999999 108.131 178.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.51 ' C ' ' HB3' ' A' ' 67' ' ' SER . 2.1 ttp180 -170.34 68.07 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 106.851 -1.537 . . . . 35.039999999999999 106.851 178.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.679 ' HB2' HG11 ' A' ' 63' ' ' VAL . 0.9 OUTLIER -29.46 117.12 0.12 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.243 -0.889 . . . . 18.719999999999999 112.063 -177.674 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -92.21 113.0 25.15 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.004 -1.11 . . . . 20.550000000000001 108.004 178.825 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.833 HD11 HG11 ' A' ' 4' ' ' VAL . 15.3 tp -81.91 153.39 26.34 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 122.078 0.942 . . . . 14.4 111.023 -178.499 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 62' ' ' THR . 33.0 m -152.23 152.14 28.86 Favored Pre-proline 0 C--N 1.304 -1.406 0 N-CA-C 107.831 -1.174 . . . . 17.649999999999999 107.831 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 22.4 Cg_endo -60.99 141.54 94.77 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.019 1.812 . . . . 25.699999999999999 110.537 179.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.557 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -73.81 122.57 22.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 49.289999999999999 109.702 -178.645 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.979 -1.01 . . . . 58.909999999999997 109.446 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.507 ' CG ' ' HB ' ' B' ' 62' ' ' THR . 1.5 ttp . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.525 -0.546 . . . . 64.909999999999997 109.525 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.89 ' CA ' HD22 ' A' ' 65' ' ' LEU . 5.3 mt -71.68 75.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.119 -1.067 . . . . 33.799999999999997 108.119 179.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.01 156.19 25.39 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.917 0.865 . . . . 32.719999999999999 111.179 -178.277 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.837 HG11 HD11 ' B' ' 83' ' ' LEU . 0.2 OUTLIER -163.67 167.68 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.468 -0.938 . . . . 14.460000000000001 108.468 -179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.544 ' N ' ' CG2' ' B' ' 4' ' ' VAL . 34.5 mt-10 -141.04 113.63 8.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.958 . . . . 22.120000000000001 109.566 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.598 HD13 ' HB3' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -72.92 103.23 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.164 -1.05 . . . . 14.23 108.164 179.317 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.589 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 24.1 mmmt -51.44 163.34 0.59 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.322 -0.861 . . . . 25.43 109.338 -179.45 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.573 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 31.3 Cg_endo -73.05 -12.54 25.9 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.05 1.833 . . . . 13.609999999999999 109.437 179.488 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.63 3.63 54.84 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.584 -0.895 . . . . 15.52 108.584 178.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.57 ' OE1' HD13 ' B' ' 32' ' ' LEU . 13.7 mm-40 -127.18 41.12 3.58 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.385 -0.822 . . . . 17.309999999999999 108.898 179.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -98.08 11.92 36.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 24.780000000000001 110.294 -179.121 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.428 ' HA ' ' CB ' ' B' ' 55' ' ' ALA . 32.7 mt-30 -136.46 134.35 37.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.106 -0.997 . . . . 47.899999999999999 110.158 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.652 ' CD1' ' HB3' ' B' ' 29' ' ' ASN . 20.6 p90 -84.7 164.8 18.36 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.355 -0.841 . . . . 21.609999999999999 109.465 179.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 23.4 m -130.86 140.34 50.22 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.39 -0.819 . . . . 14.890000000000001 109.29 179.047 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . 0.951 HG23 ' O ' ' B' ' 28' ' ' LEU . 0.4 OUTLIER -107.3 115.26 29.86 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.333 -0.854 . . . . 17.350000000000001 109.269 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . 0.459 ' O ' ' C ' ' B' ' 17' ' ' SER . 0.7 OUTLIER -129.02 72.78 1.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.093 -1.004 . . . . 34.380000000000003 109.711 -179.898 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . 0.459 ' C ' ' O ' ' B' ' 16' ' ' ARG . 0.6 OUTLIER 38.62 90.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.396 0.617 . . . . 38.770000000000003 109.905 179.73 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.591 ' HA3' ' CE1' ' B' ' 26' ' ' TYR . . . -89.59 154.01 23.73 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.677 -1.369 . . . . 34.579999999999998 109.677 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.483 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 2.4 t -128.82 123.77 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -1.143 . . . . 41.869999999999997 109.003 179.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.408 ' N ' ' CD2' ' B' ' 26' ' ' TYR . 3.4 m -56.48 -93.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.356 -0.84 . . . . 47.210000000000001 109.78 -179.386 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.462 ' NH1' ' HG3' ' B' ' 21' ' ' ARG . 0.8 OUTLIER -127.8 58.96 1.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.146 -0.971 . . . . 71.560000000000002 109.479 -179.87 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 56.32 18.66 3.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 66.599999999999994 109.337 -179.859 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.3 -52.54 0.63 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.379 -1.489 . . . . 55.490000000000002 109.379 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -138.45 143.16 37.34 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.256 -1.144 . . . . 44.990000000000002 109.164 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.94 145.01 19.4 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.512 2.141 . . . . 44.100000000000001 110.915 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.617 ' CE1' ' HB2' ' B' ' 28' ' ' LEU . 4.4 p90 -145.66 136.81 24.78 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.304 -0.872 . . . . 32.090000000000003 109.173 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.8 m -100.75 79.52 2.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.163 -0.96 . . . . 29.25 109.137 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.951 ' O ' HG23 ' B' ' 15' ' ' THR . 0.2 OUTLIER -92.59 169.28 10.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.942 . . . . 24.0 110.018 -179.557 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.652 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 0.0 OUTLIER -103.01 131.58 49.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.555 -0.715 . . . . 23.309999999999999 109.155 -179.928 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 0.5 OUTLIER -117.13 148.53 41.48 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 40.030000000000001 109.708 -179.74 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.796 ' HB2' HD23 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -126.78 -163.84 1.28 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.173 -0.955 . . . . 12.390000000000001 109.503 179.704 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.992 ' HB3' HD11 ' B' ' 44' ' ' LEU . 0.5 OUTLIER -136.46 177.92 7.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 17.420000000000002 109.573 -179.785 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.58 ' HB2' HG21 ' B' ' 4' ' ' VAL . 0.1 OUTLIER -171.69 162.56 6.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.018 -1.051 . . . . 13.84 108.718 -179.679 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.764 ' HE1' HD13 ' B' ' 44' ' ' LEU . 3.5 m-30 -115.6 111.4 20.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.181 -0.949 . . . . 21.140000000000001 108.763 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.814 ' O ' HG22 ' B' ' 43' ' ' VAL . 99.4 t -100.87 144.65 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.896 -1.128 . . . . 10.66 110.521 -179.541 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' B' ' 38' ' ' GLY . 0.7 OUTLIER -125.46 -137.87 0.27 Allowed 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.519 -0.919 . . . . 25.890000000000001 108.519 179.462 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.907 ' HB3' HD11 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 68.5 -62.71 0.37 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.877 -1.139 . . . . 24.239999999999998 108.754 -179.974 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -88.41 24.12 13.1 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 108.589 -1.804 . . . . 31.02 108.589 179.291 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.781 ' ND2' HG11 ' B' ' 43' ' ' VAL . 0.3 OUTLIER 176.48 114.39 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.588 -0.948 . . . . 43.229999999999997 108.644 -179.722 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' B' ' 39' ' ' ASN . 4.4 mt-10 -38.77 -64.21 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.511 -0.743 . . . . 42.340000000000003 109.985 -179.306 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -68.51 162.92 58.47 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 108.722 -0.844 . . . . 8.0399999999999991 108.722 179.578 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.644 ' HB2' ' CD2' ' B' ' 34' ' ' TYR . 36.0 Cg_endo -78.19 148.8 24.58 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.159 1.906 . . . . 17.920000000000002 110.314 179.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.937 ' CG2' HG21 ' A' ' 70' ' ' VAL . 18.5 m -119.71 119.66 61.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 119.575 -0.85 . . . . 20.57 109.222 179.297 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.992 HD11 ' HB3' ' B' ' 32' ' ' LEU . 20.4 tp -71.75 114.28 9.67 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.464 0.649 . . . . 20.210000000000001 109.52 -179.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 75' ' ' SER . 3.1 p -122.18 162.78 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.478 -0.763 . . . . 10.81 109.327 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.52 172.95 12.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.246 -0.908 . . . . 36.740000000000002 110.374 -179.163 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.7 HD12 ' CE1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -163.89 131.37 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.513 -0.921 . . . . 19.739999999999998 108.513 179.995 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.48 ' CG2' HD22 ' B' ' 28' ' ' LEU . 3.8 m -74.84 154.17 38.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.918 -1.114 . . . . 22.559999999999999 109.461 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.796 HD23 ' HB2' ' B' ' 31' ' ' GLN . 0.1 OUTLIER -123.09 120.1 32.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.361 -0.837 . . . . 20.41 109.059 -179.845 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.516 ' CB ' ' HB2' ' B' ' 53' ' ' GLN . 0.2 OUTLIER -54.02 137.37 39.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 33.990000000000002 109.845 -179.391 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -57.28 118.36 5.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.316 -0.865 . . . . 54.920000000000002 109.22 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.57 -12.21 69.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.342 -1.503 . . . . 36.100000000000001 109.342 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.516 ' HB2' ' CB ' ' B' ' 50' ' ' ASP . 0.2 OUTLIER -79.85 148.73 69.28 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.261 -1.141 . . . . 54.759999999999998 109.361 179.92 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' B' ' 55' ' ' ALA . 34.4 Cg_endo -77.15 120.95 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.579 2.186 . . . . 28.370000000000001 110.367 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.791 ' HA ' HD21 ' B' ' 49' ' ' LEU . . . -37.6 145.46 0.06 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.611 -0.681 . . . . 17.210000000000001 110.68 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.7 ' CE1' HD12 ' B' ' 47' ' ' ILE . 75.5 m-85 -43.57 105.13 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.49 -0.756 . . . . 17.190000000000001 109.155 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -57.26 176.04 0.24 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.298 -0.876 . . . . 17.82 109.75 -179.546 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 35.4 Cg_endo -78.38 114.48 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.678 2.252 . . . . 17.280000000000001 110.182 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.38 176.12 42.5 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.687 -1.365 . . . . 17.219999999999999 109.687 -179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' B' ' 85' ' ' PRO . 2.8 mp -73.56 145.13 45.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -1.161 . . . . 19.57 108.664 179.33 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.687 ' C ' HG13 ' B' ' 4' ' ' VAL . 38.3 m-85 -132.27 162.66 30.43 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 122.461 1.124 . . . . 14.609999999999999 111.155 -179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.702 ' O ' HG22 ' B' ' 84' ' ' VAL . 38.5 p -142.22 121.69 13.24 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.976 -1.861 . . . . 18.359999999999999 105.976 178.185 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.664 HG11 ' HB2' ' B' ' 81' ' ' LEU . 1.9 t -55.24 163.14 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 C-N-CA 118.37 -1.332 . . . . 19.129999999999999 109.07 -178.017 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.4 t-80 -122.95 131.1 53.57 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.49 -0.757 . . . . 20.649999999999999 109.374 -178.716 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.908 HD22 ' CA ' ' A' ' 2' ' ' ILE . 0.7 OUTLIER -73.87 2.73 7.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.561 -0.712 . . . . 19.649999999999999 109.894 179.769 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.5 t -56.13 -19.52 13.7 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.105 -1.443 . . . . 14.720000000000001 107.105 178.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.504 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 4.1 m -96.5 -7.35 34.92 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.896 -0.503 . . . . 11.449999999999999 110.149 -179.893 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.677 ' CD2' ' HB2' ' B' ' 65' ' ' LEU . 2.2 m-30 -83.69 161.71 20.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.912 -1.117 . . . . 14.25 109.776 -178.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -158.62 170.15 22.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.42 -0.8 . . . . 32.700000000000003 109.28 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.965 HG21 HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -121.27 116.87 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 15.630000000000001 109.253 179.748 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.99 -170.88 19.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.73 -1.348 . . . . 12.699999999999999 109.73 -179.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . 0.534 ' CG ' ' O ' ' B' ' 72' ' ' GLN . 0.0 OUTLIER -89.63 20.99 3.67 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.251 -1.147 . . . . 26.289999999999999 109.478 -179.882 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' B' ' 73' ' ' PHE . 5.7 t80 -112.51 10.36 19.63 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.392 -0.817 . . . . 20.440000000000001 109.558 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.91 56.43 20.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.657 -1.377 . . . . 13.82 109.657 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.4 m -157.52 120.01 3.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -1.174 . . . . 18.27 109.616 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' B' ' 68' ' ' PHE . 0.3 OUTLIER -70.5 155.35 40.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 12.43 109.324 179.891 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.538 ' CG ' ' O ' ' B' ' 76' ' ' LEU . 45.7 mtm -163.56 130.91 3.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 35.109999999999999 109.679 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.955 HD12 HD12 ' A' ' 78' ' ' ILE . 2.5 mp -64.78 142.25 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.346 -0.846 . . . . 13.67 109.783 179.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -105.73 -36.19 7.13 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.091 -1.078 . . . . 24.059999999999999 108.091 178.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.504 ' C ' ' HB3' ' B' ' 67' ' ' SER . 2.1 ttp180 -170.31 68.23 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.886 -1.524 . . . . 35.039999999999999 106.886 178.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.664 ' HB2' HG11 ' B' ' 63' ' ' VAL . 0.9 OUTLIER -29.57 117.1 0.13 Allowed 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.212 -0.904 . . . . 18.719999999999999 112.104 -177.683 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.3 OUTLIER -92.18 112.94 25.07 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.051 -1.092 . . . . 20.550000000000001 108.051 178.825 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.837 HD11 HG11 ' B' ' 4' ' ' VAL . 15.3 tp -81.93 153.34 26.34 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.082 0.944 . . . . 14.4 111.008 -178.472 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.702 HG22 ' O ' ' B' ' 62' ' ' THR . 33.0 m -152.15 152.04 28.83 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 107.803 -1.184 . . . . 17.649999999999999 107.803 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 22.2 Cg_endo -60.94 141.58 94.97 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 121.951 1.767 . . . . 25.699999999999999 110.523 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -73.75 122.54 22.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 49.289999999999999 109.751 -178.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.975 -1.012 . . . . 58.909999999999997 109.442 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' C ' ' A' ' 2' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.475 -0.565 . . . . 64.909999999999997 109.475 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.833 ' N ' HD22 ' B' ' 65' ' ' LEU . 0.0 OUTLIER -43.15 131.74 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 108.614 -0.884 . . . . 33.799999999999997 108.614 179.396 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 1.3 mttp -102.82 153.78 19.84 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.117 -0.99 . . . . 32.719999999999999 110.394 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.892 HG22 HG22 ' A' ' 35' ' ' VAL . 32.7 t -159.78 166.13 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-O 121.684 0.754 . . . . 14.460000000000001 109.777 -179.435 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.552 ' N ' HG12 ' A' ' 4' ' ' VAL . 32.7 mt-10 -153.05 103.06 2.7 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.684 -0.858 . . . . 22.120000000000001 108.684 179.941 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.762 HG21 ' O ' ' A' ' 56' ' ' TYR . 0.5 OUTLIER -71.84 103.77 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.032 -1.099 . . . . 14.23 108.032 179.837 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.647 ' CD ' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -45.63 171.19 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.446 -0.784 . . . . 25.43 109.643 -179.258 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 7' ' ' LYS . 33.1 Cg_endo -75.05 -22.66 14.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.334 2.023 . . . . 13.609999999999999 109.718 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.54 2.18 54.19 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.975 -0.75 . . . . 15.52 108.975 178.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 6' ' ' ILE . 8.7 mm-40 -121.49 40.99 3.46 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.263 -0.898 . . . . 17.309999999999999 109.205 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . -109.37 12.34 24.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.16 -0.963 . . . . 24.780000000000001 109.796 -179.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -131.7 141.63 49.61 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.509 -0.922 . . . . 47.899999999999999 108.509 179.846 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.7 ' HD2' ' HB2' ' A' ' 55' ' ' ALA . 37.1 p90 -93.68 167.65 11.52 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.019 -1.051 . . . . 21.609999999999999 109.73 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.7 m -135.1 149.96 50.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.79 -0.819 . . . . 14.890000000000001 108.79 179.159 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.22 111.89 19.78 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.212 -0.93 . . . . 17.350000000000001 109.413 -179.763 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.87 139.15 46.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 34.380000000000003 109.408 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.63 125.32 8.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 38.770000000000003 109.332 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 26' ' ' TYR . . . -121.0 175.62 16.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.385 -1.486 . . . . 34.579999999999998 109.385 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.431 ' C ' ' CE2' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -144.66 116.47 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.164 -1.197 . . . . 41.869999999999997 109.021 179.499 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 21' ' ' ARG . 0.3 OUTLIER -44.28 -86.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.353 -0.842 . . . . 47.210000000000001 109.398 -179.371 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.519 ' N ' ' OG ' ' A' ' 20' ' ' SER . 6.0 ttp180 -136.97 56.25 1.8 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.907 . . . . 71.560000000000002 109.423 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.6 OUTLIER 69.78 16.06 7.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 66.599999999999994 109.448 -179.95 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.39 -54.87 0.93 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.505 -1.438 . . . . 55.490000000000002 109.505 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.57 149.93 29.74 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.281 -1.129 . . . . 44.990000000000002 109.393 179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 18' ' ' GLY . 35.2 Cg_endo -78.13 133.56 12.32 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.689 2.259 . . . . 44.100000000000001 110.769 -179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.592 ' CD1' ' HB2' ' A' ' 28' ' ' LEU . 6.9 p90 -126.7 144.31 50.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.312 -0.868 . . . . 32.090000000000003 109.441 179.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.4 m -98.98 79.41 2.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.033 -1.042 . . . . 29.25 109.234 179.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.592 ' HB2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -102.57 155.02 18.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.939 . . . . 24.0 109.979 -179.624 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.591 ' HB3' ' CD1' ' A' ' 13' ' ' PHE . 97.3 m-20 -69.39 129.91 41.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.841 . . . . 23.309999999999999 109.378 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 13' ' ' PHE . 33.9 mt-10 -112.06 163.62 14.08 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.148 -0.97 . . . . 40.030000000000001 109.16 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.679 ' HG3' ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -150.7 -176.83 5.66 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.987 -1.071 . . . . 12.390000000000001 110.038 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.865 ' HB3' HD11 ' A' ' 44' ' ' LEU . 27.9 mt -133.31 158.61 42.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.464 -0.772 . . . . 17.420000000000002 109.076 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.557 ' SG ' HD11 ' A' ' 6' ' ' ILE . 12.4 m -155.51 172.92 17.45 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.161 -1.052 . . . . 13.84 108.161 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.678 ' CD1' ' HB2' ' A' ' 42' ' ' PRO . 32.6 m-85 -121.9 104.48 9.58 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.092 -1.005 . . . . 21.140000000000001 109.176 -179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.892 HG22 HG22 ' A' ' 4' ' ' VAL . 42.4 t -79.8 159.55 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.096 -1.002 . . . . 10.66 110.655 -179.294 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 38' ' ' GLY . 31.6 m-20 -140.84 -147.96 0.23 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.714 -0.847 . . . . 25.890000000000001 108.714 179.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.973 ' CG ' HD11 ' B' ' 65' ' ' LEU . 0.2 OUTLIER 67.71 -61.89 0.35 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.131 -0.981 . . . . 24.239999999999998 109.188 -179.983 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 36' ' ' ASP . . . -87.15 21.18 21.86 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.059 -1.616 . . . . 31.02 109.059 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 36' ' ' ASP . 1.5 p30 176.19 112.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -1.063 . . . . 43.229999999999997 109.324 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' ASN . 3.1 mt-10 -41.7 -63.13 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 42.340000000000003 109.955 -179.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -65.0 154.55 86.28 Favored Pre-proline 0 C--N 1.294 -1.814 0 O-C-N 121.512 -0.742 . . . . 8.3100000000000005 109.001 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.678 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 37.8 Cg_endo -78.26 143.92 20.28 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.233 1.955 . . . . 17.920000000000002 110.248 -179.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.654 HG21 HG21 ' B' ' 70' ' ' VAL . 19.3 m -116.15 116.11 51.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.236 -0.915 . . . . 20.57 109.194 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.865 HD11 ' HB3' ' A' ' 32' ' ' LEU . 55.2 tp -73.14 102.35 3.56 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.29 -0.882 . . . . 20.210000000000001 109.683 -179.754 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.76 HG12 HG11 ' B' ' 70' ' ' VAL . 1.2 m -107.14 -178.41 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.568 -0.708 . . . . 10.81 109.164 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.62 ' HA ' HD23 ' A' ' 32' ' ' LEU . 1.1 mtpt -101.07 154.3 18.83 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.569 -0.852 . . . . 36.740000000000002 109.748 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.987 HD11 ' HB2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -140.55 173.45 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.336 -0.852 . . . . 19.739999999999998 109.364 -179.879 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.16 145.89 37.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.277 -0.889 . . . . 22.559999999999999 109.263 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.7 HD11 ' O ' ' A' ' 53' ' ' GLN . 3.0 tm? -127.34 126.97 43.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.315 -0.865 . . . . 20.41 109.041 -179.669 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.666 ' O ' HD13 ' A' ' 49' ' ' LEU . 3.2 m-20 -63.39 142.38 58.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 33.990000000000002 109.821 -179.417 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.66 123.63 17.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 54.920000000000002 109.295 179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.23 -16.08 50.32 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.391 -1.484 . . . . 36.100000000000001 109.391 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.7 ' O ' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -75.18 153.72 86.33 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.309 -1.113 . . . . 54.759999999999998 109.381 179.96 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 55' ' ' ALA . 35.2 Cg_endo -77.57 110.03 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.621 2.214 . . . . 28.370000000000001 110.334 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.7 ' HB2' ' HD2' ' A' ' 13' ' ' PHE . . . -41.69 151.34 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.374 -0.829 . . . . 17.210000000000001 109.849 -179.777 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.762 ' O ' HG21 ' A' ' 6' ' ' ILE . 89.8 m-85 -46.03 101.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.871 . . . . 17.190000000000001 109.072 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.9 ' HB1' ' HD2' ' A' ' 58' ' ' PRO . . . -53.07 173.6 0.17 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.248 -0.907 . . . . 17.82 109.492 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.9 ' HD2' ' HB1' ' A' ' 57' ' ' ALA . 35.7 Cg_endo -78.13 114.62 3.61 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.682 2.255 . . . . 17.280000000000001 110.34 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.47 -178.91 45.19 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.695 -1.362 . . . . 17.219999999999999 109.695 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . 3.4 mp -74.16 147.2 42.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -1.134 . . . . 19.57 108.717 179.45 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.676 ' HB3' HD22 ' A' ' 83' ' ' LEU . 25.7 m-85 -136.28 166.32 23.71 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 120.962 -1.086 . . . . 14.609999999999999 111.059 -179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 33.4 p -149.51 123.27 9.26 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.902 -1.888 . . . . 18.359999999999999 105.902 178.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.601 HG23 ' HB ' ' A' ' 2' ' ' ILE . 1.7 t -54.17 162.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 C-N-CA 118.338 -1.345 . . . . 19.129999999999999 108.693 -178.268 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 82' ' ' ARG . 2.1 t-80 -124.83 128.14 48.24 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.393 -0.817 . . . . 20.649999999999999 109.066 -179.116 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.957 HD11 ' CG ' ' B' ' 37' ' ' LEU . 0.7 OUTLIER -72.43 2.82 5.56 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.463 -0.773 . . . . 19.649999999999999 110.141 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 t -56.09 -20.09 15.84 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.114 -1.439 . . . . 14.720000000000001 107.114 178.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.487 ' HB3' ' C ' ' A' ' 80' ' ' ARG . 26.4 m -96.43 -8.44 32.28 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 116.126 -0.488 . . . . 11.449999999999999 110.154 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.652 ' CD2' ' CB ' ' A' ' 65' ' ' LEU . 2.2 m-30 -79.88 161.56 25.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.951 -1.093 . . . . 14.25 109.872 -178.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.514 ' NZ ' ' HB2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -165.68 174.35 9.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.427 -0.795 . . . . 32.700000000000003 109.151 179.673 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.778 HG11 HG12 ' B' ' 45' ' ' VAL . 0.0 OUTLIER -100.06 104.46 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.907 . . . . 15.630000000000001 109.466 -179.893 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.51 -168.01 37.74 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.595 -1.402 . . . . 12.699999999999999 109.595 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.55 23.32 2.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.129 -1.218 . . . . 26.289999999999999 109.888 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -93.86 -13.2 27.49 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.51 -0.744 . . . . 20.440000000000001 109.51 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' B' ' 46' ' ' LYS . . . 87.07 49.89 3.86 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.613 -1.395 . . . . 13.82 109.613 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 171.2 172.79 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -1.197 . . . . 18.27 109.645 -179.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.551 HD13 HG11 ' B' ' 35' ' ' VAL . 14.7 tp -77.15 149.94 35.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 12.43 109.622 -179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 76' ' ' LEU . 8.6 mtp -155.57 135.51 12.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 35.109999999999999 109.401 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 1.011 HD12 HD12 ' B' ' 78' ' ' ILE . 2.2 mp -67.15 142.09 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 13.67 110.028 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.456 ' OD1' ' HD3' ' A' ' 69' ' ' LYS . 1.5 t70 -107.66 -41.18 5.09 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.572 -1.269 . . . . 24.059999999999999 107.572 178.014 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.487 ' C ' ' HB3' ' A' ' 67' ' ' SER . 0.3 OUTLIER -163.43 66.73 0.18 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.167 -1.42 . . . . 35.039999999999999 107.167 178.457 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.653 HD23 ' O ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -28.41 119.61 0.12 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.218 -0.901 . . . . 18.719999999999999 112.095 -177.99 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 64' ' ' HIS . 0.0 OUTLIER -92.98 101.14 13.48 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.296 -1.002 . . . . 20.550000000000001 108.296 178.896 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.987 ' HB2' HD11 ' A' ' 47' ' ' ILE . 0.4 OUTLIER -70.72 146.51 49.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.085 -1.01 . . . . 14.4 110.943 -178.625 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 62' ' ' THR . 16.8 m -145.9 152.02 46.97 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.283 -1.006 . . . . 17.649999999999999 108.283 179.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 26.6 Cg_endo -64.76 144.34 83.37 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.306 2.004 . . . . 25.699999999999999 110.496 179.248 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . . . -75.99 120.48 21.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.268 -0.895 . . . . 49.289999999999999 109.535 -179.07 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.981 -1.009 . . . . 58.909999999999997 109.463 179.979 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.458 ' O ' ' C ' ' B' ' 2' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.454 -0.573 . . . . 64.909999999999997 109.454 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.837 ' CA ' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -42.87 131.68 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.701 -0.851 . . . . 33.799999999999997 108.701 179.318 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' B' ' 4' ' ' VAL . 1.4 mttp -102.84 153.73 19.9 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.122 -0.986 . . . . 32.719999999999999 110.37 -178.878 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.907 HG22 HG22 ' B' ' 35' ' ' VAL . 33.4 t -159.79 166.19 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.68 0.752 . . . . 14.460000000000001 109.75 -179.393 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.558 ' N ' HG12 ' B' ' 4' ' ' VAL . 32.5 mt-10 -153.21 102.96 2.66 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.67 -0.863 . . . . 22.120000000000001 108.67 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.768 HG21 ' O ' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -71.77 103.89 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.047 -1.094 . . . . 14.23 108.047 179.769 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.658 ' HD3' ' CD2' ' B' ' 34' ' ' TYR . 0.0 OUTLIER -45.68 171.23 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 121.366 -0.834 . . . . 25.43 109.619 -179.28 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' B' ' 7' ' ' LYS . 33.1 Cg_endo -74.97 -22.78 14.52 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.433 2.089 . . . . 13.609999999999999 109.759 179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.6 2.32 54.12 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.977 -0.749 . . . . 15.52 108.977 179.074 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.597 ' O ' HG23 ' B' ' 6' ' ' ILE . 8.8 mm-40 -121.67 41.06 3.46 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.289 -0.882 . . . . 17.309999999999999 109.136 179.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' B' ' 55' ' ' ALA . . . -109.41 12.31 24.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.958 . . . . 24.780000000000001 109.785 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.487 ' HA ' ' HB3' ' B' ' 55' ' ' ALA . 0.8 OUTLIER -131.52 141.8 49.81 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.198 -0.939 . . . . 47.899999999999999 108.577 179.825 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . 0.701 ' HD2' ' HB2' ' B' ' 55' ' ' ALA . 37.2 p90 -93.96 167.45 11.6 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.011 -1.056 . . . . 21.609999999999999 109.713 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 100.0 m -134.82 150.22 50.47 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.795 -0.817 . . . . 14.890000000000001 108.795 179.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.53 111.91 19.93 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.204 -0.935 . . . . 17.350000000000001 109.415 -179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.9 139.12 45.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.299 -0.876 . . . . 34.380000000000003 109.38 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.63 125.38 8.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 38.770000000000003 109.324 -179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 26' ' ' TYR . . . -121.0 175.75 16.13 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.396 -1.482 . . . . 34.579999999999998 109.396 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.433 ' C ' ' CE2' ' B' ' 26' ' ' TYR . 0.9 OUTLIER -144.75 116.47 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.118 -1.224 . . . . 41.869999999999997 108.985 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' B' ' 21' ' ' ARG . 0.3 OUTLIER -44.31 -86.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.88 . . . . 47.210000000000001 109.494 -179.404 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . 0.492 ' N ' ' OG ' ' B' ' 20' ' ' SER . 5.9 ttp180 -137.1 56.28 1.79 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.205 -0.934 . . . . 71.560000000000002 109.447 -179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 22' ' ' GLN . . . . . 0.43 ' CB ' ' O ' ' B' ' 21' ' ' ARG . 0.7 OUTLIER 69.86 15.87 7.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -0.906 . . . . 66.599999999999994 109.451 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.21 -55.06 0.93 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.48 -1.448 . . . . 55.490000000000002 109.48 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 149.92 30.04 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.269 -1.136 . . . . 44.990000000000002 109.351 179.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' B' ' 18' ' ' GLY . 35.3 Cg_endo -78.1 133.79 12.54 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.608 2.205 . . . . 44.100000000000001 110.754 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.588 ' O ' ' CD1' ' B' ' 26' ' ' TYR . 6.9 p90 -126.92 144.13 51.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 32.090000000000003 109.493 179.788 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.5 m -98.82 79.3 2.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.012 . . . . 29.25 109.297 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.588 ' HB2' ' CD1' ' B' ' 26' ' ' TYR . 0.1 OUTLIER -102.46 155.04 18.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.166 -0.959 . . . . 24.0 110.024 -179.65 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.576 ' HB3' ' CD1' ' B' ' 13' ' ' PHE . 97.0 m-20 -69.3 129.99 41.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 23.309999999999999 109.368 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' B' ' 13' ' ' PHE . 34.1 mt-10 -112.16 163.61 14.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.058 -1.026 . . . . 40.030000000000001 109.157 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.668 ' HG3' ' HB1' ' B' ' 55' ' ' ALA . 0.0 OUTLIER -150.77 -176.91 5.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 12.390000000000001 110.021 -179.902 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 32' ' ' LEU . . . . . 0.887 ' HB3' HD11 ' B' ' 44' ' ' LEU . 27.9 mt -133.19 158.71 42.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.468 -0.77 . . . . 17.420000000000002 109.101 179.6 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' B' ' 6' ' ' ILE . 12.2 m -155.66 172.91 17.51 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.146 -1.057 . . . . 13.84 108.146 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.675 ' CD1' ' HB2' ' B' ' 42' ' ' PRO . 32.4 m-85 -122.01 104.57 9.61 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.051 -1.031 . . . . 21.140000000000001 109.109 -179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.907 HG22 HG22 ' B' ' 4' ' ' VAL . 42.4 t -79.85 159.67 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.073 -1.017 . . . . 10.66 110.686 -179.311 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' B' ' 38' ' ' GLY . 31.7 m-20 -140.89 -147.9 0.23 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.728 -0.841 . . . . 25.890000000000001 108.728 179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 37' ' ' LEU . . . . . 0.957 ' CG ' HD11 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 67.78 -61.96 0.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 24.239999999999998 109.183 179.966 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' B' ' 36' ' ' ASP . . . -87.13 21.14 22.01 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.074 -1.61 . . . . 31.02 109.074 179.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' B' ' 36' ' ' ASP . 1.5 p30 176.23 112.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -1.076 . . . . 43.229999999999997 109.361 -179.901 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' B' ' 39' ' ' ASN . 3.2 mt-10 -41.65 -63.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.372 -0.83 . . . . 42.340000000000003 109.898 -179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -65.0 154.43 86.57 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 109.002 -0.74 . . . . 8.3399999999999999 109.002 179.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.675 ' HB2' ' CD1' ' B' ' 34' ' ' TYR . 37.9 Cg_endo -78.19 143.74 20.29 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.245 1.963 . . . . 17.920000000000002 110.241 -179.666 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 43' ' ' VAL . . . . . 0.632 HG21 HG21 ' A' ' 70' ' ' VAL . 19.2 m -115.97 116.22 51.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.318 -0.863 . . . . 20.57 109.15 179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' B' ' 32' ' ' LEU . 54.9 tp -73.3 102.59 3.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.271 -0.893 . . . . 20.210000000000001 109.68 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.778 HG12 HG11 ' A' ' 70' ' ' VAL . 1.2 m -107.27 -178.38 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.552 -0.718 . . . . 10.81 109.23 179.797 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.645 ' HA ' HD23 ' B' ' 32' ' ' LEU . 1.1 mtpt -101.08 154.42 18.74 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 119.469 -0.892 . . . . 36.740000000000002 109.718 179.785 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 47' ' ' ILE . . . . . 0.994 HD11 ' HB2' ' B' ' 83' ' ' LEU . 0.5 OUTLIER -140.72 173.38 9.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.325 -0.86 . . . . 19.739999999999998 109.317 -179.894 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.14 145.85 37.89 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 22.559999999999999 109.274 179.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.677 HD11 ' O ' ' B' ' 53' ' ' GLN . 2.9 tm? -127.3 126.9 43.44 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.311 -0.868 . . . . 20.41 109.061 -179.678 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.658 ' O ' HD13 ' B' ' 49' ' ' LEU . 3.1 m-20 -63.34 142.27 58.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.152 -0.968 . . . . 33.990000000000002 109.868 -179.441 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -58.42 123.78 17.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.289 -0.882 . . . . 54.920000000000002 109.395 179.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.0 -15.97 50.23 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.437 -1.465 . . . . 36.100000000000001 109.437 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 53' ' ' GLN . . . . . 0.677 ' O ' HD11 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -75.25 153.85 86.2 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.29 -1.123 . . . . 54.759999999999998 109.469 179.943 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' B' ' 55' ' ' ALA . 35.2 Cg_endo -77.67 109.79 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.628 2.218 . . . . 28.370000000000001 110.383 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.701 ' HB2' ' HD2' ' B' ' 13' ' ' PHE . . . -41.39 150.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.387 -0.82 . . . . 17.210000000000001 110.041 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.768 ' O ' HG21 ' B' ' 6' ' ' ILE . 90.2 m-85 -45.53 101.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.375 -0.828 . . . . 17.190000000000001 109.003 179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 57' ' ' ALA . . . . . 0.903 ' HB1' ' HD2' ' B' ' 58' ' ' PRO . . . -53.02 173.56 0.17 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 17.82 109.654 -179.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.903 ' HD2' ' HB1' ' B' ' 57' ' ' ALA . 34.9 Cg_endo -77.79 113.44 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.617 2.211 . . . . 17.280000000000001 110.077 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 175.4 -179.43 46.63 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.776 -1.33 . . . . 17.219999999999999 109.776 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.57 ' HB3' ' HB3' ' B' ' 86' ' ' ALA . 3.1 mp -74.47 146.8 42.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -1.167 . . . . 19.57 108.414 179.14 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.664 ' HB3' HD22 ' B' ' 83' ' ' LEU . 27.1 m-85 -135.9 166.1 24.1 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.956 -1.09 . . . . 14.609999999999999 110.978 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . 0.526 ' O ' HG22 ' B' ' 84' ' ' VAL . 33.0 p -149.14 123.24 9.47 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 105.943 -1.873 . . . . 18.359999999999999 105.943 178.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.59 HG23 ' HB ' ' B' ' 2' ' ' ILE . 1.7 t -54.12 162.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 118.276 -1.37 . . . . 19.129999999999999 108.721 -178.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 64' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' B' ' 82' ' ' ARG . 2.1 t-80 -124.89 128.23 48.33 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.422 -0.799 . . . . 20.649999999999999 109.06 -179.16 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.973 HD11 ' CG ' ' A' ' 37' ' ' LEU . 0.7 OUTLIER -72.67 2.84 5.79 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.46 -0.775 . . . . 19.649999999999999 110.132 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 66' ' ' SER . . . . . . . . . . . . . 1.1 t -56.01 -20.08 15.2 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 107.099 -1.445 . . . . 14.720000000000001 107.099 178.284 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.484 ' HB3' ' C ' ' B' ' 80' ' ' ARG . 25.8 m -96.41 -8.45 32.33 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 116.096 -0.502 . . . . 11.449999999999999 110.239 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.662 ' CD2' ' CB ' ' B' ' 65' ' ' LEU . 2.3 m-30 -79.86 161.46 25.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.004 -1.06 . . . . 14.25 109.756 -178.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.522 ' NZ ' ' HB2' ' B' ' 69' ' ' LYS . 0.0 OUTLIER -165.56 174.41 9.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.455 -0.778 . . . . 32.700000000000003 109.132 179.679 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.76 HG11 HG12 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -100.1 104.48 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.14 -0.975 . . . . 15.630000000000001 109.393 -179.93 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.45 -167.87 37.32 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.613 -1.395 . . . . 12.699999999999999 109.613 179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 23.02 2.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.113 -1.228 . . . . 26.289999999999999 109.863 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -93.6 -13.35 27.78 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.493 -0.755 . . . . 20.440000000000001 109.481 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 46' ' ' LYS . . . 87.26 49.9 3.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.547 -1.421 . . . . 13.82 109.547 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' B' ' 74' ' ' GLY . 0.3 OUTLIER 171.28 172.91 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.229 -1.16 . . . . 18.27 109.588 -179.971 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.622 HD13 HG11 ' A' ' 35' ' ' VAL . 14.7 tp -77.23 150.02 35.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.295 -0.878 . . . . 12.43 109.659 -179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' B' ' 76' ' ' LEU . 8.5 mtp -155.71 135.15 12.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 35.109999999999999 109.493 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 1.011 HD12 HD12 ' A' ' 78' ' ' ILE . 2.2 mp -66.81 142.1 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -0.896 . . . . 13.67 110.116 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.455 ' OD1' ' HD3' ' B' ' 69' ' ' LYS . 1.5 t70 -107.8 -40.98 5.12 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.606 -1.257 . . . . 24.059999999999999 107.606 177.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 80' ' ' ARG . . . . . 0.484 ' C ' ' HB3' ' B' ' 67' ' ' SER . 0.3 OUTLIER -163.56 66.79 0.18 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.12 -1.437 . . . . 35.039999999999999 107.12 178.422 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.637 HD23 ' O ' ' B' ' 81' ' ' LEU . 0.8 OUTLIER -28.47 119.58 0.12 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.215 -0.902 . . . . 18.719999999999999 112.036 -178.046 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 82' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' B' ' 64' ' ' HIS . 0.0 OUTLIER -92.94 101.12 13.46 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.268 -1.012 . . . . 20.550000000000001 108.268 178.861 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.994 ' HB2' HD11 ' B' ' 47' ' ' ILE . 0.4 OUTLIER -70.7 146.47 49.87 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.977 . . . . 14.4 110.91 -178.67 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.526 HG22 ' O ' ' B' ' 62' ' ' THR . 16.8 m -145.82 152.34 48.06 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.296 -1.001 . . . . 17.649999999999999 108.296 179.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 26.7 Cg_endo -65.05 144.45 82.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.254 1.969 . . . . 25.699999999999999 110.56 179.274 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' B' ' 60' ' ' LEU . . . -75.97 120.38 21.22 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.25 -0.906 . . . . 49.289999999999999 109.605 -179.096 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.001 -0.999 . . . . 58.909999999999997 109.471 -179.945 . . . . . . . . 0 0 . 1 stop_ save_